data_2mtb_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2mtb _Structure_validation_residue.Date_analyzed 2016-10-08 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.497 1.905 0 N-CA-C 111.146 0.054 . . . . 0.0 111.146 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 22.3 p-10 -130.88 164.17 25.83 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 124.649 1.179 . . . . 0.0 111.487 -173.725 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 16.0 mtt -130.72 124.3 31.21 Favored 'General case' 0 CA--C 1.523 -0.087 0 C-N-CA 123.201 0.6 . . . . 0.0 111.258 179.798 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -87.33 152.18 24.13 Favored Glycine 0 CA--C 1.525 0.682 0 N-CA-C 106.838 -2.505 . . . . 0.0 106.838 166.895 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 2.7 tt -140.11 97.01 3.15 Favored 'General case' 0 N--CA 1.469 0.477 0 N-CA-C 105.783 -1.932 . . . . 0.0 105.783 -172.629 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -105.08 144.0 32.48 Favored 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 123.172 0.589 . . . . 0.0 111.063 -171.664 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 43.1 p90 . . . . . 0 C--O 1.234 0.28 0 C-N-CA 124.16 0.984 . . . . 0.0 109.941 -179.881 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.536 0.408 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -64.0 -48.47 76.26 Favored 'General case' 0 N--CA 1.455 -0.223 0 C-N-CA 123.785 0.834 . . . . 0.0 111.511 -177.909 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -52.76 -47.59 67.37 Favored 'General case' 0 C--O 1.235 0.334 0 C-N-CA 124.146 0.978 . . . . 0.0 109.72 175.492 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 28.7 mtpp -75.82 -42.13 50.65 Favored 'General case' 0 C--O 1.221 -0.428 0 CA-C-O 117.982 -1.008 . . . . 0.0 110.521 -170.446 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 39.0 mt -52.37 -53.34 19.87 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.352 0 CA-C-N 120.258 1.39 . . . . 0.0 108.614 173.494 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.15 -39.23 91.93 Favored 'General case' 0 C--O 1.222 -0.358 0 C-N-CA 123.367 0.667 . . . . 0.0 109.798 -176.821 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -66.46 -42.3 87.77 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 118.599 0.636 . . . . 0.0 110.943 179.678 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 54.7 mt -74.0 -53.78 16.64 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.605 0 C-N-CA 124.995 1.318 . . . . 0.0 109.767 -169.789 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 75.3 mt -65.45 -46.1 90.98 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.446 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 178.76 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 140.21 125.85 2.23 Favored Glycine 0 CA--C 1.533 1.176 0 C-N-CA 124.676 1.132 . . . . 0.0 111.952 172.832 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -71.6 -6.88 20.07 Favored 'Trans proline' 0 CA--C 1.539 0.749 0 C-N-CA 123.701 2.934 . . . . 0.0 113.684 -174.025 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -81.55 -19.24 42.47 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-N 119.123 0.874 . . . . 0.0 111.245 176.812 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -127.25 -5.83 6.01 Favored 'General case' 0 C--N 1.345 0.372 0 C-N-CA 124.653 1.181 . . . . 0.0 113.792 -174.53 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 26.9 t -113.32 147.21 17.07 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.266 0 N-CA-C 108.007 -1.109 . . . . 0.0 108.007 170.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 36.4 m -135.03 132.15 37.93 Favored 'General case' 0 C--O 1.234 0.267 0 C-N-CA 125.896 1.678 . . . . 0.0 106.667 -174.819 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 14.7 mt -76.01 138.09 40.68 Favored 'General case' 0 C--O 1.231 0.101 0 N-CA-C 107.885 -1.154 . . . . 0.0 107.885 174.696 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 35.0 t-80 -126.85 56.48 1.5 Allowed 'General case' 0 CA--C 1.531 0.217 0 N-CA-C 107.422 -1.325 . . . . 0.0 107.422 177.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 48.5 t30 -61.21 128.92 38.75 Favored 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 107.099 -1.445 . . . . 0.0 107.099 176.123 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 40.2 mt -70.33 -29.98 66.82 Favored 'General case' 0 N--CA 1.469 0.496 0 N-CA-C 114.138 1.162 . . . . 0.0 114.138 -167.65 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 21.5 mmmt -62.72 -26.16 68.54 Favored 'General case' 0 N--CA 1.466 0.344 0 O-C-N 121.703 -0.623 . . . . 0.0 111.698 168.369 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -92.62 -34.62 13.93 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-N 118.568 0.622 . . . . 0.0 112.405 -172.566 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 2.2 t0 -146.4 150.73 36.22 Favored 'General case' 0 N--CA 1.466 0.363 0 N-CA-C 113.025 0.75 . . . . 0.0 113.025 177.008 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 15.2 m -72.14 158.11 88.17 Favored Pre-proline 0 CA--C 1.541 0.6 0 C-N-CA 126.083 1.753 . . . . 0.0 111.499 -169.555 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -71.8 -27.5 17.89 Favored 'Trans proline' 0 C--N 1.35 0.628 0 C-N-CA 122.388 2.059 . . . . 0.0 113.385 -170.466 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 14.8 mmmt -68.36 -16.12 63.81 Favored 'General case' 0 N--CA 1.472 0.644 0 O-C-N 120.897 -1.127 . . . . 0.0 111.286 -175.822 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -62.95 -27.97 69.75 Favored 'General case' 0 N--CA 1.465 0.277 0 C-N-CA 125.741 1.616 . . . . 0.0 110.422 171.821 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 47.5 mtt -56.37 -25.39 49.39 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 119.134 0.879 . . . . 0.0 111.422 178.335 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -66.57 -30.21 70.45 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 118.445 0.566 . . . . 0.0 110.895 -176.585 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 23.1 mt-30 -68.88 -41.5 78.23 Favored 'General case' 0 N--CA 1.465 0.277 0 N-CA-C 113.082 0.771 . . . . 0.0 113.082 -170.071 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 43.3 m-85 -72.75 137.47 45.89 Favored 'General case' 0 N--CA 1.461 0.104 0 C-N-CA 123.534 0.734 . . . . 0.0 109.721 -167.197 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -68.27 -36.54 79.56 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 118.539 0.609 . . . . 0.0 110.181 178.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 5.9 t -110.39 144.14 19.03 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.295 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 170.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 59.4 tp -131.02 108.55 9.87 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 173.484 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 22.8 mt -85.49 131.27 34.7 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 N-CA-C 106.246 -1.761 . . . . 0.0 106.246 175.067 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -107.29 133.36 51.96 Favored 'General case' 0 N--CA 1.456 -0.134 0 C-N-CA 125.574 1.55 . . . . 0.0 107.918 172.058 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -127.65 126.7 5.59 Favored Glycine 0 C--N 1.331 0.299 0 N-CA-C 109.457 -1.457 . . . . 0.0 109.457 170.47 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 7.0 tt -148.92 123.23 4.77 Favored Pre-proline 0 N--CA 1.471 0.584 0 CA-C-N 119.305 1.552 . . . . 0.0 111.582 170.846 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_exo . . . . . 0 N--CA 1.459 -0.525 0 C-N-CA 122.444 2.096 . . . . 0.0 110.664 166.604 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 78.8 mt . . . . . 0 CA--C 1.545 0.77 0 CA-C-O 122.149 0.976 . . . . 0.0 112.772 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.68 163.26 4.46 Favored 'General case' 0 CA--C 1.542 0.655 0 CA-C-O 122.257 1.027 . . . . 0.0 112.376 171.761 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -59.79 -42.27 93.02 Favored 'General case' 0 N--CA 1.455 -0.206 0 C-N-CA 124.377 1.071 . . . . 0.0 112.599 -168.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 55.4 m-20 -66.3 -23.1 66.32 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-N 119.615 1.098 . . . . 0.0 111.723 -169.62 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 12.7 t90 -91.32 -44.83 8.94 Favored 'General case' 0 N--CA 1.456 -0.166 0 C-N-CA 124.379 1.071 . . . . 0.0 110.133 175.419 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -61.7 -35.31 77.66 Favored 'General case' 0 CA--C 1.535 0.396 0 O-C-N 121.266 -0.896 . . . . 0.0 109.945 -178.383 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -58.38 -24.73 60.79 Favored 'General case' 0 C--O 1.233 0.199 0 C-N-CA 124.465 1.106 . . . . 0.0 111.738 -177.725 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 35.7 m -115.13 -13.87 11.07 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.245 0 CA-C-O 117.327 -1.321 . . . . 0.0 112.354 178.0 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 25.1 t90 -52.64 -38.94 61.24 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 120.291 1.405 . . . . 0.0 110.576 -179.02 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -63.17 -26.93 69.03 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 125.098 1.359 . . . . 0.0 113.216 176.543 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 26.0 mt-30 -92.4 -20.09 21.4 Favored 'General case' 0 C--N 1.342 0.243 0 C-N-CA 125.735 1.614 . . . . 0.0 112.31 178.114 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 47.9 mt -64.12 -23.17 67.22 Favored 'General case' 0 N--CA 1.465 0.305 0 O-C-N 121.212 -0.93 . . . . 0.0 111.337 -175.756 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -79.99 -22.25 42.72 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-N 118.372 0.533 . . . . 0.0 111.877 174.684 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -70.72 -27.47 63.99 Favored 'General case' 0 N--CA 1.471 0.618 0 O-C-N 120.979 -1.076 . . . . 0.0 111.521 176.608 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 27.3 mt -62.06 149.67 40.43 Favored 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 124.855 1.262 . . . . 0.0 109.592 -179.636 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 28.1 t-20 -72.0 -59.86 2.53 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-O 122.634 1.206 . . . . 0.0 112.424 -174.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 16.7 mt 58.44 2.25 0.21 Allowed 'General case' 0 C--N 1.32 -0.686 0 C-N-CA 129.5 3.12 . . . . 0.0 116.739 175.679 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 30.9 mt-10 -58.59 130.12 45.33 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 120.188 1.358 . . . . 0.0 111.864 -169.186 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 71.18 0.1 34.35 Favored Glycine 0 CA--C 1.533 1.159 0 CA-C-O 117.964 -1.464 . . . . 0.0 114.908 176.24 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.11 155.29 37.25 Favored 'General case' 0 C--N 1.343 0.323 0 CA-C-N 120.681 2.241 . . . . 0.0 110.225 -174.414 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 1.9 mt -84.71 140.91 15.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 N-CA-C 106.875 -1.528 . . . . 0.0 106.875 178.194 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 54.9 t -135.4 138.98 47.58 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.706 0 C-N-CA 124.012 0.925 . . . . 0.0 109.024 -179.161 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -111.19 142.68 43.06 Favored 'General case' 0 CA--C 1.517 -0.301 0 N-CA-C 104.365 -2.458 . . . . 0.0 104.365 166.763 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 30.8 mt -122.19 144.88 48.69 Favored 'General case' 0 CA--C 1.51 -0.594 0 CA-C-N 120.262 1.392 . . . . 0.0 107.373 169.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 41.6 p90 -150.4 162.75 39.94 Favored 'General case' 0 N--CA 1.44 -0.934 0 N-CA-C 107.744 -1.206 . . . . 0.0 107.744 168.286 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -157.58 171.58 34.78 Favored Glycine 0 N--CA 1.443 -0.897 0 N-CA-C 109.691 -1.364 . . . . 0.0 109.691 171.459 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 6.8 tt . . . . . 0 N--CA 1.446 -0.632 0 C-N-CA 125.04 1.336 . . . . 0.0 108.334 175.677 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 97.5 mt . . . . . 0 N--CA 1.472 0.663 0 N-CA-C 113.807 1.04 . . . . 0.0 113.807 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -67.28 -32.22 73.06 Favored 'General case' 0 C--N 1.329 -0.302 0 O-C-N 120.539 -1.35 . . . . 0.0 110.577 -171.685 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -70.68 -30.25 66.79 Favored 'General case' 0 CA--C 1.535 0.396 0 O-C-N 121.503 -0.748 . . . . 0.0 111.834 173.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 6.3 tt -61.77 -46.52 89.23 Favored 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 107.845 -1.169 . . . . 0.0 107.845 169.349 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -62.04 -38.07 95.48 Favored Glycine 0 CA--C 1.524 0.603 0 N-CA-C 111.086 -0.806 . . . . 0.0 111.086 -177.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 74.3 mtm -68.5 -39.26 81.34 Favored 'General case' 0 N--CA 1.454 -0.243 0 CA-C-O 118.246 -0.883 . . . . 0.0 111.489 177.705 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -71.98 -32.08 66.88 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-N 120.52 1.509 . . . . 0.0 110.649 177.209 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -56.5 -56.58 19.46 Favored 'General case' 0 N--CA 1.462 0.146 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 167.891 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -63.39 -38.53 91.52 Favored 'General case' 0 C--O 1.235 0.338 0 C-N-CA 123.49 0.716 . . . . 0.0 112.025 -170.852 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 23.5 ttmm -58.34 -44.42 88.72 Favored 'General case' 0 CA--C 1.529 0.161 0 C-N-CA 122.804 0.442 . . . . 0.0 109.834 171.619 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 49.0 mt -83.49 -20.05 34.67 Favored 'General case' 0 CA--C 1.519 -0.238 0 N-CA-C 114.445 1.276 . . . . 0.0 114.445 -169.512 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 1.1 m -59.57 -36.53 76.41 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 120.567 1.53 . . . . 0.0 111.375 -172.544 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 20.0 p -84.33 -15.35 46.86 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 124.922 1.289 . . . . 0.0 111.732 -178.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 30.7 mmmt -78.34 -14.1 59.56 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 124.212 1.005 . . . . 0.0 110.844 173.869 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 79.28 33.45 35.61 Favored Glycine 0 CA--C 1.524 0.653 0 CA-C-O 119.333 -0.704 . . . . 0.0 112.335 170.22 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 12.9 m -75.91 170.04 1.58 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.458 0 CA-C-N 118.518 1.159 . . . . 0.0 110.203 173.218 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 16.5 tptm -101.62 129.29 47.71 Favored 'General case' 0 CA--C 1.515 -0.402 0 N-CA-C 105.086 -2.19 . . . . 0.0 105.086 168.219 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 65.9 m-85 -93.78 123.92 37.44 Favored 'General case' 0 C--N 1.33 -0.239 0 N-CA-C 107.654 -1.239 . . . . 0.0 107.654 171.303 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 30.2 m -106.18 160.95 5.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 C-N-CA 123.914 0.886 . . . . 0.0 109.387 168.649 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 99.18 -77.07 0.51 Allowed Glycine 0 N--CA 1.446 -0.67 0 C-N-CA 125.122 1.344 . . . . 0.0 111.839 170.651 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 20.8 m-85 55.39 -170.17 0.07 Allowed 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 124.129 0.972 . . . . 0.0 110.861 -169.639 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -154.57 143.41 14.77 Favored Pre-proline 0 N--CA 1.466 0.332 0 CA-C-O 117.628 -1.177 . . . . 0.0 108.809 168.737 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_exo -61.97 127.72 22.16 Favored 'Trans proline' 0 CA--C 1.533 0.461 0 C-N-CA 122.209 1.94 . . . . 0.0 111.144 178.403 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 10.4 p . . . . . 0 N--CA 1.47 0.527 0 N-CA-C 112.753 0.649 . . . . 0.0 112.753 174.199 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 23.6 ttmt . . . . . 0 CA--C 1.54 0.586 0 CA-C-O 117.457 -1.259 . . . . 0.0 113.844 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -81.99 5.35 6.38 Favored 'Trans proline' 0 C--N 1.352 0.746 0 CA-C-N 122.187 1.817 . . . . 0.0 113.551 -176.588 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 17.1 m -135.5 170.05 19.85 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.249 0 CA-C-N 120.622 1.556 . . . . 0.0 111.36 -169.574 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 14.5 pt -141.1 175.23 6.02 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.657 0 C-N-CA 127.876 2.47 . . . . 0.0 108.254 -179.472 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . 54.8 42.59 31.04 Favored 'General case' 0 N--CA 1.464 0.266 0 C-N-CA 125.27 1.428 . . . . 0.0 112.342 173.849 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 27.1 t0 53.69 41.5 32.06 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 126.184 1.794 . . . . 0.0 111.696 -176.452 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 88.03 14.51 62.49 Favored Glycine 0 CA--C 1.526 0.758 0 CA-C-O 118.496 -1.169 . . . . 0.0 113.771 174.037 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 45.7 mt-30 -84.65 -17.31 39.0 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 119.462 1.631 . . . . 0.0 112.658 -179.892 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -143.91 144.74 31.86 Favored 'General case' 0 C--N 1.342 0.252 0 CA-C-N 119.266 0.939 . . . . 0.0 110.379 174.174 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 68.3 m-85 -73.71 141.43 46.38 Favored 'General case' 0 CA--C 1.512 -0.489 0 N-CA-C 105.08 -2.192 . . . . 0.0 105.08 165.173 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 8.0 p -79.05 14.46 0.35 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.672 0 CA-C-O 121.363 0.601 . . . . 0.0 111.714 -176.412 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -178.82 172.87 45.18 Favored Glycine 0 CA--C 1.525 0.712 0 N-CA-C 109.209 -1.556 . . . . 0.0 109.209 177.262 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -66.21 138.66 57.83 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 117.658 0.729 . . . . 0.0 111.122 -176.214 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -98.5 118.47 35.27 Favored 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 125.716 1.607 . . . . 0.0 109.068 175.883 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 93.5 mt . . . . . 0 C--N 1.33 -0.256 0 C-N-CA 123.776 0.831 . . . . 0.0 109.153 169.651 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 50.7 m . . . . . 0 CA--C 1.536 0.425 0 CA-C-O 119.606 -0.235 . . . . 0.0 110.582 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -60.71 -40.74 93.39 Favored 'General case' 0 N--CA 1.464 0.231 0 C-N-CA 123.35 0.66 . . . . 0.0 111.448 170.398 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -65.02 -45.11 86.88 Favored 'General case' 0 C--O 1.234 0.288 0 C-N-CA 124.869 1.268 . . . . 0.0 110.315 177.042 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 81.8 mtt180 -58.06 -47.58 82.71 Favored 'General case' 0 N--CA 1.462 0.148 0 CA-C-O 118.649 -0.691 . . . . 0.0 110.089 176.314 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 46.4 mt -62.8 -53.23 49.5 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.281 0 N-CA-C 107.904 -1.147 . . . . 0.0 107.904 179.696 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 69.8 tp60 -53.68 -61.15 2.49 Favored 'General case' 0 C--O 1.233 0.22 0 C-N-CA 124.024 0.929 . . . . 0.0 110.867 -175.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 44.3 p -65.02 -36.84 85.66 Favored 'General case' 0 C--N 1.326 -0.418 0 O-C-N 123.062 0.227 . . . . 0.0 110.95 -170.375 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 160' ' ' TRP . . . . . . . . . . . . . 36.0 t90 -67.73 -44.17 78.21 Favored 'General case' 0 C--O 1.221 -0.395 0 O-C-N 122.248 -0.283 . . . . 0.0 110.929 177.465 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 58.7 m -59.18 -44.29 92.18 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 123.039 0.536 . . . . 0.0 110.703 178.541 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -62.49 -41.96 99.16 Favored 'General case' 0 N--CA 1.456 -0.13 0 CA-C-O 121.071 0.463 . . . . 0.0 109.888 176.38 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 12.6 tt0 -62.9 -52.92 61.19 Favored 'General case' 0 N--CA 1.448 -0.537 0 O-C-N 121.664 -0.647 . . . . 0.0 110.095 -179.02 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 45.0 pt -62.47 -37.77 79.65 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.399 0 CA-C-O 117.582 -1.199 . . . . 0.0 109.23 -174.401 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -65.53 -33.34 75.69 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 119.552 1.069 . . . . 0.0 110.488 -179.45 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 34.6 m-80 -71.88 -51.68 21.11 Favored 'General case' 0 N--CA 1.465 0.315 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 175.786 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 8.9 tt0 -72.38 -31.92 65.97 Favored 'General case' 0 N--CA 1.441 -0.92 0 C-N-CA 123.79 0.836 . . . . 0.0 110.941 -168.566 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 168' ' ' MET . . . . . . . . . . . . . 21.3 ptp -69.88 -31.8 69.8 Favored 'General case' 0 C--N 1.331 -0.196 0 O-C-N 121.068 -1.02 . . . . 0.0 111.407 171.744 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -78.57 -44.12 24.94 Favored 'General case' 0 N--CA 1.443 -0.796 0 CA-C-O 120.375 0.131 . . . . 0.0 110.983 -175.518 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 . . . . . 0 CA--C 1.54 0.566 0 N-CA-C 110.088 -0.338 . . . . 0.0 110.088 176.893 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.496 1.85 0 N-CA-C 111.252 0.093 . . . . 0.0 111.252 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 3.0 t30 -119.03 151.62 37.9 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 124.223 1.009 . . . . 0.0 109.784 -174.558 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 1.4 mpt? -116.88 125.89 52.18 Favored 'General case' 0 N--CA 1.463 0.22 0 C-N-CA 123.76 0.824 . . . . 0.0 110.706 179.23 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -82.83 153.2 30.92 Favored Glycine 0 CA--C 1.527 0.811 0 N-CA-C 107.51 -2.236 . . . . 0.0 107.51 166.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 3.1 tt -140.26 97.11 3.16 Favored 'General case' 0 N--CA 1.465 0.312 0 N-CA-C 104.888 -2.264 . . . . 0.0 104.888 -176.06 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -103.44 147.02 27.64 Favored 'General case' 0 N--CA 1.455 -0.181 0 CA-C-O 121.577 0.703 . . . . 0.0 111.914 -172.155 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 47.6 p90 . . . . . 0 C--N 1.33 -0.281 0 C-N-CA 126.294 1.838 . . . . 0.0 107.994 176.425 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.223 -0.337 0 CA-C-O 118.523 -0.751 . . . . 0.0 111.054 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -66.11 -43.49 87.05 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 119.94 1.245 . . . . 0.0 111.609 -179.751 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 67.0 mm-40 -62.68 -47.53 83.23 Favored 'General case' 0 N--CA 1.464 0.261 0 N-CA-C 109.16 -0.682 . . . . 0.0 109.16 173.023 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 29.2 mtpp -70.16 -36.85 74.98 Favored 'General case' 0 C--O 1.221 -0.397 0 CA-C-O 118.428 -0.796 . . . . 0.0 110.796 -169.351 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 32.1 mt -53.95 -55.93 11.71 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.223 0 CA-C-N 119.307 0.958 . . . . 0.0 108.687 173.472 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 18.2 ptt180 -65.25 -38.44 90.36 Favored 'General case' 0 C--N 1.344 0.343 0 C-N-CA 120.153 -0.619 . . . . 0.0 110.03 -176.687 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -64.69 -38.63 91.65 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 -174.553 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 64.0 mt -78.27 -56.13 8.3 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.63 0 C-N-CA 125.496 1.518 . . . . 0.0 110.057 -174.435 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 77.0 mt -64.66 -45.88 94.02 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 -177.755 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 141.58 120.35 1.62 Allowed Glycine 0 CA--C 1.53 0.975 0 C-N-CA 125.452 1.501 . . . . 0.0 110.595 176.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -75.53 -4.43 15.26 Favored 'Trans proline' 0 CA--C 1.538 0.705 0 C-N-CA 122.82 2.347 . . . . 0.0 113.183 -171.554 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -82.99 -20.5 35.01 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 118.945 0.793 . . . . 0.0 111.418 176.551 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 1.2 pt? -120.96 -14.19 8.49 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 125.057 1.343 . . . . 0.0 113.589 -175.689 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 62.5 t -97.46 148.02 6.01 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 N-CA-C 107.315 -1.365 . . . . 0.0 107.315 168.622 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 46.6 m -135.3 133.08 38.49 Favored 'General case' 0 C--N 1.332 -0.175 0 C-N-CA 125.659 1.584 . . . . 0.0 108.188 -178.906 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 35.7 mt -82.3 142.57 31.96 Favored 'General case' 0 C--O 1.234 0.263 0 N-CA-C 108.574 -0.898 . . . . 0.0 108.574 177.682 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 28.6 t-80 -139.39 60.65 1.57 Allowed 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 124.481 1.112 . . . . 0.0 108.335 -173.577 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 64.3 t-20 -60.88 126.76 28.57 Favored 'General case' 0 C--O 1.232 0.181 0 N-CA-C 107.128 -1.434 . . . . 0.0 107.128 173.309 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 83.3 mt -66.72 -22.44 66.06 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 123.24 0.616 . . . . 0.0 112.16 -179.64 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 56.7 tttt -66.66 -22.11 66.1 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 118.147 0.43 . . . . 0.0 111.708 169.143 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -107.62 -35.3 6.75 Favored 'General case' 0 C--O 1.234 0.272 0 C-N-CA 124.081 0.953 . . . . 0.0 113.25 -169.661 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 2.9 t0 -139.14 155.53 47.79 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 118.717 0.69 . . . . 0.0 112.151 178.128 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 17.2 m -75.06 157.94 84.81 Favored Pre-proline 0 CA--C 1.54 0.595 0 C-N-CA 125.618 1.567 . . . . 0.0 111.482 -170.68 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -73.89 -26.29 13.44 Favored 'Trans proline' 0 C--N 1.349 0.563 0 C-N-CA 122.778 2.318 . . . . 0.0 113.236 -171.68 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 22.7 mmmt -71.27 -12.08 61.26 Favored 'General case' 0 N--CA 1.471 0.576 0 O-C-N 120.395 -1.441 . . . . 0.0 111.716 -176.44 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -61.21 -28.41 69.13 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 125.451 1.5 . . . . 0.0 110.38 168.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 45.5 mtt -58.71 -25.96 63.42 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 118.591 0.632 . . . . 0.0 111.745 177.478 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 88.0 mt-10 -65.93 -32.56 74.14 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-O 119.017 -0.516 . . . . 0.0 110.249 -176.567 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 21.2 mt-30 -65.9 -44.28 85.69 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 123.601 0.76 . . . . 0.0 112.541 -170.362 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 52.5 m-85 -74.78 142.24 44.3 Favored 'General case' 0 N--CA 1.456 -0.153 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.662 -166.724 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -69.21 -42.48 75.68 Favored 'General case' 0 C--O 1.235 0.29 0 N-CA-C 109.894 -0.41 . . . . 0.0 109.894 176.413 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 7.2 t -106.33 143.76 16.7 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.368 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 175.306 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 37.8 tp -131.64 114.36 14.71 Favored 'General case' 0 N--CA 1.444 -0.77 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 174.295 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 31.8 mt -94.44 132.75 37.61 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 N-CA-C 106.781 -1.563 . . . . 0.0 106.781 178.416 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 3.1 mp -113.95 130.15 56.54 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 125.641 1.577 . . . . 0.0 107.102 -176.583 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -135.67 126.83 4.06 Favored Glycine 0 C--N 1.335 0.491 0 N-CA-C 109.908 -1.277 . . . . 0.0 109.908 177.607 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 7.4 tt -153.57 127.3 4.36 Favored Pre-proline 0 CA--C 1.538 0.496 0 CA-C-N 117.872 0.836 . . . . 0.0 109.892 172.298 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo . . . . . 0 N--CA 1.459 -0.544 0 C-N-CA 122.268 1.979 . . . . 0.0 112.782 169.496 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 65.9 mt . . . . . 0 N--CA 1.449 -0.492 0 N-CA-C 107.378 -1.342 . . . . 0.0 107.378 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -85.32 164.81 17.76 Favored 'General case' 0 C--O 1.234 0.254 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 173.661 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -55.2 -38.41 68.37 Favored 'General case' 0 C--O 1.222 -0.36 0 C-N-CA 123.811 0.844 . . . . 0.0 110.741 179.793 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -61.2 -24.48 66.36 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-N 118.792 0.724 . . . . 0.0 112.562 -177.074 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 12.2 t90 -96.63 -47.57 5.86 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 124.89 1.276 . . . . 0.0 109.348 176.611 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -64.41 -33.71 76.49 Favored 'General case' 0 CA--C 1.539 0.534 0 O-C-N 120.833 -1.167 . . . . 0.0 110.593 -175.282 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -63.46 -26.58 68.79 Favored 'General case' 0 CA--C 1.529 0.135 0 C-N-CA 123.273 0.629 . . . . 0.0 110.872 -173.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 29.1 m -108.57 -15.43 9.36 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.314 0 CA-C-O 117.366 -1.302 . . . . 0.0 111.879 177.12 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 29.4 t90 -51.35 -35.5 38.73 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-N 120.189 1.359 . . . . 0.0 110.679 177.108 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -62.86 -29.33 70.67 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 125.441 1.496 . . . . 0.0 113.303 175.367 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 31.0 mt-30 -92.42 -18.3 23.44 Favored 'General case' 0 N--CA 1.463 0.209 0 C-N-CA 126.09 1.756 . . . . 0.0 112.324 177.29 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 56.7 mt -63.48 -21.04 66.09 Favored 'General case' 0 CA--C 1.534 0.338 0 O-C-N 121.304 -0.872 . . . . 0.0 111.496 -178.119 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -80.11 -23.05 41.49 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 123.011 0.525 . . . . 0.0 111.868 173.671 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -71.83 -30.32 65.36 Favored 'General case' 0 N--CA 1.468 0.466 0 O-C-N 120.705 -1.247 . . . . 0.0 111.843 177.529 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 79.5 mt -52.96 140.85 23.68 Favored 'General case' 0 C--N 1.34 0.174 0 C-N-CA 125.012 1.325 . . . . 0.0 112.757 -168.787 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 28.9 t-20 -74.97 106.43 6.47 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 169.312 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 64.7 mt -128.61 0.07 5.52 Favored 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 113.891 1.071 . . . . 0.0 113.891 -174.393 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 27.2 mt-10 -57.79 128.38 36.81 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 119.658 1.117 . . . . 0.0 110.689 -169.031 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 71.65 -0.05 37.45 Favored Glycine 0 CA--C 1.532 1.127 0 C-N-CA 125.397 1.475 . . . . 0.0 115.046 179.445 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.26 151.55 39.87 Favored 'General case' 0 C--N 1.348 0.51 0 CA-C-N 120.798 2.299 . . . . 0.0 109.649 -177.775 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 3.6 mt -80.67 136.9 22.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 N-CA-C 106.765 -1.568 . . . . 0.0 106.765 178.876 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 68.8 t -132.17 131.56 61.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 C-N-CA 123.813 0.845 . . . . 0.0 109.833 -178.555 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -105.39 150.12 25.52 Favored 'General case' 0 N--CA 1.463 0.192 0 N-CA-C 107.417 -1.327 . . . . 0.0 107.417 168.603 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 3.6 mt -132.24 134.19 45.02 Favored 'General case' 0 CA--C 1.51 -0.594 0 N-CA-C 107.265 -1.383 . . . . 0.0 107.265 177.77 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 35.8 p90 -151.03 165.84 32.55 Favored 'General case' 0 N--CA 1.447 -0.595 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 168.764 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -162.62 159.59 31.9 Favored Glycine 0 N--CA 1.444 -0.784 0 N-CA-C 108.556 -1.817 . . . . 0.0 108.556 172.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 7.0 tt . . . . . 0 N--CA 1.445 -0.7 0 N-CA-C 108.493 -0.929 . . . . 0.0 108.493 171.56 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 83.8 mt . . . . . 0 N--CA 1.467 0.379 0 N-CA-C 115.679 1.733 . . . . 0.0 115.679 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -61.84 -36.62 81.72 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-N 121.511 1.959 . . . . 0.0 111.29 -173.37 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -65.83 -27.74 68.47 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 124.328 1.051 . . . . 0.0 112.295 174.52 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 5.3 tt -66.56 -46.69 75.22 Favored 'General case' 0 N--CA 1.467 0.424 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 173.056 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -63.47 -34.6 90.4 Favored Glycine 0 CA--C 1.529 0.944 0 N-CA-C 110.659 -0.976 . . . . 0.0 110.659 -179.732 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 5.2 tpp -50.89 -54.08 27.03 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 124.963 1.305 . . . . 0.0 111.527 175.88 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -76.82 -36.61 56.77 Favored 'General case' 0 C--N 1.341 0.238 0 O-C-N 121.891 -0.506 . . . . 0.0 109.782 -175.195 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 43.1 t-80 -55.71 -48.88 74.41 Favored 'General case' 0 N--CA 1.464 0.231 0 O-C-N 121.436 -0.79 . . . . 0.0 110.872 176.261 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -63.44 -38.77 92.42 Favored 'General case' 0 C--O 1.234 0.288 0 C-N-CA 123.288 0.635 . . . . 0.0 112.103 -176.323 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 24.4 ttmm -57.45 -36.09 70.98 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 123.382 0.673 . . . . 0.0 110.727 172.825 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 22.3 mt -91.86 -20.49 21.4 Favored 'General case' 0 CA--C 1.513 -0.45 0 N-CA-C 115.8 1.778 . . . . 0.0 115.8 -168.238 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 6.0 m -58.15 -33.62 69.38 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-N 120.481 1.491 . . . . 0.0 111.627 -178.218 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 20.7 p -87.39 -9.33 55.04 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 124.884 1.274 . . . . 0.0 112.287 -179.807 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 32.5 mmmt -84.53 -4.63 59.06 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 124.461 1.104 . . . . 0.0 111.453 172.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 69.92 31.96 69.89 Favored Glycine 0 CA--C 1.525 0.657 0 CA-C-N 118.605 0.639 . . . . 0.0 112.105 171.827 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 3.5 m -76.33 172.38 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.474 0 CA-C-N 118.104 0.952 . . . . 0.0 109.457 175.237 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -111.9 121.1 44.11 Favored 'General case' 0 CA--C 1.515 -0.386 0 N-CA-C 106.474 -1.676 . . . . 0.0 106.474 173.615 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 64.0 m-85 -88.32 145.35 25.88 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 119.61 1.095 . . . . 0.0 109.378 -178.13 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 27.7 m -129.4 161.08 39.58 Favored 'Isoleucine or valine' 0 C--O 1.233 0.212 0 C-N-CA 124.223 1.009 . . . . 0.0 109.289 171.588 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 93.2 -94.18 1.83 Allowed Glycine 0 N--CA 1.443 -0.877 0 C-N-CA 124.817 1.199 . . . . 0.0 110.804 176.435 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 8.0 m-30 59.57 177.05 0.08 Allowed 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 125.109 1.364 . . . . 0.0 110.188 -167.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -155.27 140.94 12.65 Favored Pre-proline 0 N--CA 1.473 0.7 0 CA-C-O 116.872 -1.537 . . . . 0.0 108.76 -179.468 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -68.13 127.77 16.47 Favored 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 122.698 2.265 . . . . 0.0 112.64 -176.166 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 68.0 p . . . . . 0 N--CA 1.473 0.696 0 N-CA-C 112.393 0.516 . . . . 0.0 112.393 169.619 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 32.5 ttmt . . . . . 0 N--CA 1.471 0.618 0 CA-C-O 117.668 -1.158 . . . . 0.0 113.412 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 62.9 Cg_endo -84.77 13.86 2.64 Favored 'Trans proline' 0 C--N 1.348 0.539 0 C-N-CA 121.844 1.696 . . . . 0.0 113.581 -178.866 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 35.1 m -128.63 154.9 40.11 Favored 'Isoleucine or valine' 0 C--O 1.235 0.3 0 CA-C-N 121.777 2.08 . . . . 0.0 111.109 179.065 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 17.8 pt -114.32 167.94 6.66 Favored 'Isoleucine or valine' 0 C--O 1.235 0.319 0 C-N-CA 126.41 1.884 . . . . 0.0 109.145 174.82 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . 57.73 32.94 22.61 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 124.967 1.307 . . . . 0.0 113.484 167.687 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 27.6 t70 54.99 39.83 31.78 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 126.251 1.82 . . . . 0.0 111.592 -175.164 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 93.63 72.21 1.18 Allowed Glycine 0 CA--C 1.528 0.854 0 C-N-CA 124.487 1.042 . . . . 0.0 111.243 177.013 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 78.8 mm-40 -116.66 -49.57 2.64 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 123.168 0.587 . . . . 0.0 110.354 167.375 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -132.48 146.52 51.99 Favored 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 123.017 0.527 . . . . 0.0 110.969 -179.252 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 58.9 m-85 -77.63 16.79 0.61 Allowed 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 126.189 1.796 . . . . 0.0 115.65 177.879 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 3.7 m 49.64 11.73 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.547 0.831 0 C-N-CA 126.927 2.091 . . . . 0.0 114.469 -176.586 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 170.42 170.06 34.28 Favored Glycine 0 CA--C 1.527 0.805 0 N-CA-C 108.368 -1.893 . . . . 0.0 108.368 -171.562 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -69.24 134.95 49.84 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 117.977 0.888 . . . . 0.0 111.007 -178.347 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -95.87 109.94 22.21 Favored 'General case' 0 N--CA 1.448 -0.571 0 C-N-CA 125.52 1.528 . . . . 0.0 109.056 175.291 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 83.8 mt . . . . . 0 C--N 1.332 -0.179 0 CA-C-N 118.845 0.748 . . . . 0.0 109.561 170.157 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 13.3 m . . . . . 0 CA--C 1.543 0.681 0 N-CA-C 110.156 -0.312 . . . . 0.0 110.156 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -63.96 -39.54 94.36 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 123.972 0.909 . . . . 0.0 111.671 172.645 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 -64.55 -46.98 80.51 Favored 'General case' 0 C--O 1.234 0.263 0 C-N-CA 124.294 1.038 . . . . 0.0 109.858 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 72.1 mtt180 -55.32 -41.1 71.98 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-O 118.795 -0.622 . . . . 0.0 110.627 177.039 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 75.9 mt -68.39 -57.97 7.39 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.299 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 177.316 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 70.8 tp60 -49.64 -63.04 1.23 Allowed 'General case' 0 C--O 1.233 0.193 0 C-N-CA 125.12 1.368 . . . . 0.0 112.106 -173.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 20.0 m -66.8 -31.95 72.91 Favored 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 120.826 -0.35 . . . . 0.0 111.245 -170.342 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 160' ' ' TRP . . . . . . . . . . . . . 34.0 t90 -70.87 -44.32 66.61 Favored 'General case' 0 CA--C 1.516 -0.342 0 O-C-N 122.005 -0.434 . . . . 0.0 110.898 176.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 98.4 m -59.46 -42.79 92.81 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 122.846 0.458 . . . . 0.0 110.093 177.454 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -63.44 -41.86 98.66 Favored 'General case' 0 N--CA 1.456 -0.147 0 CA-C-O 121.006 0.431 . . . . 0.0 110.181 175.72 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 14.7 tt0 -62.61 -51.99 65.14 Favored 'General case' 0 N--CA 1.449 -0.495 0 O-C-N 121.692 -0.63 . . . . 0.0 109.934 -178.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 42.2 pt -63.27 -37.98 80.9 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.328 0 CA-C-O 117.669 -1.158 . . . . 0.0 109.231 -175.714 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -65.75 -34.91 79.28 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 119.776 1.171 . . . . 0.0 110.486 -179.548 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 31.2 m-80 -68.49 -50.59 51.13 Favored 'General case' 0 CA--C 1.516 -0.34 0 N-CA-C 108.785 -0.821 . . . . 0.0 108.785 175.285 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 15.5 tt0 -71.14 -33.61 70.24 Favored 'General case' 0 N--CA 1.438 -1.062 0 C-N-CA 124.174 0.99 . . . . 0.0 111.131 -168.616 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 168' ' ' MET . . . . . . . . . . . . . 22.9 ptp -72.42 -30.18 64.39 Favored 'General case' 0 C--N 1.332 -0.171 0 O-C-N 121.136 -0.978 . . . . 0.0 111.702 173.738 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -79.48 -41.16 28.08 Favored 'General case' 0 N--CA 1.447 -0.601 0 C-N-CA 122.636 0.375 . . . . 0.0 111.416 -179.765 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 . . . . . 0 CA--C 1.535 0.379 0 C-N-CA 122.964 0.506 . . . . 0.0 110.454 -178.578 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.498 1.931 0 CA-C-O 120.011 -0.042 . . . . 0.0 111.078 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 4.0 t30 -116.66 151.36 36.47 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 124.195 0.998 . . . . 0.0 110.134 -173.483 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 1.2 mpt? -118.75 123.31 44.52 Favored 'General case' 0 C--N 1.334 -0.096 0 C-N-CA 123.747 0.819 . . . . 0.0 111.183 179.47 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -81.85 153.93 33.37 Favored Glycine 0 CA--C 1.524 0.655 0 N-CA-C 107.521 -2.232 . . . . 0.0 107.521 166.655 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 3.3 tt -140.3 96.47 3.05 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 105.422 -2.066 . . . . 0.0 105.422 -176.414 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -102.98 143.83 32.04 Favored 'General case' 0 CA--C 1.517 -0.303 0 CA-C-O 121.769 0.795 . . . . 0.0 112.186 -170.86 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 36.3 p90 . . . . . 0 N--CA 1.451 -0.393 0 C-N-CA 127.676 2.391 . . . . 0.0 106.237 177.141 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.222 -0.373 0 CA-C-O 117.954 -1.022 . . . . 0.0 113.082 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -58.74 -47.09 85.85 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 120.188 1.358 . . . . 0.0 111.077 -179.002 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -64.53 -46.43 82.91 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 123.104 0.562 . . . . 0.0 109.568 177.088 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 58.4 mttm -60.33 -45.58 92.93 Favored 'General case' 0 N--CA 1.466 0.367 0 O-C-N 121.755 -0.59 . . . . 0.0 111.596 -178.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 44.2 mt -53.72 -55.74 12.18 Favored 'Isoleucine or valine' 0 C--O 1.234 0.242 0 C-N-CA 124.465 1.106 . . . . 0.0 108.505 176.215 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 1.3 ttp180 -60.73 -41.29 95.04 Favored 'General case' 0 C--O 1.223 -0.31 0 CA-C-O 118.929 -0.558 . . . . 0.0 109.687 -174.675 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -68.02 -42.66 80.3 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 123.206 0.602 . . . . 0.0 111.173 -177.724 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 61.6 mt -74.12 -53.39 17.48 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.351 0 C-N-CA 124.508 1.123 . . . . 0.0 109.619 -171.251 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 74.5 mt -64.79 -46.0 93.35 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.434 0 N-CA-C 109.195 -0.669 . . . . 0.0 109.195 178.359 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 139.96 126.41 2.3 Favored Glycine 0 CA--C 1.534 1.221 0 C-N-CA 124.868 1.223 . . . . 0.0 112.132 172.562 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -71.23 -7.37 21.2 Favored 'Trans proline' 0 CA--C 1.536 0.585 0 C-N-CA 124.067 3.178 . . . . 0.0 113.613 -176.22 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -83.8 -17.22 41.79 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 119.081 0.855 . . . . 0.0 111.251 177.873 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 1.2 pt? -128.32 -16.14 4.49 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 124.998 1.319 . . . . 0.0 113.625 -175.239 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 41.5 t -97.05 154.79 3.62 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.542 0 N-CA-C 107.292 -1.373 . . . . 0.0 107.292 168.012 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 27.9 m -142.34 130.14 21.65 Favored 'General case' 0 C--O 1.232 0.146 0 N-CA-C 105.934 -1.876 . . . . 0.0 105.934 -176.136 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 17.8 mt -80.57 141.43 35.08 Favored 'General case' 0 C--O 1.232 0.18 0 N-CA-C 107.77 -1.196 . . . . 0.0 107.77 175.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 35.0 t-80 -131.9 61.03 1.66 Allowed 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 124.671 1.188 . . . . 0.0 107.847 -174.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 64.6 t-20 -72.09 116.56 12.65 Favored 'General case' 0 C--O 1.234 0.267 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 -178.039 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 99.1 mt -65.54 -13.44 58.94 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 124.345 1.058 . . . . 0.0 112.787 -177.229 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 28.5 tptp -57.06 -25.87 59.42 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 123.243 0.617 . . . . 0.0 110.953 168.631 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -129.46 -40.35 1.43 Allowed 'General case' 0 N--CA 1.464 0.246 0 C-N-CA 123.871 0.868 . . . . 0.0 113.279 -175.002 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 34.0 m-20 -89.59 141.01 28.99 Favored 'General case' 0 C--O 1.234 0.285 0 C-N-CA 123.382 0.673 . . . . 0.0 110.551 -175.676 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 15.2 m -75.88 155.38 84.87 Favored Pre-proline 0 CA--C 1.543 0.677 0 C-N-CA 124.213 1.005 . . . . 0.0 109.992 175.411 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_endo -77.29 -26.27 7.64 Favored 'Trans proline' 0 C--N 1.35 0.615 0 C-N-CA 122.431 2.087 . . . . 0.0 113.588 -169.924 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 22.5 mmmt -71.63 -11.92 61.08 Favored 'General case' 0 N--CA 1.472 0.634 0 O-C-N 120.5 -1.375 . . . . 0.0 111.478 -175.702 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -60.54 -28.66 68.6 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 125.769 1.627 . . . . 0.0 110.145 168.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 45.9 mtt -58.08 -26.18 62.23 Favored 'General case' 0 C--N 1.343 0.306 0 C-N-CA 123.198 0.599 . . . . 0.0 111.895 177.353 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 90.8 mt-10 -66.85 -32.7 74.14 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 118.245 0.475 . . . . 0.0 110.307 -176.601 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 18.3 mt-30 -66.17 -44.74 83.17 Favored 'General case' 0 N--CA 1.464 0.267 0 C-N-CA 123.714 0.806 . . . . 0.0 112.022 -171.214 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 20.4 m-85 -70.88 139.74 50.87 Favored 'General case' 0 N--CA 1.456 -0.135 0 CA-C-N 115.403 -0.817 . . . . 0.0 109.758 -166.765 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -72.96 -38.07 66.87 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 118.506 0.594 . . . . 0.0 110.257 -179.023 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 10.5 t -108.57 146.61 14.11 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.304 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 170.715 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 43.1 tp -133.01 106.74 7.83 Favored 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 176.678 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 19.8 mt -86.22 135.78 24.32 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 N-CA-C 107.096 -1.446 . . . . 0.0 107.096 176.704 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 1.9 mp -114.0 131.38 56.36 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 126.042 1.737 . . . . 0.0 106.774 -179.013 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -136.69 126.91 3.9 Favored Glycine 0 C--N 1.332 0.343 0 N-CA-C 109.072 -1.611 . . . . 0.0 109.072 177.085 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 4.7 tt -153.74 133.71 7.66 Favored Pre-proline 0 CA--C 1.538 0.511 0 CA-C-N 118.247 1.024 . . . . 0.0 111.055 174.432 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo . . . . . 0 CA--C 1.534 0.501 0 C-N-CA 122.799 2.332 . . . . 0.0 112.78 168.278 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . 0.282 24.7 mt . . . . . 0 CA--C 1.539 0.55 0 CA-C-O 122.985 1.374 . . . . 0.0 112.111 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 3.3 mp0 -117.33 155.81 28.9 Favored 'General case' 0 C--O 1.235 0.331 0 C-N-CA 126.214 1.805 . . . . 0.0 106.568 -173.289 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -57.08 -43.4 82.12 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 122.891 0.476 . . . . 0.0 110.724 -171.458 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 -66.64 -20.9 66.09 Favored 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 112.357 0.503 . . . . 0.0 112.357 -176.023 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 11.3 t90 -91.86 -48.47 6.76 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 124.409 1.084 . . . . 0.0 109.031 177.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -64.27 -34.65 78.6 Favored 'General case' 0 CA--C 1.537 0.463 0 O-C-N 121.03 -1.044 . . . . 0.0 109.763 -178.218 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -59.54 -25.62 64.67 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 123.612 0.765 . . . . 0.0 111.815 -177.208 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 28.5 m -111.29 -14.67 10.54 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.315 0 CA-C-O 117.082 -1.437 . . . . 0.0 112.442 177.033 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 30.1 t90 -51.58 -35.13 40.04 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 120.491 1.496 . . . . 0.0 110.97 179.296 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -64.24 -27.9 69.37 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 125.222 1.409 . . . . 0.0 113.524 175.428 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 29.4 mt-30 -92.71 -18.98 22.29 Favored 'General case' 0 N--CA 1.463 0.22 0 C-N-CA 126.11 1.764 . . . . 0.0 112.441 175.786 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 56.3 mt -63.86 -20.57 65.92 Favored 'General case' 0 N--CA 1.465 0.319 0 O-C-N 121.21 -0.931 . . . . 0.0 111.608 -176.081 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -78.52 -22.81 46.79 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 122.985 0.514 . . . . 0.0 111.666 174.37 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -72.8 -29.79 63.55 Favored 'General case' 0 N--CA 1.467 0.411 0 O-C-N 120.729 -1.232 . . . . 0.0 111.942 178.005 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 80.9 mt -52.96 138.53 30.02 Favored 'General case' 0 C--O 1.231 0.101 0 C-N-CA 124.907 1.283 . . . . 0.0 112.896 -168.499 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 3.2 t30 -74.01 98.78 3.14 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 124.02 0.928 . . . . 0.0 108.631 170.515 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 32.8 mt -118.83 -0.76 11.17 Favored 'General case' 0 N--CA 1.472 0.659 0 N-CA-C 113.858 1.058 . . . . 0.0 113.858 -178.091 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 26.8 mt-10 -54.86 127.55 29.11 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-N 119.831 1.196 . . . . 0.0 111.623 -168.522 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 73.41 -2.24 38.84 Favored Glycine 0 CA--C 1.535 1.298 0 CA-C-O 117.824 -1.542 . . . . 0.0 115.108 179.345 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.4 154.82 36.93 Favored 'General case' 0 C--N 1.344 0.363 0 CA-C-N 120.942 2.371 . . . . 0.0 109.759 -176.678 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 2.3 mt -83.91 138.59 18.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 N-CA-C 106.866 -1.531 . . . . 0.0 106.866 177.508 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 54.3 t -130.71 135.75 59.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 C-N-CA 124.538 1.135 . . . . 0.0 108.498 -179.118 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -108.33 156.93 18.84 Favored 'General case' 0 CA--C 1.517 -0.299 0 N-CA-C 107.885 -1.154 . . . . 0.0 107.885 168.867 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 5.7 mt -137.76 132.42 32.72 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 107.783 -1.191 . . . . 0.0 107.783 178.714 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 39.2 p90 -149.15 165.68 31.08 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 168.421 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -167.84 157.8 30.29 Favored Glycine 0 N--CA 1.448 -0.517 0 N-CA-C 111.032 -0.827 . . . . 0.0 111.032 175.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 58.5 tp . . . . . 0 N--CA 1.445 -0.708 0 C-N-CA 125.691 1.596 . . . . 0.0 109.748 175.057 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 89.7 mt . . . . . 0 N--CA 1.475 0.776 0 N-CA-C 114.257 1.206 . . . . 0.0 114.257 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -62.96 -37.69 88.1 Favored 'General case' 0 C--N 1.328 -0.331 0 O-C-N 120.86 -1.15 . . . . 0.0 111.217 -173.061 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -67.66 -29.31 68.57 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 123.674 0.789 . . . . 0.0 112.416 174.391 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 5.9 tt -63.73 -49.45 73.0 Favored 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 173.375 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -61.29 -36.5 92.54 Favored Glycine 0 CA--C 1.526 0.767 0 N-CA-C 111.623 -0.591 . . . . 0.0 111.623 177.806 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 6.4 tpp -53.99 -48.52 70.31 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 124.756 1.222 . . . . 0.0 111.454 -179.152 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -77.93 -39.69 41.98 Favored 'General case' 0 C--N 1.341 0.238 0 N-CA-C 109.813 -0.439 . . . . 0.0 109.813 -177.898 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 77.9 t60 -54.14 -45.46 71.99 Favored 'General case' 0 CA--C 1.534 0.333 0 O-C-N 121.517 -0.739 . . . . 0.0 111.335 176.638 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -61.53 -41.94 98.08 Favored 'General case' 0 C--O 1.235 0.326 0 C-N-CA 123.801 0.84 . . . . 0.0 111.536 -179.506 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 24.3 ttmm -57.48 -43.39 84.04 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 123.614 0.765 . . . . 0.0 110.278 174.286 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 27.7 mt -87.25 -14.41 41.07 Favored 'General case' 0 CA--C 1.518 -0.281 0 N-CA-C 113.9 1.074 . . . . 0.0 113.9 -170.552 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 70.9 m -60.13 -32.67 71.23 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 119.835 1.198 . . . . 0.0 111.218 -174.508 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 24.6 p -89.7 -5.17 57.3 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 124.946 1.298 . . . . 0.0 112.085 179.194 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 31.7 mmmt -86.32 -6.29 58.98 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 125.014 1.326 . . . . 0.0 111.6 175.762 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 72.29 34.99 60.53 Favored Glycine 0 CA--C 1.526 0.762 0 CA-C-N 118.622 0.646 . . . . 0.0 112.522 171.483 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 5.6 m -80.97 172.12 1.16 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.51 0 CA-C-N 118.085 0.943 . . . . 0.0 109.815 173.744 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 53.0 tptt -101.85 132.73 47.46 Favored 'General case' 0 N--CA 1.469 0.477 0 N-CA-C 105.378 -2.082 . . . . 0.0 105.378 167.698 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 74.9 m-85 -99.16 123.76 43.69 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 119.161 0.891 . . . . 0.0 108.674 174.107 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 31.6 m -109.9 160.05 9.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 C-N-CA 125.196 1.398 . . . . 0.0 108.459 168.03 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 85.34 27.6 32.7 Favored Glycine 0 CA--C 1.523 0.588 0 CA-C-O 118.526 -1.152 . . . . 0.0 114.928 170.176 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 17.4 m-30 -58.21 158.21 7.37 Favored 'General case' 0 CA--C 1.54 0.596 0 CA-C-N 119.028 1.414 . . . . 0.0 110.463 168.891 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 49.4 t-105 -138.22 147.22 54.96 Favored Pre-proline 0 N--CA 1.468 0.444 0 CA-C-O 118.264 -0.874 . . . . 0.0 111.357 -169.591 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -65.03 130.99 27.27 Favored 'Trans proline' 0 CA--C 1.534 0.516 0 C-N-CA 122.765 2.31 . . . . 0.0 112.441 -179.137 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 11.3 p . . . . . 0 CA--C 1.54 0.564 0 C-N-CA 123.876 0.87 . . . . 0.0 112.002 169.412 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 16.8 ttmt . . . . . 0 CA--C 1.54 0.561 0 CA-C-O 117.355 -1.307 . . . . 0.0 113.801 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -87.5 7.76 4.56 Favored 'Trans proline' 0 C--N 1.35 0.634 0 CA-C-N 121.842 1.693 . . . . 0.0 113.777 -176.702 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 16.4 m -130.21 165.9 29.22 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.278 0 CA-C-N 121.115 1.78 . . . . 0.0 112.481 -171.167 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 12.9 pt -135.09 172.2 16.39 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.531 0 C-N-CA 128.239 2.616 . . . . 0.0 108.263 179.501 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . 53.59 42.2 31.94 Favored 'General case' 0 N--CA 1.464 0.226 0 C-N-CA 125.471 1.509 . . . . 0.0 112.648 173.726 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 27.0 t0 55.0 41.63 31.73 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 126.231 1.812 . . . . 0.0 111.766 -177.509 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 91.31 13.22 58.92 Favored Glycine 0 CA--C 1.527 0.8 0 CA-C-O 118.916 -0.935 . . . . 0.0 113.808 174.442 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 45.2 mt-30 -87.37 -7.65 57.5 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 119.29 1.545 . . . . 0.0 112.862 -177.9 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 7.6 tp -155.58 145.76 21.69 Favored 'General case' 0 C--N 1.344 0.358 0 CA-C-N 119.509 1.05 . . . . 0.0 110.797 172.238 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 61.7 m-85 -82.96 147.16 28.38 Favored 'General case' 0 CA--C 1.518 -0.279 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 169.596 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 16.7 m -77.1 2.62 1.68 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.576 0 C-N-CA 123.881 0.872 . . . . 0.0 112.393 177.234 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -172.28 169.81 42.89 Favored Glycine 0 CA--C 1.526 0.739 0 N-CA-C 110.829 -0.908 . . . . 0.0 110.829 -179.195 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 4.8 tp -63.6 135.01 56.48 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 124.272 1.029 . . . . 0.0 111.19 -179.566 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -92.99 128.04 38.71 Favored 'General case' 0 N--CA 1.446 -0.643 0 C-N-CA 124.981 1.312 . . . . 0.0 109.131 173.254 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 89.8 mt . . . . . 0 N--CA 1.464 0.248 0 C-N-CA 123.708 0.803 . . . . 0.0 109.69 169.886 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 60.9 m . . . . . 0 CA--C 1.537 0.476 0 N-CA-C 110.223 -0.288 . . . . 0.0 110.223 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -56.8 -41.78 78.35 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 123.814 0.846 . . . . 0.0 111.181 169.269 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 28.8 tt0 -70.19 -40.48 74.61 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 124.811 1.244 . . . . 0.0 111.144 -179.636 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 10.9 mmt180 -59.43 -44.22 92.94 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-O 118.296 -0.859 . . . . 0.0 109.271 174.434 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 51.5 mt -60.99 -55.28 25.74 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.242 0 N-CA-C 107.806 -1.183 . . . . 0.0 107.806 175.441 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 1.6 tm0? -53.64 -60.74 2.92 Favored 'General case' 0 N--CA 1.454 -0.275 0 CA-C-N 119.141 0.882 . . . . 0.0 112.327 -172.765 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 31.7 m -61.52 -35.92 79.08 Favored 'General case' 0 C--N 1.32 -0.701 0 C-N-CA 122.895 0.478 . . . . 0.0 111.703 -177.022 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 160' ' ' TRP . . . . . . . . . . . . . 57.6 t90 -64.04 -45.47 88.72 Favored 'General case' 0 C--O 1.222 -0.361 0 CA-C-N 118.625 0.648 . . . . 0.0 110.53 173.618 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 99.0 m -61.61 -42.98 99.64 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 123.086 0.554 . . . . 0.0 110.703 -178.551 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -64.91 -35.88 82.58 Favored 'General case' 0 C--N 1.333 -0.123 0 CA-C-N 117.946 0.339 . . . . 0.0 110.857 175.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 17.1 tt0 -68.71 -52.27 32.55 Favored 'General case' 0 N--CA 1.445 -0.689 0 O-C-N 121.485 -0.76 . . . . 0.0 110.029 179.82 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 42.0 pt -62.48 -36.5 75.19 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.445 0 CA-C-O 117.997 -1.001 . . . . 0.0 109.605 -175.704 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -64.57 -36.68 85.02 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 119.466 1.03 . . . . 0.0 109.824 -179.536 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 34.7 m-80 -67.45 -50.55 58.74 Favored 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 174.739 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 25.8 tt0 -73.36 -16.74 61.34 Favored 'General case' 0 N--CA 1.442 -0.858 0 C-N-CA 125.852 1.661 . . . . 0.0 112.034 -169.392 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 168' ' ' MET . . . . . . . . . . . . . 21.2 ptp -90.08 -40.11 12.48 Favored 'General case' 0 N--CA 1.456 -0.168 0 C-N-CA 124.323 1.049 . . . . 0.0 111.448 168.507 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -73.68 -26.37 60.69 Favored 'General case' 0 N--CA 1.454 -0.265 0 CA-C-O 119.147 -0.454 . . . . 0.0 112.152 -173.574 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 . . . . . 0 CA--C 1.541 0.606 0 C-N-CA 123.22 0.608 . . . . 0.0 112.102 -179.427 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.497 1.887 0 N-CA-C 111.261 0.097 . . . . 0.0 111.261 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 26.5 p-10 -126.26 166.22 17.52 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 125.107 1.363 . . . . 0.0 111.385 -173.341 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 11.4 mtt -131.28 123.87 29.27 Favored 'General case' 0 CA--C 1.522 -0.107 0 C-N-CA 123.29 0.636 . . . . 0.0 111.371 178.225 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -86.33 153.27 26.26 Favored Glycine 0 CA--C 1.523 0.594 0 N-CA-C 106.985 -2.446 . . . . 0.0 106.985 167.127 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 1.9 tt -141.73 96.11 2.92 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 119.664 1.732 . . . . 0.0 106.373 -173.265 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -101.68 141.56 34.36 Favored 'General case' 0 CA--C 1.518 -0.267 0 CA-C-O 121.271 0.558 . . . . 0.0 111.938 -170.192 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 43.1 p90 . . . . . 0 CA--C 1.538 0.501 0 C-N-CA 126.749 2.02 . . . . 0.0 107.389 -177.923 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.463 0.223 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -62.84 -48.14 80.33 Favored 'General case' 0 N--CA 1.452 -0.364 0 C-N-CA 122.999 0.52 . . . . 0.0 111.402 -174.832 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -68.42 -37.15 80.03 Favored 'General case' 0 CA--C 1.534 0.327 0 O-C-N 121.743 -0.598 . . . . 0.0 110.485 -179.43 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 28.6 mtpp -66.04 -40.23 90.83 Favored 'General case' 0 C--O 1.224 -0.244 0 CA-C-O 118.564 -0.731 . . . . 0.0 110.629 177.523 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 33.4 mt -55.69 -54.36 26.89 Favored 'Isoleucine or valine' 0 C--O 1.233 0.218 0 CA-C-N 119.642 1.11 . . . . 0.0 109.355 177.023 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 17.5 ptt180 -63.53 -38.6 91.76 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 118.801 0.728 . . . . 0.0 110.113 -177.039 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -64.02 -37.8 88.76 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-O 121.051 0.453 . . . . 0.0 110.151 -175.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 66.7 mt -76.03 -55.11 12.15 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.678 0 C-N-CA 125.136 1.374 . . . . 0.0 110.141 -176.275 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 62.7 mt -61.72 -47.84 91.44 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.403 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 -178.883 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 141.71 114.09 1.04 Allowed Glycine 0 CA--C 1.526 0.773 0 C-N-CA 125.396 1.474 . . . . 0.0 109.465 -175.912 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 70.5 Cg_endo -73.33 -8.4 21.83 Favored 'Trans proline' 0 CA--C 1.538 0.678 0 C-N-CA 122.517 2.145 . . . . 0.0 113.51 -169.729 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -76.63 -21.37 55.59 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 119.116 0.871 . . . . 0.0 111.839 179.107 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -122.74 7.87 9.41 Favored 'General case' 0 C--N 1.342 0.282 0 C-N-CA 124.842 1.257 . . . . 0.0 113.256 -171.542 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 44.0 t -124.89 151.18 30.27 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.369 0 N-CA-C 107.604 -1.258 . . . . 0.0 107.604 175.252 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 24.6 m -136.23 133.9 37.53 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 125.714 1.606 . . . . 0.0 107.927 -176.893 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 17.6 mt -80.52 138.17 36.5 Favored 'General case' 0 N--CA 1.463 0.222 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 176.086 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 24.7 t-80 -131.89 59.9 1.69 Allowed 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 124.588 1.155 . . . . 0.0 108.629 -176.576 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 37.9 t30 -59.7 124.22 19.44 Favored 'General case' 0 CA--C 1.531 0.226 0 N-CA-C 107.935 -1.135 . . . . 0.0 107.935 172.209 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 55.1 mt -71.37 -31.06 66.87 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-N 118.857 0.753 . . . . 0.0 112.73 -169.705 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 22.8 tptm -60.33 -27.46 67.37 Favored 'General case' 0 C--O 1.234 0.264 0 C-N-CA 123.507 0.723 . . . . 0.0 110.379 170.345 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -93.12 -34.64 13.57 Favored 'General case' 0 C--O 1.234 0.282 0 N-CA-C 112.834 0.679 . . . . 0.0 112.834 -174.639 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 3.8 t0 -144.69 148.49 34.28 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 118.869 0.759 . . . . 0.0 113.048 -176.831 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 15.2 m -70.7 157.22 90.67 Favored Pre-proline 0 CA--C 1.543 0.683 0 C-N-CA 125.925 1.69 . . . . 0.0 112.292 -169.342 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -74.64 -26.76 11.37 Favored 'Trans proline' 0 C--N 1.352 0.753 0 C-N-CA 122.662 2.241 . . . . 0.0 113.938 -172.317 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.87 -15.95 63.39 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-N 120.421 1.464 . . . . 0.0 112.187 -179.442 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -57.65 -31.21 66.08 Favored 'General case' 0 N--CA 1.466 0.363 0 C-N-CA 125.811 1.644 . . . . 0.0 110.166 170.777 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 57.2 mtt -56.4 -26.17 52.41 Favored 'General case' 0 N--CA 1.467 0.379 0 C-N-CA 123.699 0.799 . . . . 0.0 111.565 179.133 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 60.1 mt-10 -66.64 -32.93 74.58 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 118.436 0.562 . . . . 0.0 110.553 -177.659 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 19.8 mt-30 -67.65 -43.55 80.0 Favored 'General case' 0 C--O 1.232 0.181 0 N-CA-C 112.872 0.693 . . . . 0.0 112.872 -169.366 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 37.5 m-85 -72.23 135.91 46.21 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.733 -167.103 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -71.19 -38.03 72.11 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-N 118.101 0.41 . . . . 0.0 110.404 -179.468 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 14.8 t -105.31 143.66 16.18 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.56 0 N-CA-C 107.202 -1.407 . . . . 0.0 107.202 168.766 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 33.8 tp -131.6 115.34 15.97 Favored 'General case' 0 N--CA 1.446 -0.657 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 174.078 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 27.9 mt -91.99 131.94 37.72 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.681 0 N-CA-C 106.863 -1.532 . . . . 0.0 106.863 176.802 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 2.4 mp -109.72 127.35 54.54 Favored 'General case' 0 CA--C 1.516 -0.338 0 C-N-CA 125.717 1.607 . . . . 0.0 107.106 -179.832 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -129.18 130.72 6.5 Favored Glycine 0 C--N 1.332 0.329 0 N-CA-C 108.617 -1.793 . . . . 0.0 108.617 176.556 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 4.6 tt -152.26 129.56 5.72 Favored Pre-proline 0 CA--C 1.531 0.226 0 CA-C-N 117.636 0.718 . . . . 0.0 110.914 172.574 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo . . . . . 0 N--CA 1.447 -1.25 0 N-CA-C 107.017 -1.955 . . . . 0.0 107.017 165.548 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 8.4 mt . . . . . 0 CA--C 1.543 0.707 0 N-CA-C 113.039 0.755 . . . . 0.0 113.039 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 3.9 mp0 -74.87 153.8 38.51 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 125.294 1.438 . . . . 0.0 109.5 179.636 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -54.7 -46.17 74.12 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 123.669 0.788 . . . . 0.0 112.207 -169.184 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 23.3 t0 -62.35 -32.71 73.54 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-O 121.57 0.7 . . . . 0.0 112.184 -174.738 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -82.5 -43.5 17.1 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 123.739 0.816 . . . . 0.0 109.257 -179.587 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 6.1 tt0 -63.05 -35.11 79.15 Favored 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 124.79 1.236 . . . . 0.0 109.805 -179.287 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -58.97 -24.45 62.67 Favored 'General case' 0 C--O 1.233 0.2 0 C-N-CA 124.129 0.971 . . . . 0.0 111.69 -175.825 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 34.6 m -114.7 -14.99 10.5 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.228 0 CA-C-O 117.471 -1.252 . . . . 0.0 112.66 177.206 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 30.6 t90 -52.02 -38.86 58.36 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 119.974 1.261 . . . . 0.0 111.031 -177.032 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -68.36 -23.82 64.73 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 125.039 1.336 . . . . 0.0 113.185 178.218 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 22.7 mt-30 -91.73 -23.94 19.61 Favored 'General case' 0 C--N 1.34 0.167 0 C-N-CA 125.377 1.471 . . . . 0.0 111.973 -179.379 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 19.7 mt -64.26 -25.69 68.17 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 118.167 0.44 . . . . 0.0 111.63 -172.012 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -69.13 -21.77 64.0 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-N 117.966 0.348 . . . . 0.0 111.388 177.284 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -76.39 -24.05 54.08 Favored 'General case' 0 CA--C 1.537 0.462 0 O-C-N 120.971 -1.08 . . . . 0.0 112.68 -178.811 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 49.2 mt -65.63 149.54 49.92 Favored 'General case' 0 C--O 1.233 0.205 0 C-N-CA 124.794 1.238 . . . . 0.0 111.537 -170.296 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 27.8 t-20 -83.77 113.32 20.82 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 171.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 65.2 mt -128.66 1.8 5.5 Favored 'General case' 0 N--CA 1.472 0.659 0 N-CA-C 113.318 0.859 . . . . 0.0 113.318 -172.37 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 30.4 mt-10 -55.55 130.73 44.06 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-O 122.046 0.927 . . . . 0.0 111.347 -168.889 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 73.29 -2.45 36.74 Favored Glycine 0 CA--C 1.533 1.202 0 CA-C-O 117.987 -1.452 . . . . 0.0 115.105 176.791 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.64 149.55 41.93 Favored 'General case' 0 C--N 1.346 0.418 0 CA-C-N 120.749 2.274 . . . . 0.0 109.646 -177.036 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 7.6 mt -80.47 135.56 25.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 N-CA-C 106.269 -1.752 . . . . 0.0 106.269 178.372 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 63.4 t -129.11 128.56 67.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 C-N-CA 123.466 0.706 . . . . 0.0 109.715 -177.769 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -98.3 143.75 28.45 Favored 'General case' 0 CA--C 1.522 -0.114 0 N-CA-C 106.98 -1.489 . . . . 0.0 106.98 167.847 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 9.5 mt -122.11 132.24 54.38 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 107.243 -1.392 . . . . 0.0 107.243 176.241 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 22.9 p90 -150.72 165.05 34.63 Favored 'General case' 0 N--CA 1.444 -0.75 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 168.088 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -163.91 178.2 39.43 Favored Glycine 0 N--CA 1.435 -1.414 0 N-CA-C 109.739 -1.344 . . . . 0.0 109.739 171.314 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 5.8 tt . . . . . 0 N--CA 1.445 -0.706 0 C-N-CA 125.253 1.421 . . . . 0.0 107.448 178.682 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 91.9 mt . . . . . 0 N--CA 1.469 0.521 0 N-CA-C 114.613 1.338 . . . . 0.0 114.613 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -62.62 -35.22 78.89 Favored 'General case' 0 N--CA 1.465 0.311 0 O-C-N 120.651 -1.281 . . . . 0.0 110.672 -172.074 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -72.98 -28.67 62.53 Favored 'General case' 0 N--CA 1.452 -0.334 0 N-CA-C 113.096 0.776 . . . . 0.0 113.096 176.543 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 5.0 tt -61.43 -45.33 94.75 Favored 'General case' 0 CA--C 1.535 0.394 0 N-CA-C 107.308 -1.367 . . . . 0.0 107.308 170.276 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -61.76 -42.24 99.72 Favored Glycine 0 C--N 1.341 0.806 0 N-CA-C 111.302 -0.719 . . . . 0.0 111.302 179.162 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 74.8 mtm -61.94 -41.14 97.62 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 118.094 0.947 . . . . 0.0 111.662 178.244 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -72.22 -38.1 69.05 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 119.944 1.247 . . . . 0.0 111.131 -179.297 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 29.4 t-80 -57.21 -46.85 82.53 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 117.855 0.298 . . . . 0.0 110.38 172.587 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -63.85 -45.54 89.06 Favored 'General case' 0 C--N 1.33 -0.239 0 C-N-CA 123.457 0.703 . . . . 0.0 111.604 -177.753 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 24.5 ttmm -54.04 -45.26 71.56 Favored 'General case' 0 N--CA 1.464 0.227 0 C-N-CA 123.764 0.825 . . . . 0.0 109.735 173.287 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 22.2 mt -83.2 -19.89 35.67 Favored 'General case' 0 CA--C 1.514 -0.419 0 N-CA-C 114.887 1.44 . . . . 0.0 114.887 -169.43 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 6.5 t -57.85 -36.12 71.87 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-N 119.826 1.194 . . . . 0.0 110.598 -175.378 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 22.0 p -87.17 -8.33 57.03 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 124.802 1.241 . . . . 0.0 112.341 -179.184 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 32.3 mmmt -85.29 -7.13 59.15 Favored 'General case' 0 C--N 1.345 0.398 0 C-N-CA 124.61 1.164 . . . . 0.0 111.556 174.512 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 72.84 31.93 61.73 Favored Glycine 0 CA--C 1.523 0.567 0 CA-C-O 119.459 -0.634 . . . . 0.0 112.516 171.035 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 17.0 m -74.59 177.45 0.56 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.572 0 CA-C-N 118.386 1.093 . . . . 0.0 109.836 172.758 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -116.66 125.8 52.29 Favored 'General case' 0 CA--C 1.515 -0.388 0 N-CA-C 106.332 -1.729 . . . . 0.0 106.332 170.649 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 68.7 m-85 -91.45 146.03 24.14 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 119.847 1.203 . . . . 0.0 110.198 -177.594 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 33.5 m -133.3 158.43 42.98 Favored 'Isoleucine or valine' 0 C--O 1.235 0.323 0 C-N-CA 125.385 1.474 . . . . 0.0 107.503 169.044 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 85.41 35.19 12.34 Favored Glycine 0 N--CA 1.452 -0.252 0 CA-C-O 118.919 -0.934 . . . . 0.0 114.349 169.729 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 8.2 m-30 -67.86 155.2 39.89 Favored 'General case' 0 CA--C 1.544 0.729 0 CA-C-N 118.815 1.307 . . . . 0.0 109.403 169.611 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 1.6 t90 -136.46 137.96 25.52 Favored Pre-proline 0 CA--C 1.541 0.609 0 CA-C-O 117.305 -1.331 . . . . 0.0 108.342 -171.243 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_exo -70.58 130.92 19.1 Favored 'Trans proline' 0 C--N 1.348 0.501 0 C-N-CA 123.179 2.586 . . . . 0.0 113.037 -170.32 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 40.1 p . . . . . 0 N--CA 1.472 0.667 0 N-CA-C 113.457 0.91 . . . . 0.0 113.457 172.919 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 26.2 ttmt . . . . . 0 CA--C 1.541 0.616 0 CA-C-O 117.091 -1.433 . . . . 0.0 114.791 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_endo -74.63 -4.5 15.51 Favored 'Trans proline' 0 C--N 1.352 0.717 0 CA-C-N 122.108 1.789 . . . . 0.0 114.11 -178.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 20.8 m -131.76 167.89 25.27 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.412 0 CA-C-N 120.96 1.709 . . . . 0.0 111.673 -169.552 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 25.1 pt -127.87 170.05 18.28 Favored 'Isoleucine or valine' 0 C--O 1.234 0.27 0 C-N-CA 126.689 1.996 . . . . 0.0 109.207 175.169 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . 57.91 32.92 22.59 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 125.416 1.486 . . . . 0.0 113.768 167.711 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 27.7 t70 56.21 40.11 30.1 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 126.323 1.849 . . . . 0.0 111.254 -174.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 91.31 74.99 1.29 Allowed Glycine 0 C--N 1.338 0.657 0 C-N-CA 124.46 1.029 . . . . 0.0 111.259 177.682 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 74.1 mm-40 -120.66 -49.62 2.23 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 123.179 0.592 . . . . 0.0 110.771 168.251 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -131.0 145.03 51.92 Favored 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 122.997 0.519 . . . . 0.0 110.205 -178.86 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 73.3 m-85 -76.61 17.71 0.38 Allowed 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 125.573 1.549 . . . . 0.0 114.644 174.795 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 4.1 m 47.84 15.26 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.546 0.802 0 C-N-CA 127.915 2.486 . . . . 0.0 114.37 -174.053 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 168.22 174.0 36.66 Favored Glycine 0 CA--C 1.526 0.78 0 N-CA-C 108.792 -1.723 . . . . 0.0 108.792 -169.339 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . 0.439 ' HB2' ' CD1' ' A' ' 160' ' ' TRP . 1.7 tp -71.88 142.13 49.55 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 118.215 1.008 . . . . 0.0 111.92 179.701 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -104.8 130.0 52.99 Favored 'General case' 0 N--CA 1.447 -0.585 0 C-N-CA 127.482 2.313 . . . . 0.0 109.416 178.034 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 87.5 mt . . . . . 0 N--CA 1.471 0.608 0 C-N-CA 125.038 1.335 . . . . 0.0 108.461 173.103 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 73.3 m . . . . . 0 CA--C 1.539 0.535 0 CA-C-O 118.716 -0.659 . . . . 0.0 111.64 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -60.35 -45.48 93.33 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 119.51 1.05 . . . . 0.0 111.882 172.387 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 -67.29 -44.23 79.78 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 125.38 1.472 . . . . 0.0 110.244 177.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 38.7 mtp180 -62.52 -40.08 95.62 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-O 117.826 -1.083 . . . . 0.0 109.682 179.35 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 48.7 mt -63.18 -55.38 23.68 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.475 0 CA-C-N 119.891 1.223 . . . . 0.0 107.991 172.453 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 70.5 tp60 -50.21 -63.78 1.01 Allowed 'General case' 0 C--O 1.232 0.176 0 C-N-CA 124.808 1.243 . . . . 0.0 111.86 -174.584 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 24.0 m -66.0 -32.99 74.8 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 120.666 -0.414 . . . . 0.0 111.136 -170.365 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 160' ' ' TRP . . . . . 0.439 ' CD1' ' HB2' ' A' ' 142' ' ' LEU . 82.4 t90 -67.09 -46.13 75.16 Favored 'General case' 0 C--O 1.222 -0.39 0 O-C-N 121.999 -0.438 . . . . 0.0 110.889 175.257 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 61.4 m -58.2 -43.9 87.84 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 118.48 0.582 . . . . 0.0 110.157 179.502 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -62.28 -43.91 97.74 Favored 'General case' 0 CA--C 1.528 0.123 0 N-CA-C 109.886 -0.413 . . . . 0.0 109.886 176.842 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 14.9 tt0 -62.58 -50.32 71.76 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-O 117.946 -1.026 . . . . 0.0 110.225 -177.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 41.6 pt -65.01 -33.53 64.35 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.485 0 CA-C-N 119.678 1.126 . . . . 0.0 110.224 -176.335 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -70.48 -34.19 72.11 Favored 'General case' 0 C--O 1.223 -0.322 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 -175.998 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -71.33 -45.19 63.58 Favored 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 124.531 1.132 . . . . 0.0 109.982 175.082 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 21.9 tt0 -78.3 -24.57 46.63 Favored 'General case' 0 N--CA 1.441 -0.905 0 C-N-CA 124.22 1.008 . . . . 0.0 110.319 -169.374 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 168' ' ' MET . . . . . . . . . . . . . 19.2 ptp -82.26 -29.72 31.1 Favored 'General case' 0 N--CA 1.461 0.104 0 O-C-N 121.694 -0.629 . . . . 0.0 111.657 171.843 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -79.36 -36.3 39.52 Favored 'General case' 0 N--CA 1.447 -0.613 0 C-N-CA 122.573 0.349 . . . . 0.0 111.001 -178.198 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 . . . . . 0 CA--C 1.535 0.392 0 O-C-N 122.138 -0.351 . . . . 0.0 110.396 177.356 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.498 1.926 0 CA-C-O 118.986 -0.531 . . . . 0.0 110.15 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 5.7 t30 -111.22 147.54 34.77 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-N 119.729 1.149 . . . . 0.0 111.377 -171.5 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 17.5 mtt -112.79 130.12 56.19 Favored 'General case' 0 N--CA 1.462 0.174 0 C-N-CA 124.414 1.086 . . . . 0.0 110.203 -177.467 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -98.94 131.02 10.42 Favored Glycine 0 CA--C 1.522 0.506 0 N-CA-C 107.264 -2.334 . . . . 0.0 107.264 168.54 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -105.74 108.14 19.51 Favored 'General case' 0 N--CA 1.467 0.422 0 N-CA-C 105.058 -2.201 . . . . 0.0 105.058 173.974 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -99.62 145.84 27.12 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 119.401 1.0 . . . . 0.0 112.663 179.335 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 79.5 m-85 . . . . . 0 N--CA 1.451 -0.416 0 C-N-CA 126.681 1.992 . . . . 0.0 108.726 -178.401 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.536 0.428 0 CA-C-O 119.002 -0.523 . . . . 0.0 110.236 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -57.18 -55.18 38.1 Favored 'General case' 0 N--CA 1.465 0.318 0 C-N-CA 123.672 0.789 . . . . 0.0 112.337 179.112 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 70.5 mm-40 -61.08 -45.73 93.54 Favored 'General case' 0 CA--C 1.517 -0.319 0 N-CA-C 108.134 -1.062 . . . . 0.0 108.134 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 30.0 mtpp -66.42 -39.6 89.06 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-O 118.498 -0.763 . . . . 0.0 110.107 -171.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 17.6 mt -54.61 -58.65 3.44 Favored 'Isoleucine or valine' 0 C--O 1.233 0.188 0 C-N-CA 124.639 1.175 . . . . 0.0 108.858 176.548 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 18.7 ptt180 -64.91 -39.42 93.49 Favored 'General case' 0 C--O 1.222 -0.372 0 CA-C-O 118.761 -0.637 . . . . 0.0 110.45 -177.272 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -65.53 -39.92 92.32 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.142 0.496 . . . . 0.0 110.018 -172.511 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 70.5 mt -75.5 -53.72 15.43 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.576 0 C-N-CA 125.236 1.415 . . . . 0.0 109.875 -175.419 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 71.8 mt -62.48 -46.89 95.32 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.441 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 -179.232 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 140.77 116.58 1.3 Allowed Glycine 0 CA--C 1.528 0.881 0 C-N-CA 125.842 1.687 . . . . 0.0 109.395 179.26 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -72.78 -8.18 21.97 Favored 'Trans proline' 0 CA--C 1.539 0.743 0 C-N-CA 122.739 2.292 . . . . 0.0 113.337 -170.229 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -79.67 -17.65 53.18 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 118.757 0.708 . . . . 0.0 111.865 178.02 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -125.37 8.08 7.77 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 125.204 1.402 . . . . 0.0 113.343 -174.878 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 61.3 t -124.55 149.22 28.82 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.265 0 N-CA-C 107.925 -1.139 . . . . 0.0 107.925 174.21 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 11.9 m -138.71 136.32 35.68 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 126.034 1.734 . . . . 0.0 107.023 -176.804 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 23.8 mt -90.67 146.59 23.9 Favored 'General case' 0 N--CA 1.466 0.339 0 N-CA-C 107.691 -1.226 . . . . 0.0 107.691 175.553 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 40.5 t-80 -140.34 128.27 22.03 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 107.459 -1.311 . . . . 0.0 107.459 -169.261 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 53.8 t-20 -128.66 111.18 12.91 Favored 'General case' 0 CA--C 1.516 -0.345 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 -169.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 88.9 mt -66.86 -10.7 50.97 Favored 'General case' 0 CA--C 1.535 0.381 0 N-CA-C 113.355 0.872 . . . . 0.0 113.355 -174.222 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 40.3 tptt -57.92 -29.13 64.88 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 118.82 0.737 . . . . 0.0 111.234 168.153 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -129.39 -38.01 1.59 Allowed 'General case' 0 N--CA 1.465 0.299 0 C-N-CA 123.84 0.856 . . . . 0.0 112.67 -173.049 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 42.8 m-20 -79.55 130.12 35.1 Favored 'General case' 0 C--O 1.236 0.373 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 179.758 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 14.4 m -73.28 152.7 90.26 Favored Pre-proline 0 CA--C 1.542 0.649 0 C-N-CA 123.22 0.608 . . . . 0.0 109.526 173.368 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -73.04 -24.86 16.81 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.032 1.821 . . . . 0.0 113.992 -169.616 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 1.4 mptm? -63.21 -18.06 63.11 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 119.275 0.943 . . . . 0.0 111.726 178.176 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -63.28 -25.31 68.26 Favored 'General case' 0 N--CA 1.465 0.309 0 C-N-CA 124.847 1.259 . . . . 0.0 110.746 174.341 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 54.2 mtt -61.75 -23.95 66.49 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 119.361 0.982 . . . . 0.0 111.496 177.346 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -64.32 -32.25 73.78 Favored 'General case' 0 CA--C 1.535 0.365 0 O-C-N 121.792 -0.568 . . . . 0.0 110.566 -177.602 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 25.4 mt-30 -67.17 -42.23 84.61 Favored 'General case' 0 CA--C 1.533 0.29 0 N-CA-C 113.594 0.961 . . . . 0.0 113.594 -169.397 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 62.7 m-85 -73.79 144.09 45.73 Favored 'General case' 0 C--O 1.231 0.113 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.637 -165.346 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 41.7 m-20 -77.23 -29.19 54.01 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 122.785 0.434 . . . . 0.0 109.948 -176.433 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 13.5 t -124.57 144.85 33.03 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.34 0 N-CA-C 106.564 -1.643 . . . . 0.0 106.564 168.886 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 25.0 tp -125.2 105.95 9.52 Favored 'General case' 0 N--CA 1.446 -0.669 0 N-CA-C 107.304 -1.369 . . . . 0.0 107.304 175.542 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 51.0 mt -85.83 128.6 39.13 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.687 0 N-CA-C 105.947 -1.872 . . . . 0.0 105.947 174.435 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 1.3 mp -102.55 124.1 47.5 Favored 'General case' 0 CA--C 1.515 -0.375 0 N-CA-C 106.415 -1.698 . . . . 0.0 106.415 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -122.4 120.39 4.3 Favored Glycine 0 N--CA 1.449 -0.449 0 N-CA-C 106.951 -2.46 . . . . 0.0 106.951 177.656 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 5.8 tt -149.64 116.46 3.61 Favored Pre-proline 0 C--N 1.332 -0.185 0 CA-C-N 118.033 0.916 . . . . 0.0 109.483 169.823 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 62.9 Cg_exo . . . . . 0 N--CA 1.456 -0.687 0 C-N-CA 120.706 0.937 . . . . 0.0 110.394 166.194 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 48.1 mt . . . . . 0 CA--C 1.538 0.512 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 1.5 pm0 -75.82 154.28 36.29 Favored 'General case' 0 C--O 1.233 0.225 0 C-N-CA 124.711 1.204 . . . . 0.0 109.821 173.662 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -57.11 -41.86 79.76 Favored 'General case' 0 C--O 1.224 -0.289 0 C-N-CA 124.045 0.938 . . . . 0.0 110.952 -171.375 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 27.8 m-20 -69.76 -15.56 63.15 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-N 119.108 0.867 . . . . 0.0 112.395 -173.912 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 11.5 t90 -92.11 -46.86 7.56 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 124.52 1.128 . . . . 0.0 108.139 173.313 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -62.66 -35.36 79.41 Favored 'General case' 0 CA--C 1.536 0.428 0 O-C-N 120.789 -1.194 . . . . 0.0 110.585 -178.785 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -61.48 -25.78 67.47 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 124.119 0.968 . . . . 0.0 110.913 -174.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 28.1 m -111.21 -14.94 10.39 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.328 0 CA-C-O 117.352 -1.308 . . . . 0.0 112.207 177.502 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 28.3 t90 -51.56 -37.51 49.98 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 120.161 1.346 . . . . 0.0 110.526 177.342 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -63.35 -27.45 69.33 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 125.305 1.442 . . . . 0.0 113.196 176.399 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 30.9 mt-30 -92.4 -20.18 21.31 Favored 'General case' 0 C--O 1.226 -0.163 0 C-N-CA 125.853 1.661 . . . . 0.0 112.567 178.004 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 41.7 mt -63.34 -24.08 67.69 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 118.895 0.77 . . . . 0.0 111.458 -176.108 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -75.8 -27.18 57.87 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 117.903 0.32 . . . . 0.0 111.373 174.541 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -79.32 -17.01 55.42 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 123.951 0.9 . . . . 0.0 112.609 -174.717 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 38.1 mt -62.53 147.9 47.55 Favored 'General case' 0 C--O 1.234 0.275 0 C-N-CA 124.261 1.025 . . . . 0.0 111.43 -170.912 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 24.7 t-20 -83.38 82.58 8.22 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 124.856 1.263 . . . . 0.0 107.933 174.373 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 3.7 pp -140.92 131.6 25.64 Favored 'General case' 0 N--CA 1.453 -0.282 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 170.903 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 25.3 mt-10 -141.1 146.59 37.29 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 127.843 2.457 . . . . 0.0 107.585 168.414 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 69.74 -3.44 9.23 Favored Glycine 0 CA--C 1.534 1.243 0 CA-C-O 118.111 -1.383 . . . . 0.0 116.285 169.658 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.93 161.96 30.07 Favored 'General case' 0 C--N 1.343 0.312 0 CA-C-N 120.282 2.041 . . . . 0.0 109.681 -177.345 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 2.2 mt -85.05 135.41 24.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 N-CA-C 107.329 -1.36 . . . . 0.0 107.329 177.794 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 77.4 t -128.47 138.23 55.19 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 -179.766 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -113.7 156.81 23.1 Favored 'General case' 0 CA--C 1.521 -0.156 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 169.305 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 2.0 mt -138.7 134.73 33.98 Favored 'General case' 0 CA--C 1.515 -0.374 0 N-CA-C 107.002 -1.481 . . . . 0.0 107.002 -178.568 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 12.2 p90 -165.15 171.24 13.99 Favored 'General case' 0 N--CA 1.451 -0.386 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 170.698 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -178.08 176.71 48.16 Favored Glycine 0 N--CA 1.449 -0.439 0 N-CA-C 109.955 -1.258 . . . . 0.0 109.955 167.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.329 -0.316 0 C-N-CA 124.696 1.199 . . . . 0.0 109.905 171.922 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 71.5 mt . . . . . 0 CA--C 1.534 0.327 0 N-CA-C 115.49 1.663 . . . . 0.0 115.49 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -60.16 -28.7 68.14 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 120.394 1.452 . . . . 0.0 110.967 -175.37 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -71.31 -26.65 62.94 Favored 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 123.968 0.907 . . . . 0.0 112.491 176.82 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 10.1 mp -63.69 -43.47 96.56 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 119.846 1.203 . . . . 0.0 107.854 170.832 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -65.46 -39.83 95.92 Favored Glycine 0 C--N 1.339 0.747 0 N-CA-C 110.801 -0.92 . . . . 0.0 110.801 -174.875 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 70.7 mtm -63.85 -44.74 92.25 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 117.288 0.544 . . . . 0.0 111.762 178.3 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -71.04 -39.63 72.19 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 119.635 1.107 . . . . 0.0 109.908 178.865 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 42.9 t-80 -55.13 -51.79 65.32 Favored 'General case' 0 CA--C 1.53 0.206 0 O-C-N 121.64 -0.662 . . . . 0.0 110.516 176.59 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -61.38 -39.7 91.64 Favored 'General case' 0 C--O 1.235 0.311 0 C-N-CA 123.491 0.716 . . . . 0.0 111.864 -176.716 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 24.2 ttmm -56.84 -41.82 78.55 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 123.325 0.65 . . . . 0.0 110.598 173.486 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 38.2 mt -87.21 -16.5 35.12 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-O 117.628 -1.177 . . . . 0.0 114.077 -169.798 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 17.7 m -57.61 -37.83 73.91 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 120.412 1.46 . . . . 0.0 111.247 -179.759 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 21.1 p -82.52 -12.52 57.71 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 124.194 0.998 . . . . 0.0 111.561 -179.409 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 32.0 mmmt -82.27 -6.39 59.2 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 124.517 1.127 . . . . 0.0 110.853 169.582 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 71.44 27.19 71.83 Favored Glycine 0 CA--C 1.527 0.831 0 CA-C-N 119.312 0.96 . . . . 0.0 113.098 168.829 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 7.9 m -74.09 170.29 1.48 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 CA-C-N 118.5 1.15 . . . . 0.0 110.068 178.345 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 54.4 tptt -95.04 135.55 36.45 Favored 'General case' 0 CA--C 1.513 -0.472 0 N-CA-C 105.26 -2.126 . . . . 0.0 105.26 167.785 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 64.7 m-85 -103.14 122.39 44.6 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 108.099 -1.075 . . . . 0.0 108.099 171.815 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 26.2 m -107.84 158.23 7.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 C-N-CA 124.5 1.12 . . . . 0.0 108.685 168.033 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 86.1 24.69 39.91 Favored Glycine 0 CA--C 1.524 0.654 0 CA-C-O 118.076 -1.402 . . . . 0.0 115.13 169.699 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 12.3 m-30 -59.91 156.38 14.58 Favored 'General case' 0 CA--C 1.544 0.721 0 CA-C-N 119.44 1.62 . . . . 0.0 109.298 168.613 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 58.3 t-105 -135.71 143.86 46.52 Favored Pre-proline 0 N--CA 1.472 0.635 0 CA-C-O 118.094 -0.955 . . . . 0.0 111.553 -168.359 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -64.46 129.64 24.44 Favored 'Trans proline' 0 C--N 1.348 0.548 0 C-N-CA 123.344 2.696 . . . . 0.0 112.429 -178.133 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 3.7 p . . . . . 0 CA--C 1.535 0.384 0 C-N-CA 125.022 1.329 . . . . 0.0 111.062 169.709 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 23.9 ttmt . . . . . 0 N--CA 1.474 0.762 0 CA-C-O 117.453 -1.261 . . . . 0.0 114.305 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 80.7 Cg_endo -76.66 -0.53 10.57 Favored 'Trans proline' 0 C--N 1.353 0.812 0 CA-C-N 122.216 1.827 . . . . 0.0 114.079 179.526 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 19.5 m -120.48 149.28 23.3 Favored 'Isoleucine or valine' 0 C--O 1.232 0.171 0 CA-C-N 120.479 1.491 . . . . 0.0 110.217 -178.759 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 3.2 pt -88.08 169.1 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.721 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 169.013 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . 56.0 -154.12 0.33 Allowed 'General case' 0 N--CA 1.441 -0.907 0 CA-C-N 113.603 -1.635 . . . . 0.0 109.175 169.604 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 22.4 t0 -80.67 60.7 4.08 Favored 'General case' 0 C--N 1.325 -0.482 0 C-N-CA 125.022 1.329 . . . . 0.0 109.123 169.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 63.54 30.0 76.3 Favored Glycine 0 CA--C 1.529 0.927 0 C-N-CA 124.607 1.099 . . . . 0.0 112.868 177.659 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 56.0 mm-40 -78.33 -29.19 47.49 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 117.706 0.753 . . . . 0.0 111.688 -168.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 11.7 tp -158.67 148.96 19.78 Favored 'General case' 0 CA--C 1.53 0.207 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 -174.602 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 72.5 m-85 -77.48 148.53 35.3 Favored 'General case' 0 CA--C 1.522 -0.113 0 CA-C-N 119.146 0.884 . . . . 0.0 108.789 170.088 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 33.8 m -71.43 -0.67 1.82 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.624 0 C-N-CA 123.195 0.598 . . . . 0.0 112.265 175.762 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -176.58 171.9 44.87 Favored Glycine 0 CA--C 1.524 0.633 0 O-C-N 120.745 -1.222 . . . . 0.0 110.346 -172.659 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 1.6 tp -64.67 136.13 56.64 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 118.006 0.903 . . . . 0.0 110.939 179.454 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -101.72 112.81 25.52 Favored 'General case' 0 N--CA 1.447 -0.617 0 C-N-CA 125.841 1.656 . . . . 0.0 108.873 176.266 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 95.7 mt . . . . . 0 N--CA 1.465 0.295 0 C-N-CA 124.448 1.099 . . . . 0.0 109.317 170.584 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 12.5 m . . . . . 0 CA--C 1.54 0.564 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -59.91 -42.5 94.03 Favored 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 124.235 1.014 . . . . 0.0 111.65 169.673 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -64.41 -47.01 80.79 Favored 'General case' 0 C--N 1.334 -0.102 0 C-N-CA 124.31 1.044 . . . . 0.0 109.848 178.907 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 68.5 mtt180 -57.58 -46.76 83.59 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-O 118.125 -0.94 . . . . 0.0 110.501 177.151 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 47.8 mt -61.03 -51.96 67.14 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.403 0 CA-C-N 119.443 1.02 . . . . 0.0 108.383 177.192 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 71.0 tp60 -52.78 -64.19 0.9 Allowed 'General case' 0 C--O 1.234 0.27 0 C-N-CA 124.633 1.173 . . . . 0.0 111.302 -177.6 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 41.3 m -66.21 -33.26 75.35 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 119.315 -0.374 . . . . 0.0 111.268 -171.459 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 160' ' ' TRP . . . . . . . . . . . . . 60.5 t90 -65.73 -47.87 73.88 Favored 'General case' 0 C--O 1.225 -0.225 0 CA-C-N 118.676 0.671 . . . . 0.0 110.707 174.705 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 64.7 m -61.3 -42.22 98.29 Favored 'General case' 0 N--CA 1.455 -0.204 0 CA-C-N 118.217 0.462 . . . . 0.0 110.299 -178.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -61.55 -44.54 96.85 Favored 'General case' 0 N--CA 1.455 -0.203 0 CA-C-N 118.308 0.504 . . . . 0.0 110.076 174.886 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 14.8 tt0 -62.6 -50.81 69.79 Favored 'General case' 0 CA--C 1.512 -0.489 0 CA-C-O 117.699 -1.143 . . . . 0.0 109.803 -176.415 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 44.7 pt -63.98 -34.13 66.58 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.425 0 CA-C-O 117.59 -1.195 . . . . 0.0 109.835 -176.578 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -71.48 -32.36 68.18 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 119.653 1.115 . . . . 0.0 108.955 -174.982 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -70.74 -53.54 15.15 Favored 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 124.347 1.059 . . . . 0.0 109.374 173.737 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 20.1 tt0 -69.02 -31.44 70.24 Favored 'General case' 0 N--CA 1.445 -0.719 0 C-N-CA 125.601 1.561 . . . . 0.0 109.943 -168.619 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 168' ' ' MET . . . . . . . . . . . . . 22.1 ptp -74.11 -34.02 63.78 Favored 'General case' 0 C--O 1.23 0.078 0 O-C-N 122.143 -0.348 . . . . 0.0 111.047 174.658 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -74.86 -37.16 62.28 Favored 'General case' 0 N--CA 1.442 -0.852 0 CA-C-O 119.276 -0.393 . . . . 0.0 111.811 -177.251 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 5.5 mt-10 . . . . . 0 CA--C 1.532 0.283 0 CA-C-O 121.572 0.701 . . . . 0.0 109.682 177.244 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.497 1.898 0 CA-C-O 120.433 0.159 . . . . 0.0 111.286 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 26.1 p-10 -116.39 165.87 12.72 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 125.392 1.477 . . . . 0.0 111.414 -174.425 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 13.9 mtt -130.69 128.44 40.89 Favored 'General case' 0 CA--C 1.522 -0.119 0 C-N-CA 123.27 0.628 . . . . 0.0 110.717 175.367 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -90.12 149.4 20.3 Favored Glycine 0 CA--C 1.525 0.672 0 N-CA-C 106.786 -2.526 . . . . 0.0 106.786 166.56 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 2.4 tt -134.26 100.16 4.61 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 105.364 -2.087 . . . . 0.0 105.364 -178.099 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -106.22 142.84 35.23 Favored 'General case' 0 CA--C 1.519 -0.238 0 CA-C-O 121.63 0.729 . . . . 0.0 112.252 -172.727 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 34.7 p90 . . . . . 0 N--CA 1.45 -0.433 0 C-N-CA 126.697 1.999 . . . . 0.0 106.85 179.425 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.226 -0.136 0 N-CA-C 109.3 -0.629 . . . . 0.0 109.3 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -63.77 -45.53 89.32 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 122.195 0.198 . . . . 0.0 110.872 -176.74 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -60.24 -45.38 93.44 Favored 'General case' 0 N--CA 1.465 0.298 0 C-N-CA 123.296 0.638 . . . . 0.0 109.667 176.392 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 30.0 mtpp -70.52 -39.91 73.8 Favored 'General case' 0 C--O 1.222 -0.373 0 CA-C-O 118.441 -0.79 . . . . 0.0 110.144 -173.512 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 43.8 mt -54.88 -54.86 19.47 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.189 0 CA-C-N 119.765 1.166 . . . . 0.0 109.174 176.024 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.83 -33.87 76.56 Favored 'General case' 0 C--O 1.221 -0.399 0 CA-C-N 118.259 0.481 . . . . 0.0 111.316 -174.628 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -63.4 -40.75 98.06 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 122.67 0.388 . . . . 0.0 111.119 175.273 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 55.6 mt -76.72 -55.67 10.25 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.515 0 C-N-CA 124.644 1.178 . . . . 0.0 110.451 -171.698 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 73.4 mt -64.48 -46.3 93.18 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 -179.858 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 143.73 124.01 1.78 Allowed Glycine 0 CA--C 1.527 0.817 0 C-N-CA 124.442 1.02 . . . . 0.0 110.871 174.46 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -73.13 -9.41 23.35 Favored 'Trans proline' 0 CA--C 1.54 0.782 0 C-N-CA 123.101 2.534 . . . . 0.0 113.387 -170.914 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -81.35 -19.09 43.49 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 118.768 0.713 . . . . 0.0 111.416 178.174 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -125.12 -7.2 7.13 Favored 'General case' 0 C--N 1.344 0.335 0 C-N-CA 124.828 1.251 . . . . 0.0 113.724 -174.032 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 40.4 t -115.02 137.27 49.04 Favored 'Isoleucine or valine' 0 C--O 1.233 0.216 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 171.193 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 51.7 m -129.91 132.99 46.57 Favored 'General case' 0 C--O 1.233 0.197 0 C-N-CA 124.807 1.243 . . . . 0.0 108.268 -174.503 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 23.7 mt -75.22 144.22 42.73 Favored 'General case' 0 C--O 1.233 0.194 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 177.073 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . 0.443 ' HE2' ' HB2' ' A' ' 42' ' ' LEU . 44.4 t-80 -132.7 66.55 1.56 Allowed 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 125.141 1.376 . . . . 0.0 107.291 -177.679 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 57.0 t-20 -70.43 118.08 12.78 Favored 'General case' 0 C--O 1.233 0.234 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 -179.329 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 48.6 mt -67.74 -18.0 64.74 Favored 'General case' 0 C--O 1.232 0.183 0 N-CA-C 113.16 0.8 . . . . 0.0 113.16 -174.78 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 35.1 tptt -60.14 -23.6 64.03 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 118.698 0.681 . . . . 0.0 111.777 169.445 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -119.46 -39.41 2.89 Favored 'General case' 0 C--O 1.234 0.262 0 N-CA-C 113.279 0.844 . . . . 0.0 113.279 -172.846 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 33.1 m-20 -101.42 139.15 37.48 Favored 'General case' 0 N--CA 1.465 0.302 0 C-N-CA 123.947 0.899 . . . . 0.0 110.531 -177.654 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 11.4 m -75.28 155.82 85.83 Favored Pre-proline 0 CA--C 1.542 0.644 0 C-N-CA 124.124 0.97 . . . . 0.0 110.16 174.779 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -74.71 -25.68 12.26 Favored 'Trans proline' 0 C--N 1.349 0.553 0 C-N-CA 121.909 1.74 . . . . 0.0 113.472 -170.196 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 1.7 mptm? -62.9 -21.08 65.76 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-N 120.329 1.422 . . . . 0.0 112.082 -179.186 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.443 ' HB2' ' HE2' ' A' ' 33' ' ' HIS . 2.1 mm? -62.25 -26.53 68.44 Favored 'General case' 0 N--CA 1.465 0.292 0 C-N-CA 125.119 1.368 . . . . 0.0 110.389 174.634 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 68.4 mtt -58.19 -27.66 64.07 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 118.94 0.791 . . . . 0.0 111.43 177.128 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 69.1 mt-10 -63.37 -32.59 74.05 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 118.238 0.472 . . . . 0.0 109.969 -175.814 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 26.2 mt-30 -67.47 -39.78 85.28 Favored 'General case' 0 C--N 1.342 0.278 0 C-N-CA 123.911 0.884 . . . . 0.0 113.191 -172.145 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 71.6 m-85 -72.95 135.16 44.99 Favored 'General case' 0 C--O 1.233 0.219 0 N-CA-C 109.446 -0.575 . . . . 0.0 109.446 -167.904 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -69.7 -44.01 71.27 Favored 'General case' 0 C--O 1.233 0.208 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 -178.843 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 12.3 t -103.52 145.49 12.53 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.396 0 N-CA-C 107.996 -1.113 . . . . 0.0 107.996 169.894 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 34.8 tp -135.41 105.97 6.47 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 175.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 32.6 mt -85.11 128.34 39.11 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.826 0 N-CA-C 106.638 -1.616 . . . . 0.0 106.638 177.698 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -94.05 144.32 25.58 Favored 'General case' 0 CA--C 1.516 -0.363 0 C-N-CA 124.787 1.235 . . . . 0.0 109.824 169.588 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -145.34 134.78 5.67 Favored Glycine 0 CA--C 1.52 0.385 0 N-CA-C 109.244 -1.542 . . . . 0.0 109.244 169.234 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 3.5 tt -156.68 139.6 10.81 Favored Pre-proline 0 CA--C 1.542 0.655 0 CA-C-N 118.737 1.268 . . . . 0.0 111.411 172.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo . . . . . 0 CA--C 1.538 0.718 0 C-N-CA 122.749 2.3 . . . . 0.0 111.554 167.192 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . 0.253 49.9 mt . . . . . 0 CA--C 1.546 0.804 0 CA-C-O 122.581 1.181 . . . . 0.0 112.415 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 4.2 mp0 -108.1 153.69 22.78 Favored 'General case' 0 C--N 1.34 0.173 0 C-N-CA 125.569 1.548 . . . . 0.0 107.157 -177.317 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -57.0 -42.47 80.32 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 123.178 0.591 . . . . 0.0 110.951 -173.312 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 23.0 m-20 -66.99 -18.24 65.29 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 122.844 0.458 . . . . 0.0 112.004 -176.409 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 13.6 t90 -95.76 -44.79 7.27 Favored 'General case' 0 C--N 1.339 0.14 0 C-N-CA 124.358 1.063 . . . . 0.0 110.263 175.304 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -62.9 -34.75 78.07 Favored 'General case' 0 CA--C 1.538 0.503 0 O-C-N 120.692 -1.255 . . . . 0.0 109.673 -178.864 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -60.16 -25.32 65.43 Favored 'General case' 0 C--O 1.233 0.216 0 C-N-CA 123.839 0.856 . . . . 0.0 111.567 179.29 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 12.2 m -109.85 -16.04 9.25 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.321 0 CA-C-O 117.46 -1.257 . . . . 0.0 112.467 179.446 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 27.9 t90 -53.71 -38.53 64.37 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 120.025 1.284 . . . . 0.0 110.198 176.822 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -66.59 -27.36 67.66 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 125.476 1.51 . . . . 0.0 112.945 175.532 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 68.1 mt-30 -90.73 -23.07 20.8 Favored 'General case' 0 C--O 1.224 -0.289 0 C-N-CA 125.67 1.588 . . . . 0.0 111.978 -176.787 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 50.3 mt -57.74 -32.0 67.02 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 118.537 0.608 . . . . 0.0 110.275 173.398 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -70.4 -26.5 63.72 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 122.694 0.397 . . . . 0.0 111.233 174.548 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -81.31 -34.36 31.97 Favored 'General case' 0 CA--C 1.537 0.475 0 N-CA-C 113.307 0.854 . . . . 0.0 113.307 176.267 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 24.7 mt -59.62 149.56 29.95 Favored 'General case' 0 N--CA 1.464 0.27 0 C-N-CA 124.476 1.11 . . . . 0.0 111.104 -176.117 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 19.9 t-20 -91.15 118.42 30.43 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 169.171 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 70.4 mt -127.98 8.9 6.25 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 123.73 0.812 . . . . 0.0 112.263 -173.113 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 28.9 mt-10 -52.18 129.15 27.04 Favored 'General case' 0 C--O 1.234 0.273 0 C-N-CA 124.3 1.04 . . . . 0.0 112.272 -168.049 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 68.43 0.09 15.3 Favored Glycine 0 CA--C 1.535 1.3 0 C-N-CA 125.436 1.493 . . . . 0.0 115.525 175.828 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.66 151.34 40.81 Favored 'General case' 0 C--N 1.345 0.391 0 CA-C-N 120.555 2.177 . . . . 0.0 109.499 -174.262 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 5.8 mt -80.38 136.47 23.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 N-CA-C 106.65 -1.611 . . . . 0.0 106.65 179.649 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 43.2 t -131.16 134.26 61.52 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 C-N-CA 123.755 0.822 . . . . 0.0 109.809 -179.567 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -105.34 152.73 22.57 Favored 'General case' 0 N--CA 1.462 0.139 0 N-CA-C 105.865 -1.902 . . . . 0.0 105.865 166.804 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 2.6 mt -134.08 134.4 42.26 Favored 'General case' 0 CA--C 1.512 -0.497 0 N-CA-C 107.096 -1.446 . . . . 0.0 107.096 175.537 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 36.0 p90 -148.86 168.77 22.13 Favored 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 169.628 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -163.41 173.6 39.56 Favored Glycine 0 N--CA 1.446 -0.661 0 N-CA-C 109.91 -1.276 . . . . 0.0 109.91 169.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.327 -0.375 0 C-N-CA 125.012 1.325 . . . . 0.0 108.435 171.035 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 84.3 mt . . . . . 0 N--CA 1.47 0.541 0 N-CA-C 116.253 1.945 . . . . 0.0 116.253 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -64.61 -35.03 79.69 Favored 'General case' 0 C--N 1.328 -0.348 0 O-C-N 120.441 -1.412 . . . . 0.0 111.116 -174.305 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -65.9 -31.43 72.36 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 123.845 0.858 . . . . 0.0 111.944 173.458 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 4.2 tt -65.92 -47.93 73.1 Favored 'General case' 0 N--CA 1.468 0.446 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 173.542 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -58.84 -40.53 95.25 Favored Glycine 0 CA--C 1.525 0.713 0 N-CA-C 111.09 -0.804 . . . . 0.0 111.09 178.081 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 3.0 tpp -49.75 -45.44 49.41 Favored 'General case' 0 N--CA 1.464 0.256 0 C-N-CA 124.685 1.194 . . . . 0.0 110.867 172.328 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -83.81 -31.26 25.95 Favored 'General case' 0 CA--C 1.52 -0.174 0 O-C-N 122.122 -0.361 . . . . 0.0 111.607 -171.683 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 36.8 t-80 -60.33 -45.26 94.08 Favored 'General case' 0 C--N 1.331 -0.234 0 O-C-N 121.964 -0.46 . . . . 0.0 109.813 169.482 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -63.42 -47.58 81.33 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 123.472 0.709 . . . . 0.0 111.088 179.511 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 2.2 tppm? -54.38 -31.05 53.88 Favored 'General case' 0 N--CA 1.466 0.352 0 C-N-CA 125.342 1.457 . . . . 0.0 111.854 173.863 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 49.2 mt -101.55 -22.32 14.52 Favored 'General case' 0 N--CA 1.465 0.28 0 N-CA-C 114.231 1.197 . . . . 0.0 114.231 -173.668 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 69.0 m -60.42 -34.88 74.59 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 119.897 1.226 . . . . 0.0 111.188 -176.718 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 24.3 p -80.38 -13.13 59.41 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 124.817 1.247 . . . . 0.0 111.833 -179.344 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 31.3 mmmt -88.24 -10.84 48.38 Favored 'General case' 0 C--N 1.342 0.281 0 C-N-CA 125.297 1.439 . . . . 0.0 111.64 179.778 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 75.04 32.92 55.94 Favored Glycine 0 CA--C 1.523 0.572 0 CA-C-O 119.567 -0.574 . . . . 0.0 111.795 173.166 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 9.9 m -72.88 172.42 1.04 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.582 0 CA-C-N 118.26 1.03 . . . . 0.0 109.024 169.721 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -112.25 121.38 44.74 Favored 'General case' 0 CA--C 1.514 -0.422 0 N-CA-C 106.224 -1.769 . . . . 0.0 106.224 176.073 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 63.3 m-85 -88.79 143.99 26.53 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 119.513 1.051 . . . . 0.0 109.756 -176.176 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 30.6 m -129.53 161.17 39.57 Favored 'Isoleucine or valine' 0 C--O 1.234 0.269 0 C-N-CA 124.787 1.235 . . . . 0.0 108.623 170.044 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 95.79 -93.5 1.57 Allowed Glycine 0 N--CA 1.444 -0.79 0 C-N-CA 124.581 1.086 . . . . 0.0 111.122 177.463 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 14.4 m-30 59.25 -178.3 0.08 Allowed 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 124.345 1.058 . . . . 0.0 109.011 -167.275 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -154.93 144.44 15.32 Favored Pre-proline 0 N--CA 1.471 0.6 0 O-C-N 120.192 -1.568 . . . . 0.0 110.604 179.416 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -67.74 123.84 11.21 Favored 'Trans proline' 0 CA--C 1.534 0.515 0 C-N-CA 123.222 2.614 . . . . 0.0 111.705 179.114 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 3.0 p . . . . . 0 CA--C 1.538 0.492 0 O-C-N 121.669 -0.644 . . . . 0.0 112.315 174.692 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 24.3 ttmt . . . . . 0 CA--C 1.542 0.666 0 CA-C-O 117.603 -1.189 . . . . 0.0 113.538 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_endo -83.83 8.22 4.75 Favored 'Trans proline' 0 C--N 1.351 0.681 0 C-N-CA 122.144 1.896 . . . . 0.0 114.436 -179.6 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 29.0 m -126.4 165.31 24.8 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.285 0 CA-C-N 121.156 1.798 . . . . 0.0 111.791 -176.622 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 9.5 pt -132.81 169.2 22.48 Favored 'Isoleucine or valine' 0 C--O 1.234 0.277 0 C-N-CA 127.746 2.419 . . . . 0.0 108.576 179.714 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . 53.87 42.03 31.85 Favored 'General case' 0 C--O 1.227 -0.109 0 C-N-CA 125.296 1.438 . . . . 0.0 112.263 174.109 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 27.7 t70 54.04 42.57 31.57 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 126.479 1.912 . . . . 0.0 111.684 -177.527 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 91.78 16.82 50.66 Favored Glycine 0 CA--C 1.527 0.827 0 CA-C-O 118.721 -1.044 . . . . 0.0 113.642 173.873 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 46.2 mt-30 -89.32 -7.74 54.72 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 119.345 1.573 . . . . 0.0 112.946 179.635 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 7.4 tp -156.23 147.37 22.29 Favored 'General case' 0 C--N 1.344 0.339 0 CA-C-N 119.462 1.028 . . . . 0.0 110.829 169.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 67.6 m-85 -81.08 146.7 30.47 Favored 'General case' 0 CA--C 1.52 -0.175 0 N-CA-C 107.817 -1.179 . . . . 0.0 107.817 168.4 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 12.5 m -80.55 9.24 0.82 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 C-N-CA 123.722 0.809 . . . . 0.0 112.386 177.225 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -177.81 170.29 42.56 Favored Glycine 0 CA--C 1.524 0.644 0 N-CA-C 110.271 -1.132 . . . . 0.0 110.271 179.42 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -65.07 137.82 57.93 Favored 'General case' 0 N--CA 1.465 0.305 0 C-N-CA 123.326 0.65 . . . . 0.0 111.295 -176.3 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -93.76 122.84 36.65 Favored 'General case' 0 N--CA 1.444 -0.737 0 C-N-CA 126.229 1.812 . . . . 0.0 109.717 176.447 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 86.5 mt . . . . . 0 C--N 1.332 -0.177 0 N-CA-C 106.096 -1.816 . . . . 0.0 106.096 168.209 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 48.6 m . . . . . 0 CA--C 1.53 0.197 0 CA-C-O 119.417 -0.325 . . . . 0.0 110.829 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -60.87 -40.99 95.07 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 118.105 0.412 . . . . 0.0 110.902 174.593 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 -67.43 -50.37 59.65 Favored 'General case' 0 C--O 1.234 0.271 0 C-N-CA 124.614 1.165 . . . . 0.0 110.376 179.662 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 60.4 mtm180 -58.16 -41.46 83.85 Favored 'General case' 0 N--CA 1.463 0.214 0 C-N-CA 123.969 0.908 . . . . 0.0 109.734 -179.042 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 56.2 mt -69.47 -54.18 20.99 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.441 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 176.074 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 70.0 tp60 -52.78 -62.33 1.72 Allowed 'General case' 0 C--O 1.234 0.273 0 C-N-CA 124.546 1.139 . . . . 0.0 111.854 -171.767 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 20.0 m -66.13 -32.28 73.64 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 120.758 -0.377 . . . . 0.0 110.89 -169.493 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 160' ' ' TRP . . . . . . . . . . . . . 40.1 t90 -70.75 -43.84 68.0 Favored 'General case' 0 C--O 1.222 -0.386 0 O-C-N 121.99 -0.444 . . . . 0.0 111.267 176.553 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 67.2 m -58.31 -44.65 88.67 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 118.215 0.461 . . . . 0.0 110.173 176.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -62.45 -40.93 98.19 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-O 121.009 0.433 . . . . 0.0 110.153 176.752 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 13.6 tt0 -63.03 -52.85 61.23 Favored 'General case' 0 N--CA 1.447 -0.584 0 CA-C-O 118.732 -0.651 . . . . 0.0 110.036 -179.632 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 41.8 pt -63.43 -38.54 82.46 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.345 0 CA-C-O 117.973 -1.013 . . . . 0.0 109.185 -175.37 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -66.67 -32.82 74.38 Favored 'General case' 0 CA--C 1.529 0.152 0 CA-C-N 119.385 0.993 . . . . 0.0 110.414 -178.622 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 31.7 m-80 -68.66 -59.02 3.41 Favored 'General case' 0 CA--C 1.516 -0.352 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 173.303 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 16.2 tt0 -61.04 -37.9 84.22 Favored 'General case' 0 N--CA 1.441 -0.916 0 C-N-CA 125.895 1.678 . . . . 0.0 111.482 -168.904 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 168' ' ' MET . . . . . . . . . . . . . 19.9 ptp -70.06 -30.03 67.19 Favored 'General case' 0 C--N 1.333 -0.131 0 O-C-N 121.442 -0.786 . . . . 0.0 112.23 174.814 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -77.28 -38.52 50.66 Favored 'General case' 0 N--CA 1.446 -0.627 0 C-N-CA 123.126 0.57 . . . . 0.0 112.249 178.658 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 . . . . . 0 N--CA 1.468 0.439 0 CA-C-O 121.907 0.86 . . . . 0.0 109.698 -179.276 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.498 1.932 0 N-CA-C 111.684 0.253 . . . . 0.0 111.684 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 5.8 t30 -113.53 153.08 29.34 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 124.294 1.037 . . . . 0.0 109.297 177.333 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 15.9 mtt -113.7 129.34 56.59 Favored 'General case' 0 N--CA 1.462 0.128 0 C-N-CA 123.802 0.841 . . . . 0.0 110.137 -179.471 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -83.86 150.7 26.78 Favored Glycine 0 CA--C 1.526 0.721 0 N-CA-C 107.43 -2.268 . . . . 0.0 107.43 167.215 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 2.0 tt -138.33 99.15 3.77 Favored 'General case' 0 N--CA 1.467 0.39 0 N-CA-C 105.63 -1.989 . . . . 0.0 105.63 -177.821 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 1.1 p90 -105.18 147.78 27.63 Favored 'General case' 0 CA--C 1.519 -0.229 0 CA-C-N 118.592 0.633 . . . . 0.0 112.028 -171.372 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 43.0 p90 . . . . . 0 CA--C 1.536 0.442 0 C-N-CA 126.077 1.751 . . . . 0.0 107.728 170.483 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.224 -0.24 0 N-CA-C 109.076 -0.712 . . . . 0.0 109.076 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -62.74 -47.7 82.44 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 123.944 0.898 . . . . 0.0 111.381 -174.261 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 31.2 mt-10 -57.98 -44.82 87.35 Favored 'General case' 0 CA--C 1.518 -0.267 0 C-N-CA 123.202 0.601 . . . . 0.0 109.556 175.179 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 49.9 mttm -64.91 -47.54 77.41 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-O 118.796 -0.621 . . . . 0.0 110.484 -177.623 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 83.3 mt -53.12 -55.06 14.08 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.2 0 CA-C-N 118.897 0.771 . . . . 0.0 109.307 -178.812 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.58 -35.06 79.29 Favored 'General case' 0 CA--C 1.513 -0.461 0 CA-C-O 118.812 -0.613 . . . . 0.0 111.313 -175.434 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -64.46 -39.9 94.69 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.997 0.427 . . . . 0.0 110.563 178.194 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 61.1 mt -78.01 -54.76 11.78 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.786 0 C-N-CA 124.77 1.228 . . . . 0.0 110.236 -171.092 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 71.3 mt -64.16 -46.22 94.17 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.326 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 179.257 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 141.98 124.1 1.93 Allowed Glycine 0 CA--C 1.528 0.898 0 C-N-CA 124.632 1.111 . . . . 0.0 110.969 173.528 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -69.94 -13.61 34.45 Favored 'Trans proline' 0 CA--C 1.539 0.738 0 C-N-CA 122.982 2.455 . . . . 0.0 112.836 -173.288 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -73.48 -21.42 60.43 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 118.509 0.595 . . . . 0.0 111.928 177.701 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -130.53 3.44 4.6 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 124.459 1.104 . . . . 0.0 113.535 -169.692 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 44.9 t -123.74 142.09 41.69 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.241 0 N-CA-C 107.62 -1.252 . . . . 0.0 107.62 171.262 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 30.5 m -129.27 132.48 47.19 Favored 'General case' 0 C--N 1.332 -0.182 0 C-N-CA 124.703 1.201 . . . . 0.0 108.427 -175.771 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 27.7 mt -75.25 135.73 40.97 Favored 'General case' 0 N--CA 1.456 -0.161 0 N-CA-C 107.999 -1.111 . . . . 0.0 107.999 175.432 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 28.5 t-80 -126.19 59.48 1.33 Allowed 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 125.148 1.379 . . . . 0.0 107.416 -176.811 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 33.3 t30 -69.55 113.26 6.67 Favored 'General case' 0 C--O 1.235 0.307 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 -176.296 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 77.6 mt -69.0 -14.89 63.31 Favored 'General case' 0 C--O 1.234 0.289 0 N-CA-C 112.554 0.576 . . . . 0.0 112.554 -171.775 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 1.3 tmtm? -58.81 -20.6 51.66 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 118.843 0.747 . . . . 0.0 111.173 168.82 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -128.03 -41.68 1.6 Allowed 'General case' 0 C--O 1.234 0.255 0 N-CA-C 113.287 0.847 . . . . 0.0 113.287 -175.801 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 30.5 m-20 -91.72 144.17 25.79 Favored 'General case' 0 C--O 1.235 0.301 0 C-N-CA 123.696 0.798 . . . . 0.0 111.07 -174.508 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 14.8 m -79.39 155.47 76.54 Favored Pre-proline 0 CA--C 1.539 0.551 0 C-N-CA 124.563 1.145 . . . . 0.0 110.258 176.361 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -76.93 -26.27 8.12 Favored 'Trans proline' 0 C--N 1.348 0.519 0 C-N-CA 122.232 1.955 . . . . 0.0 113.945 -171.082 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 8.2 mptt -62.64 -21.02 65.38 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 120.236 1.38 . . . . 0.0 111.8 -177.92 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -57.75 -29.74 65.04 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 125.865 1.666 . . . . 0.0 110.5 173.877 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 47.1 mtt -60.22 -26.21 66.23 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 118.763 0.71 . . . . 0.0 111.385 177.84 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 58.6 mt-10 -66.48 -33.51 75.85 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 118.714 0.688 . . . . 0.0 110.471 -176.651 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 24.3 mt-30 -63.77 -45.8 88.15 Favored 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 123.778 0.831 . . . . 0.0 112.868 -169.406 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 45.9 m-85 -76.24 136.02 39.67 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 115.393 -0.821 . . . . 0.0 109.473 -166.82 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -72.48 -30.19 64.31 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 118.865 0.757 . . . . 0.0 110.473 178.374 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 45.0 t -106.16 141.83 20.54 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.368 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 171.517 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 26.6 tp -136.82 118.46 14.95 Favored 'General case' 0 N--CA 1.446 -0.664 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 173.167 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 11.7 mt -93.61 133.48 34.54 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.829 0 N-CA-C 106.37 -1.715 . . . . 0.0 106.37 174.678 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 1.3 mp -111.23 134.07 53.1 Favored 'General case' 0 CA--C 1.518 -0.273 0 N-CA-C 106.703 -1.591 . . . . 0.0 106.703 -177.665 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -130.2 137.43 9.51 Favored Glycine 0 CA--C 1.518 0.257 0 N-CA-C 109.96 -1.256 . . . . 0.0 109.96 173.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 2.3 tt -151.57 133.86 8.45 Favored Pre-proline 0 CA--C 1.541 0.604 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 169.491 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_endo . . . . . 0 CA--C 1.538 0.703 0 C-N-CA 121.576 1.517 . . . . 0.0 114.521 -170.512 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 24.8 mt . . . . . 0 CA--C 1.542 0.635 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -93.27 161.61 14.33 Favored 'General case' 0 C--O 1.231 0.122 0 C-N-CA 124.313 1.045 . . . . 0.0 109.929 -178.724 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -54.56 -41.56 69.95 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 124.436 1.094 . . . . 0.0 111.63 -169.285 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 27.5 m-20 -59.71 -27.64 66.64 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-N 118.453 0.57 . . . . 0.0 112.026 -176.785 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 4.5 t90 -96.49 -44.86 6.99 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 125.688 1.595 . . . . 0.0 109.479 -178.069 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -63.02 -36.72 84.51 Favored 'General case' 0 CA--C 1.53 0.199 0 O-C-N 121.013 -1.054 . . . . 0.0 110.221 -179.177 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -61.12 -25.57 67.07 Favored 'General case' 0 C--O 1.234 0.268 0 C-N-CA 123.356 0.662 . . . . 0.0 111.015 -177.481 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 23.5 m -106.41 -17.97 7.41 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.539 0 CA-C-O 116.581 -1.676 . . . . 0.0 112.535 176.402 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 18.2 t90 -54.99 -35.65 64.57 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 121.492 1.951 . . . . 0.0 110.995 -179.275 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -63.43 -28.92 70.31 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 125.249 1.42 . . . . 0.0 112.715 174.1 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 62.9 mt-30 -92.57 -25.37 18.37 Favored 'General case' 0 C--O 1.224 -0.287 0 C-N-CA 126.436 1.894 . . . . 0.0 111.31 -179.842 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 37.6 mt -64.16 -26.43 68.52 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 118.727 0.694 . . . . 0.0 110.361 179.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -76.59 -25.67 54.21 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 117.794 0.27 . . . . 0.0 110.824 171.463 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -79.55 -33.38 41.93 Favored 'General case' 0 CA--C 1.538 0.494 0 O-C-N 121.257 -0.902 . . . . 0.0 113.049 179.403 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 30.6 mt -56.37 148.67 18.35 Favored 'General case' 0 C--O 1.234 0.265 0 C-N-CA 124.75 1.22 . . . . 0.0 111.02 -177.876 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 20.5 t-20 -86.03 122.88 30.68 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 170.325 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 74.2 mt -130.43 8.78 5.06 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 123.622 0.769 . . . . 0.0 112.222 -173.328 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 29.1 mt-10 -53.52 128.46 29.02 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 124.038 0.935 . . . . 0.0 112.256 -168.418 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 68.13 -0.26 12.42 Favored Glycine 0 CA--C 1.533 1.195 0 C-N-CA 125.443 1.497 . . . . 0.0 115.293 177.92 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.92 149.71 43.17 Favored 'General case' 0 C--N 1.343 0.308 0 CA-C-N 120.388 2.094 . . . . 0.0 109.635 -173.178 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 3.1 mt -80.56 133.33 29.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 N-CA-C 106.596 -1.631 . . . . 0.0 106.596 179.916 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 79.8 t -129.3 140.06 50.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 C-N-CA 124.122 0.969 . . . . 0.0 109.877 -176.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -128.42 154.31 46.17 Favored 'General case' 0 CA--C 1.53 0.173 0 C-N-CA 124.809 1.244 . . . . 0.0 108.052 169.795 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 2.4 mt -132.08 131.68 42.62 Favored 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 124.744 1.218 . . . . 0.0 108.334 -171.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 45.3 m-85 -130.28 141.93 50.58 Favored 'General case' 0 N--CA 1.451 -0.385 0 N-CA-C 106.643 -1.614 . . . . 0.0 106.643 -177.771 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -157.55 172.27 34.86 Favored Glycine 0 N--CA 1.442 -0.92 0 N-CA-C 108.965 -1.654 . . . . 0.0 108.965 168.502 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.324 -0.537 0 C-N-CA 124.527 1.131 . . . . 0.0 109.54 170.149 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 84.4 mt . . . . . 0 CA--C 1.537 0.47 0 N-CA-C 113.668 0.988 . . . . 0.0 113.668 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -56.51 -42.73 78.87 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 120.394 1.452 . . . . 0.0 112.592 -168.468 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -80.95 -14.87 57.57 Favored 'General case' 0 CA--C 1.534 0.329 0 N-CA-C 113.389 0.885 . . . . 0.0 113.389 179.786 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 6.6 tt -60.58 -43.55 97.2 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-N 120.056 1.298 . . . . 0.0 107.911 169.24 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -66.75 -32.7 82.03 Favored Glycine 0 C--N 1.337 0.595 0 N-CA-C 112.031 -0.428 . . . . 0.0 112.031 -175.52 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 77.2 mtm -72.37 -26.9 62.08 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-O 118.363 -0.827 . . . . 0.0 111.796 -175.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -76.41 -43.17 41.6 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 120.365 1.439 . . . . 0.0 109.372 169.019 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 82.1 t60 -53.34 -47.98 68.9 Favored 'General case' 0 N--CA 1.467 0.393 0 O-C-N 121.758 -0.589 . . . . 0.0 110.974 179.632 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -62.68 -37.24 85.68 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 123.676 0.79 . . . . 0.0 112.682 -177.505 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 25.1 ttmm -58.41 -36.41 73.54 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 123.575 0.75 . . . . 0.0 110.484 172.485 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 24.0 mt -91.95 -20.14 21.69 Favored 'General case' 0 CA--C 1.513 -0.453 0 N-CA-C 115.95 1.833 . . . . 0.0 115.95 -168.158 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 3.2 m -58.28 -32.97 68.92 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 120.665 1.575 . . . . 0.0 111.632 -176.433 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 21.1 p -88.27 -10.66 48.89 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 125.23 1.412 . . . . 0.0 112.409 -179.883 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 32.4 mmmt -82.99 -9.25 59.37 Favored 'General case' 0 C--N 1.347 0.458 0 C-N-CA 124.494 1.117 . . . . 0.0 111.435 175.169 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 73.81 31.93 59.67 Favored Glycine 0 CA--C 1.525 0.663 0 CA-C-O 119.645 -0.531 . . . . 0.0 112.165 172.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 5.8 m -73.25 174.44 0.78 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.618 0 CA-C-N 118.219 1.009 . . . . 0.0 109.158 169.748 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -115.63 131.28 56.98 Favored 'General case' 0 CA--C 1.518 -0.265 0 N-CA-C 106.909 -1.515 . . . . 0.0 106.909 172.772 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 80.3 m-85 -96.48 148.29 22.96 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 119.677 1.126 . . . . 0.0 109.384 -179.722 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 31.3 m -126.37 163.91 27.47 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.263 0 C-N-CA 123.847 0.859 . . . . 0.0 109.799 172.006 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 86.91 -91.34 1.73 Allowed Glycine 0 N--CA 1.444 -0.817 0 C-N-CA 124.996 1.284 . . . . 0.0 112.292 172.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 16.8 m-30 59.68 170.49 0.08 Allowed 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 126.081 1.752 . . . . 0.0 110.251 -165.599 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -141.09 140.86 21.94 Favored Pre-proline 0 N--CA 1.471 0.58 0 O-C-N 120.442 -1.411 . . . . 0.0 109.479 174.033 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_exo -54.51 129.12 33.16 Favored 'Trans proline' 0 N--CA 1.456 -0.731 0 C-N-CA 122.622 2.215 . . . . 0.0 110.65 169.796 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 20.7 p . . . . . 0 N--CA 1.47 0.564 0 N-CA-C 112.465 0.542 . . . . 0.0 112.465 171.681 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 54.3 mttt . . . . . 0 CA--C 1.54 0.582 0 CA-C-O 117.717 -1.135 . . . . 0.0 112.256 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -86.07 11.75 3.23 Favored 'Trans proline' 0 C--N 1.35 0.642 0 C-N-CA 122.001 1.801 . . . . 0.0 113.742 -172.725 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 21.9 m -129.54 161.26 39.4 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.171 0 CA-C-N 120.629 1.559 . . . . 0.0 111.797 -175.155 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 21.5 pt -132.92 173.16 15.26 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.344 0 C-N-CA 127.151 2.18 . . . . 0.0 108.988 -179.788 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . 54.12 43.43 30.7 Favored 'General case' 0 N--CA 1.461 0.112 0 C-N-CA 125.406 1.482 . . . . 0.0 112.07 174.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 27.3 t0 54.0 43.44 30.79 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 126.609 1.964 . . . . 0.0 111.603 -176.785 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 87.6 29.5 21.3 Favored Glycine 0 CA--C 1.526 0.77 0 CA-C-O 118.207 -1.329 . . . . 0.0 113.635 171.559 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 47.3 mt-30 -95.54 -23.39 17.1 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 119.141 1.471 . . . . 0.0 113.201 179.201 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -138.79 141.0 38.78 Favored 'General case' 0 CA--C 1.513 -0.477 0 CA-C-N 119.641 1.11 . . . . 0.0 110.56 176.026 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 67.5 m-85 -76.98 138.27 39.52 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 105.106 -2.183 . . . . 0.0 105.106 164.257 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 25.7 m -76.74 4.43 1.17 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.643 0 C-N-CA 123.188 0.595 . . . . 0.0 112.067 -177.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -168.5 -174.19 37.01 Favored Glycine 0 CA--C 1.523 0.537 0 C-N-CA 125.742 1.639 . . . . 0.0 109.16 -175.806 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 29.4 tp -75.06 140.95 43.86 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 122.892 0.477 . . . . 0.0 111.722 -171.739 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -89.43 132.71 34.87 Favored 'General case' 0 N--CA 1.447 -0.586 0 C-N-CA 125.876 1.67 . . . . 0.0 109.081 169.2 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 89.9 mt . . . . . 0 N--CA 1.467 0.425 0 N-CA-C 106.643 -1.614 . . . . 0.0 106.643 172.222 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 47.9 m . . . . . 0 CA--C 1.538 0.507 0 N-CA-C 109.745 -0.465 . . . . 0.0 109.745 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -60.12 -44.59 94.78 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 123.431 0.693 . . . . 0.0 110.497 174.154 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 27.3 tt0 -58.46 -46.89 85.68 Favored 'General case' 0 C--O 1.231 0.09 0 C-N-CA 124.171 0.989 . . . . 0.0 110.435 174.367 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.29 -46.24 86.45 Favored 'General case' 0 C--O 1.225 -0.224 0 CA-C-O 117.959 -1.019 . . . . 0.0 109.554 179.023 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 47.6 mt -60.45 -52.44 61.4 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.233 0 CA-C-N 119.687 1.131 . . . . 0.0 108.038 176.928 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 72.7 tp60 -53.29 -65.11 0.62 Allowed 'General case' 0 C--O 1.232 0.155 0 CA-C-N 119.23 0.923 . . . . 0.0 112.073 -177.151 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 19.9 m -68.75 -32.36 72.07 Favored 'General case' 0 C--N 1.325 -0.489 0 C-N-CA 121.4 -0.12 . . . . 0.0 111.309 -168.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 160' ' ' TRP . . . . . . . . . . . . . 2.8 t90 -73.13 -41.77 63.6 Favored 'General case' 0 C--O 1.221 -0.423 0 CA-C-O 118.977 -0.535 . . . . 0.0 110.618 177.465 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 23.2 m -55.47 -47.84 75.47 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 118.519 0.599 . . . . 0.0 110.343 173.387 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -60.3 -43.36 96.38 Favored 'General case' 0 C--N 1.332 -0.156 0 N-CA-C 109.681 -0.488 . . . . 0.0 109.681 178.752 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 15.0 tt0 -63.29 -51.71 64.96 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-O 117.904 -1.046 . . . . 0.0 110.383 -178.182 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 39.7 pt -64.15 -33.06 60.01 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.412 0 CA-C-O 118.127 -0.94 . . . . 0.0 109.441 -175.829 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -72.82 -31.45 64.82 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 119.395 0.998 . . . . 0.0 108.856 -174.375 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -71.53 -52.1 20.04 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 124.692 1.197 . . . . 0.0 109.084 173.277 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -67.7 -35.3 78.56 Favored 'General case' 0 N--CA 1.441 -0.883 0 C-N-CA 125.78 1.632 . . . . 0.0 109.425 -169.485 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 168' ' ' MET . . . . . . . . . . . . . 21.5 ptp -73.03 -29.11 62.76 Favored 'General case' 0 C--N 1.333 -0.128 0 O-C-N 122.28 -0.262 . . . . 0.0 111.583 176.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -75.62 -36.56 60.21 Favored 'General case' 0 N--CA 1.444 -0.726 0 CA-C-O 119.16 -0.448 . . . . 0.0 111.779 178.2 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 5.8 mt-10 . . . . . 0 N--CA 1.466 0.332 0 CA-C-O 122.248 1.023 . . . . 0.0 109.275 178.486 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.498 1.964 0 CA-C-O 120.322 0.106 . . . . 0.0 111.197 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 24.8 p-10 -120.61 165.95 14.33 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 125.082 1.353 . . . . 0.0 111.512 -175.333 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 11.9 mtt -130.27 133.91 46.84 Favored 'General case' 0 CA--C 1.52 -0.195 0 C-N-CA 123.361 0.665 . . . . 0.0 110.507 175.625 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -100.48 142.42 15.84 Favored Glycine 0 CA--C 1.523 0.559 0 N-CA-C 106.769 -2.532 . . . . 0.0 106.769 167.538 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 2.2 tt -128.22 101.15 6.12 Favored 'General case' 0 CA--C 1.518 -0.252 0 N-CA-C 105.852 -1.907 . . . . 0.0 105.852 -172.899 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -102.49 144.26 31.16 Favored 'General case' 0 N--CA 1.455 -0.216 0 CA-C-O 121.588 0.709 . . . . 0.0 111.672 -173.809 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 43.7 p90 . . . . . 0 CA--C 1.537 0.478 0 C-N-CA 127.04 2.136 . . . . 0.0 106.489 175.0 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.462 0.168 0 N-CA-C 109.03 -0.729 . . . . 0.0 109.03 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -64.02 -47.45 80.22 Favored 'General case' 0 N--CA 1.455 -0.19 0 C-N-CA 122.921 0.489 . . . . 0.0 111.54 -175.276 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 10.2 mt-10 -60.95 -42.99 99.33 Favored 'General case' 0 CA--C 1.517 -0.309 0 CA-C-O 118.903 -0.57 . . . . 0.0 109.949 176.678 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 29.3 mtpp -71.14 -40.67 71.22 Favored 'General case' 0 C--O 1.221 -0.435 0 CA-C-O 118.057 -0.973 . . . . 0.0 110.775 -174.132 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 47.6 mt -53.81 -54.27 20.92 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.267 0 CA-C-N 120.014 1.279 . . . . 0.0 108.818 173.07 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 8.5 ttp180 -60.56 -41.07 93.82 Favored 'General case' 0 C--O 1.223 -0.298 0 C-N-CA 123.397 0.679 . . . . 0.0 109.65 -176.703 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -66.74 -41.17 88.25 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 122.945 0.498 . . . . 0.0 111.066 -178.894 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 41.0 mt -68.76 -56.18 13.13 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.57 0 C-N-CA 124.345 1.058 . . . . 0.0 109.691 -175.61 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 79.0 mt -67.89 -44.23 85.4 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.428 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 -175.649 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 138.55 125.39 2.32 Favored Glycine 0 CA--C 1.53 1.022 0 C-N-CA 125.061 1.315 . . . . 0.0 111.493 173.22 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -71.95 -6.21 18.66 Favored 'Trans proline' 0 CA--C 1.537 0.666 0 C-N-CA 123.505 2.803 . . . . 0.0 114.044 -175.674 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -80.15 -18.63 49.23 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 119.232 0.924 . . . . 0.0 111.241 175.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -128.66 -10.1 5.03 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 124.532 1.133 . . . . 0.0 113.994 -173.803 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 31.5 t -106.97 150.07 9.84 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.352 0 CA-C-N 119.375 0.989 . . . . 0.0 108.346 170.702 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 2.7 m -137.23 130.97 31.74 Favored 'General case' 0 N--CA 1.456 -0.174 0 N-CA-C 106.599 -1.63 . . . . 0.0 106.599 -172.909 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 21.3 mt -80.46 143.71 33.16 Favored 'General case' 0 CA--C 1.53 0.202 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 176.916 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 39.0 t-80 -136.77 64.88 1.53 Allowed 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 124.451 1.1 . . . . 0.0 108.195 -174.554 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 64.4 t-20 -72.39 119.12 16.15 Favored 'General case' 0 CA--C 1.53 0.193 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 -178.407 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 81.9 mt -66.06 -18.31 65.26 Favored 'General case' 0 C--O 1.233 0.206 0 C-N-CA 123.782 0.833 . . . . 0.0 112.918 -176.839 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 28.3 tptp -55.35 -27.12 45.19 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-O 118.879 -0.581 . . . . 0.0 111.156 168.654 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -121.47 -41.45 2.49 Favored 'General case' 0 N--CA 1.464 0.271 0 N-CA-C 113.549 0.944 . . . . 0.0 113.549 -173.856 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 29.6 m-20 -96.53 142.29 28.78 Favored 'General case' 0 C--O 1.234 0.276 0 C-N-CA 123.334 0.654 . . . . 0.0 110.702 -176.151 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 14.0 m -75.97 156.27 84.31 Favored Pre-proline 0 CA--C 1.542 0.646 0 C-N-CA 124.181 0.992 . . . . 0.0 109.986 173.632 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo -77.27 -25.1 8.79 Favored 'Trans proline' 0 C--N 1.348 0.533 0 C-N-CA 122.212 1.941 . . . . 0.0 113.312 -169.785 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 23.7 mmmt -69.38 -15.26 63.27 Favored 'General case' 0 N--CA 1.474 0.758 0 O-C-N 120.512 -1.368 . . . . 0.0 111.693 -176.029 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -62.01 -26.82 68.46 Favored 'General case' 0 N--CA 1.464 0.263 0 C-N-CA 125.555 1.542 . . . . 0.0 110.603 169.426 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 51.3 mtt -58.99 -25.29 63.5 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 119.207 0.912 . . . . 0.0 111.48 177.308 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -64.06 -31.83 73.17 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 118.395 0.543 . . . . 0.0 110.127 -176.535 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 27.3 mt-30 -67.05 -38.79 86.46 Favored 'General case' 0 CA--C 1.534 0.364 0 N-CA-C 113.302 0.852 . . . . 0.0 113.302 -170.873 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 61.0 m-85 -76.08 136.25 39.88 Favored 'General case' 0 CA--C 1.52 -0.202 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 -167.49 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -71.84 -37.75 70.23 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-N 118.281 0.491 . . . . 0.0 110.576 -178.349 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 15.4 t -107.22 144.95 15.26 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.364 0 N-CA-C 107.52 -1.289 . . . . 0.0 107.52 169.003 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 28.8 tp -132.97 120.29 21.22 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 175.098 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 48.3 mt -99.41 129.25 50.19 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.606 0 N-CA-C 106.47 -1.678 . . . . 0.0 106.47 179.774 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -110.13 132.47 54.14 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 125.539 1.536 . . . . 0.0 107.793 -175.342 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -138.44 138.73 9.71 Favored Glycine 0 C--N 1.332 0.346 0 N-CA-C 109.821 -1.312 . . . . 0.0 109.821 178.233 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 3.9 tt -155.75 133.46 6.75 Favored Pre-proline 0 CA--C 1.535 0.37 0 CA-C-N 117.555 0.677 . . . . 0.0 111.164 172.805 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_exo . . . . . 0 N--CA 1.456 -0.704 0 C-N-CA 122.376 2.051 . . . . 0.0 109.197 164.06 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 12.8 mt . . . . . 0 CA--C 1.543 0.682 0 CA-C-O 121.581 0.705 . . . . 0.0 112.289 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 4.1 mp0 -72.59 153.99 41.0 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 124.836 1.254 . . . . 0.0 109.828 179.421 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -59.07 -42.84 91.35 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 123.338 0.655 . . . . 0.0 111.593 -170.255 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -60.54 -24.67 65.55 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 123.591 0.757 . . . . 0.0 111.95 -177.639 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 1.8 t90 -96.04 -42.63 8.16 Favored 'General case' 0 N--CA 1.447 -0.588 0 C-N-CA 124.695 1.198 . . . . 0.0 109.773 -178.425 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 7.8 tt0 -63.14 -33.86 76.38 Favored 'General case' 0 N--CA 1.446 -0.665 0 O-C-N 120.749 -1.219 . . . . 0.0 109.868 178.708 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -55.82 -24.65 37.47 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 124.333 1.053 . . . . 0.0 111.965 -179.497 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 35.3 m -116.84 -11.42 11.81 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.171 0 CA-C-O 117.596 -1.192 . . . . 0.0 113.179 178.245 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 25.0 t90 -52.87 -38.28 61.41 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 119.959 1.254 . . . . 0.0 110.435 -178.891 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -64.6 -27.11 68.72 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 125.361 1.464 . . . . 0.0 113.303 177.041 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 30.0 mt-30 -92.6 -19.41 21.93 Favored 'General case' 0 C--N 1.342 0.244 0 C-N-CA 125.309 1.443 . . . . 0.0 112.617 178.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 60.1 mt -59.55 -25.94 64.96 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 118.633 0.651 . . . . 0.0 111.137 -178.414 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -77.1 -25.15 51.92 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 118.085 0.402 . . . . 0.0 111.626 176.704 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -72.98 -29.98 63.47 Favored 'General case' 0 N--CA 1.467 0.376 0 O-C-N 121.058 -1.026 . . . . 0.0 111.828 178.866 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 76.5 mt -53.62 139.86 30.65 Favored 'General case' 0 C--N 1.341 0.218 0 C-N-CA 125.016 1.326 . . . . 0.0 112.289 -169.008 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 28.8 t-20 -77.2 107.44 9.6 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 169.707 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 65.2 mt -127.6 1.48 6.18 Favored 'General case' 0 N--CA 1.474 0.734 0 N-CA-C 113.912 1.079 . . . . 0.0 113.912 -173.237 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -51.87 129.16 26.04 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-N 119.228 0.922 . . . . 0.0 111.482 -168.442 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 70.63 -2.0 18.69 Favored Glycine 0 CA--C 1.535 1.326 0 C-N-CA 125.935 1.731 . . . . 0.0 115.972 177.523 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.05 151.85 38.67 Favored 'General case' 0 C--N 1.344 0.366 0 CA-C-N 121.002 2.401 . . . . 0.0 110.53 -172.097 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 6.7 mt -81.1 137.49 21.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 N-CA-C 106.676 -1.601 . . . . 0.0 106.676 178.849 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 78.0 t -134.68 136.4 52.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 C-N-CA 123.729 0.812 . . . . 0.0 110.235 -174.365 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -110.82 150.77 28.67 Favored 'General case' 0 N--CA 1.468 0.45 0 N-CA-C 107.878 -1.156 . . . . 0.0 107.878 169.257 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 2.8 mt -130.87 136.54 48.72 Favored 'General case' 0 CA--C 1.51 -0.562 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 174.603 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 43.6 p90 -147.42 166.82 26.06 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 168.669 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -162.46 160.03 32.27 Favored Glycine 0 N--CA 1.447 -0.582 0 N-CA-C 109.811 -1.316 . . . . 0.0 109.811 172.416 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 4.1 tt . . . . . 0 N--CA 1.448 -0.553 0 C-N-CA 125.457 1.503 . . . . 0.0 108.001 173.934 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 80.2 mt . . . . . 0 N--CA 1.468 0.433 0 N-CA-C 110.111 -0.329 . . . . 0.0 110.111 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -59.78 -33.77 72.14 Favored 'General case' 0 N--CA 1.467 0.376 0 O-C-N 120.581 -1.325 . . . . 0.0 111.944 -171.415 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -73.45 -27.92 61.68 Favored 'General case' 0 CA--C 1.535 0.367 0 O-C-N 121.234 -0.916 . . . . 0.0 112.44 177.268 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 4.4 tt -60.67 -47.06 87.93 Favored 'General case' 0 N--CA 1.467 0.419 0 N-CA-C 107.458 -1.312 . . . . 0.0 107.458 169.065 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -62.31 -42.03 99.72 Favored Glycine 0 C--N 1.339 0.715 0 N-CA-C 111.44 -0.664 . . . . 0.0 111.44 -178.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 76.3 mtm -63.96 -38.37 90.82 Favored 'General case' 0 CA--C 1.529 0.166 0 CA-C-N 118.182 0.991 . . . . 0.0 111.726 179.564 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 4.2 tp -71.61 -35.45 70.48 Favored 'General case' 0 C--N 1.345 0.373 0 CA-C-N 120.247 1.385 . . . . 0.0 110.341 178.885 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -54.56 -51.65 64.55 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 118.899 0.772 . . . . 0.0 110.283 169.132 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -64.47 -42.77 95.71 Favored 'General case' 0 C--O 1.233 0.229 0 C-N-CA 122.754 0.422 . . . . 0.0 111.466 -172.289 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 22.5 ttmm -58.43 -39.36 79.6 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 123.897 0.879 . . . . 0.0 110.655 173.225 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 52.0 mt -87.11 -22.23 25.51 Favored 'General case' 0 CA--C 1.517 -0.29 0 N-CA-C 114.152 1.167 . . . . 0.0 114.152 -169.454 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 8.3 t -56.95 -36.24 70.03 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-N 119.393 0.997 . . . . 0.0 110.879 -175.673 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 21.1 p -86.21 -8.1 58.04 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 124.581 1.152 . . . . 0.0 112.2 -178.298 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 32.4 mmmt -83.15 -8.32 59.51 Favored 'General case' 0 C--N 1.346 0.441 0 C-N-CA 124.573 1.149 . . . . 0.0 111.709 175.393 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 74.7 29.11 61.85 Favored Glycine 0 CA--C 1.526 0.777 0 CA-C-N 118.424 0.557 . . . . 0.0 112.462 173.343 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 17.1 m -75.23 176.44 0.64 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 CA-C-N 117.957 0.879 . . . . 0.0 109.989 171.887 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -121.54 125.95 48.01 Favored 'General case' 0 CA--C 1.52 -0.208 0 N-CA-C 106.918 -1.512 . . . . 0.0 106.918 174.442 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 79.5 m-85 -89.5 145.03 25.57 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 119.562 1.074 . . . . 0.0 109.337 -178.649 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 27.3 m -126.68 157.86 37.41 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.212 0 C-N-CA 124.237 1.015 . . . . 0.0 109.084 171.149 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 95.38 -88.4 1.09 Allowed Glycine 0 C--N 1.333 0.364 0 CA-C-O 119.109 -0.829 . . . . 0.0 111.259 173.185 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 22.0 m-30 57.56 -173.49 0.08 Allowed 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 124.104 0.961 . . . . 0.0 110.446 -168.735 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -153.96 146.3 17.33 Favored Pre-proline 0 N--CA 1.473 0.69 0 CA-C-N 120.359 1.436 . . . . 0.0 109.656 178.952 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_endo -67.71 124.42 11.91 Favored 'Trans proline' 0 CA--C 1.535 0.568 0 C-N-CA 122.959 2.439 . . . . 0.0 112.121 178.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 2.9 p . . . . . 0 CA--C 1.538 0.51 0 O-C-N 121.507 -0.746 . . . . 0.0 112.296 171.958 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 7.6 ttmt . . . . . 0 CA--C 1.542 0.647 0 CA-C-O 117.441 -1.266 . . . . 0.0 113.929 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_endo -77.41 5.81 4.86 Favored 'Trans proline' 0 C--N 1.352 0.752 0 CA-C-N 122.012 1.754 . . . . 0.0 114.385 179.154 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 26.9 m -132.02 169.58 21.56 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.215 0 CA-C-N 120.411 1.459 . . . . 0.0 110.434 -176.844 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 23.0 pt -138.49 171.97 14.5 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.507 0 C-N-CA 126.768 2.027 . . . . 0.0 108.594 -177.606 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . 54.76 41.27 32.05 Favored 'General case' 0 CA--C 1.528 0.106 0 C-N-CA 125.081 1.352 . . . . 0.0 112.46 174.302 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 27.3 t70 55.7 42.15 29.63 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 126.187 1.795 . . . . 0.0 111.734 -176.121 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 88.19 15.6 60.46 Favored Glycine 0 CA--C 1.528 0.891 0 CA-C-O 118.93 -0.928 . . . . 0.0 113.679 174.446 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 45.4 mt-30 -88.46 -7.59 56.31 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 118.934 1.367 . . . . 0.0 112.524 -179.06 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 8.3 tp -155.44 146.05 22.13 Favored 'General case' 0 C--N 1.344 0.35 0 CA-C-N 119.241 0.928 . . . . 0.0 110.291 172.304 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 58.4 m-85 -76.9 144.1 39.14 Favored 'General case' 0 CA--C 1.514 -0.425 0 N-CA-C 107.472 -1.307 . . . . 0.0 107.472 169.294 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 4.4 p -82.23 14.1 0.52 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.573 0 CA-C-O 121.159 0.504 . . . . 0.0 112.13 -179.6 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 178.47 172.42 42.83 Favored Glycine 0 CA--C 1.525 0.685 0 N-CA-C 110.009 -1.237 . . . . 0.0 110.009 176.623 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 1.1 tp -65.79 138.04 57.65 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 117.631 0.715 . . . . 0.0 110.883 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -98.89 114.38 26.96 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 125.941 1.697 . . . . 0.0 110.178 -179.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 3.9 mm? . . . . . 0 CA--C 1.537 0.457 0 N-CA-C 106.386 -1.709 . . . . 0.0 106.386 166.945 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 21.9 m . . . . . 0 CA--C 1.534 0.328 0 N-CA-C 110.283 -0.266 . . . . 0.0 110.283 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -61.23 -40.43 93.98 Favored 'General case' 0 N--CA 1.463 0.179 0 O-C-N 121.917 -0.489 . . . . 0.0 110.884 172.19 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 -65.95 -47.4 74.78 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 124.106 0.962 . . . . 0.0 110.505 179.396 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 75.5 mtt-85 -52.2 -46.01 65.44 Favored 'General case' 0 N--CA 1.463 0.19 0 C-N-CA 124.509 1.124 . . . . 0.0 110.397 176.415 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 30.6 mt -70.37 -53.71 21.7 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 N-CA-C 107.847 -1.168 . . . . 0.0 107.847 179.302 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 68.7 tp60 -49.66 -64.77 0.71 Allowed 'General case' 0 C--O 1.233 0.22 0 C-N-CA 125.569 1.548 . . . . 0.0 112.202 -174.132 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 20.1 m -67.8 -31.86 72.02 Favored 'General case' 0 C--N 1.324 -0.512 0 C-N-CA 120.924 -0.31 . . . . 0.0 110.768 -169.075 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 160' ' ' TRP . . . . . . . . . . . . . 36.2 t90 -68.86 -44.2 73.83 Favored 'General case' 0 C--O 1.221 -0.407 0 O-C-N 122.128 -0.357 . . . . 0.0 110.914 176.455 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 87.8 m -60.68 -42.53 97.3 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 122.889 0.476 . . . . 0.0 110.636 177.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -63.35 -40.95 98.68 Favored 'General case' 0 CA--C 1.529 0.148 0 CA-C-O 121.481 0.658 . . . . 0.0 110.041 175.153 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 13.7 tt0 -64.67 -49.08 72.35 Favored 'General case' 0 N--CA 1.451 -0.419 0 O-C-N 121.375 -0.828 . . . . 0.0 110.735 -178.798 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 45.7 pt -64.6 -38.88 83.78 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.348 0 CA-C-O 118.089 -0.958 . . . . 0.0 109.62 -176.265 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -64.93 -32.59 74.39 Favored 'General case' 0 CA--C 1.53 0.176 0 CA-C-N 118.913 0.779 . . . . 0.0 110.229 179.698 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 29.6 m-80 -67.71 -60.69 2.33 Favored 'General case' 0 C--O 1.221 -0.444 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 172.523 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -53.21 -43.93 67.62 Favored 'General case' 0 N--CA 1.441 -0.89 0 C-N-CA 126.965 2.106 . . . . 0.0 111.168 -171.247 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 168' ' ' MET . . . . . . . . . . . . . 19.7 ptp -70.92 -31.68 68.36 Favored 'General case' 0 C--N 1.333 -0.151 0 N-CA-C 112.143 0.423 . . . . 0.0 112.143 179.244 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -75.35 -35.28 61.19 Favored 'General case' 0 N--CA 1.445 -0.723 0 N-CA-C 111.74 0.274 . . . . 0.0 111.74 177.918 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 . . . . . 0 N--CA 1.467 0.387 0 CA-C-O 121.579 0.704 . . . . 0.0 109.581 178.634 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.498 1.971 0 N-CA-C 111.108 0.04 . . . . 0.0 111.108 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 19.3 p-10 -128.68 163.83 24.25 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 124.843 1.257 . . . . 0.0 111.49 -171.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 10.2 mtt -129.15 133.19 47.5 Favored 'General case' 0 CA--C 1.521 -0.153 0 C-N-CA 123.385 0.674 . . . . 0.0 111.418 179.118 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -98.43 147.24 18.48 Favored Glycine 0 CA--C 1.53 1.007 0 N-CA-C 106.395 -2.682 . . . . 0.0 106.395 166.718 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 1.2 tt -133.67 96.7 3.74 Favored 'General case' 0 N--CA 1.465 0.315 0 N-CA-C 105.573 -2.01 . . . . 0.0 105.573 -173.028 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -97.36 146.75 24.87 Favored 'General case' 0 CA--C 1.514 -0.419 0 CA-C-N 118.03 0.377 . . . . 0.0 111.109 -173.635 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 34.2 p90 . . . . . 0 C--N 1.33 -0.268 0 C-N-CA 124.471 1.108 . . . . 0.0 109.518 176.7 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.224 -0.264 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -61.99 -46.52 88.86 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 118.443 0.565 . . . . 0.0 111.133 -175.49 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -59.54 -48.22 82.5 Favored 'General case' 0 N--CA 1.451 -0.398 0 C-N-CA 124.379 1.072 . . . . 0.0 110.11 176.479 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 28.8 mtpp -68.99 -37.76 78.93 Favored 'General case' 0 C--O 1.224 -0.253 0 CA-C-O 117.992 -1.004 . . . . 0.0 111.033 -175.22 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 63.1 mt -54.21 -57.75 5.28 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.199 0 CA-C-N 119.712 1.142 . . . . 0.0 108.471 175.652 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 15.1 ptt180 -62.84 -39.14 93.46 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-O 118.834 -0.603 . . . . 0.0 110.067 -177.149 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -65.38 -39.18 91.95 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 118.339 0.518 . . . . 0.0 110.358 -173.673 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 62.9 mt -76.62 -52.61 16.82 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.699 0 C-N-CA 124.886 1.274 . . . . 0.0 110.091 -175.855 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 64.1 mt -60.55 -47.54 92.36 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.336 0 C-N-CA 123.025 0.53 . . . . 0.0 109.841 179.283 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 139.61 113.97 1.14 Allowed Glycine 0 CA--C 1.525 0.66 0 C-N-CA 125.656 1.598 . . . . 0.0 109.258 -179.113 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -72.87 -7.93 21.52 Favored 'Trans proline' 0 CA--C 1.537 0.666 0 C-N-CA 122.509 2.139 . . . . 0.0 113.423 -169.599 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -77.39 -20.57 54.5 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 118.934 0.788 . . . . 0.0 111.57 178.726 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -122.37 7.59 9.61 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 124.886 1.275 . . . . 0.0 113.383 -173.49 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 45.4 t -124.28 148.77 28.42 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.231 0 C-N-CA 124.924 1.29 . . . . 0.0 107.713 175.596 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 7.8 m -134.11 133.27 40.89 Favored 'General case' 0 C--N 1.331 -0.211 0 C-N-CA 124.959 1.303 . . . . 0.0 108.045 -175.861 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 21.8 mt -78.62 139.31 38.57 Favored 'General case' 0 C--O 1.232 0.158 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 175.695 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 36.0 t-80 -137.98 54.28 1.8 Allowed 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 124.321 1.049 . . . . 0.0 108.704 -174.409 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 21.3 t-20 -57.0 134.02 55.43 Favored 'General case' 0 CA--C 1.533 0.312 0 O-C-N 120.838 -1.164 . . . . 0.0 108.386 172.695 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 51.6 mt -74.17 -20.98 60.03 Favored 'General case' 0 CA--C 1.531 0.24 0 N-CA-C 114.344 1.238 . . . . 0.0 114.344 -168.872 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 14.9 tmtt? -73.29 -38.46 65.87 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 119.25 0.932 . . . . 0.0 109.014 168.501 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -73.53 -37.69 65.54 Favored 'General case' 0 C--O 1.234 0.258 0 N-CA-C 113.429 0.9 . . . . 0.0 113.429 -173.151 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 3.2 t0 -143.36 153.9 43.19 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 118.762 0.71 . . . . 0.0 112.249 175.405 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 17.2 m -73.68 157.17 87.89 Favored Pre-proline 0 CA--C 1.54 0.596 0 C-N-CA 125.842 1.657 . . . . 0.0 111.759 -169.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -72.72 -26.87 15.64 Favored 'Trans proline' 0 C--N 1.349 0.565 0 C-N-CA 122.761 2.307 . . . . 0.0 113.282 -171.211 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 22.4 mmmt -70.78 -13.22 61.97 Favored 'General case' 0 N--CA 1.473 0.696 0 O-C-N 120.252 -1.53 . . . . 0.0 111.842 -175.817 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -60.64 -29.1 69.06 Favored 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 125.526 1.53 . . . . 0.0 110.08 169.409 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 45.7 mtt -56.63 -25.05 52.16 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 118.966 0.803 . . . . 0.0 111.732 178.419 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 93.8 mt-10 -65.3 -31.69 72.96 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 118.432 0.56 . . . . 0.0 110.325 -177.13 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 24.9 mt-30 -67.39 -42.72 82.86 Favored 'General case' 0 N--CA 1.466 0.342 0 N-CA-C 113.259 0.837 . . . . 0.0 113.259 -169.788 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 34.8 m-85 -73.77 140.05 45.63 Favored 'General case' 0 C--O 1.23 0.045 0 C-N-CA 123.53 0.732 . . . . 0.0 109.966 -167.181 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -67.07 -45.22 78.03 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 118.588 0.631 . . . . 0.0 109.801 174.109 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 6.4 t -102.05 142.22 16.85 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.591 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 175.139 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 31.3 tp -129.94 112.77 13.84 Favored 'General case' 0 N--CA 1.442 -0.842 0 N-CA-C 108.439 -0.949 . . . . 0.0 108.439 173.34 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 17.8 mt -88.41 133.57 30.47 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.591 0 N-CA-C 106.334 -1.728 . . . . 0.0 106.334 172.069 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -109.52 140.61 43.08 Favored 'General case' 0 CA--C 1.517 -0.299 0 C-N-CA 125.904 1.681 . . . . 0.0 106.52 179.404 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -141.99 146.89 18.24 Favored Glycine 0 CA--C 1.518 0.249 0 N-CA-C 110.261 -1.136 . . . . 0.0 110.261 175.036 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 16.5 tt -157.97 139.09 9.55 Favored Pre-proline 0 CA--C 1.538 0.506 0 N-CA-C 107.599 -1.259 . . . . 0.0 107.599 177.276 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo . . . . . 0 CA--C 1.548 1.194 0 C-N-CA 123.163 2.576 . . . . 0.0 112.835 170.187 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 72.0 mt . . . . . 0 CA--C 1.546 0.808 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -77.73 156.82 30.38 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-O 121.583 0.706 . . . . 0.0 111.192 178.979 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -57.99 -42.32 84.89 Favored 'General case' 0 C--O 1.225 -0.236 0 C-N-CA 124.269 1.028 . . . . 0.0 111.722 -169.249 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 45.5 m-20 -61.44 -23.47 65.87 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 119.108 0.867 . . . . 0.0 112.049 -173.861 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 6.9 t90 -96.09 -48.01 5.84 Favored 'General case' 0 CA--C 1.527 0.071 0 C-N-CA 124.496 1.118 . . . . 0.0 109.652 177.374 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 8.2 tt0 -65.33 -36.02 82.77 Favored 'General case' 0 N--CA 1.447 -0.62 0 O-C-N 120.962 -1.086 . . . . 0.0 110.556 -174.182 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -61.49 -25.99 67.61 Favored 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 123.653 0.781 . . . . 0.0 111.055 -174.709 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 28.5 m -108.48 -15.64 9.2 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.289 0 CA-C-O 117.234 -1.365 . . . . 0.0 112.195 177.071 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 34.8 t90 -52.27 -35.09 49.11 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 120.526 1.512 . . . . 0.0 110.861 178.049 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -62.61 -29.42 70.59 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 125.31 1.444 . . . . 0.0 113.163 175.272 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 29.3 mt-30 -92.15 -19.62 22.09 Favored 'General case' 0 C--N 1.341 0.218 0 C-N-CA 125.874 1.67 . . . . 0.0 112.393 177.453 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 53.4 mt -63.05 -20.71 65.59 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-N 118.903 0.774 . . . . 0.0 111.474 -177.607 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -78.93 -23.94 44.34 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 123.055 0.542 . . . . 0.0 111.773 174.602 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -72.21 -29.18 63.72 Favored 'General case' 0 N--CA 1.469 0.514 0 O-C-N 120.918 -1.114 . . . . 0.0 111.706 179.049 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 79.8 mt -53.36 141.15 25.19 Favored 'General case' 0 C--N 1.34 0.194 0 C-N-CA 125.141 1.376 . . . . 0.0 113.106 -168.509 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 3.2 t30 -75.7 102.67 5.48 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 170.025 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 61.3 mt -125.26 -0.14 7.72 Favored 'General case' 0 N--CA 1.475 0.821 0 N-CA-C 114.205 1.187 . . . . 0.0 114.205 -174.025 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 26.9 mt-10 -56.68 129.2 40.09 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-N 119.666 1.121 . . . . 0.0 111.115 -168.613 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 74.18 -2.12 45.69 Favored Glycine 0 CA--C 1.534 1.228 0 C-N-CA 125.493 1.521 . . . . 0.0 114.998 178.525 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.4 151.37 38.16 Favored 'General case' 0 C--N 1.346 0.426 0 CA-C-N 120.617 2.208 . . . . 0.0 110.021 -175.025 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 6.7 mt -80.67 136.29 23.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 N-CA-C 106.661 -1.607 . . . . 0.0 106.661 178.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 65.2 t -132.48 140.51 47.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 C-N-CA 124.054 0.942 . . . . 0.0 109.192 -177.376 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -125.28 144.72 50.34 Favored 'General case' 0 N--CA 1.456 -0.162 0 N-CA-C 108.118 -1.068 . . . . 0.0 108.118 170.575 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 4.2 mt -117.83 120.76 38.89 Favored 'General case' 0 CA--C 1.518 -0.26 0 C-N-CA 124.416 1.086 . . . . 0.0 108.612 -175.769 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 22.5 m-85 -113.07 151.98 30.09 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 107.406 -1.331 . . . . 0.0 107.406 169.861 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -155.81 137.5 5.57 Favored Glycine 0 N--CA 1.449 -0.485 0 N-CA-C 107.825 -2.11 . . . . 0.0 107.825 167.619 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 27.1 tp . . . . . 0 N--CA 1.442 -0.831 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 169.971 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 90.3 mt . . . . . 0 N--CA 1.468 0.458 0 N-CA-C 113.15 0.796 . . . . 0.0 113.15 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -61.71 -39.19 90.62 Favored 'General case' 0 N--CA 1.465 0.285 0 O-C-N 120.687 -1.258 . . . . 0.0 111.366 -168.679 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -79.0 -15.86 57.69 Favored 'General case' 0 N--CA 1.445 -0.698 0 O-C-N 121.093 -1.004 . . . . 0.0 112.885 178.768 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 5.4 tt -63.44 -42.2 98.67 Favored 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 106.568 -1.641 . . . . 0.0 106.568 167.679 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -63.83 -37.58 94.88 Favored Glycine 0 C--N 1.341 0.812 0 N-CA-C 111.34 -0.704 . . . . 0.0 111.34 178.67 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 28.5 mtm -64.53 -45.23 88.08 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 118.397 1.099 . . . . 0.0 111.813 177.873 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.7 -39.69 88.16 Favored 'General case' 0 C--N 1.344 0.354 0 CA-C-N 120.233 1.379 . . . . 0.0 109.942 177.277 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 85.3 t60 -57.38 -51.34 69.79 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 118.492 0.587 . . . . 0.0 111.053 177.254 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -62.73 -39.26 93.52 Favored 'General case' 0 C--O 1.235 0.3 0 C-N-CA 124.04 0.936 . . . . 0.0 112.067 -176.335 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 25.0 ttmm -56.21 -35.03 66.86 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 123.657 0.783 . . . . 0.0 110.737 172.392 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 21.0 mt -94.34 -20.05 20.1 Favored 'General case' 0 CA--C 1.515 -0.371 0 N-CA-C 115.761 1.763 . . . . 0.0 115.761 -168.92 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 4.0 m -58.24 -33.98 69.95 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-N 120.673 1.579 . . . . 0.0 111.452 -177.843 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 20.0 p -85.79 -10.71 55.05 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 125.4 1.48 . . . . 0.0 112.324 179.871 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 32.6 mmmt -84.69 -6.05 59.34 Favored 'General case' 0 N--CA 1.466 0.342 0 C-N-CA 124.555 1.142 . . . . 0.0 111.334 173.875 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 70.09 33.49 69.65 Favored Glycine 0 CA--C 1.525 0.69 0 CA-C-N 118.438 0.563 . . . . 0.0 112.125 172.001 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 4.9 m -77.48 175.33 0.76 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.599 0 CA-C-N 117.907 0.853 . . . . 0.0 109.635 173.726 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -117.62 116.21 26.63 Favored 'General case' 0 N--CA 1.465 0.317 0 N-CA-C 107.318 -1.364 . . . . 0.0 107.318 175.069 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 71.2 m-85 -83.52 147.25 27.9 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 119.249 0.931 . . . . 0.0 109.185 -179.037 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 35.8 m -125.21 159.17 32.69 Favored 'Isoleucine or valine' 0 C--O 1.234 0.289 0 C-N-CA 123.696 0.798 . . . . 0.0 110.652 172.157 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 93.52 -87.57 1.18 Allowed Glycine 0 N--CA 1.446 -0.65 0 C-N-CA 125.144 1.354 . . . . 0.0 111.956 169.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 15.7 m-30 58.53 176.68 0.07 Allowed 'General case' 0 CA--C 1.552 1.04 0 C-N-CA 125.293 1.437 . . . . 0.0 110.87 -168.031 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -148.98 147.15 23.07 Favored Pre-proline 0 N--CA 1.476 0.853 0 O-C-N 120.199 -1.563 . . . . 0.0 110.149 177.8 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo -61.97 127.11 20.41 Favored 'Trans proline' 0 C--N 1.349 0.559 0 C-N-CA 122.831 2.354 . . . . 0.0 110.336 169.387 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 13.7 p . . . . . 0 N--CA 1.472 0.629 0 N-CA-C 113.32 0.859 . . . . 0.0 113.32 175.618 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 9.5 ttmm . . . . . 0 CA--C 1.542 0.658 0 N-CA-C 114.68 1.363 . . . . 0.0 114.68 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_exo -79.49 -0.34 10.64 Favored 'Trans proline' 0 CA--C 1.538 0.723 0 CA-C-N 122.036 1.763 . . . . 0.0 114.271 -179.109 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 31.4 m -131.51 165.51 31.46 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.427 0 CA-C-N 120.39 1.45 . . . . 0.0 112.647 -168.493 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 10.3 pt -136.5 176.42 8.09 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 C-N-CA 128.723 2.809 . . . . 0.0 108.439 -176.848 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . 56.33 41.87 28.51 Favored 'General case' 0 N--CA 1.465 0.297 0 C-N-CA 125.362 1.465 . . . . 0.0 112.35 174.134 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 27.7 t70 55.2 42.13 30.82 Favored 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 125.938 1.695 . . . . 0.0 111.479 -175.545 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 87.63 16.87 59.39 Favored Glycine 0 CA--C 1.528 0.906 0 CA-C-O 118.715 -1.047 . . . . 0.0 113.974 173.552 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 45.6 mt-30 -91.07 -9.23 46.49 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-N 119.072 1.436 . . . . 0.0 113.168 -178.336 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 4.9 tp -151.66 138.65 19.07 Favored 'General case' 0 C--N 1.342 0.273 0 CA-C-N 119.797 1.18 . . . . 0.0 111.054 -178.646 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 61.9 m-85 -77.82 143.7 37.66 Favored 'General case' 0 CA--C 1.517 -0.314 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 169.931 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 19.4 m -78.31 3.01 1.74 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 C-N-CA 123.587 0.755 . . . . 0.0 112.352 178.306 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -168.91 -172.93 36.2 Favored Glycine 0 C--N 1.335 0.483 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 -178.905 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 46.5 tp -74.65 129.67 38.13 Favored 'General case' 0 N--CA 1.451 -0.384 0 C-N-CA 123.659 0.784 . . . . 0.0 110.505 -179.605 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -81.19 117.36 21.66 Favored 'General case' 0 N--CA 1.443 -0.824 0 N-CA-C 107.322 -1.362 . . . . 0.0 107.322 167.36 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 61.4 mt . . . . . 0 N--CA 1.462 0.172 0 N-CA-C 107.031 -1.47 . . . . 0.0 107.031 167.827 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 4.9 p . . . . . 0 CA--C 1.532 0.27 0 N-CA-C 110.016 -0.365 . . . . 0.0 110.016 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -65.17 -38.75 91.51 Favored 'General case' 0 N--CA 1.461 0.11 0 C-N-CA 123.016 0.526 . . . . 0.0 110.641 177.662 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 2.8 tp10 -62.23 -49.06 77.24 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 124.31 1.044 . . . . 0.0 110.78 178.381 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 41.5 mtt180 -56.87 -44.83 82.63 Favored 'General case' 0 C--O 1.226 -0.182 0 C-N-CA 124.617 1.167 . . . . 0.0 109.761 178.536 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 53.8 mt -65.45 -56.0 17.37 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.358 0 N-CA-C 107.91 -1.144 . . . . 0.0 107.91 177.212 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 68.8 tp60 -55.77 -63.65 1.11 Allowed 'General case' 0 C--O 1.232 0.179 0 C-N-CA 124.09 0.956 . . . . 0.0 112.173 -170.503 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 20.2 m -67.35 -32.68 73.79 Favored 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 121.051 -0.259 . . . . 0.0 111.035 -168.695 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 160' ' ' TRP . . . . . . . . . . . . . 3.6 t90 -73.53 -42.37 61.83 Favored 'General case' 0 C--O 1.22 -0.45 0 CA-C-O 119.085 -0.483 . . . . 0.0 110.684 177.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 55.2 m -57.12 -45.33 83.55 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 118.525 0.602 . . . . 0.0 110.378 174.398 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -61.21 -42.3 98.36 Favored 'General case' 0 CA--C 1.528 0.111 0 CA-C-O 121.467 0.651 . . . . 0.0 110.191 177.097 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 16.5 tt0 -64.2 -53.44 49.29 Favored 'General case' 0 N--CA 1.448 -0.561 0 O-C-N 121.655 -0.653 . . . . 0.0 110.202 -178.721 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 41.2 pt -62.26 -37.04 77.6 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.331 0 CA-C-O 117.653 -1.165 . . . . 0.0 109.16 -174.814 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -63.47 -37.55 87.75 Favored 'General case' 0 C--O 1.224 -0.268 0 CA-C-N 119.57 1.077 . . . . 0.0 109.708 -179.729 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 34.1 m-80 -67.05 -50.41 61.98 Favored 'General case' 0 N--CA 1.465 0.294 0 N-CA-C 108.887 -0.782 . . . . 0.0 108.887 176.338 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 67.3 tt0 -72.69 -18.03 61.58 Favored 'General case' 0 N--CA 1.437 -1.122 0 C-N-CA 126.167 1.787 . . . . 0.0 112.157 -169.181 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 168' ' ' MET . . . . . . . . . . . . . 19.0 ptp -89.86 -40.05 12.67 Favored 'General case' 0 N--CA 1.456 -0.151 0 C-N-CA 124.115 0.966 . . . . 0.0 111.168 168.813 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -74.35 -24.82 59.23 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 112.647 0.61 . . . . 0.0 112.647 -174.021 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 . . . . . 0 CA--C 1.539 0.545 0 CA-C-N 118.511 0.596 . . . . 0.0 111.626 179.209 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.411 ' HA ' ' OD2' ' A' ' 47' ' ' ASP . 11.1 tmm? . . . . . 0 N--CA 1.495 1.819 0 N-CA-C 109.832 -0.433 . . . . 0.0 109.832 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 3.0 t30 -142.53 151.41 41.59 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 125.263 1.425 . . . . 0.0 107.911 174.489 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -112.0 128.05 56.06 Favored 'General case' 0 N--CA 1.463 0.221 0 C-N-CA 123.977 0.911 . . . . 0.0 111.573 -177.915 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -87.1 155.49 27.5 Favored Glycine 0 CA--C 1.523 0.584 0 N-CA-C 107.812 -2.115 . . . . 0.0 107.812 167.231 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 3.1 tt -140.39 96.53 3.05 Favored 'General case' 0 N--CA 1.466 0.341 0 N-CA-C 105.397 -2.075 . . . . 0.0 105.397 -177.504 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -98.95 140.51 33.0 Favored 'General case' 0 CA--C 1.516 -0.336 0 CA-C-O 121.225 0.536 . . . . 0.0 111.379 -173.656 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 43.6 p90 . . . . . 0 N--CA 1.454 -0.265 0 C-N-CA 125.679 1.592 . . . . 0.0 107.95 177.698 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.226 -0.152 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -63.03 -47.42 83.12 Favored 'General case' 0 C--O 1.233 0.191 0 C-N-CA 122.756 0.422 . . . . 0.0 111.353 -176.047 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 10.4 mt-10 -62.06 -43.04 99.69 Favored 'General case' 0 CA--C 1.516 -0.338 0 CA-C-O 118.912 -0.566 . . . . 0.0 110.275 176.801 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 29.7 mtpp -71.58 -40.39 69.93 Favored 'General case' 0 C--O 1.22 -0.476 0 CA-C-O 117.97 -1.014 . . . . 0.0 110.892 -174.036 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 47.3 mt -52.54 -54.3 16.06 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.255 0 CA-C-N 120.052 1.296 . . . . 0.0 108.524 172.27 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 8.0 ttp180 -61.72 -41.06 97.14 Favored 'General case' 0 C--O 1.223 -0.296 0 C-N-CA 123.209 0.604 . . . . 0.0 109.425 -175.758 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -66.43 -41.61 88.93 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 118.481 0.582 . . . . 0.0 111.421 -179.177 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 49.3 mt -72.58 -53.17 20.01 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.526 0 C-N-CA 124.7 1.2 . . . . 0.0 109.686 -172.171 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 78.0 mt -67.05 -45.3 87.19 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 179.828 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 139.24 125.5 2.28 Favored Glycine 0 CA--C 1.532 1.137 0 C-N-CA 125.165 1.364 . . . . 0.0 112.067 173.737 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 82.2 Cg_endo -73.17 -5.3 16.93 Favored 'Trans proline' 0 CA--C 1.537 0.636 0 C-N-CA 123.664 2.91 . . . . 0.0 113.873 -175.822 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -82.27 -17.41 46.01 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 118.996 0.816 . . . . 0.0 111.072 177.229 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 1.3 pt? -129.94 -13.76 4.05 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 125.114 1.366 . . . . 0.0 113.871 -174.331 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 33.8 t -98.48 153.45 4.08 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.517 0 N-CA-C 107.691 -1.226 . . . . 0.0 107.691 168.56 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 50.5 m -139.65 131.93 28.3 Favored 'General case' 0 C--O 1.234 0.279 0 C-N-CA 126.464 1.905 . . . . 0.0 106.239 -177.117 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 24.3 mt -81.25 142.38 33.21 Favored 'General case' 0 C--O 1.233 0.191 0 N-CA-C 107.839 -1.171 . . . . 0.0 107.839 176.763 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 34.2 t-80 -134.28 57.65 1.8 Allowed 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 124.574 1.15 . . . . 0.0 108.218 -175.157 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 64.3 t-20 -70.43 118.01 12.69 Favored 'General case' 0 C--O 1.235 0.327 0 O-C-N 121.076 -1.015 . . . . 0.0 108.779 -176.673 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 93.9 mt -68.45 -12.94 61.92 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 124.092 0.957 . . . . 0.0 112.505 -174.807 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 65.3 mmtt -53.73 -27.19 26.89 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-O 118.685 -0.674 . . . . 0.0 111.178 167.013 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -132.04 -41.71 1.01 Allowed 'General case' 0 C--O 1.236 0.347 0 N-CA-C 113.437 0.903 . . . . 0.0 113.437 -173.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 29.8 m-20 -85.56 141.2 30.03 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-N 118.475 0.58 . . . . 0.0 110.568 -174.324 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 14.8 m -76.32 154.23 84.13 Favored Pre-proline 0 CA--C 1.54 0.59 0 C-N-CA 124.378 1.071 . . . . 0.0 110.342 176.658 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -77.26 -26.84 7.13 Favored 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 122.267 1.978 . . . . 0.0 113.683 -170.085 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.79 -15.38 63.54 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-N 120.657 1.571 . . . . 0.0 112.269 -178.612 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -58.77 -29.23 66.64 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 125.403 1.481 . . . . 0.0 110.363 170.317 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 55.3 mtt -57.43 -27.75 62.68 Favored 'General case' 0 C--N 1.342 0.264 0 C-N-CA 123.589 0.756 . . . . 0.0 111.498 177.339 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 56.7 mt-10 -66.83 -33.09 74.85 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 118.348 0.522 . . . . 0.0 110.537 -176.22 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 16.5 mt-30 -66.9 -43.18 84.09 Favored 'General case' 0 N--CA 1.464 0.232 0 C-N-CA 123.346 0.659 . . . . 0.0 112.336 -170.003 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 22.2 m-85 -70.92 142.11 51.11 Favored 'General case' 0 N--CA 1.454 -0.227 0 CA-C-N 115.387 -0.824 . . . . 0.0 110.528 -166.469 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . 0.411 ' OD2' ' HA ' ' A' ' 1' ' ' MET . 24.4 m-20 -74.77 -35.7 62.57 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-O 121.118 0.485 . . . . 0.0 109.726 -178.098 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 25.6 t -113.94 147.49 17.44 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.216 0 N-CA-C 107.178 -1.416 . . . . 0.0 107.178 170.003 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 29.8 tp -132.19 109.69 10.12 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 123.778 0.831 . . . . 0.0 108.843 174.889 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 32.0 mt -87.22 133.1 30.93 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.552 0 N-CA-C 107.077 -1.453 . . . . 0.0 107.077 176.583 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 2.4 mp -111.22 127.34 55.57 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 126.141 1.777 . . . . 0.0 106.966 -179.26 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -135.0 136.6 8.65 Favored Glycine 0 C--N 1.335 0.48 0 N-CA-C 109.439 -1.464 . . . . 0.0 109.439 -179.561 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 4.1 tt -150.46 129.31 6.19 Favored Pre-proline 0 CA--C 1.542 0.645 0 CA-C-N 118.772 1.286 . . . . 0.0 110.926 -175.054 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo . . . . . 0 CA--C 1.542 0.902 0 C-N-CA 122.992 2.461 . . . . 0.0 115.539 170.087 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 13.1 mt . . . . . 0 CA--C 1.543 0.706 0 CA-C-O 121.759 0.79 . . . . 0.0 111.464 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . 0.494 ' H ' ' CD ' ' A' ' 62' ' ' GLN . 0.3 OUTLIER -56.02 146.89 21.27 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 126.741 2.016 . . . . 0.0 109.715 175.012 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -57.15 -48.23 79.21 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 118.348 0.522 . . . . 0.0 112.172 -169.629 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -69.71 -17.87 63.49 Favored 'General case' 0 N--CA 1.475 0.807 0 CA-C-N 119.019 0.827 . . . . 0.0 112.177 -173.864 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -93.28 -43.44 8.8 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 124.92 1.288 . . . . 0.0 107.636 -179.822 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -63.46 -35.12 79.39 Favored 'General case' 0 N--CA 1.435 -1.217 0 C-N-CA 126.229 1.812 . . . . 0.0 111.075 177.347 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -55.93 -23.88 34.53 Favored 'General case' 0 CA--C 1.53 0.174 0 C-N-CA 124.582 1.153 . . . . 0.0 112.001 -176.821 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 35.7 m -116.47 -13.49 11.01 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.224 0 CA-C-O 117.913 -1.041 . . . . 0.0 112.709 178.902 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 26.5 t90 -52.55 -38.68 60.31 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 119.824 1.193 . . . . 0.0 111.083 -177.063 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -68.04 -24.02 65.04 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 125.12 1.368 . . . . 0.0 112.967 178.62 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 20.4 mt-30 -91.67 -23.74 19.72 Favored 'General case' 0 C--N 1.34 0.166 0 C-N-CA 125.273 1.429 . . . . 0.0 111.877 -179.347 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 24.7 mt -64.63 -26.13 68.26 Favored 'General case' 0 N--CA 1.468 0.456 0 O-C-N 121.792 -0.567 . . . . 0.0 111.646 -172.227 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -69.27 -22.27 63.83 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-N 118.06 0.391 . . . . 0.0 111.518 176.233 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -77.36 -23.51 50.83 Favored 'General case' 0 CA--C 1.537 0.472 0 O-C-N 120.707 -1.245 . . . . 0.0 112.56 -178.743 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 51.2 mt -65.67 152.07 45.07 Favored 'General case' 0 C--O 1.233 0.226 0 C-N-CA 124.772 1.229 . . . . 0.0 112.056 -170.205 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 3.3 t30 -82.71 100.95 10.55 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 124.682 1.193 . . . . 0.0 108.154 174.127 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 57.2 mt -119.22 0.09 11.12 Favored 'General case' 0 N--CA 1.47 0.548 0 N-CA-C 113.389 0.885 . . . . 0.0 113.389 -174.474 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 25.0 mt-10 -57.41 128.92 39.47 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 119.135 0.88 . . . . 0.0 110.828 -169.705 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 74.25 -3.04 41.71 Favored Glycine 0 CA--C 1.532 1.145 0 CA-C-O 117.749 -1.584 . . . . 0.0 114.824 178.535 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.79 152.86 40.19 Favored 'General case' 0 C--N 1.347 0.49 0 CA-C-N 121.098 2.449 . . . . 0.0 109.503 -179.402 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 2.1 mt -86.18 141.69 14.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 N-CA-C 106.877 -1.527 . . . . 0.0 106.877 179.414 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 61.6 t -135.68 137.58 49.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 C-N-CA 124.279 1.032 . . . . 0.0 109.109 -177.067 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -111.39 152.72 27.02 Favored 'General case' 0 N--CA 1.465 0.291 0 N-CA-C 106.733 -1.58 . . . . 0.0 106.733 168.118 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 1.2 mt -134.19 135.25 42.91 Favored 'General case' 0 CA--C 1.508 -0.637 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 175.366 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 40.9 p90 -147.34 166.14 28.03 Favored 'General case' 0 N--CA 1.447 -0.594 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 169.235 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -160.01 155.01 26.09 Favored Glycine 0 N--CA 1.448 -0.542 0 N-CA-C 109.123 -1.591 . . . . 0.0 109.123 171.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 13.0 tp . . . . . 0 N--CA 1.444 -0.737 0 C-N-CA 125.031 1.332 . . . . 0.0 109.08 177.02 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 96.7 mt . . . . . 0 N--CA 1.471 0.621 0 N-CA-C 109.964 -0.384 . . . . 0.0 109.964 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -52.73 -47.57 67.27 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 123.754 0.821 . . . . 0.0 112.7 -168.783 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -78.94 -19.56 51.44 Favored 'General case' 0 N--CA 1.451 -0.397 0 O-C-N 121.129 -0.982 . . . . 0.0 113.347 -176.323 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 3.8 tt -60.84 -44.79 96.5 Favored 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 107.543 -1.28 . . . . 0.0 107.543 171.383 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -61.24 -43.94 98.74 Favored Glycine 0 C--N 1.341 0.839 0 CA-C-O 119.617 -0.546 . . . . 0.0 111.914 176.398 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 75.1 mtm -63.25 -40.62 97.94 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 118.382 1.091 . . . . 0.0 111.957 -178.863 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -69.95 -34.22 73.14 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-N 120.035 1.289 . . . . 0.0 111.241 -179.604 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 56.3 t-80 -58.97 -49.5 77.62 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-N 118.477 0.58 . . . . 0.0 109.533 172.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -62.36 -41.66 98.78 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 123.38 0.672 . . . . 0.0 112.295 -177.11 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 24.2 ttmm -55.56 -40.96 72.62 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 123.401 0.681 . . . . 0.0 110.166 173.14 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 28.4 mt -89.82 -20.2 23.75 Favored 'General case' 0 CA--C 1.517 -0.317 0 N-CA-C 115.764 1.765 . . . . 0.0 115.764 -167.653 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 15.9 m -58.28 -36.44 73.3 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 120.732 1.605 . . . . 0.0 111.334 -178.301 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 20.5 p -83.85 -12.88 54.92 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 124.585 1.154 . . . . 0.0 111.903 -179.678 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 32.0 mmmt -83.15 -9.64 59.08 Favored 'General case' 0 C--N 1.343 0.3 0 C-N-CA 124.525 1.13 . . . . 0.0 110.984 170.881 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 72.3 35.91 60.0 Favored Glycine 0 CA--C 1.523 0.561 0 CA-C-N 118.651 0.66 . . . . 0.0 112.469 169.661 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 5.3 m -77.02 170.67 1.46 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.582 0 CA-C-N 117.858 0.829 . . . . 0.0 109.713 172.001 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 53.0 tptt -100.06 130.64 46.23 Favored 'General case' 0 N--CA 1.47 0.564 0 N-CA-C 105.132 -2.173 . . . . 0.0 105.132 167.756 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 73.8 m-85 -94.95 123.01 38.18 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 172.071 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 32.8 m -105.15 154.31 6.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 C-N-CA 124.032 0.933 . . . . 0.0 108.505 167.701 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 105.85 -95.9 1.11 Allowed Glycine 0 N--CA 1.448 -0.56 0 C-N-CA 124.105 0.86 . . . . 0.0 112.011 174.173 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . 0.42 ' CD2' ' HA ' ' A' ' 140' ' ' VAL . 75.6 m-85 60.17 -179.61 0.09 Allowed 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 125.182 1.393 . . . . 0.0 109.424 -166.928 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER -153.22 143.55 15.54 Favored Pre-proline 0 N--CA 1.476 0.825 0 O-C-N 120.122 -1.611 . . . . 0.0 111.069 177.17 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -68.9 122.66 9.57 Favored 'Trans proline' 0 CA--C 1.536 0.595 0 C-N-CA 123.505 2.804 . . . . 0.0 111.621 179.238 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 18.1 p . . . . . 0 CA--C 1.538 0.492 0 N-CA-C 113.791 1.034 . . . . 0.0 113.791 -179.343 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 24.7 ttmt . . . . . 0 N--CA 1.475 0.79 0 N-CA-C 114.734 1.383 . . . . 0.0 114.734 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -82.76 3.83 7.54 Favored 'Trans proline' 0 C--N 1.35 0.615 0 CA-C-N 121.836 1.691 . . . . 0.0 114.162 -178.43 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 20.0 m -130.26 165.82 29.46 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.371 0 CA-C-N 120.537 1.517 . . . . 0.0 111.57 -172.252 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 7.4 pt -135.42 171.29 17.68 Favored 'Isoleucine or valine' 0 C--O 1.234 0.279 0 C-N-CA 127.913 2.485 . . . . 0.0 108.969 -177.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . 53.88 45.13 28.4 Favored 'General case' 0 N--CA 1.464 0.261 0 C-N-CA 125.488 1.515 . . . . 0.0 112.509 172.553 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 27.0 t0 54.32 43.58 30.28 Favored 'General case' 0 C--N 1.324 -0.521 0 C-N-CA 126.056 1.742 . . . . 0.0 111.624 -176.596 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 87.41 17.4 58.83 Favored Glycine 0 CA--C 1.527 0.825 0 CA-C-O 118.662 -1.077 . . . . 0.0 113.611 173.357 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 60.6 mm-40 -92.09 -8.07 46.82 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 119.399 1.6 . . . . 0.0 113.142 -177.368 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 7.9 tp -152.59 145.03 24.06 Favored 'General case' 0 C--N 1.344 0.33 0 CA-C-N 119.356 0.98 . . . . 0.0 110.761 170.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 65.5 m-85 -81.59 144.83 30.97 Favored 'General case' 0 CA--C 1.514 -0.423 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 169.373 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . 0.42 ' HA ' ' CD2' ' A' ' 118' ' ' TYR . 13.9 m -76.43 11.07 0.43 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.627 0 N-CA-C 113.128 0.788 . . . . 0.0 113.128 179.512 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 177.39 171.9 41.37 Favored Glycine 0 CA--C 1.525 0.696 0 C-N-CA 124.927 1.251 . . . . 0.0 109.997 -177.617 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 3.2 tp -66.72 133.44 50.19 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 117.962 0.881 . . . . 0.0 110.771 -177.725 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -91.56 117.05 29.37 Favored 'General case' 0 N--CA 1.445 -0.694 0 C-N-CA 125.835 1.654 . . . . 0.0 108.408 173.017 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.463 0.199 0 C-N-CA 124.288 1.035 . . . . 0.0 109.385 172.242 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 21.9 m . . . . . 0 CA--C 1.539 0.535 0 N-CA-C 110.642 -0.132 . . . . 0.0 110.642 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -64.21 -38.53 91.39 Favored 'General case' 0 N--CA 1.463 0.188 0 C-N-CA 123.208 0.603 . . . . 0.0 111.037 169.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -70.23 -40.64 74.36 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 124.599 1.159 . . . . 0.0 111.276 -178.484 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 17.9 mmm-85 -49.39 -43.76 44.56 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 124.23 1.012 . . . . 0.0 109.889 171.253 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 58.0 mt -75.03 -56.74 7.95 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.399 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 -179.716 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 73.1 tp60 -50.68 -62.76 1.4 Allowed 'General case' 0 CA--C 1.521 -0.151 0 C-N-CA 125.709 1.604 . . . . 0.0 112.673 -170.298 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 15.0 m -68.09 -34.16 75.89 Favored 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 121.049 -0.26 . . . . 0.0 110.841 -168.57 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 160' ' ' TRP . . . . . . . . . . . . . 38.0 t90 -67.66 -44.25 78.31 Favored 'General case' 0 C--O 1.222 -0.353 0 O-C-N 122.167 -0.333 . . . . 0.0 110.838 175.128 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 61.2 m -59.74 -43.82 94.07 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 122.834 0.454 . . . . 0.0 110.377 178.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -62.03 -41.69 98.37 Favored 'General case' 0 CA--C 1.529 0.141 0 CA-C-N 118.053 0.388 . . . . 0.0 110.173 176.614 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 11.7 tt0 -62.68 -54.13 43.93 Favored 'General case' 0 CA--C 1.514 -0.415 0 CA-C-O 118.15 -0.928 . . . . 0.0 109.929 -179.099 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 40.4 pt -62.78 -33.0 57.71 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.497 0 CA-C-O 118.012 -0.994 . . . . 0.0 109.871 -176.475 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -70.66 -36.58 73.44 Favored 'General case' 0 C--O 1.223 -0.324 0 CA-C-N 119.837 1.198 . . . . 0.0 108.605 -175.572 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -68.73 -45.63 71.02 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 123.386 0.674 . . . . 0.0 109.844 175.096 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 25.1 tt0 -80.79 -13.63 58.79 Favored 'General case' 0 N--CA 1.437 -1.119 0 C-N-CA 124.303 1.041 . . . . 0.0 110.328 -169.382 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 168' ' ' MET . . . . . . . . . . . . . 20.6 ptp -90.7 -41.61 11.19 Favored 'General case' 0 N--CA 1.457 -0.125 0 C-N-CA 122.914 0.486 . . . . 0.0 111.242 168.774 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -70.58 -27.59 64.23 Favored 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 122.652 0.381 . . . . 0.0 111.651 -172.258 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 . . . . . 0 CA--C 1.543 0.693 0 C-N-CA 123.257 0.623 . . . . 0.0 112.4 178.9 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.498 1.938 0 N-CA-C 111.578 0.214 . . . . 0.0 111.578 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 6.0 t30 -127.36 151.52 48.67 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 124.624 1.17 . . . . 0.0 108.458 175.414 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 17.3 mtt -110.93 126.37 54.65 Favored 'General case' 0 C--N 1.332 -0.182 0 C-N-CA 123.475 0.71 . . . . 0.0 110.359 -177.385 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -84.22 145.98 22.57 Favored Glycine 0 CA--C 1.522 0.514 0 N-CA-C 107.139 -2.384 . . . . 0.0 107.139 168.023 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 1.2 tt -135.03 93.94 3.08 Favored 'General case' 0 N--CA 1.464 0.273 0 N-CA-C 105.345 -2.094 . . . . 0.0 105.345 -172.927 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -101.59 143.25 31.8 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-O 121.703 0.763 . . . . 0.0 110.728 -173.322 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 32.3 p90 . . . . . 0 N--CA 1.448 -0.541 0 C-N-CA 125.071 1.348 . . . . 0.0 108.078 -178.071 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.268 0 N-CA-C 109.079 -0.712 . . . . 0.0 109.079 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -65.74 -45.66 81.76 Favored 'General case' 0 N--CA 1.455 -0.182 0 C-N-CA 123.732 0.813 . . . . 0.0 111.577 -175.239 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -54.34 -47.69 72.27 Favored 'General case' 0 CA--C 1.517 -0.289 0 C-N-CA 125.262 1.425 . . . . 0.0 109.312 173.647 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 29.8 mtpp -73.51 -38.91 65.18 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-O 118.459 -0.781 . . . . 0.0 110.215 -172.272 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 37.3 mt -53.72 -56.7 7.71 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.288 0 CA-C-N 119.469 1.031 . . . . 0.0 109.024 173.378 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.33 -35.02 79.3 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 118.49 0.586 . . . . 0.0 111.196 -173.858 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -62.38 -42.7 99.62 Favored 'General case' 0 C--N 1.328 -0.358 0 O-C-N 123.363 0.414 . . . . 0.0 110.892 176.093 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 39.5 mt -72.23 -55.65 12.6 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.52 0 C-N-CA 123.619 0.767 . . . . 0.0 109.971 -174.356 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 73.0 mt -65.8 -45.23 92.17 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.296 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 -175.33 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 141.62 120.69 1.65 Allowed Glycine 0 CA--C 1.53 0.994 0 N-CA-C 110.26 -1.136 . . . . 0.0 110.26 176.335 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -68.64 -10.2 28.37 Favored 'Trans proline' 0 N--CA 1.456 -0.697 0 C-N-CA 123.124 2.55 . . . . 0.0 113.373 -173.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 2.4 pm0 -81.56 -18.25 45.56 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-N 119.573 1.079 . . . . 0.0 111.831 179.138 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -126.96 5.74 6.56 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 124.735 1.214 . . . . 0.0 113.679 -173.096 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 38.2 t -126.55 146.2 32.8 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.281 0 N-CA-C 107.842 -1.17 . . . . 0.0 107.842 173.169 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 34.0 m -133.02 131.89 41.22 Favored 'General case' 0 C--N 1.333 -0.129 0 C-N-CA 125.045 1.338 . . . . 0.0 108.635 -175.481 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 22.9 mt -75.53 137.71 41.04 Favored 'General case' 0 C--O 1.231 0.092 0 N-CA-C 108.809 -0.811 . . . . 0.0 108.809 177.393 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 23.2 t-80 -135.45 54.51 1.92 Allowed 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 124.788 1.235 . . . . 0.0 108.477 -177.006 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 38.3 t-20 -53.58 123.52 12.41 Favored 'General case' 0 C--O 1.237 0.41 0 N-CA-C 107.485 -1.302 . . . . 0.0 107.485 170.675 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 31.7 mt -70.46 -19.74 62.93 Favored 'General case' 0 C--O 1.235 0.302 0 N-CA-C 112.824 0.676 . . . . 0.0 112.824 -173.782 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 55.9 tptt -70.63 -19.44 62.82 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-N 118.915 0.78 . . . . 0.0 110.91 169.771 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -103.38 -36.49 8.0 Favored 'General case' 0 C--O 1.233 0.235 0 C-N-CA 123.975 0.91 . . . . 0.0 113.107 -170.732 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 3.3 t0 -139.64 156.24 46.95 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 118.668 0.667 . . . . 0.0 112.539 178.268 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 19.9 m -75.4 157.88 84.17 Favored Pre-proline 0 CA--C 1.541 0.623 0 C-N-CA 125.931 1.692 . . . . 0.0 111.714 -170.58 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 78.1 Cg_endo -74.86 -26.49 11.16 Favored 'Trans proline' 0 C--N 1.349 0.584 0 C-N-CA 122.68 2.254 . . . . 0.0 113.493 -170.297 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 23.0 mmmt -70.79 -12.42 61.54 Favored 'General case' 0 N--CA 1.472 0.65 0 O-C-N 120.685 -1.26 . . . . 0.0 111.531 -176.159 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -60.24 -29.36 68.72 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 125.423 1.489 . . . . 0.0 110.354 168.832 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 48.4 mtt -59.41 -25.37 64.26 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 118.65 0.659 . . . . 0.0 111.436 178.425 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 89.9 mt-10 -65.83 -33.06 74.99 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-O 118.96 -0.543 . . . . 0.0 110.027 -176.84 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 24.9 mt-30 -65.22 -45.51 84.41 Favored 'General case' 0 N--CA 1.465 0.313 0 C-N-CA 123.424 0.69 . . . . 0.0 112.771 -169.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 44.5 m-85 -77.73 133.2 38.34 Favored 'General case' 0 CA--C 1.52 -0.204 0 C-N-CA 123.718 0.807 . . . . 0.0 109.205 -167.234 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -75.58 -22.22 57.14 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-N 118.883 0.765 . . . . 0.0 111.833 -177.135 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 53.0 t -113.6 143.33 23.53 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.588 0 N-CA-C 106.633 -1.618 . . . . 0.0 106.633 169.441 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 31.2 tp -133.65 149.03 51.56 Favored 'General case' 0 N--CA 1.444 -0.763 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 172.278 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 28.9 mt -128.71 133.34 66.57 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 N-CA-C 105.38 -2.082 . . . . 0.0 105.38 179.917 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 3.1 mp -118.25 128.76 54.99 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 125.701 1.6 . . . . 0.0 107.781 -172.842 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -131.57 134.23 7.58 Favored Glycine 0 C--N 1.332 0.315 0 N-CA-C 110.912 -0.875 . . . . 0.0 110.912 174.69 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 2.9 tt -153.88 137.06 10.16 Favored Pre-proline 0 CA--C 1.542 0.667 0 CA-C-N 118.654 1.227 . . . . 0.0 111.662 170.37 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_exo . . . . . 0 CA--C 1.536 0.599 0 C-N-CA 123.347 2.698 . . . . 0.0 113.081 167.976 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . 0.256 59.0 mt . . . . . 0 CA--C 1.55 0.965 0 CA-C-O 122.952 1.358 . . . . 0.0 111.361 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -118.22 156.7 28.32 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 125.265 1.426 . . . . 0.0 107.579 -175.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -57.41 -45.01 85.05 Favored 'General case' 0 CA--C 1.529 0.153 0 C-N-CA 123.233 0.613 . . . . 0.0 110.677 -172.053 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -64.42 -19.54 65.58 Favored 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 113.219 0.822 . . . . 0.0 113.219 -177.115 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 13.0 t90 -95.91 -47.2 6.23 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 124.754 1.222 . . . . 0.0 109.485 178.23 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 10.9 tt0 -62.79 -35.26 79.26 Favored 'General case' 0 N--CA 1.446 -0.642 0 O-C-N 120.877 -1.139 . . . . 0.0 109.975 -178.899 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -58.13 -25.76 61.82 Favored 'General case' 0 CA--C 1.529 0.173 0 C-N-CA 124.034 0.933 . . . . 0.0 111.711 -177.262 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 28.6 m -113.29 -13.4 11.4 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.266 0 CA-C-O 117.21 -1.376 . . . . 0.0 112.484 177.675 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 26.0 t90 -52.75 -35.21 55.8 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 120.53 1.514 . . . . 0.0 110.968 -178.908 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -64.3 -27.72 69.23 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 125.567 1.547 . . . . 0.0 113.269 175.944 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 29.3 mt-30 -92.47 -19.61 21.83 Favored 'General case' 0 C--N 1.343 0.288 0 C-N-CA 125.93 1.692 . . . . 0.0 112.524 176.214 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 52.5 mt -63.69 -20.96 66.13 Favored 'General case' 0 CA--C 1.536 0.415 0 O-C-N 121.318 -0.864 . . . . 0.0 111.467 -176.398 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -79.01 -23.34 44.42 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 123.112 0.565 . . . . 0.0 111.503 174.401 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -72.83 -29.82 63.53 Favored 'General case' 0 N--CA 1.469 0.509 0 O-C-N 120.628 -1.295 . . . . 0.0 111.883 178.714 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 80.1 mt -52.85 141.05 22.61 Favored 'General case' 0 C--N 1.34 0.16 0 C-N-CA 125.239 1.415 . . . . 0.0 113.009 -168.484 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 3.7 t30 -75.62 102.48 5.34 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 123.832 0.853 . . . . 0.0 108.729 170.437 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 66.7 mt -125.03 -0.48 7.85 Favored 'General case' 0 N--CA 1.475 0.784 0 N-CA-C 114.058 1.133 . . . . 0.0 114.058 -173.572 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 27.0 mt-10 -57.25 128.78 38.75 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 119.528 1.058 . . . . 0.0 111.144 -169.253 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 73.43 -1.79 41.45 Favored Glycine 0 CA--C 1.534 1.25 0 C-N-CA 125.394 1.474 . . . . 0.0 115.103 178.518 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.68 148.95 40.13 Favored 'General case' 0 C--N 1.344 0.354 0 CA-C-N 120.543 2.171 . . . . 0.0 109.474 -176.362 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 1.8 mt -80.49 136.28 23.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 N-CA-C 106.712 -1.588 . . . . 0.0 106.712 179.246 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 76.2 t -133.0 125.1 51.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 C-N-CA 123.97 0.908 . . . . 0.0 109.805 -175.608 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -98.72 151.73 20.43 Favored 'General case' 0 N--CA 1.463 0.177 0 N-CA-C 107.938 -1.134 . . . . 0.0 107.938 166.674 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 1.2 mt -133.93 138.73 45.69 Favored 'General case' 0 CA--C 1.512 -0.493 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 175.382 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 45.6 p90 -150.48 168.92 22.77 Favored 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 171.223 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -168.12 166.63 39.61 Favored Glycine 0 N--CA 1.444 -0.775 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 173.386 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.327 -0.401 0 C-N-CA 124.315 1.046 . . . . 0.0 109.037 170.546 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 92.8 mt . . . . . 0 N--CA 1.467 0.412 0 N-CA-C 114.014 1.116 . . . . 0.0 114.014 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -62.8 -33.82 76.0 Favored 'General case' 0 C--N 1.332 -0.176 0 O-C-N 120.538 -1.351 . . . . 0.0 110.708 -174.873 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -72.08 -29.97 64.65 Favored 'General case' 0 CA--C 1.533 0.315 0 O-C-N 121.563 -0.711 . . . . 0.0 112.216 176.377 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 4.1 tt -62.04 -46.68 88.11 Favored 'General case' 0 N--CA 1.467 0.395 0 N-CA-C 107.574 -1.269 . . . . 0.0 107.574 170.226 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -63.59 -37.29 94.53 Favored Glycine 0 C--N 1.341 0.84 0 CA-C-O 119.212 -0.771 . . . . 0.0 112.088 178.793 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 65.1 mtm -63.58 -42.9 98.26 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 118.823 1.312 . . . . 0.0 111.69 -179.67 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -70.25 -37.18 74.87 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 120.238 1.381 . . . . 0.0 109.793 176.335 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 59.1 t60 -56.98 -48.6 78.04 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 118.798 0.727 . . . . 0.0 110.892 177.177 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -61.97 -39.27 91.6 Favored 'General case' 0 C--O 1.235 0.315 0 C-N-CA 124.176 0.99 . . . . 0.0 112.041 -178.072 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 24.0 ttmm -58.45 -33.8 70.12 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 123.235 0.614 . . . . 0.0 110.649 172.854 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 19.4 mt -94.63 -21.18 18.97 Favored 'General case' 0 CA--C 1.513 -0.45 0 N-CA-C 116.297 1.962 . . . . 0.0 116.297 -168.956 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 4.3 m -59.01 -33.59 70.9 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 120.951 1.705 . . . . 0.0 111.424 -176.272 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 20.1 p -85.8 -11.97 52.1 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 125.252 1.421 . . . . 0.0 112.152 179.758 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 31.7 mmmt -83.14 -6.32 59.44 Favored 'General case' 0 C--N 1.344 0.352 0 C-N-CA 124.907 1.283 . . . . 0.0 111.386 173.785 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 71.44 32.42 64.9 Favored Glycine 0 C--N 1.337 0.597 0 CA-C-N 118.779 0.718 . . . . 0.0 112.103 170.499 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 4.2 m -75.37 172.3 1.13 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.532 0 CA-C-N 118.027 0.913 . . . . 0.0 109.316 173.563 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -113.15 122.11 46.54 Favored 'General case' 0 N--CA 1.466 0.327 0 N-CA-C 106.579 -1.637 . . . . 0.0 106.579 173.265 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 81.3 m-85 -88.86 145.89 25.29 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 119.422 1.01 . . . . 0.0 109.672 -176.343 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 29.5 m -132.73 160.69 42.44 Favored 'Isoleucine or valine' 0 C--O 1.236 0.355 0 C-N-CA 124.583 1.153 . . . . 0.0 109.153 171.338 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 98.7 -83.29 0.63 Allowed Glycine 0 N--CA 1.448 -0.559 0 C-N-CA 124.906 1.241 . . . . 0.0 111.106 174.196 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 16.7 m-30 55.69 -171.15 0.07 Allowed 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 124.503 1.121 . . . . 0.0 110.179 -169.152 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -154.41 144.05 15.31 Favored Pre-proline 0 N--CA 1.468 0.451 0 O-C-N 120.651 -1.281 . . . . 0.0 108.712 169.902 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -68.5 124.99 12.21 Favored 'Trans proline' 0 CA--C 1.534 0.517 0 C-N-CA 122.34 2.027 . . . . 0.0 111.321 179.612 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 5.9 p . . . . . 0 N--CA 1.469 0.48 0 O-C-N 121.794 -0.566 . . . . 0.0 111.804 174.314 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 24.2 ttmt . . . . . 0 CA--C 1.542 0.648 0 CA-C-O 117.578 -1.201 . . . . 0.0 113.769 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -80.49 5.67 5.94 Favored 'Trans proline' 0 C--N 1.351 0.663 0 C-N-CA 121.944 1.763 . . . . 0.0 114.84 179.002 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 20.3 m -124.77 152.08 30.71 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.379 0 CA-C-N 122.152 2.251 . . . . 0.0 111.486 -178.4 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 15.0 pt -96.53 163.69 2.34 Favored 'Isoleucine or valine' 0 C--O 1.236 0.355 0 C-N-CA 124.765 1.226 . . . . 0.0 109.556 169.246 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . 53.69 43.0 31.7 Favored 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 124.62 1.168 . . . . 0.0 112.19 167.61 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 31.5 t70 63.93 -32.32 0.12 Allowed 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 129.09 2.956 . . . . 0.0 114.616 -171.313 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 177.1 28.51 0.04 OUTLIER Glycine 0 CA--C 1.527 0.809 0 CA-C-O 117.867 -1.518 . . . . 0.0 114.616 177.499 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 74.2 mm-40 -76.2 -41.42 49.56 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 120.351 2.075 . . . . 0.0 111.248 -177.909 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -143.74 153.05 42.03 Favored 'General case' 0 CA--C 1.519 -0.238 0 C-N-CA 123.489 0.716 . . . . 0.0 109.888 176.727 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 74.7 m-85 -72.5 141.35 48.53 Favored 'General case' 0 N--CA 1.447 -0.595 0 N-CA-C 104.994 -2.224 . . . . 0.0 104.994 163.642 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 4.3 m -76.07 4.86 1.01 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.904 0 C-N-CA 122.968 0.507 . . . . 0.0 111.427 -176.608 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -174.06 171.53 44.6 Favored Glycine 0 CA--C 1.528 0.869 0 C-N-CA 125.847 1.689 . . . . 0.0 109.771 -179.139 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -64.2 136.37 57.15 Favored 'General case' 0 N--CA 1.466 0.375 0 C-N-CA 123.642 0.777 . . . . 0.0 111.361 -177.221 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -101.12 113.08 25.78 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 126.161 1.784 . . . . 0.0 109.222 -179.824 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 96.1 mt . . . . . 0 N--CA 1.464 0.255 0 C-N-CA 124.607 1.163 . . . . 0.0 110.218 175.583 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 8.1 m . . . . . 0 CA--C 1.539 0.521 0 N-CA-C 110.481 -0.192 . . . . 0.0 110.481 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -65.19 -43.73 90.7 Favored 'General case' 0 N--CA 1.463 0.191 0 C-N-CA 123.507 0.723 . . . . 0.0 111.376 173.317 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 19.9 tt0 -64.39 -43.56 94.08 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 124.702 1.201 . . . . 0.0 110.894 -179.094 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 54.0 mtp85 -62.41 -36.83 83.58 Favored 'General case' 0 N--CA 1.462 0.141 0 C-N-CA 124.119 0.967 . . . . 0.0 109.989 -179.858 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 55.7 mt -70.01 -57.38 8.32 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.461 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 172.495 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 68.2 tp60 -46.56 -65.77 0.51 Allowed 'General case' 0 C--O 1.235 0.314 0 C-N-CA 126.203 1.801 . . . . 0.0 112.476 -172.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 16.9 m -68.23 -29.09 67.84 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 123.091 0.244 . . . . 0.0 111.014 -169.483 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 160' ' ' TRP . . . . . . . . . . . . . 62.2 t90 -72.03 -44.6 63.14 Favored 'General case' 0 CA--C 1.515 -0.391 0 O-C-N 121.808 -0.558 . . . . 0.0 111.156 177.264 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 95.8 m -61.39 -40.52 94.68 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 122.717 0.407 . . . . 0.0 109.951 177.498 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -62.74 -42.58 99.74 Favored 'General case' 0 C--O 1.227 -0.098 0 CA-C-O 121.078 0.466 . . . . 0.0 110.254 174.028 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 12.1 tt0 -62.66 -51.57 66.74 Favored 'General case' 0 N--CA 1.449 -0.513 0 O-C-N 121.614 -0.679 . . . . 0.0 110.154 -178.445 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 45.5 pt -63.04 -38.13 81.22 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.367 0 CA-C-O 117.976 -1.011 . . . . 0.0 109.481 -174.962 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -65.02 -33.59 76.4 Favored 'General case' 0 C--O 1.225 -0.235 0 CA-C-N 119.416 1.007 . . . . 0.0 110.351 179.788 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 35.0 m-80 -69.23 -57.47 5.31 Favored 'General case' 0 C--O 1.223 -0.32 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 174.592 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 13.0 tt0 -63.45 -36.47 83.86 Favored 'General case' 0 N--CA 1.445 -0.68 0 C-N-CA 125.514 1.526 . . . . 0.0 111.131 -169.251 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 168' ' ' MET . . . . . . . . . . . . . 20.0 ptp -70.27 -32.75 70.7 Favored 'General case' 0 C--O 1.226 -0.16 0 O-C-N 121.63 -0.669 . . . . 0.0 111.761 174.08 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -75.28 -34.72 61.35 Favored 'General case' 0 N--CA 1.448 -0.568 0 CA-C-O 119.082 -0.485 . . . . 0.0 112.174 -178.776 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 6.2 mt-10 . . . . . 0 N--CA 1.465 0.306 0 CA-C-O 121.794 0.807 . . . . 0.0 109.317 177.613 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.498 1.961 0 N-CA-C 111.316 0.117 . . . . 0.0 111.316 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 9.0 t30 -114.31 152.04 32.02 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 123.736 0.815 . . . . 0.0 110.136 -179.082 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 16.0 mtt -116.21 129.55 56.35 Favored 'General case' 0 N--CA 1.461 0.103 0 C-N-CA 123.948 0.899 . . . . 0.0 110.731 -179.265 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -85.35 154.62 28.85 Favored Glycine 0 CA--C 1.524 0.644 0 N-CA-C 107.484 -2.246 . . . . 0.0 107.484 167.192 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 1.4 tt -142.05 96.51 2.97 Favored 'General case' 0 N--CA 1.466 0.343 0 N-CA-C 106.338 -1.727 . . . . 0.0 106.338 -175.447 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -106.06 144.67 32.44 Favored 'General case' 0 CA--C 1.519 -0.238 0 CA-C-O 121.481 0.658 . . . . 0.0 111.9 -170.761 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 23.6 p90 . . . . . 0 N--CA 1.453 -0.314 0 C-N-CA 125.879 1.671 . . . . 0.0 108.015 -177.53 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.338 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -63.45 -47.68 80.87 Favored 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 123.17 0.588 . . . . 0.0 111.907 -174.161 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.1 pp20? -67.38 -35.73 79.91 Favored 'General case' 0 CA--C 1.535 0.383 0 O-C-N 121.596 -0.69 . . . . 0.0 109.274 -179.671 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 29.3 mtpp -67.37 -40.58 85.77 Favored 'General case' 0 C--O 1.225 -0.232 0 O-C-N 121.126 -0.984 . . . . 0.0 110.916 175.968 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 37.8 mt -56.24 -56.18 14.68 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.198 0 CA-C-N 119.995 1.27 . . . . 0.0 109.171 176.196 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.5 -35.89 82.4 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 118.529 0.604 . . . . 0.0 110.946 -175.494 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -63.42 -40.14 96.39 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 117.94 0.336 . . . . 0.0 110.888 177.94 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 67.6 mt -77.14 -53.58 14.49 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 C-N-CA 124.23 1.012 . . . . 0.0 110.353 -174.17 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 70.7 mt -60.3 -49.53 83.85 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.317 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 177.917 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 144.25 119.14 1.31 Allowed Glycine 0 CA--C 1.528 0.887 0 N-CA-C 110.133 -1.187 . . . . 0.0 110.133 179.209 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -68.71 -14.52 39.42 Favored 'Trans proline' 0 CA--C 1.536 0.588 0 C-N-CA 122.955 2.436 . . . . 0.0 113.022 -173.278 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -73.56 -21.54 60.33 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 118.579 0.627 . . . . 0.0 112.051 179.396 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -129.57 8.12 5.36 Favored 'General case' 0 CA--C 1.536 0.405 0 N-CA-C 113.862 1.06 . . . . 0.0 113.862 -169.162 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 33.7 t -128.13 147.09 32.77 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.387 0 C-N-CA 124.449 1.099 . . . . 0.0 108.066 172.308 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 26.9 m -131.53 131.74 43.62 Favored 'General case' 0 C--N 1.332 -0.164 0 C-N-CA 125.643 1.577 . . . . 0.0 108.419 -174.716 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 18.4 mt -75.93 134.01 40.35 Favored 'General case' 0 C--O 1.232 0.154 0 N-CA-C 108.401 -0.963 . . . . 0.0 108.401 175.018 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 25.4 t-80 -130.67 55.75 1.81 Allowed 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 124.806 1.242 . . . . 0.0 108.528 -176.741 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 54.2 t-20 -60.11 125.09 22.33 Favored 'General case' 0 C--O 1.233 0.193 0 N-CA-C 107.974 -1.121 . . . . 0.0 107.974 176.817 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 80.9 mt -69.94 -20.58 63.33 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 118.429 0.559 . . . . 0.0 112.282 -176.93 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 58.2 tptt -63.61 -25.91 68.44 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 118.467 0.576 . . . . 0.0 110.712 168.931 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -106.01 -37.9 6.49 Favored 'General case' 0 C--O 1.235 0.327 0 N-CA-C 113.452 0.908 . . . . 0.0 113.452 -169.426 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 2.6 t0 -134.64 155.82 49.83 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-N 118.834 0.743 . . . . 0.0 112.627 -175.578 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 19.5 m -76.32 156.67 83.49 Favored Pre-proline 0 CA--C 1.539 0.555 0 C-N-CA 125.551 1.54 . . . . 0.0 111.415 -172.097 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -75.59 -26.25 10.19 Favored 'Trans proline' 0 C--N 1.348 0.506 0 C-N-CA 122.603 2.202 . . . . 0.0 113.882 -171.173 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 21.4 mmmt -70.84 -11.75 61.14 Favored 'General case' 0 N--CA 1.474 0.731 0 O-C-N 120.271 -1.518 . . . . 0.0 111.654 -176.232 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -58.02 -30.96 66.53 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 125.879 1.672 . . . . 0.0 110.089 168.329 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 46.1 mtt -57.77 -25.12 60.05 Favored 'General case' 0 N--CA 1.463 0.206 0 C-N-CA 123.341 0.656 . . . . 0.0 111.838 178.616 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 87.1 mt-10 -66.77 -33.92 76.69 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 118.463 0.574 . . . . 0.0 110.02 -177.693 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 13.8 mt-30 -67.49 -45.17 76.64 Favored 'General case' 0 N--CA 1.465 0.307 0 C-N-CA 123.202 0.601 . . . . 0.0 112.412 -169.874 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 26.1 m-85 -72.05 137.55 47.23 Favored 'General case' 0 N--CA 1.456 -0.132 0 CA-C-N 115.317 -0.856 . . . . 0.0 110.042 -166.574 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -74.26 -35.08 63.78 Favored 'General case' 0 N--CA 1.466 0.355 0 O-C-N 121.872 -0.518 . . . . 0.0 110.788 -177.265 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 20.5 t -108.56 145.69 15.21 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.436 0 N-CA-C 106.991 -1.485 . . . . 0.0 106.991 169.386 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 36.4 tp -133.95 112.78 11.53 Favored 'General case' 0 N--CA 1.447 -0.606 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 175.379 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 22.8 mt -89.92 134.47 28.89 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.665 0 N-CA-C 107.15 -1.426 . . . . 0.0 107.15 176.248 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 2.7 mp -115.54 130.63 56.94 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 125.613 1.565 . . . . 0.0 107.473 -178.365 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -135.65 136.28 8.38 Favored Glycine 0 C--N 1.333 0.368 0 N-CA-C 109.413 -1.475 . . . . 0.0 109.413 173.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 3.1 tt -152.98 137.34 10.71 Favored Pre-proline 0 CA--C 1.536 0.424 0 CA-C-N 118.477 1.138 . . . . 0.0 110.451 171.534 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo . . . . . 0 N--CA 1.453 -0.871 0 C-N-CA 122.476 2.118 . . . . 0.0 109.886 167.561 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 55.7 mt . . . . . 0 CA--C 1.549 0.91 0 CA-C-O 122.598 1.19 . . . . 0.0 112.821 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 1.2 pm0 -125.77 156.85 38.8 Favored 'General case' 0 C--O 1.232 0.162 0 C-N-CA 126.172 1.789 . . . . 0.0 108.682 -176.437 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -54.92 -43.26 73.16 Favored 'General case' 0 C--O 1.224 -0.261 0 C-N-CA 124.524 1.13 . . . . 0.0 112.355 -168.746 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -65.23 -20.33 66.38 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-N 119.156 0.889 . . . . 0.0 111.835 -174.082 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 12.6 t90 -96.24 -49.04 5.38 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 124.448 1.099 . . . . 0.0 109.75 175.344 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -62.98 -35.28 79.65 Favored 'General case' 0 CA--C 1.536 0.426 0 O-C-N 121.041 -1.037 . . . . 0.0 110.413 -175.434 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -61.89 -27.41 68.78 Favored 'General case' 0 CA--C 1.53 0.179 0 C-N-CA 123.087 0.555 . . . . 0.0 111.059 -174.637 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 30.9 m -107.35 -17.08 8.1 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.372 0 CA-C-O 117.199 -1.382 . . . . 0.0 112.156 177.014 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 35.8 t90 -50.66 -34.75 27.65 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 120.447 1.476 . . . . 0.0 110.931 177.823 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -62.56 -31.14 71.89 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 125.315 1.446 . . . . 0.0 113.319 174.901 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 30.4 mt-30 -88.8 -20.89 24.12 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 126.555 1.942 . . . . 0.0 111.273 178.73 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 50.8 mt -65.25 -20.62 66.51 Favored 'General case' 0 CA--C 1.533 0.301 0 O-C-N 121.41 -0.806 . . . . 0.0 111.672 -173.603 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -79.0 -23.4 44.43 Favored 'General case' 0 CA--C 1.542 0.653 0 CA-C-N 118.399 0.545 . . . . 0.0 111.793 175.25 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -71.99 -30.03 64.84 Favored 'General case' 0 N--CA 1.468 0.47 0 O-C-N 120.723 -1.236 . . . . 0.0 111.958 178.177 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 80.1 mt -52.89 140.92 23.14 Favored 'General case' 0 C--N 1.338 0.102 0 C-N-CA 124.887 1.275 . . . . 0.0 112.994 -168.417 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 29.2 t-20 -76.14 108.95 9.41 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 169.688 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 70.2 mt -131.6 -0.07 3.96 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 114.317 1.228 . . . . 0.0 114.317 -172.348 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 28.8 mt-10 -57.2 129.8 43.38 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 119.68 1.127 . . . . 0.0 111.25 -168.544 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 73.9 -2.0 44.07 Favored Glycine 0 CA--C 1.533 1.204 0 C-N-CA 125.531 1.539 . . . . 0.0 115.023 178.32 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.04 150.3 40.71 Favored 'General case' 0 C--N 1.346 0.414 0 CA-C-N 120.663 2.231 . . . . 0.0 109.683 -176.649 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 4.3 mt -82.25 137.51 20.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 N-CA-C 106.489 -1.671 . . . . 0.0 106.489 179.068 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 67.0 t -130.92 129.49 63.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 C-N-CA 123.629 0.771 . . . . 0.0 109.515 -176.879 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -100.66 151.59 21.46 Favored 'General case' 0 N--CA 1.463 0.213 0 N-CA-C 107.735 -1.209 . . . . 0.0 107.735 168.715 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 4.5 mt -133.02 134.61 44.65 Favored 'General case' 0 CA--C 1.514 -0.409 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 176.394 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 37.4 p90 -149.91 168.14 24.64 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 107.692 -1.225 . . . . 0.0 107.692 168.655 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -168.19 171.22 42.42 Favored Glycine 0 N--CA 1.446 -0.656 0 N-CA-C 110.449 -1.061 . . . . 0.0 110.449 176.119 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 1.9 tm? . . . . . 0 N--CA 1.449 -0.492 0 C-N-CA 126.171 1.789 . . . . 0.0 106.781 -175.805 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 97.0 mt . . . . . 0 N--CA 1.469 0.524 0 N-CA-C 113.234 0.828 . . . . 0.0 113.234 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -65.05 -37.75 88.6 Favored 'General case' 0 N--CA 1.465 0.3 0 O-C-N 120.659 -1.275 . . . . 0.0 110.786 -170.766 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -65.45 -28.79 69.47 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 123.783 0.833 . . . . 0.0 112.304 173.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 5.3 tt -64.77 -49.28 71.35 Favored 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 108.039 -1.097 . . . . 0.0 108.039 174.01 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -62.33 -34.08 88.14 Favored Glycine 0 CA--C 1.529 0.948 0 N-CA-C 111.213 -0.755 . . . . 0.0 111.213 179.277 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 7.2 tpp -53.86 -50.97 65.08 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 124.683 1.193 . . . . 0.0 111.566 178.729 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -76.52 -36.17 57.89 Favored 'General case' 0 CA--C 1.534 0.355 0 N-CA-C 109.433 -0.581 . . . . 0.0 109.433 -174.966 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 51.0 t-80 -56.99 -44.81 83.11 Favored 'General case' 0 N--CA 1.467 0.381 0 O-C-N 121.463 -0.773 . . . . 0.0 111.296 174.032 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -63.86 -43.68 95.38 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 123.609 0.764 . . . . 0.0 111.384 -178.633 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 25.1 ttmm -56.14 -43.12 77.92 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 123.476 0.71 . . . . 0.0 110.289 173.125 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 21.3 mt -85.75 -19.29 31.01 Favored 'General case' 0 CA--C 1.511 -0.529 0 N-CA-C 115.141 1.534 . . . . 0.0 115.141 -169.755 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 67.8 m -59.97 -29.8 68.67 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 119.659 1.118 . . . . 0.0 111.488 -175.375 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 27.5 p -93.66 -4.23 51.0 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 125.348 1.459 . . . . 0.0 112.316 179.62 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 32.3 mmmt -87.42 -5.94 58.64 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 124.762 1.225 . . . . 0.0 111.685 175.081 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 73.05 30.94 62.4 Favored Glycine 0 CA--C 1.523 0.586 0 CA-C-N 118.368 0.531 . . . . 0.0 112.116 172.712 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 5.3 m -76.15 174.48 0.84 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 CA-C-N 118.211 1.005 . . . . 0.0 109.151 171.752 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -114.29 127.36 55.83 Favored 'General case' 0 CA--C 1.515 -0.372 0 N-CA-C 106.786 -1.561 . . . . 0.0 106.786 170.385 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 66.9 m-85 -92.31 144.69 25.13 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 119.652 1.115 . . . . 0.0 109.865 -178.155 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 35.4 m -131.83 157.34 43.12 Favored 'Isoleucine or valine' 0 C--O 1.234 0.267 0 C-N-CA 125.493 1.517 . . . . 0.0 107.527 169.396 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 86.15 29.61 24.9 Favored Glycine 0 CA--C 1.521 0.41 0 CA-C-O 118.334 -1.259 . . . . 0.0 114.741 169.833 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 11.7 m-30 -62.96 157.91 20.59 Favored 'General case' 0 CA--C 1.541 0.626 0 CA-C-N 119.07 1.435 . . . . 0.0 108.918 168.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 36.3 t-105 -135.72 143.55 45.17 Favored Pre-proline 0 N--CA 1.467 0.39 0 CA-C-O 118.008 -0.996 . . . . 0.0 111.95 -168.833 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -59.02 129.05 30.07 Favored 'Trans proline' 0 N--CA 1.458 -0.58 0 C-N-CA 122.986 2.457 . . . . 0.0 111.044 176.124 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 9.0 p . . . . . 0 CA--C 1.534 0.364 0 C-N-CA 123.297 0.639 . . . . 0.0 111.705 169.884 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 28.2 ttmt . . . . . 0 CA--C 1.542 0.654 0 CA-C-O 117.531 -1.223 . . . . 0.0 114.073 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -82.59 4.9 6.74 Favored 'Trans proline' 0 C--N 1.351 0.674 0 C-N-CA 122.017 1.812 . . . . 0.0 113.882 -179.074 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 16.7 m -128.06 166.09 25.91 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.186 0 CA-C-N 121.033 1.742 . . . . 0.0 112.24 -172.805 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 16.1 pt -131.48 168.57 23.6 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.474 0 C-N-CA 127.674 2.39 . . . . 0.0 108.833 179.023 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . 55.88 39.03 30.67 Favored 'General case' 0 CA--C 1.529 0.163 0 C-N-CA 125.199 1.4 . . . . 0.0 113.328 169.746 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 27.6 t70 59.22 43.29 17.22 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 126.412 1.885 . . . . 0.0 111.715 -177.528 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 89.8 18.86 50.01 Favored Glycine 0 CA--C 1.528 0.905 0 CA-C-N 115.574 -0.739 . . . . 0.0 113.461 171.204 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -85.9 -21.78 27.81 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 125.016 1.326 . . . . 0.0 111.836 -177.662 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 9.8 tp -150.13 144.97 26.04 Favored 'General case' 0 C--N 1.341 0.222 0 CA-C-N 119.322 0.964 . . . . 0.0 110.785 176.948 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 55.8 m-85 -82.33 144.26 30.7 Favored 'General case' 0 CA--C 1.517 -0.293 0 N-CA-C 107.864 -1.162 . . . . 0.0 107.864 169.922 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 17.0 m -76.77 12.03 0.39 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.57 0 C-N-CA 124.43 1.092 . . . . 0.0 112.238 178.827 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -179.64 171.76 43.45 Favored Glycine 0 CA--C 1.526 0.769 0 N-CA-C 109.761 -1.335 . . . . 0.0 109.761 -178.321 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 8.0 tp -64.11 134.24 54.51 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 117.617 0.709 . . . . 0.0 110.891 177.579 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -93.49 127.57 39.2 Favored 'General case' 0 N--CA 1.441 -0.9 0 C-N-CA 125.393 1.477 . . . . 0.0 109.627 174.441 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 84.5 mt . . . . . 0 C--O 1.234 0.239 0 N-CA-C 105.83 -1.915 . . . . 0.0 105.83 167.718 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 5.2 m . . . . . 0 CA--C 1.535 0.388 0 N-CA-C 110.296 -0.261 . . . . 0.0 110.296 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -62.17 -45.87 91.48 Favored 'General case' 0 N--CA 1.463 0.178 0 C-N-CA 123.285 0.634 . . . . 0.0 110.415 175.157 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 -63.04 -43.04 99.78 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 123.593 0.757 . . . . 0.0 110.416 179.549 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 2.3 mpt_? -59.14 -45.83 89.92 Favored 'General case' 0 C--N 1.335 -0.05 0 C-N-CA 123.976 0.91 . . . . 0.0 110.368 177.598 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 34.9 mt -64.67 -53.09 46.48 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 176.847 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -54.28 -66.34 0.41 Allowed 'General case' 0 CA--C 1.518 -0.287 0 C-N-CA 125.437 1.495 . . . . 0.0 112.246 -169.916 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 16.3 m -60.94 -33.7 73.59 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.747 -0.66 . . . . 0.0 111.594 -174.825 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 160' ' ' TRP . . . . . . . . . . . . . 67.5 t90 -65.14 -44.99 86.86 Favored 'General case' 0 C--O 1.223 -0.293 0 O-C-N 121.956 -0.465 . . . . 0.0 110.552 173.9 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 65.8 m -60.33 -41.24 93.15 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 118.298 0.499 . . . . 0.0 110.763 179.672 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -62.57 -45.68 91.79 Favored 'General case' 0 C--O 1.228 -0.073 0 CA-C-N 118.818 0.736 . . . . 0.0 110.063 173.201 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 14.4 tt0 -61.53 -48.56 80.49 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-O 117.923 -1.037 . . . . 0.0 110.363 -175.522 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 40.7 pt -65.57 -33.8 66.08 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.422 0 CA-C-O 117.918 -1.039 . . . . 0.0 110.282 -178.299 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -73.05 -31.02 64.14 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 119.58 1.082 . . . . 0.0 108.765 -175.033 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -69.08 -55.87 9.42 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 125.028 1.331 . . . . 0.0 109.194 170.945 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 19.5 tt0 -67.76 -30.68 70.2 Favored 'General case' 0 N--CA 1.442 -0.837 0 C-N-CA 125.546 1.538 . . . . 0.0 110.504 -168.545 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 168' ' ' MET . . . . . . . . . . . . . 20.2 ptp -75.8 -29.13 58.62 Favored 'General case' 0 CA--C 1.523 -0.058 0 O-C-N 122.023 -0.423 . . . . 0.0 111.743 174.708 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -78.3 -33.37 49.41 Favored 'General case' 0 N--CA 1.444 -0.73 0 C-N-CA 123.228 0.611 . . . . 0.0 111.639 179.729 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 . . . . . 0 N--CA 1.468 0.447 0 CA-C-O 122.324 1.059 . . . . 0.0 109.149 175.822 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 34.6 ttp . . . . . 0 N--CA 1.494 1.753 0 N-CA-C 110.368 -0.234 . . . . 0.0 110.368 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 29.1 p-10 -144.51 166.66 24.51 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 126.612 1.965 . . . . 0.0 108.367 177.955 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 1.5 mpt? -129.04 124.4 34.78 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 118.567 0.621 . . . . 0.0 111.1 -179.797 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -90.42 142.1 16.19 Favored Glycine 0 CA--C 1.526 0.724 0 N-CA-C 107.139 -2.384 . . . . 0.0 107.139 167.815 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 1.2 tt -132.2 97.55 4.16 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 119.911 1.855 . . . . 0.0 106.659 -169.866 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -105.03 144.48 31.78 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-O 121.64 0.733 . . . . 0.0 112.138 -170.408 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 35.4 p90 . . . . . 0 CA--C 1.533 0.326 0 C-N-CA 126.698 1.999 . . . . 0.0 107.539 179.512 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.338 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -62.74 -48.26 79.99 Favored 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 123.761 0.825 . . . . 0.0 111.379 -175.707 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -67.51 -35.78 79.79 Favored 'General case' 0 CA--C 1.535 0.402 0 O-C-N 121.795 -0.565 . . . . 0.0 110.426 178.96 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 28.9 mtpp -67.39 -37.63 83.42 Favored 'General case' 0 N--CA 1.465 0.293 0 O-C-N 121.272 -0.893 . . . . 0.0 111.182 177.568 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 32.9 mt -56.75 -54.58 27.47 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.25 0 N-CA-C 108.404 -0.961 . . . . 0.0 108.404 175.09 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 22.2 ptt180 -63.31 -37.73 88.42 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 118.904 0.774 . . . . 0.0 110.635 -178.11 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -64.57 -37.78 88.72 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 109.865 -0.42 . . . . 0.0 109.865 -174.736 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 75.6 mt -79.79 -54.47 11.09 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.573 0 C-N-CA 124.805 1.242 . . . . 0.0 110.167 -175.081 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 77.7 mt -62.61 -48.3 88.86 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.292 0 C-N-CA 122.719 0.408 . . . . 0.0 110.172 179.908 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 142.01 119.24 1.48 Allowed Glycine 0 CA--C 1.53 1.026 0 C-N-CA 125.207 1.384 . . . . 0.0 110.449 -179.087 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -76.88 -4.43 14.91 Favored 'Trans proline' 0 CA--C 1.538 0.717 0 C-N-CA 122.829 2.353 . . . . 0.0 113.491 -171.141 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -82.35 -22.68 35.42 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 118.918 0.781 . . . . 0.0 111.157 177.15 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 1.2 pt? -118.51 -21.28 8.06 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 124.847 1.259 . . . . 0.0 113.216 -174.117 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 59.0 t -91.45 147.23 5.41 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.504 0 N-CA-C 107.608 -1.256 . . . . 0.0 107.608 168.714 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 16.5 m -132.13 134.11 45.06 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 125.193 1.397 . . . . 0.0 107.833 178.494 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 18.7 mt -79.43 141.13 37.09 Favored 'General case' 0 N--CA 1.466 0.336 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 175.248 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 21.8 t-80 -135.15 54.09 1.95 Allowed 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 124.761 1.224 . . . . 0.0 108.259 -176.766 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 28.4 t-20 -55.21 124.13 15.96 Favored 'General case' 0 C--O 1.235 0.311 0 N-CA-C 107.348 -1.352 . . . . 0.0 107.348 170.935 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 32.3 mt -72.56 -16.94 61.75 Favored 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 113.105 0.78 . . . . 0.0 113.105 -170.509 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 9.8 tppt? -66.88 -31.06 71.41 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-N 119.354 0.979 . . . . 0.0 109.492 168.078 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -92.48 -36.35 13.12 Favored 'General case' 0 C--O 1.235 0.321 0 N-CA-C 113.525 0.935 . . . . 0.0 113.525 -168.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 2.3 t0 -140.47 156.96 46.18 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-N 118.949 0.795 . . . . 0.0 112.477 178.13 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 17.8 m -79.97 160.06 69.58 Favored Pre-proline 0 CA--C 1.541 0.625 0 C-N-CA 126.23 1.812 . . . . 0.0 111.299 -170.249 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -76.0 -24.85 10.92 Favored 'Trans proline' 0 C--N 1.351 0.7 0 C-N-CA 122.41 2.073 . . . . 0.0 113.41 -171.412 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 3.7 mmmm -67.12 -17.74 65.0 Favored 'General case' 0 CA--C 1.542 0.671 0 O-C-N 120.745 -1.222 . . . . 0.0 110.774 -174.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -59.49 -31.05 69.0 Favored 'General case' 0 N--CA 1.465 0.317 0 C-N-CA 126.803 2.041 . . . . 0.0 110.548 171.235 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 56.3 mtt -59.24 -24.31 63.07 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 118.83 0.741 . . . . 0.0 111.157 -178.672 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 63.3 mt-10 -64.78 -31.83 73.24 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-N 118.464 0.575 . . . . 0.0 110.385 -178.791 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 24.0 mt-30 -69.93 -39.37 76.16 Favored 'General case' 0 N--CA 1.466 0.354 0 N-CA-C 114.093 1.146 . . . . 0.0 114.093 -169.2 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 53.6 m-85 -72.25 141.58 48.95 Favored 'General case' 0 CA--C 1.528 0.12 0 C-N-CA 123.075 0.55 . . . . 0.0 111.388 -165.928 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 57.6 m-20 -69.68 -30.24 67.86 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 123.651 0.78 . . . . 0.0 110.268 176.564 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 19.0 t -126.15 147.2 30.98 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.467 0 N-CA-C 106.973 -1.491 . . . . 0.0 106.973 172.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 22.5 tp -124.87 150.01 46.92 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 169.873 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 43.5 mt -128.9 127.73 66.58 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 N-CA-C 104.596 -2.372 . . . . 0.0 104.596 178.426 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 3.2 mp -107.59 132.88 52.81 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 125.867 1.667 . . . . 0.0 106.791 -178.164 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -139.15 128.7 4.13 Favored Glycine 0 C--N 1.34 0.771 0 N-CA-C 109.182 -1.567 . . . . 0.0 109.182 -177.825 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 3.5 tt -151.77 134.45 8.79 Favored Pre-proline 0 CA--C 1.534 0.363 0 CA-C-N 118.437 1.119 . . . . 0.0 111.685 -179.136 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 75.6 Cg_endo . . . . . 0 N--CA 1.454 -0.843 0 C-N-CA 121.834 1.69 . . . . 0.0 108.827 168.049 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 73.8 mt . . . . . 0 CA--C 1.544 0.717 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 -76.98 159.77 29.68 Favored 'General case' 0 N--CA 1.465 0.32 0 C-N-CA 123.723 0.809 . . . . 0.0 109.074 178.33 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -55.36 -41.94 73.24 Favored 'General case' 0 C--O 1.225 -0.23 0 C-N-CA 123.645 0.778 . . . . 0.0 110.643 -179.96 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 22.7 m-20 -62.95 -26.25 68.74 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 123.123 0.569 . . . . 0.0 112.013 -177.84 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' TRP . . . . . 0.436 ' CZ3' ' CE3' ' A' ' 69' ' ' TRP . 0.0 OUTLIER -92.53 -46.43 7.63 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 125.462 1.505 . . . . 0.0 107.483 -176.407 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 13.7 tt0 -63.21 -36.65 84.34 Favored 'General case' 0 N--CA 1.445 -0.69 0 O-C-N 120.073 -1.642 . . . . 0.0 110.355 179.396 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -58.53 -26.09 63.15 Favored 'General case' 0 C--O 1.234 0.239 0 C-N-CA 123.844 0.858 . . . . 0.0 111.368 -175.115 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 34.9 m -105.15 -18.01 7.17 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.416 0 CA-C-O 117.221 -1.371 . . . . 0.0 112.51 177.607 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' TRP . . . . . 0.436 ' CE3' ' CZ3' ' A' ' 65' ' ' TRP . 1.8 t-105 -52.32 -35.04 49.77 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 120.464 1.484 . . . . 0.0 111.118 -176.023 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -68.01 -27.12 66.28 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 126.02 1.728 . . . . 0.0 113.357 177.04 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 23.1 mt-30 -92.65 -23.11 19.09 Favored 'General case' 0 C--N 1.341 0.222 0 C-N-CA 126.179 1.792 . . . . 0.0 112.262 178.249 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 71.8 mt -64.66 -26.21 68.29 Favored 'General case' 0 N--CA 1.465 0.285 0 O-C-N 121.514 -0.741 . . . . 0.0 111.861 -174.326 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -76.93 -22.55 53.13 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-N 118.329 0.513 . . . . 0.0 111.465 173.321 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -79.11 -27.88 42.92 Favored 'General case' 0 CA--C 1.534 0.36 0 O-C-N 120.986 -1.071 . . . . 0.0 112.13 179.706 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 39.3 mt -58.25 145.11 38.71 Favored 'General case' 0 C--O 1.234 0.265 0 C-N-CA 124.433 1.093 . . . . 0.0 110.629 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 22.3 t-20 -87.86 112.09 22.11 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 169.839 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 62.0 mt -120.95 6.92 10.35 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 123.558 0.743 . . . . 0.0 111.9 -172.421 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 32.1 mt-10 -51.13 133.24 28.09 Favored 'General case' 0 C--O 1.235 0.319 0 C-N-CA 124.837 1.255 . . . . 0.0 112.551 -168.857 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 71.81 -6.16 10.19 Favored Glycine 0 CA--C 1.531 1.074 0 C-N-CA 125.521 1.534 . . . . 0.0 115.598 173.177 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.34 157.92 33.55 Favored 'General case' 0 C--N 1.346 0.43 0 CA-C-N 120.759 2.28 . . . . 0.0 110.02 -174.476 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 7.3 mt -84.41 139.3 17.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 N-CA-C 106.894 -1.521 . . . . 0.0 106.894 176.576 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 99.2 t -130.97 126.98 60.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 C-N-CA 123.217 0.607 . . . . 0.0 110.864 178.065 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -94.02 146.16 24.14 Favored 'General case' 0 C--O 1.233 0.223 0 N-CA-C 106.464 -1.68 . . . . 0.0 106.464 165.751 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 2.0 mt -123.75 139.61 53.81 Favored 'General case' 0 CA--C 1.513 -0.475 0 N-CA-C 106.399 -1.704 . . . . 0.0 106.399 171.93 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 31.7 p90 -152.09 167.35 28.76 Favored 'General case' 0 N--CA 1.445 -0.714 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 167.921 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -164.04 179.06 39.17 Favored Glycine 0 N--CA 1.433 -1.523 0 N-CA-C 109.643 -1.383 . . . . 0.0 109.643 170.511 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 6.1 tt . . . . . 0 N--CA 1.44 -0.956 0 N-CA-C 107.245 -1.391 . . . . 0.0 107.245 172.971 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 92.0 mt . . . . . 0 N--CA 1.47 0.543 0 N-CA-C 114.739 1.385 . . . . 0.0 114.739 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -60.56 -33.89 73.36 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 120.643 1.565 . . . . 0.0 111.554 -170.163 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -71.77 -29.86 64.94 Favored 'General case' 0 CA--C 1.535 0.397 0 N-CA-C 112.714 0.635 . . . . 0.0 112.714 176.335 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 5.5 tt -59.07 -43.92 91.82 Favored 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 173.194 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -67.07 -32.96 82.01 Favored Glycine 0 C--N 1.338 0.639 0 CA-C-O 119.678 -0.512 . . . . 0.0 112.053 -176.156 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 75.6 mtm -68.4 -41.1 80.97 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 118.108 0.954 . . . . 0.0 110.899 -178.298 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -72.75 -38.04 67.5 Favored 'General case' 0 C--N 1.347 0.497 0 CA-C-N 120.507 1.503 . . . . 0.0 110.693 175.997 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 84.9 t60 -50.61 -49.0 57.74 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 118.37 0.532 . . . . 0.0 110.517 173.589 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -65.4 -41.81 93.27 Favored 'General case' 0 C--O 1.235 0.33 0 C-N-CA 123.522 0.729 . . . . 0.0 112.804 -177.784 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 24.1 ttmm -54.7 -43.46 72.54 Favored 'General case' 0 N--CA 1.465 0.31 0 C-N-CA 123.103 0.561 . . . . 0.0 109.847 171.55 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 7.9 mt -77.91 -25.66 48.57 Favored 'General case' 0 CA--C 1.516 -0.349 0 N-CA-C 115.35 1.611 . . . . 0.0 115.35 -168.247 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 14.1 m -58.73 -33.16 69.91 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-N 120.124 1.329 . . . . 0.0 112.245 -172.658 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 22.8 p -87.23 -9.65 54.55 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 124.413 1.085 . . . . 0.0 111.956 -179.139 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 30.9 mmmt -82.04 -10.01 59.36 Favored 'General case' 0 C--N 1.346 0.416 0 C-N-CA 124.419 1.088 . . . . 0.0 111.383 173.143 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 75.13 32.93 55.51 Favored Glycine 0 CA--C 1.524 0.638 0 CA-C-O 119.665 -0.519 . . . . 0.0 112.615 169.728 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 29.8 m -76.5 179.79 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 CA-C-N 118.208 1.004 . . . . 0.0 110.38 169.602 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -116.6 134.26 55.04 Favored 'General case' 0 CA--C 1.515 -0.369 0 N-CA-C 106.374 -1.713 . . . . 0.0 106.374 169.655 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 59.3 m-85 -95.38 145.01 25.44 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 119.502 1.047 . . . . 0.0 110.17 -179.26 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 35.3 m -132.8 159.61 43.07 Favored 'Isoleucine or valine' 0 C--O 1.233 0.21 0 C-N-CA 125.03 1.332 . . . . 0.0 108.399 171.954 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 82.02 33.44 26.63 Favored Glycine 0 CA--C 1.521 0.456 0 CA-C-O 118.666 -1.074 . . . . 0.0 113.858 170.556 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 8.3 m-30 -62.38 149.93 41.09 Favored 'General case' 0 CA--C 1.544 0.749 0 CA-C-N 119.297 1.549 . . . . 0.0 109.47 169.633 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 1.5 t90 -134.65 136.37 25.33 Favored Pre-proline 0 CA--C 1.541 0.603 0 CA-C-O 117.273 -1.346 . . . . 0.0 108.592 -170.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_exo -66.45 130.26 23.3 Favored 'Trans proline' 0 C--N 1.349 0.574 0 C-N-CA 123.006 2.471 . . . . 0.0 113.366 -172.369 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 33.6 p . . . . . 0 CA--C 1.545 0.773 0 N-CA-C 113.235 0.828 . . . . 0.0 113.235 172.875 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 47.1 mttp . . . . . 0 N--CA 1.473 0.679 0 CA-C-O 117.848 -1.072 . . . . 0.0 113.199 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -86.58 13.44 2.72 Favored 'Trans proline' 0 N--CA 1.457 -0.659 0 C-N-CA 122.043 1.829 . . . . 0.0 113.057 -171.524 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 15.2 m -127.55 146.23 33.62 Favored 'Isoleucine or valine' 0 C--O 1.232 0.179 0 CA-C-N 121.521 1.964 . . . . 0.0 111.04 -179.297 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 14.5 pt -102.8 169.01 2.01 Favored 'Isoleucine or valine' 0 C--O 1.235 0.313 0 C-N-CA 125.68 1.592 . . . . 0.0 108.96 170.483 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . 56.72 30.96 18.5 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 124.829 1.251 . . . . 0.0 113.514 167.93 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 27.6 t70 55.1 38.98 31.34 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 126.736 2.014 . . . . 0.0 111.292 -176.23 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 98.14 71.74 1.04 Allowed Glycine 0 C--N 1.338 0.693 0 C-N-CA 124.401 1.0 . . . . 0.0 111.29 176.721 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 76.3 mm-40 -120.33 -48.56 2.31 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 123.048 0.539 . . . . 0.0 110.895 167.784 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -131.34 141.98 50.0 Favored 'General case' 0 N--CA 1.467 0.408 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 179.52 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 62.9 m-85 -75.82 18.83 0.23 Allowed 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 125.86 1.664 . . . . 0.0 115.215 177.315 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 4.2 m 49.25 10.8 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.552 1.031 0 C-N-CA 127.576 2.351 . . . . 0.0 114.546 -176.491 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 170.46 175.2 39.05 Favored Glycine 0 CA--C 1.53 1.005 0 C-N-CA 125.941 1.734 . . . . 0.0 108.883 -169.334 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -71.6 141.07 50.0 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 118.439 1.12 . . . . 0.0 111.983 -177.382 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -99.72 129.77 45.87 Favored 'General case' 0 N--CA 1.446 -0.65 0 C-N-CA 126.523 1.929 . . . . 0.0 110.004 174.167 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 86.2 mt . . . . . 0 N--CA 1.463 0.214 0 N-CA-C 106.554 -1.647 . . . . 0.0 106.554 168.178 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 16.0 m . . . . . 0 CA--C 1.534 0.362 0 CA-C-O 119.623 -0.227 . . . . 0.0 111.404 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -62.61 -43.53 98.58 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 118.141 0.428 . . . . 0.0 110.705 176.109 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 12.6 tt0 -67.88 -41.01 83.46 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 124.889 1.276 . . . . 0.0 110.747 -178.497 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.88 -45.11 86.88 Favored 'General case' 0 N--CA 1.463 0.221 0 C-N-CA 124.338 1.055 . . . . 0.0 110.43 173.464 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 43.8 mt -67.03 -55.74 16.54 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.345 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 179.112 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -50.25 -69.13 0.12 Allowed 'General case' 0 C--O 1.234 0.263 0 C-N-CA 125.888 1.675 . . . . 0.0 112.035 -170.338 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 8.3 m -61.31 -33.42 73.57 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.859 -0.609 . . . . 0.0 111.744 -172.955 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 160' ' ' TRP . . . . . . . . . . . . . 79.6 t90 -66.13 -44.71 83.45 Favored 'General case' 0 CA--C 1.517 -0.326 0 O-C-N 121.833 -0.542 . . . . 0.0 110.988 175.041 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 68.6 m -59.51 -42.15 91.56 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 122.937 0.495 . . . . 0.0 110.501 179.095 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -62.05 -42.45 99.2 Favored 'General case' 0 CA--C 1.523 -0.082 0 CA-C-N 118.57 0.623 . . . . 0.0 110.467 174.869 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 16.4 tt0 -64.58 -51.01 64.95 Favored 'General case' 0 N--CA 1.446 -0.641 0 CA-C-O 118.691 -0.671 . . . . 0.0 110.019 -177.018 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 40.3 pt -63.27 -37.62 79.96 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.442 0 CA-C-O 117.815 -1.088 . . . . 0.0 109.531 -175.465 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -65.87 -32.97 74.79 Favored 'General case' 0 N--CA 1.462 0.165 0 CA-C-N 119.495 1.043 . . . . 0.0 110.329 -178.948 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 35.1 m-80 -69.6 -59.2 3.12 Favored 'General case' 0 C--O 1.223 -0.302 0 N-CA-C 108.099 -1.075 . . . . 0.0 108.099 174.053 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 19.4 tt0 -61.41 -34.31 75.15 Favored 'General case' 0 N--CA 1.443 -0.779 0 C-N-CA 126.412 1.885 . . . . 0.0 111.765 -168.788 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 168' ' ' MET . . . . . . . . . . . . . 22.1 ptp -72.46 -35.09 68.16 Favored 'General case' 0 C--O 1.228 -0.077 0 C-N-CA 123.415 0.686 . . . . 0.0 111.67 173.512 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -74.98 -38.35 61.66 Favored 'General case' 0 N--CA 1.445 -0.724 0 CA-C-O 119.153 -0.451 . . . . 0.0 111.935 -177.026 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 . . . . . 0 N--CA 1.465 0.303 0 CA-C-O 121.446 0.641 . . . . 0.0 109.839 178.611 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.7 tmm? . . . . . 0 N--CA 1.494 1.755 0 CA-C-O 120.604 0.24 . . . . 0.0 110.603 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 21.9 p-10 -146.6 165.58 29.11 Favored 'General case' 0 N--CA 1.465 0.321 0 C-N-CA 126.334 1.854 . . . . 0.0 109.327 174.567 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 17.5 mtt -127.07 133.87 50.37 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 118.287 0.494 . . . . 0.0 111.144 -179.191 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -104.11 135.82 12.66 Favored Glycine 0 CA--C 1.526 0.722 0 N-CA-C 107.574 -2.21 . . . . 0.0 107.574 168.215 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 4.0 tt -122.93 111.11 16.24 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 105.78 -1.933 . . . . 0.0 105.78 -173.937 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 1.1 p90 -114.64 146.48 40.8 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 118.71 0.686 . . . . 0.0 110.683 -177.711 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 33.0 p90 . . . . . 0 CA--C 1.533 0.318 0 C-N-CA 124.312 1.045 . . . . 0.0 108.44 179.666 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.259 0 N-CA-C 109.935 -0.395 . . . . 0.0 109.935 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -64.27 -48.74 74.56 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 124.274 1.029 . . . . 0.0 111.18 -176.777 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 6.4 mt-10 -58.96 -43.56 91.33 Favored 'General case' 0 CA--C 1.516 -0.351 0 N-CA-C 109.972 -0.381 . . . . 0.0 109.972 175.641 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 28.9 mtpp -72.13 -41.99 66.55 Favored 'General case' 0 C--O 1.221 -0.402 0 CA-C-O 117.848 -1.072 . . . . 0.0 110.533 -173.334 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 41.2 mt -51.88 -54.93 11.17 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.314 0 CA-C-N 120.301 1.409 . . . . 0.0 108.349 172.544 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 7.9 ttp180 -61.74 -41.7 98.0 Favored 'General case' 0 C--O 1.222 -0.386 0 C-N-CA 123.605 0.762 . . . . 0.0 109.721 -175.193 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -66.56 -42.24 87.37 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 122.878 0.471 . . . . 0.0 111.159 -178.653 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 51.3 mt -71.48 -52.52 25.7 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 C-N-CA 124.749 1.22 . . . . 0.0 109.843 -172.652 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 82.8 mt -67.66 -45.86 83.97 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.433 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 138.75 124.49 2.22 Favored Glycine 0 CA--C 1.53 1.011 0 C-N-CA 125.078 1.323 . . . . 0.0 112.144 174.613 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -71.77 -7.14 20.57 Favored 'Trans proline' 0 CA--C 1.534 0.491 0 C-N-CA 123.57 2.847 . . . . 0.0 113.965 -175.483 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -77.92 -21.15 51.58 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 119.147 0.885 . . . . 0.0 111.148 176.423 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -127.67 -8.34 5.63 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 124.675 1.19 . . . . 0.0 114.011 -172.343 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 25.4 t -106.48 151.54 8.42 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.337 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 169.64 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 2.1 m -140.07 130.1 24.89 Favored 'General case' 0 C--N 1.333 -0.135 0 N-CA-C 106.236 -1.765 . . . . 0.0 106.236 -170.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 18.7 mt -89.19 135.64 33.46 Favored 'General case' 0 N--CA 1.464 0.273 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 177.866 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 35.6 m170 -100.57 154.21 18.75 Favored 'General case' 0 N--CA 1.464 0.24 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 169.929 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 11.6 t-20 -132.65 104.11 6.48 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 105.036 -2.209 . . . . 0.0 105.036 172.416 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 69.3 mt -76.59 -6.64 52.85 Favored 'General case' 0 C--O 1.235 0.313 0 N-CA-C 113.028 0.751 . . . . 0.0 113.028 -170.049 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 51.5 tptt -81.75 -14.28 56.68 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 118.803 0.728 . . . . 0.0 109.911 168.974 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -117.76 -41.29 2.93 Favored 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 124.572 1.149 . . . . 0.0 112.97 -173.844 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -106.89 155.76 19.41 Favored 'General case' 0 C--O 1.236 0.386 0 C-N-CA 125.878 1.671 . . . . 0.0 111.588 179.484 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 15.1 m -90.95 147.46 35.91 Favored Pre-proline 0 CA--C 1.539 0.521 0 C-N-CA 124.871 1.268 . . . . 0.0 110.26 -174.209 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -66.62 -20.64 53.13 Favored 'Trans proline' 0 C--N 1.349 0.594 0 C-N-CA 122.218 1.945 . . . . 0.0 113.016 -175.722 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 4.6 mptp? -56.85 -23.32 43.34 Favored 'General case' 0 CA--C 1.538 0.491 0 O-C-N 121.328 -0.857 . . . . 0.0 111.712 174.106 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 5.9 mt -61.87 -32.33 72.68 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 119.477 1.035 . . . . 0.0 111.252 175.682 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 59.8 mtt -60.13 -25.48 65.51 Favored 'General case' 0 N--CA 1.462 0.138 0 C-N-CA 123.774 0.829 . . . . 0.0 111.631 -179.911 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -60.23 -33.83 72.82 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 118.401 0.546 . . . . 0.0 109.95 179.112 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 29.9 mt-30 -72.36 -28.08 62.8 Favored 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 114.121 1.156 . . . . 0.0 114.121 -169.679 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 63.1 m-85 -85.27 138.92 32.01 Favored 'General case' 0 N--CA 1.464 0.258 0 C-N-CA 122.718 0.407 . . . . 0.0 110.222 -167.7 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 26.8 m-20 -67.49 -39.3 85.19 Favored 'General case' 0 N--CA 1.465 0.324 0 N-CA-C 109.838 -0.43 . . . . 0.0 109.838 178.484 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 17.3 t -114.35 143.87 23.13 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.379 0 N-CA-C 107.74 -1.207 . . . . 0.0 107.74 173.302 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 18.3 tp -123.55 143.4 50.22 Favored 'General case' 0 N--CA 1.444 -0.749 0 N-CA-C 107.728 -1.212 . . . . 0.0 107.728 169.339 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 45.9 mt -124.45 126.74 72.37 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 N-CA-C 105.426 -2.065 . . . . 0.0 105.426 179.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 3.0 mp -110.02 123.2 49.24 Favored 'General case' 0 CA--C 1.516 -0.33 0 N-CA-C 107.143 -1.429 . . . . 0.0 107.143 -173.012 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -122.74 133.55 9.2 Favored Glycine 0 N--CA 1.459 0.193 0 N-CA-C 109.831 -1.307 . . . . 0.0 109.831 175.627 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 4.3 tt -155.13 125.59 3.39 Favored Pre-proline 0 CA--C 1.538 0.509 0 CA-C-N 118.648 1.224 . . . . 0.0 112.67 169.637 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_exo . . . . . 0 N--CA 1.452 -0.922 0 C-N-CA 122.378 2.052 . . . . 0.0 111.278 166.02 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 63.9 mt . . . . . 0 CA--C 1.54 0.589 0 N-CA-C 105.029 -2.212 . . . . 0.0 105.029 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . 0.405 ' NE2' ' H ' ' A' ' 62' ' ' GLN . 1.7 pm0 -74.57 162.88 28.35 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 124.182 0.993 . . . . 0.0 109.891 175.197 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -48.06 -49.22 32.18 Favored 'General case' 0 C--O 1.226 -0.179 0 C-N-CA 125.45 1.5 . . . . 0.0 112.412 -169.413 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -69.33 -19.52 63.87 Favored 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 112.559 0.577 . . . . 0.0 112.559 -170.378 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 3.6 t90 -92.68 -41.46 10.16 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 125.026 1.33 . . . . 0.0 109.022 176.916 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -64.16 -35.52 81.04 Favored 'General case' 0 CA--C 1.537 0.48 0 O-C-N 121.102 -0.999 . . . . 0.0 109.704 177.163 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -62.06 -26.26 68.16 Favored 'General case' 0 C--O 1.233 0.233 0 C-N-CA 124.301 1.04 . . . . 0.0 110.747 -178.956 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 30.5 m -102.68 -20.38 5.67 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.552 0 CA-C-O 116.438 -1.744 . . . . 0.0 112.373 175.249 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 20.5 t90 -55.18 -36.48 65.93 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 121.508 1.958 . . . . 0.0 110.713 -177.5 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -64.1 -27.77 69.32 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 125.12 1.368 . . . . 0.0 112.939 174.418 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 58.4 mt-30 -97.13 -22.72 16.59 Favored 'General case' 0 C--O 1.224 -0.254 0 C-N-CA 126.802 2.041 . . . . 0.0 112.016 -176.494 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 77.7 mt -62.39 -25.99 68.23 Favored 'General case' 0 N--CA 1.462 0.149 0 O-C-N 121.5 -0.75 . . . . 0.0 110.511 178.0 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -78.33 -29.82 47.86 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 117.845 0.293 . . . . 0.0 110.452 172.279 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -72.41 -32.05 66.03 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 123.84 0.856 . . . . 0.0 112.56 -179.261 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 26.0 mt -53.64 142.84 21.82 Favored 'General case' 0 C--O 1.235 0.322 0 C-N-CA 123.906 0.882 . . . . 0.0 112.537 -169.689 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 26.3 t-20 -81.2 88.0 6.06 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 172.154 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 3.8 pp -144.37 132.71 21.92 Favored 'General case' 0 N--CA 1.454 -0.238 0 N-CA-C 108.579 -0.896 . . . . 0.0 108.579 172.001 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 22.6 mt-10 -140.14 146.52 38.93 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 128.591 2.757 . . . . 0.0 107.19 168.693 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 68.9 -3.57 6.55 Favored Glycine 0 CA--C 1.533 1.202 0 N-CA-C 116.793 1.477 . . . . 0.0 116.793 169.968 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.19 157.86 36.34 Favored 'General case' 0 C--N 1.345 0.389 0 CA-C-N 120.181 1.99 . . . . 0.0 110.021 -174.439 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 4.4 mt -80.42 135.25 25.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 N-CA-C 107.377 -1.342 . . . . 0.0 107.377 178.587 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 67.7 t -132.91 129.73 58.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 C-N-CA 124.604 1.162 . . . . 0.0 109.405 -176.924 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -105.98 153.72 21.61 Favored 'General case' 0 N--CA 1.462 0.136 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 168.549 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 1.4 mt -134.49 137.47 43.93 Favored 'General case' 0 CA--C 1.512 -0.484 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 176.214 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 36.7 p90 -154.98 170.94 20.59 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 170.957 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 178.25 161.03 25.56 Favored Glycine 0 N--CA 1.445 -0.758 0 C-N-CA 120.701 -0.761 . . . . 0.0 111.919 168.336 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 58.4 tp . . . . . 0 N--CA 1.442 -0.841 0 C-N-CA 126.426 1.89 . . . . 0.0 110.981 178.995 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 90.6 mt . . . . . 0 CA--C 1.538 0.511 0 N-CA-C 114.117 1.155 . . . . 0.0 114.117 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -56.98 -35.17 68.86 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 124.739 1.216 . . . . 0.0 111.581 -175.457 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -72.61 -22.41 60.97 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-O 118.061 -0.971 . . . . 0.0 112.499 178.204 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 9.4 mp -65.76 -41.26 92.3 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-N 120.265 1.393 . . . . 0.0 108.172 169.003 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -65.9 -40.06 95.27 Favored Glycine 0 C--N 1.339 0.729 0 N-CA-C 110.76 -0.936 . . . . 0.0 110.76 -176.123 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 74.7 mtm -62.3 -39.9 94.54 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-O 118.681 -0.676 . . . . 0.0 111.619 178.409 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -73.23 -39.1 65.76 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 119.982 1.265 . . . . 0.0 110.34 175.498 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 58.9 t60 -57.95 -51.68 68.63 Favored 'General case' 0 N--CA 1.46 0.06 0 CA-C-N 118.282 0.492 . . . . 0.0 110.189 -179.089 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -61.86 -38.81 89.62 Favored 'General case' 0 C--O 1.234 0.259 0 C-N-CA 123.87 0.868 . . . . 0.0 112.08 -175.783 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 24.4 ttmm -56.8 -39.95 75.06 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 123.542 0.737 . . . . 0.0 110.42 172.599 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 43.6 mt -91.04 -19.83 22.74 Favored 'General case' 0 CA--C 1.52 -0.192 0 N-CA-C 114.32 1.229 . . . . 0.0 114.32 -169.78 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 6.5 m -58.45 -35.86 72.78 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 120.11 1.323 . . . . 0.0 111.179 179.324 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 20.3 p -81.73 -22.81 37.09 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 124.392 1.077 . . . . 0.0 111.418 179.762 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 32.2 mmmt -73.35 -12.21 60.75 Favored 'General case' 0 C--N 1.344 0.354 0 C-N-CA 123.62 0.768 . . . . 0.0 110.824 168.775 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 73.57 34.2 57.28 Favored Glycine 0 C--N 1.336 0.538 0 CA-C-N 118.948 0.794 . . . . 0.0 111.912 169.834 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 9.4 m -73.49 171.53 1.21 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 CA-C-N 118.629 1.215 . . . . 0.0 109.832 174.684 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -108.42 122.4 46.95 Favored 'General case' 0 CA--C 1.515 -0.377 0 N-CA-C 106.389 -1.708 . . . . 0.0 106.389 175.405 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 80.2 m-85 -91.89 144.69 25.22 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 119.072 0.851 . . . . 0.0 109.751 -175.53 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 31.2 m -131.77 160.29 42.5 Favored 'Isoleucine or valine' 0 C--O 1.233 0.234 0 C-N-CA 124.794 1.238 . . . . 0.0 109.188 171.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 96.77 -85.08 0.82 Allowed Glycine 0 N--CA 1.446 -0.691 0 C-N-CA 124.379 0.99 . . . . 0.0 110.654 175.904 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 80.7 m-85 54.57 -171.53 0.05 Allowed 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 124.608 1.163 . . . . 0.0 110.446 -169.301 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -156.37 147.26 16.39 Favored Pre-proline 0 N--CA 1.473 0.679 0 O-C-N 120.26 -1.525 . . . . 0.0 110.485 170.06 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -67.82 128.76 18.44 Favored 'Trans proline' 0 CA--C 1.538 0.706 0 C-N-CA 123.091 2.527 . . . . 0.0 112.365 178.36 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 14.4 p . . . . . 0 N--CA 1.469 0.494 0 O-C-N 121.631 -0.668 . . . . 0.0 112.379 173.761 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 21.8 ttmt . . . . . 0 N--CA 1.475 0.784 0 CA-C-O 117.046 -1.454 . . . . 0.0 114.698 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -74.08 -3.36 13.66 Favored 'Trans proline' 0 CA--C 1.538 0.685 0 CA-C-N 122.745 2.016 . . . . 0.0 114.089 -179.018 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 16.8 m -130.04 156.05 41.96 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.21 0 CA-C-N 119.75 1.159 . . . . 0.0 110.841 -170.685 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 2.4 pt -92.79 171.19 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.598 0 C-N-CA 124.151 0.98 . . . . 0.0 109.662 169.433 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . 55.0 -151.95 0.37 Allowed 'General case' 0 N--CA 1.441 -0.876 0 CA-C-N 113.695 -1.593 . . . . 0.0 109.621 168.444 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 24.8 t0 -79.14 51.87 1.23 Allowed 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 124.99 1.316 . . . . 0.0 110.556 170.815 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 68.04 28.63 73.33 Favored Glycine 0 CA--C 1.529 0.944 0 C-N-CA 124.686 1.136 . . . . 0.0 113.167 179.913 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 20.1 mt-30 -81.39 -22.25 38.45 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 118.281 1.041 . . . . 0.0 112.476 -169.902 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 8.8 tp -156.22 143.94 19.45 Favored 'General case' 0 C--N 1.344 0.326 0 CA-C-N 118.21 0.459 . . . . 0.0 111.013 -178.736 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 74.7 m-85 -73.77 140.36 45.84 Favored 'General case' 0 CA--C 1.516 -0.355 0 N-CA-C 107.479 -1.304 . . . . 0.0 107.479 169.601 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 27.6 m -66.13 -3.73 1.94 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.588 0 N-CA-C 113.285 0.846 . . . . 0.0 113.285 -179.083 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -177.33 170.87 43.57 Favored Glycine 0 N--CA 1.447 -0.607 0 C-N-CA 125.046 1.308 . . . . 0.0 110.215 -171.447 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -60.59 127.36 31.32 Favored 'General case' 0 C--O 1.234 0.287 0 C-N-CA 123.351 0.66 . . . . 0.0 110.945 -175.255 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -79.91 118.95 22.13 Favored 'General case' 0 N--CA 1.446 -0.669 0 C-N-CA 124.838 1.255 . . . . 0.0 108.521 169.87 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 13.8 tp . . . . . 0 N--CA 1.449 -0.499 0 N-CA-C 108.169 -1.048 . . . . 0.0 108.169 172.811 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 7.7 m . . . . . 0 CA--C 1.536 0.425 0 N-CA-C 110.012 -0.366 . . . . 0.0 110.012 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -63.17 -43.74 97.41 Favored 'General case' 0 N--CA 1.463 0.191 0 C-N-CA 123.576 0.75 . . . . 0.0 111.369 171.307 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 29.0 tt0 -63.92 -41.22 97.71 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 124.546 1.139 . . . . 0.0 110.795 178.814 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 3.5 mmt180 -65.64 -39.48 91.49 Favored 'General case' 0 CA--C 1.527 0.063 0 CA-C-O 118.627 -0.702 . . . . 0.0 109.187 -178.225 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 35.3 mt -66.0 -57.71 9.54 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.426 0 N-CA-C 107.474 -1.306 . . . . 0.0 107.474 173.771 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 68.4 tp60 -47.69 -65.12 0.62 Allowed 'General case' 0 CA--C 1.52 -0.196 0 C-N-CA 125.298 1.439 . . . . 0.0 112.861 -174.619 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 19.9 m -66.31 -31.36 72.11 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 121.26 -0.176 . . . . 0.0 110.855 -169.592 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 160' ' ' TRP . . . . . . . . . . . . . 67.3 t90 -71.28 -45.46 63.07 Favored 'General case' 0 C--O 1.224 -0.26 0 O-C-N 121.93 -0.481 . . . . 0.0 111.035 177.426 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 85.5 m -58.81 -42.13 88.44 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 123.074 0.55 . . . . 0.0 109.855 176.349 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -64.07 -43.45 95.4 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-O 121.28 0.562 . . . . 0.0 110.335 177.325 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 10.8 tt0 -60.07 -51.2 70.65 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 124.006 0.922 . . . . 0.0 110.068 -179.563 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 40.2 pt -62.86 -36.06 73.9 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.394 0 CA-C-O 117.937 -1.03 . . . . 0.0 109.253 -176.603 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -59.3 -37.93 78.97 Favored 'General case' 0 C--O 1.224 -0.27 0 C-N-CA 124.697 1.199 . . . . 0.0 109.478 177.416 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 33.2 m-80 -75.07 -52.54 10.79 Favored 'General case' 0 CA--C 1.515 -0.372 0 N-CA-C 108.644 -0.873 . . . . 0.0 108.644 -179.531 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 10.6 tt0 -70.43 -28.38 65.0 Favored 'General case' 0 N--CA 1.443 -0.808 0 C-N-CA 124.11 0.964 . . . . 0.0 111.582 -168.798 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 168' ' ' MET . . . . . . . . . . . . . 18.7 ptp -77.64 -31.53 52.77 Favored 'General case' 0 N--CA 1.456 -0.133 0 O-C-N 121.391 -0.818 . . . . 0.0 111.975 172.678 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -78.83 -42.52 27.41 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 122.5 0.32 . . . . 0.0 110.701 -176.31 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 . . . . . 0 CA--C 1.538 0.489 0 C-N-CA 123.542 0.737 . . . . 0.0 110.551 179.298 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.497 1.917 0 CA-C-O 119.771 -0.157 . . . . 0.0 111.188 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 25.2 p-10 -129.8 149.36 51.58 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 124.115 0.966 . . . . 0.0 112.186 -174.445 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 21.9 mtt -105.89 122.38 46.01 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 126.044 1.738 . . . . 0.0 107.213 -176.37 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -86.74 153.88 26.35 Favored Glycine 0 CA--C 1.529 0.942 0 N-CA-C 107.104 -2.398 . . . . 0.0 107.104 166.774 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 2.1 tt -142.6 96.84 3.01 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-N 120.042 1.921 . . . . 0.0 106.832 -173.499 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -101.69 140.52 35.87 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-O 121.033 0.444 . . . . 0.0 111.691 -170.592 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 25.2 p90 . . . . . 0 CA--C 1.538 0.513 0 C-N-CA 126.456 1.903 . . . . 0.0 108.287 -177.143 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.314 0 CA-C-O 119.738 -0.173 . . . . 0.0 110.867 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -64.93 -47.1 78.91 Favored 'General case' 0 CA--C 1.527 0.089 0 C-N-CA 122.569 0.348 . . . . 0.0 111.053 -174.932 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -66.58 -35.74 80.95 Favored 'General case' 0 C--O 1.231 0.126 0 CA-C-O 118.602 -0.713 . . . . 0.0 110.735 179.175 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 48.0 mttm -65.61 -49.99 66.7 Favored 'General case' 0 C--O 1.22 -0.486 0 CA-C-O 118.339 -0.838 . . . . 0.0 110.588 175.781 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 40.7 mt -52.46 -52.15 28.2 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.336 0 CA-C-N 119.536 1.062 . . . . 0.0 108.764 178.894 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.61 -39.95 95.38 Favored 'General case' 0 C--O 1.223 -0.323 0 C-N-CA 123.119 0.568 . . . . 0.0 110.267 -177.162 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -67.92 -42.07 81.63 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 118.412 0.551 . . . . 0.0 110.917 -178.735 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 60.6 mt -72.98 -52.77 20.81 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.545 0 C-N-CA 124.911 1.284 . . . . 0.0 109.63 -170.531 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 69.7 mt -66.03 -46.75 87.24 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.375 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 178.443 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 139.37 126.05 2.32 Favored Glycine 0 CA--C 1.531 1.037 0 C-N-CA 124.8 1.191 . . . . 0.0 111.661 174.585 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -72.51 -5.66 17.57 Favored 'Trans proline' 0 CA--C 1.537 0.651 0 C-N-CA 123.593 2.862 . . . . 0.0 114.243 -173.287 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -80.1 -20.52 44.9 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-N 119.329 0.968 . . . . 0.0 111.243 176.794 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -128.02 -1.72 5.85 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 124.793 1.237 . . . . 0.0 113.861 -171.775 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 21.9 t -117.15 147.92 20.22 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.338 0 N-CA-C 107.745 -1.206 . . . . 0.0 107.745 171.748 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 15.5 m -131.66 132.9 44.35 Favored 'General case' 0 N--CA 1.463 0.203 0 N-CA-C 107.688 -1.227 . . . . 0.0 107.688 -177.835 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 17.7 mt -79.01 133.39 36.83 Favored 'General case' 0 C--O 1.233 0.198 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 175.151 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 32.2 t-80 -128.75 58.68 1.57 Allowed 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 124.674 1.19 . . . . 0.0 108.6 -177.551 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 8.0 t-20 -55.5 122.28 10.91 Favored 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 106.413 -1.699 . . . . 0.0 106.413 168.586 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 58.9 mt -66.09 -35.42 80.46 Favored 'General case' 0 C--O 1.236 0.356 0 N-CA-C 112.693 0.627 . . . . 0.0 112.693 -173.306 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 42.3 tttm -64.21 -18.82 64.88 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-O 119.011 -0.519 . . . . 0.0 111.5 172.26 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -97.6 -34.24 11.03 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-N 119.015 0.825 . . . . 0.0 112.574 -177.186 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 4.1 t0 -145.07 145.62 31.52 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 118.763 0.711 . . . . 0.0 112.33 176.636 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 12.4 m -66.72 158.49 79.46 Favored Pre-proline 0 CA--C 1.542 0.655 0 C-N-CA 126.216 1.806 . . . . 0.0 112.261 -169.389 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -73.9 -26.83 12.86 Favored 'Trans proline' 0 C--N 1.35 0.629 0 C-N-CA 122.548 2.165 . . . . 0.0 113.222 -170.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 22.9 mmmt -70.66 -11.63 61.06 Favored 'General case' 0 CA--C 1.538 0.497 0 O-C-N 120.456 -1.403 . . . . 0.0 111.676 -176.846 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -61.93 -29.3 70.13 Favored 'General case' 0 N--CA 1.463 0.21 0 C-N-CA 125.683 1.593 . . . . 0.0 110.14 169.142 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 39.7 mtt -55.72 -26.78 46.99 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 123.588 0.755 . . . . 0.0 111.464 178.204 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 94.2 mt-10 -65.49 -31.26 72.23 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 118.191 0.451 . . . . 0.0 110.354 -176.609 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 21.1 mt-30 -69.61 -43.84 71.94 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 123.588 0.755 . . . . 0.0 112.704 -170.103 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 57.3 m-85 -68.33 147.63 51.87 Favored 'General case' 0 C--O 1.231 0.096 0 C-N-CA 123.735 0.814 . . . . 0.0 109.135 -168.47 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -80.59 -37.0 32.02 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 119.105 0.866 . . . . 0.0 108.979 -178.926 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 1.3 m -105.51 151.31 7.7 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.806 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 169.532 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 58.4 tp -140.9 106.6 5.11 Favored 'General case' 0 N--CA 1.448 -0.562 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 174.853 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 22.3 mt -84.4 131.83 33.04 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.744 0 N-CA-C 106.139 -1.8 . . . . 0.0 106.139 176.317 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -106.81 131.85 53.44 Favored 'General case' 0 C--O 1.233 0.217 0 N-CA-C 107.283 -1.377 . . . . 0.0 107.283 169.693 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -127.3 135.53 8.83 Favored Glycine 0 CA--C 1.521 0.456 0 N-CA-C 109.741 -1.344 . . . . 0.0 109.741 171.301 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 3.8 tt -152.05 134.95 9.06 Favored Pre-proline 0 CA--C 1.535 0.399 0 CA-C-N 118.521 1.161 . . . . 0.0 111.786 173.905 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_endo . . . . . 0 N--CA 1.456 -0.727 0 C-N-CA 122.176 1.917 . . . . 0.0 109.602 165.044 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 23.6 mt . . . . . 0 CA--C 1.54 0.58 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 2.2 pm0 -70.11 156.11 39.66 Favored 'General case' 0 C--O 1.232 0.179 0 C-N-CA 123.633 0.773 . . . . 0.0 110.302 176.108 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -54.54 -47.47 73.15 Favored 'General case' 0 N--CA 1.456 -0.167 0 C-N-CA 124.604 1.162 . . . . 0.0 112.457 -168.424 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -67.26 -31.44 71.78 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 119.503 1.047 . . . . 0.0 111.503 -172.225 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 5.2 t90 -73.91 -44.54 54.8 Favored 'General case' 0 N--CA 1.455 -0.222 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 178.578 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -61.83 -36.79 82.22 Favored 'General case' 0 CA--C 1.537 0.464 0 O-C-N 121.397 -0.814 . . . . 0.0 109.993 176.241 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -61.91 -25.07 67.35 Favored 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 123.312 0.645 . . . . 0.0 111.117 -174.093 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 25.4 m -108.56 -13.99 10.17 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.271 0 CA-C-O 117.073 -1.441 . . . . 0.0 112.644 175.21 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 18.2 t90 -51.31 -39.46 56.96 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 120.27 1.396 . . . . 0.0 110.075 -178.611 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -66.73 -25.35 66.47 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 125.721 1.608 . . . . 0.0 113.568 177.8 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 25.8 mt-30 -92.06 -19.23 22.56 Favored 'General case' 0 C--N 1.341 0.224 0 C-N-CA 125.688 1.595 . . . . 0.0 112.348 177.007 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 52.6 mt -62.09 -25.78 67.91 Favored 'General case' 0 N--CA 1.466 0.342 0 O-C-N 121.425 -0.797 . . . . 0.0 111.399 -174.937 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -75.92 -21.95 56.55 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-N 118.026 0.376 . . . . 0.0 111.741 176.47 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -73.47 -29.37 62.49 Favored 'General case' 0 N--CA 1.467 0.413 0 O-C-N 120.827 -1.171 . . . . 0.0 111.852 177.173 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 82.9 mt -54.16 138.25 38.66 Favored 'General case' 0 C--N 1.339 0.147 0 C-N-CA 124.926 1.291 . . . . 0.0 112.911 -168.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 3.0 t30 -74.97 98.93 3.7 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 123.973 0.909 . . . . 0.0 108.978 170.166 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 56.7 mt -123.07 -0.12 8.99 Favored 'General case' 0 N--CA 1.474 0.769 0 N-CA-C 113.765 1.024 . . . . 0.0 113.765 -176.03 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 25.2 mt-10 -55.2 128.69 35.09 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 119.72 1.146 . . . . 0.0 111.581 -168.974 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 74.88 -1.97 51.94 Favored Glycine 0 CA--C 1.532 1.107 0 C-N-CA 125.487 1.518 . . . . 0.0 114.98 177.095 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.3 155.35 34.32 Favored 'General case' 0 C--N 1.346 0.421 0 CA-C-N 120.172 1.986 . . . . 0.0 109.929 -176.035 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 12.4 mt -78.87 142.52 13.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 N-CA-C 106.615 -1.624 . . . . 0.0 106.615 177.918 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 3.0 t -138.08 139.72 41.74 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 O-C-N 121.42 -0.8 . . . . 0.0 109.251 -179.051 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -117.06 147.71 42.13 Favored 'General case' 0 CA--C 1.511 -0.532 0 N-CA-C 106.43 -1.693 . . . . 0.0 106.43 170.876 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 5.9 mp -127.82 142.08 51.39 Favored 'General case' 0 CA--C 1.509 -0.622 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 170.569 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 35.8 p90 -150.04 166.85 28.47 Favored 'General case' 0 N--CA 1.445 -0.701 0 N-CA-C 107.02 -1.474 . . . . 0.0 107.02 167.644 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -163.07 167.43 37.41 Favored Glycine 0 N--CA 1.444 -0.829 0 N-CA-C 109.915 -1.274 . . . . 0.0 109.915 173.388 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 1.7 tm? . . . . . 0 N--CA 1.447 -0.585 0 N-CA-C 106.81 -1.552 . . . . 0.0 106.81 -179.702 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 95.5 mt . . . . . 0 N--CA 1.472 0.659 0 N-CA-C 113.337 0.866 . . . . 0.0 113.337 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -57.47 -39.82 77.19 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 124.56 1.144 . . . . 0.0 110.845 -178.165 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -71.46 -32.13 67.95 Favored 'General case' 0 CA--C 1.534 0.331 0 O-C-N 121.666 -0.647 . . . . 0.0 111.9 178.926 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 4.9 tt -62.83 -47.94 81.22 Favored 'General case' 0 N--CA 1.467 0.4 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 171.957 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -63.27 -39.06 97.42 Favored Glycine 0 C--N 1.338 0.66 0 N-CA-C 111.145 -0.782 . . . . 0.0 111.145 -177.314 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 67.7 mtm -64.93 -40.38 94.97 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 118.236 1.018 . . . . 0.0 111.394 176.621 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -71.67 -31.54 66.91 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 119.752 1.16 . . . . 0.0 111.244 177.714 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 50.6 t-80 -62.65 -45.81 91.13 Favored 'General case' 0 N--CA 1.462 0.148 0 CA-C-N 118.98 0.809 . . . . 0.0 110.837 171.444 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -63.6 -44.1 95.0 Favored 'General case' 0 C--O 1.234 0.274 0 C-N-CA 122.942 0.497 . . . . 0.0 111.06 -177.09 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 22.3 ttmm -58.0 -48.6 79.53 Favored 'General case' 0 C--O 1.226 -0.177 0 C-N-CA 123.131 0.572 . . . . 0.0 109.962 172.23 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 32.9 mt -74.79 -23.27 58.48 Favored 'General case' 0 N--CA 1.461 0.091 0 CA-C-O 118.622 -0.704 . . . . 0.0 112.547 -170.839 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 70.0 m -61.04 -38.18 85.25 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 119.376 0.989 . . . . 0.0 111.261 -177.506 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 26.1 p -85.1 -6.89 59.29 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 123.551 0.74 . . . . 0.0 111.667 -178.824 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 30.7 mmmt -82.12 -7.63 59.63 Favored 'General case' 0 C--N 1.344 0.36 0 C-N-CA 124.462 1.105 . . . . 0.0 111.806 171.635 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 69.51 34.36 73.55 Favored Glycine 0 CA--C 1.525 0.688 0 CA-C-N 118.764 0.711 . . . . 0.0 111.788 173.92 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 8.0 m -77.94 172.48 1.12 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.469 0 CA-C-N 117.913 0.856 . . . . 0.0 109.383 174.34 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -111.37 116.48 31.03 Favored 'General case' 0 CA--C 1.514 -0.437 0 N-CA-C 105.938 -1.875 . . . . 0.0 105.938 177.484 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 71.4 m-85 -85.56 142.39 29.17 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 118.819 0.736 . . . . 0.0 110.135 -173.881 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 32.6 m -131.9 158.73 43.34 Favored 'Isoleucine or valine' 0 C--O 1.234 0.268 0 C-N-CA 125.612 1.565 . . . . 0.0 107.581 168.921 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 83.93 31.13 27.07 Favored Glycine 0 CA--C 1.521 0.464 0 CA-C-O 118.779 -1.012 . . . . 0.0 114.935 169.73 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 10.6 m-30 -65.78 157.13 31.12 Favored 'General case' 0 CA--C 1.546 0.823 0 CA-C-N 118.941 1.371 . . . . 0.0 109.343 169.042 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 51.1 t-105 -133.88 147.39 64.01 Favored Pre-proline 0 N--CA 1.476 0.838 0 CA-C-O 118.054 -0.974 . . . . 0.0 112.095 -168.524 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -63.25 129.92 27.05 Favored 'Trans proline' 0 C--N 1.35 0.627 0 C-N-CA 123.077 2.518 . . . . 0.0 113.202 -177.621 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 7.6 p . . . . . 0 CA--C 1.534 0.348 0 C-N-CA 124.274 1.029 . . . . 0.0 110.764 169.299 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 25.9 ttmt . . . . . 0 CA--C 1.544 0.716 0 CA-C-O 117.64 -1.171 . . . . 0.0 113.998 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_endo -80.58 5.99 5.74 Favored 'Trans proline' 0 C--N 1.352 0.721 0 C-N-CA 122.046 1.83 . . . . 0.0 114.066 -179.6 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 19.0 m -124.07 147.89 28.4 Favored 'Isoleucine or valine' 0 C--O 1.234 0.273 0 CA-C-N 120.888 1.677 . . . . 0.0 110.982 -177.589 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 2.4 pt -82.69 168.78 1.71 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 N-CA-C 108.056 -1.09 . . . . 0.0 108.056 167.158 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . 55.85 -156.12 0.27 Allowed 'General case' 0 N--CA 1.443 -0.778 0 CA-C-N 114.076 -1.42 . . . . 0.0 110.195 168.587 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 21.8 t0 -80.62 61.11 4.2 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 125.128 1.371 . . . . 0.0 108.92 169.551 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 65.13 28.39 73.49 Favored Glycine 0 CA--C 1.531 1.044 0 C-N-CA 124.302 0.953 . . . . 0.0 113.289 176.768 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 62.5 mm-40 -78.17 -27.49 48.06 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 118.125 0.963 . . . . 0.0 111.886 -169.143 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 12.7 tp -159.17 146.89 17.53 Favored 'General case' 0 C--N 1.341 0.222 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 -177.349 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 63.7 m-85 -75.82 143.09 42.06 Favored 'General case' 0 CA--C 1.517 -0.322 0 N-CA-C 107.821 -1.177 . . . . 0.0 107.821 171.775 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 4.2 m -76.77 10.23 0.5 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.89 0 C-N-CA 123.818 0.847 . . . . 0.0 111.686 -178.43 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 179.25 174.0 44.96 Favored Glycine 0 CA--C 1.529 0.934 0 C-N-CA 125.837 1.684 . . . . 0.0 109.592 -175.478 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 5.0 tp -68.29 134.86 51.02 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-N 118.557 1.179 . . . . 0.0 111.089 178.094 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -96.28 107.64 20.02 Favored 'General case' 0 N--CA 1.442 -0.836 0 C-N-CA 125.367 1.467 . . . . 0.0 108.982 172.557 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 89.6 mt . . . . . 0 C--O 1.233 0.225 0 N-CA-C 108.096 -1.076 . . . . 0.0 108.096 168.742 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 12.4 m . . . . . 0 CA--C 1.536 0.438 0 N-CA-C 110.719 -0.104 . . . . 0.0 110.719 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -67.51 -39.85 85.14 Favored 'General case' 0 N--CA 1.464 0.258 0 C-N-CA 123.081 0.553 . . . . 0.0 110.853 173.224 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 28.5 tt0 -65.97 -43.33 88.22 Favored 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 124.334 1.054 . . . . 0.0 111.008 -178.326 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.6 -39.93 74.42 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 123.251 0.621 . . . . 0.0 109.475 177.383 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 53.7 mt -70.91 -54.23 18.61 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 N-CA-C 108.277 -1.008 . . . . 0.0 108.277 176.8 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 71.7 tp60 -50.51 -62.32 1.66 Allowed 'General case' 0 N--CA 1.463 0.181 0 C-N-CA 125.183 1.393 . . . . 0.0 111.97 -174.359 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 19.9 m -68.23 -31.98 71.86 Favored 'General case' 0 C--N 1.324 -0.543 0 C-N-CA 121.273 -0.171 . . . . 0.0 110.84 -169.716 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 160' ' ' TRP . . . . . . . . . . . . . 48.7 t90 -66.04 -47.3 74.81 Favored 'General case' 0 C--O 1.223 -0.304 0 O-C-N 122.157 -0.339 . . . . 0.0 110.71 173.388 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 65.5 m -59.93 -43.14 95.13 Favored 'General case' 0 N--CA 1.455 -0.195 0 C-N-CA 122.956 0.503 . . . . 0.0 110.408 -178.554 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -63.16 -40.26 97.03 Favored 'General case' 0 N--CA 1.455 -0.22 0 N-CA-C 110.223 -0.288 . . . . 0.0 110.223 176.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 16.6 tt0 -65.85 -51.62 57.29 Favored 'General case' 0 N--CA 1.446 -0.64 0 CA-C-O 118.787 -0.625 . . . . 0.0 110.122 -179.228 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 39.4 pt -63.5 -38.0 81.07 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.377 0 CA-C-O 117.909 -1.043 . . . . 0.0 109.667 -175.212 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -63.74 -36.07 82.66 Favored 'General case' 0 C--O 1.225 -0.225 0 CA-C-N 119.351 0.978 . . . . 0.0 109.833 179.526 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 28.4 m-80 -68.28 -52.59 32.03 Favored 'General case' 0 CA--C 1.515 -0.4 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 175.808 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 15.2 tt0 -70.69 -26.76 63.57 Favored 'General case' 0 N--CA 1.443 -0.786 0 C-N-CA 124.381 1.073 . . . . 0.0 111.504 -168.767 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 168' ' ' MET . . . . . . . . . . . . . 17.1 ptp -79.58 -30.5 41.63 Favored 'General case' 0 C--O 1.227 -0.104 0 O-C-N 120.808 -1.182 . . . . 0.0 112.219 171.699 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -79.75 -40.54 28.55 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 122.923 0.489 . . . . 0.0 111.156 -178.223 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.534 0.361 0 C-N-CA 124.342 1.057 . . . . 0.0 110.532 -178.57 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 53.6 ttp . . . . . 0 N--CA 1.497 1.905 0 N-CA-C 110.002 -0.37 . . . . 0.0 110.002 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 10.4 t30 -141.44 152.11 43.98 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 124.908 1.283 . . . . 0.0 107.639 174.681 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 11.8 mtt -113.84 121.46 44.08 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 123.246 0.618 . . . . 0.0 111.136 -175.79 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -80.47 155.51 37.8 Favored Glycine 0 CA--C 1.521 0.41 0 N-CA-C 107.606 -2.198 . . . . 0.0 107.606 166.912 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 2.5 tt -141.47 96.01 2.92 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 105.805 -1.924 . . . . 0.0 105.805 -176.517 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -102.71 143.45 32.35 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-O 121.691 0.758 . . . . 0.0 112.142 -170.454 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 30.2 p90 . . . . . 0 N--CA 1.451 -0.384 0 C-N-CA 126.81 2.044 . . . . 0.0 107.278 177.016 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 0.239 0 N-CA-C 109.438 -0.578 . . . . 0.0 109.438 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -63.87 -46.43 84.95 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 123.728 0.811 . . . . 0.0 111.514 -176.822 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 26.5 mt-10 -58.44 -43.96 88.96 Favored 'General case' 0 CA--C 1.517 -0.303 0 C-N-CA 123.51 0.724 . . . . 0.0 109.843 174.559 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 51.2 mttm -65.1 -47.2 78.05 Favored 'General case' 0 C--O 1.222 -0.359 0 CA-C-O 118.725 -0.655 . . . . 0.0 109.984 -178.613 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 43.0 mt -52.88 -54.81 14.71 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.214 0 CA-C-N 119.024 0.829 . . . . 0.0 109.62 179.807 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.45 -35.8 81.2 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 118.374 0.533 . . . . 0.0 111.257 -175.372 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -64.35 -40.41 95.8 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.855 0.359 . . . . 0.0 110.592 178.582 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 62.6 mt -78.41 -54.01 12.89 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.548 0 C-N-CA 124.674 1.19 . . . . 0.0 110.038 -170.301 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 69.5 mt -62.71 -47.51 92.54 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 178.552 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 142.33 122.59 1.77 Allowed Glycine 0 CA--C 1.528 0.903 0 C-N-CA 124.646 1.117 . . . . 0.0 110.78 177.133 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -71.87 -11.18 27.32 Favored 'Trans proline' 0 CA--C 1.537 0.666 0 C-N-CA 122.885 2.39 . . . . 0.0 113.248 -170.262 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -79.96 -18.24 50.92 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 118.844 0.747 . . . . 0.0 111.953 -179.753 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -126.89 5.82 6.61 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 125.085 1.354 . . . . 0.0 113.555 -172.618 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 36.8 t -123.91 148.63 27.97 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.518 0 C-N-CA 124.85 1.26 . . . . 0.0 107.872 172.221 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 20.3 m -134.85 131.12 37.03 Favored 'General case' 0 C--N 1.332 -0.186 0 C-N-CA 125.519 1.528 . . . . 0.0 107.851 -175.267 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 20.9 mt -79.72 139.68 37.23 Favored 'General case' 0 C--O 1.232 0.17 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 177.873 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 18.0 t-80 -137.22 54.8 1.84 Allowed 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 124.177 0.991 . . . . 0.0 108.936 -173.419 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 37.8 t-20 -57.27 123.13 14.29 Favored 'General case' 0 N--CA 1.465 0.283 0 N-CA-C 106.367 -1.716 . . . . 0.0 106.367 168.629 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 31.3 mt -70.75 -31.79 68.72 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 118.661 0.664 . . . . 0.0 112.472 -169.072 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 57.7 tptt -58.96 -24.58 62.74 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 124.2 1.0 . . . . 0.0 110.355 169.765 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -95.73 -33.6 12.24 Favored 'General case' 0 C--O 1.236 0.376 0 N-CA-C 113.566 0.95 . . . . 0.0 113.566 -177.049 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 4.4 t0 -147.54 149.8 33.3 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 119.459 1.027 . . . . 0.0 113.18 178.33 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 15.7 m -71.66 158.43 87.86 Favored Pre-proline 0 CA--C 1.541 0.615 0 C-N-CA 126.236 1.814 . . . . 0.0 112.607 -168.92 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -73.53 -25.6 14.92 Favored 'Trans proline' 0 C--N 1.35 0.611 0 C-N-CA 122.467 2.111 . . . . 0.0 113.935 -173.251 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 8.6 mptt -62.4 -20.45 64.47 Favored 'General case' 0 N--CA 1.475 0.786 0 CA-C-N 120.403 1.456 . . . . 0.0 111.912 -179.587 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -58.14 -29.82 65.85 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 125.552 1.541 . . . . 0.0 110.723 173.347 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 50.4 mtt -60.87 -25.93 67.04 Favored 'General case' 0 C--N 1.339 0.151 0 C-N-CA 123.388 0.675 . . . . 0.0 111.428 178.662 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 61.2 mt-10 -64.84 -35.49 81.28 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-N 118.371 0.532 . . . . 0.0 109.717 -178.445 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 13.5 mt-30 -67.78 -46.04 73.1 Favored 'General case' 0 C--N 1.34 0.159 0 C-N-CA 123.65 0.78 . . . . 0.0 111.836 -171.519 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 17.5 m-85 -69.54 133.55 47.79 Favored 'General case' 0 CA--C 1.521 -0.159 0 CA-C-N 115.424 -0.807 . . . . 0.0 109.235 -167.372 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -75.4 -31.8 60.55 Favored 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 120.361 -0.535 . . . . 0.0 110.86 -176.187 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 20.8 t -109.54 146.08 15.42 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.368 0 N-CA-C 106.717 -1.586 . . . . 0.0 106.717 168.789 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 27.5 tp -133.08 115.77 15.51 Favored 'General case' 0 N--CA 1.445 -0.696 0 N-CA-C 108.439 -0.948 . . . . 0.0 108.439 174.427 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 23.4 mt -94.6 135.88 27.52 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.63 0 N-CA-C 107.045 -1.465 . . . . 0.0 107.045 177.396 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -119.45 131.43 55.62 Favored 'General case' 0 CA--C 1.514 -0.418 0 C-N-CA 125.234 1.413 . . . . 0.0 107.324 -174.466 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -132.64 129.77 5.61 Favored Glycine 0 CA--C 1.519 0.295 0 N-CA-C 110.318 -1.113 . . . . 0.0 110.318 175.036 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 5.8 tt -152.25 133.52 8.0 Favored Pre-proline 0 CA--C 1.541 0.616 0 CA-C-N 118.134 0.967 . . . . 0.0 110.18 169.484 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_exo . . . . . 0 N--CA 1.46 -0.481 0 C-N-CA 122.824 2.349 . . . . 0.0 112.2 167.704 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 17.5 mt . . . . . 0 CA--C 1.545 0.781 0 CA-C-O 121.469 0.652 . . . . 0.0 110.669 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 3.9 mp0 -66.61 146.65 54.26 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 125.578 1.551 . . . . 0.0 108.661 178.544 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -59.11 -42.01 89.53 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 122.906 0.483 . . . . 0.0 110.239 -179.386 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -58.8 -29.55 66.94 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 124.16 0.984 . . . . 0.0 112.043 178.512 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' TRP . . . . . 0.444 ' CH2' HD22 ' A' ' 104' ' ' LEU . 15.9 t90 -87.22 -45.23 10.83 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 124.303 1.041 . . . . 0.0 109.948 179.828 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -61.59 -35.79 78.85 Favored 'General case' 0 CA--C 1.537 0.46 0 O-C-N 120.903 -1.123 . . . . 0.0 109.656 179.851 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -59.6 -25.11 64.35 Favored 'General case' 0 C--O 1.235 0.313 0 C-N-CA 123.951 0.901 . . . . 0.0 111.473 -179.279 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 11.0 m -109.91 -15.65 9.54 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.295 0 CA-C-O 117.478 -1.249 . . . . 0.0 112.732 178.059 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 24.2 t90 -54.76 -38.31 67.05 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-N 120.042 1.292 . . . . 0.0 109.961 178.78 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -65.91 -27.63 68.33 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 125.342 1.457 . . . . 0.0 112.857 175.638 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 69.4 mt-30 -89.19 -25.05 21.99 Favored 'General case' 0 CA--C 1.514 -0.437 0 C-N-CA 125.417 1.487 . . . . 0.0 111.555 -177.154 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 48.2 mt -57.82 -32.02 67.18 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 118.846 0.748 . . . . 0.0 110.255 173.71 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -69.71 -28.03 65.48 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 122.995 0.518 . . . . 0.0 111.457 173.581 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -80.74 -34.62 34.26 Favored 'General case' 0 CA--C 1.538 0.492 0 N-CA-C 113.199 0.814 . . . . 0.0 113.199 176.846 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 21.6 mt -59.76 148.58 33.79 Favored 'General case' 0 N--CA 1.463 0.207 0 C-N-CA 124.44 1.096 . . . . 0.0 111.758 -173.421 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -82.62 114.4 20.98 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 169.667 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 76.8 mt -129.74 1.07 4.9 Favored 'General case' 0 N--CA 1.475 0.815 0 N-CA-C 113.254 0.835 . . . . 0.0 113.254 -172.982 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 32.7 mt-10 -56.8 133.16 54.07 Favored 'General case' 0 C--O 1.235 0.342 0 CA-C-O 122.122 0.963 . . . . 0.0 111.647 -168.644 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 75.07 -3.87 43.05 Favored Glycine 0 CA--C 1.534 1.263 0 C-N-CA 125.483 1.516 . . . . 0.0 114.976 176.499 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.29 149.75 40.54 Favored 'General case' 0 C--N 1.344 0.357 0 CA-C-N 120.574 2.187 . . . . 0.0 110.114 -175.597 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 5.1 mt -80.71 136.69 22.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 N-CA-C 106.344 -1.724 . . . . 0.0 106.344 178.415 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 64.9 t -130.59 128.65 63.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 C-N-CA 123.556 0.742 . . . . 0.0 109.819 -177.2 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -99.57 145.13 27.86 Favored 'General case' 0 CA--C 1.52 -0.184 0 N-CA-C 107.948 -1.13 . . . . 0.0 107.948 168.442 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 10.5 mt -124.79 132.48 53.34 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 107.406 -1.331 . . . . 0.0 107.406 176.44 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 33.7 p90 -148.69 165.06 32.48 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 168.253 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -165.37 172.46 40.94 Favored Glycine 0 N--CA 1.443 -0.85 0 N-CA-C 109.894 -1.283 . . . . 0.0 109.894 172.512 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 6.6 tt . . . . . 0 N--CA 1.447 -0.608 0 C-N-CA 125.979 1.712 . . . . 0.0 107.694 -179.922 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 92.3 mt . . . . . 0 N--CA 1.468 0.453 0 N-CA-C 114.23 1.196 . . . . 0.0 114.23 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -64.24 -33.4 75.73 Favored 'General case' 0 C--N 1.331 -0.228 0 O-C-N 120.661 -1.274 . . . . 0.0 110.872 -175.329 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -71.18 -29.43 65.17 Favored 'General case' 0 CA--C 1.535 0.394 0 O-C-N 121.731 -0.606 . . . . 0.0 111.911 175.485 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 5.4 tt -62.4 -45.31 93.72 Favored 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 108.026 -1.102 . . . . 0.0 108.026 169.64 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -64.04 -39.93 97.7 Favored Glycine 0 C--N 1.34 0.765 0 N-CA-C 111.149 -0.78 . . . . 0.0 111.149 -178.707 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 71.6 mtm -66.4 -35.42 80.28 Favored 'General case' 0 CA--C 1.529 0.166 0 CA-C-O 118.206 -0.902 . . . . 0.0 111.904 177.468 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.444 HD22 ' CH2' ' A' ' 65' ' ' TRP . 0.2 OUTLIER -72.89 -36.45 67.34 Favored 'General case' 0 C--N 1.342 0.265 0 CA-C-N 120.768 1.622 . . . . 0.0 110.811 176.234 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 1.8 t60 -54.04 -52.86 59.51 Favored 'General case' 0 CA--C 1.531 0.214 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 169.61 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -63.04 -41.62 99.55 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 123.79 0.836 . . . . 0.0 112.321 -175.239 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 1.7 tppm? -54.77 -27.87 44.53 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 125.72 1.608 . . . . 0.0 111.309 171.488 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 40.4 mt -106.94 -17.72 14.11 Favored 'General case' 0 CA--C 1.519 -0.214 0 N-CA-C 115.228 1.566 . . . . 0.0 115.228 -173.408 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -60.24 -37.11 79.36 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 121.008 1.731 . . . . 0.0 110.977 -172.611 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 16.3 p -81.25 -13.6 58.34 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 125.53 1.532 . . . . 0.0 111.833 -179.772 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 31.8 mmmt -84.8 -5.87 59.34 Favored 'General case' 0 C--N 1.344 0.328 0 C-N-CA 124.955 1.302 . . . . 0.0 111.691 178.702 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 72.76 31.33 62.61 Favored Glycine 0 CA--C 1.523 0.549 0 CA-C-N 118.399 0.545 . . . . 0.0 112.401 169.498 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 14.5 m -75.59 176.59 0.64 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.638 0 CA-C-N 118.163 0.981 . . . . 0.0 109.677 171.992 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -118.03 126.54 52.48 Favored 'General case' 0 CA--C 1.518 -0.265 0 N-CA-C 106.628 -1.619 . . . . 0.0 106.628 173.127 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 62.2 m-85 -91.96 143.29 26.63 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 119.847 1.203 . . . . 0.0 109.805 -177.064 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 35.1 m -131.6 160.88 42.05 Favored 'Isoleucine or valine' 0 C--O 1.235 0.335 0 C-N-CA 125.947 1.699 . . . . 0.0 107.334 169.314 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 84.96 28.68 30.72 Favored Glycine 0 CA--C 1.52 0.392 0 CA-C-O 118.509 -1.162 . . . . 0.0 114.133 172.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 20.8 m-30 -60.87 157.02 16.02 Favored 'General case' 0 CA--C 1.543 0.675 0 CA-C-N 118.809 1.305 . . . . 0.0 109.475 168.494 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 46.5 t-105 -134.15 142.05 41.72 Favored Pre-proline 0 N--CA 1.467 0.403 0 CA-C-O 118.608 -0.711 . . . . 0.0 109.719 -170.577 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -70.1 132.64 23.2 Favored 'Trans proline' 0 N--CA 1.458 -0.588 0 C-N-CA 122.576 2.184 . . . . 0.0 111.728 -171.197 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 20.8 p . . . . . 0 N--CA 1.473 0.677 0 C-N-CA 124.519 1.128 . . . . 0.0 113.778 -179.757 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 22.2 ttmt . . . . . 0 CA--C 1.545 0.773 0 CA-C-O 116.938 -1.506 . . . . 0.0 115.016 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 66.7 Cg_endo -79.23 2.11 8.6 Favored 'Trans proline' 0 C--N 1.353 0.798 0 CA-C-N 122.807 2.038 . . . . 0.0 114.065 -177.862 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 17.2 m -129.15 169.49 20.35 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 119.767 1.167 . . . . 0.0 110.274 -173.887 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 20.5 pt -122.34 163.92 20.14 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.012 0 C-N-CA 126.493 1.917 . . . . 0.0 108.881 172.778 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . 55.33 -154.09 0.31 Allowed 'General case' 0 N--CA 1.446 -0.649 0 C-N-CA 124.369 1.067 . . . . 0.0 108.391 -178.784 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 24.8 t0 -80.18 52.72 1.61 Allowed 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 125.082 1.353 . . . . 0.0 111.017 -179.154 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 63.82 32.16 83.25 Favored Glycine 0 CA--C 1.529 0.923 0 C-N-CA 124.065 0.84 . . . . 0.0 111.662 -174.518 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 1.3 tt0 -90.24 -24.76 20.87 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 124.711 1.205 . . . . 0.0 111.664 -169.163 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -145.54 146.14 31.3 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 119.2 0.909 . . . . 0.0 110.091 169.656 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 49.1 m-85 -74.15 139.38 44.46 Favored 'General case' 0 CA--C 1.508 -0.641 0 N-CA-C 104.393 -2.447 . . . . 0.0 104.393 165.947 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 9.9 p -77.73 6.89 0.86 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.768 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.263 -177.932 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -172.71 175.28 45.79 Favored Glycine 0 CA--C 1.532 1.109 0 C-N-CA 125.349 1.452 . . . . 0.0 110.069 175.951 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 3.9 tp -65.79 144.68 56.71 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 118.285 1.043 . . . . 0.0 111.271 177.687 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -114.97 117.7 31.37 Favored 'General case' 0 N--CA 1.448 -0.565 0 C-N-CA 126.63 1.972 . . . . 0.0 109.826 -179.632 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 79.9 mt . . . . . 0 N--CA 1.468 0.46 0 C-N-CA 124.856 1.263 . . . . 0.0 108.087 170.274 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 70.7 m . . . . . 0 CA--C 1.533 0.307 0 CA-C-O 118.962 -0.542 . . . . 0.0 110.777 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -60.02 -42.11 93.64 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 118.966 0.803 . . . . 0.0 111.307 175.22 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 67.8 mm-40 -69.4 -46.05 67.78 Favored 'General case' 0 CA--C 1.515 -0.386 0 C-N-CA 125.763 1.625 . . . . 0.0 109.944 -178.101 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 67.3 mtt180 -61.55 -46.04 91.61 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 118.228 -0.891 . . . . 0.0 109.701 178.673 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 41.7 mt -61.93 -51.01 77.67 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.204 0 N-CA-C 108.285 -1.006 . . . . 0.0 108.285 176.779 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 66.6 tp60 -48.93 -65.57 0.55 Allowed 'General case' 0 C--O 1.236 0.359 0 C-N-CA 124.527 1.131 . . . . 0.0 111.21 179.972 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 29.5 m -70.73 -28.18 64.52 Favored 'General case' 0 C--N 1.321 -0.653 0 C-N-CA 120.625 -0.43 . . . . 0.0 111.477 -169.24 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 160' ' ' TRP . . . . . . . . . . . . . 57.4 t90 -66.76 -45.92 77.01 Favored 'General case' 0 CA--C 1.518 -0.254 0 CA-C-N 118.791 0.723 . . . . 0.0 111.087 171.532 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 60.4 m -60.64 -43.16 97.9 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 118.262 0.483 . . . . 0.0 110.088 -179.068 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -61.46 -41.59 97.47 Favored 'General case' 0 N--CA 1.455 -0.203 0 CA-C-O 120.984 0.421 . . . . 0.0 110.36 175.201 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 16.3 tt0 -64.84 -51.17 63.54 Favored 'General case' 0 N--CA 1.447 -0.601 0 O-C-N 121.691 -0.631 . . . . 0.0 110.129 -178.413 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 43.4 pt -63.88 -37.55 80.04 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.388 0 CA-C-O 118.174 -0.917 . . . . 0.0 109.703 -175.583 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -64.42 -35.2 80.14 Favored 'General case' 0 CA--C 1.529 0.16 0 CA-C-N 119.247 0.93 . . . . 0.0 109.98 179.66 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 34.9 m-80 -68.56 -50.87 48.54 Favored 'General case' 0 N--CA 1.467 0.382 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 174.118 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 21.9 tt0 -71.11 -25.8 62.75 Favored 'General case' 0 N--CA 1.44 -0.957 0 C-N-CA 125.194 1.398 . . . . 0.0 111.946 -168.747 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 168' ' ' MET . . . . . . . . . . . . . 18.9 ptp -82.05 -31.26 30.98 Favored 'General case' 0 C--O 1.231 0.125 0 O-C-N 121.4 -0.813 . . . . 0.0 112.07 171.052 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -77.77 -36.35 50.62 Favored 'General case' 0 N--CA 1.448 -0.557 0 O-C-N 122.108 -0.37 . . . . 0.0 111.037 -178.419 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 . . . . . 0 CA--C 1.537 0.452 0 O-C-N 121.862 -0.524 . . . . 0.0 110.611 177.209 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 45.7 ttp . . . . . 0 N--CA 1.495 1.8 0 N-CA-C 110.239 -0.282 . . . . 0.0 110.239 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 7.4 t30 -120.48 150.02 41.48 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 124.198 0.999 . . . . 0.0 109.249 172.526 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 20.0 mtt -112.31 125.59 54.34 Favored 'General case' 0 CA--C 1.523 -0.069 0 C-N-CA 123.602 0.761 . . . . 0.0 110.774 -176.451 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -85.28 152.88 27.17 Favored Glycine 0 CA--C 1.524 0.597 0 N-CA-C 106.799 -2.521 . . . . 0.0 106.799 166.41 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 2.1 tt -140.19 96.67 3.09 Favored 'General case' 0 CA--C 1.517 -0.32 0 N-CA-C 105.274 -2.121 . . . . 0.0 105.274 -175.545 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -100.12 141.37 33.04 Favored 'General case' 0 CA--C 1.519 -0.237 0 CA-C-O 121.405 0.621 . . . . 0.0 111.834 -173.519 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 29.3 p90 . . . . . 0 C--N 1.327 -0.376 0 C-N-CA 127.464 2.306 . . . . 0.0 106.325 -178.792 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.225 -0.234 0 CA-C-O 119.331 -0.366 . . . . 0.0 110.582 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -62.31 -49.33 76.07 Favored 'General case' 0 N--CA 1.461 0.098 0 C-N-CA 123.096 0.559 . . . . 0.0 111.87 -178.315 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 7.1 mt-10 -61.45 -41.07 96.63 Favored 'General case' 0 CA--C 1.518 -0.256 0 O-C-N 121.875 -0.516 . . . . 0.0 110.032 176.086 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 30.2 mtpp -70.31 -43.24 70.75 Favored 'General case' 0 C--O 1.221 -0.4 0 CA-C-O 118.603 -0.713 . . . . 0.0 110.622 -173.991 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 43.4 mt -52.87 -55.41 11.98 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.206 0 CA-C-N 119.492 1.042 . . . . 0.0 108.587 173.53 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 5.0 ttp180 -59.6 -42.1 91.83 Favored 'General case' 0 C--O 1.224 -0.273 0 C-N-CA 123.253 0.621 . . . . 0.0 109.618 -176.256 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -65.13 -40.92 95.13 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 123.21 0.604 . . . . 0.0 111.447 -179.498 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 54.3 mt -74.14 -54.42 14.94 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.537 0 C-N-CA 124.794 1.238 . . . . 0.0 110.139 -172.385 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 73.6 mt -64.3 -46.22 93.83 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 179.03 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 139.16 125.65 2.3 Favored Glycine 0 CA--C 1.533 1.179 0 C-N-CA 125.263 1.411 . . . . 0.0 111.733 172.546 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -70.51 -8.65 24.11 Favored 'Trans proline' 0 CA--C 1.535 0.562 0 C-N-CA 123.499 2.799 . . . . 0.0 113.668 -175.584 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -74.26 -21.92 59.55 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 119.007 0.821 . . . . 0.0 111.624 175.385 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -131.83 2.86 4.07 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 124.514 1.125 . . . . 0.0 113.893 -170.454 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 34.5 t -121.61 149.72 24.79 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.393 0 C-N-CA 124.619 1.168 . . . . 0.0 108.051 171.173 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 31.1 m -137.46 130.44 30.45 Favored 'General case' 0 N--CA 1.456 -0.165 0 C-N-CA 126.043 1.737 . . . . 0.0 106.689 -172.379 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 26.3 mt -79.36 141.22 37.12 Favored 'General case' 0 C--O 1.233 0.19 0 N-CA-C 107.826 -1.176 . . . . 0.0 107.826 176.859 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 34.1 t-80 -132.13 64.9 1.59 Allowed 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 107.393 -1.336 . . . . 0.0 107.393 -177.236 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 65.1 t-20 -73.07 115.11 12.0 Favored 'General case' 0 C--O 1.235 0.29 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 -177.326 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 87.0 mt -67.85 -12.41 60.58 Favored 'General case' 0 CA--C 1.532 0.284 0 N-CA-C 112.959 0.725 . . . . 0.0 112.959 -175.86 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -57.47 -26.14 60.8 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 118.746 0.703 . . . . 0.0 110.66 168.325 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -130.14 -40.43 1.31 Allowed 'General case' 0 N--CA 1.466 0.342 0 N-CA-C 113.558 0.947 . . . . 0.0 113.558 -173.957 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 33.0 m-20 -87.32 141.42 28.65 Favored 'General case' 0 C--O 1.236 0.357 0 C-N-CA 123.33 0.652 . . . . 0.0 110.139 -176.018 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 12.9 m -78.42 156.15 78.64 Favored Pre-proline 0 CA--C 1.542 0.666 0 C-N-CA 124.214 1.006 . . . . 0.0 110.291 177.556 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -77.34 -25.22 8.57 Favored 'Trans proline' 0 C--N 1.35 0.625 0 C-N-CA 122.01 1.807 . . . . 0.0 113.589 -171.232 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 3.7 mptp? -60.94 -22.19 64.17 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-N 119.976 1.262 . . . . 0.0 112.088 -179.874 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -60.49 -28.34 68.27 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 125.945 1.698 . . . . 0.0 110.764 174.773 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 57.1 mtt -58.87 -26.28 64.09 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 118.64 0.654 . . . . 0.0 111.254 178.376 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -65.06 -33.82 76.96 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 118.427 0.558 . . . . 0.0 110.759 -176.461 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 14.4 mt-30 -67.24 -43.61 81.55 Favored 'General case' 0 CA--C 1.531 0.228 0 N-CA-C 113.589 0.959 . . . . 0.0 113.589 -168.907 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 31.1 m-85 -71.17 145.9 49.44 Favored 'General case' 0 CA--C 1.527 0.067 0 CA-C-N 115.488 -0.778 . . . . 0.0 111.634 -165.331 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 41.4 m-20 -75.22 -38.48 60.63 Favored 'General case' 0 N--CA 1.47 0.541 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 -176.833 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 17.7 t -112.64 147.41 16.37 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.279 0 N-CA-C 106.828 -1.545 . . . . 0.0 106.828 169.843 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 26.2 tp -129.45 110.22 11.7 Favored 'General case' 0 N--CA 1.447 -0.586 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 172.255 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 23.3 mt -86.67 132.25 32.78 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.583 0 N-CA-C 106.719 -1.586 . . . . 0.0 106.719 174.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 2.5 mp -111.93 124.93 53.44 Favored 'General case' 0 CA--C 1.519 -0.238 0 N-CA-C 106.886 -1.524 . . . . 0.0 106.886 -179.081 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -119.96 133.07 9.74 Favored Glycine 0 N--CA 1.451 -0.318 0 N-CA-C 108.994 -1.642 . . . . 0.0 108.994 171.248 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 5.1 tt -152.57 131.42 6.6 Favored Pre-proline 0 CA--C 1.531 0.234 0 CA-C-N 117.765 0.783 . . . . 0.0 109.746 168.766 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_exo . . . . . 0 N--CA 1.455 -0.762 0 C-N-CA 121.898 1.732 . . . . 0.0 112.87 169.063 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 4.8 mt . . . . . 0 CA--C 1.547 0.833 0 CA-C-O 120.18 0.038 . . . . 0.0 110.913 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -89.63 157.88 17.84 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 123.873 0.869 . . . . 0.0 110.356 172.499 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -52.66 -47.64 66.98 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 124.561 1.145 . . . . 0.0 112.994 -168.02 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -67.04 -22.52 65.87 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 119.274 0.943 . . . . 0.0 112.331 -170.883 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 2.1 t90 -90.17 -42.12 11.23 Favored 'General case' 0 N--CA 1.456 -0.174 0 C-N-CA 124.468 1.107 . . . . 0.0 109.29 177.147 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 9.3 tt0 -62.55 -35.59 79.93 Favored 'General case' 0 N--CA 1.446 -0.625 0 O-C-N 121.081 -1.012 . . . . 0.0 109.927 178.697 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -58.94 -24.62 62.71 Favored 'General case' 0 C--O 1.234 0.254 0 C-N-CA 124.468 1.107 . . . . 0.0 111.643 -178.279 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 28.3 m -113.54 -13.41 11.39 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.324 0 CA-C-O 117.267 -1.349 . . . . 0.0 112.65 178.305 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 25.6 t90 -52.48 -39.88 61.69 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 120.396 1.453 . . . . 0.0 110.119 177.443 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -64.54 -25.69 68.09 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 125.253 1.421 . . . . 0.0 113.167 176.353 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 60.0 mt-30 -92.44 -17.0 25.16 Favored 'General case' 0 CA--C 1.52 -0.189 0 C-N-CA 125.697 1.599 . . . . 0.0 111.716 -178.971 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 14.7 mt -69.15 -19.32 64.01 Favored 'General case' 0 CA--C 1.531 0.219 0 O-C-N 121.204 -0.935 . . . . 0.0 111.37 -175.188 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -85.53 -22.21 28.24 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-O 118.994 -0.527 . . . . 0.0 111.192 169.489 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -70.72 -31.05 67.77 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-N 119.438 1.017 . . . . 0.0 111.887 172.05 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 25.5 mt -58.04 144.46 39.76 Favored 'General case' 0 C--O 1.234 0.264 0 C-N-CA 123.752 0.821 . . . . 0.0 112.007 -176.149 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 2.9 t30 -86.75 86.33 7.32 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 125.094 1.358 . . . . 0.0 107.489 173.049 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 3.7 pp -142.09 135.34 29.02 Favored 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 169.707 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -149.52 151.66 34.27 Favored 'General case' 0 N--CA 1.439 -0.992 0 C-N-CA 127.698 2.399 . . . . 0.0 104.835 169.412 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 72.18 -6.54 10.26 Favored Glycine 0 CA--C 1.534 1.26 0 N-CA-C 116.905 1.522 . . . . 0.0 116.905 169.687 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.46 161.51 29.73 Favored 'General case' 0 C--N 1.342 0.282 0 CA-C-N 120.21 2.005 . . . . 0.0 110.047 -175.756 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 3.6 mt -80.26 135.97 24.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 106.923 -1.51 . . . . 0.0 106.923 176.689 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 73.1 t -133.03 132.49 58.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 C-N-CA 123.53 0.732 . . . . 0.0 109.509 -177.12 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -104.01 154.71 19.36 Favored 'General case' 0 CA--C 1.519 -0.25 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 168.674 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 2.0 mt -135.58 138.77 43.31 Favored 'General case' 0 CA--C 1.513 -0.447 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 172.138 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 36.0 p90 -151.89 167.63 27.72 Favored 'General case' 0 N--CA 1.446 -0.647 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 169.617 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -168.49 154.26 23.92 Favored Glycine 0 N--CA 1.448 -0.544 0 N-CA-C 109.414 -1.474 . . . . 0.0 109.414 172.143 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 CA--C 1.519 -0.232 0 C-N-CA 123.171 0.588 . . . . 0.0 111.49 169.217 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 86.5 mt . . . . . 0 N--CA 1.469 0.495 0 N-CA-C 113.805 1.039 . . . . 0.0 113.805 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -58.09 -35.81 71.96 Favored 'General case' 0 C--N 1.33 -0.264 0 O-C-N 120.853 -1.155 . . . . 0.0 111.365 174.301 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -71.99 -30.47 65.28 Favored 'General case' 0 C--N 1.343 0.31 0 O-C-N 121.636 -0.665 . . . . 0.0 112.016 177.775 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 4.8 tt -61.68 -43.14 99.42 Favored 'General case' 0 CA--C 1.539 0.553 0 N-CA-C 107.94 -1.133 . . . . 0.0 107.94 169.243 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -64.06 -39.91 97.65 Favored Glycine 0 CA--C 1.527 0.795 0 CA-C-O 119.383 -0.676 . . . . 0.0 112.823 179.345 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 71.4 mtm -60.36 -38.34 83.54 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 119.163 1.481 . . . . 0.0 112.178 -176.604 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -73.43 -34.72 65.59 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 119.221 0.919 . . . . 0.0 110.808 179.652 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 55.8 t-80 -61.29 -43.23 99.23 Favored 'General case' 0 C--O 1.232 0.14 0 O-C-N 121.681 -0.637 . . . . 0.0 110.262 174.758 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -64.54 -43.26 94.55 Favored 'General case' 0 C--O 1.234 0.239 0 C-N-CA 123.033 0.533 . . . . 0.0 111.393 -177.675 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 22.5 ttmm -55.43 -52.63 62.97 Favored 'General case' 0 N--CA 1.463 0.205 0 C-N-CA 123.204 0.602 . . . . 0.0 109.863 170.904 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 35.7 mt -77.62 -20.41 53.94 Favored 'General case' 0 CA--C 1.517 -0.297 0 N-CA-C 114.195 1.183 . . . . 0.0 114.195 -168.188 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 61.2 m -61.22 -33.37 73.39 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 119.353 0.979 . . . . 0.0 110.75 -179.672 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 40.3 p -87.59 -19.04 28.36 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 123.446 0.699 . . . . 0.0 111.16 179.581 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 20.5 mmmt -71.92 -19.87 61.85 Favored 'General case' 0 N--CA 1.468 0.47 0 O-C-N 121.576 -0.703 . . . . 0.0 109.654 167.738 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 76.21 38.02 35.53 Favored Glycine 0 C--N 1.337 0.63 0 C-N-CA 123.846 0.736 . . . . 0.0 111.655 173.811 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 9.6 m -71.57 172.58 0.95 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.581 0 CA-C-N 118.752 1.276 . . . . 0.0 109.755 171.094 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -106.49 125.1 50.58 Favored 'General case' 0 CA--C 1.517 -0.295 0 N-CA-C 106.361 -1.718 . . . . 0.0 106.361 172.348 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 78.1 m-85 -92.91 145.41 24.4 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 119.481 1.037 . . . . 0.0 109.916 -178.015 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 35.5 m -131.74 157.84 43.21 Favored 'Isoleucine or valine' 0 C--O 1.234 0.282 0 C-N-CA 125.187 1.395 . . . . 0.0 107.703 169.569 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 84.02 31.46 25.99 Favored Glycine 0 CA--C 1.524 0.628 0 CA-C-O 118.596 -1.113 . . . . 0.0 114.835 169.837 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 13.6 m-30 -63.59 160.5 16.56 Favored 'General case' 0 CA--C 1.545 0.785 0 CA-C-N 119.257 1.529 . . . . 0.0 109.417 168.784 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 48.2 t-105 -138.84 148.15 57.03 Favored Pre-proline 0 N--CA 1.47 0.561 0 CA-C-O 118.12 -0.943 . . . . 0.0 111.432 -168.236 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -67.52 130.33 22.01 Favored 'Trans proline' 0 CA--C 1.536 0.588 0 C-N-CA 123.345 2.697 . . . . 0.0 112.352 -179.413 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 22.6 p . . . . . 0 N--CA 1.474 0.771 0 C-N-CA 125.679 1.591 . . . . 0.0 112.392 170.988 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 15.2 ttmt . . . . . 0 CA--C 1.543 0.708 0 N-CA-C 115.795 1.776 . . . . 0.0 115.795 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_endo -70.66 -11.45 29.68 Favored 'Trans proline' 0 C--N 1.352 0.751 0 CA-C-N 122.345 1.873 . . . . 0.0 114.365 179.651 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 30.9 m -132.51 171.34 18.27 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.428 0 CA-C-N 119.638 1.108 . . . . 0.0 112.874 -167.205 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 14.7 pt -138.56 173.92 11.21 Favored 'Isoleucine or valine' 0 C--O 1.236 0.384 0 C-N-CA 127.985 2.514 . . . . 0.0 108.348 -178.747 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . 55.77 40.0 30.76 Favored 'General case' 0 N--CA 1.463 0.224 0 C-N-CA 125.306 1.442 . . . . 0.0 112.615 174.068 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 27.3 t0 56.0 42.57 28.41 Favored 'General case' 0 C--N 1.324 -0.536 0 C-N-CA 125.998 1.719 . . . . 0.0 111.498 -176.159 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 87.26 21.43 48.99 Favored Glycine 0 CA--C 1.528 0.874 0 CA-C-N 115.211 -0.904 . . . . 0.0 113.541 174.129 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 44.7 mt-30 -97.54 -6.22 34.05 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 118.804 1.302 . . . . 0.0 112.781 -178.844 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 8.1 tp -154.21 147.23 24.56 Favored 'General case' 0 C--N 1.344 0.369 0 CA-C-N 119.618 1.099 . . . . 0.0 110.691 169.579 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 54.7 m-85 -80.76 150.63 29.19 Favored 'General case' 0 CA--C 1.52 -0.18 0 C-N-CA 124.19 0.996 . . . . 0.0 108.695 169.944 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 15.3 m -79.82 11.88 0.54 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.589 0 N-CA-C 112.977 0.732 . . . . 0.0 112.977 173.559 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 178.35 174.87 45.0 Favored Glycine 0 CA--C 1.526 0.755 0 N-CA-C 110.485 -1.046 . . . . 0.0 110.485 -178.44 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 3.5 tp -65.63 133.66 51.62 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 118.471 1.135 . . . . 0.0 110.51 177.758 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -99.62 113.66 26.24 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 125.147 1.379 . . . . 0.0 108.927 173.545 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 69.0 mt . . . . . 0 CA--C 1.534 0.347 0 C-N-CA 125.309 1.444 . . . . 0.0 107.983 169.731 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 13.8 m . . . . . 0 CA--C 1.534 0.343 0 N-CA-C 109.97 -0.381 . . . . 0.0 109.97 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -63.85 -42.46 97.57 Favored 'General case' 0 N--CA 1.465 0.283 0 O-C-N 121.784 -0.572 . . . . 0.0 111.166 173.586 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 -65.4 -42.41 92.63 Favored 'General case' 0 N--CA 1.456 -0.165 0 C-N-CA 124.115 0.966 . . . . 0.0 110.68 177.79 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 73.9 mtt180 -62.46 -46.4 88.69 Favored 'General case' 0 N--CA 1.456 -0.146 0 CA-C-O 118.009 -0.996 . . . . 0.0 109.874 177.401 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 48.7 mt -60.54 -51.2 75.85 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.283 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 177.457 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 72.7 tp60 -53.15 -63.33 1.18 Allowed 'General case' 0 C--O 1.234 0.247 0 C-N-CA 124.3 1.04 . . . . 0.0 111.44 -177.442 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 35.9 m -67.63 -33.06 74.21 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 119.473 -0.298 . . . . 0.0 111.257 -171.092 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 160' ' ' TRP . . . . . . . . . . . . . 49.9 t90 -64.78 -46.96 79.88 Favored 'General case' 0 C--O 1.225 -0.189 0 CA-C-N 118.384 0.538 . . . . 0.0 110.447 173.794 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 55.1 m -60.32 -44.47 95.45 Favored 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 122.843 0.457 . . . . 0.0 110.653 -178.74 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -62.02 -39.17 91.37 Favored 'General case' 0 N--CA 1.456 -0.158 0 CA-C-O 120.946 0.403 . . . . 0.0 110.169 176.838 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 17.3 tt0 -66.89 -52.12 47.23 Favored 'General case' 0 N--CA 1.446 -0.641 0 O-C-N 121.736 -0.602 . . . . 0.0 109.895 -178.779 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 43.4 pt -62.92 -37.49 79.4 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.397 0 CA-C-O 118.072 -0.966 . . . . 0.0 109.36 -175.433 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -64.99 -34.12 77.67 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 119.493 1.042 . . . . 0.0 110.2 -179.672 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 32.9 m-80 -69.48 -52.26 28.23 Favored 'General case' 0 N--CA 1.465 0.277 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 174.419 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 16.1 tt0 -70.73 -26.02 63.2 Favored 'General case' 0 N--CA 1.443 -0.802 0 C-N-CA 124.863 1.265 . . . . 0.0 111.741 -168.647 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 168' ' ' MET . . . . . . . . . . . . . 19.7 ptp -80.64 -32.78 36.1 Favored 'General case' 0 C--N 1.335 -0.03 0 O-C-N 121.117 -0.99 . . . . 0.0 112.051 171.354 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -77.41 -40.08 44.82 Favored 'General case' 0 N--CA 1.447 -0.624 0 O-C-N 122.19 -0.319 . . . . 0.0 110.747 -176.702 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 . . . . . 0 CA--C 1.539 0.533 0 C-N-CA 123.15 0.58 . . . . 0.0 110.719 177.729 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 51.4 ttp . . . . . 0 N--CA 1.498 1.933 0 N-CA-C 110.134 -0.321 . . . . 0.0 110.134 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 9.7 t30 -138.26 152.43 48.55 Favored 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 107.54 -1.281 . . . . 0.0 107.54 170.898 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 20.8 mtt -112.59 123.52 50.48 Favored 'General case' 0 C--N 1.331 -0.221 0 C-N-CA 123.052 0.541 . . . . 0.0 110.835 -176.16 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -83.55 150.55 27.05 Favored Glycine 0 CA--C 1.522 0.474 0 N-CA-C 106.43 -2.668 . . . . 0.0 106.43 166.401 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 2.2 tt -138.43 96.37 3.16 Favored 'General case' 0 CA--C 1.515 -0.388 0 N-CA-C 104.629 -2.36 . . . . 0.0 104.629 -176.877 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -101.0 142.22 32.79 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-O 121.951 0.881 . . . . 0.0 111.312 -171.398 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 45.7 p90 . . . . . 0 N--CA 1.446 -0.656 0 C-N-CA 126.319 1.848 . . . . 0.0 106.727 178.937 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.227 -0.109 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -63.1 -47.83 81.15 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 122.315 0.246 . . . . 0.0 111.174 -175.889 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.7 pp20? -70.42 -33.88 71.85 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-O 118.684 -0.674 . . . . 0.0 110.036 -178.647 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 42.5 mmtt -58.88 -51.39 70.25 Favored 'General case' 0 C--O 1.224 -0.269 0 CA-C-N 119.532 1.06 . . . . 0.0 110.74 171.086 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 34.2 mt -54.23 -54.7 19.16 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.271 0 CA-C-N 119.069 0.85 . . . . 0.0 109.619 -176.638 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.55 -37.13 86.48 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-O 118.704 -0.665 . . . . 0.0 111.024 -177.128 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -64.3 -38.7 91.98 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 118.261 0.482 . . . . 0.0 110.455 179.786 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 68.7 mt -77.41 -54.52 12.58 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.624 0 C-N-CA 124.89 1.276 . . . . 0.0 110.263 -173.777 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 80.7 mt -62.03 -47.51 92.82 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 179.983 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 141.77 121.18 1.69 Allowed Glycine 0 CA--C 1.526 0.773 0 C-N-CA 125.147 1.356 . . . . 0.0 110.199 177.944 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -71.35 -9.63 25.64 Favored 'Trans proline' 0 CA--C 1.538 0.683 0 C-N-CA 123.055 2.504 . . . . 0.0 113.458 -171.476 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -81.46 -16.75 51.01 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 119.025 0.829 . . . . 0.0 111.86 -179.715 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -128.22 5.17 5.8 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 124.87 1.268 . . . . 0.0 113.58 -173.579 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 28.3 t -125.84 147.75 30.55 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.273 0 N-CA-C 107.789 -1.189 . . . . 0.0 107.789 172.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 19.8 m -134.77 130.65 36.48 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 125.38 1.472 . . . . 0.0 108.063 -174.139 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 16.7 mt -77.83 135.15 37.9 Favored 'General case' 0 C--O 1.232 0.166 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 175.404 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 38.4 t-80 -126.76 66.11 1.26 Allowed 'General case' 0 CA--C 1.53 0.201 0 N-CA-C 107.289 -1.374 . . . . 0.0 107.289 -175.747 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 65.0 t-20 -74.6 114.26 12.81 Favored 'General case' 0 C--O 1.234 0.274 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 -176.254 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 88.3 mt -66.16 -12.29 54.9 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 124.395 1.078 . . . . 0.0 112.897 -176.44 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 23.0 tptm -58.13 -27.4 63.73 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-N 118.578 0.626 . . . . 0.0 110.571 169.093 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -130.55 -39.59 1.28 Allowed 'General case' 0 N--CA 1.465 0.287 0 N-CA-C 113.486 0.921 . . . . 0.0 113.486 -173.513 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 38.4 m-20 -87.11 138.95 31.06 Favored 'General case' 0 C--O 1.234 0.288 0 C-N-CA 123.568 0.747 . . . . 0.0 110.17 -176.929 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 14.1 m -75.92 154.57 84.93 Favored Pre-proline 0 CA--C 1.541 0.622 0 C-N-CA 124.118 0.967 . . . . 0.0 110.174 177.284 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 66.7 Cg_endo -75.39 -26.12 10.61 Favored 'Trans proline' 0 C--N 1.351 0.705 0 C-N-CA 122.235 1.957 . . . . 0.0 113.908 -170.911 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.79 -16.17 64.08 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-N 120.358 1.436 . . . . 0.0 112.28 -179.057 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -60.08 -27.69 67.2 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 125.144 1.378 . . . . 0.0 110.543 170.82 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 57.1 mtt -58.05 -26.13 62.1 Favored 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 123.376 0.67 . . . . 0.0 111.62 176.832 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 59.6 mt-10 -67.22 -33.71 75.94 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 118.323 0.511 . . . . 0.0 110.391 -175.466 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 19.0 mt-30 -65.23 -43.9 89.95 Favored 'General case' 0 N--CA 1.464 0.257 0 C-N-CA 123.666 0.787 . . . . 0.0 112.396 -169.908 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 18.5 m-85 -72.89 140.05 47.27 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 123.705 0.802 . . . . 0.0 110.176 -166.869 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -74.7 -37.52 62.6 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 118.481 0.582 . . . . 0.0 110.022 -178.297 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 13.5 t -105.34 145.53 13.46 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.328 0 N-CA-C 107.498 -1.297 . . . . 0.0 107.498 170.117 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 32.9 tp -134.19 106.1 6.99 Favored 'General case' 0 N--CA 1.447 -0.611 0 N-CA-C 108.601 -0.889 . . . . 0.0 108.601 175.418 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 24.8 mt -85.76 129.62 37.74 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 N-CA-C 106.638 -1.616 . . . . 0.0 106.638 177.557 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 1.4 mp -104.13 130.79 51.87 Favored 'General case' 0 N--CA 1.467 0.417 0 N-CA-C 105.953 -1.869 . . . . 0.0 105.953 177.207 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -131.17 119.22 2.59 Favored Glycine 0 CA--C 1.505 -0.576 0 N-CA-C 108.635 -1.786 . . . . 0.0 108.635 -176.945 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 1.6 tt -144.07 120.97 6.51 Favored Pre-proline 0 CA--C 1.531 0.238 0 CA-C-N 118.235 1.018 . . . . 0.0 108.706 179.517 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 76.9 Cg_exo . . . . . 0 N--CA 1.459 -0.535 0 C-N-CA 122.499 2.133 . . . . 0.0 114.286 -178.502 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 20.8 mt . . . . . 0 CA--C 1.542 0.654 0 N-CA-C 109.768 -0.456 . . . . 0.0 109.768 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 2.0 pm0 -67.56 151.93 46.5 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 123.585 0.754 . . . . 0.0 110.913 177.197 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -49.2 -51.23 34.2 Favored 'General case' 0 N--CA 1.463 0.205 0 C-N-CA 125.843 1.657 . . . . 0.0 112.669 -168.894 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -68.65 -17.11 64.03 Favored 'General case' 0 N--CA 1.473 0.712 0 CA-C-N 119.019 0.827 . . . . 0.0 112.043 -170.413 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' TRP . . . . . 0.505 ' CZ3' ' CE3' ' A' ' 69' ' ' TRP . 0.0 OUTLIER -88.69 -47.1 8.5 Favored 'General case' 0 CA--C 1.538 0.51 0 N-CA-C 107.449 -1.315 . . . . 0.0 107.449 178.071 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 12.0 tt0 -63.6 -33.46 75.65 Favored 'General case' 0 N--CA 1.449 -0.519 0 O-C-N 120.598 -1.314 . . . . 0.0 110.542 178.804 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -54.75 -25.15 25.91 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 125.085 1.354 . . . . 0.0 112.45 -177.763 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 29.6 m -114.28 -13.85 11.14 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.209 0 CA-C-O 117.204 -1.379 . . . . 0.0 112.918 177.356 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' TRP . . . . . 0.505 ' CE3' ' CZ3' ' A' ' 65' ' ' TRP . 2.6 t-105 -51.13 -39.55 56.51 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 120.136 1.334 . . . . 0.0 111.071 -173.644 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -68.57 -23.65 64.52 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 125.11 1.364 . . . . 0.0 113.2 -179.885 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 18.7 mt-30 -89.51 -23.41 22.06 Favored 'General case' 0 C--N 1.341 0.211 0 C-N-CA 125.311 1.444 . . . . 0.0 112.363 178.613 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 40.3 mt -65.72 -24.61 67.01 Favored 'General case' 0 N--CA 1.469 0.485 0 O-C-N 121.874 -0.516 . . . . 0.0 112.065 -169.968 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -70.06 -21.29 63.18 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 118.087 0.403 . . . . 0.0 111.74 175.78 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -75.1 -23.6 57.97 Favored 'General case' 0 CA--C 1.538 0.505 0 O-C-N 121.139 -0.976 . . . . 0.0 112.635 -178.722 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 53.6 mt -66.16 150.17 49.18 Favored 'General case' 0 C--O 1.231 0.12 0 C-N-CA 124.869 1.268 . . . . 0.0 112.003 -169.594 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 3.7 t30 -82.24 105.79 13.61 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 124.551 1.14 . . . . 0.0 108.204 172.488 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 65.6 mt -124.0 1.29 8.61 Favored 'General case' 0 N--CA 1.472 0.63 0 N-CA-C 113.764 1.024 . . . . 0.0 113.764 -172.491 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 27.2 mt-10 -56.9 130.98 48.21 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-O 121.913 0.863 . . . . 0.0 111.318 -169.747 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 74.04 -2.73 41.46 Favored Glycine 0 CA--C 1.534 1.249 0 C-N-CA 125.401 1.477 . . . . 0.0 114.955 176.951 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.66 148.7 40.4 Favored 'General case' 0 C--N 1.345 0.403 0 CA-C-N 120.346 2.073 . . . . 0.0 109.347 -176.399 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 5.3 mt -81.26 139.79 17.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 N-CA-C 106.711 -1.589 . . . . 0.0 106.711 179.542 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 38.4 t -133.55 139.16 49.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 C-N-CA 124.459 1.103 . . . . 0.0 110.491 -175.897 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -115.37 162.25 17.39 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 123.971 0.908 . . . . 0.0 109.043 169.466 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 6.2 mt -141.61 136.8 31.37 Favored 'General case' 0 N--CA 1.465 0.277 0 N-CA-C 106.867 -1.531 . . . . 0.0 106.867 178.702 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 40.4 p90 -153.64 155.52 36.2 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-N 120.614 1.552 . . . . 0.0 109.116 174.913 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -175.9 -167.33 34.65 Favored Glycine 0 N--CA 1.445 -0.719 0 N-CA-C 108.514 -1.834 . . . . 0.0 108.514 170.656 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.327 -0.373 0 CA-C-O 122.443 1.116 . . . . 0.0 111.139 176.025 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 96.6 mt . . . . . 0 CA--C 1.541 0.625 0 N-CA-C 114.453 1.279 . . . . 0.0 114.453 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -57.71 -39.47 77.3 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 119.765 1.166 . . . . 0.0 113.108 -167.601 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -73.35 -19.42 61.01 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-O 118.262 -0.875 . . . . 0.0 112.666 -178.905 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 8.5 mp -65.69 -38.75 90.1 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-N 120.151 1.341 . . . . 0.0 108.45 170.248 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -63.37 -36.89 94.0 Favored Glycine 0 C--N 1.339 0.712 0 N-CA-C 111.218 -0.753 . . . . 0.0 111.218 -179.008 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 77.8 mtm -67.33 -47.82 69.37 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-O 118.077 -0.963 . . . . 0.0 111.006 179.85 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -70.57 -33.4 71.06 Favored 'General case' 0 C--N 1.348 0.535 0 CA-C-N 121.042 1.746 . . . . 0.0 110.995 178.217 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 68.2 t60 -54.51 -51.76 64.11 Favored 'General case' 0 CA--C 1.529 0.14 0 CA-C-N 118.821 0.737 . . . . 0.0 110.164 171.894 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -62.99 -40.02 96.48 Favored 'General case' 0 C--O 1.236 0.379 0 C-N-CA 123.771 0.829 . . . . 0.0 112.094 -176.098 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 24.1 ttmm -54.9 -39.68 69.01 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 123.327 0.651 . . . . 0.0 110.146 171.508 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 35.2 mt -90.96 -19.52 23.17 Favored 'General case' 0 CA--C 1.518 -0.287 0 N-CA-C 115.48 1.659 . . . . 0.0 115.48 -168.566 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 4.5 m -58.81 -36.47 74.54 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 120.86 1.664 . . . . 0.0 111.353 -177.664 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 19.9 p -84.0 -15.45 47.63 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 124.81 1.244 . . . . 0.0 111.66 179.942 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 31.7 mmmt -81.56 -9.97 59.56 Favored 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 124.542 1.137 . . . . 0.0 110.998 172.109 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 73.21 35.42 57.05 Favored Glycine 0 CA--C 1.523 0.569 0 CA-C-O 119.541 -0.589 . . . . 0.0 112.404 169.497 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 5.9 m -74.9 173.9 0.89 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.56 0 CA-C-N 118.122 0.961 . . . . 0.0 109.536 171.252 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -115.23 117.22 29.88 Favored 'General case' 0 CA--C 1.52 -0.211 0 N-CA-C 106.911 -1.515 . . . . 0.0 106.911 175.367 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 87.9 m-85 -85.71 143.15 28.53 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 119.56 1.073 . . . . 0.0 110.022 -175.312 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 32.9 m -133.47 160.7 42.14 Favored 'Isoleucine or valine' 0 C--O 1.235 0.307 0 C-N-CA 125.712 1.605 . . . . 0.0 108.052 169.748 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 86.8 26.95 30.5 Favored Glycine 0 C--N 1.332 0.339 0 CA-C-O 118.327 -1.263 . . . . 0.0 114.097 173.458 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 18.9 m-30 -60.85 159.87 10.5 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-N 119.165 1.482 . . . . 0.0 110.082 169.711 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 1.5 m95 -125.66 143.71 45.88 Favored Pre-proline 0 N--CA 1.469 0.501 0 CA-C-O 118.362 -0.828 . . . . 0.0 109.359 169.722 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -64.05 127.72 20.07 Favored 'Trans proline' 0 N--CA 1.452 -0.954 0 C-N-CA 123.335 2.69 . . . . 0.0 109.845 173.493 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 31.5 p . . . . . 0 N--CA 1.471 0.621 0 N-CA-C 113.449 0.907 . . . . 0.0 113.449 175.456 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 20.5 ttmt . . . . . 0 CA--C 1.544 0.719 0 CA-C-O 117.429 -1.272 . . . . 0.0 114.083 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -73.07 -3.66 14.04 Favored 'Trans proline' 0 C--N 1.352 0.719 0 CA-C-N 121.939 1.728 . . . . 0.0 114.447 -178.444 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 19.7 m -129.93 166.84 26.52 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 CA-C-N 119.989 1.268 . . . . 0.0 111.924 -169.588 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 10.3 pt -138.02 174.56 10.56 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.331 0 C-N-CA 127.554 2.342 . . . . 0.0 108.73 -177.088 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . 54.96 43.88 29.17 Favored 'General case' 0 N--CA 1.465 0.284 0 C-N-CA 125.351 1.46 . . . . 0.0 112.051 175.184 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 27.4 t0 54.55 43.18 30.67 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 126.046 1.738 . . . . 0.0 111.46 -175.756 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 89.95 16.06 56.78 Favored Glycine 0 CA--C 1.526 0.723 0 CA-C-O 118.356 -1.247 . . . . 0.0 114.481 171.207 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 47.6 mt-30 -88.08 -16.84 32.47 Favored 'General case' 0 CA--C 1.536 0.404 0 CA-C-N 119.366 1.583 . . . . 0.0 113.691 -175.569 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -143.45 142.86 31.36 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 119.541 1.064 . . . . 0.0 110.661 177.234 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 74.2 m-85 -75.25 141.59 43.47 Favored 'General case' 0 CA--C 1.519 -0.233 0 N-CA-C 105.095 -2.187 . . . . 0.0 105.095 164.642 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 33.5 m -69.98 -0.1 1.38 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.567 0 N-CA-C 113.011 0.745 . . . . 0.0 113.011 -178.099 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -170.13 -170.82 34.96 Favored Glycine 0 N--CA 1.447 -0.618 0 N-CA-C 109.972 -1.251 . . . . 0.0 109.972 -172.607 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . 0.463 ' HG ' ' CG ' ' A' ' 160' ' ' TRP . 1.2 tt -60.05 139.31 57.55 Favored 'General case' 0 N--CA 1.462 0.156 0 C-N-CA 124.424 1.089 . . . . 0.0 110.548 -179.815 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -105.78 96.03 6.21 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 124.553 1.141 . . . . 0.0 108.422 168.794 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 78.2 mt . . . . . 0 CA--C 1.535 0.397 0 N-CA-C 105.621 -1.992 . . . . 0.0 105.621 168.582 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 31.0 p . . . . . 0 CA--C 1.531 0.216 0 N-CA-C 110.347 -0.242 . . . . 0.0 110.347 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -58.22 -40.34 81.4 Favored 'General case' 0 N--CA 1.462 0.173 0 C-N-CA 123.921 0.889 . . . . 0.0 111.064 178.345 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 3.5 tp10 -69.67 -47.36 63.56 Favored 'General case' 0 CA--C 1.529 0.16 0 C-N-CA 124.485 1.114 . . . . 0.0 110.911 -177.485 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 69.9 mtp85 -66.71 -27.39 67.6 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 117.894 -1.051 . . . . 0.0 110.424 179.859 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 25.1 mt -73.14 -53.29 18.84 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.601 0 CA-C-N 119.908 1.231 . . . . 0.0 107.762 168.364 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 70.8 tp60 -50.14 -64.14 0.9 Allowed 'General case' 0 N--CA 1.464 0.259 0 C-N-CA 126.031 1.732 . . . . 0.0 112.14 -175.419 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 25.3 m -66.11 -32.75 74.39 Favored 'General case' 0 C--N 1.327 -0.392 0 O-C-N 123.036 0.21 . . . . 0.0 110.803 -171.01 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 160' ' ' TRP . . . . . 0.463 ' CG ' ' HG ' ' A' ' 142' ' ' LEU . 88.2 t90 -66.41 -46.84 75.22 Favored 'General case' 0 C--O 1.222 -0.349 0 O-C-N 121.958 -0.464 . . . . 0.0 110.836 174.592 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 67.2 m -59.56 -44.42 93.29 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 123.266 0.626 . . . . 0.0 110.501 178.816 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -61.05 -42.95 99.44 Favored 'General case' 0 N--CA 1.457 -0.085 0 CA-C-O 121.021 0.439 . . . . 0.0 110.199 175.723 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 14.4 tt0 -63.71 -52.1 62.07 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-O 117.791 -1.1 . . . . 0.0 109.73 -177.508 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 40.4 pt -63.02 -34.11 64.61 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.519 0 CA-C-N 119.439 1.018 . . . . 0.0 110.077 -176.57 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -70.16 -34.95 73.66 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 119.382 0.992 . . . . 0.0 108.519 -175.2 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -70.72 -46.27 63.36 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 123.707 0.803 . . . . 0.0 109.993 174.273 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 24.8 tt0 -77.91 -14.09 59.66 Favored 'General case' 0 N--CA 1.437 -1.104 0 C-N-CA 124.9 1.28 . . . . 0.0 110.359 -169.629 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 168' ' ' MET . . . . . . . . . . . . . 18.9 ptp -92.17 -38.9 11.87 Favored 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 122.751 0.42 . . . . 0.0 111.547 169.754 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -75.81 -27.82 58.09 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-O 119.327 -0.368 . . . . 0.0 111.914 -173.447 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 . . . . . 0 CA--C 1.541 0.617 0 C-N-CA 123.655 0.782 . . . . 0.0 112.398 -177.084 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.499 2.015 0 CA-C-O 119.403 -0.332 . . . . 0.0 111.11 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 11.3 t30 -127.29 151.1 49.18 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-N 119.167 0.894 . . . . 0.0 110.523 -177.815 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 17.5 mtt -117.4 130.41 56.47 Favored 'General case' 0 N--CA 1.461 0.11 0 C-N-CA 124.228 1.011 . . . . 0.0 110.958 -177.873 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -86.88 154.76 27.04 Favored Glycine 0 CA--C 1.522 0.51 0 N-CA-C 107.77 -2.132 . . . . 0.0 107.77 166.541 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 3.0 tt -141.24 99.49 3.59 Favored 'General case' 0 N--CA 1.464 0.244 0 N-CA-C 105.612 -1.995 . . . . 0.0 105.612 -176.456 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 1.2 p90 -106.18 138.43 42.38 Favored 'General case' 0 CA--C 1.521 -0.162 0 CA-C-N 118.017 0.372 . . . . 0.0 111.707 -169.54 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 19.5 p90 . . . . . 0 CA--C 1.536 0.43 0 C-N-CA 125.693 1.597 . . . . 0.0 108.736 -174.053 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.463 0.194 0 N-CA-C 109.238 -0.653 . . . . 0.0 109.238 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -62.46 -47.71 82.83 Favored 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 123.049 0.539 . . . . 0.0 111.45 -176.481 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 33.8 mt-10 -61.73 -42.38 98.88 Favored 'General case' 0 C--O 1.232 0.178 0 C-N-CA 123.415 0.686 . . . . 0.0 110.14 176.377 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 28.7 mtpp -70.98 -39.63 72.38 Favored 'General case' 0 C--O 1.221 -0.434 0 CA-C-O 118.199 -0.905 . . . . 0.0 110.32 -175.885 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 43.7 mt -53.8 -56.04 10.92 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.285 0 CA-C-N 119.805 1.184 . . . . 0.0 109.266 175.781 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.71 -35.44 80.74 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 118.406 0.548 . . . . 0.0 111.404 -175.82 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -64.31 -41.06 97.02 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.819 0.342 . . . . 0.0 110.944 177.996 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 56.4 mt -76.13 -54.08 14.24 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.47 0 C-N-CA 124.548 1.139 . . . . 0.0 109.84 -172.557 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 65.2 mt -62.63 -47.56 92.33 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.328 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 179.611 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 142.49 121.47 1.66 Allowed Glycine 0 CA--C 1.528 0.847 0 C-N-CA 124.826 1.203 . . . . 0.0 110.526 177.063 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -70.96 -12.72 31.01 Favored 'Trans proline' 0 CA--C 1.537 0.669 0 C-N-CA 122.784 2.323 . . . . 0.0 113.495 -171.027 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -77.17 -18.52 57.74 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 118.904 0.774 . . . . 0.0 111.729 179.802 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -128.71 9.1 5.88 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 124.604 1.162 . . . . 0.0 113.582 -170.639 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 31.4 t -127.93 148.07 32.55 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 N-CA-C 107.511 -1.292 . . . . 0.0 107.511 173.242 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 25.3 m -132.22 131.06 41.77 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 125.574 1.55 . . . . 0.0 108.164 -175.34 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 26.4 mt -77.73 131.46 37.68 Favored 'General case' 0 CA--C 1.521 -0.168 0 N-CA-C 108.107 -1.072 . . . . 0.0 108.107 176.104 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 22.5 t-80 -129.27 52.82 1.93 Allowed 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 124.748 1.219 . . . . 0.0 108.19 -175.552 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 18.7 t-20 -55.12 128.94 36.14 Favored 'General case' 0 CA--C 1.531 0.241 0 N-CA-C 107.834 -1.173 . . . . 0.0 107.834 171.086 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 39.0 mt -75.44 -16.17 60.36 Favored 'General case' 0 C--O 1.234 0.244 0 N-CA-C 114.021 1.119 . . . . 0.0 114.021 -169.009 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 9.0 tptm -77.47 -26.44 51.39 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 118.951 0.796 . . . . 0.0 110.154 169.614 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -88.13 -35.91 17.17 Favored 'General case' 0 C--O 1.236 0.375 0 C-N-CA 124.155 0.982 . . . . 0.0 112.783 -174.067 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 2.5 t0 -142.76 155.22 44.81 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 118.653 0.661 . . . . 0.0 112.673 178.151 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 19.1 m -75.35 158.34 83.79 Favored Pre-proline 0 CA--C 1.544 0.716 0 C-N-CA 125.998 1.719 . . . . 0.0 111.298 -170.525 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_endo -74.43 -25.75 12.79 Favored 'Trans proline' 0 C--N 1.349 0.594 0 C-N-CA 122.245 1.963 . . . . 0.0 113.231 -170.6 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 22.6 mmmt -71.19 -11.34 60.88 Favored 'General case' 0 CA--C 1.54 0.561 0 O-C-N 120.45 -1.406 . . . . 0.0 111.703 -176.368 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -61.85 -28.68 69.66 Favored 'General case' 0 N--CA 1.465 0.282 0 C-N-CA 125.159 1.384 . . . . 0.0 110.265 169.167 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 45.4 mtt -57.48 -27.3 62.39 Favored 'General case' 0 N--CA 1.464 0.275 0 C-N-CA 123.12 0.568 . . . . 0.0 111.865 177.146 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 84.7 mt-10 -66.17 -32.22 73.52 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 118.118 0.417 . . . . 0.0 110.357 -175.621 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 20.8 mt-30 -66.99 -41.63 86.44 Favored 'General case' 0 N--CA 1.464 0.243 0 C-N-CA 123.804 0.841 . . . . 0.0 112.714 -171.22 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 15.7 m-85 -72.2 147.05 46.93 Favored 'General case' 0 CA--C 1.522 -0.108 0 C-N-CA 123.5 0.72 . . . . 0.0 110.667 -166.139 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -75.98 -34.47 59.77 Favored 'General case' 0 N--CA 1.467 0.422 0 O-C-N 121.832 -0.542 . . . . 0.0 110.297 176.045 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 6.4 t -113.4 146.76 17.6 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.19 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 172.668 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 48.5 tp -132.24 113.81 13.69 Favored 'General case' 0 N--CA 1.451 -0.424 0 C-N-CA 123.625 0.77 . . . . 0.0 109.06 171.726 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 23.0 mt -89.84 130.33 39.3 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 N-CA-C 106.361 -1.718 . . . . 0.0 106.361 174.982 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -106.01 131.87 52.78 Favored 'General case' 0 C--O 1.232 0.183 0 C-N-CA 125.201 1.4 . . . . 0.0 107.929 172.675 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -127.46 139.03 10.87 Favored Glycine 0 CA--C 1.524 0.647 0 C-N-CA 124.892 1.234 . . . . 0.0 110.283 169.997 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 6.2 tt -145.47 129.65 8.75 Favored Pre-proline 0 CA--C 1.538 0.511 0 CA-C-N 118.763 1.282 . . . . 0.0 110.584 170.883 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo . . . . . 0 N--CA 1.456 -0.694 0 C-N-CA 123.099 2.533 . . . . 0.0 110.247 169.748 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.445 -0.685 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 3.0 mp0 -88.88 156.95 18.61 Favored 'General case' 0 C--O 1.231 0.104 0 C-N-CA 124.622 1.169 . . . . 0.0 108.167 179.446 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -57.41 -40.28 77.94 Favored 'General case' 0 N--CA 1.464 0.249 0 C-N-CA 123.318 0.647 . . . . 0.0 110.45 -179.096 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 80.2 m-20 -58.1 -30.84 66.58 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 124.331 1.053 . . . . 0.0 110.96 -178.439 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 1.9 t90 -95.87 -45.29 7.02 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 125.889 1.675 . . . . 0.0 108.297 -170.117 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 24.5 tt0 -63.51 -35.73 81.42 Favored 'General case' 0 N--CA 1.439 -1.011 0 C-N-CA 124.633 1.173 . . . . 0.0 110.347 178.451 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -57.83 -24.16 56.1 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 123.874 0.87 . . . . 0.0 111.759 -178.562 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 34.8 m -116.55 -12.13 11.62 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.345 0 CA-C-O 117.351 -1.309 . . . . 0.0 112.342 177.761 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 26.8 t90 -52.11 -38.71 58.26 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 120.234 1.379 . . . . 0.0 110.568 -176.387 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -65.35 -26.16 67.91 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 125.511 1.524 . . . . 0.0 113.284 177.255 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 25.7 mt-30 -92.58 -19.85 21.51 Favored 'General case' 0 C--N 1.34 0.165 0 C-N-CA 126.086 1.754 . . . . 0.0 112.538 176.836 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 72.6 mt -61.78 -24.14 66.65 Favored 'General case' 0 CA--C 1.532 0.274 0 O-C-N 121.679 -0.638 . . . . 0.0 111.289 -176.31 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -77.31 -27.67 52.99 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 118.074 0.397 . . . . 0.0 111.475 175.738 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -70.29 -33.09 71.14 Favored 'General case' 0 N--CA 1.467 0.379 0 O-C-N 121.424 -0.797 . . . . 0.0 111.381 178.823 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 83.2 mt -50.6 135.61 22.71 Favored 'General case' 0 C--N 1.341 0.2 0 C-N-CA 124.72 1.208 . . . . 0.0 111.935 -170.142 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 4.9 t-20 -74.64 105.39 5.71 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 107.308 -1.368 . . . . 0.0 107.308 168.356 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.435 ' HA ' ' HE2' ' A' ' 80' ' ' LYS . 59.6 mt -123.83 2.13 8.77 Favored 'General case' 0 N--CA 1.467 0.38 0 C-N-CA 124.691 1.196 . . . . 0.0 111.163 -179.622 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 29.6 mp0 -57.24 128.12 35.39 Favored 'General case' 0 N--CA 1.445 -0.681 0 CA-C-O 122.062 0.934 . . . . 0.0 112.287 -166.984 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 70.57 -0.04 28.92 Favored Glycine 0 CA--C 1.537 1.448 0 CA-C-N 113.792 -1.549 . . . . 0.0 115.411 -177.938 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.435 ' HE2' ' HA ' ' A' ' 77' ' ' LEU . 0.0 OUTLIER -77.87 160.01 28.56 Favored 'General case' 0 C--N 1.346 0.426 0 CA-C-N 120.892 2.346 . . . . 0.0 110.277 -175.381 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 1.9 mt -85.91 141.28 14.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 N-CA-C 106.729 -1.582 . . . . 0.0 106.729 178.215 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 94.2 t -138.42 146.63 26.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 -176.822 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -124.17 145.21 49.45 Favored 'General case' 0 CA--C 1.513 -0.456 0 N-CA-C 104.991 -2.225 . . . . 0.0 104.991 175.444 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 4.9 mp -126.83 141.74 51.74 Favored 'General case' 0 CA--C 1.501 -0.905 0 N-CA-C 107.655 -1.239 . . . . 0.0 107.655 175.007 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 34.4 p90 -153.13 168.71 25.02 Favored 'General case' 0 N--CA 1.441 -0.924 0 N-CA-C 107.236 -1.394 . . . . 0.0 107.236 167.836 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -162.69 171.53 38.53 Favored Glycine 0 N--CA 1.44 -1.042 0 N-CA-C 109.278 -1.529 . . . . 0.0 109.278 169.88 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 6.1 tt . . . . . 0 N--CA 1.442 -0.845 0 N-CA-C 106.589 -1.634 . . . . 0.0 106.589 173.764 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 91.1 mt . . . . . 0 N--CA 1.472 0.648 0 N-CA-C 113.567 0.951 . . . . 0.0 113.567 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -51.31 -48.22 62.38 Favored 'General case' 0 C--O 1.234 0.28 0 C-N-CA 125.284 1.434 . . . . 0.0 110.749 177.796 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -72.14 -23.97 61.39 Favored 'General case' 0 CA--C 1.539 0.554 0 O-C-N 121.616 -0.678 . . . . 0.0 112.576 -178.543 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 4.8 tt -65.81 -48.06 72.98 Favored 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 171.352 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -61.18 -33.31 83.8 Favored Glycine 0 CA--C 1.527 0.806 0 N-CA-C 111.164 -0.775 . . . . 0.0 111.164 -179.674 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 4.5 tpp -53.76 -52.05 61.44 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 124.647 1.179 . . . . 0.0 111.225 172.885 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -72.83 -33.19 66.02 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-O 118.425 -0.798 . . . . 0.0 110.758 -177.894 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 49.0 t60 -58.69 -50.96 71.97 Favored 'General case' 0 C--O 1.226 -0.161 0 CA-C-N 118.718 0.69 . . . . 0.0 110.604 174.696 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -62.13 -41.88 98.7 Favored 'General case' 0 C--O 1.234 0.258 0 C-N-CA 123.354 0.662 . . . . 0.0 111.585 -176.966 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 23.4 ttmm -59.57 -39.4 83.98 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 123.145 0.578 . . . . 0.0 110.098 173.128 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 16.5 mt -82.53 -25.33 33.49 Favored 'General case' 0 N--CA 1.455 -0.179 0 CA-C-O 117.584 -1.198 . . . . 0.0 113.71 -170.097 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 18.2 m -58.58 -36.73 74.43 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 120.503 1.501 . . . . 0.0 111.722 -175.785 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 21.1 p -82.15 -8.29 59.65 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 124.251 1.021 . . . . 0.0 111.719 -178.416 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 29.6 mmmt -84.03 -3.27 57.91 Favored 'General case' 0 C--N 1.343 0.284 0 C-N-CA 124.985 1.314 . . . . 0.0 111.365 173.786 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 67.53 33.35 81.12 Favored Glycine 0 CA--C 1.527 0.8 0 CA-C-N 118.698 0.681 . . . . 0.0 112.287 170.048 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 15.6 m -83.09 171.65 1.19 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 C-N-CA 123.593 0.757 . . . . 0.0 110.317 179.913 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 15.5 tptm -98.55 129.5 45.1 Favored 'General case' 0 CA--C 1.513 -0.47 0 N-CA-C 104.904 -2.258 . . . . 0.0 104.904 167.588 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 60.3 m-85 -94.84 124.31 38.81 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 171.457 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 35.3 m -107.26 157.77 7.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 C-N-CA 123.566 0.747 . . . . 0.0 109.257 168.531 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 101.12 -97.31 1.65 Allowed Glycine 0 N--CA 1.447 -0.616 0 C-N-CA 124.885 1.231 . . . . 0.0 111.505 174.16 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 11.3 m-30 61.06 172.89 0.1 Allowed 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 125.004 1.321 . . . . 0.0 110.104 -167.255 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 1.2 t90 -155.46 138.83 10.91 Favored Pre-proline 0 N--CA 1.469 0.485 0 CA-C-O 117.386 -1.292 . . . . 0.0 109.297 -177.029 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -71.72 121.67 7.87 Favored 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 123.413 2.742 . . . . 0.0 111.872 -174.49 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 37.5 p . . . . . 0 N--CA 1.47 0.545 0 N-CA-C 114.334 1.235 . . . . 0.0 114.334 179.902 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 33.4 ttmt . . . . . 0 N--CA 1.475 0.791 0 CA-C-O 117.529 -1.224 . . . . 0.0 114.142 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -73.82 -1.5 10.89 Favored 'Trans proline' 0 C--N 1.35 0.607 0 C-N-CA 121.856 1.704 . . . . 0.0 114.591 -179.527 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 12.3 m -135.91 153.0 31.55 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 CA-C-N 121.563 1.983 . . . . 0.0 112.377 -168.503 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 11.8 pt -90.27 167.73 1.62 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.444 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 167.348 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . 57.9 -156.18 0.32 Allowed 'General case' 0 N--CA 1.447 -0.6 0 C-N-CA 124.934 1.294 . . . . 0.0 109.855 169.523 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 23.1 t0 -76.78 59.0 1.51 Allowed 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 125.065 1.346 . . . . 0.0 109.389 170.08 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 62.9 46.03 94.43 Favored Glycine 0 C--N 1.336 0.583 0 C-N-CA 124.826 1.203 . . . . 0.0 112.147 176.079 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 69.2 mm-40 -93.29 -44.44 8.31 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-N 118.208 1.004 . . . . 0.0 112.571 -169.809 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -134.18 142.83 47.56 Favored 'General case' 0 N--CA 1.47 0.556 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 179.883 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 44.9 m-85 -72.11 15.51 0.16 Allowed 'General case' 0 N--CA 1.479 1.007 0 N-CA-C 116.444 2.016 . . . . 0.0 116.444 179.775 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . 0.253 1.0 OUTLIER 52.82 8.61 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.549 0.932 0 C-N-CA 127.162 2.185 . . . . 0.0 113.577 -177.245 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 171.69 171.75 37.05 Favored Glycine 0 CA--C 1.528 0.906 0 C-N-CA 126.299 1.904 . . . . 0.0 108.968 -170.433 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -70.03 140.55 52.88 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 118.149 0.975 . . . . 0.0 111.642 -178.254 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -100.36 129.71 46.37 Favored 'General case' 0 N--CA 1.447 -0.587 0 C-N-CA 125.671 1.588 . . . . 0.0 109.995 176.912 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 81.3 mt . . . . . 0 CA--C 1.533 0.3 0 N-CA-C 106.576 -1.639 . . . . 0.0 106.576 168.406 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 28.9 m . . . . . 0 CA--C 1.53 0.189 0 CA-C-O 119.232 -0.413 . . . . 0.0 110.368 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -59.24 -43.46 92.4 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 118.789 0.722 . . . . 0.0 111.2 175.636 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 -68.94 -47.6 65.3 Favored 'General case' 0 C--O 1.233 0.23 0 C-N-CA 124.934 1.294 . . . . 0.0 110.436 -179.625 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 9.6 mpt_? -54.13 -47.56 71.74 Favored 'General case' 0 N--CA 1.463 0.221 0 C-N-CA 124.355 1.062 . . . . 0.0 109.87 176.348 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 43.2 mt -68.52 -52.82 32.53 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.468 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 -179.41 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 71.4 tp60 -50.89 -63.99 0.95 Allowed 'General case' 0 CA--C 1.516 -0.329 0 C-N-CA 124.922 1.289 . . . . 0.0 111.83 -174.801 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 24.1 m -66.61 -32.62 74.07 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 120.615 -0.434 . . . . 0.0 110.965 -169.742 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 160' ' ' TRP . . . . . . . . . . . . . 36.2 t90 -69.93 -44.65 69.18 Favored 'General case' 0 CA--C 1.517 -0.325 0 O-C-N 121.89 -0.506 . . . . 0.0 111.217 177.536 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 67.1 m -59.77 -42.94 94.39 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 122.779 0.432 . . . . 0.0 110.371 178.046 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -62.06 -42.54 99.3 Favored 'General case' 0 C--O 1.227 -0.083 0 CA-C-O 121.031 0.443 . . . . 0.0 110.08 175.812 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 14.2 tt0 -62.78 -52.15 64.32 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-O 118.824 -0.608 . . . . 0.0 110.187 -178.669 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 43.8 pt -63.0 -38.56 82.35 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.321 0 CA-C-O 117.819 -1.086 . . . . 0.0 109.267 -174.724 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -65.31 -33.88 77.03 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 119.435 1.016 . . . . 0.0 110.405 -179.484 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 34.0 m-80 -69.77 -56.91 5.88 Favored 'General case' 0 CA--C 1.517 -0.305 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 175.379 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 9.9 tt0 -64.72 -37.48 87.73 Favored 'General case' 0 N--CA 1.442 -0.86 0 C-N-CA 124.813 1.245 . . . . 0.0 110.887 -168.68 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 168' ' ' MET . . . . . . . . . . . . . 21.4 ptp -66.98 -32.27 73.39 Favored 'General case' 0 CA--C 1.522 -0.098 0 O-C-N 121.66 -0.65 . . . . 0.0 111.295 174.083 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -76.14 -37.39 58.04 Favored 'General case' 0 N--CA 1.443 -0.793 0 N-CA-C 112.451 0.537 . . . . 0.0 112.451 -178.47 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 . . . . . 0 CA--C 1.533 0.326 0 N-CA-C 108.89 -0.782 . . . . 0.0 108.89 174.985 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.498 1.947 0 N-CA-C 111.191 0.071 . . . . 0.0 111.191 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 19.7 p-10 -102.3 163.33 12.3 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 124.503 1.121 . . . . 0.0 111.467 -175.771 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 16.3 mtt -129.3 127.03 40.31 Favored 'General case' 0 N--CA 1.464 0.237 0 C-N-CA 122.89 0.476 . . . . 0.0 110.712 179.1 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -94.29 121.06 6.57 Favored Glycine 0 C--O 1.225 -0.437 0 N-CA-C 107.573 -2.211 . . . . 0.0 107.573 168.904 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 4.1 tt -104.43 111.54 24.23 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 105.468 -2.049 . . . . 0.0 105.468 179.226 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -108.32 143.99 36.45 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-O 121.757 0.789 . . . . 0.0 110.434 175.637 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 20.6 p90 . . . . . 0 N--CA 1.447 -0.62 0 N-CA-C 106.454 -1.684 . . . . 0.0 106.454 176.963 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.274 0 N-CA-C 110.125 -0.324 . . . . 0.0 110.125 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -62.99 -46.44 87.69 Favored 'General case' 0 N--CA 1.455 -0.195 0 C-N-CA 123.273 0.629 . . . . 0.0 111.204 -177.11 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 50.3 mm-40 -55.01 -52.41 63.23 Favored 'General case' 0 C--O 1.23 0.043 0 C-N-CA 123.169 0.588 . . . . 0.0 109.706 173.008 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 57.8 mttm -64.21 -42.16 96.73 Favored 'General case' 0 C--O 1.222 -0.344 0 CA-C-O 118.889 -0.577 . . . . 0.0 110.704 -171.433 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 48.3 mt -55.81 -56.61 11.55 Favored 'Isoleucine or valine' 0 C--O 1.233 0.211 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 178.4 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 19.1 ptt180 -63.4 -38.01 89.48 Favored 'General case' 0 C--O 1.221 -0.416 0 CA-C-O 118.884 -0.579 . . . . 0.0 110.251 -177.12 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -66.02 -38.45 88.44 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.208 0.528 . . . . 0.0 109.956 -173.41 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 77.9 mt -80.6 -53.67 12.12 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.516 0 C-N-CA 125.195 1.398 . . . . 0.0 110.165 -173.186 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 76.4 mt -62.67 -47.82 91.11 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 N-CA-C 109.511 -0.551 . . . . 0.0 109.511 178.579 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 140.91 120.45 1.68 Allowed Glycine 0 CA--C 1.529 0.937 0 C-N-CA 125.273 1.416 . . . . 0.0 110.755 177.051 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 82.1 Cg_endo -73.78 -4.09 14.84 Favored 'Trans proline' 0 CA--C 1.541 0.832 0 C-N-CA 123.078 2.519 . . . . 0.0 113.228 -173.12 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -82.36 -21.63 35.85 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 118.841 0.746 . . . . 0.0 111.54 176.593 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -120.97 -12.91 8.68 Favored 'General case' 0 C--N 1.344 0.33 0 C-N-CA 124.927 1.291 . . . . 0.0 113.436 -175.774 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 60.0 t -100.07 145.36 10.92 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 N-CA-C 107.29 -1.374 . . . . 0.0 107.29 169.136 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 6.0 m -134.48 139.29 45.37 Favored 'General case' 0 N--CA 1.463 0.209 0 C-N-CA 125.105 1.362 . . . . 0.0 107.493 -178.2 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 34.7 mt -93.42 145.05 24.77 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 118.888 0.767 . . . . 0.0 110.033 -179.826 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 12.4 m-70 -112.19 130.74 55.81 Favored 'General case' 0 C--O 1.234 0.286 0 N-CA-C 106.454 -1.684 . . . . 0.0 106.454 168.051 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 35.5 t-20 -105.8 100.14 9.71 Favored 'General case' 0 CA--C 1.521 -0.168 0 N-CA-C 106.117 -1.808 . . . . 0.0 106.117 169.014 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 83.5 mt -70.07 -8.8 52.37 Favored 'General case' 0 N--CA 1.466 0.368 0 N-CA-C 113.414 0.894 . . . . 0.0 113.414 -169.935 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 24.5 tptt -62.41 -23.57 66.91 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 118.662 0.664 . . . . 0.0 110.684 168.261 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -129.81 -39.85 1.4 Allowed 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 124.584 1.153 . . . . 0.0 113.171 -173.87 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 41.4 m-20 -75.89 130.94 39.28 Favored 'General case' 0 C--O 1.235 0.302 0 C-N-CA 123.829 0.852 . . . . 0.0 108.727 178.708 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 15.6 m -74.31 149.22 86.69 Favored Pre-proline 0 CA--C 1.54 0.581 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 173.652 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -71.91 -22.12 23.71 Favored 'Trans proline' 0 CA--C 1.532 0.382 0 C-N-CA 121.802 1.668 . . . . 0.0 112.818 -172.961 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 11.9 mptt -56.21 -23.77 37.71 Favored 'General case' 0 N--CA 1.47 0.541 0 O-C-N 120.963 -1.085 . . . . 0.0 112.342 175.074 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -58.45 -34.15 70.53 Favored 'General case' 0 N--CA 1.465 0.314 0 C-N-CA 124.351 1.06 . . . . 0.0 110.69 175.811 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 61.3 mtt -60.02 -26.13 65.84 Favored 'General case' 0 N--CA 1.465 0.297 0 C-N-CA 124.622 1.169 . . . . 0.0 111.967 178.962 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 68.3 mt-10 -61.79 -33.46 74.15 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 118.729 0.695 . . . . 0.0 109.505 -178.466 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 30.8 mt-30 -69.11 -28.33 66.39 Favored 'General case' 0 CA--C 1.536 0.422 0 N-CA-C 113.749 1.018 . . . . 0.0 113.749 -172.189 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 76.5 m-85 -85.08 138.05 32.66 Favored 'General case' 0 N--CA 1.464 0.243 0 C-N-CA 122.991 0.516 . . . . 0.0 110.14 -167.762 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -71.14 -43.13 68.2 Favored 'General case' 0 C--O 1.233 0.237 0 CA-C-N 118.01 0.368 . . . . 0.0 110.45 -178.502 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 11.8 t -105.16 144.95 14.07 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.404 0 N-CA-C 107.101 -1.444 . . . . 0.0 107.101 169.668 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 19.1 tp -122.78 146.34 47.61 Favored 'General case' 0 N--CA 1.447 -0.618 0 N-CA-C 107.398 -1.334 . . . . 0.0 107.398 169.213 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 41.2 mt -128.05 130.0 69.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 N-CA-C 105.5 -2.037 . . . . 0.0 105.5 178.979 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 2.1 mp -114.35 131.06 56.68 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 125.729 1.612 . . . . 0.0 107.839 -172.17 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -139.19 134.61 6.82 Favored Glycine 0 C--N 1.332 0.341 0 CA-C-O 118.855 -0.969 . . . . 0.0 111.544 177.902 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 5.5 tt -155.93 137.55 9.67 Favored Pre-proline 0 CA--C 1.533 0.3 0 CA-C-N 118.252 1.026 . . . . 0.0 111.246 177.954 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_endo . . . . . 0 N--CA 1.453 -0.904 0 C-N-CA 122.383 2.055 . . . . 0.0 107.187 164.881 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 11.7 mt . . . . . 0 CA--C 1.541 0.626 0 CA-C-O 121.611 0.719 . . . . 0.0 110.674 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 3.8 mp0 -69.64 155.93 39.74 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 124.829 1.252 . . . . 0.0 109.747 -174.455 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -51.3 -46.12 62.41 Favored 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 124.664 1.186 . . . . 0.0 111.155 -173.019 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 -60.19 -27.77 67.41 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 123.624 0.769 . . . . 0.0 110.734 -170.568 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -96.04 -46.92 6.3 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 126.192 1.797 . . . . 0.0 109.054 -178.579 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 14.6 tt0 -62.81 -34.05 76.48 Favored 'General case' 0 N--CA 1.445 -0.723 0 C-N-CA 125.165 1.386 . . . . 0.0 110.437 -175.187 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -57.37 -23.9 52.0 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 124.606 1.162 . . . . 0.0 111.999 -179.065 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 17.7 m -121.4 -11.12 9.09 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.225 0 C-N-CA 124.882 1.273 . . . . 0.0 112.348 179.879 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 48.5 t90 -55.39 -36.57 66.54 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 124.362 1.065 . . . . 0.0 110.674 -178.437 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -63.52 -27.9 69.58 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 125.403 1.481 . . . . 0.0 112.949 176.183 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 41.9 mt-30 -91.73 -20.97 20.99 Favored 'General case' 0 CA--C 1.519 -0.239 0 C-N-CA 125.186 1.394 . . . . 0.0 112.506 179.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 76.1 mt -59.45 -27.47 66.11 Favored 'General case' 0 N--CA 1.467 0.391 0 O-C-N 121.538 -0.726 . . . . 0.0 111.294 178.589 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -76.94 -25.75 53.23 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 122.529 0.331 . . . . 0.0 111.316 173.974 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -77.47 -27.14 51.93 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 124.645 1.178 . . . . 0.0 112.335 -179.467 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 36.3 mt -61.8 147.46 46.34 Favored 'General case' 0 C--N 1.34 0.173 0 C-N-CA 124.296 1.039 . . . . 0.0 111.434 -178.079 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 24.4 t-20 -88.15 122.23 31.48 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 108.111 -1.07 . . . . 0.0 108.111 168.437 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 80.6 mt -130.92 9.33 4.9 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 123.577 0.751 . . . . 0.0 112.518 -170.054 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 26.8 mt-10 -52.42 127.92 23.97 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 124.055 0.942 . . . . 0.0 112.382 -168.064 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 69.35 -0.73 15.8 Favored Glycine 0 CA--C 1.534 1.22 0 C-N-CA 125.473 1.511 . . . . 0.0 115.721 176.659 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.82 149.33 39.68 Favored 'General case' 0 C--N 1.345 0.401 0 CA-C-N 120.551 2.176 . . . . 0.0 109.871 -173.29 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 4.5 mt -80.17 137.14 22.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 N-CA-C 106.923 -1.51 . . . . 0.0 106.923 177.769 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 55.6 t -131.47 124.17 54.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 C-N-CA 124.522 1.129 . . . . 0.0 109.734 -176.882 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -94.34 149.93 20.77 Favored 'General case' 0 CA--C 1.52 -0.186 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 167.147 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 8.4 mt -129.16 129.92 45.72 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 107.521 -1.288 . . . . 0.0 107.521 176.736 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 39.9 p90 -142.94 165.82 26.31 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 107.566 -1.272 . . . . 0.0 107.566 167.712 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -166.68 168.81 40.37 Favored Glycine 0 N--CA 1.442 -0.944 0 N-CA-C 110.147 -1.181 . . . . 0.0 110.147 173.517 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 1.1 mp . . . . . 0 N--CA 1.45 -0.467 0 C-N-CA 124.952 1.301 . . . . 0.0 108.925 177.249 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 94.6 mt . . . . . 0 N--CA 1.469 0.486 0 N-CA-C 113.358 0.874 . . . . 0.0 113.358 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -63.9 -34.77 78.71 Favored 'General case' 0 C--N 1.333 -0.134 0 O-C-N 120.746 -1.221 . . . . 0.0 110.741 -170.937 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -73.89 -26.34 60.49 Favored 'General case' 0 N--CA 1.453 -0.302 0 O-C-N 121.485 -0.76 . . . . 0.0 112.619 176.36 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 5.2 tt -62.22 -44.86 95.61 Favored 'General case' 0 N--CA 1.466 0.36 0 N-CA-C 107.124 -1.435 . . . . 0.0 107.124 169.126 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -64.78 -40.63 97.51 Favored Glycine 0 C--N 1.34 0.803 0 N-CA-C 111.136 -0.786 . . . . 0.0 111.136 -179.02 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 75.0 mtm -62.7 -41.13 98.98 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 118.072 0.936 . . . . 0.0 111.318 177.344 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -68.09 -40.21 82.68 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 120.164 1.347 . . . . 0.0 110.485 178.594 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 82.3 t60 -55.98 -51.92 66.01 Favored 'General case' 0 CA--C 1.528 0.112 0 N-CA-C 110.062 -0.348 . . . . 0.0 110.062 175.035 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -64.32 -39.94 94.92 Favored 'General case' 0 C--O 1.235 0.339 0 C-N-CA 123.967 0.907 . . . . 0.0 112.584 -176.102 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 22.3 ttmm -54.85 -39.05 68.22 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 123.794 0.838 . . . . 0.0 109.775 171.567 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 21.8 mt -90.6 -18.78 24.58 Favored 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 114.603 1.334 . . . . 0.0 114.603 -169.379 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 2.5 m -58.86 -33.46 70.49 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 120.561 1.528 . . . . 0.0 111.688 -175.75 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 19.5 p -86.56 -11.94 50.12 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 124.754 1.221 . . . . 0.0 111.999 -179.318 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 32.1 mmmt -82.12 -10.14 59.29 Favored 'General case' 0 C--N 1.344 0.342 0 C-N-CA 124.314 1.046 . . . . 0.0 111.414 176.37 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 73.65 32.99 58.74 Favored Glycine 0 CA--C 1.526 0.723 0 CA-C-O 119.524 -0.598 . . . . 0.0 112.102 173.153 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 17.2 m -75.19 177.54 0.57 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.613 0 CA-C-N 118.193 0.997 . . . . 0.0 109.853 171.224 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -118.91 120.25 36.74 Favored 'General case' 0 CA--C 1.518 -0.274 0 N-CA-C 106.939 -1.504 . . . . 0.0 106.939 174.373 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 76.9 m-85 -87.83 144.67 26.47 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 119.696 1.135 . . . . 0.0 110.231 -175.323 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 35.9 m -134.34 159.68 41.92 Favored 'Isoleucine or valine' 0 C--O 1.234 0.254 0 C-N-CA 125.343 1.457 . . . . 0.0 107.936 169.865 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 85.54 30.62 23.91 Favored Glycine 0 CA--C 1.522 0.513 0 CA-C-O 118.75 -1.028 . . . . 0.0 114.262 170.872 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 13.0 m-30 -62.06 157.01 19.9 Favored 'General case' 0 CA--C 1.545 0.757 0 CA-C-N 119.036 1.418 . . . . 0.0 109.691 169.09 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 2.5 t90 -135.98 144.26 47.65 Favored Pre-proline 0 N--CA 1.474 0.772 0 CA-C-O 117.712 -1.137 . . . . 0.0 111.849 -168.915 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_exo -66.96 123.0 10.41 Favored 'Trans proline' 0 C--N 1.352 0.761 0 C-N-CA 123.552 2.835 . . . . 0.0 113.144 -176.647 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 3.3 p . . . . . 0 N--CA 1.468 0.43 0 N-CA-C 113.847 1.055 . . . . 0.0 113.847 179.341 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 24.8 ttmt . . . . . 0 N--CA 1.475 0.803 0 N-CA-C 114.845 1.424 . . . . 0.0 114.845 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_endo -78.92 -1.04 11.26 Favored 'Trans proline' 0 CA--C 1.539 0.761 0 CA-C-N 122.25 1.839 . . . . 0.0 113.999 179.992 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 18.5 m -127.37 170.58 17.02 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.22 0 CA-C-N 119.875 1.216 . . . . 0.0 110.96 -171.307 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 4.9 pt -128.8 169.29 20.42 Favored 'Isoleucine or valine' 0 C--O 1.241 0.64 0 C-N-CA 127.664 2.386 . . . . 0.0 107.86 175.579 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . 56.41 -156.37 0.28 Allowed 'General case' 0 N--CA 1.446 -0.652 0 C-N-CA 124.622 1.169 . . . . 0.0 108.37 -175.924 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 24.8 t0 -78.51 52.47 1.17 Allowed 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 124.481 1.113 . . . . 0.0 110.833 174.894 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 67.19 26.67 73.4 Favored Glycine 0 CA--C 1.531 1.069 0 C-N-CA 124.657 1.123 . . . . 0.0 112.677 -175.495 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 36.8 mt-30 -88.56 -11.41 45.71 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 118.579 1.19 . . . . 0.0 112.533 -170.128 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 8.5 tp -155.71 143.28 19.54 Favored 'General case' 0 C--N 1.343 0.319 0 CA-C-N 119.255 0.934 . . . . 0.0 110.578 175.671 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 67.9 m-85 -78.4 144.92 35.48 Favored 'General case' 0 CA--C 1.516 -0.365 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 169.771 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 17.0 m -76.56 4.63 1.11 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.732 0 C-N-CA 122.773 0.429 . . . . 0.0 111.959 176.615 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -172.86 172.92 45.38 Favored Glycine 0 CA--C 1.527 0.8 0 O-C-N 120.753 -1.217 . . . . 0.0 110.6 -179.173 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 3.6 tp -62.6 131.78 50.19 Favored 'General case' 0 N--CA 1.464 0.246 0 C-N-CA 124.143 0.977 . . . . 0.0 110.942 179.638 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -91.18 129.08 37.21 Favored 'General case' 0 N--CA 1.444 -0.742 0 C-N-CA 126.288 1.835 . . . . 0.0 109.572 176.811 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 32.4 mt . . . . . 0 C--O 1.231 0.116 0 N-CA-C 105.926 -1.879 . . . . 0.0 105.926 172.152 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 14.9 m . . . . . 0 CA--C 1.537 0.477 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -56.27 -44.22 79.56 Favored 'General case' 0 N--CA 1.464 0.27 0 C-N-CA 124.438 1.095 . . . . 0.0 110.904 169.818 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -65.25 -44.56 87.74 Favored 'General case' 0 C--O 1.234 0.252 0 C-N-CA 124.605 1.162 . . . . 0.0 110.882 -178.718 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 5.9 mmt180 -58.32 -41.36 84.37 Favored 'General case' 0 N--CA 1.462 0.153 0 CA-C-O 118.765 -0.636 . . . . 0.0 109.887 177.944 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 42.0 mt -67.98 -53.97 26.04 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.236 0 N-CA-C 108.228 -1.027 . . . . 0.0 108.228 176.811 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -49.77 -66.25 0.42 Allowed 'General case' 0 CA--C 1.518 -0.267 0 C-N-CA 125.547 1.539 . . . . 0.0 112.067 -172.178 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 14.6 m -60.95 -34.1 74.22 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 115.554 -0.748 . . . . 0.0 111.713 -174.888 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 160' ' ' TRP . . . . . . . . . . . . . 79.2 t90 -65.55 -43.9 88.48 Favored 'General case' 0 C--O 1.222 -0.373 0 O-C-N 121.775 -0.578 . . . . 0.0 111.005 174.411 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 92.5 m -61.01 -41.36 96.38 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 123.159 0.584 . . . . 0.0 110.652 179.721 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -63.09 -41.1 99.33 Favored 'General case' 0 N--CA 1.462 0.15 0 CA-C-O 121.104 0.478 . . . . 0.0 110.791 173.534 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 16.1 tt0 -65.05 -51.22 62.75 Favored 'General case' 0 N--CA 1.446 -0.654 0 O-C-N 121.566 -0.708 . . . . 0.0 110.122 -177.614 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 41.6 pt -63.38 -36.82 77.65 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.403 0 CA-C-O 117.818 -1.087 . . . . 0.0 109.734 -175.863 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -64.35 -36.25 83.52 Favored 'General case' 0 C--O 1.225 -0.187 0 CA-C-N 119.561 1.073 . . . . 0.0 109.611 -179.704 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 41.3 m-80 -68.59 -51.34 43.63 Favored 'General case' 0 N--CA 1.467 0.387 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 175.422 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 22.8 tt0 -72.85 -16.04 61.6 Favored 'General case' 0 N--CA 1.443 -0.802 0 C-N-CA 125.847 1.659 . . . . 0.0 111.937 -169.448 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 168' ' ' MET . . . . . . . . . . . . . 19.5 ptp -90.94 -38.93 12.55 Favored 'General case' 0 N--CA 1.456 -0.162 0 C-N-CA 123.799 0.84 . . . . 0.0 111.544 168.722 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -75.76 -27.04 57.9 Favored 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 122.703 0.401 . . . . 0.0 112.037 -172.927 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 . . . . . 0 CA--C 1.543 0.677 0 C-N-CA 123.672 0.789 . . . . 0.0 112.252 -179.23 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.497 1.905 0 N-CA-C 111.146 0.054 . . . . 0.0 111.146 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 22.3 p-10 -130.88 164.17 25.83 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 124.649 1.179 . . . . 0.0 111.487 -173.725 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 16.0 mtt -130.72 124.3 31.21 Favored 'General case' 0 CA--C 1.523 -0.087 0 C-N-CA 123.201 0.6 . . . . 0.0 111.258 179.798 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -87.33 152.18 24.13 Favored Glycine 0 CA--C 1.525 0.682 0 N-CA-C 106.838 -2.505 . . . . 0.0 106.838 166.895 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 2.7 tt -140.11 97.01 3.15 Favored 'General case' 0 N--CA 1.469 0.477 0 N-CA-C 105.783 -1.932 . . . . 0.0 105.783 -172.629 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -105.08 144.0 32.48 Favored 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 123.172 0.589 . . . . 0.0 111.063 -171.664 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 43.1 p90 -156.89 163.41 39.2 Favored 'General case' 0 C--O 1.234 0.28 0 C-N-CA 124.16 0.984 . . . . 0.0 109.941 -179.881 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -80.47 123.95 6.27 Favored Glycine 0 C--N 1.336 0.567 0 N-CA-C 109.204 -1.558 . . . . 0.0 109.204 179.633 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 5.0 m -67.21 -29.13 68.7 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 123.832 0.853 . . . . 0.0 113.023 -169.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -79.04 -18.85 52.78 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 123.314 0.645 . . . . 0.0 111.947 -174.795 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -79.94 142.24 35.28 Favored 'General case' 0 C--O 1.236 0.362 0 C-N-CA 123.353 0.661 . . . . 0.0 110.829 -172.803 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 28.1 m -71.36 161.85 30.39 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 123.767 0.827 . . . . 0.0 110.264 174.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 10.3 t80 65.0 -33.96 0.16 Allowed 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 127.99 2.516 . . . . 0.0 116.124 175.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -61.05 -27.43 68.33 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 120.434 1.47 . . . . 0.0 111.799 -174.551 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -61.89 -47.28 85.67 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 118.794 0.724 . . . . 0.0 110.103 176.052 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 17.8 ptp -75.66 -32.55 60.21 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 119.269 0.94 . . . . 0.0 111.069 -178.369 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -56.23 -47.49 78.37 Favored 'General case' 0 CA--C 1.536 0.408 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 169.644 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -64.0 -48.47 76.26 Favored 'General case' 0 N--CA 1.455 -0.223 0 C-N-CA 123.785 0.834 . . . . 0.0 111.511 -177.909 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -52.76 -47.59 67.37 Favored 'General case' 0 C--O 1.235 0.334 0 C-N-CA 124.146 0.978 . . . . 0.0 109.72 175.492 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 28.7 mtpp -75.82 -42.13 50.65 Favored 'General case' 0 C--O 1.221 -0.428 0 CA-C-O 117.982 -1.008 . . . . 0.0 110.521 -170.446 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 39.0 mt -52.37 -53.34 19.87 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.352 0 CA-C-N 120.258 1.39 . . . . 0.0 108.614 173.494 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.15 -39.23 91.93 Favored 'General case' 0 C--O 1.222 -0.358 0 C-N-CA 123.367 0.667 . . . . 0.0 109.798 -176.821 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -66.46 -42.3 87.77 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 118.599 0.636 . . . . 0.0 110.943 179.678 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 54.7 mt -74.0 -53.78 16.64 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.605 0 C-N-CA 124.995 1.318 . . . . 0.0 109.767 -169.789 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 75.3 mt -65.45 -46.1 90.98 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.446 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 178.76 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 140.21 125.85 2.23 Favored Glycine 0 CA--C 1.533 1.176 0 C-N-CA 124.676 1.132 . . . . 0.0 111.952 172.832 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -71.6 -6.88 20.07 Favored 'Trans proline' 0 CA--C 1.539 0.749 0 C-N-CA 123.701 2.934 . . . . 0.0 113.684 -174.025 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -81.55 -19.24 42.47 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-N 119.123 0.874 . . . . 0.0 111.245 176.812 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -127.25 -5.83 6.01 Favored 'General case' 0 C--N 1.345 0.372 0 C-N-CA 124.653 1.181 . . . . 0.0 113.792 -174.53 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 26.9 t -113.32 147.21 17.07 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.266 0 N-CA-C 108.007 -1.109 . . . . 0.0 108.007 170.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 36.4 m -135.03 132.15 37.93 Favored 'General case' 0 C--O 1.234 0.267 0 C-N-CA 125.896 1.678 . . . . 0.0 106.667 -174.819 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 14.7 mt -76.01 138.09 40.68 Favored 'General case' 0 C--O 1.231 0.101 0 N-CA-C 107.885 -1.154 . . . . 0.0 107.885 174.696 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 35.0 t-80 -126.85 56.48 1.5 Allowed 'General case' 0 CA--C 1.531 0.217 0 N-CA-C 107.422 -1.325 . . . . 0.0 107.422 177.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 48.5 t30 -61.21 128.92 38.75 Favored 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 107.099 -1.445 . . . . 0.0 107.099 176.123 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 40.2 mt -70.33 -29.98 66.82 Favored 'General case' 0 N--CA 1.469 0.496 0 N-CA-C 114.138 1.162 . . . . 0.0 114.138 -167.65 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 21.5 mmmt -62.72 -26.16 68.54 Favored 'General case' 0 N--CA 1.466 0.344 0 O-C-N 121.703 -0.623 . . . . 0.0 111.698 168.369 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -92.62 -34.62 13.93 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-N 118.568 0.622 . . . . 0.0 112.405 -172.566 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 2.2 t0 -146.4 150.73 36.22 Favored 'General case' 0 N--CA 1.466 0.363 0 N-CA-C 113.025 0.75 . . . . 0.0 113.025 177.008 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 15.2 m -72.14 158.11 88.17 Favored Pre-proline 0 CA--C 1.541 0.6 0 C-N-CA 126.083 1.753 . . . . 0.0 111.499 -169.555 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -71.8 -27.5 17.89 Favored 'Trans proline' 0 C--N 1.35 0.628 0 C-N-CA 122.388 2.059 . . . . 0.0 113.385 -170.466 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 14.8 mmmt -68.36 -16.12 63.81 Favored 'General case' 0 N--CA 1.472 0.644 0 O-C-N 120.897 -1.127 . . . . 0.0 111.286 -175.822 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -62.95 -27.97 69.75 Favored 'General case' 0 N--CA 1.465 0.277 0 C-N-CA 125.741 1.616 . . . . 0.0 110.422 171.821 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 47.5 mtt -56.37 -25.39 49.39 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 119.134 0.879 . . . . 0.0 111.422 178.335 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -66.57 -30.21 70.45 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 118.445 0.566 . . . . 0.0 110.895 -176.585 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 23.1 mt-30 -68.88 -41.5 78.23 Favored 'General case' 0 N--CA 1.465 0.277 0 N-CA-C 113.082 0.771 . . . . 0.0 113.082 -170.071 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 43.3 m-85 -72.75 137.47 45.89 Favored 'General case' 0 N--CA 1.461 0.104 0 C-N-CA 123.534 0.734 . . . . 0.0 109.721 -167.197 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -68.27 -36.54 79.56 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 118.539 0.609 . . . . 0.0 110.181 178.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 5.9 t -110.39 144.14 19.03 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.295 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 170.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 59.4 tp -131.02 108.55 9.87 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 173.484 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 22.8 mt -85.49 131.27 34.7 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 N-CA-C 106.246 -1.761 . . . . 0.0 106.246 175.067 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -107.29 133.36 51.96 Favored 'General case' 0 N--CA 1.456 -0.134 0 C-N-CA 125.574 1.55 . . . . 0.0 107.918 172.058 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -127.65 126.7 5.59 Favored Glycine 0 C--N 1.331 0.299 0 N-CA-C 109.457 -1.457 . . . . 0.0 109.457 170.47 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 7.0 tt -148.92 123.23 4.77 Favored Pre-proline 0 N--CA 1.471 0.584 0 CA-C-N 119.305 1.552 . . . . 0.0 111.582 170.846 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_exo -65.79 142.54 70.16 Favored 'Trans proline' 0 N--CA 1.459 -0.525 0 C-N-CA 122.444 2.096 . . . . 0.0 110.664 166.604 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 85.3 m -98.8 131.01 45.25 Favored 'General case' 0 CA--C 1.54 0.562 0 N-CA-C 107.389 -1.337 . . . . 0.0 107.389 169.268 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' TRP . . . . . . . . . . . . 0.281 1.3 t-105 51.26 53.49 12.82 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 125.715 1.606 . . . . 0.0 113.306 177.314 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -80.33 -75.04 0.28 Allowed 'General case' 0 CA--C 1.533 0.298 0 N-CA-C 107.403 -1.332 . . . . 0.0 107.403 168.27 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 88.9 t80 -81.0 -37.68 28.78 Favored 'General case' 0 CA--C 1.539 0.552 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 168.25 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 179.7 -174.13 45.79 Favored Glycine 0 CA--C 1.526 0.74 0 C-N-CA 127.186 2.327 . . . . 0.0 107.489 178.366 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -62.93 132.5 52.3 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 118.867 1.333 . . . . 0.0 108.324 169.795 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 78.8 mt 34.05 95.66 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.545 0.77 0 C-N-CA 128.769 2.828 . . . . 0.0 112.772 174.015 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.68 163.26 4.46 Favored 'General case' 0 CA--C 1.542 0.655 0 CA-C-O 122.257 1.027 . . . . 0.0 112.376 171.761 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -59.79 -42.27 93.02 Favored 'General case' 0 N--CA 1.455 -0.206 0 C-N-CA 124.377 1.071 . . . . 0.0 112.599 -168.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 55.4 m-20 -66.3 -23.1 66.32 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-N 119.615 1.098 . . . . 0.0 111.723 -169.62 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 12.7 t90 -91.32 -44.83 8.94 Favored 'General case' 0 N--CA 1.456 -0.166 0 C-N-CA 124.379 1.071 . . . . 0.0 110.133 175.419 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -61.7 -35.31 77.66 Favored 'General case' 0 CA--C 1.535 0.396 0 O-C-N 121.266 -0.896 . . . . 0.0 109.945 -178.383 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -58.38 -24.73 60.79 Favored 'General case' 0 C--O 1.233 0.199 0 C-N-CA 124.465 1.106 . . . . 0.0 111.738 -177.725 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 35.7 m -115.13 -13.87 11.07 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.245 0 CA-C-O 117.327 -1.321 . . . . 0.0 112.354 178.0 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 25.1 t90 -52.64 -38.94 61.24 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 120.291 1.405 . . . . 0.0 110.576 -179.02 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -63.17 -26.93 69.03 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 125.098 1.359 . . . . 0.0 113.216 176.543 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 26.0 mt-30 -92.4 -20.09 21.4 Favored 'General case' 0 C--N 1.342 0.243 0 C-N-CA 125.735 1.614 . . . . 0.0 112.31 178.114 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 47.9 mt -64.12 -23.17 67.22 Favored 'General case' 0 N--CA 1.465 0.305 0 O-C-N 121.212 -0.93 . . . . 0.0 111.337 -175.756 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -79.99 -22.25 42.72 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-N 118.372 0.533 . . . . 0.0 111.877 174.684 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -70.72 -27.47 63.99 Favored 'General case' 0 N--CA 1.471 0.618 0 O-C-N 120.979 -1.076 . . . . 0.0 111.521 176.608 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 27.3 mt -62.06 149.67 40.43 Favored 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 124.855 1.262 . . . . 0.0 109.592 -179.636 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 28.1 t-20 -72.0 -59.86 2.53 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-O 122.634 1.206 . . . . 0.0 112.424 -174.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 16.7 mt 58.44 2.25 0.21 Allowed 'General case' 0 C--N 1.32 -0.686 0 C-N-CA 129.5 3.12 . . . . 0.0 116.739 175.679 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 30.9 mt-10 -58.59 130.12 45.33 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 120.188 1.358 . . . . 0.0 111.864 -169.186 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 71.18 0.1 34.35 Favored Glycine 0 CA--C 1.533 1.159 0 CA-C-O 117.964 -1.464 . . . . 0.0 114.908 176.24 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.11 155.29 37.25 Favored 'General case' 0 C--N 1.343 0.323 0 CA-C-N 120.681 2.241 . . . . 0.0 110.225 -174.414 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 1.9 mt -84.71 140.91 15.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 N-CA-C 106.875 -1.528 . . . . 0.0 106.875 178.194 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 54.9 t -135.4 138.98 47.58 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.706 0 C-N-CA 124.012 0.925 . . . . 0.0 109.024 -179.161 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -111.19 142.68 43.06 Favored 'General case' 0 CA--C 1.517 -0.301 0 N-CA-C 104.365 -2.458 . . . . 0.0 104.365 166.763 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 30.8 mt -122.19 144.88 48.69 Favored 'General case' 0 CA--C 1.51 -0.594 0 CA-C-N 120.262 1.392 . . . . 0.0 107.373 169.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 41.6 p90 -150.4 162.75 39.94 Favored 'General case' 0 N--CA 1.44 -0.934 0 N-CA-C 107.744 -1.206 . . . . 0.0 107.744 168.286 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -157.58 171.58 34.78 Favored Glycine 0 N--CA 1.443 -0.897 0 N-CA-C 109.691 -1.364 . . . . 0.0 109.691 171.459 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 6.8 tt -117.08 150.31 38.87 Favored 'General case' 0 N--CA 1.446 -0.632 0 C-N-CA 125.04 1.336 . . . . 0.0 108.334 175.677 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -160.23 -158.51 9.27 Favored Glycine 0 CA--C 1.528 0.866 0 N-CA-C 107.799 -2.12 . . . . 0.0 107.799 169.636 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -152.11 120.57 6.41 Favored 'General case' 0 N--CA 1.465 0.289 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 168.713 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 14.7 pm0 -78.55 -10.75 59.84 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 123.945 0.898 . . . . 0.0 112.81 -176.011 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 26.5 mt -76.98 -56.73 4.33 Favored 'General case' 0 C--N 1.343 0.289 0 CA-C-N 119.139 0.881 . . . . 0.0 109.748 176.164 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -88.01 -32.58 12.29 Favored Glycine 0 CA--C 1.523 0.554 0 CA-C-O 118.606 -1.108 . . . . 0.0 113.603 -170.023 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -90.35 -97.48 0.11 Allowed 'General case' 0 C--O 1.236 0.367 0 N-CA-C 106.935 -1.505 . . . . 0.0 106.935 172.268 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 84.39 133.42 2.57 Favored Glycine 0 CA--C 1.527 0.808 0 N-CA-C 107.652 -2.179 . . . . 0.0 107.652 -173.502 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 69.36 -45.37 0.56 Allowed 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 128.075 2.55 . . . . 0.0 112.251 -175.23 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' TRP . . . . . . . . . . . . . 3.4 m-90 -77.2 23.44 0.19 Allowed 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 124.545 1.138 . . . . 0.0 112.258 175.38 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 21.6 t80 -76.77 135.64 38.98 Favored 'General case' 0 N--CA 1.457 -0.105 0 O-C-N 121.297 -0.877 . . . . 0.0 108.886 -175.105 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 97.5 mt 52.27 26.69 4.17 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 124.527 1.131 . . . . 0.0 113.807 169.475 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -67.28 -32.22 73.06 Favored 'General case' 0 C--N 1.329 -0.302 0 O-C-N 120.539 -1.35 . . . . 0.0 110.577 -171.685 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -70.68 -30.25 66.79 Favored 'General case' 0 CA--C 1.535 0.396 0 O-C-N 121.503 -0.748 . . . . 0.0 111.834 173.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 6.3 tt -61.77 -46.52 89.23 Favored 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 107.845 -1.169 . . . . 0.0 107.845 169.349 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -62.04 -38.07 95.48 Favored Glycine 0 CA--C 1.524 0.603 0 N-CA-C 111.086 -0.806 . . . . 0.0 111.086 -177.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 74.3 mtm -68.5 -39.26 81.34 Favored 'General case' 0 N--CA 1.454 -0.243 0 CA-C-O 118.246 -0.883 . . . . 0.0 111.489 177.705 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -71.98 -32.08 66.88 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-N 120.52 1.509 . . . . 0.0 110.649 177.209 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -56.5 -56.58 19.46 Favored 'General case' 0 N--CA 1.462 0.146 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 167.891 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -63.39 -38.53 91.52 Favored 'General case' 0 C--O 1.235 0.338 0 C-N-CA 123.49 0.716 . . . . 0.0 112.025 -170.852 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 23.5 ttmm -58.34 -44.42 88.72 Favored 'General case' 0 CA--C 1.529 0.161 0 C-N-CA 122.804 0.442 . . . . 0.0 109.834 171.619 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 49.0 mt -83.49 -20.05 34.67 Favored 'General case' 0 CA--C 1.519 -0.238 0 N-CA-C 114.445 1.276 . . . . 0.0 114.445 -169.512 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 1.1 m -59.57 -36.53 76.41 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 120.567 1.53 . . . . 0.0 111.375 -172.544 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 20.0 p -84.33 -15.35 46.86 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 124.922 1.289 . . . . 0.0 111.732 -178.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 30.7 mmmt -78.34 -14.1 59.56 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 124.212 1.005 . . . . 0.0 110.844 173.869 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 79.28 33.45 35.61 Favored Glycine 0 CA--C 1.524 0.653 0 CA-C-O 119.333 -0.704 . . . . 0.0 112.335 170.22 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 12.9 m -75.91 170.04 1.58 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.458 0 CA-C-N 118.518 1.159 . . . . 0.0 110.203 173.218 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 16.5 tptm -101.62 129.29 47.71 Favored 'General case' 0 CA--C 1.515 -0.402 0 N-CA-C 105.086 -2.19 . . . . 0.0 105.086 168.219 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 65.9 m-85 -93.78 123.92 37.44 Favored 'General case' 0 C--N 1.33 -0.239 0 N-CA-C 107.654 -1.239 . . . . 0.0 107.654 171.303 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 30.2 m -106.18 160.95 5.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 C-N-CA 123.914 0.886 . . . . 0.0 109.387 168.649 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 99.18 -77.07 0.51 Allowed Glycine 0 N--CA 1.446 -0.67 0 C-N-CA 125.122 1.344 . . . . 0.0 111.839 170.651 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 20.8 m-85 55.39 -170.17 0.07 Allowed 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 124.129 0.972 . . . . 0.0 110.861 -169.639 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -154.57 143.41 14.77 Favored Pre-proline 0 N--CA 1.466 0.332 0 CA-C-O 117.628 -1.177 . . . . 0.0 108.809 168.737 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_exo -61.97 127.72 22.16 Favored 'Trans proline' 0 CA--C 1.533 0.461 0 C-N-CA 122.209 1.94 . . . . 0.0 111.144 178.403 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 10.4 p -79.1 -14.1 59.34 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 112.753 0.649 . . . . 0.0 112.753 174.199 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -63.12 129.14 39.05 Favored 'General case' 0 CA--C 1.536 0.415 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 -178.462 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 93.56 -11.52 71.21 Favored Glycine 0 CA--C 1.534 1.271 0 C-N-CA 124.848 1.213 . . . . 0.0 113.729 -176.39 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 11.6 m-85 -96.45 158.84 15.25 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 119.013 1.407 . . . . 0.0 109.508 169.171 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -132.11 129.75 40.29 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 124.601 1.161 . . . . 0.0 108.05 175.691 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 41.0 p90 -165.2 170.51 14.78 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 126.829 2.052 . . . . 0.0 107.345 -176.384 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 3.0 t -133.4 -3.38 3.03 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 123.489 0.716 . . . . 0.0 111.238 169.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 2.1 p -77.66 131.46 70.92 Favored Pre-proline 0 CA--C 1.543 0.675 0 C-N-CA 125.244 1.417 . . . . 0.0 109.699 -175.25 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -84.39 -24.85 2.31 Favored 'Trans proline' 0 CA--C 1.537 0.663 0 C-N-CA 122.355 2.037 . . . . 0.0 112.928 -177.733 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 23.6 ttmt -58.81 -43.66 98.02 Favored Pre-proline 0 CA--C 1.54 0.586 0 CA-C-O 117.457 -1.259 . . . . 0.0 113.844 -169.624 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -81.99 5.35 6.38 Favored 'Trans proline' 0 C--N 1.352 0.746 0 CA-C-N 122.187 1.817 . . . . 0.0 113.551 -176.588 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 17.1 m -135.5 170.05 19.85 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.249 0 CA-C-N 120.622 1.556 . . . . 0.0 111.36 -169.574 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 14.5 pt -141.1 175.23 6.02 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.657 0 C-N-CA 127.876 2.47 . . . . 0.0 108.254 -179.472 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . 54.8 42.59 31.04 Favored 'General case' 0 N--CA 1.464 0.266 0 C-N-CA 125.27 1.428 . . . . 0.0 112.342 173.849 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 27.1 t0 53.69 41.5 32.06 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 126.184 1.794 . . . . 0.0 111.696 -176.452 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 88.03 14.51 62.49 Favored Glycine 0 CA--C 1.526 0.758 0 CA-C-O 118.496 -1.169 . . . . 0.0 113.771 174.037 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 45.7 mt-30 -84.65 -17.31 39.0 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 119.462 1.631 . . . . 0.0 112.658 -179.892 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -143.91 144.74 31.86 Favored 'General case' 0 C--N 1.342 0.252 0 CA-C-N 119.266 0.939 . . . . 0.0 110.379 174.174 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 68.3 m-85 -73.71 141.43 46.38 Favored 'General case' 0 CA--C 1.512 -0.489 0 N-CA-C 105.08 -2.192 . . . . 0.0 105.08 165.173 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 8.0 p -79.05 14.46 0.35 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.672 0 CA-C-O 121.363 0.601 . . . . 0.0 111.714 -176.412 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -178.82 172.87 45.18 Favored Glycine 0 CA--C 1.525 0.712 0 N-CA-C 109.209 -1.556 . . . . 0.0 109.209 177.262 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -66.21 138.66 57.83 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 117.658 0.729 . . . . 0.0 111.122 -176.214 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -98.5 118.47 35.27 Favored 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 125.716 1.607 . . . . 0.0 109.068 175.883 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 93.5 mt -107.61 156.79 18.65 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 123.776 0.831 . . . . 0.0 109.153 169.651 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -135.54 159.76 40.61 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 125.907 1.683 . . . . 0.0 108.625 174.584 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -135.29 6.8 3.33 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 124.704 1.201 . . . . 0.0 113.105 169.558 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 80.9 m -112.78 -44.0 3.37 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 124.548 1.139 . . . . 0.0 112.062 -171.823 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 6.9 p30 -105.62 -33.81 7.95 Favored 'General case' 0 C--O 1.232 0.175 0 C-N-CA 124.235 1.014 . . . . 0.0 113.244 -169.895 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 35.5 mt-30 -141.15 33.74 1.72 Allowed 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 125.101 1.36 . . . . 0.0 110.87 -170.699 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 28.0 p90 -55.56 -29.08 58.35 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 124.27 1.028 . . . . 0.0 112.364 -178.217 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -59.58 -37.68 79.16 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 123.607 0.763 . . . . 0.0 112.005 177.89 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 3.6 pp -105.52 5.35 31.37 Favored 'General case' 0 C--N 1.34 0.17 0 C-N-CA 125.084 1.354 . . . . 0.0 112.773 -176.505 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 50.7 m -60.33 -28.88 68.49 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-N 120.593 1.542 . . . . 0.0 110.582 169.503 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -60.71 -40.74 93.39 Favored 'General case' 0 N--CA 1.464 0.231 0 C-N-CA 123.35 0.66 . . . . 0.0 111.448 170.398 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -65.02 -45.11 86.88 Favored 'General case' 0 C--O 1.234 0.288 0 C-N-CA 124.869 1.268 . . . . 0.0 110.315 177.042 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 81.8 mtt180 -58.06 -47.58 82.71 Favored 'General case' 0 N--CA 1.462 0.148 0 CA-C-O 118.649 -0.691 . . . . 0.0 110.089 176.314 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 46.4 mt -62.8 -53.23 49.5 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.281 0 N-CA-C 107.904 -1.147 . . . . 0.0 107.904 179.696 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 69.8 tp60 -53.68 -61.15 2.49 Favored 'General case' 0 C--O 1.233 0.22 0 C-N-CA 124.024 0.929 . . . . 0.0 110.867 -175.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 44.3 p -65.02 -36.84 85.66 Favored 'General case' 0 C--N 1.326 -0.418 0 O-C-N 123.062 0.227 . . . . 0.0 110.95 -170.375 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 160' ' ' TRP . . . . . . . . . . . . . 36.0 t90 -67.73 -44.17 78.21 Favored 'General case' 0 C--O 1.221 -0.395 0 O-C-N 122.248 -0.283 . . . . 0.0 110.929 177.465 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 58.7 m -59.18 -44.29 92.18 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 123.039 0.536 . . . . 0.0 110.703 178.541 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -62.49 -41.96 99.16 Favored 'General case' 0 N--CA 1.456 -0.13 0 CA-C-O 121.071 0.463 . . . . 0.0 109.888 176.38 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 12.6 tt0 -62.9 -52.92 61.19 Favored 'General case' 0 N--CA 1.448 -0.537 0 O-C-N 121.664 -0.647 . . . . 0.0 110.095 -179.02 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 45.0 pt -62.47 -37.77 79.65 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.399 0 CA-C-O 117.582 -1.199 . . . . 0.0 109.23 -174.401 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -65.53 -33.34 75.69 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 119.552 1.069 . . . . 0.0 110.488 -179.45 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 34.6 m-80 -71.88 -51.68 21.11 Favored 'General case' 0 N--CA 1.465 0.315 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 175.786 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 8.9 tt0 -72.38 -31.92 65.97 Favored 'General case' 0 N--CA 1.441 -0.92 0 C-N-CA 123.79 0.836 . . . . 0.0 110.941 -168.566 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 168' ' ' MET . . . . . . . . . . . . . 21.3 ptp -69.88 -31.8 69.8 Favored 'General case' 0 C--N 1.331 -0.196 0 O-C-N 121.068 -1.02 . . . . 0.0 111.407 171.744 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . 0.481 ' HA ' ' CD2' ' A' ' 172' ' ' TYR . . . -78.57 -44.12 24.94 Favored 'General case' 0 N--CA 1.443 -0.796 0 CA-C-O 120.375 0.131 . . . . 0.0 110.983 -175.518 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -65.06 -29.23 70.1 Favored 'General case' 0 CA--C 1.54 0.566 0 N-CA-C 110.088 -0.338 . . . . 0.0 110.088 176.893 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 65.8 t60 -65.35 -48.69 72.11 Favored 'General case' 0 C--O 1.235 0.294 0 C-N-CA 123.601 0.76 . . . . 0.0 111.04 174.129 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 172' ' ' TYR . . . . . 0.481 ' CD2' ' HA ' ' A' ' 169' ' ' ALA . 0.2 OUTLIER -77.14 -30.14 54.98 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-O 119.046 -0.502 . . . . 0.0 112.031 -172.928 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.268 0 C-N-CA 124.148 0.979 . . . . 0.0 110.73 -179.177 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.496 1.85 0 N-CA-C 111.252 0.093 . . . . 0.0 111.252 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 3.0 t30 -119.03 151.62 37.9 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 124.223 1.009 . . . . 0.0 109.784 -174.558 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 1.4 mpt? -116.88 125.89 52.18 Favored 'General case' 0 N--CA 1.463 0.22 0 C-N-CA 123.76 0.824 . . . . 0.0 110.706 179.23 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -82.83 153.2 30.92 Favored Glycine 0 CA--C 1.527 0.811 0 N-CA-C 107.51 -2.236 . . . . 0.0 107.51 166.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 3.1 tt -140.26 97.11 3.16 Favored 'General case' 0 N--CA 1.465 0.312 0 N-CA-C 104.888 -2.264 . . . . 0.0 104.888 -176.06 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -103.44 147.02 27.64 Favored 'General case' 0 N--CA 1.455 -0.181 0 CA-C-O 121.577 0.703 . . . . 0.0 111.914 -172.155 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 47.6 p90 -159.97 173.68 15.52 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 126.294 1.838 . . . . 0.0 107.994 176.425 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -123.53 153.72 17.27 Favored Glycine 0 CA--C 1.526 0.746 0 N-CA-C 108.009 -2.036 . . . . 0.0 108.009 168.683 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 29.9 p -157.38 159.81 37.79 Favored 'General case' 0 C--O 1.238 0.451 0 C-N-CA 123.903 0.881 . . . . 0.0 109.289 178.036 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 11.7 m -69.47 -44.26 71.54 Favored 'General case' 0 CA--C 1.534 0.352 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 169.77 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 1.1 p -152.59 156.46 39.34 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 126.803 2.041 . . . . 0.0 107.974 177.729 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 35.2 m 55.28 -157.26 0.23 Allowed 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 125.213 1.405 . . . . 0.0 111.983 175.031 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 1.3 p90 -66.54 153.09 43.89 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.011 0.924 . . . . 0.0 110.479 174.725 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 3.6 t -63.86 -40.07 95.68 Favored 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 171.301 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -158.87 153.85 25.07 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 105.054 -2.202 . . . . 0.0 105.054 177.524 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 9.2 mtm -62.13 -9.35 7.32 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-N 119.321 0.964 . . . . 0.0 112.239 178.132 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -50.47 -37.07 36.57 Favored 'General case' 0 C--O 1.223 -0.337 0 CA-C-N 118.972 0.806 . . . . 0.0 111.054 167.612 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -66.11 -43.49 87.05 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 119.94 1.245 . . . . 0.0 111.609 -179.751 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 67.0 mm-40 -62.68 -47.53 83.23 Favored 'General case' 0 N--CA 1.464 0.261 0 N-CA-C 109.16 -0.682 . . . . 0.0 109.16 173.023 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 29.2 mtpp -70.16 -36.85 74.98 Favored 'General case' 0 C--O 1.221 -0.397 0 CA-C-O 118.428 -0.796 . . . . 0.0 110.796 -169.351 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 32.1 mt -53.95 -55.93 11.71 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.223 0 CA-C-N 119.307 0.958 . . . . 0.0 108.687 173.472 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 18.2 ptt180 -65.25 -38.44 90.36 Favored 'General case' 0 C--N 1.344 0.343 0 C-N-CA 120.153 -0.619 . . . . 0.0 110.03 -176.687 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -64.69 -38.63 91.65 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 -174.553 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 64.0 mt -78.27 -56.13 8.3 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.63 0 C-N-CA 125.496 1.518 . . . . 0.0 110.057 -174.435 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 77.0 mt -64.66 -45.88 94.02 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 -177.755 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 141.58 120.35 1.62 Allowed Glycine 0 CA--C 1.53 0.975 0 C-N-CA 125.452 1.501 . . . . 0.0 110.595 176.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -75.53 -4.43 15.26 Favored 'Trans proline' 0 CA--C 1.538 0.705 0 C-N-CA 122.82 2.347 . . . . 0.0 113.183 -171.554 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -82.99 -20.5 35.01 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 118.945 0.793 . . . . 0.0 111.418 176.551 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 1.2 pt? -120.96 -14.19 8.49 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 125.057 1.343 . . . . 0.0 113.589 -175.689 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 62.5 t -97.46 148.02 6.01 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 N-CA-C 107.315 -1.365 . . . . 0.0 107.315 168.622 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 46.6 m -135.3 133.08 38.49 Favored 'General case' 0 C--N 1.332 -0.175 0 C-N-CA 125.659 1.584 . . . . 0.0 108.188 -178.906 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 35.7 mt -82.3 142.57 31.96 Favored 'General case' 0 C--O 1.234 0.263 0 N-CA-C 108.574 -0.898 . . . . 0.0 108.574 177.682 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 28.6 t-80 -139.39 60.65 1.57 Allowed 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 124.481 1.112 . . . . 0.0 108.335 -173.577 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 64.3 t-20 -60.88 126.76 28.57 Favored 'General case' 0 C--O 1.232 0.181 0 N-CA-C 107.128 -1.434 . . . . 0.0 107.128 173.309 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 83.3 mt -66.72 -22.44 66.06 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 123.24 0.616 . . . . 0.0 112.16 -179.64 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 56.7 tttt -66.66 -22.11 66.1 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 118.147 0.43 . . . . 0.0 111.708 169.143 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -107.62 -35.3 6.75 Favored 'General case' 0 C--O 1.234 0.272 0 C-N-CA 124.081 0.953 . . . . 0.0 113.25 -169.661 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 2.9 t0 -139.14 155.53 47.79 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 118.717 0.69 . . . . 0.0 112.151 178.128 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 17.2 m -75.06 157.94 84.81 Favored Pre-proline 0 CA--C 1.54 0.595 0 C-N-CA 125.618 1.567 . . . . 0.0 111.482 -170.68 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -73.89 -26.29 13.44 Favored 'Trans proline' 0 C--N 1.349 0.563 0 C-N-CA 122.778 2.318 . . . . 0.0 113.236 -171.68 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 22.7 mmmt -71.27 -12.08 61.26 Favored 'General case' 0 N--CA 1.471 0.576 0 O-C-N 120.395 -1.441 . . . . 0.0 111.716 -176.44 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -61.21 -28.41 69.13 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 125.451 1.5 . . . . 0.0 110.38 168.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 45.5 mtt -58.71 -25.96 63.42 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 118.591 0.632 . . . . 0.0 111.745 177.478 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 88.0 mt-10 -65.93 -32.56 74.14 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-O 119.017 -0.516 . . . . 0.0 110.249 -176.567 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 21.2 mt-30 -65.9 -44.28 85.69 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 123.601 0.76 . . . . 0.0 112.541 -170.362 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 52.5 m-85 -74.78 142.24 44.3 Favored 'General case' 0 N--CA 1.456 -0.153 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.662 -166.724 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -69.21 -42.48 75.68 Favored 'General case' 0 C--O 1.235 0.29 0 N-CA-C 109.894 -0.41 . . . . 0.0 109.894 176.413 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 7.2 t -106.33 143.76 16.7 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.368 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 175.306 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 37.8 tp -131.64 114.36 14.71 Favored 'General case' 0 N--CA 1.444 -0.77 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 174.295 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 31.8 mt -94.44 132.75 37.61 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 N-CA-C 106.781 -1.563 . . . . 0.0 106.781 178.416 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 3.1 mp -113.95 130.15 56.54 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 125.641 1.577 . . . . 0.0 107.102 -176.583 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -135.67 126.83 4.06 Favored Glycine 0 C--N 1.335 0.491 0 N-CA-C 109.908 -1.277 . . . . 0.0 109.908 177.607 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 7.4 tt -153.57 127.3 4.36 Favored Pre-proline 0 CA--C 1.538 0.496 0 CA-C-N 117.872 0.836 . . . . 0.0 109.892 172.298 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -73.67 156.33 49.09 Favored 'Trans proline' 0 N--CA 1.459 -0.544 0 C-N-CA 122.268 1.979 . . . . 0.0 112.782 169.496 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 1.9 m -132.34 135.53 46.23 Favored 'General case' 0 CA--C 1.535 0.372 0 N-CA-C 108.547 -0.909 . . . . 0.0 108.547 168.14 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 5.9 m-90 -144.19 178.85 7.6 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 125.46 1.504 . . . . 0.0 107.404 169.283 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -59.93 -29.23 68.25 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 123.512 0.725 . . . . 0.0 112.299 171.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 70.5 t80 -115.64 164.34 14.48 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 125.206 1.403 . . . . 0.0 109.856 177.349 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 79.77 -75.92 2.08 Favored Glycine 0 CA--C 1.528 0.857 0 N-CA-C 110.492 -1.043 . . . . 0.0 110.492 176.899 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.48 ' HG2' ' H ' ' A' ' 61' ' ' ILE . 5.3 tt0 53.18 -155.21 0.21 Allowed 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 124.864 1.266 . . . . 0.0 110.324 -175.126 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.48 ' H ' ' HG2' ' A' ' 60' ' ' GLU . 65.9 mt -55.18 119.38 1.82 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.492 0 C-N-CA 125.211 1.404 . . . . 0.0 107.378 169.981 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -85.32 164.81 17.76 Favored 'General case' 0 C--O 1.234 0.254 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 173.661 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -55.2 -38.41 68.37 Favored 'General case' 0 C--O 1.222 -0.36 0 C-N-CA 123.811 0.844 . . . . 0.0 110.741 179.793 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -61.2 -24.48 66.36 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-N 118.792 0.724 . . . . 0.0 112.562 -177.074 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 12.2 t90 -96.63 -47.57 5.86 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 124.89 1.276 . . . . 0.0 109.348 176.611 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -64.41 -33.71 76.49 Favored 'General case' 0 CA--C 1.539 0.534 0 O-C-N 120.833 -1.167 . . . . 0.0 110.593 -175.282 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -63.46 -26.58 68.79 Favored 'General case' 0 CA--C 1.529 0.135 0 C-N-CA 123.273 0.629 . . . . 0.0 110.872 -173.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 29.1 m -108.57 -15.43 9.36 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.314 0 CA-C-O 117.366 -1.302 . . . . 0.0 111.879 177.12 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 29.4 t90 -51.35 -35.5 38.73 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-N 120.189 1.359 . . . . 0.0 110.679 177.108 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -62.86 -29.33 70.67 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 125.441 1.496 . . . . 0.0 113.303 175.367 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 31.0 mt-30 -92.42 -18.3 23.44 Favored 'General case' 0 N--CA 1.463 0.209 0 C-N-CA 126.09 1.756 . . . . 0.0 112.324 177.29 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 56.7 mt -63.48 -21.04 66.09 Favored 'General case' 0 CA--C 1.534 0.338 0 O-C-N 121.304 -0.872 . . . . 0.0 111.496 -178.119 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -80.11 -23.05 41.49 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 123.011 0.525 . . . . 0.0 111.868 173.671 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -71.83 -30.32 65.36 Favored 'General case' 0 N--CA 1.468 0.466 0 O-C-N 120.705 -1.247 . . . . 0.0 111.843 177.529 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 79.5 mt -52.96 140.85 23.68 Favored 'General case' 0 C--N 1.34 0.174 0 C-N-CA 125.012 1.325 . . . . 0.0 112.757 -168.787 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 28.9 t-20 -74.97 106.43 6.47 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 169.312 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 64.7 mt -128.61 0.07 5.52 Favored 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 113.891 1.071 . . . . 0.0 113.891 -174.393 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 27.2 mt-10 -57.79 128.38 36.81 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 119.658 1.117 . . . . 0.0 110.689 -169.031 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 71.65 -0.05 37.45 Favored Glycine 0 CA--C 1.532 1.127 0 C-N-CA 125.397 1.475 . . . . 0.0 115.046 179.445 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.26 151.55 39.87 Favored 'General case' 0 C--N 1.348 0.51 0 CA-C-N 120.798 2.299 . . . . 0.0 109.649 -177.775 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 3.6 mt -80.67 136.9 22.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 N-CA-C 106.765 -1.568 . . . . 0.0 106.765 178.876 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 68.8 t -132.17 131.56 61.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 C-N-CA 123.813 0.845 . . . . 0.0 109.833 -178.555 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -105.39 150.12 25.52 Favored 'General case' 0 N--CA 1.463 0.192 0 N-CA-C 107.417 -1.327 . . . . 0.0 107.417 168.603 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 3.6 mt -132.24 134.19 45.02 Favored 'General case' 0 CA--C 1.51 -0.594 0 N-CA-C 107.265 -1.383 . . . . 0.0 107.265 177.77 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 35.8 p90 -151.03 165.84 32.55 Favored 'General case' 0 N--CA 1.447 -0.595 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 168.764 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -162.62 159.59 31.9 Favored Glycine 0 N--CA 1.444 -0.784 0 N-CA-C 108.556 -1.817 . . . . 0.0 108.556 172.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 7.0 tt -103.55 147.47 27.14 Favored 'General case' 0 N--CA 1.445 -0.7 0 N-CA-C 108.493 -0.929 . . . . 0.0 108.493 171.56 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -150.53 -169.39 16.45 Favored Glycine 0 CA--C 1.522 0.514 0 N-CA-C 109.904 -1.278 . . . . 0.0 109.904 174.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -148.04 139.22 23.41 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 124.823 1.249 . . . . 0.0 107.935 178.541 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 16.6 pm0 -108.81 1.05 20.69 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 124.009 0.924 . . . . 0.0 113.176 177.392 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 28.3 mt -67.06 -38.73 86.33 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 119.696 1.135 . . . . 0.0 108.701 168.361 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -74.44 43.57 1.33 Allowed Glycine 0 CA--C 1.533 1.212 0 C-N-CA 126.04 1.781 . . . . 0.0 111.82 169.237 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 49.4 m-85 62.84 -19.7 0.05 OUTLIER 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 129.267 3.027 . . . . 0.0 116.565 177.228 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 77.35 15.6 81.31 Favored Glycine 0 CA--C 1.529 0.932 0 CA-C-N 120.148 1.34 . . . . 0.0 112.132 -179.774 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -77.14 -16.89 58.98 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 118.796 1.298 . . . . 0.0 110.965 169.72 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' TRP . . . . . . . . . . . . . 53.7 m95 -109.18 6.67 24.96 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 125.074 1.35 . . . . 0.0 111.62 177.37 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 8.6 t80 -61.74 126.34 27.0 Favored 'General case' 0 C--N 1.343 0.297 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 -175.852 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 83.8 mt 51.73 19.31 0.89 Allowed 'General case' 0 N--CA 1.467 0.379 0 N-CA-C 115.679 1.733 . . . . 0.0 115.679 167.668 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -61.84 -36.62 81.72 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-N 121.511 1.959 . . . . 0.0 111.29 -173.37 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -65.83 -27.74 68.47 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 124.328 1.051 . . . . 0.0 112.295 174.52 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 5.3 tt -66.56 -46.69 75.22 Favored 'General case' 0 N--CA 1.467 0.424 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 173.056 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -63.47 -34.6 90.4 Favored Glycine 0 CA--C 1.529 0.944 0 N-CA-C 110.659 -0.976 . . . . 0.0 110.659 -179.732 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 5.2 tpp -50.89 -54.08 27.03 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 124.963 1.305 . . . . 0.0 111.527 175.88 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -76.82 -36.61 56.77 Favored 'General case' 0 C--N 1.341 0.238 0 O-C-N 121.891 -0.506 . . . . 0.0 109.782 -175.195 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 43.1 t-80 -55.71 -48.88 74.41 Favored 'General case' 0 N--CA 1.464 0.231 0 O-C-N 121.436 -0.79 . . . . 0.0 110.872 176.261 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -63.44 -38.77 92.42 Favored 'General case' 0 C--O 1.234 0.288 0 C-N-CA 123.288 0.635 . . . . 0.0 112.103 -176.323 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 24.4 ttmm -57.45 -36.09 70.98 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 123.382 0.673 . . . . 0.0 110.727 172.825 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 22.3 mt -91.86 -20.49 21.4 Favored 'General case' 0 CA--C 1.513 -0.45 0 N-CA-C 115.8 1.778 . . . . 0.0 115.8 -168.238 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 6.0 m -58.15 -33.62 69.38 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-N 120.481 1.491 . . . . 0.0 111.627 -178.218 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 20.7 p -87.39 -9.33 55.04 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 124.884 1.274 . . . . 0.0 112.287 -179.807 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 32.5 mmmt -84.53 -4.63 59.06 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 124.461 1.104 . . . . 0.0 111.453 172.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 69.92 31.96 69.89 Favored Glycine 0 CA--C 1.525 0.657 0 CA-C-N 118.605 0.639 . . . . 0.0 112.105 171.827 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 3.5 m -76.33 172.38 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.474 0 CA-C-N 118.104 0.952 . . . . 0.0 109.457 175.237 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -111.9 121.1 44.11 Favored 'General case' 0 CA--C 1.515 -0.386 0 N-CA-C 106.474 -1.676 . . . . 0.0 106.474 173.615 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 64.0 m-85 -88.32 145.35 25.88 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 119.61 1.095 . . . . 0.0 109.378 -178.13 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 27.7 m -129.4 161.08 39.58 Favored 'Isoleucine or valine' 0 C--O 1.233 0.212 0 C-N-CA 124.223 1.009 . . . . 0.0 109.289 171.588 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 93.2 -94.18 1.83 Allowed Glycine 0 N--CA 1.443 -0.877 0 C-N-CA 124.817 1.199 . . . . 0.0 110.804 176.435 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 8.0 m-30 59.57 177.05 0.08 Allowed 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 125.109 1.364 . . . . 0.0 110.188 -167.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -155.27 140.94 12.65 Favored Pre-proline 0 N--CA 1.473 0.7 0 CA-C-O 116.872 -1.537 . . . . 0.0 108.76 -179.468 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -68.13 127.77 16.47 Favored 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 122.698 2.265 . . . . 0.0 112.64 -176.166 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 68.0 p -80.88 -7.65 59.53 Favored 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 112.393 0.516 . . . . 0.0 112.393 169.619 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -59.75 122.62 14.62 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 124.031 0.933 . . . . 0.0 110.314 -169.878 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 71.48 5.01 59.02 Favored Glycine 0 CA--C 1.536 1.382 0 C-N-CA 124.495 1.045 . . . . 0.0 114.293 178.352 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 2.9 t80 -80.29 151.26 29.63 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 118.853 1.326 . . . . 0.0 110.213 -177.538 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -103.02 108.18 19.26 Favored 'General case' 0 N--CA 1.463 0.206 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 174.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 18.9 p90 -164.33 166.06 21.14 Favored 'General case' 0 C--O 1.241 0.641 0 C-N-CA 127.298 2.239 . . . . 0.0 105.583 179.538 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 86.0 m -131.81 -31.56 1.52 Allowed 'General case' 0 N--CA 1.44 -0.961 0 C-N-CA 122.683 0.393 . . . . 0.0 111.62 -173.623 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 1.4 m -53.96 127.3 53.46 Favored Pre-proline 0 CA--C 1.547 0.842 0 C-N-CA 124.325 1.05 . . . . 0.0 112.269 -176.501 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_endo -84.84 -30.01 0.62 Allowed 'Trans proline' 0 CA--C 1.541 0.829 0 C-N-CA 122.408 2.072 . . . . 0.0 112.732 177.451 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 32.5 ttmt -57.14 -42.86 98.36 Favored Pre-proline 0 N--CA 1.471 0.618 0 CA-C-O 117.668 -1.158 . . . . 0.0 113.412 -173.447 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 62.9 Cg_endo -84.77 13.86 2.64 Favored 'Trans proline' 0 C--N 1.348 0.539 0 C-N-CA 121.844 1.696 . . . . 0.0 113.581 -178.866 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 35.1 m -128.63 154.9 40.11 Favored 'Isoleucine or valine' 0 C--O 1.235 0.3 0 CA-C-N 121.777 2.08 . . . . 0.0 111.109 179.065 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 17.8 pt -114.32 167.94 6.66 Favored 'Isoleucine or valine' 0 C--O 1.235 0.319 0 C-N-CA 126.41 1.884 . . . . 0.0 109.145 174.82 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . 57.73 32.94 22.61 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 124.967 1.307 . . . . 0.0 113.484 167.687 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 27.6 t70 54.99 39.83 31.78 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 126.251 1.82 . . . . 0.0 111.592 -175.164 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 93.63 72.21 1.18 Allowed Glycine 0 CA--C 1.528 0.854 0 C-N-CA 124.487 1.042 . . . . 0.0 111.243 177.013 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 78.8 mm-40 -116.66 -49.57 2.64 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 123.168 0.587 . . . . 0.0 110.354 167.375 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -132.48 146.52 51.99 Favored 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 123.017 0.527 . . . . 0.0 110.969 -179.252 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 58.9 m-85 -77.63 16.79 0.61 Allowed 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 126.189 1.796 . . . . 0.0 115.65 177.879 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 3.7 m 49.64 11.73 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.547 0.831 0 C-N-CA 126.927 2.091 . . . . 0.0 114.469 -176.586 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 170.42 170.06 34.28 Favored Glycine 0 CA--C 1.527 0.805 0 N-CA-C 108.368 -1.893 . . . . 0.0 108.368 -171.562 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -69.24 134.95 49.84 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 117.977 0.888 . . . . 0.0 111.007 -178.347 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -95.87 109.94 22.21 Favored 'General case' 0 N--CA 1.448 -0.571 0 C-N-CA 125.52 1.528 . . . . 0.0 109.056 175.291 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 83.8 mt -101.63 154.73 18.61 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 118.845 0.748 . . . . 0.0 109.561 170.157 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -151.54 145.67 25.32 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 106.231 -1.766 . . . . 0.0 106.231 169.321 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 16.2 tt0 -140.95 26.6 2.04 Favored 'General case' 0 CA--C 1.543 0.704 0 CA-C-O 121.45 0.643 . . . . 0.0 110.013 169.82 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 56.5 m -109.9 -42.26 4.28 Favored 'General case' 0 C--O 1.235 0.324 0 C-N-CA 125.311 1.444 . . . . 0.0 109.351 175.36 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 4.5 m-80 -86.83 -34.24 19.57 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 124.069 0.948 . . . . 0.0 109.025 -176.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 3.5 mt-30 -122.03 173.76 7.34 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 127.321 2.248 . . . . 0.0 108.632 177.489 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 81.6 t80 -146.1 -47.84 0.21 Allowed 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 123.5 0.72 . . . . 0.0 110.146 170.026 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -68.26 -48.52 64.84 Favored 'General case' 0 N--CA 1.466 0.331 0 O-C-N 122.182 -0.324 . . . . 0.0 111.868 -172.741 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -85.73 -1.54 57.3 Favored 'General case' 0 N--CA 1.466 0.361 0 N-CA-C 113.13 0.789 . . . . 0.0 113.13 -173.305 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 13.3 m -59.52 -31.57 69.51 Favored 'General case' 0 CA--C 1.543 0.681 0 O-C-N 121.017 -1.052 . . . . 0.0 110.156 171.871 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -63.96 -39.54 94.36 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 123.972 0.909 . . . . 0.0 111.671 172.645 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 -64.55 -46.98 80.51 Favored 'General case' 0 C--O 1.234 0.263 0 C-N-CA 124.294 1.038 . . . . 0.0 109.858 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 72.1 mtt180 -55.32 -41.1 71.98 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-O 118.795 -0.622 . . . . 0.0 110.627 177.039 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 75.9 mt -68.39 -57.97 7.39 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.299 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 177.316 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 70.8 tp60 -49.64 -63.04 1.23 Allowed 'General case' 0 C--O 1.233 0.193 0 C-N-CA 125.12 1.368 . . . . 0.0 112.106 -173.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 20.0 m -66.8 -31.95 72.91 Favored 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 120.826 -0.35 . . . . 0.0 111.245 -170.342 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 160' ' ' TRP . . . . . . . . . . . . . 34.0 t90 -70.87 -44.32 66.61 Favored 'General case' 0 CA--C 1.516 -0.342 0 O-C-N 122.005 -0.434 . . . . 0.0 110.898 176.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 98.4 m -59.46 -42.79 92.81 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 122.846 0.458 . . . . 0.0 110.093 177.454 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -63.44 -41.86 98.66 Favored 'General case' 0 N--CA 1.456 -0.147 0 CA-C-O 121.006 0.431 . . . . 0.0 110.181 175.72 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 14.7 tt0 -62.61 -51.99 65.14 Favored 'General case' 0 N--CA 1.449 -0.495 0 O-C-N 121.692 -0.63 . . . . 0.0 109.934 -178.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 42.2 pt -63.27 -37.98 80.9 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.328 0 CA-C-O 117.669 -1.158 . . . . 0.0 109.231 -175.714 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -65.75 -34.91 79.28 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 119.776 1.171 . . . . 0.0 110.486 -179.548 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 31.2 m-80 -68.49 -50.59 51.13 Favored 'General case' 0 CA--C 1.516 -0.34 0 N-CA-C 108.785 -0.821 . . . . 0.0 108.785 175.285 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 15.5 tt0 -71.14 -33.61 70.24 Favored 'General case' 0 N--CA 1.438 -1.062 0 C-N-CA 124.174 0.99 . . . . 0.0 111.131 -168.616 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 168' ' ' MET . . . . . . . . . . . . . 22.9 ptp -72.42 -30.18 64.39 Favored 'General case' 0 C--N 1.332 -0.171 0 O-C-N 121.136 -0.978 . . . . 0.0 111.702 173.738 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -79.48 -41.16 28.08 Favored 'General case' 0 N--CA 1.447 -0.601 0 C-N-CA 122.636 0.375 . . . . 0.0 111.416 -179.765 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -71.59 -26.16 62.48 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 122.964 0.506 . . . . 0.0 110.454 -178.578 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 77.6 t60 -58.09 -27.28 63.53 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 123.65 0.78 . . . . 0.0 110.995 169.794 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 6.7 m-85 -94.17 -2.75 52.11 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 125.633 1.573 . . . . 0.0 113.731 176.015 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.254 1.339 0 CA-C-N 119.611 1.096 . . . . 0.0 109.971 177.893 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.498 1.931 0 CA-C-O 120.011 -0.042 . . . . 0.0 111.078 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 4.0 t30 -116.66 151.36 36.47 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 124.195 0.998 . . . . 0.0 110.134 -173.483 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 1.2 mpt? -118.75 123.31 44.52 Favored 'General case' 0 C--N 1.334 -0.096 0 C-N-CA 123.747 0.819 . . . . 0.0 111.183 179.47 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -81.85 153.93 33.37 Favored Glycine 0 CA--C 1.524 0.655 0 N-CA-C 107.521 -2.232 . . . . 0.0 107.521 166.655 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 3.3 tt -140.3 96.47 3.05 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 105.422 -2.066 . . . . 0.0 105.422 -176.414 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -102.98 143.83 32.04 Favored 'General case' 0 CA--C 1.517 -0.303 0 CA-C-O 121.769 0.795 . . . . 0.0 112.186 -170.86 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 36.3 p90 -161.03 173.4 15.27 Favored 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 127.676 2.391 . . . . 0.0 106.237 177.141 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -156.12 106.6 0.3 Allowed Glycine 0 CA--C 1.51 -0.259 0 N-CA-C 106.286 -2.726 . . . . 0.0 106.286 175.308 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 14.5 m -144.58 160.43 41.16 Favored 'General case' 0 C--O 1.235 0.335 0 C-N-CA 124.085 0.954 . . . . 0.0 109.745 -169.2 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 7.4 m -70.88 -31.4 68.05 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 122.842 0.457 . . . . 0.0 110.441 172.418 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 9.5 p -72.71 158.4 35.67 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 124.864 1.265 . . . . 0.0 109.914 172.446 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 62.7 m -66.35 -25.16 66.68 Favored 'General case' 0 CA--C 1.535 0.399 0 O-C-N 122.054 -0.404 . . . . 0.0 111.961 179.174 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 31.4 m-85 -138.95 173.74 11.25 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 126.362 1.865 . . . . 0.0 108.442 -176.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 22.7 p -74.46 82.43 1.96 Allowed 'General case' 0 CA--C 1.536 0.433 0 N-CA-C 106.429 -1.693 . . . . 0.0 106.429 168.821 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 59.91 -86.8 0.02 OUTLIER 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 125.387 1.475 . . . . 0.0 109.006 -167.446 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -135.87 -2.36 2.37 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 125.165 1.386 . . . . 0.0 113.008 171.259 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -68.98 -39.28 79.48 Favored 'General case' 0 C--O 1.222 -0.373 0 O-C-N 120.917 -1.114 . . . . 0.0 113.082 -167.724 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -58.74 -47.09 85.85 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 120.188 1.358 . . . . 0.0 111.077 -179.002 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -64.53 -46.43 82.91 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 123.104 0.562 . . . . 0.0 109.568 177.088 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 58.4 mttm -60.33 -45.58 92.93 Favored 'General case' 0 N--CA 1.466 0.367 0 O-C-N 121.755 -0.59 . . . . 0.0 111.596 -178.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 44.2 mt -53.72 -55.74 12.18 Favored 'Isoleucine or valine' 0 C--O 1.234 0.242 0 C-N-CA 124.465 1.106 . . . . 0.0 108.505 176.215 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 1.3 ttp180 -60.73 -41.29 95.04 Favored 'General case' 0 C--O 1.223 -0.31 0 CA-C-O 118.929 -0.558 . . . . 0.0 109.687 -174.675 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -68.02 -42.66 80.3 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 123.206 0.602 . . . . 0.0 111.173 -177.724 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 61.6 mt -74.12 -53.39 17.48 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.351 0 C-N-CA 124.508 1.123 . . . . 0.0 109.619 -171.251 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 74.5 mt -64.79 -46.0 93.35 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.434 0 N-CA-C 109.195 -0.669 . . . . 0.0 109.195 178.359 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 139.96 126.41 2.3 Favored Glycine 0 CA--C 1.534 1.221 0 C-N-CA 124.868 1.223 . . . . 0.0 112.132 172.562 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -71.23 -7.37 21.2 Favored 'Trans proline' 0 CA--C 1.536 0.585 0 C-N-CA 124.067 3.178 . . . . 0.0 113.613 -176.22 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -83.8 -17.22 41.79 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 119.081 0.855 . . . . 0.0 111.251 177.873 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 1.2 pt? -128.32 -16.14 4.49 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 124.998 1.319 . . . . 0.0 113.625 -175.239 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 41.5 t -97.05 154.79 3.62 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.542 0 N-CA-C 107.292 -1.373 . . . . 0.0 107.292 168.012 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 27.9 m -142.34 130.14 21.65 Favored 'General case' 0 C--O 1.232 0.146 0 N-CA-C 105.934 -1.876 . . . . 0.0 105.934 -176.136 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 17.8 mt -80.57 141.43 35.08 Favored 'General case' 0 C--O 1.232 0.18 0 N-CA-C 107.77 -1.196 . . . . 0.0 107.77 175.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 35.0 t-80 -131.9 61.03 1.66 Allowed 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 124.671 1.188 . . . . 0.0 107.847 -174.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 64.6 t-20 -72.09 116.56 12.65 Favored 'General case' 0 C--O 1.234 0.267 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 -178.039 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 99.1 mt -65.54 -13.44 58.94 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 124.345 1.058 . . . . 0.0 112.787 -177.229 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 28.5 tptp -57.06 -25.87 59.42 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 123.243 0.617 . . . . 0.0 110.953 168.631 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -129.46 -40.35 1.43 Allowed 'General case' 0 N--CA 1.464 0.246 0 C-N-CA 123.871 0.868 . . . . 0.0 113.279 -175.002 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 34.0 m-20 -89.59 141.01 28.99 Favored 'General case' 0 C--O 1.234 0.285 0 C-N-CA 123.382 0.673 . . . . 0.0 110.551 -175.676 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 15.2 m -75.88 155.38 84.87 Favored Pre-proline 0 CA--C 1.543 0.677 0 C-N-CA 124.213 1.005 . . . . 0.0 109.992 175.411 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_endo -77.29 -26.27 7.64 Favored 'Trans proline' 0 C--N 1.35 0.615 0 C-N-CA 122.431 2.087 . . . . 0.0 113.588 -169.924 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 22.5 mmmt -71.63 -11.92 61.08 Favored 'General case' 0 N--CA 1.472 0.634 0 O-C-N 120.5 -1.375 . . . . 0.0 111.478 -175.702 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -60.54 -28.66 68.6 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 125.769 1.627 . . . . 0.0 110.145 168.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 45.9 mtt -58.08 -26.18 62.23 Favored 'General case' 0 C--N 1.343 0.306 0 C-N-CA 123.198 0.599 . . . . 0.0 111.895 177.353 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 90.8 mt-10 -66.85 -32.7 74.14 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 118.245 0.475 . . . . 0.0 110.307 -176.601 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 18.3 mt-30 -66.17 -44.74 83.17 Favored 'General case' 0 N--CA 1.464 0.267 0 C-N-CA 123.714 0.806 . . . . 0.0 112.022 -171.214 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 20.4 m-85 -70.88 139.74 50.87 Favored 'General case' 0 N--CA 1.456 -0.135 0 CA-C-N 115.403 -0.817 . . . . 0.0 109.758 -166.765 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -72.96 -38.07 66.87 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 118.506 0.594 . . . . 0.0 110.257 -179.023 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 10.5 t -108.57 146.61 14.11 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.304 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 170.715 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 43.1 tp -133.01 106.74 7.83 Favored 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 176.678 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 19.8 mt -86.22 135.78 24.32 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 N-CA-C 107.096 -1.446 . . . . 0.0 107.096 176.704 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 1.9 mp -114.0 131.38 56.36 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 126.042 1.737 . . . . 0.0 106.774 -179.013 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -136.69 126.91 3.9 Favored Glycine 0 C--N 1.332 0.343 0 N-CA-C 109.072 -1.611 . . . . 0.0 109.072 177.085 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 4.7 tt -153.74 133.71 7.66 Favored Pre-proline 0 CA--C 1.538 0.511 0 CA-C-N 118.247 1.024 . . . . 0.0 111.055 174.432 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -73.33 153.51 50.69 Favored 'Trans proline' 0 CA--C 1.534 0.501 0 C-N-CA 122.799 2.332 . . . . 0.0 112.78 168.278 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 22.8 m -117.18 140.54 49.4 Favored 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 105.462 -2.051 . . . . 0.0 105.462 166.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 5.1 m-90 -142.06 147.72 37.27 Favored 'General case' 0 C--O 1.231 0.123 0 C-N-CA 123.933 0.893 . . . . 0.0 110.487 -174.809 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -61.48 -27.21 68.42 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 123.682 0.793 . . . . 0.0 111.304 169.492 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 14.6 m-85 -65.2 -6.16 8.7 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 124.882 1.273 . . . . 0.0 112.988 175.243 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 106.07 122.17 4.94 Favored Glycine 0 CA--C 1.525 0.691 0 N-CA-C 108.087 -2.005 . . . . 0.0 108.087 -173.322 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 2.8 pm0 -79.99 162.84 24.67 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 124.488 1.115 . . . . 0.0 111.807 179.122 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . 0.282 24.7 mt 65.09 145.48 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.55 0 C-N-CA 127.645 2.378 . . . . 0.0 112.111 -176.428 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 3.3 mp0 -117.33 155.81 28.9 Favored 'General case' 0 C--O 1.235 0.331 0 C-N-CA 126.214 1.805 . . . . 0.0 106.568 -173.289 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -57.08 -43.4 82.12 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 122.891 0.476 . . . . 0.0 110.724 -171.458 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 -66.64 -20.9 66.09 Favored 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 112.357 0.503 . . . . 0.0 112.357 -176.023 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 11.3 t90 -91.86 -48.47 6.76 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 124.409 1.084 . . . . 0.0 109.031 177.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -64.27 -34.65 78.6 Favored 'General case' 0 CA--C 1.537 0.463 0 O-C-N 121.03 -1.044 . . . . 0.0 109.763 -178.218 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -59.54 -25.62 64.67 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 123.612 0.765 . . . . 0.0 111.815 -177.208 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 28.5 m -111.29 -14.67 10.54 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.315 0 CA-C-O 117.082 -1.437 . . . . 0.0 112.442 177.033 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 30.1 t90 -51.58 -35.13 40.04 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 120.491 1.496 . . . . 0.0 110.97 179.296 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -64.24 -27.9 69.37 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 125.222 1.409 . . . . 0.0 113.524 175.428 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 29.4 mt-30 -92.71 -18.98 22.29 Favored 'General case' 0 N--CA 1.463 0.22 0 C-N-CA 126.11 1.764 . . . . 0.0 112.441 175.786 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 56.3 mt -63.86 -20.57 65.92 Favored 'General case' 0 N--CA 1.465 0.319 0 O-C-N 121.21 -0.931 . . . . 0.0 111.608 -176.081 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -78.52 -22.81 46.79 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 122.985 0.514 . . . . 0.0 111.666 174.37 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -72.8 -29.79 63.55 Favored 'General case' 0 N--CA 1.467 0.411 0 O-C-N 120.729 -1.232 . . . . 0.0 111.942 178.005 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 80.9 mt -52.96 138.53 30.02 Favored 'General case' 0 C--O 1.231 0.101 0 C-N-CA 124.907 1.283 . . . . 0.0 112.896 -168.499 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 3.2 t30 -74.01 98.78 3.14 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 124.02 0.928 . . . . 0.0 108.631 170.515 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 32.8 mt -118.83 -0.76 11.17 Favored 'General case' 0 N--CA 1.472 0.659 0 N-CA-C 113.858 1.058 . . . . 0.0 113.858 -178.091 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 26.8 mt-10 -54.86 127.55 29.11 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-N 119.831 1.196 . . . . 0.0 111.623 -168.522 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 73.41 -2.24 38.84 Favored Glycine 0 CA--C 1.535 1.298 0 CA-C-O 117.824 -1.542 . . . . 0.0 115.108 179.345 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.4 154.82 36.93 Favored 'General case' 0 C--N 1.344 0.363 0 CA-C-N 120.942 2.371 . . . . 0.0 109.759 -176.678 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 2.3 mt -83.91 138.59 18.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 N-CA-C 106.866 -1.531 . . . . 0.0 106.866 177.508 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 54.3 t -130.71 135.75 59.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 C-N-CA 124.538 1.135 . . . . 0.0 108.498 -179.118 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -108.33 156.93 18.84 Favored 'General case' 0 CA--C 1.517 -0.299 0 N-CA-C 107.885 -1.154 . . . . 0.0 107.885 168.867 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 5.7 mt -137.76 132.42 32.72 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 107.783 -1.191 . . . . 0.0 107.783 178.714 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 39.2 p90 -149.15 165.68 31.08 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 168.421 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -167.84 157.8 30.29 Favored Glycine 0 N--CA 1.448 -0.517 0 N-CA-C 111.032 -0.827 . . . . 0.0 111.032 175.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 58.5 tp -97.87 146.4 25.48 Favored 'General case' 0 N--CA 1.445 -0.708 0 C-N-CA 125.691 1.596 . . . . 0.0 109.748 175.057 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -155.83 -168.75 19.26 Favored Glycine 0 CA--C 1.529 0.944 0 N-CA-C 108.754 -1.738 . . . . 0.0 108.754 172.777 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 54.9 t0 -146.71 118.28 7.99 Favored 'General case' 0 C--O 1.234 0.276 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 172.046 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 26.1 mp0 -63.68 -31.59 72.81 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 124.69 1.196 . . . . 0.0 112.016 -179.006 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 43.9 mt -88.13 -36.06 17.09 Favored 'General case' 0 N--CA 1.463 0.221 0 C-N-CA 125.44 1.496 . . . . 0.0 109.492 -178.693 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -65.22 -48.35 70.84 Favored Glycine 0 CA--C 1.528 0.894 0 N-CA-C 111.356 -0.698 . . . . 0.0 111.356 -177.268 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -139.98 -72.74 0.37 Allowed 'General case' 0 N--CA 1.463 0.196 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 -174.995 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 77.88 -39.58 1.8 Allowed Glycine 0 CA--C 1.531 1.062 0 C-N-CA 124.16 0.886 . . . . 0.0 114.458 169.055 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -60.58 -37.54 81.69 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 118.805 1.303 . . . . 0.0 109.849 170.875 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' TRP . . . . . . . . . . . . . 4.0 m-90 -109.08 32.76 4.69 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 125.856 1.662 . . . . 0.0 110.606 -178.799 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 14.1 t80 -57.76 135.46 56.79 Favored 'General case' 0 CA--C 1.531 0.222 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 177.35 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 89.7 mt 53.82 24.65 4.59 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 124.846 1.258 . . . . 0.0 114.257 169.416 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -62.96 -37.69 88.1 Favored 'General case' 0 C--N 1.328 -0.331 0 O-C-N 120.86 -1.15 . . . . 0.0 111.217 -173.061 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -67.66 -29.31 68.57 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 123.674 0.789 . . . . 0.0 112.416 174.391 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 5.9 tt -63.73 -49.45 73.0 Favored 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 173.375 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -61.29 -36.5 92.54 Favored Glycine 0 CA--C 1.526 0.767 0 N-CA-C 111.623 -0.591 . . . . 0.0 111.623 177.806 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 6.4 tpp -53.99 -48.52 70.31 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 124.756 1.222 . . . . 0.0 111.454 -179.152 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -77.93 -39.69 41.98 Favored 'General case' 0 C--N 1.341 0.238 0 N-CA-C 109.813 -0.439 . . . . 0.0 109.813 -177.898 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 77.9 t60 -54.14 -45.46 71.99 Favored 'General case' 0 CA--C 1.534 0.333 0 O-C-N 121.517 -0.739 . . . . 0.0 111.335 176.638 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -61.53 -41.94 98.08 Favored 'General case' 0 C--O 1.235 0.326 0 C-N-CA 123.801 0.84 . . . . 0.0 111.536 -179.506 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 24.3 ttmm -57.48 -43.39 84.04 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 123.614 0.765 . . . . 0.0 110.278 174.286 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 27.7 mt -87.25 -14.41 41.07 Favored 'General case' 0 CA--C 1.518 -0.281 0 N-CA-C 113.9 1.074 . . . . 0.0 113.9 -170.552 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 70.9 m -60.13 -32.67 71.23 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 119.835 1.198 . . . . 0.0 111.218 -174.508 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 24.6 p -89.7 -5.17 57.3 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 124.946 1.298 . . . . 0.0 112.085 179.194 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 31.7 mmmt -86.32 -6.29 58.98 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 125.014 1.326 . . . . 0.0 111.6 175.762 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 72.29 34.99 60.53 Favored Glycine 0 CA--C 1.526 0.762 0 CA-C-N 118.622 0.646 . . . . 0.0 112.522 171.483 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 5.6 m -80.97 172.12 1.16 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.51 0 CA-C-N 118.085 0.943 . . . . 0.0 109.815 173.744 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 53.0 tptt -101.85 132.73 47.46 Favored 'General case' 0 N--CA 1.469 0.477 0 N-CA-C 105.378 -2.082 . . . . 0.0 105.378 167.698 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 74.9 m-85 -99.16 123.76 43.69 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 119.161 0.891 . . . . 0.0 108.674 174.107 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 31.6 m -109.9 160.05 9.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 C-N-CA 125.196 1.398 . . . . 0.0 108.459 168.03 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 85.34 27.6 32.7 Favored Glycine 0 CA--C 1.523 0.588 0 CA-C-O 118.526 -1.152 . . . . 0.0 114.928 170.176 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 17.4 m-30 -58.21 158.21 7.37 Favored 'General case' 0 CA--C 1.54 0.596 0 CA-C-N 119.028 1.414 . . . . 0.0 110.463 168.891 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 49.4 t-105 -138.22 147.22 54.96 Favored Pre-proline 0 N--CA 1.468 0.444 0 CA-C-O 118.264 -0.874 . . . . 0.0 111.357 -169.591 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -65.03 130.99 27.27 Favored 'Trans proline' 0 CA--C 1.534 0.516 0 C-N-CA 122.765 2.31 . . . . 0.0 112.441 -179.137 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 11.3 p -87.21 -11.12 50.76 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 123.876 0.87 . . . . 0.0 112.002 169.412 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -59.96 141.6 55.29 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 124.415 1.086 . . . . 0.0 111.208 -169.51 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 78.26 11.43 85.34 Favored Glycine 0 CA--C 1.532 1.148 0 CA-C-N 114.769 -1.105 . . . . 0.0 113.715 178.693 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 24.7 t80 -141.52 162.09 36.32 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 119.007 1.403 . . . . 0.0 110.196 176.865 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -140.47 144.81 36.25 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 125.62 1.568 . . . . 0.0 108.985 -176.642 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 3.8 p90 -154.37 172.41 17.74 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 127.804 2.441 . . . . 0.0 106.447 -170.256 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 6.2 t -127.65 -27.72 2.82 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-O 118.338 -0.839 . . . . 0.0 112.628 -178.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 47.9 t -65.14 129.75 94.57 Favored Pre-proline 0 CA--C 1.542 0.643 0 CA-C-N 120.026 1.284 . . . . 0.0 108.541 169.599 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -83.39 -11.37 9.55 Favored 'Trans proline' 0 CA--C 1.537 0.669 0 C-N-CA 123.071 2.514 . . . . 0.0 112.053 173.468 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 16.8 ttmt -55.12 -44.3 99.54 Favored Pre-proline 0 CA--C 1.54 0.561 0 CA-C-O 117.355 -1.307 . . . . 0.0 113.801 -168.486 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -87.5 7.76 4.56 Favored 'Trans proline' 0 C--N 1.35 0.634 0 CA-C-N 121.842 1.693 . . . . 0.0 113.777 -176.702 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 16.4 m -130.21 165.9 29.22 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.278 0 CA-C-N 121.115 1.78 . . . . 0.0 112.481 -171.167 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 12.9 pt -135.09 172.2 16.39 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.531 0 C-N-CA 128.239 2.616 . . . . 0.0 108.263 179.501 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . 53.59 42.2 31.94 Favored 'General case' 0 N--CA 1.464 0.226 0 C-N-CA 125.471 1.509 . . . . 0.0 112.648 173.726 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 27.0 t0 55.0 41.63 31.73 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 126.231 1.812 . . . . 0.0 111.766 -177.509 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 91.31 13.22 58.92 Favored Glycine 0 CA--C 1.527 0.8 0 CA-C-O 118.916 -0.935 . . . . 0.0 113.808 174.442 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 45.2 mt-30 -87.37 -7.65 57.5 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 119.29 1.545 . . . . 0.0 112.862 -177.9 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 7.6 tp -155.58 145.76 21.69 Favored 'General case' 0 C--N 1.344 0.358 0 CA-C-N 119.509 1.05 . . . . 0.0 110.797 172.238 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 61.7 m-85 -82.96 147.16 28.38 Favored 'General case' 0 CA--C 1.518 -0.279 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 169.596 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 16.7 m -77.1 2.62 1.68 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.576 0 C-N-CA 123.881 0.872 . . . . 0.0 112.393 177.234 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -172.28 169.81 42.89 Favored Glycine 0 CA--C 1.526 0.739 0 N-CA-C 110.829 -0.908 . . . . 0.0 110.829 -179.195 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 4.8 tp -63.6 135.01 56.48 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 124.272 1.029 . . . . 0.0 111.19 -179.566 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -92.99 128.04 38.71 Favored 'General case' 0 N--CA 1.446 -0.643 0 C-N-CA 124.981 1.312 . . . . 0.0 109.131 173.254 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 89.8 mt -116.47 157.92 24.4 Favored 'General case' 0 N--CA 1.464 0.248 0 C-N-CA 123.708 0.803 . . . . 0.0 109.69 169.886 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -151.79 154.45 36.27 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 126.784 2.034 . . . . 0.0 107.858 -179.606 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 74.0 mm-40 -131.56 21.84 4.7 Favored 'General case' 0 CA--C 1.546 0.827 0 C-N-CA 124.191 0.996 . . . . 0.0 111.239 176.39 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 27.5 m -131.92 -48.91 0.95 Allowed 'General case' 0 C--O 1.234 0.246 0 C-N-CA 124.703 1.201 . . . . 0.0 110.638 -173.739 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 4.6 m-80 -82.19 -42.51 18.91 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 125.896 1.678 . . . . 0.0 111.248 -170.275 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 18.5 pt20 -143.62 29.09 1.41 Allowed 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 124.453 1.101 . . . . 0.0 112.376 -168.703 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 44.1 p90 -52.32 -29.15 22.17 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 124.55 1.14 . . . . 0.0 113.685 -170.226 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -57.95 -33.59 69.0 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 124.381 1.073 . . . . 0.0 112.552 178.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . 0.282 0.2 OUTLIER -118.88 11.11 12.49 Favored 'General case' 0 C--O 1.221 -0.415 0 C-N-CA 124.583 1.153 . . . . 0.0 112.147 -179.216 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 60.9 m -60.11 -33.69 72.48 Favored 'General case' 0 CA--C 1.537 0.476 0 O-C-N 120.036 -1.665 . . . . 0.0 110.223 168.886 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -56.8 -41.78 78.35 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 123.814 0.846 . . . . 0.0 111.181 169.269 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 28.8 tt0 -70.19 -40.48 74.61 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 124.811 1.244 . . . . 0.0 111.144 -179.636 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 10.9 mmt180 -59.43 -44.22 92.94 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-O 118.296 -0.859 . . . . 0.0 109.271 174.434 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 51.5 mt -60.99 -55.28 25.74 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.242 0 N-CA-C 107.806 -1.183 . . . . 0.0 107.806 175.441 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 1.6 tm0? -53.64 -60.74 2.92 Favored 'General case' 0 N--CA 1.454 -0.275 0 CA-C-N 119.141 0.882 . . . . 0.0 112.327 -172.765 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 31.7 m -61.52 -35.92 79.08 Favored 'General case' 0 C--N 1.32 -0.701 0 C-N-CA 122.895 0.478 . . . . 0.0 111.703 -177.022 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 160' ' ' TRP . . . . . . . . . . . . . 57.6 t90 -64.04 -45.47 88.72 Favored 'General case' 0 C--O 1.222 -0.361 0 CA-C-N 118.625 0.648 . . . . 0.0 110.53 173.618 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 99.0 m -61.61 -42.98 99.64 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 123.086 0.554 . . . . 0.0 110.703 -178.551 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -64.91 -35.88 82.58 Favored 'General case' 0 C--N 1.333 -0.123 0 CA-C-N 117.946 0.339 . . . . 0.0 110.857 175.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 17.1 tt0 -68.71 -52.27 32.55 Favored 'General case' 0 N--CA 1.445 -0.689 0 O-C-N 121.485 -0.76 . . . . 0.0 110.029 179.82 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 42.0 pt -62.48 -36.5 75.19 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.445 0 CA-C-O 117.997 -1.001 . . . . 0.0 109.605 -175.704 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -64.57 -36.68 85.02 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 119.466 1.03 . . . . 0.0 109.824 -179.536 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 34.7 m-80 -67.45 -50.55 58.74 Favored 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 174.739 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 25.8 tt0 -73.36 -16.74 61.34 Favored 'General case' 0 N--CA 1.442 -0.858 0 C-N-CA 125.852 1.661 . . . . 0.0 112.034 -169.392 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 168' ' ' MET . . . . . . . . . . . . . 21.2 ptp -90.08 -40.11 12.48 Favored 'General case' 0 N--CA 1.456 -0.168 0 C-N-CA 124.323 1.049 . . . . 0.0 111.448 168.507 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -73.68 -26.37 60.69 Favored 'General case' 0 N--CA 1.454 -0.265 0 CA-C-O 119.147 -0.454 . . . . 0.0 112.152 -173.574 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -58.23 -29.82 66.03 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 123.22 0.608 . . . . 0.0 112.102 -179.427 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 98.6 m-70 -72.84 -14.0 61.41 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 124.562 1.145 . . . . 0.0 112.486 177.84 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 67.1 m-85 -132.18 17.06 4.55 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 126.866 2.067 . . . . 0.0 111.601 -169.78 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.255 1.357 0 C-N-CA 124.247 1.019 . . . . 0.0 109.893 175.537 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.497 1.887 0 N-CA-C 111.261 0.097 . . . . 0.0 111.261 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 26.5 p-10 -126.26 166.22 17.52 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 125.107 1.363 . . . . 0.0 111.385 -173.341 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 11.4 mtt -131.28 123.87 29.27 Favored 'General case' 0 CA--C 1.522 -0.107 0 C-N-CA 123.29 0.636 . . . . 0.0 111.371 178.225 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -86.33 153.27 26.26 Favored Glycine 0 CA--C 1.523 0.594 0 N-CA-C 106.985 -2.446 . . . . 0.0 106.985 167.127 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 1.9 tt -141.73 96.11 2.92 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 119.664 1.732 . . . . 0.0 106.373 -173.265 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -101.68 141.56 34.36 Favored 'General case' 0 CA--C 1.518 -0.267 0 CA-C-O 121.271 0.558 . . . . 0.0 111.938 -170.192 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 43.1 p90 -163.58 176.87 9.26 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 126.749 2.02 . . . . 0.0 107.389 -177.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 168.82 88.97 0.07 OUTLIER Glycine 0 C--N 1.337 0.587 0 N-CA-C 109.164 -1.575 . . . . 0.0 109.164 178.774 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 3.8 m -140.4 130.67 25.1 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 117.198 0.499 . . . . 0.0 110.81 -168.721 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 2.8 p -80.5 -60.27 2.38 Favored 'General case' 0 C--O 1.236 0.343 0 C-N-CA 125.026 1.33 . . . . 0.0 109.173 173.606 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 3.0 p -70.6 143.81 51.39 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 124.285 1.034 . . . . 0.0 108.746 170.421 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 71.2 m 45.59 55.64 6.52 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 125.349 1.46 . . . . 0.0 111.238 -178.337 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 43.7 p90 -51.17 122.05 7.09 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-O 122.141 0.972 . . . . 0.0 110.657 -169.212 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 4.3 m -79.0 -5.59 54.27 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 124.731 1.212 . . . . 0.0 113.598 -166.728 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -52.89 -40.91 63.88 Favored 'General case' 0 N--CA 1.466 0.363 0 C-N-CA 123.722 0.809 . . . . 0.0 111.205 -175.614 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 21.4 ptp -65.38 -43.01 92.06 Favored 'General case' 0 C--N 1.342 0.276 0 CA-C-N 118.383 0.538 . . . . 0.0 112.014 -176.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -63.12 -44.78 94.68 Favored 'General case' 0 C--N 1.342 0.264 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 175.097 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -62.84 -48.14 80.33 Favored 'General case' 0 N--CA 1.452 -0.364 0 C-N-CA 122.999 0.52 . . . . 0.0 111.402 -174.832 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -68.42 -37.15 80.03 Favored 'General case' 0 CA--C 1.534 0.327 0 O-C-N 121.743 -0.598 . . . . 0.0 110.485 -179.43 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 28.6 mtpp -66.04 -40.23 90.83 Favored 'General case' 0 C--O 1.224 -0.244 0 CA-C-O 118.564 -0.731 . . . . 0.0 110.629 177.523 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 33.4 mt -55.69 -54.36 26.89 Favored 'Isoleucine or valine' 0 C--O 1.233 0.218 0 CA-C-N 119.642 1.11 . . . . 0.0 109.355 177.023 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 17.5 ptt180 -63.53 -38.6 91.76 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 118.801 0.728 . . . . 0.0 110.113 -177.039 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -64.02 -37.8 88.76 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-O 121.051 0.453 . . . . 0.0 110.151 -175.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 66.7 mt -76.03 -55.11 12.15 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.678 0 C-N-CA 125.136 1.374 . . . . 0.0 110.141 -176.275 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 62.7 mt -61.72 -47.84 91.44 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.403 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 -178.883 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 141.71 114.09 1.04 Allowed Glycine 0 CA--C 1.526 0.773 0 C-N-CA 125.396 1.474 . . . . 0.0 109.465 -175.912 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 70.5 Cg_endo -73.33 -8.4 21.83 Favored 'Trans proline' 0 CA--C 1.538 0.678 0 C-N-CA 122.517 2.145 . . . . 0.0 113.51 -169.729 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -76.63 -21.37 55.59 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 119.116 0.871 . . . . 0.0 111.839 179.107 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -122.74 7.87 9.41 Favored 'General case' 0 C--N 1.342 0.282 0 C-N-CA 124.842 1.257 . . . . 0.0 113.256 -171.542 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 44.0 t -124.89 151.18 30.27 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.369 0 N-CA-C 107.604 -1.258 . . . . 0.0 107.604 175.252 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 24.6 m -136.23 133.9 37.53 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 125.714 1.606 . . . . 0.0 107.927 -176.893 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 17.6 mt -80.52 138.17 36.5 Favored 'General case' 0 N--CA 1.463 0.222 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 176.086 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 24.7 t-80 -131.89 59.9 1.69 Allowed 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 124.588 1.155 . . . . 0.0 108.629 -176.576 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 37.9 t30 -59.7 124.22 19.44 Favored 'General case' 0 CA--C 1.531 0.226 0 N-CA-C 107.935 -1.135 . . . . 0.0 107.935 172.209 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 55.1 mt -71.37 -31.06 66.87 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-N 118.857 0.753 . . . . 0.0 112.73 -169.705 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 22.8 tptm -60.33 -27.46 67.37 Favored 'General case' 0 C--O 1.234 0.264 0 C-N-CA 123.507 0.723 . . . . 0.0 110.379 170.345 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -93.12 -34.64 13.57 Favored 'General case' 0 C--O 1.234 0.282 0 N-CA-C 112.834 0.679 . . . . 0.0 112.834 -174.639 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 3.8 t0 -144.69 148.49 34.28 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 118.869 0.759 . . . . 0.0 113.048 -176.831 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 15.2 m -70.7 157.22 90.67 Favored Pre-proline 0 CA--C 1.543 0.683 0 C-N-CA 125.925 1.69 . . . . 0.0 112.292 -169.342 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -74.64 -26.76 11.37 Favored 'Trans proline' 0 C--N 1.352 0.753 0 C-N-CA 122.662 2.241 . . . . 0.0 113.938 -172.317 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.87 -15.95 63.39 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-N 120.421 1.464 . . . . 0.0 112.187 -179.442 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -57.65 -31.21 66.08 Favored 'General case' 0 N--CA 1.466 0.363 0 C-N-CA 125.811 1.644 . . . . 0.0 110.166 170.777 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 57.2 mtt -56.4 -26.17 52.41 Favored 'General case' 0 N--CA 1.467 0.379 0 C-N-CA 123.699 0.799 . . . . 0.0 111.565 179.133 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 60.1 mt-10 -66.64 -32.93 74.58 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 118.436 0.562 . . . . 0.0 110.553 -177.659 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 19.8 mt-30 -67.65 -43.55 80.0 Favored 'General case' 0 C--O 1.232 0.181 0 N-CA-C 112.872 0.693 . . . . 0.0 112.872 -169.366 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 37.5 m-85 -72.23 135.91 46.21 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.733 -167.103 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -71.19 -38.03 72.11 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-N 118.101 0.41 . . . . 0.0 110.404 -179.468 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 14.8 t -105.31 143.66 16.18 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.56 0 N-CA-C 107.202 -1.407 . . . . 0.0 107.202 168.766 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 33.8 tp -131.6 115.34 15.97 Favored 'General case' 0 N--CA 1.446 -0.657 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 174.078 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 27.9 mt -91.99 131.94 37.72 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.681 0 N-CA-C 106.863 -1.532 . . . . 0.0 106.863 176.802 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 2.4 mp -109.72 127.35 54.54 Favored 'General case' 0 CA--C 1.516 -0.338 0 C-N-CA 125.717 1.607 . . . . 0.0 107.106 -179.832 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -129.18 130.72 6.5 Favored Glycine 0 C--N 1.332 0.329 0 N-CA-C 108.617 -1.793 . . . . 0.0 108.617 176.556 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 4.6 tt -152.26 129.56 5.72 Favored Pre-proline 0 CA--C 1.531 0.226 0 CA-C-N 117.636 0.718 . . . . 0.0 110.914 172.574 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -80.0 132.81 9.7 Favored 'Trans proline' 0 N--CA 1.447 -1.25 0 N-CA-C 107.017 -1.955 . . . . 0.0 107.017 165.548 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 41.7 m -94.38 111.38 23.12 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 103.122 -2.918 . . . . 0.0 103.122 167.137 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 9.7 t90 -67.29 151.3 47.73 Favored 'General case' 0 CA--C 1.535 0.389 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 -176.033 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -64.72 125.07 23.6 Favored 'General case' 0 C--O 1.236 0.386 0 N-CA-C 109.889 -0.412 . . . . 0.0 109.889 -175.732 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 1.8 t80 48.01 40.47 13.29 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 124.748 1.219 . . . . 0.0 111.404 -171.298 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -140.7 -166.78 10.82 Favored Glycine 0 CA--C 1.529 0.961 0 C-N-CA 125.603 1.573 . . . . 0.0 111.261 -177.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 30.6 tt0 -147.39 169.44 19.47 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 125.087 1.355 . . . . 0.0 108.836 -173.021 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 8.4 mt -28.66 131.0 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.543 0.707 0 C-N-CA 128.688 2.795 . . . . 0.0 113.039 173.788 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 3.9 mp0 -74.87 153.8 38.51 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 125.294 1.438 . . . . 0.0 109.5 179.636 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -54.7 -46.17 74.12 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 123.669 0.788 . . . . 0.0 112.207 -169.184 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 23.3 t0 -62.35 -32.71 73.54 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-O 121.57 0.7 . . . . 0.0 112.184 -174.738 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -82.5 -43.5 17.1 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 123.739 0.816 . . . . 0.0 109.257 -179.587 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 6.1 tt0 -63.05 -35.11 79.15 Favored 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 124.79 1.236 . . . . 0.0 109.805 -179.287 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -58.97 -24.45 62.67 Favored 'General case' 0 C--O 1.233 0.2 0 C-N-CA 124.129 0.971 . . . . 0.0 111.69 -175.825 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 34.6 m -114.7 -14.99 10.5 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.228 0 CA-C-O 117.471 -1.252 . . . . 0.0 112.66 177.206 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 30.6 t90 -52.02 -38.86 58.36 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 119.974 1.261 . . . . 0.0 111.031 -177.032 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -68.36 -23.82 64.73 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 125.039 1.336 . . . . 0.0 113.185 178.218 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 22.7 mt-30 -91.73 -23.94 19.61 Favored 'General case' 0 C--N 1.34 0.167 0 C-N-CA 125.377 1.471 . . . . 0.0 111.973 -179.379 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 19.7 mt -64.26 -25.69 68.17 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 118.167 0.44 . . . . 0.0 111.63 -172.012 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -69.13 -21.77 64.0 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-N 117.966 0.348 . . . . 0.0 111.388 177.284 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -76.39 -24.05 54.08 Favored 'General case' 0 CA--C 1.537 0.462 0 O-C-N 120.971 -1.08 . . . . 0.0 112.68 -178.811 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 49.2 mt -65.63 149.54 49.92 Favored 'General case' 0 C--O 1.233 0.205 0 C-N-CA 124.794 1.238 . . . . 0.0 111.537 -170.296 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 27.8 t-20 -83.77 113.32 20.82 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 171.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 65.2 mt -128.66 1.8 5.5 Favored 'General case' 0 N--CA 1.472 0.659 0 N-CA-C 113.318 0.859 . . . . 0.0 113.318 -172.37 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 30.4 mt-10 -55.55 130.73 44.06 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-O 122.046 0.927 . . . . 0.0 111.347 -168.889 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 73.29 -2.45 36.74 Favored Glycine 0 CA--C 1.533 1.202 0 CA-C-O 117.987 -1.452 . . . . 0.0 115.105 176.791 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.64 149.55 41.93 Favored 'General case' 0 C--N 1.346 0.418 0 CA-C-N 120.749 2.274 . . . . 0.0 109.646 -177.036 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 7.6 mt -80.47 135.56 25.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 N-CA-C 106.269 -1.752 . . . . 0.0 106.269 178.372 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 63.4 t -129.11 128.56 67.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 C-N-CA 123.466 0.706 . . . . 0.0 109.715 -177.769 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -98.3 143.75 28.45 Favored 'General case' 0 CA--C 1.522 -0.114 0 N-CA-C 106.98 -1.489 . . . . 0.0 106.98 167.847 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 9.5 mt -122.11 132.24 54.38 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 107.243 -1.392 . . . . 0.0 107.243 176.241 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 22.9 p90 -150.72 165.05 34.63 Favored 'General case' 0 N--CA 1.444 -0.75 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 168.088 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -163.91 178.2 39.43 Favored Glycine 0 N--CA 1.435 -1.414 0 N-CA-C 109.739 -1.344 . . . . 0.0 109.739 171.314 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 5.8 tt -127.18 155.22 43.74 Favored 'General case' 0 N--CA 1.445 -0.706 0 C-N-CA 125.253 1.421 . . . . 0.0 107.448 178.682 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -158.95 -159.83 9.94 Favored Glycine 0 CA--C 1.523 0.535 0 N-CA-C 109.068 -1.613 . . . . 0.0 109.068 169.805 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 20.2 t0 -119.56 118.2 30.39 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 107.409 -1.33 . . . . 0.0 107.409 169.88 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 23.1 mt-30 -70.61 -21.39 62.66 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 123.559 0.744 . . . . 0.0 110.853 179.478 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 80.1 mt -75.58 -0.66 21.22 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-N 119.415 1.007 . . . . 0.0 111.109 168.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -77.06 19.67 3.4 Favored Glycine 0 CA--C 1.535 1.33 0 C-N-CA 125.237 1.399 . . . . 0.0 112.129 167.83 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 35.3 m-85 61.96 3.05 0.86 Allowed 'General case' 0 N--CA 1.465 0.289 0 C-N-CA 127.593 2.357 . . . . 0.0 115.231 171.473 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 71.19 21.13 78.45 Favored Glycine 0 CA--C 1.53 1.015 0 N-CA-C 110.8 -0.92 . . . . 0.0 110.8 -174.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -85.86 -28.63 24.29 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 124.424 1.089 . . . . 0.0 108.55 167.176 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' TRP . . . . . . . . . . . . . 7.7 m0 -126.45 1.63 6.95 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 124.838 1.255 . . . . 0.0 113.552 -168.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 14.7 t80 -73.58 131.39 41.66 Favored 'General case' 0 N--CA 1.46 0.061 0 O-C-N 121.279 -0.888 . . . . 0.0 109.022 -171.536 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 91.9 mt 52.53 23.47 2.59 Favored 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 114.613 1.338 . . . . 0.0 114.613 168.263 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -62.62 -35.22 78.89 Favored 'General case' 0 N--CA 1.465 0.311 0 O-C-N 120.651 -1.281 . . . . 0.0 110.672 -172.074 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -72.98 -28.67 62.53 Favored 'General case' 0 N--CA 1.452 -0.334 0 N-CA-C 113.096 0.776 . . . . 0.0 113.096 176.543 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 5.0 tt -61.43 -45.33 94.75 Favored 'General case' 0 CA--C 1.535 0.394 0 N-CA-C 107.308 -1.367 . . . . 0.0 107.308 170.276 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -61.76 -42.24 99.72 Favored Glycine 0 C--N 1.341 0.806 0 N-CA-C 111.302 -0.719 . . . . 0.0 111.302 179.162 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 74.8 mtm -61.94 -41.14 97.62 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 118.094 0.947 . . . . 0.0 111.662 178.244 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -72.22 -38.1 69.05 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 119.944 1.247 . . . . 0.0 111.131 -179.297 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 29.4 t-80 -57.21 -46.85 82.53 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 117.855 0.298 . . . . 0.0 110.38 172.587 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -63.85 -45.54 89.06 Favored 'General case' 0 C--N 1.33 -0.239 0 C-N-CA 123.457 0.703 . . . . 0.0 111.604 -177.753 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 24.5 ttmm -54.04 -45.26 71.56 Favored 'General case' 0 N--CA 1.464 0.227 0 C-N-CA 123.764 0.825 . . . . 0.0 109.735 173.287 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 22.2 mt -83.2 -19.89 35.67 Favored 'General case' 0 CA--C 1.514 -0.419 0 N-CA-C 114.887 1.44 . . . . 0.0 114.887 -169.43 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 6.5 t -57.85 -36.12 71.87 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-N 119.826 1.194 . . . . 0.0 110.598 -175.378 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 22.0 p -87.17 -8.33 57.03 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 124.802 1.241 . . . . 0.0 112.341 -179.184 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 32.3 mmmt -85.29 -7.13 59.15 Favored 'General case' 0 C--N 1.345 0.398 0 C-N-CA 124.61 1.164 . . . . 0.0 111.556 174.512 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 72.84 31.93 61.73 Favored Glycine 0 CA--C 1.523 0.567 0 CA-C-O 119.459 -0.634 . . . . 0.0 112.516 171.035 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 17.0 m -74.59 177.45 0.56 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.572 0 CA-C-N 118.386 1.093 . . . . 0.0 109.836 172.758 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -116.66 125.8 52.29 Favored 'General case' 0 CA--C 1.515 -0.388 0 N-CA-C 106.332 -1.729 . . . . 0.0 106.332 170.649 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 68.7 m-85 -91.45 146.03 24.14 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 119.847 1.203 . . . . 0.0 110.198 -177.594 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 33.5 m -133.3 158.43 42.98 Favored 'Isoleucine or valine' 0 C--O 1.235 0.323 0 C-N-CA 125.385 1.474 . . . . 0.0 107.503 169.044 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 85.41 35.19 12.34 Favored Glycine 0 N--CA 1.452 -0.252 0 CA-C-O 118.919 -0.934 . . . . 0.0 114.349 169.729 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 8.2 m-30 -67.86 155.2 39.89 Favored 'General case' 0 CA--C 1.544 0.729 0 CA-C-N 118.815 1.307 . . . . 0.0 109.403 169.611 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 1.6 t90 -136.46 137.96 25.52 Favored Pre-proline 0 CA--C 1.541 0.609 0 CA-C-O 117.305 -1.331 . . . . 0.0 108.342 -171.243 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_exo -70.58 130.92 19.1 Favored 'Trans proline' 0 C--N 1.348 0.501 0 C-N-CA 123.179 2.586 . . . . 0.0 113.037 -170.32 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 40.1 p -70.5 -7.56 44.53 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 113.457 0.91 . . . . 0.0 113.457 172.919 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -59.09 140.1 56.18 Favored 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 124.742 1.217 . . . . 0.0 110.122 -176.204 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 80.55 13.66 81.24 Favored Glycine 0 CA--C 1.534 1.24 0 CA-C-N 115.268 -0.878 . . . . 0.0 113.689 177.105 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 25.4 t80 -136.46 161.28 36.29 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 118.884 1.342 . . . . 0.0 109.617 174.319 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -132.64 136.51 46.54 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 125.251 1.421 . . . . 0.0 107.988 -179.203 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 13.2 p90 -154.06 170.51 20.95 Favored 'General case' 0 C--O 1.235 0.322 0 C-N-CA 125.251 1.42 . . . . 0.0 109.436 -169.319 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 11.6 t -135.77 -34.59 0.82 Allowed 'General case' 0 C--O 1.235 0.323 0 N-CA-C 112.035 0.383 . . . . 0.0 112.035 -176.046 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 58.8 m -74.06 128.83 85.75 Favored Pre-proline 0 CA--C 1.541 0.601 0 N-CA-C 108.912 -0.774 . . . . 0.0 108.912 177.566 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -83.36 -22.62 3.84 Favored 'Trans proline' 0 CA--C 1.538 0.679 0 C-N-CA 122.537 2.158 . . . . 0.0 113.304 -172.518 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 26.2 ttmt -52.88 -42.54 90.5 Favored Pre-proline 0 CA--C 1.541 0.616 0 CA-C-O 117.091 -1.433 . . . . 0.0 114.791 -171.109 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_endo -74.63 -4.5 15.51 Favored 'Trans proline' 0 C--N 1.352 0.717 0 CA-C-N 122.108 1.789 . . . . 0.0 114.11 -178.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 20.8 m -131.76 167.89 25.27 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.412 0 CA-C-N 120.96 1.709 . . . . 0.0 111.673 -169.552 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 25.1 pt -127.87 170.05 18.28 Favored 'Isoleucine or valine' 0 C--O 1.234 0.27 0 C-N-CA 126.689 1.996 . . . . 0.0 109.207 175.169 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . 57.91 32.92 22.59 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 125.416 1.486 . . . . 0.0 113.768 167.711 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 27.7 t70 56.21 40.11 30.1 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 126.323 1.849 . . . . 0.0 111.254 -174.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 91.31 74.99 1.29 Allowed Glycine 0 C--N 1.338 0.657 0 C-N-CA 124.46 1.029 . . . . 0.0 111.259 177.682 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 74.1 mm-40 -120.66 -49.62 2.23 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 123.179 0.592 . . . . 0.0 110.771 168.251 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -131.0 145.03 51.92 Favored 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 122.997 0.519 . . . . 0.0 110.205 -178.86 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 73.3 m-85 -76.61 17.71 0.38 Allowed 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 125.573 1.549 . . . . 0.0 114.644 174.795 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 4.1 m 47.84 15.26 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.546 0.802 0 C-N-CA 127.915 2.486 . . . . 0.0 114.37 -174.053 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 168.22 174.0 36.66 Favored Glycine 0 CA--C 1.526 0.78 0 N-CA-C 108.792 -1.723 . . . . 0.0 108.792 -169.339 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . 0.439 ' HB2' ' CD1' ' A' ' 160' ' ' TRP . 1.7 tp -71.88 142.13 49.55 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 118.215 1.008 . . . . 0.0 111.92 179.701 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -104.8 130.0 52.99 Favored 'General case' 0 N--CA 1.447 -0.585 0 C-N-CA 127.482 2.313 . . . . 0.0 109.416 178.034 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 87.5 mt -129.62 155.62 45.54 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 125.038 1.335 . . . . 0.0 108.461 173.103 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -128.2 155.0 45.2 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 124.776 1.231 . . . . 0.0 110.302 -179.383 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -132.48 13.12 4.54 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 123.902 0.881 . . . . 0.0 112.705 -176.819 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 97.3 m -135.79 -51.65 0.73 Allowed 'General case' 0 C--N 1.341 0.199 0 O-C-N 121.246 -0.909 . . . . 0.0 112.163 -168.787 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 3.3 p30 -110.67 -31.72 7.12 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 125.429 1.492 . . . . 0.0 111.184 -170.013 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 29.6 mt-30 -133.64 27.07 4.03 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 124.834 1.254 . . . . 0.0 111.046 -172.867 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 41.4 p90 -61.21 -27.14 68.21 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 123.458 0.703 . . . . 0.0 112.187 -176.539 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -64.41 -33.94 77.03 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 122.965 0.506 . . . . 0.0 111.142 176.542 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 97.7 mt -84.83 -14.96 46.37 Favored 'General case' 0 C--O 1.224 -0.287 0 CA-C-O 118.038 -0.982 . . . . 0.0 112.015 -179.291 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 73.3 m -57.28 -28.28 62.87 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 120.42 1.464 . . . . 0.0 111.64 178.5 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -60.35 -45.48 93.33 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 119.51 1.05 . . . . 0.0 111.882 172.387 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 -67.29 -44.23 79.78 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 125.38 1.472 . . . . 0.0 110.244 177.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 38.7 mtp180 -62.52 -40.08 95.62 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-O 117.826 -1.083 . . . . 0.0 109.682 179.35 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 48.7 mt -63.18 -55.38 23.68 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.475 0 CA-C-N 119.891 1.223 . . . . 0.0 107.991 172.453 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 70.5 tp60 -50.21 -63.78 1.01 Allowed 'General case' 0 C--O 1.232 0.176 0 C-N-CA 124.808 1.243 . . . . 0.0 111.86 -174.584 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 24.0 m -66.0 -32.99 74.8 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 120.666 -0.414 . . . . 0.0 111.136 -170.365 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 160' ' ' TRP . . . . . 0.439 ' CD1' ' HB2' ' A' ' 142' ' ' LEU . 82.4 t90 -67.09 -46.13 75.16 Favored 'General case' 0 C--O 1.222 -0.39 0 O-C-N 121.999 -0.438 . . . . 0.0 110.889 175.257 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 61.4 m -58.2 -43.9 87.84 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 118.48 0.582 . . . . 0.0 110.157 179.502 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -62.28 -43.91 97.74 Favored 'General case' 0 CA--C 1.528 0.123 0 N-CA-C 109.886 -0.413 . . . . 0.0 109.886 176.842 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 14.9 tt0 -62.58 -50.32 71.76 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-O 117.946 -1.026 . . . . 0.0 110.225 -177.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 41.6 pt -65.01 -33.53 64.35 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.485 0 CA-C-N 119.678 1.126 . . . . 0.0 110.224 -176.335 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -70.48 -34.19 72.11 Favored 'General case' 0 C--O 1.223 -0.322 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 -175.998 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -71.33 -45.19 63.58 Favored 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 124.531 1.132 . . . . 0.0 109.982 175.082 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 21.9 tt0 -78.3 -24.57 46.63 Favored 'General case' 0 N--CA 1.441 -0.905 0 C-N-CA 124.22 1.008 . . . . 0.0 110.319 -169.374 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 168' ' ' MET . . . . . . . . . . . . . 19.2 ptp -82.26 -29.72 31.1 Favored 'General case' 0 N--CA 1.461 0.104 0 O-C-N 121.694 -0.629 . . . . 0.0 111.657 171.843 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -79.36 -36.3 39.52 Favored 'General case' 0 N--CA 1.447 -0.613 0 C-N-CA 122.573 0.349 . . . . 0.0 111.001 -178.198 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -68.59 -29.06 67.51 Favored 'General case' 0 CA--C 1.535 0.392 0 O-C-N 122.138 -0.351 . . . . 0.0 110.396 177.356 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 80.9 t60 -64.77 -24.65 67.62 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 123.928 0.891 . . . . 0.0 110.863 174.433 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 2.3 m-85 -83.29 -9.64 58.98 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 124.928 1.291 . . . . 0.0 113.22 174.744 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.205 0 CA-C-N 119.461 1.028 . . . . 0.0 110.265 -178.74 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.498 1.926 0 CA-C-O 118.986 -0.531 . . . . 0.0 110.15 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 5.7 t30 -111.22 147.54 34.77 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-N 119.729 1.149 . . . . 0.0 111.377 -171.5 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 17.5 mtt -112.79 130.12 56.19 Favored 'General case' 0 N--CA 1.462 0.174 0 C-N-CA 124.414 1.086 . . . . 0.0 110.203 -177.467 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -98.94 131.02 10.42 Favored Glycine 0 CA--C 1.522 0.506 0 N-CA-C 107.264 -2.334 . . . . 0.0 107.264 168.54 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -105.74 108.14 19.51 Favored 'General case' 0 N--CA 1.467 0.422 0 N-CA-C 105.058 -2.201 . . . . 0.0 105.058 173.974 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -99.62 145.84 27.12 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 119.401 1.0 . . . . 0.0 112.663 179.335 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 79.5 m-85 -145.67 169.61 18.11 Favored 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 126.681 1.992 . . . . 0.0 108.726 -178.401 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -86.8 -168.67 45.11 Favored Glycine 0 CA--C 1.534 1.278 0 N-CA-C 109.867 -1.293 . . . . 0.0 109.867 166.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 3.1 p -65.21 -54.33 31.08 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 124.251 1.021 . . . . 0.0 109.46 169.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 7.9 m 67.39 146.62 0.04 OUTLIER 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 128.361 2.665 . . . . 0.0 113.415 178.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 5.5 m -63.35 122.17 15.55 Favored 'General case' 0 CA--C 1.535 0.397 0 N-CA-C 108.342 -0.985 . . . . 0.0 108.342 -178.488 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 34.8 m 53.0 26.45 4.77 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 124.972 1.309 . . . . 0.0 113.171 -173.66 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . 0.338 43.0 p90 53.51 157.45 0.0 OUTLIER 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 128.923 2.889 . . . . 0.0 115.58 -171.802 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 88.6 m -64.37 151.34 44.26 Favored 'General case' 0 CA--C 1.542 0.66 0 O-C-N 121.317 -0.864 . . . . 0.0 109.511 179.495 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 80.4 mm-40 -65.12 173.4 2.46 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 124.423 1.089 . . . . 0.0 111.252 -176.247 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -65.16 3.56 0.6 Allowed 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 125.629 1.572 . . . . 0.0 113.833 -173.855 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -45.33 -39.09 6.34 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 125.139 1.376 . . . . 0.0 110.236 167.888 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -57.18 -55.18 38.1 Favored 'General case' 0 N--CA 1.465 0.318 0 C-N-CA 123.672 0.789 . . . . 0.0 112.337 179.112 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 70.5 mm-40 -61.08 -45.73 93.54 Favored 'General case' 0 CA--C 1.517 -0.319 0 N-CA-C 108.134 -1.062 . . . . 0.0 108.134 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 30.0 mtpp -66.42 -39.6 89.06 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-O 118.498 -0.763 . . . . 0.0 110.107 -171.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 17.6 mt -54.61 -58.65 3.44 Favored 'Isoleucine or valine' 0 C--O 1.233 0.188 0 C-N-CA 124.639 1.175 . . . . 0.0 108.858 176.548 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 18.7 ptt180 -64.91 -39.42 93.49 Favored 'General case' 0 C--O 1.222 -0.372 0 CA-C-O 118.761 -0.637 . . . . 0.0 110.45 -177.272 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -65.53 -39.92 92.32 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.142 0.496 . . . . 0.0 110.018 -172.511 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 70.5 mt -75.5 -53.72 15.43 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.576 0 C-N-CA 125.236 1.415 . . . . 0.0 109.875 -175.419 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 71.8 mt -62.48 -46.89 95.32 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.441 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 -179.232 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 140.77 116.58 1.3 Allowed Glycine 0 CA--C 1.528 0.881 0 C-N-CA 125.842 1.687 . . . . 0.0 109.395 179.26 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -72.78 -8.18 21.97 Favored 'Trans proline' 0 CA--C 1.539 0.743 0 C-N-CA 122.739 2.292 . . . . 0.0 113.337 -170.229 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -79.67 -17.65 53.18 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 118.757 0.708 . . . . 0.0 111.865 178.02 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -125.37 8.08 7.77 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 125.204 1.402 . . . . 0.0 113.343 -174.878 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 61.3 t -124.55 149.22 28.82 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.265 0 N-CA-C 107.925 -1.139 . . . . 0.0 107.925 174.21 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 11.9 m -138.71 136.32 35.68 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 126.034 1.734 . . . . 0.0 107.023 -176.804 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 23.8 mt -90.67 146.59 23.9 Favored 'General case' 0 N--CA 1.466 0.339 0 N-CA-C 107.691 -1.226 . . . . 0.0 107.691 175.553 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 40.5 t-80 -140.34 128.27 22.03 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 107.459 -1.311 . . . . 0.0 107.459 -169.261 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 53.8 t-20 -128.66 111.18 12.91 Favored 'General case' 0 CA--C 1.516 -0.345 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 -169.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 88.9 mt -66.86 -10.7 50.97 Favored 'General case' 0 CA--C 1.535 0.381 0 N-CA-C 113.355 0.872 . . . . 0.0 113.355 -174.222 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 40.3 tptt -57.92 -29.13 64.88 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 118.82 0.737 . . . . 0.0 111.234 168.153 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -129.39 -38.01 1.59 Allowed 'General case' 0 N--CA 1.465 0.299 0 C-N-CA 123.84 0.856 . . . . 0.0 112.67 -173.049 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 42.8 m-20 -79.55 130.12 35.1 Favored 'General case' 0 C--O 1.236 0.373 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 179.758 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 14.4 m -73.28 152.7 90.26 Favored Pre-proline 0 CA--C 1.542 0.649 0 C-N-CA 123.22 0.608 . . . . 0.0 109.526 173.368 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -73.04 -24.86 16.81 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.032 1.821 . . . . 0.0 113.992 -169.616 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 1.4 mptm? -63.21 -18.06 63.11 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 119.275 0.943 . . . . 0.0 111.726 178.176 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -63.28 -25.31 68.26 Favored 'General case' 0 N--CA 1.465 0.309 0 C-N-CA 124.847 1.259 . . . . 0.0 110.746 174.341 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 54.2 mtt -61.75 -23.95 66.49 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 119.361 0.982 . . . . 0.0 111.496 177.346 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -64.32 -32.25 73.78 Favored 'General case' 0 CA--C 1.535 0.365 0 O-C-N 121.792 -0.568 . . . . 0.0 110.566 -177.602 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 25.4 mt-30 -67.17 -42.23 84.61 Favored 'General case' 0 CA--C 1.533 0.29 0 N-CA-C 113.594 0.961 . . . . 0.0 113.594 -169.397 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 62.7 m-85 -73.79 144.09 45.73 Favored 'General case' 0 C--O 1.231 0.113 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.637 -165.346 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 41.7 m-20 -77.23 -29.19 54.01 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 122.785 0.434 . . . . 0.0 109.948 -176.433 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 13.5 t -124.57 144.85 33.03 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.34 0 N-CA-C 106.564 -1.643 . . . . 0.0 106.564 168.886 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 25.0 tp -125.2 105.95 9.52 Favored 'General case' 0 N--CA 1.446 -0.669 0 N-CA-C 107.304 -1.369 . . . . 0.0 107.304 175.542 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 51.0 mt -85.83 128.6 39.13 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.687 0 N-CA-C 105.947 -1.872 . . . . 0.0 105.947 174.435 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 1.3 mp -102.55 124.1 47.5 Favored 'General case' 0 CA--C 1.515 -0.375 0 N-CA-C 106.415 -1.698 . . . . 0.0 106.415 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -122.4 120.39 4.3 Favored Glycine 0 N--CA 1.449 -0.449 0 N-CA-C 106.951 -2.46 . . . . 0.0 106.951 177.656 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 5.8 tt -149.64 116.46 3.61 Favored Pre-proline 0 C--N 1.332 -0.185 0 CA-C-N 118.033 0.916 . . . . 0.0 109.483 169.823 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 62.9 Cg_exo -64.96 146.26 87.3 Favored 'Trans proline' 0 N--CA 1.456 -0.687 0 C-N-CA 120.706 0.937 . . . . 0.0 110.394 166.194 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -129.29 134.67 48.05 Favored 'General case' 0 N--CA 1.467 0.394 0 N-CA-C 109.925 -0.398 . . . . 0.0 109.925 168.526 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 22.4 m-90 -141.61 167.17 22.78 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 126.936 2.095 . . . . 0.0 106.115 168.292 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -65.43 -39.66 92.38 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-N 118.074 0.397 . . . . 0.0 110.592 173.844 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 87.9 t80 -73.73 139.48 45.31 Favored 'General case' 0 CA--C 1.532 0.269 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 169.715 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 77.61 -61.27 3.63 Favored Glycine 0 CA--C 1.53 1.012 0 C-N-CA 123.912 0.768 . . . . 0.0 112.197 176.044 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.473 ' HG2' ' H ' ' A' ' 61' ' ' ILE . 13.5 tt0 52.94 -155.98 0.18 Allowed 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 124.504 1.122 . . . . 0.0 109.496 -169.602 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.473 ' H ' ' HG2' ' A' ' 60' ' ' GLU . 48.1 mt -47.21 121.6 0.86 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.512 0 C-N-CA 124.37 1.068 . . . . 0.0 108.605 168.868 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 1.5 pm0 -75.82 154.28 36.29 Favored 'General case' 0 C--O 1.233 0.225 0 C-N-CA 124.711 1.204 . . . . 0.0 109.821 173.662 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -57.11 -41.86 79.76 Favored 'General case' 0 C--O 1.224 -0.289 0 C-N-CA 124.045 0.938 . . . . 0.0 110.952 -171.375 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 27.8 m-20 -69.76 -15.56 63.15 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-N 119.108 0.867 . . . . 0.0 112.395 -173.912 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 11.5 t90 -92.11 -46.86 7.56 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 124.52 1.128 . . . . 0.0 108.139 173.313 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -62.66 -35.36 79.41 Favored 'General case' 0 CA--C 1.536 0.428 0 O-C-N 120.789 -1.194 . . . . 0.0 110.585 -178.785 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -61.48 -25.78 67.47 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 124.119 0.968 . . . . 0.0 110.913 -174.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 28.1 m -111.21 -14.94 10.39 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.328 0 CA-C-O 117.352 -1.308 . . . . 0.0 112.207 177.502 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 28.3 t90 -51.56 -37.51 49.98 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 120.161 1.346 . . . . 0.0 110.526 177.342 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -63.35 -27.45 69.33 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 125.305 1.442 . . . . 0.0 113.196 176.399 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 30.9 mt-30 -92.4 -20.18 21.31 Favored 'General case' 0 C--O 1.226 -0.163 0 C-N-CA 125.853 1.661 . . . . 0.0 112.567 178.004 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 41.7 mt -63.34 -24.08 67.69 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 118.895 0.77 . . . . 0.0 111.458 -176.108 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -75.8 -27.18 57.87 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 117.903 0.32 . . . . 0.0 111.373 174.541 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -79.32 -17.01 55.42 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 123.951 0.9 . . . . 0.0 112.609 -174.717 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 38.1 mt -62.53 147.9 47.55 Favored 'General case' 0 C--O 1.234 0.275 0 C-N-CA 124.261 1.025 . . . . 0.0 111.43 -170.912 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 24.7 t-20 -83.38 82.58 8.22 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 124.856 1.263 . . . . 0.0 107.933 174.373 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 3.7 pp -140.92 131.6 25.64 Favored 'General case' 0 N--CA 1.453 -0.282 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 170.903 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 25.3 mt-10 -141.1 146.59 37.29 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 127.843 2.457 . . . . 0.0 107.585 168.414 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 69.74 -3.44 9.23 Favored Glycine 0 CA--C 1.534 1.243 0 CA-C-O 118.111 -1.383 . . . . 0.0 116.285 169.658 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.93 161.96 30.07 Favored 'General case' 0 C--N 1.343 0.312 0 CA-C-N 120.282 2.041 . . . . 0.0 109.681 -177.345 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 2.2 mt -85.05 135.41 24.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 N-CA-C 107.329 -1.36 . . . . 0.0 107.329 177.794 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 77.4 t -128.47 138.23 55.19 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 -179.766 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -113.7 156.81 23.1 Favored 'General case' 0 CA--C 1.521 -0.156 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 169.305 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 2.0 mt -138.7 134.73 33.98 Favored 'General case' 0 CA--C 1.515 -0.374 0 N-CA-C 107.002 -1.481 . . . . 0.0 107.002 -178.568 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 12.2 p90 -165.15 171.24 13.99 Favored 'General case' 0 N--CA 1.451 -0.386 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 170.698 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -178.08 176.71 48.16 Favored Glycine 0 N--CA 1.449 -0.439 0 N-CA-C 109.955 -1.258 . . . . 0.0 109.955 167.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -107.93 154.87 20.98 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 124.696 1.199 . . . . 0.0 109.905 171.922 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -150.74 -153.61 6.2 Favored Glycine 0 CA--C 1.525 0.679 0 N-CA-C 107.894 -2.083 . . . . 0.0 107.894 169.71 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -145.57 123.68 12.15 Favored 'General case' 0 C--O 1.233 0.202 0 C-N-CA 123.586 0.754 . . . . 0.0 109.499 179.732 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -74.45 -13.3 60.69 Favored 'General case' 0 CA--C 1.543 0.676 0 N-CA-C 113.213 0.82 . . . . 0.0 113.213 179.62 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.414 ' C ' ' H ' ' A' ' 93' ' ' TYR . 72.1 mt -69.29 -19.28 63.9 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 119.543 1.065 . . . . 0.0 110.256 169.812 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -77.32 32.89 1.56 Allowed Glycine 0 CA--C 1.535 1.309 0 C-N-CA 124.699 1.143 . . . . 0.0 110.824 167.569 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . 0.414 ' H ' ' C ' ' A' ' 91' ' ' LEU . 56.0 m-85 56.12 -5.15 0.03 OUTLIER 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 129.051 2.94 . . . . 0.0 115.218 -172.471 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 69.39 9.99 62.2 Favored Glycine 0 CA--C 1.533 1.199 0 O-C-N 121.224 -0.922 . . . . 0.0 110.943 -168.802 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -76.42 -25.43 54.47 Favored 'General case' 0 C--N 1.342 0.25 0 CA-C-N 118.875 1.338 . . . . 0.0 109.999 169.778 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' TRP . . . . . . . . . . . . . 12.7 m0 -112.87 -5.73 13.84 Favored 'General case' 0 C--O 1.234 0.273 0 N-CA-C 113.464 0.913 . . . . 0.0 113.464 -167.75 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 1.6 p90 -82.29 155.15 24.97 Favored 'General case' 0 C--N 1.344 0.33 0 CA-C-N 119.513 1.051 . . . . 0.0 111.804 -174.803 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 71.5 mt 56.17 9.3 0.48 Allowed 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 126.41 1.884 . . . . 0.0 115.49 169.391 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -60.16 -28.7 68.14 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 120.394 1.452 . . . . 0.0 110.967 -175.37 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -71.31 -26.65 62.94 Favored 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 123.968 0.907 . . . . 0.0 112.491 176.82 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 10.1 mp -63.69 -43.47 96.56 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 119.846 1.203 . . . . 0.0 107.854 170.832 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -65.46 -39.83 95.92 Favored Glycine 0 C--N 1.339 0.747 0 N-CA-C 110.801 -0.92 . . . . 0.0 110.801 -174.875 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 70.7 mtm -63.85 -44.74 92.25 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 117.288 0.544 . . . . 0.0 111.762 178.3 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -71.04 -39.63 72.19 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 119.635 1.107 . . . . 0.0 109.908 178.865 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 42.9 t-80 -55.13 -51.79 65.32 Favored 'General case' 0 CA--C 1.53 0.206 0 O-C-N 121.64 -0.662 . . . . 0.0 110.516 176.59 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -61.38 -39.7 91.64 Favored 'General case' 0 C--O 1.235 0.311 0 C-N-CA 123.491 0.716 . . . . 0.0 111.864 -176.716 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 24.2 ttmm -56.84 -41.82 78.55 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 123.325 0.65 . . . . 0.0 110.598 173.486 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 38.2 mt -87.21 -16.5 35.12 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-O 117.628 -1.177 . . . . 0.0 114.077 -169.798 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 17.7 m -57.61 -37.83 73.91 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 120.412 1.46 . . . . 0.0 111.247 -179.759 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 21.1 p -82.52 -12.52 57.71 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 124.194 0.998 . . . . 0.0 111.561 -179.409 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 32.0 mmmt -82.27 -6.39 59.2 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 124.517 1.127 . . . . 0.0 110.853 169.582 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 71.44 27.19 71.83 Favored Glycine 0 CA--C 1.527 0.831 0 CA-C-N 119.312 0.96 . . . . 0.0 113.098 168.829 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 7.9 m -74.09 170.29 1.48 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 CA-C-N 118.5 1.15 . . . . 0.0 110.068 178.345 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 54.4 tptt -95.04 135.55 36.45 Favored 'General case' 0 CA--C 1.513 -0.472 0 N-CA-C 105.26 -2.126 . . . . 0.0 105.26 167.785 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 64.7 m-85 -103.14 122.39 44.6 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 108.099 -1.075 . . . . 0.0 108.099 171.815 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 26.2 m -107.84 158.23 7.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 C-N-CA 124.5 1.12 . . . . 0.0 108.685 168.033 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 86.1 24.69 39.91 Favored Glycine 0 CA--C 1.524 0.654 0 CA-C-O 118.076 -1.402 . . . . 0.0 115.13 169.699 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 12.3 m-30 -59.91 156.38 14.58 Favored 'General case' 0 CA--C 1.544 0.721 0 CA-C-N 119.44 1.62 . . . . 0.0 109.298 168.613 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 58.3 t-105 -135.71 143.86 46.52 Favored Pre-proline 0 N--CA 1.472 0.635 0 CA-C-O 118.094 -0.955 . . . . 0.0 111.553 -168.359 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -64.46 129.64 24.44 Favored 'Trans proline' 0 C--N 1.348 0.548 0 C-N-CA 123.344 2.696 . . . . 0.0 112.429 -178.133 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 3.7 p -84.27 -30.86 25.28 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 125.022 1.329 . . . . 0.0 111.062 169.709 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -57.37 126.69 28.42 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 124.369 1.067 . . . . 0.0 110.832 -168.833 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 77.32 -1.51 64.95 Favored Glycine 0 CA--C 1.532 1.132 0 C-N-CA 124.762 1.172 . . . . 0.0 114.288 176.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 6.4 t80 -92.46 160.94 14.84 Favored 'General case' 0 C--O 1.236 0.391 0 CA-C-N 119.468 1.634 . . . . 0.0 110.526 178.754 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 18.2 mm-40 -98.7 110.13 22.77 Favored 'General case' 0 C--O 1.233 0.226 0 N-CA-C 108.253 -1.017 . . . . 0.0 108.253 178.395 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 25.6 p90 -160.79 166.54 28.44 Favored 'General case' 0 C--O 1.237 0.395 0 C-N-CA 125.609 1.564 . . . . 0.0 108.981 -179.643 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 12.4 t -156.82 -161.5 1.1 Allowed 'General case' 0 CA--C 1.546 0.822 0 N-CA-C 106.197 -1.779 . . . . 0.0 106.197 166.874 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 75.5 m 61.63 133.02 0.03 OUTLIER Pre-proline 0 CA--C 1.552 1.041 0 C-N-CA 127.638 2.375 . . . . 0.0 113.014 -168.787 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -81.51 -24.78 4.13 Favored 'Trans proline' 0 C--N 1.351 0.68 0 C-N-CA 121.669 1.579 . . . . 0.0 113.906 -169.25 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 23.9 ttmt -58.88 -42.7 95.51 Favored Pre-proline 0 N--CA 1.474 0.762 0 CA-C-N 120.349 1.432 . . . . 0.0 114.305 -169.889 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 80.7 Cg_endo -76.66 -0.53 10.57 Favored 'Trans proline' 0 C--N 1.353 0.812 0 CA-C-N 122.216 1.827 . . . . 0.0 114.079 179.526 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 19.5 m -120.48 149.28 23.3 Favored 'Isoleucine or valine' 0 C--O 1.232 0.171 0 CA-C-N 120.479 1.491 . . . . 0.0 110.217 -178.759 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 3.2 pt -88.08 169.1 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.721 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 169.013 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . 56.0 -154.12 0.33 Allowed 'General case' 0 N--CA 1.441 -0.907 0 CA-C-N 113.603 -1.635 . . . . 0.0 109.175 169.604 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 22.4 t0 -80.67 60.7 4.08 Favored 'General case' 0 C--N 1.325 -0.482 0 C-N-CA 125.022 1.329 . . . . 0.0 109.123 169.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 63.54 30.0 76.3 Favored Glycine 0 CA--C 1.529 0.927 0 C-N-CA 124.607 1.099 . . . . 0.0 112.868 177.659 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 56.0 mm-40 -78.33 -29.19 47.49 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 117.706 0.753 . . . . 0.0 111.688 -168.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 11.7 tp -158.67 148.96 19.78 Favored 'General case' 0 CA--C 1.53 0.207 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 -174.602 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 72.5 m-85 -77.48 148.53 35.3 Favored 'General case' 0 CA--C 1.522 -0.113 0 CA-C-N 119.146 0.884 . . . . 0.0 108.789 170.088 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 33.8 m -71.43 -0.67 1.82 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.624 0 C-N-CA 123.195 0.598 . . . . 0.0 112.265 175.762 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -176.58 171.9 44.87 Favored Glycine 0 CA--C 1.524 0.633 0 O-C-N 120.745 -1.222 . . . . 0.0 110.346 -172.659 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 1.6 tp -64.67 136.13 56.64 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 118.006 0.903 . . . . 0.0 110.939 179.454 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -101.72 112.81 25.52 Favored 'General case' 0 N--CA 1.447 -0.617 0 C-N-CA 125.841 1.656 . . . . 0.0 108.873 176.266 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 95.7 mt -106.76 158.35 17.04 Favored 'General case' 0 N--CA 1.465 0.295 0 C-N-CA 124.448 1.099 . . . . 0.0 109.317 170.584 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 6.2 t0 -140.99 132.92 27.63 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 104.854 -2.276 . . . . 0.0 104.854 169.186 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -131.64 21.56 4.67 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 123.138 0.575 . . . . 0.0 110.848 177.398 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 17.5 m -98.01 -37.71 9.66 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 124.925 1.29 . . . . 0.0 109.332 170.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 41.9 m-80 -116.8 -44.63 2.82 Favored 'General case' 0 CA--C 1.515 -0.372 0 C-N-CA 125.521 1.529 . . . . 0.0 109.635 -169.372 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 24.0 mt-30 -92.03 156.04 17.68 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 124.508 1.123 . . . . 0.0 108.435 177.465 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 91.1 t80 -159.47 -51.35 0.06 Allowed 'General case' 0 N--CA 1.461 0.089 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 172.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -61.09 -43.99 98.04 Favored 'General case' 0 C--O 1.234 0.269 0 C-N-CA 123.093 0.557 . . . . 0.0 111.716 -170.78 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . 0.291 0.3 OUTLIER -100.38 0.41 39.87 Favored 'General case' 0 C--N 1.345 0.383 0 N-CA-C 113.97 1.1 . . . . 0.0 113.97 175.929 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 12.5 m -61.5 -31.85 71.85 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-N 120.575 1.534 . . . . 0.0 108.99 169.183 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -59.91 -42.5 94.03 Favored 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 124.235 1.014 . . . . 0.0 111.65 169.673 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -64.41 -47.01 80.79 Favored 'General case' 0 C--N 1.334 -0.102 0 C-N-CA 124.31 1.044 . . . . 0.0 109.848 178.907 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 68.5 mtt180 -57.58 -46.76 83.59 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-O 118.125 -0.94 . . . . 0.0 110.501 177.151 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 47.8 mt -61.03 -51.96 67.14 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.403 0 CA-C-N 119.443 1.02 . . . . 0.0 108.383 177.192 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 71.0 tp60 -52.78 -64.19 0.9 Allowed 'General case' 0 C--O 1.234 0.27 0 C-N-CA 124.633 1.173 . . . . 0.0 111.302 -177.6 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 41.3 m -66.21 -33.26 75.35 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 119.315 -0.374 . . . . 0.0 111.268 -171.459 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 160' ' ' TRP . . . . . . . . . . . . . 60.5 t90 -65.73 -47.87 73.88 Favored 'General case' 0 C--O 1.225 -0.225 0 CA-C-N 118.676 0.671 . . . . 0.0 110.707 174.705 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 64.7 m -61.3 -42.22 98.29 Favored 'General case' 0 N--CA 1.455 -0.204 0 CA-C-N 118.217 0.462 . . . . 0.0 110.299 -178.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -61.55 -44.54 96.85 Favored 'General case' 0 N--CA 1.455 -0.203 0 CA-C-N 118.308 0.504 . . . . 0.0 110.076 174.886 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 14.8 tt0 -62.6 -50.81 69.79 Favored 'General case' 0 CA--C 1.512 -0.489 0 CA-C-O 117.699 -1.143 . . . . 0.0 109.803 -176.415 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 44.7 pt -63.98 -34.13 66.58 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.425 0 CA-C-O 117.59 -1.195 . . . . 0.0 109.835 -176.578 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -71.48 -32.36 68.18 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 119.653 1.115 . . . . 0.0 108.955 -174.982 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -70.74 -53.54 15.15 Favored 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 124.347 1.059 . . . . 0.0 109.374 173.737 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 20.1 tt0 -69.02 -31.44 70.24 Favored 'General case' 0 N--CA 1.445 -0.719 0 C-N-CA 125.601 1.561 . . . . 0.0 109.943 -168.619 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 168' ' ' MET . . . . . . . . . . . . . 22.1 ptp -74.11 -34.02 63.78 Favored 'General case' 0 C--O 1.23 0.078 0 O-C-N 122.143 -0.348 . . . . 0.0 111.047 174.658 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -74.86 -37.16 62.28 Favored 'General case' 0 N--CA 1.442 -0.852 0 CA-C-O 119.276 -0.393 . . . . 0.0 111.811 -177.251 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 5.5 mt-10 -62.37 -32.91 73.78 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-O 121.572 0.701 . . . . 0.0 109.682 177.244 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 72.5 t60 -75.01 -34.55 61.93 Favored 'General case' 0 N--CA 1.446 -0.648 0 C-N-CA 124.741 1.216 . . . . 0.0 111.328 -175.774 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 4.7 m-85 -77.9 -27.6 49.61 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 123.507 0.723 . . . . 0.0 112.927 173.63 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.254 1.313 0 C-N-CA 123.461 0.704 . . . . 0.0 110.727 -177.729 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.497 1.898 0 CA-C-O 120.433 0.159 . . . . 0.0 111.286 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 26.1 p-10 -116.39 165.87 12.72 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 125.392 1.477 . . . . 0.0 111.414 -174.425 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 13.9 mtt -130.69 128.44 40.89 Favored 'General case' 0 CA--C 1.522 -0.119 0 C-N-CA 123.27 0.628 . . . . 0.0 110.717 175.367 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -90.12 149.4 20.3 Favored Glycine 0 CA--C 1.525 0.672 0 N-CA-C 106.786 -2.526 . . . . 0.0 106.786 166.56 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 2.4 tt -134.26 100.16 4.61 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 105.364 -2.087 . . . . 0.0 105.364 -178.099 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -106.22 142.84 35.23 Favored 'General case' 0 CA--C 1.519 -0.238 0 CA-C-O 121.63 0.729 . . . . 0.0 112.252 -172.727 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 34.7 p90 -155.63 165.28 37.04 Favored 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 126.697 1.999 . . . . 0.0 106.85 179.425 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -143.25 93.73 0.17 Allowed Glycine 0 CA--C 1.509 -0.306 0 N-CA-C 105.552 -3.019 . . . . 0.0 105.552 177.042 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 6.0 m -140.67 47.52 1.75 Allowed 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 124.78 1.232 . . . . 0.0 107.675 -169.735 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 6.6 m -48.21 130.18 15.81 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 125.975 1.71 . . . . 0.0 111.815 -169.193 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 6.0 m 66.1 -40.92 0.35 Allowed 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 127.834 2.453 . . . . 0.0 114.336 -176.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 61.0 m -79.94 -25.76 40.34 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 119.404 1.002 . . . . 0.0 112.84 -174.138 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 7.1 m-85 57.76 -178.69 0.06 Allowed 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 126.533 1.933 . . . . 0.0 111.752 -168.606 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 72.5 p -80.53 -175.7 5.34 Favored 'General case' 0 CA--C 1.548 0.868 0 N-CA-C 106.751 -1.574 . . . . 0.0 106.751 166.908 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 49.0 mm-40 -77.66 55.11 1.29 Allowed 'General case' 0 CA--C 1.543 0.684 0 O-C-N 120.206 -1.559 . . . . 0.0 109.254 169.886 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 52.38 24.19 2.82 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 127.776 2.43 . . . . 0.0 112.56 -171.442 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -65.65 -44.89 84.98 Favored 'General case' 0 C--N 1.34 0.179 0 O-C-N 120.946 -1.096 . . . . 0.0 109.3 -175.205 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -63.77 -45.53 89.32 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 122.195 0.198 . . . . 0.0 110.872 -176.74 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -60.24 -45.38 93.44 Favored 'General case' 0 N--CA 1.465 0.298 0 C-N-CA 123.296 0.638 . . . . 0.0 109.667 176.392 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 30.0 mtpp -70.52 -39.91 73.8 Favored 'General case' 0 C--O 1.222 -0.373 0 CA-C-O 118.441 -0.79 . . . . 0.0 110.144 -173.512 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 43.8 mt -54.88 -54.86 19.47 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.189 0 CA-C-N 119.765 1.166 . . . . 0.0 109.174 176.024 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.83 -33.87 76.56 Favored 'General case' 0 C--O 1.221 -0.399 0 CA-C-N 118.259 0.481 . . . . 0.0 111.316 -174.628 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -63.4 -40.75 98.06 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 122.67 0.388 . . . . 0.0 111.119 175.273 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 55.6 mt -76.72 -55.67 10.25 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.515 0 C-N-CA 124.644 1.178 . . . . 0.0 110.451 -171.698 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 73.4 mt -64.48 -46.3 93.18 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 -179.858 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 143.73 124.01 1.78 Allowed Glycine 0 CA--C 1.527 0.817 0 C-N-CA 124.442 1.02 . . . . 0.0 110.871 174.46 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -73.13 -9.41 23.35 Favored 'Trans proline' 0 CA--C 1.54 0.782 0 C-N-CA 123.101 2.534 . . . . 0.0 113.387 -170.914 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -81.35 -19.09 43.49 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 118.768 0.713 . . . . 0.0 111.416 178.174 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -125.12 -7.2 7.13 Favored 'General case' 0 C--N 1.344 0.335 0 C-N-CA 124.828 1.251 . . . . 0.0 113.724 -174.032 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 40.4 t -115.02 137.27 49.04 Favored 'Isoleucine or valine' 0 C--O 1.233 0.216 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 171.193 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 51.7 m -129.91 132.99 46.57 Favored 'General case' 0 C--O 1.233 0.197 0 C-N-CA 124.807 1.243 . . . . 0.0 108.268 -174.503 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 23.7 mt -75.22 144.22 42.73 Favored 'General case' 0 C--O 1.233 0.194 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 177.073 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . 0.443 ' HE2' ' HB2' ' A' ' 42' ' ' LEU . 44.4 t-80 -132.7 66.55 1.56 Allowed 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 125.141 1.376 . . . . 0.0 107.291 -177.679 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 57.0 t-20 -70.43 118.08 12.78 Favored 'General case' 0 C--O 1.233 0.234 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 -179.329 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 48.6 mt -67.74 -18.0 64.74 Favored 'General case' 0 C--O 1.232 0.183 0 N-CA-C 113.16 0.8 . . . . 0.0 113.16 -174.78 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 35.1 tptt -60.14 -23.6 64.03 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 118.698 0.681 . . . . 0.0 111.777 169.445 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -119.46 -39.41 2.89 Favored 'General case' 0 C--O 1.234 0.262 0 N-CA-C 113.279 0.844 . . . . 0.0 113.279 -172.846 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 33.1 m-20 -101.42 139.15 37.48 Favored 'General case' 0 N--CA 1.465 0.302 0 C-N-CA 123.947 0.899 . . . . 0.0 110.531 -177.654 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 11.4 m -75.28 155.82 85.83 Favored Pre-proline 0 CA--C 1.542 0.644 0 C-N-CA 124.124 0.97 . . . . 0.0 110.16 174.779 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -74.71 -25.68 12.26 Favored 'Trans proline' 0 C--N 1.349 0.553 0 C-N-CA 121.909 1.74 . . . . 0.0 113.472 -170.196 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 1.7 mptm? -62.9 -21.08 65.76 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-N 120.329 1.422 . . . . 0.0 112.082 -179.186 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.443 ' HB2' ' HE2' ' A' ' 33' ' ' HIS . 2.1 mm? -62.25 -26.53 68.44 Favored 'General case' 0 N--CA 1.465 0.292 0 C-N-CA 125.119 1.368 . . . . 0.0 110.389 174.634 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 68.4 mtt -58.19 -27.66 64.07 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 118.94 0.791 . . . . 0.0 111.43 177.128 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 69.1 mt-10 -63.37 -32.59 74.05 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 118.238 0.472 . . . . 0.0 109.969 -175.814 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 26.2 mt-30 -67.47 -39.78 85.28 Favored 'General case' 0 C--N 1.342 0.278 0 C-N-CA 123.911 0.884 . . . . 0.0 113.191 -172.145 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 71.6 m-85 -72.95 135.16 44.99 Favored 'General case' 0 C--O 1.233 0.219 0 N-CA-C 109.446 -0.575 . . . . 0.0 109.446 -167.904 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -69.7 -44.01 71.27 Favored 'General case' 0 C--O 1.233 0.208 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 -178.843 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 12.3 t -103.52 145.49 12.53 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.396 0 N-CA-C 107.996 -1.113 . . . . 0.0 107.996 169.894 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 34.8 tp -135.41 105.97 6.47 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 175.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 32.6 mt -85.11 128.34 39.11 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.826 0 N-CA-C 106.638 -1.616 . . . . 0.0 106.638 177.698 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -94.05 144.32 25.58 Favored 'General case' 0 CA--C 1.516 -0.363 0 C-N-CA 124.787 1.235 . . . . 0.0 109.824 169.588 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -145.34 134.78 5.67 Favored Glycine 0 CA--C 1.52 0.385 0 N-CA-C 109.244 -1.542 . . . . 0.0 109.244 169.234 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 3.5 tt -156.68 139.6 10.81 Favored Pre-proline 0 CA--C 1.542 0.655 0 CA-C-N 118.737 1.268 . . . . 0.0 111.411 172.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -78.39 145.14 20.95 Favored 'Trans proline' 0 CA--C 1.538 0.718 0 C-N-CA 122.749 2.3 . . . . 0.0 111.554 167.192 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 38.6 m -106.36 147.65 28.99 Favored 'General case' 0 CA--C 1.542 0.665 0 N-CA-C 107.082 -1.451 . . . . 0.0 107.082 167.426 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 20.6 t90 -148.02 145.3 28.44 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 124.327 1.051 . . . . 0.0 109.119 -175.525 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -70.02 -38.21 75.85 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 123.429 0.692 . . . . 0.0 112.361 -176.452 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 69.3 t80 -65.07 -32.95 74.92 Favored 'General case' 0 CA--C 1.537 0.472 0 O-C-N 122.186 -0.321 . . . . 0.0 110.683 -176.712 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 172.8 120.34 0.56 Allowed Glycine 0 CA--C 1.524 0.632 0 N-CA-C 108.269 -1.933 . . . . 0.0 108.269 171.406 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 3.4 pm0 -74.76 158.92 32.68 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 123.331 0.653 . . . . 0.0 110.642 176.361 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . 0.253 49.9 mt 66.74 144.56 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.546 0.804 0 C-N-CA 127.34 2.256 . . . . 0.0 112.415 178.184 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 4.2 mp0 -108.1 153.69 22.78 Favored 'General case' 0 C--N 1.34 0.173 0 C-N-CA 125.569 1.548 . . . . 0.0 107.157 -177.317 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -57.0 -42.47 80.32 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 123.178 0.591 . . . . 0.0 110.951 -173.312 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 23.0 m-20 -66.99 -18.24 65.29 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 122.844 0.458 . . . . 0.0 112.004 -176.409 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 13.6 t90 -95.76 -44.79 7.27 Favored 'General case' 0 C--N 1.339 0.14 0 C-N-CA 124.358 1.063 . . . . 0.0 110.263 175.304 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -62.9 -34.75 78.07 Favored 'General case' 0 CA--C 1.538 0.503 0 O-C-N 120.692 -1.255 . . . . 0.0 109.673 -178.864 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -60.16 -25.32 65.43 Favored 'General case' 0 C--O 1.233 0.216 0 C-N-CA 123.839 0.856 . . . . 0.0 111.567 179.29 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 12.2 m -109.85 -16.04 9.25 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.321 0 CA-C-O 117.46 -1.257 . . . . 0.0 112.467 179.446 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 27.9 t90 -53.71 -38.53 64.37 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 120.025 1.284 . . . . 0.0 110.198 176.822 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -66.59 -27.36 67.66 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 125.476 1.51 . . . . 0.0 112.945 175.532 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 68.1 mt-30 -90.73 -23.07 20.8 Favored 'General case' 0 C--O 1.224 -0.289 0 C-N-CA 125.67 1.588 . . . . 0.0 111.978 -176.787 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 50.3 mt -57.74 -32.0 67.02 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 118.537 0.608 . . . . 0.0 110.275 173.398 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -70.4 -26.5 63.72 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 122.694 0.397 . . . . 0.0 111.233 174.548 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -81.31 -34.36 31.97 Favored 'General case' 0 CA--C 1.537 0.475 0 N-CA-C 113.307 0.854 . . . . 0.0 113.307 176.267 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 24.7 mt -59.62 149.56 29.95 Favored 'General case' 0 N--CA 1.464 0.27 0 C-N-CA 124.476 1.11 . . . . 0.0 111.104 -176.117 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 19.9 t-20 -91.15 118.42 30.43 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 169.171 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 70.4 mt -127.98 8.9 6.25 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 123.73 0.812 . . . . 0.0 112.263 -173.113 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 28.9 mt-10 -52.18 129.15 27.04 Favored 'General case' 0 C--O 1.234 0.273 0 C-N-CA 124.3 1.04 . . . . 0.0 112.272 -168.049 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 68.43 0.09 15.3 Favored Glycine 0 CA--C 1.535 1.3 0 C-N-CA 125.436 1.493 . . . . 0.0 115.525 175.828 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.66 151.34 40.81 Favored 'General case' 0 C--N 1.345 0.391 0 CA-C-N 120.555 2.177 . . . . 0.0 109.499 -174.262 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 5.8 mt -80.38 136.47 23.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 N-CA-C 106.65 -1.611 . . . . 0.0 106.65 179.649 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 43.2 t -131.16 134.26 61.52 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 C-N-CA 123.755 0.822 . . . . 0.0 109.809 -179.567 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -105.34 152.73 22.57 Favored 'General case' 0 N--CA 1.462 0.139 0 N-CA-C 105.865 -1.902 . . . . 0.0 105.865 166.804 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 2.6 mt -134.08 134.4 42.26 Favored 'General case' 0 CA--C 1.512 -0.497 0 N-CA-C 107.096 -1.446 . . . . 0.0 107.096 175.537 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 36.0 p90 -148.86 168.77 22.13 Favored 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 169.628 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -163.41 173.6 39.56 Favored Glycine 0 N--CA 1.446 -0.661 0 N-CA-C 109.91 -1.276 . . . . 0.0 109.91 169.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -119.75 153.45 35.65 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 125.012 1.325 . . . . 0.0 108.435 171.035 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -166.06 -155.41 8.76 Favored Glycine 0 CA--C 1.526 0.764 0 N-CA-C 109.595 -1.402 . . . . 0.0 109.595 174.083 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -124.95 146.77 49.22 Favored 'General case' 0 C--O 1.236 0.355 0 C-N-CA 124.733 1.213 . . . . 0.0 109.625 179.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . 0.525 ' H ' ' ND2' ' A' ' 148' ' ' ASN . 4.8 pt20 -120.55 6.72 10.56 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 124.592 1.157 . . . . 0.0 113.464 171.271 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 21.8 mt -65.88 -40.44 91.59 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 120.1 1.318 . . . . 0.0 109.509 170.078 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -76.01 45.04 1.91 Allowed Glycine 0 CA--C 1.529 0.917 0 C-N-CA 125.233 1.397 . . . . 0.0 111.226 170.533 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 48.6 m-85 57.45 0.57 0.1 Allowed 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 127.675 2.39 . . . . 0.0 114.717 -176.938 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 70.57 27.59 72.31 Favored Glycine 0 CA--C 1.526 0.765 0 O-C-N 121.21 -0.931 . . . . 0.0 110.794 -169.879 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -72.37 -31.14 65.33 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-N 118.507 1.153 . . . . 0.0 108.007 167.316 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' TRP . . . . . . . . . . . . . 14.4 m0 -86.2 -0.68 56.3 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 125.639 1.576 . . . . 0.0 111.979 176.34 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 4.3 t80 -75.31 131.13 40.09 Favored 'General case' 0 C--N 1.341 0.226 0 O-C-N 121.313 -0.867 . . . . 0.0 111.361 -169.139 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 84.3 mt 50.7 23.07 1.25 Allowed 'General case' 0 N--CA 1.47 0.541 0 N-CA-C 116.253 1.945 . . . . 0.0 116.253 166.205 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -64.61 -35.03 79.69 Favored 'General case' 0 C--N 1.328 -0.348 0 O-C-N 120.441 -1.412 . . . . 0.0 111.116 -174.305 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -65.9 -31.43 72.36 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 123.845 0.858 . . . . 0.0 111.944 173.458 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 4.2 tt -65.92 -47.93 73.1 Favored 'General case' 0 N--CA 1.468 0.446 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 173.542 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -58.84 -40.53 95.25 Favored Glycine 0 CA--C 1.525 0.713 0 N-CA-C 111.09 -0.804 . . . . 0.0 111.09 178.081 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 3.0 tpp -49.75 -45.44 49.41 Favored 'General case' 0 N--CA 1.464 0.256 0 C-N-CA 124.685 1.194 . . . . 0.0 110.867 172.328 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -83.81 -31.26 25.95 Favored 'General case' 0 CA--C 1.52 -0.174 0 O-C-N 122.122 -0.361 . . . . 0.0 111.607 -171.683 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 36.8 t-80 -60.33 -45.26 94.08 Favored 'General case' 0 C--N 1.331 -0.234 0 O-C-N 121.964 -0.46 . . . . 0.0 109.813 169.482 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -63.42 -47.58 81.33 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 123.472 0.709 . . . . 0.0 111.088 179.511 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 2.2 tppm? -54.38 -31.05 53.88 Favored 'General case' 0 N--CA 1.466 0.352 0 C-N-CA 125.342 1.457 . . . . 0.0 111.854 173.863 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 49.2 mt -101.55 -22.32 14.52 Favored 'General case' 0 N--CA 1.465 0.28 0 N-CA-C 114.231 1.197 . . . . 0.0 114.231 -173.668 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 69.0 m -60.42 -34.88 74.59 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 119.897 1.226 . . . . 0.0 111.188 -176.718 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 24.3 p -80.38 -13.13 59.41 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 124.817 1.247 . . . . 0.0 111.833 -179.344 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 31.3 mmmt -88.24 -10.84 48.38 Favored 'General case' 0 C--N 1.342 0.281 0 C-N-CA 125.297 1.439 . . . . 0.0 111.64 179.778 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 75.04 32.92 55.94 Favored Glycine 0 CA--C 1.523 0.572 0 CA-C-O 119.567 -0.574 . . . . 0.0 111.795 173.166 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 9.9 m -72.88 172.42 1.04 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.582 0 CA-C-N 118.26 1.03 . . . . 0.0 109.024 169.721 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -112.25 121.38 44.74 Favored 'General case' 0 CA--C 1.514 -0.422 0 N-CA-C 106.224 -1.769 . . . . 0.0 106.224 176.073 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 63.3 m-85 -88.79 143.99 26.53 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 119.513 1.051 . . . . 0.0 109.756 -176.176 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 30.6 m -129.53 161.17 39.57 Favored 'Isoleucine or valine' 0 C--O 1.234 0.269 0 C-N-CA 124.787 1.235 . . . . 0.0 108.623 170.044 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 95.79 -93.5 1.57 Allowed Glycine 0 N--CA 1.444 -0.79 0 C-N-CA 124.581 1.086 . . . . 0.0 111.122 177.463 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 14.4 m-30 59.25 -178.3 0.08 Allowed 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 124.345 1.058 . . . . 0.0 109.011 -167.275 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -154.93 144.44 15.32 Favored Pre-proline 0 N--CA 1.471 0.6 0 O-C-N 120.192 -1.568 . . . . 0.0 110.604 179.416 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -67.74 123.84 11.21 Favored 'Trans proline' 0 CA--C 1.534 0.515 0 C-N-CA 123.222 2.614 . . . . 0.0 111.705 179.114 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 3.0 p -79.61 -16.57 55.59 Favored 'General case' 0 CA--C 1.538 0.492 0 O-C-N 121.669 -0.644 . . . . 0.0 112.315 174.692 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -59.84 124.05 18.95 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 123.625 0.77 . . . . 0.0 110.476 -169.691 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 73.63 1.59 58.6 Favored Glycine 0 CA--C 1.534 1.242 0 C-N-CA 124.592 1.091 . . . . 0.0 114.083 177.826 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 4.1 t80 -89.39 153.32 20.94 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-N 119.052 1.426 . . . . 0.0 109.956 -179.855 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 18.5 mm-40 -91.92 113.5 25.78 Favored 'General case' 0 C--O 1.233 0.21 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 176.222 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 24.2 p90 -155.81 156.56 34.95 Favored 'General case' 0 C--O 1.237 0.404 0 C-N-CA 125.784 1.633 . . . . 0.0 107.662 172.57 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 5.7 t -148.2 2.32 0.66 Allowed 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 122.663 0.385 . . . . 0.0 111.254 168.521 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 5.0 p -71.75 128.23 89.86 Favored Pre-proline 0 CA--C 1.542 0.662 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 171.673 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -80.16 -28.06 3.3 Favored 'Trans proline' 0 CA--C 1.537 0.654 0 C-N-CA 122.241 1.96 . . . . 0.0 112.286 176.927 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 24.3 ttmt -57.68 -43.03 98.5 Favored Pre-proline 0 CA--C 1.542 0.666 0 CA-C-O 117.603 -1.189 . . . . 0.0 113.538 -173.776 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_endo -83.83 8.22 4.75 Favored 'Trans proline' 0 C--N 1.351 0.681 0 C-N-CA 122.144 1.896 . . . . 0.0 114.436 -179.6 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 29.0 m -126.4 165.31 24.8 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.285 0 CA-C-N 121.156 1.798 . . . . 0.0 111.791 -176.622 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 9.5 pt -132.81 169.2 22.48 Favored 'Isoleucine or valine' 0 C--O 1.234 0.277 0 C-N-CA 127.746 2.419 . . . . 0.0 108.576 179.714 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . 53.87 42.03 31.85 Favored 'General case' 0 C--O 1.227 -0.109 0 C-N-CA 125.296 1.438 . . . . 0.0 112.263 174.109 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 27.7 t70 54.04 42.57 31.57 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 126.479 1.912 . . . . 0.0 111.684 -177.527 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 91.78 16.82 50.66 Favored Glycine 0 CA--C 1.527 0.827 0 CA-C-O 118.721 -1.044 . . . . 0.0 113.642 173.873 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 46.2 mt-30 -89.32 -7.74 54.72 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 119.345 1.573 . . . . 0.0 112.946 179.635 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 7.4 tp -156.23 147.37 22.29 Favored 'General case' 0 C--N 1.344 0.339 0 CA-C-N 119.462 1.028 . . . . 0.0 110.829 169.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 67.6 m-85 -81.08 146.7 30.47 Favored 'General case' 0 CA--C 1.52 -0.175 0 N-CA-C 107.817 -1.179 . . . . 0.0 107.817 168.4 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 12.5 m -80.55 9.24 0.82 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 C-N-CA 123.722 0.809 . . . . 0.0 112.386 177.225 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -177.81 170.29 42.56 Favored Glycine 0 CA--C 1.524 0.644 0 N-CA-C 110.271 -1.132 . . . . 0.0 110.271 179.42 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -65.07 137.82 57.93 Favored 'General case' 0 N--CA 1.465 0.305 0 C-N-CA 123.326 0.65 . . . . 0.0 111.295 -176.3 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -93.76 122.84 36.65 Favored 'General case' 0 N--CA 1.444 -0.737 0 C-N-CA 126.229 1.812 . . . . 0.0 109.717 176.447 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 86.5 mt -122.42 161.28 23.8 Favored 'General case' 0 C--N 1.332 -0.177 0 N-CA-C 106.096 -1.816 . . . . 0.0 106.096 168.209 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -138.34 147.38 43.44 Favored 'General case' 0 C--O 1.235 0.314 0 N-CA-C 108.655 -0.869 . . . . 0.0 108.655 178.036 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -125.48 12.88 8.13 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 124.835 1.254 . . . . 0.0 112.94 -174.398 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 16.7 m -135.07 -36.33 0.82 Allowed 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 124.962 1.305 . . . . 0.0 111.929 -178.655 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . 0.525 ' ND2' ' H ' ' A' ' 90' ' ' GLN . 5.1 m-80 -93.93 -53.7 3.89 Favored 'General case' 0 CA--C 1.518 -0.264 0 C-N-CA 124.628 1.171 . . . . 0.0 112.234 -166.908 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 3.6 mp0 -134.85 133.04 39.31 Favored 'General case' 0 CA--C 1.523 -0.086 0 N-CA-C 107.72 -1.215 . . . . 0.0 107.72 -179.146 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 91.1 m-85 -113.35 -28.15 7.68 Favored 'General case' 0 N--CA 1.465 0.277 0 C-N-CA 123.68 0.792 . . . . 0.0 111.751 179.29 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -69.79 -43.3 72.41 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 118.272 0.487 . . . . 0.0 111.486 -169.875 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . 0.27 0.4 OUTLIER -84.73 5.36 28.69 Favored 'General case' 0 C--N 1.343 0.324 0 N-CA-C 113.401 0.889 . . . . 0.0 113.401 -177.402 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 48.6 m -59.81 -35.12 74.04 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 120.649 1.568 . . . . 0.0 110.829 174.45 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -60.87 -40.99 95.07 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 118.105 0.412 . . . . 0.0 110.902 174.593 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 -67.43 -50.37 59.65 Favored 'General case' 0 C--O 1.234 0.271 0 C-N-CA 124.614 1.165 . . . . 0.0 110.376 179.662 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 60.4 mtm180 -58.16 -41.46 83.85 Favored 'General case' 0 N--CA 1.463 0.214 0 C-N-CA 123.969 0.908 . . . . 0.0 109.734 -179.042 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 56.2 mt -69.47 -54.18 20.99 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.441 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 176.074 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 70.0 tp60 -52.78 -62.33 1.72 Allowed 'General case' 0 C--O 1.234 0.273 0 C-N-CA 124.546 1.139 . . . . 0.0 111.854 -171.767 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 20.0 m -66.13 -32.28 73.64 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 120.758 -0.377 . . . . 0.0 110.89 -169.493 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 160' ' ' TRP . . . . . . . . . . . . . 40.1 t90 -70.75 -43.84 68.0 Favored 'General case' 0 C--O 1.222 -0.386 0 O-C-N 121.99 -0.444 . . . . 0.0 111.267 176.553 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 67.2 m -58.31 -44.65 88.67 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 118.215 0.461 . . . . 0.0 110.173 176.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -62.45 -40.93 98.19 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-O 121.009 0.433 . . . . 0.0 110.153 176.752 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 13.6 tt0 -63.03 -52.85 61.23 Favored 'General case' 0 N--CA 1.447 -0.584 0 CA-C-O 118.732 -0.651 . . . . 0.0 110.036 -179.632 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 41.8 pt -63.43 -38.54 82.46 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.345 0 CA-C-O 117.973 -1.013 . . . . 0.0 109.185 -175.37 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -66.67 -32.82 74.38 Favored 'General case' 0 CA--C 1.529 0.152 0 CA-C-N 119.385 0.993 . . . . 0.0 110.414 -178.622 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 31.7 m-80 -68.66 -59.02 3.41 Favored 'General case' 0 CA--C 1.516 -0.352 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 173.303 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 16.2 tt0 -61.04 -37.9 84.22 Favored 'General case' 0 N--CA 1.441 -0.916 0 C-N-CA 125.895 1.678 . . . . 0.0 111.482 -168.904 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 168' ' ' MET . . . . . . . . . . . . . 19.9 ptp -70.06 -30.03 67.19 Favored 'General case' 0 C--N 1.333 -0.131 0 O-C-N 121.442 -0.786 . . . . 0.0 112.23 174.814 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -77.28 -38.52 50.66 Favored 'General case' 0 N--CA 1.446 -0.627 0 C-N-CA 123.126 0.57 . . . . 0.0 112.249 178.658 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -64.91 -32.58 74.35 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-O 121.907 0.86 . . . . 0.0 109.698 -179.276 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 57.4 t60 -62.6 -22.27 66.26 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 124.817 1.247 . . . . 0.0 111.438 178.425 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 24.2 m-85 -107.38 9.57 29.79 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 126.422 1.889 . . . . 0.0 113.871 172.878 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.255 1.356 0 CA-C-N 119.412 1.005 . . . . 0.0 110.05 174.53 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.498 1.932 0 N-CA-C 111.684 0.253 . . . . 0.0 111.684 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 5.8 t30 -113.53 153.08 29.34 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 124.294 1.037 . . . . 0.0 109.297 177.333 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 15.9 mtt -113.7 129.34 56.59 Favored 'General case' 0 N--CA 1.462 0.128 0 C-N-CA 123.802 0.841 . . . . 0.0 110.137 -179.471 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -83.86 150.7 26.78 Favored Glycine 0 CA--C 1.526 0.721 0 N-CA-C 107.43 -2.268 . . . . 0.0 107.43 167.215 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 2.0 tt -138.33 99.15 3.77 Favored 'General case' 0 N--CA 1.467 0.39 0 N-CA-C 105.63 -1.989 . . . . 0.0 105.63 -177.821 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 1.1 p90 -105.18 147.78 27.63 Favored 'General case' 0 CA--C 1.519 -0.229 0 CA-C-N 118.592 0.633 . . . . 0.0 112.028 -171.372 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 43.0 p90 -157.16 171.33 20.62 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 126.077 1.751 . . . . 0.0 107.728 170.483 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -72.92 -88.14 0.17 Allowed Glycine 0 CA--C 1.523 0.593 0 C-N-CA 123.968 0.794 . . . . 0.0 113.232 -168.786 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 3.9 m -105.76 149.67 26.23 Favored 'General case' 0 C--O 1.233 0.214 0 C-N-CA 123.543 0.737 . . . . 0.0 110.453 -169.701 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 1.2 m -58.8 -30.5 67.64 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 124.222 1.009 . . . . 0.0 111.622 176.785 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 3.5 p -75.7 -14.83 60.35 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 125.583 1.553 . . . . 0.0 112.665 -177.028 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 82.1 m -70.63 148.95 47.54 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 119.074 0.852 . . . . 0.0 110.343 -179.117 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 60.9 m-85 -62.83 -18.4 62.78 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 122.716 0.407 . . . . 0.0 112.025 174.859 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -49.99 -27.74 5.89 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 125.876 1.671 . . . . 0.0 112.427 170.007 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 -58.79 -40.05 82.88 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 119.871 1.214 . . . . 0.0 110.649 177.61 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 2.6 mpp? -70.49 -39.87 73.93 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 118.96 0.8 . . . . 0.0 110.284 -178.378 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -59.77 -46.94 87.61 Favored 'General case' 0 C--O 1.224 -0.24 0 N-CA-C 109.076 -0.712 . . . . 0.0 109.076 171.315 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -62.74 -47.7 82.44 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 123.944 0.898 . . . . 0.0 111.381 -174.261 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 31.2 mt-10 -57.98 -44.82 87.35 Favored 'General case' 0 CA--C 1.518 -0.267 0 C-N-CA 123.202 0.601 . . . . 0.0 109.556 175.179 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 49.9 mttm -64.91 -47.54 77.41 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-O 118.796 -0.621 . . . . 0.0 110.484 -177.623 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 83.3 mt -53.12 -55.06 14.08 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.2 0 CA-C-N 118.897 0.771 . . . . 0.0 109.307 -178.812 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.58 -35.06 79.29 Favored 'General case' 0 CA--C 1.513 -0.461 0 CA-C-O 118.812 -0.613 . . . . 0.0 111.313 -175.434 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -64.46 -39.9 94.69 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.997 0.427 . . . . 0.0 110.563 178.194 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 61.1 mt -78.01 -54.76 11.78 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.786 0 C-N-CA 124.77 1.228 . . . . 0.0 110.236 -171.092 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 71.3 mt -64.16 -46.22 94.17 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.326 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 179.257 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 141.98 124.1 1.93 Allowed Glycine 0 CA--C 1.528 0.898 0 C-N-CA 124.632 1.111 . . . . 0.0 110.969 173.528 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -69.94 -13.61 34.45 Favored 'Trans proline' 0 CA--C 1.539 0.738 0 C-N-CA 122.982 2.455 . . . . 0.0 112.836 -173.288 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -73.48 -21.42 60.43 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 118.509 0.595 . . . . 0.0 111.928 177.701 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -130.53 3.44 4.6 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 124.459 1.104 . . . . 0.0 113.535 -169.692 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 44.9 t -123.74 142.09 41.69 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.241 0 N-CA-C 107.62 -1.252 . . . . 0.0 107.62 171.262 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 30.5 m -129.27 132.48 47.19 Favored 'General case' 0 C--N 1.332 -0.182 0 C-N-CA 124.703 1.201 . . . . 0.0 108.427 -175.771 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 27.7 mt -75.25 135.73 40.97 Favored 'General case' 0 N--CA 1.456 -0.161 0 N-CA-C 107.999 -1.111 . . . . 0.0 107.999 175.432 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 28.5 t-80 -126.19 59.48 1.33 Allowed 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 125.148 1.379 . . . . 0.0 107.416 -176.811 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 33.3 t30 -69.55 113.26 6.67 Favored 'General case' 0 C--O 1.235 0.307 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 -176.296 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 77.6 mt -69.0 -14.89 63.31 Favored 'General case' 0 C--O 1.234 0.289 0 N-CA-C 112.554 0.576 . . . . 0.0 112.554 -171.775 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 1.3 tmtm? -58.81 -20.6 51.66 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 118.843 0.747 . . . . 0.0 111.173 168.82 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -128.03 -41.68 1.6 Allowed 'General case' 0 C--O 1.234 0.255 0 N-CA-C 113.287 0.847 . . . . 0.0 113.287 -175.801 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 30.5 m-20 -91.72 144.17 25.79 Favored 'General case' 0 C--O 1.235 0.301 0 C-N-CA 123.696 0.798 . . . . 0.0 111.07 -174.508 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 14.8 m -79.39 155.47 76.54 Favored Pre-proline 0 CA--C 1.539 0.551 0 C-N-CA 124.563 1.145 . . . . 0.0 110.258 176.361 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -76.93 -26.27 8.12 Favored 'Trans proline' 0 C--N 1.348 0.519 0 C-N-CA 122.232 1.955 . . . . 0.0 113.945 -171.082 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 8.2 mptt -62.64 -21.02 65.38 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 120.236 1.38 . . . . 0.0 111.8 -177.92 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -57.75 -29.74 65.04 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 125.865 1.666 . . . . 0.0 110.5 173.877 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 47.1 mtt -60.22 -26.21 66.23 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 118.763 0.71 . . . . 0.0 111.385 177.84 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 58.6 mt-10 -66.48 -33.51 75.85 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 118.714 0.688 . . . . 0.0 110.471 -176.651 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 24.3 mt-30 -63.77 -45.8 88.15 Favored 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 123.778 0.831 . . . . 0.0 112.868 -169.406 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 45.9 m-85 -76.24 136.02 39.67 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 115.393 -0.821 . . . . 0.0 109.473 -166.82 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -72.48 -30.19 64.31 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 118.865 0.757 . . . . 0.0 110.473 178.374 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 45.0 t -106.16 141.83 20.54 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.368 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 171.517 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 26.6 tp -136.82 118.46 14.95 Favored 'General case' 0 N--CA 1.446 -0.664 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 173.167 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 11.7 mt -93.61 133.48 34.54 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.829 0 N-CA-C 106.37 -1.715 . . . . 0.0 106.37 174.678 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 1.3 mp -111.23 134.07 53.1 Favored 'General case' 0 CA--C 1.518 -0.273 0 N-CA-C 106.703 -1.591 . . . . 0.0 106.703 -177.665 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -130.2 137.43 9.51 Favored Glycine 0 CA--C 1.518 0.257 0 N-CA-C 109.96 -1.256 . . . . 0.0 109.96 173.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 2.3 tt -151.57 133.86 8.45 Favored Pre-proline 0 CA--C 1.541 0.604 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 169.491 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_endo -82.38 -21.64 5.23 Favored 'Trans proline' 0 CA--C 1.538 0.703 0 C-N-CA 121.576 1.517 . . . . 0.0 114.521 -170.512 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 58.9 m 61.67 -62.9 0.09 Allowed 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 126.712 2.005 . . . . 0.0 112.261 -168.632 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 2.1 t90 65.72 169.35 0.21 Allowed 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 128.384 2.674 . . . . 0.0 115.335 171.096 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -65.05 109.02 2.0 Favored 'General case' 0 N--CA 1.466 0.342 0 C-N-CA 125.61 1.564 . . . . 0.0 111.409 -171.309 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 29.7 t80 48.8 25.87 1.14 Allowed 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 124.944 1.298 . . . . 0.0 111.563 -169.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -85.0 176.38 50.58 Favored Glycine 0 N--CA 1.443 -0.842 0 C-N-CA 124.287 0.946 . . . . 0.0 110.744 -178.623 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -150.17 170.15 19.61 Favored 'General case' 0 C--O 1.238 0.492 0 N-CA-C 106.429 -1.693 . . . . 0.0 106.429 174.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 24.8 mt -44.88 128.99 1.63 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.635 0 C-N-CA 124.849 1.26 . . . . 0.0 108.175 167.887 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -93.27 161.61 14.33 Favored 'General case' 0 C--O 1.231 0.122 0 C-N-CA 124.313 1.045 . . . . 0.0 109.929 -178.724 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -54.56 -41.56 69.95 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 124.436 1.094 . . . . 0.0 111.63 -169.285 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 27.5 m-20 -59.71 -27.64 66.64 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-N 118.453 0.57 . . . . 0.0 112.026 -176.785 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 4.5 t90 -96.49 -44.86 6.99 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 125.688 1.595 . . . . 0.0 109.479 -178.069 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -63.02 -36.72 84.51 Favored 'General case' 0 CA--C 1.53 0.199 0 O-C-N 121.013 -1.054 . . . . 0.0 110.221 -179.177 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -61.12 -25.57 67.07 Favored 'General case' 0 C--O 1.234 0.268 0 C-N-CA 123.356 0.662 . . . . 0.0 111.015 -177.481 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 23.5 m -106.41 -17.97 7.41 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.539 0 CA-C-O 116.581 -1.676 . . . . 0.0 112.535 176.402 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 18.2 t90 -54.99 -35.65 64.57 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 121.492 1.951 . . . . 0.0 110.995 -179.275 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -63.43 -28.92 70.31 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 125.249 1.42 . . . . 0.0 112.715 174.1 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 62.9 mt-30 -92.57 -25.37 18.37 Favored 'General case' 0 C--O 1.224 -0.287 0 C-N-CA 126.436 1.894 . . . . 0.0 111.31 -179.842 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 37.6 mt -64.16 -26.43 68.52 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 118.727 0.694 . . . . 0.0 110.361 179.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -76.59 -25.67 54.21 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 117.794 0.27 . . . . 0.0 110.824 171.463 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -79.55 -33.38 41.93 Favored 'General case' 0 CA--C 1.538 0.494 0 O-C-N 121.257 -0.902 . . . . 0.0 113.049 179.403 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 30.6 mt -56.37 148.67 18.35 Favored 'General case' 0 C--O 1.234 0.265 0 C-N-CA 124.75 1.22 . . . . 0.0 111.02 -177.876 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 20.5 t-20 -86.03 122.88 30.68 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 170.325 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 74.2 mt -130.43 8.78 5.06 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 123.622 0.769 . . . . 0.0 112.222 -173.328 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 29.1 mt-10 -53.52 128.46 29.02 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 124.038 0.935 . . . . 0.0 112.256 -168.418 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 68.13 -0.26 12.42 Favored Glycine 0 CA--C 1.533 1.195 0 C-N-CA 125.443 1.497 . . . . 0.0 115.293 177.92 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.92 149.71 43.17 Favored 'General case' 0 C--N 1.343 0.308 0 CA-C-N 120.388 2.094 . . . . 0.0 109.635 -173.178 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 3.1 mt -80.56 133.33 29.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 N-CA-C 106.596 -1.631 . . . . 0.0 106.596 179.916 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 79.8 t -129.3 140.06 50.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 C-N-CA 124.122 0.969 . . . . 0.0 109.877 -176.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -128.42 154.31 46.17 Favored 'General case' 0 CA--C 1.53 0.173 0 C-N-CA 124.809 1.244 . . . . 0.0 108.052 169.795 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 2.4 mt -132.08 131.68 42.62 Favored 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 124.744 1.218 . . . . 0.0 108.334 -171.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 45.3 m-85 -130.28 141.93 50.58 Favored 'General case' 0 N--CA 1.451 -0.385 0 N-CA-C 106.643 -1.614 . . . . 0.0 106.643 -177.771 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -157.55 172.27 34.86 Favored Glycine 0 N--CA 1.442 -0.92 0 N-CA-C 108.965 -1.654 . . . . 0.0 108.965 168.502 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -119.94 162.7 18.75 Favored 'General case' 0 C--N 1.324 -0.537 0 C-N-CA 124.527 1.131 . . . . 0.0 109.54 170.149 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -157.98 132.6 3.2 Favored Glycine 0 N--CA 1.443 -0.852 0 N-CA-C 107.362 -2.295 . . . . 0.0 107.362 169.531 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 17.1 t0 -89.95 119.78 30.6 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 108.24 -1.022 . . . . 0.0 108.24 173.333 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 13.3 pt20 -65.5 -22.23 66.71 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 124.2 1.0 . . . . 0.0 112.056 178.372 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 13.9 mt -86.16 -58.9 2.45 Favored 'General case' 0 C--N 1.342 0.259 0 CA-C-N 118.981 0.809 . . . . 0.0 111.287 -174.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -67.4 -36.58 89.27 Favored Glycine 0 CA--C 1.525 0.659 0 C-N-CA 124.231 0.919 . . . . 0.0 113.242 -169.153 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 2.7 p90 -136.2 -71.85 0.46 Allowed 'General case' 0 CA--C 1.52 -0.208 0 N-CA-C 108.215 -1.032 . . . . 0.0 108.215 -178.457 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 76.81 -40.1 1.6 Allowed Glycine 0 CA--C 1.529 0.951 0 C-N-CA 124.589 1.09 . . . . 0.0 112.334 172.295 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -59.03 -42.49 90.31 Favored 'General case' 0 CA--C 1.528 0.117 0 CA-C-N 118.557 1.178 . . . . 0.0 109.644 174.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' TRP . . . . . . . . . . . . . 2.9 m0 -92.64 26.81 2.53 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 125.392 1.477 . . . . 0.0 111.809 -177.675 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 34.7 t80 -49.26 125.88 11.79 Favored 'General case' 0 N--CA 1.465 0.313 0 N-CA-C 107.942 -1.133 . . . . 0.0 107.942 174.36 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 84.4 mt 55.71 20.77 4.18 Favored 'General case' 0 CA--C 1.537 0.47 0 N-CA-C 113.668 0.988 . . . . 0.0 113.668 173.836 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -56.51 -42.73 78.87 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 120.394 1.452 . . . . 0.0 112.592 -168.468 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -80.95 -14.87 57.57 Favored 'General case' 0 CA--C 1.534 0.329 0 N-CA-C 113.389 0.885 . . . . 0.0 113.389 179.786 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 6.6 tt -60.58 -43.55 97.2 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-N 120.056 1.298 . . . . 0.0 107.911 169.24 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -66.75 -32.7 82.03 Favored Glycine 0 C--N 1.337 0.595 0 N-CA-C 112.031 -0.428 . . . . 0.0 112.031 -175.52 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 77.2 mtm -72.37 -26.9 62.08 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-O 118.363 -0.827 . . . . 0.0 111.796 -175.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -76.41 -43.17 41.6 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 120.365 1.439 . . . . 0.0 109.372 169.019 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 82.1 t60 -53.34 -47.98 68.9 Favored 'General case' 0 N--CA 1.467 0.393 0 O-C-N 121.758 -0.589 . . . . 0.0 110.974 179.632 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -62.68 -37.24 85.68 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 123.676 0.79 . . . . 0.0 112.682 -177.505 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 25.1 ttmm -58.41 -36.41 73.54 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 123.575 0.75 . . . . 0.0 110.484 172.485 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 24.0 mt -91.95 -20.14 21.69 Favored 'General case' 0 CA--C 1.513 -0.453 0 N-CA-C 115.95 1.833 . . . . 0.0 115.95 -168.158 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 3.2 m -58.28 -32.97 68.92 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 120.665 1.575 . . . . 0.0 111.632 -176.433 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 21.1 p -88.27 -10.66 48.89 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 125.23 1.412 . . . . 0.0 112.409 -179.883 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 32.4 mmmt -82.99 -9.25 59.37 Favored 'General case' 0 C--N 1.347 0.458 0 C-N-CA 124.494 1.117 . . . . 0.0 111.435 175.169 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 73.81 31.93 59.67 Favored Glycine 0 CA--C 1.525 0.663 0 CA-C-O 119.645 -0.531 . . . . 0.0 112.165 172.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 5.8 m -73.25 174.44 0.78 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.618 0 CA-C-N 118.219 1.009 . . . . 0.0 109.158 169.748 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -115.63 131.28 56.98 Favored 'General case' 0 CA--C 1.518 -0.265 0 N-CA-C 106.909 -1.515 . . . . 0.0 106.909 172.772 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 80.3 m-85 -96.48 148.29 22.96 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 119.677 1.126 . . . . 0.0 109.384 -179.722 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 31.3 m -126.37 163.91 27.47 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.263 0 C-N-CA 123.847 0.859 . . . . 0.0 109.799 172.006 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 86.91 -91.34 1.73 Allowed Glycine 0 N--CA 1.444 -0.817 0 C-N-CA 124.996 1.284 . . . . 0.0 112.292 172.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 16.8 m-30 59.68 170.49 0.08 Allowed 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 126.081 1.752 . . . . 0.0 110.251 -165.599 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -141.09 140.86 21.94 Favored Pre-proline 0 N--CA 1.471 0.58 0 O-C-N 120.442 -1.411 . . . . 0.0 109.479 174.033 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_exo -54.51 129.12 33.16 Favored 'Trans proline' 0 N--CA 1.456 -0.731 0 C-N-CA 122.622 2.215 . . . . 0.0 110.65 169.796 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 20.7 p -70.74 -16.99 62.81 Favored 'General case' 0 N--CA 1.47 0.564 0 N-CA-C 112.465 0.542 . . . . 0.0 112.465 171.681 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -59.55 132.32 53.62 Favored 'General case' 0 C--O 1.237 0.4 0 C-N-CA 123.918 0.887 . . . . 0.0 109.775 -175.344 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 86.79 -9.62 71.01 Favored Glycine 0 CA--C 1.533 1.195 0 CA-C-O 118.509 -1.161 . . . . 0.0 113.963 178.878 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 42.7 m-85 -94.35 156.13 16.65 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-N 119.25 1.525 . . . . 0.0 110.173 171.703 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -123.03 127.27 48.55 Favored 'General case' 0 CA--C 1.531 0.243 0 N-CA-C 106.796 -1.557 . . . . 0.0 106.796 171.664 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 46.5 p90 -164.86 156.64 15.47 Favored 'General case' 0 C--O 1.237 0.446 0 C-N-CA 126.301 1.84 . . . . 0.0 106.263 -170.237 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 25.8 m -126.25 -38.64 2.12 Favored 'General case' 0 N--CA 1.446 -0.667 0 CA-C-N 118.607 0.64 . . . . 0.0 111.596 -171.24 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 41.8 t -59.45 135.54 88.86 Favored Pre-proline 0 CA--C 1.539 0.529 0 CA-C-N 118.145 0.429 . . . . 0.0 110.036 177.354 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_endo -82.38 -13.5 9.83 Favored 'Trans proline' 0 N--CA 1.455 -0.755 0 C-N-CA 122.869 2.379 . . . . 0.0 112.186 172.636 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 54.3 mttt -54.92 -48.1 96.72 Favored Pre-proline 0 CA--C 1.54 0.582 0 CA-C-N 119.888 1.222 . . . . 0.0 112.256 -170.848 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -86.07 11.75 3.23 Favored 'Trans proline' 0 C--N 1.35 0.642 0 C-N-CA 122.001 1.801 . . . . 0.0 113.742 -172.725 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 21.9 m -129.54 161.26 39.4 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.171 0 CA-C-N 120.629 1.559 . . . . 0.0 111.797 -175.155 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 21.5 pt -132.92 173.16 15.26 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.344 0 C-N-CA 127.151 2.18 . . . . 0.0 108.988 -179.788 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . 54.12 43.43 30.7 Favored 'General case' 0 N--CA 1.461 0.112 0 C-N-CA 125.406 1.482 . . . . 0.0 112.07 174.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 27.3 t0 54.0 43.44 30.79 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 126.609 1.964 . . . . 0.0 111.603 -176.785 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 87.6 29.5 21.3 Favored Glycine 0 CA--C 1.526 0.77 0 CA-C-O 118.207 -1.329 . . . . 0.0 113.635 171.559 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 47.3 mt-30 -95.54 -23.39 17.1 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 119.141 1.471 . . . . 0.0 113.201 179.201 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -138.79 141.0 38.78 Favored 'General case' 0 CA--C 1.513 -0.477 0 CA-C-N 119.641 1.11 . . . . 0.0 110.56 176.026 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 67.5 m-85 -76.98 138.27 39.52 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 105.106 -2.183 . . . . 0.0 105.106 164.257 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 25.7 m -76.74 4.43 1.17 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.643 0 C-N-CA 123.188 0.595 . . . . 0.0 112.067 -177.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -168.5 -174.19 37.01 Favored Glycine 0 CA--C 1.523 0.537 0 C-N-CA 125.742 1.639 . . . . 0.0 109.16 -175.806 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 29.4 tp -75.06 140.95 43.86 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 122.892 0.477 . . . . 0.0 111.722 -171.739 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -89.43 132.71 34.87 Favored 'General case' 0 N--CA 1.447 -0.586 0 C-N-CA 125.876 1.67 . . . . 0.0 109.081 169.2 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 89.9 mt -136.81 141.33 42.89 Favored 'General case' 0 N--CA 1.467 0.425 0 N-CA-C 106.643 -1.614 . . . . 0.0 106.643 172.222 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -104.26 -57.02 2.09 Favored 'General case' 0 C--O 1.233 0.202 0 C-N-CA 123.545 0.738 . . . . 0.0 110.649 -176.835 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 46.69 38.17 5.46 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 125.806 1.643 . . . . 0.0 114.611 174.862 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 53.7 m -136.45 -39.9 0.65 Allowed 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 124.911 1.284 . . . . 0.0 109.81 169.055 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 20.2 m-80 -121.44 -36.93 2.98 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 126.393 1.877 . . . . 0.0 110.912 -166.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 34.0 mt-30 -127.56 52.23 1.85 Allowed 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 126.173 1.789 . . . . 0.0 109.786 -168.555 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -56.92 -38.36 72.75 Favored 'General case' 0 N--CA 1.468 0.471 0 O-C-N 121.205 -0.934 . . . . 0.0 111.278 -177.441 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -66.86 -36.61 82.71 Favored 'General case' 0 N--CA 1.466 0.36 0 O-C-N 121.969 -0.457 . . . . 0.0 111.444 -179.44 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -80.92 -23.97 38.55 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-O 118.812 -0.614 . . . . 0.0 110.927 177.619 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 47.9 m -68.77 -42.53 77.33 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 119.008 0.822 . . . . 0.0 109.745 170.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -60.12 -44.59 94.78 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 123.431 0.693 . . . . 0.0 110.497 174.154 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 27.3 tt0 -58.46 -46.89 85.68 Favored 'General case' 0 C--O 1.231 0.09 0 C-N-CA 124.171 0.989 . . . . 0.0 110.435 174.367 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.29 -46.24 86.45 Favored 'General case' 0 C--O 1.225 -0.224 0 CA-C-O 117.959 -1.019 . . . . 0.0 109.554 179.023 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 47.6 mt -60.45 -52.44 61.4 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.233 0 CA-C-N 119.687 1.131 . . . . 0.0 108.038 176.928 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 72.7 tp60 -53.29 -65.11 0.62 Allowed 'General case' 0 C--O 1.232 0.155 0 CA-C-N 119.23 0.923 . . . . 0.0 112.073 -177.151 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 19.9 m -68.75 -32.36 72.07 Favored 'General case' 0 C--N 1.325 -0.489 0 C-N-CA 121.4 -0.12 . . . . 0.0 111.309 -168.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 160' ' ' TRP . . . . . . . . . . . . . 2.8 t90 -73.13 -41.77 63.6 Favored 'General case' 0 C--O 1.221 -0.423 0 CA-C-O 118.977 -0.535 . . . . 0.0 110.618 177.465 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 23.2 m -55.47 -47.84 75.47 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 118.519 0.599 . . . . 0.0 110.343 173.387 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -60.3 -43.36 96.38 Favored 'General case' 0 C--N 1.332 -0.156 0 N-CA-C 109.681 -0.488 . . . . 0.0 109.681 178.752 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 15.0 tt0 -63.29 -51.71 64.96 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-O 117.904 -1.046 . . . . 0.0 110.383 -178.182 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 39.7 pt -64.15 -33.06 60.01 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.412 0 CA-C-O 118.127 -0.94 . . . . 0.0 109.441 -175.829 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -72.82 -31.45 64.82 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 119.395 0.998 . . . . 0.0 108.856 -174.375 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -71.53 -52.1 20.04 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 124.692 1.197 . . . . 0.0 109.084 173.277 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -67.7 -35.3 78.56 Favored 'General case' 0 N--CA 1.441 -0.883 0 C-N-CA 125.78 1.632 . . . . 0.0 109.425 -169.485 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 168' ' ' MET . . . . . . . . . . . . . 21.5 ptp -73.03 -29.11 62.76 Favored 'General case' 0 C--N 1.333 -0.128 0 O-C-N 122.28 -0.262 . . . . 0.0 111.583 176.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -75.62 -36.56 60.21 Favored 'General case' 0 N--CA 1.444 -0.726 0 CA-C-O 119.16 -0.448 . . . . 0.0 111.779 178.2 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 5.8 mt-10 -64.17 -36.98 85.82 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-O 122.248 1.023 . . . . 0.0 109.275 178.486 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 61.2 t60 -64.33 -25.76 68.18 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 124.966 1.306 . . . . 0.0 110.936 177.391 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -78.87 -44.71 22.27 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 124.363 1.065 . . . . 0.0 111.721 174.767 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.254 1.312 0 C-N-CA 124.907 1.283 . . . . 0.0 109.602 -174.594 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.498 1.964 0 CA-C-O 120.322 0.106 . . . . 0.0 111.197 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 24.8 p-10 -120.61 165.95 14.33 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 125.082 1.353 . . . . 0.0 111.512 -175.333 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 11.9 mtt -130.27 133.91 46.84 Favored 'General case' 0 CA--C 1.52 -0.195 0 C-N-CA 123.361 0.665 . . . . 0.0 110.507 175.625 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -100.48 142.42 15.84 Favored Glycine 0 CA--C 1.523 0.559 0 N-CA-C 106.769 -2.532 . . . . 0.0 106.769 167.538 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 2.2 tt -128.22 101.15 6.12 Favored 'General case' 0 CA--C 1.518 -0.252 0 N-CA-C 105.852 -1.907 . . . . 0.0 105.852 -172.899 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -102.49 144.26 31.16 Favored 'General case' 0 N--CA 1.455 -0.216 0 CA-C-O 121.588 0.709 . . . . 0.0 111.672 -173.809 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 43.7 p90 -160.02 179.7 8.53 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 127.04 2.136 . . . . 0.0 106.489 175.0 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 174.46 74.73 0.05 OUTLIER Glycine 0 N--CA 1.464 0.511 0 N-CA-C 109.388 -1.485 . . . . 0.0 109.388 175.881 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 38.0 m -150.03 132.64 15.81 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 117.717 0.759 . . . . 0.0 109.361 -175.141 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 14.7 m -93.06 -37.07 12.36 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 123.717 0.807 . . . . 0.0 110.757 174.778 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 3.7 m -67.09 124.2 22.4 Favored 'General case' 0 CA--C 1.533 0.292 0 N-CA-C 107.215 -1.402 . . . . 0.0 107.215 174.442 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 58.0 m 47.17 57.18 5.99 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 124.494 1.118 . . . . 0.0 110.05 -170.695 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 19.9 p90 -45.9 128.36 8.91 Favored 'General case' 0 C--N 1.343 0.288 0 C-N-CA 125.132 1.373 . . . . 0.0 113.361 -168.292 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 2.8 m -80.76 -6.53 58.62 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 124.207 1.003 . . . . 0.0 112.21 -169.842 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -55.95 -36.51 67.88 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 124.457 1.103 . . . . 0.0 111.545 -174.631 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 30.0 mmt -67.82 -43.27 79.99 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 118.541 0.61 . . . . 0.0 110.323 -177.842 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -64.1 -45.39 88.85 Favored 'General case' 0 N--CA 1.462 0.168 0 N-CA-C 109.03 -0.729 . . . . 0.0 109.03 176.321 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -64.02 -47.45 80.22 Favored 'General case' 0 N--CA 1.455 -0.19 0 C-N-CA 122.921 0.489 . . . . 0.0 111.54 -175.276 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 10.2 mt-10 -60.95 -42.99 99.33 Favored 'General case' 0 CA--C 1.517 -0.309 0 CA-C-O 118.903 -0.57 . . . . 0.0 109.949 176.678 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 29.3 mtpp -71.14 -40.67 71.22 Favored 'General case' 0 C--O 1.221 -0.435 0 CA-C-O 118.057 -0.973 . . . . 0.0 110.775 -174.132 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 47.6 mt -53.81 -54.27 20.92 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.267 0 CA-C-N 120.014 1.279 . . . . 0.0 108.818 173.07 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 8.5 ttp180 -60.56 -41.07 93.82 Favored 'General case' 0 C--O 1.223 -0.298 0 C-N-CA 123.397 0.679 . . . . 0.0 109.65 -176.703 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -66.74 -41.17 88.25 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 122.945 0.498 . . . . 0.0 111.066 -178.894 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 41.0 mt -68.76 -56.18 13.13 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.57 0 C-N-CA 124.345 1.058 . . . . 0.0 109.691 -175.61 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 79.0 mt -67.89 -44.23 85.4 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.428 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 -175.649 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 138.55 125.39 2.32 Favored Glycine 0 CA--C 1.53 1.022 0 C-N-CA 125.061 1.315 . . . . 0.0 111.493 173.22 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -71.95 -6.21 18.66 Favored 'Trans proline' 0 CA--C 1.537 0.666 0 C-N-CA 123.505 2.803 . . . . 0.0 114.044 -175.674 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -80.15 -18.63 49.23 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 119.232 0.924 . . . . 0.0 111.241 175.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -128.66 -10.1 5.03 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 124.532 1.133 . . . . 0.0 113.994 -173.803 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 31.5 t -106.97 150.07 9.84 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.352 0 CA-C-N 119.375 0.989 . . . . 0.0 108.346 170.702 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 2.7 m -137.23 130.97 31.74 Favored 'General case' 0 N--CA 1.456 -0.174 0 N-CA-C 106.599 -1.63 . . . . 0.0 106.599 -172.909 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 21.3 mt -80.46 143.71 33.16 Favored 'General case' 0 CA--C 1.53 0.202 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 176.916 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 39.0 t-80 -136.77 64.88 1.53 Allowed 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 124.451 1.1 . . . . 0.0 108.195 -174.554 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 64.4 t-20 -72.39 119.12 16.15 Favored 'General case' 0 CA--C 1.53 0.193 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 -178.407 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 81.9 mt -66.06 -18.31 65.26 Favored 'General case' 0 C--O 1.233 0.206 0 C-N-CA 123.782 0.833 . . . . 0.0 112.918 -176.839 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 28.3 tptp -55.35 -27.12 45.19 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-O 118.879 -0.581 . . . . 0.0 111.156 168.654 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -121.47 -41.45 2.49 Favored 'General case' 0 N--CA 1.464 0.271 0 N-CA-C 113.549 0.944 . . . . 0.0 113.549 -173.856 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 29.6 m-20 -96.53 142.29 28.78 Favored 'General case' 0 C--O 1.234 0.276 0 C-N-CA 123.334 0.654 . . . . 0.0 110.702 -176.151 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 14.0 m -75.97 156.27 84.31 Favored Pre-proline 0 CA--C 1.542 0.646 0 C-N-CA 124.181 0.992 . . . . 0.0 109.986 173.632 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo -77.27 -25.1 8.79 Favored 'Trans proline' 0 C--N 1.348 0.533 0 C-N-CA 122.212 1.941 . . . . 0.0 113.312 -169.785 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 23.7 mmmt -69.38 -15.26 63.27 Favored 'General case' 0 N--CA 1.474 0.758 0 O-C-N 120.512 -1.368 . . . . 0.0 111.693 -176.029 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -62.01 -26.82 68.46 Favored 'General case' 0 N--CA 1.464 0.263 0 C-N-CA 125.555 1.542 . . . . 0.0 110.603 169.426 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 51.3 mtt -58.99 -25.29 63.5 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 119.207 0.912 . . . . 0.0 111.48 177.308 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -64.06 -31.83 73.17 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 118.395 0.543 . . . . 0.0 110.127 -176.535 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 27.3 mt-30 -67.05 -38.79 86.46 Favored 'General case' 0 CA--C 1.534 0.364 0 N-CA-C 113.302 0.852 . . . . 0.0 113.302 -170.873 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 61.0 m-85 -76.08 136.25 39.88 Favored 'General case' 0 CA--C 1.52 -0.202 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 -167.49 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -71.84 -37.75 70.23 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-N 118.281 0.491 . . . . 0.0 110.576 -178.349 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 15.4 t -107.22 144.95 15.26 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.364 0 N-CA-C 107.52 -1.289 . . . . 0.0 107.52 169.003 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 28.8 tp -132.97 120.29 21.22 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 175.098 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 48.3 mt -99.41 129.25 50.19 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.606 0 N-CA-C 106.47 -1.678 . . . . 0.0 106.47 179.774 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -110.13 132.47 54.14 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 125.539 1.536 . . . . 0.0 107.793 -175.342 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -138.44 138.73 9.71 Favored Glycine 0 C--N 1.332 0.346 0 N-CA-C 109.821 -1.312 . . . . 0.0 109.821 178.233 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 3.9 tt -155.75 133.46 6.75 Favored Pre-proline 0 CA--C 1.535 0.37 0 CA-C-N 117.555 0.677 . . . . 0.0 111.164 172.805 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_exo -75.24 127.39 10.48 Favored 'Trans proline' 0 N--CA 1.456 -0.704 0 C-N-CA 122.376 2.051 . . . . 0.0 109.197 164.06 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 20.9 m -97.81 106.96 19.34 Favored 'General case' 0 CA--C 1.535 0.383 0 N-CA-C 104.434 -2.432 . . . . 0.0 104.434 167.084 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 2.6 t90 -91.98 169.36 10.71 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-O 121.021 0.438 . . . . 0.0 111.402 -175.443 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -63.14 -30.2 71.4 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 124.972 1.309 . . . . 0.0 113.062 -172.075 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 84.4 t80 -139.24 155.34 47.85 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 124.788 1.235 . . . . 0.0 109.555 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 74.24 2.65 63.24 Favored Glycine 0 CA--C 1.534 1.273 0 CA-C-O 118.178 -1.346 . . . . 0.0 114.765 170.483 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . 0.273 10.7 pt-20 45.76 -153.87 0.05 OUTLIER 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 126.55 1.94 . . . . 0.0 112.692 -177.928 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 12.8 mt -27.75 129.43 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.543 0.682 0 C-N-CA 128.894 2.878 . . . . 0.0 112.289 170.002 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 4.1 mp0 -72.59 153.99 41.0 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 124.836 1.254 . . . . 0.0 109.828 179.421 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -59.07 -42.84 91.35 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 123.338 0.655 . . . . 0.0 111.593 -170.255 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -60.54 -24.67 65.55 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 123.591 0.757 . . . . 0.0 111.95 -177.639 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 1.8 t90 -96.04 -42.63 8.16 Favored 'General case' 0 N--CA 1.447 -0.588 0 C-N-CA 124.695 1.198 . . . . 0.0 109.773 -178.425 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 7.8 tt0 -63.14 -33.86 76.38 Favored 'General case' 0 N--CA 1.446 -0.665 0 O-C-N 120.749 -1.219 . . . . 0.0 109.868 178.708 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -55.82 -24.65 37.47 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 124.333 1.053 . . . . 0.0 111.965 -179.497 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 35.3 m -116.84 -11.42 11.81 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.171 0 CA-C-O 117.596 -1.192 . . . . 0.0 113.179 178.245 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 25.0 t90 -52.87 -38.28 61.41 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 119.959 1.254 . . . . 0.0 110.435 -178.891 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -64.6 -27.11 68.72 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 125.361 1.464 . . . . 0.0 113.303 177.041 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 30.0 mt-30 -92.6 -19.41 21.93 Favored 'General case' 0 C--N 1.342 0.244 0 C-N-CA 125.309 1.443 . . . . 0.0 112.617 178.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 60.1 mt -59.55 -25.94 64.96 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 118.633 0.651 . . . . 0.0 111.137 -178.414 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -77.1 -25.15 51.92 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 118.085 0.402 . . . . 0.0 111.626 176.704 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -72.98 -29.98 63.47 Favored 'General case' 0 N--CA 1.467 0.376 0 O-C-N 121.058 -1.026 . . . . 0.0 111.828 178.866 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 76.5 mt -53.62 139.86 30.65 Favored 'General case' 0 C--N 1.341 0.218 0 C-N-CA 125.016 1.326 . . . . 0.0 112.289 -169.008 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 28.8 t-20 -77.2 107.44 9.6 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 169.707 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 65.2 mt -127.6 1.48 6.18 Favored 'General case' 0 N--CA 1.474 0.734 0 N-CA-C 113.912 1.079 . . . . 0.0 113.912 -173.237 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -51.87 129.16 26.04 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-N 119.228 0.922 . . . . 0.0 111.482 -168.442 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 70.63 -2.0 18.69 Favored Glycine 0 CA--C 1.535 1.326 0 C-N-CA 125.935 1.731 . . . . 0.0 115.972 177.523 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.05 151.85 38.67 Favored 'General case' 0 C--N 1.344 0.366 0 CA-C-N 121.002 2.401 . . . . 0.0 110.53 -172.097 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 6.7 mt -81.1 137.49 21.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 N-CA-C 106.676 -1.601 . . . . 0.0 106.676 178.849 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 78.0 t -134.68 136.4 52.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 C-N-CA 123.729 0.812 . . . . 0.0 110.235 -174.365 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -110.82 150.77 28.67 Favored 'General case' 0 N--CA 1.468 0.45 0 N-CA-C 107.878 -1.156 . . . . 0.0 107.878 169.257 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 2.8 mt -130.87 136.54 48.72 Favored 'General case' 0 CA--C 1.51 -0.562 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 174.603 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 43.6 p90 -147.42 166.82 26.06 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 168.669 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -162.46 160.03 32.27 Favored Glycine 0 N--CA 1.447 -0.582 0 N-CA-C 109.811 -1.316 . . . . 0.0 109.811 172.416 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 4.1 tt -112.15 151.6 29.29 Favored 'General case' 0 N--CA 1.448 -0.553 0 C-N-CA 125.457 1.503 . . . . 0.0 108.001 173.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -171.75 -155.96 11.52 Favored Glycine 0 CA--C 1.52 0.403 0 N-CA-C 109.89 -1.284 . . . . 0.0 109.89 169.787 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 5.2 t0 -138.54 131.63 29.88 Favored 'General case' 0 C--O 1.234 0.244 0 C-N-CA 124.116 0.966 . . . . 0.0 108.802 172.86 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 3.4 pt20 -81.37 -14.41 57.25 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 124.221 1.009 . . . . 0.0 113.253 179.326 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 98.8 mt -88.76 -46.85 8.65 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 119.439 1.018 . . . . 0.0 112.503 -169.822 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -64.71 -33.22 86.65 Favored Glycine 0 CA--C 1.528 0.905 0 C-N-CA 123.767 0.699 . . . . 0.0 113.557 -169.494 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 5.8 t80 -148.97 -40.85 0.15 Allowed 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 117.785 0.793 . . . . 0.0 110.945 177.083 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 81.57 -39.3 2.51 Favored Glycine 0 C--N 1.336 0.565 0 C-N-CA 124.153 0.882 . . . . 0.0 112.288 173.511 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -64.05 -36.31 83.59 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 118.981 1.39 . . . . 0.0 109.722 174.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' TRP . . . . . . . . . . . . . 46.7 m0 -98.17 36.86 1.51 Allowed 'General case' 0 CA--C 1.539 0.528 0 O-C-N 121.358 -0.839 . . . . 0.0 111.352 174.589 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 12.0 t80 -61.27 -53.0 62.4 Favored 'General case' 0 N--CA 1.467 0.381 0 O-C-N 121.461 -0.774 . . . . 0.0 109.479 173.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 80.2 mt -141.79 27.84 1.81 Allowed 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 124.236 1.014 . . . . 0.0 110.111 -175.097 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -59.78 -33.77 72.14 Favored 'General case' 0 N--CA 1.467 0.376 0 O-C-N 120.581 -1.325 . . . . 0.0 111.944 -171.415 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -73.45 -27.92 61.68 Favored 'General case' 0 CA--C 1.535 0.367 0 O-C-N 121.234 -0.916 . . . . 0.0 112.44 177.268 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 4.4 tt -60.67 -47.06 87.93 Favored 'General case' 0 N--CA 1.467 0.419 0 N-CA-C 107.458 -1.312 . . . . 0.0 107.458 169.065 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -62.31 -42.03 99.72 Favored Glycine 0 C--N 1.339 0.715 0 N-CA-C 111.44 -0.664 . . . . 0.0 111.44 -178.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 76.3 mtm -63.96 -38.37 90.82 Favored 'General case' 0 CA--C 1.529 0.166 0 CA-C-N 118.182 0.991 . . . . 0.0 111.726 179.564 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 4.2 tp -71.61 -35.45 70.48 Favored 'General case' 0 C--N 1.345 0.373 0 CA-C-N 120.247 1.385 . . . . 0.0 110.341 178.885 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -54.56 -51.65 64.55 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 118.899 0.772 . . . . 0.0 110.283 169.132 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -64.47 -42.77 95.71 Favored 'General case' 0 C--O 1.233 0.229 0 C-N-CA 122.754 0.422 . . . . 0.0 111.466 -172.289 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 22.5 ttmm -58.43 -39.36 79.6 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 123.897 0.879 . . . . 0.0 110.655 173.225 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 52.0 mt -87.11 -22.23 25.51 Favored 'General case' 0 CA--C 1.517 -0.29 0 N-CA-C 114.152 1.167 . . . . 0.0 114.152 -169.454 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 8.3 t -56.95 -36.24 70.03 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-N 119.393 0.997 . . . . 0.0 110.879 -175.673 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 21.1 p -86.21 -8.1 58.04 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 124.581 1.152 . . . . 0.0 112.2 -178.298 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 32.4 mmmt -83.15 -8.32 59.51 Favored 'General case' 0 C--N 1.346 0.441 0 C-N-CA 124.573 1.149 . . . . 0.0 111.709 175.393 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 74.7 29.11 61.85 Favored Glycine 0 CA--C 1.526 0.777 0 CA-C-N 118.424 0.557 . . . . 0.0 112.462 173.343 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 17.1 m -75.23 176.44 0.64 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 CA-C-N 117.957 0.879 . . . . 0.0 109.989 171.887 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -121.54 125.95 48.01 Favored 'General case' 0 CA--C 1.52 -0.208 0 N-CA-C 106.918 -1.512 . . . . 0.0 106.918 174.442 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 79.5 m-85 -89.5 145.03 25.57 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 119.562 1.074 . . . . 0.0 109.337 -178.649 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 27.3 m -126.68 157.86 37.41 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.212 0 C-N-CA 124.237 1.015 . . . . 0.0 109.084 171.149 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 95.38 -88.4 1.09 Allowed Glycine 0 C--N 1.333 0.364 0 CA-C-O 119.109 -0.829 . . . . 0.0 111.259 173.185 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 22.0 m-30 57.56 -173.49 0.08 Allowed 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 124.104 0.961 . . . . 0.0 110.446 -168.735 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -153.96 146.3 17.33 Favored Pre-proline 0 N--CA 1.473 0.69 0 CA-C-N 120.359 1.436 . . . . 0.0 109.656 178.952 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_endo -67.71 124.42 11.91 Favored 'Trans proline' 0 CA--C 1.535 0.568 0 C-N-CA 122.959 2.439 . . . . 0.0 112.121 178.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 2.9 p -77.87 -12.71 60.0 Favored 'General case' 0 CA--C 1.538 0.51 0 O-C-N 121.507 -0.746 . . . . 0.0 112.296 171.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -59.84 122.91 15.41 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 123.665 0.786 . . . . 0.0 109.934 -171.403 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 74.64 -0.09 57.28 Favored Glycine 0 CA--C 1.535 1.286 0 CA-C-O 118.563 -1.132 . . . . 0.0 114.066 179.146 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 2.2 t80 -82.87 154.7 24.51 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 119.345 1.572 . . . . 0.0 109.939 177.6 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -106.01 111.08 23.57 Favored 'General case' 0 CA--C 1.532 0.277 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 176.055 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 40.1 p90 -147.68 167.76 23.79 Favored 'General case' 0 C--O 1.236 0.391 0 C-N-CA 126.635 1.974 . . . . 0.0 107.404 178.457 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 14.7 t -143.48 -28.18 0.54 Allowed 'General case' 0 N--CA 1.468 0.433 0 N-CA-C 112.649 0.611 . . . . 0.0 112.649 -177.504 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 3.5 p -77.57 141.34 65.01 Favored Pre-proline 0 CA--C 1.539 0.548 0 CA-C-N 118.741 0.7 . . . . 0.0 109.7 -177.163 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -79.4 -28.01 3.89 Favored 'Trans proline' 0 CA--C 1.537 0.663 0 C-N-CA 122.506 2.138 . . . . 0.0 112.221 178.805 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 7.6 ttmt -61.03 -41.87 83.63 Favored Pre-proline 0 CA--C 1.542 0.647 0 CA-C-O 117.441 -1.266 . . . . 0.0 113.929 -171.784 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_endo -77.41 5.81 4.86 Favored 'Trans proline' 0 C--N 1.352 0.752 0 CA-C-N 122.012 1.754 . . . . 0.0 114.385 179.154 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 26.9 m -132.02 169.58 21.56 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.215 0 CA-C-N 120.411 1.459 . . . . 0.0 110.434 -176.844 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 23.0 pt -138.49 171.97 14.5 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.507 0 C-N-CA 126.768 2.027 . . . . 0.0 108.594 -177.606 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . 54.76 41.27 32.05 Favored 'General case' 0 CA--C 1.528 0.106 0 C-N-CA 125.081 1.352 . . . . 0.0 112.46 174.302 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 27.3 t70 55.7 42.15 29.63 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 126.187 1.795 . . . . 0.0 111.734 -176.121 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 88.19 15.6 60.46 Favored Glycine 0 CA--C 1.528 0.891 0 CA-C-O 118.93 -0.928 . . . . 0.0 113.679 174.446 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 45.4 mt-30 -88.46 -7.59 56.31 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 118.934 1.367 . . . . 0.0 112.524 -179.06 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 8.3 tp -155.44 146.05 22.13 Favored 'General case' 0 C--N 1.344 0.35 0 CA-C-N 119.241 0.928 . . . . 0.0 110.291 172.304 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 58.4 m-85 -76.9 144.1 39.14 Favored 'General case' 0 CA--C 1.514 -0.425 0 N-CA-C 107.472 -1.307 . . . . 0.0 107.472 169.294 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 4.4 p -82.23 14.1 0.52 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.573 0 CA-C-O 121.159 0.504 . . . . 0.0 112.13 -179.6 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 178.47 172.42 42.83 Favored Glycine 0 CA--C 1.525 0.685 0 N-CA-C 110.009 -1.237 . . . . 0.0 110.009 176.623 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 1.1 tp -65.79 138.04 57.65 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 117.631 0.715 . . . . 0.0 110.883 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -98.89 114.38 26.96 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 125.941 1.697 . . . . 0.0 110.178 -179.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -104.87 144.45 31.76 Favored 'General case' 0 CA--C 1.537 0.457 0 N-CA-C 106.386 -1.709 . . . . 0.0 106.386 166.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -144.04 130.56 20.0 Favored 'General case' 0 CA--C 1.531 0.224 0 N-CA-C 107.186 -1.413 . . . . 0.0 107.186 171.2 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 44.7 mm-40 -120.73 21.91 11.33 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 124.254 1.022 . . . . 0.0 111.468 -174.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 57.6 m -115.5 -40.44 3.4 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 124.808 1.243 . . . . 0.0 109.555 172.803 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 4.3 m-80 -92.9 -31.84 14.8 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 125.068 1.347 . . . . 0.0 110.223 -171.376 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 68.3 mt-30 -134.01 156.16 48.7 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 126.314 1.846 . . . . 0.0 108.29 -175.023 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 98.4 m-85 -147.28 -48.76 0.18 Allowed 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 124.148 0.979 . . . . 0.0 109.94 -179.421 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -68.5 -43.97 75.7 Favored 'General case' 0 N--CA 1.465 0.32 0 O-C-N 122.162 -0.336 . . . . 0.0 111.818 -171.171 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -90.57 8.83 32.1 Favored 'General case' 0 N--CA 1.465 0.295 0 N-CA-C 113.577 0.955 . . . . 0.0 113.577 -175.338 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 21.9 m -64.12 -33.15 75.11 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 119.56 1.073 . . . . 0.0 110.283 175.375 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -61.23 -40.43 93.98 Favored 'General case' 0 N--CA 1.463 0.179 0 O-C-N 121.917 -0.489 . . . . 0.0 110.884 172.19 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 -65.95 -47.4 74.78 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 124.106 0.962 . . . . 0.0 110.505 179.396 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 75.5 mtt-85 -52.2 -46.01 65.44 Favored 'General case' 0 N--CA 1.463 0.19 0 C-N-CA 124.509 1.124 . . . . 0.0 110.397 176.415 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 30.6 mt -70.37 -53.71 21.7 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 N-CA-C 107.847 -1.168 . . . . 0.0 107.847 179.302 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 68.7 tp60 -49.66 -64.77 0.71 Allowed 'General case' 0 C--O 1.233 0.22 0 C-N-CA 125.569 1.548 . . . . 0.0 112.202 -174.132 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 20.1 m -67.8 -31.86 72.02 Favored 'General case' 0 C--N 1.324 -0.512 0 C-N-CA 120.924 -0.31 . . . . 0.0 110.768 -169.075 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 160' ' ' TRP . . . . . . . . . . . . . 36.2 t90 -68.86 -44.2 73.83 Favored 'General case' 0 C--O 1.221 -0.407 0 O-C-N 122.128 -0.357 . . . . 0.0 110.914 176.455 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 87.8 m -60.68 -42.53 97.3 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 122.889 0.476 . . . . 0.0 110.636 177.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -63.35 -40.95 98.68 Favored 'General case' 0 CA--C 1.529 0.148 0 CA-C-O 121.481 0.658 . . . . 0.0 110.041 175.153 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 13.7 tt0 -64.67 -49.08 72.35 Favored 'General case' 0 N--CA 1.451 -0.419 0 O-C-N 121.375 -0.828 . . . . 0.0 110.735 -178.798 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 45.7 pt -64.6 -38.88 83.78 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.348 0 CA-C-O 118.089 -0.958 . . . . 0.0 109.62 -176.265 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -64.93 -32.59 74.39 Favored 'General case' 0 CA--C 1.53 0.176 0 CA-C-N 118.913 0.779 . . . . 0.0 110.229 179.698 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 29.6 m-80 -67.71 -60.69 2.33 Favored 'General case' 0 C--O 1.221 -0.444 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 172.523 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -53.21 -43.93 67.62 Favored 'General case' 0 N--CA 1.441 -0.89 0 C-N-CA 126.965 2.106 . . . . 0.0 111.168 -171.247 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 168' ' ' MET . . . . . . . . . . . . . 19.7 ptp -70.92 -31.68 68.36 Favored 'General case' 0 C--N 1.333 -0.151 0 N-CA-C 112.143 0.423 . . . . 0.0 112.143 179.244 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -75.35 -35.28 61.19 Favored 'General case' 0 N--CA 1.445 -0.723 0 N-CA-C 111.74 0.274 . . . . 0.0 111.74 177.918 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -66.48 -32.99 74.71 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-O 121.579 0.704 . . . . 0.0 109.581 178.634 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 64.9 t60 -67.47 -27.05 66.7 Favored 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 124.868 1.267 . . . . 0.0 111.077 177.851 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 -76.87 -46.43 24.64 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 124.074 0.949 . . . . 0.0 111.55 170.189 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.254 1.309 0 C-N-CA 125.841 1.657 . . . . 0.0 110.571 -169.77 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.498 1.971 0 N-CA-C 111.108 0.04 . . . . 0.0 111.108 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 19.3 p-10 -128.68 163.83 24.25 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 124.843 1.257 . . . . 0.0 111.49 -171.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 10.2 mtt -129.15 133.19 47.5 Favored 'General case' 0 CA--C 1.521 -0.153 0 C-N-CA 123.385 0.674 . . . . 0.0 111.418 179.118 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -98.43 147.24 18.48 Favored Glycine 0 CA--C 1.53 1.007 0 N-CA-C 106.395 -2.682 . . . . 0.0 106.395 166.718 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 1.2 tt -133.67 96.7 3.74 Favored 'General case' 0 N--CA 1.465 0.315 0 N-CA-C 105.573 -2.01 . . . . 0.0 105.573 -173.028 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -97.36 146.75 24.87 Favored 'General case' 0 CA--C 1.514 -0.419 0 CA-C-N 118.03 0.377 . . . . 0.0 111.109 -173.635 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 34.2 p90 -158.18 163.53 37.44 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 124.471 1.108 . . . . 0.0 109.518 176.7 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -96.03 -157.34 31.69 Favored Glycine 0 C--N 1.333 0.415 0 C-N-CA 124.17 0.891 . . . . 0.0 111.969 -174.365 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 10.0 m 61.39 167.97 0.1 Allowed 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 126.494 1.917 . . . . 0.0 113.264 -177.073 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 5.8 p -144.06 -49.02 0.28 Allowed 'General case' 0 C--O 1.237 0.396 0 C-N-CA 124.425 1.09 . . . . 0.0 110.51 -179.621 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 8.2 p -69.71 -54.15 15.15 Favored 'General case' 0 CA--C 1.535 0.376 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 171.877 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 83.2 m -82.6 160.08 22.58 Favored 'General case' 0 CA--C 1.536 0.435 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 167.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 36.5 p90 -127.5 20.29 6.71 Favored 'General case' 0 CA--C 1.537 0.461 0 N-CA-C 112.945 0.72 . . . . 0.0 112.945 -169.693 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 86.5 m 59.66 28.99 18.53 Favored 'General case' 0 CA--C 1.55 0.976 0 C-N-CA 123.782 0.833 . . . . 0.0 111.906 -178.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 58.71 177.47 0.07 Allowed 'General case' 0 CA--C 1.549 0.925 0 C-N-CA 125.501 1.521 . . . . 0.0 111.63 -177.332 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 36.8 mmt -69.43 13.69 0.12 Allowed 'General case' 0 CA--C 1.536 0.429 0 O-C-N 119.845 -1.784 . . . . 0.0 113.434 175.109 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -55.77 -49.25 73.64 Favored 'General case' 0 C--O 1.224 -0.264 0 CA-C-N 120.398 1.454 . . . . 0.0 109.656 173.7 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -61.99 -46.52 88.86 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 118.443 0.565 . . . . 0.0 111.133 -175.49 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -59.54 -48.22 82.5 Favored 'General case' 0 N--CA 1.451 -0.398 0 C-N-CA 124.379 1.072 . . . . 0.0 110.11 176.479 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 28.8 mtpp -68.99 -37.76 78.93 Favored 'General case' 0 C--O 1.224 -0.253 0 CA-C-O 117.992 -1.004 . . . . 0.0 111.033 -175.22 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 63.1 mt -54.21 -57.75 5.28 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.199 0 CA-C-N 119.712 1.142 . . . . 0.0 108.471 175.652 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 15.1 ptt180 -62.84 -39.14 93.46 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-O 118.834 -0.603 . . . . 0.0 110.067 -177.149 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -65.38 -39.18 91.95 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 118.339 0.518 . . . . 0.0 110.358 -173.673 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 62.9 mt -76.62 -52.61 16.82 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.699 0 C-N-CA 124.886 1.274 . . . . 0.0 110.091 -175.855 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 64.1 mt -60.55 -47.54 92.36 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.336 0 C-N-CA 123.025 0.53 . . . . 0.0 109.841 179.283 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 139.61 113.97 1.14 Allowed Glycine 0 CA--C 1.525 0.66 0 C-N-CA 125.656 1.598 . . . . 0.0 109.258 -179.113 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -72.87 -7.93 21.52 Favored 'Trans proline' 0 CA--C 1.537 0.666 0 C-N-CA 122.509 2.139 . . . . 0.0 113.423 -169.599 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -77.39 -20.57 54.5 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 118.934 0.788 . . . . 0.0 111.57 178.726 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -122.37 7.59 9.61 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 124.886 1.275 . . . . 0.0 113.383 -173.49 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 45.4 t -124.28 148.77 28.42 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.231 0 C-N-CA 124.924 1.29 . . . . 0.0 107.713 175.596 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 7.8 m -134.11 133.27 40.89 Favored 'General case' 0 C--N 1.331 -0.211 0 C-N-CA 124.959 1.303 . . . . 0.0 108.045 -175.861 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 21.8 mt -78.62 139.31 38.57 Favored 'General case' 0 C--O 1.232 0.158 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 175.695 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 36.0 t-80 -137.98 54.28 1.8 Allowed 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 124.321 1.049 . . . . 0.0 108.704 -174.409 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 21.3 t-20 -57.0 134.02 55.43 Favored 'General case' 0 CA--C 1.533 0.312 0 O-C-N 120.838 -1.164 . . . . 0.0 108.386 172.695 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 51.6 mt -74.17 -20.98 60.03 Favored 'General case' 0 CA--C 1.531 0.24 0 N-CA-C 114.344 1.238 . . . . 0.0 114.344 -168.872 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 14.9 tmtt? -73.29 -38.46 65.87 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 119.25 0.932 . . . . 0.0 109.014 168.501 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -73.53 -37.69 65.54 Favored 'General case' 0 C--O 1.234 0.258 0 N-CA-C 113.429 0.9 . . . . 0.0 113.429 -173.151 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 3.2 t0 -143.36 153.9 43.19 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 118.762 0.71 . . . . 0.0 112.249 175.405 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 17.2 m -73.68 157.17 87.89 Favored Pre-proline 0 CA--C 1.54 0.596 0 C-N-CA 125.842 1.657 . . . . 0.0 111.759 -169.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -72.72 -26.87 15.64 Favored 'Trans proline' 0 C--N 1.349 0.565 0 C-N-CA 122.761 2.307 . . . . 0.0 113.282 -171.211 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 22.4 mmmt -70.78 -13.22 61.97 Favored 'General case' 0 N--CA 1.473 0.696 0 O-C-N 120.252 -1.53 . . . . 0.0 111.842 -175.817 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -60.64 -29.1 69.06 Favored 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 125.526 1.53 . . . . 0.0 110.08 169.409 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 45.7 mtt -56.63 -25.05 52.16 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 118.966 0.803 . . . . 0.0 111.732 178.419 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 93.8 mt-10 -65.3 -31.69 72.96 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 118.432 0.56 . . . . 0.0 110.325 -177.13 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 24.9 mt-30 -67.39 -42.72 82.86 Favored 'General case' 0 N--CA 1.466 0.342 0 N-CA-C 113.259 0.837 . . . . 0.0 113.259 -169.788 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 34.8 m-85 -73.77 140.05 45.63 Favored 'General case' 0 C--O 1.23 0.045 0 C-N-CA 123.53 0.732 . . . . 0.0 109.966 -167.181 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -67.07 -45.22 78.03 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 118.588 0.631 . . . . 0.0 109.801 174.109 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 6.4 t -102.05 142.22 16.85 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.591 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 175.139 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 31.3 tp -129.94 112.77 13.84 Favored 'General case' 0 N--CA 1.442 -0.842 0 N-CA-C 108.439 -0.949 . . . . 0.0 108.439 173.34 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 17.8 mt -88.41 133.57 30.47 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.591 0 N-CA-C 106.334 -1.728 . . . . 0.0 106.334 172.069 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -109.52 140.61 43.08 Favored 'General case' 0 CA--C 1.517 -0.299 0 C-N-CA 125.904 1.681 . . . . 0.0 106.52 179.404 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -141.99 146.89 18.24 Favored Glycine 0 CA--C 1.518 0.249 0 N-CA-C 110.261 -1.136 . . . . 0.0 110.261 175.036 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 16.5 tt -157.97 139.09 9.55 Favored Pre-proline 0 CA--C 1.538 0.506 0 N-CA-C 107.599 -1.259 . . . . 0.0 107.599 177.276 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -77.65 27.44 0.46 Allowed 'Trans proline' 0 CA--C 1.548 1.194 0 C-N-CA 123.163 2.576 . . . . 0.0 112.835 170.187 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' THR . . . . . 0.471 HG23 ' H ' ' A' ' 100' ' ' ALA . 82.5 m 57.95 -56.04 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 128.76 2.824 . . . . 0.0 114.092 -167.129 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -154.39 169.95 22.51 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 125.227 1.411 . . . . 0.0 111.045 -173.757 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 21.3 t0 -103.23 51.66 0.79 Allowed 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 124.678 1.191 . . . . 0.0 107.882 167.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 92.5 m-85 49.99 44.66 25.58 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 125.889 1.676 . . . . 0.0 112.58 -174.541 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -172.38 -60.2 0.04 OUTLIER Glycine 0 C--N 1.338 0.664 0 N-CA-C 109.684 -1.367 . . . . 0.0 109.684 176.213 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 22.6 tt0 -155.46 174.07 15.77 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 124.989 1.316 . . . . 0.0 107.984 175.83 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 72.0 mt -46.39 136.92 2.26 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.808 0 C-N-CA 126.004 1.722 . . . . 0.0 109.267 169.048 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -77.73 156.82 30.38 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-O 121.583 0.706 . . . . 0.0 111.192 178.979 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -57.99 -42.32 84.89 Favored 'General case' 0 C--O 1.225 -0.236 0 C-N-CA 124.269 1.028 . . . . 0.0 111.722 -169.249 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 45.5 m-20 -61.44 -23.47 65.87 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 119.108 0.867 . . . . 0.0 112.049 -173.861 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 6.9 t90 -96.09 -48.01 5.84 Favored 'General case' 0 CA--C 1.527 0.071 0 C-N-CA 124.496 1.118 . . . . 0.0 109.652 177.374 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 8.2 tt0 -65.33 -36.02 82.77 Favored 'General case' 0 N--CA 1.447 -0.62 0 O-C-N 120.962 -1.086 . . . . 0.0 110.556 -174.182 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -61.49 -25.99 67.61 Favored 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 123.653 0.781 . . . . 0.0 111.055 -174.709 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 28.5 m -108.48 -15.64 9.2 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.289 0 CA-C-O 117.234 -1.365 . . . . 0.0 112.195 177.071 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 34.8 t90 -52.27 -35.09 49.11 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 120.526 1.512 . . . . 0.0 110.861 178.049 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -62.61 -29.42 70.59 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 125.31 1.444 . . . . 0.0 113.163 175.272 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 29.3 mt-30 -92.15 -19.62 22.09 Favored 'General case' 0 C--N 1.341 0.218 0 C-N-CA 125.874 1.67 . . . . 0.0 112.393 177.453 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 53.4 mt -63.05 -20.71 65.59 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-N 118.903 0.774 . . . . 0.0 111.474 -177.607 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -78.93 -23.94 44.34 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 123.055 0.542 . . . . 0.0 111.773 174.602 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -72.21 -29.18 63.72 Favored 'General case' 0 N--CA 1.469 0.514 0 O-C-N 120.918 -1.114 . . . . 0.0 111.706 179.049 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 79.8 mt -53.36 141.15 25.19 Favored 'General case' 0 C--N 1.34 0.194 0 C-N-CA 125.141 1.376 . . . . 0.0 113.106 -168.509 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 3.2 t30 -75.7 102.67 5.48 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 170.025 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 61.3 mt -125.26 -0.14 7.72 Favored 'General case' 0 N--CA 1.475 0.821 0 N-CA-C 114.205 1.187 . . . . 0.0 114.205 -174.025 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 26.9 mt-10 -56.68 129.2 40.09 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-N 119.666 1.121 . . . . 0.0 111.115 -168.613 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 74.18 -2.12 45.69 Favored Glycine 0 CA--C 1.534 1.228 0 C-N-CA 125.493 1.521 . . . . 0.0 114.998 178.525 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.4 151.37 38.16 Favored 'General case' 0 C--N 1.346 0.426 0 CA-C-N 120.617 2.208 . . . . 0.0 110.021 -175.025 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 6.7 mt -80.67 136.29 23.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 N-CA-C 106.661 -1.607 . . . . 0.0 106.661 178.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 65.2 t -132.48 140.51 47.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 C-N-CA 124.054 0.942 . . . . 0.0 109.192 -177.376 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -125.28 144.72 50.34 Favored 'General case' 0 N--CA 1.456 -0.162 0 N-CA-C 108.118 -1.068 . . . . 0.0 108.118 170.575 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 4.2 mt -117.83 120.76 38.89 Favored 'General case' 0 CA--C 1.518 -0.26 0 C-N-CA 124.416 1.086 . . . . 0.0 108.612 -175.769 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 22.5 m-85 -113.07 151.98 30.09 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 107.406 -1.331 . . . . 0.0 107.406 169.861 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -155.81 137.5 5.57 Favored Glycine 0 N--CA 1.449 -0.485 0 N-CA-C 107.825 -2.11 . . . . 0.0 107.825 167.619 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 27.1 tp -99.97 146.34 26.82 Favored 'General case' 0 N--CA 1.442 -0.831 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 169.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -166.89 -174.72 36.39 Favored Glycine 0 CA--C 1.527 0.798 0 N-CA-C 108.524 -1.83 . . . . 0.0 108.524 175.042 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 2.9 t0 -151.67 127.14 10.03 Favored 'General case' 0 C--O 1.234 0.261 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 176.823 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 16.8 pm0 -72.74 -11.85 60.78 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 125.582 1.553 . . . . 0.0 113.088 -177.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 96.5 mt -88.09 -46.1 9.59 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 119.758 1.163 . . . . 0.0 111.29 177.865 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -60.61 -41.45 98.86 Favored Glycine 0 CA--C 1.529 0.947 0 C-N-CA 124.292 0.949 . . . . 0.0 112.26 -172.671 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 23.1 t80 -148.19 -62.95 0.26 Allowed 'General case' 0 N--CA 1.462 0.146 0 N-CA-C 108.871 -0.788 . . . . 0.0 108.871 169.142 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 80.59 -19.99 6.67 Favored Glycine 0 CA--C 1.524 0.606 0 CA-C-O 118.984 -0.898 . . . . 0.0 114.101 168.847 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -64.54 -37.29 87.05 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 119.402 1.601 . . . . 0.0 109.348 174.335 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' TRP . . . . . . . . . . . . . 47.8 m0 -102.85 33.45 3.22 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 126.147 1.779 . . . . 0.0 111.127 177.703 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 27.6 t80 -52.58 129.91 30.52 Favored 'General case' 0 N--CA 1.466 0.369 0 N-CA-C 108.056 -1.09 . . . . 0.0 108.056 174.755 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 90.3 mt 54.35 22.46 3.78 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 123.866 0.866 . . . . 0.0 113.15 173.308 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -61.71 -39.19 90.62 Favored 'General case' 0 N--CA 1.465 0.285 0 O-C-N 120.687 -1.258 . . . . 0.0 111.366 -168.679 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . 0.471 ' H ' HG23 ' A' ' 55' ' ' THR . . . -79.0 -15.86 57.69 Favored 'General case' 0 N--CA 1.445 -0.698 0 O-C-N 121.093 -1.004 . . . . 0.0 112.885 178.768 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 5.4 tt -63.44 -42.2 98.67 Favored 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 106.568 -1.641 . . . . 0.0 106.568 167.679 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -63.83 -37.58 94.88 Favored Glycine 0 C--N 1.341 0.812 0 N-CA-C 111.34 -0.704 . . . . 0.0 111.34 178.67 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 28.5 mtm -64.53 -45.23 88.08 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 118.397 1.099 . . . . 0.0 111.813 177.873 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.7 -39.69 88.16 Favored 'General case' 0 C--N 1.344 0.354 0 CA-C-N 120.233 1.379 . . . . 0.0 109.942 177.277 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 85.3 t60 -57.38 -51.34 69.79 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 118.492 0.587 . . . . 0.0 111.053 177.254 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -62.73 -39.26 93.52 Favored 'General case' 0 C--O 1.235 0.3 0 C-N-CA 124.04 0.936 . . . . 0.0 112.067 -176.335 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 25.0 ttmm -56.21 -35.03 66.86 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 123.657 0.783 . . . . 0.0 110.737 172.392 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 21.0 mt -94.34 -20.05 20.1 Favored 'General case' 0 CA--C 1.515 -0.371 0 N-CA-C 115.761 1.763 . . . . 0.0 115.761 -168.92 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 4.0 m -58.24 -33.98 69.95 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-N 120.673 1.579 . . . . 0.0 111.452 -177.843 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 20.0 p -85.79 -10.71 55.05 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 125.4 1.48 . . . . 0.0 112.324 179.871 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 32.6 mmmt -84.69 -6.05 59.34 Favored 'General case' 0 N--CA 1.466 0.342 0 C-N-CA 124.555 1.142 . . . . 0.0 111.334 173.875 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 70.09 33.49 69.65 Favored Glycine 0 CA--C 1.525 0.69 0 CA-C-N 118.438 0.563 . . . . 0.0 112.125 172.001 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 4.9 m -77.48 175.33 0.76 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.599 0 CA-C-N 117.907 0.853 . . . . 0.0 109.635 173.726 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -117.62 116.21 26.63 Favored 'General case' 0 N--CA 1.465 0.317 0 N-CA-C 107.318 -1.364 . . . . 0.0 107.318 175.069 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 71.2 m-85 -83.52 147.25 27.9 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 119.249 0.931 . . . . 0.0 109.185 -179.037 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 35.8 m -125.21 159.17 32.69 Favored 'Isoleucine or valine' 0 C--O 1.234 0.289 0 C-N-CA 123.696 0.798 . . . . 0.0 110.652 172.157 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 93.52 -87.57 1.18 Allowed Glycine 0 N--CA 1.446 -0.65 0 C-N-CA 125.144 1.354 . . . . 0.0 111.956 169.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 15.7 m-30 58.53 176.68 0.07 Allowed 'General case' 0 CA--C 1.552 1.04 0 C-N-CA 125.293 1.437 . . . . 0.0 110.87 -168.031 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -148.98 147.15 23.07 Favored Pre-proline 0 N--CA 1.476 0.853 0 O-C-N 120.199 -1.563 . . . . 0.0 110.149 177.8 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo -61.97 127.11 20.41 Favored 'Trans proline' 0 C--N 1.349 0.559 0 C-N-CA 122.831 2.354 . . . . 0.0 110.336 169.387 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 13.7 p -73.08 -13.63 61.24 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 113.32 0.859 . . . . 0.0 113.32 175.618 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -60.07 130.97 49.34 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 123.642 0.777 . . . . 0.0 109.937 -173.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 87.59 -6.87 82.74 Favored Glycine 0 CA--C 1.534 1.236 0 C-N-CA 124.798 1.189 . . . . 0.0 114.227 177.357 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 58.3 m-85 -85.96 157.9 20.02 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-N 119.327 1.563 . . . . 0.0 109.783 171.668 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -123.11 118.94 28.84 Favored 'General case' 0 C--O 1.233 0.186 0 N-CA-C 106.51 -1.663 . . . . 0.0 106.51 170.629 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 49.3 p90 -161.27 146.25 13.72 Favored 'General case' 0 C--O 1.237 0.439 0 N-CA-C 106.367 -1.716 . . . . 0.0 106.367 -174.185 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 7.5 m -107.51 -47.85 3.55 Favored 'General case' 0 N--CA 1.447 -0.587 0 N-CA-C 112.318 0.488 . . . . 0.0 112.318 -169.728 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 41.8 m -70.79 142.51 88.35 Favored Pre-proline 0 CA--C 1.542 0.658 0 CA-C-O 119.179 -0.439 . . . . 0.0 110.801 -174.738 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo -82.55 -14.85 8.93 Favored 'Trans proline' 0 CA--C 1.539 0.741 0 C-N-CA 123.108 2.539 . . . . 0.0 113.403 -178.027 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 9.5 ttmm -54.27 -37.41 53.32 Favored Pre-proline 0 CA--C 1.542 0.658 0 N-CA-C 114.68 1.363 . . . . 0.0 114.68 -172.696 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_exo -79.49 -0.34 10.64 Favored 'Trans proline' 0 CA--C 1.538 0.723 0 CA-C-N 122.036 1.763 . . . . 0.0 114.271 -179.109 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 31.4 m -131.51 165.51 31.46 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.427 0 CA-C-N 120.39 1.45 . . . . 0.0 112.647 -168.493 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 10.3 pt -136.5 176.42 8.09 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 C-N-CA 128.723 2.809 . . . . 0.0 108.439 -176.848 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . 56.33 41.87 28.51 Favored 'General case' 0 N--CA 1.465 0.297 0 C-N-CA 125.362 1.465 . . . . 0.0 112.35 174.134 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 27.7 t70 55.2 42.13 30.82 Favored 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 125.938 1.695 . . . . 0.0 111.479 -175.545 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 87.63 16.87 59.39 Favored Glycine 0 CA--C 1.528 0.906 0 CA-C-O 118.715 -1.047 . . . . 0.0 113.974 173.552 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 45.6 mt-30 -91.07 -9.23 46.49 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-N 119.072 1.436 . . . . 0.0 113.168 -178.336 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 4.9 tp -151.66 138.65 19.07 Favored 'General case' 0 C--N 1.342 0.273 0 CA-C-N 119.797 1.18 . . . . 0.0 111.054 -178.646 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 61.9 m-85 -77.82 143.7 37.66 Favored 'General case' 0 CA--C 1.517 -0.314 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 169.931 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 19.4 m -78.31 3.01 1.74 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 C-N-CA 123.587 0.755 . . . . 0.0 112.352 178.306 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -168.91 -172.93 36.2 Favored Glycine 0 C--N 1.335 0.483 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 -178.905 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 46.5 tp -74.65 129.67 38.13 Favored 'General case' 0 N--CA 1.451 -0.384 0 C-N-CA 123.659 0.784 . . . . 0.0 110.505 -179.605 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -81.19 117.36 21.66 Favored 'General case' 0 N--CA 1.443 -0.824 0 N-CA-C 107.322 -1.362 . . . . 0.0 107.322 167.36 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 61.4 mt -108.37 131.87 54.32 Favored 'General case' 0 N--CA 1.462 0.172 0 N-CA-C 107.031 -1.47 . . . . 0.0 107.031 167.827 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -151.89 135.52 16.21 Favored 'General case' 0 C--O 1.236 0.37 0 C-N-CA 128.074 2.549 . . . . 0.0 104.272 177.637 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -134.31 0.44 3.08 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 125.347 1.459 . . . . 0.0 111.338 -179.543 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 36.6 m -89.88 -42.94 10.94 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 124.456 1.102 . . . . 0.0 109.164 -171.523 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 8.1 m-80 -80.95 -34.48 33.18 Favored 'General case' 0 C--N 1.332 -0.176 0 C-N-CA 123.672 0.789 . . . . 0.0 111.29 -168.515 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -143.29 137.09 28.6 Favored 'General case' 0 CA--C 1.533 0.298 0 N-CA-C 105.482 -2.044 . . . . 0.0 105.482 177.677 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 39.8 m-85 -91.37 -19.24 23.12 Favored 'General case' 0 N--CA 1.466 0.325 0 N-CA-C 112.883 0.697 . . . . 0.0 112.883 -169.246 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -90.3 -31.97 16.72 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 123.016 0.527 . . . . 0.0 112.163 -176.69 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 82.5 mt -78.18 -10.48 59.66 Favored 'General case' 0 C--O 1.224 -0.25 0 N-CA-C 113.337 0.865 . . . . 0.0 113.337 -169.147 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 4.9 p -64.12 -47.22 80.85 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 120.331 1.423 . . . . 0.0 110.016 176.116 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -65.17 -38.75 91.51 Favored 'General case' 0 N--CA 1.461 0.11 0 C-N-CA 123.016 0.526 . . . . 0.0 110.641 177.662 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 2.8 tp10 -62.23 -49.06 77.24 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 124.31 1.044 . . . . 0.0 110.78 178.381 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 41.5 mtt180 -56.87 -44.83 82.63 Favored 'General case' 0 C--O 1.226 -0.182 0 C-N-CA 124.617 1.167 . . . . 0.0 109.761 178.536 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 53.8 mt -65.45 -56.0 17.37 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.358 0 N-CA-C 107.91 -1.144 . . . . 0.0 107.91 177.212 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 68.8 tp60 -55.77 -63.65 1.11 Allowed 'General case' 0 C--O 1.232 0.179 0 C-N-CA 124.09 0.956 . . . . 0.0 112.173 -170.503 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 20.2 m -67.35 -32.68 73.79 Favored 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 121.051 -0.259 . . . . 0.0 111.035 -168.695 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 160' ' ' TRP . . . . . . . . . . . . . 3.6 t90 -73.53 -42.37 61.83 Favored 'General case' 0 C--O 1.22 -0.45 0 CA-C-O 119.085 -0.483 . . . . 0.0 110.684 177.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 55.2 m -57.12 -45.33 83.55 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 118.525 0.602 . . . . 0.0 110.378 174.398 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -61.21 -42.3 98.36 Favored 'General case' 0 CA--C 1.528 0.111 0 CA-C-O 121.467 0.651 . . . . 0.0 110.191 177.097 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 16.5 tt0 -64.2 -53.44 49.29 Favored 'General case' 0 N--CA 1.448 -0.561 0 O-C-N 121.655 -0.653 . . . . 0.0 110.202 -178.721 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 41.2 pt -62.26 -37.04 77.6 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.331 0 CA-C-O 117.653 -1.165 . . . . 0.0 109.16 -174.814 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -63.47 -37.55 87.75 Favored 'General case' 0 C--O 1.224 -0.268 0 CA-C-N 119.57 1.077 . . . . 0.0 109.708 -179.729 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 34.1 m-80 -67.05 -50.41 61.98 Favored 'General case' 0 N--CA 1.465 0.294 0 N-CA-C 108.887 -0.782 . . . . 0.0 108.887 176.338 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 67.3 tt0 -72.69 -18.03 61.58 Favored 'General case' 0 N--CA 1.437 -1.122 0 C-N-CA 126.167 1.787 . . . . 0.0 112.157 -169.181 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 168' ' ' MET . . . . . . . . . . . . . 19.0 ptp -89.86 -40.05 12.67 Favored 'General case' 0 N--CA 1.456 -0.151 0 C-N-CA 124.115 0.966 . . . . 0.0 111.168 168.813 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -74.35 -24.82 59.23 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 112.647 0.61 . . . . 0.0 112.647 -174.021 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -58.7 -29.69 66.85 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 118.511 0.596 . . . . 0.0 111.626 179.209 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 78.9 m-70 -75.18 -14.13 60.52 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 124.783 1.233 . . . . 0.0 112.401 177.181 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 14.1 m-85 -115.38 -5.43 12.3 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 127.432 2.293 . . . . 0.0 112.173 -174.325 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.255 1.35 0 C-N-CA 124.378 1.071 . . . . 0.0 109.971 175.592 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.411 ' HA ' ' OD2' ' A' ' 47' ' ' ASP . 11.1 tmm? . . . . . 0 N--CA 1.495 1.819 0 N-CA-C 109.832 -0.433 . . . . 0.0 109.832 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 3.0 t30 -142.53 151.41 41.59 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 125.263 1.425 . . . . 0.0 107.911 174.489 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -112.0 128.05 56.06 Favored 'General case' 0 N--CA 1.463 0.221 0 C-N-CA 123.977 0.911 . . . . 0.0 111.573 -177.915 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -87.1 155.49 27.5 Favored Glycine 0 CA--C 1.523 0.584 0 N-CA-C 107.812 -2.115 . . . . 0.0 107.812 167.231 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 3.1 tt -140.39 96.53 3.05 Favored 'General case' 0 N--CA 1.466 0.341 0 N-CA-C 105.397 -2.075 . . . . 0.0 105.397 -177.504 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -98.95 140.51 33.0 Favored 'General case' 0 CA--C 1.516 -0.336 0 CA-C-O 121.225 0.536 . . . . 0.0 111.379 -173.656 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . 0.432 ' CD2' ' HB ' ' A' ' 14' ' ' THR . 43.6 p90 -160.88 -177.56 6.22 Favored 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 125.679 1.592 . . . . 0.0 107.95 177.698 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -175.28 105.55 0.21 Allowed Glycine 0 C--N 1.333 0.376 0 N-CA-C 106.53 -2.628 . . . . 0.0 106.53 179.156 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 65.1 m -79.15 157.63 27.87 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 124.354 1.062 . . . . 0.0 112.249 -169.712 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 74.7 p -120.64 -144.3 0.35 Allowed 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 126.22 1.808 . . . . 0.0 107.353 169.808 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 3.2 p -61.89 -29.31 70.12 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 124.065 0.946 . . . . 0.0 109.377 167.265 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 6.5 t -94.24 128.78 40.9 Favored 'General case' 0 C--N 1.343 0.299 0 N-CA-C 105.13 -2.174 . . . . 0.0 105.13 168.26 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 44.2 p90 -120.15 156.1 31.75 Favored 'General case' 0 N--CA 1.464 0.274 0 N-CA-C 113.811 1.041 . . . . 0.0 113.811 -167.838 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.432 ' HB ' ' CD2' ' A' ' 7' ' ' TYR . 0.3 OUTLIER -116.64 -8.7 11.43 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 124.706 1.203 . . . . 0.0 112.539 -169.875 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -59.97 -38.09 81.52 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 118.983 0.81 . . . . 0.0 111.956 -167.631 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 30.6 mmt -66.97 -42.26 85.46 Favored 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 -177.326 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -65.09 -46.04 82.73 Favored 'General case' 0 C--O 1.226 -0.152 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 177.825 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -63.03 -47.42 83.12 Favored 'General case' 0 C--O 1.233 0.191 0 C-N-CA 122.756 0.422 . . . . 0.0 111.353 -176.047 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 10.4 mt-10 -62.06 -43.04 99.69 Favored 'General case' 0 CA--C 1.516 -0.338 0 CA-C-O 118.912 -0.566 . . . . 0.0 110.275 176.801 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 29.7 mtpp -71.58 -40.39 69.93 Favored 'General case' 0 C--O 1.22 -0.476 0 CA-C-O 117.97 -1.014 . . . . 0.0 110.892 -174.036 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 47.3 mt -52.54 -54.3 16.06 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.255 0 CA-C-N 120.052 1.296 . . . . 0.0 108.524 172.27 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 8.0 ttp180 -61.72 -41.06 97.14 Favored 'General case' 0 C--O 1.223 -0.296 0 C-N-CA 123.209 0.604 . . . . 0.0 109.425 -175.758 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -66.43 -41.61 88.93 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 118.481 0.582 . . . . 0.0 111.421 -179.177 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 49.3 mt -72.58 -53.17 20.01 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.526 0 C-N-CA 124.7 1.2 . . . . 0.0 109.686 -172.171 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 78.0 mt -67.05 -45.3 87.19 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 179.828 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 139.24 125.5 2.28 Favored Glycine 0 CA--C 1.532 1.137 0 C-N-CA 125.165 1.364 . . . . 0.0 112.067 173.737 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 82.2 Cg_endo -73.17 -5.3 16.93 Favored 'Trans proline' 0 CA--C 1.537 0.636 0 C-N-CA 123.664 2.91 . . . . 0.0 113.873 -175.822 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -82.27 -17.41 46.01 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 118.996 0.816 . . . . 0.0 111.072 177.229 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 1.3 pt? -129.94 -13.76 4.05 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 125.114 1.366 . . . . 0.0 113.871 -174.331 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 33.8 t -98.48 153.45 4.08 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.517 0 N-CA-C 107.691 -1.226 . . . . 0.0 107.691 168.56 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 50.5 m -139.65 131.93 28.3 Favored 'General case' 0 C--O 1.234 0.279 0 C-N-CA 126.464 1.905 . . . . 0.0 106.239 -177.117 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 24.3 mt -81.25 142.38 33.21 Favored 'General case' 0 C--O 1.233 0.191 0 N-CA-C 107.839 -1.171 . . . . 0.0 107.839 176.763 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 34.2 t-80 -134.28 57.65 1.8 Allowed 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 124.574 1.15 . . . . 0.0 108.218 -175.157 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 64.3 t-20 -70.43 118.01 12.69 Favored 'General case' 0 C--O 1.235 0.327 0 O-C-N 121.076 -1.015 . . . . 0.0 108.779 -176.673 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 93.9 mt -68.45 -12.94 61.92 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 124.092 0.957 . . . . 0.0 112.505 -174.807 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 65.3 mmtt -53.73 -27.19 26.89 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-O 118.685 -0.674 . . . . 0.0 111.178 167.013 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -132.04 -41.71 1.01 Allowed 'General case' 0 C--O 1.236 0.347 0 N-CA-C 113.437 0.903 . . . . 0.0 113.437 -173.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 29.8 m-20 -85.56 141.2 30.03 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-N 118.475 0.58 . . . . 0.0 110.568 -174.324 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 14.8 m -76.32 154.23 84.13 Favored Pre-proline 0 CA--C 1.54 0.59 0 C-N-CA 124.378 1.071 . . . . 0.0 110.342 176.658 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -77.26 -26.84 7.13 Favored 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 122.267 1.978 . . . . 0.0 113.683 -170.085 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.79 -15.38 63.54 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-N 120.657 1.571 . . . . 0.0 112.269 -178.612 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -58.77 -29.23 66.64 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 125.403 1.481 . . . . 0.0 110.363 170.317 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 55.3 mtt -57.43 -27.75 62.68 Favored 'General case' 0 C--N 1.342 0.264 0 C-N-CA 123.589 0.756 . . . . 0.0 111.498 177.339 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 56.7 mt-10 -66.83 -33.09 74.85 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 118.348 0.522 . . . . 0.0 110.537 -176.22 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 16.5 mt-30 -66.9 -43.18 84.09 Favored 'General case' 0 N--CA 1.464 0.232 0 C-N-CA 123.346 0.659 . . . . 0.0 112.336 -170.003 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 22.2 m-85 -70.92 142.11 51.11 Favored 'General case' 0 N--CA 1.454 -0.227 0 CA-C-N 115.387 -0.824 . . . . 0.0 110.528 -166.469 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . 0.411 ' OD2' ' HA ' ' A' ' 1' ' ' MET . 24.4 m-20 -74.77 -35.7 62.57 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-O 121.118 0.485 . . . . 0.0 109.726 -178.098 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 25.6 t -113.94 147.49 17.44 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.216 0 N-CA-C 107.178 -1.416 . . . . 0.0 107.178 170.003 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 29.8 tp -132.19 109.69 10.12 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 123.778 0.831 . . . . 0.0 108.843 174.889 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 32.0 mt -87.22 133.1 30.93 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.552 0 N-CA-C 107.077 -1.453 . . . . 0.0 107.077 176.583 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 2.4 mp -111.22 127.34 55.57 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 126.141 1.777 . . . . 0.0 106.966 -179.26 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -135.0 136.6 8.65 Favored Glycine 0 C--N 1.335 0.48 0 N-CA-C 109.439 -1.464 . . . . 0.0 109.439 -179.561 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 4.1 tt -150.46 129.31 6.19 Favored Pre-proline 0 CA--C 1.542 0.645 0 CA-C-N 118.772 1.286 . . . . 0.0 110.926 -175.054 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -76.6 -21.63 12.79 Favored 'Trans proline' 0 CA--C 1.542 0.902 0 C-N-CA 122.992 2.461 . . . . 0.0 115.539 170.087 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' THR . . . . . 0.418 HG21 ' H ' ' A' ' 56' ' ' TRP . 25.7 m 56.75 -167.47 0.12 Allowed 'General case' 0 CA--C 1.558 1.255 0 CA-C-N 119.592 1.087 . . . . 0.0 109.453 -169.265 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' TRP . . . . . 0.418 ' H ' HG21 ' A' ' 55' ' ' THR . 0.3 OUTLIER -133.74 159.58 40.14 Favored 'General case' 0 CA--C 1.535 0.369 0 O-C-N 120.582 -1.324 . . . . 0.0 108.814 169.914 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -65.7 109.56 2.47 Favored 'General case' 0 C--O 1.236 0.377 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 -179.836 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 85.6 m-85 47.36 37.27 5.77 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 124.001 0.92 . . . . 0.0 111.507 -169.266 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -136.37 149.81 20.25 Favored Glycine 0 C--N 1.337 0.598 0 N-CA-C 110.501 -1.04 . . . . 0.0 110.501 -175.215 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.407 ' HG2' ' H ' ' A' ' 61' ' ' ILE . 14.3 tt0 -77.74 -171.34 2.18 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-O 121.998 0.904 . . . . 0.0 109.738 -177.932 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.407 ' H ' ' HG2' ' A' ' 60' ' ' GLU . 13.1 mt -57.69 141.24 14.94 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.706 0 C-N-CA 126.292 1.837 . . . . 0.0 111.464 -172.622 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . 0.494 ' H ' ' CD ' ' A' ' 62' ' ' GLN . 0.3 OUTLIER -56.02 146.89 21.27 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 126.741 2.016 . . . . 0.0 109.715 175.012 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -57.15 -48.23 79.21 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 118.348 0.522 . . . . 0.0 112.172 -169.629 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -69.71 -17.87 63.49 Favored 'General case' 0 N--CA 1.475 0.807 0 CA-C-N 119.019 0.827 . . . . 0.0 112.177 -173.864 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -93.28 -43.44 8.8 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 124.92 1.288 . . . . 0.0 107.636 -179.822 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -63.46 -35.12 79.39 Favored 'General case' 0 N--CA 1.435 -1.217 0 C-N-CA 126.229 1.812 . . . . 0.0 111.075 177.347 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -55.93 -23.88 34.53 Favored 'General case' 0 CA--C 1.53 0.174 0 C-N-CA 124.582 1.153 . . . . 0.0 112.001 -176.821 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 35.7 m -116.47 -13.49 11.01 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.224 0 CA-C-O 117.913 -1.041 . . . . 0.0 112.709 178.902 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 26.5 t90 -52.55 -38.68 60.31 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 119.824 1.193 . . . . 0.0 111.083 -177.063 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -68.04 -24.02 65.04 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 125.12 1.368 . . . . 0.0 112.967 178.62 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 20.4 mt-30 -91.67 -23.74 19.72 Favored 'General case' 0 C--N 1.34 0.166 0 C-N-CA 125.273 1.429 . . . . 0.0 111.877 -179.347 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 24.7 mt -64.63 -26.13 68.26 Favored 'General case' 0 N--CA 1.468 0.456 0 O-C-N 121.792 -0.567 . . . . 0.0 111.646 -172.227 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -69.27 -22.27 63.83 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-N 118.06 0.391 . . . . 0.0 111.518 176.233 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -77.36 -23.51 50.83 Favored 'General case' 0 CA--C 1.537 0.472 0 O-C-N 120.707 -1.245 . . . . 0.0 112.56 -178.743 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 51.2 mt -65.67 152.07 45.07 Favored 'General case' 0 C--O 1.233 0.226 0 C-N-CA 124.772 1.229 . . . . 0.0 112.056 -170.205 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 3.3 t30 -82.71 100.95 10.55 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 124.682 1.193 . . . . 0.0 108.154 174.127 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 57.2 mt -119.22 0.09 11.12 Favored 'General case' 0 N--CA 1.47 0.548 0 N-CA-C 113.389 0.885 . . . . 0.0 113.389 -174.474 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 25.0 mt-10 -57.41 128.92 39.47 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 119.135 0.88 . . . . 0.0 110.828 -169.705 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 74.25 -3.04 41.71 Favored Glycine 0 CA--C 1.532 1.145 0 CA-C-O 117.749 -1.584 . . . . 0.0 114.824 178.535 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.79 152.86 40.19 Favored 'General case' 0 C--N 1.347 0.49 0 CA-C-N 121.098 2.449 . . . . 0.0 109.503 -179.402 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 2.1 mt -86.18 141.69 14.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 N-CA-C 106.877 -1.527 . . . . 0.0 106.877 179.414 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 61.6 t -135.68 137.58 49.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 C-N-CA 124.279 1.032 . . . . 0.0 109.109 -177.067 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -111.39 152.72 27.02 Favored 'General case' 0 N--CA 1.465 0.291 0 N-CA-C 106.733 -1.58 . . . . 0.0 106.733 168.118 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 1.2 mt -134.19 135.25 42.91 Favored 'General case' 0 CA--C 1.508 -0.637 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 175.366 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 40.9 p90 -147.34 166.14 28.03 Favored 'General case' 0 N--CA 1.447 -0.594 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 169.235 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -160.01 155.01 26.09 Favored Glycine 0 N--CA 1.448 -0.542 0 N-CA-C 109.123 -1.591 . . . . 0.0 109.123 171.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 13.0 tp -99.35 146.52 26.19 Favored 'General case' 0 N--CA 1.444 -0.737 0 C-N-CA 125.031 1.332 . . . . 0.0 109.08 177.02 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -152.01 158.11 27.61 Favored Glycine 0 CA--C 1.527 0.786 0 N-CA-C 109.004 -1.638 . . . . 0.0 109.004 169.099 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -94.63 -3.24 49.89 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 124.147 0.979 . . . . 0.0 113.395 -174.084 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 39.4 mt-30 50.95 2.1 0.01 OUTLIER 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 128.637 2.775 . . . . 0.0 116.234 -176.507 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 28.6 mt -111.86 -39.69 4.48 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 125.789 1.636 . . . . 0.0 110.522 -170.851 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -112.48 -41.58 1.03 Allowed Glycine 0 CA--C 1.533 1.168 0 C-N-CA 126.276 1.893 . . . . 0.0 109.21 168.415 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 17.1 m-85 -78.47 61.27 2.82 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 127.047 2.139 . . . . 0.0 107.586 172.062 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -98.99 -67.52 0.88 Allowed Glycine 0 CA--C 1.522 0.475 0 N-CA-C 109.146 -1.582 . . . . 0.0 109.146 179.295 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -73.08 -17.33 61.43 Favored 'General case' 0 CA--C 1.538 0.51 0 O-C-N 122.289 -0.536 . . . . 0.0 110.573 172.346 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' TRP . . . . . . . . . . . . . 4.8 t-105 -118.19 38.25 3.75 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 125.73 1.612 . . . . 0.0 109.883 -178.74 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 11.5 t80 -59.68 -54.89 41.19 Favored 'General case' 0 C--N 1.342 0.261 0 N-CA-C 112.938 0.718 . . . . 0.0 112.938 -172.1 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 96.7 mt -141.84 37.94 1.63 Allowed 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 123.945 0.898 . . . . 0.0 109.964 -169.054 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -52.73 -47.57 67.27 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 123.754 0.821 . . . . 0.0 112.7 -168.783 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -78.94 -19.56 51.44 Favored 'General case' 0 N--CA 1.451 -0.397 0 O-C-N 121.129 -0.982 . . . . 0.0 113.347 -176.323 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 3.8 tt -60.84 -44.79 96.5 Favored 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 107.543 -1.28 . . . . 0.0 107.543 171.383 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -61.24 -43.94 98.74 Favored Glycine 0 C--N 1.341 0.839 0 CA-C-O 119.617 -0.546 . . . . 0.0 111.914 176.398 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 75.1 mtm -63.25 -40.62 97.94 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 118.382 1.091 . . . . 0.0 111.957 -178.863 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -69.95 -34.22 73.14 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-N 120.035 1.289 . . . . 0.0 111.241 -179.604 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 56.3 t-80 -58.97 -49.5 77.62 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-N 118.477 0.58 . . . . 0.0 109.533 172.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -62.36 -41.66 98.78 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 123.38 0.672 . . . . 0.0 112.295 -177.11 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 24.2 ttmm -55.56 -40.96 72.62 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 123.401 0.681 . . . . 0.0 110.166 173.14 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 28.4 mt -89.82 -20.2 23.75 Favored 'General case' 0 CA--C 1.517 -0.317 0 N-CA-C 115.764 1.765 . . . . 0.0 115.764 -167.653 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 15.9 m -58.28 -36.44 73.3 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 120.732 1.605 . . . . 0.0 111.334 -178.301 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 20.5 p -83.85 -12.88 54.92 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 124.585 1.154 . . . . 0.0 111.903 -179.678 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 32.0 mmmt -83.15 -9.64 59.08 Favored 'General case' 0 C--N 1.343 0.3 0 C-N-CA 124.525 1.13 . . . . 0.0 110.984 170.881 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 72.3 35.91 60.0 Favored Glycine 0 CA--C 1.523 0.561 0 CA-C-N 118.651 0.66 . . . . 0.0 112.469 169.661 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 5.3 m -77.02 170.67 1.46 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.582 0 CA-C-N 117.858 0.829 . . . . 0.0 109.713 172.001 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 53.0 tptt -100.06 130.64 46.23 Favored 'General case' 0 N--CA 1.47 0.564 0 N-CA-C 105.132 -2.173 . . . . 0.0 105.132 167.756 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 73.8 m-85 -94.95 123.01 38.18 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 172.071 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 32.8 m -105.15 154.31 6.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 C-N-CA 124.032 0.933 . . . . 0.0 108.505 167.701 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 105.85 -95.9 1.11 Allowed Glycine 0 N--CA 1.448 -0.56 0 C-N-CA 124.105 0.86 . . . . 0.0 112.011 174.173 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . 0.42 ' CD2' ' HA ' ' A' ' 140' ' ' VAL . 75.6 m-85 60.17 -179.61 0.09 Allowed 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 125.182 1.393 . . . . 0.0 109.424 -166.928 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER -153.22 143.55 15.54 Favored Pre-proline 0 N--CA 1.476 0.825 0 O-C-N 120.122 -1.611 . . . . 0.0 111.069 177.17 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -68.9 122.66 9.57 Favored 'Trans proline' 0 CA--C 1.536 0.595 0 C-N-CA 123.505 2.804 . . . . 0.0 111.621 179.238 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 18.1 p -81.85 -14.93 55.61 Favored 'General case' 0 CA--C 1.538 0.492 0 N-CA-C 113.791 1.034 . . . . 0.0 113.791 -179.343 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -47.13 130.37 12.63 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 124.545 1.138 . . . . 0.0 112.414 -168.534 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 82.87 30.2 32.67 Favored Glycine 0 CA--C 1.538 1.52 0 C-N-CA 124.1 0.857 . . . . 0.0 112.802 -174.624 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 50.1 p90 -71.62 158.79 35.57 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-N 118.115 0.958 . . . . 0.0 113.004 -175.893 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -128.3 6.7 5.85 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 125.053 1.341 . . . . 0.0 112.188 171.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 3.5 p90 -76.94 175.52 9.46 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 124.721 1.208 . . . . 0.0 110.631 176.607 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 7.4 t -144.34 -38.34 0.3 Allowed 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 124.497 1.119 . . . . 0.0 110.265 174.152 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 13.5 m -59.76 128.04 86.02 Favored Pre-proline 0 CA--C 1.544 0.716 0 C-N-CA 125.071 1.348 . . . . 0.0 110.727 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -84.81 -16.9 5.18 Favored 'Trans proline' 0 CA--C 1.535 0.564 0 C-N-CA 122.448 2.099 . . . . 0.0 114.379 -169.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 24.7 ttmt -53.88 -43.96 97.36 Favored Pre-proline 0 N--CA 1.475 0.79 0 N-CA-C 114.734 1.383 . . . . 0.0 114.734 -169.108 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -82.76 3.83 7.54 Favored 'Trans proline' 0 C--N 1.35 0.615 0 CA-C-N 121.836 1.691 . . . . 0.0 114.162 -178.43 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 20.0 m -130.26 165.82 29.46 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.371 0 CA-C-N 120.537 1.517 . . . . 0.0 111.57 -172.252 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 7.4 pt -135.42 171.29 17.68 Favored 'Isoleucine or valine' 0 C--O 1.234 0.279 0 C-N-CA 127.913 2.485 . . . . 0.0 108.969 -177.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . 53.88 45.13 28.4 Favored 'General case' 0 N--CA 1.464 0.261 0 C-N-CA 125.488 1.515 . . . . 0.0 112.509 172.553 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 27.0 t0 54.32 43.58 30.28 Favored 'General case' 0 C--N 1.324 -0.521 0 C-N-CA 126.056 1.742 . . . . 0.0 111.624 -176.596 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 87.41 17.4 58.83 Favored Glycine 0 CA--C 1.527 0.825 0 CA-C-O 118.662 -1.077 . . . . 0.0 113.611 173.357 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 60.6 mm-40 -92.09 -8.07 46.82 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 119.399 1.6 . . . . 0.0 113.142 -177.368 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 7.9 tp -152.59 145.03 24.06 Favored 'General case' 0 C--N 1.344 0.33 0 CA-C-N 119.356 0.98 . . . . 0.0 110.761 170.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 65.5 m-85 -81.59 144.83 30.97 Favored 'General case' 0 CA--C 1.514 -0.423 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 169.373 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . 0.42 ' HA ' ' CD2' ' A' ' 118' ' ' TYR . 13.9 m -76.43 11.07 0.43 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.627 0 N-CA-C 113.128 0.788 . . . . 0.0 113.128 179.512 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 177.39 171.9 41.37 Favored Glycine 0 CA--C 1.525 0.696 0 C-N-CA 124.927 1.251 . . . . 0.0 109.997 -177.617 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 3.2 tp -66.72 133.44 50.19 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 117.962 0.881 . . . . 0.0 110.771 -177.725 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -91.56 117.05 29.37 Favored 'General case' 0 N--CA 1.445 -0.694 0 C-N-CA 125.835 1.654 . . . . 0.0 108.408 173.017 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -99.95 145.33 27.96 Favored 'General case' 0 N--CA 1.463 0.199 0 C-N-CA 124.288 1.035 . . . . 0.0 109.385 172.242 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -140.03 134.01 30.8 Favored 'General case' 0 C--O 1.233 0.187 0 N-CA-C 106.016 -1.846 . . . . 0.0 106.016 168.204 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 25.8 tt0 -141.08 47.34 1.72 Allowed 'General case' 0 CA--C 1.539 0.528 0 N-CA-C 107.607 -1.256 . . . . 0.0 107.607 169.631 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 87.6 m -132.16 -57.59 0.96 Allowed 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 126.329 1.852 . . . . 0.0 108.56 -174.49 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 31.5 m-80 -87.14 -31.01 20.63 Favored 'General case' 0 N--CA 1.453 -0.28 0 C-N-CA 124.559 1.144 . . . . 0.0 108.409 179.057 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 79.6 mt-30 -110.56 162.1 15.05 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 126.761 2.024 . . . . 0.0 108.593 175.284 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 45.7 p90 -151.53 -43.21 0.11 Allowed 'General case' 0 N--CA 1.463 0.224 0 C-N-CA 123.594 0.758 . . . . 0.0 109.574 170.81 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -70.61 -50.19 39.69 Favored 'General case' 0 N--CA 1.465 0.298 0 O-C-N 122.089 -0.382 . . . . 0.0 110.429 -177.849 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -84.68 -0.47 53.62 Favored 'General case' 0 C--O 1.222 -0.39 0 CA-C-O 118.651 -0.69 . . . . 0.0 112.322 179.144 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 21.9 m -60.59 -29.88 69.47 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 120.314 1.415 . . . . 0.0 110.642 170.04 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -64.21 -38.53 91.39 Favored 'General case' 0 N--CA 1.463 0.188 0 C-N-CA 123.208 0.603 . . . . 0.0 111.037 169.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -70.23 -40.64 74.36 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 124.599 1.159 . . . . 0.0 111.276 -178.484 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 17.9 mmm-85 -49.39 -43.76 44.56 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 124.23 1.012 . . . . 0.0 109.889 171.253 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 58.0 mt -75.03 -56.74 7.95 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.399 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 -179.716 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 73.1 tp60 -50.68 -62.76 1.4 Allowed 'General case' 0 CA--C 1.521 -0.151 0 C-N-CA 125.709 1.604 . . . . 0.0 112.673 -170.298 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 15.0 m -68.09 -34.16 75.89 Favored 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 121.049 -0.26 . . . . 0.0 110.841 -168.57 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 160' ' ' TRP . . . . . . . . . . . . . 38.0 t90 -67.66 -44.25 78.31 Favored 'General case' 0 C--O 1.222 -0.353 0 O-C-N 122.167 -0.333 . . . . 0.0 110.838 175.128 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 61.2 m -59.74 -43.82 94.07 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 122.834 0.454 . . . . 0.0 110.377 178.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -62.03 -41.69 98.37 Favored 'General case' 0 CA--C 1.529 0.141 0 CA-C-N 118.053 0.388 . . . . 0.0 110.173 176.614 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 11.7 tt0 -62.68 -54.13 43.93 Favored 'General case' 0 CA--C 1.514 -0.415 0 CA-C-O 118.15 -0.928 . . . . 0.0 109.929 -179.099 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 40.4 pt -62.78 -33.0 57.71 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.497 0 CA-C-O 118.012 -0.994 . . . . 0.0 109.871 -176.475 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -70.66 -36.58 73.44 Favored 'General case' 0 C--O 1.223 -0.324 0 CA-C-N 119.837 1.198 . . . . 0.0 108.605 -175.572 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -68.73 -45.63 71.02 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 123.386 0.674 . . . . 0.0 109.844 175.096 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 25.1 tt0 -80.79 -13.63 58.79 Favored 'General case' 0 N--CA 1.437 -1.119 0 C-N-CA 124.303 1.041 . . . . 0.0 110.328 -169.382 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 168' ' ' MET . . . . . . . . . . . . . 20.6 ptp -90.7 -41.61 11.19 Favored 'General case' 0 N--CA 1.457 -0.125 0 C-N-CA 122.914 0.486 . . . . 0.0 111.242 168.774 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -70.58 -27.59 64.23 Favored 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 122.652 0.381 . . . . 0.0 111.651 -172.258 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -57.18 -26.78 61.18 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 123.257 0.623 . . . . 0.0 112.4 178.9 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 99.0 m-70 -77.91 -19.84 53.94 Favored 'General case' 0 C--O 1.235 0.291 0 C-N-CA 124.3 1.04 . . . . 0.0 112.64 179.132 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 58.5 m-85 -113.66 -18.82 11.8 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 125.719 1.608 . . . . 0.0 112.656 -173.62 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.254 1.29 0 C-N-CA 124.317 1.047 . . . . 0.0 110.106 175.157 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.498 1.938 0 N-CA-C 111.578 0.214 . . . . 0.0 111.578 . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 6.0 t30 -127.36 151.52 48.67 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 124.624 1.17 . . . . 0.0 108.458 175.414 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 17.3 mtt -110.93 126.37 54.65 Favored 'General case' 0 C--N 1.332 -0.182 0 C-N-CA 123.475 0.71 . . . . 0.0 110.359 -177.385 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -84.22 145.98 22.57 Favored Glycine 0 CA--C 1.522 0.514 0 N-CA-C 107.139 -2.384 . . . . 0.0 107.139 168.023 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 1.2 tt -135.03 93.94 3.08 Favored 'General case' 0 N--CA 1.464 0.273 0 N-CA-C 105.345 -2.094 . . . . 0.0 105.345 -172.927 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -101.59 143.25 31.8 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-O 121.703 0.763 . . . . 0.0 110.728 -173.322 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 32.3 p90 -158.53 162.39 37.41 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 125.071 1.348 . . . . 0.0 108.078 -178.071 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -97.12 140.35 15.0 Favored Glycine 0 CA--C 1.52 0.398 0 N-CA-C 110.145 -1.182 . . . . 0.0 110.145 176.017 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 46.0 m -144.11 104.83 4.17 Favored 'General case' 0 N--CA 1.446 -0.651 0 C-N-CA 125.207 1.403 . . . . 0.0 107.826 169.288 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 55.8 m -107.39 -122.07 0.24 Allowed 'General case' 0 CA--C 1.541 0.606 0 N-CA-C 106.587 -1.634 . . . . 0.0 106.587 169.946 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 2.8 p -64.89 -45.28 86.6 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 119.453 1.024 . . . . 0.0 109.789 172.911 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 6.3 p -90.24 149.87 22.2 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 124.607 1.163 . . . . 0.0 108.215 168.345 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 23.6 p90 -140.0 150.12 44.06 Favored 'General case' 0 C--O 1.234 0.264 0 C-N-CA 123.357 0.663 . . . . 0.0 112.116 -169.549 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 51.7 m -110.45 6.82 22.43 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 125.26 1.424 . . . . 0.0 111.509 -172.395 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -54.6 -37.19 65.28 Favored 'General case' 0 N--CA 1.465 0.3 0 O-C-N 120.992 -1.068 . . . . 0.0 113.415 -168.674 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 3.2 mpp? -65.54 -37.57 87.12 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 119.592 1.087 . . . . 0.0 111.51 -172.25 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -64.21 -44.3 92.34 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 118.849 0.75 . . . . 0.0 109.079 174.557 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -65.74 -45.66 81.76 Favored 'General case' 0 N--CA 1.455 -0.182 0 C-N-CA 123.732 0.813 . . . . 0.0 111.577 -175.239 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -54.34 -47.69 72.27 Favored 'General case' 0 CA--C 1.517 -0.289 0 C-N-CA 125.262 1.425 . . . . 0.0 109.312 173.647 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 29.8 mtpp -73.51 -38.91 65.18 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-O 118.459 -0.781 . . . . 0.0 110.215 -172.272 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 37.3 mt -53.72 -56.7 7.71 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.288 0 CA-C-N 119.469 1.031 . . . . 0.0 109.024 173.378 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.33 -35.02 79.3 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 118.49 0.586 . . . . 0.0 111.196 -173.858 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -62.38 -42.7 99.62 Favored 'General case' 0 C--N 1.328 -0.358 0 O-C-N 123.363 0.414 . . . . 0.0 110.892 176.093 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 39.5 mt -72.23 -55.65 12.6 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.52 0 C-N-CA 123.619 0.767 . . . . 0.0 109.971 -174.356 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 73.0 mt -65.8 -45.23 92.17 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.296 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 -175.33 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 141.62 120.69 1.65 Allowed Glycine 0 CA--C 1.53 0.994 0 N-CA-C 110.26 -1.136 . . . . 0.0 110.26 176.335 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -68.64 -10.2 28.37 Favored 'Trans proline' 0 N--CA 1.456 -0.697 0 C-N-CA 123.124 2.55 . . . . 0.0 113.373 -173.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 2.4 pm0 -81.56 -18.25 45.56 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-N 119.573 1.079 . . . . 0.0 111.831 179.138 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -126.96 5.74 6.56 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 124.735 1.214 . . . . 0.0 113.679 -173.096 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 38.2 t -126.55 146.2 32.8 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.281 0 N-CA-C 107.842 -1.17 . . . . 0.0 107.842 173.169 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 34.0 m -133.02 131.89 41.22 Favored 'General case' 0 C--N 1.333 -0.129 0 C-N-CA 125.045 1.338 . . . . 0.0 108.635 -175.481 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 22.9 mt -75.53 137.71 41.04 Favored 'General case' 0 C--O 1.231 0.092 0 N-CA-C 108.809 -0.811 . . . . 0.0 108.809 177.393 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 23.2 t-80 -135.45 54.51 1.92 Allowed 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 124.788 1.235 . . . . 0.0 108.477 -177.006 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 38.3 t-20 -53.58 123.52 12.41 Favored 'General case' 0 C--O 1.237 0.41 0 N-CA-C 107.485 -1.302 . . . . 0.0 107.485 170.675 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 31.7 mt -70.46 -19.74 62.93 Favored 'General case' 0 C--O 1.235 0.302 0 N-CA-C 112.824 0.676 . . . . 0.0 112.824 -173.782 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 55.9 tptt -70.63 -19.44 62.82 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-N 118.915 0.78 . . . . 0.0 110.91 169.771 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -103.38 -36.49 8.0 Favored 'General case' 0 C--O 1.233 0.235 0 C-N-CA 123.975 0.91 . . . . 0.0 113.107 -170.732 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 3.3 t0 -139.64 156.24 46.95 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 118.668 0.667 . . . . 0.0 112.539 178.268 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 19.9 m -75.4 157.88 84.17 Favored Pre-proline 0 CA--C 1.541 0.623 0 C-N-CA 125.931 1.692 . . . . 0.0 111.714 -170.58 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 78.1 Cg_endo -74.86 -26.49 11.16 Favored 'Trans proline' 0 C--N 1.349 0.584 0 C-N-CA 122.68 2.254 . . . . 0.0 113.493 -170.297 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 23.0 mmmt -70.79 -12.42 61.54 Favored 'General case' 0 N--CA 1.472 0.65 0 O-C-N 120.685 -1.26 . . . . 0.0 111.531 -176.159 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -60.24 -29.36 68.72 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 125.423 1.489 . . . . 0.0 110.354 168.832 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 48.4 mtt -59.41 -25.37 64.26 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 118.65 0.659 . . . . 0.0 111.436 178.425 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 89.9 mt-10 -65.83 -33.06 74.99 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-O 118.96 -0.543 . . . . 0.0 110.027 -176.84 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 24.9 mt-30 -65.22 -45.51 84.41 Favored 'General case' 0 N--CA 1.465 0.313 0 C-N-CA 123.424 0.69 . . . . 0.0 112.771 -169.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 44.5 m-85 -77.73 133.2 38.34 Favored 'General case' 0 CA--C 1.52 -0.204 0 C-N-CA 123.718 0.807 . . . . 0.0 109.205 -167.234 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -75.58 -22.22 57.14 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-N 118.883 0.765 . . . . 0.0 111.833 -177.135 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 53.0 t -113.6 143.33 23.53 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.588 0 N-CA-C 106.633 -1.618 . . . . 0.0 106.633 169.441 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 31.2 tp -133.65 149.03 51.56 Favored 'General case' 0 N--CA 1.444 -0.763 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 172.278 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 28.9 mt -128.71 133.34 66.57 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 N-CA-C 105.38 -2.082 . . . . 0.0 105.38 179.917 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 3.1 mp -118.25 128.76 54.99 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 125.701 1.6 . . . . 0.0 107.781 -172.842 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -131.57 134.23 7.58 Favored Glycine 0 C--N 1.332 0.315 0 N-CA-C 110.912 -0.875 . . . . 0.0 110.912 174.69 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 2.9 tt -153.88 137.06 10.16 Favored Pre-proline 0 CA--C 1.542 0.667 0 CA-C-N 118.654 1.227 . . . . 0.0 111.662 170.37 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_exo -72.36 156.87 54.24 Favored 'Trans proline' 0 CA--C 1.536 0.599 0 C-N-CA 123.347 2.698 . . . . 0.0 113.081 167.976 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 3.1 m -132.87 146.71 52.04 Favored 'General case' 0 CA--C 1.538 0.485 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 167.409 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 11.4 m-90 -138.76 169.81 17.12 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 126.013 1.725 . . . . 0.0 108.441 174.319 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -61.88 -31.13 71.39 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 123.383 0.673 . . . . 0.0 112.597 -177.604 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 52.4 p90 -142.44 159.13 42.84 Favored 'General case' 0 C--O 1.239 0.509 0 C-N-CA 124.986 1.314 . . . . 0.0 108.317 172.921 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 66.13 30.29 76.58 Favored Glycine 0 CA--C 1.534 1.241 0 N-CA-C 111.501 -0.639 . . . . 0.0 111.501 -178.953 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 3.9 pm0 -65.54 149.55 49.88 Favored 'General case' 0 C--O 1.239 0.524 0 CA-C-N 117.946 0.873 . . . . 0.0 109.548 170.932 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . 0.256 59.0 mt 60.32 151.4 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.55 0.965 0 C-N-CA 126.208 1.803 . . . . 0.0 111.361 -168.881 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -118.22 156.7 28.32 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 125.265 1.426 . . . . 0.0 107.579 -175.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -57.41 -45.01 85.05 Favored 'General case' 0 CA--C 1.529 0.153 0 C-N-CA 123.233 0.613 . . . . 0.0 110.677 -172.053 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -64.42 -19.54 65.58 Favored 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 113.219 0.822 . . . . 0.0 113.219 -177.115 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 13.0 t90 -95.91 -47.2 6.23 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 124.754 1.222 . . . . 0.0 109.485 178.23 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 10.9 tt0 -62.79 -35.26 79.26 Favored 'General case' 0 N--CA 1.446 -0.642 0 O-C-N 120.877 -1.139 . . . . 0.0 109.975 -178.899 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -58.13 -25.76 61.82 Favored 'General case' 0 CA--C 1.529 0.173 0 C-N-CA 124.034 0.933 . . . . 0.0 111.711 -177.262 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 28.6 m -113.29 -13.4 11.4 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.266 0 CA-C-O 117.21 -1.376 . . . . 0.0 112.484 177.675 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 26.0 t90 -52.75 -35.21 55.8 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 120.53 1.514 . . . . 0.0 110.968 -178.908 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -64.3 -27.72 69.23 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 125.567 1.547 . . . . 0.0 113.269 175.944 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 29.3 mt-30 -92.47 -19.61 21.83 Favored 'General case' 0 C--N 1.343 0.288 0 C-N-CA 125.93 1.692 . . . . 0.0 112.524 176.214 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 52.5 mt -63.69 -20.96 66.13 Favored 'General case' 0 CA--C 1.536 0.415 0 O-C-N 121.318 -0.864 . . . . 0.0 111.467 -176.398 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -79.01 -23.34 44.42 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 123.112 0.565 . . . . 0.0 111.503 174.401 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -72.83 -29.82 63.53 Favored 'General case' 0 N--CA 1.469 0.509 0 O-C-N 120.628 -1.295 . . . . 0.0 111.883 178.714 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 80.1 mt -52.85 141.05 22.61 Favored 'General case' 0 C--N 1.34 0.16 0 C-N-CA 125.239 1.415 . . . . 0.0 113.009 -168.484 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 3.7 t30 -75.62 102.48 5.34 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 123.832 0.853 . . . . 0.0 108.729 170.437 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 66.7 mt -125.03 -0.48 7.85 Favored 'General case' 0 N--CA 1.475 0.784 0 N-CA-C 114.058 1.133 . . . . 0.0 114.058 -173.572 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 27.0 mt-10 -57.25 128.78 38.75 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 119.528 1.058 . . . . 0.0 111.144 -169.253 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 73.43 -1.79 41.45 Favored Glycine 0 CA--C 1.534 1.25 0 C-N-CA 125.394 1.474 . . . . 0.0 115.103 178.518 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.68 148.95 40.13 Favored 'General case' 0 C--N 1.344 0.354 0 CA-C-N 120.543 2.171 . . . . 0.0 109.474 -176.362 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 1.8 mt -80.49 136.28 23.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 N-CA-C 106.712 -1.588 . . . . 0.0 106.712 179.246 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 76.2 t -133.0 125.1 51.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 C-N-CA 123.97 0.908 . . . . 0.0 109.805 -175.608 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -98.72 151.73 20.43 Favored 'General case' 0 N--CA 1.463 0.177 0 N-CA-C 107.938 -1.134 . . . . 0.0 107.938 166.674 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 1.2 mt -133.93 138.73 45.69 Favored 'General case' 0 CA--C 1.512 -0.493 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 175.382 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 45.6 p90 -150.48 168.92 22.77 Favored 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 171.223 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -168.12 166.63 39.61 Favored Glycine 0 N--CA 1.444 -0.775 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 173.386 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -111.96 148.46 33.72 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 124.315 1.046 . . . . 0.0 109.037 170.546 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -162.45 -176.44 34.53 Favored Glycine 0 CA--C 1.527 0.814 0 N-CA-C 107.685 -2.166 . . . . 0.0 107.685 174.453 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -146.06 134.25 21.66 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 117.777 0.789 . . . . 0.0 110.223 -179.179 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 15.0 pm0 -78.56 -20.4 50.69 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 126.715 2.006 . . . . 0.0 112.726 -179.799 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 95.3 mt -81.12 -41.48 22.42 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 119.657 1.117 . . . . 0.0 111.826 -175.768 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -58.34 -48.99 80.47 Favored Glycine 0 CA--C 1.528 0.844 0 C-N-CA 123.886 0.755 . . . . 0.0 111.716 -172.873 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 16.9 t80 -156.74 -43.79 0.07 Allowed 'General case' 0 N--CA 1.464 0.27 0 C-N-CA 122.941 0.497 . . . . 0.0 111.012 169.283 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 91.24 -22.98 26.82 Favored Glycine 0 CA--C 1.525 0.701 0 CA-C-O 118.695 -1.058 . . . . 0.0 112.963 171.396 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 81.7 mt-10 -72.62 -15.54 61.73 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 119.677 1.739 . . . . 0.0 112.112 179.53 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' TRP . . . . . . . . . . . . . 38.1 m95 -109.27 22.58 15.65 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 124.422 1.089 . . . . 0.0 111.85 174.354 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 18.0 t80 -54.87 124.42 16.56 Favored 'General case' 0 C--N 1.342 0.27 0 O-C-N 121.066 -1.021 . . . . 0.0 108.903 174.952 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 92.8 mt 53.05 23.54 3.01 Favored 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 124.533 1.133 . . . . 0.0 114.014 169.75 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -62.8 -33.82 76.0 Favored 'General case' 0 C--N 1.332 -0.176 0 O-C-N 120.538 -1.351 . . . . 0.0 110.708 -174.873 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -72.08 -29.97 64.65 Favored 'General case' 0 CA--C 1.533 0.315 0 O-C-N 121.563 -0.711 . . . . 0.0 112.216 176.377 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 4.1 tt -62.04 -46.68 88.11 Favored 'General case' 0 N--CA 1.467 0.395 0 N-CA-C 107.574 -1.269 . . . . 0.0 107.574 170.226 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -63.59 -37.29 94.53 Favored Glycine 0 C--N 1.341 0.84 0 CA-C-O 119.212 -0.771 . . . . 0.0 112.088 178.793 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 65.1 mtm -63.58 -42.9 98.26 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 118.823 1.312 . . . . 0.0 111.69 -179.67 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -70.25 -37.18 74.87 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 120.238 1.381 . . . . 0.0 109.793 176.335 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 59.1 t60 -56.98 -48.6 78.04 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 118.798 0.727 . . . . 0.0 110.892 177.177 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -61.97 -39.27 91.6 Favored 'General case' 0 C--O 1.235 0.315 0 C-N-CA 124.176 0.99 . . . . 0.0 112.041 -178.072 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 24.0 ttmm -58.45 -33.8 70.12 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 123.235 0.614 . . . . 0.0 110.649 172.854 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 19.4 mt -94.63 -21.18 18.97 Favored 'General case' 0 CA--C 1.513 -0.45 0 N-CA-C 116.297 1.962 . . . . 0.0 116.297 -168.956 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 4.3 m -59.01 -33.59 70.9 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 120.951 1.705 . . . . 0.0 111.424 -176.272 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 20.1 p -85.8 -11.97 52.1 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 125.252 1.421 . . . . 0.0 112.152 179.758 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 31.7 mmmt -83.14 -6.32 59.44 Favored 'General case' 0 C--N 1.344 0.352 0 C-N-CA 124.907 1.283 . . . . 0.0 111.386 173.785 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 71.44 32.42 64.9 Favored Glycine 0 C--N 1.337 0.597 0 CA-C-N 118.779 0.718 . . . . 0.0 112.103 170.499 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 4.2 m -75.37 172.3 1.13 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.532 0 CA-C-N 118.027 0.913 . . . . 0.0 109.316 173.563 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -113.15 122.11 46.54 Favored 'General case' 0 N--CA 1.466 0.327 0 N-CA-C 106.579 -1.637 . . . . 0.0 106.579 173.265 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 81.3 m-85 -88.86 145.89 25.29 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 119.422 1.01 . . . . 0.0 109.672 -176.343 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 29.5 m -132.73 160.69 42.44 Favored 'Isoleucine or valine' 0 C--O 1.236 0.355 0 C-N-CA 124.583 1.153 . . . . 0.0 109.153 171.338 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 98.7 -83.29 0.63 Allowed Glycine 0 N--CA 1.448 -0.559 0 C-N-CA 124.906 1.241 . . . . 0.0 111.106 174.196 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 16.7 m-30 55.69 -171.15 0.07 Allowed 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 124.503 1.121 . . . . 0.0 110.179 -169.152 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -154.41 144.05 15.31 Favored Pre-proline 0 N--CA 1.468 0.451 0 O-C-N 120.651 -1.281 . . . . 0.0 108.712 169.902 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -68.5 124.99 12.21 Favored 'Trans proline' 0 CA--C 1.534 0.517 0 C-N-CA 122.34 2.027 . . . . 0.0 111.321 179.612 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 5.9 p -76.78 -25.16 53.07 Favored 'General case' 0 N--CA 1.469 0.48 0 O-C-N 121.794 -0.566 . . . . 0.0 111.804 174.314 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -62.91 127.31 30.64 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 124.056 0.942 . . . . 0.0 109.467 -170.869 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 77.01 1.54 74.0 Favored Glycine 0 CA--C 1.534 1.239 0 CA-C-O 118.76 -1.022 . . . . 0.0 114.072 178.455 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 14.5 t80 -89.46 174.43 7.8 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 119.035 1.417 . . . . 0.0 110.064 173.162 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 48.6 mm-40 -80.86 -99.83 0.03 OUTLIER 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 124.303 1.041 . . . . 0.0 109.697 178.372 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 3.1 p90 46.84 176.51 0.0 OUTLIER 'General case' 0 CA--C 1.548 0.897 0 C-N-CA 129.849 3.26 . . . . 0.0 115.789 -178.027 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 11.3 t -156.97 -31.79 0.08 Allowed 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 123.844 0.858 . . . . 0.0 110.737 168.583 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 11.4 m -54.47 132.45 63.08 Favored Pre-proline 0 CA--C 1.543 0.678 0 C-N-CA 125.234 1.413 . . . . 0.0 112.571 -173.702 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -81.62 -32.08 0.96 Allowed 'Trans proline' 0 CA--C 1.537 0.65 0 C-N-CA 122.773 2.315 . . . . 0.0 113.153 178.875 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 24.2 ttmt -56.6 -40.5 85.4 Favored Pre-proline 0 CA--C 1.542 0.648 0 CA-C-O 117.578 -1.201 . . . . 0.0 113.769 -176.178 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -80.49 5.67 5.94 Favored 'Trans proline' 0 C--N 1.351 0.663 0 C-N-CA 121.944 1.763 . . . . 0.0 114.84 179.002 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 20.3 m -124.77 152.08 30.71 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.379 0 CA-C-N 122.152 2.251 . . . . 0.0 111.486 -178.4 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 15.0 pt -96.53 163.69 2.34 Favored 'Isoleucine or valine' 0 C--O 1.236 0.355 0 C-N-CA 124.765 1.226 . . . . 0.0 109.556 169.246 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . 53.69 43.0 31.7 Favored 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 124.62 1.168 . . . . 0.0 112.19 167.61 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 31.5 t70 63.93 -32.32 0.12 Allowed 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 129.09 2.956 . . . . 0.0 114.616 -171.313 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 177.1 28.51 0.04 OUTLIER Glycine 0 CA--C 1.527 0.809 0 CA-C-O 117.867 -1.518 . . . . 0.0 114.616 177.499 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 74.2 mm-40 -76.2 -41.42 49.56 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 120.351 2.075 . . . . 0.0 111.248 -177.909 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -143.74 153.05 42.03 Favored 'General case' 0 CA--C 1.519 -0.238 0 C-N-CA 123.489 0.716 . . . . 0.0 109.888 176.727 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 74.7 m-85 -72.5 141.35 48.53 Favored 'General case' 0 N--CA 1.447 -0.595 0 N-CA-C 104.994 -2.224 . . . . 0.0 104.994 163.642 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 4.3 m -76.07 4.86 1.01 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.904 0 C-N-CA 122.968 0.507 . . . . 0.0 111.427 -176.608 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -174.06 171.53 44.6 Favored Glycine 0 CA--C 1.528 0.869 0 C-N-CA 125.847 1.689 . . . . 0.0 109.771 -179.139 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -64.2 136.37 57.15 Favored 'General case' 0 N--CA 1.466 0.375 0 C-N-CA 123.642 0.777 . . . . 0.0 111.361 -177.221 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -101.12 113.08 25.78 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 126.161 1.784 . . . . 0.0 109.222 -179.824 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 96.1 mt -108.16 151.64 25.64 Favored 'General case' 0 N--CA 1.464 0.255 0 C-N-CA 124.607 1.163 . . . . 0.0 110.218 175.583 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -154.45 156.35 36.59 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 126.198 1.799 . . . . 0.0 106.87 167.903 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -132.7 -2.1 3.37 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 126.104 1.762 . . . . 0.0 110.637 174.293 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 7.0 m -80.43 -52.12 8.03 Favored 'General case' 0 C--O 1.234 0.274 0 C-N-CA 125.829 1.652 . . . . 0.0 110.187 -171.814 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 6.6 m-80 -80.48 -33.36 36.66 Favored 'General case' 0 C--N 1.331 -0.207 0 C-N-CA 124.549 1.14 . . . . 0.0 110.181 -169.101 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 12.5 pt20 -159.62 152.38 21.57 Favored 'General case' 0 C--O 1.236 0.352 0 C-N-CA 127.073 2.149 . . . . 0.0 106.687 -175.121 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 85.8 t80 -124.26 -27.49 3.8 Favored 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 123.762 0.825 . . . . 0.0 111.594 -176.701 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -68.19 -33.15 73.9 Favored 'General case' 0 N--CA 1.465 0.317 0 O-C-N 121.545 -0.722 . . . . 0.0 111.516 -174.583 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -84.66 -13.52 51.25 Favored 'General case' 0 C--N 1.344 0.334 0 CA-C-O 118.206 -0.902 . . . . 0.0 111.956 -179.943 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 8.1 m -60.57 -34.94 74.91 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 120.824 1.647 . . . . 0.0 110.481 -176.731 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -65.19 -43.73 90.7 Favored 'General case' 0 N--CA 1.463 0.191 0 C-N-CA 123.507 0.723 . . . . 0.0 111.376 173.317 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 19.9 tt0 -64.39 -43.56 94.08 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 124.702 1.201 . . . . 0.0 110.894 -179.094 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 54.0 mtp85 -62.41 -36.83 83.58 Favored 'General case' 0 N--CA 1.462 0.141 0 C-N-CA 124.119 0.967 . . . . 0.0 109.989 -179.858 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 55.7 mt -70.01 -57.38 8.32 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.461 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 172.495 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 68.2 tp60 -46.56 -65.77 0.51 Allowed 'General case' 0 C--O 1.235 0.314 0 C-N-CA 126.203 1.801 . . . . 0.0 112.476 -172.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 16.9 m -68.23 -29.09 67.84 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 123.091 0.244 . . . . 0.0 111.014 -169.483 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 160' ' ' TRP . . . . . . . . . . . . . 62.2 t90 -72.03 -44.6 63.14 Favored 'General case' 0 CA--C 1.515 -0.391 0 O-C-N 121.808 -0.558 . . . . 0.0 111.156 177.264 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 95.8 m -61.39 -40.52 94.68 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 122.717 0.407 . . . . 0.0 109.951 177.498 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -62.74 -42.58 99.74 Favored 'General case' 0 C--O 1.227 -0.098 0 CA-C-O 121.078 0.466 . . . . 0.0 110.254 174.028 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 12.1 tt0 -62.66 -51.57 66.74 Favored 'General case' 0 N--CA 1.449 -0.513 0 O-C-N 121.614 -0.679 . . . . 0.0 110.154 -178.445 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 45.5 pt -63.04 -38.13 81.22 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.367 0 CA-C-O 117.976 -1.011 . . . . 0.0 109.481 -174.962 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -65.02 -33.59 76.4 Favored 'General case' 0 C--O 1.225 -0.235 0 CA-C-N 119.416 1.007 . . . . 0.0 110.351 179.788 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 35.0 m-80 -69.23 -57.47 5.31 Favored 'General case' 0 C--O 1.223 -0.32 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 174.592 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 13.0 tt0 -63.45 -36.47 83.86 Favored 'General case' 0 N--CA 1.445 -0.68 0 C-N-CA 125.514 1.526 . . . . 0.0 111.131 -169.251 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 168' ' ' MET . . . . . . . . . . . . . 20.0 ptp -70.27 -32.75 70.7 Favored 'General case' 0 C--O 1.226 -0.16 0 O-C-N 121.63 -0.669 . . . . 0.0 111.761 174.08 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -75.28 -34.72 61.35 Favored 'General case' 0 N--CA 1.448 -0.568 0 CA-C-O 119.082 -0.485 . . . . 0.0 112.174 -178.776 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 6.2 mt-10 -63.57 -35.74 81.5 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-O 121.794 0.807 . . . . 0.0 109.317 177.613 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 74.0 t60 -67.15 -22.5 65.77 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 125.127 1.371 . . . . 0.0 111.751 -177.612 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 45.4 m-85 -84.78 -9.9 57.73 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 124.356 1.062 . . . . 0.0 113.441 173.587 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.254 1.311 0 CA-C-N 119.69 1.132 . . . . 0.0 110.122 -178.766 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.498 1.961 0 N-CA-C 111.316 0.117 . . . . 0.0 111.316 . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 9.0 t30 -114.31 152.04 32.02 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 123.736 0.815 . . . . 0.0 110.136 -179.082 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 16.0 mtt -116.21 129.55 56.35 Favored 'General case' 0 N--CA 1.461 0.103 0 C-N-CA 123.948 0.899 . . . . 0.0 110.731 -179.265 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -85.35 154.62 28.85 Favored Glycine 0 CA--C 1.524 0.644 0 N-CA-C 107.484 -2.246 . . . . 0.0 107.484 167.192 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 1.4 tt -142.05 96.51 2.97 Favored 'General case' 0 N--CA 1.466 0.343 0 N-CA-C 106.338 -1.727 . . . . 0.0 106.338 -175.447 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -106.06 144.67 32.44 Favored 'General case' 0 CA--C 1.519 -0.238 0 CA-C-O 121.481 0.658 . . . . 0.0 111.9 -170.761 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 23.6 p90 -162.82 165.69 25.05 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 125.879 1.671 . . . . 0.0 108.015 -177.53 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -159.15 125.86 1.57 Allowed Glycine 0 C--N 1.33 0.232 0 N-CA-C 104.952 -3.259 . . . . 0.0 104.952 169.882 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 8.5 p -148.97 158.36 44.12 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 118.617 1.209 . . . . 0.0 110.412 -168.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 13.5 m -58.63 129.32 41.54 Favored 'General case' 0 CA--C 1.534 0.359 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 172.867 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER 53.65 26.81 6.14 Favored 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 124.327 1.051 . . . . 0.0 112.08 -177.492 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 77.3 m 48.78 35.21 6.08 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 125.529 1.531 . . . . 0.0 112.853 -174.296 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 47.9 t80 -60.6 -32.03 71.17 Favored 'General case' 0 CA--C 1.539 0.521 0 O-C-N 121.318 -0.864 . . . . 0.0 112.5 -172.052 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 25.2 m -67.01 -11.38 56.86 Favored 'General case' 0 CA--C 1.54 0.571 0 O-C-N 121.14 -0.975 . . . . 0.0 111.798 178.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 5.5 tt0 -62.97 -25.42 68.35 Favored 'General case' 0 CA--C 1.536 0.408 0 O-C-N 120.867 -1.146 . . . . 0.0 111.446 176.665 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 5.2 mpp? -71.56 -40.7 69.79 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 119.7 1.136 . . . . 0.0 110.802 175.203 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -60.9 -45.28 95.22 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 119.259 0.936 . . . . 0.0 108.78 170.547 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -63.45 -47.68 80.87 Favored 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 123.17 0.588 . . . . 0.0 111.907 -174.161 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.1 pp20? -67.38 -35.73 79.91 Favored 'General case' 0 CA--C 1.535 0.383 0 O-C-N 121.596 -0.69 . . . . 0.0 109.274 -179.671 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 29.3 mtpp -67.37 -40.58 85.77 Favored 'General case' 0 C--O 1.225 -0.232 0 O-C-N 121.126 -0.984 . . . . 0.0 110.916 175.968 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 37.8 mt -56.24 -56.18 14.68 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.198 0 CA-C-N 119.995 1.27 . . . . 0.0 109.171 176.196 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.5 -35.89 82.4 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 118.529 0.604 . . . . 0.0 110.946 -175.494 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -63.42 -40.14 96.39 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 117.94 0.336 . . . . 0.0 110.888 177.94 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 67.6 mt -77.14 -53.58 14.49 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 C-N-CA 124.23 1.012 . . . . 0.0 110.353 -174.17 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 70.7 mt -60.3 -49.53 83.85 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.317 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 177.917 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 144.25 119.14 1.31 Allowed Glycine 0 CA--C 1.528 0.887 0 N-CA-C 110.133 -1.187 . . . . 0.0 110.133 179.209 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -68.71 -14.52 39.42 Favored 'Trans proline' 0 CA--C 1.536 0.588 0 C-N-CA 122.955 2.436 . . . . 0.0 113.022 -173.278 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -73.56 -21.54 60.33 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 118.579 0.627 . . . . 0.0 112.051 179.396 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -129.57 8.12 5.36 Favored 'General case' 0 CA--C 1.536 0.405 0 N-CA-C 113.862 1.06 . . . . 0.0 113.862 -169.162 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 33.7 t -128.13 147.09 32.77 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.387 0 C-N-CA 124.449 1.099 . . . . 0.0 108.066 172.308 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 26.9 m -131.53 131.74 43.62 Favored 'General case' 0 C--N 1.332 -0.164 0 C-N-CA 125.643 1.577 . . . . 0.0 108.419 -174.716 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 18.4 mt -75.93 134.01 40.35 Favored 'General case' 0 C--O 1.232 0.154 0 N-CA-C 108.401 -0.963 . . . . 0.0 108.401 175.018 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 25.4 t-80 -130.67 55.75 1.81 Allowed 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 124.806 1.242 . . . . 0.0 108.528 -176.741 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 54.2 t-20 -60.11 125.09 22.33 Favored 'General case' 0 C--O 1.233 0.193 0 N-CA-C 107.974 -1.121 . . . . 0.0 107.974 176.817 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 80.9 mt -69.94 -20.58 63.33 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 118.429 0.559 . . . . 0.0 112.282 -176.93 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 58.2 tptt -63.61 -25.91 68.44 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 118.467 0.576 . . . . 0.0 110.712 168.931 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -106.01 -37.9 6.49 Favored 'General case' 0 C--O 1.235 0.327 0 N-CA-C 113.452 0.908 . . . . 0.0 113.452 -169.426 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 2.6 t0 -134.64 155.82 49.83 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-N 118.834 0.743 . . . . 0.0 112.627 -175.578 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 19.5 m -76.32 156.67 83.49 Favored Pre-proline 0 CA--C 1.539 0.555 0 C-N-CA 125.551 1.54 . . . . 0.0 111.415 -172.097 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -75.59 -26.25 10.19 Favored 'Trans proline' 0 C--N 1.348 0.506 0 C-N-CA 122.603 2.202 . . . . 0.0 113.882 -171.173 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 21.4 mmmt -70.84 -11.75 61.14 Favored 'General case' 0 N--CA 1.474 0.731 0 O-C-N 120.271 -1.518 . . . . 0.0 111.654 -176.232 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -58.02 -30.96 66.53 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 125.879 1.672 . . . . 0.0 110.089 168.329 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 46.1 mtt -57.77 -25.12 60.05 Favored 'General case' 0 N--CA 1.463 0.206 0 C-N-CA 123.341 0.656 . . . . 0.0 111.838 178.616 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 87.1 mt-10 -66.77 -33.92 76.69 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 118.463 0.574 . . . . 0.0 110.02 -177.693 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 13.8 mt-30 -67.49 -45.17 76.64 Favored 'General case' 0 N--CA 1.465 0.307 0 C-N-CA 123.202 0.601 . . . . 0.0 112.412 -169.874 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 26.1 m-85 -72.05 137.55 47.23 Favored 'General case' 0 N--CA 1.456 -0.132 0 CA-C-N 115.317 -0.856 . . . . 0.0 110.042 -166.574 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -74.26 -35.08 63.78 Favored 'General case' 0 N--CA 1.466 0.355 0 O-C-N 121.872 -0.518 . . . . 0.0 110.788 -177.265 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 20.5 t -108.56 145.69 15.21 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.436 0 N-CA-C 106.991 -1.485 . . . . 0.0 106.991 169.386 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 36.4 tp -133.95 112.78 11.53 Favored 'General case' 0 N--CA 1.447 -0.606 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 175.379 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 22.8 mt -89.92 134.47 28.89 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.665 0 N-CA-C 107.15 -1.426 . . . . 0.0 107.15 176.248 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 2.7 mp -115.54 130.63 56.94 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 125.613 1.565 . . . . 0.0 107.473 -178.365 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -135.65 136.28 8.38 Favored Glycine 0 C--N 1.333 0.368 0 N-CA-C 109.413 -1.475 . . . . 0.0 109.413 173.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 3.1 tt -152.98 137.34 10.71 Favored Pre-proline 0 CA--C 1.536 0.424 0 CA-C-N 118.477 1.138 . . . . 0.0 110.451 171.534 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -82.04 138.62 10.33 Favored 'Trans proline' 0 N--CA 1.453 -0.871 0 C-N-CA 122.476 2.118 . . . . 0.0 109.886 167.561 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 30.2 m -94.63 144.29 25.72 Favored 'General case' 0 CA--C 1.543 0.698 0 N-CA-C 106.084 -1.821 . . . . 0.0 106.084 167.775 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 37.1 m0 -78.62 169.77 17.71 Favored 'General case' 0 CA--C 1.535 0.391 0 O-C-N 121.701 -0.624 . . . . 0.0 110.604 -174.9 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -63.11 -33.17 74.87 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 123.414 0.686 . . . . 0.0 111.196 171.402 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 43.6 t80 -146.12 136.46 23.87 Favored 'General case' 0 C--O 1.235 0.318 0 C-N-CA 125.336 1.454 . . . . 0.0 107.357 173.62 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 71.4 -167.57 51.84 Favored Glycine 0 CA--C 1.535 1.32 0 N-CA-C 110.659 -0.976 . . . . 0.0 110.659 -169.733 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -160.29 161.92 33.45 Favored 'General case' 0 CA--C 1.54 0.562 0 O-C-N 121.822 -0.811 . . . . 0.0 112.234 -179.154 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 55.7 mt 66.17 151.29 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.549 0.91 0 C-N-CA 128.196 2.598 . . . . 0.0 112.821 170.689 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 1.2 pm0 -125.77 156.85 38.8 Favored 'General case' 0 C--O 1.232 0.162 0 C-N-CA 126.172 1.789 . . . . 0.0 108.682 -176.437 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -54.92 -43.26 73.16 Favored 'General case' 0 C--O 1.224 -0.261 0 C-N-CA 124.524 1.13 . . . . 0.0 112.355 -168.746 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -65.23 -20.33 66.38 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-N 119.156 0.889 . . . . 0.0 111.835 -174.082 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 12.6 t90 -96.24 -49.04 5.38 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 124.448 1.099 . . . . 0.0 109.75 175.344 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -62.98 -35.28 79.65 Favored 'General case' 0 CA--C 1.536 0.426 0 O-C-N 121.041 -1.037 . . . . 0.0 110.413 -175.434 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -61.89 -27.41 68.78 Favored 'General case' 0 CA--C 1.53 0.179 0 C-N-CA 123.087 0.555 . . . . 0.0 111.059 -174.637 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 30.9 m -107.35 -17.08 8.1 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.372 0 CA-C-O 117.199 -1.382 . . . . 0.0 112.156 177.014 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 35.8 t90 -50.66 -34.75 27.65 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 120.447 1.476 . . . . 0.0 110.931 177.823 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -62.56 -31.14 71.89 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 125.315 1.446 . . . . 0.0 113.319 174.901 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 30.4 mt-30 -88.8 -20.89 24.12 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 126.555 1.942 . . . . 0.0 111.273 178.73 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 50.8 mt -65.25 -20.62 66.51 Favored 'General case' 0 CA--C 1.533 0.301 0 O-C-N 121.41 -0.806 . . . . 0.0 111.672 -173.603 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -79.0 -23.4 44.43 Favored 'General case' 0 CA--C 1.542 0.653 0 CA-C-N 118.399 0.545 . . . . 0.0 111.793 175.25 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -71.99 -30.03 64.84 Favored 'General case' 0 N--CA 1.468 0.47 0 O-C-N 120.723 -1.236 . . . . 0.0 111.958 178.177 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 80.1 mt -52.89 140.92 23.14 Favored 'General case' 0 C--N 1.338 0.102 0 C-N-CA 124.887 1.275 . . . . 0.0 112.994 -168.417 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 29.2 t-20 -76.14 108.95 9.41 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 169.688 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 70.2 mt -131.6 -0.07 3.96 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 114.317 1.228 . . . . 0.0 114.317 -172.348 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 28.8 mt-10 -57.2 129.8 43.38 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 119.68 1.127 . . . . 0.0 111.25 -168.544 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 73.9 -2.0 44.07 Favored Glycine 0 CA--C 1.533 1.204 0 C-N-CA 125.531 1.539 . . . . 0.0 115.023 178.32 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.04 150.3 40.71 Favored 'General case' 0 C--N 1.346 0.414 0 CA-C-N 120.663 2.231 . . . . 0.0 109.683 -176.649 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 4.3 mt -82.25 137.51 20.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 N-CA-C 106.489 -1.671 . . . . 0.0 106.489 179.068 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 67.0 t -130.92 129.49 63.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 C-N-CA 123.629 0.771 . . . . 0.0 109.515 -176.879 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -100.66 151.59 21.46 Favored 'General case' 0 N--CA 1.463 0.213 0 N-CA-C 107.735 -1.209 . . . . 0.0 107.735 168.715 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 4.5 mt -133.02 134.61 44.65 Favored 'General case' 0 CA--C 1.514 -0.409 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 176.394 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 37.4 p90 -149.91 168.14 24.64 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 107.692 -1.225 . . . . 0.0 107.692 168.655 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -168.19 171.22 42.42 Favored Glycine 0 N--CA 1.446 -0.656 0 N-CA-C 110.449 -1.061 . . . . 0.0 110.449 176.119 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -126.94 148.34 50.06 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 126.171 1.789 . . . . 0.0 106.781 -175.805 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -166.14 -160.68 13.75 Favored Glycine 0 CA--C 1.521 0.435 0 N-CA-C 109.174 -1.57 . . . . 0.0 109.174 173.25 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 49.5 t0 -140.5 109.98 6.3 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 108.041 -1.096 . . . . 0.0 108.041 169.515 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -68.81 -21.49 64.31 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 123.223 0.609 . . . . 0.0 111.828 -176.948 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 49.1 mt -84.15 -22.96 30.83 Favored 'General case' 0 N--CA 1.466 0.344 0 C-N-CA 124.739 1.216 . . . . 0.0 109.98 174.503 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -66.75 -45.14 86.81 Favored Glycine 0 CA--C 1.529 0.956 0 C-N-CA 124.243 0.925 . . . . 0.0 111.584 -174.902 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 9.4 t80 -146.7 -45.22 0.18 Allowed 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 117.114 0.457 . . . . 0.0 111.825 177.111 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 78.76 -31.58 1.95 Allowed Glycine 0 N--CA 1.47 0.924 0 C-N-CA 124.43 1.014 . . . . 0.0 113.892 172.161 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -72.51 -16.74 61.78 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 124.277 1.031 . . . . 0.0 111.359 171.621 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' TRP . . . . . . . . . . . . . 31.9 m0 -129.57 30.72 4.88 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 125.399 1.48 . . . . 0.0 111.092 179.262 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 15.9 t80 -61.88 134.44 56.69 Favored 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 107.445 -1.317 . . . . 0.0 107.445 173.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 97.0 mt 53.4 25.9 4.98 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 124.306 1.042 . . . . 0.0 113.234 172.705 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -65.05 -37.75 88.6 Favored 'General case' 0 N--CA 1.465 0.3 0 O-C-N 120.659 -1.275 . . . . 0.0 110.786 -170.766 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -65.45 -28.79 69.47 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 123.783 0.833 . . . . 0.0 112.304 173.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 5.3 tt -64.77 -49.28 71.35 Favored 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 108.039 -1.097 . . . . 0.0 108.039 174.01 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -62.33 -34.08 88.14 Favored Glycine 0 CA--C 1.529 0.948 0 N-CA-C 111.213 -0.755 . . . . 0.0 111.213 179.277 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 7.2 tpp -53.86 -50.97 65.08 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 124.683 1.193 . . . . 0.0 111.566 178.729 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -76.52 -36.17 57.89 Favored 'General case' 0 CA--C 1.534 0.355 0 N-CA-C 109.433 -0.581 . . . . 0.0 109.433 -174.966 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 51.0 t-80 -56.99 -44.81 83.11 Favored 'General case' 0 N--CA 1.467 0.381 0 O-C-N 121.463 -0.773 . . . . 0.0 111.296 174.032 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -63.86 -43.68 95.38 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 123.609 0.764 . . . . 0.0 111.384 -178.633 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 25.1 ttmm -56.14 -43.12 77.92 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 123.476 0.71 . . . . 0.0 110.289 173.125 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 21.3 mt -85.75 -19.29 31.01 Favored 'General case' 0 CA--C 1.511 -0.529 0 N-CA-C 115.141 1.534 . . . . 0.0 115.141 -169.755 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 67.8 m -59.97 -29.8 68.67 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 119.659 1.118 . . . . 0.0 111.488 -175.375 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 27.5 p -93.66 -4.23 51.0 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 125.348 1.459 . . . . 0.0 112.316 179.62 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 32.3 mmmt -87.42 -5.94 58.64 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 124.762 1.225 . . . . 0.0 111.685 175.081 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 73.05 30.94 62.4 Favored Glycine 0 CA--C 1.523 0.586 0 CA-C-N 118.368 0.531 . . . . 0.0 112.116 172.712 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 5.3 m -76.15 174.48 0.84 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 CA-C-N 118.211 1.005 . . . . 0.0 109.151 171.752 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -114.29 127.36 55.83 Favored 'General case' 0 CA--C 1.515 -0.372 0 N-CA-C 106.786 -1.561 . . . . 0.0 106.786 170.385 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 66.9 m-85 -92.31 144.69 25.13 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 119.652 1.115 . . . . 0.0 109.865 -178.155 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 35.4 m -131.83 157.34 43.12 Favored 'Isoleucine or valine' 0 C--O 1.234 0.267 0 C-N-CA 125.493 1.517 . . . . 0.0 107.527 169.396 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 86.15 29.61 24.9 Favored Glycine 0 CA--C 1.521 0.41 0 CA-C-O 118.334 -1.259 . . . . 0.0 114.741 169.833 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 11.7 m-30 -62.96 157.91 20.59 Favored 'General case' 0 CA--C 1.541 0.626 0 CA-C-N 119.07 1.435 . . . . 0.0 108.918 168.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 36.3 t-105 -135.72 143.55 45.17 Favored Pre-proline 0 N--CA 1.467 0.39 0 CA-C-O 118.008 -0.996 . . . . 0.0 111.95 -168.833 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -59.02 129.05 30.07 Favored 'Trans proline' 0 N--CA 1.458 -0.58 0 C-N-CA 122.986 2.457 . . . . 0.0 111.044 176.124 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 9.0 p -77.74 -20.42 53.48 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 123.297 0.639 . . . . 0.0 111.705 169.884 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -61.53 131.09 48.99 Favored 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 -178.229 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 91.83 -12.45 69.42 Favored Glycine 0 CA--C 1.533 1.195 0 CA-C-O 118.546 -1.141 . . . . 0.0 113.543 -177.586 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 55.9 m-85 -92.02 148.46 22.18 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-N 119.246 1.523 . . . . 0.0 108.596 169.609 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -125.38 104.81 8.66 Favored 'General case' 0 C--N 1.332 -0.163 0 N-CA-C 107.436 -1.32 . . . . 0.0 107.436 175.207 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 21.4 p90 -153.21 172.52 16.84 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 127.674 2.389 . . . . 0.0 106.947 -172.787 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 2.6 t -143.9 6.65 1.39 Allowed 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 112.495 0.554 . . . . 0.0 112.495 176.34 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 1.9 p -65.0 125.24 88.75 Favored Pre-proline 0 CA--C 1.541 0.623 0 O-C-N 121.108 -0.995 . . . . 0.0 109.495 172.778 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -81.84 -26.6 2.95 Favored 'Trans proline' 0 CA--C 1.539 0.746 0 C-N-CA 122.421 2.081 . . . . 0.0 112.305 175.677 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 28.2 ttmt -57.55 -42.46 95.84 Favored Pre-proline 0 CA--C 1.542 0.654 0 CA-C-O 117.531 -1.223 . . . . 0.0 114.073 -173.283 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -82.59 4.9 6.74 Favored 'Trans proline' 0 C--N 1.351 0.674 0 C-N-CA 122.017 1.812 . . . . 0.0 113.882 -179.074 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 16.7 m -128.06 166.09 25.91 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.186 0 CA-C-N 121.033 1.742 . . . . 0.0 112.24 -172.805 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 16.1 pt -131.48 168.57 23.6 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.474 0 C-N-CA 127.674 2.39 . . . . 0.0 108.833 179.023 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . 55.88 39.03 30.67 Favored 'General case' 0 CA--C 1.529 0.163 0 C-N-CA 125.199 1.4 . . . . 0.0 113.328 169.746 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 27.6 t70 59.22 43.29 17.22 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 126.412 1.885 . . . . 0.0 111.715 -177.528 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 89.8 18.86 50.01 Favored Glycine 0 CA--C 1.528 0.905 0 CA-C-N 115.574 -0.739 . . . . 0.0 113.461 171.204 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -85.9 -21.78 27.81 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 125.016 1.326 . . . . 0.0 111.836 -177.662 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 9.8 tp -150.13 144.97 26.04 Favored 'General case' 0 C--N 1.341 0.222 0 CA-C-N 119.322 0.964 . . . . 0.0 110.785 176.948 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 55.8 m-85 -82.33 144.26 30.7 Favored 'General case' 0 CA--C 1.517 -0.293 0 N-CA-C 107.864 -1.162 . . . . 0.0 107.864 169.922 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 17.0 m -76.77 12.03 0.39 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.57 0 C-N-CA 124.43 1.092 . . . . 0.0 112.238 178.827 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -179.64 171.76 43.45 Favored Glycine 0 CA--C 1.526 0.769 0 N-CA-C 109.761 -1.335 . . . . 0.0 109.761 -178.321 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 8.0 tp -64.11 134.24 54.51 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 117.617 0.709 . . . . 0.0 110.891 177.579 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -93.49 127.57 39.2 Favored 'General case' 0 N--CA 1.441 -0.9 0 C-N-CA 125.393 1.477 . . . . 0.0 109.627 174.441 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 84.5 mt -120.61 151.5 39.36 Favored 'General case' 0 C--O 1.234 0.239 0 N-CA-C 105.83 -1.915 . . . . 0.0 105.83 167.718 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -137.01 133.57 35.68 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-N 118.445 0.566 . . . . 0.0 110.054 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 30.1 tp10 -80.34 -22.58 41.3 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 125.112 1.365 . . . . 0.0 112.688 -171.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 93.3 m -115.38 -41.97 3.21 Favored 'General case' 0 C--O 1.234 0.261 0 C-N-CA 124.561 1.144 . . . . 0.0 110.988 -169.076 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 4.3 m-80 -79.84 -21.9 43.62 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 124.423 1.089 . . . . 0.0 110.953 -170.768 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 64.9 mt-30 -128.8 155.57 44.96 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 125.562 1.545 . . . . 0.0 109.495 -178.198 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 89.9 t80 -147.18 -56.58 0.25 Allowed 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 124.552 1.141 . . . . 0.0 108.167 169.593 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -67.79 -44.97 76.12 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-O 121.386 0.612 . . . . 0.0 110.577 175.194 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 6.4 tp -74.58 -15.98 60.82 Favored 'General case' 0 C--N 1.34 0.194 0 CA-C-O 118.638 -0.696 . . . . 0.0 112.338 -170.813 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 5.2 m -61.09 -38.38 86.08 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 119.015 0.825 . . . . 0.0 110.296 179.798 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -62.17 -45.87 91.48 Favored 'General case' 0 N--CA 1.463 0.178 0 C-N-CA 123.285 0.634 . . . . 0.0 110.415 175.157 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 -63.04 -43.04 99.78 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 123.593 0.757 . . . . 0.0 110.416 179.549 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 2.3 mpt_? -59.14 -45.83 89.92 Favored 'General case' 0 C--N 1.335 -0.05 0 C-N-CA 123.976 0.91 . . . . 0.0 110.368 177.598 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 34.9 mt -64.67 -53.09 46.48 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 176.847 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -54.28 -66.34 0.41 Allowed 'General case' 0 CA--C 1.518 -0.287 0 C-N-CA 125.437 1.495 . . . . 0.0 112.246 -169.916 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 16.3 m -60.94 -33.7 73.59 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.747 -0.66 . . . . 0.0 111.594 -174.825 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 160' ' ' TRP . . . . . . . . . . . . . 67.5 t90 -65.14 -44.99 86.86 Favored 'General case' 0 C--O 1.223 -0.293 0 O-C-N 121.956 -0.465 . . . . 0.0 110.552 173.9 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 65.8 m -60.33 -41.24 93.15 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 118.298 0.499 . . . . 0.0 110.763 179.672 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -62.57 -45.68 91.79 Favored 'General case' 0 C--O 1.228 -0.073 0 CA-C-N 118.818 0.736 . . . . 0.0 110.063 173.201 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 14.4 tt0 -61.53 -48.56 80.49 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-O 117.923 -1.037 . . . . 0.0 110.363 -175.522 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 40.7 pt -65.57 -33.8 66.08 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.422 0 CA-C-O 117.918 -1.039 . . . . 0.0 110.282 -178.299 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -73.05 -31.02 64.14 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 119.58 1.082 . . . . 0.0 108.765 -175.033 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -69.08 -55.87 9.42 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 125.028 1.331 . . . . 0.0 109.194 170.945 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 19.5 tt0 -67.76 -30.68 70.2 Favored 'General case' 0 N--CA 1.442 -0.837 0 C-N-CA 125.546 1.538 . . . . 0.0 110.504 -168.545 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 168' ' ' MET . . . . . . . . . . . . . 20.2 ptp -75.8 -29.13 58.62 Favored 'General case' 0 CA--C 1.523 -0.058 0 O-C-N 122.023 -0.423 . . . . 0.0 111.743 174.708 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -78.3 -33.37 49.41 Favored 'General case' 0 N--CA 1.444 -0.73 0 C-N-CA 123.228 0.611 . . . . 0.0 111.639 179.729 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -57.05 -40.7 77.28 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-O 122.324 1.059 . . . . 0.0 109.149 175.822 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 81.0 t60 -71.1 -16.56 62.58 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 126.155 1.782 . . . . 0.0 111.733 -174.068 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 1.4 m-85 -77.47 -19.38 56.04 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 123.883 0.873 . . . . 0.0 112.163 171.249 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.254 1.323 0 C-N-CA 126.336 1.854 . . . . 0.0 110.974 -177.748 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 34.6 ttp . . . . . 0 N--CA 1.494 1.753 0 N-CA-C 110.368 -0.234 . . . . 0.0 110.368 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 29.1 p-10 -144.51 166.66 24.51 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 126.612 1.965 . . . . 0.0 108.367 177.955 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 1.5 mpt? -129.04 124.4 34.78 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 118.567 0.621 . . . . 0.0 111.1 -179.797 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -90.42 142.1 16.19 Favored Glycine 0 CA--C 1.526 0.724 0 N-CA-C 107.139 -2.384 . . . . 0.0 107.139 167.815 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 1.2 tt -132.2 97.55 4.16 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 119.911 1.855 . . . . 0.0 106.659 -169.866 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -105.03 144.48 31.78 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-O 121.64 0.733 . . . . 0.0 112.138 -170.408 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 35.4 p90 -160.14 176.29 11.95 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 126.698 1.999 . . . . 0.0 107.539 179.512 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -84.75 -141.09 5.18 Favored Glycine 0 CA--C 1.526 0.752 0 C-N-CA 124.241 0.924 . . . . 0.0 112.214 -171.394 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 3.5 m -58.42 148.03 29.41 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 124.926 1.29 . . . . 0.0 111.584 -173.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 1.8 m -59.39 -22.9 62.08 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 124.559 1.144 . . . . 0.0 112.751 -179.878 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 4.3 p -71.01 -15.62 62.57 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 125.494 1.518 . . . . 0.0 112.612 177.367 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 63.9 m -68.9 136.32 52.41 Favored 'General case' 0 C--N 1.343 0.299 0 CA-C-N 119.244 0.929 . . . . 0.0 108.855 176.861 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 85.3 m-85 -60.32 -19.85 56.94 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 122.746 0.418 . . . . 0.0 111.573 173.152 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 3.8 m -49.07 -28.31 4.03 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 126.779 2.031 . . . . 0.0 112.669 170.065 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 7.7 tt0 -65.74 -33.69 76.45 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-N 120.435 1.47 . . . . 0.0 110.67 178.678 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 4.8 mpp? -70.17 -39.78 75.09 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 118.931 0.787 . . . . 0.0 110.048 176.464 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -59.33 -42.97 92.68 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 118.809 0.731 . . . . 0.0 109.679 170.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -62.74 -48.26 79.99 Favored 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 123.761 0.825 . . . . 0.0 111.379 -175.707 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -67.51 -35.78 79.79 Favored 'General case' 0 CA--C 1.535 0.402 0 O-C-N 121.795 -0.565 . . . . 0.0 110.426 178.96 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 28.9 mtpp -67.39 -37.63 83.42 Favored 'General case' 0 N--CA 1.465 0.293 0 O-C-N 121.272 -0.893 . . . . 0.0 111.182 177.568 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 32.9 mt -56.75 -54.58 27.47 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.25 0 N-CA-C 108.404 -0.961 . . . . 0.0 108.404 175.09 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 22.2 ptt180 -63.31 -37.73 88.42 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 118.904 0.774 . . . . 0.0 110.635 -178.11 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -64.57 -37.78 88.72 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 109.865 -0.42 . . . . 0.0 109.865 -174.736 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 75.6 mt -79.79 -54.47 11.09 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.573 0 C-N-CA 124.805 1.242 . . . . 0.0 110.167 -175.081 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 77.7 mt -62.61 -48.3 88.86 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.292 0 C-N-CA 122.719 0.408 . . . . 0.0 110.172 179.908 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 142.01 119.24 1.48 Allowed Glycine 0 CA--C 1.53 1.026 0 C-N-CA 125.207 1.384 . . . . 0.0 110.449 -179.087 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -76.88 -4.43 14.91 Favored 'Trans proline' 0 CA--C 1.538 0.717 0 C-N-CA 122.829 2.353 . . . . 0.0 113.491 -171.141 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -82.35 -22.68 35.42 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 118.918 0.781 . . . . 0.0 111.157 177.15 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 1.2 pt? -118.51 -21.28 8.06 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 124.847 1.259 . . . . 0.0 113.216 -174.117 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 59.0 t -91.45 147.23 5.41 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.504 0 N-CA-C 107.608 -1.256 . . . . 0.0 107.608 168.714 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 16.5 m -132.13 134.11 45.06 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 125.193 1.397 . . . . 0.0 107.833 178.494 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 18.7 mt -79.43 141.13 37.09 Favored 'General case' 0 N--CA 1.466 0.336 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 175.248 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 21.8 t-80 -135.15 54.09 1.95 Allowed 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 124.761 1.224 . . . . 0.0 108.259 -176.766 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 28.4 t-20 -55.21 124.13 15.96 Favored 'General case' 0 C--O 1.235 0.311 0 N-CA-C 107.348 -1.352 . . . . 0.0 107.348 170.935 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 32.3 mt -72.56 -16.94 61.75 Favored 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 113.105 0.78 . . . . 0.0 113.105 -170.509 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 9.8 tppt? -66.88 -31.06 71.41 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-N 119.354 0.979 . . . . 0.0 109.492 168.078 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -92.48 -36.35 13.12 Favored 'General case' 0 C--O 1.235 0.321 0 N-CA-C 113.525 0.935 . . . . 0.0 113.525 -168.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 2.3 t0 -140.47 156.96 46.18 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-N 118.949 0.795 . . . . 0.0 112.477 178.13 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 17.8 m -79.97 160.06 69.58 Favored Pre-proline 0 CA--C 1.541 0.625 0 C-N-CA 126.23 1.812 . . . . 0.0 111.299 -170.249 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -76.0 -24.85 10.92 Favored 'Trans proline' 0 C--N 1.351 0.7 0 C-N-CA 122.41 2.073 . . . . 0.0 113.41 -171.412 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 3.7 mmmm -67.12 -17.74 65.0 Favored 'General case' 0 CA--C 1.542 0.671 0 O-C-N 120.745 -1.222 . . . . 0.0 110.774 -174.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -59.49 -31.05 69.0 Favored 'General case' 0 N--CA 1.465 0.317 0 C-N-CA 126.803 2.041 . . . . 0.0 110.548 171.235 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 56.3 mtt -59.24 -24.31 63.07 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 118.83 0.741 . . . . 0.0 111.157 -178.672 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 63.3 mt-10 -64.78 -31.83 73.24 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-N 118.464 0.575 . . . . 0.0 110.385 -178.791 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 24.0 mt-30 -69.93 -39.37 76.16 Favored 'General case' 0 N--CA 1.466 0.354 0 N-CA-C 114.093 1.146 . . . . 0.0 114.093 -169.2 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 53.6 m-85 -72.25 141.58 48.95 Favored 'General case' 0 CA--C 1.528 0.12 0 C-N-CA 123.075 0.55 . . . . 0.0 111.388 -165.928 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 57.6 m-20 -69.68 -30.24 67.86 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 123.651 0.78 . . . . 0.0 110.268 176.564 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 19.0 t -126.15 147.2 30.98 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.467 0 N-CA-C 106.973 -1.491 . . . . 0.0 106.973 172.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 22.5 tp -124.87 150.01 46.92 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 169.873 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 43.5 mt -128.9 127.73 66.58 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 N-CA-C 104.596 -2.372 . . . . 0.0 104.596 178.426 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 3.2 mp -107.59 132.88 52.81 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 125.867 1.667 . . . . 0.0 106.791 -178.164 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -139.15 128.7 4.13 Favored Glycine 0 C--N 1.34 0.771 0 N-CA-C 109.182 -1.567 . . . . 0.0 109.182 -177.825 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 3.5 tt -151.77 134.45 8.79 Favored Pre-proline 0 CA--C 1.534 0.363 0 CA-C-N 118.437 1.119 . . . . 0.0 111.685 -179.136 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 75.6 Cg_endo -85.64 135.99 5.2 Favored 'Trans proline' 0 N--CA 1.454 -0.843 0 C-N-CA 121.834 1.69 . . . . 0.0 108.827 168.049 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 23.1 m -102.81 127.24 50.06 Favored 'General case' 0 CA--C 1.536 0.431 0 N-CA-C 106.881 -1.525 . . . . 0.0 106.881 168.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 5.2 m-90 -143.72 154.17 43.2 Favored 'General case' 0 C--O 1.232 0.175 0 C-N-CA 125.798 1.639 . . . . 0.0 106.975 172.642 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -63.83 142.32 58.44 Favored 'General case' 0 C--O 1.234 0.277 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 169.419 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 64.7 t80 63.7 -43.3 0.24 Allowed 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 128.289 2.636 . . . . 0.0 114.472 -175.033 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -65.42 -60.1 7.06 Favored Glycine 0 CA--C 1.529 0.927 0 N-CA-C 109.985 -1.246 . . . . 0.0 109.985 178.485 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.474 ' HG2' ' H ' ' A' ' 61' ' ' ILE . 12.0 tt0 49.99 -149.92 0.24 Allowed 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 124.668 1.187 . . . . 0.0 111.029 178.022 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.474 ' H ' ' HG2' ' A' ' 60' ' ' GLU . 73.8 mt -58.59 126.41 16.17 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.717 0 C-N-CA 126.692 1.997 . . . . 0.0 107.644 169.087 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 -76.98 159.77 29.68 Favored 'General case' 0 N--CA 1.465 0.32 0 C-N-CA 123.723 0.809 . . . . 0.0 109.074 178.33 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -55.36 -41.94 73.24 Favored 'General case' 0 C--O 1.225 -0.23 0 C-N-CA 123.645 0.778 . . . . 0.0 110.643 -179.96 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 22.7 m-20 -62.95 -26.25 68.74 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 123.123 0.569 . . . . 0.0 112.013 -177.84 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' TRP . . . . . 0.436 ' CZ3' ' CE3' ' A' ' 69' ' ' TRP . 0.0 OUTLIER -92.53 -46.43 7.63 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 125.462 1.505 . . . . 0.0 107.483 -176.407 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 13.7 tt0 -63.21 -36.65 84.34 Favored 'General case' 0 N--CA 1.445 -0.69 0 O-C-N 120.073 -1.642 . . . . 0.0 110.355 179.396 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -58.53 -26.09 63.15 Favored 'General case' 0 C--O 1.234 0.239 0 C-N-CA 123.844 0.858 . . . . 0.0 111.368 -175.115 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 34.9 m -105.15 -18.01 7.17 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.416 0 CA-C-O 117.221 -1.371 . . . . 0.0 112.51 177.607 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' TRP . . . . . 0.436 ' CE3' ' CZ3' ' A' ' 65' ' ' TRP . 1.8 t-105 -52.32 -35.04 49.77 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 120.464 1.484 . . . . 0.0 111.118 -176.023 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -68.01 -27.12 66.28 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 126.02 1.728 . . . . 0.0 113.357 177.04 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 23.1 mt-30 -92.65 -23.11 19.09 Favored 'General case' 0 C--N 1.341 0.222 0 C-N-CA 126.179 1.792 . . . . 0.0 112.262 178.249 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 71.8 mt -64.66 -26.21 68.29 Favored 'General case' 0 N--CA 1.465 0.285 0 O-C-N 121.514 -0.741 . . . . 0.0 111.861 -174.326 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -76.93 -22.55 53.13 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-N 118.329 0.513 . . . . 0.0 111.465 173.321 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -79.11 -27.88 42.92 Favored 'General case' 0 CA--C 1.534 0.36 0 O-C-N 120.986 -1.071 . . . . 0.0 112.13 179.706 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 39.3 mt -58.25 145.11 38.71 Favored 'General case' 0 C--O 1.234 0.265 0 C-N-CA 124.433 1.093 . . . . 0.0 110.629 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 22.3 t-20 -87.86 112.09 22.11 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 169.839 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 62.0 mt -120.95 6.92 10.35 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 123.558 0.743 . . . . 0.0 111.9 -172.421 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 32.1 mt-10 -51.13 133.24 28.09 Favored 'General case' 0 C--O 1.235 0.319 0 C-N-CA 124.837 1.255 . . . . 0.0 112.551 -168.857 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 71.81 -6.16 10.19 Favored Glycine 0 CA--C 1.531 1.074 0 C-N-CA 125.521 1.534 . . . . 0.0 115.598 173.177 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.34 157.92 33.55 Favored 'General case' 0 C--N 1.346 0.43 0 CA-C-N 120.759 2.28 . . . . 0.0 110.02 -174.476 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 7.3 mt -84.41 139.3 17.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 N-CA-C 106.894 -1.521 . . . . 0.0 106.894 176.576 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 99.2 t -130.97 126.98 60.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 C-N-CA 123.217 0.607 . . . . 0.0 110.864 178.065 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -94.02 146.16 24.14 Favored 'General case' 0 C--O 1.233 0.223 0 N-CA-C 106.464 -1.68 . . . . 0.0 106.464 165.751 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 2.0 mt -123.75 139.61 53.81 Favored 'General case' 0 CA--C 1.513 -0.475 0 N-CA-C 106.399 -1.704 . . . . 0.0 106.399 171.93 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 31.7 p90 -152.09 167.35 28.76 Favored 'General case' 0 N--CA 1.445 -0.714 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 167.921 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -164.04 179.06 39.17 Favored Glycine 0 N--CA 1.433 -1.523 0 N-CA-C 109.643 -1.383 . . . . 0.0 109.643 170.511 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 6.1 tt -115.71 143.96 44.63 Favored 'General case' 0 N--CA 1.44 -0.956 0 N-CA-C 107.245 -1.391 . . . . 0.0 107.245 172.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -138.45 -174.62 13.51 Favored Glycine 0 CA--C 1.524 0.637 0 N-CA-C 109.167 -1.573 . . . . 0.0 109.167 177.939 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -145.85 136.16 23.92 Favored 'General case' 0 C--O 1.235 0.293 0 C-N-CA 123.843 0.857 . . . . 0.0 109.137 -179.03 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . 0.534 ' H ' ' ND2' ' A' ' 148' ' ' ASN . 43.0 mt-30 -101.97 -6.44 23.45 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 124.827 1.251 . . . . 0.0 112.005 177.153 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 49.5 mt -65.65 -41.25 92.8 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 119.817 1.19 . . . . 0.0 108.859 174.664 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -77.55 37.94 1.64 Allowed Glycine 0 CA--C 1.533 1.19 0 C-N-CA 125.706 1.622 . . . . 0.0 111.623 168.467 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 28.2 t80 54.69 6.17 0.11 Allowed 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 128.104 2.562 . . . . 0.0 115.516 -179.863 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 69.61 26.38 74.54 Favored Glycine 0 C--N 1.343 0.96 0 O-C-N 120.332 -1.48 . . . . 0.0 110.833 -172.592 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -75.1 -16.56 60.54 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-N 117.985 0.892 . . . . 0.0 108.871 165.889 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' TRP . . . . . . . . . . . . . 9.3 m0 -112.68 7.08 18.56 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 126.459 1.904 . . . . 0.0 111.278 -179.5 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 3.1 t80 -68.26 115.51 7.8 Favored 'General case' 0 C--N 1.34 0.172 0 CA-C-N 119.769 1.168 . . . . 0.0 110.557 -172.115 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 92.0 mt 54.67 18.97 2.27 Favored 'General case' 0 N--CA 1.47 0.543 0 N-CA-C 114.739 1.385 . . . . 0.0 114.739 168.156 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -60.56 -33.89 73.36 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 120.643 1.565 . . . . 0.0 111.554 -170.163 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -71.77 -29.86 64.94 Favored 'General case' 0 CA--C 1.535 0.397 0 N-CA-C 112.714 0.635 . . . . 0.0 112.714 176.335 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 5.5 tt -59.07 -43.92 91.82 Favored 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 173.194 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -67.07 -32.96 82.01 Favored Glycine 0 C--N 1.338 0.639 0 CA-C-O 119.678 -0.512 . . . . 0.0 112.053 -176.156 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 75.6 mtm -68.4 -41.1 80.97 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 118.108 0.954 . . . . 0.0 110.899 -178.298 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -72.75 -38.04 67.5 Favored 'General case' 0 C--N 1.347 0.497 0 CA-C-N 120.507 1.503 . . . . 0.0 110.693 175.997 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 84.9 t60 -50.61 -49.0 57.74 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 118.37 0.532 . . . . 0.0 110.517 173.589 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -65.4 -41.81 93.27 Favored 'General case' 0 C--O 1.235 0.33 0 C-N-CA 123.522 0.729 . . . . 0.0 112.804 -177.784 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 24.1 ttmm -54.7 -43.46 72.54 Favored 'General case' 0 N--CA 1.465 0.31 0 C-N-CA 123.103 0.561 . . . . 0.0 109.847 171.55 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 7.9 mt -77.91 -25.66 48.57 Favored 'General case' 0 CA--C 1.516 -0.349 0 N-CA-C 115.35 1.611 . . . . 0.0 115.35 -168.247 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 14.1 m -58.73 -33.16 69.91 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-N 120.124 1.329 . . . . 0.0 112.245 -172.658 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 22.8 p -87.23 -9.65 54.55 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 124.413 1.085 . . . . 0.0 111.956 -179.139 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 30.9 mmmt -82.04 -10.01 59.36 Favored 'General case' 0 C--N 1.346 0.416 0 C-N-CA 124.419 1.088 . . . . 0.0 111.383 173.143 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 75.13 32.93 55.51 Favored Glycine 0 CA--C 1.524 0.638 0 CA-C-O 119.665 -0.519 . . . . 0.0 112.615 169.728 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 29.8 m -76.5 179.79 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 CA-C-N 118.208 1.004 . . . . 0.0 110.38 169.602 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -116.6 134.26 55.04 Favored 'General case' 0 CA--C 1.515 -0.369 0 N-CA-C 106.374 -1.713 . . . . 0.0 106.374 169.655 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 59.3 m-85 -95.38 145.01 25.44 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 119.502 1.047 . . . . 0.0 110.17 -179.26 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 35.3 m -132.8 159.61 43.07 Favored 'Isoleucine or valine' 0 C--O 1.233 0.21 0 C-N-CA 125.03 1.332 . . . . 0.0 108.399 171.954 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 82.02 33.44 26.63 Favored Glycine 0 CA--C 1.521 0.456 0 CA-C-O 118.666 -1.074 . . . . 0.0 113.858 170.556 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 8.3 m-30 -62.38 149.93 41.09 Favored 'General case' 0 CA--C 1.544 0.749 0 CA-C-N 119.297 1.549 . . . . 0.0 109.47 169.633 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 1.5 t90 -134.65 136.37 25.33 Favored Pre-proline 0 CA--C 1.541 0.603 0 CA-C-O 117.273 -1.346 . . . . 0.0 108.592 -170.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_exo -66.45 130.26 23.3 Favored 'Trans proline' 0 C--N 1.349 0.574 0 C-N-CA 123.006 2.471 . . . . 0.0 113.366 -172.369 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 33.6 p -68.05 -13.82 62.49 Favored 'General case' 0 CA--C 1.545 0.773 0 N-CA-C 113.235 0.828 . . . . 0.0 113.235 172.875 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -61.13 136.49 58.09 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 124.514 1.126 . . . . 0.0 110.571 -174.329 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 83.65 -8.74 64.38 Favored Glycine 0 CA--C 1.534 1.265 0 C-N-CA 124.99 1.281 . . . . 0.0 114.202 174.282 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 20.7 m-85 -93.33 150.97 20.07 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 118.529 1.164 . . . . 0.0 109.296 172.893 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -116.63 112.45 21.28 Favored 'General case' 0 C--O 1.233 0.221 0 N-CA-C 107.196 -1.409 . . . . 0.0 107.196 175.371 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 36.4 p90 -156.25 171.3 20.44 Favored 'General case' 0 C--O 1.235 0.321 0 C-N-CA 124.745 1.218 . . . . 0.0 109.661 -175.786 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 10.3 t -139.88 -14.37 1.06 Allowed 'General case' 0 CA--C 1.54 0.593 0 CA-C-O 118.695 -0.669 . . . . 0.0 112.515 177.611 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 16.7 m -53.09 119.61 17.26 Favored Pre-proline 0 CA--C 1.546 0.795 0 CA-C-N 119.629 1.104 . . . . 0.0 111.118 176.896 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -90.25 -26.54 0.36 Allowed 'Trans proline' 0 C--N 1.353 0.785 0 C-N-CA 121.929 1.753 . . . . 0.0 113.531 -171.628 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 47.1 mttp -54.74 -45.75 99.55 Favored Pre-proline 0 N--CA 1.473 0.679 0 CA-C-N 119.56 1.073 . . . . 0.0 113.199 -174.887 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -86.58 13.44 2.72 Favored 'Trans proline' 0 N--CA 1.457 -0.659 0 C-N-CA 122.043 1.829 . . . . 0.0 113.057 -171.524 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 15.2 m -127.55 146.23 33.62 Favored 'Isoleucine or valine' 0 C--O 1.232 0.179 0 CA-C-N 121.521 1.964 . . . . 0.0 111.04 -179.297 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 14.5 pt -102.8 169.01 2.01 Favored 'Isoleucine or valine' 0 C--O 1.235 0.313 0 C-N-CA 125.68 1.592 . . . . 0.0 108.96 170.483 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . 56.72 30.96 18.5 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 124.829 1.251 . . . . 0.0 113.514 167.93 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 27.6 t70 55.1 38.98 31.34 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 126.736 2.014 . . . . 0.0 111.292 -176.23 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 98.14 71.74 1.04 Allowed Glycine 0 C--N 1.338 0.693 0 C-N-CA 124.401 1.0 . . . . 0.0 111.29 176.721 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 76.3 mm-40 -120.33 -48.56 2.31 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 123.048 0.539 . . . . 0.0 110.895 167.784 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -131.34 141.98 50.0 Favored 'General case' 0 N--CA 1.467 0.408 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 179.52 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 62.9 m-85 -75.82 18.83 0.23 Allowed 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 125.86 1.664 . . . . 0.0 115.215 177.315 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 4.2 m 49.25 10.8 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.552 1.031 0 C-N-CA 127.576 2.351 . . . . 0.0 114.546 -176.491 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 170.46 175.2 39.05 Favored Glycine 0 CA--C 1.53 1.005 0 C-N-CA 125.941 1.734 . . . . 0.0 108.883 -169.334 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -71.6 141.07 50.0 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 118.439 1.12 . . . . 0.0 111.983 -177.382 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -99.72 129.77 45.87 Favored 'General case' 0 N--CA 1.446 -0.65 0 C-N-CA 126.523 1.929 . . . . 0.0 110.004 174.167 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 86.2 mt -121.71 141.51 51.09 Favored 'General case' 0 N--CA 1.463 0.214 0 N-CA-C 106.554 -1.647 . . . . 0.0 106.554 168.178 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 65.6 t0 -148.12 71.19 1.17 Allowed 'General case' 0 C--O 1.235 0.322 0 CA-C-O 122.705 1.24 . . . . 0.0 109.095 175.202 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -65.52 -26.4 67.88 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-N 114.572 -1.195 . . . . 0.0 110.401 177.532 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 56.4 m -61.01 -44.86 96.8 Favored 'General case' 0 C--O 1.237 0.433 0 O-C-N 121.531 -0.731 . . . . 0.0 110.448 178.782 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . 0.534 ' ND2' ' H ' ' A' ' 90' ' ' GLN . 5.7 m-80 -93.77 -37.7 11.65 Favored 'General case' 0 CA--C 1.528 0.134 0 CA-C-O 118.501 -0.761 . . . . 0.0 111.374 -172.784 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 18.7 pt20 -148.77 65.71 1.05 Allowed 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 118.873 0.761 . . . . 0.0 111.545 -172.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 31.8 p90 -50.65 -27.97 7.97 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 124.945 1.298 . . . . 0.0 113.414 176.207 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -62.64 -29.69 70.81 Favored 'General case' 0 CA--C 1.535 0.393 0 O-C-N 121.803 -0.56 . . . . 0.0 112.231 -179.46 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -94.76 -10.19 32.33 Favored 'General case' 0 C--N 1.345 0.381 0 CA-C-O 117.791 -1.1 . . . . 0.0 112.714 178.698 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 16.0 m -61.49 -38.2 86.45 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 121.124 1.783 . . . . 0.0 111.404 -172.185 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -62.61 -43.53 98.58 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 118.141 0.428 . . . . 0.0 110.705 176.109 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 12.6 tt0 -67.88 -41.01 83.46 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 124.889 1.276 . . . . 0.0 110.747 -178.497 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.88 -45.11 86.88 Favored 'General case' 0 N--CA 1.463 0.221 0 C-N-CA 124.338 1.055 . . . . 0.0 110.43 173.464 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 43.8 mt -67.03 -55.74 16.54 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.345 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 179.112 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -50.25 -69.13 0.12 Allowed 'General case' 0 C--O 1.234 0.263 0 C-N-CA 125.888 1.675 . . . . 0.0 112.035 -170.338 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 8.3 m -61.31 -33.42 73.57 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.859 -0.609 . . . . 0.0 111.744 -172.955 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 160' ' ' TRP . . . . . . . . . . . . . 79.6 t90 -66.13 -44.71 83.45 Favored 'General case' 0 CA--C 1.517 -0.326 0 O-C-N 121.833 -0.542 . . . . 0.0 110.988 175.041 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 68.6 m -59.51 -42.15 91.56 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 122.937 0.495 . . . . 0.0 110.501 179.095 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -62.05 -42.45 99.2 Favored 'General case' 0 CA--C 1.523 -0.082 0 CA-C-N 118.57 0.623 . . . . 0.0 110.467 174.869 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 16.4 tt0 -64.58 -51.01 64.95 Favored 'General case' 0 N--CA 1.446 -0.641 0 CA-C-O 118.691 -0.671 . . . . 0.0 110.019 -177.018 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 40.3 pt -63.27 -37.62 79.96 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.442 0 CA-C-O 117.815 -1.088 . . . . 0.0 109.531 -175.465 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -65.87 -32.97 74.79 Favored 'General case' 0 N--CA 1.462 0.165 0 CA-C-N 119.495 1.043 . . . . 0.0 110.329 -178.948 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 35.1 m-80 -69.6 -59.2 3.12 Favored 'General case' 0 C--O 1.223 -0.302 0 N-CA-C 108.099 -1.075 . . . . 0.0 108.099 174.053 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 19.4 tt0 -61.41 -34.31 75.15 Favored 'General case' 0 N--CA 1.443 -0.779 0 C-N-CA 126.412 1.885 . . . . 0.0 111.765 -168.788 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 168' ' ' MET . . . . . . . . . . . . . 22.1 ptp -72.46 -35.09 68.16 Favored 'General case' 0 C--O 1.228 -0.077 0 C-N-CA 123.415 0.686 . . . . 0.0 111.67 173.512 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -74.98 -38.35 61.66 Favored 'General case' 0 N--CA 1.445 -0.724 0 CA-C-O 119.153 -0.451 . . . . 0.0 111.935 -177.026 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -61.69 -31.55 71.7 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 121.446 0.641 . . . . 0.0 109.839 178.611 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 79.3 t60 -74.69 -32.48 62.21 Favored 'General case' 0 N--CA 1.447 -0.604 0 C-N-CA 124.6 1.16 . . . . 0.0 111.727 -174.834 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 12.0 m-85 -83.86 -24.84 30.72 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 123.531 0.732 . . . . 0.0 112.972 172.656 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.254 1.295 0 CA-C-O 118.198 -0.906 . . . . 0.0 110.564 -177.909 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.7 tmm? . . . . . 0 N--CA 1.494 1.755 0 CA-C-O 120.604 0.24 . . . . 0.0 110.603 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 21.9 p-10 -146.6 165.58 29.11 Favored 'General case' 0 N--CA 1.465 0.321 0 C-N-CA 126.334 1.854 . . . . 0.0 109.327 174.567 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 17.5 mtt -127.07 133.87 50.37 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 118.287 0.494 . . . . 0.0 111.144 -179.191 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -104.11 135.82 12.66 Favored Glycine 0 CA--C 1.526 0.722 0 N-CA-C 107.574 -2.21 . . . . 0.0 107.574 168.215 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 4.0 tt -122.93 111.11 16.24 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 105.78 -1.933 . . . . 0.0 105.78 -173.937 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 1.1 p90 -114.64 146.48 40.8 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 118.71 0.686 . . . . 0.0 110.683 -177.711 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 33.0 p90 -159.97 169.99 22.29 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 124.312 1.045 . . . . 0.0 108.44 179.666 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -71.49 126.6 12.98 Favored Glycine 0 CA--C 1.528 0.865 0 N-CA-C 109.28 -1.528 . . . . 0.0 109.28 177.756 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 1.3 m -88.64 4.87 45.55 Favored 'General case' 0 CA--C 1.538 0.486 0 N-CA-C 114.958 1.466 . . . . 0.0 114.958 -166.654 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 9.1 m -79.01 44.22 0.55 Allowed 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 124.702 1.201 . . . . 0.0 113.17 -171.532 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 2.0 m 54.79 35.98 25.38 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 125.538 1.535 . . . . 0.0 111.129 -176.594 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 58.6 m -74.92 158.02 34.04 Favored 'General case' 0 CA--C 1.534 0.337 0 O-C-N 121.53 -0.731 . . . . 0.0 109.189 178.382 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 41.7 t80 -62.95 -18.21 62.9 Favored 'General case' 0 N--CA 1.469 0.514 0 O-C-N 121.761 -0.587 . . . . 0.0 111.838 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -51.29 -24.72 4.82 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 125.217 1.407 . . . . 0.0 112.369 170.789 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -57.6 -39.43 76.82 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 119.943 1.247 . . . . 0.0 110.867 174.602 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 2.5 mpp? -71.33 -42.28 68.78 Favored 'General case' 0 C--N 1.339 0.127 0 CA-C-O 118.95 -0.547 . . . . 0.0 109.587 179.357 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -58.96 -43.84 91.38 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 119.038 0.836 . . . . 0.0 109.935 173.609 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -64.27 -48.74 74.56 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 124.274 1.029 . . . . 0.0 111.18 -176.777 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 6.4 mt-10 -58.96 -43.56 91.33 Favored 'General case' 0 CA--C 1.516 -0.351 0 N-CA-C 109.972 -0.381 . . . . 0.0 109.972 175.641 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 28.9 mtpp -72.13 -41.99 66.55 Favored 'General case' 0 C--O 1.221 -0.402 0 CA-C-O 117.848 -1.072 . . . . 0.0 110.533 -173.334 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 41.2 mt -51.88 -54.93 11.17 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.314 0 CA-C-N 120.301 1.409 . . . . 0.0 108.349 172.544 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 7.9 ttp180 -61.74 -41.7 98.0 Favored 'General case' 0 C--O 1.222 -0.386 0 C-N-CA 123.605 0.762 . . . . 0.0 109.721 -175.193 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -66.56 -42.24 87.37 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 122.878 0.471 . . . . 0.0 111.159 -178.653 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 51.3 mt -71.48 -52.52 25.7 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 C-N-CA 124.749 1.22 . . . . 0.0 109.843 -172.652 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 82.8 mt -67.66 -45.86 83.97 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.433 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 138.75 124.49 2.22 Favored Glycine 0 CA--C 1.53 1.011 0 C-N-CA 125.078 1.323 . . . . 0.0 112.144 174.613 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -71.77 -7.14 20.57 Favored 'Trans proline' 0 CA--C 1.534 0.491 0 C-N-CA 123.57 2.847 . . . . 0.0 113.965 -175.483 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -77.92 -21.15 51.58 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 119.147 0.885 . . . . 0.0 111.148 176.423 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -127.67 -8.34 5.63 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 124.675 1.19 . . . . 0.0 114.011 -172.343 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 25.4 t -106.48 151.54 8.42 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.337 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 169.64 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 2.1 m -140.07 130.1 24.89 Favored 'General case' 0 C--N 1.333 -0.135 0 N-CA-C 106.236 -1.765 . . . . 0.0 106.236 -170.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 18.7 mt -89.19 135.64 33.46 Favored 'General case' 0 N--CA 1.464 0.273 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 177.866 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 35.6 m170 -100.57 154.21 18.75 Favored 'General case' 0 N--CA 1.464 0.24 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 169.929 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 11.6 t-20 -132.65 104.11 6.48 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 105.036 -2.209 . . . . 0.0 105.036 172.416 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 69.3 mt -76.59 -6.64 52.85 Favored 'General case' 0 C--O 1.235 0.313 0 N-CA-C 113.028 0.751 . . . . 0.0 113.028 -170.049 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 51.5 tptt -81.75 -14.28 56.68 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 118.803 0.728 . . . . 0.0 109.911 168.974 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -117.76 -41.29 2.93 Favored 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 124.572 1.149 . . . . 0.0 112.97 -173.844 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -106.89 155.76 19.41 Favored 'General case' 0 C--O 1.236 0.386 0 C-N-CA 125.878 1.671 . . . . 0.0 111.588 179.484 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 15.1 m -90.95 147.46 35.91 Favored Pre-proline 0 CA--C 1.539 0.521 0 C-N-CA 124.871 1.268 . . . . 0.0 110.26 -174.209 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -66.62 -20.64 53.13 Favored 'Trans proline' 0 C--N 1.349 0.594 0 C-N-CA 122.218 1.945 . . . . 0.0 113.016 -175.722 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 4.6 mptp? -56.85 -23.32 43.34 Favored 'General case' 0 CA--C 1.538 0.491 0 O-C-N 121.328 -0.857 . . . . 0.0 111.712 174.106 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 5.9 mt -61.87 -32.33 72.68 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 119.477 1.035 . . . . 0.0 111.252 175.682 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 59.8 mtt -60.13 -25.48 65.51 Favored 'General case' 0 N--CA 1.462 0.138 0 C-N-CA 123.774 0.829 . . . . 0.0 111.631 -179.911 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -60.23 -33.83 72.82 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 118.401 0.546 . . . . 0.0 109.95 179.112 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 29.9 mt-30 -72.36 -28.08 62.8 Favored 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 114.121 1.156 . . . . 0.0 114.121 -169.679 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 63.1 m-85 -85.27 138.92 32.01 Favored 'General case' 0 N--CA 1.464 0.258 0 C-N-CA 122.718 0.407 . . . . 0.0 110.222 -167.7 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 26.8 m-20 -67.49 -39.3 85.19 Favored 'General case' 0 N--CA 1.465 0.324 0 N-CA-C 109.838 -0.43 . . . . 0.0 109.838 178.484 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 17.3 t -114.35 143.87 23.13 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.379 0 N-CA-C 107.74 -1.207 . . . . 0.0 107.74 173.302 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 18.3 tp -123.55 143.4 50.22 Favored 'General case' 0 N--CA 1.444 -0.749 0 N-CA-C 107.728 -1.212 . . . . 0.0 107.728 169.339 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 45.9 mt -124.45 126.74 72.37 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 N-CA-C 105.426 -2.065 . . . . 0.0 105.426 179.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 3.0 mp -110.02 123.2 49.24 Favored 'General case' 0 CA--C 1.516 -0.33 0 N-CA-C 107.143 -1.429 . . . . 0.0 107.143 -173.012 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -122.74 133.55 9.2 Favored Glycine 0 N--CA 1.459 0.193 0 N-CA-C 109.831 -1.307 . . . . 0.0 109.831 175.627 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 4.3 tt -155.13 125.59 3.39 Favored Pre-proline 0 CA--C 1.538 0.509 0 CA-C-N 118.648 1.224 . . . . 0.0 112.67 169.637 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_exo -63.44 137.93 62.77 Favored 'Trans proline' 0 N--CA 1.452 -0.922 0 C-N-CA 122.378 2.052 . . . . 0.0 111.278 166.02 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 7.7 m -113.22 114.91 27.4 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 106.551 -1.648 . . . . 0.0 106.551 168.65 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 3.2 m0 -167.91 148.95 5.21 Favored 'General case' 0 C--O 1.231 0.092 0 C-N-CA 125.903 1.681 . . . . 0.0 108.609 -174.49 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -61.73 -27.04 68.44 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 122.604 0.362 . . . . 0.0 111.404 169.786 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 9.6 m-85 -70.15 -5.09 24.71 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 125.06 1.344 . . . . 0.0 113.77 -173.631 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -173.94 -34.37 0.04 OUTLIER Glycine 0 CA--C 1.528 0.873 0 CA-C-N 119.186 0.903 . . . . 0.0 113.095 178.01 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 2.8 tp10 51.81 -152.35 0.23 Allowed 'General case' 0 C--O 1.237 0.432 0 C-N-CA 125.035 1.334 . . . . 0.0 110.323 178.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 63.9 mt -62.48 101.67 0.21 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.589 0 N-CA-C 105.029 -2.212 . . . . 0.0 105.029 166.486 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . 0.405 ' NE2' ' H ' ' A' ' 62' ' ' GLN . 1.7 pm0 -74.57 162.88 28.35 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 124.182 0.993 . . . . 0.0 109.891 175.197 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -48.06 -49.22 32.18 Favored 'General case' 0 C--O 1.226 -0.179 0 C-N-CA 125.45 1.5 . . . . 0.0 112.412 -169.413 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -69.33 -19.52 63.87 Favored 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 112.559 0.577 . . . . 0.0 112.559 -170.378 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 3.6 t90 -92.68 -41.46 10.16 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 125.026 1.33 . . . . 0.0 109.022 176.916 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -64.16 -35.52 81.04 Favored 'General case' 0 CA--C 1.537 0.48 0 O-C-N 121.102 -0.999 . . . . 0.0 109.704 177.163 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -62.06 -26.26 68.16 Favored 'General case' 0 C--O 1.233 0.233 0 C-N-CA 124.301 1.04 . . . . 0.0 110.747 -178.956 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 30.5 m -102.68 -20.38 5.67 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.552 0 CA-C-O 116.438 -1.744 . . . . 0.0 112.373 175.249 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 20.5 t90 -55.18 -36.48 65.93 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 121.508 1.958 . . . . 0.0 110.713 -177.5 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -64.1 -27.77 69.32 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 125.12 1.368 . . . . 0.0 112.939 174.418 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 58.4 mt-30 -97.13 -22.72 16.59 Favored 'General case' 0 C--O 1.224 -0.254 0 C-N-CA 126.802 2.041 . . . . 0.0 112.016 -176.494 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 77.7 mt -62.39 -25.99 68.23 Favored 'General case' 0 N--CA 1.462 0.149 0 O-C-N 121.5 -0.75 . . . . 0.0 110.511 178.0 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -78.33 -29.82 47.86 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 117.845 0.293 . . . . 0.0 110.452 172.279 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -72.41 -32.05 66.03 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 123.84 0.856 . . . . 0.0 112.56 -179.261 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 26.0 mt -53.64 142.84 21.82 Favored 'General case' 0 C--O 1.235 0.322 0 C-N-CA 123.906 0.882 . . . . 0.0 112.537 -169.689 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 26.3 t-20 -81.2 88.0 6.06 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 172.154 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 3.8 pp -144.37 132.71 21.92 Favored 'General case' 0 N--CA 1.454 -0.238 0 N-CA-C 108.579 -0.896 . . . . 0.0 108.579 172.001 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 22.6 mt-10 -140.14 146.52 38.93 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 128.591 2.757 . . . . 0.0 107.19 168.693 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 68.9 -3.57 6.55 Favored Glycine 0 CA--C 1.533 1.202 0 N-CA-C 116.793 1.477 . . . . 0.0 116.793 169.968 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.19 157.86 36.34 Favored 'General case' 0 C--N 1.345 0.389 0 CA-C-N 120.181 1.99 . . . . 0.0 110.021 -174.439 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 4.4 mt -80.42 135.25 25.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 N-CA-C 107.377 -1.342 . . . . 0.0 107.377 178.587 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 67.7 t -132.91 129.73 58.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 C-N-CA 124.604 1.162 . . . . 0.0 109.405 -176.924 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -105.98 153.72 21.61 Favored 'General case' 0 N--CA 1.462 0.136 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 168.549 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 1.4 mt -134.49 137.47 43.93 Favored 'General case' 0 CA--C 1.512 -0.484 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 176.214 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 36.7 p90 -154.98 170.94 20.59 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 170.957 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 178.25 161.03 25.56 Favored Glycine 0 N--CA 1.445 -0.758 0 C-N-CA 120.701 -0.761 . . . . 0.0 111.919 168.336 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 58.4 tp -90.66 153.68 20.13 Favored 'General case' 0 N--CA 1.442 -0.841 0 C-N-CA 126.426 1.89 . . . . 0.0 110.981 178.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -167.12 -162.67 19.38 Favored Glycine 0 CA--C 1.528 0.888 0 N-CA-C 109.049 -1.62 . . . . 0.0 109.049 169.099 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 2.2 t0 -138.88 113.84 9.32 Favored 'General case' 0 CA--C 1.518 -0.28 0 N-CA-C 105.733 -1.951 . . . . 0.0 105.733 168.849 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 1.9 pt20 -66.36 -10.67 45.49 Favored 'General case' 0 CA--C 1.542 0.654 0 N-CA-C 113.207 0.817 . . . . 0.0 113.207 -175.853 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 84.4 mt -85.48 -57.48 3.05 Favored 'General case' 0 C--O 1.232 0.181 0 C-N-CA 124.132 0.973 . . . . 0.0 109.326 -177.707 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -73.09 -37.61 55.69 Favored Glycine 0 CA--C 1.529 0.949 0 C-N-CA 123.654 0.645 . . . . 0.0 111.699 178.314 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -115.85 75.66 0.96 Allowed 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 126.024 1.73 . . . . 0.0 106.466 -179.561 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -90.5 -55.25 1.95 Allowed Glycine 0 CA--C 1.525 0.698 0 N-CA-C 110.574 -1.01 . . . . 0.0 110.574 178.629 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -70.42 -13.07 61.98 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 124.988 1.315 . . . . 0.0 111.247 172.539 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' TRP . . . . . . . . . . . . . 3.6 m-90 -123.63 15.35 9.5 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 124.138 0.975 . . . . 0.0 110.976 -177.45 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 11.7 t80 -57.34 129.02 39.94 Favored 'General case' 0 C--N 1.341 0.198 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 179.1 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 90.6 mt 54.28 19.25 2.14 Favored 'General case' 0 CA--C 1.538 0.511 0 N-CA-C 114.117 1.155 . . . . 0.0 114.117 170.106 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -56.98 -35.17 68.86 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 124.739 1.216 . . . . 0.0 111.581 -175.457 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -72.61 -22.41 60.97 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-O 118.061 -0.971 . . . . 0.0 112.499 178.204 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 9.4 mp -65.76 -41.26 92.3 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-N 120.265 1.393 . . . . 0.0 108.172 169.003 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -65.9 -40.06 95.27 Favored Glycine 0 C--N 1.339 0.729 0 N-CA-C 110.76 -0.936 . . . . 0.0 110.76 -176.123 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 74.7 mtm -62.3 -39.9 94.54 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-O 118.681 -0.676 . . . . 0.0 111.619 178.409 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -73.23 -39.1 65.76 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 119.982 1.265 . . . . 0.0 110.34 175.498 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 58.9 t60 -57.95 -51.68 68.63 Favored 'General case' 0 N--CA 1.46 0.06 0 CA-C-N 118.282 0.492 . . . . 0.0 110.189 -179.089 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -61.86 -38.81 89.62 Favored 'General case' 0 C--O 1.234 0.259 0 C-N-CA 123.87 0.868 . . . . 0.0 112.08 -175.783 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 24.4 ttmm -56.8 -39.95 75.06 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 123.542 0.737 . . . . 0.0 110.42 172.599 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 43.6 mt -91.04 -19.83 22.74 Favored 'General case' 0 CA--C 1.52 -0.192 0 N-CA-C 114.32 1.229 . . . . 0.0 114.32 -169.78 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 6.5 m -58.45 -35.86 72.78 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 120.11 1.323 . . . . 0.0 111.179 179.324 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 20.3 p -81.73 -22.81 37.09 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 124.392 1.077 . . . . 0.0 111.418 179.762 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 32.2 mmmt -73.35 -12.21 60.75 Favored 'General case' 0 C--N 1.344 0.354 0 C-N-CA 123.62 0.768 . . . . 0.0 110.824 168.775 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 73.57 34.2 57.28 Favored Glycine 0 C--N 1.336 0.538 0 CA-C-N 118.948 0.794 . . . . 0.0 111.912 169.834 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 9.4 m -73.49 171.53 1.21 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 CA-C-N 118.629 1.215 . . . . 0.0 109.832 174.684 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -108.42 122.4 46.95 Favored 'General case' 0 CA--C 1.515 -0.377 0 N-CA-C 106.389 -1.708 . . . . 0.0 106.389 175.405 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 80.2 m-85 -91.89 144.69 25.22 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 119.072 0.851 . . . . 0.0 109.751 -175.53 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 31.2 m -131.77 160.29 42.5 Favored 'Isoleucine or valine' 0 C--O 1.233 0.234 0 C-N-CA 124.794 1.238 . . . . 0.0 109.188 171.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 96.77 -85.08 0.82 Allowed Glycine 0 N--CA 1.446 -0.691 0 C-N-CA 124.379 0.99 . . . . 0.0 110.654 175.904 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 80.7 m-85 54.57 -171.53 0.05 Allowed 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 124.608 1.163 . . . . 0.0 110.446 -169.301 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -156.37 147.26 16.39 Favored Pre-proline 0 N--CA 1.473 0.679 0 O-C-N 120.26 -1.525 . . . . 0.0 110.485 170.06 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -67.82 128.76 18.44 Favored 'Trans proline' 0 CA--C 1.538 0.706 0 C-N-CA 123.091 2.527 . . . . 0.0 112.365 178.36 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 14.4 p -83.53 -17.17 42.74 Favored 'General case' 0 N--CA 1.469 0.494 0 O-C-N 121.631 -0.668 . . . . 0.0 112.379 173.761 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -64.23 126.59 28.26 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 123.239 0.616 . . . . 0.0 109.552 -169.753 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 76.69 -0.93 63.72 Favored Glycine 0 CA--C 1.534 1.256 0 C-N-CA 124.677 1.132 . . . . 0.0 114.12 -179.786 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 1.1 t80 -81.8 158.54 24.07 Favored 'General case' 0 C--O 1.237 0.423 0 CA-C-N 119.185 1.493 . . . . 0.0 109.776 175.271 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -120.5 109.52 15.38 Favored 'General case' 0 CA--C 1.531 0.217 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 179.702 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 21.6 p90 -163.94 173.71 12.32 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 127.571 2.348 . . . . 0.0 106.703 -179.404 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 7.6 t -147.16 -167.9 2.9 Favored 'General case' 0 CA--C 1.542 0.663 0 O-C-N 121.425 -0.797 . . . . 0.0 109.968 168.522 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 49.3 m 60.27 152.16 0.09 OUTLIER Pre-proline 0 CA--C 1.55 0.959 0 C-N-CA 129.022 2.929 . . . . 0.0 113.891 -167.748 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo -86.38 -22.91 1.98 Allowed 'Trans proline' 0 C--N 1.352 0.715 0 C-N-CA 122.164 1.909 . . . . 0.0 114.055 -170.17 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 21.8 ttmt -55.38 -41.21 89.57 Favored Pre-proline 0 N--CA 1.475 0.784 0 CA-C-N 120.684 1.583 . . . . 0.0 114.698 -170.953 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -74.08 -3.36 13.66 Favored 'Trans proline' 0 CA--C 1.538 0.685 0 CA-C-N 122.745 2.016 . . . . 0.0 114.089 -179.018 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 16.8 m -130.04 156.05 41.96 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.21 0 CA-C-N 119.75 1.159 . . . . 0.0 110.841 -170.685 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 2.4 pt -92.79 171.19 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.598 0 C-N-CA 124.151 0.98 . . . . 0.0 109.662 169.433 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . 55.0 -151.95 0.37 Allowed 'General case' 0 N--CA 1.441 -0.876 0 CA-C-N 113.695 -1.593 . . . . 0.0 109.621 168.444 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 24.8 t0 -79.14 51.87 1.23 Allowed 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 124.99 1.316 . . . . 0.0 110.556 170.815 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 68.04 28.63 73.33 Favored Glycine 0 CA--C 1.529 0.944 0 C-N-CA 124.686 1.136 . . . . 0.0 113.167 179.913 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 20.1 mt-30 -81.39 -22.25 38.45 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 118.281 1.041 . . . . 0.0 112.476 -169.902 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 8.8 tp -156.22 143.94 19.45 Favored 'General case' 0 C--N 1.344 0.326 0 CA-C-N 118.21 0.459 . . . . 0.0 111.013 -178.736 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 74.7 m-85 -73.77 140.36 45.84 Favored 'General case' 0 CA--C 1.516 -0.355 0 N-CA-C 107.479 -1.304 . . . . 0.0 107.479 169.601 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 27.6 m -66.13 -3.73 1.94 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.588 0 N-CA-C 113.285 0.846 . . . . 0.0 113.285 -179.083 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -177.33 170.87 43.57 Favored Glycine 0 N--CA 1.447 -0.607 0 C-N-CA 125.046 1.308 . . . . 0.0 110.215 -171.447 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -60.59 127.36 31.32 Favored 'General case' 0 C--O 1.234 0.287 0 C-N-CA 123.351 0.66 . . . . 0.0 110.945 -175.255 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -79.91 118.95 22.13 Favored 'General case' 0 N--CA 1.446 -0.669 0 C-N-CA 124.838 1.255 . . . . 0.0 108.521 169.87 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 13.8 tp -120.86 143.51 48.86 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 108.169 -1.048 . . . . 0.0 108.169 172.811 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -148.73 145.97 27.89 Favored 'General case' 0 C--O 1.237 0.407 0 C-N-CA 124.706 1.202 . . . . 0.0 107.895 -172.276 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -130.47 1.71 4.55 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 124.42 1.088 . . . . 0.0 112.993 -178.16 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 3.7 m -102.48 -43.91 5.51 Favored 'General case' 0 C--O 1.234 0.264 0 C-N-CA 125.269 1.428 . . . . 0.0 108.28 179.179 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 6.5 m-80 -90.03 -30.12 17.95 Favored 'General case' 0 C--N 1.331 -0.202 0 C-N-CA 125.27 1.428 . . . . 0.0 110.027 -173.249 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 76.6 mt-30 -130.21 158.54 39.44 Favored 'General case' 0 CA--C 1.529 0.171 0 C-N-CA 125.941 1.696 . . . . 0.0 108.376 177.763 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 82.7 t80 -148.14 -47.65 0.16 Allowed 'General case' 0 CA--C 1.528 0.126 0 C-N-CA 123.876 0.87 . . . . 0.0 108.767 169.857 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -68.24 -41.18 81.58 Favored 'General case' 0 C--N 1.344 0.352 0 C-N-CA 122.186 0.194 . . . . 0.0 111.025 176.839 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -75.57 -16.85 60.2 Favored 'General case' 0 C--N 1.346 0.452 0 CA-C-O 117.693 -1.146 . . . . 0.0 112.028 177.594 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 7.7 m -62.27 -34.27 76.23 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-N 120.995 1.725 . . . . 0.0 110.012 -173.729 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -63.17 -43.74 97.41 Favored 'General case' 0 N--CA 1.463 0.191 0 C-N-CA 123.576 0.75 . . . . 0.0 111.369 171.307 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 29.0 tt0 -63.92 -41.22 97.71 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 124.546 1.139 . . . . 0.0 110.795 178.814 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 3.5 mmt180 -65.64 -39.48 91.49 Favored 'General case' 0 CA--C 1.527 0.063 0 CA-C-O 118.627 -0.702 . . . . 0.0 109.187 -178.225 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 35.3 mt -66.0 -57.71 9.54 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.426 0 N-CA-C 107.474 -1.306 . . . . 0.0 107.474 173.771 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 68.4 tp60 -47.69 -65.12 0.62 Allowed 'General case' 0 CA--C 1.52 -0.196 0 C-N-CA 125.298 1.439 . . . . 0.0 112.861 -174.619 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 19.9 m -66.31 -31.36 72.11 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 121.26 -0.176 . . . . 0.0 110.855 -169.592 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 160' ' ' TRP . . . . . . . . . . . . . 67.3 t90 -71.28 -45.46 63.07 Favored 'General case' 0 C--O 1.224 -0.26 0 O-C-N 121.93 -0.481 . . . . 0.0 111.035 177.426 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 85.5 m -58.81 -42.13 88.44 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 123.074 0.55 . . . . 0.0 109.855 176.349 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -64.07 -43.45 95.4 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-O 121.28 0.562 . . . . 0.0 110.335 177.325 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 10.8 tt0 -60.07 -51.2 70.65 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 124.006 0.922 . . . . 0.0 110.068 -179.563 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 40.2 pt -62.86 -36.06 73.9 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.394 0 CA-C-O 117.937 -1.03 . . . . 0.0 109.253 -176.603 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -59.3 -37.93 78.97 Favored 'General case' 0 C--O 1.224 -0.27 0 C-N-CA 124.697 1.199 . . . . 0.0 109.478 177.416 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 33.2 m-80 -75.07 -52.54 10.79 Favored 'General case' 0 CA--C 1.515 -0.372 0 N-CA-C 108.644 -0.873 . . . . 0.0 108.644 -179.531 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 10.6 tt0 -70.43 -28.38 65.0 Favored 'General case' 0 N--CA 1.443 -0.808 0 C-N-CA 124.11 0.964 . . . . 0.0 111.582 -168.798 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 168' ' ' MET . . . . . . . . . . . . . 18.7 ptp -77.64 -31.53 52.77 Favored 'General case' 0 N--CA 1.456 -0.133 0 O-C-N 121.391 -0.818 . . . . 0.0 111.975 172.678 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -78.83 -42.52 27.41 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 122.5 0.32 . . . . 0.0 110.701 -176.31 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -65.43 -28.23 69.09 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 123.542 0.737 . . . . 0.0 110.551 179.298 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 59.2 t60 -64.9 -40.35 94.96 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 124.354 1.061 . . . . 0.0 111.084 174.496 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 12.8 m-85 -80.65 -24.7 38.79 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 123.398 0.679 . . . . 0.0 112.78 177.599 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.242 0 C-N-CA 123.759 0.824 . . . . 0.0 111.087 -177.143 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.497 1.917 0 CA-C-O 119.771 -0.157 . . . . 0.0 111.188 . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 25.2 p-10 -129.8 149.36 51.58 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 124.115 0.966 . . . . 0.0 112.186 -174.445 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 21.9 mtt -105.89 122.38 46.01 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 126.044 1.738 . . . . 0.0 107.213 -176.37 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -86.74 153.88 26.35 Favored Glycine 0 CA--C 1.529 0.942 0 N-CA-C 107.104 -2.398 . . . . 0.0 107.104 166.774 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 2.1 tt -142.6 96.84 3.01 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-N 120.042 1.921 . . . . 0.0 106.832 -173.499 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -101.69 140.52 35.87 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-O 121.033 0.444 . . . . 0.0 111.691 -170.592 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 25.2 p90 -162.93 174.98 11.65 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 126.456 1.903 . . . . 0.0 108.287 -177.143 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -74.48 -165.94 14.37 Favored Glycine 0 CA--C 1.537 1.417 0 C-N-CA 123.364 0.507 . . . . 0.0 112.378 178.169 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 1.6 m -58.11 122.95 14.33 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 124.154 0.982 . . . . 0.0 111.441 -177.472 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 8.2 m -54.87 150.14 10.43 Favored 'General case' 0 C--O 1.236 0.369 0 C-N-CA 124.307 1.043 . . . . 0.0 111.238 176.646 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 4.9 m 67.76 -39.94 0.4 Allowed 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 127.091 2.157 . . . . 0.0 113.164 179.764 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 59.6 m -69.36 -41.46 76.52 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 119.278 0.945 . . . . 0.0 109.995 172.284 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 26.7 m-85 -140.05 162.07 36.1 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 124.815 1.246 . . . . 0.0 109.892 -172.673 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 2.8 m 51.14 44.58 28.63 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 125.187 1.395 . . . . 0.0 111.069 174.928 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -61.53 138.99 58.31 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 122.859 0.464 . . . . 0.0 110.494 -171.794 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' MET . . . . . . . . . . . . 0.261 5.9 ptt? 53.48 -23.32 0.01 OUTLIER 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 130.515 3.526 . . . . 0.0 118.475 -179.847 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -61.64 -45.89 92.13 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 121.252 1.842 . . . . 0.0 110.867 -172.58 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -64.93 -47.1 78.91 Favored 'General case' 0 CA--C 1.527 0.089 0 C-N-CA 122.569 0.348 . . . . 0.0 111.053 -174.932 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -66.58 -35.74 80.95 Favored 'General case' 0 C--O 1.231 0.126 0 CA-C-O 118.602 -0.713 . . . . 0.0 110.735 179.175 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 48.0 mttm -65.61 -49.99 66.7 Favored 'General case' 0 C--O 1.22 -0.486 0 CA-C-O 118.339 -0.838 . . . . 0.0 110.588 175.781 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 40.7 mt -52.46 -52.15 28.2 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.336 0 CA-C-N 119.536 1.062 . . . . 0.0 108.764 178.894 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.61 -39.95 95.38 Favored 'General case' 0 C--O 1.223 -0.323 0 C-N-CA 123.119 0.568 . . . . 0.0 110.267 -177.162 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -67.92 -42.07 81.63 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 118.412 0.551 . . . . 0.0 110.917 -178.735 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 60.6 mt -72.98 -52.77 20.81 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.545 0 C-N-CA 124.911 1.284 . . . . 0.0 109.63 -170.531 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 69.7 mt -66.03 -46.75 87.24 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.375 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 178.443 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 139.37 126.05 2.32 Favored Glycine 0 CA--C 1.531 1.037 0 C-N-CA 124.8 1.191 . . . . 0.0 111.661 174.585 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -72.51 -5.66 17.57 Favored 'Trans proline' 0 CA--C 1.537 0.651 0 C-N-CA 123.593 2.862 . . . . 0.0 114.243 -173.287 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -80.1 -20.52 44.9 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-N 119.329 0.968 . . . . 0.0 111.243 176.794 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -128.02 -1.72 5.85 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 124.793 1.237 . . . . 0.0 113.861 -171.775 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 21.9 t -117.15 147.92 20.22 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.338 0 N-CA-C 107.745 -1.206 . . . . 0.0 107.745 171.748 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 15.5 m -131.66 132.9 44.35 Favored 'General case' 0 N--CA 1.463 0.203 0 N-CA-C 107.688 -1.227 . . . . 0.0 107.688 -177.835 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 17.7 mt -79.01 133.39 36.83 Favored 'General case' 0 C--O 1.233 0.198 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 175.151 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 32.2 t-80 -128.75 58.68 1.57 Allowed 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 124.674 1.19 . . . . 0.0 108.6 -177.551 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 8.0 t-20 -55.5 122.28 10.91 Favored 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 106.413 -1.699 . . . . 0.0 106.413 168.586 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 58.9 mt -66.09 -35.42 80.46 Favored 'General case' 0 C--O 1.236 0.356 0 N-CA-C 112.693 0.627 . . . . 0.0 112.693 -173.306 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 42.3 tttm -64.21 -18.82 64.88 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-O 119.011 -0.519 . . . . 0.0 111.5 172.26 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -97.6 -34.24 11.03 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-N 119.015 0.825 . . . . 0.0 112.574 -177.186 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 4.1 t0 -145.07 145.62 31.52 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 118.763 0.711 . . . . 0.0 112.33 176.636 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 12.4 m -66.72 158.49 79.46 Favored Pre-proline 0 CA--C 1.542 0.655 0 C-N-CA 126.216 1.806 . . . . 0.0 112.261 -169.389 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -73.9 -26.83 12.86 Favored 'Trans proline' 0 C--N 1.35 0.629 0 C-N-CA 122.548 2.165 . . . . 0.0 113.222 -170.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 22.9 mmmt -70.66 -11.63 61.06 Favored 'General case' 0 CA--C 1.538 0.497 0 O-C-N 120.456 -1.403 . . . . 0.0 111.676 -176.846 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -61.93 -29.3 70.13 Favored 'General case' 0 N--CA 1.463 0.21 0 C-N-CA 125.683 1.593 . . . . 0.0 110.14 169.142 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 39.7 mtt -55.72 -26.78 46.99 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 123.588 0.755 . . . . 0.0 111.464 178.204 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 94.2 mt-10 -65.49 -31.26 72.23 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 118.191 0.451 . . . . 0.0 110.354 -176.609 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 21.1 mt-30 -69.61 -43.84 71.94 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 123.588 0.755 . . . . 0.0 112.704 -170.103 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 57.3 m-85 -68.33 147.63 51.87 Favored 'General case' 0 C--O 1.231 0.096 0 C-N-CA 123.735 0.814 . . . . 0.0 109.135 -168.47 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -80.59 -37.0 32.02 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 119.105 0.866 . . . . 0.0 108.979 -178.926 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 1.3 m -105.51 151.31 7.7 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.806 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 169.532 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 58.4 tp -140.9 106.6 5.11 Favored 'General case' 0 N--CA 1.448 -0.562 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 174.853 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 22.3 mt -84.4 131.83 33.04 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.744 0 N-CA-C 106.139 -1.8 . . . . 0.0 106.139 176.317 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -106.81 131.85 53.44 Favored 'General case' 0 C--O 1.233 0.217 0 N-CA-C 107.283 -1.377 . . . . 0.0 107.283 169.693 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -127.3 135.53 8.83 Favored Glycine 0 CA--C 1.521 0.456 0 N-CA-C 109.741 -1.344 . . . . 0.0 109.741 171.301 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 3.8 tt -152.05 134.95 9.06 Favored Pre-proline 0 CA--C 1.535 0.399 0 CA-C-N 118.521 1.161 . . . . 0.0 111.786 173.905 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_endo -75.14 133.59 16.56 Favored 'Trans proline' 0 N--CA 1.456 -0.727 0 C-N-CA 122.176 1.917 . . . . 0.0 109.602 165.044 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 91.0 m -100.76 133.29 45.45 Favored 'General case' 0 CA--C 1.534 0.365 0 N-CA-C 106.546 -1.65 . . . . 0.0 106.546 167.976 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 6.1 m-90 -138.91 143.4 38.65 Favored 'General case' 0 C--O 1.236 0.386 0 N-CA-C 105.781 -1.933 . . . . 0.0 105.781 169.628 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -66.76 -45.66 77.84 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 118.938 0.79 . . . . 0.0 110.525 -179.316 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 30.8 p90 -83.92 148.54 26.88 Favored 'General case' 0 CA--C 1.531 0.228 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 168.832 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 78.61 -50.89 3.63 Favored Glycine 0 CA--C 1.533 1.198 0 CA-C-O 118.833 -0.982 . . . . 0.0 112.007 -178.872 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.51 ' HG2' ' H ' ' A' ' 61' ' ' ILE . 13.8 tt0 55.1 -159.38 0.19 Allowed 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 125.175 1.39 . . . . 0.0 110.344 -176.194 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.51 ' H ' ' HG2' ' A' ' 60' ' ' GLU . 23.6 mt -38.05 122.72 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.58 0 C-N-CA 126.33 1.852 . . . . 0.0 109.712 168.451 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 2.2 pm0 -70.11 156.11 39.66 Favored 'General case' 0 C--O 1.232 0.179 0 C-N-CA 123.633 0.773 . . . . 0.0 110.302 176.108 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -54.54 -47.47 73.15 Favored 'General case' 0 N--CA 1.456 -0.167 0 C-N-CA 124.604 1.162 . . . . 0.0 112.457 -168.424 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -67.26 -31.44 71.78 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 119.503 1.047 . . . . 0.0 111.503 -172.225 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 5.2 t90 -73.91 -44.54 54.8 Favored 'General case' 0 N--CA 1.455 -0.222 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 178.578 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -61.83 -36.79 82.22 Favored 'General case' 0 CA--C 1.537 0.464 0 O-C-N 121.397 -0.814 . . . . 0.0 109.993 176.241 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -61.91 -25.07 67.35 Favored 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 123.312 0.645 . . . . 0.0 111.117 -174.093 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 25.4 m -108.56 -13.99 10.17 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.271 0 CA-C-O 117.073 -1.441 . . . . 0.0 112.644 175.21 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 18.2 t90 -51.31 -39.46 56.96 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 120.27 1.396 . . . . 0.0 110.075 -178.611 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -66.73 -25.35 66.47 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 125.721 1.608 . . . . 0.0 113.568 177.8 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 25.8 mt-30 -92.06 -19.23 22.56 Favored 'General case' 0 C--N 1.341 0.224 0 C-N-CA 125.688 1.595 . . . . 0.0 112.348 177.007 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 52.6 mt -62.09 -25.78 67.91 Favored 'General case' 0 N--CA 1.466 0.342 0 O-C-N 121.425 -0.797 . . . . 0.0 111.399 -174.937 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -75.92 -21.95 56.55 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-N 118.026 0.376 . . . . 0.0 111.741 176.47 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -73.47 -29.37 62.49 Favored 'General case' 0 N--CA 1.467 0.413 0 O-C-N 120.827 -1.171 . . . . 0.0 111.852 177.173 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 82.9 mt -54.16 138.25 38.66 Favored 'General case' 0 C--N 1.339 0.147 0 C-N-CA 124.926 1.291 . . . . 0.0 112.911 -168.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 3.0 t30 -74.97 98.93 3.7 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 123.973 0.909 . . . . 0.0 108.978 170.166 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 56.7 mt -123.07 -0.12 8.99 Favored 'General case' 0 N--CA 1.474 0.769 0 N-CA-C 113.765 1.024 . . . . 0.0 113.765 -176.03 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 25.2 mt-10 -55.2 128.69 35.09 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 119.72 1.146 . . . . 0.0 111.581 -168.974 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 74.88 -1.97 51.94 Favored Glycine 0 CA--C 1.532 1.107 0 C-N-CA 125.487 1.518 . . . . 0.0 114.98 177.095 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.3 155.35 34.32 Favored 'General case' 0 C--N 1.346 0.421 0 CA-C-N 120.172 1.986 . . . . 0.0 109.929 -176.035 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 12.4 mt -78.87 142.52 13.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 N-CA-C 106.615 -1.624 . . . . 0.0 106.615 177.918 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 3.0 t -138.08 139.72 41.74 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 O-C-N 121.42 -0.8 . . . . 0.0 109.251 -179.051 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -117.06 147.71 42.13 Favored 'General case' 0 CA--C 1.511 -0.532 0 N-CA-C 106.43 -1.693 . . . . 0.0 106.43 170.876 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 5.9 mp -127.82 142.08 51.39 Favored 'General case' 0 CA--C 1.509 -0.622 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 170.569 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 35.8 p90 -150.04 166.85 28.47 Favored 'General case' 0 N--CA 1.445 -0.701 0 N-CA-C 107.02 -1.474 . . . . 0.0 107.02 167.644 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -163.07 167.43 37.41 Favored Glycine 0 N--CA 1.444 -0.829 0 N-CA-C 109.915 -1.274 . . . . 0.0 109.915 173.388 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -113.43 142.47 45.86 Favored 'General case' 0 N--CA 1.447 -0.585 0 N-CA-C 106.81 -1.552 . . . . 0.0 106.81 -179.702 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -160.68 -167.75 21.62 Favored Glycine 0 CA--C 1.525 0.676 0 N-CA-C 109.304 -1.519 . . . . 0.0 109.304 175.056 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 4.2 t0 -149.4 122.8 9.05 Favored 'General case' 0 C--O 1.234 0.272 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 171.439 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 16.3 pm0 -75.96 -15.25 60.2 Favored 'General case' 0 N--CA 1.448 -0.556 0 C-N-CA 124.573 1.149 . . . . 0.0 113.337 -178.653 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 94.7 mt -80.11 -49.61 11.49 Favored 'General case' 0 C--O 1.231 0.12 0 CA-C-N 119.232 0.924 . . . . 0.0 109.527 -178.819 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -76.26 -46.43 12.71 Favored Glycine 0 CA--C 1.522 0.502 0 C-N-CA 123.907 0.765 . . . . 0.0 112.077 -179.359 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 18.6 m-85 -98.86 -88.73 0.32 Allowed 'General case' 0 C--N 1.339 0.147 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 -176.448 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 79.14 -43.69 2.52 Favored Glycine 0 CA--C 1.529 0.945 0 C-N-CA 124.097 0.856 . . . . 0.0 112.825 171.897 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -84.27 -14.15 50.59 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 126.095 1.758 . . . . 0.0 111.528 171.086 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' TRP . . . . . . . . . . . . . 2.7 m-90 -128.98 29.01 5.26 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 125.297 1.439 . . . . 0.0 110.416 -178.57 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 18.3 t80 -66.28 132.74 49.07 Favored 'General case' 0 C--N 1.339 0.143 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 -176.056 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 95.5 mt 50.62 28.88 3.73 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 124.841 1.256 . . . . 0.0 113.337 169.456 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -57.47 -39.82 77.19 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 124.56 1.144 . . . . 0.0 110.845 -178.165 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -71.46 -32.13 67.95 Favored 'General case' 0 CA--C 1.534 0.331 0 O-C-N 121.666 -0.647 . . . . 0.0 111.9 178.926 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 4.9 tt -62.83 -47.94 81.22 Favored 'General case' 0 N--CA 1.467 0.4 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 171.957 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -63.27 -39.06 97.42 Favored Glycine 0 C--N 1.338 0.66 0 N-CA-C 111.145 -0.782 . . . . 0.0 111.145 -177.314 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 67.7 mtm -64.93 -40.38 94.97 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 118.236 1.018 . . . . 0.0 111.394 176.621 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -71.67 -31.54 66.91 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 119.752 1.16 . . . . 0.0 111.244 177.714 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 50.6 t-80 -62.65 -45.81 91.13 Favored 'General case' 0 N--CA 1.462 0.148 0 CA-C-N 118.98 0.809 . . . . 0.0 110.837 171.444 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -63.6 -44.1 95.0 Favored 'General case' 0 C--O 1.234 0.274 0 C-N-CA 122.942 0.497 . . . . 0.0 111.06 -177.09 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 22.3 ttmm -58.0 -48.6 79.53 Favored 'General case' 0 C--O 1.226 -0.177 0 C-N-CA 123.131 0.572 . . . . 0.0 109.962 172.23 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 32.9 mt -74.79 -23.27 58.48 Favored 'General case' 0 N--CA 1.461 0.091 0 CA-C-O 118.622 -0.704 . . . . 0.0 112.547 -170.839 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 70.0 m -61.04 -38.18 85.25 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 119.376 0.989 . . . . 0.0 111.261 -177.506 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 26.1 p -85.1 -6.89 59.29 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 123.551 0.74 . . . . 0.0 111.667 -178.824 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 30.7 mmmt -82.12 -7.63 59.63 Favored 'General case' 0 C--N 1.344 0.36 0 C-N-CA 124.462 1.105 . . . . 0.0 111.806 171.635 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 69.51 34.36 73.55 Favored Glycine 0 CA--C 1.525 0.688 0 CA-C-N 118.764 0.711 . . . . 0.0 111.788 173.92 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 8.0 m -77.94 172.48 1.12 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.469 0 CA-C-N 117.913 0.856 . . . . 0.0 109.383 174.34 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -111.37 116.48 31.03 Favored 'General case' 0 CA--C 1.514 -0.437 0 N-CA-C 105.938 -1.875 . . . . 0.0 105.938 177.484 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 71.4 m-85 -85.56 142.39 29.17 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 118.819 0.736 . . . . 0.0 110.135 -173.881 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 32.6 m -131.9 158.73 43.34 Favored 'Isoleucine or valine' 0 C--O 1.234 0.268 0 C-N-CA 125.612 1.565 . . . . 0.0 107.581 168.921 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 83.93 31.13 27.07 Favored Glycine 0 CA--C 1.521 0.464 0 CA-C-O 118.779 -1.012 . . . . 0.0 114.935 169.73 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 10.6 m-30 -65.78 157.13 31.12 Favored 'General case' 0 CA--C 1.546 0.823 0 CA-C-N 118.941 1.371 . . . . 0.0 109.343 169.042 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 51.1 t-105 -133.88 147.39 64.01 Favored Pre-proline 0 N--CA 1.476 0.838 0 CA-C-O 118.054 -0.974 . . . . 0.0 112.095 -168.524 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -63.25 129.92 27.05 Favored 'Trans proline' 0 C--N 1.35 0.627 0 C-N-CA 123.077 2.518 . . . . 0.0 113.202 -177.621 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 7.6 p -88.36 -26.63 22.1 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 124.274 1.029 . . . . 0.0 110.764 169.299 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 14.0 mm-40 -65.43 130.52 43.59 Favored 'General case' 0 N--CA 1.451 -0.409 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 -178.954 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 77.67 -5.26 53.24 Favored Glycine 0 CA--C 1.535 1.316 0 CA-C-O 119.029 -0.873 . . . . 0.0 113.436 -176.033 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -87.13 163.34 17.03 Favored 'General case' 0 C--O 1.236 0.342 0 CA-C-N 118.798 1.299 . . . . 0.0 109.096 170.708 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -125.17 124.94 42.86 Favored 'General case' 0 N--CA 1.462 0.135 0 N-CA-C 107.817 -1.179 . . . . 0.0 107.817 175.727 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 22.5 p90 -173.06 170.9 4.3 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 128.091 2.556 . . . . 0.0 106.311 179.706 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 4.8 t -136.44 -10.7 1.9 Allowed 'General case' 0 N--CA 1.472 0.652 0 CA-C-N 118.792 0.724 . . . . 0.0 112.82 168.164 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 14.7 m -59.25 126.66 82.52 Favored Pre-proline 0 CA--C 1.543 0.686 0 C-N-CA 123.796 0.838 . . . . 0.0 111.807 179.227 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_endo -83.57 -22.92 3.57 Favored 'Trans proline' 0 CA--C 1.542 0.905 0 C-N-CA 122.257 1.971 . . . . 0.0 112.999 176.631 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 25.9 ttmt -60.08 -42.07 88.08 Favored Pre-proline 0 CA--C 1.544 0.716 0 O-C-N 120.734 -1.229 . . . . 0.0 113.998 -176.198 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_endo -80.58 5.99 5.74 Favored 'Trans proline' 0 C--N 1.352 0.721 0 C-N-CA 122.046 1.83 . . . . 0.0 114.066 -179.6 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 19.0 m -124.07 147.89 28.4 Favored 'Isoleucine or valine' 0 C--O 1.234 0.273 0 CA-C-N 120.888 1.677 . . . . 0.0 110.982 -177.589 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 2.4 pt -82.69 168.78 1.71 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 N-CA-C 108.056 -1.09 . . . . 0.0 108.056 167.158 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . 55.85 -156.12 0.27 Allowed 'General case' 0 N--CA 1.443 -0.778 0 CA-C-N 114.076 -1.42 . . . . 0.0 110.195 168.587 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 21.8 t0 -80.62 61.11 4.2 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 125.128 1.371 . . . . 0.0 108.92 169.551 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 65.13 28.39 73.49 Favored Glycine 0 CA--C 1.531 1.044 0 C-N-CA 124.302 0.953 . . . . 0.0 113.289 176.768 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 62.5 mm-40 -78.17 -27.49 48.06 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 118.125 0.963 . . . . 0.0 111.886 -169.143 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 12.7 tp -159.17 146.89 17.53 Favored 'General case' 0 C--N 1.341 0.222 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 -177.349 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 63.7 m-85 -75.82 143.09 42.06 Favored 'General case' 0 CA--C 1.517 -0.322 0 N-CA-C 107.821 -1.177 . . . . 0.0 107.821 171.775 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 4.2 m -76.77 10.23 0.5 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.89 0 C-N-CA 123.818 0.847 . . . . 0.0 111.686 -178.43 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 179.25 174.0 44.96 Favored Glycine 0 CA--C 1.529 0.934 0 C-N-CA 125.837 1.684 . . . . 0.0 109.592 -175.478 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 5.0 tp -68.29 134.86 51.02 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-N 118.557 1.179 . . . . 0.0 111.089 178.094 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -96.28 107.64 20.02 Favored 'General case' 0 N--CA 1.442 -0.836 0 C-N-CA 125.367 1.467 . . . . 0.0 108.982 172.557 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 89.6 mt -91.36 151.15 20.97 Favored 'General case' 0 C--O 1.233 0.225 0 N-CA-C 108.096 -1.076 . . . . 0.0 108.096 168.742 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -136.24 155.58 49.9 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 126.537 1.935 . . . . 0.0 107.584 171.799 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 4.9 tp10 -144.0 36.68 1.27 Allowed 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 123.906 0.882 . . . . 0.0 109.773 171.438 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 55.8 m -141.29 -47.87 0.39 Allowed 'General case' 0 C--O 1.236 0.354 0 C-N-CA 124.847 1.259 . . . . 0.0 110.104 -176.612 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 6.1 m-80 -76.14 -35.81 59.06 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 124.5 1.12 . . . . 0.0 108.936 -179.17 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 7.5 mm-40 -121.95 162.59 20.8 Favored 'General case' 0 N--CA 1.452 -0.368 0 C-N-CA 127.103 2.161 . . . . 0.0 109.139 174.594 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 92.8 m-85 -138.57 -36.12 0.58 Allowed 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 124.766 1.226 . . . . 0.0 109.198 167.855 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -71.27 -41.99 69.35 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 123.274 0.63 . . . . 0.0 111.906 177.578 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 87.6 mt -81.83 -6.46 59.1 Favored 'General case' 0 N--CA 1.467 0.424 0 N-CA-C 112.926 0.714 . . . . 0.0 112.926 -170.959 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 12.4 m -62.21 -35.9 80.3 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 119.423 1.011 . . . . 0.0 110.719 -172.492 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -67.51 -39.85 85.14 Favored 'General case' 0 N--CA 1.464 0.258 0 C-N-CA 123.081 0.553 . . . . 0.0 110.853 173.224 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 28.5 tt0 -65.97 -43.33 88.22 Favored 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 124.334 1.054 . . . . 0.0 111.008 -178.326 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.6 -39.93 74.42 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 123.251 0.621 . . . . 0.0 109.475 177.383 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 53.7 mt -70.91 -54.23 18.61 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 N-CA-C 108.277 -1.008 . . . . 0.0 108.277 176.8 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 71.7 tp60 -50.51 -62.32 1.66 Allowed 'General case' 0 N--CA 1.463 0.181 0 C-N-CA 125.183 1.393 . . . . 0.0 111.97 -174.359 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 19.9 m -68.23 -31.98 71.86 Favored 'General case' 0 C--N 1.324 -0.543 0 C-N-CA 121.273 -0.171 . . . . 0.0 110.84 -169.716 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 160' ' ' TRP . . . . . . . . . . . . . 48.7 t90 -66.04 -47.3 74.81 Favored 'General case' 0 C--O 1.223 -0.304 0 O-C-N 122.157 -0.339 . . . . 0.0 110.71 173.388 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 65.5 m -59.93 -43.14 95.13 Favored 'General case' 0 N--CA 1.455 -0.195 0 C-N-CA 122.956 0.503 . . . . 0.0 110.408 -178.554 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -63.16 -40.26 97.03 Favored 'General case' 0 N--CA 1.455 -0.22 0 N-CA-C 110.223 -0.288 . . . . 0.0 110.223 176.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 16.6 tt0 -65.85 -51.62 57.29 Favored 'General case' 0 N--CA 1.446 -0.64 0 CA-C-O 118.787 -0.625 . . . . 0.0 110.122 -179.228 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 39.4 pt -63.5 -38.0 81.07 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.377 0 CA-C-O 117.909 -1.043 . . . . 0.0 109.667 -175.212 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -63.74 -36.07 82.66 Favored 'General case' 0 C--O 1.225 -0.225 0 CA-C-N 119.351 0.978 . . . . 0.0 109.833 179.526 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 28.4 m-80 -68.28 -52.59 32.03 Favored 'General case' 0 CA--C 1.515 -0.4 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 175.808 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 15.2 tt0 -70.69 -26.76 63.57 Favored 'General case' 0 N--CA 1.443 -0.786 0 C-N-CA 124.381 1.073 . . . . 0.0 111.504 -168.767 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 168' ' ' MET . . . . . . . . . . . . . 17.1 ptp -79.58 -30.5 41.63 Favored 'General case' 0 C--O 1.227 -0.104 0 O-C-N 120.808 -1.182 . . . . 0.0 112.219 171.699 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -79.75 -40.54 28.55 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 122.923 0.489 . . . . 0.0 111.156 -178.223 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -69.71 -26.15 64.2 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 124.342 1.057 . . . . 0.0 110.532 -178.57 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 52.5 t60 -60.63 -28.18 68.35 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 124.072 0.949 . . . . 0.0 110.97 170.684 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 29.5 m-85 -101.46 10.39 40.47 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 126.064 1.746 . . . . 0.0 113.31 175.125 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.255 1.367 0 CA-C-N 119.475 1.034 . . . . 0.0 109.794 173.595 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 53.6 ttp . . . . . 0 N--CA 1.497 1.905 0 N-CA-C 110.002 -0.37 . . . . 0.0 110.002 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 10.4 t30 -141.44 152.11 43.98 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 124.908 1.283 . . . . 0.0 107.639 174.681 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 11.8 mtt -113.84 121.46 44.08 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 123.246 0.618 . . . . 0.0 111.136 -175.79 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -80.47 155.51 37.8 Favored Glycine 0 CA--C 1.521 0.41 0 N-CA-C 107.606 -2.198 . . . . 0.0 107.606 166.912 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 2.5 tt -141.47 96.01 2.92 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 105.805 -1.924 . . . . 0.0 105.805 -176.517 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -102.71 143.45 32.35 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-O 121.691 0.758 . . . . 0.0 112.142 -170.454 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 30.2 p90 -157.76 160.35 37.76 Favored 'General case' 0 N--CA 1.451 -0.384 0 C-N-CA 126.81 2.044 . . . . 0.0 107.278 177.016 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -101.08 143.28 16.11 Favored Glycine 0 CA--C 1.523 0.58 0 N-CA-C 110.711 -0.956 . . . . 0.0 110.711 -177.99 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 17.5 m 62.73 147.26 0.02 OUTLIER 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 128.084 2.554 . . . . 0.0 115.395 175.965 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 4.8 m -77.85 165.7 23.82 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 114.62 -1.173 . . . . 0.0 109.506 168.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 1.3 m 60.32 36.47 20.59 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 124.433 1.093 . . . . 0.0 111.213 171.935 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 76.6 m -124.66 149.03 47.6 Favored 'General case' 0 C--O 1.234 0.243 0 C-N-CA 125.715 1.606 . . . . 0.0 107.048 173.782 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 50.3 t80 -62.43 -21.08 65.14 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 119.064 0.847 . . . . 0.0 112.46 -170.743 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 1.3 m -53.28 -29.44 33.22 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-O 118.182 -0.914 . . . . 0.0 112.045 174.39 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -71.91 -27.88 63.12 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 120.525 1.511 . . . . 0.0 111.519 179.036 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 2.2 mpp? -71.29 -41.94 69.33 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 119.162 0.892 . . . . 0.0 109.163 174.898 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -59.18 -44.15 92.17 Favored 'General case' 0 CA--C 1.531 0.239 0 N-CA-C 109.438 -0.578 . . . . 0.0 109.438 171.758 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -63.87 -46.43 84.95 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 123.728 0.811 . . . . 0.0 111.514 -176.822 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 26.5 mt-10 -58.44 -43.96 88.96 Favored 'General case' 0 CA--C 1.517 -0.303 0 C-N-CA 123.51 0.724 . . . . 0.0 109.843 174.559 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 51.2 mttm -65.1 -47.2 78.05 Favored 'General case' 0 C--O 1.222 -0.359 0 CA-C-O 118.725 -0.655 . . . . 0.0 109.984 -178.613 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 43.0 mt -52.88 -54.81 14.71 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.214 0 CA-C-N 119.024 0.829 . . . . 0.0 109.62 179.807 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.45 -35.8 81.2 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 118.374 0.533 . . . . 0.0 111.257 -175.372 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -64.35 -40.41 95.8 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.855 0.359 . . . . 0.0 110.592 178.582 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 62.6 mt -78.41 -54.01 12.89 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.548 0 C-N-CA 124.674 1.19 . . . . 0.0 110.038 -170.301 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 69.5 mt -62.71 -47.51 92.54 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 178.552 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 142.33 122.59 1.77 Allowed Glycine 0 CA--C 1.528 0.903 0 C-N-CA 124.646 1.117 . . . . 0.0 110.78 177.133 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -71.87 -11.18 27.32 Favored 'Trans proline' 0 CA--C 1.537 0.666 0 C-N-CA 122.885 2.39 . . . . 0.0 113.248 -170.262 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -79.96 -18.24 50.92 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 118.844 0.747 . . . . 0.0 111.953 -179.753 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -126.89 5.82 6.61 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 125.085 1.354 . . . . 0.0 113.555 -172.618 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 36.8 t -123.91 148.63 27.97 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.518 0 C-N-CA 124.85 1.26 . . . . 0.0 107.872 172.221 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 20.3 m -134.85 131.12 37.03 Favored 'General case' 0 C--N 1.332 -0.186 0 C-N-CA 125.519 1.528 . . . . 0.0 107.851 -175.267 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 20.9 mt -79.72 139.68 37.23 Favored 'General case' 0 C--O 1.232 0.17 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 177.873 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 18.0 t-80 -137.22 54.8 1.84 Allowed 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 124.177 0.991 . . . . 0.0 108.936 -173.419 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 37.8 t-20 -57.27 123.13 14.29 Favored 'General case' 0 N--CA 1.465 0.283 0 N-CA-C 106.367 -1.716 . . . . 0.0 106.367 168.629 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 31.3 mt -70.75 -31.79 68.72 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 118.661 0.664 . . . . 0.0 112.472 -169.072 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 57.7 tptt -58.96 -24.58 62.74 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 124.2 1.0 . . . . 0.0 110.355 169.765 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -95.73 -33.6 12.24 Favored 'General case' 0 C--O 1.236 0.376 0 N-CA-C 113.566 0.95 . . . . 0.0 113.566 -177.049 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 4.4 t0 -147.54 149.8 33.3 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 119.459 1.027 . . . . 0.0 113.18 178.33 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 15.7 m -71.66 158.43 87.86 Favored Pre-proline 0 CA--C 1.541 0.615 0 C-N-CA 126.236 1.814 . . . . 0.0 112.607 -168.92 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -73.53 -25.6 14.92 Favored 'Trans proline' 0 C--N 1.35 0.611 0 C-N-CA 122.467 2.111 . . . . 0.0 113.935 -173.251 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 8.6 mptt -62.4 -20.45 64.47 Favored 'General case' 0 N--CA 1.475 0.786 0 CA-C-N 120.403 1.456 . . . . 0.0 111.912 -179.587 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -58.14 -29.82 65.85 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 125.552 1.541 . . . . 0.0 110.723 173.347 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 50.4 mtt -60.87 -25.93 67.04 Favored 'General case' 0 C--N 1.339 0.151 0 C-N-CA 123.388 0.675 . . . . 0.0 111.428 178.662 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 61.2 mt-10 -64.84 -35.49 81.28 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-N 118.371 0.532 . . . . 0.0 109.717 -178.445 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 13.5 mt-30 -67.78 -46.04 73.1 Favored 'General case' 0 C--N 1.34 0.159 0 C-N-CA 123.65 0.78 . . . . 0.0 111.836 -171.519 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 17.5 m-85 -69.54 133.55 47.79 Favored 'General case' 0 CA--C 1.521 -0.159 0 CA-C-N 115.424 -0.807 . . . . 0.0 109.235 -167.372 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -75.4 -31.8 60.55 Favored 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 120.361 -0.535 . . . . 0.0 110.86 -176.187 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 20.8 t -109.54 146.08 15.42 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.368 0 N-CA-C 106.717 -1.586 . . . . 0.0 106.717 168.789 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 27.5 tp -133.08 115.77 15.51 Favored 'General case' 0 N--CA 1.445 -0.696 0 N-CA-C 108.439 -0.948 . . . . 0.0 108.439 174.427 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 23.4 mt -94.6 135.88 27.52 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.63 0 N-CA-C 107.045 -1.465 . . . . 0.0 107.045 177.396 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -119.45 131.43 55.62 Favored 'General case' 0 CA--C 1.514 -0.418 0 C-N-CA 125.234 1.413 . . . . 0.0 107.324 -174.466 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -132.64 129.77 5.61 Favored Glycine 0 CA--C 1.519 0.295 0 N-CA-C 110.318 -1.113 . . . . 0.0 110.318 175.036 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 5.8 tt -152.25 133.52 8.0 Favored Pre-proline 0 CA--C 1.541 0.616 0 CA-C-N 118.134 0.967 . . . . 0.0 110.18 169.484 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_exo -76.3 150.05 32.28 Favored 'Trans proline' 0 N--CA 1.46 -0.481 0 C-N-CA 122.824 2.349 . . . . 0.0 112.2 167.704 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 6.2 m -122.93 134.13 54.37 Favored 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 107.252 -1.388 . . . . 0.0 107.252 167.489 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 6.4 m-90 -140.88 148.85 41.14 Favored 'General case' 0 C--O 1.232 0.172 0 C-N-CA 124.91 1.284 . . . . 0.0 107.815 173.626 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -68.29 -33.53 74.51 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-N 118.576 0.626 . . . . 0.0 110.836 173.804 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 33.2 p90 -81.12 7.08 11.87 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 124.313 1.045 . . . . 0.0 112.248 175.67 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -139.23 -171.38 12.19 Favored Glycine 0 CA--C 1.527 0.832 0 C-N-CA 124.603 1.097 . . . . 0.0 111.199 -177.585 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -164.86 163.39 21.12 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 126.324 1.85 . . . . 0.0 106.919 178.43 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 17.5 mt -37.25 132.9 0.24 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.781 0 C-N-CA 125.632 1.573 . . . . 0.0 110.669 167.47 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 3.9 mp0 -66.61 146.65 54.26 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 125.578 1.551 . . . . 0.0 108.661 178.544 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -59.11 -42.01 89.53 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 122.906 0.483 . . . . 0.0 110.239 -179.386 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -58.8 -29.55 66.94 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 124.16 0.984 . . . . 0.0 112.043 178.512 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' TRP . . . . . 0.444 ' CH2' HD22 ' A' ' 104' ' ' LEU . 15.9 t90 -87.22 -45.23 10.83 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 124.303 1.041 . . . . 0.0 109.948 179.828 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -61.59 -35.79 78.85 Favored 'General case' 0 CA--C 1.537 0.46 0 O-C-N 120.903 -1.123 . . . . 0.0 109.656 179.851 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -59.6 -25.11 64.35 Favored 'General case' 0 C--O 1.235 0.313 0 C-N-CA 123.951 0.901 . . . . 0.0 111.473 -179.279 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 11.0 m -109.91 -15.65 9.54 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.295 0 CA-C-O 117.478 -1.249 . . . . 0.0 112.732 178.059 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 24.2 t90 -54.76 -38.31 67.05 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-N 120.042 1.292 . . . . 0.0 109.961 178.78 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -65.91 -27.63 68.33 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 125.342 1.457 . . . . 0.0 112.857 175.638 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 69.4 mt-30 -89.19 -25.05 21.99 Favored 'General case' 0 CA--C 1.514 -0.437 0 C-N-CA 125.417 1.487 . . . . 0.0 111.555 -177.154 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 48.2 mt -57.82 -32.02 67.18 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 118.846 0.748 . . . . 0.0 110.255 173.71 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -69.71 -28.03 65.48 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 122.995 0.518 . . . . 0.0 111.457 173.581 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -80.74 -34.62 34.26 Favored 'General case' 0 CA--C 1.538 0.492 0 N-CA-C 113.199 0.814 . . . . 0.0 113.199 176.846 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 21.6 mt -59.76 148.58 33.79 Favored 'General case' 0 N--CA 1.463 0.207 0 C-N-CA 124.44 1.096 . . . . 0.0 111.758 -173.421 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -82.62 114.4 20.98 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 169.667 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 76.8 mt -129.74 1.07 4.9 Favored 'General case' 0 N--CA 1.475 0.815 0 N-CA-C 113.254 0.835 . . . . 0.0 113.254 -172.982 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 32.7 mt-10 -56.8 133.16 54.07 Favored 'General case' 0 C--O 1.235 0.342 0 CA-C-O 122.122 0.963 . . . . 0.0 111.647 -168.644 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 75.07 -3.87 43.05 Favored Glycine 0 CA--C 1.534 1.263 0 C-N-CA 125.483 1.516 . . . . 0.0 114.976 176.499 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.29 149.75 40.54 Favored 'General case' 0 C--N 1.344 0.357 0 CA-C-N 120.574 2.187 . . . . 0.0 110.114 -175.597 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 5.1 mt -80.71 136.69 22.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 N-CA-C 106.344 -1.724 . . . . 0.0 106.344 178.415 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 64.9 t -130.59 128.65 63.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 C-N-CA 123.556 0.742 . . . . 0.0 109.819 -177.2 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -99.57 145.13 27.86 Favored 'General case' 0 CA--C 1.52 -0.184 0 N-CA-C 107.948 -1.13 . . . . 0.0 107.948 168.442 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 10.5 mt -124.79 132.48 53.34 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 107.406 -1.331 . . . . 0.0 107.406 176.44 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 33.7 p90 -148.69 165.06 32.48 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 168.253 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -165.37 172.46 40.94 Favored Glycine 0 N--CA 1.443 -0.85 0 N-CA-C 109.894 -1.283 . . . . 0.0 109.894 172.512 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 6.6 tt -119.45 148.61 43.05 Favored 'General case' 0 N--CA 1.447 -0.608 0 C-N-CA 125.979 1.712 . . . . 0.0 107.694 -179.922 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -165.17 -156.25 9.0 Favored Glycine 0 CA--C 1.524 0.655 0 N-CA-C 111.329 -0.708 . . . . 0.0 111.329 -178.839 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 14.7 t0 -146.68 117.94 7.85 Favored 'General case' 0 C--O 1.234 0.281 0 C-N-CA 124.732 1.213 . . . . 0.0 109.413 -177.186 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 4.2 pt20 -69.51 -15.52 63.26 Favored 'General case' 0 CA--C 1.536 0.407 0 N-CA-C 112.512 0.56 . . . . 0.0 112.512 178.776 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 34.0 mt -73.26 -5.33 38.74 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 119.065 0.848 . . . . 0.0 110.563 170.784 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -79.15 24.34 2.96 Favored Glycine 0 CA--C 1.534 1.236 0 C-N-CA 125.117 1.341 . . . . 0.0 112.586 168.422 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 44.5 m-85 59.27 5.57 0.61 Allowed 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 128.089 2.556 . . . . 0.0 115.568 172.276 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 66.52 18.37 67.73 Favored Glycine 0 CA--C 1.536 1.35 0 CA-C-N 119.08 0.855 . . . . 0.0 111.067 -172.064 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -91.58 -31.21 15.99 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 124.846 1.259 . . . . 0.0 108.722 168.405 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' TRP . . . . . . . . . . . . . 13.3 m0 -119.09 -2.22 10.79 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 124.121 0.968 . . . . 0.0 113.056 -169.01 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 21.3 t80 -71.25 130.67 42.01 Favored 'General case' 0 N--CA 1.458 -0.066 0 O-C-N 121.591 -0.693 . . . . 0.0 109.506 -172.509 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 92.3 mt 51.35 27.08 3.42 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 124.81 1.244 . . . . 0.0 114.23 167.916 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -64.24 -33.4 75.73 Favored 'General case' 0 C--N 1.331 -0.228 0 O-C-N 120.661 -1.274 . . . . 0.0 110.872 -175.329 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -71.18 -29.43 65.17 Favored 'General case' 0 CA--C 1.535 0.394 0 O-C-N 121.731 -0.606 . . . . 0.0 111.911 175.485 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 5.4 tt -62.4 -45.31 93.72 Favored 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 108.026 -1.102 . . . . 0.0 108.026 169.64 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -64.04 -39.93 97.7 Favored Glycine 0 C--N 1.34 0.765 0 N-CA-C 111.149 -0.78 . . . . 0.0 111.149 -178.707 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 71.6 mtm -66.4 -35.42 80.28 Favored 'General case' 0 CA--C 1.529 0.166 0 CA-C-O 118.206 -0.902 . . . . 0.0 111.904 177.468 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.444 HD22 ' CH2' ' A' ' 65' ' ' TRP . 0.2 OUTLIER -72.89 -36.45 67.34 Favored 'General case' 0 C--N 1.342 0.265 0 CA-C-N 120.768 1.622 . . . . 0.0 110.811 176.234 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 1.8 t60 -54.04 -52.86 59.51 Favored 'General case' 0 CA--C 1.531 0.214 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 169.61 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -63.04 -41.62 99.55 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 123.79 0.836 . . . . 0.0 112.321 -175.239 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 1.7 tppm? -54.77 -27.87 44.53 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 125.72 1.608 . . . . 0.0 111.309 171.488 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 40.4 mt -106.94 -17.72 14.11 Favored 'General case' 0 CA--C 1.519 -0.214 0 N-CA-C 115.228 1.566 . . . . 0.0 115.228 -173.408 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -60.24 -37.11 79.36 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 121.008 1.731 . . . . 0.0 110.977 -172.611 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 16.3 p -81.25 -13.6 58.34 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 125.53 1.532 . . . . 0.0 111.833 -179.772 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 31.8 mmmt -84.8 -5.87 59.34 Favored 'General case' 0 C--N 1.344 0.328 0 C-N-CA 124.955 1.302 . . . . 0.0 111.691 178.702 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 72.76 31.33 62.61 Favored Glycine 0 CA--C 1.523 0.549 0 CA-C-N 118.399 0.545 . . . . 0.0 112.401 169.498 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 14.5 m -75.59 176.59 0.64 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.638 0 CA-C-N 118.163 0.981 . . . . 0.0 109.677 171.992 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -118.03 126.54 52.48 Favored 'General case' 0 CA--C 1.518 -0.265 0 N-CA-C 106.628 -1.619 . . . . 0.0 106.628 173.127 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 62.2 m-85 -91.96 143.29 26.63 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 119.847 1.203 . . . . 0.0 109.805 -177.064 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 35.1 m -131.6 160.88 42.05 Favored 'Isoleucine or valine' 0 C--O 1.235 0.335 0 C-N-CA 125.947 1.699 . . . . 0.0 107.334 169.314 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 84.96 28.68 30.72 Favored Glycine 0 CA--C 1.52 0.392 0 CA-C-O 118.509 -1.162 . . . . 0.0 114.133 172.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 20.8 m-30 -60.87 157.02 16.02 Favored 'General case' 0 CA--C 1.543 0.675 0 CA-C-N 118.809 1.305 . . . . 0.0 109.475 168.494 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 46.5 t-105 -134.15 142.05 41.72 Favored Pre-proline 0 N--CA 1.467 0.403 0 CA-C-O 118.608 -0.711 . . . . 0.0 109.719 -170.577 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -70.1 132.64 23.2 Favored 'Trans proline' 0 N--CA 1.458 -0.588 0 C-N-CA 122.576 2.184 . . . . 0.0 111.728 -171.197 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 20.8 p -96.52 -4.64 41.05 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 124.519 1.128 . . . . 0.0 113.778 -179.757 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -64.83 129.36 39.45 Favored 'General case' 0 CA--C 1.537 0.452 0 O-C-N 121.119 -0.988 . . . . 0.0 109.456 -169.608 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 84.39 -0.13 89.34 Favored Glycine 0 CA--C 1.534 1.275 0 C-N-CA 124.785 1.184 . . . . 0.0 113.978 -177.367 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 11.0 t80 -91.72 155.09 18.53 Favored 'General case' 0 CA--C 1.542 0.663 0 CA-C-N 118.898 1.349 . . . . 0.0 108.925 174.366 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 76.9 mm-40 -113.38 138.75 49.61 Favored 'General case' 0 N--CA 1.465 0.323 0 C-N-CA 124.621 1.169 . . . . 0.0 109.247 179.777 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 93.3 m-85 -130.88 136.58 48.76 Favored 'General case' 0 CA--C 1.513 -0.467 0 C-N-CA 123.597 0.759 . . . . 0.0 110.172 -168.85 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 6.6 m -126.73 -43.86 1.69 Allowed 'General case' 0 N--CA 1.431 -1.393 0 CA-C-N 115.206 -0.907 . . . . 0.0 109.221 -177.1 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 54.9 m -104.42 128.46 26.94 Favored Pre-proline 0 CA--C 1.544 0.733 0 C-N-CA 124.948 1.299 . . . . 0.0 108.744 168.745 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -89.37 -3.13 5.97 Favored 'Trans proline' 0 CA--C 1.542 0.881 0 C-N-CA 123.251 2.634 . . . . 0.0 114.488 -171.674 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 22.2 ttmt -54.76 -38.34 65.72 Favored Pre-proline 0 CA--C 1.545 0.773 0 CA-C-O 116.938 -1.506 . . . . 0.0 115.016 -175.051 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 66.7 Cg_endo -79.23 2.11 8.6 Favored 'Trans proline' 0 C--N 1.353 0.798 0 CA-C-N 122.807 2.038 . . . . 0.0 114.065 -177.862 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 17.2 m -129.15 169.49 20.35 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 119.767 1.167 . . . . 0.0 110.274 -173.887 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 20.5 pt -122.34 163.92 20.14 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.012 0 C-N-CA 126.493 1.917 . . . . 0.0 108.881 172.778 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . 55.33 -154.09 0.31 Allowed 'General case' 0 N--CA 1.446 -0.649 0 C-N-CA 124.369 1.067 . . . . 0.0 108.391 -178.784 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 24.8 t0 -80.18 52.72 1.61 Allowed 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 125.082 1.353 . . . . 0.0 111.017 -179.154 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 63.82 32.16 83.25 Favored Glycine 0 CA--C 1.529 0.923 0 C-N-CA 124.065 0.84 . . . . 0.0 111.662 -174.518 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 1.3 tt0 -90.24 -24.76 20.87 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 124.711 1.205 . . . . 0.0 111.664 -169.163 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -145.54 146.14 31.3 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 119.2 0.909 . . . . 0.0 110.091 169.656 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 49.1 m-85 -74.15 139.38 44.46 Favored 'General case' 0 CA--C 1.508 -0.641 0 N-CA-C 104.393 -2.447 . . . . 0.0 104.393 165.947 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 9.9 p -77.73 6.89 0.86 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.768 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.263 -177.932 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -172.71 175.28 45.79 Favored Glycine 0 CA--C 1.532 1.109 0 C-N-CA 125.349 1.452 . . . . 0.0 110.069 175.951 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 3.9 tp -65.79 144.68 56.71 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 118.285 1.043 . . . . 0.0 111.271 177.687 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -114.97 117.7 31.37 Favored 'General case' 0 N--CA 1.448 -0.565 0 C-N-CA 126.63 1.972 . . . . 0.0 109.826 -179.632 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 79.9 mt -107.94 149.44 28.34 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 124.856 1.263 . . . . 0.0 108.087 170.274 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 17.5 t0 -143.41 108.88 5.07 Favored 'General case' 0 C--O 1.235 0.296 0 C-N-CA 124.127 0.971 . . . . 0.0 109.139 -178.643 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 39.0 mm-40 -88.88 -26.42 21.62 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 123.025 0.53 . . . . 0.0 111.836 -177.85 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 98.1 m -65.9 -36.77 84.32 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 123.323 0.649 . . . . 0.0 110.67 -176.863 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 40.6 m-80 -114.07 -34.21 5.45 Favored 'General case' 0 C--O 1.232 0.163 0 N-CA-C 113.716 1.006 . . . . 0.0 113.716 -166.516 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 17.7 pt20 -151.45 48.02 0.82 Allowed 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 118.835 0.743 . . . . 0.0 111.876 -169.617 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 47.2 p90 -54.75 -29.34 53.59 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 123.821 0.848 . . . . 0.0 112.94 -179.163 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -59.51 -31.37 69.31 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 123.387 0.675 . . . . 0.0 111.633 178.663 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 81.8 mt -82.8 -14.89 53.57 Favored 'General case' 0 CA--C 1.52 -0.2 0 CA-C-O 117.787 -1.101 . . . . 0.0 112.467 179.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 70.7 m -60.69 -35.89 77.43 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 120.723 1.601 . . . . 0.0 110.777 -173.448 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -60.02 -42.11 93.64 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 118.966 0.803 . . . . 0.0 111.307 175.22 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 67.8 mm-40 -69.4 -46.05 67.78 Favored 'General case' 0 CA--C 1.515 -0.386 0 C-N-CA 125.763 1.625 . . . . 0.0 109.944 -178.101 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 67.3 mtt180 -61.55 -46.04 91.61 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 118.228 -0.891 . . . . 0.0 109.701 178.673 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 41.7 mt -61.93 -51.01 77.67 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.204 0 N-CA-C 108.285 -1.006 . . . . 0.0 108.285 176.779 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 66.6 tp60 -48.93 -65.57 0.55 Allowed 'General case' 0 C--O 1.236 0.359 0 C-N-CA 124.527 1.131 . . . . 0.0 111.21 179.972 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 29.5 m -70.73 -28.18 64.52 Favored 'General case' 0 C--N 1.321 -0.653 0 C-N-CA 120.625 -0.43 . . . . 0.0 111.477 -169.24 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 160' ' ' TRP . . . . . . . . . . . . . 57.4 t90 -66.76 -45.92 77.01 Favored 'General case' 0 CA--C 1.518 -0.254 0 CA-C-N 118.791 0.723 . . . . 0.0 111.087 171.532 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 60.4 m -60.64 -43.16 97.9 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 118.262 0.483 . . . . 0.0 110.088 -179.068 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -61.46 -41.59 97.47 Favored 'General case' 0 N--CA 1.455 -0.203 0 CA-C-O 120.984 0.421 . . . . 0.0 110.36 175.201 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 16.3 tt0 -64.84 -51.17 63.54 Favored 'General case' 0 N--CA 1.447 -0.601 0 O-C-N 121.691 -0.631 . . . . 0.0 110.129 -178.413 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 43.4 pt -63.88 -37.55 80.04 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.388 0 CA-C-O 118.174 -0.917 . . . . 0.0 109.703 -175.583 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -64.42 -35.2 80.14 Favored 'General case' 0 CA--C 1.529 0.16 0 CA-C-N 119.247 0.93 . . . . 0.0 109.98 179.66 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 34.9 m-80 -68.56 -50.87 48.54 Favored 'General case' 0 N--CA 1.467 0.382 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 174.118 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 21.9 tt0 -71.11 -25.8 62.75 Favored 'General case' 0 N--CA 1.44 -0.957 0 C-N-CA 125.194 1.398 . . . . 0.0 111.946 -168.747 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 168' ' ' MET . . . . . . . . . . . . . 18.9 ptp -82.05 -31.26 30.98 Favored 'General case' 0 C--O 1.231 0.125 0 O-C-N 121.4 -0.813 . . . . 0.0 112.07 171.052 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -77.77 -36.35 50.62 Favored 'General case' 0 N--CA 1.448 -0.557 0 O-C-N 122.108 -0.37 . . . . 0.0 111.037 -178.419 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -69.97 -26.62 64.19 Favored 'General case' 0 CA--C 1.537 0.452 0 O-C-N 121.862 -0.524 . . . . 0.0 110.611 177.209 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 66.4 t60 -66.84 -33.86 76.54 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 123.951 0.9 . . . . 0.0 110.5 172.296 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -71.1 -45.06 64.41 Favored 'General case' 0 C--O 1.237 0.426 0 C-N-CA 123.861 0.864 . . . . 0.0 111.66 171.649 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.286 0 C-N-CA 125.966 1.706 . . . . 0.0 110.398 -170.004 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 45.7 ttp . . . . . 0 N--CA 1.495 1.8 0 N-CA-C 110.239 -0.282 . . . . 0.0 110.239 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 7.4 t30 -120.48 150.02 41.48 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 124.198 0.999 . . . . 0.0 109.249 172.526 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 20.0 mtt -112.31 125.59 54.34 Favored 'General case' 0 CA--C 1.523 -0.069 0 C-N-CA 123.602 0.761 . . . . 0.0 110.774 -176.451 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -85.28 152.88 27.17 Favored Glycine 0 CA--C 1.524 0.597 0 N-CA-C 106.799 -2.521 . . . . 0.0 106.799 166.41 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 2.1 tt -140.19 96.67 3.09 Favored 'General case' 0 CA--C 1.517 -0.32 0 N-CA-C 105.274 -2.121 . . . . 0.0 105.274 -175.545 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -100.12 141.37 33.04 Favored 'General case' 0 CA--C 1.519 -0.237 0 CA-C-O 121.405 0.621 . . . . 0.0 111.834 -173.519 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 29.3 p90 -159.86 175.88 12.56 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 127.464 2.306 . . . . 0.0 106.325 -178.792 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -153.63 157.01 27.14 Favored Glycine 0 CA--C 1.518 0.222 0 N-CA-C 109.847 -1.301 . . . . 0.0 109.847 178.298 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 75.2 m -146.89 139.37 24.89 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 106.838 -1.541 . . . . 0.0 106.838 179.305 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 15.2 m -136.18 -110.47 0.2 Allowed 'General case' 0 CA--C 1.537 0.474 0 N-CA-C 106.478 -1.675 . . . . 0.0 106.478 177.848 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 3.6 p -69.96 -51.72 30.36 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 119.169 0.895 . . . . 0.0 109.169 169.71 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 56.1 m -83.89 149.92 26.05 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 123.963 0.905 . . . . 0.0 108.646 169.771 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -124.81 136.75 54.11 Favored 'General case' 0 C--O 1.233 0.227 0 C-N-CA 123.913 0.885 . . . . 0.0 110.333 -170.486 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 89.5 m -68.36 141.94 55.61 Favored 'General case' 0 CA--C 1.542 0.64 0 N-CA-C 107.004 -1.48 . . . . 0.0 107.004 167.854 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.402 ' C ' ' H ' ' A' ' 17' ' ' ALA . 9.3 tp10 -65.76 164.08 15.36 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 123.595 0.758 . . . . 0.0 109.27 175.657 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 37.9 mmt -69.07 19.75 0.03 OUTLIER 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 124.852 1.261 . . . . 0.0 113.887 -178.825 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.402 ' H ' ' C ' ' A' ' 15' ' ' GLU . . . -47.7 -40.04 19.09 Favored 'General case' 0 C--O 1.225 -0.234 0 C-N-CA 126.164 1.786 . . . . 0.0 110.582 169.632 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -62.31 -49.33 76.07 Favored 'General case' 0 N--CA 1.461 0.098 0 C-N-CA 123.096 0.559 . . . . 0.0 111.87 -178.315 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 7.1 mt-10 -61.45 -41.07 96.63 Favored 'General case' 0 CA--C 1.518 -0.256 0 O-C-N 121.875 -0.516 . . . . 0.0 110.032 176.086 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 30.2 mtpp -70.31 -43.24 70.75 Favored 'General case' 0 C--O 1.221 -0.4 0 CA-C-O 118.603 -0.713 . . . . 0.0 110.622 -173.991 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 43.4 mt -52.87 -55.41 11.98 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.206 0 CA-C-N 119.492 1.042 . . . . 0.0 108.587 173.53 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 5.0 ttp180 -59.6 -42.1 91.83 Favored 'General case' 0 C--O 1.224 -0.273 0 C-N-CA 123.253 0.621 . . . . 0.0 109.618 -176.256 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -65.13 -40.92 95.13 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 123.21 0.604 . . . . 0.0 111.447 -179.498 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 54.3 mt -74.14 -54.42 14.94 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.537 0 C-N-CA 124.794 1.238 . . . . 0.0 110.139 -172.385 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 73.6 mt -64.3 -46.22 93.83 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 179.03 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 139.16 125.65 2.3 Favored Glycine 0 CA--C 1.533 1.179 0 C-N-CA 125.263 1.411 . . . . 0.0 111.733 172.546 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -70.51 -8.65 24.11 Favored 'Trans proline' 0 CA--C 1.535 0.562 0 C-N-CA 123.499 2.799 . . . . 0.0 113.668 -175.584 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -74.26 -21.92 59.55 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 119.007 0.821 . . . . 0.0 111.624 175.385 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -131.83 2.86 4.07 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 124.514 1.125 . . . . 0.0 113.893 -170.454 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 34.5 t -121.61 149.72 24.79 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.393 0 C-N-CA 124.619 1.168 . . . . 0.0 108.051 171.173 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 31.1 m -137.46 130.44 30.45 Favored 'General case' 0 N--CA 1.456 -0.165 0 C-N-CA 126.043 1.737 . . . . 0.0 106.689 -172.379 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 26.3 mt -79.36 141.22 37.12 Favored 'General case' 0 C--O 1.233 0.19 0 N-CA-C 107.826 -1.176 . . . . 0.0 107.826 176.859 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 34.1 t-80 -132.13 64.9 1.59 Allowed 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 107.393 -1.336 . . . . 0.0 107.393 -177.236 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 65.1 t-20 -73.07 115.11 12.0 Favored 'General case' 0 C--O 1.235 0.29 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 -177.326 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 87.0 mt -67.85 -12.41 60.58 Favored 'General case' 0 CA--C 1.532 0.284 0 N-CA-C 112.959 0.725 . . . . 0.0 112.959 -175.86 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -57.47 -26.14 60.8 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 118.746 0.703 . . . . 0.0 110.66 168.325 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -130.14 -40.43 1.31 Allowed 'General case' 0 N--CA 1.466 0.342 0 N-CA-C 113.558 0.947 . . . . 0.0 113.558 -173.957 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 33.0 m-20 -87.32 141.42 28.65 Favored 'General case' 0 C--O 1.236 0.357 0 C-N-CA 123.33 0.652 . . . . 0.0 110.139 -176.018 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 12.9 m -78.42 156.15 78.64 Favored Pre-proline 0 CA--C 1.542 0.666 0 C-N-CA 124.214 1.006 . . . . 0.0 110.291 177.556 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -77.34 -25.22 8.57 Favored 'Trans proline' 0 C--N 1.35 0.625 0 C-N-CA 122.01 1.807 . . . . 0.0 113.589 -171.232 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 3.7 mptp? -60.94 -22.19 64.17 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-N 119.976 1.262 . . . . 0.0 112.088 -179.874 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -60.49 -28.34 68.27 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 125.945 1.698 . . . . 0.0 110.764 174.773 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 57.1 mtt -58.87 -26.28 64.09 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 118.64 0.654 . . . . 0.0 111.254 178.376 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -65.06 -33.82 76.96 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 118.427 0.558 . . . . 0.0 110.759 -176.461 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 14.4 mt-30 -67.24 -43.61 81.55 Favored 'General case' 0 CA--C 1.531 0.228 0 N-CA-C 113.589 0.959 . . . . 0.0 113.589 -168.907 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 31.1 m-85 -71.17 145.9 49.44 Favored 'General case' 0 CA--C 1.527 0.067 0 CA-C-N 115.488 -0.778 . . . . 0.0 111.634 -165.331 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 41.4 m-20 -75.22 -38.48 60.63 Favored 'General case' 0 N--CA 1.47 0.541 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 -176.833 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 17.7 t -112.64 147.41 16.37 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.279 0 N-CA-C 106.828 -1.545 . . . . 0.0 106.828 169.843 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 26.2 tp -129.45 110.22 11.7 Favored 'General case' 0 N--CA 1.447 -0.586 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 172.255 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 23.3 mt -86.67 132.25 32.78 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.583 0 N-CA-C 106.719 -1.586 . . . . 0.0 106.719 174.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 2.5 mp -111.93 124.93 53.44 Favored 'General case' 0 CA--C 1.519 -0.238 0 N-CA-C 106.886 -1.524 . . . . 0.0 106.886 -179.081 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -119.96 133.07 9.74 Favored Glycine 0 N--CA 1.451 -0.318 0 N-CA-C 108.994 -1.642 . . . . 0.0 108.994 171.248 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 5.1 tt -152.57 131.42 6.6 Favored Pre-proline 0 CA--C 1.531 0.234 0 CA-C-N 117.765 0.783 . . . . 0.0 109.746 168.766 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_exo -74.74 149.66 38.33 Favored 'Trans proline' 0 N--CA 1.455 -0.762 0 C-N-CA 121.898 1.732 . . . . 0.0 112.87 169.063 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 8.4 m -133.0 101.97 5.44 Favored 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 103.666 -2.716 . . . . 0.0 103.666 165.921 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 13.6 m-90 -78.84 69.35 5.0 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 118.757 0.708 . . . . 0.0 110.889 -170.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 12.1 t0 62.08 -85.16 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.268 0 C-N-CA 126.516 1.926 . . . . 0.0 110.146 -170.86 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 31.8 p90 -95.43 -17.02 21.87 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 125.531 1.532 . . . . 0.0 112.092 172.467 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -65.03 151.2 51.59 Favored Glycine 0 CA--C 1.528 0.9 0 C-N-CA 124.183 0.897 . . . . 0.0 111.141 179.61 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 26.5 tt0 -119.58 179.21 4.29 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 124.699 1.2 . . . . 0.0 111.571 -167.333 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 4.8 mt -43.53 138.16 0.82 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.833 0 C-N-CA 128.302 2.641 . . . . 0.0 110.913 175.322 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -89.63 157.88 17.84 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 123.873 0.869 . . . . 0.0 110.356 172.499 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -52.66 -47.64 66.98 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 124.561 1.145 . . . . 0.0 112.994 -168.02 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -67.04 -22.52 65.87 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 119.274 0.943 . . . . 0.0 112.331 -170.883 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 2.1 t90 -90.17 -42.12 11.23 Favored 'General case' 0 N--CA 1.456 -0.174 0 C-N-CA 124.468 1.107 . . . . 0.0 109.29 177.147 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 9.3 tt0 -62.55 -35.59 79.93 Favored 'General case' 0 N--CA 1.446 -0.625 0 O-C-N 121.081 -1.012 . . . . 0.0 109.927 178.697 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -58.94 -24.62 62.71 Favored 'General case' 0 C--O 1.234 0.254 0 C-N-CA 124.468 1.107 . . . . 0.0 111.643 -178.279 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 28.3 m -113.54 -13.41 11.39 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.324 0 CA-C-O 117.267 -1.349 . . . . 0.0 112.65 178.305 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 25.6 t90 -52.48 -39.88 61.69 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 120.396 1.453 . . . . 0.0 110.119 177.443 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -64.54 -25.69 68.09 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 125.253 1.421 . . . . 0.0 113.167 176.353 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 60.0 mt-30 -92.44 -17.0 25.16 Favored 'General case' 0 CA--C 1.52 -0.189 0 C-N-CA 125.697 1.599 . . . . 0.0 111.716 -178.971 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 14.7 mt -69.15 -19.32 64.01 Favored 'General case' 0 CA--C 1.531 0.219 0 O-C-N 121.204 -0.935 . . . . 0.0 111.37 -175.188 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -85.53 -22.21 28.24 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-O 118.994 -0.527 . . . . 0.0 111.192 169.489 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -70.72 -31.05 67.77 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-N 119.438 1.017 . . . . 0.0 111.887 172.05 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 25.5 mt -58.04 144.46 39.76 Favored 'General case' 0 C--O 1.234 0.264 0 C-N-CA 123.752 0.821 . . . . 0.0 112.007 -176.149 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 2.9 t30 -86.75 86.33 7.32 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 125.094 1.358 . . . . 0.0 107.489 173.049 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 3.7 pp -142.09 135.34 29.02 Favored 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 169.707 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -149.52 151.66 34.27 Favored 'General case' 0 N--CA 1.439 -0.992 0 C-N-CA 127.698 2.399 . . . . 0.0 104.835 169.412 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 72.18 -6.54 10.26 Favored Glycine 0 CA--C 1.534 1.26 0 N-CA-C 116.905 1.522 . . . . 0.0 116.905 169.687 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.46 161.51 29.73 Favored 'General case' 0 C--N 1.342 0.282 0 CA-C-N 120.21 2.005 . . . . 0.0 110.047 -175.756 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 3.6 mt -80.26 135.97 24.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 106.923 -1.51 . . . . 0.0 106.923 176.689 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 73.1 t -133.03 132.49 58.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 C-N-CA 123.53 0.732 . . . . 0.0 109.509 -177.12 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -104.01 154.71 19.36 Favored 'General case' 0 CA--C 1.519 -0.25 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 168.674 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 2.0 mt -135.58 138.77 43.31 Favored 'General case' 0 CA--C 1.513 -0.447 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 172.138 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 36.0 p90 -151.89 167.63 27.72 Favored 'General case' 0 N--CA 1.446 -0.647 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 169.617 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -168.49 154.26 23.92 Favored Glycine 0 N--CA 1.448 -0.544 0 N-CA-C 109.414 -1.474 . . . . 0.0 109.414 172.143 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -109.55 158.69 17.75 Favored 'General case' 0 CA--C 1.519 -0.232 0 C-N-CA 123.171 0.588 . . . . 0.0 111.49 169.217 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -161.72 -153.47 7.09 Favored Glycine 0 N--CA 1.448 -0.56 0 N-CA-C 109.938 -1.265 . . . . 0.0 109.938 179.446 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 7.9 t0 -138.74 162.72 34.02 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 106.254 -1.758 . . . . 0.0 106.254 172.729 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 6.3 pt20 -124.25 -6.27 7.71 Favored 'General case' 0 N--CA 1.446 -0.63 0 C-N-CA 125.876 1.671 . . . . 0.0 112.182 178.386 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 90.3 mt -83.22 -5.14 59.02 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 124.534 1.134 . . . . 0.0 112.315 -174.351 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -81.01 -57.55 2.81 Favored Glycine 0 CA--C 1.527 0.829 0 N-CA-C 107.772 -2.131 . . . . 0.0 107.772 168.78 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 27.6 t80 -156.16 -34.48 0.09 Allowed 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 125.043 1.337 . . . . 0.0 111.204 170.609 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 77.41 -34.18 1.56 Allowed Glycine 0 C--N 1.335 0.487 0 C-N-CA 125.474 1.511 . . . . 0.0 114.668 172.554 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 26.6 mt-10 -71.74 -0.48 11.11 Favored 'General case' 0 CA--C 1.543 0.679 0 CA-C-N 119.569 1.684 . . . . 0.0 112.572 -179.305 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' TRP . . . . . . . . . . . . . 8.5 m0 -110.29 -5.72 15.19 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 127.093 2.157 . . . . 0.0 112.463 174.751 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -74.34 166.01 24.21 Favored 'General case' 0 C--N 1.341 0.198 0 CA-C-N 118.992 0.815 . . . . 0.0 112.188 -167.765 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 86.5 mt 56.19 19.32 3.77 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 125.824 1.65 . . . . 0.0 113.805 -177.095 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -58.09 -35.81 71.96 Favored 'General case' 0 C--N 1.33 -0.264 0 O-C-N 120.853 -1.155 . . . . 0.0 111.365 174.301 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -71.99 -30.47 65.28 Favored 'General case' 0 C--N 1.343 0.31 0 O-C-N 121.636 -0.665 . . . . 0.0 112.016 177.775 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 4.8 tt -61.68 -43.14 99.42 Favored 'General case' 0 CA--C 1.539 0.553 0 N-CA-C 107.94 -1.133 . . . . 0.0 107.94 169.243 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -64.06 -39.91 97.65 Favored Glycine 0 CA--C 1.527 0.795 0 CA-C-O 119.383 -0.676 . . . . 0.0 112.823 179.345 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 71.4 mtm -60.36 -38.34 83.54 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 119.163 1.481 . . . . 0.0 112.178 -176.604 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -73.43 -34.72 65.59 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 119.221 0.919 . . . . 0.0 110.808 179.652 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 55.8 t-80 -61.29 -43.23 99.23 Favored 'General case' 0 C--O 1.232 0.14 0 O-C-N 121.681 -0.637 . . . . 0.0 110.262 174.758 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -64.54 -43.26 94.55 Favored 'General case' 0 C--O 1.234 0.239 0 C-N-CA 123.033 0.533 . . . . 0.0 111.393 -177.675 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 22.5 ttmm -55.43 -52.63 62.97 Favored 'General case' 0 N--CA 1.463 0.205 0 C-N-CA 123.204 0.602 . . . . 0.0 109.863 170.904 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 35.7 mt -77.62 -20.41 53.94 Favored 'General case' 0 CA--C 1.517 -0.297 0 N-CA-C 114.195 1.183 . . . . 0.0 114.195 -168.188 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 61.2 m -61.22 -33.37 73.39 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 119.353 0.979 . . . . 0.0 110.75 -179.672 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 40.3 p -87.59 -19.04 28.36 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 123.446 0.699 . . . . 0.0 111.16 179.581 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 20.5 mmmt -71.92 -19.87 61.85 Favored 'General case' 0 N--CA 1.468 0.47 0 O-C-N 121.576 -0.703 . . . . 0.0 109.654 167.738 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 76.21 38.02 35.53 Favored Glycine 0 C--N 1.337 0.63 0 C-N-CA 123.846 0.736 . . . . 0.0 111.655 173.811 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 9.6 m -71.57 172.58 0.95 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.581 0 CA-C-N 118.752 1.276 . . . . 0.0 109.755 171.094 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -106.49 125.1 50.58 Favored 'General case' 0 CA--C 1.517 -0.295 0 N-CA-C 106.361 -1.718 . . . . 0.0 106.361 172.348 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 78.1 m-85 -92.91 145.41 24.4 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 119.481 1.037 . . . . 0.0 109.916 -178.015 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 35.5 m -131.74 157.84 43.21 Favored 'Isoleucine or valine' 0 C--O 1.234 0.282 0 C-N-CA 125.187 1.395 . . . . 0.0 107.703 169.569 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 84.02 31.46 25.99 Favored Glycine 0 CA--C 1.524 0.628 0 CA-C-O 118.596 -1.113 . . . . 0.0 114.835 169.837 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 13.6 m-30 -63.59 160.5 16.56 Favored 'General case' 0 CA--C 1.545 0.785 0 CA-C-N 119.257 1.529 . . . . 0.0 109.417 168.784 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 48.2 t-105 -138.84 148.15 57.03 Favored Pre-proline 0 N--CA 1.47 0.561 0 CA-C-O 118.12 -0.943 . . . . 0.0 111.432 -168.236 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -67.52 130.33 22.01 Favored 'Trans proline' 0 CA--C 1.536 0.588 0 C-N-CA 123.345 2.697 . . . . 0.0 112.352 -179.413 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 22.6 p -93.3 6.58 47.6 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 125.679 1.591 . . . . 0.0 112.392 170.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -61.68 126.95 29.16 Favored 'General case' 0 CA--C 1.534 0.36 0 O-C-N 121.024 -1.048 . . . . 0.0 109.697 -169.497 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 80.93 5.37 90.16 Favored Glycine 0 CA--C 1.535 1.298 0 C-N-CA 124.723 1.154 . . . . 0.0 113.918 -178.0 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 4.5 t80 -95.36 162.35 13.7 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 119.386 1.593 . . . . 0.0 109.196 175.034 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 74.9 mm-40 -126.75 143.92 51.1 Favored 'General case' 0 N--CA 1.463 0.213 0 C-N-CA 124.467 1.107 . . . . 0.0 108.948 178.91 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 50.4 m-85 -137.93 150.79 47.37 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-O 121.679 0.752 . . . . 0.0 112.337 -175.121 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 8.9 t -132.18 -32.05 1.41 Allowed 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 113.892 -1.504 . . . . 0.0 108.525 168.034 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 56.6 m -83.61 120.45 75.35 Favored Pre-proline 0 CA--C 1.542 0.644 0 N-CA-C 108.08 -1.081 . . . . 0.0 108.08 168.617 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -82.6 -22.73 4.4 Favored 'Trans proline' 0 CA--C 1.538 0.713 0 C-N-CA 122.376 2.051 . . . . 0.0 112.846 -176.292 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 15.2 ttmt -50.24 -41.77 68.36 Favored Pre-proline 0 CA--C 1.543 0.708 0 N-CA-C 115.795 1.776 . . . . 0.0 115.795 -170.712 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_endo -70.66 -11.45 29.68 Favored 'Trans proline' 0 C--N 1.352 0.751 0 CA-C-N 122.345 1.873 . . . . 0.0 114.365 179.651 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 30.9 m -132.51 171.34 18.27 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.428 0 CA-C-N 119.638 1.108 . . . . 0.0 112.874 -167.205 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 14.7 pt -138.56 173.92 11.21 Favored 'Isoleucine or valine' 0 C--O 1.236 0.384 0 C-N-CA 127.985 2.514 . . . . 0.0 108.348 -178.747 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . 55.77 40.0 30.76 Favored 'General case' 0 N--CA 1.463 0.224 0 C-N-CA 125.306 1.442 . . . . 0.0 112.615 174.068 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 27.3 t0 56.0 42.57 28.41 Favored 'General case' 0 C--N 1.324 -0.536 0 C-N-CA 125.998 1.719 . . . . 0.0 111.498 -176.159 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 87.26 21.43 48.99 Favored Glycine 0 CA--C 1.528 0.874 0 CA-C-N 115.211 -0.904 . . . . 0.0 113.541 174.129 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 44.7 mt-30 -97.54 -6.22 34.05 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 118.804 1.302 . . . . 0.0 112.781 -178.844 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 8.1 tp -154.21 147.23 24.56 Favored 'General case' 0 C--N 1.344 0.369 0 CA-C-N 119.618 1.099 . . . . 0.0 110.691 169.579 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 54.7 m-85 -80.76 150.63 29.19 Favored 'General case' 0 CA--C 1.52 -0.18 0 C-N-CA 124.19 0.996 . . . . 0.0 108.695 169.944 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 15.3 m -79.82 11.88 0.54 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.589 0 N-CA-C 112.977 0.732 . . . . 0.0 112.977 173.559 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 178.35 174.87 45.0 Favored Glycine 0 CA--C 1.526 0.755 0 N-CA-C 110.485 -1.046 . . . . 0.0 110.485 -178.44 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 3.5 tp -65.63 133.66 51.62 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 118.471 1.135 . . . . 0.0 110.51 177.758 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -99.62 113.66 26.24 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 125.147 1.379 . . . . 0.0 108.927 173.545 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 69.0 mt -104.45 167.91 9.43 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 125.309 1.444 . . . . 0.0 107.983 169.731 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -137.47 147.28 45.17 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 124.366 1.067 . . . . 0.0 108.243 174.668 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 19.4 tt0 -109.83 -11.11 14.73 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 125.842 1.657 . . . . 0.0 112.04 -172.587 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 76.7 m -124.51 -36.37 2.63 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 125.165 1.386 . . . . 0.0 111.979 -168.125 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 6.1 m-80 -95.46 -34.57 12.03 Favored 'General case' 0 C--N 1.332 -0.188 0 C-N-CA 124.278 1.031 . . . . 0.0 111.598 -168.423 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 68.8 mt-30 -128.26 151.17 49.59 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 125.269 1.428 . . . . 0.0 108.477 179.576 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 92.7 m-85 -137.17 -52.61 0.68 Allowed 'General case' 0 N--CA 1.463 0.192 0 C-N-CA 124.102 0.961 . . . . 0.0 109.044 177.262 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -65.15 -41.81 94.37 Favored 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 122.952 0.501 . . . . 0.0 111.04 179.089 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 67.7 mt -74.78 -22.9 58.5 Favored 'General case' 0 CA--C 1.519 -0.237 0 CA-C-O 118.619 -0.705 . . . . 0.0 111.589 -176.71 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 13.8 m -62.8 -34.11 76.59 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-N 119.487 1.04 . . . . 0.0 109.97 -179.056 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -63.85 -42.46 97.57 Favored 'General case' 0 N--CA 1.465 0.283 0 O-C-N 121.784 -0.572 . . . . 0.0 111.166 173.586 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 -65.4 -42.41 92.63 Favored 'General case' 0 N--CA 1.456 -0.165 0 C-N-CA 124.115 0.966 . . . . 0.0 110.68 177.79 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 73.9 mtt180 -62.46 -46.4 88.69 Favored 'General case' 0 N--CA 1.456 -0.146 0 CA-C-O 118.009 -0.996 . . . . 0.0 109.874 177.401 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 48.7 mt -60.54 -51.2 75.85 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.283 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 177.457 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 72.7 tp60 -53.15 -63.33 1.18 Allowed 'General case' 0 C--O 1.234 0.247 0 C-N-CA 124.3 1.04 . . . . 0.0 111.44 -177.442 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 35.9 m -67.63 -33.06 74.21 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 119.473 -0.298 . . . . 0.0 111.257 -171.092 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 160' ' ' TRP . . . . . . . . . . . . . 49.9 t90 -64.78 -46.96 79.88 Favored 'General case' 0 C--O 1.225 -0.189 0 CA-C-N 118.384 0.538 . . . . 0.0 110.447 173.794 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 55.1 m -60.32 -44.47 95.45 Favored 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 122.843 0.457 . . . . 0.0 110.653 -178.74 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -62.02 -39.17 91.37 Favored 'General case' 0 N--CA 1.456 -0.158 0 CA-C-O 120.946 0.403 . . . . 0.0 110.169 176.838 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 17.3 tt0 -66.89 -52.12 47.23 Favored 'General case' 0 N--CA 1.446 -0.641 0 O-C-N 121.736 -0.602 . . . . 0.0 109.895 -178.779 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 43.4 pt -62.92 -37.49 79.4 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.397 0 CA-C-O 118.072 -0.966 . . . . 0.0 109.36 -175.433 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -64.99 -34.12 77.67 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 119.493 1.042 . . . . 0.0 110.2 -179.672 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 32.9 m-80 -69.48 -52.26 28.23 Favored 'General case' 0 N--CA 1.465 0.277 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 174.419 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 16.1 tt0 -70.73 -26.02 63.2 Favored 'General case' 0 N--CA 1.443 -0.802 0 C-N-CA 124.863 1.265 . . . . 0.0 111.741 -168.647 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 168' ' ' MET . . . . . . . . . . . . . 19.7 ptp -80.64 -32.78 36.1 Favored 'General case' 0 C--N 1.335 -0.03 0 O-C-N 121.117 -0.99 . . . . 0.0 112.051 171.354 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -77.41 -40.08 44.82 Favored 'General case' 0 N--CA 1.447 -0.624 0 O-C-N 122.19 -0.319 . . . . 0.0 110.747 -176.702 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -65.95 -28.46 68.92 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 123.15 0.58 . . . . 0.0 110.719 177.729 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 64.5 t60 -66.51 -38.67 87.72 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 124.105 0.962 . . . . 0.0 111.06 173.727 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 1.9 m-85 -75.2 -29.02 60.21 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 123.551 0.74 . . . . 0.0 112.64 176.105 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.155 0 CA-C-O 118.074 -0.965 . . . . 0.0 111.014 -175.571 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 51.4 ttp . . . . . 0 N--CA 1.498 1.933 0 N-CA-C 110.134 -0.321 . . . . 0.0 110.134 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 9.7 t30 -138.26 152.43 48.55 Favored 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 107.54 -1.281 . . . . 0.0 107.54 170.898 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 20.8 mtt -112.59 123.52 50.48 Favored 'General case' 0 C--N 1.331 -0.221 0 C-N-CA 123.052 0.541 . . . . 0.0 110.835 -176.16 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -83.55 150.55 27.05 Favored Glycine 0 CA--C 1.522 0.474 0 N-CA-C 106.43 -2.668 . . . . 0.0 106.43 166.401 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 2.2 tt -138.43 96.37 3.16 Favored 'General case' 0 CA--C 1.515 -0.388 0 N-CA-C 104.629 -2.36 . . . . 0.0 104.629 -176.877 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -101.0 142.22 32.79 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-O 121.951 0.881 . . . . 0.0 111.312 -171.398 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 45.7 p90 -162.5 -179.22 6.78 Favored 'General case' 0 N--CA 1.446 -0.656 0 C-N-CA 126.319 1.848 . . . . 0.0 106.727 178.937 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -148.11 159.84 28.15 Favored Glycine 0 CA--C 1.52 0.389 0 N-CA-C 107.737 -2.145 . . . . 0.0 107.737 169.955 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 71.0 m -137.42 120.21 16.31 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 107.207 -1.405 . . . . 0.0 107.207 -179.537 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -143.99 -70.99 0.3 Allowed 'General case' 0 CA--C 1.535 0.393 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 -178.531 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 4.5 p -91.01 -71.14 0.65 Allowed 'General case' 0 C--O 1.234 0.28 0 N-CA-C 106.368 -1.716 . . . . 0.0 106.368 173.859 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 96.7 m -79.69 162.48 25.19 Favored 'General case' 0 C--O 1.237 0.402 0 N-CA-C 107.696 -1.224 . . . . 0.0 107.696 165.834 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 33.6 p90 -137.85 151.55 48.18 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 124.442 1.097 . . . . 0.0 109.781 -178.989 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 8.2 m -125.97 -0.11 7.24 Favored 'General case' 0 CA--C 1.541 0.618 0 N-CA-C 113.11 0.781 . . . . 0.0 113.11 -167.751 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -64.09 -30.94 71.98 Favored 'General case' 0 CA--C 1.535 0.365 0 O-C-N 120.525 -1.359 . . . . 0.0 112.951 -167.589 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -63.19 -46.75 85.62 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 119.663 1.119 . . . . 0.0 109.63 -177.356 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -65.59 -43.65 89.03 Favored 'General case' 0 C--O 1.227 -0.109 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 178.574 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -63.1 -47.83 81.15 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 122.315 0.246 . . . . 0.0 111.174 -175.889 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.7 pp20? -70.42 -33.88 71.85 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-O 118.684 -0.674 . . . . 0.0 110.036 -178.647 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 42.5 mmtt -58.88 -51.39 70.25 Favored 'General case' 0 C--O 1.224 -0.269 0 CA-C-N 119.532 1.06 . . . . 0.0 110.74 171.086 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 34.2 mt -54.23 -54.7 19.16 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.271 0 CA-C-N 119.069 0.85 . . . . 0.0 109.619 -176.638 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.55 -37.13 86.48 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-O 118.704 -0.665 . . . . 0.0 111.024 -177.128 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -64.3 -38.7 91.98 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 118.261 0.482 . . . . 0.0 110.455 179.786 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 68.7 mt -77.41 -54.52 12.58 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.624 0 C-N-CA 124.89 1.276 . . . . 0.0 110.263 -173.777 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 80.7 mt -62.03 -47.51 92.82 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 179.983 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 141.77 121.18 1.69 Allowed Glycine 0 CA--C 1.526 0.773 0 C-N-CA 125.147 1.356 . . . . 0.0 110.199 177.944 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -71.35 -9.63 25.64 Favored 'Trans proline' 0 CA--C 1.538 0.683 0 C-N-CA 123.055 2.504 . . . . 0.0 113.458 -171.476 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -81.46 -16.75 51.01 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 119.025 0.829 . . . . 0.0 111.86 -179.715 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -128.22 5.17 5.8 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 124.87 1.268 . . . . 0.0 113.58 -173.579 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 28.3 t -125.84 147.75 30.55 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.273 0 N-CA-C 107.789 -1.189 . . . . 0.0 107.789 172.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 19.8 m -134.77 130.65 36.48 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 125.38 1.472 . . . . 0.0 108.063 -174.139 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 16.7 mt -77.83 135.15 37.9 Favored 'General case' 0 C--O 1.232 0.166 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 175.404 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 38.4 t-80 -126.76 66.11 1.26 Allowed 'General case' 0 CA--C 1.53 0.201 0 N-CA-C 107.289 -1.374 . . . . 0.0 107.289 -175.747 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 65.0 t-20 -74.6 114.26 12.81 Favored 'General case' 0 C--O 1.234 0.274 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 -176.254 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 88.3 mt -66.16 -12.29 54.9 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 124.395 1.078 . . . . 0.0 112.897 -176.44 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 23.0 tptm -58.13 -27.4 63.73 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-N 118.578 0.626 . . . . 0.0 110.571 169.093 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -130.55 -39.59 1.28 Allowed 'General case' 0 N--CA 1.465 0.287 0 N-CA-C 113.486 0.921 . . . . 0.0 113.486 -173.513 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 38.4 m-20 -87.11 138.95 31.06 Favored 'General case' 0 C--O 1.234 0.288 0 C-N-CA 123.568 0.747 . . . . 0.0 110.17 -176.929 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 14.1 m -75.92 154.57 84.93 Favored Pre-proline 0 CA--C 1.541 0.622 0 C-N-CA 124.118 0.967 . . . . 0.0 110.174 177.284 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 66.7 Cg_endo -75.39 -26.12 10.61 Favored 'Trans proline' 0 C--N 1.351 0.705 0 C-N-CA 122.235 1.957 . . . . 0.0 113.908 -170.911 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.79 -16.17 64.08 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-N 120.358 1.436 . . . . 0.0 112.28 -179.057 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -60.08 -27.69 67.2 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 125.144 1.378 . . . . 0.0 110.543 170.82 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 57.1 mtt -58.05 -26.13 62.1 Favored 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 123.376 0.67 . . . . 0.0 111.62 176.832 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 59.6 mt-10 -67.22 -33.71 75.94 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 118.323 0.511 . . . . 0.0 110.391 -175.466 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 19.0 mt-30 -65.23 -43.9 89.95 Favored 'General case' 0 N--CA 1.464 0.257 0 C-N-CA 123.666 0.787 . . . . 0.0 112.396 -169.908 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 18.5 m-85 -72.89 140.05 47.27 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 123.705 0.802 . . . . 0.0 110.176 -166.869 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -74.7 -37.52 62.6 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 118.481 0.582 . . . . 0.0 110.022 -178.297 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 13.5 t -105.34 145.53 13.46 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.328 0 N-CA-C 107.498 -1.297 . . . . 0.0 107.498 170.117 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 32.9 tp -134.19 106.1 6.99 Favored 'General case' 0 N--CA 1.447 -0.611 0 N-CA-C 108.601 -0.889 . . . . 0.0 108.601 175.418 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 24.8 mt -85.76 129.62 37.74 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 N-CA-C 106.638 -1.616 . . . . 0.0 106.638 177.557 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 1.4 mp -104.13 130.79 51.87 Favored 'General case' 0 N--CA 1.467 0.417 0 N-CA-C 105.953 -1.869 . . . . 0.0 105.953 177.207 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -131.17 119.22 2.59 Favored Glycine 0 CA--C 1.505 -0.576 0 N-CA-C 108.635 -1.786 . . . . 0.0 108.635 -176.945 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 1.6 tt -144.07 120.97 6.51 Favored Pre-proline 0 CA--C 1.531 0.238 0 CA-C-N 118.235 1.018 . . . . 0.0 108.706 179.517 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 76.9 Cg_exo -56.58 -40.21 85.99 Favored 'Trans proline' 0 N--CA 1.459 -0.535 0 C-N-CA 122.499 2.133 . . . . 0.0 114.286 -178.502 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 88.9 m 67.21 136.09 0.03 OUTLIER 'General case' 0 CA--C 1.55 0.965 0 C-N-CA 126.495 1.918 . . . . 0.0 110.165 -167.254 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 22.5 t90 -158.01 128.78 6.38 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 124.455 1.102 . . . . 0.0 108.153 -169.651 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -76.41 142.07 41.22 Favored 'General case' 0 C--O 1.236 0.358 0 C-N-CA 123.343 0.657 . . . . 0.0 110.528 177.63 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 30.0 t80 52.6 49.06 21.2 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 125.24 1.416 . . . . 0.0 111.298 178.817 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 178.89 -37.12 0.08 OUTLIER Glycine 0 CA--C 1.532 1.097 0 CA-C-N 115.669 -0.696 . . . . 0.0 111.381 -179.277 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . 0.299 10.7 pt-20 50.53 -156.56 0.11 Allowed 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 126.949 2.099 . . . . 0.0 113.818 169.913 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 20.8 mt -44.05 120.75 0.47 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.654 0 C-N-CA 127.374 2.27 . . . . 0.0 109.768 177.268 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 2.0 pm0 -67.56 151.93 46.5 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 123.585 0.754 . . . . 0.0 110.913 177.197 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -49.2 -51.23 34.2 Favored 'General case' 0 N--CA 1.463 0.205 0 C-N-CA 125.843 1.657 . . . . 0.0 112.669 -168.894 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -68.65 -17.11 64.03 Favored 'General case' 0 N--CA 1.473 0.712 0 CA-C-N 119.019 0.827 . . . . 0.0 112.043 -170.413 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' TRP . . . . . 0.505 ' CZ3' ' CE3' ' A' ' 69' ' ' TRP . 0.0 OUTLIER -88.69 -47.1 8.5 Favored 'General case' 0 CA--C 1.538 0.51 0 N-CA-C 107.449 -1.315 . . . . 0.0 107.449 178.071 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 12.0 tt0 -63.6 -33.46 75.65 Favored 'General case' 0 N--CA 1.449 -0.519 0 O-C-N 120.598 -1.314 . . . . 0.0 110.542 178.804 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -54.75 -25.15 25.91 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 125.085 1.354 . . . . 0.0 112.45 -177.763 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 29.6 m -114.28 -13.85 11.14 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.209 0 CA-C-O 117.204 -1.379 . . . . 0.0 112.918 177.356 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' TRP . . . . . 0.505 ' CE3' ' CZ3' ' A' ' 65' ' ' TRP . 2.6 t-105 -51.13 -39.55 56.51 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 120.136 1.334 . . . . 0.0 111.071 -173.644 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -68.57 -23.65 64.52 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 125.11 1.364 . . . . 0.0 113.2 -179.885 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 18.7 mt-30 -89.51 -23.41 22.06 Favored 'General case' 0 C--N 1.341 0.211 0 C-N-CA 125.311 1.444 . . . . 0.0 112.363 178.613 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 40.3 mt -65.72 -24.61 67.01 Favored 'General case' 0 N--CA 1.469 0.485 0 O-C-N 121.874 -0.516 . . . . 0.0 112.065 -169.968 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -70.06 -21.29 63.18 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 118.087 0.403 . . . . 0.0 111.74 175.78 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -75.1 -23.6 57.97 Favored 'General case' 0 CA--C 1.538 0.505 0 O-C-N 121.139 -0.976 . . . . 0.0 112.635 -178.722 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 53.6 mt -66.16 150.17 49.18 Favored 'General case' 0 C--O 1.231 0.12 0 C-N-CA 124.869 1.268 . . . . 0.0 112.003 -169.594 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 3.7 t30 -82.24 105.79 13.61 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 124.551 1.14 . . . . 0.0 108.204 172.488 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 65.6 mt -124.0 1.29 8.61 Favored 'General case' 0 N--CA 1.472 0.63 0 N-CA-C 113.764 1.024 . . . . 0.0 113.764 -172.491 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 27.2 mt-10 -56.9 130.98 48.21 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-O 121.913 0.863 . . . . 0.0 111.318 -169.747 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 74.04 -2.73 41.46 Favored Glycine 0 CA--C 1.534 1.249 0 C-N-CA 125.401 1.477 . . . . 0.0 114.955 176.951 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.66 148.7 40.4 Favored 'General case' 0 C--N 1.345 0.403 0 CA-C-N 120.346 2.073 . . . . 0.0 109.347 -176.399 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 5.3 mt -81.26 139.79 17.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 N-CA-C 106.711 -1.589 . . . . 0.0 106.711 179.542 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 38.4 t -133.55 139.16 49.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 C-N-CA 124.459 1.103 . . . . 0.0 110.491 -175.897 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -115.37 162.25 17.39 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 123.971 0.908 . . . . 0.0 109.043 169.466 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 6.2 mt -141.61 136.8 31.37 Favored 'General case' 0 N--CA 1.465 0.277 0 N-CA-C 106.867 -1.531 . . . . 0.0 106.867 178.702 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 40.4 p90 -153.64 155.52 36.2 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-N 120.614 1.552 . . . . 0.0 109.116 174.913 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -175.9 -167.33 34.65 Favored Glycine 0 N--CA 1.445 -0.719 0 N-CA-C 108.514 -1.834 . . . . 0.0 108.514 170.656 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -116.09 152.46 33.59 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 122.443 1.116 . . . . 0.0 111.139 176.025 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -131.69 -171.53 12.86 Favored Glycine 0 N--CA 1.445 -0.758 0 N-CA-C 107.589 -2.205 . . . . 0.0 107.589 168.707 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 3.0 t0 -151.19 115.04 4.95 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 105.954 -1.869 . . . . 0.0 105.954 172.405 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -68.25 -7.69 32.73 Favored 'General case' 0 CA--C 1.547 0.853 0 N-CA-C 112.76 0.652 . . . . 0.0 112.76 -175.479 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 66.3 mt -88.82 -65.11 1.05 Allowed 'General case' 0 C--N 1.341 0.201 0 C-N-CA 124.745 1.218 . . . . 0.0 109.461 -179.053 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -94.06 -39.36 4.88 Favored Glycine 0 CA--C 1.527 0.83 0 C-N-CA 124.583 1.087 . . . . 0.0 112.911 -174.235 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 7.6 m-85 -87.28 50.64 2.05 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 118.392 1.096 . . . . 0.0 109.308 -174.773 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -73.12 -41.29 48.0 Favored Glycine 0 CA--C 1.525 0.713 0 O-C-N 120.756 -1.215 . . . . 0.0 110.936 -178.246 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -90.68 -9.28 47.4 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.431 1.093 . . . . 0.0 111.423 174.519 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' TRP . . . . . . . . . . . . . 6.7 m0 -115.49 -5.74 12.25 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 124.199 0.999 . . . . 0.0 112.815 -169.766 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 5.8 t80 -49.11 120.2 3.8 Favored 'General case' 0 C--N 1.343 0.294 0 C-N-CA 124.378 1.071 . . . . 0.0 109.582 -175.7 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 96.6 mt 51.64 23.39 1.92 Allowed 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 114.453 1.279 . . . . 0.0 114.453 170.549 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -57.71 -39.47 77.3 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 119.765 1.166 . . . . 0.0 113.108 -167.601 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -73.35 -19.42 61.01 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-O 118.262 -0.875 . . . . 0.0 112.666 -178.905 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 8.5 mp -65.69 -38.75 90.1 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-N 120.151 1.341 . . . . 0.0 108.45 170.248 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -63.37 -36.89 94.0 Favored Glycine 0 C--N 1.339 0.712 0 N-CA-C 111.218 -0.753 . . . . 0.0 111.218 -179.008 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 77.8 mtm -67.33 -47.82 69.37 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-O 118.077 -0.963 . . . . 0.0 111.006 179.85 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -70.57 -33.4 71.06 Favored 'General case' 0 C--N 1.348 0.535 0 CA-C-N 121.042 1.746 . . . . 0.0 110.995 178.217 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 68.2 t60 -54.51 -51.76 64.11 Favored 'General case' 0 CA--C 1.529 0.14 0 CA-C-N 118.821 0.737 . . . . 0.0 110.164 171.894 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -62.99 -40.02 96.48 Favored 'General case' 0 C--O 1.236 0.379 0 C-N-CA 123.771 0.829 . . . . 0.0 112.094 -176.098 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 24.1 ttmm -54.9 -39.68 69.01 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 123.327 0.651 . . . . 0.0 110.146 171.508 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 35.2 mt -90.96 -19.52 23.17 Favored 'General case' 0 CA--C 1.518 -0.287 0 N-CA-C 115.48 1.659 . . . . 0.0 115.48 -168.566 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 4.5 m -58.81 -36.47 74.54 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 120.86 1.664 . . . . 0.0 111.353 -177.664 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 19.9 p -84.0 -15.45 47.63 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 124.81 1.244 . . . . 0.0 111.66 179.942 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 31.7 mmmt -81.56 -9.97 59.56 Favored 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 124.542 1.137 . . . . 0.0 110.998 172.109 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 73.21 35.42 57.05 Favored Glycine 0 CA--C 1.523 0.569 0 CA-C-O 119.541 -0.589 . . . . 0.0 112.404 169.497 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 5.9 m -74.9 173.9 0.89 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.56 0 CA-C-N 118.122 0.961 . . . . 0.0 109.536 171.252 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -115.23 117.22 29.88 Favored 'General case' 0 CA--C 1.52 -0.211 0 N-CA-C 106.911 -1.515 . . . . 0.0 106.911 175.367 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 87.9 m-85 -85.71 143.15 28.53 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 119.56 1.073 . . . . 0.0 110.022 -175.312 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 32.9 m -133.47 160.7 42.14 Favored 'Isoleucine or valine' 0 C--O 1.235 0.307 0 C-N-CA 125.712 1.605 . . . . 0.0 108.052 169.748 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 86.8 26.95 30.5 Favored Glycine 0 C--N 1.332 0.339 0 CA-C-O 118.327 -1.263 . . . . 0.0 114.097 173.458 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 18.9 m-30 -60.85 159.87 10.5 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-N 119.165 1.482 . . . . 0.0 110.082 169.711 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 1.5 m95 -125.66 143.71 45.88 Favored Pre-proline 0 N--CA 1.469 0.501 0 CA-C-O 118.362 -0.828 . . . . 0.0 109.359 169.722 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -64.05 127.72 20.07 Favored 'Trans proline' 0 N--CA 1.452 -0.954 0 C-N-CA 123.335 2.69 . . . . 0.0 109.845 173.493 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 31.5 p -79.42 -4.05 49.32 Favored 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 113.449 0.907 . . . . 0.0 113.449 175.456 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -60.45 120.07 9.23 Favored 'General case' 0 CA--C 1.535 0.395 0 O-C-N 121.28 -0.888 . . . . 0.0 110.464 -169.124 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 80.89 3.38 90.55 Favored Glycine 0 CA--C 1.535 1.314 0 CA-C-O 118.746 -1.03 . . . . 0.0 114.691 176.734 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 18.5 m-85 -77.02 147.26 36.88 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-N 119.33 1.565 . . . . 0.0 109.695 176.904 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -99.35 106.19 18.25 Favored 'General case' 0 CA--C 1.528 0.127 0 N-CA-C 107.515 -1.291 . . . . 0.0 107.515 171.913 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 20.4 p90 -159.75 167.18 28.88 Favored 'General case' 0 C--O 1.239 0.54 0 C-N-CA 127.254 2.221 . . . . 0.0 106.131 176.001 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 1.9 t -140.04 -14.41 1.04 Allowed 'General case' 0 CA--C 1.537 0.462 0 N-CA-C 112.856 0.688 . . . . 0.0 112.856 179.689 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 2.9 p -72.79 137.52 79.96 Favored Pre-proline 0 CA--C 1.543 0.678 0 O-C-N 121.351 -0.843 . . . . 0.0 110.715 -176.742 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -83.22 -27.8 1.73 Allowed 'Trans proline' 0 CA--C 1.539 0.733 0 C-N-CA 122.406 2.071 . . . . 0.0 112.456 177.377 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 20.5 ttmt -53.92 -44.42 98.17 Favored Pre-proline 0 CA--C 1.544 0.719 0 CA-C-O 117.429 -1.272 . . . . 0.0 114.083 -176.376 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -73.07 -3.66 14.04 Favored 'Trans proline' 0 C--N 1.352 0.719 0 CA-C-N 121.939 1.728 . . . . 0.0 114.447 -178.444 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 19.7 m -129.93 166.84 26.52 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 CA-C-N 119.989 1.268 . . . . 0.0 111.924 -169.588 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 10.3 pt -138.02 174.56 10.56 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.331 0 C-N-CA 127.554 2.342 . . . . 0.0 108.73 -177.088 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . 54.96 43.88 29.17 Favored 'General case' 0 N--CA 1.465 0.284 0 C-N-CA 125.351 1.46 . . . . 0.0 112.051 175.184 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 27.4 t0 54.55 43.18 30.67 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 126.046 1.738 . . . . 0.0 111.46 -175.756 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 89.95 16.06 56.78 Favored Glycine 0 CA--C 1.526 0.723 0 CA-C-O 118.356 -1.247 . . . . 0.0 114.481 171.207 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 47.6 mt-30 -88.08 -16.84 32.47 Favored 'General case' 0 CA--C 1.536 0.404 0 CA-C-N 119.366 1.583 . . . . 0.0 113.691 -175.569 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -143.45 142.86 31.36 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 119.541 1.064 . . . . 0.0 110.661 177.234 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 74.2 m-85 -75.25 141.59 43.47 Favored 'General case' 0 CA--C 1.519 -0.233 0 N-CA-C 105.095 -2.187 . . . . 0.0 105.095 164.642 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 33.5 m -69.98 -0.1 1.38 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.567 0 N-CA-C 113.011 0.745 . . . . 0.0 113.011 -178.099 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -170.13 -170.82 34.96 Favored Glycine 0 N--CA 1.447 -0.618 0 N-CA-C 109.972 -1.251 . . . . 0.0 109.972 -172.607 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . 0.463 ' HG ' ' CG ' ' A' ' 160' ' ' TRP . 1.2 tt -60.05 139.31 57.55 Favored 'General case' 0 N--CA 1.462 0.156 0 C-N-CA 124.424 1.089 . . . . 0.0 110.548 -179.815 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -105.78 96.03 6.21 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 124.553 1.141 . . . . 0.0 108.422 168.794 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 78.2 mt -89.59 147.13 24.1 Favored 'General case' 0 CA--C 1.535 0.397 0 N-CA-C 105.621 -1.992 . . . . 0.0 105.621 168.582 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 29.3 t0 -149.02 102.39 3.25 Favored 'General case' 0 N--CA 1.464 0.266 0 N-CA-C 107.489 -1.301 . . . . 0.0 107.489 176.059 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -82.92 -30.55 28.34 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.536 -178.354 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 86.4 m -61.57 -42.3 98.64 Favored 'General case' 0 C--O 1.235 0.303 0 C-N-CA 123.288 0.635 . . . . 0.0 110.542 -173.909 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 7.2 m-80 -93.66 -27.67 16.42 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-O 119.117 -0.468 . . . . 0.0 112.161 -169.965 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 14.6 pt20 -155.02 57.15 0.66 Allowed 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 123.211 0.604 . . . . 0.0 110.978 -168.628 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 41.9 p90 -53.45 -29.93 38.13 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 124.688 1.195 . . . . 0.0 113.028 -177.108 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -66.9 -24.32 66.09 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 118.597 0.635 . . . . 0.0 112.175 -179.075 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 74.6 mt -92.22 4.59 52.94 Favored 'General case' 0 C--N 1.341 0.217 0 C-N-CA 124.138 0.975 . . . . 0.0 113.143 -172.942 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 31.0 p -59.32 -47.54 85.02 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 120.14 1.336 . . . . 0.0 110.347 -175.122 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -58.22 -40.34 81.4 Favored 'General case' 0 N--CA 1.462 0.173 0 C-N-CA 123.921 0.889 . . . . 0.0 111.064 178.345 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 3.5 tp10 -69.67 -47.36 63.56 Favored 'General case' 0 CA--C 1.529 0.16 0 C-N-CA 124.485 1.114 . . . . 0.0 110.911 -177.485 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 69.9 mtp85 -66.71 -27.39 67.6 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 117.894 -1.051 . . . . 0.0 110.424 179.859 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 25.1 mt -73.14 -53.29 18.84 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.601 0 CA-C-N 119.908 1.231 . . . . 0.0 107.762 168.364 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 70.8 tp60 -50.14 -64.14 0.9 Allowed 'General case' 0 N--CA 1.464 0.259 0 C-N-CA 126.031 1.732 . . . . 0.0 112.14 -175.419 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 25.3 m -66.11 -32.75 74.39 Favored 'General case' 0 C--N 1.327 -0.392 0 O-C-N 123.036 0.21 . . . . 0.0 110.803 -171.01 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 160' ' ' TRP . . . . . 0.463 ' CG ' ' HG ' ' A' ' 142' ' ' LEU . 88.2 t90 -66.41 -46.84 75.22 Favored 'General case' 0 C--O 1.222 -0.349 0 O-C-N 121.958 -0.464 . . . . 0.0 110.836 174.592 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 67.2 m -59.56 -44.42 93.29 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 123.266 0.626 . . . . 0.0 110.501 178.816 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -61.05 -42.95 99.44 Favored 'General case' 0 N--CA 1.457 -0.085 0 CA-C-O 121.021 0.439 . . . . 0.0 110.199 175.723 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 14.4 tt0 -63.71 -52.1 62.07 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-O 117.791 -1.1 . . . . 0.0 109.73 -177.508 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 40.4 pt -63.02 -34.11 64.61 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.519 0 CA-C-N 119.439 1.018 . . . . 0.0 110.077 -176.57 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -70.16 -34.95 73.66 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 119.382 0.992 . . . . 0.0 108.519 -175.2 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -70.72 -46.27 63.36 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 123.707 0.803 . . . . 0.0 109.993 174.273 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 24.8 tt0 -77.91 -14.09 59.66 Favored 'General case' 0 N--CA 1.437 -1.104 0 C-N-CA 124.9 1.28 . . . . 0.0 110.359 -169.629 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 168' ' ' MET . . . . . . . . . . . . . 18.9 ptp -92.17 -38.9 11.87 Favored 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 122.751 0.42 . . . . 0.0 111.547 169.754 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -75.81 -27.82 58.09 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-O 119.327 -0.368 . . . . 0.0 111.914 -173.447 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -57.02 -27.68 61.83 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 123.655 0.782 . . . . 0.0 112.398 -177.084 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 60.3 m-70 -72.98 -23.64 60.67 Favored 'General case' 0 C--O 1.235 0.339 0 C-N-CA 124.696 1.198 . . . . 0.0 112.036 179.145 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 22.8 m-30 -112.48 -16.33 12.9 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 126.407 1.883 . . . . 0.0 112.402 -172.184 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.285 0 C-N-CA 124.779 1.232 . . . . 0.0 110.123 175.071 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.499 2.015 0 CA-C-O 119.403 -0.332 . . . . 0.0 111.11 . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 11.3 t30 -127.29 151.1 49.18 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-N 119.167 0.894 . . . . 0.0 110.523 -177.815 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 17.5 mtt -117.4 130.41 56.47 Favored 'General case' 0 N--CA 1.461 0.11 0 C-N-CA 124.228 1.011 . . . . 0.0 110.958 -177.873 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -86.88 154.76 27.04 Favored Glycine 0 CA--C 1.522 0.51 0 N-CA-C 107.77 -2.132 . . . . 0.0 107.77 166.541 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 3.0 tt -141.24 99.49 3.59 Favored 'General case' 0 N--CA 1.464 0.244 0 N-CA-C 105.612 -1.995 . . . . 0.0 105.612 -176.456 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 1.2 p90 -106.18 138.43 42.38 Favored 'General case' 0 CA--C 1.521 -0.162 0 CA-C-N 118.017 0.372 . . . . 0.0 111.707 -169.54 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 19.5 p90 -161.03 160.57 30.73 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 125.693 1.597 . . . . 0.0 108.736 -174.053 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -95.06 163.36 24.31 Favored Glycine 0 CA--C 1.53 1.029 0 N-CA-C 110.029 -1.228 . . . . 0.0 110.029 170.136 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 1.5 m -85.06 -30.84 23.76 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 117.766 0.783 . . . . 0.0 112.778 -169.833 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -88.89 165.03 14.89 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.748 1.219 . . . . 0.0 111.607 -171.87 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 23.2 m 66.98 115.45 0.03 OUTLIER 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 126.988 2.115 . . . . 0.0 112.727 179.426 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 42.6 m 51.46 33.78 10.93 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 125.799 1.639 . . . . 0.0 113.513 172.226 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 78.1 m-85 57.67 -64.25 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 128.216 2.606 . . . . 0.0 115.678 -174.794 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 21.3 m 63.15 -23.27 0.06 Allowed 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 127.019 2.128 . . . . 0.0 113.003 -167.957 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -55.59 -38.71 69.77 Favored 'General case' 0 CA--C 1.534 0.333 0 O-C-N 120.565 -1.335 . . . . 0.0 111.478 174.722 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -63.86 -42.24 97.58 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 118.809 0.731 . . . . 0.0 109.454 179.754 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -63.98 -47.02 81.99 Favored 'General case' 0 N--CA 1.463 0.194 0 N-CA-C 109.238 -0.653 . . . . 0.0 109.238 177.734 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -62.46 -47.71 82.83 Favored 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 123.049 0.539 . . . . 0.0 111.45 -176.481 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 33.8 mt-10 -61.73 -42.38 98.88 Favored 'General case' 0 C--O 1.232 0.178 0 C-N-CA 123.415 0.686 . . . . 0.0 110.14 176.377 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 28.7 mtpp -70.98 -39.63 72.38 Favored 'General case' 0 C--O 1.221 -0.434 0 CA-C-O 118.199 -0.905 . . . . 0.0 110.32 -175.885 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 43.7 mt -53.8 -56.04 10.92 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.285 0 CA-C-N 119.805 1.184 . . . . 0.0 109.266 175.781 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.71 -35.44 80.74 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 118.406 0.548 . . . . 0.0 111.404 -175.82 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -64.31 -41.06 97.02 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.819 0.342 . . . . 0.0 110.944 177.996 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 56.4 mt -76.13 -54.08 14.24 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.47 0 C-N-CA 124.548 1.139 . . . . 0.0 109.84 -172.557 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 65.2 mt -62.63 -47.56 92.33 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.328 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 179.611 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 142.49 121.47 1.66 Allowed Glycine 0 CA--C 1.528 0.847 0 C-N-CA 124.826 1.203 . . . . 0.0 110.526 177.063 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -70.96 -12.72 31.01 Favored 'Trans proline' 0 CA--C 1.537 0.669 0 C-N-CA 122.784 2.323 . . . . 0.0 113.495 -171.027 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -77.17 -18.52 57.74 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 118.904 0.774 . . . . 0.0 111.729 179.802 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -128.71 9.1 5.88 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 124.604 1.162 . . . . 0.0 113.582 -170.639 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 31.4 t -127.93 148.07 32.55 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 N-CA-C 107.511 -1.292 . . . . 0.0 107.511 173.242 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 25.3 m -132.22 131.06 41.77 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 125.574 1.55 . . . . 0.0 108.164 -175.34 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 26.4 mt -77.73 131.46 37.68 Favored 'General case' 0 CA--C 1.521 -0.168 0 N-CA-C 108.107 -1.072 . . . . 0.0 108.107 176.104 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 22.5 t-80 -129.27 52.82 1.93 Allowed 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 124.748 1.219 . . . . 0.0 108.19 -175.552 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 18.7 t-20 -55.12 128.94 36.14 Favored 'General case' 0 CA--C 1.531 0.241 0 N-CA-C 107.834 -1.173 . . . . 0.0 107.834 171.086 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 39.0 mt -75.44 -16.17 60.36 Favored 'General case' 0 C--O 1.234 0.244 0 N-CA-C 114.021 1.119 . . . . 0.0 114.021 -169.009 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 9.0 tptm -77.47 -26.44 51.39 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 118.951 0.796 . . . . 0.0 110.154 169.614 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -88.13 -35.91 17.17 Favored 'General case' 0 C--O 1.236 0.375 0 C-N-CA 124.155 0.982 . . . . 0.0 112.783 -174.067 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 2.5 t0 -142.76 155.22 44.81 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 118.653 0.661 . . . . 0.0 112.673 178.151 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 19.1 m -75.35 158.34 83.79 Favored Pre-proline 0 CA--C 1.544 0.716 0 C-N-CA 125.998 1.719 . . . . 0.0 111.298 -170.525 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_endo -74.43 -25.75 12.79 Favored 'Trans proline' 0 C--N 1.349 0.594 0 C-N-CA 122.245 1.963 . . . . 0.0 113.231 -170.6 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 22.6 mmmt -71.19 -11.34 60.88 Favored 'General case' 0 CA--C 1.54 0.561 0 O-C-N 120.45 -1.406 . . . . 0.0 111.703 -176.368 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -61.85 -28.68 69.66 Favored 'General case' 0 N--CA 1.465 0.282 0 C-N-CA 125.159 1.384 . . . . 0.0 110.265 169.167 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 45.4 mtt -57.48 -27.3 62.39 Favored 'General case' 0 N--CA 1.464 0.275 0 C-N-CA 123.12 0.568 . . . . 0.0 111.865 177.146 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 84.7 mt-10 -66.17 -32.22 73.52 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 118.118 0.417 . . . . 0.0 110.357 -175.621 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 20.8 mt-30 -66.99 -41.63 86.44 Favored 'General case' 0 N--CA 1.464 0.243 0 C-N-CA 123.804 0.841 . . . . 0.0 112.714 -171.22 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 15.7 m-85 -72.2 147.05 46.93 Favored 'General case' 0 CA--C 1.522 -0.108 0 C-N-CA 123.5 0.72 . . . . 0.0 110.667 -166.139 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -75.98 -34.47 59.77 Favored 'General case' 0 N--CA 1.467 0.422 0 O-C-N 121.832 -0.542 . . . . 0.0 110.297 176.045 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 6.4 t -113.4 146.76 17.6 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.19 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 172.668 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 48.5 tp -132.24 113.81 13.69 Favored 'General case' 0 N--CA 1.451 -0.424 0 C-N-CA 123.625 0.77 . . . . 0.0 109.06 171.726 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 23.0 mt -89.84 130.33 39.3 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 N-CA-C 106.361 -1.718 . . . . 0.0 106.361 174.982 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -106.01 131.87 52.78 Favored 'General case' 0 C--O 1.232 0.183 0 C-N-CA 125.201 1.4 . . . . 0.0 107.929 172.675 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -127.46 139.03 10.87 Favored Glycine 0 CA--C 1.524 0.647 0 C-N-CA 124.892 1.234 . . . . 0.0 110.283 169.997 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 6.2 tt -145.47 129.65 8.75 Favored Pre-proline 0 CA--C 1.538 0.511 0 CA-C-N 118.763 1.282 . . . . 0.0 110.584 170.883 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -81.93 84.74 1.82 Allowed 'Trans proline' 0 N--CA 1.456 -0.694 0 C-N-CA 123.099 2.533 . . . . 0.0 110.247 169.748 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 93.1 m -58.33 -39.23 78.9 Favored 'General case' 0 CA--C 1.542 0.665 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 168.198 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 23.4 t90 48.99 -142.59 0.54 Allowed 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 125.75 1.62 . . . . 0.0 109.185 -170.763 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -74.78 -62.58 1.49 Allowed 'General case' 0 C--N 1.332 -0.159 0 C-N-CA 123.725 0.81 . . . . 0.0 109.79 175.68 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 20.3 t80 -140.1 31.84 1.96 Allowed 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 124.106 0.962 . . . . 0.0 109.967 178.771 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -67.7 -40.5 90.12 Favored Glycine 0 CA--C 1.53 1.017 0 N-CA-C 109.036 -1.626 . . . . 0.0 109.036 169.715 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.405 ' HG2' ' H ' ' A' ' 61' ' ' ILE . 9.8 tt0 54.73 -144.09 0.7 Allowed 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 124.189 0.996 . . . . 0.0 109.253 -178.357 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.405 ' H ' ' HG2' ' A' ' 60' ' ' GLU . 0.9 OUTLIER -83.19 133.98 27.91 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.685 0 C-N-CA 126.663 1.985 . . . . 0.0 108.999 -178.41 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 3.0 mp0 -88.88 156.95 18.61 Favored 'General case' 0 C--O 1.231 0.104 0 C-N-CA 124.622 1.169 . . . . 0.0 108.167 179.446 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -57.41 -40.28 77.94 Favored 'General case' 0 N--CA 1.464 0.249 0 C-N-CA 123.318 0.647 . . . . 0.0 110.45 -179.096 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 80.2 m-20 -58.1 -30.84 66.58 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 124.331 1.053 . . . . 0.0 110.96 -178.439 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 1.9 t90 -95.87 -45.29 7.02 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 125.889 1.675 . . . . 0.0 108.297 -170.117 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 24.5 tt0 -63.51 -35.73 81.42 Favored 'General case' 0 N--CA 1.439 -1.011 0 C-N-CA 124.633 1.173 . . . . 0.0 110.347 178.451 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -57.83 -24.16 56.1 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 123.874 0.87 . . . . 0.0 111.759 -178.562 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 34.8 m -116.55 -12.13 11.62 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.345 0 CA-C-O 117.351 -1.309 . . . . 0.0 112.342 177.761 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 26.8 t90 -52.11 -38.71 58.26 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 120.234 1.379 . . . . 0.0 110.568 -176.387 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -65.35 -26.16 67.91 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 125.511 1.524 . . . . 0.0 113.284 177.255 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 25.7 mt-30 -92.58 -19.85 21.51 Favored 'General case' 0 C--N 1.34 0.165 0 C-N-CA 126.086 1.754 . . . . 0.0 112.538 176.836 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 72.6 mt -61.78 -24.14 66.65 Favored 'General case' 0 CA--C 1.532 0.274 0 O-C-N 121.679 -0.638 . . . . 0.0 111.289 -176.31 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -77.31 -27.67 52.99 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 118.074 0.397 . . . . 0.0 111.475 175.738 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -70.29 -33.09 71.14 Favored 'General case' 0 N--CA 1.467 0.379 0 O-C-N 121.424 -0.797 . . . . 0.0 111.381 178.823 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 83.2 mt -50.6 135.61 22.71 Favored 'General case' 0 C--N 1.341 0.2 0 C-N-CA 124.72 1.208 . . . . 0.0 111.935 -170.142 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 4.9 t-20 -74.64 105.39 5.71 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 107.308 -1.368 . . . . 0.0 107.308 168.356 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.435 ' HA ' ' HE2' ' A' ' 80' ' ' LYS . 59.6 mt -123.83 2.13 8.77 Favored 'General case' 0 N--CA 1.467 0.38 0 C-N-CA 124.691 1.196 . . . . 0.0 111.163 -179.622 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 29.6 mp0 -57.24 128.12 35.39 Favored 'General case' 0 N--CA 1.445 -0.681 0 CA-C-O 122.062 0.934 . . . . 0.0 112.287 -166.984 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 70.57 -0.04 28.92 Favored Glycine 0 CA--C 1.537 1.448 0 CA-C-N 113.792 -1.549 . . . . 0.0 115.411 -177.938 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.435 ' HE2' ' HA ' ' A' ' 77' ' ' LEU . 0.0 OUTLIER -77.87 160.01 28.56 Favored 'General case' 0 C--N 1.346 0.426 0 CA-C-N 120.892 2.346 . . . . 0.0 110.277 -175.381 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 1.9 mt -85.91 141.28 14.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 N-CA-C 106.729 -1.582 . . . . 0.0 106.729 178.215 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 94.2 t -138.42 146.63 26.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 -176.822 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -124.17 145.21 49.45 Favored 'General case' 0 CA--C 1.513 -0.456 0 N-CA-C 104.991 -2.225 . . . . 0.0 104.991 175.444 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 4.9 mp -126.83 141.74 51.74 Favored 'General case' 0 CA--C 1.501 -0.905 0 N-CA-C 107.655 -1.239 . . . . 0.0 107.655 175.007 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 34.4 p90 -153.13 168.71 25.02 Favored 'General case' 0 N--CA 1.441 -0.924 0 N-CA-C 107.236 -1.394 . . . . 0.0 107.236 167.836 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -162.69 171.53 38.53 Favored Glycine 0 N--CA 1.44 -1.042 0 N-CA-C 109.278 -1.529 . . . . 0.0 109.278 169.88 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 6.1 tt -111.08 140.71 45.39 Favored 'General case' 0 N--CA 1.442 -0.845 0 N-CA-C 106.589 -1.634 . . . . 0.0 106.589 173.764 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -136.59 -169.97 11.84 Favored Glycine 0 CA--C 1.526 0.723 0 C-N-CA 125.471 1.51 . . . . 0.0 110.043 -173.98 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 46.0 t0 -148.29 113.61 5.58 Favored 'General case' 0 C--O 1.234 0.252 0 N-CA-C 107.548 -1.278 . . . . 0.0 107.548 169.615 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 5.9 pt20 -82.02 -5.88 58.71 Favored 'General case' 0 CA--C 1.545 0.768 0 N-CA-C 113.726 1.01 . . . . 0.0 113.726 -176.242 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 2.8 tp -114.46 -36.78 4.5 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 126.824 2.05 . . . . 0.0 110.401 -169.699 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -55.85 -40.18 80.05 Favored Glycine 0 CA--C 1.534 1.256 0 C-N-CA 124.027 0.822 . . . . 0.0 112.137 179.43 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 20.6 t80 -155.1 -31.7 0.1 Allowed 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 117.758 0.779 . . . . 0.0 112.001 171.986 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 85.31 -54.26 4.84 Favored Glycine 0 C--N 1.338 0.655 0 C-N-CA 124.124 0.869 . . . . 0.0 110.945 174.183 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 17.5 mt-10 -60.04 -16.88 34.99 Favored 'General case' 0 CA--C 1.542 0.666 0 CA-C-N 118.399 1.1 . . . . 0.0 113.244 -178.578 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' TRP . . . . . . . . . . . . . 33.9 m0 -102.17 9.92 39.78 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 123.97 0.908 . . . . 0.0 112.544 -178.833 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 22.5 t80 -58.56 128.38 36.87 Favored 'General case' 0 C--N 1.343 0.318 0 CA-C-N 119.155 0.888 . . . . 0.0 109.507 -174.514 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 91.1 mt 52.38 25.73 3.67 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 124.201 1.0 . . . . 0.0 113.567 170.129 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -51.31 -48.22 62.38 Favored 'General case' 0 C--O 1.234 0.28 0 C-N-CA 125.284 1.434 . . . . 0.0 110.749 177.796 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -72.14 -23.97 61.39 Favored 'General case' 0 CA--C 1.539 0.554 0 O-C-N 121.616 -0.678 . . . . 0.0 112.576 -178.543 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 4.8 tt -65.81 -48.06 72.98 Favored 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 171.352 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -61.18 -33.31 83.8 Favored Glycine 0 CA--C 1.527 0.806 0 N-CA-C 111.164 -0.775 . . . . 0.0 111.164 -179.674 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 4.5 tpp -53.76 -52.05 61.44 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 124.647 1.179 . . . . 0.0 111.225 172.885 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -72.83 -33.19 66.02 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-O 118.425 -0.798 . . . . 0.0 110.758 -177.894 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 49.0 t60 -58.69 -50.96 71.97 Favored 'General case' 0 C--O 1.226 -0.161 0 CA-C-N 118.718 0.69 . . . . 0.0 110.604 174.696 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -62.13 -41.88 98.7 Favored 'General case' 0 C--O 1.234 0.258 0 C-N-CA 123.354 0.662 . . . . 0.0 111.585 -176.966 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 23.4 ttmm -59.57 -39.4 83.98 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 123.145 0.578 . . . . 0.0 110.098 173.128 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 16.5 mt -82.53 -25.33 33.49 Favored 'General case' 0 N--CA 1.455 -0.179 0 CA-C-O 117.584 -1.198 . . . . 0.0 113.71 -170.097 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 18.2 m -58.58 -36.73 74.43 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 120.503 1.501 . . . . 0.0 111.722 -175.785 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 21.1 p -82.15 -8.29 59.65 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 124.251 1.021 . . . . 0.0 111.719 -178.416 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 29.6 mmmt -84.03 -3.27 57.91 Favored 'General case' 0 C--N 1.343 0.284 0 C-N-CA 124.985 1.314 . . . . 0.0 111.365 173.786 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 67.53 33.35 81.12 Favored Glycine 0 CA--C 1.527 0.8 0 CA-C-N 118.698 0.681 . . . . 0.0 112.287 170.048 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 15.6 m -83.09 171.65 1.19 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 C-N-CA 123.593 0.757 . . . . 0.0 110.317 179.913 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 15.5 tptm -98.55 129.5 45.1 Favored 'General case' 0 CA--C 1.513 -0.47 0 N-CA-C 104.904 -2.258 . . . . 0.0 104.904 167.588 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 60.3 m-85 -94.84 124.31 38.81 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 171.457 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 35.3 m -107.26 157.77 7.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 C-N-CA 123.566 0.747 . . . . 0.0 109.257 168.531 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 101.12 -97.31 1.65 Allowed Glycine 0 N--CA 1.447 -0.616 0 C-N-CA 124.885 1.231 . . . . 0.0 111.505 174.16 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 11.3 m-30 61.06 172.89 0.1 Allowed 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 125.004 1.321 . . . . 0.0 110.104 -167.255 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 1.2 t90 -155.46 138.83 10.91 Favored Pre-proline 0 N--CA 1.469 0.485 0 CA-C-O 117.386 -1.292 . . . . 0.0 109.297 -177.029 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -71.72 121.67 7.87 Favored 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 123.413 2.742 . . . . 0.0 111.872 -174.49 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 37.5 p -67.35 -18.72 65.26 Favored 'General case' 0 N--CA 1.47 0.545 0 N-CA-C 114.334 1.235 . . . . 0.0 114.334 179.902 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -58.83 127.37 31.88 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 123.417 0.687 . . . . 0.0 110.92 -168.503 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 90.62 -8.22 80.13 Favored Glycine 0 CA--C 1.535 1.338 0 C-N-CA 125.382 1.468 . . . . 0.0 114.264 176.968 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 8.8 m-85 -90.71 167.89 12.17 Favored 'General case' 0 C--O 1.236 0.381 0 CA-C-N 119.194 1.497 . . . . 0.0 110.745 175.948 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -117.25 134.34 54.91 Favored 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 107.316 -1.365 . . . . 0.0 107.316 169.329 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 23.0 p90 -160.02 -31.72 0.06 Allowed 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 124.111 0.964 . . . . 0.0 112.103 -173.108 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 1.9 m 63.81 -61.04 0.17 Allowed 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 128.08 2.552 . . . . 0.0 116.566 168.132 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 70.4 m -69.04 150.85 97.45 Favored Pre-proline 0 CA--C 1.537 0.469 0 C-N-CA 125.574 1.549 . . . . 0.0 110.965 -177.23 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_endo -81.16 -23.7 5.09 Favored 'Trans proline' 0 C--N 1.35 0.641 0 C-N-CA 122.608 2.205 . . . . 0.0 113.061 -177.257 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 33.4 ttmt -50.53 -46.48 85.07 Favored Pre-proline 0 N--CA 1.475 0.791 0 CA-C-N 119.978 1.263 . . . . 0.0 114.142 -175.598 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -73.82 -1.5 10.89 Favored 'Trans proline' 0 C--N 1.35 0.607 0 C-N-CA 121.856 1.704 . . . . 0.0 114.591 -179.527 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 12.3 m -135.91 153.0 31.55 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 CA-C-N 121.563 1.983 . . . . 0.0 112.377 -168.503 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 11.8 pt -90.27 167.73 1.62 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.444 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 167.348 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . 57.9 -156.18 0.32 Allowed 'General case' 0 N--CA 1.447 -0.6 0 C-N-CA 124.934 1.294 . . . . 0.0 109.855 169.523 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 23.1 t0 -76.78 59.0 1.51 Allowed 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 125.065 1.346 . . . . 0.0 109.389 170.08 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 62.9 46.03 94.43 Favored Glycine 0 C--N 1.336 0.583 0 C-N-CA 124.826 1.203 . . . . 0.0 112.147 176.079 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 69.2 mm-40 -93.29 -44.44 8.31 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-N 118.208 1.004 . . . . 0.0 112.571 -169.809 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -134.18 142.83 47.56 Favored 'General case' 0 N--CA 1.47 0.556 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 179.883 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 44.9 m-85 -72.11 15.51 0.16 Allowed 'General case' 0 N--CA 1.479 1.007 0 N-CA-C 116.444 2.016 . . . . 0.0 116.444 179.775 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . 0.253 1.0 OUTLIER 52.82 8.61 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.549 0.932 0 C-N-CA 127.162 2.185 . . . . 0.0 113.577 -177.245 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 171.69 171.75 37.05 Favored Glycine 0 CA--C 1.528 0.906 0 C-N-CA 126.299 1.904 . . . . 0.0 108.968 -170.433 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -70.03 140.55 52.88 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 118.149 0.975 . . . . 0.0 111.642 -178.254 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -100.36 129.71 46.37 Favored 'General case' 0 N--CA 1.447 -0.587 0 C-N-CA 125.671 1.588 . . . . 0.0 109.995 176.912 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 81.3 mt -124.59 156.45 37.42 Favored 'General case' 0 CA--C 1.533 0.3 0 N-CA-C 106.576 -1.639 . . . . 0.0 106.576 168.406 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -127.29 179.96 5.19 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 124.899 1.279 . . . . 0.0 107.949 173.584 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 3.6 tm-20 -146.29 -49.29 0.21 Allowed 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 124.183 0.993 . . . . 0.0 108.545 176.832 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 39.0 m -62.64 -44.9 95.1 Favored 'General case' 0 C--O 1.235 0.341 0 C-N-CA 124.727 1.211 . . . . 0.0 111.383 -176.847 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 8.2 m-80 -81.11 -48.99 11.4 Favored 'General case' 0 C--O 1.232 0.171 0 C-N-CA 123.042 0.537 . . . . 0.0 111.004 -167.445 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 16.7 pt20 -159.7 149.79 18.68 Favored 'General case' 0 C--O 1.233 0.214 0 C-N-CA 124.842 1.257 . . . . 0.0 108.145 -178.004 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 46.6 p90 -126.56 -17.3 5.1 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 123.825 0.85 . . . . 0.0 112.391 179.715 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -70.64 -35.29 72.83 Favored 'General case' 0 N--CA 1.466 0.37 0 O-C-N 121.515 -0.741 . . . . 0.0 111.072 -177.111 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -77.27 -11.16 59.79 Favored 'General case' 0 C--N 1.344 0.36 0 CA-C-O 118.553 -0.737 . . . . 0.0 111.902 -179.801 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 28.9 m -60.7 -34.79 74.89 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-N 119.997 1.272 . . . . 0.0 110.368 179.959 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -59.24 -43.46 92.4 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 118.789 0.722 . . . . 0.0 111.2 175.636 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 -68.94 -47.6 65.3 Favored 'General case' 0 C--O 1.233 0.23 0 C-N-CA 124.934 1.294 . . . . 0.0 110.436 -179.625 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 9.6 mpt_? -54.13 -47.56 71.74 Favored 'General case' 0 N--CA 1.463 0.221 0 C-N-CA 124.355 1.062 . . . . 0.0 109.87 176.348 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 43.2 mt -68.52 -52.82 32.53 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.468 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 -179.41 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 71.4 tp60 -50.89 -63.99 0.95 Allowed 'General case' 0 CA--C 1.516 -0.329 0 C-N-CA 124.922 1.289 . . . . 0.0 111.83 -174.801 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 24.1 m -66.61 -32.62 74.07 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 120.615 -0.434 . . . . 0.0 110.965 -169.742 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 160' ' ' TRP . . . . . . . . . . . . . 36.2 t90 -69.93 -44.65 69.18 Favored 'General case' 0 CA--C 1.517 -0.325 0 O-C-N 121.89 -0.506 . . . . 0.0 111.217 177.536 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 67.1 m -59.77 -42.94 94.39 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 122.779 0.432 . . . . 0.0 110.371 178.046 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -62.06 -42.54 99.3 Favored 'General case' 0 C--O 1.227 -0.083 0 CA-C-O 121.031 0.443 . . . . 0.0 110.08 175.812 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 14.2 tt0 -62.78 -52.15 64.32 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-O 118.824 -0.608 . . . . 0.0 110.187 -178.669 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 43.8 pt -63.0 -38.56 82.35 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.321 0 CA-C-O 117.819 -1.086 . . . . 0.0 109.267 -174.724 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -65.31 -33.88 77.03 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 119.435 1.016 . . . . 0.0 110.405 -179.484 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 34.0 m-80 -69.77 -56.91 5.88 Favored 'General case' 0 CA--C 1.517 -0.305 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 175.379 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 9.9 tt0 -64.72 -37.48 87.73 Favored 'General case' 0 N--CA 1.442 -0.86 0 C-N-CA 124.813 1.245 . . . . 0.0 110.887 -168.68 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 168' ' ' MET . . . . . . . . . . . . . 21.4 ptp -66.98 -32.27 73.39 Favored 'General case' 0 CA--C 1.522 -0.098 0 O-C-N 121.66 -0.65 . . . . 0.0 111.295 174.083 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . 0.485 ' HA ' ' CD2' ' A' ' 172' ' ' TYR . . . -76.14 -37.39 58.04 Favored 'General case' 0 N--CA 1.443 -0.793 0 N-CA-C 112.451 0.537 . . . . 0.0 112.451 -178.47 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 -62.38 -35.55 79.53 Favored 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 108.89 -0.782 . . . . 0.0 108.89 174.985 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 63.3 t60 -69.94 -45.31 67.76 Favored 'General case' 0 N--CA 1.446 -0.656 0 C-N-CA 124.592 1.157 . . . . 0.0 111.726 -176.865 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 172' ' ' TYR . . . . . 0.485 ' CD2' ' HA ' ' A' ' 169' ' ' ALA . 0.2 OUTLIER -79.51 -28.97 41.39 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-O 118.935 -0.555 . . . . 0.0 112.21 -174.472 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.286 0 C-N-CA 123.717 0.807 . . . . 0.0 110.794 -179.75 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.498 1.947 0 N-CA-C 111.191 0.071 . . . . 0.0 111.191 . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 19.7 p-10 -102.3 163.33 12.3 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 124.503 1.121 . . . . 0.0 111.467 -175.771 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 16.3 mtt -129.3 127.03 40.31 Favored 'General case' 0 N--CA 1.464 0.237 0 C-N-CA 122.89 0.476 . . . . 0.0 110.712 179.1 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -94.29 121.06 6.57 Favored Glycine 0 C--O 1.225 -0.437 0 N-CA-C 107.573 -2.211 . . . . 0.0 107.573 168.904 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 4.1 tt -104.43 111.54 24.23 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 105.468 -2.049 . . . . 0.0 105.468 179.226 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -108.32 143.99 36.45 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-O 121.757 0.789 . . . . 0.0 110.434 175.637 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 20.6 p90 -159.31 178.5 9.89 Favored 'General case' 0 N--CA 1.447 -0.62 0 N-CA-C 106.454 -1.684 . . . . 0.0 106.454 176.963 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -156.56 -138.47 2.54 Favored Glycine 0 CA--C 1.521 0.426 0 N-CA-C 105.697 -2.961 . . . . 0.0 105.697 173.951 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 7.2 m 56.23 61.72 2.62 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-O 122.138 0.971 . . . . 0.0 109.524 178.801 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 38.2 m -50.3 142.86 9.45 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 124.037 0.935 . . . . 0.0 110.955 -178.138 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 1.5 m 69.3 -8.07 0.76 Allowed 'General case' 0 CA--C 1.549 0.939 0 C-N-CA 126.689 1.996 . . . . 0.0 114.306 -178.747 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 64.1 m -74.81 165.75 24.73 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 120.554 1.524 . . . . 0.0 110.27 170.702 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 53.8 m-85 -62.27 -12.88 23.03 Favored 'General case' 0 N--CA 1.469 0.499 0 N-CA-C 113.221 0.823 . . . . 0.0 113.221 179.785 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -51.79 -30.75 24.33 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 124.825 1.25 . . . . 0.0 112.028 171.646 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 91.7 mt-10 -63.63 -44.32 94.23 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-N 119.057 0.844 . . . . 0.0 109.845 178.518 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 32.2 mtm -73.64 -31.7 63.64 Favored 'General case' 0 N--CA 1.462 0.126 0 CA-C-O 118.384 -0.817 . . . . 0.0 110.687 177.701 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -59.28 -48.21 82.46 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 119.618 1.099 . . . . 0.0 110.125 170.575 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -62.99 -46.44 87.69 Favored 'General case' 0 N--CA 1.455 -0.195 0 C-N-CA 123.273 0.629 . . . . 0.0 111.204 -177.11 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 50.3 mm-40 -55.01 -52.41 63.23 Favored 'General case' 0 C--O 1.23 0.043 0 C-N-CA 123.169 0.588 . . . . 0.0 109.706 173.008 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 57.8 mttm -64.21 -42.16 96.73 Favored 'General case' 0 C--O 1.222 -0.344 0 CA-C-O 118.889 -0.577 . . . . 0.0 110.704 -171.433 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 48.3 mt -55.81 -56.61 11.55 Favored 'Isoleucine or valine' 0 C--O 1.233 0.211 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 178.4 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 19.1 ptt180 -63.4 -38.01 89.48 Favored 'General case' 0 C--O 1.221 -0.416 0 CA-C-O 118.884 -0.579 . . . . 0.0 110.251 -177.12 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -66.02 -38.45 88.44 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.208 0.528 . . . . 0.0 109.956 -173.41 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 77.9 mt -80.6 -53.67 12.12 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.516 0 C-N-CA 125.195 1.398 . . . . 0.0 110.165 -173.186 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 76.4 mt -62.67 -47.82 91.11 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 N-CA-C 109.511 -0.551 . . . . 0.0 109.511 178.579 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 140.91 120.45 1.68 Allowed Glycine 0 CA--C 1.529 0.937 0 C-N-CA 125.273 1.416 . . . . 0.0 110.755 177.051 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 82.1 Cg_endo -73.78 -4.09 14.84 Favored 'Trans proline' 0 CA--C 1.541 0.832 0 C-N-CA 123.078 2.519 . . . . 0.0 113.228 -173.12 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -82.36 -21.63 35.85 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 118.841 0.746 . . . . 0.0 111.54 176.593 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -120.97 -12.91 8.68 Favored 'General case' 0 C--N 1.344 0.33 0 C-N-CA 124.927 1.291 . . . . 0.0 113.436 -175.774 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 60.0 t -100.07 145.36 10.92 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 N-CA-C 107.29 -1.374 . . . . 0.0 107.29 169.136 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 6.0 m -134.48 139.29 45.37 Favored 'General case' 0 N--CA 1.463 0.209 0 C-N-CA 125.105 1.362 . . . . 0.0 107.493 -178.2 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 34.7 mt -93.42 145.05 24.77 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 118.888 0.767 . . . . 0.0 110.033 -179.826 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 12.4 m-70 -112.19 130.74 55.81 Favored 'General case' 0 C--O 1.234 0.286 0 N-CA-C 106.454 -1.684 . . . . 0.0 106.454 168.051 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 35.5 t-20 -105.8 100.14 9.71 Favored 'General case' 0 CA--C 1.521 -0.168 0 N-CA-C 106.117 -1.808 . . . . 0.0 106.117 169.014 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 83.5 mt -70.07 -8.8 52.37 Favored 'General case' 0 N--CA 1.466 0.368 0 N-CA-C 113.414 0.894 . . . . 0.0 113.414 -169.935 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 24.5 tptt -62.41 -23.57 66.91 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 118.662 0.664 . . . . 0.0 110.684 168.261 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -129.81 -39.85 1.4 Allowed 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 124.584 1.153 . . . . 0.0 113.171 -173.87 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 41.4 m-20 -75.89 130.94 39.28 Favored 'General case' 0 C--O 1.235 0.302 0 C-N-CA 123.829 0.852 . . . . 0.0 108.727 178.708 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 15.6 m -74.31 149.22 86.69 Favored Pre-proline 0 CA--C 1.54 0.581 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 173.652 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -71.91 -22.12 23.71 Favored 'Trans proline' 0 CA--C 1.532 0.382 0 C-N-CA 121.802 1.668 . . . . 0.0 112.818 -172.961 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 11.9 mptt -56.21 -23.77 37.71 Favored 'General case' 0 N--CA 1.47 0.541 0 O-C-N 120.963 -1.085 . . . . 0.0 112.342 175.074 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -58.45 -34.15 70.53 Favored 'General case' 0 N--CA 1.465 0.314 0 C-N-CA 124.351 1.06 . . . . 0.0 110.69 175.811 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 61.3 mtt -60.02 -26.13 65.84 Favored 'General case' 0 N--CA 1.465 0.297 0 C-N-CA 124.622 1.169 . . . . 0.0 111.967 178.962 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 68.3 mt-10 -61.79 -33.46 74.15 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 118.729 0.695 . . . . 0.0 109.505 -178.466 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 30.8 mt-30 -69.11 -28.33 66.39 Favored 'General case' 0 CA--C 1.536 0.422 0 N-CA-C 113.749 1.018 . . . . 0.0 113.749 -172.189 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 76.5 m-85 -85.08 138.05 32.66 Favored 'General case' 0 N--CA 1.464 0.243 0 C-N-CA 122.991 0.516 . . . . 0.0 110.14 -167.762 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -71.14 -43.13 68.2 Favored 'General case' 0 C--O 1.233 0.237 0 CA-C-N 118.01 0.368 . . . . 0.0 110.45 -178.502 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 11.8 t -105.16 144.95 14.07 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.404 0 N-CA-C 107.101 -1.444 . . . . 0.0 107.101 169.668 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 19.1 tp -122.78 146.34 47.61 Favored 'General case' 0 N--CA 1.447 -0.618 0 N-CA-C 107.398 -1.334 . . . . 0.0 107.398 169.213 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 41.2 mt -128.05 130.0 69.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 N-CA-C 105.5 -2.037 . . . . 0.0 105.5 178.979 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 2.1 mp -114.35 131.06 56.68 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 125.729 1.612 . . . . 0.0 107.839 -172.17 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -139.19 134.61 6.82 Favored Glycine 0 C--N 1.332 0.341 0 CA-C-O 118.855 -0.969 . . . . 0.0 111.544 177.902 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 5.5 tt -155.93 137.55 9.67 Favored Pre-proline 0 CA--C 1.533 0.3 0 CA-C-N 118.252 1.026 . . . . 0.0 111.246 177.954 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_endo -84.36 130.34 4.59 Favored 'Trans proline' 0 N--CA 1.453 -0.904 0 C-N-CA 122.383 2.055 . . . . 0.0 107.187 164.881 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 61.6 m -86.51 143.21 27.84 Favored 'General case' 0 CA--C 1.538 0.482 0 N-CA-C 107.843 -1.169 . . . . 0.0 107.843 170.895 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 14.1 t90 -147.81 125.43 11.78 Favored 'General case' 0 C--N 1.334 -0.068 0 N-CA-C 105.375 -2.083 . . . . 0.0 105.375 172.71 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -68.23 -43.9 76.92 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 118.801 0.728 . . . . 0.0 112.141 -170.126 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 79.6 t80 -69.09 -47.67 64.61 Favored 'General case' 0 C--O 1.236 0.352 0 C-N-CA 121.24 -0.184 . . . . 0.0 110.7 -170.866 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -83.99 -21.9 56.32 Favored Glycine 0 CA--C 1.532 1.132 0 CA-C-O 118.752 -1.027 . . . . 0.0 113.046 -178.415 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 57.8 -179.03 0.06 Allowed 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 125.455 1.502 . . . . 0.0 110.408 -167.658 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 11.7 mt -29.46 123.35 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.626 0 C-N-CA 126.668 1.987 . . . . 0.0 110.674 168.855 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 3.8 mp0 -69.64 155.93 39.74 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 124.829 1.252 . . . . 0.0 109.747 -174.455 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -51.3 -46.12 62.41 Favored 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 124.664 1.186 . . . . 0.0 111.155 -173.019 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 -60.19 -27.77 67.41 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 123.624 0.769 . . . . 0.0 110.734 -170.568 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -96.04 -46.92 6.3 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 126.192 1.797 . . . . 0.0 109.054 -178.579 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 14.6 tt0 -62.81 -34.05 76.48 Favored 'General case' 0 N--CA 1.445 -0.723 0 C-N-CA 125.165 1.386 . . . . 0.0 110.437 -175.187 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -57.37 -23.9 52.0 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 124.606 1.162 . . . . 0.0 111.999 -179.065 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 17.7 m -121.4 -11.12 9.09 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.225 0 C-N-CA 124.882 1.273 . . . . 0.0 112.348 179.879 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 48.5 t90 -55.39 -36.57 66.54 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 124.362 1.065 . . . . 0.0 110.674 -178.437 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -63.52 -27.9 69.58 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 125.403 1.481 . . . . 0.0 112.949 176.183 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 41.9 mt-30 -91.73 -20.97 20.99 Favored 'General case' 0 CA--C 1.519 -0.239 0 C-N-CA 125.186 1.394 . . . . 0.0 112.506 179.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 76.1 mt -59.45 -27.47 66.11 Favored 'General case' 0 N--CA 1.467 0.391 0 O-C-N 121.538 -0.726 . . . . 0.0 111.294 178.589 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -76.94 -25.75 53.23 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 122.529 0.331 . . . . 0.0 111.316 173.974 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -77.47 -27.14 51.93 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 124.645 1.178 . . . . 0.0 112.335 -179.467 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 36.3 mt -61.8 147.46 46.34 Favored 'General case' 0 C--N 1.34 0.173 0 C-N-CA 124.296 1.039 . . . . 0.0 111.434 -178.079 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 24.4 t-20 -88.15 122.23 31.48 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 108.111 -1.07 . . . . 0.0 108.111 168.437 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 80.6 mt -130.92 9.33 4.9 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 123.577 0.751 . . . . 0.0 112.518 -170.054 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 26.8 mt-10 -52.42 127.92 23.97 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 124.055 0.942 . . . . 0.0 112.382 -168.064 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 69.35 -0.73 15.8 Favored Glycine 0 CA--C 1.534 1.22 0 C-N-CA 125.473 1.511 . . . . 0.0 115.721 176.659 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.82 149.33 39.68 Favored 'General case' 0 C--N 1.345 0.401 0 CA-C-N 120.551 2.176 . . . . 0.0 109.871 -173.29 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 4.5 mt -80.17 137.14 22.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 N-CA-C 106.923 -1.51 . . . . 0.0 106.923 177.769 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 55.6 t -131.47 124.17 54.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 C-N-CA 124.522 1.129 . . . . 0.0 109.734 -176.882 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -94.34 149.93 20.77 Favored 'General case' 0 CA--C 1.52 -0.186 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 167.147 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 8.4 mt -129.16 129.92 45.72 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 107.521 -1.288 . . . . 0.0 107.521 176.736 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 39.9 p90 -142.94 165.82 26.31 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 107.566 -1.272 . . . . 0.0 107.566 167.712 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -166.68 168.81 40.37 Favored Glycine 0 N--CA 1.442 -0.944 0 N-CA-C 110.147 -1.181 . . . . 0.0 110.147 173.517 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 1.1 mp -115.73 157.17 24.69 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 124.952 1.301 . . . . 0.0 108.925 177.249 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -167.44 -161.26 16.43 Favored Glycine 0 CA--C 1.525 0.7 0 N-CA-C 109.414 -1.475 . . . . 0.0 109.414 174.121 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 60.0 t0 -147.66 114.54 6.11 Favored 'General case' 0 C--O 1.234 0.252 0 N-CA-C 107.121 -1.437 . . . . 0.0 107.121 174.92 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 5.6 pt20 -81.61 -7.89 59.64 Favored 'General case' 0 CA--C 1.541 0.628 0 N-CA-C 112.954 0.724 . . . . 0.0 112.954 -177.603 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 49.1 mt -91.66 -49.86 6.06 Favored 'General case' 0 N--CA 1.465 0.285 0 C-N-CA 124.448 1.099 . . . . 0.0 108.355 171.643 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -71.22 -44.93 51.81 Favored Glycine 0 CA--C 1.524 0.601 0 C-N-CA 124.575 1.083 . . . . 0.0 112.119 -174.604 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 5.5 m-85 -105.33 -78.19 0.57 Allowed 'General case' 0 C--N 1.339 0.14 0 N-CA-C 107.665 -1.235 . . . . 0.0 107.665 -178.55 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 78.06 -51.6 3.55 Favored Glycine 0 CA--C 1.526 0.751 0 C-N-CA 125.658 1.599 . . . . 0.0 111.593 173.323 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -67.18 -28.27 67.96 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 123.511 0.724 . . . . 0.0 110.675 173.917 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' TRP . . . . . . . . . . . . . 4.2 m-90 -122.18 27.6 7.91 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 125.16 1.384 . . . . 0.0 111.24 -169.858 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 14.2 t80 -60.36 131.05 49.56 Favored 'General case' 0 N--CA 1.462 0.162 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 -178.801 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 94.6 mt 52.59 24.98 3.37 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 124.253 1.021 . . . . 0.0 113.358 172.206 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -63.9 -34.77 78.71 Favored 'General case' 0 C--N 1.333 -0.134 0 O-C-N 120.746 -1.221 . . . . 0.0 110.741 -170.937 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -73.89 -26.34 60.49 Favored 'General case' 0 N--CA 1.453 -0.302 0 O-C-N 121.485 -0.76 . . . . 0.0 112.619 176.36 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 5.2 tt -62.22 -44.86 95.61 Favored 'General case' 0 N--CA 1.466 0.36 0 N-CA-C 107.124 -1.435 . . . . 0.0 107.124 169.126 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -64.78 -40.63 97.51 Favored Glycine 0 C--N 1.34 0.803 0 N-CA-C 111.136 -0.786 . . . . 0.0 111.136 -179.02 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 75.0 mtm -62.7 -41.13 98.98 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 118.072 0.936 . . . . 0.0 111.318 177.344 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -68.09 -40.21 82.68 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 120.164 1.347 . . . . 0.0 110.485 178.594 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 82.3 t60 -55.98 -51.92 66.01 Favored 'General case' 0 CA--C 1.528 0.112 0 N-CA-C 110.062 -0.348 . . . . 0.0 110.062 175.035 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -64.32 -39.94 94.92 Favored 'General case' 0 C--O 1.235 0.339 0 C-N-CA 123.967 0.907 . . . . 0.0 112.584 -176.102 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 22.3 ttmm -54.85 -39.05 68.22 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 123.794 0.838 . . . . 0.0 109.775 171.567 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 21.8 mt -90.6 -18.78 24.58 Favored 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 114.603 1.334 . . . . 0.0 114.603 -169.379 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 2.5 m -58.86 -33.46 70.49 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 120.561 1.528 . . . . 0.0 111.688 -175.75 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 19.5 p -86.56 -11.94 50.12 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 124.754 1.221 . . . . 0.0 111.999 -179.318 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 32.1 mmmt -82.12 -10.14 59.29 Favored 'General case' 0 C--N 1.344 0.342 0 C-N-CA 124.314 1.046 . . . . 0.0 111.414 176.37 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 73.65 32.99 58.74 Favored Glycine 0 CA--C 1.526 0.723 0 CA-C-O 119.524 -0.598 . . . . 0.0 112.102 173.153 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 17.2 m -75.19 177.54 0.57 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.613 0 CA-C-N 118.193 0.997 . . . . 0.0 109.853 171.224 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -118.91 120.25 36.74 Favored 'General case' 0 CA--C 1.518 -0.274 0 N-CA-C 106.939 -1.504 . . . . 0.0 106.939 174.373 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 76.9 m-85 -87.83 144.67 26.47 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 119.696 1.135 . . . . 0.0 110.231 -175.323 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 35.9 m -134.34 159.68 41.92 Favored 'Isoleucine or valine' 0 C--O 1.234 0.254 0 C-N-CA 125.343 1.457 . . . . 0.0 107.936 169.865 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 85.54 30.62 23.91 Favored Glycine 0 CA--C 1.522 0.513 0 CA-C-O 118.75 -1.028 . . . . 0.0 114.262 170.872 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 13.0 m-30 -62.06 157.01 19.9 Favored 'General case' 0 CA--C 1.545 0.757 0 CA-C-N 119.036 1.418 . . . . 0.0 109.691 169.09 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 2.5 t90 -135.98 144.26 47.65 Favored Pre-proline 0 N--CA 1.474 0.772 0 CA-C-O 117.712 -1.137 . . . . 0.0 111.849 -168.915 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_exo -66.96 123.0 10.41 Favored 'Trans proline' 0 C--N 1.352 0.761 0 C-N-CA 123.552 2.835 . . . . 0.0 113.144 -176.647 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 3.3 p -77.25 -15.27 59.53 Favored 'General case' 0 N--CA 1.468 0.43 0 N-CA-C 113.847 1.055 . . . . 0.0 113.847 179.341 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -62.33 127.51 31.68 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 118.556 0.616 . . . . 0.0 109.58 -171.475 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 87.01 -7.77 79.13 Favored Glycine 0 CA--C 1.534 1.252 0 C-N-CA 124.888 1.232 . . . . 0.0 114.325 178.448 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 4.9 m-85 -88.76 153.82 20.78 Favored 'General case' 0 C--O 1.237 0.396 0 CA-C-N 119.507 1.654 . . . . 0.0 110.141 172.265 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -105.36 130.94 53.36 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 124.488 1.115 . . . . 0.0 108.181 171.849 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 36.8 p90 -162.84 134.84 5.28 Favored 'General case' 0 CA--C 1.534 0.329 0 N-CA-C 106.135 -1.802 . . . . 0.0 106.135 175.316 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 2.5 m -92.33 -53.45 4.22 Favored 'General case' 0 N--CA 1.45 -0.453 0 O-C-N 121.631 -0.668 . . . . 0.0 111.496 -176.236 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 43.5 m -76.45 149.4 81.41 Favored Pre-proline 0 CA--C 1.543 0.696 0 C-N-CA 123.617 0.767 . . . . 0.0 111.227 -173.698 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 82.1 Cg_endo -84.84 -10.08 8.5 Favored 'Trans proline' 0 CA--C 1.541 0.842 0 C-N-CA 122.905 2.403 . . . . 0.0 113.903 -176.412 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 24.8 ttmt -53.04 -42.27 89.91 Favored Pre-proline 0 N--CA 1.475 0.803 0 N-CA-C 114.845 1.424 . . . . 0.0 114.845 -174.134 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_endo -78.92 -1.04 11.26 Favored 'Trans proline' 0 CA--C 1.539 0.761 0 CA-C-N 122.25 1.839 . . . . 0.0 113.999 179.992 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 18.5 m -127.37 170.58 17.02 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.22 0 CA-C-N 119.875 1.216 . . . . 0.0 110.96 -171.307 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 4.9 pt -128.8 169.29 20.42 Favored 'Isoleucine or valine' 0 C--O 1.241 0.64 0 C-N-CA 127.664 2.386 . . . . 0.0 107.86 175.579 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . 56.41 -156.37 0.28 Allowed 'General case' 0 N--CA 1.446 -0.652 0 C-N-CA 124.622 1.169 . . . . 0.0 108.37 -175.924 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 24.8 t0 -78.51 52.47 1.17 Allowed 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 124.481 1.113 . . . . 0.0 110.833 174.894 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 67.19 26.67 73.4 Favored Glycine 0 CA--C 1.531 1.069 0 C-N-CA 124.657 1.123 . . . . 0.0 112.677 -175.495 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 36.8 mt-30 -88.56 -11.41 45.71 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 118.579 1.19 . . . . 0.0 112.533 -170.128 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 8.5 tp -155.71 143.28 19.54 Favored 'General case' 0 C--N 1.343 0.319 0 CA-C-N 119.255 0.934 . . . . 0.0 110.578 175.671 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 67.9 m-85 -78.4 144.92 35.48 Favored 'General case' 0 CA--C 1.516 -0.365 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 169.771 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 17.0 m -76.56 4.63 1.11 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.732 0 C-N-CA 122.773 0.429 . . . . 0.0 111.959 176.615 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -172.86 172.92 45.38 Favored Glycine 0 CA--C 1.527 0.8 0 O-C-N 120.753 -1.217 . . . . 0.0 110.6 -179.173 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 3.6 tp -62.6 131.78 50.19 Favored 'General case' 0 N--CA 1.464 0.246 0 C-N-CA 124.143 0.977 . . . . 0.0 110.942 179.638 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -91.18 129.08 37.21 Favored 'General case' 0 N--CA 1.444 -0.742 0 C-N-CA 126.288 1.835 . . . . 0.0 109.572 176.811 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 32.4 mt -130.32 144.25 51.26 Favored 'General case' 0 C--O 1.231 0.116 0 N-CA-C 105.926 -1.879 . . . . 0.0 105.926 172.152 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -130.93 130.16 43.11 Favored 'General case' 0 N--CA 1.453 -0.281 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 -179.518 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -90.65 -4.6 56.67 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 124.144 0.977 . . . . 0.0 112.957 -169.871 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 90.0 m -125.37 -44.83 1.84 Allowed 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 124.526 1.13 . . . . 0.0 111.13 -172.743 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 4.9 m-80 -77.88 -29.52 50.31 Favored 'General case' 0 C--N 1.331 -0.197 0 C-N-CA 124.331 1.052 . . . . 0.0 110.871 -172.203 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 76.8 mt-30 -128.42 157.16 41.85 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 125.313 1.445 . . . . 0.0 109.196 -178.329 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 86.8 t80 -152.22 -51.66 0.11 Allowed 'General case' 0 CA--C 1.529 0.164 0 C-N-CA 124.216 1.007 . . . . 0.0 108.752 171.325 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -64.31 -48.8 74.26 Favored 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 122.956 0.503 . . . . 0.0 111.454 -174.823 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . 0.275 0.6 OUTLIER -95.7 6.23 49.44 Favored 'General case' 0 C--N 1.341 0.231 0 N-CA-C 112.971 0.73 . . . . 0.0 112.971 -178.699 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 14.9 m -60.45 -36.02 77.23 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 120.02 1.282 . . . . 0.0 109.299 169.237 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -56.27 -44.22 79.56 Favored 'General case' 0 N--CA 1.464 0.27 0 C-N-CA 124.438 1.095 . . . . 0.0 110.904 169.818 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -65.25 -44.56 87.74 Favored 'General case' 0 C--O 1.234 0.252 0 C-N-CA 124.605 1.162 . . . . 0.0 110.882 -178.718 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 5.9 mmt180 -58.32 -41.36 84.37 Favored 'General case' 0 N--CA 1.462 0.153 0 CA-C-O 118.765 -0.636 . . . . 0.0 109.887 177.944 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 42.0 mt -67.98 -53.97 26.04 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.236 0 N-CA-C 108.228 -1.027 . . . . 0.0 108.228 176.811 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -49.77 -66.25 0.42 Allowed 'General case' 0 CA--C 1.518 -0.267 0 C-N-CA 125.547 1.539 . . . . 0.0 112.067 -172.178 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 14.6 m -60.95 -34.1 74.22 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 115.554 -0.748 . . . . 0.0 111.713 -174.888 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 160' ' ' TRP . . . . . . . . . . . . . 79.2 t90 -65.55 -43.9 88.48 Favored 'General case' 0 C--O 1.222 -0.373 0 O-C-N 121.775 -0.578 . . . . 0.0 111.005 174.411 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 92.5 m -61.01 -41.36 96.38 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 123.159 0.584 . . . . 0.0 110.652 179.721 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -63.09 -41.1 99.33 Favored 'General case' 0 N--CA 1.462 0.15 0 CA-C-O 121.104 0.478 . . . . 0.0 110.791 173.534 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 16.1 tt0 -65.05 -51.22 62.75 Favored 'General case' 0 N--CA 1.446 -0.654 0 O-C-N 121.566 -0.708 . . . . 0.0 110.122 -177.614 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 41.6 pt -63.38 -36.82 77.65 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.403 0 CA-C-O 117.818 -1.087 . . . . 0.0 109.734 -175.863 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -64.35 -36.25 83.52 Favored 'General case' 0 C--O 1.225 -0.187 0 CA-C-N 119.561 1.073 . . . . 0.0 109.611 -179.704 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 41.3 m-80 -68.59 -51.34 43.63 Favored 'General case' 0 N--CA 1.467 0.387 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 175.422 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 22.8 tt0 -72.85 -16.04 61.6 Favored 'General case' 0 N--CA 1.443 -0.802 0 C-N-CA 125.847 1.659 . . . . 0.0 111.937 -169.448 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 168' ' ' MET . . . . . . . . . . . . . 19.5 ptp -90.94 -38.93 12.55 Favored 'General case' 0 N--CA 1.456 -0.162 0 C-N-CA 123.799 0.84 . . . . 0.0 111.544 168.722 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -75.76 -27.04 57.9 Favored 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 122.703 0.401 . . . . 0.0 112.037 -172.927 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -56.79 -26.58 58.07 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 123.672 0.789 . . . . 0.0 112.252 -179.23 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 80.3 m-70 -78.76 -14.96 58.99 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 124.919 1.288 . . . . 0.0 112.843 178.967 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 50.0 m-85 -127.13 -16.76 4.96 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 125.626 1.571 . . . . 0.0 113.694 -168.694 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.254 1.335 0 C-N-CA 124.442 1.097 . . . . 0.0 110.07 173.694 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.497 1.905 0 N-CA-C 111.146 0.054 . . . . 0.0 111.146 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 22.3 p-10 -130.88 164.17 25.83 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 124.649 1.179 . . . . 0.0 111.487 -173.725 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 16.0 mtt -130.72 124.3 31.21 Favored 'General case' 0 CA--C 1.523 -0.087 0 C-N-CA 123.201 0.6 . . . . 0.0 111.258 179.798 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -87.33 152.18 24.13 Favored Glycine 0 CA--C 1.525 0.682 0 N-CA-C 106.838 -2.505 . . . . 0.0 106.838 166.895 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 2.7 tt -140.11 97.01 3.15 Favored 'General case' 0 N--CA 1.469 0.477 0 N-CA-C 105.783 -1.932 . . . . 0.0 105.783 -172.629 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' PHE . . . . . 0.694 ' CZ ' HD23 ' A' ' 51' ' ' LEU . 0.7 OUTLIER -105.08 144.0 32.48 Favored 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 123.172 0.589 . . . . 0.0 111.063 -171.664 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 43.1 p90 . . . . . 0 C--O 1.234 0.28 0 C-N-CA 124.16 0.984 . . . . 0.0 109.941 -179.881 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.536 0.408 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -64.0 -48.47 76.26 Favored 'General case' 0 N--CA 1.455 -0.223 0 C-N-CA 123.785 0.834 . . . . 0.0 111.511 -177.909 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -52.76 -47.59 67.37 Favored 'General case' 0 C--O 1.235 0.334 0 C-N-CA 124.146 0.978 . . . . 0.0 109.72 175.492 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 28.7 mtpp -75.82 -42.13 50.65 Favored 'General case' 0 C--O 1.221 -0.428 0 CA-C-O 117.982 -1.008 . . . . 0.0 110.521 -170.446 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 39.0 mt -52.37 -53.34 19.87 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.352 0 CA-C-N 120.258 1.39 . . . . 0.0 108.614 173.494 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.15 -39.23 91.93 Favored 'General case' 0 C--O 1.222 -0.358 0 C-N-CA 123.367 0.667 . . . . 0.0 109.798 -176.821 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -66.46 -42.3 87.77 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 118.599 0.636 . . . . 0.0 110.943 179.678 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 54.7 mt -74.0 -53.78 16.64 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.605 0 C-N-CA 124.995 1.318 . . . . 0.0 109.767 -169.789 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 75.3 mt -65.45 -46.1 90.98 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.446 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 178.76 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 140.21 125.85 2.23 Favored Glycine 0 CA--C 1.533 1.176 0 C-N-CA 124.676 1.132 . . . . 0.0 111.952 172.832 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -71.6 -6.88 20.07 Favored 'Trans proline' 0 CA--C 1.539 0.749 0 C-N-CA 123.701 2.934 . . . . 0.0 113.684 -174.025 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -81.55 -19.24 42.47 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-N 119.123 0.874 . . . . 0.0 111.245 176.812 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -127.25 -5.83 6.01 Favored 'General case' 0 C--N 1.345 0.372 0 C-N-CA 124.653 1.181 . . . . 0.0 113.792 -174.53 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 26.9 t -113.32 147.21 17.07 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.266 0 N-CA-C 108.007 -1.109 . . . . 0.0 108.007 170.984 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 36.4 m -135.03 132.15 37.93 Favored 'General case' 0 C--O 1.234 0.267 0 C-N-CA 125.896 1.678 . . . . 0.0 106.667 -174.819 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 14.7 mt -76.01 138.09 40.68 Favored 'General case' 0 C--O 1.231 0.101 0 N-CA-C 107.885 -1.154 . . . . 0.0 107.885 174.696 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 35.0 t-80 -126.85 56.48 1.5 Allowed 'General case' 0 CA--C 1.531 0.217 0 N-CA-C 107.422 -1.325 . . . . 0.0 107.422 177.928 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 48.5 t30 -61.21 128.92 38.75 Favored 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 107.099 -1.445 . . . . 0.0 107.099 176.123 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 40.2 mt -70.33 -29.98 66.82 Favored 'General case' 0 N--CA 1.469 0.496 0 N-CA-C 114.138 1.162 . . . . 0.0 114.138 -167.65 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 21.5 mmmt -62.72 -26.16 68.54 Favored 'General case' 0 N--CA 1.466 0.344 0 O-C-N 121.703 -0.623 . . . . 0.0 111.698 168.369 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -92.62 -34.62 13.93 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-N 118.568 0.622 . . . . 0.0 112.405 -172.566 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 2.2 t0 -146.4 150.73 36.22 Favored 'General case' 0 N--CA 1.466 0.363 0 N-CA-C 113.025 0.75 . . . . 0.0 113.025 177.008 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 15.2 m -72.14 158.11 88.17 Favored Pre-proline 0 CA--C 1.541 0.6 0 C-N-CA 126.083 1.753 . . . . 0.0 111.499 -169.555 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -71.8 -27.5 17.89 Favored 'Trans proline' 0 C--N 1.35 0.628 0 C-N-CA 122.388 2.059 . . . . 0.0 113.385 -170.466 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 14.8 mmmt -68.36 -16.12 63.81 Favored 'General case' 0 N--CA 1.472 0.644 0 O-C-N 120.897 -1.127 . . . . 0.0 111.286 -175.822 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -62.95 -27.97 69.75 Favored 'General case' 0 N--CA 1.465 0.277 0 C-N-CA 125.741 1.616 . . . . 0.0 110.422 171.821 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 47.5 mtt -56.37 -25.39 49.39 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 119.134 0.879 . . . . 0.0 111.422 178.335 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -66.57 -30.21 70.45 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 118.445 0.566 . . . . 0.0 110.895 -176.585 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 23.1 mt-30 -68.88 -41.5 78.23 Favored 'General case' 0 N--CA 1.465 0.277 0 N-CA-C 113.082 0.771 . . . . 0.0 113.082 -170.071 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 43.3 m-85 -72.75 137.47 45.89 Favored 'General case' 0 N--CA 1.461 0.104 0 C-N-CA 123.534 0.734 . . . . 0.0 109.721 -167.197 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -68.27 -36.54 79.56 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 118.539 0.609 . . . . 0.0 110.181 178.908 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 5.9 t -110.39 144.14 19.03 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.295 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 170.948 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 59.4 tp -131.02 108.55 9.87 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 173.484 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 22.8 mt -85.49 131.27 34.7 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 N-CA-C 106.246 -1.761 . . . . 0.0 106.246 175.067 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.694 HD23 ' CZ ' ' A' ' 6' ' ' PHE . 0.8 OUTLIER -107.29 133.36 51.96 Favored 'General case' 0 N--CA 1.456 -0.134 0 C-N-CA 125.574 1.55 . . . . 0.0 107.918 172.058 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.527 ' N ' HD22 ' A' ' 51' ' ' LEU . . . -127.65 126.7 5.59 Favored Glycine 0 C--N 1.331 0.299 0 N-CA-C 109.457 -1.457 . . . . 0.0 109.457 170.47 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 7.0 tt -148.92 123.23 4.77 Favored Pre-proline 0 N--CA 1.471 0.584 0 CA-C-N 119.305 1.552 . . . . 0.0 111.582 170.846 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_exo . . . . . 0 N--CA 1.459 -0.525 0 C-N-CA 122.444 2.096 . . . . 0.0 110.664 166.604 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.425 HD11 ' HE3' ' A' ' 103' ' ' MET . 78.8 mt . . . . . 0 CA--C 1.545 0.77 0 CA-C-O 122.149 0.976 . . . . 0.0 112.772 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.68 163.26 4.46 Favored 'General case' 0 CA--C 1.542 0.655 0 CA-C-O 122.257 1.027 . . . . 0.0 112.376 171.761 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -59.79 -42.27 93.02 Favored 'General case' 0 N--CA 1.455 -0.206 0 C-N-CA 124.377 1.071 . . . . 0.0 112.599 -168.947 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 55.4 m-20 -66.3 -23.1 66.32 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-N 119.615 1.098 . . . . 0.0 111.723 -169.62 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 12.7 t90 -91.32 -44.83 8.94 Favored 'General case' 0 N--CA 1.456 -0.166 0 C-N-CA 124.379 1.071 . . . . 0.0 110.133 175.419 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -61.7 -35.31 77.66 Favored 'General case' 0 CA--C 1.535 0.396 0 O-C-N 121.266 -0.896 . . . . 0.0 109.945 -178.383 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -58.38 -24.73 60.79 Favored 'General case' 0 C--O 1.233 0.199 0 C-N-CA 124.465 1.106 . . . . 0.0 111.738 -177.725 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 35.7 m -115.13 -13.87 11.07 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.245 0 CA-C-O 117.327 -1.321 . . . . 0.0 112.354 178.0 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 25.1 t90 -52.64 -38.94 61.24 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 120.291 1.405 . . . . 0.0 110.576 -179.02 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -63.17 -26.93 69.03 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 125.098 1.359 . . . . 0.0 113.216 176.543 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 26.0 mt-30 -92.4 -20.09 21.4 Favored 'General case' 0 C--N 1.342 0.243 0 C-N-CA 125.735 1.614 . . . . 0.0 112.31 178.114 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 47.9 mt -64.12 -23.17 67.22 Favored 'General case' 0 N--CA 1.465 0.305 0 O-C-N 121.212 -0.93 . . . . 0.0 111.337 -175.756 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -79.99 -22.25 42.72 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-N 118.372 0.533 . . . . 0.0 111.877 174.684 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -70.72 -27.47 63.99 Favored 'General case' 0 N--CA 1.471 0.618 0 O-C-N 120.979 -1.076 . . . . 0.0 111.521 176.608 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 27.3 mt -62.06 149.67 40.43 Favored 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 124.855 1.262 . . . . 0.0 109.592 -179.636 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 28.1 t-20 -72.0 -59.86 2.53 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-O 122.634 1.206 . . . . 0.0 112.424 -174.987 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 16.7 mt 58.44 2.25 0.21 Allowed 'General case' 0 C--N 1.32 -0.686 0 C-N-CA 129.5 3.12 . . . . 0.0 116.739 175.679 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 30.9 mt-10 -58.59 130.12 45.33 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 120.188 1.358 . . . . 0.0 111.864 -169.186 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 71.18 0.1 34.35 Favored Glycine 0 CA--C 1.533 1.159 0 CA-C-O 117.964 -1.464 . . . . 0.0 114.908 176.24 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.11 155.29 37.25 Favored 'General case' 0 C--N 1.343 0.323 0 CA-C-N 120.681 2.241 . . . . 0.0 110.225 -174.414 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 1.9 mt -84.71 140.91 15.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 N-CA-C 106.875 -1.528 . . . . 0.0 106.875 178.194 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 54.9 t -135.4 138.98 47.58 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.706 0 C-N-CA 124.012 0.925 . . . . 0.0 109.024 -179.161 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.488 ' HB1' ' CH2' ' A' ' 160' ' ' TRP . . . -111.19 142.68 43.06 Favored 'General case' 0 CA--C 1.517 -0.301 0 N-CA-C 104.365 -2.458 . . . . 0.0 104.365 166.763 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 30.8 mt -122.19 144.88 48.69 Favored 'General case' 0 CA--C 1.51 -0.594 0 CA-C-N 120.262 1.392 . . . . 0.0 107.373 169.973 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 41.6 p90 -150.4 162.75 39.94 Favored 'General case' 0 N--CA 1.44 -0.934 0 N-CA-C 107.744 -1.206 . . . . 0.0 107.744 168.286 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -157.58 171.58 34.78 Favored Glycine 0 N--CA 1.443 -0.897 0 N-CA-C 109.691 -1.364 . . . . 0.0 109.691 171.459 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 6.8 tt . . . . . 0 N--CA 1.446 -0.632 0 C-N-CA 125.04 1.336 . . . . 0.0 108.334 175.677 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 97.5 mt . . . . . 0 N--CA 1.472 0.663 0 N-CA-C 113.807 1.04 . . . . 0.0 113.807 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -67.28 -32.22 73.06 Favored 'General case' 0 C--N 1.329 -0.302 0 O-C-N 120.539 -1.35 . . . . 0.0 110.577 -171.685 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -70.68 -30.25 66.79 Favored 'General case' 0 CA--C 1.535 0.396 0 O-C-N 121.503 -0.748 . . . . 0.0 111.834 173.968 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 6.3 tt -61.77 -46.52 89.23 Favored 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 107.845 -1.169 . . . . 0.0 107.845 169.349 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -62.04 -38.07 95.48 Favored Glycine 0 CA--C 1.524 0.603 0 N-CA-C 111.086 -0.806 . . . . 0.0 111.086 -177.996 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 103' ' ' MET . . . . . 0.425 ' HE3' HD11 ' A' ' 61' ' ' ILE . 74.3 mtm -68.5 -39.26 81.34 Favored 'General case' 0 N--CA 1.454 -0.243 0 CA-C-O 118.246 -0.883 . . . . 0.0 111.489 177.705 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.46 ' HA ' HD22 ' A' ' 104' ' ' LEU . 0.2 OUTLIER -71.98 -32.08 66.88 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-N 120.52 1.509 . . . . 0.0 110.649 177.209 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -56.5 -56.58 19.46 Favored 'General case' 0 N--CA 1.462 0.146 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 167.891 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -63.39 -38.53 91.52 Favored 'General case' 0 C--O 1.235 0.338 0 C-N-CA 123.49 0.716 . . . . 0.0 112.025 -170.852 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 23.5 ttmm -58.34 -44.42 88.72 Favored 'General case' 0 CA--C 1.529 0.161 0 C-N-CA 122.804 0.442 . . . . 0.0 109.834 171.619 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 49.0 mt -83.49 -20.05 34.67 Favored 'General case' 0 CA--C 1.519 -0.238 0 N-CA-C 114.445 1.276 . . . . 0.0 114.445 -169.512 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 1.1 m -59.57 -36.53 76.41 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 120.567 1.53 . . . . 0.0 111.375 -172.544 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 20.0 p -84.33 -15.35 46.86 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 124.922 1.289 . . . . 0.0 111.732 -178.948 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 30.7 mmmt -78.34 -14.1 59.56 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 124.212 1.005 . . . . 0.0 110.844 173.869 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 79.28 33.45 35.61 Favored Glycine 0 CA--C 1.524 0.653 0 CA-C-O 119.333 -0.704 . . . . 0.0 112.335 170.22 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 12.9 m -75.91 170.04 1.58 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.458 0 CA-C-N 118.518 1.159 . . . . 0.0 110.203 173.218 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 16.5 tptm -101.62 129.29 47.71 Favored 'General case' 0 CA--C 1.515 -0.402 0 N-CA-C 105.086 -2.19 . . . . 0.0 105.086 168.219 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 65.9 m-85 -93.78 123.92 37.44 Favored 'General case' 0 C--N 1.33 -0.239 0 N-CA-C 107.654 -1.239 . . . . 0.0 107.654 171.303 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 30.2 m -106.18 160.95 5.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 C-N-CA 123.914 0.886 . . . . 0.0 109.387 168.649 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 99.18 -77.07 0.51 Allowed Glycine 0 N--CA 1.446 -0.67 0 C-N-CA 125.122 1.344 . . . . 0.0 111.839 170.651 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 20.8 m-85 55.39 -170.17 0.07 Allowed 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 124.129 0.972 . . . . 0.0 110.861 -169.639 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -154.57 143.41 14.77 Favored Pre-proline 0 N--CA 1.466 0.332 0 CA-C-O 117.628 -1.177 . . . . 0.0 108.809 168.737 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_exo -61.97 127.72 22.16 Favored 'Trans proline' 0 CA--C 1.533 0.461 0 C-N-CA 122.209 1.94 . . . . 0.0 111.144 178.403 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 10.4 p . . . . . 0 N--CA 1.47 0.527 0 N-CA-C 112.753 0.649 . . . . 0.0 112.753 174.199 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 23.6 ttmt . . . . . 0 CA--C 1.54 0.586 0 CA-C-O 117.457 -1.259 . . . . 0.0 113.844 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -81.99 5.35 6.38 Favored 'Trans proline' 0 C--N 1.352 0.746 0 CA-C-N 122.187 1.817 . . . . 0.0 113.551 -176.588 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 17.1 m -135.5 170.05 19.85 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.249 0 CA-C-N 120.622 1.556 . . . . 0.0 111.36 -169.574 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 14.5 pt -141.1 175.23 6.02 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.657 0 C-N-CA 127.876 2.47 . . . . 0.0 108.254 -179.472 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . 54.8 42.59 31.04 Favored 'General case' 0 N--CA 1.464 0.266 0 C-N-CA 125.27 1.428 . . . . 0.0 112.342 173.849 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 27.1 t0 53.69 41.5 32.06 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 126.184 1.794 . . . . 0.0 111.696 -176.452 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 88.03 14.51 62.49 Favored Glycine 0 CA--C 1.526 0.758 0 CA-C-O 118.496 -1.169 . . . . 0.0 113.771 174.037 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 45.7 mt-30 -84.65 -17.31 39.0 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 119.462 1.631 . . . . 0.0 112.658 -179.892 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -143.91 144.74 31.86 Favored 'General case' 0 C--N 1.342 0.252 0 CA-C-N 119.266 0.939 . . . . 0.0 110.379 174.174 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 68.3 m-85 -73.71 141.43 46.38 Favored 'General case' 0 CA--C 1.512 -0.489 0 N-CA-C 105.08 -2.192 . . . . 0.0 105.08 165.173 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 8.0 p -79.05 14.46 0.35 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.672 0 CA-C-O 121.363 0.601 . . . . 0.0 111.714 -176.412 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -178.82 172.87 45.18 Favored Glycine 0 CA--C 1.525 0.712 0 N-CA-C 109.209 -1.556 . . . . 0.0 109.209 177.262 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -66.21 138.66 57.83 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 117.658 0.729 . . . . 0.0 111.122 -176.214 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -98.5 118.47 35.27 Favored 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 125.716 1.607 . . . . 0.0 109.068 175.883 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 93.5 mt . . . . . 0 C--N 1.33 -0.256 0 C-N-CA 123.776 0.831 . . . . 0.0 109.153 169.651 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 50.7 m . . . . . 0 CA--C 1.536 0.425 0 CA-C-O 119.606 -0.235 . . . . 0.0 110.582 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -60.71 -40.74 93.39 Favored 'General case' 0 N--CA 1.464 0.231 0 C-N-CA 123.35 0.66 . . . . 0.0 111.448 170.398 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -65.02 -45.11 86.88 Favored 'General case' 0 C--O 1.234 0.288 0 C-N-CA 124.869 1.268 . . . . 0.0 110.315 177.042 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 81.8 mtt180 -58.06 -47.58 82.71 Favored 'General case' 0 N--CA 1.462 0.148 0 CA-C-O 118.649 -0.691 . . . . 0.0 110.089 176.314 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 46.4 mt -62.8 -53.23 49.5 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.281 0 N-CA-C 107.904 -1.147 . . . . 0.0 107.904 179.696 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 69.8 tp60 -53.68 -61.15 2.49 Favored 'General case' 0 C--O 1.233 0.22 0 C-N-CA 124.024 0.929 . . . . 0.0 110.867 -175.943 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 44.3 p -65.02 -36.84 85.66 Favored 'General case' 0 C--N 1.326 -0.418 0 O-C-N 123.062 0.227 . . . . 0.0 110.95 -170.375 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 160' ' ' TRP . . . . . 0.488 ' CH2' ' HB1' ' A' ' 83' ' ' ALA . 36.0 t90 -67.73 -44.17 78.21 Favored 'General case' 0 C--O 1.221 -0.395 0 O-C-N 122.248 -0.283 . . . . 0.0 110.929 177.465 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 58.7 m -59.18 -44.29 92.18 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 123.039 0.536 . . . . 0.0 110.703 178.541 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -62.49 -41.96 99.16 Favored 'General case' 0 N--CA 1.456 -0.13 0 CA-C-O 121.071 0.463 . . . . 0.0 109.888 176.38 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 12.6 tt0 -62.9 -52.92 61.19 Favored 'General case' 0 N--CA 1.448 -0.537 0 O-C-N 121.664 -0.647 . . . . 0.0 110.095 -179.02 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 45.0 pt -62.47 -37.77 79.65 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.399 0 CA-C-O 117.582 -1.199 . . . . 0.0 109.23 -174.401 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -65.53 -33.34 75.69 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 119.552 1.069 . . . . 0.0 110.488 -179.45 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 34.6 m-80 -71.88 -51.68 21.11 Favored 'General case' 0 N--CA 1.465 0.315 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 175.786 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 8.9 tt0 -72.38 -31.92 65.97 Favored 'General case' 0 N--CA 1.441 -0.92 0 C-N-CA 123.79 0.836 . . . . 0.0 110.941 -168.566 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 168' ' ' MET . . . . . . . . . . . . . 21.3 ptp -69.88 -31.8 69.8 Favored 'General case' 0 C--N 1.331 -0.196 0 O-C-N 121.068 -1.02 . . . . 0.0 111.407 171.744 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -78.57 -44.12 24.94 Favored 'General case' 0 N--CA 1.443 -0.796 0 CA-C-O 120.375 0.131 . . . . 0.0 110.983 -175.518 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 . . . . . 0 CA--C 1.54 0.566 0 N-CA-C 110.088 -0.338 . . . . 0.0 110.088 176.893 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.496 1.85 0 N-CA-C 111.252 0.093 . . . . 0.0 111.252 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 3.0 t30 -119.03 151.62 37.9 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 124.223 1.009 . . . . 0.0 109.784 -174.558 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 1.4 mpt? -116.88 125.89 52.18 Favored 'General case' 0 N--CA 1.463 0.22 0 C-N-CA 123.76 0.824 . . . . 0.0 110.706 179.23 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -82.83 153.2 30.92 Favored Glycine 0 CA--C 1.527 0.811 0 N-CA-C 107.51 -2.236 . . . . 0.0 107.51 166.96 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 3.1 tt -140.26 97.11 3.16 Favored 'General case' 0 N--CA 1.465 0.312 0 N-CA-C 104.888 -2.264 . . . . 0.0 104.888 -176.06 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' PHE . . . . . 0.414 ' CE2' ' HG ' ' A' ' 51' ' ' LEU . 0.3 OUTLIER -103.44 147.02 27.64 Favored 'General case' 0 N--CA 1.455 -0.181 0 CA-C-O 121.577 0.703 . . . . 0.0 111.914 -172.155 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 47.6 p90 . . . . . 0 C--N 1.33 -0.281 0 C-N-CA 126.294 1.838 . . . . 0.0 107.994 176.425 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.223 -0.337 0 CA-C-O 118.523 -0.751 . . . . 0.0 111.054 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -66.11 -43.49 87.05 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 119.94 1.245 . . . . 0.0 111.609 -179.751 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 67.0 mm-40 -62.68 -47.53 83.23 Favored 'General case' 0 N--CA 1.464 0.261 0 N-CA-C 109.16 -0.682 . . . . 0.0 109.16 173.023 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 29.2 mtpp -70.16 -36.85 74.98 Favored 'General case' 0 C--O 1.221 -0.397 0 CA-C-O 118.428 -0.796 . . . . 0.0 110.796 -169.351 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 32.1 mt -53.95 -55.93 11.71 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.223 0 CA-C-N 119.307 0.958 . . . . 0.0 108.687 173.472 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 18.2 ptt180 -65.25 -38.44 90.36 Favored 'General case' 0 C--N 1.344 0.343 0 C-N-CA 120.153 -0.619 . . . . 0.0 110.03 -176.687 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -64.69 -38.63 91.65 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 -174.553 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 64.0 mt -78.27 -56.13 8.3 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.63 0 C-N-CA 125.496 1.518 . . . . 0.0 110.057 -174.435 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 77.0 mt -64.66 -45.88 94.02 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 -177.755 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 141.58 120.35 1.62 Allowed Glycine 0 CA--C 1.53 0.975 0 C-N-CA 125.452 1.501 . . . . 0.0 110.595 176.969 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -75.53 -4.43 15.26 Favored 'Trans proline' 0 CA--C 1.538 0.705 0 C-N-CA 122.82 2.347 . . . . 0.0 113.183 -171.554 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -82.99 -20.5 35.01 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 118.945 0.793 . . . . 0.0 111.418 176.551 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 1.2 pt? -120.96 -14.19 8.49 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 125.057 1.343 . . . . 0.0 113.589 -175.689 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 62.5 t -97.46 148.02 6.01 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 N-CA-C 107.315 -1.365 . . . . 0.0 107.315 168.622 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 46.6 m -135.3 133.08 38.49 Favored 'General case' 0 C--N 1.332 -0.175 0 C-N-CA 125.659 1.584 . . . . 0.0 108.188 -178.906 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 35.7 mt -82.3 142.57 31.96 Favored 'General case' 0 C--O 1.234 0.263 0 N-CA-C 108.574 -0.898 . . . . 0.0 108.574 177.682 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 28.6 t-80 -139.39 60.65 1.57 Allowed 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 124.481 1.112 . . . . 0.0 108.335 -173.577 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 64.3 t-20 -60.88 126.76 28.57 Favored 'General case' 0 C--O 1.232 0.181 0 N-CA-C 107.128 -1.434 . . . . 0.0 107.128 173.309 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 83.3 mt -66.72 -22.44 66.06 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 123.24 0.616 . . . . 0.0 112.16 -179.64 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 56.7 tttt -66.66 -22.11 66.1 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 118.147 0.43 . . . . 0.0 111.708 169.143 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -107.62 -35.3 6.75 Favored 'General case' 0 C--O 1.234 0.272 0 C-N-CA 124.081 0.953 . . . . 0.0 113.25 -169.661 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 2.9 t0 -139.14 155.53 47.79 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 118.717 0.69 . . . . 0.0 112.151 178.128 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 17.2 m -75.06 157.94 84.81 Favored Pre-proline 0 CA--C 1.54 0.595 0 C-N-CA 125.618 1.567 . . . . 0.0 111.482 -170.68 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -73.89 -26.29 13.44 Favored 'Trans proline' 0 C--N 1.349 0.563 0 C-N-CA 122.778 2.318 . . . . 0.0 113.236 -171.68 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 22.7 mmmt -71.27 -12.08 61.26 Favored 'General case' 0 N--CA 1.471 0.576 0 O-C-N 120.395 -1.441 . . . . 0.0 111.716 -176.44 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -61.21 -28.41 69.13 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 125.451 1.5 . . . . 0.0 110.38 168.923 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 45.5 mtt -58.71 -25.96 63.42 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 118.591 0.632 . . . . 0.0 111.745 177.478 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 88.0 mt-10 -65.93 -32.56 74.14 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-O 119.017 -0.516 . . . . 0.0 110.249 -176.567 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 21.2 mt-30 -65.9 -44.28 85.69 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 123.601 0.76 . . . . 0.0 112.541 -170.362 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 52.5 m-85 -74.78 142.24 44.3 Favored 'General case' 0 N--CA 1.456 -0.153 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.662 -166.724 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -69.21 -42.48 75.68 Favored 'General case' 0 C--O 1.235 0.29 0 N-CA-C 109.894 -0.41 . . . . 0.0 109.894 176.413 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 7.2 t -106.33 143.76 16.7 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.368 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 175.306 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 37.8 tp -131.64 114.36 14.71 Favored 'General case' 0 N--CA 1.444 -0.77 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 174.295 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 31.8 mt -94.44 132.75 37.61 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 N-CA-C 106.781 -1.563 . . . . 0.0 106.781 178.416 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.414 ' HG ' ' CE2' ' A' ' 6' ' ' PHE . 3.1 mp -113.95 130.15 56.54 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 125.641 1.577 . . . . 0.0 107.102 -176.583 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -135.67 126.83 4.06 Favored Glycine 0 C--N 1.335 0.491 0 N-CA-C 109.908 -1.277 . . . . 0.0 109.908 177.607 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 7.4 tt -153.57 127.3 4.36 Favored Pre-proline 0 CA--C 1.538 0.496 0 CA-C-N 117.872 0.836 . . . . 0.0 109.892 172.298 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo . . . . . 0 N--CA 1.459 -0.544 0 C-N-CA 122.268 1.979 . . . . 0.0 112.782 169.496 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 65.9 mt . . . . . 0 N--CA 1.449 -0.492 0 N-CA-C 107.378 -1.342 . . . . 0.0 107.378 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -85.32 164.81 17.76 Favored 'General case' 0 C--O 1.234 0.254 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 173.661 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -55.2 -38.41 68.37 Favored 'General case' 0 C--O 1.222 -0.36 0 C-N-CA 123.811 0.844 . . . . 0.0 110.741 179.793 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -61.2 -24.48 66.36 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-N 118.792 0.724 . . . . 0.0 112.562 -177.074 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' TRP . . . . . 0.415 ' CH2' HD23 ' A' ' 104' ' ' LEU . 12.2 t90 -96.63 -47.57 5.86 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 124.89 1.276 . . . . 0.0 109.348 176.611 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -64.41 -33.71 76.49 Favored 'General case' 0 CA--C 1.539 0.534 0 O-C-N 120.833 -1.167 . . . . 0.0 110.593 -175.282 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -63.46 -26.58 68.79 Favored 'General case' 0 CA--C 1.529 0.135 0 C-N-CA 123.273 0.629 . . . . 0.0 110.872 -173.956 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 29.1 m -108.57 -15.43 9.36 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.314 0 CA-C-O 117.366 -1.302 . . . . 0.0 111.879 177.12 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 29.4 t90 -51.35 -35.5 38.73 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-N 120.189 1.359 . . . . 0.0 110.679 177.108 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -62.86 -29.33 70.67 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 125.441 1.496 . . . . 0.0 113.303 175.367 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 31.0 mt-30 -92.42 -18.3 23.44 Favored 'General case' 0 N--CA 1.463 0.209 0 C-N-CA 126.09 1.756 . . . . 0.0 112.324 177.29 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 56.7 mt -63.48 -21.04 66.09 Favored 'General case' 0 CA--C 1.534 0.338 0 O-C-N 121.304 -0.872 . . . . 0.0 111.496 -178.119 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -80.11 -23.05 41.49 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 123.011 0.525 . . . . 0.0 111.868 173.671 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -71.83 -30.32 65.36 Favored 'General case' 0 N--CA 1.468 0.466 0 O-C-N 120.705 -1.247 . . . . 0.0 111.843 177.529 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 79.5 mt -52.96 140.85 23.68 Favored 'General case' 0 C--N 1.34 0.174 0 C-N-CA 125.012 1.325 . . . . 0.0 112.757 -168.787 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 28.9 t-20 -74.97 106.43 6.47 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 169.312 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 64.7 mt -128.61 0.07 5.52 Favored 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 113.891 1.071 . . . . 0.0 113.891 -174.393 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 27.2 mt-10 -57.79 128.38 36.81 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 119.658 1.117 . . . . 0.0 110.689 -169.031 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 71.65 -0.05 37.45 Favored Glycine 0 CA--C 1.532 1.127 0 C-N-CA 125.397 1.475 . . . . 0.0 115.046 179.445 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.26 151.55 39.87 Favored 'General case' 0 C--N 1.348 0.51 0 CA-C-N 120.798 2.299 . . . . 0.0 109.649 -177.775 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 3.6 mt -80.67 136.9 22.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 N-CA-C 106.765 -1.568 . . . . 0.0 106.765 178.876 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 68.8 t -132.17 131.56 61.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 C-N-CA 123.813 0.845 . . . . 0.0 109.833 -178.555 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -105.39 150.12 25.52 Favored 'General case' 0 N--CA 1.463 0.192 0 N-CA-C 107.417 -1.327 . . . . 0.0 107.417 168.603 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 3.6 mt -132.24 134.19 45.02 Favored 'General case' 0 CA--C 1.51 -0.594 0 N-CA-C 107.265 -1.383 . . . . 0.0 107.265 177.77 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 35.8 p90 -151.03 165.84 32.55 Favored 'General case' 0 N--CA 1.447 -0.595 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 168.764 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -162.62 159.59 31.9 Favored Glycine 0 N--CA 1.444 -0.784 0 N-CA-C 108.556 -1.817 . . . . 0.0 108.556 172.963 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 7.0 tt . . . . . 0 N--CA 1.445 -0.7 0 N-CA-C 108.493 -0.929 . . . . 0.0 108.493 171.56 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 83.8 mt . . . . . 0 N--CA 1.467 0.379 0 N-CA-C 115.679 1.733 . . . . 0.0 115.679 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -61.84 -36.62 81.72 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-N 121.511 1.959 . . . . 0.0 111.29 -173.37 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -65.83 -27.74 68.47 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 124.328 1.051 . . . . 0.0 112.295 174.52 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 5.3 tt -66.56 -46.69 75.22 Favored 'General case' 0 N--CA 1.467 0.424 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 173.056 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -63.47 -34.6 90.4 Favored Glycine 0 CA--C 1.529 0.944 0 N-CA-C 110.659 -0.976 . . . . 0.0 110.659 -179.732 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 5.2 tpp -50.89 -54.08 27.03 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 124.963 1.305 . . . . 0.0 111.527 175.88 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.415 HD23 ' CH2' ' A' ' 65' ' ' TRP . 0.2 OUTLIER -76.82 -36.61 56.77 Favored 'General case' 0 C--N 1.341 0.238 0 O-C-N 121.891 -0.506 . . . . 0.0 109.782 -175.195 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 43.1 t-80 -55.71 -48.88 74.41 Favored 'General case' 0 N--CA 1.464 0.231 0 O-C-N 121.436 -0.79 . . . . 0.0 110.872 176.261 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -63.44 -38.77 92.42 Favored 'General case' 0 C--O 1.234 0.288 0 C-N-CA 123.288 0.635 . . . . 0.0 112.103 -176.323 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 24.4 ttmm -57.45 -36.09 70.98 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 123.382 0.673 . . . . 0.0 110.727 172.825 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 22.3 mt -91.86 -20.49 21.4 Favored 'General case' 0 CA--C 1.513 -0.45 0 N-CA-C 115.8 1.778 . . . . 0.0 115.8 -168.238 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 6.0 m -58.15 -33.62 69.38 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-N 120.481 1.491 . . . . 0.0 111.627 -178.218 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 20.7 p -87.39 -9.33 55.04 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 124.884 1.274 . . . . 0.0 112.287 -179.807 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 32.5 mmmt -84.53 -4.63 59.06 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 124.461 1.104 . . . . 0.0 111.453 172.975 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 69.92 31.96 69.89 Favored Glycine 0 CA--C 1.525 0.657 0 CA-C-N 118.605 0.639 . . . . 0.0 112.105 171.827 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 3.5 m -76.33 172.38 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.474 0 CA-C-N 118.104 0.952 . . . . 0.0 109.457 175.237 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -111.9 121.1 44.11 Favored 'General case' 0 CA--C 1.515 -0.386 0 N-CA-C 106.474 -1.676 . . . . 0.0 106.474 173.615 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 64.0 m-85 -88.32 145.35 25.88 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 119.61 1.095 . . . . 0.0 109.378 -178.13 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 27.7 m -129.4 161.08 39.58 Favored 'Isoleucine or valine' 0 C--O 1.233 0.212 0 C-N-CA 124.223 1.009 . . . . 0.0 109.289 171.588 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 93.2 -94.18 1.83 Allowed Glycine 0 N--CA 1.443 -0.877 0 C-N-CA 124.817 1.199 . . . . 0.0 110.804 176.435 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 8.0 m-30 59.57 177.05 0.08 Allowed 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 125.109 1.364 . . . . 0.0 110.188 -167.986 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -155.27 140.94 12.65 Favored Pre-proline 0 N--CA 1.473 0.7 0 CA-C-O 116.872 -1.537 . . . . 0.0 108.76 -179.468 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -68.13 127.77 16.47 Favored 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 122.698 2.265 . . . . 0.0 112.64 -176.166 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 68.0 p . . . . . 0 N--CA 1.473 0.696 0 N-CA-C 112.393 0.516 . . . . 0.0 112.393 169.619 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 32.5 ttmt . . . . . 0 N--CA 1.471 0.618 0 CA-C-O 117.668 -1.158 . . . . 0.0 113.412 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 62.9 Cg_endo -84.77 13.86 2.64 Favored 'Trans proline' 0 C--N 1.348 0.539 0 C-N-CA 121.844 1.696 . . . . 0.0 113.581 -178.866 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 35.1 m -128.63 154.9 40.11 Favored 'Isoleucine or valine' 0 C--O 1.235 0.3 0 CA-C-N 121.777 2.08 . . . . 0.0 111.109 179.065 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 17.8 pt -114.32 167.94 6.66 Favored 'Isoleucine or valine' 0 C--O 1.235 0.319 0 C-N-CA 126.41 1.884 . . . . 0.0 109.145 174.82 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . 57.73 32.94 22.61 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 124.967 1.307 . . . . 0.0 113.484 167.687 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 27.6 t70 54.99 39.83 31.78 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 126.251 1.82 . . . . 0.0 111.592 -175.164 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 93.63 72.21 1.18 Allowed Glycine 0 CA--C 1.528 0.854 0 C-N-CA 124.487 1.042 . . . . 0.0 111.243 177.013 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 78.8 mm-40 -116.66 -49.57 2.64 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 123.168 0.587 . . . . 0.0 110.354 167.375 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -132.48 146.52 51.99 Favored 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 123.017 0.527 . . . . 0.0 110.969 -179.252 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 58.9 m-85 -77.63 16.79 0.61 Allowed 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 126.189 1.796 . . . . 0.0 115.65 177.879 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 3.7 m 49.64 11.73 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.547 0.831 0 C-N-CA 126.927 2.091 . . . . 0.0 114.469 -176.586 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 170.42 170.06 34.28 Favored Glycine 0 CA--C 1.527 0.805 0 N-CA-C 108.368 -1.893 . . . . 0.0 108.368 -171.562 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -69.24 134.95 49.84 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 117.977 0.888 . . . . 0.0 111.007 -178.347 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -95.87 109.94 22.21 Favored 'General case' 0 N--CA 1.448 -0.571 0 C-N-CA 125.52 1.528 . . . . 0.0 109.056 175.291 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 83.8 mt . . . . . 0 C--N 1.332 -0.179 0 CA-C-N 118.845 0.748 . . . . 0.0 109.561 170.157 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 13.3 m . . . . . 0 CA--C 1.543 0.681 0 N-CA-C 110.156 -0.312 . . . . 0.0 110.156 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -63.96 -39.54 94.36 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 123.972 0.909 . . . . 0.0 111.671 172.645 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 -64.55 -46.98 80.51 Favored 'General case' 0 C--O 1.234 0.263 0 C-N-CA 124.294 1.038 . . . . 0.0 109.858 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 72.1 mtt180 -55.32 -41.1 71.98 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-O 118.795 -0.622 . . . . 0.0 110.627 177.039 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 75.9 mt -68.39 -57.97 7.39 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.299 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 177.316 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 70.8 tp60 -49.64 -63.04 1.23 Allowed 'General case' 0 C--O 1.233 0.193 0 C-N-CA 125.12 1.368 . . . . 0.0 112.106 -173.94 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 20.0 m -66.8 -31.95 72.91 Favored 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 120.826 -0.35 . . . . 0.0 111.245 -170.342 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 160' ' ' TRP . . . . . . . . . . . . . 34.0 t90 -70.87 -44.32 66.61 Favored 'General case' 0 CA--C 1.516 -0.342 0 O-C-N 122.005 -0.434 . . . . 0.0 110.898 176.999 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 98.4 m -59.46 -42.79 92.81 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 122.846 0.458 . . . . 0.0 110.093 177.454 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -63.44 -41.86 98.66 Favored 'General case' 0 N--CA 1.456 -0.147 0 CA-C-O 121.006 0.431 . . . . 0.0 110.181 175.72 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 14.7 tt0 -62.61 -51.99 65.14 Favored 'General case' 0 N--CA 1.449 -0.495 0 O-C-N 121.692 -0.63 . . . . 0.0 109.934 -178.938 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 42.2 pt -63.27 -37.98 80.9 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.328 0 CA-C-O 117.669 -1.158 . . . . 0.0 109.231 -175.714 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -65.75 -34.91 79.28 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 119.776 1.171 . . . . 0.0 110.486 -179.548 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 31.2 m-80 -68.49 -50.59 51.13 Favored 'General case' 0 CA--C 1.516 -0.34 0 N-CA-C 108.785 -0.821 . . . . 0.0 108.785 175.285 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 15.5 tt0 -71.14 -33.61 70.24 Favored 'General case' 0 N--CA 1.438 -1.062 0 C-N-CA 124.174 0.99 . . . . 0.0 111.131 -168.616 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 168' ' ' MET . . . . . . . . . . . . . 22.9 ptp -72.42 -30.18 64.39 Favored 'General case' 0 C--N 1.332 -0.171 0 O-C-N 121.136 -0.978 . . . . 0.0 111.702 173.738 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -79.48 -41.16 28.08 Favored 'General case' 0 N--CA 1.447 -0.601 0 C-N-CA 122.636 0.375 . . . . 0.0 111.416 -179.765 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 . . . . . 0 CA--C 1.535 0.379 0 C-N-CA 122.964 0.506 . . . . 0.0 110.454 -178.578 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.498 1.931 0 CA-C-O 120.011 -0.042 . . . . 0.0 111.078 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 4.0 t30 -116.66 151.36 36.47 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 124.195 0.998 . . . . 0.0 110.134 -173.483 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 1.2 mpt? -118.75 123.31 44.52 Favored 'General case' 0 C--N 1.334 -0.096 0 C-N-CA 123.747 0.819 . . . . 0.0 111.183 179.47 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -81.85 153.93 33.37 Favored Glycine 0 CA--C 1.524 0.655 0 N-CA-C 107.521 -2.232 . . . . 0.0 107.521 166.655 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 3.3 tt -140.3 96.47 3.05 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 105.422 -2.066 . . . . 0.0 105.422 -176.414 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -102.98 143.83 32.04 Favored 'General case' 0 CA--C 1.517 -0.303 0 CA-C-O 121.769 0.795 . . . . 0.0 112.186 -170.86 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 36.3 p90 . . . . . 0 N--CA 1.451 -0.393 0 C-N-CA 127.676 2.391 . . . . 0.0 106.237 177.141 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.222 -0.373 0 CA-C-O 117.954 -1.022 . . . . 0.0 113.082 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -58.74 -47.09 85.85 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 120.188 1.358 . . . . 0.0 111.077 -179.002 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -64.53 -46.43 82.91 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 123.104 0.562 . . . . 0.0 109.568 177.088 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 58.4 mttm -60.33 -45.58 92.93 Favored 'General case' 0 N--CA 1.466 0.367 0 O-C-N 121.755 -0.59 . . . . 0.0 111.596 -178.964 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 44.2 mt -53.72 -55.74 12.18 Favored 'Isoleucine or valine' 0 C--O 1.234 0.242 0 C-N-CA 124.465 1.106 . . . . 0.0 108.505 176.215 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 1.3 ttp180 -60.73 -41.29 95.04 Favored 'General case' 0 C--O 1.223 -0.31 0 CA-C-O 118.929 -0.558 . . . . 0.0 109.687 -174.675 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -68.02 -42.66 80.3 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 123.206 0.602 . . . . 0.0 111.173 -177.724 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.413 HD13 ' HA ' ' A' ' 158' ' ' GLN . 61.6 mt -74.12 -53.39 17.48 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.351 0 C-N-CA 124.508 1.123 . . . . 0.0 109.619 -171.251 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 74.5 mt -64.79 -46.0 93.35 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.434 0 N-CA-C 109.195 -0.669 . . . . 0.0 109.195 178.359 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 139.96 126.41 2.3 Favored Glycine 0 CA--C 1.534 1.221 0 C-N-CA 124.868 1.223 . . . . 0.0 112.132 172.562 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -71.23 -7.37 21.2 Favored 'Trans proline' 0 CA--C 1.536 0.585 0 C-N-CA 124.067 3.178 . . . . 0.0 113.613 -176.22 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -83.8 -17.22 41.79 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 119.081 0.855 . . . . 0.0 111.251 177.873 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 1.2 pt? -128.32 -16.14 4.49 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 124.998 1.319 . . . . 0.0 113.625 -175.239 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 41.5 t -97.05 154.79 3.62 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.542 0 N-CA-C 107.292 -1.373 . . . . 0.0 107.292 168.012 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 27.9 m -142.34 130.14 21.65 Favored 'General case' 0 C--O 1.232 0.146 0 N-CA-C 105.934 -1.876 . . . . 0.0 105.934 -176.136 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 17.8 mt -80.57 141.43 35.08 Favored 'General case' 0 C--O 1.232 0.18 0 N-CA-C 107.77 -1.196 . . . . 0.0 107.77 175.952 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 35.0 t-80 -131.9 61.03 1.66 Allowed 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 124.671 1.188 . . . . 0.0 107.847 -174.97 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 64.6 t-20 -72.09 116.56 12.65 Favored 'General case' 0 C--O 1.234 0.267 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 -178.039 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 99.1 mt -65.54 -13.44 58.94 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 124.345 1.058 . . . . 0.0 112.787 -177.229 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 28.5 tptp -57.06 -25.87 59.42 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 123.243 0.617 . . . . 0.0 110.953 168.631 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -129.46 -40.35 1.43 Allowed 'General case' 0 N--CA 1.464 0.246 0 C-N-CA 123.871 0.868 . . . . 0.0 113.279 -175.002 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 34.0 m-20 -89.59 141.01 28.99 Favored 'General case' 0 C--O 1.234 0.285 0 C-N-CA 123.382 0.673 . . . . 0.0 110.551 -175.676 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 15.2 m -75.88 155.38 84.87 Favored Pre-proline 0 CA--C 1.543 0.677 0 C-N-CA 124.213 1.005 . . . . 0.0 109.992 175.411 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_endo -77.29 -26.27 7.64 Favored 'Trans proline' 0 C--N 1.35 0.615 0 C-N-CA 122.431 2.087 . . . . 0.0 113.588 -169.924 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 22.5 mmmt -71.63 -11.92 61.08 Favored 'General case' 0 N--CA 1.472 0.634 0 O-C-N 120.5 -1.375 . . . . 0.0 111.478 -175.702 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -60.54 -28.66 68.6 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 125.769 1.627 . . . . 0.0 110.145 168.919 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 45.9 mtt -58.08 -26.18 62.23 Favored 'General case' 0 C--N 1.343 0.306 0 C-N-CA 123.198 0.599 . . . . 0.0 111.895 177.353 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 90.8 mt-10 -66.85 -32.7 74.14 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 118.245 0.475 . . . . 0.0 110.307 -176.601 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 18.3 mt-30 -66.17 -44.74 83.17 Favored 'General case' 0 N--CA 1.464 0.267 0 C-N-CA 123.714 0.806 . . . . 0.0 112.022 -171.214 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 20.4 m-85 -70.88 139.74 50.87 Favored 'General case' 0 N--CA 1.456 -0.135 0 CA-C-N 115.403 -0.817 . . . . 0.0 109.758 -166.765 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -72.96 -38.07 66.87 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 118.506 0.594 . . . . 0.0 110.257 -179.023 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 10.5 t -108.57 146.61 14.11 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.304 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 170.715 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 43.1 tp -133.01 106.74 7.83 Favored 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 176.678 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.404 ' HA ' ' HB3' ' A' ' 83' ' ' ALA . 19.8 mt -86.22 135.78 24.32 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 N-CA-C 107.096 -1.446 . . . . 0.0 107.096 176.704 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 1.9 mp -114.0 131.38 56.36 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 126.042 1.737 . . . . 0.0 106.774 -179.013 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -136.69 126.91 3.9 Favored Glycine 0 C--N 1.332 0.343 0 N-CA-C 109.072 -1.611 . . . . 0.0 109.072 177.085 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 4.7 tt -153.74 133.71 7.66 Favored Pre-proline 0 CA--C 1.538 0.511 0 CA-C-N 118.247 1.024 . . . . 0.0 111.055 174.432 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo . . . . . 0 CA--C 1.534 0.501 0 C-N-CA 122.799 2.332 . . . . 0.0 112.78 168.278 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . 0.282 24.7 mt . . . . . 0 CA--C 1.539 0.55 0 CA-C-O 122.985 1.374 . . . . 0.0 112.111 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 3.3 mp0 -117.33 155.81 28.9 Favored 'General case' 0 C--O 1.235 0.331 0 C-N-CA 126.214 1.805 . . . . 0.0 106.568 -173.289 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -57.08 -43.4 82.12 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 122.891 0.476 . . . . 0.0 110.724 -171.458 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 -66.64 -20.9 66.09 Favored 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 112.357 0.503 . . . . 0.0 112.357 -176.023 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 11.3 t90 -91.86 -48.47 6.76 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 124.409 1.084 . . . . 0.0 109.031 177.959 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -64.27 -34.65 78.6 Favored 'General case' 0 CA--C 1.537 0.463 0 O-C-N 121.03 -1.044 . . . . 0.0 109.763 -178.218 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -59.54 -25.62 64.67 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 123.612 0.765 . . . . 0.0 111.815 -177.208 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 28.5 m -111.29 -14.67 10.54 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.315 0 CA-C-O 117.082 -1.437 . . . . 0.0 112.442 177.033 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 30.1 t90 -51.58 -35.13 40.04 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 120.491 1.496 . . . . 0.0 110.97 179.296 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -64.24 -27.9 69.37 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 125.222 1.409 . . . . 0.0 113.524 175.428 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 29.4 mt-30 -92.71 -18.98 22.29 Favored 'General case' 0 N--CA 1.463 0.22 0 C-N-CA 126.11 1.764 . . . . 0.0 112.441 175.786 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 56.3 mt -63.86 -20.57 65.92 Favored 'General case' 0 N--CA 1.465 0.319 0 O-C-N 121.21 -0.931 . . . . 0.0 111.608 -176.081 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -78.52 -22.81 46.79 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 122.985 0.514 . . . . 0.0 111.666 174.37 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -72.8 -29.79 63.55 Favored 'General case' 0 N--CA 1.467 0.411 0 O-C-N 120.729 -1.232 . . . . 0.0 111.942 178.005 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 80.9 mt -52.96 138.53 30.02 Favored 'General case' 0 C--O 1.231 0.101 0 C-N-CA 124.907 1.283 . . . . 0.0 112.896 -168.499 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 3.2 t30 -74.01 98.78 3.14 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 124.02 0.928 . . . . 0.0 108.631 170.515 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.427 HD12 HD22 ' A' ' 108' ' ' LEU . 32.8 mt -118.83 -0.76 11.17 Favored 'General case' 0 N--CA 1.472 0.659 0 N-CA-C 113.858 1.058 . . . . 0.0 113.858 -178.091 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 26.8 mt-10 -54.86 127.55 29.11 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-N 119.831 1.196 . . . . 0.0 111.623 -168.522 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 73.41 -2.24 38.84 Favored Glycine 0 CA--C 1.535 1.298 0 CA-C-O 117.824 -1.542 . . . . 0.0 115.108 179.345 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.4 154.82 36.93 Favored 'General case' 0 C--N 1.344 0.363 0 CA-C-N 120.942 2.371 . . . . 0.0 109.759 -176.678 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 2.3 mt -83.91 138.59 18.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 N-CA-C 106.866 -1.531 . . . . 0.0 106.866 177.508 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 54.3 t -130.71 135.75 59.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 C-N-CA 124.538 1.135 . . . . 0.0 108.498 -179.118 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.404 ' HB3' ' HA ' ' A' ' 50' ' ' ILE . . . -108.33 156.93 18.84 Favored 'General case' 0 CA--C 1.517 -0.299 0 N-CA-C 107.885 -1.154 . . . . 0.0 107.885 168.867 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 5.7 mt -137.76 132.42 32.72 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 107.783 -1.191 . . . . 0.0 107.783 178.714 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 39.2 p90 -149.15 165.68 31.08 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 168.421 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -167.84 157.8 30.29 Favored Glycine 0 N--CA 1.448 -0.517 0 N-CA-C 111.032 -0.827 . . . . 0.0 111.032 175.951 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 58.5 tp . . . . . 0 N--CA 1.445 -0.708 0 C-N-CA 125.691 1.596 . . . . 0.0 109.748 175.057 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 89.7 mt . . . . . 0 N--CA 1.475 0.776 0 N-CA-C 114.257 1.206 . . . . 0.0 114.257 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -62.96 -37.69 88.1 Favored 'General case' 0 C--N 1.328 -0.331 0 O-C-N 120.86 -1.15 . . . . 0.0 111.217 -173.061 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -67.66 -29.31 68.57 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 123.674 0.789 . . . . 0.0 112.416 174.391 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 5.9 tt -63.73 -49.45 73.0 Favored 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 173.375 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -61.29 -36.5 92.54 Favored Glycine 0 CA--C 1.526 0.767 0 N-CA-C 111.623 -0.591 . . . . 0.0 111.623 177.806 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 6.4 tpp -53.99 -48.52 70.31 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 124.756 1.222 . . . . 0.0 111.454 -179.152 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -77.93 -39.69 41.98 Favored 'General case' 0 C--N 1.341 0.238 0 N-CA-C 109.813 -0.439 . . . . 0.0 109.813 -177.898 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 77.9 t60 -54.14 -45.46 71.99 Favored 'General case' 0 CA--C 1.534 0.333 0 O-C-N 121.517 -0.739 . . . . 0.0 111.335 176.638 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -61.53 -41.94 98.08 Favored 'General case' 0 C--O 1.235 0.326 0 C-N-CA 123.801 0.84 . . . . 0.0 111.536 -179.506 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 24.3 ttmm -57.48 -43.39 84.04 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 123.614 0.765 . . . . 0.0 110.278 174.286 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.427 HD22 HD12 ' A' ' 77' ' ' LEU . 27.7 mt -87.25 -14.41 41.07 Favored 'General case' 0 CA--C 1.518 -0.281 0 N-CA-C 113.9 1.074 . . . . 0.0 113.9 -170.552 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 70.9 m -60.13 -32.67 71.23 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 119.835 1.198 . . . . 0.0 111.218 -174.508 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 24.6 p -89.7 -5.17 57.3 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 124.946 1.298 . . . . 0.0 112.085 179.194 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 31.7 mmmt -86.32 -6.29 58.98 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 125.014 1.326 . . . . 0.0 111.6 175.762 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 72.29 34.99 60.53 Favored Glycine 0 CA--C 1.526 0.762 0 CA-C-N 118.622 0.646 . . . . 0.0 112.522 171.483 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 5.6 m -80.97 172.12 1.16 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.51 0 CA-C-N 118.085 0.943 . . . . 0.0 109.815 173.744 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 53.0 tptt -101.85 132.73 47.46 Favored 'General case' 0 N--CA 1.469 0.477 0 N-CA-C 105.378 -2.082 . . . . 0.0 105.378 167.698 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 74.9 m-85 -99.16 123.76 43.69 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 119.161 0.891 . . . . 0.0 108.674 174.107 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 31.6 m -109.9 160.05 9.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 C-N-CA 125.196 1.398 . . . . 0.0 108.459 168.03 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 85.34 27.6 32.7 Favored Glycine 0 CA--C 1.523 0.588 0 CA-C-O 118.526 -1.152 . . . . 0.0 114.928 170.176 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 17.4 m-30 -58.21 158.21 7.37 Favored 'General case' 0 CA--C 1.54 0.596 0 CA-C-N 119.028 1.414 . . . . 0.0 110.463 168.891 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 49.4 t-105 -138.22 147.22 54.96 Favored Pre-proline 0 N--CA 1.468 0.444 0 CA-C-O 118.264 -0.874 . . . . 0.0 111.357 -169.591 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -65.03 130.99 27.27 Favored 'Trans proline' 0 CA--C 1.534 0.516 0 C-N-CA 122.765 2.31 . . . . 0.0 112.441 -179.137 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 11.3 p . . . . . 0 CA--C 1.54 0.564 0 C-N-CA 123.876 0.87 . . . . 0.0 112.002 169.412 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 16.8 ttmt . . . . . 0 CA--C 1.54 0.561 0 CA-C-O 117.355 -1.307 . . . . 0.0 113.801 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -87.5 7.76 4.56 Favored 'Trans proline' 0 C--N 1.35 0.634 0 CA-C-N 121.842 1.693 . . . . 0.0 113.777 -176.702 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 16.4 m -130.21 165.9 29.22 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.278 0 CA-C-N 121.115 1.78 . . . . 0.0 112.481 -171.167 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 12.9 pt -135.09 172.2 16.39 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.531 0 C-N-CA 128.239 2.616 . . . . 0.0 108.263 179.501 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . 53.59 42.2 31.94 Favored 'General case' 0 N--CA 1.464 0.226 0 C-N-CA 125.471 1.509 . . . . 0.0 112.648 173.726 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 27.0 t0 55.0 41.63 31.73 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 126.231 1.812 . . . . 0.0 111.766 -177.509 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 91.31 13.22 58.92 Favored Glycine 0 CA--C 1.527 0.8 0 CA-C-O 118.916 -0.935 . . . . 0.0 113.808 174.442 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 45.2 mt-30 -87.37 -7.65 57.5 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 119.29 1.545 . . . . 0.0 112.862 -177.9 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 7.6 tp -155.58 145.76 21.69 Favored 'General case' 0 C--N 1.344 0.358 0 CA-C-N 119.509 1.05 . . . . 0.0 110.797 172.238 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 61.7 m-85 -82.96 147.16 28.38 Favored 'General case' 0 CA--C 1.518 -0.279 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 169.596 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 16.7 m -77.1 2.62 1.68 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.576 0 C-N-CA 123.881 0.872 . . . . 0.0 112.393 177.234 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -172.28 169.81 42.89 Favored Glycine 0 CA--C 1.526 0.739 0 N-CA-C 110.829 -0.908 . . . . 0.0 110.829 -179.195 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 4.8 tp -63.6 135.01 56.48 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 124.272 1.029 . . . . 0.0 111.19 -179.566 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -92.99 128.04 38.71 Favored 'General case' 0 N--CA 1.446 -0.643 0 C-N-CA 124.981 1.312 . . . . 0.0 109.131 173.254 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 89.8 mt . . . . . 0 N--CA 1.464 0.248 0 C-N-CA 123.708 0.803 . . . . 0.0 109.69 169.886 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 60.9 m . . . . . 0 CA--C 1.537 0.476 0 N-CA-C 110.223 -0.288 . . . . 0.0 110.223 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -56.8 -41.78 78.35 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 123.814 0.846 . . . . 0.0 111.181 169.269 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 28.8 tt0 -70.19 -40.48 74.61 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 124.811 1.244 . . . . 0.0 111.144 -179.636 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 10.9 mmt180 -59.43 -44.22 92.94 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-O 118.296 -0.859 . . . . 0.0 109.271 174.434 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 51.5 mt -60.99 -55.28 25.74 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.242 0 N-CA-C 107.806 -1.183 . . . . 0.0 107.806 175.441 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 158' ' ' GLN . . . . . 0.413 ' HA ' HD13 ' A' ' 24' ' ' ILE . 0.8 OUTLIER -53.64 -60.74 2.92 Favored 'General case' 0 N--CA 1.454 -0.275 0 CA-C-N 119.141 0.882 . . . . 0.0 112.327 -172.765 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 31.7 m -61.52 -35.92 79.08 Favored 'General case' 0 C--N 1.32 -0.701 0 C-N-CA 122.895 0.478 . . . . 0.0 111.703 -177.022 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 160' ' ' TRP . . . . . . . . . . . . . 57.6 t90 -64.04 -45.47 88.72 Favored 'General case' 0 C--O 1.222 -0.361 0 CA-C-N 118.625 0.648 . . . . 0.0 110.53 173.618 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 99.0 m -61.61 -42.98 99.64 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 123.086 0.554 . . . . 0.0 110.703 -178.551 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -64.91 -35.88 82.58 Favored 'General case' 0 C--N 1.333 -0.123 0 CA-C-N 117.946 0.339 . . . . 0.0 110.857 175.934 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 17.1 tt0 -68.71 -52.27 32.55 Favored 'General case' 0 N--CA 1.445 -0.689 0 O-C-N 121.485 -0.76 . . . . 0.0 110.029 179.82 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 42.0 pt -62.48 -36.5 75.19 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.445 0 CA-C-O 117.997 -1.001 . . . . 0.0 109.605 -175.704 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -64.57 -36.68 85.02 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 119.466 1.03 . . . . 0.0 109.824 -179.536 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 34.7 m-80 -67.45 -50.55 58.74 Favored 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 174.739 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 25.8 tt0 -73.36 -16.74 61.34 Favored 'General case' 0 N--CA 1.442 -0.858 0 C-N-CA 125.852 1.661 . . . . 0.0 112.034 -169.392 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 168' ' ' MET . . . . . . . . . . . . . 21.2 ptp -90.08 -40.11 12.48 Favored 'General case' 0 N--CA 1.456 -0.168 0 C-N-CA 124.323 1.049 . . . . 0.0 111.448 168.507 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -73.68 -26.37 60.69 Favored 'General case' 0 N--CA 1.454 -0.265 0 CA-C-O 119.147 -0.454 . . . . 0.0 112.152 -173.574 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 . . . . . 0 CA--C 1.541 0.606 0 C-N-CA 123.22 0.608 . . . . 0.0 112.102 -179.427 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.497 1.887 0 N-CA-C 111.261 0.097 . . . . 0.0 111.261 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 26.5 p-10 -126.26 166.22 17.52 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 125.107 1.363 . . . . 0.0 111.385 -173.341 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 11.4 mtt -131.28 123.87 29.27 Favored 'General case' 0 CA--C 1.522 -0.107 0 C-N-CA 123.29 0.636 . . . . 0.0 111.371 178.225 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -86.33 153.27 26.26 Favored Glycine 0 CA--C 1.523 0.594 0 N-CA-C 106.985 -2.446 . . . . 0.0 106.985 167.127 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 1.9 tt -141.73 96.11 2.92 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 119.664 1.732 . . . . 0.0 106.373 -173.265 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -101.68 141.56 34.36 Favored 'General case' 0 CA--C 1.518 -0.267 0 CA-C-O 121.271 0.558 . . . . 0.0 111.938 -170.192 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 43.1 p90 . . . . . 0 CA--C 1.538 0.501 0 C-N-CA 126.749 2.02 . . . . 0.0 107.389 -177.923 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.463 0.223 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -62.84 -48.14 80.33 Favored 'General case' 0 N--CA 1.452 -0.364 0 C-N-CA 122.999 0.52 . . . . 0.0 111.402 -174.832 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -68.42 -37.15 80.03 Favored 'General case' 0 CA--C 1.534 0.327 0 O-C-N 121.743 -0.598 . . . . 0.0 110.485 -179.43 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 28.6 mtpp -66.04 -40.23 90.83 Favored 'General case' 0 C--O 1.224 -0.244 0 CA-C-O 118.564 -0.731 . . . . 0.0 110.629 177.523 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 33.4 mt -55.69 -54.36 26.89 Favored 'Isoleucine or valine' 0 C--O 1.233 0.218 0 CA-C-N 119.642 1.11 . . . . 0.0 109.355 177.023 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 17.5 ptt180 -63.53 -38.6 91.76 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 118.801 0.728 . . . . 0.0 110.113 -177.039 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -64.02 -37.8 88.76 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-O 121.051 0.453 . . . . 0.0 110.151 -175.98 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 66.7 mt -76.03 -55.11 12.15 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.678 0 C-N-CA 125.136 1.374 . . . . 0.0 110.141 -176.275 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 62.7 mt -61.72 -47.84 91.44 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.403 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 -178.883 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 141.71 114.09 1.04 Allowed Glycine 0 CA--C 1.526 0.773 0 C-N-CA 125.396 1.474 . . . . 0.0 109.465 -175.912 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 70.5 Cg_endo -73.33 -8.4 21.83 Favored 'Trans proline' 0 CA--C 1.538 0.678 0 C-N-CA 122.517 2.145 . . . . 0.0 113.51 -169.729 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -76.63 -21.37 55.59 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 119.116 0.871 . . . . 0.0 111.839 179.107 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -122.74 7.87 9.41 Favored 'General case' 0 C--N 1.342 0.282 0 C-N-CA 124.842 1.257 . . . . 0.0 113.256 -171.542 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 44.0 t -124.89 151.18 30.27 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.369 0 N-CA-C 107.604 -1.258 . . . . 0.0 107.604 175.252 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 24.6 m -136.23 133.9 37.53 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 125.714 1.606 . . . . 0.0 107.927 -176.893 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 17.6 mt -80.52 138.17 36.5 Favored 'General case' 0 N--CA 1.463 0.222 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 176.086 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 24.7 t-80 -131.89 59.9 1.69 Allowed 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 124.588 1.155 . . . . 0.0 108.629 -176.576 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 37.9 t30 -59.7 124.22 19.44 Favored 'General case' 0 CA--C 1.531 0.226 0 N-CA-C 107.935 -1.135 . . . . 0.0 107.935 172.209 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 55.1 mt -71.37 -31.06 66.87 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-N 118.857 0.753 . . . . 0.0 112.73 -169.705 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 22.8 tptm -60.33 -27.46 67.37 Favored 'General case' 0 C--O 1.234 0.264 0 C-N-CA 123.507 0.723 . . . . 0.0 110.379 170.345 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -93.12 -34.64 13.57 Favored 'General case' 0 C--O 1.234 0.282 0 N-CA-C 112.834 0.679 . . . . 0.0 112.834 -174.639 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 3.8 t0 -144.69 148.49 34.28 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 118.869 0.759 . . . . 0.0 113.048 -176.831 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 15.2 m -70.7 157.22 90.67 Favored Pre-proline 0 CA--C 1.543 0.683 0 C-N-CA 125.925 1.69 . . . . 0.0 112.292 -169.342 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -74.64 -26.76 11.37 Favored 'Trans proline' 0 C--N 1.352 0.753 0 C-N-CA 122.662 2.241 . . . . 0.0 113.938 -172.317 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.87 -15.95 63.39 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-N 120.421 1.464 . . . . 0.0 112.187 -179.442 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -57.65 -31.21 66.08 Favored 'General case' 0 N--CA 1.466 0.363 0 C-N-CA 125.811 1.644 . . . . 0.0 110.166 170.777 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 57.2 mtt -56.4 -26.17 52.41 Favored 'General case' 0 N--CA 1.467 0.379 0 C-N-CA 123.699 0.799 . . . . 0.0 111.565 179.133 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 60.1 mt-10 -66.64 -32.93 74.58 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 118.436 0.562 . . . . 0.0 110.553 -177.659 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 19.8 mt-30 -67.65 -43.55 80.0 Favored 'General case' 0 C--O 1.232 0.181 0 N-CA-C 112.872 0.693 . . . . 0.0 112.872 -169.366 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 37.5 m-85 -72.23 135.91 46.21 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.733 -167.103 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -71.19 -38.03 72.11 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-N 118.101 0.41 . . . . 0.0 110.404 -179.468 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 14.8 t -105.31 143.66 16.18 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.56 0 N-CA-C 107.202 -1.407 . . . . 0.0 107.202 168.766 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 33.8 tp -131.6 115.34 15.97 Favored 'General case' 0 N--CA 1.446 -0.657 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 174.078 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 27.9 mt -91.99 131.94 37.72 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.681 0 N-CA-C 106.863 -1.532 . . . . 0.0 106.863 176.802 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 2.4 mp -109.72 127.35 54.54 Favored 'General case' 0 CA--C 1.516 -0.338 0 C-N-CA 125.717 1.607 . . . . 0.0 107.106 -179.832 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -129.18 130.72 6.5 Favored Glycine 0 C--N 1.332 0.329 0 N-CA-C 108.617 -1.793 . . . . 0.0 108.617 176.556 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.417 HD12 ' CD2' ' A' ' 65' ' ' TRP . 4.6 tt -152.26 129.56 5.72 Favored Pre-proline 0 CA--C 1.531 0.226 0 CA-C-N 117.636 0.718 . . . . 0.0 110.914 172.574 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo . . . . . 0 N--CA 1.447 -1.25 0 N-CA-C 107.017 -1.955 . . . . 0.0 107.017 165.548 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 8.4 mt . . . . . 0 CA--C 1.543 0.707 0 N-CA-C 113.039 0.755 . . . . 0.0 113.039 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 3.9 mp0 -74.87 153.8 38.51 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 125.294 1.438 . . . . 0.0 109.5 179.636 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -54.7 -46.17 74.12 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 123.669 0.788 . . . . 0.0 112.207 -169.184 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 23.3 t0 -62.35 -32.71 73.54 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-O 121.57 0.7 . . . . 0.0 112.184 -174.738 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' TRP . . . . . 0.596 ' CH2' HD23 ' A' ' 104' ' ' LEU . 0.9 OUTLIER -82.5 -43.5 17.1 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 123.739 0.816 . . . . 0.0 109.257 -179.587 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 6.1 tt0 -63.05 -35.11 79.15 Favored 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 124.79 1.236 . . . . 0.0 109.805 -179.287 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -58.97 -24.45 62.67 Favored 'General case' 0 C--O 1.233 0.2 0 C-N-CA 124.129 0.971 . . . . 0.0 111.69 -175.825 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 34.6 m -114.7 -14.99 10.5 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.228 0 CA-C-O 117.471 -1.252 . . . . 0.0 112.66 177.206 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 30.6 t90 -52.02 -38.86 58.36 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 119.974 1.261 . . . . 0.0 111.031 -177.032 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -68.36 -23.82 64.73 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 125.039 1.336 . . . . 0.0 113.185 178.218 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 22.7 mt-30 -91.73 -23.94 19.61 Favored 'General case' 0 C--N 1.34 0.167 0 C-N-CA 125.377 1.471 . . . . 0.0 111.973 -179.379 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 19.7 mt -64.26 -25.69 68.17 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 118.167 0.44 . . . . 0.0 111.63 -172.012 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -69.13 -21.77 64.0 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-N 117.966 0.348 . . . . 0.0 111.388 177.284 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -76.39 -24.05 54.08 Favored 'General case' 0 CA--C 1.537 0.462 0 O-C-N 120.971 -1.08 . . . . 0.0 112.68 -178.811 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 49.2 mt -65.63 149.54 49.92 Favored 'General case' 0 C--O 1.233 0.205 0 C-N-CA 124.794 1.238 . . . . 0.0 111.537 -170.296 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 27.8 t-20 -83.77 113.32 20.82 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 171.955 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 65.2 mt -128.66 1.8 5.5 Favored 'General case' 0 N--CA 1.472 0.659 0 N-CA-C 113.318 0.859 . . . . 0.0 113.318 -172.37 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 30.4 mt-10 -55.55 130.73 44.06 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-O 122.046 0.927 . . . . 0.0 111.347 -168.889 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 73.29 -2.45 36.74 Favored Glycine 0 CA--C 1.533 1.202 0 CA-C-O 117.987 -1.452 . . . . 0.0 115.105 176.791 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.64 149.55 41.93 Favored 'General case' 0 C--N 1.346 0.418 0 CA-C-N 120.749 2.274 . . . . 0.0 109.646 -177.036 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 7.6 mt -80.47 135.56 25.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 N-CA-C 106.269 -1.752 . . . . 0.0 106.269 178.372 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 63.4 t -129.11 128.56 67.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 C-N-CA 123.466 0.706 . . . . 0.0 109.715 -177.769 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -98.3 143.75 28.45 Favored 'General case' 0 CA--C 1.522 -0.114 0 N-CA-C 106.98 -1.489 . . . . 0.0 106.98 167.847 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 9.5 mt -122.11 132.24 54.38 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 107.243 -1.392 . . . . 0.0 107.243 176.241 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 22.9 p90 -150.72 165.05 34.63 Favored 'General case' 0 N--CA 1.444 -0.75 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 168.088 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -163.91 178.2 39.43 Favored Glycine 0 N--CA 1.435 -1.414 0 N-CA-C 109.739 -1.344 . . . . 0.0 109.739 171.314 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 5.8 tt . . . . . 0 N--CA 1.445 -0.706 0 C-N-CA 125.253 1.421 . . . . 0.0 107.448 178.682 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 91.9 mt . . . . . 0 N--CA 1.469 0.521 0 N-CA-C 114.613 1.338 . . . . 0.0 114.613 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -62.62 -35.22 78.89 Favored 'General case' 0 N--CA 1.465 0.311 0 O-C-N 120.651 -1.281 . . . . 0.0 110.672 -172.074 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 100' ' ' ALA . . . . . 0.415 ' HB1' HD13 ' A' ' 53' ' ' ILE . . . -72.98 -28.67 62.53 Favored 'General case' 0 N--CA 1.452 -0.334 0 N-CA-C 113.096 0.776 . . . . 0.0 113.096 176.543 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 5.0 tt -61.43 -45.33 94.75 Favored 'General case' 0 CA--C 1.535 0.394 0 N-CA-C 107.308 -1.367 . . . . 0.0 107.308 170.276 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -61.76 -42.24 99.72 Favored Glycine 0 C--N 1.341 0.806 0 N-CA-C 111.302 -0.719 . . . . 0.0 111.302 179.162 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 74.8 mtm -61.94 -41.14 97.62 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 118.094 0.947 . . . . 0.0 111.662 178.244 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.596 HD23 ' CH2' ' A' ' 65' ' ' TRP . 0.1 OUTLIER -72.22 -38.1 69.05 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 119.944 1.247 . . . . 0.0 111.131 -179.297 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 29.4 t-80 -57.21 -46.85 82.53 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 117.855 0.298 . . . . 0.0 110.38 172.587 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -63.85 -45.54 89.06 Favored 'General case' 0 C--N 1.33 -0.239 0 C-N-CA 123.457 0.703 . . . . 0.0 111.604 -177.753 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 24.5 ttmm -54.04 -45.26 71.56 Favored 'General case' 0 N--CA 1.464 0.227 0 C-N-CA 123.764 0.825 . . . . 0.0 109.735 173.287 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 22.2 mt -83.2 -19.89 35.67 Favored 'General case' 0 CA--C 1.514 -0.419 0 N-CA-C 114.887 1.44 . . . . 0.0 114.887 -169.43 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 6.5 t -57.85 -36.12 71.87 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-N 119.826 1.194 . . . . 0.0 110.598 -175.378 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 22.0 p -87.17 -8.33 57.03 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 124.802 1.241 . . . . 0.0 112.341 -179.184 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 32.3 mmmt -85.29 -7.13 59.15 Favored 'General case' 0 C--N 1.345 0.398 0 C-N-CA 124.61 1.164 . . . . 0.0 111.556 174.512 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 72.84 31.93 61.73 Favored Glycine 0 CA--C 1.523 0.567 0 CA-C-O 119.459 -0.634 . . . . 0.0 112.516 171.035 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 17.0 m -74.59 177.45 0.56 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.572 0 CA-C-N 118.386 1.093 . . . . 0.0 109.836 172.758 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -116.66 125.8 52.29 Favored 'General case' 0 CA--C 1.515 -0.388 0 N-CA-C 106.332 -1.729 . . . . 0.0 106.332 170.649 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 68.7 m-85 -91.45 146.03 24.14 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 119.847 1.203 . . . . 0.0 110.198 -177.594 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 33.5 m -133.3 158.43 42.98 Favored 'Isoleucine or valine' 0 C--O 1.235 0.323 0 C-N-CA 125.385 1.474 . . . . 0.0 107.503 169.044 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 85.41 35.19 12.34 Favored Glycine 0 N--CA 1.452 -0.252 0 CA-C-O 118.919 -0.934 . . . . 0.0 114.349 169.729 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 8.2 m-30 -67.86 155.2 39.89 Favored 'General case' 0 CA--C 1.544 0.729 0 CA-C-N 118.815 1.307 . . . . 0.0 109.403 169.611 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 1.6 t90 -136.46 137.96 25.52 Favored Pre-proline 0 CA--C 1.541 0.609 0 CA-C-O 117.305 -1.331 . . . . 0.0 108.342 -171.243 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_exo -70.58 130.92 19.1 Favored 'Trans proline' 0 C--N 1.348 0.501 0 C-N-CA 123.179 2.586 . . . . 0.0 113.037 -170.32 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 40.1 p . . . . . 0 N--CA 1.472 0.667 0 N-CA-C 113.457 0.91 . . . . 0.0 113.457 172.919 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 26.2 ttmt . . . . . 0 CA--C 1.541 0.616 0 CA-C-O 117.091 -1.433 . . . . 0.0 114.791 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_endo -74.63 -4.5 15.51 Favored 'Trans proline' 0 C--N 1.352 0.717 0 CA-C-N 122.108 1.789 . . . . 0.0 114.11 -178.928 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 20.8 m -131.76 167.89 25.27 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.412 0 CA-C-N 120.96 1.709 . . . . 0.0 111.673 -169.552 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 25.1 pt -127.87 170.05 18.28 Favored 'Isoleucine or valine' 0 C--O 1.234 0.27 0 C-N-CA 126.689 1.996 . . . . 0.0 109.207 175.169 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . 57.91 32.92 22.59 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 125.416 1.486 . . . . 0.0 113.768 167.711 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 27.7 t70 56.21 40.11 30.1 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 126.323 1.849 . . . . 0.0 111.254 -174.931 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 91.31 74.99 1.29 Allowed Glycine 0 C--N 1.338 0.657 0 C-N-CA 124.46 1.029 . . . . 0.0 111.259 177.682 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 74.1 mm-40 -120.66 -49.62 2.23 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 123.179 0.592 . . . . 0.0 110.771 168.251 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -131.0 145.03 51.92 Favored 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 122.997 0.519 . . . . 0.0 110.205 -178.86 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 73.3 m-85 -76.61 17.71 0.38 Allowed 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 125.573 1.549 . . . . 0.0 114.644 174.795 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 4.1 m 47.84 15.26 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.546 0.802 0 C-N-CA 127.915 2.486 . . . . 0.0 114.37 -174.053 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 168.22 174.0 36.66 Favored Glycine 0 CA--C 1.526 0.78 0 N-CA-C 108.792 -1.723 . . . . 0.0 108.792 -169.339 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 0.477 ' HB2' ' CD1' ' A' ' 160' ' ' TRP . 1.7 tp -71.88 142.13 49.55 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 118.215 1.008 . . . . 0.0 111.92 179.701 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -104.8 130.0 52.99 Favored 'General case' 0 N--CA 1.447 -0.585 0 C-N-CA 127.482 2.313 . . . . 0.0 109.416 178.034 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 87.5 mt . . . . . 0 N--CA 1.471 0.608 0 C-N-CA 125.038 1.335 . . . . 0.0 108.461 173.103 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 73.3 m . . . . . 0 CA--C 1.539 0.535 0 CA-C-O 118.716 -0.659 . . . . 0.0 111.64 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -60.35 -45.48 93.33 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 119.51 1.05 . . . . 0.0 111.882 172.387 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 -67.29 -44.23 79.78 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 125.38 1.472 . . . . 0.0 110.244 177.931 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 38.7 mtp180 -62.52 -40.08 95.62 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-O 117.826 -1.083 . . . . 0.0 109.682 179.35 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 48.7 mt -63.18 -55.38 23.68 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.475 0 CA-C-N 119.891 1.223 . . . . 0.0 107.991 172.453 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 70.5 tp60 -50.21 -63.78 1.01 Allowed 'General case' 0 C--O 1.232 0.176 0 C-N-CA 124.808 1.243 . . . . 0.0 111.86 -174.584 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 24.0 m -66.0 -32.99 74.8 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 120.666 -0.414 . . . . 0.0 111.136 -170.365 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 160' ' ' TRP . . . . . 0.477 ' CD1' ' HB2' ' A' ' 142' ' ' LEU . 82.4 t90 -67.09 -46.13 75.16 Favored 'General case' 0 C--O 1.222 -0.39 0 O-C-N 121.999 -0.438 . . . . 0.0 110.889 175.257 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 61.4 m -58.2 -43.9 87.84 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 118.48 0.582 . . . . 0.0 110.157 179.502 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -62.28 -43.91 97.74 Favored 'General case' 0 CA--C 1.528 0.123 0 N-CA-C 109.886 -0.413 . . . . 0.0 109.886 176.842 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 14.9 tt0 -62.58 -50.32 71.76 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-O 117.946 -1.026 . . . . 0.0 110.225 -177.923 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 41.6 pt -65.01 -33.53 64.35 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.485 0 CA-C-N 119.678 1.126 . . . . 0.0 110.224 -176.335 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -70.48 -34.19 72.11 Favored 'General case' 0 C--O 1.223 -0.322 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 -175.998 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -71.33 -45.19 63.58 Favored 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 124.531 1.132 . . . . 0.0 109.982 175.082 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 21.9 tt0 -78.3 -24.57 46.63 Favored 'General case' 0 N--CA 1.441 -0.905 0 C-N-CA 124.22 1.008 . . . . 0.0 110.319 -169.374 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 168' ' ' MET . . . . . . . . . . . . . 19.2 ptp -82.26 -29.72 31.1 Favored 'General case' 0 N--CA 1.461 0.104 0 O-C-N 121.694 -0.629 . . . . 0.0 111.657 171.843 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -79.36 -36.3 39.52 Favored 'General case' 0 N--CA 1.447 -0.613 0 C-N-CA 122.573 0.349 . . . . 0.0 111.001 -178.198 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 . . . . . 0 CA--C 1.535 0.392 0 O-C-N 122.138 -0.351 . . . . 0.0 110.396 177.356 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.498 1.926 0 CA-C-O 118.986 -0.531 . . . . 0.0 110.15 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 5.7 t30 -111.22 147.54 34.77 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-N 119.729 1.149 . . . . 0.0 111.377 -171.5 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 17.5 mtt -112.79 130.12 56.19 Favored 'General case' 0 N--CA 1.462 0.174 0 C-N-CA 124.414 1.086 . . . . 0.0 110.203 -177.467 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -98.94 131.02 10.42 Favored Glycine 0 CA--C 1.522 0.506 0 N-CA-C 107.264 -2.334 . . . . 0.0 107.264 168.54 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -105.74 108.14 19.51 Favored 'General case' 0 N--CA 1.467 0.422 0 N-CA-C 105.058 -2.201 . . . . 0.0 105.058 173.974 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -99.62 145.84 27.12 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 119.401 1.0 . . . . 0.0 112.663 179.335 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 79.5 m-85 . . . . . 0 N--CA 1.451 -0.416 0 C-N-CA 126.681 1.992 . . . . 0.0 108.726 -178.401 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.536 0.428 0 CA-C-O 119.002 -0.523 . . . . 0.0 110.236 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -57.18 -55.18 38.1 Favored 'General case' 0 N--CA 1.465 0.318 0 C-N-CA 123.672 0.789 . . . . 0.0 112.337 179.112 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 70.5 mm-40 -61.08 -45.73 93.54 Favored 'General case' 0 CA--C 1.517 -0.319 0 N-CA-C 108.134 -1.062 . . . . 0.0 108.134 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 30.0 mtpp -66.42 -39.6 89.06 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-O 118.498 -0.763 . . . . 0.0 110.107 -171.971 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 17.6 mt -54.61 -58.65 3.44 Favored 'Isoleucine or valine' 0 C--O 1.233 0.188 0 C-N-CA 124.639 1.175 . . . . 0.0 108.858 176.548 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 18.7 ptt180 -64.91 -39.42 93.49 Favored 'General case' 0 C--O 1.222 -0.372 0 CA-C-O 118.761 -0.637 . . . . 0.0 110.45 -177.272 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -65.53 -39.92 92.32 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.142 0.496 . . . . 0.0 110.018 -172.511 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 70.5 mt -75.5 -53.72 15.43 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.576 0 C-N-CA 125.236 1.415 . . . . 0.0 109.875 -175.419 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 71.8 mt -62.48 -46.89 95.32 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.441 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 -179.232 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 140.77 116.58 1.3 Allowed Glycine 0 CA--C 1.528 0.881 0 C-N-CA 125.842 1.687 . . . . 0.0 109.395 179.26 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -72.78 -8.18 21.97 Favored 'Trans proline' 0 CA--C 1.539 0.743 0 C-N-CA 122.739 2.292 . . . . 0.0 113.337 -170.229 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -79.67 -17.65 53.18 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 118.757 0.708 . . . . 0.0 111.865 178.02 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -125.37 8.08 7.77 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 125.204 1.402 . . . . 0.0 113.343 -174.878 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 61.3 t -124.55 149.22 28.82 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.265 0 N-CA-C 107.925 -1.139 . . . . 0.0 107.925 174.21 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 11.9 m -138.71 136.32 35.68 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 126.034 1.734 . . . . 0.0 107.023 -176.804 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 23.8 mt -90.67 146.59 23.9 Favored 'General case' 0 N--CA 1.466 0.339 0 N-CA-C 107.691 -1.226 . . . . 0.0 107.691 175.553 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 40.5 t-80 -140.34 128.27 22.03 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 107.459 -1.311 . . . . 0.0 107.459 -169.261 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 53.8 t-20 -128.66 111.18 12.91 Favored 'General case' 0 CA--C 1.516 -0.345 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 -169.993 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 88.9 mt -66.86 -10.7 50.97 Favored 'General case' 0 CA--C 1.535 0.381 0 N-CA-C 113.355 0.872 . . . . 0.0 113.355 -174.222 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 40.3 tptt -57.92 -29.13 64.88 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 118.82 0.737 . . . . 0.0 111.234 168.153 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -129.39 -38.01 1.59 Allowed 'General case' 0 N--CA 1.465 0.299 0 C-N-CA 123.84 0.856 . . . . 0.0 112.67 -173.049 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 42.8 m-20 -79.55 130.12 35.1 Favored 'General case' 0 C--O 1.236 0.373 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 179.758 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 14.4 m -73.28 152.7 90.26 Favored Pre-proline 0 CA--C 1.542 0.649 0 C-N-CA 123.22 0.608 . . . . 0.0 109.526 173.368 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -73.04 -24.86 16.81 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.032 1.821 . . . . 0.0 113.992 -169.616 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 1.4 mptm? -63.21 -18.06 63.11 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 119.275 0.943 . . . . 0.0 111.726 178.176 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -63.28 -25.31 68.26 Favored 'General case' 0 N--CA 1.465 0.309 0 C-N-CA 124.847 1.259 . . . . 0.0 110.746 174.341 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 54.2 mtt -61.75 -23.95 66.49 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 119.361 0.982 . . . . 0.0 111.496 177.346 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -64.32 -32.25 73.78 Favored 'General case' 0 CA--C 1.535 0.365 0 O-C-N 121.792 -0.568 . . . . 0.0 110.566 -177.602 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 25.4 mt-30 -67.17 -42.23 84.61 Favored 'General case' 0 CA--C 1.533 0.29 0 N-CA-C 113.594 0.961 . . . . 0.0 113.594 -169.397 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 62.7 m-85 -73.79 144.09 45.73 Favored 'General case' 0 C--O 1.231 0.113 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.637 -165.346 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 41.7 m-20 -77.23 -29.19 54.01 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 122.785 0.434 . . . . 0.0 109.948 -176.433 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 13.5 t -124.57 144.85 33.03 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.34 0 N-CA-C 106.564 -1.643 . . . . 0.0 106.564 168.886 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 25.0 tp -125.2 105.95 9.52 Favored 'General case' 0 N--CA 1.446 -0.669 0 N-CA-C 107.304 -1.369 . . . . 0.0 107.304 175.542 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 51.0 mt -85.83 128.6 39.13 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.687 0 N-CA-C 105.947 -1.872 . . . . 0.0 105.947 174.435 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 1.3 mp -102.55 124.1 47.5 Favored 'General case' 0 CA--C 1.515 -0.375 0 N-CA-C 106.415 -1.698 . . . . 0.0 106.415 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -122.4 120.39 4.3 Favored Glycine 0 N--CA 1.449 -0.449 0 N-CA-C 106.951 -2.46 . . . . 0.0 106.951 177.656 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 5.8 tt -149.64 116.46 3.61 Favored Pre-proline 0 C--N 1.332 -0.185 0 CA-C-N 118.033 0.916 . . . . 0.0 109.483 169.823 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 62.9 Cg_exo . . . . . 0 N--CA 1.456 -0.687 0 C-N-CA 120.706 0.937 . . . . 0.0 110.394 166.194 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 48.1 mt . . . . . 0 CA--C 1.538 0.512 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 62' ' ' GLN . . . . . 0.423 ' H ' ' CD ' ' A' ' 62' ' ' GLN . 1.5 pm0 -75.82 154.28 36.29 Favored 'General case' 0 C--O 1.233 0.225 0 C-N-CA 124.711 1.204 . . . . 0.0 109.821 173.662 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -57.11 -41.86 79.76 Favored 'General case' 0 C--O 1.224 -0.289 0 C-N-CA 124.045 0.938 . . . . 0.0 110.952 -171.375 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 27.8 m-20 -69.76 -15.56 63.15 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-N 119.108 0.867 . . . . 0.0 112.395 -173.912 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' TRP . . . . . 0.408 ' CH2' HD23 ' A' ' 104' ' ' LEU . 11.5 t90 -92.11 -46.86 7.56 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 124.52 1.128 . . . . 0.0 108.139 173.313 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -62.66 -35.36 79.41 Favored 'General case' 0 CA--C 1.536 0.428 0 O-C-N 120.789 -1.194 . . . . 0.0 110.585 -178.785 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -61.48 -25.78 67.47 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 124.119 0.968 . . . . 0.0 110.913 -174.926 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 28.1 m -111.21 -14.94 10.39 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.328 0 CA-C-O 117.352 -1.308 . . . . 0.0 112.207 177.502 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 28.3 t90 -51.56 -37.51 49.98 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 120.161 1.346 . . . . 0.0 110.526 177.342 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -63.35 -27.45 69.33 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 125.305 1.442 . . . . 0.0 113.196 176.399 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 30.9 mt-30 -92.4 -20.18 21.31 Favored 'General case' 0 C--O 1.226 -0.163 0 C-N-CA 125.853 1.661 . . . . 0.0 112.567 178.004 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 41.7 mt -63.34 -24.08 67.69 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 118.895 0.77 . . . . 0.0 111.458 -176.108 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -75.8 -27.18 57.87 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 117.903 0.32 . . . . 0.0 111.373 174.541 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -79.32 -17.01 55.42 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 123.951 0.9 . . . . 0.0 112.609 -174.717 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 38.1 mt -62.53 147.9 47.55 Favored 'General case' 0 C--O 1.234 0.275 0 C-N-CA 124.261 1.025 . . . . 0.0 111.43 -170.912 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 24.7 t-20 -83.38 82.58 8.22 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 124.856 1.263 . . . . 0.0 107.933 174.373 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 3.7 pp -140.92 131.6 25.64 Favored 'General case' 0 N--CA 1.453 -0.282 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 170.903 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 25.3 mt-10 -141.1 146.59 37.29 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 127.843 2.457 . . . . 0.0 107.585 168.414 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 69.74 -3.44 9.23 Favored Glycine 0 CA--C 1.534 1.243 0 CA-C-O 118.111 -1.383 . . . . 0.0 116.285 169.658 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.93 161.96 30.07 Favored 'General case' 0 C--N 1.343 0.312 0 CA-C-N 120.282 2.041 . . . . 0.0 109.681 -177.345 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 2.2 mt -85.05 135.41 24.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 N-CA-C 107.329 -1.36 . . . . 0.0 107.329 177.794 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 77.4 t -128.47 138.23 55.19 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 -179.766 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -113.7 156.81 23.1 Favored 'General case' 0 CA--C 1.521 -0.156 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 169.305 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 2.0 mt -138.7 134.73 33.98 Favored 'General case' 0 CA--C 1.515 -0.374 0 N-CA-C 107.002 -1.481 . . . . 0.0 107.002 -178.568 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 12.2 p90 -165.15 171.24 13.99 Favored 'General case' 0 N--CA 1.451 -0.386 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 170.698 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -178.08 176.71 48.16 Favored Glycine 0 N--CA 1.449 -0.439 0 N-CA-C 109.955 -1.258 . . . . 0.0 109.955 167.984 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.329 -0.316 0 C-N-CA 124.696 1.199 . . . . 0.0 109.905 171.922 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 71.5 mt . . . . . 0 CA--C 1.534 0.327 0 N-CA-C 115.49 1.663 . . . . 0.0 115.49 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -60.16 -28.7 68.14 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 120.394 1.452 . . . . 0.0 110.967 -175.37 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -71.31 -26.65 62.94 Favored 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 123.968 0.907 . . . . 0.0 112.491 176.82 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 10.1 mp -63.69 -43.47 96.56 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 119.846 1.203 . . . . 0.0 107.854 170.832 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -65.46 -39.83 95.92 Favored Glycine 0 C--N 1.339 0.747 0 N-CA-C 110.801 -0.92 . . . . 0.0 110.801 -174.875 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 70.7 mtm -63.85 -44.74 92.25 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 117.288 0.544 . . . . 0.0 111.762 178.3 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.408 HD23 ' CH2' ' A' ' 65' ' ' TRP . 0.2 OUTLIER -71.04 -39.63 72.19 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 119.635 1.107 . . . . 0.0 109.908 178.865 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 42.9 t-80 -55.13 -51.79 65.32 Favored 'General case' 0 CA--C 1.53 0.206 0 O-C-N 121.64 -0.662 . . . . 0.0 110.516 176.59 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -61.38 -39.7 91.64 Favored 'General case' 0 C--O 1.235 0.311 0 C-N-CA 123.491 0.716 . . . . 0.0 111.864 -176.716 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 24.2 ttmm -56.84 -41.82 78.55 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 123.325 0.65 . . . . 0.0 110.598 173.486 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 38.2 mt -87.21 -16.5 35.12 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-O 117.628 -1.177 . . . . 0.0 114.077 -169.798 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 17.7 m -57.61 -37.83 73.91 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 120.412 1.46 . . . . 0.0 111.247 -179.759 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 21.1 p -82.52 -12.52 57.71 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 124.194 0.998 . . . . 0.0 111.561 -179.409 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 32.0 mmmt -82.27 -6.39 59.2 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 124.517 1.127 . . . . 0.0 110.853 169.582 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 71.44 27.19 71.83 Favored Glycine 0 CA--C 1.527 0.831 0 CA-C-N 119.312 0.96 . . . . 0.0 113.098 168.829 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 7.9 m -74.09 170.29 1.48 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 CA-C-N 118.5 1.15 . . . . 0.0 110.068 178.345 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 54.4 tptt -95.04 135.55 36.45 Favored 'General case' 0 CA--C 1.513 -0.472 0 N-CA-C 105.26 -2.126 . . . . 0.0 105.26 167.785 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 64.7 m-85 -103.14 122.39 44.6 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 108.099 -1.075 . . . . 0.0 108.099 171.815 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 26.2 m -107.84 158.23 7.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 C-N-CA 124.5 1.12 . . . . 0.0 108.685 168.033 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 86.1 24.69 39.91 Favored Glycine 0 CA--C 1.524 0.654 0 CA-C-O 118.076 -1.402 . . . . 0.0 115.13 169.699 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 12.3 m-30 -59.91 156.38 14.58 Favored 'General case' 0 CA--C 1.544 0.721 0 CA-C-N 119.44 1.62 . . . . 0.0 109.298 168.613 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 58.3 t-105 -135.71 143.86 46.52 Favored Pre-proline 0 N--CA 1.472 0.635 0 CA-C-O 118.094 -0.955 . . . . 0.0 111.553 -168.359 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -64.46 129.64 24.44 Favored 'Trans proline' 0 C--N 1.348 0.548 0 C-N-CA 123.344 2.696 . . . . 0.0 112.429 -178.133 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 3.7 p . . . . . 0 CA--C 1.535 0.384 0 C-N-CA 125.022 1.329 . . . . 0.0 111.062 169.709 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 23.9 ttmt . . . . . 0 N--CA 1.474 0.762 0 CA-C-O 117.453 -1.261 . . . . 0.0 114.305 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 80.7 Cg_endo -76.66 -0.53 10.57 Favored 'Trans proline' 0 C--N 1.353 0.812 0 CA-C-N 122.216 1.827 . . . . 0.0 114.079 179.526 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 19.5 m -120.48 149.28 23.3 Favored 'Isoleucine or valine' 0 C--O 1.232 0.171 0 CA-C-N 120.479 1.491 . . . . 0.0 110.217 -178.759 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 133' ' ' ILE . . . . . 0.477 HG23 HG12 ' A' ' 140' ' ' VAL . 3.2 pt -88.08 169.1 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.721 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 169.013 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . 56.0 -154.12 0.33 Allowed 'General case' 0 N--CA 1.441 -0.907 0 CA-C-N 113.603 -1.635 . . . . 0.0 109.175 169.604 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 22.4 t0 -80.67 60.7 4.08 Favored 'General case' 0 C--N 1.325 -0.482 0 C-N-CA 125.022 1.329 . . . . 0.0 109.123 169.94 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 63.54 30.0 76.3 Favored Glycine 0 CA--C 1.529 0.927 0 C-N-CA 124.607 1.099 . . . . 0.0 112.868 177.659 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 56.0 mm-40 -78.33 -29.19 47.49 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 117.706 0.753 . . . . 0.0 111.688 -168.955 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 11.7 tp -158.67 148.96 19.78 Favored 'General case' 0 CA--C 1.53 0.207 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 -174.602 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 72.5 m-85 -77.48 148.53 35.3 Favored 'General case' 0 CA--C 1.522 -0.113 0 CA-C-N 119.146 0.884 . . . . 0.0 108.789 170.088 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 140' ' ' VAL . . . . . 0.477 HG12 HG23 ' A' ' 133' ' ' ILE . 33.8 m -71.43 -0.67 1.82 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.624 0 C-N-CA 123.195 0.598 . . . . 0.0 112.265 175.762 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -176.58 171.9 44.87 Favored Glycine 0 CA--C 1.524 0.633 0 O-C-N 120.745 -1.222 . . . . 0.0 110.346 -172.659 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 1.6 tp -64.67 136.13 56.64 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 118.006 0.903 . . . . 0.0 110.939 179.454 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -101.72 112.81 25.52 Favored 'General case' 0 N--CA 1.447 -0.617 0 C-N-CA 125.841 1.656 . . . . 0.0 108.873 176.266 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 95.7 mt . . . . . 0 N--CA 1.465 0.295 0 C-N-CA 124.448 1.099 . . . . 0.0 109.317 170.584 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 12.5 m . . . . . 0 CA--C 1.54 0.564 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -59.91 -42.5 94.03 Favored 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 124.235 1.014 . . . . 0.0 111.65 169.673 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -64.41 -47.01 80.79 Favored 'General case' 0 C--N 1.334 -0.102 0 C-N-CA 124.31 1.044 . . . . 0.0 109.848 178.907 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 68.5 mtt180 -57.58 -46.76 83.59 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-O 118.125 -0.94 . . . . 0.0 110.501 177.151 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 47.8 mt -61.03 -51.96 67.14 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.403 0 CA-C-N 119.443 1.02 . . . . 0.0 108.383 177.192 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 71.0 tp60 -52.78 -64.19 0.9 Allowed 'General case' 0 C--O 1.234 0.27 0 C-N-CA 124.633 1.173 . . . . 0.0 111.302 -177.6 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 41.3 m -66.21 -33.26 75.35 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 119.315 -0.374 . . . . 0.0 111.268 -171.459 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 160' ' ' TRP . . . . . . . . . . . . . 60.5 t90 -65.73 -47.87 73.88 Favored 'General case' 0 C--O 1.225 -0.225 0 CA-C-N 118.676 0.671 . . . . 0.0 110.707 174.705 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 64.7 m -61.3 -42.22 98.29 Favored 'General case' 0 N--CA 1.455 -0.204 0 CA-C-N 118.217 0.462 . . . . 0.0 110.299 -178.986 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -61.55 -44.54 96.85 Favored 'General case' 0 N--CA 1.455 -0.203 0 CA-C-N 118.308 0.504 . . . . 0.0 110.076 174.886 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 14.8 tt0 -62.6 -50.81 69.79 Favored 'General case' 0 CA--C 1.512 -0.489 0 CA-C-O 117.699 -1.143 . . . . 0.0 109.803 -176.415 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 44.7 pt -63.98 -34.13 66.58 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.425 0 CA-C-O 117.59 -1.195 . . . . 0.0 109.835 -176.578 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -71.48 -32.36 68.18 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 119.653 1.115 . . . . 0.0 108.955 -174.982 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -70.74 -53.54 15.15 Favored 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 124.347 1.059 . . . . 0.0 109.374 173.737 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 20.1 tt0 -69.02 -31.44 70.24 Favored 'General case' 0 N--CA 1.445 -0.719 0 C-N-CA 125.601 1.561 . . . . 0.0 109.943 -168.619 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 168' ' ' MET . . . . . . . . . . . . . 22.1 ptp -74.11 -34.02 63.78 Favored 'General case' 0 C--O 1.23 0.078 0 O-C-N 122.143 -0.348 . . . . 0.0 111.047 174.658 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -74.86 -37.16 62.28 Favored 'General case' 0 N--CA 1.442 -0.852 0 CA-C-O 119.276 -0.393 . . . . 0.0 111.811 -177.251 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 5.5 mt-10 . . . . . 0 CA--C 1.532 0.283 0 CA-C-O 121.572 0.701 . . . . 0.0 109.682 177.244 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.497 1.898 0 CA-C-O 120.433 0.159 . . . . 0.0 111.286 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 26.1 p-10 -116.39 165.87 12.72 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 125.392 1.477 . . . . 0.0 111.414 -174.425 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 13.9 mtt -130.69 128.44 40.89 Favored 'General case' 0 CA--C 1.522 -0.119 0 C-N-CA 123.27 0.628 . . . . 0.0 110.717 175.367 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -90.12 149.4 20.3 Favored Glycine 0 CA--C 1.525 0.672 0 N-CA-C 106.786 -2.526 . . . . 0.0 106.786 166.56 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 2.4 tt -134.26 100.16 4.61 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 105.364 -2.087 . . . . 0.0 105.364 -178.099 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' PHE . . . . . 0.557 ' CZ ' HD11 ' A' ' 51' ' ' LEU . 0.5 OUTLIER -106.22 142.84 35.23 Favored 'General case' 0 CA--C 1.519 -0.238 0 CA-C-O 121.63 0.729 . . . . 0.0 112.252 -172.727 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 34.7 p90 . . . . . 0 N--CA 1.45 -0.433 0 C-N-CA 126.697 1.999 . . . . 0.0 106.85 179.425 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.226 -0.136 0 N-CA-C 109.3 -0.629 . . . . 0.0 109.3 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -63.77 -45.53 89.32 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 122.195 0.198 . . . . 0.0 110.872 -176.74 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -60.24 -45.38 93.44 Favored 'General case' 0 N--CA 1.465 0.298 0 C-N-CA 123.296 0.638 . . . . 0.0 109.667 176.392 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 30.0 mtpp -70.52 -39.91 73.8 Favored 'General case' 0 C--O 1.222 -0.373 0 CA-C-O 118.441 -0.79 . . . . 0.0 110.144 -173.512 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 43.8 mt -54.88 -54.86 19.47 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.189 0 CA-C-N 119.765 1.166 . . . . 0.0 109.174 176.024 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.83 -33.87 76.56 Favored 'General case' 0 C--O 1.221 -0.399 0 CA-C-N 118.259 0.481 . . . . 0.0 111.316 -174.628 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -63.4 -40.75 98.06 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 122.67 0.388 . . . . 0.0 111.119 175.273 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 55.6 mt -76.72 -55.67 10.25 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.515 0 C-N-CA 124.644 1.178 . . . . 0.0 110.451 -171.698 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 73.4 mt -64.48 -46.3 93.18 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 -179.858 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 143.73 124.01 1.78 Allowed Glycine 0 CA--C 1.527 0.817 0 C-N-CA 124.442 1.02 . . . . 0.0 110.871 174.46 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -73.13 -9.41 23.35 Favored 'Trans proline' 0 CA--C 1.54 0.782 0 C-N-CA 123.101 2.534 . . . . 0.0 113.387 -170.914 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -81.35 -19.09 43.49 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 118.768 0.713 . . . . 0.0 111.416 178.174 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -125.12 -7.2 7.13 Favored 'General case' 0 C--N 1.344 0.335 0 C-N-CA 124.828 1.251 . . . . 0.0 113.724 -174.032 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 40.4 t -115.02 137.27 49.04 Favored 'Isoleucine or valine' 0 C--O 1.233 0.216 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 171.193 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 51.7 m -129.91 132.99 46.57 Favored 'General case' 0 C--O 1.233 0.197 0 C-N-CA 124.807 1.243 . . . . 0.0 108.268 -174.503 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 23.7 mt -75.22 144.22 42.73 Favored 'General case' 0 C--O 1.233 0.194 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 177.073 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' HIS . . . . . 0.417 ' HD1' ' HB2' ' A' ' 6' ' ' PHE . 44.4 t-80 -132.7 66.55 1.56 Allowed 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 125.141 1.376 . . . . 0.0 107.291 -177.679 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 57.0 t-20 -70.43 118.08 12.78 Favored 'General case' 0 C--O 1.233 0.234 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 -179.329 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 48.6 mt -67.74 -18.0 64.74 Favored 'General case' 0 C--O 1.232 0.183 0 N-CA-C 113.16 0.8 . . . . 0.0 113.16 -174.78 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 35.1 tptt -60.14 -23.6 64.03 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 118.698 0.681 . . . . 0.0 111.777 169.445 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -119.46 -39.41 2.89 Favored 'General case' 0 C--O 1.234 0.262 0 N-CA-C 113.279 0.844 . . . . 0.0 113.279 -172.846 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 33.1 m-20 -101.42 139.15 37.48 Favored 'General case' 0 N--CA 1.465 0.302 0 C-N-CA 123.947 0.899 . . . . 0.0 110.531 -177.654 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 11.4 m -75.28 155.82 85.83 Favored Pre-proline 0 CA--C 1.542 0.644 0 C-N-CA 124.124 0.97 . . . . 0.0 110.16 174.779 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -74.71 -25.68 12.26 Favored 'Trans proline' 0 C--N 1.349 0.553 0 C-N-CA 121.909 1.74 . . . . 0.0 113.472 -170.196 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 1.7 mptm? -62.9 -21.08 65.76 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-N 120.329 1.422 . . . . 0.0 112.082 -179.186 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -62.25 -26.53 68.44 Favored 'General case' 0 N--CA 1.465 0.292 0 C-N-CA 125.119 1.368 . . . . 0.0 110.389 174.634 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 68.4 mtt -58.19 -27.66 64.07 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 118.94 0.791 . . . . 0.0 111.43 177.128 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 69.1 mt-10 -63.37 -32.59 74.05 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 118.238 0.472 . . . . 0.0 109.969 -175.814 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 26.2 mt-30 -67.47 -39.78 85.28 Favored 'General case' 0 C--N 1.342 0.278 0 C-N-CA 123.911 0.884 . . . . 0.0 113.191 -172.145 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 71.6 m-85 -72.95 135.16 44.99 Favored 'General case' 0 C--O 1.233 0.219 0 N-CA-C 109.446 -0.575 . . . . 0.0 109.446 -167.904 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -69.7 -44.01 71.27 Favored 'General case' 0 C--O 1.233 0.208 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 -178.843 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 12.3 t -103.52 145.49 12.53 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.396 0 N-CA-C 107.996 -1.113 . . . . 0.0 107.996 169.894 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 34.8 tp -135.41 105.97 6.47 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 175.943 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 32.6 mt -85.11 128.34 39.11 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.826 0 N-CA-C 106.638 -1.616 . . . . 0.0 106.638 177.698 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.557 HD11 ' CZ ' ' A' ' 6' ' ' PHE . 0.8 OUTLIER -94.05 144.32 25.58 Favored 'General case' 0 CA--C 1.516 -0.363 0 C-N-CA 124.787 1.235 . . . . 0.0 109.824 169.588 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -145.34 134.78 5.67 Favored Glycine 0 CA--C 1.52 0.385 0 N-CA-C 109.244 -1.542 . . . . 0.0 109.244 169.234 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 3.5 tt -156.68 139.6 10.81 Favored Pre-proline 0 CA--C 1.542 0.655 0 CA-C-N 118.737 1.268 . . . . 0.0 111.411 172.956 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo . . . . . 0 CA--C 1.538 0.718 0 C-N-CA 122.749 2.3 . . . . 0.0 111.554 167.192 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . 0.253 49.9 mt . . . . . 0 CA--C 1.546 0.804 0 CA-C-O 122.581 1.181 . . . . 0.0 112.415 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 4.2 mp0 -108.1 153.69 22.78 Favored 'General case' 0 C--N 1.34 0.173 0 C-N-CA 125.569 1.548 . . . . 0.0 107.157 -177.317 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -57.0 -42.47 80.32 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 123.178 0.591 . . . . 0.0 110.951 -173.312 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 23.0 m-20 -66.99 -18.24 65.29 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 122.844 0.458 . . . . 0.0 112.004 -176.409 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' TRP . . . . . 0.788 ' CH2' HD23 ' A' ' 104' ' ' LEU . 13.6 t90 -95.76 -44.79 7.27 Favored 'General case' 0 C--N 1.339 0.14 0 C-N-CA 124.358 1.063 . . . . 0.0 110.263 175.304 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -62.9 -34.75 78.07 Favored 'General case' 0 CA--C 1.538 0.503 0 O-C-N 120.692 -1.255 . . . . 0.0 109.673 -178.864 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -60.16 -25.32 65.43 Favored 'General case' 0 C--O 1.233 0.216 0 C-N-CA 123.839 0.856 . . . . 0.0 111.567 179.29 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 12.2 m -109.85 -16.04 9.25 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.321 0 CA-C-O 117.46 -1.257 . . . . 0.0 112.467 179.446 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 27.9 t90 -53.71 -38.53 64.37 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 120.025 1.284 . . . . 0.0 110.198 176.822 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -66.59 -27.36 67.66 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 125.476 1.51 . . . . 0.0 112.945 175.532 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 68.1 mt-30 -90.73 -23.07 20.8 Favored 'General case' 0 C--O 1.224 -0.289 0 C-N-CA 125.67 1.588 . . . . 0.0 111.978 -176.787 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.608 ' CD1' HD21 ' A' ' 104' ' ' LEU . 50.3 mt -57.74 -32.0 67.02 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 118.537 0.608 . . . . 0.0 110.275 173.398 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -70.4 -26.5 63.72 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 122.694 0.397 . . . . 0.0 111.233 174.548 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -81.31 -34.36 31.97 Favored 'General case' 0 CA--C 1.537 0.475 0 N-CA-C 113.307 0.854 . . . . 0.0 113.307 176.267 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 24.7 mt -59.62 149.56 29.95 Favored 'General case' 0 N--CA 1.464 0.27 0 C-N-CA 124.476 1.11 . . . . 0.0 111.104 -176.117 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 19.9 t-20 -91.15 118.42 30.43 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 169.171 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 70.4 mt -127.98 8.9 6.25 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 123.73 0.812 . . . . 0.0 112.263 -173.113 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 28.9 mt-10 -52.18 129.15 27.04 Favored 'General case' 0 C--O 1.234 0.273 0 C-N-CA 124.3 1.04 . . . . 0.0 112.272 -168.049 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 68.43 0.09 15.3 Favored Glycine 0 CA--C 1.535 1.3 0 C-N-CA 125.436 1.493 . . . . 0.0 115.525 175.828 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.66 151.34 40.81 Favored 'General case' 0 C--N 1.345 0.391 0 CA-C-N 120.555 2.177 . . . . 0.0 109.499 -174.262 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 5.8 mt -80.38 136.47 23.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 N-CA-C 106.65 -1.611 . . . . 0.0 106.65 179.649 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 43.2 t -131.16 134.26 61.52 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 C-N-CA 123.755 0.822 . . . . 0.0 109.809 -179.567 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.415 ' HB1' ' CH2' ' A' ' 160' ' ' TRP . . . -105.34 152.73 22.57 Favored 'General case' 0 N--CA 1.462 0.139 0 N-CA-C 105.865 -1.902 . . . . 0.0 105.865 166.804 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 2.6 mt -134.08 134.4 42.26 Favored 'General case' 0 CA--C 1.512 -0.497 0 N-CA-C 107.096 -1.446 . . . . 0.0 107.096 175.537 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 36.0 p90 -148.86 168.77 22.13 Favored 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 169.628 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -163.41 173.6 39.56 Favored Glycine 0 N--CA 1.446 -0.661 0 N-CA-C 109.91 -1.276 . . . . 0.0 109.91 169.979 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.327 -0.375 0 C-N-CA 125.012 1.325 . . . . 0.0 108.435 171.035 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 84.3 mt . . . . . 0 N--CA 1.47 0.541 0 N-CA-C 116.253 1.945 . . . . 0.0 116.253 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -64.61 -35.03 79.69 Favored 'General case' 0 C--N 1.328 -0.348 0 O-C-N 120.441 -1.412 . . . . 0.0 111.116 -174.305 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -65.9 -31.43 72.36 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 123.845 0.858 . . . . 0.0 111.944 173.458 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 4.2 tt -65.92 -47.93 73.1 Favored 'General case' 0 N--CA 1.468 0.446 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 173.542 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -58.84 -40.53 95.25 Favored Glycine 0 CA--C 1.525 0.713 0 N-CA-C 111.09 -0.804 . . . . 0.0 111.09 178.081 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 3.0 tpp -49.75 -45.44 49.41 Favored 'General case' 0 N--CA 1.464 0.256 0 C-N-CA 124.685 1.194 . . . . 0.0 110.867 172.328 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.788 HD23 ' CH2' ' A' ' 65' ' ' TRP . 0.2 OUTLIER -83.81 -31.26 25.95 Favored 'General case' 0 CA--C 1.52 -0.174 0 O-C-N 122.122 -0.361 . . . . 0.0 111.607 -171.683 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 36.8 t-80 -60.33 -45.26 94.08 Favored 'General case' 0 C--N 1.331 -0.234 0 O-C-N 121.964 -0.46 . . . . 0.0 109.813 169.482 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -63.42 -47.58 81.33 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 123.472 0.709 . . . . 0.0 111.088 179.511 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 2.2 tppm? -54.38 -31.05 53.88 Favored 'General case' 0 N--CA 1.466 0.352 0 C-N-CA 125.342 1.457 . . . . 0.0 111.854 173.863 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 49.2 mt -101.55 -22.32 14.52 Favored 'General case' 0 N--CA 1.465 0.28 0 N-CA-C 114.231 1.197 . . . . 0.0 114.231 -173.668 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 69.0 m -60.42 -34.88 74.59 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 119.897 1.226 . . . . 0.0 111.188 -176.718 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 24.3 p -80.38 -13.13 59.41 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 124.817 1.247 . . . . 0.0 111.833 -179.344 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 31.3 mmmt -88.24 -10.84 48.38 Favored 'General case' 0 C--N 1.342 0.281 0 C-N-CA 125.297 1.439 . . . . 0.0 111.64 179.778 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 75.04 32.92 55.94 Favored Glycine 0 CA--C 1.523 0.572 0 CA-C-O 119.567 -0.574 . . . . 0.0 111.795 173.166 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 9.9 m -72.88 172.42 1.04 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.582 0 CA-C-N 118.26 1.03 . . . . 0.0 109.024 169.721 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -112.25 121.38 44.74 Favored 'General case' 0 CA--C 1.514 -0.422 0 N-CA-C 106.224 -1.769 . . . . 0.0 106.224 176.073 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 63.3 m-85 -88.79 143.99 26.53 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 119.513 1.051 . . . . 0.0 109.756 -176.176 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 30.6 m -129.53 161.17 39.57 Favored 'Isoleucine or valine' 0 C--O 1.234 0.269 0 C-N-CA 124.787 1.235 . . . . 0.0 108.623 170.044 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 95.79 -93.5 1.57 Allowed Glycine 0 N--CA 1.444 -0.79 0 C-N-CA 124.581 1.086 . . . . 0.0 111.122 177.463 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 14.4 m-30 59.25 -178.3 0.08 Allowed 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 124.345 1.058 . . . . 0.0 109.011 -167.275 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -154.93 144.44 15.32 Favored Pre-proline 0 N--CA 1.471 0.6 0 O-C-N 120.192 -1.568 . . . . 0.0 110.604 179.416 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -67.74 123.84 11.21 Favored 'Trans proline' 0 CA--C 1.534 0.515 0 C-N-CA 123.222 2.614 . . . . 0.0 111.705 179.114 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 3.0 p . . . . . 0 CA--C 1.538 0.492 0 O-C-N 121.669 -0.644 . . . . 0.0 112.315 174.692 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 24.3 ttmt . . . . . 0 CA--C 1.542 0.666 0 CA-C-O 117.603 -1.189 . . . . 0.0 113.538 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_endo -83.83 8.22 4.75 Favored 'Trans proline' 0 C--N 1.351 0.681 0 C-N-CA 122.144 1.896 . . . . 0.0 114.436 -179.6 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 29.0 m -126.4 165.31 24.8 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.285 0 CA-C-N 121.156 1.798 . . . . 0.0 111.791 -176.622 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 9.5 pt -132.81 169.2 22.48 Favored 'Isoleucine or valine' 0 C--O 1.234 0.277 0 C-N-CA 127.746 2.419 . . . . 0.0 108.576 179.714 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . 53.87 42.03 31.85 Favored 'General case' 0 C--O 1.227 -0.109 0 C-N-CA 125.296 1.438 . . . . 0.0 112.263 174.109 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 27.7 t70 54.04 42.57 31.57 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 126.479 1.912 . . . . 0.0 111.684 -177.527 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 91.78 16.82 50.66 Favored Glycine 0 CA--C 1.527 0.827 0 CA-C-O 118.721 -1.044 . . . . 0.0 113.642 173.873 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 46.2 mt-30 -89.32 -7.74 54.72 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 119.345 1.573 . . . . 0.0 112.946 179.635 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 7.4 tp -156.23 147.37 22.29 Favored 'General case' 0 C--N 1.344 0.339 0 CA-C-N 119.462 1.028 . . . . 0.0 110.829 169.964 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 67.6 m-85 -81.08 146.7 30.47 Favored 'General case' 0 CA--C 1.52 -0.175 0 N-CA-C 107.817 -1.179 . . . . 0.0 107.817 168.4 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 12.5 m -80.55 9.24 0.82 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 C-N-CA 123.722 0.809 . . . . 0.0 112.386 177.225 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -177.81 170.29 42.56 Favored Glycine 0 CA--C 1.524 0.644 0 N-CA-C 110.271 -1.132 . . . . 0.0 110.271 179.42 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -65.07 137.82 57.93 Favored 'General case' 0 N--CA 1.465 0.305 0 C-N-CA 123.326 0.65 . . . . 0.0 111.295 -176.3 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -93.76 122.84 36.65 Favored 'General case' 0 N--CA 1.444 -0.737 0 C-N-CA 126.229 1.812 . . . . 0.0 109.717 176.447 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 86.5 mt . . . . . 0 C--N 1.332 -0.177 0 N-CA-C 106.096 -1.816 . . . . 0.0 106.096 168.209 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 48.6 m . . . . . 0 CA--C 1.53 0.197 0 CA-C-O 119.417 -0.325 . . . . 0.0 110.829 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -60.87 -40.99 95.07 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 118.105 0.412 . . . . 0.0 110.902 174.593 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 -67.43 -50.37 59.65 Favored 'General case' 0 C--O 1.234 0.271 0 C-N-CA 124.614 1.165 . . . . 0.0 110.376 179.662 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 60.4 mtm180 -58.16 -41.46 83.85 Favored 'General case' 0 N--CA 1.463 0.214 0 C-N-CA 123.969 0.908 . . . . 0.0 109.734 -179.042 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 56.2 mt -69.47 -54.18 20.99 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.441 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 176.074 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 70.0 tp60 -52.78 -62.33 1.72 Allowed 'General case' 0 C--O 1.234 0.273 0 C-N-CA 124.546 1.139 . . . . 0.0 111.854 -171.767 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 20.0 m -66.13 -32.28 73.64 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 120.758 -0.377 . . . . 0.0 110.89 -169.493 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 160' ' ' TRP . . . . . 0.415 ' CH2' ' HB1' ' A' ' 83' ' ' ALA . 40.1 t90 -70.75 -43.84 68.0 Favored 'General case' 0 C--O 1.222 -0.386 0 O-C-N 121.99 -0.444 . . . . 0.0 111.267 176.553 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 67.2 m -58.31 -44.65 88.67 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 118.215 0.461 . . . . 0.0 110.173 176.917 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -62.45 -40.93 98.19 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-O 121.009 0.433 . . . . 0.0 110.153 176.752 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 13.6 tt0 -63.03 -52.85 61.23 Favored 'General case' 0 N--CA 1.447 -0.584 0 CA-C-O 118.732 -0.651 . . . . 0.0 110.036 -179.632 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 41.8 pt -63.43 -38.54 82.46 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.345 0 CA-C-O 117.973 -1.013 . . . . 0.0 109.185 -175.37 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -66.67 -32.82 74.38 Favored 'General case' 0 CA--C 1.529 0.152 0 CA-C-N 119.385 0.993 . . . . 0.0 110.414 -178.622 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 31.7 m-80 -68.66 -59.02 3.41 Favored 'General case' 0 CA--C 1.516 -0.352 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 173.303 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 16.2 tt0 -61.04 -37.9 84.22 Favored 'General case' 0 N--CA 1.441 -0.916 0 C-N-CA 125.895 1.678 . . . . 0.0 111.482 -168.904 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 168' ' ' MET . . . . . . . . . . . . . 19.9 ptp -70.06 -30.03 67.19 Favored 'General case' 0 C--N 1.333 -0.131 0 O-C-N 121.442 -0.786 . . . . 0.0 112.23 174.814 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -77.28 -38.52 50.66 Favored 'General case' 0 N--CA 1.446 -0.627 0 C-N-CA 123.126 0.57 . . . . 0.0 112.249 178.658 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 . . . . . 0 N--CA 1.468 0.439 0 CA-C-O 121.907 0.86 . . . . 0.0 109.698 -179.276 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.498 1.932 0 N-CA-C 111.684 0.253 . . . . 0.0 111.684 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 5.8 t30 -113.53 153.08 29.34 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 124.294 1.037 . . . . 0.0 109.297 177.333 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 15.9 mtt -113.7 129.34 56.59 Favored 'General case' 0 N--CA 1.462 0.128 0 C-N-CA 123.802 0.841 . . . . 0.0 110.137 -179.471 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -83.86 150.7 26.78 Favored Glycine 0 CA--C 1.526 0.721 0 N-CA-C 107.43 -2.268 . . . . 0.0 107.43 167.215 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 2.0 tt -138.33 99.15 3.77 Favored 'General case' 0 N--CA 1.467 0.39 0 N-CA-C 105.63 -1.989 . . . . 0.0 105.63 -177.821 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 1.1 p90 -105.18 147.78 27.63 Favored 'General case' 0 CA--C 1.519 -0.229 0 CA-C-N 118.592 0.633 . . . . 0.0 112.028 -171.372 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 43.0 p90 . . . . . 0 CA--C 1.536 0.442 0 C-N-CA 126.077 1.751 . . . . 0.0 107.728 170.483 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.224 -0.24 0 N-CA-C 109.076 -0.712 . . . . 0.0 109.076 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -62.74 -47.7 82.44 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 123.944 0.898 . . . . 0.0 111.381 -174.261 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 31.2 mt-10 -57.98 -44.82 87.35 Favored 'General case' 0 CA--C 1.518 -0.267 0 C-N-CA 123.202 0.601 . . . . 0.0 109.556 175.179 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 49.9 mttm -64.91 -47.54 77.41 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-O 118.796 -0.621 . . . . 0.0 110.484 -177.623 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 83.3 mt -53.12 -55.06 14.08 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.2 0 CA-C-N 118.897 0.771 . . . . 0.0 109.307 -178.812 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.475 ' HG2' HD21 ' A' ' 32' ' ' LEU . 0.0 OUTLIER -66.58 -35.06 79.29 Favored 'General case' 0 CA--C 1.513 -0.461 0 CA-C-O 118.812 -0.613 . . . . 0.0 111.313 -175.434 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -64.46 -39.9 94.69 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.997 0.427 . . . . 0.0 110.563 178.194 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 61.1 mt -78.01 -54.76 11.78 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.786 0 C-N-CA 124.77 1.228 . . . . 0.0 110.236 -171.092 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 71.3 mt -64.16 -46.22 94.17 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.326 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 179.257 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 141.98 124.1 1.93 Allowed Glycine 0 CA--C 1.528 0.898 0 C-N-CA 124.632 1.111 . . . . 0.0 110.969 173.528 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -69.94 -13.61 34.45 Favored 'Trans proline' 0 CA--C 1.539 0.738 0 C-N-CA 122.982 2.455 . . . . 0.0 112.836 -173.288 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -73.48 -21.42 60.43 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 118.509 0.595 . . . . 0.0 111.928 177.701 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -130.53 3.44 4.6 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 124.459 1.104 . . . . 0.0 113.535 -169.692 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 44.9 t -123.74 142.09 41.69 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.241 0 N-CA-C 107.62 -1.252 . . . . 0.0 107.62 171.262 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 30.5 m -129.27 132.48 47.19 Favored 'General case' 0 C--N 1.332 -0.182 0 C-N-CA 124.703 1.201 . . . . 0.0 108.427 -175.771 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.475 HD21 ' HG2' ' A' ' 22' ' ' ARG . 27.7 mt -75.25 135.73 40.97 Favored 'General case' 0 N--CA 1.456 -0.161 0 N-CA-C 107.999 -1.111 . . . . 0.0 107.999 175.432 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 28.5 t-80 -126.19 59.48 1.33 Allowed 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 125.148 1.379 . . . . 0.0 107.416 -176.811 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 33.3 t30 -69.55 113.26 6.67 Favored 'General case' 0 C--O 1.235 0.307 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 -176.296 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 77.6 mt -69.0 -14.89 63.31 Favored 'General case' 0 C--O 1.234 0.289 0 N-CA-C 112.554 0.576 . . . . 0.0 112.554 -171.775 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 1.3 tmtm? -58.81 -20.6 51.66 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 118.843 0.747 . . . . 0.0 111.173 168.82 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -128.03 -41.68 1.6 Allowed 'General case' 0 C--O 1.234 0.255 0 N-CA-C 113.287 0.847 . . . . 0.0 113.287 -175.801 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 30.5 m-20 -91.72 144.17 25.79 Favored 'General case' 0 C--O 1.235 0.301 0 C-N-CA 123.696 0.798 . . . . 0.0 111.07 -174.508 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 14.8 m -79.39 155.47 76.54 Favored Pre-proline 0 CA--C 1.539 0.551 0 C-N-CA 124.563 1.145 . . . . 0.0 110.258 176.361 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -76.93 -26.27 8.12 Favored 'Trans proline' 0 C--N 1.348 0.519 0 C-N-CA 122.232 1.955 . . . . 0.0 113.945 -171.082 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 8.2 mptt -62.64 -21.02 65.38 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 120.236 1.38 . . . . 0.0 111.8 -177.92 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -57.75 -29.74 65.04 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 125.865 1.666 . . . . 0.0 110.5 173.877 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 47.1 mtt -60.22 -26.21 66.23 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 118.763 0.71 . . . . 0.0 111.385 177.84 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 58.6 mt-10 -66.48 -33.51 75.85 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 118.714 0.688 . . . . 0.0 110.471 -176.651 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 24.3 mt-30 -63.77 -45.8 88.15 Favored 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 123.778 0.831 . . . . 0.0 112.868 -169.406 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 45.9 m-85 -76.24 136.02 39.67 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 115.393 -0.821 . . . . 0.0 109.473 -166.82 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -72.48 -30.19 64.31 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 118.865 0.757 . . . . 0.0 110.473 178.374 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 45.0 t -106.16 141.83 20.54 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.368 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 171.517 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 26.6 tp -136.82 118.46 14.95 Favored 'General case' 0 N--CA 1.446 -0.664 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 173.167 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 11.7 mt -93.61 133.48 34.54 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.829 0 N-CA-C 106.37 -1.715 . . . . 0.0 106.37 174.678 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 1.3 mp -111.23 134.07 53.1 Favored 'General case' 0 CA--C 1.518 -0.273 0 N-CA-C 106.703 -1.591 . . . . 0.0 106.703 -177.665 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -130.2 137.43 9.51 Favored Glycine 0 CA--C 1.518 0.257 0 N-CA-C 109.96 -1.256 . . . . 0.0 109.96 173.97 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 2.3 tt -151.57 133.86 8.45 Favored Pre-proline 0 CA--C 1.541 0.604 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 169.491 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_endo . . . . . 0 CA--C 1.538 0.703 0 C-N-CA 121.576 1.517 . . . . 0.0 114.521 -170.512 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 24.8 mt . . . . . 0 CA--C 1.542 0.635 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -93.27 161.61 14.33 Favored 'General case' 0 C--O 1.231 0.122 0 C-N-CA 124.313 1.045 . . . . 0.0 109.929 -178.724 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -54.56 -41.56 69.95 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 124.436 1.094 . . . . 0.0 111.63 -169.285 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 27.5 m-20 -59.71 -27.64 66.64 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-N 118.453 0.57 . . . . 0.0 112.026 -176.785 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' TRP . . . . . 0.464 ' CH2' HD23 ' A' ' 104' ' ' LEU . 4.5 t90 -96.49 -44.86 6.99 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 125.688 1.595 . . . . 0.0 109.479 -178.069 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -63.02 -36.72 84.51 Favored 'General case' 0 CA--C 1.53 0.199 0 O-C-N 121.013 -1.054 . . . . 0.0 110.221 -179.177 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -61.12 -25.57 67.07 Favored 'General case' 0 C--O 1.234 0.268 0 C-N-CA 123.356 0.662 . . . . 0.0 111.015 -177.481 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 23.5 m -106.41 -17.97 7.41 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.539 0 CA-C-O 116.581 -1.676 . . . . 0.0 112.535 176.402 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 18.2 t90 -54.99 -35.65 64.57 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 121.492 1.951 . . . . 0.0 110.995 -179.275 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -63.43 -28.92 70.31 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 125.249 1.42 . . . . 0.0 112.715 174.1 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 62.9 mt-30 -92.57 -25.37 18.37 Favored 'General case' 0 C--O 1.224 -0.287 0 C-N-CA 126.436 1.894 . . . . 0.0 111.31 -179.842 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 37.6 mt -64.16 -26.43 68.52 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 118.727 0.694 . . . . 0.0 110.361 179.927 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -76.59 -25.67 54.21 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 117.794 0.27 . . . . 0.0 110.824 171.463 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -79.55 -33.38 41.93 Favored 'General case' 0 CA--C 1.538 0.494 0 O-C-N 121.257 -0.902 . . . . 0.0 113.049 179.403 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 30.6 mt -56.37 148.67 18.35 Favored 'General case' 0 C--O 1.234 0.265 0 C-N-CA 124.75 1.22 . . . . 0.0 111.02 -177.876 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 20.5 t-20 -86.03 122.88 30.68 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 170.325 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 74.2 mt -130.43 8.78 5.06 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 123.622 0.769 . . . . 0.0 112.222 -173.328 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 29.1 mt-10 -53.52 128.46 29.02 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 124.038 0.935 . . . . 0.0 112.256 -168.418 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 68.13 -0.26 12.42 Favored Glycine 0 CA--C 1.533 1.195 0 C-N-CA 125.443 1.497 . . . . 0.0 115.293 177.92 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.92 149.71 43.17 Favored 'General case' 0 C--N 1.343 0.308 0 CA-C-N 120.388 2.094 . . . . 0.0 109.635 -173.178 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 3.1 mt -80.56 133.33 29.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 N-CA-C 106.596 -1.631 . . . . 0.0 106.596 179.916 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 79.8 t -129.3 140.06 50.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 C-N-CA 124.122 0.969 . . . . 0.0 109.877 -176.93 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -128.42 154.31 46.17 Favored 'General case' 0 CA--C 1.53 0.173 0 C-N-CA 124.809 1.244 . . . . 0.0 108.052 169.795 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 2.4 mt -132.08 131.68 42.62 Favored 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 124.744 1.218 . . . . 0.0 108.334 -171.957 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' TYR . . . . . 0.41 ' CD2' HD23 ' A' ' 142' ' ' LEU . 45.3 m-85 -130.28 141.93 50.58 Favored 'General case' 0 N--CA 1.451 -0.385 0 N-CA-C 106.643 -1.614 . . . . 0.0 106.643 -177.771 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -157.55 172.27 34.86 Favored Glycine 0 N--CA 1.442 -0.92 0 N-CA-C 108.965 -1.654 . . . . 0.0 108.965 168.502 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.324 -0.537 0 C-N-CA 124.527 1.131 . . . . 0.0 109.54 170.149 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 84.4 mt . . . . . 0 CA--C 1.537 0.47 0 N-CA-C 113.668 0.988 . . . . 0.0 113.668 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -56.51 -42.73 78.87 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 120.394 1.452 . . . . 0.0 112.592 -168.468 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -80.95 -14.87 57.57 Favored 'General case' 0 CA--C 1.534 0.329 0 N-CA-C 113.389 0.885 . . . . 0.0 113.389 179.786 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 6.6 tt -60.58 -43.55 97.2 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-N 120.056 1.298 . . . . 0.0 107.911 169.24 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -66.75 -32.7 82.03 Favored Glycine 0 C--N 1.337 0.595 0 N-CA-C 112.031 -0.428 . . . . 0.0 112.031 -175.52 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 77.2 mtm -72.37 -26.9 62.08 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-O 118.363 -0.827 . . . . 0.0 111.796 -175.987 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.464 HD23 ' CH2' ' A' ' 65' ' ' TRP . 0.2 OUTLIER -76.41 -43.17 41.6 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 120.365 1.439 . . . . 0.0 109.372 169.019 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 82.1 t60 -53.34 -47.98 68.9 Favored 'General case' 0 N--CA 1.467 0.393 0 O-C-N 121.758 -0.589 . . . . 0.0 110.974 179.632 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -62.68 -37.24 85.68 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 123.676 0.79 . . . . 0.0 112.682 -177.505 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 25.1 ttmm -58.41 -36.41 73.54 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 123.575 0.75 . . . . 0.0 110.484 172.485 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 24.0 mt -91.95 -20.14 21.69 Favored 'General case' 0 CA--C 1.513 -0.453 0 N-CA-C 115.95 1.833 . . . . 0.0 115.95 -168.158 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 3.2 m -58.28 -32.97 68.92 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 120.665 1.575 . . . . 0.0 111.632 -176.433 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 21.1 p -88.27 -10.66 48.89 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 125.23 1.412 . . . . 0.0 112.409 -179.883 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 32.4 mmmt -82.99 -9.25 59.37 Favored 'General case' 0 C--N 1.347 0.458 0 C-N-CA 124.494 1.117 . . . . 0.0 111.435 175.169 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 73.81 31.93 59.67 Favored Glycine 0 CA--C 1.525 0.663 0 CA-C-O 119.645 -0.531 . . . . 0.0 112.165 172.99 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 5.8 m -73.25 174.44 0.78 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.618 0 CA-C-N 118.219 1.009 . . . . 0.0 109.158 169.748 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -115.63 131.28 56.98 Favored 'General case' 0 CA--C 1.518 -0.265 0 N-CA-C 106.909 -1.515 . . . . 0.0 106.909 172.772 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 80.3 m-85 -96.48 148.29 22.96 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 119.677 1.126 . . . . 0.0 109.384 -179.722 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 31.3 m -126.37 163.91 27.47 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.263 0 C-N-CA 123.847 0.859 . . . . 0.0 109.799 172.006 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 86.91 -91.34 1.73 Allowed Glycine 0 N--CA 1.444 -0.817 0 C-N-CA 124.996 1.284 . . . . 0.0 112.292 172.975 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 16.8 m-30 59.68 170.49 0.08 Allowed 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 126.081 1.752 . . . . 0.0 110.251 -165.599 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -141.09 140.86 21.94 Favored Pre-proline 0 N--CA 1.471 0.58 0 O-C-N 120.442 -1.411 . . . . 0.0 109.479 174.033 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_exo -54.51 129.12 33.16 Favored 'Trans proline' 0 N--CA 1.456 -0.731 0 C-N-CA 122.622 2.215 . . . . 0.0 110.65 169.796 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 20.7 p . . . . . 0 N--CA 1.47 0.564 0 N-CA-C 112.465 0.542 . . . . 0.0 112.465 171.681 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 54.3 mttt . . . . . 0 CA--C 1.54 0.582 0 CA-C-O 117.717 -1.135 . . . . 0.0 112.256 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -86.07 11.75 3.23 Favored 'Trans proline' 0 C--N 1.35 0.642 0 C-N-CA 122.001 1.801 . . . . 0.0 113.742 -172.725 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 21.9 m -129.54 161.26 39.4 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.171 0 CA-C-N 120.629 1.559 . . . . 0.0 111.797 -175.155 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 21.5 pt -132.92 173.16 15.26 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.344 0 C-N-CA 127.151 2.18 . . . . 0.0 108.988 -179.788 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . 54.12 43.43 30.7 Favored 'General case' 0 N--CA 1.461 0.112 0 C-N-CA 125.406 1.482 . . . . 0.0 112.07 174.93 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 27.3 t0 54.0 43.44 30.79 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 126.609 1.964 . . . . 0.0 111.603 -176.785 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 87.6 29.5 21.3 Favored Glycine 0 CA--C 1.526 0.77 0 CA-C-O 118.207 -1.329 . . . . 0.0 113.635 171.559 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 47.3 mt-30 -95.54 -23.39 17.1 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 119.141 1.471 . . . . 0.0 113.201 179.201 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -138.79 141.0 38.78 Favored 'General case' 0 CA--C 1.513 -0.477 0 CA-C-N 119.641 1.11 . . . . 0.0 110.56 176.026 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 67.5 m-85 -76.98 138.27 39.52 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 105.106 -2.183 . . . . 0.0 105.106 164.257 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 25.7 m -76.74 4.43 1.17 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.643 0 C-N-CA 123.188 0.595 . . . . 0.0 112.067 -177.945 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -168.5 -174.19 37.01 Favored Glycine 0 CA--C 1.523 0.537 0 C-N-CA 125.742 1.639 . . . . 0.0 109.16 -175.806 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 0.41 HD23 ' CD2' ' A' ' 85' ' ' TYR . 29.4 tp -75.06 140.95 43.86 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 122.892 0.477 . . . . 0.0 111.722 -171.739 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -89.43 132.71 34.87 Favored 'General case' 0 N--CA 1.447 -0.586 0 C-N-CA 125.876 1.67 . . . . 0.0 109.081 169.2 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 89.9 mt . . . . . 0 N--CA 1.467 0.425 0 N-CA-C 106.643 -1.614 . . . . 0.0 106.643 172.222 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 47.9 m . . . . . 0 CA--C 1.538 0.507 0 N-CA-C 109.745 -0.465 . . . . 0.0 109.745 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -60.12 -44.59 94.78 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 123.431 0.693 . . . . 0.0 110.497 174.154 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 27.3 tt0 -58.46 -46.89 85.68 Favored 'General case' 0 C--O 1.231 0.09 0 C-N-CA 124.171 0.989 . . . . 0.0 110.435 174.367 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.29 -46.24 86.45 Favored 'General case' 0 C--O 1.225 -0.224 0 CA-C-O 117.959 -1.019 . . . . 0.0 109.554 179.023 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 47.6 mt -60.45 -52.44 61.4 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.233 0 CA-C-N 119.687 1.131 . . . . 0.0 108.038 176.928 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 72.7 tp60 -53.29 -65.11 0.62 Allowed 'General case' 0 C--O 1.232 0.155 0 CA-C-N 119.23 0.923 . . . . 0.0 112.073 -177.151 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 19.9 m -68.75 -32.36 72.07 Favored 'General case' 0 C--N 1.325 -0.489 0 C-N-CA 121.4 -0.12 . . . . 0.0 111.309 -168.997 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 160' ' ' TRP . . . . . . . . . . . . . 2.8 t90 -73.13 -41.77 63.6 Favored 'General case' 0 C--O 1.221 -0.423 0 CA-C-O 118.977 -0.535 . . . . 0.0 110.618 177.465 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 23.2 m -55.47 -47.84 75.47 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 118.519 0.599 . . . . 0.0 110.343 173.387 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 162' ' ' GLU . . . . . 0.4 ' HA ' HD23 ' A' ' 165' ' ' LEU . 40.3 mt-10 -60.3 -43.36 96.38 Favored 'General case' 0 C--N 1.332 -0.156 0 N-CA-C 109.681 -0.488 . . . . 0.0 109.681 178.752 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 42.6 tt0 -63.29 -51.71 64.96 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-O 117.904 -1.046 . . . . 0.0 110.383 -178.182 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 39.7 pt -64.15 -33.06 60.01 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.412 0 CA-C-O 118.127 -0.94 . . . . 0.0 109.441 -175.829 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 165' ' ' LEU . . . . . 0.4 HD23 ' HA ' ' A' ' 162' ' ' GLU . 0.3 OUTLIER -72.82 -31.45 64.82 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 119.395 0.998 . . . . 0.0 108.856 -174.375 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -71.53 -52.1 20.04 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 124.692 1.197 . . . . 0.0 109.084 173.277 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -67.7 -35.3 78.56 Favored 'General case' 0 N--CA 1.441 -0.883 0 C-N-CA 125.78 1.632 . . . . 0.0 109.425 -169.485 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 168' ' ' MET . . . . . . . . . . . . . 21.5 ptp -73.03 -29.11 62.76 Favored 'General case' 0 C--N 1.333 -0.128 0 O-C-N 122.28 -0.262 . . . . 0.0 111.583 176.96 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -75.62 -36.56 60.21 Favored 'General case' 0 N--CA 1.444 -0.726 0 CA-C-O 119.16 -0.448 . . . . 0.0 111.779 178.2 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 5.8 mt-10 . . . . . 0 N--CA 1.466 0.332 0 CA-C-O 122.248 1.023 . . . . 0.0 109.275 178.486 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.498 1.964 0 CA-C-O 120.322 0.106 . . . . 0.0 111.197 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 24.8 p-10 -120.61 165.95 14.33 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 125.082 1.353 . . . . 0.0 111.512 -175.333 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 11.9 mtt -130.27 133.91 46.84 Favored 'General case' 0 CA--C 1.52 -0.195 0 C-N-CA 123.361 0.665 . . . . 0.0 110.507 175.625 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -100.48 142.42 15.84 Favored Glycine 0 CA--C 1.523 0.559 0 N-CA-C 106.769 -2.532 . . . . 0.0 106.769 167.538 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 2.2 tt -128.22 101.15 6.12 Favored 'General case' 0 CA--C 1.518 -0.252 0 N-CA-C 105.852 -1.907 . . . . 0.0 105.852 -172.899 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -102.49 144.26 31.16 Favored 'General case' 0 N--CA 1.455 -0.216 0 CA-C-O 121.588 0.709 . . . . 0.0 111.672 -173.809 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 43.7 p90 . . . . . 0 CA--C 1.537 0.478 0 C-N-CA 127.04 2.136 . . . . 0.0 106.489 175.0 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.462 0.168 0 N-CA-C 109.03 -0.729 . . . . 0.0 109.03 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -64.02 -47.45 80.22 Favored 'General case' 0 N--CA 1.455 -0.19 0 C-N-CA 122.921 0.489 . . . . 0.0 111.54 -175.276 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 10.2 mt-10 -60.95 -42.99 99.33 Favored 'General case' 0 CA--C 1.517 -0.309 0 CA-C-O 118.903 -0.57 . . . . 0.0 109.949 176.678 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 29.3 mtpp -71.14 -40.67 71.22 Favored 'General case' 0 C--O 1.221 -0.435 0 CA-C-O 118.057 -0.973 . . . . 0.0 110.775 -174.132 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 47.6 mt -53.81 -54.27 20.92 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.267 0 CA-C-N 120.014 1.279 . . . . 0.0 108.818 173.07 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 8.5 ttp180 -60.56 -41.07 93.82 Favored 'General case' 0 C--O 1.223 -0.298 0 C-N-CA 123.397 0.679 . . . . 0.0 109.65 -176.703 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -66.74 -41.17 88.25 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 122.945 0.498 . . . . 0.0 111.066 -178.894 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.617 HD13 ' HA ' ' A' ' 158' ' ' GLN . 41.0 mt -68.76 -56.18 13.13 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.57 0 C-N-CA 124.345 1.058 . . . . 0.0 109.691 -175.61 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 79.0 mt -67.89 -44.23 85.4 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.428 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 -175.649 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 138.55 125.39 2.32 Favored Glycine 0 CA--C 1.53 1.022 0 C-N-CA 125.061 1.315 . . . . 0.0 111.493 173.22 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -71.95 -6.21 18.66 Favored 'Trans proline' 0 CA--C 1.537 0.666 0 C-N-CA 123.505 2.803 . . . . 0.0 114.044 -175.674 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -80.15 -18.63 49.23 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 119.232 0.924 . . . . 0.0 111.241 175.953 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -128.66 -10.1 5.03 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 124.532 1.133 . . . . 0.0 113.994 -173.803 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 31.5 t -106.97 150.07 9.84 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.352 0 CA-C-N 119.375 0.989 . . . . 0.0 108.346 170.702 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 2.7 m -137.23 130.97 31.74 Favored 'General case' 0 N--CA 1.456 -0.174 0 N-CA-C 106.599 -1.63 . . . . 0.0 106.599 -172.909 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 21.3 mt -80.46 143.71 33.16 Favored 'General case' 0 CA--C 1.53 0.202 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 176.916 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' HIS . . . . . 0.465 ' HE2' ' HB2' ' A' ' 42' ' ' LEU . 39.0 t-80 -136.77 64.88 1.53 Allowed 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 124.451 1.1 . . . . 0.0 108.195 -174.554 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 64.4 t-20 -72.39 119.12 16.15 Favored 'General case' 0 CA--C 1.53 0.193 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 -178.407 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 81.9 mt -66.06 -18.31 65.26 Favored 'General case' 0 C--O 1.233 0.206 0 C-N-CA 123.782 0.833 . . . . 0.0 112.918 -176.839 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 28.3 tptp -55.35 -27.12 45.19 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-O 118.879 -0.581 . . . . 0.0 111.156 168.654 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -121.47 -41.45 2.49 Favored 'General case' 0 N--CA 1.464 0.271 0 N-CA-C 113.549 0.944 . . . . 0.0 113.549 -173.856 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 29.6 m-20 -96.53 142.29 28.78 Favored 'General case' 0 C--O 1.234 0.276 0 C-N-CA 123.334 0.654 . . . . 0.0 110.702 -176.151 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 14.0 m -75.97 156.27 84.31 Favored Pre-proline 0 CA--C 1.542 0.646 0 C-N-CA 124.181 0.992 . . . . 0.0 109.986 173.632 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo -77.27 -25.1 8.79 Favored 'Trans proline' 0 C--N 1.348 0.533 0 C-N-CA 122.212 1.941 . . . . 0.0 113.312 -169.785 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 23.7 mmmt -69.38 -15.26 63.27 Favored 'General case' 0 N--CA 1.474 0.758 0 O-C-N 120.512 -1.368 . . . . 0.0 111.693 -176.029 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.465 ' HB2' ' HE2' ' A' ' 33' ' ' HIS . 2.1 mm? -62.01 -26.82 68.46 Favored 'General case' 0 N--CA 1.464 0.263 0 C-N-CA 125.555 1.542 . . . . 0.0 110.603 169.426 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 51.3 mtt -58.99 -25.29 63.5 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 119.207 0.912 . . . . 0.0 111.48 177.308 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -64.06 -31.83 73.17 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 118.395 0.543 . . . . 0.0 110.127 -176.535 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 27.3 mt-30 -67.05 -38.79 86.46 Favored 'General case' 0 CA--C 1.534 0.364 0 N-CA-C 113.302 0.852 . . . . 0.0 113.302 -170.873 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 61.0 m-85 -76.08 136.25 39.88 Favored 'General case' 0 CA--C 1.52 -0.202 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 -167.49 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -71.84 -37.75 70.23 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-N 118.281 0.491 . . . . 0.0 110.576 -178.349 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 15.4 t -107.22 144.95 15.26 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.364 0 N-CA-C 107.52 -1.289 . . . . 0.0 107.52 169.003 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 28.8 tp -132.97 120.29 21.22 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 175.098 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 48.3 mt -99.41 129.25 50.19 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.606 0 N-CA-C 106.47 -1.678 . . . . 0.0 106.47 179.774 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -110.13 132.47 54.14 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 125.539 1.536 . . . . 0.0 107.793 -175.342 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -138.44 138.73 9.71 Favored Glycine 0 C--N 1.332 0.346 0 N-CA-C 109.821 -1.312 . . . . 0.0 109.821 178.233 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.427 HD12 ' CD2' ' A' ' 65' ' ' TRP . 3.9 tt -155.75 133.46 6.75 Favored Pre-proline 0 CA--C 1.535 0.37 0 CA-C-N 117.555 0.677 . . . . 0.0 111.164 172.805 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_exo . . . . . 0 N--CA 1.456 -0.704 0 C-N-CA 122.376 2.051 . . . . 0.0 109.197 164.06 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 12.8 mt . . . . . 0 CA--C 1.543 0.682 0 CA-C-O 121.581 0.705 . . . . 0.0 112.289 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 4.1 mp0 -72.59 153.99 41.0 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 124.836 1.254 . . . . 0.0 109.828 179.421 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -59.07 -42.84 91.35 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 123.338 0.655 . . . . 0.0 111.593 -170.255 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -60.54 -24.67 65.55 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 123.591 0.757 . . . . 0.0 111.95 -177.639 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' TRP . . . . . 0.433 ' CH2' HD22 ' A' ' 104' ' ' LEU . 1.8 t90 -96.04 -42.63 8.16 Favored 'General case' 0 N--CA 1.447 -0.588 0 C-N-CA 124.695 1.198 . . . . 0.0 109.773 -178.425 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 7.8 tt0 -63.14 -33.86 76.38 Favored 'General case' 0 N--CA 1.446 -0.665 0 O-C-N 120.749 -1.219 . . . . 0.0 109.868 178.708 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -55.82 -24.65 37.47 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 124.333 1.053 . . . . 0.0 111.965 -179.497 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 35.3 m -116.84 -11.42 11.81 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.171 0 CA-C-O 117.596 -1.192 . . . . 0.0 113.179 178.245 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 25.0 t90 -52.87 -38.28 61.41 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 119.959 1.254 . . . . 0.0 110.435 -178.891 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -64.6 -27.11 68.72 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 125.361 1.464 . . . . 0.0 113.303 177.041 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 30.0 mt-30 -92.6 -19.41 21.93 Favored 'General case' 0 C--N 1.342 0.244 0 C-N-CA 125.309 1.443 . . . . 0.0 112.617 178.966 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 60.1 mt -59.55 -25.94 64.96 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 118.633 0.651 . . . . 0.0 111.137 -178.414 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -77.1 -25.15 51.92 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 118.085 0.402 . . . . 0.0 111.626 176.704 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -72.98 -29.98 63.47 Favored 'General case' 0 N--CA 1.467 0.376 0 O-C-N 121.058 -1.026 . . . . 0.0 111.828 178.866 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 76.5 mt -53.62 139.86 30.65 Favored 'General case' 0 C--N 1.341 0.218 0 C-N-CA 125.016 1.326 . . . . 0.0 112.289 -169.008 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 28.8 t-20 -77.2 107.44 9.6 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 169.707 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 65.2 mt -127.6 1.48 6.18 Favored 'General case' 0 N--CA 1.474 0.734 0 N-CA-C 113.912 1.079 . . . . 0.0 113.912 -173.237 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -51.87 129.16 26.04 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-N 119.228 0.922 . . . . 0.0 111.482 -168.442 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 70.63 -2.0 18.69 Favored Glycine 0 CA--C 1.535 1.326 0 C-N-CA 125.935 1.731 . . . . 0.0 115.972 177.523 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.05 151.85 38.67 Favored 'General case' 0 C--N 1.344 0.366 0 CA-C-N 121.002 2.401 . . . . 0.0 110.53 -172.097 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 6.7 mt -81.1 137.49 21.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 N-CA-C 106.676 -1.601 . . . . 0.0 106.676 178.849 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 78.0 t -134.68 136.4 52.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 C-N-CA 123.729 0.812 . . . . 0.0 110.235 -174.365 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -110.82 150.77 28.67 Favored 'General case' 0 N--CA 1.468 0.45 0 N-CA-C 107.878 -1.156 . . . . 0.0 107.878 169.257 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 2.8 mt -130.87 136.54 48.72 Favored 'General case' 0 CA--C 1.51 -0.562 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 174.603 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 43.6 p90 -147.42 166.82 26.06 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 168.669 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -162.46 160.03 32.27 Favored Glycine 0 N--CA 1.447 -0.582 0 N-CA-C 109.811 -1.316 . . . . 0.0 109.811 172.416 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 4.1 tt . . . . . 0 N--CA 1.448 -0.553 0 C-N-CA 125.457 1.503 . . . . 0.0 108.001 173.934 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 80.2 mt . . . . . 0 N--CA 1.468 0.433 0 N-CA-C 110.111 -0.329 . . . . 0.0 110.111 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -59.78 -33.77 72.14 Favored 'General case' 0 N--CA 1.467 0.376 0 O-C-N 120.581 -1.325 . . . . 0.0 111.944 -171.415 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 100' ' ' ALA . . . . . 0.421 ' HB1' HD13 ' A' ' 53' ' ' ILE . . . -73.45 -27.92 61.68 Favored 'General case' 0 CA--C 1.535 0.367 0 O-C-N 121.234 -0.916 . . . . 0.0 112.44 177.268 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 4.4 tt -60.67 -47.06 87.93 Favored 'General case' 0 N--CA 1.467 0.419 0 N-CA-C 107.458 -1.312 . . . . 0.0 107.458 169.065 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -62.31 -42.03 99.72 Favored Glycine 0 C--N 1.339 0.715 0 N-CA-C 111.44 -0.664 . . . . 0.0 111.44 -178.925 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 76.3 mtm -63.96 -38.37 90.82 Favored 'General case' 0 CA--C 1.529 0.166 0 CA-C-N 118.182 0.991 . . . . 0.0 111.726 179.564 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.433 HD22 ' CH2' ' A' ' 65' ' ' TRP . 4.2 tp -71.61 -35.45 70.48 Favored 'General case' 0 C--N 1.345 0.373 0 CA-C-N 120.247 1.385 . . . . 0.0 110.341 178.885 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 105' ' ' HIS . . . . . 0.415 ' CG ' HG21 ' A' ' 140' ' ' VAL . 0.2 OUTLIER -54.56 -51.65 64.55 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 118.899 0.772 . . . . 0.0 110.283 169.132 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -64.47 -42.77 95.71 Favored 'General case' 0 C--O 1.233 0.229 0 C-N-CA 122.754 0.422 . . . . 0.0 111.466 -172.289 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 22.5 ttmm -58.43 -39.36 79.6 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 123.897 0.879 . . . . 0.0 110.655 173.225 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 52.0 mt -87.11 -22.23 25.51 Favored 'General case' 0 CA--C 1.517 -0.29 0 N-CA-C 114.152 1.167 . . . . 0.0 114.152 -169.454 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 8.3 t -56.95 -36.24 70.03 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-N 119.393 0.997 . . . . 0.0 110.879 -175.673 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 21.1 p -86.21 -8.1 58.04 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 124.581 1.152 . . . . 0.0 112.2 -178.298 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 32.4 mmmt -83.15 -8.32 59.51 Favored 'General case' 0 C--N 1.346 0.441 0 C-N-CA 124.573 1.149 . . . . 0.0 111.709 175.393 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 74.7 29.11 61.85 Favored Glycine 0 CA--C 1.526 0.777 0 CA-C-N 118.424 0.557 . . . . 0.0 112.462 173.343 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 17.1 m -75.23 176.44 0.64 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 CA-C-N 117.957 0.879 . . . . 0.0 109.989 171.887 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -121.54 125.95 48.01 Favored 'General case' 0 CA--C 1.52 -0.208 0 N-CA-C 106.918 -1.512 . . . . 0.0 106.918 174.442 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 79.5 m-85 -89.5 145.03 25.57 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 119.562 1.074 . . . . 0.0 109.337 -178.649 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 27.3 m -126.68 157.86 37.41 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.212 0 C-N-CA 124.237 1.015 . . . . 0.0 109.084 171.149 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 95.38 -88.4 1.09 Allowed Glycine 0 C--N 1.333 0.364 0 CA-C-O 119.109 -0.829 . . . . 0.0 111.259 173.185 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 22.0 m-30 57.56 -173.49 0.08 Allowed 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 124.104 0.961 . . . . 0.0 110.446 -168.735 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -153.96 146.3 17.33 Favored Pre-proline 0 N--CA 1.473 0.69 0 CA-C-N 120.359 1.436 . . . . 0.0 109.656 178.952 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_endo -67.71 124.42 11.91 Favored 'Trans proline' 0 CA--C 1.535 0.568 0 C-N-CA 122.959 2.439 . . . . 0.0 112.121 178.993 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 2.9 p . . . . . 0 CA--C 1.538 0.51 0 O-C-N 121.507 -0.746 . . . . 0.0 112.296 171.958 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 7.6 ttmt . . . . . 0 CA--C 1.542 0.647 0 CA-C-O 117.441 -1.266 . . . . 0.0 113.929 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_endo -77.41 5.81 4.86 Favored 'Trans proline' 0 C--N 1.352 0.752 0 CA-C-N 122.012 1.754 . . . . 0.0 114.385 179.154 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 26.9 m -132.02 169.58 21.56 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.215 0 CA-C-N 120.411 1.459 . . . . 0.0 110.434 -176.844 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 23.0 pt -138.49 171.97 14.5 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.507 0 C-N-CA 126.768 2.027 . . . . 0.0 108.594 -177.606 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . 54.76 41.27 32.05 Favored 'General case' 0 CA--C 1.528 0.106 0 C-N-CA 125.081 1.352 . . . . 0.0 112.46 174.302 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 27.3 t70 55.7 42.15 29.63 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 126.187 1.795 . . . . 0.0 111.734 -176.121 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 88.19 15.6 60.46 Favored Glycine 0 CA--C 1.528 0.891 0 CA-C-O 118.93 -0.928 . . . . 0.0 113.679 174.446 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 45.4 mt-30 -88.46 -7.59 56.31 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 118.934 1.367 . . . . 0.0 112.524 -179.06 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 8.3 tp -155.44 146.05 22.13 Favored 'General case' 0 C--N 1.344 0.35 0 CA-C-N 119.241 0.928 . . . . 0.0 110.291 172.304 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 58.4 m-85 -76.9 144.1 39.14 Favored 'General case' 0 CA--C 1.514 -0.425 0 N-CA-C 107.472 -1.307 . . . . 0.0 107.472 169.294 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 140' ' ' VAL . . . . . 0.415 HG21 ' CG ' ' A' ' 105' ' ' HIS . 4.4 p -82.23 14.1 0.52 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.573 0 CA-C-O 121.159 0.504 . . . . 0.0 112.13 -179.6 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 178.47 172.42 42.83 Favored Glycine 0 CA--C 1.525 0.685 0 N-CA-C 110.009 -1.237 . . . . 0.0 110.009 176.623 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 1.1 tp -65.79 138.04 57.65 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 117.631 0.715 . . . . 0.0 110.883 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -98.89 114.38 26.96 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 125.941 1.697 . . . . 0.0 110.178 -179.931 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 3.9 mm? . . . . . 0 CA--C 1.537 0.457 0 N-CA-C 106.386 -1.709 . . . . 0.0 106.386 166.945 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 21.9 m . . . . . 0 CA--C 1.534 0.328 0 N-CA-C 110.283 -0.266 . . . . 0.0 110.283 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -61.23 -40.43 93.98 Favored 'General case' 0 N--CA 1.463 0.179 0 O-C-N 121.917 -0.489 . . . . 0.0 110.884 172.19 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 -65.95 -47.4 74.78 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 124.106 0.962 . . . . 0.0 110.505 179.396 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 75.5 mtt-85 -52.2 -46.01 65.44 Favored 'General case' 0 N--CA 1.463 0.19 0 C-N-CA 124.509 1.124 . . . . 0.0 110.397 176.415 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 30.6 mt -70.37 -53.71 21.7 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 N-CA-C 107.847 -1.168 . . . . 0.0 107.847 179.302 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 158' ' ' GLN . . . . . 0.617 ' HA ' HD13 ' A' ' 24' ' ' ILE . 68.7 tp60 -49.66 -64.77 0.71 Allowed 'General case' 0 C--O 1.233 0.22 0 C-N-CA 125.569 1.548 . . . . 0.0 112.202 -174.132 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 20.1 m -67.8 -31.86 72.02 Favored 'General case' 0 C--N 1.324 -0.512 0 C-N-CA 120.924 -0.31 . . . . 0.0 110.768 -169.075 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 160' ' ' TRP . . . . . . . . . . . . . 36.2 t90 -68.86 -44.2 73.83 Favored 'General case' 0 C--O 1.221 -0.407 0 O-C-N 122.128 -0.357 . . . . 0.0 110.914 176.455 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 87.8 m -60.68 -42.53 97.3 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 122.889 0.476 . . . . 0.0 110.636 177.97 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 162' ' ' GLU . . . . . 0.423 ' HA ' HD23 ' A' ' 165' ' ' LEU . 39.9 mt-10 -63.35 -40.95 98.68 Favored 'General case' 0 CA--C 1.529 0.148 0 CA-C-O 121.481 0.658 . . . . 0.0 110.041 175.153 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 13.7 tt0 -64.67 -49.08 72.35 Favored 'General case' 0 N--CA 1.451 -0.419 0 O-C-N 121.375 -0.828 . . . . 0.0 110.735 -178.798 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 45.7 pt -64.6 -38.88 83.78 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.348 0 CA-C-O 118.089 -0.958 . . . . 0.0 109.62 -176.265 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 165' ' ' LEU . . . . . 0.423 HD23 ' HA ' ' A' ' 162' ' ' GLU . 0.3 OUTLIER -64.93 -32.59 74.39 Favored 'General case' 0 CA--C 1.53 0.176 0 CA-C-N 118.913 0.779 . . . . 0.0 110.229 179.698 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 29.6 m-80 -67.71 -60.69 2.33 Favored 'General case' 0 C--O 1.221 -0.444 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 172.523 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -53.21 -43.93 67.62 Favored 'General case' 0 N--CA 1.441 -0.89 0 C-N-CA 126.965 2.106 . . . . 0.0 111.168 -171.247 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 168' ' ' MET . . . . . . . . . . . . . 19.7 ptp -70.92 -31.68 68.36 Favored 'General case' 0 C--N 1.333 -0.151 0 N-CA-C 112.143 0.423 . . . . 0.0 112.143 179.244 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -75.35 -35.28 61.19 Favored 'General case' 0 N--CA 1.445 -0.723 0 N-CA-C 111.74 0.274 . . . . 0.0 111.74 177.918 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 . . . . . 0 N--CA 1.467 0.387 0 CA-C-O 121.579 0.704 . . . . 0.0 109.581 178.634 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.498 1.971 0 N-CA-C 111.108 0.04 . . . . 0.0 111.108 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 19.3 p-10 -128.68 163.83 24.25 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 124.843 1.257 . . . . 0.0 111.49 -171.948 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 10.2 mtt -129.15 133.19 47.5 Favored 'General case' 0 CA--C 1.521 -0.153 0 C-N-CA 123.385 0.674 . . . . 0.0 111.418 179.118 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -98.43 147.24 18.48 Favored Glycine 0 CA--C 1.53 1.007 0 N-CA-C 106.395 -2.682 . . . . 0.0 106.395 166.718 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 1.2 tt -133.67 96.7 3.74 Favored 'General case' 0 N--CA 1.465 0.315 0 N-CA-C 105.573 -2.01 . . . . 0.0 105.573 -173.028 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -97.36 146.75 24.87 Favored 'General case' 0 CA--C 1.514 -0.419 0 CA-C-N 118.03 0.377 . . . . 0.0 111.109 -173.635 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 34.2 p90 . . . . . 0 C--N 1.33 -0.268 0 C-N-CA 124.471 1.108 . . . . 0.0 109.518 176.7 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.224 -0.264 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -61.99 -46.52 88.86 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 118.443 0.565 . . . . 0.0 111.133 -175.49 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -59.54 -48.22 82.5 Favored 'General case' 0 N--CA 1.451 -0.398 0 C-N-CA 124.379 1.072 . . . . 0.0 110.11 176.479 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 28.8 mtpp -68.99 -37.76 78.93 Favored 'General case' 0 C--O 1.224 -0.253 0 CA-C-O 117.992 -1.004 . . . . 0.0 111.033 -175.22 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 63.1 mt -54.21 -57.75 5.28 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.199 0 CA-C-N 119.712 1.142 . . . . 0.0 108.471 175.652 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 15.1 ptt180 -62.84 -39.14 93.46 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-O 118.834 -0.603 . . . . 0.0 110.067 -177.149 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -65.38 -39.18 91.95 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 118.339 0.518 . . . . 0.0 110.358 -173.673 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 62.9 mt -76.62 -52.61 16.82 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.699 0 C-N-CA 124.886 1.274 . . . . 0.0 110.091 -175.855 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 64.1 mt -60.55 -47.54 92.36 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.336 0 C-N-CA 123.025 0.53 . . . . 0.0 109.841 179.283 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 139.61 113.97 1.14 Allowed Glycine 0 CA--C 1.525 0.66 0 C-N-CA 125.656 1.598 . . . . 0.0 109.258 -179.113 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -72.87 -7.93 21.52 Favored 'Trans proline' 0 CA--C 1.537 0.666 0 C-N-CA 122.509 2.139 . . . . 0.0 113.423 -169.599 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -77.39 -20.57 54.5 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 118.934 0.788 . . . . 0.0 111.57 178.726 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -122.37 7.59 9.61 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 124.886 1.275 . . . . 0.0 113.383 -173.49 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 45.4 t -124.28 148.77 28.42 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.231 0 C-N-CA 124.924 1.29 . . . . 0.0 107.713 175.596 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 7.8 m -134.11 133.27 40.89 Favored 'General case' 0 C--N 1.331 -0.211 0 C-N-CA 124.959 1.303 . . . . 0.0 108.045 -175.861 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 21.8 mt -78.62 139.31 38.57 Favored 'General case' 0 C--O 1.232 0.158 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 175.695 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 36.0 t-80 -137.98 54.28 1.8 Allowed 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 124.321 1.049 . . . . 0.0 108.704 -174.409 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 21.3 t-20 -57.0 134.02 55.43 Favored 'General case' 0 CA--C 1.533 0.312 0 O-C-N 120.838 -1.164 . . . . 0.0 108.386 172.695 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 51.6 mt -74.17 -20.98 60.03 Favored 'General case' 0 CA--C 1.531 0.24 0 N-CA-C 114.344 1.238 . . . . 0.0 114.344 -168.872 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 14.9 tmtt? -73.29 -38.46 65.87 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 119.25 0.932 . . . . 0.0 109.014 168.501 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -73.53 -37.69 65.54 Favored 'General case' 0 C--O 1.234 0.258 0 N-CA-C 113.429 0.9 . . . . 0.0 113.429 -173.151 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 3.2 t0 -143.36 153.9 43.19 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 118.762 0.71 . . . . 0.0 112.249 175.405 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 17.2 m -73.68 157.17 87.89 Favored Pre-proline 0 CA--C 1.54 0.596 0 C-N-CA 125.842 1.657 . . . . 0.0 111.759 -169.997 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -72.72 -26.87 15.64 Favored 'Trans proline' 0 C--N 1.349 0.565 0 C-N-CA 122.761 2.307 . . . . 0.0 113.282 -171.211 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 22.4 mmmt -70.78 -13.22 61.97 Favored 'General case' 0 N--CA 1.473 0.696 0 O-C-N 120.252 -1.53 . . . . 0.0 111.842 -175.817 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -60.64 -29.1 69.06 Favored 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 125.526 1.53 . . . . 0.0 110.08 169.409 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 45.7 mtt -56.63 -25.05 52.16 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 118.966 0.803 . . . . 0.0 111.732 178.419 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 93.8 mt-10 -65.3 -31.69 72.96 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 118.432 0.56 . . . . 0.0 110.325 -177.13 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 24.9 mt-30 -67.39 -42.72 82.86 Favored 'General case' 0 N--CA 1.466 0.342 0 N-CA-C 113.259 0.837 . . . . 0.0 113.259 -169.788 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 34.8 m-85 -73.77 140.05 45.63 Favored 'General case' 0 C--O 1.23 0.045 0 C-N-CA 123.53 0.732 . . . . 0.0 109.966 -167.181 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -67.07 -45.22 78.03 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 118.588 0.631 . . . . 0.0 109.801 174.109 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 6.4 t -102.05 142.22 16.85 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.591 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 175.139 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 31.3 tp -129.94 112.77 13.84 Favored 'General case' 0 N--CA 1.442 -0.842 0 N-CA-C 108.439 -0.949 . . . . 0.0 108.439 173.34 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.421 HG23 ' CE1' ' A' ' 85' ' ' TYR . 17.8 mt -88.41 133.57 30.47 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.591 0 N-CA-C 106.334 -1.728 . . . . 0.0 106.334 172.069 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -109.52 140.61 43.08 Favored 'General case' 0 CA--C 1.517 -0.299 0 C-N-CA 125.904 1.681 . . . . 0.0 106.52 179.404 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -141.99 146.89 18.24 Favored Glycine 0 CA--C 1.518 0.249 0 N-CA-C 110.261 -1.136 . . . . 0.0 110.261 175.036 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.519 HD13 ' CB ' ' A' ' 100' ' ' ALA . 16.5 tt -157.97 139.09 9.55 Favored Pre-proline 0 CA--C 1.538 0.506 0 N-CA-C 107.599 -1.259 . . . . 0.0 107.599 177.276 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo . . . . . 0 CA--C 1.548 1.194 0 C-N-CA 123.163 2.576 . . . . 0.0 112.835 170.187 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 72.0 mt . . . . . 0 CA--C 1.546 0.808 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -77.73 156.82 30.38 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-O 121.583 0.706 . . . . 0.0 111.192 178.979 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -57.99 -42.32 84.89 Favored 'General case' 0 C--O 1.225 -0.236 0 C-N-CA 124.269 1.028 . . . . 0.0 111.722 -169.249 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 45.5 m-20 -61.44 -23.47 65.87 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 119.108 0.867 . . . . 0.0 112.049 -173.861 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' TRP . . . . . 0.475 ' CZ2' HD12 ' A' ' 53' ' ' ILE . 6.9 t90 -96.09 -48.01 5.84 Favored 'General case' 0 CA--C 1.527 0.071 0 C-N-CA 124.496 1.118 . . . . 0.0 109.652 177.374 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 8.2 tt0 -65.33 -36.02 82.77 Favored 'General case' 0 N--CA 1.447 -0.62 0 O-C-N 120.962 -1.086 . . . . 0.0 110.556 -174.182 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -61.49 -25.99 67.61 Favored 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 123.653 0.781 . . . . 0.0 111.055 -174.709 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 28.5 m -108.48 -15.64 9.2 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.289 0 CA-C-O 117.234 -1.365 . . . . 0.0 112.195 177.071 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 34.8 t90 -52.27 -35.09 49.11 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 120.526 1.512 . . . . 0.0 110.861 178.049 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -62.61 -29.42 70.59 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 125.31 1.444 . . . . 0.0 113.163 175.272 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 29.3 mt-30 -92.15 -19.62 22.09 Favored 'General case' 0 C--N 1.341 0.218 0 C-N-CA 125.874 1.67 . . . . 0.0 112.393 177.453 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 53.4 mt -63.05 -20.71 65.59 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-N 118.903 0.774 . . . . 0.0 111.474 -177.607 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -78.93 -23.94 44.34 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 123.055 0.542 . . . . 0.0 111.773 174.602 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -72.21 -29.18 63.72 Favored 'General case' 0 N--CA 1.469 0.514 0 O-C-N 120.918 -1.114 . . . . 0.0 111.706 179.049 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 79.8 mt -53.36 141.15 25.19 Favored 'General case' 0 C--N 1.34 0.194 0 C-N-CA 125.141 1.376 . . . . 0.0 113.106 -168.509 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 3.2 t30 -75.7 102.67 5.48 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 170.025 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 61.3 mt -125.26 -0.14 7.72 Favored 'General case' 0 N--CA 1.475 0.821 0 N-CA-C 114.205 1.187 . . . . 0.0 114.205 -174.025 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 26.9 mt-10 -56.68 129.2 40.09 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-N 119.666 1.121 . . . . 0.0 111.115 -168.613 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 74.18 -2.12 45.69 Favored Glycine 0 CA--C 1.534 1.228 0 C-N-CA 125.493 1.521 . . . . 0.0 114.998 178.525 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.4 151.37 38.16 Favored 'General case' 0 C--N 1.346 0.426 0 CA-C-N 120.617 2.208 . . . . 0.0 110.021 -175.025 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 6.7 mt -80.67 136.29 23.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 N-CA-C 106.661 -1.607 . . . . 0.0 106.661 178.999 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 65.2 t -132.48 140.51 47.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 C-N-CA 124.054 0.942 . . . . 0.0 109.192 -177.376 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -125.28 144.72 50.34 Favored 'General case' 0 N--CA 1.456 -0.162 0 N-CA-C 108.118 -1.068 . . . . 0.0 108.118 170.575 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 4.2 mt -117.83 120.76 38.89 Favored 'General case' 0 CA--C 1.518 -0.26 0 C-N-CA 124.416 1.086 . . . . 0.0 108.612 -175.769 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' TYR . . . . . 0.488 ' CD2' HD23 ' A' ' 142' ' ' LEU . 22.5 m-85 -113.07 151.98 30.09 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 107.406 -1.331 . . . . 0.0 107.406 169.861 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -155.81 137.5 5.57 Favored Glycine 0 N--CA 1.449 -0.485 0 N-CA-C 107.825 -2.11 . . . . 0.0 107.825 167.619 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 27.1 tp . . . . . 0 N--CA 1.442 -0.831 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 169.971 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 90.3 mt . . . . . 0 N--CA 1.468 0.458 0 N-CA-C 113.15 0.796 . . . . 0.0 113.15 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -61.71 -39.19 90.62 Favored 'General case' 0 N--CA 1.465 0.285 0 O-C-N 120.687 -1.258 . . . . 0.0 111.366 -168.679 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 100' ' ' ALA . . . . . 0.519 ' CB ' HD13 ' A' ' 53' ' ' ILE . . . -79.0 -15.86 57.69 Favored 'General case' 0 N--CA 1.445 -0.698 0 O-C-N 121.093 -1.004 . . . . 0.0 112.885 178.768 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 5.4 tt -63.44 -42.2 98.67 Favored 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 106.568 -1.641 . . . . 0.0 106.568 167.679 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -63.83 -37.58 94.88 Favored Glycine 0 C--N 1.341 0.812 0 N-CA-C 111.34 -0.704 . . . . 0.0 111.34 178.67 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 28.5 mtm -64.53 -45.23 88.08 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 118.397 1.099 . . . . 0.0 111.813 177.873 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.411 HD23 ' CH2' ' A' ' 65' ' ' TRP . 0.2 OUTLIER -66.7 -39.69 88.16 Favored 'General case' 0 C--N 1.344 0.354 0 CA-C-N 120.233 1.379 . . . . 0.0 109.942 177.277 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 85.3 t60 -57.38 -51.34 69.79 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 118.492 0.587 . . . . 0.0 111.053 177.254 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -62.73 -39.26 93.52 Favored 'General case' 0 C--O 1.235 0.3 0 C-N-CA 124.04 0.936 . . . . 0.0 112.067 -176.335 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 25.0 ttmm -56.21 -35.03 66.86 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 123.657 0.783 . . . . 0.0 110.737 172.392 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 21.0 mt -94.34 -20.05 20.1 Favored 'General case' 0 CA--C 1.515 -0.371 0 N-CA-C 115.761 1.763 . . . . 0.0 115.761 -168.92 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 4.0 m -58.24 -33.98 69.95 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-N 120.673 1.579 . . . . 0.0 111.452 -177.843 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 20.0 p -85.79 -10.71 55.05 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 125.4 1.48 . . . . 0.0 112.324 179.871 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 32.6 mmmt -84.69 -6.05 59.34 Favored 'General case' 0 N--CA 1.466 0.342 0 C-N-CA 124.555 1.142 . . . . 0.0 111.334 173.875 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 70.09 33.49 69.65 Favored Glycine 0 CA--C 1.525 0.69 0 CA-C-N 118.438 0.563 . . . . 0.0 112.125 172.001 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 4.9 m -77.48 175.33 0.76 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.599 0 CA-C-N 117.907 0.853 . . . . 0.0 109.635 173.726 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -117.62 116.21 26.63 Favored 'General case' 0 N--CA 1.465 0.317 0 N-CA-C 107.318 -1.364 . . . . 0.0 107.318 175.069 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 71.2 m-85 -83.52 147.25 27.9 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 119.249 0.931 . . . . 0.0 109.185 -179.037 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 35.8 m -125.21 159.17 32.69 Favored 'Isoleucine or valine' 0 C--O 1.234 0.289 0 C-N-CA 123.696 0.798 . . . . 0.0 110.652 172.157 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 93.52 -87.57 1.18 Allowed Glycine 0 N--CA 1.446 -0.65 0 C-N-CA 125.144 1.354 . . . . 0.0 111.956 169.924 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 15.7 m-30 58.53 176.68 0.07 Allowed 'General case' 0 CA--C 1.552 1.04 0 C-N-CA 125.293 1.437 . . . . 0.0 110.87 -168.031 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -148.98 147.15 23.07 Favored Pre-proline 0 N--CA 1.476 0.853 0 O-C-N 120.199 -1.563 . . . . 0.0 110.149 177.8 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo -61.97 127.11 20.41 Favored 'Trans proline' 0 C--N 1.349 0.559 0 C-N-CA 122.831 2.354 . . . . 0.0 110.336 169.387 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 13.7 p . . . . . 0 N--CA 1.472 0.629 0 N-CA-C 113.32 0.859 . . . . 0.0 113.32 175.618 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 9.5 ttmm . . . . . 0 CA--C 1.542 0.658 0 N-CA-C 114.68 1.363 . . . . 0.0 114.68 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_exo -79.49 -0.34 10.64 Favored 'Trans proline' 0 CA--C 1.538 0.723 0 CA-C-N 122.036 1.763 . . . . 0.0 114.271 -179.109 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 31.4 m -131.51 165.51 31.46 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.427 0 CA-C-N 120.39 1.45 . . . . 0.0 112.647 -168.493 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 10.3 pt -136.5 176.42 8.09 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 C-N-CA 128.723 2.809 . . . . 0.0 108.439 -176.848 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . 56.33 41.87 28.51 Favored 'General case' 0 N--CA 1.465 0.297 0 C-N-CA 125.362 1.465 . . . . 0.0 112.35 174.134 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 27.7 t70 55.2 42.13 30.82 Favored 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 125.938 1.695 . . . . 0.0 111.479 -175.545 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 87.63 16.87 59.39 Favored Glycine 0 CA--C 1.528 0.906 0 CA-C-O 118.715 -1.047 . . . . 0.0 113.974 173.552 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 45.6 mt-30 -91.07 -9.23 46.49 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-N 119.072 1.436 . . . . 0.0 113.168 -178.336 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 4.9 tp -151.66 138.65 19.07 Favored 'General case' 0 C--N 1.342 0.273 0 CA-C-N 119.797 1.18 . . . . 0.0 111.054 -178.646 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 61.9 m-85 -77.82 143.7 37.66 Favored 'General case' 0 CA--C 1.517 -0.314 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 169.931 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 19.4 m -78.31 3.01 1.74 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 C-N-CA 123.587 0.755 . . . . 0.0 112.352 178.306 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -168.91 -172.93 36.2 Favored Glycine 0 C--N 1.335 0.483 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 -178.905 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 0.488 HD23 ' CD2' ' A' ' 85' ' ' TYR . 46.5 tp -74.65 129.67 38.13 Favored 'General case' 0 N--CA 1.451 -0.384 0 C-N-CA 123.659 0.784 . . . . 0.0 110.505 -179.605 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -81.19 117.36 21.66 Favored 'General case' 0 N--CA 1.443 -0.824 0 N-CA-C 107.322 -1.362 . . . . 0.0 107.322 167.36 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 61.4 mt . . . . . 0 N--CA 1.462 0.172 0 N-CA-C 107.031 -1.47 . . . . 0.0 107.031 167.827 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 4.9 p . . . . . 0 CA--C 1.532 0.27 0 N-CA-C 110.016 -0.365 . . . . 0.0 110.016 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -65.17 -38.75 91.51 Favored 'General case' 0 N--CA 1.461 0.11 0 C-N-CA 123.016 0.526 . . . . 0.0 110.641 177.662 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 2.8 tp10 -62.23 -49.06 77.24 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 124.31 1.044 . . . . 0.0 110.78 178.381 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 41.5 mtt180 -56.87 -44.83 82.63 Favored 'General case' 0 C--O 1.226 -0.182 0 C-N-CA 124.617 1.167 . . . . 0.0 109.761 178.536 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 53.8 mt -65.45 -56.0 17.37 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.358 0 N-CA-C 107.91 -1.144 . . . . 0.0 107.91 177.212 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 68.8 tp60 -55.77 -63.65 1.11 Allowed 'General case' 0 C--O 1.232 0.179 0 C-N-CA 124.09 0.956 . . . . 0.0 112.173 -170.503 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 20.2 m -67.35 -32.68 73.79 Favored 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 121.051 -0.259 . . . . 0.0 111.035 -168.695 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 160' ' ' TRP . . . . . . . . . . . . . 3.6 t90 -73.53 -42.37 61.83 Favored 'General case' 0 C--O 1.22 -0.45 0 CA-C-O 119.085 -0.483 . . . . 0.0 110.684 177.962 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 55.2 m -57.12 -45.33 83.55 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 118.525 0.602 . . . . 0.0 110.378 174.398 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -61.21 -42.3 98.36 Favored 'General case' 0 CA--C 1.528 0.111 0 CA-C-O 121.467 0.651 . . . . 0.0 110.191 177.097 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 16.5 tt0 -64.2 -53.44 49.29 Favored 'General case' 0 N--CA 1.448 -0.561 0 O-C-N 121.655 -0.653 . . . . 0.0 110.202 -178.721 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 41.2 pt -62.26 -37.04 77.6 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.331 0 CA-C-O 117.653 -1.165 . . . . 0.0 109.16 -174.814 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -63.47 -37.55 87.75 Favored 'General case' 0 C--O 1.224 -0.268 0 CA-C-N 119.57 1.077 . . . . 0.0 109.708 -179.729 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 34.1 m-80 -67.05 -50.41 61.98 Favored 'General case' 0 N--CA 1.465 0.294 0 N-CA-C 108.887 -0.782 . . . . 0.0 108.887 176.338 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 67.3 tt0 -72.69 -18.03 61.58 Favored 'General case' 0 N--CA 1.437 -1.122 0 C-N-CA 126.167 1.787 . . . . 0.0 112.157 -169.181 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 168' ' ' MET . . . . . . . . . . . . . 19.0 ptp -89.86 -40.05 12.67 Favored 'General case' 0 N--CA 1.456 -0.151 0 C-N-CA 124.115 0.966 . . . . 0.0 111.168 168.813 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -74.35 -24.82 59.23 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 112.647 0.61 . . . . 0.0 112.647 -174.021 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 . . . . . 0 CA--C 1.539 0.545 0 CA-C-N 118.511 0.596 . . . . 0.0 111.626 179.209 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.406 ' HA ' ' OD2' ' A' ' 47' ' ' ASP . 11.1 tmm? . . . . . 0 N--CA 1.495 1.819 0 N-CA-C 109.832 -0.433 . . . . 0.0 109.832 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 3.0 t30 -142.53 151.41 41.59 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 125.263 1.425 . . . . 0.0 107.911 174.489 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -112.0 128.05 56.06 Favored 'General case' 0 N--CA 1.463 0.221 0 C-N-CA 123.977 0.911 . . . . 0.0 111.573 -177.915 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -87.1 155.49 27.5 Favored Glycine 0 CA--C 1.523 0.584 0 N-CA-C 107.812 -2.115 . . . . 0.0 107.812 167.231 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 3.1 tt -140.39 96.53 3.05 Favored 'General case' 0 N--CA 1.466 0.341 0 N-CA-C 105.397 -2.075 . . . . 0.0 105.397 -177.504 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -98.95 140.51 33.0 Favored 'General case' 0 CA--C 1.516 -0.336 0 CA-C-O 121.225 0.536 . . . . 0.0 111.379 -173.656 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 43.6 p90 . . . . . 0 N--CA 1.454 -0.265 0 C-N-CA 125.679 1.592 . . . . 0.0 107.95 177.698 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.226 -0.152 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -63.03 -47.42 83.12 Favored 'General case' 0 C--O 1.233 0.191 0 C-N-CA 122.756 0.422 . . . . 0.0 111.353 -176.047 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 10.4 mt-10 -62.06 -43.04 99.69 Favored 'General case' 0 CA--C 1.516 -0.338 0 CA-C-O 118.912 -0.566 . . . . 0.0 110.275 176.801 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 29.7 mtpp -71.58 -40.39 69.93 Favored 'General case' 0 C--O 1.22 -0.476 0 CA-C-O 117.97 -1.014 . . . . 0.0 110.892 -174.036 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 47.3 mt -52.54 -54.3 16.06 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.255 0 CA-C-N 120.052 1.296 . . . . 0.0 108.524 172.27 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 8.0 ttp180 -61.72 -41.06 97.14 Favored 'General case' 0 C--O 1.223 -0.296 0 C-N-CA 123.209 0.604 . . . . 0.0 109.425 -175.758 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -66.43 -41.61 88.93 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 118.481 0.582 . . . . 0.0 111.421 -179.177 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 49.3 mt -72.58 -53.17 20.01 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.526 0 C-N-CA 124.7 1.2 . . . . 0.0 109.686 -172.171 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 78.0 mt -67.05 -45.3 87.19 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 179.828 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 139.24 125.5 2.28 Favored Glycine 0 CA--C 1.532 1.137 0 C-N-CA 125.165 1.364 . . . . 0.0 112.067 173.737 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 82.2 Cg_endo -73.17 -5.3 16.93 Favored 'Trans proline' 0 CA--C 1.537 0.636 0 C-N-CA 123.664 2.91 . . . . 0.0 113.873 -175.822 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -82.27 -17.41 46.01 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 118.996 0.816 . . . . 0.0 111.072 177.229 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 1.3 pt? -129.94 -13.76 4.05 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 125.114 1.366 . . . . 0.0 113.871 -174.331 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 33.8 t -98.48 153.45 4.08 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.517 0 N-CA-C 107.691 -1.226 . . . . 0.0 107.691 168.56 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 50.5 m -139.65 131.93 28.3 Favored 'General case' 0 C--O 1.234 0.279 0 C-N-CA 126.464 1.905 . . . . 0.0 106.239 -177.117 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 24.3 mt -81.25 142.38 33.21 Favored 'General case' 0 C--O 1.233 0.191 0 N-CA-C 107.839 -1.171 . . . . 0.0 107.839 176.763 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 34.2 t-80 -134.28 57.65 1.8 Allowed 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 124.574 1.15 . . . . 0.0 108.218 -175.157 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 64.3 t-20 -70.43 118.01 12.69 Favored 'General case' 0 C--O 1.235 0.327 0 O-C-N 121.076 -1.015 . . . . 0.0 108.779 -176.673 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 93.9 mt -68.45 -12.94 61.92 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 124.092 0.957 . . . . 0.0 112.505 -174.807 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 65.3 mmtt -53.73 -27.19 26.89 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-O 118.685 -0.674 . . . . 0.0 111.178 167.013 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -132.04 -41.71 1.01 Allowed 'General case' 0 C--O 1.236 0.347 0 N-CA-C 113.437 0.903 . . . . 0.0 113.437 -173.941 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 29.8 m-20 -85.56 141.2 30.03 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-N 118.475 0.58 . . . . 0.0 110.568 -174.324 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 14.8 m -76.32 154.23 84.13 Favored Pre-proline 0 CA--C 1.54 0.59 0 C-N-CA 124.378 1.071 . . . . 0.0 110.342 176.658 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -77.26 -26.84 7.13 Favored 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 122.267 1.978 . . . . 0.0 113.683 -170.085 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.79 -15.38 63.54 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-N 120.657 1.571 . . . . 0.0 112.269 -178.612 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -58.77 -29.23 66.64 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 125.403 1.481 . . . . 0.0 110.363 170.317 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 55.3 mtt -57.43 -27.75 62.68 Favored 'General case' 0 C--N 1.342 0.264 0 C-N-CA 123.589 0.756 . . . . 0.0 111.498 177.339 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 56.7 mt-10 -66.83 -33.09 74.85 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 118.348 0.522 . . . . 0.0 110.537 -176.22 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 16.5 mt-30 -66.9 -43.18 84.09 Favored 'General case' 0 N--CA 1.464 0.232 0 C-N-CA 123.346 0.659 . . . . 0.0 112.336 -170.003 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 22.2 m-85 -70.92 142.11 51.11 Favored 'General case' 0 N--CA 1.454 -0.227 0 CA-C-N 115.387 -0.824 . . . . 0.0 110.528 -166.469 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' ASP . . . . . 0.406 ' OD2' ' HA ' ' A' ' 1' ' ' MET . 24.4 m-20 -74.77 -35.7 62.57 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-O 121.118 0.485 . . . . 0.0 109.726 -178.098 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.525 HG21 ' SD ' ' A' ' 168' ' ' MET . 25.6 t -113.94 147.49 17.44 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.216 0 N-CA-C 107.178 -1.416 . . . . 0.0 107.178 170.003 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 29.8 tp -132.19 109.69 10.12 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 123.778 0.831 . . . . 0.0 108.843 174.889 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 32.0 mt -87.22 133.1 30.93 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.552 0 N-CA-C 107.077 -1.453 . . . . 0.0 107.077 176.583 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 2.4 mp -111.22 127.34 55.57 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 126.141 1.777 . . . . 0.0 106.966 -179.26 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -135.0 136.6 8.65 Favored Glycine 0 C--N 1.335 0.48 0 N-CA-C 109.439 -1.464 . . . . 0.0 109.439 -179.561 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 4.1 tt -150.46 129.31 6.19 Favored Pre-proline 0 CA--C 1.542 0.645 0 CA-C-N 118.772 1.286 . . . . 0.0 110.926 -175.054 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo . . . . . 0 CA--C 1.542 0.902 0 C-N-CA 122.992 2.461 . . . . 0.0 115.539 170.087 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 13.1 mt . . . . . 0 CA--C 1.543 0.706 0 CA-C-O 121.759 0.79 . . . . 0.0 111.464 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 62' ' ' GLN . . . . . 0.555 ' H ' ' CD ' ' A' ' 62' ' ' GLN . 0.3 OUTLIER -56.02 146.89 21.27 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 126.741 2.016 . . . . 0.0 109.715 175.012 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -57.15 -48.23 79.21 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 118.348 0.522 . . . . 0.0 112.172 -169.629 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -69.71 -17.87 63.49 Favored 'General case' 0 N--CA 1.475 0.807 0 CA-C-N 119.019 0.827 . . . . 0.0 112.177 -173.864 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' TRP . . . . . 0.44 ' CH2' HD23 ' A' ' 104' ' ' LEU . 0.2 OUTLIER -93.28 -43.44 8.8 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 124.92 1.288 . . . . 0.0 107.636 -179.822 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -63.46 -35.12 79.39 Favored 'General case' 0 N--CA 1.435 -1.217 0 C-N-CA 126.229 1.812 . . . . 0.0 111.075 177.347 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -55.93 -23.88 34.53 Favored 'General case' 0 CA--C 1.53 0.174 0 C-N-CA 124.582 1.153 . . . . 0.0 112.001 -176.821 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 35.7 m -116.47 -13.49 11.01 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.224 0 CA-C-O 117.913 -1.041 . . . . 0.0 112.709 178.902 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 26.5 t90 -52.55 -38.68 60.31 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 119.824 1.193 . . . . 0.0 111.083 -177.063 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -68.04 -24.02 65.04 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 125.12 1.368 . . . . 0.0 112.967 178.62 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 20.4 mt-30 -91.67 -23.74 19.72 Favored 'General case' 0 C--N 1.34 0.166 0 C-N-CA 125.273 1.429 . . . . 0.0 111.877 -179.347 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 24.7 mt -64.63 -26.13 68.26 Favored 'General case' 0 N--CA 1.468 0.456 0 O-C-N 121.792 -0.567 . . . . 0.0 111.646 -172.227 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -69.27 -22.27 63.83 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-N 118.06 0.391 . . . . 0.0 111.518 176.233 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -77.36 -23.51 50.83 Favored 'General case' 0 CA--C 1.537 0.472 0 O-C-N 120.707 -1.245 . . . . 0.0 112.56 -178.743 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 51.2 mt -65.67 152.07 45.07 Favored 'General case' 0 C--O 1.233 0.226 0 C-N-CA 124.772 1.229 . . . . 0.0 112.056 -170.205 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 3.3 t30 -82.71 100.95 10.55 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 124.682 1.193 . . . . 0.0 108.154 174.127 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 57.2 mt -119.22 0.09 11.12 Favored 'General case' 0 N--CA 1.47 0.548 0 N-CA-C 113.389 0.885 . . . . 0.0 113.389 -174.474 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 25.0 mt-10 -57.41 128.92 39.47 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 119.135 0.88 . . . . 0.0 110.828 -169.705 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 74.25 -3.04 41.71 Favored Glycine 0 CA--C 1.532 1.145 0 CA-C-O 117.749 -1.584 . . . . 0.0 114.824 178.535 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.79 152.86 40.19 Favored 'General case' 0 C--N 1.347 0.49 0 CA-C-N 121.098 2.449 . . . . 0.0 109.503 -179.402 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 2.1 mt -86.18 141.69 14.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 N-CA-C 106.877 -1.527 . . . . 0.0 106.877 179.414 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 61.6 t -135.68 137.58 49.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 C-N-CA 124.279 1.032 . . . . 0.0 109.109 -177.067 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -111.39 152.72 27.02 Favored 'General case' 0 N--CA 1.465 0.291 0 N-CA-C 106.733 -1.58 . . . . 0.0 106.733 168.118 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 1.2 mt -134.19 135.25 42.91 Favored 'General case' 0 CA--C 1.508 -0.637 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 175.366 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 40.9 p90 -147.34 166.14 28.03 Favored 'General case' 0 N--CA 1.447 -0.594 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 169.235 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -160.01 155.01 26.09 Favored Glycine 0 N--CA 1.448 -0.542 0 N-CA-C 109.123 -1.591 . . . . 0.0 109.123 171.946 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 13.0 tp . . . . . 0 N--CA 1.444 -0.737 0 C-N-CA 125.031 1.332 . . . . 0.0 109.08 177.02 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 96.7 mt . . . . . 0 N--CA 1.471 0.621 0 N-CA-C 109.964 -0.384 . . . . 0.0 109.964 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -52.73 -47.57 67.27 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 123.754 0.821 . . . . 0.0 112.7 -168.783 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -78.94 -19.56 51.44 Favored 'General case' 0 N--CA 1.451 -0.397 0 O-C-N 121.129 -0.982 . . . . 0.0 113.347 -176.323 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 3.8 tt -60.84 -44.79 96.5 Favored 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 107.543 -1.28 . . . . 0.0 107.543 171.383 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -61.24 -43.94 98.74 Favored Glycine 0 C--N 1.341 0.839 0 CA-C-O 119.617 -0.546 . . . . 0.0 111.914 176.398 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 75.1 mtm -63.25 -40.62 97.94 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 118.382 1.091 . . . . 0.0 111.957 -178.863 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.44 HD23 ' CH2' ' A' ' 65' ' ' TRP . 0.1 OUTLIER -69.95 -34.22 73.14 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-N 120.035 1.289 . . . . 0.0 111.241 -179.604 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 56.3 t-80 -58.97 -49.5 77.62 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-N 118.477 0.58 . . . . 0.0 109.533 172.996 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -62.36 -41.66 98.78 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 123.38 0.672 . . . . 0.0 112.295 -177.11 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 24.2 ttmm -55.56 -40.96 72.62 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 123.401 0.681 . . . . 0.0 110.166 173.14 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 28.4 mt -89.82 -20.2 23.75 Favored 'General case' 0 CA--C 1.517 -0.317 0 N-CA-C 115.764 1.765 . . . . 0.0 115.764 -167.653 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 15.9 m -58.28 -36.44 73.3 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 120.732 1.605 . . . . 0.0 111.334 -178.301 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 20.5 p -83.85 -12.88 54.92 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 124.585 1.154 . . . . 0.0 111.903 -179.678 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 32.0 mmmt -83.15 -9.64 59.08 Favored 'General case' 0 C--N 1.343 0.3 0 C-N-CA 124.525 1.13 . . . . 0.0 110.984 170.881 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 72.3 35.91 60.0 Favored Glycine 0 CA--C 1.523 0.561 0 CA-C-N 118.651 0.66 . . . . 0.0 112.469 169.661 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 5.3 m -77.02 170.67 1.46 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.582 0 CA-C-N 117.858 0.829 . . . . 0.0 109.713 172.001 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 53.0 tptt -100.06 130.64 46.23 Favored 'General case' 0 N--CA 1.47 0.564 0 N-CA-C 105.132 -2.173 . . . . 0.0 105.132 167.756 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 73.8 m-85 -94.95 123.01 38.18 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 172.071 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 32.8 m -105.15 154.31 6.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 C-N-CA 124.032 0.933 . . . . 0.0 108.505 167.701 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 105.85 -95.9 1.11 Allowed Glycine 0 N--CA 1.448 -0.56 0 C-N-CA 124.105 0.86 . . . . 0.0 112.011 174.173 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 118' ' ' TYR . . . . . 0.438 ' CD2' ' HA ' ' A' ' 140' ' ' VAL . 75.6 m-85 60.17 -179.61 0.09 Allowed 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 125.182 1.393 . . . . 0.0 109.424 -166.928 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER -153.22 143.55 15.54 Favored Pre-proline 0 N--CA 1.476 0.825 0 O-C-N 120.122 -1.611 . . . . 0.0 111.069 177.17 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -68.9 122.66 9.57 Favored 'Trans proline' 0 CA--C 1.536 0.595 0 C-N-CA 123.505 2.804 . . . . 0.0 111.621 179.238 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 18.1 p . . . . . 0 CA--C 1.538 0.492 0 N-CA-C 113.791 1.034 . . . . 0.0 113.791 -179.343 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 24.7 ttmt . . . . . 0 N--CA 1.475 0.79 0 N-CA-C 114.734 1.383 . . . . 0.0 114.734 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -82.76 3.83 7.54 Favored 'Trans proline' 0 C--N 1.35 0.615 0 CA-C-N 121.836 1.691 . . . . 0.0 114.162 -178.43 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 20.0 m -130.26 165.82 29.46 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.371 0 CA-C-N 120.537 1.517 . . . . 0.0 111.57 -172.252 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 7.4 pt -135.42 171.29 17.68 Favored 'Isoleucine or valine' 0 C--O 1.234 0.279 0 C-N-CA 127.913 2.485 . . . . 0.0 108.969 -177.949 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . 53.88 45.13 28.4 Favored 'General case' 0 N--CA 1.464 0.261 0 C-N-CA 125.488 1.515 . . . . 0.0 112.509 172.553 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 27.0 t0 54.32 43.58 30.28 Favored 'General case' 0 C--N 1.324 -0.521 0 C-N-CA 126.056 1.742 . . . . 0.0 111.624 -176.596 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 87.41 17.4 58.83 Favored Glycine 0 CA--C 1.527 0.825 0 CA-C-O 118.662 -1.077 . . . . 0.0 113.611 173.357 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 60.6 mm-40 -92.09 -8.07 46.82 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 119.399 1.6 . . . . 0.0 113.142 -177.368 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 7.9 tp -152.59 145.03 24.06 Favored 'General case' 0 C--N 1.344 0.33 0 CA-C-N 119.356 0.98 . . . . 0.0 110.761 170.941 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 65.5 m-85 -81.59 144.83 30.97 Favored 'General case' 0 CA--C 1.514 -0.423 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 169.373 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 140' ' ' VAL . . . . . 0.438 ' HA ' ' CD2' ' A' ' 118' ' ' TYR . 13.9 m -76.43 11.07 0.43 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.627 0 N-CA-C 113.128 0.788 . . . . 0.0 113.128 179.512 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 177.39 171.9 41.37 Favored Glycine 0 CA--C 1.525 0.696 0 C-N-CA 124.927 1.251 . . . . 0.0 109.997 -177.617 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 3.2 tp -66.72 133.44 50.19 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 117.962 0.881 . . . . 0.0 110.771 -177.725 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -91.56 117.05 29.37 Favored 'General case' 0 N--CA 1.445 -0.694 0 C-N-CA 125.835 1.654 . . . . 0.0 108.408 173.017 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.463 0.199 0 C-N-CA 124.288 1.035 . . . . 0.0 109.385 172.242 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 21.9 m . . . . . 0 CA--C 1.539 0.535 0 N-CA-C 110.642 -0.132 . . . . 0.0 110.642 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -64.21 -38.53 91.39 Favored 'General case' 0 N--CA 1.463 0.188 0 C-N-CA 123.208 0.603 . . . . 0.0 111.037 169.998 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -70.23 -40.64 74.36 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 124.599 1.159 . . . . 0.0 111.276 -178.484 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 17.9 mmm-85 -49.39 -43.76 44.56 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 124.23 1.012 . . . . 0.0 109.889 171.253 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 58.0 mt -75.03 -56.74 7.95 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.399 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 -179.716 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 73.1 tp60 -50.68 -62.76 1.4 Allowed 'General case' 0 CA--C 1.521 -0.151 0 C-N-CA 125.709 1.604 . . . . 0.0 112.673 -170.298 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 15.0 m -68.09 -34.16 75.89 Favored 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 121.049 -0.26 . . . . 0.0 110.841 -168.57 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 160' ' ' TRP . . . . . . . . . . . . . 38.0 t90 -67.66 -44.25 78.31 Favored 'General case' 0 C--O 1.222 -0.353 0 O-C-N 122.167 -0.333 . . . . 0.0 110.838 175.128 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 61.2 m -59.74 -43.82 94.07 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 122.834 0.454 . . . . 0.0 110.377 178.965 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -62.03 -41.69 98.37 Favored 'General case' 0 CA--C 1.529 0.141 0 CA-C-N 118.053 0.388 . . . . 0.0 110.173 176.614 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 11.7 tt0 -62.68 -54.13 43.93 Favored 'General case' 0 CA--C 1.514 -0.415 0 CA-C-O 118.15 -0.928 . . . . 0.0 109.929 -179.099 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 40.4 pt -62.78 -33.0 57.71 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.497 0 CA-C-O 118.012 -0.994 . . . . 0.0 109.871 -176.475 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -70.66 -36.58 73.44 Favored 'General case' 0 C--O 1.223 -0.324 0 CA-C-N 119.837 1.198 . . . . 0.0 108.605 -175.572 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -68.73 -45.63 71.02 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 123.386 0.674 . . . . 0.0 109.844 175.096 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 25.1 tt0 -80.79 -13.63 58.79 Favored 'General case' 0 N--CA 1.437 -1.119 0 C-N-CA 124.303 1.041 . . . . 0.0 110.328 -169.382 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 168' ' ' MET . . . . . 0.525 ' SD ' HG21 ' A' ' 48' ' ' VAL . 20.6 ptp -90.7 -41.61 11.19 Favored 'General case' 0 N--CA 1.457 -0.125 0 C-N-CA 122.914 0.486 . . . . 0.0 111.242 168.774 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -70.58 -27.59 64.23 Favored 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 122.652 0.381 . . . . 0.0 111.651 -172.258 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 . . . . . 0 CA--C 1.543 0.693 0 C-N-CA 123.257 0.623 . . . . 0.0 112.4 178.9 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.498 1.938 0 N-CA-C 111.578 0.214 . . . . 0.0 111.578 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 6.0 t30 -127.36 151.52 48.67 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 124.624 1.17 . . . . 0.0 108.458 175.414 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 17.3 mtt -110.93 126.37 54.65 Favored 'General case' 0 C--N 1.332 -0.182 0 C-N-CA 123.475 0.71 . . . . 0.0 110.359 -177.385 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -84.22 145.98 22.57 Favored Glycine 0 CA--C 1.522 0.514 0 N-CA-C 107.139 -2.384 . . . . 0.0 107.139 168.023 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 1.2 tt -135.03 93.94 3.08 Favored 'General case' 0 N--CA 1.464 0.273 0 N-CA-C 105.345 -2.094 . . . . 0.0 105.345 -172.927 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 6' ' ' PHE . . . . . 0.413 ' CE2' ' HG ' ' A' ' 51' ' ' LEU . 0.1 OUTLIER -101.59 143.25 31.8 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-O 121.703 0.763 . . . . 0.0 110.728 -173.322 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 32.3 p90 . . . . . 0 N--CA 1.448 -0.541 0 C-N-CA 125.071 1.348 . . . . 0.0 108.078 -178.071 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.268 0 N-CA-C 109.079 -0.712 . . . . 0.0 109.079 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -65.74 -45.66 81.76 Favored 'General case' 0 N--CA 1.455 -0.182 0 C-N-CA 123.732 0.813 . . . . 0.0 111.577 -175.239 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -54.34 -47.69 72.27 Favored 'General case' 0 CA--C 1.517 -0.289 0 C-N-CA 125.262 1.425 . . . . 0.0 109.312 173.647 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 29.8 mtpp -73.51 -38.91 65.18 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-O 118.459 -0.781 . . . . 0.0 110.215 -172.272 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 37.3 mt -53.72 -56.7 7.71 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.288 0 CA-C-N 119.469 1.031 . . . . 0.0 109.024 173.378 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.483 ' HG2' HD21 ' A' ' 32' ' ' LEU . 0.0 OUTLIER -66.33 -35.02 79.3 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 118.49 0.586 . . . . 0.0 111.196 -173.858 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -62.38 -42.7 99.62 Favored 'General case' 0 C--N 1.328 -0.358 0 O-C-N 123.363 0.414 . . . . 0.0 110.892 176.093 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.611 HD13 ' HA ' ' A' ' 158' ' ' GLN . 39.5 mt -72.23 -55.65 12.6 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.52 0 C-N-CA 123.619 0.767 . . . . 0.0 109.971 -174.356 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 73.0 mt -65.8 -45.23 92.17 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.296 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 -175.33 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 141.62 120.69 1.65 Allowed Glycine 0 CA--C 1.53 0.994 0 N-CA-C 110.26 -1.136 . . . . 0.0 110.26 176.335 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -68.64 -10.2 28.37 Favored 'Trans proline' 0 N--CA 1.456 -0.697 0 C-N-CA 123.124 2.55 . . . . 0.0 113.373 -173.985 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 2.4 pm0 -81.56 -18.25 45.56 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-N 119.573 1.079 . . . . 0.0 111.831 179.138 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -126.96 5.74 6.56 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 124.735 1.214 . . . . 0.0 113.679 -173.096 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 38.2 t -126.55 146.2 32.8 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.281 0 N-CA-C 107.842 -1.17 . . . . 0.0 107.842 173.169 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 34.0 m -133.02 131.89 41.22 Favored 'General case' 0 C--N 1.333 -0.129 0 C-N-CA 125.045 1.338 . . . . 0.0 108.635 -175.481 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.483 HD21 ' HG2' ' A' ' 22' ' ' ARG . 22.9 mt -75.53 137.71 41.04 Favored 'General case' 0 C--O 1.231 0.092 0 N-CA-C 108.809 -0.811 . . . . 0.0 108.809 177.393 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 23.2 t-80 -135.45 54.51 1.92 Allowed 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 124.788 1.235 . . . . 0.0 108.477 -177.006 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 38.3 t-20 -53.58 123.52 12.41 Favored 'General case' 0 C--O 1.237 0.41 0 N-CA-C 107.485 -1.302 . . . . 0.0 107.485 170.675 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.405 HD23 ' HA ' ' A' ' 35' ' ' LEU . 31.7 mt -70.46 -19.74 62.93 Favored 'General case' 0 C--O 1.235 0.302 0 N-CA-C 112.824 0.676 . . . . 0.0 112.824 -173.782 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 55.9 tptt -70.63 -19.44 62.82 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-N 118.915 0.78 . . . . 0.0 110.91 169.771 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -103.38 -36.49 8.0 Favored 'General case' 0 C--O 1.233 0.235 0 C-N-CA 123.975 0.91 . . . . 0.0 113.107 -170.732 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 3.3 t0 -139.64 156.24 46.95 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 118.668 0.667 . . . . 0.0 112.539 178.268 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 19.9 m -75.4 157.88 84.17 Favored Pre-proline 0 CA--C 1.541 0.623 0 C-N-CA 125.931 1.692 . . . . 0.0 111.714 -170.58 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 78.1 Cg_endo -74.86 -26.49 11.16 Favored 'Trans proline' 0 C--N 1.349 0.584 0 C-N-CA 122.68 2.254 . . . . 0.0 113.493 -170.297 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 23.0 mmmt -70.79 -12.42 61.54 Favored 'General case' 0 N--CA 1.472 0.65 0 O-C-N 120.685 -1.26 . . . . 0.0 111.531 -176.159 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -60.24 -29.36 68.72 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 125.423 1.489 . . . . 0.0 110.354 168.832 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 48.4 mtt -59.41 -25.37 64.26 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 118.65 0.659 . . . . 0.0 111.436 178.425 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 89.9 mt-10 -65.83 -33.06 74.99 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-O 118.96 -0.543 . . . . 0.0 110.027 -176.84 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 24.9 mt-30 -65.22 -45.51 84.41 Favored 'General case' 0 N--CA 1.465 0.313 0 C-N-CA 123.424 0.69 . . . . 0.0 112.771 -169.959 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 44.5 m-85 -77.73 133.2 38.34 Favored 'General case' 0 CA--C 1.52 -0.204 0 C-N-CA 123.718 0.807 . . . . 0.0 109.205 -167.234 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -75.58 -22.22 57.14 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-N 118.883 0.765 . . . . 0.0 111.833 -177.135 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 53.0 t -113.6 143.33 23.53 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.588 0 N-CA-C 106.633 -1.618 . . . . 0.0 106.633 169.441 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 31.2 tp -133.65 149.03 51.56 Favored 'General case' 0 N--CA 1.444 -0.763 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 172.278 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 28.9 mt -128.71 133.34 66.57 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 N-CA-C 105.38 -2.082 . . . . 0.0 105.38 179.917 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.413 ' HG ' ' CE2' ' A' ' 6' ' ' PHE . 3.1 mp -118.25 128.76 54.99 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 125.701 1.6 . . . . 0.0 107.781 -172.842 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -131.57 134.23 7.58 Favored Glycine 0 C--N 1.332 0.315 0 N-CA-C 110.912 -0.875 . . . . 0.0 110.912 174.69 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 2.9 tt -153.88 137.06 10.16 Favored Pre-proline 0 CA--C 1.542 0.667 0 CA-C-N 118.654 1.227 . . . . 0.0 111.662 170.37 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_exo . . . . . 0 CA--C 1.536 0.599 0 C-N-CA 123.347 2.698 . . . . 0.0 113.081 167.976 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . 0.256 59.0 mt . . . . . 0 CA--C 1.55 0.965 0 CA-C-O 122.952 1.358 . . . . 0.0 111.361 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -118.22 156.7 28.32 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 125.265 1.426 . . . . 0.0 107.579 -175.974 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -57.41 -45.01 85.05 Favored 'General case' 0 CA--C 1.529 0.153 0 C-N-CA 123.233 0.613 . . . . 0.0 110.677 -172.053 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -64.42 -19.54 65.58 Favored 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 113.219 0.822 . . . . 0.0 113.219 -177.115 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 13.0 t90 -95.91 -47.2 6.23 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 124.754 1.222 . . . . 0.0 109.485 178.23 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 10.9 tt0 -62.79 -35.26 79.26 Favored 'General case' 0 N--CA 1.446 -0.642 0 O-C-N 120.877 -1.139 . . . . 0.0 109.975 -178.899 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -58.13 -25.76 61.82 Favored 'General case' 0 CA--C 1.529 0.173 0 C-N-CA 124.034 0.933 . . . . 0.0 111.711 -177.262 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 28.6 m -113.29 -13.4 11.4 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.266 0 CA-C-O 117.21 -1.376 . . . . 0.0 112.484 177.675 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 26.0 t90 -52.75 -35.21 55.8 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 120.53 1.514 . . . . 0.0 110.968 -178.908 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -64.3 -27.72 69.23 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 125.567 1.547 . . . . 0.0 113.269 175.944 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 29.3 mt-30 -92.47 -19.61 21.83 Favored 'General case' 0 C--N 1.343 0.288 0 C-N-CA 125.93 1.692 . . . . 0.0 112.524 176.214 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 52.5 mt -63.69 -20.96 66.13 Favored 'General case' 0 CA--C 1.536 0.415 0 O-C-N 121.318 -0.864 . . . . 0.0 111.467 -176.398 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -79.01 -23.34 44.42 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 123.112 0.565 . . . . 0.0 111.503 174.401 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -72.83 -29.82 63.53 Favored 'General case' 0 N--CA 1.469 0.509 0 O-C-N 120.628 -1.295 . . . . 0.0 111.883 178.714 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 80.1 mt -52.85 141.05 22.61 Favored 'General case' 0 C--N 1.34 0.16 0 C-N-CA 125.239 1.415 . . . . 0.0 113.009 -168.484 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 3.7 t30 -75.62 102.48 5.34 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 123.832 0.853 . . . . 0.0 108.729 170.437 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 66.7 mt -125.03 -0.48 7.85 Favored 'General case' 0 N--CA 1.475 0.784 0 N-CA-C 114.058 1.133 . . . . 0.0 114.058 -173.572 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 27.0 mt-10 -57.25 128.78 38.75 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 119.528 1.058 . . . . 0.0 111.144 -169.253 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 73.43 -1.79 41.45 Favored Glycine 0 CA--C 1.534 1.25 0 C-N-CA 125.394 1.474 . . . . 0.0 115.103 178.518 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.68 148.95 40.13 Favored 'General case' 0 C--N 1.344 0.354 0 CA-C-N 120.543 2.171 . . . . 0.0 109.474 -176.362 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 1.8 mt -80.49 136.28 23.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 N-CA-C 106.712 -1.588 . . . . 0.0 106.712 179.246 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 76.2 t -133.0 125.1 51.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 C-N-CA 123.97 0.908 . . . . 0.0 109.805 -175.608 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -98.72 151.73 20.43 Favored 'General case' 0 N--CA 1.463 0.177 0 N-CA-C 107.938 -1.134 . . . . 0.0 107.938 166.674 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 1.2 mt -133.93 138.73 45.69 Favored 'General case' 0 CA--C 1.512 -0.493 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 175.382 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 45.6 p90 -150.48 168.92 22.77 Favored 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 171.223 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -168.12 166.63 39.61 Favored Glycine 0 N--CA 1.444 -0.775 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 173.386 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.327 -0.401 0 C-N-CA 124.315 1.046 . . . . 0.0 109.037 170.546 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 92.8 mt . . . . . 0 N--CA 1.467 0.412 0 N-CA-C 114.014 1.116 . . . . 0.0 114.014 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -62.8 -33.82 76.0 Favored 'General case' 0 C--N 1.332 -0.176 0 O-C-N 120.538 -1.351 . . . . 0.0 110.708 -174.873 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -72.08 -29.97 64.65 Favored 'General case' 0 CA--C 1.533 0.315 0 O-C-N 121.563 -0.711 . . . . 0.0 112.216 176.377 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 4.1 tt -62.04 -46.68 88.11 Favored 'General case' 0 N--CA 1.467 0.395 0 N-CA-C 107.574 -1.269 . . . . 0.0 107.574 170.226 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -63.59 -37.29 94.53 Favored Glycine 0 C--N 1.341 0.84 0 CA-C-O 119.212 -0.771 . . . . 0.0 112.088 178.793 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 65.1 mtm -63.58 -42.9 98.26 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 118.823 1.312 . . . . 0.0 111.69 -179.67 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -70.25 -37.18 74.87 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 120.238 1.381 . . . . 0.0 109.793 176.335 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 59.1 t60 -56.98 -48.6 78.04 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 118.798 0.727 . . . . 0.0 110.892 177.177 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -61.97 -39.27 91.6 Favored 'General case' 0 C--O 1.235 0.315 0 C-N-CA 124.176 0.99 . . . . 0.0 112.041 -178.072 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 24.0 ttmm -58.45 -33.8 70.12 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 123.235 0.614 . . . . 0.0 110.649 172.854 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 19.4 mt -94.63 -21.18 18.97 Favored 'General case' 0 CA--C 1.513 -0.45 0 N-CA-C 116.297 1.962 . . . . 0.0 116.297 -168.956 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 4.3 m -59.01 -33.59 70.9 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 120.951 1.705 . . . . 0.0 111.424 -176.272 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 20.1 p -85.8 -11.97 52.1 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 125.252 1.421 . . . . 0.0 112.152 179.758 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 31.7 mmmt -83.14 -6.32 59.44 Favored 'General case' 0 C--N 1.344 0.352 0 C-N-CA 124.907 1.283 . . . . 0.0 111.386 173.785 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 71.44 32.42 64.9 Favored Glycine 0 C--N 1.337 0.597 0 CA-C-N 118.779 0.718 . . . . 0.0 112.103 170.499 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 4.2 m -75.37 172.3 1.13 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.532 0 CA-C-N 118.027 0.913 . . . . 0.0 109.316 173.563 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -113.15 122.11 46.54 Favored 'General case' 0 N--CA 1.466 0.327 0 N-CA-C 106.579 -1.637 . . . . 0.0 106.579 173.265 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 81.3 m-85 -88.86 145.89 25.29 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 119.422 1.01 . . . . 0.0 109.672 -176.343 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 29.5 m -132.73 160.69 42.44 Favored 'Isoleucine or valine' 0 C--O 1.236 0.355 0 C-N-CA 124.583 1.153 . . . . 0.0 109.153 171.338 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 98.7 -83.29 0.63 Allowed Glycine 0 N--CA 1.448 -0.559 0 C-N-CA 124.906 1.241 . . . . 0.0 111.106 174.196 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 16.7 m-30 55.69 -171.15 0.07 Allowed 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 124.503 1.121 . . . . 0.0 110.179 -169.152 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -154.41 144.05 15.31 Favored Pre-proline 0 N--CA 1.468 0.451 0 O-C-N 120.651 -1.281 . . . . 0.0 108.712 169.902 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -68.5 124.99 12.21 Favored 'Trans proline' 0 CA--C 1.534 0.517 0 C-N-CA 122.34 2.027 . . . . 0.0 111.321 179.612 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 5.9 p . . . . . 0 N--CA 1.469 0.48 0 O-C-N 121.794 -0.566 . . . . 0.0 111.804 174.314 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 24.2 ttmt . . . . . 0 CA--C 1.542 0.648 0 CA-C-O 117.578 -1.201 . . . . 0.0 113.769 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -80.49 5.67 5.94 Favored 'Trans proline' 0 C--N 1.351 0.663 0 C-N-CA 121.944 1.763 . . . . 0.0 114.84 179.002 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 20.3 m -124.77 152.08 30.71 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.379 0 CA-C-N 122.152 2.251 . . . . 0.0 111.486 -178.4 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 133' ' ' ILE . . . . . 0.894 HG23 HG12 ' A' ' 140' ' ' VAL . 15.0 pt -96.53 163.69 2.34 Favored 'Isoleucine or valine' 0 C--O 1.236 0.355 0 C-N-CA 124.765 1.226 . . . . 0.0 109.556 169.246 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . 53.69 43.0 31.7 Favored 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 124.62 1.168 . . . . 0.0 112.19 167.61 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 31.5 t70 63.93 -32.32 0.12 Allowed 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 129.09 2.956 . . . . 0.0 114.616 -171.313 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 177.1 28.51 0.04 OUTLIER Glycine 0 CA--C 1.527 0.809 0 CA-C-O 117.867 -1.518 . . . . 0.0 114.616 177.499 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 74.2 mm-40 -76.2 -41.42 49.56 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 120.351 2.075 . . . . 0.0 111.248 -177.909 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -143.74 153.05 42.03 Favored 'General case' 0 CA--C 1.519 -0.238 0 C-N-CA 123.489 0.716 . . . . 0.0 109.888 176.727 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 74.7 m-85 -72.5 141.35 48.53 Favored 'General case' 0 N--CA 1.447 -0.595 0 N-CA-C 104.994 -2.224 . . . . 0.0 104.994 163.642 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 140' ' ' VAL . . . . . 0.894 HG12 HG23 ' A' ' 133' ' ' ILE . 4.3 m -76.07 4.86 1.01 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.904 0 C-N-CA 122.968 0.507 . . . . 0.0 111.427 -176.608 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -174.06 171.53 44.6 Favored Glycine 0 CA--C 1.528 0.869 0 C-N-CA 125.847 1.689 . . . . 0.0 109.771 -179.139 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -64.2 136.37 57.15 Favored 'General case' 0 N--CA 1.466 0.375 0 C-N-CA 123.642 0.777 . . . . 0.0 111.361 -177.221 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -101.12 113.08 25.78 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 126.161 1.784 . . . . 0.0 109.222 -179.824 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 96.1 mt . . . . . 0 N--CA 1.464 0.255 0 C-N-CA 124.607 1.163 . . . . 0.0 110.218 175.583 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 8.1 m . . . . . 0 CA--C 1.539 0.521 0 N-CA-C 110.481 -0.192 . . . . 0.0 110.481 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -65.19 -43.73 90.7 Favored 'General case' 0 N--CA 1.463 0.191 0 C-N-CA 123.507 0.723 . . . . 0.0 111.376 173.317 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 19.9 tt0 -64.39 -43.56 94.08 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 124.702 1.201 . . . . 0.0 110.894 -179.094 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 54.0 mtp85 -62.41 -36.83 83.58 Favored 'General case' 0 N--CA 1.462 0.141 0 C-N-CA 124.119 0.967 . . . . 0.0 109.989 -179.858 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 55.7 mt -70.01 -57.38 8.32 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.461 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 172.495 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 158' ' ' GLN . . . . . 0.611 ' HA ' HD13 ' A' ' 24' ' ' ILE . 68.2 tp60 -46.56 -65.77 0.51 Allowed 'General case' 0 C--O 1.235 0.314 0 C-N-CA 126.203 1.801 . . . . 0.0 112.476 -172.974 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 16.9 m -68.23 -29.09 67.84 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 123.091 0.244 . . . . 0.0 111.014 -169.483 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 160' ' ' TRP . . . . . . . . . . . . . 62.2 t90 -72.03 -44.6 63.14 Favored 'General case' 0 CA--C 1.515 -0.391 0 O-C-N 121.808 -0.558 . . . . 0.0 111.156 177.264 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 95.8 m -61.39 -40.52 94.68 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 122.717 0.407 . . . . 0.0 109.951 177.498 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -62.74 -42.58 99.74 Favored 'General case' 0 C--O 1.227 -0.098 0 CA-C-O 121.078 0.466 . . . . 0.0 110.254 174.028 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 12.1 tt0 -62.66 -51.57 66.74 Favored 'General case' 0 N--CA 1.449 -0.513 0 O-C-N 121.614 -0.679 . . . . 0.0 110.154 -178.445 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 45.5 pt -63.04 -38.13 81.22 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.367 0 CA-C-O 117.976 -1.011 . . . . 0.0 109.481 -174.962 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -65.02 -33.59 76.4 Favored 'General case' 0 C--O 1.225 -0.235 0 CA-C-N 119.416 1.007 . . . . 0.0 110.351 179.788 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 35.0 m-80 -69.23 -57.47 5.31 Favored 'General case' 0 C--O 1.223 -0.32 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 174.592 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 13.0 tt0 -63.45 -36.47 83.86 Favored 'General case' 0 N--CA 1.445 -0.68 0 C-N-CA 125.514 1.526 . . . . 0.0 111.131 -169.251 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 168' ' ' MET . . . . . . . . . . . . . 20.0 ptp -70.27 -32.75 70.7 Favored 'General case' 0 C--O 1.226 -0.16 0 O-C-N 121.63 -0.669 . . . . 0.0 111.761 174.08 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -75.28 -34.72 61.35 Favored 'General case' 0 N--CA 1.448 -0.568 0 CA-C-O 119.082 -0.485 . . . . 0.0 112.174 -178.776 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 6.2 mt-10 . . . . . 0 N--CA 1.465 0.306 0 CA-C-O 121.794 0.807 . . . . 0.0 109.317 177.613 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.498 1.961 0 N-CA-C 111.316 0.117 . . . . 0.0 111.316 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 9.0 t30 -114.31 152.04 32.02 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 123.736 0.815 . . . . 0.0 110.136 -179.082 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 16.0 mtt -116.21 129.55 56.35 Favored 'General case' 0 N--CA 1.461 0.103 0 C-N-CA 123.948 0.899 . . . . 0.0 110.731 -179.265 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -85.35 154.62 28.85 Favored Glycine 0 CA--C 1.524 0.644 0 N-CA-C 107.484 -2.246 . . . . 0.0 107.484 167.192 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 1.4 tt -142.05 96.51 2.97 Favored 'General case' 0 N--CA 1.466 0.343 0 N-CA-C 106.338 -1.727 . . . . 0.0 106.338 -175.447 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -106.06 144.67 32.44 Favored 'General case' 0 CA--C 1.519 -0.238 0 CA-C-O 121.481 0.658 . . . . 0.0 111.9 -170.761 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 23.6 p90 . . . . . 0 N--CA 1.453 -0.314 0 C-N-CA 125.879 1.671 . . . . 0.0 108.015 -177.53 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.338 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -63.45 -47.68 80.87 Favored 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 123.17 0.588 . . . . 0.0 111.907 -174.161 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.1 pp20? -67.38 -35.73 79.91 Favored 'General case' 0 CA--C 1.535 0.383 0 O-C-N 121.596 -0.69 . . . . 0.0 109.274 -179.671 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 29.3 mtpp -67.37 -40.58 85.77 Favored 'General case' 0 C--O 1.225 -0.232 0 O-C-N 121.126 -0.984 . . . . 0.0 110.916 175.968 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 37.8 mt -56.24 -56.18 14.68 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.198 0 CA-C-N 119.995 1.27 . . . . 0.0 109.171 176.196 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.5 -35.89 82.4 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 118.529 0.604 . . . . 0.0 110.946 -175.494 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -63.42 -40.14 96.39 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 117.94 0.336 . . . . 0.0 110.888 177.94 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.4 HD13 ' HA ' ' A' ' 158' ' ' GLN . 67.6 mt -77.14 -53.58 14.49 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 C-N-CA 124.23 1.012 . . . . 0.0 110.353 -174.17 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 70.7 mt -60.3 -49.53 83.85 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.317 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 177.917 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 144.25 119.14 1.31 Allowed Glycine 0 CA--C 1.528 0.887 0 N-CA-C 110.133 -1.187 . . . . 0.0 110.133 179.209 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -68.71 -14.52 39.42 Favored 'Trans proline' 0 CA--C 1.536 0.588 0 C-N-CA 122.955 2.436 . . . . 0.0 113.022 -173.278 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -73.56 -21.54 60.33 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 118.579 0.627 . . . . 0.0 112.051 179.396 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -129.57 8.12 5.36 Favored 'General case' 0 CA--C 1.536 0.405 0 N-CA-C 113.862 1.06 . . . . 0.0 113.862 -169.162 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 33.7 t -128.13 147.09 32.77 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.387 0 C-N-CA 124.449 1.099 . . . . 0.0 108.066 172.308 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 26.9 m -131.53 131.74 43.62 Favored 'General case' 0 C--N 1.332 -0.164 0 C-N-CA 125.643 1.577 . . . . 0.0 108.419 -174.716 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 18.4 mt -75.93 134.01 40.35 Favored 'General case' 0 C--O 1.232 0.154 0 N-CA-C 108.401 -0.963 . . . . 0.0 108.401 175.018 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 25.4 t-80 -130.67 55.75 1.81 Allowed 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 124.806 1.242 . . . . 0.0 108.528 -176.741 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 54.2 t-20 -60.11 125.09 22.33 Favored 'General case' 0 C--O 1.233 0.193 0 N-CA-C 107.974 -1.121 . . . . 0.0 107.974 176.817 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 80.9 mt -69.94 -20.58 63.33 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 118.429 0.559 . . . . 0.0 112.282 -176.93 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 58.2 tptt -63.61 -25.91 68.44 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 118.467 0.576 . . . . 0.0 110.712 168.931 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -106.01 -37.9 6.49 Favored 'General case' 0 C--O 1.235 0.327 0 N-CA-C 113.452 0.908 . . . . 0.0 113.452 -169.426 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 2.6 t0 -134.64 155.82 49.83 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-N 118.834 0.743 . . . . 0.0 112.627 -175.578 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 19.5 m -76.32 156.67 83.49 Favored Pre-proline 0 CA--C 1.539 0.555 0 C-N-CA 125.551 1.54 . . . . 0.0 111.415 -172.097 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -75.59 -26.25 10.19 Favored 'Trans proline' 0 C--N 1.348 0.506 0 C-N-CA 122.603 2.202 . . . . 0.0 113.882 -171.173 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 21.4 mmmt -70.84 -11.75 61.14 Favored 'General case' 0 N--CA 1.474 0.731 0 O-C-N 120.271 -1.518 . . . . 0.0 111.654 -176.232 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -58.02 -30.96 66.53 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 125.879 1.672 . . . . 0.0 110.089 168.329 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 46.1 mtt -57.77 -25.12 60.05 Favored 'General case' 0 N--CA 1.463 0.206 0 C-N-CA 123.341 0.656 . . . . 0.0 111.838 178.616 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 87.1 mt-10 -66.77 -33.92 76.69 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 118.463 0.574 . . . . 0.0 110.02 -177.693 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 13.8 mt-30 -67.49 -45.17 76.64 Favored 'General case' 0 N--CA 1.465 0.307 0 C-N-CA 123.202 0.601 . . . . 0.0 112.412 -169.874 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 26.1 m-85 -72.05 137.55 47.23 Favored 'General case' 0 N--CA 1.456 -0.132 0 CA-C-N 115.317 -0.856 . . . . 0.0 110.042 -166.574 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -74.26 -35.08 63.78 Favored 'General case' 0 N--CA 1.466 0.355 0 O-C-N 121.872 -0.518 . . . . 0.0 110.788 -177.265 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 20.5 t -108.56 145.69 15.21 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.436 0 N-CA-C 106.991 -1.485 . . . . 0.0 106.991 169.386 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 36.4 tp -133.95 112.78 11.53 Favored 'General case' 0 N--CA 1.447 -0.606 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 175.379 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.426 ' HA ' ' HB3' ' A' ' 83' ' ' ALA . 22.8 mt -89.92 134.47 28.89 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.665 0 N-CA-C 107.15 -1.426 . . . . 0.0 107.15 176.248 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 2.7 mp -115.54 130.63 56.94 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 125.613 1.565 . . . . 0.0 107.473 -178.365 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -135.65 136.28 8.38 Favored Glycine 0 C--N 1.333 0.368 0 N-CA-C 109.413 -1.475 . . . . 0.0 109.413 173.986 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 3.1 tt -152.98 137.34 10.71 Favored Pre-proline 0 CA--C 1.536 0.424 0 CA-C-N 118.477 1.138 . . . . 0.0 110.451 171.534 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo . . . . . 0 N--CA 1.453 -0.871 0 C-N-CA 122.476 2.118 . . . . 0.0 109.886 167.561 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 55.7 mt . . . . . 0 CA--C 1.549 0.91 0 CA-C-O 122.598 1.19 . . . . 0.0 112.821 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 1.2 pm0 -125.77 156.85 38.8 Favored 'General case' 0 C--O 1.232 0.162 0 C-N-CA 126.172 1.789 . . . . 0.0 108.682 -176.437 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -54.92 -43.26 73.16 Favored 'General case' 0 C--O 1.224 -0.261 0 C-N-CA 124.524 1.13 . . . . 0.0 112.355 -168.746 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -65.23 -20.33 66.38 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-N 119.156 0.889 . . . . 0.0 111.835 -174.082 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' TRP . . . . . 0.407 ' CH2' HD23 ' A' ' 104' ' ' LEU . 12.6 t90 -96.24 -49.04 5.38 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 124.448 1.099 . . . . 0.0 109.75 175.344 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -62.98 -35.28 79.65 Favored 'General case' 0 CA--C 1.536 0.426 0 O-C-N 121.041 -1.037 . . . . 0.0 110.413 -175.434 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -61.89 -27.41 68.78 Favored 'General case' 0 CA--C 1.53 0.179 0 C-N-CA 123.087 0.555 . . . . 0.0 111.059 -174.637 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 30.9 m -107.35 -17.08 8.1 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.372 0 CA-C-O 117.199 -1.382 . . . . 0.0 112.156 177.014 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 35.8 t90 -50.66 -34.75 27.65 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 120.447 1.476 . . . . 0.0 110.931 177.823 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -62.56 -31.14 71.89 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 125.315 1.446 . . . . 0.0 113.319 174.901 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 30.4 mt-30 -88.8 -20.89 24.12 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 126.555 1.942 . . . . 0.0 111.273 178.73 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 50.8 mt -65.25 -20.62 66.51 Favored 'General case' 0 CA--C 1.533 0.301 0 O-C-N 121.41 -0.806 . . . . 0.0 111.672 -173.603 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -79.0 -23.4 44.43 Favored 'General case' 0 CA--C 1.542 0.653 0 CA-C-N 118.399 0.545 . . . . 0.0 111.793 175.25 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -71.99 -30.03 64.84 Favored 'General case' 0 N--CA 1.468 0.47 0 O-C-N 120.723 -1.236 . . . . 0.0 111.958 178.177 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 80.1 mt -52.89 140.92 23.14 Favored 'General case' 0 C--N 1.338 0.102 0 C-N-CA 124.887 1.275 . . . . 0.0 112.994 -168.417 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 29.2 t-20 -76.14 108.95 9.41 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 169.688 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 70.2 mt -131.6 -0.07 3.96 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 114.317 1.228 . . . . 0.0 114.317 -172.348 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 28.8 mt-10 -57.2 129.8 43.38 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 119.68 1.127 . . . . 0.0 111.25 -168.544 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 73.9 -2.0 44.07 Favored Glycine 0 CA--C 1.533 1.204 0 C-N-CA 125.531 1.539 . . . . 0.0 115.023 178.32 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.04 150.3 40.71 Favored 'General case' 0 C--N 1.346 0.414 0 CA-C-N 120.663 2.231 . . . . 0.0 109.683 -176.649 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 4.3 mt -82.25 137.51 20.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 N-CA-C 106.489 -1.671 . . . . 0.0 106.489 179.068 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 67.0 t -130.92 129.49 63.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 C-N-CA 123.629 0.771 . . . . 0.0 109.515 -176.879 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.426 ' HB3' ' HA ' ' A' ' 50' ' ' ILE . . . -100.66 151.59 21.46 Favored 'General case' 0 N--CA 1.463 0.213 0 N-CA-C 107.735 -1.209 . . . . 0.0 107.735 168.715 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 4.5 mt -133.02 134.61 44.65 Favored 'General case' 0 CA--C 1.514 -0.409 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 176.394 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 37.4 p90 -149.91 168.14 24.64 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 107.692 -1.225 . . . . 0.0 107.692 168.655 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -168.19 171.22 42.42 Favored Glycine 0 N--CA 1.446 -0.656 0 N-CA-C 110.449 -1.061 . . . . 0.0 110.449 176.119 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 1.9 tm? . . . . . 0 N--CA 1.449 -0.492 0 C-N-CA 126.171 1.789 . . . . 0.0 106.781 -175.805 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 97.0 mt . . . . . 0 N--CA 1.469 0.524 0 N-CA-C 113.234 0.828 . . . . 0.0 113.234 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -65.05 -37.75 88.6 Favored 'General case' 0 N--CA 1.465 0.3 0 O-C-N 120.659 -1.275 . . . . 0.0 110.786 -170.766 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -65.45 -28.79 69.47 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 123.783 0.833 . . . . 0.0 112.304 173.971 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 5.3 tt -64.77 -49.28 71.35 Favored 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 108.039 -1.097 . . . . 0.0 108.039 174.01 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -62.33 -34.08 88.14 Favored Glycine 0 CA--C 1.529 0.948 0 N-CA-C 111.213 -0.755 . . . . 0.0 111.213 179.277 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 7.2 tpp -53.86 -50.97 65.08 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 124.683 1.193 . . . . 0.0 111.566 178.729 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.407 HD23 ' CH2' ' A' ' 65' ' ' TRP . 0.2 OUTLIER -76.52 -36.17 57.89 Favored 'General case' 0 CA--C 1.534 0.355 0 N-CA-C 109.433 -0.581 . . . . 0.0 109.433 -174.966 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 51.0 t-80 -56.99 -44.81 83.11 Favored 'General case' 0 N--CA 1.467 0.381 0 O-C-N 121.463 -0.773 . . . . 0.0 111.296 174.032 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -63.86 -43.68 95.38 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 123.609 0.764 . . . . 0.0 111.384 -178.633 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 25.1 ttmm -56.14 -43.12 77.92 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 123.476 0.71 . . . . 0.0 110.289 173.125 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 21.3 mt -85.75 -19.29 31.01 Favored 'General case' 0 CA--C 1.511 -0.529 0 N-CA-C 115.141 1.534 . . . . 0.0 115.141 -169.755 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 67.8 m -59.97 -29.8 68.67 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 119.659 1.118 . . . . 0.0 111.488 -175.375 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 27.5 p -93.66 -4.23 51.0 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 125.348 1.459 . . . . 0.0 112.316 179.62 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 32.3 mmmt -87.42 -5.94 58.64 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 124.762 1.225 . . . . 0.0 111.685 175.081 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 73.05 30.94 62.4 Favored Glycine 0 CA--C 1.523 0.586 0 CA-C-N 118.368 0.531 . . . . 0.0 112.116 172.712 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 5.3 m -76.15 174.48 0.84 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 CA-C-N 118.211 1.005 . . . . 0.0 109.151 171.752 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -114.29 127.36 55.83 Favored 'General case' 0 CA--C 1.515 -0.372 0 N-CA-C 106.786 -1.561 . . . . 0.0 106.786 170.385 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 66.9 m-85 -92.31 144.69 25.13 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 119.652 1.115 . . . . 0.0 109.865 -178.155 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 35.4 m -131.83 157.34 43.12 Favored 'Isoleucine or valine' 0 C--O 1.234 0.267 0 C-N-CA 125.493 1.517 . . . . 0.0 107.527 169.396 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 86.15 29.61 24.9 Favored Glycine 0 CA--C 1.521 0.41 0 CA-C-O 118.334 -1.259 . . . . 0.0 114.741 169.833 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 11.7 m-30 -62.96 157.91 20.59 Favored 'General case' 0 CA--C 1.541 0.626 0 CA-C-N 119.07 1.435 . . . . 0.0 108.918 168.978 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 36.3 t-105 -135.72 143.55 45.17 Favored Pre-proline 0 N--CA 1.467 0.39 0 CA-C-O 118.008 -0.996 . . . . 0.0 111.95 -168.833 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -59.02 129.05 30.07 Favored 'Trans proline' 0 N--CA 1.458 -0.58 0 C-N-CA 122.986 2.457 . . . . 0.0 111.044 176.124 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 9.0 p . . . . . 0 CA--C 1.534 0.364 0 C-N-CA 123.297 0.639 . . . . 0.0 111.705 169.884 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 28.2 ttmt . . . . . 0 CA--C 1.542 0.654 0 CA-C-O 117.531 -1.223 . . . . 0.0 114.073 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -82.59 4.9 6.74 Favored 'Trans proline' 0 C--N 1.351 0.674 0 C-N-CA 122.017 1.812 . . . . 0.0 113.882 -179.074 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 16.7 m -128.06 166.09 25.91 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.186 0 CA-C-N 121.033 1.742 . . . . 0.0 112.24 -172.805 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 16.1 pt -131.48 168.57 23.6 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.474 0 C-N-CA 127.674 2.39 . . . . 0.0 108.833 179.023 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . 55.88 39.03 30.67 Favored 'General case' 0 CA--C 1.529 0.163 0 C-N-CA 125.199 1.4 . . . . 0.0 113.328 169.746 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 27.6 t70 59.22 43.29 17.22 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 126.412 1.885 . . . . 0.0 111.715 -177.528 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 89.8 18.86 50.01 Favored Glycine 0 CA--C 1.528 0.905 0 CA-C-N 115.574 -0.739 . . . . 0.0 113.461 171.204 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -85.9 -21.78 27.81 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 125.016 1.326 . . . . 0.0 111.836 -177.662 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 9.8 tp -150.13 144.97 26.04 Favored 'General case' 0 C--N 1.341 0.222 0 CA-C-N 119.322 0.964 . . . . 0.0 110.785 176.948 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 55.8 m-85 -82.33 144.26 30.7 Favored 'General case' 0 CA--C 1.517 -0.293 0 N-CA-C 107.864 -1.162 . . . . 0.0 107.864 169.922 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 17.0 m -76.77 12.03 0.39 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.57 0 C-N-CA 124.43 1.092 . . . . 0.0 112.238 178.827 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -179.64 171.76 43.45 Favored Glycine 0 CA--C 1.526 0.769 0 N-CA-C 109.761 -1.335 . . . . 0.0 109.761 -178.321 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 0.413 ' HB2' ' CD1' ' A' ' 160' ' ' TRP . 8.0 tp -64.11 134.24 54.51 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 117.617 0.709 . . . . 0.0 110.891 177.579 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -93.49 127.57 39.2 Favored 'General case' 0 N--CA 1.441 -0.9 0 C-N-CA 125.393 1.477 . . . . 0.0 109.627 174.441 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 84.5 mt . . . . . 0 C--O 1.234 0.239 0 N-CA-C 105.83 -1.915 . . . . 0.0 105.83 167.718 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 5.2 m . . . . . 0 CA--C 1.535 0.388 0 N-CA-C 110.296 -0.261 . . . . 0.0 110.296 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -62.17 -45.87 91.48 Favored 'General case' 0 N--CA 1.463 0.178 0 C-N-CA 123.285 0.634 . . . . 0.0 110.415 175.157 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 -63.04 -43.04 99.78 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 123.593 0.757 . . . . 0.0 110.416 179.549 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 2.3 mpt_? -59.14 -45.83 89.92 Favored 'General case' 0 C--N 1.335 -0.05 0 C-N-CA 123.976 0.91 . . . . 0.0 110.368 177.598 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 34.9 mt -64.67 -53.09 46.48 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 176.847 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 158' ' ' GLN . . . . . 0.4 ' HA ' HD13 ' A' ' 24' ' ' ILE . 0.9 OUTLIER -54.28 -66.34 0.41 Allowed 'General case' 0 CA--C 1.518 -0.287 0 C-N-CA 125.437 1.495 . . . . 0.0 112.246 -169.916 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 16.3 m -60.94 -33.7 73.59 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.747 -0.66 . . . . 0.0 111.594 -174.825 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 160' ' ' TRP . . . . . 0.413 ' CD1' ' HB2' ' A' ' 142' ' ' LEU . 67.5 t90 -65.14 -44.99 86.86 Favored 'General case' 0 C--O 1.223 -0.293 0 O-C-N 121.956 -0.465 . . . . 0.0 110.552 173.9 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 65.8 m -60.33 -41.24 93.15 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 118.298 0.499 . . . . 0.0 110.763 179.672 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -62.57 -45.68 91.79 Favored 'General case' 0 C--O 1.228 -0.073 0 CA-C-N 118.818 0.736 . . . . 0.0 110.063 173.201 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 14.4 tt0 -61.53 -48.56 80.49 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-O 117.923 -1.037 . . . . 0.0 110.363 -175.522 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 40.7 pt -65.57 -33.8 66.08 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.422 0 CA-C-O 117.918 -1.039 . . . . 0.0 110.282 -178.299 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -73.05 -31.02 64.14 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 119.58 1.082 . . . . 0.0 108.765 -175.033 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -69.08 -55.87 9.42 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 125.028 1.331 . . . . 0.0 109.194 170.945 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 19.5 tt0 -67.76 -30.68 70.2 Favored 'General case' 0 N--CA 1.442 -0.837 0 C-N-CA 125.546 1.538 . . . . 0.0 110.504 -168.545 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 168' ' ' MET . . . . . . . . . . . . . 20.2 ptp -75.8 -29.13 58.62 Favored 'General case' 0 CA--C 1.523 -0.058 0 O-C-N 122.023 -0.423 . . . . 0.0 111.743 174.708 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -78.3 -33.37 49.41 Favored 'General case' 0 N--CA 1.444 -0.73 0 C-N-CA 123.228 0.611 . . . . 0.0 111.639 179.729 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 . . . . . 0 N--CA 1.468 0.447 0 CA-C-O 122.324 1.059 . . . . 0.0 109.149 175.822 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 34.6 ttp . . . . . 0 N--CA 1.494 1.753 0 N-CA-C 110.368 -0.234 . . . . 0.0 110.368 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 29.1 p-10 -144.51 166.66 24.51 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 126.612 1.965 . . . . 0.0 108.367 177.955 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 1.5 mpt? -129.04 124.4 34.78 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 118.567 0.621 . . . . 0.0 111.1 -179.797 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -90.42 142.1 16.19 Favored Glycine 0 CA--C 1.526 0.724 0 N-CA-C 107.139 -2.384 . . . . 0.0 107.139 167.815 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 1.2 tt -132.2 97.55 4.16 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 119.911 1.855 . . . . 0.0 106.659 -169.866 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -105.03 144.48 31.78 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-O 121.64 0.733 . . . . 0.0 112.138 -170.408 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 35.4 p90 . . . . . 0 CA--C 1.533 0.326 0 C-N-CA 126.698 1.999 . . . . 0.0 107.539 179.512 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.338 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -62.74 -48.26 79.99 Favored 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 123.761 0.825 . . . . 0.0 111.379 -175.707 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -67.51 -35.78 79.79 Favored 'General case' 0 CA--C 1.535 0.402 0 O-C-N 121.795 -0.565 . . . . 0.0 110.426 178.96 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 28.9 mtpp -67.39 -37.63 83.42 Favored 'General case' 0 N--CA 1.465 0.293 0 O-C-N 121.272 -0.893 . . . . 0.0 111.182 177.568 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 32.9 mt -56.75 -54.58 27.47 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.25 0 N-CA-C 108.404 -0.961 . . . . 0.0 108.404 175.09 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 22.2 ptt180 -63.31 -37.73 88.42 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 118.904 0.774 . . . . 0.0 110.635 -178.11 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -64.57 -37.78 88.72 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 109.865 -0.42 . . . . 0.0 109.865 -174.736 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.431 HD13 ' HA ' ' A' ' 158' ' ' GLN . 75.6 mt -79.79 -54.47 11.09 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.573 0 C-N-CA 124.805 1.242 . . . . 0.0 110.167 -175.081 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 77.7 mt -62.61 -48.3 88.86 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.292 0 C-N-CA 122.719 0.408 . . . . 0.0 110.172 179.908 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 142.01 119.24 1.48 Allowed Glycine 0 CA--C 1.53 1.026 0 C-N-CA 125.207 1.384 . . . . 0.0 110.449 -179.087 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -76.88 -4.43 14.91 Favored 'Trans proline' 0 CA--C 1.538 0.717 0 C-N-CA 122.829 2.353 . . . . 0.0 113.491 -171.141 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -82.35 -22.68 35.42 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 118.918 0.781 . . . . 0.0 111.157 177.15 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 1.2 pt? -118.51 -21.28 8.06 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 124.847 1.259 . . . . 0.0 113.216 -174.117 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 59.0 t -91.45 147.23 5.41 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.504 0 N-CA-C 107.608 -1.256 . . . . 0.0 107.608 168.714 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 16.5 m -132.13 134.11 45.06 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 125.193 1.397 . . . . 0.0 107.833 178.494 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 18.7 mt -79.43 141.13 37.09 Favored 'General case' 0 N--CA 1.466 0.336 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 175.248 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 21.8 t-80 -135.15 54.09 1.95 Allowed 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 124.761 1.224 . . . . 0.0 108.259 -176.766 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 28.4 t-20 -55.21 124.13 15.96 Favored 'General case' 0 C--O 1.235 0.311 0 N-CA-C 107.348 -1.352 . . . . 0.0 107.348 170.935 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 32.3 mt -72.56 -16.94 61.75 Favored 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 113.105 0.78 . . . . 0.0 113.105 -170.509 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 9.8 tppt? -66.88 -31.06 71.41 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-N 119.354 0.979 . . . . 0.0 109.492 168.078 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -92.48 -36.35 13.12 Favored 'General case' 0 C--O 1.235 0.321 0 N-CA-C 113.525 0.935 . . . . 0.0 113.525 -168.985 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 2.3 t0 -140.47 156.96 46.18 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-N 118.949 0.795 . . . . 0.0 112.477 178.13 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 17.8 m -79.97 160.06 69.58 Favored Pre-proline 0 CA--C 1.541 0.625 0 C-N-CA 126.23 1.812 . . . . 0.0 111.299 -170.249 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -76.0 -24.85 10.92 Favored 'Trans proline' 0 C--N 1.351 0.7 0 C-N-CA 122.41 2.073 . . . . 0.0 113.41 -171.412 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 3.7 mmmm -67.12 -17.74 65.0 Favored 'General case' 0 CA--C 1.542 0.671 0 O-C-N 120.745 -1.222 . . . . 0.0 110.774 -174.968 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -59.49 -31.05 69.0 Favored 'General case' 0 N--CA 1.465 0.317 0 C-N-CA 126.803 2.041 . . . . 0.0 110.548 171.235 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 56.3 mtt -59.24 -24.31 63.07 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 118.83 0.741 . . . . 0.0 111.157 -178.672 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 63.3 mt-10 -64.78 -31.83 73.24 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-N 118.464 0.575 . . . . 0.0 110.385 -178.791 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 24.0 mt-30 -69.93 -39.37 76.16 Favored 'General case' 0 N--CA 1.466 0.354 0 N-CA-C 114.093 1.146 . . . . 0.0 114.093 -169.2 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 53.6 m-85 -72.25 141.58 48.95 Favored 'General case' 0 CA--C 1.528 0.12 0 C-N-CA 123.075 0.55 . . . . 0.0 111.388 -165.928 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 57.6 m-20 -69.68 -30.24 67.86 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 123.651 0.78 . . . . 0.0 110.268 176.564 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 19.0 t -126.15 147.2 30.98 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.467 0 N-CA-C 106.973 -1.491 . . . . 0.0 106.973 172.946 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 22.5 tp -124.87 150.01 46.92 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 169.873 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.44 HG12 ' HB3' ' A' ' 83' ' ' ALA . 43.5 mt -128.9 127.73 66.58 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 N-CA-C 104.596 -2.372 . . . . 0.0 104.596 178.426 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 3.2 mp -107.59 132.88 52.81 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 125.867 1.667 . . . . 0.0 106.791 -178.164 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -139.15 128.7 4.13 Favored Glycine 0 C--N 1.34 0.771 0 N-CA-C 109.182 -1.567 . . . . 0.0 109.182 -177.825 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 3.5 tt -151.77 134.45 8.79 Favored Pre-proline 0 CA--C 1.534 0.363 0 CA-C-N 118.437 1.119 . . . . 0.0 111.685 -179.136 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 75.6 Cg_endo . . . . . 0 N--CA 1.454 -0.843 0 C-N-CA 121.834 1.69 . . . . 0.0 108.827 168.049 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 73.8 mt . . . . . 0 CA--C 1.544 0.717 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 -76.98 159.77 29.68 Favored 'General case' 0 N--CA 1.465 0.32 0 C-N-CA 123.723 0.809 . . . . 0.0 109.074 178.33 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -55.36 -41.94 73.24 Favored 'General case' 0 C--O 1.225 -0.23 0 C-N-CA 123.645 0.778 . . . . 0.0 110.643 -179.96 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 22.7 m-20 -62.95 -26.25 68.74 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 123.123 0.569 . . . . 0.0 112.013 -177.84 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' TRP . . . . . 0.436 ' CZ3' ' CE3' ' A' ' 69' ' ' TRP . 0.0 OUTLIER -92.53 -46.43 7.63 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 125.462 1.505 . . . . 0.0 107.483 -176.407 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 13.7 tt0 -63.21 -36.65 84.34 Favored 'General case' 0 N--CA 1.445 -0.69 0 O-C-N 120.073 -1.642 . . . . 0.0 110.355 179.396 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -58.53 -26.09 63.15 Favored 'General case' 0 C--O 1.234 0.239 0 C-N-CA 123.844 0.858 . . . . 0.0 111.368 -175.115 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 34.9 m -105.15 -18.01 7.17 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.416 0 CA-C-O 117.221 -1.371 . . . . 0.0 112.51 177.607 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' TRP . . . . . 0.436 ' CE3' ' CZ3' ' A' ' 65' ' ' TRP . 1.8 t-105 -52.32 -35.04 49.77 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 120.464 1.484 . . . . 0.0 111.118 -176.023 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -68.01 -27.12 66.28 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 126.02 1.728 . . . . 0.0 113.357 177.04 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 23.1 mt-30 -92.65 -23.11 19.09 Favored 'General case' 0 C--N 1.341 0.222 0 C-N-CA 126.179 1.792 . . . . 0.0 112.262 178.249 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 71.8 mt -64.66 -26.21 68.29 Favored 'General case' 0 N--CA 1.465 0.285 0 O-C-N 121.514 -0.741 . . . . 0.0 111.861 -174.326 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -76.93 -22.55 53.13 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-N 118.329 0.513 . . . . 0.0 111.465 173.321 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -79.11 -27.88 42.92 Favored 'General case' 0 CA--C 1.534 0.36 0 O-C-N 120.986 -1.071 . . . . 0.0 112.13 179.706 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 39.3 mt -58.25 145.11 38.71 Favored 'General case' 0 C--O 1.234 0.265 0 C-N-CA 124.433 1.093 . . . . 0.0 110.629 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 22.3 t-20 -87.86 112.09 22.11 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 169.839 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 62.0 mt -120.95 6.92 10.35 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 123.558 0.743 . . . . 0.0 111.9 -172.421 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 32.1 mt-10 -51.13 133.24 28.09 Favored 'General case' 0 C--O 1.235 0.319 0 C-N-CA 124.837 1.255 . . . . 0.0 112.551 -168.857 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 71.81 -6.16 10.19 Favored Glycine 0 CA--C 1.531 1.074 0 C-N-CA 125.521 1.534 . . . . 0.0 115.598 173.177 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.34 157.92 33.55 Favored 'General case' 0 C--N 1.346 0.43 0 CA-C-N 120.759 2.28 . . . . 0.0 110.02 -174.476 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 7.3 mt -84.41 139.3 17.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 N-CA-C 106.894 -1.521 . . . . 0.0 106.894 176.576 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 99.2 t -130.97 126.98 60.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 C-N-CA 123.217 0.607 . . . . 0.0 110.864 178.065 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.44 ' HB3' HG12 ' A' ' 50' ' ' ILE . . . -94.02 146.16 24.14 Favored 'General case' 0 C--O 1.233 0.223 0 N-CA-C 106.464 -1.68 . . . . 0.0 106.464 165.751 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 2.0 mt -123.75 139.61 53.81 Favored 'General case' 0 CA--C 1.513 -0.475 0 N-CA-C 106.399 -1.704 . . . . 0.0 106.399 171.93 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 31.7 p90 -152.09 167.35 28.76 Favored 'General case' 0 N--CA 1.445 -0.714 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 167.921 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -164.04 179.06 39.17 Favored Glycine 0 N--CA 1.433 -1.523 0 N-CA-C 109.643 -1.383 . . . . 0.0 109.643 170.511 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 6.1 tt . . . . . 0 N--CA 1.44 -0.956 0 N-CA-C 107.245 -1.391 . . . . 0.0 107.245 172.971 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 92.0 mt . . . . . 0 N--CA 1.47 0.543 0 N-CA-C 114.739 1.385 . . . . 0.0 114.739 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -60.56 -33.89 73.36 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 120.643 1.565 . . . . 0.0 111.554 -170.163 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -71.77 -29.86 64.94 Favored 'General case' 0 CA--C 1.535 0.397 0 N-CA-C 112.714 0.635 . . . . 0.0 112.714 176.335 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 5.5 tt -59.07 -43.92 91.82 Favored 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 173.194 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -67.07 -32.96 82.01 Favored Glycine 0 C--N 1.338 0.639 0 CA-C-O 119.678 -0.512 . . . . 0.0 112.053 -176.156 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 75.6 mtm -68.4 -41.1 80.97 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 118.108 0.954 . . . . 0.0 110.899 -178.298 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -72.75 -38.04 67.5 Favored 'General case' 0 C--N 1.347 0.497 0 CA-C-N 120.507 1.503 . . . . 0.0 110.693 175.997 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 84.9 t60 -50.61 -49.0 57.74 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 118.37 0.532 . . . . 0.0 110.517 173.589 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -65.4 -41.81 93.27 Favored 'General case' 0 C--O 1.235 0.33 0 C-N-CA 123.522 0.729 . . . . 0.0 112.804 -177.784 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 24.1 ttmm -54.7 -43.46 72.54 Favored 'General case' 0 N--CA 1.465 0.31 0 C-N-CA 123.103 0.561 . . . . 0.0 109.847 171.55 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 7.9 mt -77.91 -25.66 48.57 Favored 'General case' 0 CA--C 1.516 -0.349 0 N-CA-C 115.35 1.611 . . . . 0.0 115.35 -168.247 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 14.1 m -58.73 -33.16 69.91 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-N 120.124 1.329 . . . . 0.0 112.245 -172.658 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 22.8 p -87.23 -9.65 54.55 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 124.413 1.085 . . . . 0.0 111.956 -179.139 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 30.9 mmmt -82.04 -10.01 59.36 Favored 'General case' 0 C--N 1.346 0.416 0 C-N-CA 124.419 1.088 . . . . 0.0 111.383 173.143 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 75.13 32.93 55.51 Favored Glycine 0 CA--C 1.524 0.638 0 CA-C-O 119.665 -0.519 . . . . 0.0 112.615 169.728 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 29.8 m -76.5 179.79 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 CA-C-N 118.208 1.004 . . . . 0.0 110.38 169.602 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -116.6 134.26 55.04 Favored 'General case' 0 CA--C 1.515 -0.369 0 N-CA-C 106.374 -1.713 . . . . 0.0 106.374 169.655 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 59.3 m-85 -95.38 145.01 25.44 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 119.502 1.047 . . . . 0.0 110.17 -179.26 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 35.3 m -132.8 159.61 43.07 Favored 'Isoleucine or valine' 0 C--O 1.233 0.21 0 C-N-CA 125.03 1.332 . . . . 0.0 108.399 171.954 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 82.02 33.44 26.63 Favored Glycine 0 CA--C 1.521 0.456 0 CA-C-O 118.666 -1.074 . . . . 0.0 113.858 170.556 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 8.3 m-30 -62.38 149.93 41.09 Favored 'General case' 0 CA--C 1.544 0.749 0 CA-C-N 119.297 1.549 . . . . 0.0 109.47 169.633 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 119' ' ' TRP . . . . . 0.428 ' HA ' ' HD3' ' A' ' 120' ' ' PRO . 1.5 t90 -134.65 136.37 25.33 Favored Pre-proline 0 CA--C 1.541 0.603 0 CA-C-O 117.273 -1.346 . . . . 0.0 108.592 -170.998 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 120' ' ' PRO . . . . . 0.428 ' HD3' ' HA ' ' A' ' 119' ' ' TRP . 45.2 Cg_exo -66.45 130.26 23.3 Favored 'Trans proline' 0 C--N 1.349 0.574 0 C-N-CA 123.006 2.471 . . . . 0.0 113.366 -172.369 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 33.6 p . . . . . 0 CA--C 1.545 0.773 0 N-CA-C 113.235 0.828 . . . . 0.0 113.235 172.875 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 47.1 mttp . . . . . 0 N--CA 1.473 0.679 0 CA-C-O 117.848 -1.072 . . . . 0.0 113.199 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -86.58 13.44 2.72 Favored 'Trans proline' 0 N--CA 1.457 -0.659 0 C-N-CA 122.043 1.829 . . . . 0.0 113.057 -171.524 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 15.2 m -127.55 146.23 33.62 Favored 'Isoleucine or valine' 0 C--O 1.232 0.179 0 CA-C-N 121.521 1.964 . . . . 0.0 111.04 -179.297 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 14.5 pt -102.8 169.01 2.01 Favored 'Isoleucine or valine' 0 C--O 1.235 0.313 0 C-N-CA 125.68 1.592 . . . . 0.0 108.96 170.483 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . 56.72 30.96 18.5 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 124.829 1.251 . . . . 0.0 113.514 167.93 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 27.6 t70 55.1 38.98 31.34 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 126.736 2.014 . . . . 0.0 111.292 -176.23 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 98.14 71.74 1.04 Allowed Glycine 0 C--N 1.338 0.693 0 C-N-CA 124.401 1.0 . . . . 0.0 111.29 176.721 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 76.3 mm-40 -120.33 -48.56 2.31 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 123.048 0.539 . . . . 0.0 110.895 167.784 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -131.34 141.98 50.0 Favored 'General case' 0 N--CA 1.467 0.408 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 179.52 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 62.9 m-85 -75.82 18.83 0.23 Allowed 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 125.86 1.664 . . . . 0.0 115.215 177.315 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 4.2 m 49.25 10.8 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.552 1.031 0 C-N-CA 127.576 2.351 . . . . 0.0 114.546 -176.491 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 170.46 175.2 39.05 Favored Glycine 0 CA--C 1.53 1.005 0 C-N-CA 125.941 1.734 . . . . 0.0 108.883 -169.334 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -71.6 141.07 50.0 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 118.439 1.12 . . . . 0.0 111.983 -177.382 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -99.72 129.77 45.87 Favored 'General case' 0 N--CA 1.446 -0.65 0 C-N-CA 126.523 1.929 . . . . 0.0 110.004 174.167 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 86.2 mt . . . . . 0 N--CA 1.463 0.214 0 N-CA-C 106.554 -1.647 . . . . 0.0 106.554 168.178 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 16.0 m . . . . . 0 CA--C 1.534 0.362 0 CA-C-O 119.623 -0.227 . . . . 0.0 111.404 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -62.61 -43.53 98.58 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 118.141 0.428 . . . . 0.0 110.705 176.109 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 12.6 tt0 -67.88 -41.01 83.46 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 124.889 1.276 . . . . 0.0 110.747 -178.497 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.88 -45.11 86.88 Favored 'General case' 0 N--CA 1.463 0.221 0 C-N-CA 124.338 1.055 . . . . 0.0 110.43 173.464 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 43.8 mt -67.03 -55.74 16.54 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.345 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 179.112 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 158' ' ' GLN . . . . . 0.431 ' HA ' HD13 ' A' ' 24' ' ' ILE . 0.4 OUTLIER -50.25 -69.13 0.12 Allowed 'General case' 0 C--O 1.234 0.263 0 C-N-CA 125.888 1.675 . . . . 0.0 112.035 -170.338 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 8.3 m -61.31 -33.42 73.57 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.859 -0.609 . . . . 0.0 111.744 -172.955 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 160' ' ' TRP . . . . . . . . . . . . . 79.6 t90 -66.13 -44.71 83.45 Favored 'General case' 0 CA--C 1.517 -0.326 0 O-C-N 121.833 -0.542 . . . . 0.0 110.988 175.041 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 68.6 m -59.51 -42.15 91.56 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 122.937 0.495 . . . . 0.0 110.501 179.095 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -62.05 -42.45 99.2 Favored 'General case' 0 CA--C 1.523 -0.082 0 CA-C-N 118.57 0.623 . . . . 0.0 110.467 174.869 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 16.4 tt0 -64.58 -51.01 64.95 Favored 'General case' 0 N--CA 1.446 -0.641 0 CA-C-O 118.691 -0.671 . . . . 0.0 110.019 -177.018 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 40.3 pt -63.27 -37.62 79.96 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.442 0 CA-C-O 117.815 -1.088 . . . . 0.0 109.531 -175.465 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -65.87 -32.97 74.79 Favored 'General case' 0 N--CA 1.462 0.165 0 CA-C-N 119.495 1.043 . . . . 0.0 110.329 -178.948 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 35.1 m-80 -69.6 -59.2 3.12 Favored 'General case' 0 C--O 1.223 -0.302 0 N-CA-C 108.099 -1.075 . . . . 0.0 108.099 174.053 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 19.4 tt0 -61.41 -34.31 75.15 Favored 'General case' 0 N--CA 1.443 -0.779 0 C-N-CA 126.412 1.885 . . . . 0.0 111.765 -168.788 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 168' ' ' MET . . . . . . . . . . . . . 22.1 ptp -72.46 -35.09 68.16 Favored 'General case' 0 C--O 1.228 -0.077 0 C-N-CA 123.415 0.686 . . . . 0.0 111.67 173.512 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -74.98 -38.35 61.66 Favored 'General case' 0 N--CA 1.445 -0.724 0 CA-C-O 119.153 -0.451 . . . . 0.0 111.935 -177.026 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 . . . . . 0 N--CA 1.465 0.303 0 CA-C-O 121.446 0.641 . . . . 0.0 109.839 178.611 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.7 tmm? . . . . . 0 N--CA 1.494 1.755 0 CA-C-O 120.604 0.24 . . . . 0.0 110.603 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 21.9 p-10 -146.6 165.58 29.11 Favored 'General case' 0 N--CA 1.465 0.321 0 C-N-CA 126.334 1.854 . . . . 0.0 109.327 174.567 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 17.5 mtt -127.07 133.87 50.37 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 118.287 0.494 . . . . 0.0 111.144 -179.191 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -104.11 135.82 12.66 Favored Glycine 0 CA--C 1.526 0.722 0 N-CA-C 107.574 -2.21 . . . . 0.0 107.574 168.215 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 4.0 tt -122.93 111.11 16.24 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 105.78 -1.933 . . . . 0.0 105.78 -173.937 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 6' ' ' PHE . . . . . 0.426 ' CD1' HD11 ' A' ' 35' ' ' LEU . 1.1 p90 -114.64 146.48 40.8 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 118.71 0.686 . . . . 0.0 110.683 -177.711 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 33.0 p90 . . . . . 0 CA--C 1.533 0.318 0 C-N-CA 124.312 1.045 . . . . 0.0 108.44 179.666 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.259 0 N-CA-C 109.935 -0.395 . . . . 0.0 109.935 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -64.27 -48.74 74.56 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 124.274 1.029 . . . . 0.0 111.18 -176.777 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 6.4 mt-10 -58.96 -43.56 91.33 Favored 'General case' 0 CA--C 1.516 -0.351 0 N-CA-C 109.972 -0.381 . . . . 0.0 109.972 175.641 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 28.9 mtpp -72.13 -41.99 66.55 Favored 'General case' 0 C--O 1.221 -0.402 0 CA-C-O 117.848 -1.072 . . . . 0.0 110.533 -173.334 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 41.2 mt -51.88 -54.93 11.17 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.314 0 CA-C-N 120.301 1.409 . . . . 0.0 108.349 172.544 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 7.9 ttp180 -61.74 -41.7 98.0 Favored 'General case' 0 C--O 1.222 -0.386 0 C-N-CA 123.605 0.762 . . . . 0.0 109.721 -175.193 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -66.56 -42.24 87.37 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 122.878 0.471 . . . . 0.0 111.159 -178.653 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 51.3 mt -71.48 -52.52 25.7 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 C-N-CA 124.749 1.22 . . . . 0.0 109.843 -172.652 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 82.8 mt -67.66 -45.86 83.97 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.433 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 138.75 124.49 2.22 Favored Glycine 0 CA--C 1.53 1.011 0 C-N-CA 125.078 1.323 . . . . 0.0 112.144 174.613 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -71.77 -7.14 20.57 Favored 'Trans proline' 0 CA--C 1.534 0.491 0 C-N-CA 123.57 2.847 . . . . 0.0 113.965 -175.483 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -77.92 -21.15 51.58 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 119.147 0.885 . . . . 0.0 111.148 176.423 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -127.67 -8.34 5.63 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 124.675 1.19 . . . . 0.0 114.011 -172.343 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 25.4 t -106.48 151.54 8.42 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.337 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 169.64 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 2.1 m -140.07 130.1 24.89 Favored 'General case' 0 C--N 1.333 -0.135 0 N-CA-C 106.236 -1.765 . . . . 0.0 106.236 -170.976 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 18.7 mt -89.19 135.64 33.46 Favored 'General case' 0 N--CA 1.464 0.273 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 177.866 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 35.6 m170 -100.57 154.21 18.75 Favored 'General case' 0 N--CA 1.464 0.24 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 169.929 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 11.6 t-20 -132.65 104.11 6.48 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 105.036 -2.209 . . . . 0.0 105.036 172.416 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.426 HD11 ' CD1' ' A' ' 6' ' ' PHE . 69.3 mt -76.59 -6.64 52.85 Favored 'General case' 0 C--O 1.235 0.313 0 N-CA-C 113.028 0.751 . . . . 0.0 113.028 -170.049 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 51.5 tptt -81.75 -14.28 56.68 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 118.803 0.728 . . . . 0.0 109.911 168.974 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -117.76 -41.29 2.93 Favored 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 124.572 1.149 . . . . 0.0 112.97 -173.844 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -106.89 155.76 19.41 Favored 'General case' 0 C--O 1.236 0.386 0 C-N-CA 125.878 1.671 . . . . 0.0 111.588 179.484 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 15.1 m -90.95 147.46 35.91 Favored Pre-proline 0 CA--C 1.539 0.521 0 C-N-CA 124.871 1.268 . . . . 0.0 110.26 -174.209 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -66.62 -20.64 53.13 Favored 'Trans proline' 0 C--N 1.349 0.594 0 C-N-CA 122.218 1.945 . . . . 0.0 113.016 -175.722 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 4.6 mptp? -56.85 -23.32 43.34 Favored 'General case' 0 CA--C 1.538 0.491 0 O-C-N 121.328 -0.857 . . . . 0.0 111.712 174.106 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 5.9 mt -61.87 -32.33 72.68 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 119.477 1.035 . . . . 0.0 111.252 175.682 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 59.8 mtt -60.13 -25.48 65.51 Favored 'General case' 0 N--CA 1.462 0.138 0 C-N-CA 123.774 0.829 . . . . 0.0 111.631 -179.911 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -60.23 -33.83 72.82 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 118.401 0.546 . . . . 0.0 109.95 179.112 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 29.9 mt-30 -72.36 -28.08 62.8 Favored 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 114.121 1.156 . . . . 0.0 114.121 -169.679 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 63.1 m-85 -85.27 138.92 32.01 Favored 'General case' 0 N--CA 1.464 0.258 0 C-N-CA 122.718 0.407 . . . . 0.0 110.222 -167.7 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 26.8 m-20 -67.49 -39.3 85.19 Favored 'General case' 0 N--CA 1.465 0.324 0 N-CA-C 109.838 -0.43 . . . . 0.0 109.838 178.484 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 17.3 t -114.35 143.87 23.13 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.379 0 N-CA-C 107.74 -1.207 . . . . 0.0 107.74 173.302 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 18.3 tp -123.55 143.4 50.22 Favored 'General case' 0 N--CA 1.444 -0.749 0 N-CA-C 107.728 -1.212 . . . . 0.0 107.728 169.339 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 45.9 mt -124.45 126.74 72.37 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 N-CA-C 105.426 -2.065 . . . . 0.0 105.426 179.98 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 3.0 mp -110.02 123.2 49.24 Favored 'General case' 0 CA--C 1.516 -0.33 0 N-CA-C 107.143 -1.429 . . . . 0.0 107.143 -173.012 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -122.74 133.55 9.2 Favored Glycine 0 N--CA 1.459 0.193 0 N-CA-C 109.831 -1.307 . . . . 0.0 109.831 175.627 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 4.3 tt -155.13 125.59 3.39 Favored Pre-proline 0 CA--C 1.538 0.509 0 CA-C-N 118.648 1.224 . . . . 0.0 112.67 169.637 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_exo . . . . . 0 N--CA 1.452 -0.922 0 C-N-CA 122.378 2.052 . . . . 0.0 111.278 166.02 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 63.9 mt . . . . . 0 CA--C 1.54 0.589 0 N-CA-C 105.029 -2.212 . . . . 0.0 105.029 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -74.57 162.88 28.35 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 124.182 0.993 . . . . 0.0 109.891 175.197 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -48.06 -49.22 32.18 Favored 'General case' 0 C--O 1.226 -0.179 0 C-N-CA 125.45 1.5 . . . . 0.0 112.412 -169.413 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -69.33 -19.52 63.87 Favored 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 112.559 0.577 . . . . 0.0 112.559 -170.378 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 65' ' ' TRP . . . . . 0.806 ' CH2' HD23 ' A' ' 104' ' ' LEU . 3.6 t90 -92.68 -41.46 10.16 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 125.026 1.33 . . . . 0.0 109.022 176.916 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -64.16 -35.52 81.04 Favored 'General case' 0 CA--C 1.537 0.48 0 O-C-N 121.102 -0.999 . . . . 0.0 109.704 177.163 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -62.06 -26.26 68.16 Favored 'General case' 0 C--O 1.233 0.233 0 C-N-CA 124.301 1.04 . . . . 0.0 110.747 -178.956 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.424 HG21 HD13 ' A' ' 35' ' ' LEU . 30.5 m -102.68 -20.38 5.67 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.552 0 CA-C-O 116.438 -1.744 . . . . 0.0 112.373 175.249 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 20.5 t90 -55.18 -36.48 65.93 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 121.508 1.958 . . . . 0.0 110.713 -177.5 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -64.1 -27.77 69.32 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 125.12 1.368 . . . . 0.0 112.939 174.418 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 58.4 mt-30 -97.13 -22.72 16.59 Favored 'General case' 0 C--O 1.224 -0.254 0 C-N-CA 126.802 2.041 . . . . 0.0 112.016 -176.494 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.494 ' CD1' HD21 ' A' ' 104' ' ' LEU . 77.7 mt -62.39 -25.99 68.23 Favored 'General case' 0 N--CA 1.462 0.149 0 O-C-N 121.5 -0.75 . . . . 0.0 110.511 178.0 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -78.33 -29.82 47.86 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 117.845 0.293 . . . . 0.0 110.452 172.279 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -72.41 -32.05 66.03 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 123.84 0.856 . . . . 0.0 112.56 -179.261 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 26.0 mt -53.64 142.84 21.82 Favored 'General case' 0 C--O 1.235 0.322 0 C-N-CA 123.906 0.882 . . . . 0.0 112.537 -169.689 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 26.3 t-20 -81.2 88.0 6.06 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 172.154 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 3.8 pp -144.37 132.71 21.92 Favored 'General case' 0 N--CA 1.454 -0.238 0 N-CA-C 108.579 -0.896 . . . . 0.0 108.579 172.001 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 22.6 mt-10 -140.14 146.52 38.93 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 128.591 2.757 . . . . 0.0 107.19 168.693 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 68.9 -3.57 6.55 Favored Glycine 0 CA--C 1.533 1.202 0 N-CA-C 116.793 1.477 . . . . 0.0 116.793 169.968 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.19 157.86 36.34 Favored 'General case' 0 C--N 1.345 0.389 0 CA-C-N 120.181 1.99 . . . . 0.0 110.021 -174.439 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 4.4 mt -80.42 135.25 25.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 N-CA-C 107.377 -1.342 . . . . 0.0 107.377 178.587 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 67.7 t -132.91 129.73 58.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 C-N-CA 124.604 1.162 . . . . 0.0 109.405 -176.924 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -105.98 153.72 21.61 Favored 'General case' 0 N--CA 1.462 0.136 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 168.549 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 1.4 mt -134.49 137.47 43.93 Favored 'General case' 0 CA--C 1.512 -0.484 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 176.214 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 36.7 p90 -154.98 170.94 20.59 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 170.957 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 86' ' ' GLY . . . . . 0.435 ' HA3' HD11 ' A' ' 101' ' ' LEU . . . 178.25 161.03 25.56 Favored Glycine 0 N--CA 1.445 -0.758 0 C-N-CA 120.701 -0.761 . . . . 0.0 111.919 168.336 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 58.4 tp . . . . . 0 N--CA 1.442 -0.841 0 C-N-CA 126.426 1.89 . . . . 0.0 110.981 178.995 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 90.6 mt . . . . . 0 CA--C 1.538 0.511 0 N-CA-C 114.117 1.155 . . . . 0.0 114.117 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -56.98 -35.17 68.86 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 124.739 1.216 . . . . 0.0 111.581 -175.457 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -72.61 -22.41 60.97 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-O 118.061 -0.971 . . . . 0.0 112.499 178.204 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.435 HD11 ' HA3' ' A' ' 86' ' ' GLY . 9.4 mp -65.76 -41.26 92.3 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-N 120.265 1.393 . . . . 0.0 108.172 169.003 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -65.9 -40.06 95.27 Favored Glycine 0 C--N 1.339 0.729 0 N-CA-C 110.76 -0.936 . . . . 0.0 110.76 -176.123 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 74.7 mtm -62.3 -39.9 94.54 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-O 118.681 -0.676 . . . . 0.0 111.619 178.409 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.806 HD23 ' CH2' ' A' ' 65' ' ' TRP . 0.1 OUTLIER -73.23 -39.1 65.76 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 119.982 1.265 . . . . 0.0 110.34 175.498 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 58.9 t60 -57.95 -51.68 68.63 Favored 'General case' 0 N--CA 1.46 0.06 0 CA-C-N 118.282 0.492 . . . . 0.0 110.189 -179.089 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -61.86 -38.81 89.62 Favored 'General case' 0 C--O 1.234 0.259 0 C-N-CA 123.87 0.868 . . . . 0.0 112.08 -175.783 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 24.4 ttmm -56.8 -39.95 75.06 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 123.542 0.737 . . . . 0.0 110.42 172.599 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 43.6 mt -91.04 -19.83 22.74 Favored 'General case' 0 CA--C 1.52 -0.192 0 N-CA-C 114.32 1.229 . . . . 0.0 114.32 -169.78 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 6.5 m -58.45 -35.86 72.78 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 120.11 1.323 . . . . 0.0 111.179 179.324 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 20.3 p -81.73 -22.81 37.09 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 124.392 1.077 . . . . 0.0 111.418 179.762 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 32.2 mmmt -73.35 -12.21 60.75 Favored 'General case' 0 C--N 1.344 0.354 0 C-N-CA 123.62 0.768 . . . . 0.0 110.824 168.775 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 73.57 34.2 57.28 Favored Glycine 0 C--N 1.336 0.538 0 CA-C-N 118.948 0.794 . . . . 0.0 111.912 169.834 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 9.4 m -73.49 171.53 1.21 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 CA-C-N 118.629 1.215 . . . . 0.0 109.832 174.684 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -108.42 122.4 46.95 Favored 'General case' 0 CA--C 1.515 -0.377 0 N-CA-C 106.389 -1.708 . . . . 0.0 106.389 175.405 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 80.2 m-85 -91.89 144.69 25.22 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 119.072 0.851 . . . . 0.0 109.751 -175.53 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 31.2 m -131.77 160.29 42.5 Favored 'Isoleucine or valine' 0 C--O 1.233 0.234 0 C-N-CA 124.794 1.238 . . . . 0.0 109.188 171.991 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 96.77 -85.08 0.82 Allowed Glycine 0 N--CA 1.446 -0.691 0 C-N-CA 124.379 0.99 . . . . 0.0 110.654 175.904 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 80.7 m-85 54.57 -171.53 0.05 Allowed 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 124.608 1.163 . . . . 0.0 110.446 -169.301 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -156.37 147.26 16.39 Favored Pre-proline 0 N--CA 1.473 0.679 0 O-C-N 120.26 -1.525 . . . . 0.0 110.485 170.06 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -67.82 128.76 18.44 Favored 'Trans proline' 0 CA--C 1.538 0.706 0 C-N-CA 123.091 2.527 . . . . 0.0 112.365 178.36 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 14.4 p . . . . . 0 N--CA 1.469 0.494 0 O-C-N 121.631 -0.668 . . . . 0.0 112.379 173.761 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 21.8 ttmt . . . . . 0 N--CA 1.475 0.784 0 CA-C-O 117.046 -1.454 . . . . 0.0 114.698 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -74.08 -3.36 13.66 Favored 'Trans proline' 0 CA--C 1.538 0.685 0 CA-C-N 122.745 2.016 . . . . 0.0 114.089 -179.018 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 16.8 m -130.04 156.05 41.96 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.21 0 CA-C-N 119.75 1.159 . . . . 0.0 110.841 -170.685 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 133' ' ' ILE . . . . . 0.412 HG23 HG12 ' A' ' 140' ' ' VAL . 2.4 pt -92.79 171.19 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.598 0 C-N-CA 124.151 0.98 . . . . 0.0 109.662 169.433 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . 55.0 -151.95 0.37 Allowed 'General case' 0 N--CA 1.441 -0.876 0 CA-C-N 113.695 -1.593 . . . . 0.0 109.621 168.444 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 24.8 t0 -79.14 51.87 1.23 Allowed 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 124.99 1.316 . . . . 0.0 110.556 170.815 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 68.04 28.63 73.33 Favored Glycine 0 CA--C 1.529 0.944 0 C-N-CA 124.686 1.136 . . . . 0.0 113.167 179.913 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 20.1 mt-30 -81.39 -22.25 38.45 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 118.281 1.041 . . . . 0.0 112.476 -169.902 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 8.8 tp -156.22 143.94 19.45 Favored 'General case' 0 C--N 1.344 0.326 0 CA-C-N 118.21 0.459 . . . . 0.0 111.013 -178.736 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 74.7 m-85 -73.77 140.36 45.84 Favored 'General case' 0 CA--C 1.516 -0.355 0 N-CA-C 107.479 -1.304 . . . . 0.0 107.479 169.601 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 140' ' ' VAL . . . . . 0.412 HG12 HG23 ' A' ' 133' ' ' ILE . 27.6 m -66.13 -3.73 1.94 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.588 0 N-CA-C 113.285 0.846 . . . . 0.0 113.285 -179.083 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -177.33 170.87 43.57 Favored Glycine 0 N--CA 1.447 -0.607 0 C-N-CA 125.046 1.308 . . . . 0.0 110.215 -171.447 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -60.59 127.36 31.32 Favored 'General case' 0 C--O 1.234 0.287 0 C-N-CA 123.351 0.66 . . . . 0.0 110.945 -175.255 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -79.91 118.95 22.13 Favored 'General case' 0 N--CA 1.446 -0.669 0 C-N-CA 124.838 1.255 . . . . 0.0 108.521 169.87 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 13.8 tp . . . . . 0 N--CA 1.449 -0.499 0 N-CA-C 108.169 -1.048 . . . . 0.0 108.169 172.811 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 7.7 m . . . . . 0 CA--C 1.536 0.425 0 N-CA-C 110.012 -0.366 . . . . 0.0 110.012 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -63.17 -43.74 97.41 Favored 'General case' 0 N--CA 1.463 0.191 0 C-N-CA 123.576 0.75 . . . . 0.0 111.369 171.307 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 29.0 tt0 -63.92 -41.22 97.71 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 124.546 1.139 . . . . 0.0 110.795 178.814 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 3.5 mmt180 -65.64 -39.48 91.49 Favored 'General case' 0 CA--C 1.527 0.063 0 CA-C-O 118.627 -0.702 . . . . 0.0 109.187 -178.225 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 35.3 mt -66.0 -57.71 9.54 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.426 0 N-CA-C 107.474 -1.306 . . . . 0.0 107.474 173.771 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 68.4 tp60 -47.69 -65.12 0.62 Allowed 'General case' 0 CA--C 1.52 -0.196 0 C-N-CA 125.298 1.439 . . . . 0.0 112.861 -174.619 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 19.9 m -66.31 -31.36 72.11 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 121.26 -0.176 . . . . 0.0 110.855 -169.592 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 160' ' ' TRP . . . . . . . . . . . . . 67.3 t90 -71.28 -45.46 63.07 Favored 'General case' 0 C--O 1.224 -0.26 0 O-C-N 121.93 -0.481 . . . . 0.0 111.035 177.426 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 85.5 m -58.81 -42.13 88.44 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 123.074 0.55 . . . . 0.0 109.855 176.349 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 162' ' ' GLU . . . . . 0.427 ' HA ' HD23 ' A' ' 165' ' ' LEU . 38.0 mt-10 -64.07 -43.45 95.4 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-O 121.28 0.562 . . . . 0.0 110.335 177.325 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 10.8 tt0 -60.07 -51.2 70.65 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 124.006 0.922 . . . . 0.0 110.068 -179.563 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 40.2 pt -62.86 -36.06 73.9 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.394 0 CA-C-O 117.937 -1.03 . . . . 0.0 109.253 -176.603 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 165' ' ' LEU . . . . . 0.427 HD23 ' HA ' ' A' ' 162' ' ' GLU . 0.1 OUTLIER -59.3 -37.93 78.97 Favored 'General case' 0 C--O 1.224 -0.27 0 C-N-CA 124.697 1.199 . . . . 0.0 109.478 177.416 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 33.2 m-80 -75.07 -52.54 10.79 Favored 'General case' 0 CA--C 1.515 -0.372 0 N-CA-C 108.644 -0.873 . . . . 0.0 108.644 -179.531 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 10.6 tt0 -70.43 -28.38 65.0 Favored 'General case' 0 N--CA 1.443 -0.808 0 C-N-CA 124.11 0.964 . . . . 0.0 111.582 -168.798 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 168' ' ' MET . . . . . . . . . . . . . 18.7 ptp -77.64 -31.53 52.77 Favored 'General case' 0 N--CA 1.456 -0.133 0 O-C-N 121.391 -0.818 . . . . 0.0 111.975 172.678 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -78.83 -42.52 27.41 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 122.5 0.32 . . . . 0.0 110.701 -176.31 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 . . . . . 0 CA--C 1.538 0.489 0 C-N-CA 123.542 0.737 . . . . 0.0 110.551 179.298 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.497 1.917 0 CA-C-O 119.771 -0.157 . . . . 0.0 111.188 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 25.2 p-10 -129.8 149.36 51.58 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 124.115 0.966 . . . . 0.0 112.186 -174.445 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 21.9 mtt -105.89 122.38 46.01 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 126.044 1.738 . . . . 0.0 107.213 -176.37 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -86.74 153.88 26.35 Favored Glycine 0 CA--C 1.529 0.942 0 N-CA-C 107.104 -2.398 . . . . 0.0 107.104 166.774 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 2.1 tt -142.6 96.84 3.01 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-N 120.042 1.921 . . . . 0.0 106.832 -173.499 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 6' ' ' PHE . . . . . 0.696 ' CZ ' HD23 ' A' ' 51' ' ' LEU . 0.5 OUTLIER -101.69 140.52 35.87 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-O 121.033 0.444 . . . . 0.0 111.691 -170.592 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 25.2 p90 . . . . . 0 CA--C 1.538 0.513 0 C-N-CA 126.456 1.903 . . . . 0.0 108.287 -177.143 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.314 0 CA-C-O 119.738 -0.173 . . . . 0.0 110.867 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -64.93 -47.1 78.91 Favored 'General case' 0 CA--C 1.527 0.089 0 C-N-CA 122.569 0.348 . . . . 0.0 111.053 -174.932 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -66.58 -35.74 80.95 Favored 'General case' 0 C--O 1.231 0.126 0 CA-C-O 118.602 -0.713 . . . . 0.0 110.735 179.175 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 48.0 mttm -65.61 -49.99 66.7 Favored 'General case' 0 C--O 1.22 -0.486 0 CA-C-O 118.339 -0.838 . . . . 0.0 110.588 175.781 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 40.7 mt -52.46 -52.15 28.2 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.336 0 CA-C-N 119.536 1.062 . . . . 0.0 108.764 178.894 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.61 -39.95 95.38 Favored 'General case' 0 C--O 1.223 -0.323 0 C-N-CA 123.119 0.568 . . . . 0.0 110.267 -177.162 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -67.92 -42.07 81.63 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 118.412 0.551 . . . . 0.0 110.917 -178.735 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 60.6 mt -72.98 -52.77 20.81 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.545 0 C-N-CA 124.911 1.284 . . . . 0.0 109.63 -170.531 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 69.7 mt -66.03 -46.75 87.24 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.375 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 178.443 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 139.37 126.05 2.32 Favored Glycine 0 CA--C 1.531 1.037 0 C-N-CA 124.8 1.191 . . . . 0.0 111.661 174.585 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -72.51 -5.66 17.57 Favored 'Trans proline' 0 CA--C 1.537 0.651 0 C-N-CA 123.593 2.862 . . . . 0.0 114.243 -173.287 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -80.1 -20.52 44.9 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-N 119.329 0.968 . . . . 0.0 111.243 176.794 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -128.02 -1.72 5.85 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 124.793 1.237 . . . . 0.0 113.861 -171.775 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 21.9 t -117.15 147.92 20.22 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.338 0 N-CA-C 107.745 -1.206 . . . . 0.0 107.745 171.748 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 15.5 m -131.66 132.9 44.35 Favored 'General case' 0 N--CA 1.463 0.203 0 N-CA-C 107.688 -1.227 . . . . 0.0 107.688 -177.835 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 17.7 mt -79.01 133.39 36.83 Favored 'General case' 0 C--O 1.233 0.198 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 175.151 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 32.2 t-80 -128.75 58.68 1.57 Allowed 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 124.674 1.19 . . . . 0.0 108.6 -177.551 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 8.0 t-20 -55.5 122.28 10.91 Favored 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 106.413 -1.699 . . . . 0.0 106.413 168.586 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 58.9 mt -66.09 -35.42 80.46 Favored 'General case' 0 C--O 1.236 0.356 0 N-CA-C 112.693 0.627 . . . . 0.0 112.693 -173.306 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 42.3 tttm -64.21 -18.82 64.88 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-O 119.011 -0.519 . . . . 0.0 111.5 172.26 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -97.6 -34.24 11.03 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-N 119.015 0.825 . . . . 0.0 112.574 -177.186 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 4.1 t0 -145.07 145.62 31.52 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 118.763 0.711 . . . . 0.0 112.33 176.636 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 12.4 m -66.72 158.49 79.46 Favored Pre-proline 0 CA--C 1.542 0.655 0 C-N-CA 126.216 1.806 . . . . 0.0 112.261 -169.389 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -73.9 -26.83 12.86 Favored 'Trans proline' 0 C--N 1.35 0.629 0 C-N-CA 122.548 2.165 . . . . 0.0 113.222 -170.993 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 22.9 mmmt -70.66 -11.63 61.06 Favored 'General case' 0 CA--C 1.538 0.497 0 O-C-N 120.456 -1.403 . . . . 0.0 111.676 -176.846 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -61.93 -29.3 70.13 Favored 'General case' 0 N--CA 1.463 0.21 0 C-N-CA 125.683 1.593 . . . . 0.0 110.14 169.142 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 39.7 mtt -55.72 -26.78 46.99 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 123.588 0.755 . . . . 0.0 111.464 178.204 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 94.2 mt-10 -65.49 -31.26 72.23 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 118.191 0.451 . . . . 0.0 110.354 -176.609 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 21.1 mt-30 -69.61 -43.84 71.94 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 123.588 0.755 . . . . 0.0 112.704 -170.103 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 57.3 m-85 -68.33 147.63 51.87 Favored 'General case' 0 C--O 1.231 0.096 0 C-N-CA 123.735 0.814 . . . . 0.0 109.135 -168.47 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -80.59 -37.0 32.02 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 119.105 0.866 . . . . 0.0 108.979 -178.926 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 1.3 m -105.51 151.31 7.7 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.806 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 169.532 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 58.4 tp -140.9 106.6 5.11 Favored 'General case' 0 N--CA 1.448 -0.562 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 174.853 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 22.3 mt -84.4 131.83 33.04 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.744 0 N-CA-C 106.139 -1.8 . . . . 0.0 106.139 176.317 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.696 HD23 ' CZ ' ' A' ' 6' ' ' PHE . 0.5 OUTLIER -106.81 131.85 53.44 Favored 'General case' 0 C--O 1.233 0.217 0 N-CA-C 107.283 -1.377 . . . . 0.0 107.283 169.693 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.579 ' N ' HD22 ' A' ' 51' ' ' LEU . . . -127.3 135.53 8.83 Favored Glycine 0 CA--C 1.521 0.456 0 N-CA-C 109.741 -1.344 . . . . 0.0 109.741 171.301 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 3.8 tt -152.05 134.95 9.06 Favored Pre-proline 0 CA--C 1.535 0.399 0 CA-C-N 118.521 1.161 . . . . 0.0 111.786 173.905 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_endo . . . . . 0 N--CA 1.456 -0.727 0 C-N-CA 122.176 1.917 . . . . 0.0 109.602 165.044 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 23.6 mt . . . . . 0 CA--C 1.54 0.58 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 2.2 pm0 -70.11 156.11 39.66 Favored 'General case' 0 C--O 1.232 0.179 0 C-N-CA 123.633 0.773 . . . . 0.0 110.302 176.108 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -54.54 -47.47 73.15 Favored 'General case' 0 N--CA 1.456 -0.167 0 C-N-CA 124.604 1.162 . . . . 0.0 112.457 -168.424 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -67.26 -31.44 71.78 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 119.503 1.047 . . . . 0.0 111.503 -172.225 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' TRP . . . . . 0.546 ' CH2' HD23 ' A' ' 104' ' ' LEU . 5.2 t90 -73.91 -44.54 54.8 Favored 'General case' 0 N--CA 1.455 -0.222 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 178.578 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -61.83 -36.79 82.22 Favored 'General case' 0 CA--C 1.537 0.464 0 O-C-N 121.397 -0.814 . . . . 0.0 109.993 176.241 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -61.91 -25.07 67.35 Favored 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 123.312 0.645 . . . . 0.0 111.117 -174.093 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 25.4 m -108.56 -13.99 10.17 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.271 0 CA-C-O 117.073 -1.441 . . . . 0.0 112.644 175.21 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 18.2 t90 -51.31 -39.46 56.96 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 120.27 1.396 . . . . 0.0 110.075 -178.611 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -66.73 -25.35 66.47 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 125.721 1.608 . . . . 0.0 113.568 177.8 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 25.8 mt-30 -92.06 -19.23 22.56 Favored 'General case' 0 C--N 1.341 0.224 0 C-N-CA 125.688 1.595 . . . . 0.0 112.348 177.007 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 52.6 mt -62.09 -25.78 67.91 Favored 'General case' 0 N--CA 1.466 0.342 0 O-C-N 121.425 -0.797 . . . . 0.0 111.399 -174.937 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -75.92 -21.95 56.55 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-N 118.026 0.376 . . . . 0.0 111.741 176.47 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -73.47 -29.37 62.49 Favored 'General case' 0 N--CA 1.467 0.413 0 O-C-N 120.827 -1.171 . . . . 0.0 111.852 177.173 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 82.9 mt -54.16 138.25 38.66 Favored 'General case' 0 C--N 1.339 0.147 0 C-N-CA 124.926 1.291 . . . . 0.0 112.911 -168.988 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 3.0 t30 -74.97 98.93 3.7 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 123.973 0.909 . . . . 0.0 108.978 170.166 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 56.7 mt -123.07 -0.12 8.99 Favored 'General case' 0 N--CA 1.474 0.769 0 N-CA-C 113.765 1.024 . . . . 0.0 113.765 -176.03 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 25.2 mt-10 -55.2 128.69 35.09 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 119.72 1.146 . . . . 0.0 111.581 -168.974 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 74.88 -1.97 51.94 Favored Glycine 0 CA--C 1.532 1.107 0 C-N-CA 125.487 1.518 . . . . 0.0 114.98 177.095 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.3 155.35 34.32 Favored 'General case' 0 C--N 1.346 0.421 0 CA-C-N 120.172 1.986 . . . . 0.0 109.929 -176.035 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 12.4 mt -78.87 142.52 13.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 N-CA-C 106.615 -1.624 . . . . 0.0 106.615 177.918 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 3.0 t -138.08 139.72 41.74 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 O-C-N 121.42 -0.8 . . . . 0.0 109.251 -179.051 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -117.06 147.71 42.13 Favored 'General case' 0 CA--C 1.511 -0.532 0 N-CA-C 106.43 -1.693 . . . . 0.0 106.43 170.876 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 5.9 mp -127.82 142.08 51.39 Favored 'General case' 0 CA--C 1.509 -0.622 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 170.569 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 35.8 p90 -150.04 166.85 28.47 Favored 'General case' 0 N--CA 1.445 -0.701 0 N-CA-C 107.02 -1.474 . . . . 0.0 107.02 167.644 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -163.07 167.43 37.41 Favored Glycine 0 N--CA 1.444 -0.829 0 N-CA-C 109.915 -1.274 . . . . 0.0 109.915 173.388 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 1.7 tm? . . . . . 0 N--CA 1.447 -0.585 0 N-CA-C 106.81 -1.552 . . . . 0.0 106.81 -179.702 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 95.5 mt . . . . . 0 N--CA 1.472 0.659 0 N-CA-C 113.337 0.866 . . . . 0.0 113.337 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -57.47 -39.82 77.19 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 124.56 1.144 . . . . 0.0 110.845 -178.165 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -71.46 -32.13 67.95 Favored 'General case' 0 CA--C 1.534 0.331 0 O-C-N 121.666 -0.647 . . . . 0.0 111.9 178.926 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 4.9 tt -62.83 -47.94 81.22 Favored 'General case' 0 N--CA 1.467 0.4 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 171.957 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -63.27 -39.06 97.42 Favored Glycine 0 C--N 1.338 0.66 0 N-CA-C 111.145 -0.782 . . . . 0.0 111.145 -177.314 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 67.7 mtm -64.93 -40.38 94.97 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 118.236 1.018 . . . . 0.0 111.394 176.621 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.546 HD23 ' CH2' ' A' ' 65' ' ' TRP . 0.2 OUTLIER -71.67 -31.54 66.91 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 119.752 1.16 . . . . 0.0 111.244 177.714 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 50.6 t-80 -62.65 -45.81 91.13 Favored 'General case' 0 N--CA 1.462 0.148 0 CA-C-N 118.98 0.809 . . . . 0.0 110.837 171.444 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -63.6 -44.1 95.0 Favored 'General case' 0 C--O 1.234 0.274 0 C-N-CA 122.942 0.497 . . . . 0.0 111.06 -177.09 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 22.3 ttmm -58.0 -48.6 79.53 Favored 'General case' 0 C--O 1.226 -0.177 0 C-N-CA 123.131 0.572 . . . . 0.0 109.962 172.23 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 32.9 mt -74.79 -23.27 58.48 Favored 'General case' 0 N--CA 1.461 0.091 0 CA-C-O 118.622 -0.704 . . . . 0.0 112.547 -170.839 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 70.0 m -61.04 -38.18 85.25 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 119.376 0.989 . . . . 0.0 111.261 -177.506 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 26.1 p -85.1 -6.89 59.29 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 123.551 0.74 . . . . 0.0 111.667 -178.824 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 30.7 mmmt -82.12 -7.63 59.63 Favored 'General case' 0 C--N 1.344 0.36 0 C-N-CA 124.462 1.105 . . . . 0.0 111.806 171.635 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 69.51 34.36 73.55 Favored Glycine 0 CA--C 1.525 0.688 0 CA-C-N 118.764 0.711 . . . . 0.0 111.788 173.92 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 8.0 m -77.94 172.48 1.12 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.469 0 CA-C-N 117.913 0.856 . . . . 0.0 109.383 174.34 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -111.37 116.48 31.03 Favored 'General case' 0 CA--C 1.514 -0.437 0 N-CA-C 105.938 -1.875 . . . . 0.0 105.938 177.484 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 71.4 m-85 -85.56 142.39 29.17 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 118.819 0.736 . . . . 0.0 110.135 -173.881 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 32.6 m -131.9 158.73 43.34 Favored 'Isoleucine or valine' 0 C--O 1.234 0.268 0 C-N-CA 125.612 1.565 . . . . 0.0 107.581 168.921 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 83.93 31.13 27.07 Favored Glycine 0 CA--C 1.521 0.464 0 CA-C-O 118.779 -1.012 . . . . 0.0 114.935 169.73 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 10.6 m-30 -65.78 157.13 31.12 Favored 'General case' 0 CA--C 1.546 0.823 0 CA-C-N 118.941 1.371 . . . . 0.0 109.343 169.042 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 119' ' ' TRP . . . . . 0.4 ' HA ' ' HD3' ' A' ' 120' ' ' PRO . 51.1 t-105 -133.88 147.39 64.01 Favored Pre-proline 0 N--CA 1.476 0.838 0 CA-C-O 118.054 -0.974 . . . . 0.0 112.095 -168.524 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 120' ' ' PRO . . . . . 0.4 ' HD3' ' HA ' ' A' ' 119' ' ' TRP . 50.3 Cg_exo -63.25 129.92 27.05 Favored 'Trans proline' 0 C--N 1.35 0.627 0 C-N-CA 123.077 2.518 . . . . 0.0 113.202 -177.621 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 7.6 p . . . . . 0 CA--C 1.534 0.348 0 C-N-CA 124.274 1.029 . . . . 0.0 110.764 169.299 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 25.9 ttmt . . . . . 0 CA--C 1.544 0.716 0 CA-C-O 117.64 -1.171 . . . . 0.0 113.998 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_endo -80.58 5.99 5.74 Favored 'Trans proline' 0 C--N 1.352 0.721 0 C-N-CA 122.046 1.83 . . . . 0.0 114.066 -179.6 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 19.0 m -124.07 147.89 28.4 Favored 'Isoleucine or valine' 0 C--O 1.234 0.273 0 CA-C-N 120.888 1.677 . . . . 0.0 110.982 -177.589 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 133' ' ' ILE . . . . . 0.822 HG23 HG12 ' A' ' 140' ' ' VAL . 2.4 pt -82.69 168.78 1.71 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 N-CA-C 108.056 -1.09 . . . . 0.0 108.056 167.158 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . 55.85 -156.12 0.27 Allowed 'General case' 0 N--CA 1.443 -0.778 0 CA-C-N 114.076 -1.42 . . . . 0.0 110.195 168.587 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 21.8 t0 -80.62 61.11 4.2 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 125.128 1.371 . . . . 0.0 108.92 169.551 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 65.13 28.39 73.49 Favored Glycine 0 CA--C 1.531 1.044 0 C-N-CA 124.302 0.953 . . . . 0.0 113.289 176.768 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 62.5 mm-40 -78.17 -27.49 48.06 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 118.125 0.963 . . . . 0.0 111.886 -169.143 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 12.7 tp -159.17 146.89 17.53 Favored 'General case' 0 C--N 1.341 0.222 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 -177.349 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 63.7 m-85 -75.82 143.09 42.06 Favored 'General case' 0 CA--C 1.517 -0.322 0 N-CA-C 107.821 -1.177 . . . . 0.0 107.821 171.775 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 140' ' ' VAL . . . . . 0.822 HG12 HG23 ' A' ' 133' ' ' ILE . 4.2 m -76.77 10.23 0.5 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.89 0 C-N-CA 123.818 0.847 . . . . 0.0 111.686 -178.43 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 179.25 174.0 44.96 Favored Glycine 0 CA--C 1.529 0.934 0 C-N-CA 125.837 1.684 . . . . 0.0 109.592 -175.478 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 5.0 tp -68.29 134.86 51.02 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-N 118.557 1.179 . . . . 0.0 111.089 178.094 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -96.28 107.64 20.02 Favored 'General case' 0 N--CA 1.442 -0.836 0 C-N-CA 125.367 1.467 . . . . 0.0 108.982 172.557 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 89.6 mt . . . . . 0 C--O 1.233 0.225 0 N-CA-C 108.096 -1.076 . . . . 0.0 108.096 168.742 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 12.4 m . . . . . 0 CA--C 1.536 0.438 0 N-CA-C 110.719 -0.104 . . . . 0.0 110.719 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -67.51 -39.85 85.14 Favored 'General case' 0 N--CA 1.464 0.258 0 C-N-CA 123.081 0.553 . . . . 0.0 110.853 173.224 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 28.5 tt0 -65.97 -43.33 88.22 Favored 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 124.334 1.054 . . . . 0.0 111.008 -178.326 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.6 -39.93 74.42 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 123.251 0.621 . . . . 0.0 109.475 177.383 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 53.7 mt -70.91 -54.23 18.61 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 N-CA-C 108.277 -1.008 . . . . 0.0 108.277 176.8 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 71.7 tp60 -50.51 -62.32 1.66 Allowed 'General case' 0 N--CA 1.463 0.181 0 C-N-CA 125.183 1.393 . . . . 0.0 111.97 -174.359 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 19.9 m -68.23 -31.98 71.86 Favored 'General case' 0 C--N 1.324 -0.543 0 C-N-CA 121.273 -0.171 . . . . 0.0 110.84 -169.716 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 160' ' ' TRP . . . . . . . . . . . . . 48.7 t90 -66.04 -47.3 74.81 Favored 'General case' 0 C--O 1.223 -0.304 0 O-C-N 122.157 -0.339 . . . . 0.0 110.71 173.388 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 65.5 m -59.93 -43.14 95.13 Favored 'General case' 0 N--CA 1.455 -0.195 0 C-N-CA 122.956 0.503 . . . . 0.0 110.408 -178.554 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -63.16 -40.26 97.03 Favored 'General case' 0 N--CA 1.455 -0.22 0 N-CA-C 110.223 -0.288 . . . . 0.0 110.223 176.995 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 16.6 tt0 -65.85 -51.62 57.29 Favored 'General case' 0 N--CA 1.446 -0.64 0 CA-C-O 118.787 -0.625 . . . . 0.0 110.122 -179.228 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 39.4 pt -63.5 -38.0 81.07 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.377 0 CA-C-O 117.909 -1.043 . . . . 0.0 109.667 -175.212 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -63.74 -36.07 82.66 Favored 'General case' 0 C--O 1.225 -0.225 0 CA-C-N 119.351 0.978 . . . . 0.0 109.833 179.526 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 28.4 m-80 -68.28 -52.59 32.03 Favored 'General case' 0 CA--C 1.515 -0.4 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 175.808 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 15.2 tt0 -70.69 -26.76 63.57 Favored 'General case' 0 N--CA 1.443 -0.786 0 C-N-CA 124.381 1.073 . . . . 0.0 111.504 -168.767 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 168' ' ' MET . . . . . . . . . . . . . 17.1 ptp -79.58 -30.5 41.63 Favored 'General case' 0 C--O 1.227 -0.104 0 O-C-N 120.808 -1.182 . . . . 0.0 112.219 171.699 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -79.75 -40.54 28.55 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 122.923 0.489 . . . . 0.0 111.156 -178.223 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.534 0.361 0 C-N-CA 124.342 1.057 . . . . 0.0 110.532 -178.57 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 53.6 ttp . . . . . 0 N--CA 1.497 1.905 0 N-CA-C 110.002 -0.37 . . . . 0.0 110.002 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 10.4 t30 -141.44 152.11 43.98 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 124.908 1.283 . . . . 0.0 107.639 174.681 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 11.8 mtt -113.84 121.46 44.08 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 123.246 0.618 . . . . 0.0 111.136 -175.79 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 4' ' ' GLY . . . . . 0.407 ' HA3' ' CD2' ' A' ' 46' ' ' TYR . . . -80.47 155.51 37.8 Favored Glycine 0 CA--C 1.521 0.41 0 N-CA-C 107.606 -2.198 . . . . 0.0 107.606 166.912 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 2.5 tt -141.47 96.01 2.92 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 105.805 -1.924 . . . . 0.0 105.805 -176.517 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -102.71 143.45 32.35 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-O 121.691 0.758 . . . . 0.0 112.142 -170.454 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 30.2 p90 . . . . . 0 N--CA 1.451 -0.384 0 C-N-CA 126.81 2.044 . . . . 0.0 107.278 177.016 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 0.239 0 N-CA-C 109.438 -0.578 . . . . 0.0 109.438 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -63.87 -46.43 84.95 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 123.728 0.811 . . . . 0.0 111.514 -176.822 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 26.5 mt-10 -58.44 -43.96 88.96 Favored 'General case' 0 CA--C 1.517 -0.303 0 C-N-CA 123.51 0.724 . . . . 0.0 109.843 174.559 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 51.2 mttm -65.1 -47.2 78.05 Favored 'General case' 0 C--O 1.222 -0.359 0 CA-C-O 118.725 -0.655 . . . . 0.0 109.984 -178.613 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 43.0 mt -52.88 -54.81 14.71 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.214 0 CA-C-N 119.024 0.829 . . . . 0.0 109.62 179.807 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.465 ' HG2' HD21 ' A' ' 32' ' ' LEU . 0.0 OUTLIER -66.45 -35.8 81.2 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 118.374 0.533 . . . . 0.0 111.257 -175.372 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -64.35 -40.41 95.8 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.855 0.359 . . . . 0.0 110.592 178.582 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 62.6 mt -78.41 -54.01 12.89 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.548 0 C-N-CA 124.674 1.19 . . . . 0.0 110.038 -170.301 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 69.5 mt -62.71 -47.51 92.54 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 178.552 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 142.33 122.59 1.77 Allowed Glycine 0 CA--C 1.528 0.903 0 C-N-CA 124.646 1.117 . . . . 0.0 110.78 177.133 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -71.87 -11.18 27.32 Favored 'Trans proline' 0 CA--C 1.537 0.666 0 C-N-CA 122.885 2.39 . . . . 0.0 113.248 -170.262 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -79.96 -18.24 50.92 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 118.844 0.747 . . . . 0.0 111.953 -179.753 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -126.89 5.82 6.61 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 125.085 1.354 . . . . 0.0 113.555 -172.618 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 36.8 t -123.91 148.63 27.97 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.518 0 C-N-CA 124.85 1.26 . . . . 0.0 107.872 172.221 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 20.3 m -134.85 131.12 37.03 Favored 'General case' 0 C--N 1.332 -0.186 0 C-N-CA 125.519 1.528 . . . . 0.0 107.851 -175.267 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.465 HD21 ' HG2' ' A' ' 22' ' ' ARG . 20.9 mt -79.72 139.68 37.23 Favored 'General case' 0 C--O 1.232 0.17 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 177.873 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 18.0 t-80 -137.22 54.8 1.84 Allowed 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 124.177 0.991 . . . . 0.0 108.936 -173.419 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 37.8 t-20 -57.27 123.13 14.29 Favored 'General case' 0 N--CA 1.465 0.283 0 N-CA-C 106.367 -1.716 . . . . 0.0 106.367 168.629 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 31.3 mt -70.75 -31.79 68.72 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 118.661 0.664 . . . . 0.0 112.472 -169.072 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 57.7 tptt -58.96 -24.58 62.74 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 124.2 1.0 . . . . 0.0 110.355 169.765 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -95.73 -33.6 12.24 Favored 'General case' 0 C--O 1.236 0.376 0 N-CA-C 113.566 0.95 . . . . 0.0 113.566 -177.049 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 4.4 t0 -147.54 149.8 33.3 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 119.459 1.027 . . . . 0.0 113.18 178.33 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 15.7 m -71.66 158.43 87.86 Favored Pre-proline 0 CA--C 1.541 0.615 0 C-N-CA 126.236 1.814 . . . . 0.0 112.607 -168.92 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -73.53 -25.6 14.92 Favored 'Trans proline' 0 C--N 1.35 0.611 0 C-N-CA 122.467 2.111 . . . . 0.0 113.935 -173.251 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 8.6 mptt -62.4 -20.45 64.47 Favored 'General case' 0 N--CA 1.475 0.786 0 CA-C-N 120.403 1.456 . . . . 0.0 111.912 -179.587 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -58.14 -29.82 65.85 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 125.552 1.541 . . . . 0.0 110.723 173.347 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 50.4 mtt -60.87 -25.93 67.04 Favored 'General case' 0 C--N 1.339 0.151 0 C-N-CA 123.388 0.675 . . . . 0.0 111.428 178.662 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 61.2 mt-10 -64.84 -35.49 81.28 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-N 118.371 0.532 . . . . 0.0 109.717 -178.445 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 13.5 mt-30 -67.78 -46.04 73.1 Favored 'General case' 0 C--N 1.34 0.159 0 C-N-CA 123.65 0.78 . . . . 0.0 111.836 -171.519 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' TYR . . . . . 0.407 ' CD2' ' HA3' ' A' ' 4' ' ' GLY . 17.5 m-85 -69.54 133.55 47.79 Favored 'General case' 0 CA--C 1.521 -0.159 0 CA-C-N 115.424 -0.807 . . . . 0.0 109.235 -167.372 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -75.4 -31.8 60.55 Favored 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 120.361 -0.535 . . . . 0.0 110.86 -176.187 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 20.8 t -109.54 146.08 15.42 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.368 0 N-CA-C 106.717 -1.586 . . . . 0.0 106.717 168.789 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 27.5 tp -133.08 115.77 15.51 Favored 'General case' 0 N--CA 1.445 -0.696 0 N-CA-C 108.439 -0.948 . . . . 0.0 108.439 174.427 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 23.4 mt -94.6 135.88 27.52 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.63 0 N-CA-C 107.045 -1.465 . . . . 0.0 107.045 177.396 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.513 ' CD2' HD12 ' A' ' 104' ' ' LEU . 0.8 OUTLIER -119.45 131.43 55.62 Favored 'General case' 0 CA--C 1.514 -0.418 0 C-N-CA 125.234 1.413 . . . . 0.0 107.324 -174.466 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -132.64 129.77 5.61 Favored Glycine 0 CA--C 1.519 0.295 0 N-CA-C 110.318 -1.113 . . . . 0.0 110.318 175.036 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 5.8 tt -152.25 133.52 8.0 Favored Pre-proline 0 CA--C 1.541 0.616 0 CA-C-N 118.134 0.967 . . . . 0.0 110.18 169.484 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_exo . . . . . 0 N--CA 1.46 -0.481 0 C-N-CA 122.824 2.349 . . . . 0.0 112.2 167.704 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 17.5 mt . . . . . 0 CA--C 1.545 0.781 0 CA-C-O 121.469 0.652 . . . . 0.0 110.669 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 12.7 mp0 -66.61 146.65 54.26 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 125.578 1.551 . . . . 0.0 108.661 178.544 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -59.11 -42.01 89.53 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 122.906 0.483 . . . . 0.0 110.239 -179.386 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -58.8 -29.55 66.94 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 124.16 0.984 . . . . 0.0 112.043 178.512 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' TRP . . . . . 0.679 ' CH2' HD23 ' A' ' 104' ' ' LEU . 15.9 t90 -87.22 -45.23 10.83 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 124.303 1.041 . . . . 0.0 109.948 179.828 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -61.59 -35.79 78.85 Favored 'General case' 0 CA--C 1.537 0.46 0 O-C-N 120.903 -1.123 . . . . 0.0 109.656 179.851 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -59.6 -25.11 64.35 Favored 'General case' 0 C--O 1.235 0.313 0 C-N-CA 123.951 0.901 . . . . 0.0 111.473 -179.279 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 11.0 m -109.91 -15.65 9.54 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.295 0 CA-C-O 117.478 -1.249 . . . . 0.0 112.732 178.059 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 24.2 t90 -54.76 -38.31 67.05 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-N 120.042 1.292 . . . . 0.0 109.961 178.78 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -65.91 -27.63 68.33 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 125.342 1.457 . . . . 0.0 112.857 175.638 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 69.4 mt-30 -89.19 -25.05 21.99 Favored 'General case' 0 CA--C 1.514 -0.437 0 C-N-CA 125.417 1.487 . . . . 0.0 111.555 -177.154 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.556 ' CD1' HD21 ' A' ' 104' ' ' LEU . 48.2 mt -57.82 -32.02 67.18 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 118.846 0.748 . . . . 0.0 110.255 173.71 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -69.71 -28.03 65.48 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 122.995 0.518 . . . . 0.0 111.457 173.581 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -80.74 -34.62 34.26 Favored 'General case' 0 CA--C 1.538 0.492 0 N-CA-C 113.199 0.814 . . . . 0.0 113.199 176.846 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 21.6 mt -59.76 148.58 33.79 Favored 'General case' 0 N--CA 1.463 0.207 0 C-N-CA 124.44 1.096 . . . . 0.0 111.758 -173.421 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -82.62 114.4 20.98 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 169.667 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 76.8 mt -129.74 1.07 4.9 Favored 'General case' 0 N--CA 1.475 0.815 0 N-CA-C 113.254 0.835 . . . . 0.0 113.254 -172.982 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 32.7 mt-10 -56.8 133.16 54.07 Favored 'General case' 0 C--O 1.235 0.342 0 CA-C-O 122.122 0.963 . . . . 0.0 111.647 -168.644 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 75.07 -3.87 43.05 Favored Glycine 0 CA--C 1.534 1.263 0 C-N-CA 125.483 1.516 . . . . 0.0 114.976 176.499 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.29 149.75 40.54 Favored 'General case' 0 C--N 1.344 0.357 0 CA-C-N 120.574 2.187 . . . . 0.0 110.114 -175.597 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 5.1 mt -80.71 136.69 22.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 N-CA-C 106.344 -1.724 . . . . 0.0 106.344 178.415 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 64.9 t -130.59 128.65 63.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 C-N-CA 123.556 0.742 . . . . 0.0 109.819 -177.2 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -99.57 145.13 27.86 Favored 'General case' 0 CA--C 1.52 -0.184 0 N-CA-C 107.948 -1.13 . . . . 0.0 107.948 168.442 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 10.5 mt -124.79 132.48 53.34 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 107.406 -1.331 . . . . 0.0 107.406 176.44 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 33.7 p90 -148.69 165.06 32.48 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 168.253 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -165.37 172.46 40.94 Favored Glycine 0 N--CA 1.443 -0.85 0 N-CA-C 109.894 -1.283 . . . . 0.0 109.894 172.512 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 6.6 tt . . . . . 0 N--CA 1.447 -0.608 0 C-N-CA 125.979 1.712 . . . . 0.0 107.694 -179.922 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 92.3 mt . . . . . 0 N--CA 1.468 0.453 0 N-CA-C 114.23 1.196 . . . . 0.0 114.23 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -64.24 -33.4 75.73 Favored 'General case' 0 C--N 1.331 -0.228 0 O-C-N 120.661 -1.274 . . . . 0.0 110.872 -175.329 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -71.18 -29.43 65.17 Favored 'General case' 0 CA--C 1.535 0.394 0 O-C-N 121.731 -0.606 . . . . 0.0 111.911 175.485 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 5.4 tt -62.4 -45.31 93.72 Favored 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 108.026 -1.102 . . . . 0.0 108.026 169.64 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -64.04 -39.93 97.7 Favored Glycine 0 C--N 1.34 0.765 0 N-CA-C 111.149 -0.78 . . . . 0.0 111.149 -178.707 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 71.6 mtm -66.4 -35.42 80.28 Favored 'General case' 0 CA--C 1.529 0.166 0 CA-C-O 118.206 -0.902 . . . . 0.0 111.904 177.468 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.679 HD23 ' CH2' ' A' ' 65' ' ' TRP . 0.2 OUTLIER -72.89 -36.45 67.34 Favored 'General case' 0 C--N 1.342 0.265 0 CA-C-N 120.768 1.622 . . . . 0.0 110.811 176.234 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 1.8 t60 -54.04 -52.86 59.51 Favored 'General case' 0 CA--C 1.531 0.214 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 169.61 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -63.04 -41.62 99.55 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 123.79 0.836 . . . . 0.0 112.321 -175.239 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 1.7 tppm? -54.77 -27.87 44.53 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 125.72 1.608 . . . . 0.0 111.309 171.488 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 40.4 mt -106.94 -17.72 14.11 Favored 'General case' 0 CA--C 1.519 -0.214 0 N-CA-C 115.228 1.566 . . . . 0.0 115.228 -173.408 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -60.24 -37.11 79.36 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 121.008 1.731 . . . . 0.0 110.977 -172.611 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 16.3 p -81.25 -13.6 58.34 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 125.53 1.532 . . . . 0.0 111.833 -179.772 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 31.8 mmmt -84.8 -5.87 59.34 Favored 'General case' 0 C--N 1.344 0.328 0 C-N-CA 124.955 1.302 . . . . 0.0 111.691 178.702 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 72.76 31.33 62.61 Favored Glycine 0 CA--C 1.523 0.549 0 CA-C-N 118.399 0.545 . . . . 0.0 112.401 169.498 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 14.5 m -75.59 176.59 0.64 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.638 0 CA-C-N 118.163 0.981 . . . . 0.0 109.677 171.992 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -118.03 126.54 52.48 Favored 'General case' 0 CA--C 1.518 -0.265 0 N-CA-C 106.628 -1.619 . . . . 0.0 106.628 173.127 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 62.2 m-85 -91.96 143.29 26.63 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 119.847 1.203 . . . . 0.0 109.805 -177.064 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 35.1 m -131.6 160.88 42.05 Favored 'Isoleucine or valine' 0 C--O 1.235 0.335 0 C-N-CA 125.947 1.699 . . . . 0.0 107.334 169.314 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 84.96 28.68 30.72 Favored Glycine 0 CA--C 1.52 0.392 0 CA-C-O 118.509 -1.162 . . . . 0.0 114.133 172.999 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 20.8 m-30 -60.87 157.02 16.02 Favored 'General case' 0 CA--C 1.543 0.675 0 CA-C-N 118.809 1.305 . . . . 0.0 109.475 168.494 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 46.5 t-105 -134.15 142.05 41.72 Favored Pre-proline 0 N--CA 1.467 0.403 0 CA-C-O 118.608 -0.711 . . . . 0.0 109.719 -170.577 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -70.1 132.64 23.2 Favored 'Trans proline' 0 N--CA 1.458 -0.588 0 C-N-CA 122.576 2.184 . . . . 0.0 111.728 -171.197 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 20.8 p . . . . . 0 N--CA 1.473 0.677 0 C-N-CA 124.519 1.128 . . . . 0.0 113.778 -179.757 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 22.2 ttmt . . . . . 0 CA--C 1.545 0.773 0 CA-C-O 116.938 -1.506 . . . . 0.0 115.016 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 66.7 Cg_endo -79.23 2.11 8.6 Favored 'Trans proline' 0 C--N 1.353 0.798 0 CA-C-N 122.807 2.038 . . . . 0.0 114.065 -177.862 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.416 HG12 ' HA ' ' A' ' 139' ' ' PHE . 17.2 m -129.15 169.49 20.35 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 119.767 1.167 . . . . 0.0 110.274 -173.887 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 20.5 pt -122.34 163.92 20.14 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.012 0 C-N-CA 126.493 1.917 . . . . 0.0 108.881 172.778 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . 55.33 -154.09 0.31 Allowed 'General case' 0 N--CA 1.446 -0.649 0 C-N-CA 124.369 1.067 . . . . 0.0 108.391 -178.784 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 24.8 t0 -80.18 52.72 1.61 Allowed 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 125.082 1.353 . . . . 0.0 111.017 -179.154 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 63.82 32.16 83.25 Favored Glycine 0 CA--C 1.529 0.923 0 C-N-CA 124.065 0.84 . . . . 0.0 111.662 -174.518 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 1.3 tt0 -90.24 -24.76 20.87 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 124.711 1.205 . . . . 0.0 111.664 -169.163 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -145.54 146.14 31.3 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 119.2 0.909 . . . . 0.0 110.091 169.656 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 139' ' ' PHE . . . . . 0.416 ' HA ' HG12 ' A' ' 132' ' ' VAL . 49.1 m-85 -74.15 139.38 44.46 Favored 'General case' 0 CA--C 1.508 -0.641 0 N-CA-C 104.393 -2.447 . . . . 0.0 104.393 165.947 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 9.9 p -77.73 6.89 0.86 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.768 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.263 -177.932 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -172.71 175.28 45.79 Favored Glycine 0 CA--C 1.532 1.109 0 C-N-CA 125.349 1.452 . . . . 0.0 110.069 175.951 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 3.9 tp -65.79 144.68 56.71 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 118.285 1.043 . . . . 0.0 111.271 177.687 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -114.97 117.7 31.37 Favored 'General case' 0 N--CA 1.448 -0.565 0 C-N-CA 126.63 1.972 . . . . 0.0 109.826 -179.632 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 79.9 mt . . . . . 0 N--CA 1.468 0.46 0 C-N-CA 124.856 1.263 . . . . 0.0 108.087 170.274 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 70.7 m . . . . . 0 CA--C 1.533 0.307 0 CA-C-O 118.962 -0.542 . . . . 0.0 110.777 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -60.02 -42.11 93.64 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 118.966 0.803 . . . . 0.0 111.307 175.22 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 67.8 mm-40 -69.4 -46.05 67.78 Favored 'General case' 0 CA--C 1.515 -0.386 0 C-N-CA 125.763 1.625 . . . . 0.0 109.944 -178.101 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 67.3 mtt180 -61.55 -46.04 91.61 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 118.228 -0.891 . . . . 0.0 109.701 178.673 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 41.7 mt -61.93 -51.01 77.67 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.204 0 N-CA-C 108.285 -1.006 . . . . 0.0 108.285 176.779 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 66.6 tp60 -48.93 -65.57 0.55 Allowed 'General case' 0 C--O 1.236 0.359 0 C-N-CA 124.527 1.131 . . . . 0.0 111.21 179.972 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 29.5 m -70.73 -28.18 64.52 Favored 'General case' 0 C--N 1.321 -0.653 0 C-N-CA 120.625 -0.43 . . . . 0.0 111.477 -169.24 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 160' ' ' TRP . . . . . . . . . . . . . 57.4 t90 -66.76 -45.92 77.01 Favored 'General case' 0 CA--C 1.518 -0.254 0 CA-C-N 118.791 0.723 . . . . 0.0 111.087 171.532 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 60.4 m -60.64 -43.16 97.9 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 118.262 0.483 . . . . 0.0 110.088 -179.068 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -61.46 -41.59 97.47 Favored 'General case' 0 N--CA 1.455 -0.203 0 CA-C-O 120.984 0.421 . . . . 0.0 110.36 175.201 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 16.3 tt0 -64.84 -51.17 63.54 Favored 'General case' 0 N--CA 1.447 -0.601 0 O-C-N 121.691 -0.631 . . . . 0.0 110.129 -178.413 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 43.4 pt -63.88 -37.55 80.04 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.388 0 CA-C-O 118.174 -0.917 . . . . 0.0 109.703 -175.583 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -64.42 -35.2 80.14 Favored 'General case' 0 CA--C 1.529 0.16 0 CA-C-N 119.247 0.93 . . . . 0.0 109.98 179.66 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 34.9 m-80 -68.56 -50.87 48.54 Favored 'General case' 0 N--CA 1.467 0.382 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 174.118 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 21.9 tt0 -71.11 -25.8 62.75 Favored 'General case' 0 N--CA 1.44 -0.957 0 C-N-CA 125.194 1.398 . . . . 0.0 111.946 -168.747 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 168' ' ' MET . . . . . . . . . . . . . 18.9 ptp -82.05 -31.26 30.98 Favored 'General case' 0 C--O 1.231 0.125 0 O-C-N 121.4 -0.813 . . . . 0.0 112.07 171.052 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -77.77 -36.35 50.62 Favored 'General case' 0 N--CA 1.448 -0.557 0 O-C-N 122.108 -0.37 . . . . 0.0 111.037 -178.419 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 . . . . . 0 CA--C 1.537 0.452 0 O-C-N 121.862 -0.524 . . . . 0.0 110.611 177.209 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 45.7 ttp . . . . . 0 N--CA 1.495 1.8 0 N-CA-C 110.239 -0.282 . . . . 0.0 110.239 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 7.4 t30 -120.48 150.02 41.48 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 124.198 0.999 . . . . 0.0 109.249 172.526 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 20.0 mtt -112.31 125.59 54.34 Favored 'General case' 0 CA--C 1.523 -0.069 0 C-N-CA 123.602 0.761 . . . . 0.0 110.774 -176.451 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -85.28 152.88 27.17 Favored Glycine 0 CA--C 1.524 0.597 0 N-CA-C 106.799 -2.521 . . . . 0.0 106.799 166.41 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 2.1 tt -140.19 96.67 3.09 Favored 'General case' 0 CA--C 1.517 -0.32 0 N-CA-C 105.274 -2.121 . . . . 0.0 105.274 -175.545 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -100.12 141.37 33.04 Favored 'General case' 0 CA--C 1.519 -0.237 0 CA-C-O 121.405 0.621 . . . . 0.0 111.834 -173.519 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 29.3 p90 . . . . . 0 C--N 1.327 -0.376 0 C-N-CA 127.464 2.306 . . . . 0.0 106.325 -178.792 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.225 -0.234 0 CA-C-O 119.331 -0.366 . . . . 0.0 110.582 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -62.31 -49.33 76.07 Favored 'General case' 0 N--CA 1.461 0.098 0 C-N-CA 123.096 0.559 . . . . 0.0 111.87 -178.315 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 7.1 mt-10 -61.45 -41.07 96.63 Favored 'General case' 0 CA--C 1.518 -0.256 0 O-C-N 121.875 -0.516 . . . . 0.0 110.032 176.086 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 30.2 mtpp -70.31 -43.24 70.75 Favored 'General case' 0 C--O 1.221 -0.4 0 CA-C-O 118.603 -0.713 . . . . 0.0 110.622 -173.991 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 43.4 mt -52.87 -55.41 11.98 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.206 0 CA-C-N 119.492 1.042 . . . . 0.0 108.587 173.53 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 5.0 ttp180 -59.6 -42.1 91.83 Favored 'General case' 0 C--O 1.224 -0.273 0 C-N-CA 123.253 0.621 . . . . 0.0 109.618 -176.256 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -65.13 -40.92 95.13 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 123.21 0.604 . . . . 0.0 111.447 -179.498 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 54.3 mt -74.14 -54.42 14.94 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.537 0 C-N-CA 124.794 1.238 . . . . 0.0 110.139 -172.385 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 73.6 mt -64.3 -46.22 93.83 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 179.03 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 139.16 125.65 2.3 Favored Glycine 0 CA--C 1.533 1.179 0 C-N-CA 125.263 1.411 . . . . 0.0 111.733 172.546 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -70.51 -8.65 24.11 Favored 'Trans proline' 0 CA--C 1.535 0.562 0 C-N-CA 123.499 2.799 . . . . 0.0 113.668 -175.584 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -74.26 -21.92 59.55 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 119.007 0.821 . . . . 0.0 111.624 175.385 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -131.83 2.86 4.07 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 124.514 1.125 . . . . 0.0 113.893 -170.454 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 34.5 t -121.61 149.72 24.79 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.393 0 C-N-CA 124.619 1.168 . . . . 0.0 108.051 171.173 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 31.1 m -137.46 130.44 30.45 Favored 'General case' 0 N--CA 1.456 -0.165 0 C-N-CA 126.043 1.737 . . . . 0.0 106.689 -172.379 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 26.3 mt -79.36 141.22 37.12 Favored 'General case' 0 C--O 1.233 0.19 0 N-CA-C 107.826 -1.176 . . . . 0.0 107.826 176.859 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 34.1 t-80 -132.13 64.9 1.59 Allowed 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 107.393 -1.336 . . . . 0.0 107.393 -177.236 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 65.1 t-20 -73.07 115.11 12.0 Favored 'General case' 0 C--O 1.235 0.29 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 -177.326 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.403 HD13 ' CG2' ' A' ' 68' ' ' VAL . 87.0 mt -67.85 -12.41 60.58 Favored 'General case' 0 CA--C 1.532 0.284 0 N-CA-C 112.959 0.725 . . . . 0.0 112.959 -175.86 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -57.47 -26.14 60.8 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 118.746 0.703 . . . . 0.0 110.66 168.325 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -130.14 -40.43 1.31 Allowed 'General case' 0 N--CA 1.466 0.342 0 N-CA-C 113.558 0.947 . . . . 0.0 113.558 -173.957 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 33.0 m-20 -87.32 141.42 28.65 Favored 'General case' 0 C--O 1.236 0.357 0 C-N-CA 123.33 0.652 . . . . 0.0 110.139 -176.018 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 12.9 m -78.42 156.15 78.64 Favored Pre-proline 0 CA--C 1.542 0.666 0 C-N-CA 124.214 1.006 . . . . 0.0 110.291 177.556 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -77.34 -25.22 8.57 Favored 'Trans proline' 0 C--N 1.35 0.625 0 C-N-CA 122.01 1.807 . . . . 0.0 113.589 -171.232 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 3.7 mptp? -60.94 -22.19 64.17 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-N 119.976 1.262 . . . . 0.0 112.088 -179.874 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -60.49 -28.34 68.27 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 125.945 1.698 . . . . 0.0 110.764 174.773 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 57.1 mtt -58.87 -26.28 64.09 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 118.64 0.654 . . . . 0.0 111.254 178.376 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -65.06 -33.82 76.96 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 118.427 0.558 . . . . 0.0 110.759 -176.461 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 14.4 mt-30 -67.24 -43.61 81.55 Favored 'General case' 0 CA--C 1.531 0.228 0 N-CA-C 113.589 0.959 . . . . 0.0 113.589 -168.907 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 31.1 m-85 -71.17 145.9 49.44 Favored 'General case' 0 CA--C 1.527 0.067 0 CA-C-N 115.488 -0.778 . . . . 0.0 111.634 -165.331 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 41.4 m-20 -75.22 -38.48 60.63 Favored 'General case' 0 N--CA 1.47 0.541 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 -176.833 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.407 HG21 ' SD ' ' A' ' 168' ' ' MET . 17.7 t -112.64 147.41 16.37 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.279 0 N-CA-C 106.828 -1.545 . . . . 0.0 106.828 169.843 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 26.2 tp -129.45 110.22 11.7 Favored 'General case' 0 N--CA 1.447 -0.586 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 172.255 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 23.3 mt -86.67 132.25 32.78 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.583 0 N-CA-C 106.719 -1.586 . . . . 0.0 106.719 174.998 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 2.5 mp -111.93 124.93 53.44 Favored 'General case' 0 CA--C 1.519 -0.238 0 N-CA-C 106.886 -1.524 . . . . 0.0 106.886 -179.081 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -119.96 133.07 9.74 Favored Glycine 0 N--CA 1.451 -0.318 0 N-CA-C 108.994 -1.642 . . . . 0.0 108.994 171.248 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 5.1 tt -152.57 131.42 6.6 Favored Pre-proline 0 CA--C 1.531 0.234 0 CA-C-N 117.765 0.783 . . . . 0.0 109.746 168.766 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_exo . . . . . 0 N--CA 1.455 -0.762 0 C-N-CA 121.898 1.732 . . . . 0.0 112.87 169.063 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 4.8 mt . . . . . 0 CA--C 1.547 0.833 0 CA-C-O 120.18 0.038 . . . . 0.0 110.913 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -89.63 157.88 17.84 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 123.873 0.869 . . . . 0.0 110.356 172.499 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -52.66 -47.64 66.98 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 124.561 1.145 . . . . 0.0 112.994 -168.02 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -67.04 -22.52 65.87 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 119.274 0.943 . . . . 0.0 112.331 -170.883 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' TRP . . . . . 0.78 ' CH2' HD23 ' A' ' 104' ' ' LEU . 2.1 t90 -90.17 -42.12 11.23 Favored 'General case' 0 N--CA 1.456 -0.174 0 C-N-CA 124.468 1.107 . . . . 0.0 109.29 177.147 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 9.3 tt0 -62.55 -35.59 79.93 Favored 'General case' 0 N--CA 1.446 -0.625 0 O-C-N 121.081 -1.012 . . . . 0.0 109.927 178.697 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -58.94 -24.62 62.71 Favored 'General case' 0 C--O 1.234 0.254 0 C-N-CA 124.468 1.107 . . . . 0.0 111.643 -178.279 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.403 ' CG2' HD13 ' A' ' 35' ' ' LEU . 28.3 m -113.54 -13.41 11.39 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.324 0 CA-C-O 117.267 -1.349 . . . . 0.0 112.65 178.305 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 25.6 t90 -52.48 -39.88 61.69 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 120.396 1.453 . . . . 0.0 110.119 177.443 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -64.54 -25.69 68.09 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 125.253 1.421 . . . . 0.0 113.167 176.353 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 60.0 mt-30 -92.44 -17.0 25.16 Favored 'General case' 0 CA--C 1.52 -0.189 0 C-N-CA 125.697 1.599 . . . . 0.0 111.716 -178.971 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.601 HD12 HD21 ' A' ' 104' ' ' LEU . 14.7 mt -69.15 -19.32 64.01 Favored 'General case' 0 CA--C 1.531 0.219 0 O-C-N 121.204 -0.935 . . . . 0.0 111.37 -175.188 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -85.53 -22.21 28.24 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-O 118.994 -0.527 . . . . 0.0 111.192 169.489 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -70.72 -31.05 67.77 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-N 119.438 1.017 . . . . 0.0 111.887 172.05 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 25.5 mt -58.04 144.46 39.76 Favored 'General case' 0 C--O 1.234 0.264 0 C-N-CA 123.752 0.821 . . . . 0.0 112.007 -176.149 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 2.9 t30 -86.75 86.33 7.32 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 125.094 1.358 . . . . 0.0 107.489 173.049 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 3.7 pp -142.09 135.34 29.02 Favored 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 169.707 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -149.52 151.66 34.27 Favored 'General case' 0 N--CA 1.439 -0.992 0 C-N-CA 127.698 2.399 . . . . 0.0 104.835 169.412 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 72.18 -6.54 10.26 Favored Glycine 0 CA--C 1.534 1.26 0 N-CA-C 116.905 1.522 . . . . 0.0 116.905 169.687 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.46 161.51 29.73 Favored 'General case' 0 C--N 1.342 0.282 0 CA-C-N 120.21 2.005 . . . . 0.0 110.047 -175.756 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 3.6 mt -80.26 135.97 24.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 106.923 -1.51 . . . . 0.0 106.923 176.689 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 73.1 t -133.03 132.49 58.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 C-N-CA 123.53 0.732 . . . . 0.0 109.509 -177.12 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -104.01 154.71 19.36 Favored 'General case' 0 CA--C 1.519 -0.25 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 168.674 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 2.0 mt -135.58 138.77 43.31 Favored 'General case' 0 CA--C 1.513 -0.447 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 172.138 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 36.0 p90 -151.89 167.63 27.72 Favored 'General case' 0 N--CA 1.446 -0.647 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 169.617 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -168.49 154.26 23.92 Favored Glycine 0 N--CA 1.448 -0.544 0 N-CA-C 109.414 -1.474 . . . . 0.0 109.414 172.143 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 CA--C 1.519 -0.232 0 C-N-CA 123.171 0.588 . . . . 0.0 111.49 169.217 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 86.5 mt . . . . . 0 N--CA 1.469 0.495 0 N-CA-C 113.805 1.039 . . . . 0.0 113.805 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -58.09 -35.81 71.96 Favored 'General case' 0 C--N 1.33 -0.264 0 O-C-N 120.853 -1.155 . . . . 0.0 111.365 174.301 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -71.99 -30.47 65.28 Favored 'General case' 0 C--N 1.343 0.31 0 O-C-N 121.636 -0.665 . . . . 0.0 112.016 177.775 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 4.8 tt -61.68 -43.14 99.42 Favored 'General case' 0 CA--C 1.539 0.553 0 N-CA-C 107.94 -1.133 . . . . 0.0 107.94 169.243 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -64.06 -39.91 97.65 Favored Glycine 0 CA--C 1.527 0.795 0 CA-C-O 119.383 -0.676 . . . . 0.0 112.823 179.345 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 71.4 mtm -60.36 -38.34 83.54 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 119.163 1.481 . . . . 0.0 112.178 -176.604 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.78 HD23 ' CH2' ' A' ' 65' ' ' TRP . 0.1 OUTLIER -73.43 -34.72 65.59 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 119.221 0.919 . . . . 0.0 110.808 179.652 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 55.8 t-80 -61.29 -43.23 99.23 Favored 'General case' 0 C--O 1.232 0.14 0 O-C-N 121.681 -0.637 . . . . 0.0 110.262 174.758 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -64.54 -43.26 94.55 Favored 'General case' 0 C--O 1.234 0.239 0 C-N-CA 123.033 0.533 . . . . 0.0 111.393 -177.675 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 22.5 ttmm -55.43 -52.63 62.97 Favored 'General case' 0 N--CA 1.463 0.205 0 C-N-CA 123.204 0.602 . . . . 0.0 109.863 170.904 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 35.7 mt -77.62 -20.41 53.94 Favored 'General case' 0 CA--C 1.517 -0.297 0 N-CA-C 114.195 1.183 . . . . 0.0 114.195 -168.188 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 61.2 m -61.22 -33.37 73.39 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 119.353 0.979 . . . . 0.0 110.75 -179.672 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 40.3 p -87.59 -19.04 28.36 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 123.446 0.699 . . . . 0.0 111.16 179.581 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 20.5 mmmt -71.92 -19.87 61.85 Favored 'General case' 0 N--CA 1.468 0.47 0 O-C-N 121.576 -0.703 . . . . 0.0 109.654 167.738 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 76.21 38.02 35.53 Favored Glycine 0 C--N 1.337 0.63 0 C-N-CA 123.846 0.736 . . . . 0.0 111.655 173.811 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 9.6 m -71.57 172.58 0.95 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.581 0 CA-C-N 118.752 1.276 . . . . 0.0 109.755 171.094 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -106.49 125.1 50.58 Favored 'General case' 0 CA--C 1.517 -0.295 0 N-CA-C 106.361 -1.718 . . . . 0.0 106.361 172.348 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 78.1 m-85 -92.91 145.41 24.4 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 119.481 1.037 . . . . 0.0 109.916 -178.015 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 35.5 m -131.74 157.84 43.21 Favored 'Isoleucine or valine' 0 C--O 1.234 0.282 0 C-N-CA 125.187 1.395 . . . . 0.0 107.703 169.569 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 84.02 31.46 25.99 Favored Glycine 0 CA--C 1.524 0.628 0 CA-C-O 118.596 -1.113 . . . . 0.0 114.835 169.837 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 13.6 m-30 -63.59 160.5 16.56 Favored 'General case' 0 CA--C 1.545 0.785 0 CA-C-N 119.257 1.529 . . . . 0.0 109.417 168.784 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 48.2 t-105 -138.84 148.15 57.03 Favored Pre-proline 0 N--CA 1.47 0.561 0 CA-C-O 118.12 -0.943 . . . . 0.0 111.432 -168.236 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -67.52 130.33 22.01 Favored 'Trans proline' 0 CA--C 1.536 0.588 0 C-N-CA 123.345 2.697 . . . . 0.0 112.352 -179.413 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 22.6 p . . . . . 0 N--CA 1.474 0.771 0 C-N-CA 125.679 1.591 . . . . 0.0 112.392 170.988 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 15.2 ttmt . . . . . 0 CA--C 1.543 0.708 0 N-CA-C 115.795 1.776 . . . . 0.0 115.795 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_endo -70.66 -11.45 29.68 Favored 'Trans proline' 0 C--N 1.352 0.751 0 CA-C-N 122.345 1.873 . . . . 0.0 114.365 179.651 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 30.9 m -132.51 171.34 18.27 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.428 0 CA-C-N 119.638 1.108 . . . . 0.0 112.874 -167.205 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 14.7 pt -138.56 173.92 11.21 Favored 'Isoleucine or valine' 0 C--O 1.236 0.384 0 C-N-CA 127.985 2.514 . . . . 0.0 108.348 -178.747 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . 55.77 40.0 30.76 Favored 'General case' 0 N--CA 1.463 0.224 0 C-N-CA 125.306 1.442 . . . . 0.0 112.615 174.068 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 27.3 t0 56.0 42.57 28.41 Favored 'General case' 0 C--N 1.324 -0.536 0 C-N-CA 125.998 1.719 . . . . 0.0 111.498 -176.159 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 87.26 21.43 48.99 Favored Glycine 0 CA--C 1.528 0.874 0 CA-C-N 115.211 -0.904 . . . . 0.0 113.541 174.129 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 44.7 mt-30 -97.54 -6.22 34.05 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 118.804 1.302 . . . . 0.0 112.781 -178.844 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 8.1 tp -154.21 147.23 24.56 Favored 'General case' 0 C--N 1.344 0.369 0 CA-C-N 119.618 1.099 . . . . 0.0 110.691 169.579 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 54.7 m-85 -80.76 150.63 29.19 Favored 'General case' 0 CA--C 1.52 -0.18 0 C-N-CA 124.19 0.996 . . . . 0.0 108.695 169.944 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 15.3 m -79.82 11.88 0.54 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.589 0 N-CA-C 112.977 0.732 . . . . 0.0 112.977 173.559 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 178.35 174.87 45.0 Favored Glycine 0 CA--C 1.526 0.755 0 N-CA-C 110.485 -1.046 . . . . 0.0 110.485 -178.44 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 3.5 tp -65.63 133.66 51.62 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 118.471 1.135 . . . . 0.0 110.51 177.758 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -99.62 113.66 26.24 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 125.147 1.379 . . . . 0.0 108.927 173.545 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 69.0 mt . . . . . 0 CA--C 1.534 0.347 0 C-N-CA 125.309 1.444 . . . . 0.0 107.983 169.731 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 13.8 m . . . . . 0 CA--C 1.534 0.343 0 N-CA-C 109.97 -0.381 . . . . 0.0 109.97 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -63.85 -42.46 97.57 Favored 'General case' 0 N--CA 1.465 0.283 0 O-C-N 121.784 -0.572 . . . . 0.0 111.166 173.586 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 -65.4 -42.41 92.63 Favored 'General case' 0 N--CA 1.456 -0.165 0 C-N-CA 124.115 0.966 . . . . 0.0 110.68 177.79 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 73.9 mtt180 -62.46 -46.4 88.69 Favored 'General case' 0 N--CA 1.456 -0.146 0 CA-C-O 118.009 -0.996 . . . . 0.0 109.874 177.401 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 48.7 mt -60.54 -51.2 75.85 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.283 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 177.457 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 72.7 tp60 -53.15 -63.33 1.18 Allowed 'General case' 0 C--O 1.234 0.247 0 C-N-CA 124.3 1.04 . . . . 0.0 111.44 -177.442 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 35.9 m -67.63 -33.06 74.21 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 119.473 -0.298 . . . . 0.0 111.257 -171.092 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 160' ' ' TRP . . . . . . . . . . . . . 49.9 t90 -64.78 -46.96 79.88 Favored 'General case' 0 C--O 1.225 -0.189 0 CA-C-N 118.384 0.538 . . . . 0.0 110.447 173.794 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 55.1 m -60.32 -44.47 95.45 Favored 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 122.843 0.457 . . . . 0.0 110.653 -178.74 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -62.02 -39.17 91.37 Favored 'General case' 0 N--CA 1.456 -0.158 0 CA-C-O 120.946 0.403 . . . . 0.0 110.169 176.838 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 17.3 tt0 -66.89 -52.12 47.23 Favored 'General case' 0 N--CA 1.446 -0.641 0 O-C-N 121.736 -0.602 . . . . 0.0 109.895 -178.779 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 43.4 pt -62.92 -37.49 79.4 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.397 0 CA-C-O 118.072 -0.966 . . . . 0.0 109.36 -175.433 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -64.99 -34.12 77.67 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 119.493 1.042 . . . . 0.0 110.2 -179.672 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 32.9 m-80 -69.48 -52.26 28.23 Favored 'General case' 0 N--CA 1.465 0.277 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 174.419 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 16.1 tt0 -70.73 -26.02 63.2 Favored 'General case' 0 N--CA 1.443 -0.802 0 C-N-CA 124.863 1.265 . . . . 0.0 111.741 -168.647 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 168' ' ' MET . . . . . 0.407 ' SD ' HG21 ' A' ' 48' ' ' VAL . 19.7 ptp -80.64 -32.78 36.1 Favored 'General case' 0 C--N 1.335 -0.03 0 O-C-N 121.117 -0.99 . . . . 0.0 112.051 171.354 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -77.41 -40.08 44.82 Favored 'General case' 0 N--CA 1.447 -0.624 0 O-C-N 122.19 -0.319 . . . . 0.0 110.747 -176.702 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 . . . . . 0 CA--C 1.539 0.533 0 C-N-CA 123.15 0.58 . . . . 0.0 110.719 177.729 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 51.4 ttp . . . . . 0 N--CA 1.498 1.933 0 N-CA-C 110.134 -0.321 . . . . 0.0 110.134 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 9.7 t30 -138.26 152.43 48.55 Favored 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 107.54 -1.281 . . . . 0.0 107.54 170.898 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 20.8 mtt -112.59 123.52 50.48 Favored 'General case' 0 C--N 1.331 -0.221 0 C-N-CA 123.052 0.541 . . . . 0.0 110.835 -176.16 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -83.55 150.55 27.05 Favored Glycine 0 CA--C 1.522 0.474 0 N-CA-C 106.43 -2.668 . . . . 0.0 106.43 166.401 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 2.2 tt -138.43 96.37 3.16 Favored 'General case' 0 CA--C 1.515 -0.388 0 N-CA-C 104.629 -2.36 . . . . 0.0 104.629 -176.877 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -101.0 142.22 32.79 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-O 121.951 0.881 . . . . 0.0 111.312 -171.398 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 45.7 p90 . . . . . 0 N--CA 1.446 -0.656 0 C-N-CA 126.319 1.848 . . . . 0.0 106.727 178.937 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.227 -0.109 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -63.1 -47.83 81.15 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 122.315 0.246 . . . . 0.0 111.174 -175.889 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.7 pp20? -70.42 -33.88 71.85 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-O 118.684 -0.674 . . . . 0.0 110.036 -178.647 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 42.5 mmtt -58.88 -51.39 70.25 Favored 'General case' 0 C--O 1.224 -0.269 0 CA-C-N 119.532 1.06 . . . . 0.0 110.74 171.086 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 34.2 mt -54.23 -54.7 19.16 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.271 0 CA-C-N 119.069 0.85 . . . . 0.0 109.619 -176.638 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.404 ' HG2' HD21 ' A' ' 32' ' ' LEU . 0.0 OUTLIER -64.55 -37.13 86.48 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-O 118.704 -0.665 . . . . 0.0 111.024 -177.128 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -64.3 -38.7 91.98 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 118.261 0.482 . . . . 0.0 110.455 179.786 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 68.7 mt -77.41 -54.52 12.58 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.624 0 C-N-CA 124.89 1.276 . . . . 0.0 110.263 -173.777 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 80.7 mt -62.03 -47.51 92.82 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 179.983 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 141.77 121.18 1.69 Allowed Glycine 0 CA--C 1.526 0.773 0 C-N-CA 125.147 1.356 . . . . 0.0 110.199 177.944 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -71.35 -9.63 25.64 Favored 'Trans proline' 0 CA--C 1.538 0.683 0 C-N-CA 123.055 2.504 . . . . 0.0 113.458 -171.476 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -81.46 -16.75 51.01 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 119.025 0.829 . . . . 0.0 111.86 -179.715 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -128.22 5.17 5.8 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 124.87 1.268 . . . . 0.0 113.58 -173.579 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 28.3 t -125.84 147.75 30.55 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.273 0 N-CA-C 107.789 -1.189 . . . . 0.0 107.789 172.972 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 19.8 m -134.77 130.65 36.48 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 125.38 1.472 . . . . 0.0 108.063 -174.139 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.404 HD21 ' HG2' ' A' ' 22' ' ' ARG . 16.7 mt -77.83 135.15 37.9 Favored 'General case' 0 C--O 1.232 0.166 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 175.404 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 38.4 t-80 -126.76 66.11 1.26 Allowed 'General case' 0 CA--C 1.53 0.201 0 N-CA-C 107.289 -1.374 . . . . 0.0 107.289 -175.747 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 65.0 t-20 -74.6 114.26 12.81 Favored 'General case' 0 C--O 1.234 0.274 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 -176.254 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 88.3 mt -66.16 -12.29 54.9 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 124.395 1.078 . . . . 0.0 112.897 -176.44 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 23.0 tptm -58.13 -27.4 63.73 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-N 118.578 0.626 . . . . 0.0 110.571 169.093 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -130.55 -39.59 1.28 Allowed 'General case' 0 N--CA 1.465 0.287 0 N-CA-C 113.486 0.921 . . . . 0.0 113.486 -173.513 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 38.4 m-20 -87.11 138.95 31.06 Favored 'General case' 0 C--O 1.234 0.288 0 C-N-CA 123.568 0.747 . . . . 0.0 110.17 -176.929 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 14.1 m -75.92 154.57 84.93 Favored Pre-proline 0 CA--C 1.541 0.622 0 C-N-CA 124.118 0.967 . . . . 0.0 110.174 177.284 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 66.7 Cg_endo -75.39 -26.12 10.61 Favored 'Trans proline' 0 C--N 1.351 0.705 0 C-N-CA 122.235 1.957 . . . . 0.0 113.908 -170.911 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.79 -16.17 64.08 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-N 120.358 1.436 . . . . 0.0 112.28 -179.057 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -60.08 -27.69 67.2 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 125.144 1.378 . . . . 0.0 110.543 170.82 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 57.1 mtt -58.05 -26.13 62.1 Favored 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 123.376 0.67 . . . . 0.0 111.62 176.832 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 59.6 mt-10 -67.22 -33.71 75.94 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 118.323 0.511 . . . . 0.0 110.391 -175.466 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 19.0 mt-30 -65.23 -43.9 89.95 Favored 'General case' 0 N--CA 1.464 0.257 0 C-N-CA 123.666 0.787 . . . . 0.0 112.396 -169.908 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 18.5 m-85 -72.89 140.05 47.27 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 123.705 0.802 . . . . 0.0 110.176 -166.869 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -74.7 -37.52 62.6 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 118.481 0.582 . . . . 0.0 110.022 -178.297 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 13.5 t -105.34 145.53 13.46 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.328 0 N-CA-C 107.498 -1.297 . . . . 0.0 107.498 170.117 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 32.9 tp -134.19 106.1 6.99 Favored 'General case' 0 N--CA 1.447 -0.611 0 N-CA-C 108.601 -0.889 . . . . 0.0 108.601 175.418 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 24.8 mt -85.76 129.62 37.74 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 N-CA-C 106.638 -1.616 . . . . 0.0 106.638 177.557 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 1.4 mp -104.13 130.79 51.87 Favored 'General case' 0 N--CA 1.467 0.417 0 N-CA-C 105.953 -1.869 . . . . 0.0 105.953 177.207 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -131.17 119.22 2.59 Favored Glycine 0 CA--C 1.505 -0.576 0 N-CA-C 108.635 -1.786 . . . . 0.0 108.635 -176.945 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 1.6 tt -144.07 120.97 6.51 Favored Pre-proline 0 CA--C 1.531 0.238 0 CA-C-N 118.235 1.018 . . . . 0.0 108.706 179.517 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 76.9 Cg_exo . . . . . 0 N--CA 1.459 -0.535 0 C-N-CA 122.499 2.133 . . . . 0.0 114.286 -178.502 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 20.8 mt . . . . . 0 CA--C 1.542 0.654 0 N-CA-C 109.768 -0.456 . . . . 0.0 109.768 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 2.0 pm0 -67.56 151.93 46.5 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 123.585 0.754 . . . . 0.0 110.913 177.197 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -49.2 -51.23 34.2 Favored 'General case' 0 N--CA 1.463 0.205 0 C-N-CA 125.843 1.657 . . . . 0.0 112.669 -168.894 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -68.65 -17.11 64.03 Favored 'General case' 0 N--CA 1.473 0.712 0 CA-C-N 119.019 0.827 . . . . 0.0 112.043 -170.413 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' TRP . . . . . 0.505 ' CZ3' ' CE3' ' A' ' 69' ' ' TRP . 0.0 OUTLIER -88.69 -47.1 8.5 Favored 'General case' 0 CA--C 1.538 0.51 0 N-CA-C 107.449 -1.315 . . . . 0.0 107.449 178.071 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 12.0 tt0 -63.6 -33.46 75.65 Favored 'General case' 0 N--CA 1.449 -0.519 0 O-C-N 120.598 -1.314 . . . . 0.0 110.542 178.804 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -54.75 -25.15 25.91 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 125.085 1.354 . . . . 0.0 112.45 -177.763 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 29.6 m -114.28 -13.85 11.14 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.209 0 CA-C-O 117.204 -1.379 . . . . 0.0 112.918 177.356 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 69' ' ' TRP . . . . . 0.505 ' CE3' ' CZ3' ' A' ' 65' ' ' TRP . 2.6 t-105 -51.13 -39.55 56.51 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 120.136 1.334 . . . . 0.0 111.071 -173.644 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -68.57 -23.65 64.52 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 125.11 1.364 . . . . 0.0 113.2 -179.885 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 18.7 mt-30 -89.51 -23.41 22.06 Favored 'General case' 0 C--N 1.341 0.211 0 C-N-CA 125.311 1.444 . . . . 0.0 112.363 178.613 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 40.3 mt -65.72 -24.61 67.01 Favored 'General case' 0 N--CA 1.469 0.485 0 O-C-N 121.874 -0.516 . . . . 0.0 112.065 -169.968 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -70.06 -21.29 63.18 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 118.087 0.403 . . . . 0.0 111.74 175.78 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -75.1 -23.6 57.97 Favored 'General case' 0 CA--C 1.538 0.505 0 O-C-N 121.139 -0.976 . . . . 0.0 112.635 -178.722 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 53.6 mt -66.16 150.17 49.18 Favored 'General case' 0 C--O 1.231 0.12 0 C-N-CA 124.869 1.268 . . . . 0.0 112.003 -169.594 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 3.7 t30 -82.24 105.79 13.61 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 124.551 1.14 . . . . 0.0 108.204 172.488 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 65.6 mt -124.0 1.29 8.61 Favored 'General case' 0 N--CA 1.472 0.63 0 N-CA-C 113.764 1.024 . . . . 0.0 113.764 -172.491 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 27.2 mt-10 -56.9 130.98 48.21 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-O 121.913 0.863 . . . . 0.0 111.318 -169.747 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 74.04 -2.73 41.46 Favored Glycine 0 CA--C 1.534 1.249 0 C-N-CA 125.401 1.477 . . . . 0.0 114.955 176.951 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.66 148.7 40.4 Favored 'General case' 0 C--N 1.345 0.403 0 CA-C-N 120.346 2.073 . . . . 0.0 109.347 -176.399 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 5.3 mt -81.26 139.79 17.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 N-CA-C 106.711 -1.589 . . . . 0.0 106.711 179.542 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 38.4 t -133.55 139.16 49.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 C-N-CA 124.459 1.103 . . . . 0.0 110.491 -175.897 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -115.37 162.25 17.39 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 123.971 0.908 . . . . 0.0 109.043 169.466 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 6.2 mt -141.61 136.8 31.37 Favored 'General case' 0 N--CA 1.465 0.277 0 N-CA-C 106.867 -1.531 . . . . 0.0 106.867 178.702 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 40.4 p90 -153.64 155.52 36.2 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-N 120.614 1.552 . . . . 0.0 109.116 174.913 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -175.9 -167.33 34.65 Favored Glycine 0 N--CA 1.445 -0.719 0 N-CA-C 108.514 -1.834 . . . . 0.0 108.514 170.656 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.327 -0.373 0 CA-C-O 122.443 1.116 . . . . 0.0 111.139 176.025 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 96.6 mt . . . . . 0 CA--C 1.541 0.625 0 N-CA-C 114.453 1.279 . . . . 0.0 114.453 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -57.71 -39.47 77.3 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 119.765 1.166 . . . . 0.0 113.108 -167.601 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -73.35 -19.42 61.01 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-O 118.262 -0.875 . . . . 0.0 112.666 -178.905 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 8.5 mp -65.69 -38.75 90.1 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-N 120.151 1.341 . . . . 0.0 108.45 170.248 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -63.37 -36.89 94.0 Favored Glycine 0 C--N 1.339 0.712 0 N-CA-C 111.218 -0.753 . . . . 0.0 111.218 -179.008 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 77.8 mtm -67.33 -47.82 69.37 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-O 118.077 -0.963 . . . . 0.0 111.006 179.85 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -70.57 -33.4 71.06 Favored 'General case' 0 C--N 1.348 0.535 0 CA-C-N 121.042 1.746 . . . . 0.0 110.995 178.217 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 68.2 t60 -54.51 -51.76 64.11 Favored 'General case' 0 CA--C 1.529 0.14 0 CA-C-N 118.821 0.737 . . . . 0.0 110.164 171.894 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -62.99 -40.02 96.48 Favored 'General case' 0 C--O 1.236 0.379 0 C-N-CA 123.771 0.829 . . . . 0.0 112.094 -176.098 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 24.1 ttmm -54.9 -39.68 69.01 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 123.327 0.651 . . . . 0.0 110.146 171.508 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 35.2 mt -90.96 -19.52 23.17 Favored 'General case' 0 CA--C 1.518 -0.287 0 N-CA-C 115.48 1.659 . . . . 0.0 115.48 -168.566 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 4.5 m -58.81 -36.47 74.54 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 120.86 1.664 . . . . 0.0 111.353 -177.664 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 19.9 p -84.0 -15.45 47.63 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 124.81 1.244 . . . . 0.0 111.66 179.942 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 31.7 mmmt -81.56 -9.97 59.56 Favored 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 124.542 1.137 . . . . 0.0 110.998 172.109 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 73.21 35.42 57.05 Favored Glycine 0 CA--C 1.523 0.569 0 CA-C-O 119.541 -0.589 . . . . 0.0 112.404 169.497 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 5.9 m -74.9 173.9 0.89 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.56 0 CA-C-N 118.122 0.961 . . . . 0.0 109.536 171.252 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -115.23 117.22 29.88 Favored 'General case' 0 CA--C 1.52 -0.211 0 N-CA-C 106.911 -1.515 . . . . 0.0 106.911 175.367 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 87.9 m-85 -85.71 143.15 28.53 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 119.56 1.073 . . . . 0.0 110.022 -175.312 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 32.9 m -133.47 160.7 42.14 Favored 'Isoleucine or valine' 0 C--O 1.235 0.307 0 C-N-CA 125.712 1.605 . . . . 0.0 108.052 169.748 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 86.8 26.95 30.5 Favored Glycine 0 C--N 1.332 0.339 0 CA-C-O 118.327 -1.263 . . . . 0.0 114.097 173.458 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 18.9 m-30 -60.85 159.87 10.5 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-N 119.165 1.482 . . . . 0.0 110.082 169.711 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 1.5 m95 -125.66 143.71 45.88 Favored Pre-proline 0 N--CA 1.469 0.501 0 CA-C-O 118.362 -0.828 . . . . 0.0 109.359 169.722 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -64.05 127.72 20.07 Favored 'Trans proline' 0 N--CA 1.452 -0.954 0 C-N-CA 123.335 2.69 . . . . 0.0 109.845 173.493 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 31.5 p . . . . . 0 N--CA 1.471 0.621 0 N-CA-C 113.449 0.907 . . . . 0.0 113.449 175.456 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 20.5 ttmt . . . . . 0 CA--C 1.544 0.719 0 CA-C-O 117.429 -1.272 . . . . 0.0 114.083 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -73.07 -3.66 14.04 Favored 'Trans proline' 0 C--N 1.352 0.719 0 CA-C-N 121.939 1.728 . . . . 0.0 114.447 -178.444 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 19.7 m -129.93 166.84 26.52 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 CA-C-N 119.989 1.268 . . . . 0.0 111.924 -169.588 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 10.3 pt -138.02 174.56 10.56 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.331 0 C-N-CA 127.554 2.342 . . . . 0.0 108.73 -177.088 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . 54.96 43.88 29.17 Favored 'General case' 0 N--CA 1.465 0.284 0 C-N-CA 125.351 1.46 . . . . 0.0 112.051 175.184 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 27.4 t0 54.55 43.18 30.67 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 126.046 1.738 . . . . 0.0 111.46 -175.756 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 89.95 16.06 56.78 Favored Glycine 0 CA--C 1.526 0.723 0 CA-C-O 118.356 -1.247 . . . . 0.0 114.481 171.207 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 47.6 mt-30 -88.08 -16.84 32.47 Favored 'General case' 0 CA--C 1.536 0.404 0 CA-C-N 119.366 1.583 . . . . 0.0 113.691 -175.569 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -143.45 142.86 31.36 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 119.541 1.064 . . . . 0.0 110.661 177.234 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 74.2 m-85 -75.25 141.59 43.47 Favored 'General case' 0 CA--C 1.519 -0.233 0 N-CA-C 105.095 -2.187 . . . . 0.0 105.095 164.642 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 33.5 m -69.98 -0.1 1.38 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.567 0 N-CA-C 113.011 0.745 . . . . 0.0 113.011 -178.099 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -170.13 -170.82 34.96 Favored Glycine 0 N--CA 1.447 -0.618 0 N-CA-C 109.972 -1.251 . . . . 0.0 109.972 -172.607 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 0.453 ' HG ' ' CG ' ' A' ' 160' ' ' TRP . 1.2 tt -60.05 139.31 57.55 Favored 'General case' 0 N--CA 1.462 0.156 0 C-N-CA 124.424 1.089 . . . . 0.0 110.548 -179.815 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -105.78 96.03 6.21 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 124.553 1.141 . . . . 0.0 108.422 168.794 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 78.2 mt . . . . . 0 CA--C 1.535 0.397 0 N-CA-C 105.621 -1.992 . . . . 0.0 105.621 168.582 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 31.0 p . . . . . 0 CA--C 1.531 0.216 0 N-CA-C 110.347 -0.242 . . . . 0.0 110.347 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -58.22 -40.34 81.4 Favored 'General case' 0 N--CA 1.462 0.173 0 C-N-CA 123.921 0.889 . . . . 0.0 111.064 178.345 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 3.5 tp10 -69.67 -47.36 63.56 Favored 'General case' 0 CA--C 1.529 0.16 0 C-N-CA 124.485 1.114 . . . . 0.0 110.911 -177.485 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 69.9 mtp85 -66.71 -27.39 67.6 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 117.894 -1.051 . . . . 0.0 110.424 179.859 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 25.1 mt -73.14 -53.29 18.84 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.601 0 CA-C-N 119.908 1.231 . . . . 0.0 107.762 168.364 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 70.8 tp60 -50.14 -64.14 0.9 Allowed 'General case' 0 N--CA 1.464 0.259 0 C-N-CA 126.031 1.732 . . . . 0.0 112.14 -175.419 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 25.3 m -66.11 -32.75 74.39 Favored 'General case' 0 C--N 1.327 -0.392 0 O-C-N 123.036 0.21 . . . . 0.0 110.803 -171.01 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 160' ' ' TRP . . . . . 0.453 ' CG ' ' HG ' ' A' ' 142' ' ' LEU . 88.2 t90 -66.41 -46.84 75.22 Favored 'General case' 0 C--O 1.222 -0.349 0 O-C-N 121.958 -0.464 . . . . 0.0 110.836 174.592 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 67.2 m -59.56 -44.42 93.29 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 123.266 0.626 . . . . 0.0 110.501 178.816 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 162' ' ' GLU . . . . . 0.409 ' HA ' HD23 ' A' ' 165' ' ' LEU . 39.7 mt-10 -61.05 -42.95 99.44 Favored 'General case' 0 N--CA 1.457 -0.085 0 CA-C-O 121.021 0.439 . . . . 0.0 110.199 175.723 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 14.4 tt0 -63.71 -52.1 62.07 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-O 117.791 -1.1 . . . . 0.0 109.73 -177.508 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 40.4 pt -63.02 -34.11 64.61 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.519 0 CA-C-N 119.439 1.018 . . . . 0.0 110.077 -176.57 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 165' ' ' LEU . . . . . 0.409 HD23 ' HA ' ' A' ' 162' ' ' GLU . 0.3 OUTLIER -70.16 -34.95 73.66 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 119.382 0.992 . . . . 0.0 108.519 -175.2 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -70.72 -46.27 63.36 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 123.707 0.803 . . . . 0.0 109.993 174.273 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 24.8 tt0 -77.91 -14.09 59.66 Favored 'General case' 0 N--CA 1.437 -1.104 0 C-N-CA 124.9 1.28 . . . . 0.0 110.359 -169.629 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 168' ' ' MET . . . . . . . . . . . . . 18.9 ptp -92.17 -38.9 11.87 Favored 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 122.751 0.42 . . . . 0.0 111.547 169.754 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -75.81 -27.82 58.09 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-O 119.327 -0.368 . . . . 0.0 111.914 -173.447 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 . . . . . 0 CA--C 1.541 0.617 0 C-N-CA 123.655 0.782 . . . . 0.0 112.398 -177.084 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.499 2.015 0 CA-C-O 119.403 -0.332 . . . . 0.0 111.11 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 11.3 t30 -127.29 151.1 49.18 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-N 119.167 0.894 . . . . 0.0 110.523 -177.815 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 17.5 mtt -117.4 130.41 56.47 Favored 'General case' 0 N--CA 1.461 0.11 0 C-N-CA 124.228 1.011 . . . . 0.0 110.958 -177.873 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 4' ' ' GLY . . . . . 0.409 ' HA3' ' CD2' ' A' ' 46' ' ' TYR . . . -86.88 154.76 27.04 Favored Glycine 0 CA--C 1.522 0.51 0 N-CA-C 107.77 -2.132 . . . . 0.0 107.77 166.541 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 3.0 tt -141.24 99.49 3.59 Favored 'General case' 0 N--CA 1.464 0.244 0 N-CA-C 105.612 -1.995 . . . . 0.0 105.612 -176.456 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 6' ' ' PHE . . . . . 0.756 ' CZ ' HD23 ' A' ' 51' ' ' LEU . 1.2 p90 -106.18 138.43 42.38 Favored 'General case' 0 CA--C 1.521 -0.162 0 CA-C-N 118.017 0.372 . . . . 0.0 111.707 -169.54 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 19.5 p90 . . . . . 0 CA--C 1.536 0.43 0 C-N-CA 125.693 1.597 . . . . 0.0 108.736 -174.053 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.463 0.194 0 N-CA-C 109.238 -0.653 . . . . 0.0 109.238 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -62.46 -47.71 82.83 Favored 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 123.049 0.539 . . . . 0.0 111.45 -176.481 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 33.8 mt-10 -61.73 -42.38 98.88 Favored 'General case' 0 C--O 1.232 0.178 0 C-N-CA 123.415 0.686 . . . . 0.0 110.14 176.377 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 28.7 mtpp -70.98 -39.63 72.38 Favored 'General case' 0 C--O 1.221 -0.434 0 CA-C-O 118.199 -0.905 . . . . 0.0 110.32 -175.885 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 43.7 mt -53.8 -56.04 10.92 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.285 0 CA-C-N 119.805 1.184 . . . . 0.0 109.266 175.781 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.484 ' HG2' HD21 ' A' ' 32' ' ' LEU . 0.0 OUTLIER -65.71 -35.44 80.74 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 118.406 0.548 . . . . 0.0 111.404 -175.82 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -64.31 -41.06 97.02 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.819 0.342 . . . . 0.0 110.944 177.996 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 56.4 mt -76.13 -54.08 14.24 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.47 0 C-N-CA 124.548 1.139 . . . . 0.0 109.84 -172.557 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 65.2 mt -62.63 -47.56 92.33 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.328 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 179.611 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 142.49 121.47 1.66 Allowed Glycine 0 CA--C 1.528 0.847 0 C-N-CA 124.826 1.203 . . . . 0.0 110.526 177.063 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -70.96 -12.72 31.01 Favored 'Trans proline' 0 CA--C 1.537 0.669 0 C-N-CA 122.784 2.323 . . . . 0.0 113.495 -171.027 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -77.17 -18.52 57.74 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 118.904 0.774 . . . . 0.0 111.729 179.802 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -128.71 9.1 5.88 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 124.604 1.162 . . . . 0.0 113.582 -170.639 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 31.4 t -127.93 148.07 32.55 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 N-CA-C 107.511 -1.292 . . . . 0.0 107.511 173.242 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 25.3 m -132.22 131.06 41.77 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 125.574 1.55 . . . . 0.0 108.164 -175.34 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.484 HD21 ' HG2' ' A' ' 22' ' ' ARG . 26.4 mt -77.73 131.46 37.68 Favored 'General case' 0 CA--C 1.521 -0.168 0 N-CA-C 108.107 -1.072 . . . . 0.0 108.107 176.104 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 22.5 t-80 -129.27 52.82 1.93 Allowed 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 124.748 1.219 . . . . 0.0 108.19 -175.552 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 18.7 t-20 -55.12 128.94 36.14 Favored 'General case' 0 CA--C 1.531 0.241 0 N-CA-C 107.834 -1.173 . . . . 0.0 107.834 171.086 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 39.0 mt -75.44 -16.17 60.36 Favored 'General case' 0 C--O 1.234 0.244 0 N-CA-C 114.021 1.119 . . . . 0.0 114.021 -169.009 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 9.0 tptm -77.47 -26.44 51.39 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 118.951 0.796 . . . . 0.0 110.154 169.614 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -88.13 -35.91 17.17 Favored 'General case' 0 C--O 1.236 0.375 0 C-N-CA 124.155 0.982 . . . . 0.0 112.783 -174.067 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 2.5 t0 -142.76 155.22 44.81 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 118.653 0.661 . . . . 0.0 112.673 178.151 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 19.1 m -75.35 158.34 83.79 Favored Pre-proline 0 CA--C 1.544 0.716 0 C-N-CA 125.998 1.719 . . . . 0.0 111.298 -170.525 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_endo -74.43 -25.75 12.79 Favored 'Trans proline' 0 C--N 1.349 0.594 0 C-N-CA 122.245 1.963 . . . . 0.0 113.231 -170.6 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 22.6 mmmt -71.19 -11.34 60.88 Favored 'General case' 0 CA--C 1.54 0.561 0 O-C-N 120.45 -1.406 . . . . 0.0 111.703 -176.368 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -61.85 -28.68 69.66 Favored 'General case' 0 N--CA 1.465 0.282 0 C-N-CA 125.159 1.384 . . . . 0.0 110.265 169.167 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 45.4 mtt -57.48 -27.3 62.39 Favored 'General case' 0 N--CA 1.464 0.275 0 C-N-CA 123.12 0.568 . . . . 0.0 111.865 177.146 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 84.7 mt-10 -66.17 -32.22 73.52 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 118.118 0.417 . . . . 0.0 110.357 -175.621 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 20.8 mt-30 -66.99 -41.63 86.44 Favored 'General case' 0 N--CA 1.464 0.243 0 C-N-CA 123.804 0.841 . . . . 0.0 112.714 -171.22 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' TYR . . . . . 0.409 ' CD2' ' HA3' ' A' ' 4' ' ' GLY . 15.7 m-85 -72.2 147.05 46.93 Favored 'General case' 0 CA--C 1.522 -0.108 0 C-N-CA 123.5 0.72 . . . . 0.0 110.667 -166.139 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -75.98 -34.47 59.77 Favored 'General case' 0 N--CA 1.467 0.422 0 O-C-N 121.832 -0.542 . . . . 0.0 110.297 176.045 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 6.4 t -113.4 146.76 17.6 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.19 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 172.668 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 48.5 tp -132.24 113.81 13.69 Favored 'General case' 0 N--CA 1.451 -0.424 0 C-N-CA 123.625 0.77 . . . . 0.0 109.06 171.726 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 23.0 mt -89.84 130.33 39.3 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 N-CA-C 106.361 -1.718 . . . . 0.0 106.361 174.982 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.756 HD23 ' CZ ' ' A' ' 6' ' ' PHE . 0.6 OUTLIER -106.01 131.87 52.78 Favored 'General case' 0 C--O 1.232 0.183 0 C-N-CA 125.201 1.4 . . . . 0.0 107.929 172.675 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.587 ' N ' HD22 ' A' ' 51' ' ' LEU . . . -127.46 139.03 10.87 Favored Glycine 0 CA--C 1.524 0.647 0 C-N-CA 124.892 1.234 . . . . 0.0 110.283 169.997 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.611 HD13 ' HB1' ' A' ' 100' ' ' ALA . 6.2 tt -145.47 129.65 8.75 Favored Pre-proline 0 CA--C 1.538 0.511 0 CA-C-N 118.763 1.282 . . . . 0.0 110.584 170.883 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo . . . . . 0 N--CA 1.456 -0.694 0 C-N-CA 123.099 2.533 . . . . 0.0 110.247 169.748 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.426 ' HA ' HD11 ' A' ' 53' ' ' ILE . 0.9 OUTLIER . . . . . 0 N--CA 1.445 -0.685 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 . . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 3.0 mp0 -88.88 156.95 18.61 Favored 'General case' 0 C--O 1.231 0.104 0 C-N-CA 124.622 1.169 . . . . 0.0 108.167 179.446 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -57.41 -40.28 77.94 Favored 'General case' 0 N--CA 1.464 0.249 0 C-N-CA 123.318 0.647 . . . . 0.0 110.45 -179.096 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 80.2 m-20 -58.1 -30.84 66.58 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 124.331 1.053 . . . . 0.0 110.96 -178.439 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' TRP . . . . . 0.67 ' CH2' HD23 ' A' ' 104' ' ' LEU . 1.9 t90 -95.87 -45.29 7.02 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 125.889 1.675 . . . . 0.0 108.297 -170.117 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 24.5 tt0 -63.51 -35.73 81.42 Favored 'General case' 0 N--CA 1.439 -1.011 0 C-N-CA 124.633 1.173 . . . . 0.0 110.347 178.451 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -57.83 -24.16 56.1 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 123.874 0.87 . . . . 0.0 111.759 -178.562 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 34.8 m -116.55 -12.13 11.62 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.345 0 CA-C-O 117.351 -1.309 . . . . 0.0 112.342 177.761 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 26.8 t90 -52.11 -38.71 58.26 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 120.234 1.379 . . . . 0.0 110.568 -176.387 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -65.35 -26.16 67.91 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 125.511 1.524 . . . . 0.0 113.284 177.255 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 25.7 mt-30 -92.58 -19.85 21.51 Favored 'General case' 0 C--N 1.34 0.165 0 C-N-CA 126.086 1.754 . . . . 0.0 112.538 176.836 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 72.6 mt -61.78 -24.14 66.65 Favored 'General case' 0 CA--C 1.532 0.274 0 O-C-N 121.679 -0.638 . . . . 0.0 111.289 -176.31 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -77.31 -27.67 52.99 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 118.074 0.397 . . . . 0.0 111.475 175.738 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -70.29 -33.09 71.14 Favored 'General case' 0 N--CA 1.467 0.379 0 O-C-N 121.424 -0.797 . . . . 0.0 111.381 178.823 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 83.2 mt -50.6 135.61 22.71 Favored 'General case' 0 C--N 1.341 0.2 0 C-N-CA 124.72 1.208 . . . . 0.0 111.935 -170.142 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 4.9 t-20 -74.64 105.39 5.71 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 107.308 -1.368 . . . . 0.0 107.308 168.356 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.448 ' HA ' ' HE2' ' A' ' 80' ' ' LYS . 59.6 mt -123.83 2.13 8.77 Favored 'General case' 0 N--CA 1.467 0.38 0 C-N-CA 124.691 1.196 . . . . 0.0 111.163 -179.622 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 29.6 mp0 -57.24 128.12 35.39 Favored 'General case' 0 N--CA 1.445 -0.681 0 CA-C-O 122.062 0.934 . . . . 0.0 112.287 -166.984 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 70.57 -0.04 28.92 Favored Glycine 0 CA--C 1.537 1.448 0 CA-C-N 113.792 -1.549 . . . . 0.0 115.411 -177.938 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.448 ' HE2' ' HA ' ' A' ' 77' ' ' LEU . 0.0 OUTLIER -77.87 160.01 28.56 Favored 'General case' 0 C--N 1.346 0.426 0 CA-C-N 120.892 2.346 . . . . 0.0 110.277 -175.381 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 1.9 mt -85.91 141.28 14.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 N-CA-C 106.729 -1.582 . . . . 0.0 106.729 178.215 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.409 HG11 HD13 ' A' ' 108' ' ' LEU . 94.2 t -138.42 146.63 26.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 -176.822 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -124.17 145.21 49.45 Favored 'General case' 0 CA--C 1.513 -0.456 0 N-CA-C 104.991 -2.225 . . . . 0.0 104.991 175.444 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 4.9 mp -126.83 141.74 51.74 Favored 'General case' 0 CA--C 1.501 -0.905 0 N-CA-C 107.655 -1.239 . . . . 0.0 107.655 175.007 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 34.4 p90 -153.13 168.71 25.02 Favored 'General case' 0 N--CA 1.441 -0.924 0 N-CA-C 107.236 -1.394 . . . . 0.0 107.236 167.836 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -162.69 171.53 38.53 Favored Glycine 0 N--CA 1.44 -1.042 0 N-CA-C 109.278 -1.529 . . . . 0.0 109.278 169.88 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 6.1 tt . . . . . 0 N--CA 1.442 -0.845 0 N-CA-C 106.589 -1.634 . . . . 0.0 106.589 173.764 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 91.1 mt . . . . . 0 N--CA 1.472 0.648 0 N-CA-C 113.567 0.951 . . . . 0.0 113.567 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -51.31 -48.22 62.38 Favored 'General case' 0 C--O 1.234 0.28 0 C-N-CA 125.284 1.434 . . . . 0.0 110.749 177.796 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 100' ' ' ALA . . . . . 0.611 ' HB1' HD13 ' A' ' 53' ' ' ILE . . . -72.14 -23.97 61.39 Favored 'General case' 0 CA--C 1.539 0.554 0 O-C-N 121.616 -0.678 . . . . 0.0 112.576 -178.543 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 4.8 tt -65.81 -48.06 72.98 Favored 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 171.352 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -61.18 -33.31 83.8 Favored Glycine 0 CA--C 1.527 0.806 0 N-CA-C 111.164 -0.775 . . . . 0.0 111.164 -179.674 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 4.5 tpp -53.76 -52.05 61.44 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 124.647 1.179 . . . . 0.0 111.225 172.885 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.67 HD23 ' CH2' ' A' ' 65' ' ' TRP . 0.2 OUTLIER -72.83 -33.19 66.02 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-O 118.425 -0.798 . . . . 0.0 110.758 -177.894 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 49.0 t60 -58.69 -50.96 71.97 Favored 'General case' 0 C--O 1.226 -0.161 0 CA-C-N 118.718 0.69 . . . . 0.0 110.604 174.696 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -62.13 -41.88 98.7 Favored 'General case' 0 C--O 1.234 0.258 0 C-N-CA 123.354 0.662 . . . . 0.0 111.585 -176.966 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 23.4 ttmm -59.57 -39.4 83.98 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 123.145 0.578 . . . . 0.0 110.098 173.128 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.409 HD13 HG11 ' A' ' 82' ' ' VAL . 16.5 mt -82.53 -25.33 33.49 Favored 'General case' 0 N--CA 1.455 -0.179 0 CA-C-O 117.584 -1.198 . . . . 0.0 113.71 -170.097 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 18.2 m -58.58 -36.73 74.43 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 120.503 1.501 . . . . 0.0 111.722 -175.785 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 21.1 p -82.15 -8.29 59.65 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 124.251 1.021 . . . . 0.0 111.719 -178.416 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 29.6 mmmt -84.03 -3.27 57.91 Favored 'General case' 0 C--N 1.343 0.284 0 C-N-CA 124.985 1.314 . . . . 0.0 111.365 173.786 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 67.53 33.35 81.12 Favored Glycine 0 CA--C 1.527 0.8 0 CA-C-N 118.698 0.681 . . . . 0.0 112.287 170.048 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 15.6 m -83.09 171.65 1.19 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 C-N-CA 123.593 0.757 . . . . 0.0 110.317 179.913 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 15.5 tptm -98.55 129.5 45.1 Favored 'General case' 0 CA--C 1.513 -0.47 0 N-CA-C 104.904 -2.258 . . . . 0.0 104.904 167.588 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 60.3 m-85 -94.84 124.31 38.81 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 171.457 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 35.3 m -107.26 157.77 7.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 C-N-CA 123.566 0.747 . . . . 0.0 109.257 168.531 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 101.12 -97.31 1.65 Allowed Glycine 0 N--CA 1.447 -0.616 0 C-N-CA 124.885 1.231 . . . . 0.0 111.505 174.16 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 11.3 m-30 61.06 172.89 0.1 Allowed 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 125.004 1.321 . . . . 0.0 110.104 -167.255 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 1.2 t90 -155.46 138.83 10.91 Favored Pre-proline 0 N--CA 1.469 0.485 0 CA-C-O 117.386 -1.292 . . . . 0.0 109.297 -177.029 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -71.72 121.67 7.87 Favored 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 123.413 2.742 . . . . 0.0 111.872 -174.49 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 37.5 p . . . . . 0 N--CA 1.47 0.545 0 N-CA-C 114.334 1.235 . . . . 0.0 114.334 179.902 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 33.4 ttmt . . . . . 0 N--CA 1.475 0.791 0 CA-C-O 117.529 -1.224 . . . . 0.0 114.142 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -73.82 -1.5 10.89 Favored 'Trans proline' 0 C--N 1.35 0.607 0 C-N-CA 121.856 1.704 . . . . 0.0 114.591 -179.527 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 12.3 m -135.91 153.0 31.55 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 CA-C-N 121.563 1.983 . . . . 0.0 112.377 -168.503 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 133' ' ' ILE . . . . . 0.718 HG23 HG12 ' A' ' 140' ' ' VAL . 11.8 pt -90.27 167.73 1.62 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.444 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 167.348 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . 57.9 -156.18 0.32 Allowed 'General case' 0 N--CA 1.447 -0.6 0 C-N-CA 124.934 1.294 . . . . 0.0 109.855 169.523 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 23.1 t0 -76.78 59.0 1.51 Allowed 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 125.065 1.346 . . . . 0.0 109.389 170.08 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 62.9 46.03 94.43 Favored Glycine 0 C--N 1.336 0.583 0 C-N-CA 124.826 1.203 . . . . 0.0 112.147 176.079 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 69.2 mm-40 -93.29 -44.44 8.31 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-N 118.208 1.004 . . . . 0.0 112.571 -169.809 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -134.18 142.83 47.56 Favored 'General case' 0 N--CA 1.47 0.556 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 179.883 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 44.9 m-85 -72.11 15.51 0.16 Allowed 'General case' 0 N--CA 1.479 1.007 0 N-CA-C 116.444 2.016 . . . . 0.0 116.444 179.775 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 140' ' ' VAL . . . . . 0.718 HG12 HG23 ' A' ' 133' ' ' ILE 0.253 1.0 OUTLIER 52.82 8.61 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.549 0.932 0 C-N-CA 127.162 2.185 . . . . 0.0 113.577 -177.245 . . . . . . . . 4 4 . 1 . 019 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 171.69 171.75 37.05 Favored Glycine 0 CA--C 1.528 0.906 0 C-N-CA 126.299 1.904 . . . . 0.0 108.968 -170.433 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -70.03 140.55 52.88 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 118.149 0.975 . . . . 0.0 111.642 -178.254 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -100.36 129.71 46.37 Favored 'General case' 0 N--CA 1.447 -0.587 0 C-N-CA 125.671 1.588 . . . . 0.0 109.995 176.912 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 81.3 mt . . . . . 0 CA--C 1.533 0.3 0 N-CA-C 106.576 -1.639 . . . . 0.0 106.576 168.406 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 28.9 m . . . . . 0 CA--C 1.53 0.189 0 CA-C-O 119.232 -0.413 . . . . 0.0 110.368 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -59.24 -43.46 92.4 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 118.789 0.722 . . . . 0.0 111.2 175.636 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 -68.94 -47.6 65.3 Favored 'General case' 0 C--O 1.233 0.23 0 C-N-CA 124.934 1.294 . . . . 0.0 110.436 -179.625 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 9.6 mpt_? -54.13 -47.56 71.74 Favored 'General case' 0 N--CA 1.463 0.221 0 C-N-CA 124.355 1.062 . . . . 0.0 109.87 176.348 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 43.2 mt -68.52 -52.82 32.53 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.468 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 -179.41 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 71.4 tp60 -50.89 -63.99 0.95 Allowed 'General case' 0 CA--C 1.516 -0.329 0 C-N-CA 124.922 1.289 . . . . 0.0 111.83 -174.801 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 24.1 m -66.61 -32.62 74.07 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 120.615 -0.434 . . . . 0.0 110.965 -169.742 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 160' ' ' TRP . . . . . . . . . . . . . 36.2 t90 -69.93 -44.65 69.18 Favored 'General case' 0 CA--C 1.517 -0.325 0 O-C-N 121.89 -0.506 . . . . 0.0 111.217 177.536 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 67.1 m -59.77 -42.94 94.39 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 122.779 0.432 . . . . 0.0 110.371 178.046 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -62.06 -42.54 99.3 Favored 'General case' 0 C--O 1.227 -0.083 0 CA-C-O 121.031 0.443 . . . . 0.0 110.08 175.812 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 14.2 tt0 -62.78 -52.15 64.32 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-O 118.824 -0.608 . . . . 0.0 110.187 -178.669 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 43.8 pt -63.0 -38.56 82.35 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.321 0 CA-C-O 117.819 -1.086 . . . . 0.0 109.267 -174.724 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -65.31 -33.88 77.03 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 119.435 1.016 . . . . 0.0 110.405 -179.484 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 34.0 m-80 -69.77 -56.91 5.88 Favored 'General case' 0 CA--C 1.517 -0.305 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 175.379 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 9.9 tt0 -64.72 -37.48 87.73 Favored 'General case' 0 N--CA 1.442 -0.86 0 C-N-CA 124.813 1.245 . . . . 0.0 110.887 -168.68 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 168' ' ' MET . . . . . . . . . . . . . 21.4 ptp -66.98 -32.27 73.39 Favored 'General case' 0 CA--C 1.522 -0.098 0 O-C-N 121.66 -0.65 . . . . 0.0 111.295 174.083 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -76.14 -37.39 58.04 Favored 'General case' 0 N--CA 1.443 -0.793 0 N-CA-C 112.451 0.537 . . . . 0.0 112.451 -178.47 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 . . . . . 0 CA--C 1.533 0.326 0 N-CA-C 108.89 -0.782 . . . . 0.0 108.89 174.985 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.498 1.947 0 N-CA-C 111.191 0.071 . . . . 0.0 111.191 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 19.7 p-10 -102.3 163.33 12.3 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 124.503 1.121 . . . . 0.0 111.467 -175.771 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 16.3 mtt -129.3 127.03 40.31 Favored 'General case' 0 N--CA 1.464 0.237 0 C-N-CA 122.89 0.476 . . . . 0.0 110.712 179.1 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -94.29 121.06 6.57 Favored Glycine 0 C--O 1.225 -0.437 0 N-CA-C 107.573 -2.211 . . . . 0.0 107.573 168.904 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 4.1 tt -104.43 111.54 24.23 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 105.468 -2.049 . . . . 0.0 105.468 179.226 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 6' ' ' PHE . . . . . 0.423 ' CD1' HD11 ' A' ' 35' ' ' LEU . 0.6 OUTLIER -108.32 143.99 36.45 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-O 121.757 0.789 . . . . 0.0 110.434 175.637 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 20.6 p90 . . . . . 0 N--CA 1.447 -0.62 0 N-CA-C 106.454 -1.684 . . . . 0.0 106.454 176.963 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.274 0 N-CA-C 110.125 -0.324 . . . . 0.0 110.125 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -62.99 -46.44 87.69 Favored 'General case' 0 N--CA 1.455 -0.195 0 C-N-CA 123.273 0.629 . . . . 0.0 111.204 -177.11 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 50.3 mm-40 -55.01 -52.41 63.23 Favored 'General case' 0 C--O 1.23 0.043 0 C-N-CA 123.169 0.588 . . . . 0.0 109.706 173.008 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 57.8 mttm -64.21 -42.16 96.73 Favored 'General case' 0 C--O 1.222 -0.344 0 CA-C-O 118.889 -0.577 . . . . 0.0 110.704 -171.433 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 48.3 mt -55.81 -56.61 11.55 Favored 'Isoleucine or valine' 0 C--O 1.233 0.211 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 178.4 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 19.1 ptt180 -63.4 -38.01 89.48 Favored 'General case' 0 C--O 1.221 -0.416 0 CA-C-O 118.884 -0.579 . . . . 0.0 110.251 -177.12 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -66.02 -38.45 88.44 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.208 0.528 . . . . 0.0 109.956 -173.41 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.472 HD13 ' HA ' ' A' ' 158' ' ' GLN . 77.9 mt -80.6 -53.67 12.12 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.516 0 C-N-CA 125.195 1.398 . . . . 0.0 110.165 -173.186 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 76.4 mt -62.67 -47.82 91.11 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 N-CA-C 109.511 -0.551 . . . . 0.0 109.511 178.579 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 140.91 120.45 1.68 Allowed Glycine 0 CA--C 1.529 0.937 0 C-N-CA 125.273 1.416 . . . . 0.0 110.755 177.051 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 82.1 Cg_endo -73.78 -4.09 14.84 Favored 'Trans proline' 0 CA--C 1.541 0.832 0 C-N-CA 123.078 2.519 . . . . 0.0 113.228 -173.12 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -82.36 -21.63 35.85 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 118.841 0.746 . . . . 0.0 111.54 176.593 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -120.97 -12.91 8.68 Favored 'General case' 0 C--N 1.344 0.33 0 C-N-CA 124.927 1.291 . . . . 0.0 113.436 -175.774 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 60.0 t -100.07 145.36 10.92 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 N-CA-C 107.29 -1.374 . . . . 0.0 107.29 169.136 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 6.0 m -134.48 139.29 45.37 Favored 'General case' 0 N--CA 1.463 0.209 0 C-N-CA 125.105 1.362 . . . . 0.0 107.493 -178.2 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 34.7 mt -93.42 145.05 24.77 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 118.888 0.767 . . . . 0.0 110.033 -179.826 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 12.4 m-70 -112.19 130.74 55.81 Favored 'General case' 0 C--O 1.234 0.286 0 N-CA-C 106.454 -1.684 . . . . 0.0 106.454 168.051 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 35.5 t-20 -105.8 100.14 9.71 Favored 'General case' 0 CA--C 1.521 -0.168 0 N-CA-C 106.117 -1.808 . . . . 0.0 106.117 169.014 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.423 HD11 ' CD1' ' A' ' 6' ' ' PHE . 83.5 mt -70.07 -8.8 52.37 Favored 'General case' 0 N--CA 1.466 0.368 0 N-CA-C 113.414 0.894 . . . . 0.0 113.414 -169.935 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 24.5 tptt -62.41 -23.57 66.91 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 118.662 0.664 . . . . 0.0 110.684 168.261 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -129.81 -39.85 1.4 Allowed 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 124.584 1.153 . . . . 0.0 113.171 -173.87 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 41.4 m-20 -75.89 130.94 39.28 Favored 'General case' 0 C--O 1.235 0.302 0 C-N-CA 123.829 0.852 . . . . 0.0 108.727 178.708 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 15.6 m -74.31 149.22 86.69 Favored Pre-proline 0 CA--C 1.54 0.581 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 173.652 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -71.91 -22.12 23.71 Favored 'Trans proline' 0 CA--C 1.532 0.382 0 C-N-CA 121.802 1.668 . . . . 0.0 112.818 -172.961 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 11.9 mptt -56.21 -23.77 37.71 Favored 'General case' 0 N--CA 1.47 0.541 0 O-C-N 120.963 -1.085 . . . . 0.0 112.342 175.074 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -58.45 -34.15 70.53 Favored 'General case' 0 N--CA 1.465 0.314 0 C-N-CA 124.351 1.06 . . . . 0.0 110.69 175.811 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 61.3 mtt -60.02 -26.13 65.84 Favored 'General case' 0 N--CA 1.465 0.297 0 C-N-CA 124.622 1.169 . . . . 0.0 111.967 178.962 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 68.3 mt-10 -61.79 -33.46 74.15 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 118.729 0.695 . . . . 0.0 109.505 -178.466 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 30.8 mt-30 -69.11 -28.33 66.39 Favored 'General case' 0 CA--C 1.536 0.422 0 N-CA-C 113.749 1.018 . . . . 0.0 113.749 -172.189 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 76.5 m-85 -85.08 138.05 32.66 Favored 'General case' 0 N--CA 1.464 0.243 0 C-N-CA 122.991 0.516 . . . . 0.0 110.14 -167.762 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -71.14 -43.13 68.2 Favored 'General case' 0 C--O 1.233 0.237 0 CA-C-N 118.01 0.368 . . . . 0.0 110.45 -178.502 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 11.8 t -105.16 144.95 14.07 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.404 0 N-CA-C 107.101 -1.444 . . . . 0.0 107.101 169.668 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 19.1 tp -122.78 146.34 47.61 Favored 'General case' 0 N--CA 1.447 -0.618 0 N-CA-C 107.398 -1.334 . . . . 0.0 107.398 169.213 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 41.2 mt -128.05 130.0 69.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 N-CA-C 105.5 -2.037 . . . . 0.0 105.5 178.979 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 2.1 mp -114.35 131.06 56.68 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 125.729 1.612 . . . . 0.0 107.839 -172.17 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.438 ' HA3' ' CZ ' ' A' ' 85' ' ' TYR . . . -139.19 134.61 6.82 Favored Glycine 0 C--N 1.332 0.341 0 CA-C-O 118.855 -0.969 . . . . 0.0 111.544 177.902 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.454 HD13 ' HB1' ' A' ' 100' ' ' ALA . 5.5 tt -155.93 137.55 9.67 Favored Pre-proline 0 CA--C 1.533 0.3 0 CA-C-N 118.252 1.026 . . . . 0.0 111.246 177.954 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_endo . . . . . 0 N--CA 1.453 -0.904 0 C-N-CA 122.383 2.055 . . . . 0.0 107.187 164.881 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 11.7 mt . . . . . 0 CA--C 1.541 0.626 0 CA-C-O 121.611 0.719 . . . . 0.0 110.674 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 20.9 mp0 -69.64 155.93 39.74 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 124.829 1.252 . . . . 0.0 109.747 -174.455 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -51.3 -46.12 62.41 Favored 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 124.664 1.186 . . . . 0.0 111.155 -173.019 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 -60.19 -27.77 67.41 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 123.624 0.769 . . . . 0.0 110.734 -170.568 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' TRP . . . . . 0.646 ' CH2' HD23 ' A' ' 104' ' ' LEU . 0.1 OUTLIER -96.04 -46.92 6.3 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 126.192 1.797 . . . . 0.0 109.054 -178.579 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 14.6 tt0 -62.81 -34.05 76.48 Favored 'General case' 0 N--CA 1.445 -0.723 0 C-N-CA 125.165 1.386 . . . . 0.0 110.437 -175.187 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -57.37 -23.9 52.0 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 124.606 1.162 . . . . 0.0 111.999 -179.065 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 17.7 m -121.4 -11.12 9.09 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.225 0 C-N-CA 124.882 1.273 . . . . 0.0 112.348 179.879 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 48.5 t90 -55.39 -36.57 66.54 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 124.362 1.065 . . . . 0.0 110.674 -178.437 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -63.52 -27.9 69.58 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 125.403 1.481 . . . . 0.0 112.949 176.183 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 41.9 mt-30 -91.73 -20.97 20.99 Favored 'General case' 0 CA--C 1.519 -0.239 0 C-N-CA 125.186 1.394 . . . . 0.0 112.506 179.998 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 76.1 mt -59.45 -27.47 66.11 Favored 'General case' 0 N--CA 1.467 0.391 0 O-C-N 121.538 -0.726 . . . . 0.0 111.294 178.589 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -76.94 -25.75 53.23 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 122.529 0.331 . . . . 0.0 111.316 173.974 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -77.47 -27.14 51.93 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 124.645 1.178 . . . . 0.0 112.335 -179.467 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 36.3 mt -61.8 147.46 46.34 Favored 'General case' 0 C--N 1.34 0.173 0 C-N-CA 124.296 1.039 . . . . 0.0 111.434 -178.079 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 24.4 t-20 -88.15 122.23 31.48 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 108.111 -1.07 . . . . 0.0 108.111 168.437 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 80.6 mt -130.92 9.33 4.9 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 123.577 0.751 . . . . 0.0 112.518 -170.054 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 26.8 mt-10 -52.42 127.92 23.97 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 124.055 0.942 . . . . 0.0 112.382 -168.064 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 69.35 -0.73 15.8 Favored Glycine 0 CA--C 1.534 1.22 0 C-N-CA 125.473 1.511 . . . . 0.0 115.721 176.659 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.82 149.33 39.68 Favored 'General case' 0 C--N 1.345 0.401 0 CA-C-N 120.551 2.176 . . . . 0.0 109.871 -173.29 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 4.5 mt -80.17 137.14 22.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 N-CA-C 106.923 -1.51 . . . . 0.0 106.923 177.769 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 55.6 t -131.47 124.17 54.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 C-N-CA 124.522 1.129 . . . . 0.0 109.734 -176.882 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -94.34 149.93 20.77 Favored 'General case' 0 CA--C 1.52 -0.186 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 167.147 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 8.4 mt -129.16 129.92 45.72 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 107.521 -1.288 . . . . 0.0 107.521 176.736 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 85' ' ' TYR . . . . . 0.438 ' CZ ' ' HA3' ' A' ' 52' ' ' GLY . 39.9 p90 -142.94 165.82 26.31 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 107.566 -1.272 . . . . 0.0 107.566 167.712 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -166.68 168.81 40.37 Favored Glycine 0 N--CA 1.442 -0.944 0 N-CA-C 110.147 -1.181 . . . . 0.0 110.147 173.517 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 1.1 mp . . . . . 0 N--CA 1.45 -0.467 0 C-N-CA 124.952 1.301 . . . . 0.0 108.925 177.249 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 94.6 mt . . . . . 0 N--CA 1.469 0.486 0 N-CA-C 113.358 0.874 . . . . 0.0 113.358 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -63.9 -34.77 78.71 Favored 'General case' 0 C--N 1.333 -0.134 0 O-C-N 120.746 -1.221 . . . . 0.0 110.741 -170.937 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 100' ' ' ALA . . . . . 0.454 ' HB1' HD13 ' A' ' 53' ' ' ILE . . . -73.89 -26.34 60.49 Favored 'General case' 0 N--CA 1.453 -0.302 0 O-C-N 121.485 -0.76 . . . . 0.0 112.619 176.36 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 5.2 tt -62.22 -44.86 95.61 Favored 'General case' 0 N--CA 1.466 0.36 0 N-CA-C 107.124 -1.435 . . . . 0.0 107.124 169.126 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -64.78 -40.63 97.51 Favored Glycine 0 C--N 1.34 0.803 0 N-CA-C 111.136 -0.786 . . . . 0.0 111.136 -179.02 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 75.0 mtm -62.7 -41.13 98.98 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 118.072 0.936 . . . . 0.0 111.318 177.344 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.646 HD23 ' CH2' ' A' ' 65' ' ' TRP . 0.1 OUTLIER -68.09 -40.21 82.68 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 120.164 1.347 . . . . 0.0 110.485 178.594 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 82.3 t60 -55.98 -51.92 66.01 Favored 'General case' 0 CA--C 1.528 0.112 0 N-CA-C 110.062 -0.348 . . . . 0.0 110.062 175.035 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -64.32 -39.94 94.92 Favored 'General case' 0 C--O 1.235 0.339 0 C-N-CA 123.967 0.907 . . . . 0.0 112.584 -176.102 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 22.3 ttmm -54.85 -39.05 68.22 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 123.794 0.838 . . . . 0.0 109.775 171.567 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 21.8 mt -90.6 -18.78 24.58 Favored 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 114.603 1.334 . . . . 0.0 114.603 -169.379 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 2.5 m -58.86 -33.46 70.49 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 120.561 1.528 . . . . 0.0 111.688 -175.75 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 19.5 p -86.56 -11.94 50.12 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 124.754 1.221 . . . . 0.0 111.999 -179.318 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 32.1 mmmt -82.12 -10.14 59.29 Favored 'General case' 0 C--N 1.344 0.342 0 C-N-CA 124.314 1.046 . . . . 0.0 111.414 176.37 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 73.65 32.99 58.74 Favored Glycine 0 CA--C 1.526 0.723 0 CA-C-O 119.524 -0.598 . . . . 0.0 112.102 173.153 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 17.2 m -75.19 177.54 0.57 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.613 0 CA-C-N 118.193 0.997 . . . . 0.0 109.853 171.224 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -118.91 120.25 36.74 Favored 'General case' 0 CA--C 1.518 -0.274 0 N-CA-C 106.939 -1.504 . . . . 0.0 106.939 174.373 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 76.9 m-85 -87.83 144.67 26.47 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 119.696 1.135 . . . . 0.0 110.231 -175.323 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 35.9 m -134.34 159.68 41.92 Favored 'Isoleucine or valine' 0 C--O 1.234 0.254 0 C-N-CA 125.343 1.457 . . . . 0.0 107.936 169.865 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 85.54 30.62 23.91 Favored Glycine 0 CA--C 1.522 0.513 0 CA-C-O 118.75 -1.028 . . . . 0.0 114.262 170.872 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 13.0 m-30 -62.06 157.01 19.9 Favored 'General case' 0 CA--C 1.545 0.757 0 CA-C-N 119.036 1.418 . . . . 0.0 109.691 169.09 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 119' ' ' TRP . . . . . 0.42 ' HA ' ' HD3' ' A' ' 120' ' ' PRO . 2.5 t90 -135.98 144.26 47.65 Favored Pre-proline 0 N--CA 1.474 0.772 0 CA-C-O 117.712 -1.137 . . . . 0.0 111.849 -168.915 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 120' ' ' PRO . . . . . 0.42 ' HD3' ' HA ' ' A' ' 119' ' ' TRP . 36.2 Cg_exo -66.96 123.0 10.41 Favored 'Trans proline' 0 C--N 1.352 0.761 0 C-N-CA 123.552 2.835 . . . . 0.0 113.144 -176.647 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 3.3 p . . . . . 0 N--CA 1.468 0.43 0 N-CA-C 113.847 1.055 . . . . 0.0 113.847 179.341 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 24.8 ttmt . . . . . 0 N--CA 1.475 0.803 0 N-CA-C 114.845 1.424 . . . . 0.0 114.845 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_endo -78.92 -1.04 11.26 Favored 'Trans proline' 0 CA--C 1.539 0.761 0 CA-C-N 122.25 1.839 . . . . 0.0 113.999 179.992 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 18.5 m -127.37 170.58 17.02 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.22 0 CA-C-N 119.875 1.216 . . . . 0.0 110.96 -171.307 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 4.9 pt -128.8 169.29 20.42 Favored 'Isoleucine or valine' 0 C--O 1.241 0.64 0 C-N-CA 127.664 2.386 . . . . 0.0 107.86 175.579 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . 56.41 -156.37 0.28 Allowed 'General case' 0 N--CA 1.446 -0.652 0 C-N-CA 124.622 1.169 . . . . 0.0 108.37 -175.924 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 24.8 t0 -78.51 52.47 1.17 Allowed 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 124.481 1.113 . . . . 0.0 110.833 174.894 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 67.19 26.67 73.4 Favored Glycine 0 CA--C 1.531 1.069 0 C-N-CA 124.657 1.123 . . . . 0.0 112.677 -175.495 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 36.8 mt-30 -88.56 -11.41 45.71 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 118.579 1.19 . . . . 0.0 112.533 -170.128 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 8.5 tp -155.71 143.28 19.54 Favored 'General case' 0 C--N 1.343 0.319 0 CA-C-N 119.255 0.934 . . . . 0.0 110.578 175.671 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 67.9 m-85 -78.4 144.92 35.48 Favored 'General case' 0 CA--C 1.516 -0.365 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 169.771 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 17.0 m -76.56 4.63 1.11 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.732 0 C-N-CA 122.773 0.429 . . . . 0.0 111.959 176.615 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -172.86 172.92 45.38 Favored Glycine 0 CA--C 1.527 0.8 0 O-C-N 120.753 -1.217 . . . . 0.0 110.6 -179.173 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 3.6 tp -62.6 131.78 50.19 Favored 'General case' 0 N--CA 1.464 0.246 0 C-N-CA 124.143 0.977 . . . . 0.0 110.942 179.638 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -91.18 129.08 37.21 Favored 'General case' 0 N--CA 1.444 -0.742 0 C-N-CA 126.288 1.835 . . . . 0.0 109.572 176.811 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 32.4 mt . . . . . 0 C--O 1.231 0.116 0 N-CA-C 105.926 -1.879 . . . . 0.0 105.926 172.152 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 14.9 m . . . . . 0 CA--C 1.537 0.477 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -56.27 -44.22 79.56 Favored 'General case' 0 N--CA 1.464 0.27 0 C-N-CA 124.438 1.095 . . . . 0.0 110.904 169.818 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -65.25 -44.56 87.74 Favored 'General case' 0 C--O 1.234 0.252 0 C-N-CA 124.605 1.162 . . . . 0.0 110.882 -178.718 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 5.9 mmt180 -58.32 -41.36 84.37 Favored 'General case' 0 N--CA 1.462 0.153 0 CA-C-O 118.765 -0.636 . . . . 0.0 109.887 177.944 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 42.0 mt -67.98 -53.97 26.04 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.236 0 N-CA-C 108.228 -1.027 . . . . 0.0 108.228 176.811 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 158' ' ' GLN . . . . . 0.472 ' HA ' HD13 ' A' ' 24' ' ' ILE . 0.8 OUTLIER -49.77 -66.25 0.42 Allowed 'General case' 0 CA--C 1.518 -0.267 0 C-N-CA 125.547 1.539 . . . . 0.0 112.067 -172.178 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 14.6 m -60.95 -34.1 74.22 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 115.554 -0.748 . . . . 0.0 111.713 -174.888 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 160' ' ' TRP . . . . . . . . . . . . . 79.2 t90 -65.55 -43.9 88.48 Favored 'General case' 0 C--O 1.222 -0.373 0 O-C-N 121.775 -0.578 . . . . 0.0 111.005 174.411 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 92.5 m -61.01 -41.36 96.38 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 123.159 0.584 . . . . 0.0 110.652 179.721 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -63.09 -41.1 99.33 Favored 'General case' 0 N--CA 1.462 0.15 0 CA-C-O 121.104 0.478 . . . . 0.0 110.791 173.534 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 16.1 tt0 -65.05 -51.22 62.75 Favored 'General case' 0 N--CA 1.446 -0.654 0 O-C-N 121.566 -0.708 . . . . 0.0 110.122 -177.614 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 41.6 pt -63.38 -36.82 77.65 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.403 0 CA-C-O 117.818 -1.087 . . . . 0.0 109.734 -175.863 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -64.35 -36.25 83.52 Favored 'General case' 0 C--O 1.225 -0.187 0 CA-C-N 119.561 1.073 . . . . 0.0 109.611 -179.704 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 41.3 m-80 -68.59 -51.34 43.63 Favored 'General case' 0 N--CA 1.467 0.387 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 175.422 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 22.8 tt0 -72.85 -16.04 61.6 Favored 'General case' 0 N--CA 1.443 -0.802 0 C-N-CA 125.847 1.659 . . . . 0.0 111.937 -169.448 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 168' ' ' MET . . . . . . . . . . . . . 19.5 ptp -90.94 -38.93 12.55 Favored 'General case' 0 N--CA 1.456 -0.162 0 C-N-CA 123.799 0.84 . . . . 0.0 111.544 168.722 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -75.76 -27.04 57.9 Favored 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 122.703 0.401 . . . . 0.0 112.037 -172.927 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 . . . . . 0 CA--C 1.543 0.677 0 C-N-CA 123.672 0.789 . . . . 0.0 112.252 -179.23 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.497 1.905 0 N-CA-C 111.146 0.054 . . . . 0.0 111.146 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 22.3 p-10 -130.88 164.17 25.83 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 124.649 1.179 . . . . 0.0 111.487 -173.725 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 16.0 mtt -130.72 124.3 31.21 Favored 'General case' 0 CA--C 1.523 -0.087 0 C-N-CA 123.201 0.6 . . . . 0.0 111.258 179.798 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -87.33 152.18 24.13 Favored Glycine 0 CA--C 1.525 0.682 0 N-CA-C 106.838 -2.505 . . . . 0.0 106.838 166.895 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 2.7 tt -140.11 97.01 3.15 Favored 'General case' 0 N--CA 1.469 0.477 0 N-CA-C 105.783 -1.932 . . . . 0.0 105.783 -172.629 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.694 ' CZ ' HD23 ' A' ' 51' ' ' LEU . 0.7 OUTLIER -105.08 144.0 32.48 Favored 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 123.172 0.589 . . . . 0.0 111.063 -171.664 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 43.1 p90 -156.89 163.41 39.2 Favored 'General case' 0 C--O 1.234 0.28 0 C-N-CA 124.16 0.984 . . . . 0.0 109.941 -179.881 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -80.47 123.95 6.27 Favored Glycine 0 C--N 1.336 0.567 0 N-CA-C 109.204 -1.558 . . . . 0.0 109.204 179.633 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 5.0 m -67.21 -29.13 68.7 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 123.832 0.853 . . . . 0.0 113.023 -169.942 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -79.04 -18.85 52.78 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 123.314 0.645 . . . . 0.0 111.947 -174.795 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -79.94 142.24 35.28 Favored 'General case' 0 C--O 1.236 0.362 0 C-N-CA 123.353 0.661 . . . . 0.0 110.829 -172.803 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 28.1 m -71.36 161.85 30.39 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 123.767 0.827 . . . . 0.0 110.264 174.929 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 10.3 t80 65.0 -33.96 0.16 Allowed 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 127.99 2.516 . . . . 0.0 116.124 175.937 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -61.05 -27.43 68.33 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 120.434 1.47 . . . . 0.0 111.799 -174.551 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -61.89 -47.28 85.67 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 118.794 0.724 . . . . 0.0 110.103 176.052 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 17.8 ptp -75.66 -32.55 60.21 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 119.269 0.94 . . . . 0.0 111.069 -178.369 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -56.23 -47.49 78.37 Favored 'General case' 0 CA--C 1.536 0.408 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 169.644 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -64.0 -48.47 76.26 Favored 'General case' 0 N--CA 1.455 -0.223 0 C-N-CA 123.785 0.834 . . . . 0.0 111.511 -177.909 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -52.76 -47.59 67.37 Favored 'General case' 0 C--O 1.235 0.334 0 C-N-CA 124.146 0.978 . . . . 0.0 109.72 175.492 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 28.7 mtpp -75.82 -42.13 50.65 Favored 'General case' 0 C--O 1.221 -0.428 0 CA-C-O 117.982 -1.008 . . . . 0.0 110.521 -170.446 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 39.0 mt -52.37 -53.34 19.87 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.352 0 CA-C-N 120.258 1.39 . . . . 0.0 108.614 173.494 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.15 -39.23 91.93 Favored 'General case' 0 C--O 1.222 -0.358 0 C-N-CA 123.367 0.667 . . . . 0.0 109.798 -176.821 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -66.46 -42.3 87.77 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 118.599 0.636 . . . . 0.0 110.943 179.678 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 54.7 mt -74.0 -53.78 16.64 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.605 0 C-N-CA 124.995 1.318 . . . . 0.0 109.767 -169.789 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 75.3 mt -65.45 -46.1 90.98 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.446 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 178.76 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 140.21 125.85 2.23 Favored Glycine 0 CA--C 1.533 1.176 0 C-N-CA 124.676 1.132 . . . . 0.0 111.952 172.832 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -71.6 -6.88 20.07 Favored 'Trans proline' 0 CA--C 1.539 0.749 0 C-N-CA 123.701 2.934 . . . . 0.0 113.684 -174.025 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -81.55 -19.24 42.47 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-N 119.123 0.874 . . . . 0.0 111.245 176.812 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -127.25 -5.83 6.01 Favored 'General case' 0 C--N 1.345 0.372 0 C-N-CA 124.653 1.181 . . . . 0.0 113.792 -174.53 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 26.9 t -113.32 147.21 17.07 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.266 0 N-CA-C 108.007 -1.109 . . . . 0.0 108.007 170.984 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 36.4 m -135.03 132.15 37.93 Favored 'General case' 0 C--O 1.234 0.267 0 C-N-CA 125.896 1.678 . . . . 0.0 106.667 -174.819 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 14.7 mt -76.01 138.09 40.68 Favored 'General case' 0 C--O 1.231 0.101 0 N-CA-C 107.885 -1.154 . . . . 0.0 107.885 174.696 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 35.0 t-80 -126.85 56.48 1.5 Allowed 'General case' 0 CA--C 1.531 0.217 0 N-CA-C 107.422 -1.325 . . . . 0.0 107.422 177.928 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 48.5 t30 -61.21 128.92 38.75 Favored 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 107.099 -1.445 . . . . 0.0 107.099 176.123 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 40.2 mt -70.33 -29.98 66.82 Favored 'General case' 0 N--CA 1.469 0.496 0 N-CA-C 114.138 1.162 . . . . 0.0 114.138 -167.65 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 21.5 mmmt -62.72 -26.16 68.54 Favored 'General case' 0 N--CA 1.466 0.344 0 O-C-N 121.703 -0.623 . . . . 0.0 111.698 168.369 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -92.62 -34.62 13.93 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-N 118.568 0.622 . . . . 0.0 112.405 -172.566 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 2.2 t0 -146.4 150.73 36.22 Favored 'General case' 0 N--CA 1.466 0.363 0 N-CA-C 113.025 0.75 . . . . 0.0 113.025 177.008 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 15.2 m -72.14 158.11 88.17 Favored Pre-proline 0 CA--C 1.541 0.6 0 C-N-CA 126.083 1.753 . . . . 0.0 111.499 -169.555 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -71.8 -27.5 17.89 Favored 'Trans proline' 0 C--N 1.35 0.628 0 C-N-CA 122.388 2.059 . . . . 0.0 113.385 -170.466 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 14.8 mmmt -68.36 -16.12 63.81 Favored 'General case' 0 N--CA 1.472 0.644 0 O-C-N 120.897 -1.127 . . . . 0.0 111.286 -175.822 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -62.95 -27.97 69.75 Favored 'General case' 0 N--CA 1.465 0.277 0 C-N-CA 125.741 1.616 . . . . 0.0 110.422 171.821 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 47.5 mtt -56.37 -25.39 49.39 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 119.134 0.879 . . . . 0.0 111.422 178.335 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -66.57 -30.21 70.45 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 118.445 0.566 . . . . 0.0 110.895 -176.585 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 23.1 mt-30 -68.88 -41.5 78.23 Favored 'General case' 0 N--CA 1.465 0.277 0 N-CA-C 113.082 0.771 . . . . 0.0 113.082 -170.071 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 43.3 m-85 -72.75 137.47 45.89 Favored 'General case' 0 N--CA 1.461 0.104 0 C-N-CA 123.534 0.734 . . . . 0.0 109.721 -167.197 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -68.27 -36.54 79.56 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 118.539 0.609 . . . . 0.0 110.181 178.908 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 5.9 t -110.39 144.14 19.03 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.295 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 170.948 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 59.4 tp -131.02 108.55 9.87 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 173.484 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 22.8 mt -85.49 131.27 34.7 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 N-CA-C 106.246 -1.761 . . . . 0.0 106.246 175.067 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.694 HD23 ' CZ ' ' A' ' 6' ' ' PHE . 0.8 OUTLIER -107.29 133.36 51.96 Favored 'General case' 0 N--CA 1.456 -0.134 0 C-N-CA 125.574 1.55 . . . . 0.0 107.918 172.058 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.527 ' N ' HD22 ' A' ' 51' ' ' LEU . . . -127.65 126.7 5.59 Favored Glycine 0 C--N 1.331 0.299 0 N-CA-C 109.457 -1.457 . . . . 0.0 109.457 170.47 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 7.0 tt -148.92 123.23 4.77 Favored Pre-proline 0 N--CA 1.471 0.584 0 CA-C-N 119.305 1.552 . . . . 0.0 111.582 170.846 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_exo -65.79 142.54 70.16 Favored 'Trans proline' 0 N--CA 1.459 -0.525 0 C-N-CA 122.444 2.096 . . . . 0.0 110.664 166.604 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.415 HG21 ' H ' ' A' ' 99' ' ' ASP . 85.3 m -98.8 131.01 45.25 Favored 'General case' 0 CA--C 1.54 0.562 0 N-CA-C 107.389 -1.337 . . . . 0.0 107.389 169.268 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' TRP . . . . . . . . . . . . 0.281 1.3 t-105 51.26 53.49 12.82 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 125.715 1.606 . . . . 0.0 113.306 177.314 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -80.33 -75.04 0.28 Allowed 'General case' 0 CA--C 1.533 0.298 0 N-CA-C 107.403 -1.332 . . . . 0.0 107.403 168.27 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 88.9 t80 -81.0 -37.68 28.78 Favored 'General case' 0 CA--C 1.539 0.552 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 168.25 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 179.7 -174.13 45.79 Favored Glycine 0 CA--C 1.526 0.74 0 C-N-CA 127.186 2.327 . . . . 0.0 107.489 178.366 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -62.93 132.5 52.3 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 118.867 1.333 . . . . 0.0 108.324 169.795 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.425 HD11 ' HE3' ' A' ' 103' ' ' MET . 78.8 mt 34.05 95.66 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.545 0.77 0 C-N-CA 128.769 2.828 . . . . 0.0 112.772 174.015 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.68 163.26 4.46 Favored 'General case' 0 CA--C 1.542 0.655 0 CA-C-O 122.257 1.027 . . . . 0.0 112.376 171.761 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -59.79 -42.27 93.02 Favored 'General case' 0 N--CA 1.455 -0.206 0 C-N-CA 124.377 1.071 . . . . 0.0 112.599 -168.947 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 55.4 m-20 -66.3 -23.1 66.32 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-N 119.615 1.098 . . . . 0.0 111.723 -169.62 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 12.7 t90 -91.32 -44.83 8.94 Favored 'General case' 0 N--CA 1.456 -0.166 0 C-N-CA 124.379 1.071 . . . . 0.0 110.133 175.419 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -61.7 -35.31 77.66 Favored 'General case' 0 CA--C 1.535 0.396 0 O-C-N 121.266 -0.896 . . . . 0.0 109.945 -178.383 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -58.38 -24.73 60.79 Favored 'General case' 0 C--O 1.233 0.199 0 C-N-CA 124.465 1.106 . . . . 0.0 111.738 -177.725 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 35.7 m -115.13 -13.87 11.07 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.245 0 CA-C-O 117.327 -1.321 . . . . 0.0 112.354 178.0 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 25.1 t90 -52.64 -38.94 61.24 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 120.291 1.405 . . . . 0.0 110.576 -179.02 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -63.17 -26.93 69.03 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 125.098 1.359 . . . . 0.0 113.216 176.543 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 26.0 mt-30 -92.4 -20.09 21.4 Favored 'General case' 0 C--N 1.342 0.243 0 C-N-CA 125.735 1.614 . . . . 0.0 112.31 178.114 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 47.9 mt -64.12 -23.17 67.22 Favored 'General case' 0 N--CA 1.465 0.305 0 O-C-N 121.212 -0.93 . . . . 0.0 111.337 -175.756 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -79.99 -22.25 42.72 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-N 118.372 0.533 . . . . 0.0 111.877 174.684 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -70.72 -27.47 63.99 Favored 'General case' 0 N--CA 1.471 0.618 0 O-C-N 120.979 -1.076 . . . . 0.0 111.521 176.608 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 27.3 mt -62.06 149.67 40.43 Favored 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 124.855 1.262 . . . . 0.0 109.592 -179.636 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 28.1 t-20 -72.0 -59.86 2.53 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-O 122.634 1.206 . . . . 0.0 112.424 -174.987 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 16.7 mt 58.44 2.25 0.21 Allowed 'General case' 0 C--N 1.32 -0.686 0 C-N-CA 129.5 3.12 . . . . 0.0 116.739 175.679 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 30.9 mt-10 -58.59 130.12 45.33 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 120.188 1.358 . . . . 0.0 111.864 -169.186 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 71.18 0.1 34.35 Favored Glycine 0 CA--C 1.533 1.159 0 CA-C-O 117.964 -1.464 . . . . 0.0 114.908 176.24 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.11 155.29 37.25 Favored 'General case' 0 C--N 1.343 0.323 0 CA-C-N 120.681 2.241 . . . . 0.0 110.225 -174.414 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 1.9 mt -84.71 140.91 15.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 N-CA-C 106.875 -1.528 . . . . 0.0 106.875 178.194 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 54.9 t -135.4 138.98 47.58 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.706 0 C-N-CA 124.012 0.925 . . . . 0.0 109.024 -179.161 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.488 ' HB1' ' CH2' ' A' ' 160' ' ' TRP . . . -111.19 142.68 43.06 Favored 'General case' 0 CA--C 1.517 -0.301 0 N-CA-C 104.365 -2.458 . . . . 0.0 104.365 166.763 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 30.8 mt -122.19 144.88 48.69 Favored 'General case' 0 CA--C 1.51 -0.594 0 CA-C-N 120.262 1.392 . . . . 0.0 107.373 169.973 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 41.6 p90 -150.4 162.75 39.94 Favored 'General case' 0 N--CA 1.44 -0.934 0 N-CA-C 107.744 -1.206 . . . . 0.0 107.744 168.286 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -157.58 171.58 34.78 Favored Glycine 0 N--CA 1.443 -0.897 0 N-CA-C 109.691 -1.364 . . . . 0.0 109.691 171.459 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 6.8 tt -117.08 150.31 38.87 Favored 'General case' 0 N--CA 1.446 -0.632 0 C-N-CA 125.04 1.336 . . . . 0.0 108.334 175.677 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -160.23 -158.51 9.27 Favored Glycine 0 CA--C 1.528 0.866 0 N-CA-C 107.799 -2.12 . . . . 0.0 107.799 169.636 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -152.11 120.57 6.41 Favored 'General case' 0 N--CA 1.465 0.289 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 168.713 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 14.7 pm0 -78.55 -10.75 59.84 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 123.945 0.898 . . . . 0.0 112.81 -176.011 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 26.5 mt -76.98 -56.73 4.33 Favored 'General case' 0 C--N 1.343 0.289 0 CA-C-N 119.139 0.881 . . . . 0.0 109.748 176.164 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -88.01 -32.58 12.29 Favored Glycine 0 CA--C 1.523 0.554 0 CA-C-O 118.606 -1.108 . . . . 0.0 113.603 -170.023 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -90.35 -97.48 0.11 Allowed 'General case' 0 C--O 1.236 0.367 0 N-CA-C 106.935 -1.505 . . . . 0.0 106.935 172.268 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 84.39 133.42 2.57 Favored Glycine 0 CA--C 1.527 0.808 0 N-CA-C 107.652 -2.179 . . . . 0.0 107.652 -173.502 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 69.36 -45.37 0.56 Allowed 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 128.075 2.55 . . . . 0.0 112.251 -175.23 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' TRP . . . . . . . . . . . . . 3.4 m-90 -77.2 23.44 0.19 Allowed 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 124.545 1.138 . . . . 0.0 112.258 175.38 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 21.6 t80 -76.77 135.64 38.98 Favored 'General case' 0 N--CA 1.457 -0.105 0 O-C-N 121.297 -0.877 . . . . 0.0 108.886 -175.105 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 97.5 mt 52.27 26.69 4.17 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 124.527 1.131 . . . . 0.0 113.807 169.475 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' ASP . . . . . 0.415 ' H ' HG21 ' A' ' 55' ' ' THR . 11.2 t70 -67.28 -32.22 73.06 Favored 'General case' 0 C--N 1.329 -0.302 0 O-C-N 120.539 -1.35 . . . . 0.0 110.577 -171.685 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -70.68 -30.25 66.79 Favored 'General case' 0 CA--C 1.535 0.396 0 O-C-N 121.503 -0.748 . . . . 0.0 111.834 173.968 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 6.3 tt -61.77 -46.52 89.23 Favored 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 107.845 -1.169 . . . . 0.0 107.845 169.349 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -62.04 -38.07 95.48 Favored Glycine 0 CA--C 1.524 0.603 0 N-CA-C 111.086 -0.806 . . . . 0.0 111.086 -177.996 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' MET . . . . . 0.425 ' HE3' HD11 ' A' ' 61' ' ' ILE . 74.3 mtm -68.5 -39.26 81.34 Favored 'General case' 0 N--CA 1.454 -0.243 0 CA-C-O 118.246 -0.883 . . . . 0.0 111.489 177.705 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.46 ' HA ' HD22 ' A' ' 104' ' ' LEU . 0.2 OUTLIER -71.98 -32.08 66.88 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-N 120.52 1.509 . . . . 0.0 110.649 177.209 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -56.5 -56.58 19.46 Favored 'General case' 0 N--CA 1.462 0.146 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 167.891 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -63.39 -38.53 91.52 Favored 'General case' 0 C--O 1.235 0.338 0 C-N-CA 123.49 0.716 . . . . 0.0 112.025 -170.852 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 23.5 ttmm -58.34 -44.42 88.72 Favored 'General case' 0 CA--C 1.529 0.161 0 C-N-CA 122.804 0.442 . . . . 0.0 109.834 171.619 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 49.0 mt -83.49 -20.05 34.67 Favored 'General case' 0 CA--C 1.519 -0.238 0 N-CA-C 114.445 1.276 . . . . 0.0 114.445 -169.512 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 1.1 m -59.57 -36.53 76.41 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 120.567 1.53 . . . . 0.0 111.375 -172.544 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 20.0 p -84.33 -15.35 46.86 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 124.922 1.289 . . . . 0.0 111.732 -178.948 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 30.7 mmmt -78.34 -14.1 59.56 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 124.212 1.005 . . . . 0.0 110.844 173.869 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 79.28 33.45 35.61 Favored Glycine 0 CA--C 1.524 0.653 0 CA-C-O 119.333 -0.704 . . . . 0.0 112.335 170.22 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 12.9 m -75.91 170.04 1.58 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.458 0 CA-C-N 118.518 1.159 . . . . 0.0 110.203 173.218 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 16.5 tptm -101.62 129.29 47.71 Favored 'General case' 0 CA--C 1.515 -0.402 0 N-CA-C 105.086 -2.19 . . . . 0.0 105.086 168.219 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 65.9 m-85 -93.78 123.92 37.44 Favored 'General case' 0 C--N 1.33 -0.239 0 N-CA-C 107.654 -1.239 . . . . 0.0 107.654 171.303 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 30.2 m -106.18 160.95 5.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 C-N-CA 123.914 0.886 . . . . 0.0 109.387 168.649 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 99.18 -77.07 0.51 Allowed Glycine 0 N--CA 1.446 -0.67 0 C-N-CA 125.122 1.344 . . . . 0.0 111.839 170.651 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 20.8 m-85 55.39 -170.17 0.07 Allowed 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 124.129 0.972 . . . . 0.0 110.861 -169.639 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -154.57 143.41 14.77 Favored Pre-proline 0 N--CA 1.466 0.332 0 CA-C-O 117.628 -1.177 . . . . 0.0 108.809 168.737 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_exo -61.97 127.72 22.16 Favored 'Trans proline' 0 CA--C 1.533 0.461 0 C-N-CA 122.209 1.94 . . . . 0.0 111.144 178.403 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 10.4 p -79.1 -14.1 59.34 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 112.753 0.649 . . . . 0.0 112.753 174.199 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -63.12 129.14 39.05 Favored 'General case' 0 CA--C 1.536 0.415 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 -178.462 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 93.56 -11.52 71.21 Favored Glycine 0 CA--C 1.534 1.271 0 C-N-CA 124.848 1.213 . . . . 0.0 113.729 -176.39 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 11.6 m-85 -96.45 158.84 15.25 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 119.013 1.407 . . . . 0.0 109.508 169.171 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -132.11 129.75 40.29 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 124.601 1.161 . . . . 0.0 108.05 175.691 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 41.0 p90 -165.2 170.51 14.78 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 126.829 2.052 . . . . 0.0 107.345 -176.384 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 3.0 t -133.4 -3.38 3.03 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 123.489 0.716 . . . . 0.0 111.238 169.961 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 2.1 p -77.66 131.46 70.92 Favored Pre-proline 0 CA--C 1.543 0.675 0 C-N-CA 125.244 1.417 . . . . 0.0 109.699 -175.25 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -84.39 -24.85 2.31 Favored 'Trans proline' 0 CA--C 1.537 0.663 0 C-N-CA 122.355 2.037 . . . . 0.0 112.928 -177.733 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 23.6 ttmt -58.81 -43.66 98.02 Favored Pre-proline 0 CA--C 1.54 0.586 0 CA-C-O 117.457 -1.259 . . . . 0.0 113.844 -169.624 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -81.99 5.35 6.38 Favored 'Trans proline' 0 C--N 1.352 0.746 0 CA-C-N 122.187 1.817 . . . . 0.0 113.551 -176.588 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 17.1 m -135.5 170.05 19.85 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.249 0 CA-C-N 120.622 1.556 . . . . 0.0 111.36 -169.574 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 14.5 pt -141.1 175.23 6.02 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.657 0 C-N-CA 127.876 2.47 . . . . 0.0 108.254 -179.472 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . 54.8 42.59 31.04 Favored 'General case' 0 N--CA 1.464 0.266 0 C-N-CA 125.27 1.428 . . . . 0.0 112.342 173.849 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 27.1 t0 53.69 41.5 32.06 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 126.184 1.794 . . . . 0.0 111.696 -176.452 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 88.03 14.51 62.49 Favored Glycine 0 CA--C 1.526 0.758 0 CA-C-O 118.496 -1.169 . . . . 0.0 113.771 174.037 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 45.7 mt-30 -84.65 -17.31 39.0 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 119.462 1.631 . . . . 0.0 112.658 -179.892 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -143.91 144.74 31.86 Favored 'General case' 0 C--N 1.342 0.252 0 CA-C-N 119.266 0.939 . . . . 0.0 110.379 174.174 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 68.3 m-85 -73.71 141.43 46.38 Favored 'General case' 0 CA--C 1.512 -0.489 0 N-CA-C 105.08 -2.192 . . . . 0.0 105.08 165.173 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 8.0 p -79.05 14.46 0.35 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.672 0 CA-C-O 121.363 0.601 . . . . 0.0 111.714 -176.412 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -178.82 172.87 45.18 Favored Glycine 0 CA--C 1.525 0.712 0 N-CA-C 109.209 -1.556 . . . . 0.0 109.209 177.262 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -66.21 138.66 57.83 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 117.658 0.729 . . . . 0.0 111.122 -176.214 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -98.5 118.47 35.27 Favored 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 125.716 1.607 . . . . 0.0 109.068 175.883 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 93.5 mt -107.61 156.79 18.65 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 123.776 0.831 . . . . 0.0 109.153 169.651 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -135.54 159.76 40.61 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 125.907 1.683 . . . . 0.0 108.625 174.584 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -135.29 6.8 3.33 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 124.704 1.201 . . . . 0.0 113.105 169.558 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 80.9 m -112.78 -44.0 3.37 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 124.548 1.139 . . . . 0.0 112.062 -171.823 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 6.9 p30 -105.62 -33.81 7.95 Favored 'General case' 0 C--O 1.232 0.175 0 C-N-CA 124.235 1.014 . . . . 0.0 113.244 -169.895 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 35.5 mt-30 -141.15 33.74 1.72 Allowed 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 125.101 1.36 . . . . 0.0 110.87 -170.699 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 28.0 p90 -55.56 -29.08 58.35 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 124.27 1.028 . . . . 0.0 112.364 -178.217 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -59.58 -37.68 79.16 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 123.607 0.763 . . . . 0.0 112.005 177.89 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 3.6 pp -105.52 5.35 31.37 Favored 'General case' 0 C--N 1.34 0.17 0 C-N-CA 125.084 1.354 . . . . 0.0 112.773 -176.505 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 50.7 m -60.33 -28.88 68.49 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-N 120.593 1.542 . . . . 0.0 110.582 169.503 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -60.71 -40.74 93.39 Favored 'General case' 0 N--CA 1.464 0.231 0 C-N-CA 123.35 0.66 . . . . 0.0 111.448 170.398 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -65.02 -45.11 86.88 Favored 'General case' 0 C--O 1.234 0.288 0 C-N-CA 124.869 1.268 . . . . 0.0 110.315 177.042 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 81.8 mtt180 -58.06 -47.58 82.71 Favored 'General case' 0 N--CA 1.462 0.148 0 CA-C-O 118.649 -0.691 . . . . 0.0 110.089 176.314 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 46.4 mt -62.8 -53.23 49.5 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.281 0 N-CA-C 107.904 -1.147 . . . . 0.0 107.904 179.696 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 69.8 tp60 -53.68 -61.15 2.49 Favored 'General case' 0 C--O 1.233 0.22 0 C-N-CA 124.024 0.929 . . . . 0.0 110.867 -175.943 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 44.3 p -65.02 -36.84 85.66 Favored 'General case' 0 C--N 1.326 -0.418 0 O-C-N 123.062 0.227 . . . . 0.0 110.95 -170.375 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 160' ' ' TRP . . . . . 0.488 ' CH2' ' HB1' ' A' ' 83' ' ' ALA . 36.0 t90 -67.73 -44.17 78.21 Favored 'General case' 0 C--O 1.221 -0.395 0 O-C-N 122.248 -0.283 . . . . 0.0 110.929 177.465 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 58.7 m -59.18 -44.29 92.18 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 123.039 0.536 . . . . 0.0 110.703 178.541 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -62.49 -41.96 99.16 Favored 'General case' 0 N--CA 1.456 -0.13 0 CA-C-O 121.071 0.463 . . . . 0.0 109.888 176.38 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 12.6 tt0 -62.9 -52.92 61.19 Favored 'General case' 0 N--CA 1.448 -0.537 0 O-C-N 121.664 -0.647 . . . . 0.0 110.095 -179.02 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 45.0 pt -62.47 -37.77 79.65 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.399 0 CA-C-O 117.582 -1.199 . . . . 0.0 109.23 -174.401 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -65.53 -33.34 75.69 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 119.552 1.069 . . . . 0.0 110.488 -179.45 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 34.6 m-80 -71.88 -51.68 21.11 Favored 'General case' 0 N--CA 1.465 0.315 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 175.786 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 8.9 tt0 -72.38 -31.92 65.97 Favored 'General case' 0 N--CA 1.441 -0.92 0 C-N-CA 123.79 0.836 . . . . 0.0 110.941 -168.566 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 168' ' ' MET . . . . . . . . . . . . . 21.3 ptp -69.88 -31.8 69.8 Favored 'General case' 0 C--N 1.331 -0.196 0 O-C-N 121.068 -1.02 . . . . 0.0 111.407 171.744 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 169' ' ' ALA . . . . . 0.504 ' HA ' ' CD2' ' A' ' 172' ' ' TYR . . . -78.57 -44.12 24.94 Favored 'General case' 0 N--CA 1.443 -0.796 0 CA-C-O 120.375 0.131 . . . . 0.0 110.983 -175.518 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -65.06 -29.23 70.1 Favored 'General case' 0 CA--C 1.54 0.566 0 N-CA-C 110.088 -0.338 . . . . 0.0 110.088 176.893 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 65.8 t60 -65.35 -48.69 72.11 Favored 'General case' 0 C--O 1.235 0.294 0 C-N-CA 123.601 0.76 . . . . 0.0 111.04 174.129 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 172' ' ' TYR . . . . . 0.504 ' CD2' ' HA ' ' A' ' 169' ' ' ALA . 0.2 OUTLIER -77.14 -30.14 54.98 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-O 119.046 -0.502 . . . . 0.0 112.031 -172.928 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.268 0 C-N-CA 124.148 0.979 . . . . 0.0 110.73 -179.177 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.496 1.85 0 N-CA-C 111.252 0.093 . . . . 0.0 111.252 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 3.0 t30 -119.03 151.62 37.9 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 124.223 1.009 . . . . 0.0 109.784 -174.558 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 1.4 mpt? -116.88 125.89 52.18 Favored 'General case' 0 N--CA 1.463 0.22 0 C-N-CA 123.76 0.824 . . . . 0.0 110.706 179.23 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -82.83 153.2 30.92 Favored Glycine 0 CA--C 1.527 0.811 0 N-CA-C 107.51 -2.236 . . . . 0.0 107.51 166.96 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 3.1 tt -140.26 97.11 3.16 Favored 'General case' 0 N--CA 1.465 0.312 0 N-CA-C 104.888 -2.264 . . . . 0.0 104.888 -176.06 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.414 ' CE2' ' HG ' ' A' ' 51' ' ' LEU . 0.3 OUTLIER -103.44 147.02 27.64 Favored 'General case' 0 N--CA 1.455 -0.181 0 CA-C-O 121.577 0.703 . . . . 0.0 111.914 -172.155 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 47.6 p90 -159.97 173.68 15.52 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 126.294 1.838 . . . . 0.0 107.994 176.425 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -123.53 153.72 17.27 Favored Glycine 0 CA--C 1.526 0.746 0 N-CA-C 108.009 -2.036 . . . . 0.0 108.009 168.683 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 29.9 p -157.38 159.81 37.79 Favored 'General case' 0 C--O 1.238 0.451 0 C-N-CA 123.903 0.881 . . . . 0.0 109.289 178.036 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 11.7 m -69.47 -44.26 71.54 Favored 'General case' 0 CA--C 1.534 0.352 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 169.77 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 1.1 p -152.59 156.46 39.34 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 126.803 2.041 . . . . 0.0 107.974 177.729 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 35.2 m 55.28 -157.26 0.23 Allowed 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 125.213 1.405 . . . . 0.0 111.983 175.031 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 1.3 p90 -66.54 153.09 43.89 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.011 0.924 . . . . 0.0 110.479 174.725 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 3.6 t -63.86 -40.07 95.68 Favored 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 171.301 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -158.87 153.85 25.07 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 105.054 -2.202 . . . . 0.0 105.054 177.524 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 9.2 mtm -62.13 -9.35 7.32 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-N 119.321 0.964 . . . . 0.0 112.239 178.132 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -50.47 -37.07 36.57 Favored 'General case' 0 C--O 1.223 -0.337 0 CA-C-N 118.972 0.806 . . . . 0.0 111.054 167.612 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -66.11 -43.49 87.05 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 119.94 1.245 . . . . 0.0 111.609 -179.751 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 67.0 mm-40 -62.68 -47.53 83.23 Favored 'General case' 0 N--CA 1.464 0.261 0 N-CA-C 109.16 -0.682 . . . . 0.0 109.16 173.023 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 29.2 mtpp -70.16 -36.85 74.98 Favored 'General case' 0 C--O 1.221 -0.397 0 CA-C-O 118.428 -0.796 . . . . 0.0 110.796 -169.351 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 32.1 mt -53.95 -55.93 11.71 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.223 0 CA-C-N 119.307 0.958 . . . . 0.0 108.687 173.472 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 18.2 ptt180 -65.25 -38.44 90.36 Favored 'General case' 0 C--N 1.344 0.343 0 C-N-CA 120.153 -0.619 . . . . 0.0 110.03 -176.687 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -64.69 -38.63 91.65 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 -174.553 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 64.0 mt -78.27 -56.13 8.3 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.63 0 C-N-CA 125.496 1.518 . . . . 0.0 110.057 -174.435 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 77.0 mt -64.66 -45.88 94.02 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 -177.755 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 141.58 120.35 1.62 Allowed Glycine 0 CA--C 1.53 0.975 0 C-N-CA 125.452 1.501 . . . . 0.0 110.595 176.969 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -75.53 -4.43 15.26 Favored 'Trans proline' 0 CA--C 1.538 0.705 0 C-N-CA 122.82 2.347 . . . . 0.0 113.183 -171.554 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -82.99 -20.5 35.01 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 118.945 0.793 . . . . 0.0 111.418 176.551 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 1.2 pt? -120.96 -14.19 8.49 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 125.057 1.343 . . . . 0.0 113.589 -175.689 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 62.5 t -97.46 148.02 6.01 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 N-CA-C 107.315 -1.365 . . . . 0.0 107.315 168.622 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 46.6 m -135.3 133.08 38.49 Favored 'General case' 0 C--N 1.332 -0.175 0 C-N-CA 125.659 1.584 . . . . 0.0 108.188 -178.906 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 35.7 mt -82.3 142.57 31.96 Favored 'General case' 0 C--O 1.234 0.263 0 N-CA-C 108.574 -0.898 . . . . 0.0 108.574 177.682 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 28.6 t-80 -139.39 60.65 1.57 Allowed 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 124.481 1.112 . . . . 0.0 108.335 -173.577 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 64.3 t-20 -60.88 126.76 28.57 Favored 'General case' 0 C--O 1.232 0.181 0 N-CA-C 107.128 -1.434 . . . . 0.0 107.128 173.309 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 83.3 mt -66.72 -22.44 66.06 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 123.24 0.616 . . . . 0.0 112.16 -179.64 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 56.7 tttt -66.66 -22.11 66.1 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 118.147 0.43 . . . . 0.0 111.708 169.143 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -107.62 -35.3 6.75 Favored 'General case' 0 C--O 1.234 0.272 0 C-N-CA 124.081 0.953 . . . . 0.0 113.25 -169.661 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 2.9 t0 -139.14 155.53 47.79 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 118.717 0.69 . . . . 0.0 112.151 178.128 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 17.2 m -75.06 157.94 84.81 Favored Pre-proline 0 CA--C 1.54 0.595 0 C-N-CA 125.618 1.567 . . . . 0.0 111.482 -170.68 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -73.89 -26.29 13.44 Favored 'Trans proline' 0 C--N 1.349 0.563 0 C-N-CA 122.778 2.318 . . . . 0.0 113.236 -171.68 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 22.7 mmmt -71.27 -12.08 61.26 Favored 'General case' 0 N--CA 1.471 0.576 0 O-C-N 120.395 -1.441 . . . . 0.0 111.716 -176.44 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -61.21 -28.41 69.13 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 125.451 1.5 . . . . 0.0 110.38 168.923 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 45.5 mtt -58.71 -25.96 63.42 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 118.591 0.632 . . . . 0.0 111.745 177.478 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 88.0 mt-10 -65.93 -32.56 74.14 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-O 119.017 -0.516 . . . . 0.0 110.249 -176.567 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 21.2 mt-30 -65.9 -44.28 85.69 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 123.601 0.76 . . . . 0.0 112.541 -170.362 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 52.5 m-85 -74.78 142.24 44.3 Favored 'General case' 0 N--CA 1.456 -0.153 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.662 -166.724 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -69.21 -42.48 75.68 Favored 'General case' 0 C--O 1.235 0.29 0 N-CA-C 109.894 -0.41 . . . . 0.0 109.894 176.413 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 7.2 t -106.33 143.76 16.7 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.368 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 175.306 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 37.8 tp -131.64 114.36 14.71 Favored 'General case' 0 N--CA 1.444 -0.77 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 174.295 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 31.8 mt -94.44 132.75 37.61 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 N-CA-C 106.781 -1.563 . . . . 0.0 106.781 178.416 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.414 ' HG ' ' CE2' ' A' ' 6' ' ' PHE . 3.1 mp -113.95 130.15 56.54 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 125.641 1.577 . . . . 0.0 107.102 -176.583 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -135.67 126.83 4.06 Favored Glycine 0 C--N 1.335 0.491 0 N-CA-C 109.908 -1.277 . . . . 0.0 109.908 177.607 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 7.4 tt -153.57 127.3 4.36 Favored Pre-proline 0 CA--C 1.538 0.496 0 CA-C-N 117.872 0.836 . . . . 0.0 109.892 172.298 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -73.67 156.33 49.09 Favored 'Trans proline' 0 N--CA 1.459 -0.544 0 C-N-CA 122.268 1.979 . . . . 0.0 112.782 169.496 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 1.9 m -132.34 135.53 46.23 Favored 'General case' 0 CA--C 1.535 0.372 0 N-CA-C 108.547 -0.909 . . . . 0.0 108.547 168.14 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 5.9 m-90 -144.19 178.85 7.6 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 125.46 1.504 . . . . 0.0 107.404 169.283 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -59.93 -29.23 68.25 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 123.512 0.725 . . . . 0.0 112.299 171.989 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 70.5 t80 -115.64 164.34 14.48 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 125.206 1.403 . . . . 0.0 109.856 177.349 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 79.77 -75.92 2.08 Favored Glycine 0 CA--C 1.528 0.857 0 N-CA-C 110.492 -1.043 . . . . 0.0 110.492 176.899 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.505 ' HG2' ' H ' ' A' ' 61' ' ' ILE . 5.3 tt0 53.18 -155.21 0.21 Allowed 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 124.864 1.266 . . . . 0.0 110.324 -175.126 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.505 ' H ' ' HG2' ' A' ' 60' ' ' GLU . 65.9 mt -55.18 119.38 1.82 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.492 0 C-N-CA 125.211 1.404 . . . . 0.0 107.378 169.981 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -85.32 164.81 17.76 Favored 'General case' 0 C--O 1.234 0.254 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 173.661 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -55.2 -38.41 68.37 Favored 'General case' 0 C--O 1.222 -0.36 0 C-N-CA 123.811 0.844 . . . . 0.0 110.741 179.793 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -61.2 -24.48 66.36 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-N 118.792 0.724 . . . . 0.0 112.562 -177.074 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' TRP . . . . . 0.415 ' CH2' HD23 ' A' ' 104' ' ' LEU . 12.2 t90 -96.63 -47.57 5.86 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 124.89 1.276 . . . . 0.0 109.348 176.611 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -64.41 -33.71 76.49 Favored 'General case' 0 CA--C 1.539 0.534 0 O-C-N 120.833 -1.167 . . . . 0.0 110.593 -175.282 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -63.46 -26.58 68.79 Favored 'General case' 0 CA--C 1.529 0.135 0 C-N-CA 123.273 0.629 . . . . 0.0 110.872 -173.956 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 29.1 m -108.57 -15.43 9.36 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.314 0 CA-C-O 117.366 -1.302 . . . . 0.0 111.879 177.12 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 29.4 t90 -51.35 -35.5 38.73 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-N 120.189 1.359 . . . . 0.0 110.679 177.108 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -62.86 -29.33 70.67 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 125.441 1.496 . . . . 0.0 113.303 175.367 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 31.0 mt-30 -92.42 -18.3 23.44 Favored 'General case' 0 N--CA 1.463 0.209 0 C-N-CA 126.09 1.756 . . . . 0.0 112.324 177.29 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 56.7 mt -63.48 -21.04 66.09 Favored 'General case' 0 CA--C 1.534 0.338 0 O-C-N 121.304 -0.872 . . . . 0.0 111.496 -178.119 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -80.11 -23.05 41.49 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 123.011 0.525 . . . . 0.0 111.868 173.671 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -71.83 -30.32 65.36 Favored 'General case' 0 N--CA 1.468 0.466 0 O-C-N 120.705 -1.247 . . . . 0.0 111.843 177.529 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 79.5 mt -52.96 140.85 23.68 Favored 'General case' 0 C--N 1.34 0.174 0 C-N-CA 125.012 1.325 . . . . 0.0 112.757 -168.787 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 28.9 t-20 -74.97 106.43 6.47 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 169.312 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 64.7 mt -128.61 0.07 5.52 Favored 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 113.891 1.071 . . . . 0.0 113.891 -174.393 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 27.2 mt-10 -57.79 128.38 36.81 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 119.658 1.117 . . . . 0.0 110.689 -169.031 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 71.65 -0.05 37.45 Favored Glycine 0 CA--C 1.532 1.127 0 C-N-CA 125.397 1.475 . . . . 0.0 115.046 179.445 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.26 151.55 39.87 Favored 'General case' 0 C--N 1.348 0.51 0 CA-C-N 120.798 2.299 . . . . 0.0 109.649 -177.775 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 3.6 mt -80.67 136.9 22.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 N-CA-C 106.765 -1.568 . . . . 0.0 106.765 178.876 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 68.8 t -132.17 131.56 61.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 C-N-CA 123.813 0.845 . . . . 0.0 109.833 -178.555 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -105.39 150.12 25.52 Favored 'General case' 0 N--CA 1.463 0.192 0 N-CA-C 107.417 -1.327 . . . . 0.0 107.417 168.603 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 3.6 mt -132.24 134.19 45.02 Favored 'General case' 0 CA--C 1.51 -0.594 0 N-CA-C 107.265 -1.383 . . . . 0.0 107.265 177.77 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 35.8 p90 -151.03 165.84 32.55 Favored 'General case' 0 N--CA 1.447 -0.595 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 168.764 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -162.62 159.59 31.9 Favored Glycine 0 N--CA 1.444 -0.784 0 N-CA-C 108.556 -1.817 . . . . 0.0 108.556 172.963 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 7.0 tt -103.55 147.47 27.14 Favored 'General case' 0 N--CA 1.445 -0.7 0 N-CA-C 108.493 -0.929 . . . . 0.0 108.493 171.56 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -150.53 -169.39 16.45 Favored Glycine 0 CA--C 1.522 0.514 0 N-CA-C 109.904 -1.278 . . . . 0.0 109.904 174.96 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -148.04 139.22 23.41 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 124.823 1.249 . . . . 0.0 107.935 178.541 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 16.6 pm0 -108.81 1.05 20.69 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 124.009 0.924 . . . . 0.0 113.176 177.392 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 28.3 mt -67.06 -38.73 86.33 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 119.696 1.135 . . . . 0.0 108.701 168.361 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -74.44 43.57 1.33 Allowed Glycine 0 CA--C 1.533 1.212 0 C-N-CA 126.04 1.781 . . . . 0.0 111.82 169.237 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 49.4 m-85 62.84 -19.7 0.05 OUTLIER 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 129.267 3.027 . . . . 0.0 116.565 177.228 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 77.35 15.6 81.31 Favored Glycine 0 CA--C 1.529 0.932 0 CA-C-N 120.148 1.34 . . . . 0.0 112.132 -179.774 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -77.14 -16.89 58.98 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 118.796 1.298 . . . . 0.0 110.965 169.72 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' TRP . . . . . . . . . . . . . 53.7 m95 -109.18 6.67 24.96 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 125.074 1.35 . . . . 0.0 111.62 177.37 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 8.6 t80 -61.74 126.34 27.0 Favored 'General case' 0 C--N 1.343 0.297 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 -175.852 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 83.8 mt 51.73 19.31 0.89 Allowed 'General case' 0 N--CA 1.467 0.379 0 N-CA-C 115.679 1.733 . . . . 0.0 115.679 167.668 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -61.84 -36.62 81.72 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-N 121.511 1.959 . . . . 0.0 111.29 -173.37 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -65.83 -27.74 68.47 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 124.328 1.051 . . . . 0.0 112.295 174.52 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 5.3 tt -66.56 -46.69 75.22 Favored 'General case' 0 N--CA 1.467 0.424 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 173.056 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -63.47 -34.6 90.4 Favored Glycine 0 CA--C 1.529 0.944 0 N-CA-C 110.659 -0.976 . . . . 0.0 110.659 -179.732 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 5.2 tpp -50.89 -54.08 27.03 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 124.963 1.305 . . . . 0.0 111.527 175.88 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.415 HD23 ' CH2' ' A' ' 65' ' ' TRP . 0.2 OUTLIER -76.82 -36.61 56.77 Favored 'General case' 0 C--N 1.341 0.238 0 O-C-N 121.891 -0.506 . . . . 0.0 109.782 -175.195 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 43.1 t-80 -55.71 -48.88 74.41 Favored 'General case' 0 N--CA 1.464 0.231 0 O-C-N 121.436 -0.79 . . . . 0.0 110.872 176.261 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -63.44 -38.77 92.42 Favored 'General case' 0 C--O 1.234 0.288 0 C-N-CA 123.288 0.635 . . . . 0.0 112.103 -176.323 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 24.4 ttmm -57.45 -36.09 70.98 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 123.382 0.673 . . . . 0.0 110.727 172.825 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 22.3 mt -91.86 -20.49 21.4 Favored 'General case' 0 CA--C 1.513 -0.45 0 N-CA-C 115.8 1.778 . . . . 0.0 115.8 -168.238 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 6.0 m -58.15 -33.62 69.38 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-N 120.481 1.491 . . . . 0.0 111.627 -178.218 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 20.7 p -87.39 -9.33 55.04 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 124.884 1.274 . . . . 0.0 112.287 -179.807 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 32.5 mmmt -84.53 -4.63 59.06 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 124.461 1.104 . . . . 0.0 111.453 172.975 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 69.92 31.96 69.89 Favored Glycine 0 CA--C 1.525 0.657 0 CA-C-N 118.605 0.639 . . . . 0.0 112.105 171.827 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 3.5 m -76.33 172.38 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.474 0 CA-C-N 118.104 0.952 . . . . 0.0 109.457 175.237 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -111.9 121.1 44.11 Favored 'General case' 0 CA--C 1.515 -0.386 0 N-CA-C 106.474 -1.676 . . . . 0.0 106.474 173.615 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 64.0 m-85 -88.32 145.35 25.88 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 119.61 1.095 . . . . 0.0 109.378 -178.13 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 27.7 m -129.4 161.08 39.58 Favored 'Isoleucine or valine' 0 C--O 1.233 0.212 0 C-N-CA 124.223 1.009 . . . . 0.0 109.289 171.588 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 93.2 -94.18 1.83 Allowed Glycine 0 N--CA 1.443 -0.877 0 C-N-CA 124.817 1.199 . . . . 0.0 110.804 176.435 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 8.0 m-30 59.57 177.05 0.08 Allowed 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 125.109 1.364 . . . . 0.0 110.188 -167.986 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -155.27 140.94 12.65 Favored Pre-proline 0 N--CA 1.473 0.7 0 CA-C-O 116.872 -1.537 . . . . 0.0 108.76 -179.468 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -68.13 127.77 16.47 Favored 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 122.698 2.265 . . . . 0.0 112.64 -176.166 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 68.0 p -80.88 -7.65 59.53 Favored 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 112.393 0.516 . . . . 0.0 112.393 169.619 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -59.75 122.62 14.62 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 124.031 0.933 . . . . 0.0 110.314 -169.878 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 71.48 5.01 59.02 Favored Glycine 0 CA--C 1.536 1.382 0 C-N-CA 124.495 1.045 . . . . 0.0 114.293 178.352 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 2.9 t80 -80.29 151.26 29.63 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 118.853 1.326 . . . . 0.0 110.213 -177.538 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -103.02 108.18 19.26 Favored 'General case' 0 N--CA 1.463 0.206 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 174.967 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 18.9 p90 -164.33 166.06 21.14 Favored 'General case' 0 C--O 1.241 0.641 0 C-N-CA 127.298 2.239 . . . . 0.0 105.583 179.538 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 86.0 m -131.81 -31.56 1.52 Allowed 'General case' 0 N--CA 1.44 -0.961 0 C-N-CA 122.683 0.393 . . . . 0.0 111.62 -173.623 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 1.4 m -53.96 127.3 53.46 Favored Pre-proline 0 CA--C 1.547 0.842 0 C-N-CA 124.325 1.05 . . . . 0.0 112.269 -176.501 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_endo -84.84 -30.01 0.62 Allowed 'Trans proline' 0 CA--C 1.541 0.829 0 C-N-CA 122.408 2.072 . . . . 0.0 112.732 177.451 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 32.5 ttmt -57.14 -42.86 98.36 Favored Pre-proline 0 N--CA 1.471 0.618 0 CA-C-O 117.668 -1.158 . . . . 0.0 113.412 -173.447 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 62.9 Cg_endo -84.77 13.86 2.64 Favored 'Trans proline' 0 C--N 1.348 0.539 0 C-N-CA 121.844 1.696 . . . . 0.0 113.581 -178.866 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 35.1 m -128.63 154.9 40.11 Favored 'Isoleucine or valine' 0 C--O 1.235 0.3 0 CA-C-N 121.777 2.08 . . . . 0.0 111.109 179.065 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 17.8 pt -114.32 167.94 6.66 Favored 'Isoleucine or valine' 0 C--O 1.235 0.319 0 C-N-CA 126.41 1.884 . . . . 0.0 109.145 174.82 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . 57.73 32.94 22.61 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 124.967 1.307 . . . . 0.0 113.484 167.687 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 27.6 t70 54.99 39.83 31.78 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 126.251 1.82 . . . . 0.0 111.592 -175.164 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 93.63 72.21 1.18 Allowed Glycine 0 CA--C 1.528 0.854 0 C-N-CA 124.487 1.042 . . . . 0.0 111.243 177.013 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 78.8 mm-40 -116.66 -49.57 2.64 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 123.168 0.587 . . . . 0.0 110.354 167.375 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -132.48 146.52 51.99 Favored 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 123.017 0.527 . . . . 0.0 110.969 -179.252 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 58.9 m-85 -77.63 16.79 0.61 Allowed 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 126.189 1.796 . . . . 0.0 115.65 177.879 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 3.7 m 49.64 11.73 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.547 0.831 0 C-N-CA 126.927 2.091 . . . . 0.0 114.469 -176.586 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 170.42 170.06 34.28 Favored Glycine 0 CA--C 1.527 0.805 0 N-CA-C 108.368 -1.893 . . . . 0.0 108.368 -171.562 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -69.24 134.95 49.84 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 117.977 0.888 . . . . 0.0 111.007 -178.347 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -95.87 109.94 22.21 Favored 'General case' 0 N--CA 1.448 -0.571 0 C-N-CA 125.52 1.528 . . . . 0.0 109.056 175.291 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 83.8 mt -101.63 154.73 18.61 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 118.845 0.748 . . . . 0.0 109.561 170.157 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -151.54 145.67 25.32 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 106.231 -1.766 . . . . 0.0 106.231 169.321 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 16.2 tt0 -140.95 26.6 2.04 Favored 'General case' 0 CA--C 1.543 0.704 0 CA-C-O 121.45 0.643 . . . . 0.0 110.013 169.82 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 56.5 m -109.9 -42.26 4.28 Favored 'General case' 0 C--O 1.235 0.324 0 C-N-CA 125.311 1.444 . . . . 0.0 109.351 175.36 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 4.5 m-80 -86.83 -34.24 19.57 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 124.069 0.948 . . . . 0.0 109.025 -176.975 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 3.5 mt-30 -122.03 173.76 7.34 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 127.321 2.248 . . . . 0.0 108.632 177.489 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 81.6 t80 -146.1 -47.84 0.21 Allowed 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 123.5 0.72 . . . . 0.0 110.146 170.026 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -68.26 -48.52 64.84 Favored 'General case' 0 N--CA 1.466 0.331 0 O-C-N 122.182 -0.324 . . . . 0.0 111.868 -172.741 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -85.73 -1.54 57.3 Favored 'General case' 0 N--CA 1.466 0.361 0 N-CA-C 113.13 0.789 . . . . 0.0 113.13 -173.305 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 13.3 m -59.52 -31.57 69.51 Favored 'General case' 0 CA--C 1.543 0.681 0 O-C-N 121.017 -1.052 . . . . 0.0 110.156 171.871 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -63.96 -39.54 94.36 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 123.972 0.909 . . . . 0.0 111.671 172.645 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 -64.55 -46.98 80.51 Favored 'General case' 0 C--O 1.234 0.263 0 C-N-CA 124.294 1.038 . . . . 0.0 109.858 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 72.1 mtt180 -55.32 -41.1 71.98 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-O 118.795 -0.622 . . . . 0.0 110.627 177.039 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 75.9 mt -68.39 -57.97 7.39 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.299 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 177.316 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 70.8 tp60 -49.64 -63.04 1.23 Allowed 'General case' 0 C--O 1.233 0.193 0 C-N-CA 125.12 1.368 . . . . 0.0 112.106 -173.94 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 20.0 m -66.8 -31.95 72.91 Favored 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 120.826 -0.35 . . . . 0.0 111.245 -170.342 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 160' ' ' TRP . . . . . . . . . . . . . 34.0 t90 -70.87 -44.32 66.61 Favored 'General case' 0 CA--C 1.516 -0.342 0 O-C-N 122.005 -0.434 . . . . 0.0 110.898 176.999 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 98.4 m -59.46 -42.79 92.81 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 122.846 0.458 . . . . 0.0 110.093 177.454 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -63.44 -41.86 98.66 Favored 'General case' 0 N--CA 1.456 -0.147 0 CA-C-O 121.006 0.431 . . . . 0.0 110.181 175.72 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 14.7 tt0 -62.61 -51.99 65.14 Favored 'General case' 0 N--CA 1.449 -0.495 0 O-C-N 121.692 -0.63 . . . . 0.0 109.934 -178.938 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 42.2 pt -63.27 -37.98 80.9 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.328 0 CA-C-O 117.669 -1.158 . . . . 0.0 109.231 -175.714 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -65.75 -34.91 79.28 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 119.776 1.171 . . . . 0.0 110.486 -179.548 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 31.2 m-80 -68.49 -50.59 51.13 Favored 'General case' 0 CA--C 1.516 -0.34 0 N-CA-C 108.785 -0.821 . . . . 0.0 108.785 175.285 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 15.5 tt0 -71.14 -33.61 70.24 Favored 'General case' 0 N--CA 1.438 -1.062 0 C-N-CA 124.174 0.99 . . . . 0.0 111.131 -168.616 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 168' ' ' MET . . . . . . . . . . . . . 22.9 ptp -72.42 -30.18 64.39 Favored 'General case' 0 C--N 1.332 -0.171 0 O-C-N 121.136 -0.978 . . . . 0.0 111.702 173.738 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -79.48 -41.16 28.08 Favored 'General case' 0 N--CA 1.447 -0.601 0 C-N-CA 122.636 0.375 . . . . 0.0 111.416 -179.765 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -71.59 -26.16 62.48 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 122.964 0.506 . . . . 0.0 110.454 -178.578 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 77.6 t60 -58.09 -27.28 63.53 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 123.65 0.78 . . . . 0.0 110.995 169.794 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 6.7 m-85 -94.17 -2.75 52.11 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 125.633 1.573 . . . . 0.0 113.731 176.015 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.254 1.339 0 CA-C-N 119.611 1.096 . . . . 0.0 109.971 177.893 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.498 1.931 0 CA-C-O 120.011 -0.042 . . . . 0.0 111.078 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 4.0 t30 -116.66 151.36 36.47 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 124.195 0.998 . . . . 0.0 110.134 -173.483 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 1.2 mpt? -118.75 123.31 44.52 Favored 'General case' 0 C--N 1.334 -0.096 0 C-N-CA 123.747 0.819 . . . . 0.0 111.183 179.47 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -81.85 153.93 33.37 Favored Glycine 0 CA--C 1.524 0.655 0 N-CA-C 107.521 -2.232 . . . . 0.0 107.521 166.655 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 3.3 tt -140.3 96.47 3.05 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 105.422 -2.066 . . . . 0.0 105.422 -176.414 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -102.98 143.83 32.04 Favored 'General case' 0 CA--C 1.517 -0.303 0 CA-C-O 121.769 0.795 . . . . 0.0 112.186 -170.86 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 36.3 p90 -161.03 173.4 15.27 Favored 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 127.676 2.391 . . . . 0.0 106.237 177.141 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -156.12 106.6 0.3 Allowed Glycine 0 CA--C 1.51 -0.259 0 N-CA-C 106.286 -2.726 . . . . 0.0 106.286 175.308 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 14.5 m -144.58 160.43 41.16 Favored 'General case' 0 C--O 1.235 0.335 0 C-N-CA 124.085 0.954 . . . . 0.0 109.745 -169.2 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 7.4 m -70.88 -31.4 68.05 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 122.842 0.457 . . . . 0.0 110.441 172.418 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 9.5 p -72.71 158.4 35.67 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 124.864 1.265 . . . . 0.0 109.914 172.446 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 62.7 m -66.35 -25.16 66.68 Favored 'General case' 0 CA--C 1.535 0.399 0 O-C-N 122.054 -0.404 . . . . 0.0 111.961 179.174 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 31.4 m-85 -138.95 173.74 11.25 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 126.362 1.865 . . . . 0.0 108.442 -176.98 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 22.7 p -74.46 82.43 1.96 Allowed 'General case' 0 CA--C 1.536 0.433 0 N-CA-C 106.429 -1.693 . . . . 0.0 106.429 168.821 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 59.91 -86.8 0.02 OUTLIER 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 125.387 1.475 . . . . 0.0 109.006 -167.446 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -135.87 -2.36 2.37 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 125.165 1.386 . . . . 0.0 113.008 171.259 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -68.98 -39.28 79.48 Favored 'General case' 0 C--O 1.222 -0.373 0 O-C-N 120.917 -1.114 . . . . 0.0 113.082 -167.724 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -58.74 -47.09 85.85 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 120.188 1.358 . . . . 0.0 111.077 -179.002 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -64.53 -46.43 82.91 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 123.104 0.562 . . . . 0.0 109.568 177.088 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 58.4 mttm -60.33 -45.58 92.93 Favored 'General case' 0 N--CA 1.466 0.367 0 O-C-N 121.755 -0.59 . . . . 0.0 111.596 -178.964 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 44.2 mt -53.72 -55.74 12.18 Favored 'Isoleucine or valine' 0 C--O 1.234 0.242 0 C-N-CA 124.465 1.106 . . . . 0.0 108.505 176.215 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 1.3 ttp180 -60.73 -41.29 95.04 Favored 'General case' 0 C--O 1.223 -0.31 0 CA-C-O 118.929 -0.558 . . . . 0.0 109.687 -174.675 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -68.02 -42.66 80.3 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 123.206 0.602 . . . . 0.0 111.173 -177.724 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.413 HD13 ' HA ' ' A' ' 158' ' ' GLN . 61.6 mt -74.12 -53.39 17.48 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.351 0 C-N-CA 124.508 1.123 . . . . 0.0 109.619 -171.251 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 74.5 mt -64.79 -46.0 93.35 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.434 0 N-CA-C 109.195 -0.669 . . . . 0.0 109.195 178.359 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 139.96 126.41 2.3 Favored Glycine 0 CA--C 1.534 1.221 0 C-N-CA 124.868 1.223 . . . . 0.0 112.132 172.562 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -71.23 -7.37 21.2 Favored 'Trans proline' 0 CA--C 1.536 0.585 0 C-N-CA 124.067 3.178 . . . . 0.0 113.613 -176.22 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -83.8 -17.22 41.79 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 119.081 0.855 . . . . 0.0 111.251 177.873 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 1.2 pt? -128.32 -16.14 4.49 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 124.998 1.319 . . . . 0.0 113.625 -175.239 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 41.5 t -97.05 154.79 3.62 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.542 0 N-CA-C 107.292 -1.373 . . . . 0.0 107.292 168.012 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 27.9 m -142.34 130.14 21.65 Favored 'General case' 0 C--O 1.232 0.146 0 N-CA-C 105.934 -1.876 . . . . 0.0 105.934 -176.136 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 17.8 mt -80.57 141.43 35.08 Favored 'General case' 0 C--O 1.232 0.18 0 N-CA-C 107.77 -1.196 . . . . 0.0 107.77 175.952 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 35.0 t-80 -131.9 61.03 1.66 Allowed 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 124.671 1.188 . . . . 0.0 107.847 -174.97 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 64.6 t-20 -72.09 116.56 12.65 Favored 'General case' 0 C--O 1.234 0.267 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 -178.039 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 99.1 mt -65.54 -13.44 58.94 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 124.345 1.058 . . . . 0.0 112.787 -177.229 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 28.5 tptp -57.06 -25.87 59.42 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 123.243 0.617 . . . . 0.0 110.953 168.631 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -129.46 -40.35 1.43 Allowed 'General case' 0 N--CA 1.464 0.246 0 C-N-CA 123.871 0.868 . . . . 0.0 113.279 -175.002 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 34.0 m-20 -89.59 141.01 28.99 Favored 'General case' 0 C--O 1.234 0.285 0 C-N-CA 123.382 0.673 . . . . 0.0 110.551 -175.676 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 15.2 m -75.88 155.38 84.87 Favored Pre-proline 0 CA--C 1.543 0.677 0 C-N-CA 124.213 1.005 . . . . 0.0 109.992 175.411 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_endo -77.29 -26.27 7.64 Favored 'Trans proline' 0 C--N 1.35 0.615 0 C-N-CA 122.431 2.087 . . . . 0.0 113.588 -169.924 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 22.5 mmmt -71.63 -11.92 61.08 Favored 'General case' 0 N--CA 1.472 0.634 0 O-C-N 120.5 -1.375 . . . . 0.0 111.478 -175.702 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -60.54 -28.66 68.6 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 125.769 1.627 . . . . 0.0 110.145 168.919 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 45.9 mtt -58.08 -26.18 62.23 Favored 'General case' 0 C--N 1.343 0.306 0 C-N-CA 123.198 0.599 . . . . 0.0 111.895 177.353 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 90.8 mt-10 -66.85 -32.7 74.14 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 118.245 0.475 . . . . 0.0 110.307 -176.601 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 18.3 mt-30 -66.17 -44.74 83.17 Favored 'General case' 0 N--CA 1.464 0.267 0 C-N-CA 123.714 0.806 . . . . 0.0 112.022 -171.214 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 20.4 m-85 -70.88 139.74 50.87 Favored 'General case' 0 N--CA 1.456 -0.135 0 CA-C-N 115.403 -0.817 . . . . 0.0 109.758 -166.765 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -72.96 -38.07 66.87 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 118.506 0.594 . . . . 0.0 110.257 -179.023 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 10.5 t -108.57 146.61 14.11 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.304 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 170.715 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 43.1 tp -133.01 106.74 7.83 Favored 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 176.678 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.404 ' HA ' ' HB3' ' A' ' 83' ' ' ALA . 19.8 mt -86.22 135.78 24.32 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 N-CA-C 107.096 -1.446 . . . . 0.0 107.096 176.704 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 1.9 mp -114.0 131.38 56.36 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 126.042 1.737 . . . . 0.0 106.774 -179.013 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -136.69 126.91 3.9 Favored Glycine 0 C--N 1.332 0.343 0 N-CA-C 109.072 -1.611 . . . . 0.0 109.072 177.085 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 4.7 tt -153.74 133.71 7.66 Favored Pre-proline 0 CA--C 1.538 0.511 0 CA-C-N 118.247 1.024 . . . . 0.0 111.055 174.432 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -73.33 153.51 50.69 Favored 'Trans proline' 0 CA--C 1.534 0.501 0 C-N-CA 122.799 2.332 . . . . 0.0 112.78 168.278 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.446 HG21 ' H ' ' A' ' 99' ' ' ASP . 22.8 m -117.18 140.54 49.4 Favored 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 105.462 -2.051 . . . . 0.0 105.462 166.912 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 5.1 m-90 -142.06 147.72 37.27 Favored 'General case' 0 C--O 1.231 0.123 0 C-N-CA 123.933 0.893 . . . . 0.0 110.487 -174.809 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -61.48 -27.21 68.42 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 123.682 0.793 . . . . 0.0 111.304 169.492 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 14.6 m-85 -65.2 -6.16 8.7 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 124.882 1.273 . . . . 0.0 112.988 175.243 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 106.07 122.17 4.94 Favored Glycine 0 CA--C 1.525 0.691 0 N-CA-C 108.087 -2.005 . . . . 0.0 108.087 -173.322 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 2.8 pm0 -79.99 162.84 24.67 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 124.488 1.115 . . . . 0.0 111.807 179.122 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . 0.282 24.7 mt 65.09 145.48 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.55 0 C-N-CA 127.645 2.378 . . . . 0.0 112.111 -176.428 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 3.3 mp0 -117.33 155.81 28.9 Favored 'General case' 0 C--O 1.235 0.331 0 C-N-CA 126.214 1.805 . . . . 0.0 106.568 -173.289 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -57.08 -43.4 82.12 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 122.891 0.476 . . . . 0.0 110.724 -171.458 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 -66.64 -20.9 66.09 Favored 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 112.357 0.503 . . . . 0.0 112.357 -176.023 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 11.3 t90 -91.86 -48.47 6.76 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 124.409 1.084 . . . . 0.0 109.031 177.959 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -64.27 -34.65 78.6 Favored 'General case' 0 CA--C 1.537 0.463 0 O-C-N 121.03 -1.044 . . . . 0.0 109.763 -178.218 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -59.54 -25.62 64.67 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 123.612 0.765 . . . . 0.0 111.815 -177.208 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 28.5 m -111.29 -14.67 10.54 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.315 0 CA-C-O 117.082 -1.437 . . . . 0.0 112.442 177.033 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 30.1 t90 -51.58 -35.13 40.04 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 120.491 1.496 . . . . 0.0 110.97 179.296 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -64.24 -27.9 69.37 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 125.222 1.409 . . . . 0.0 113.524 175.428 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 29.4 mt-30 -92.71 -18.98 22.29 Favored 'General case' 0 N--CA 1.463 0.22 0 C-N-CA 126.11 1.764 . . . . 0.0 112.441 175.786 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 56.3 mt -63.86 -20.57 65.92 Favored 'General case' 0 N--CA 1.465 0.319 0 O-C-N 121.21 -0.931 . . . . 0.0 111.608 -176.081 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -78.52 -22.81 46.79 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 122.985 0.514 . . . . 0.0 111.666 174.37 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -72.8 -29.79 63.55 Favored 'General case' 0 N--CA 1.467 0.411 0 O-C-N 120.729 -1.232 . . . . 0.0 111.942 178.005 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 80.9 mt -52.96 138.53 30.02 Favored 'General case' 0 C--O 1.231 0.101 0 C-N-CA 124.907 1.283 . . . . 0.0 112.896 -168.499 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 3.2 t30 -74.01 98.78 3.14 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 124.02 0.928 . . . . 0.0 108.631 170.515 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.427 HD12 HD22 ' A' ' 108' ' ' LEU . 32.8 mt -118.83 -0.76 11.17 Favored 'General case' 0 N--CA 1.472 0.659 0 N-CA-C 113.858 1.058 . . . . 0.0 113.858 -178.091 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 26.8 mt-10 -54.86 127.55 29.11 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-N 119.831 1.196 . . . . 0.0 111.623 -168.522 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 73.41 -2.24 38.84 Favored Glycine 0 CA--C 1.535 1.298 0 CA-C-O 117.824 -1.542 . . . . 0.0 115.108 179.345 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.4 154.82 36.93 Favored 'General case' 0 C--N 1.344 0.363 0 CA-C-N 120.942 2.371 . . . . 0.0 109.759 -176.678 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 2.3 mt -83.91 138.59 18.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 N-CA-C 106.866 -1.531 . . . . 0.0 106.866 177.508 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 54.3 t -130.71 135.75 59.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 C-N-CA 124.538 1.135 . . . . 0.0 108.498 -179.118 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.404 ' HB3' ' HA ' ' A' ' 50' ' ' ILE . . . -108.33 156.93 18.84 Favored 'General case' 0 CA--C 1.517 -0.299 0 N-CA-C 107.885 -1.154 . . . . 0.0 107.885 168.867 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 5.7 mt -137.76 132.42 32.72 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 107.783 -1.191 . . . . 0.0 107.783 178.714 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 39.2 p90 -149.15 165.68 31.08 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 168.421 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -167.84 157.8 30.29 Favored Glycine 0 N--CA 1.448 -0.517 0 N-CA-C 111.032 -0.827 . . . . 0.0 111.032 175.951 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 58.5 tp -97.87 146.4 25.48 Favored 'General case' 0 N--CA 1.445 -0.708 0 C-N-CA 125.691 1.596 . . . . 0.0 109.748 175.057 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -155.83 -168.75 19.26 Favored Glycine 0 CA--C 1.529 0.944 0 N-CA-C 108.754 -1.738 . . . . 0.0 108.754 172.777 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 54.9 t0 -146.71 118.28 7.99 Favored 'General case' 0 C--O 1.234 0.276 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 172.046 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 26.1 mp0 -63.68 -31.59 72.81 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 124.69 1.196 . . . . 0.0 112.016 -179.006 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 43.9 mt -88.13 -36.06 17.09 Favored 'General case' 0 N--CA 1.463 0.221 0 C-N-CA 125.44 1.496 . . . . 0.0 109.492 -178.693 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -65.22 -48.35 70.84 Favored Glycine 0 CA--C 1.528 0.894 0 N-CA-C 111.356 -0.698 . . . . 0.0 111.356 -177.268 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -139.98 -72.74 0.37 Allowed 'General case' 0 N--CA 1.463 0.196 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 -174.995 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 77.88 -39.58 1.8 Allowed Glycine 0 CA--C 1.531 1.062 0 C-N-CA 124.16 0.886 . . . . 0.0 114.458 169.055 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -60.58 -37.54 81.69 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 118.805 1.303 . . . . 0.0 109.849 170.875 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' TRP . . . . . . . . . . . . . 4.0 m-90 -109.08 32.76 4.69 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 125.856 1.662 . . . . 0.0 110.606 -178.799 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 14.1 t80 -57.76 135.46 56.79 Favored 'General case' 0 CA--C 1.531 0.222 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 177.35 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 89.7 mt 53.82 24.65 4.59 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 124.846 1.258 . . . . 0.0 114.257 169.416 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' ASP . . . . . 0.446 ' H ' HG21 ' A' ' 55' ' ' THR . 8.2 t70 -62.96 -37.69 88.1 Favored 'General case' 0 C--N 1.328 -0.331 0 O-C-N 120.86 -1.15 . . . . 0.0 111.217 -173.061 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -67.66 -29.31 68.57 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 123.674 0.789 . . . . 0.0 112.416 174.391 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 5.9 tt -63.73 -49.45 73.0 Favored 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 173.375 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -61.29 -36.5 92.54 Favored Glycine 0 CA--C 1.526 0.767 0 N-CA-C 111.623 -0.591 . . . . 0.0 111.623 177.806 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 6.4 tpp -53.99 -48.52 70.31 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 124.756 1.222 . . . . 0.0 111.454 -179.152 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -77.93 -39.69 41.98 Favored 'General case' 0 C--N 1.341 0.238 0 N-CA-C 109.813 -0.439 . . . . 0.0 109.813 -177.898 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 77.9 t60 -54.14 -45.46 71.99 Favored 'General case' 0 CA--C 1.534 0.333 0 O-C-N 121.517 -0.739 . . . . 0.0 111.335 176.638 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -61.53 -41.94 98.08 Favored 'General case' 0 C--O 1.235 0.326 0 C-N-CA 123.801 0.84 . . . . 0.0 111.536 -179.506 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 24.3 ttmm -57.48 -43.39 84.04 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 123.614 0.765 . . . . 0.0 110.278 174.286 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.427 HD22 HD12 ' A' ' 77' ' ' LEU . 27.7 mt -87.25 -14.41 41.07 Favored 'General case' 0 CA--C 1.518 -0.281 0 N-CA-C 113.9 1.074 . . . . 0.0 113.9 -170.552 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 70.9 m -60.13 -32.67 71.23 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 119.835 1.198 . . . . 0.0 111.218 -174.508 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 24.6 p -89.7 -5.17 57.3 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 124.946 1.298 . . . . 0.0 112.085 179.194 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 31.7 mmmt -86.32 -6.29 58.98 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 125.014 1.326 . . . . 0.0 111.6 175.762 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 72.29 34.99 60.53 Favored Glycine 0 CA--C 1.526 0.762 0 CA-C-N 118.622 0.646 . . . . 0.0 112.522 171.483 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 5.6 m -80.97 172.12 1.16 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.51 0 CA-C-N 118.085 0.943 . . . . 0.0 109.815 173.744 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 53.0 tptt -101.85 132.73 47.46 Favored 'General case' 0 N--CA 1.469 0.477 0 N-CA-C 105.378 -2.082 . . . . 0.0 105.378 167.698 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 74.9 m-85 -99.16 123.76 43.69 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 119.161 0.891 . . . . 0.0 108.674 174.107 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 31.6 m -109.9 160.05 9.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 C-N-CA 125.196 1.398 . . . . 0.0 108.459 168.03 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 85.34 27.6 32.7 Favored Glycine 0 CA--C 1.523 0.588 0 CA-C-O 118.526 -1.152 . . . . 0.0 114.928 170.176 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 17.4 m-30 -58.21 158.21 7.37 Favored 'General case' 0 CA--C 1.54 0.596 0 CA-C-N 119.028 1.414 . . . . 0.0 110.463 168.891 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 49.4 t-105 -138.22 147.22 54.96 Favored Pre-proline 0 N--CA 1.468 0.444 0 CA-C-O 118.264 -0.874 . . . . 0.0 111.357 -169.591 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -65.03 130.99 27.27 Favored 'Trans proline' 0 CA--C 1.534 0.516 0 C-N-CA 122.765 2.31 . . . . 0.0 112.441 -179.137 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 11.3 p -87.21 -11.12 50.76 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 123.876 0.87 . . . . 0.0 112.002 169.412 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -59.96 141.6 55.29 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 124.415 1.086 . . . . 0.0 111.208 -169.51 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 78.26 11.43 85.34 Favored Glycine 0 CA--C 1.532 1.148 0 CA-C-N 114.769 -1.105 . . . . 0.0 113.715 178.693 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 24.7 t80 -141.52 162.09 36.32 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 119.007 1.403 . . . . 0.0 110.196 176.865 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -140.47 144.81 36.25 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 125.62 1.568 . . . . 0.0 108.985 -176.642 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 3.8 p90 -154.37 172.41 17.74 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 127.804 2.441 . . . . 0.0 106.447 -170.256 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 6.2 t -127.65 -27.72 2.82 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-O 118.338 -0.839 . . . . 0.0 112.628 -178.932 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 47.9 t -65.14 129.75 94.57 Favored Pre-proline 0 CA--C 1.542 0.643 0 CA-C-N 120.026 1.284 . . . . 0.0 108.541 169.599 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -83.39 -11.37 9.55 Favored 'Trans proline' 0 CA--C 1.537 0.669 0 C-N-CA 123.071 2.514 . . . . 0.0 112.053 173.468 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 16.8 ttmt -55.12 -44.3 99.54 Favored Pre-proline 0 CA--C 1.54 0.561 0 CA-C-O 117.355 -1.307 . . . . 0.0 113.801 -168.486 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -87.5 7.76 4.56 Favored 'Trans proline' 0 C--N 1.35 0.634 0 CA-C-N 121.842 1.693 . . . . 0.0 113.777 -176.702 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 16.4 m -130.21 165.9 29.22 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.278 0 CA-C-N 121.115 1.78 . . . . 0.0 112.481 -171.167 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 12.9 pt -135.09 172.2 16.39 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.531 0 C-N-CA 128.239 2.616 . . . . 0.0 108.263 179.501 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . 53.59 42.2 31.94 Favored 'General case' 0 N--CA 1.464 0.226 0 C-N-CA 125.471 1.509 . . . . 0.0 112.648 173.726 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 27.0 t0 55.0 41.63 31.73 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 126.231 1.812 . . . . 0.0 111.766 -177.509 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 91.31 13.22 58.92 Favored Glycine 0 CA--C 1.527 0.8 0 CA-C-O 118.916 -0.935 . . . . 0.0 113.808 174.442 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 45.2 mt-30 -87.37 -7.65 57.5 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 119.29 1.545 . . . . 0.0 112.862 -177.9 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 7.6 tp -155.58 145.76 21.69 Favored 'General case' 0 C--N 1.344 0.358 0 CA-C-N 119.509 1.05 . . . . 0.0 110.797 172.238 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 61.7 m-85 -82.96 147.16 28.38 Favored 'General case' 0 CA--C 1.518 -0.279 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 169.596 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 16.7 m -77.1 2.62 1.68 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.576 0 C-N-CA 123.881 0.872 . . . . 0.0 112.393 177.234 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -172.28 169.81 42.89 Favored Glycine 0 CA--C 1.526 0.739 0 N-CA-C 110.829 -0.908 . . . . 0.0 110.829 -179.195 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 4.8 tp -63.6 135.01 56.48 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 124.272 1.029 . . . . 0.0 111.19 -179.566 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -92.99 128.04 38.71 Favored 'General case' 0 N--CA 1.446 -0.643 0 C-N-CA 124.981 1.312 . . . . 0.0 109.131 173.254 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 89.8 mt -116.47 157.92 24.4 Favored 'General case' 0 N--CA 1.464 0.248 0 C-N-CA 123.708 0.803 . . . . 0.0 109.69 169.886 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -151.79 154.45 36.27 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 126.784 2.034 . . . . 0.0 107.858 -179.606 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 74.0 mm-40 -131.56 21.84 4.7 Favored 'General case' 0 CA--C 1.546 0.827 0 C-N-CA 124.191 0.996 . . . . 0.0 111.239 176.39 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 27.5 m -131.92 -48.91 0.95 Allowed 'General case' 0 C--O 1.234 0.246 0 C-N-CA 124.703 1.201 . . . . 0.0 110.638 -173.739 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 4.6 m-80 -82.19 -42.51 18.91 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 125.896 1.678 . . . . 0.0 111.248 -170.275 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 18.5 pt20 -143.62 29.09 1.41 Allowed 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 124.453 1.101 . . . . 0.0 112.376 -168.703 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 44.1 p90 -52.32 -29.15 22.17 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 124.55 1.14 . . . . 0.0 113.685 -170.226 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -57.95 -33.59 69.0 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 124.381 1.073 . . . . 0.0 112.552 178.958 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . 0.282 0.2 OUTLIER -118.88 11.11 12.49 Favored 'General case' 0 C--O 1.221 -0.415 0 C-N-CA 124.583 1.153 . . . . 0.0 112.147 -179.216 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 60.9 m -60.11 -33.69 72.48 Favored 'General case' 0 CA--C 1.537 0.476 0 O-C-N 120.036 -1.665 . . . . 0.0 110.223 168.886 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -56.8 -41.78 78.35 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 123.814 0.846 . . . . 0.0 111.181 169.269 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 28.8 tt0 -70.19 -40.48 74.61 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 124.811 1.244 . . . . 0.0 111.144 -179.636 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 10.9 mmt180 -59.43 -44.22 92.94 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-O 118.296 -0.859 . . . . 0.0 109.271 174.434 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 51.5 mt -60.99 -55.28 25.74 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.242 0 N-CA-C 107.806 -1.183 . . . . 0.0 107.806 175.441 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 158' ' ' GLN . . . . . 0.413 ' HA ' HD13 ' A' ' 24' ' ' ILE . 0.8 OUTLIER -53.64 -60.74 2.92 Favored 'General case' 0 N--CA 1.454 -0.275 0 CA-C-N 119.141 0.882 . . . . 0.0 112.327 -172.765 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 31.7 m -61.52 -35.92 79.08 Favored 'General case' 0 C--N 1.32 -0.701 0 C-N-CA 122.895 0.478 . . . . 0.0 111.703 -177.022 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 160' ' ' TRP . . . . . . . . . . . . . 57.6 t90 -64.04 -45.47 88.72 Favored 'General case' 0 C--O 1.222 -0.361 0 CA-C-N 118.625 0.648 . . . . 0.0 110.53 173.618 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 99.0 m -61.61 -42.98 99.64 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 123.086 0.554 . . . . 0.0 110.703 -178.551 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -64.91 -35.88 82.58 Favored 'General case' 0 C--N 1.333 -0.123 0 CA-C-N 117.946 0.339 . . . . 0.0 110.857 175.934 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 17.1 tt0 -68.71 -52.27 32.55 Favored 'General case' 0 N--CA 1.445 -0.689 0 O-C-N 121.485 -0.76 . . . . 0.0 110.029 179.82 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 42.0 pt -62.48 -36.5 75.19 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.445 0 CA-C-O 117.997 -1.001 . . . . 0.0 109.605 -175.704 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -64.57 -36.68 85.02 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 119.466 1.03 . . . . 0.0 109.824 -179.536 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 34.7 m-80 -67.45 -50.55 58.74 Favored 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 174.739 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 25.8 tt0 -73.36 -16.74 61.34 Favored 'General case' 0 N--CA 1.442 -0.858 0 C-N-CA 125.852 1.661 . . . . 0.0 112.034 -169.392 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 168' ' ' MET . . . . . . . . . . . . . 21.2 ptp -90.08 -40.11 12.48 Favored 'General case' 0 N--CA 1.456 -0.168 0 C-N-CA 124.323 1.049 . . . . 0.0 111.448 168.507 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -73.68 -26.37 60.69 Favored 'General case' 0 N--CA 1.454 -0.265 0 CA-C-O 119.147 -0.454 . . . . 0.0 112.152 -173.574 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -58.23 -29.82 66.03 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 123.22 0.608 . . . . 0.0 112.102 -179.427 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 98.6 m-70 -72.84 -14.0 61.41 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 124.562 1.145 . . . . 0.0 112.486 177.84 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 67.1 m-85 -132.18 17.06 4.55 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 126.866 2.067 . . . . 0.0 111.601 -169.78 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.255 1.357 0 C-N-CA 124.247 1.019 . . . . 0.0 109.893 175.537 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.497 1.887 0 N-CA-C 111.261 0.097 . . . . 0.0 111.261 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 26.5 p-10 -126.26 166.22 17.52 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 125.107 1.363 . . . . 0.0 111.385 -173.341 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 11.4 mtt -131.28 123.87 29.27 Favored 'General case' 0 CA--C 1.522 -0.107 0 C-N-CA 123.29 0.636 . . . . 0.0 111.371 178.225 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -86.33 153.27 26.26 Favored Glycine 0 CA--C 1.523 0.594 0 N-CA-C 106.985 -2.446 . . . . 0.0 106.985 167.127 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 1.9 tt -141.73 96.11 2.92 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 119.664 1.732 . . . . 0.0 106.373 -173.265 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -101.68 141.56 34.36 Favored 'General case' 0 CA--C 1.518 -0.267 0 CA-C-O 121.271 0.558 . . . . 0.0 111.938 -170.192 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 43.1 p90 -163.58 176.87 9.26 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 126.749 2.02 . . . . 0.0 107.389 -177.923 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 168.82 88.97 0.07 OUTLIER Glycine 0 C--N 1.337 0.587 0 N-CA-C 109.164 -1.575 . . . . 0.0 109.164 178.774 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 3.8 m -140.4 130.67 25.1 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 117.198 0.499 . . . . 0.0 110.81 -168.721 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 2.8 p -80.5 -60.27 2.38 Favored 'General case' 0 C--O 1.236 0.343 0 C-N-CA 125.026 1.33 . . . . 0.0 109.173 173.606 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 3.0 p -70.6 143.81 51.39 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 124.285 1.034 . . . . 0.0 108.746 170.421 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 71.2 m 45.59 55.64 6.52 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 125.349 1.46 . . . . 0.0 111.238 -178.337 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 43.7 p90 -51.17 122.05 7.09 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-O 122.141 0.972 . . . . 0.0 110.657 -169.212 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 4.3 m -79.0 -5.59 54.27 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 124.731 1.212 . . . . 0.0 113.598 -166.728 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -52.89 -40.91 63.88 Favored 'General case' 0 N--CA 1.466 0.363 0 C-N-CA 123.722 0.809 . . . . 0.0 111.205 -175.614 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 21.4 ptp -65.38 -43.01 92.06 Favored 'General case' 0 C--N 1.342 0.276 0 CA-C-N 118.383 0.538 . . . . 0.0 112.014 -176.996 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -63.12 -44.78 94.68 Favored 'General case' 0 C--N 1.342 0.264 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 175.097 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -62.84 -48.14 80.33 Favored 'General case' 0 N--CA 1.452 -0.364 0 C-N-CA 122.999 0.52 . . . . 0.0 111.402 -174.832 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -68.42 -37.15 80.03 Favored 'General case' 0 CA--C 1.534 0.327 0 O-C-N 121.743 -0.598 . . . . 0.0 110.485 -179.43 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 28.6 mtpp -66.04 -40.23 90.83 Favored 'General case' 0 C--O 1.224 -0.244 0 CA-C-O 118.564 -0.731 . . . . 0.0 110.629 177.523 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 33.4 mt -55.69 -54.36 26.89 Favored 'Isoleucine or valine' 0 C--O 1.233 0.218 0 CA-C-N 119.642 1.11 . . . . 0.0 109.355 177.023 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 17.5 ptt180 -63.53 -38.6 91.76 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 118.801 0.728 . . . . 0.0 110.113 -177.039 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -64.02 -37.8 88.76 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-O 121.051 0.453 . . . . 0.0 110.151 -175.98 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 66.7 mt -76.03 -55.11 12.15 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.678 0 C-N-CA 125.136 1.374 . . . . 0.0 110.141 -176.275 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 62.7 mt -61.72 -47.84 91.44 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.403 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 -178.883 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 141.71 114.09 1.04 Allowed Glycine 0 CA--C 1.526 0.773 0 C-N-CA 125.396 1.474 . . . . 0.0 109.465 -175.912 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 70.5 Cg_endo -73.33 -8.4 21.83 Favored 'Trans proline' 0 CA--C 1.538 0.678 0 C-N-CA 122.517 2.145 . . . . 0.0 113.51 -169.729 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -76.63 -21.37 55.59 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 119.116 0.871 . . . . 0.0 111.839 179.107 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -122.74 7.87 9.41 Favored 'General case' 0 C--N 1.342 0.282 0 C-N-CA 124.842 1.257 . . . . 0.0 113.256 -171.542 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 44.0 t -124.89 151.18 30.27 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.369 0 N-CA-C 107.604 -1.258 . . . . 0.0 107.604 175.252 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 24.6 m -136.23 133.9 37.53 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 125.714 1.606 . . . . 0.0 107.927 -176.893 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 17.6 mt -80.52 138.17 36.5 Favored 'General case' 0 N--CA 1.463 0.222 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 176.086 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 24.7 t-80 -131.89 59.9 1.69 Allowed 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 124.588 1.155 . . . . 0.0 108.629 -176.576 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 37.9 t30 -59.7 124.22 19.44 Favored 'General case' 0 CA--C 1.531 0.226 0 N-CA-C 107.935 -1.135 . . . . 0.0 107.935 172.209 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 55.1 mt -71.37 -31.06 66.87 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-N 118.857 0.753 . . . . 0.0 112.73 -169.705 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 22.8 tptm -60.33 -27.46 67.37 Favored 'General case' 0 C--O 1.234 0.264 0 C-N-CA 123.507 0.723 . . . . 0.0 110.379 170.345 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -93.12 -34.64 13.57 Favored 'General case' 0 C--O 1.234 0.282 0 N-CA-C 112.834 0.679 . . . . 0.0 112.834 -174.639 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 3.8 t0 -144.69 148.49 34.28 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 118.869 0.759 . . . . 0.0 113.048 -176.831 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 15.2 m -70.7 157.22 90.67 Favored Pre-proline 0 CA--C 1.543 0.683 0 C-N-CA 125.925 1.69 . . . . 0.0 112.292 -169.342 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -74.64 -26.76 11.37 Favored 'Trans proline' 0 C--N 1.352 0.753 0 C-N-CA 122.662 2.241 . . . . 0.0 113.938 -172.317 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.87 -15.95 63.39 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-N 120.421 1.464 . . . . 0.0 112.187 -179.442 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -57.65 -31.21 66.08 Favored 'General case' 0 N--CA 1.466 0.363 0 C-N-CA 125.811 1.644 . . . . 0.0 110.166 170.777 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 57.2 mtt -56.4 -26.17 52.41 Favored 'General case' 0 N--CA 1.467 0.379 0 C-N-CA 123.699 0.799 . . . . 0.0 111.565 179.133 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 60.1 mt-10 -66.64 -32.93 74.58 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 118.436 0.562 . . . . 0.0 110.553 -177.659 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 19.8 mt-30 -67.65 -43.55 80.0 Favored 'General case' 0 C--O 1.232 0.181 0 N-CA-C 112.872 0.693 . . . . 0.0 112.872 -169.366 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 37.5 m-85 -72.23 135.91 46.21 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.733 -167.103 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -71.19 -38.03 72.11 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-N 118.101 0.41 . . . . 0.0 110.404 -179.468 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 14.8 t -105.31 143.66 16.18 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.56 0 N-CA-C 107.202 -1.407 . . . . 0.0 107.202 168.766 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 33.8 tp -131.6 115.34 15.97 Favored 'General case' 0 N--CA 1.446 -0.657 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 174.078 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 27.9 mt -91.99 131.94 37.72 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.681 0 N-CA-C 106.863 -1.532 . . . . 0.0 106.863 176.802 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 2.4 mp -109.72 127.35 54.54 Favored 'General case' 0 CA--C 1.516 -0.338 0 C-N-CA 125.717 1.607 . . . . 0.0 107.106 -179.832 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -129.18 130.72 6.5 Favored Glycine 0 C--N 1.332 0.329 0 N-CA-C 108.617 -1.793 . . . . 0.0 108.617 176.556 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.417 HD12 ' CD2' ' A' ' 65' ' ' TRP . 4.6 tt -152.26 129.56 5.72 Favored Pre-proline 0 CA--C 1.531 0.226 0 CA-C-N 117.636 0.718 . . . . 0.0 110.914 172.574 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -80.0 132.81 9.7 Favored 'Trans proline' 0 N--CA 1.447 -1.25 0 N-CA-C 107.017 -1.955 . . . . 0.0 107.017 165.548 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 41.7 m -94.38 111.38 23.12 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 103.122 -2.918 . . . . 0.0 103.122 167.137 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 9.7 t90 -67.29 151.3 47.73 Favored 'General case' 0 CA--C 1.535 0.389 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 -176.033 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -64.72 125.07 23.6 Favored 'General case' 0 C--O 1.236 0.386 0 N-CA-C 109.889 -0.412 . . . . 0.0 109.889 -175.732 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 1.8 t80 48.01 40.47 13.29 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 124.748 1.219 . . . . 0.0 111.404 -171.298 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -140.7 -166.78 10.82 Favored Glycine 0 CA--C 1.529 0.961 0 C-N-CA 125.603 1.573 . . . . 0.0 111.261 -177.964 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 30.6 tt0 -147.39 169.44 19.47 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 125.087 1.355 . . . . 0.0 108.836 -173.021 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 8.4 mt -28.66 131.0 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.543 0.707 0 C-N-CA 128.688 2.795 . . . . 0.0 113.039 173.788 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 3.9 mp0 -74.87 153.8 38.51 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 125.294 1.438 . . . . 0.0 109.5 179.636 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -54.7 -46.17 74.12 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 123.669 0.788 . . . . 0.0 112.207 -169.184 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 23.3 t0 -62.35 -32.71 73.54 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-O 121.57 0.7 . . . . 0.0 112.184 -174.738 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' TRP . . . . . 0.596 ' CH2' HD23 ' A' ' 104' ' ' LEU . 0.9 OUTLIER -82.5 -43.5 17.1 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 123.739 0.816 . . . . 0.0 109.257 -179.587 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 6.1 tt0 -63.05 -35.11 79.15 Favored 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 124.79 1.236 . . . . 0.0 109.805 -179.287 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -58.97 -24.45 62.67 Favored 'General case' 0 C--O 1.233 0.2 0 C-N-CA 124.129 0.971 . . . . 0.0 111.69 -175.825 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 34.6 m -114.7 -14.99 10.5 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.228 0 CA-C-O 117.471 -1.252 . . . . 0.0 112.66 177.206 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 30.6 t90 -52.02 -38.86 58.36 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 119.974 1.261 . . . . 0.0 111.031 -177.032 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -68.36 -23.82 64.73 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 125.039 1.336 . . . . 0.0 113.185 178.218 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 22.7 mt-30 -91.73 -23.94 19.61 Favored 'General case' 0 C--N 1.34 0.167 0 C-N-CA 125.377 1.471 . . . . 0.0 111.973 -179.379 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 19.7 mt -64.26 -25.69 68.17 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 118.167 0.44 . . . . 0.0 111.63 -172.012 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -69.13 -21.77 64.0 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-N 117.966 0.348 . . . . 0.0 111.388 177.284 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -76.39 -24.05 54.08 Favored 'General case' 0 CA--C 1.537 0.462 0 O-C-N 120.971 -1.08 . . . . 0.0 112.68 -178.811 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 49.2 mt -65.63 149.54 49.92 Favored 'General case' 0 C--O 1.233 0.205 0 C-N-CA 124.794 1.238 . . . . 0.0 111.537 -170.296 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 27.8 t-20 -83.77 113.32 20.82 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 171.955 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 65.2 mt -128.66 1.8 5.5 Favored 'General case' 0 N--CA 1.472 0.659 0 N-CA-C 113.318 0.859 . . . . 0.0 113.318 -172.37 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 30.4 mt-10 -55.55 130.73 44.06 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-O 122.046 0.927 . . . . 0.0 111.347 -168.889 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 73.29 -2.45 36.74 Favored Glycine 0 CA--C 1.533 1.202 0 CA-C-O 117.987 -1.452 . . . . 0.0 115.105 176.791 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.64 149.55 41.93 Favored 'General case' 0 C--N 1.346 0.418 0 CA-C-N 120.749 2.274 . . . . 0.0 109.646 -177.036 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 7.6 mt -80.47 135.56 25.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 N-CA-C 106.269 -1.752 . . . . 0.0 106.269 178.372 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 63.4 t -129.11 128.56 67.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 C-N-CA 123.466 0.706 . . . . 0.0 109.715 -177.769 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -98.3 143.75 28.45 Favored 'General case' 0 CA--C 1.522 -0.114 0 N-CA-C 106.98 -1.489 . . . . 0.0 106.98 167.847 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 9.5 mt -122.11 132.24 54.38 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 107.243 -1.392 . . . . 0.0 107.243 176.241 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 22.9 p90 -150.72 165.05 34.63 Favored 'General case' 0 N--CA 1.444 -0.75 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 168.088 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -163.91 178.2 39.43 Favored Glycine 0 N--CA 1.435 -1.414 0 N-CA-C 109.739 -1.344 . . . . 0.0 109.739 171.314 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 5.8 tt -127.18 155.22 43.74 Favored 'General case' 0 N--CA 1.445 -0.706 0 C-N-CA 125.253 1.421 . . . . 0.0 107.448 178.682 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -158.95 -159.83 9.94 Favored Glycine 0 CA--C 1.523 0.535 0 N-CA-C 109.068 -1.613 . . . . 0.0 109.068 169.805 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 20.2 t0 -119.56 118.2 30.39 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 107.409 -1.33 . . . . 0.0 107.409 169.88 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 23.1 mt-30 -70.61 -21.39 62.66 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 123.559 0.744 . . . . 0.0 110.853 179.478 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 80.1 mt -75.58 -0.66 21.22 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-N 119.415 1.007 . . . . 0.0 111.109 168.947 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -77.06 19.67 3.4 Favored Glycine 0 CA--C 1.535 1.33 0 C-N-CA 125.237 1.399 . . . . 0.0 112.129 167.83 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 35.3 m-85 61.96 3.05 0.86 Allowed 'General case' 0 N--CA 1.465 0.289 0 C-N-CA 127.593 2.357 . . . . 0.0 115.231 171.473 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 71.19 21.13 78.45 Favored Glycine 0 CA--C 1.53 1.015 0 N-CA-C 110.8 -0.92 . . . . 0.0 110.8 -174.958 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -85.86 -28.63 24.29 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 124.424 1.089 . . . . 0.0 108.55 167.176 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' TRP . . . . . . . . . . . . . 7.7 m0 -126.45 1.63 6.95 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 124.838 1.255 . . . . 0.0 113.552 -168.972 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 14.7 t80 -73.58 131.39 41.66 Favored 'General case' 0 N--CA 1.46 0.061 0 O-C-N 121.279 -0.888 . . . . 0.0 109.022 -171.536 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 91.9 mt 52.53 23.47 2.59 Favored 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 114.613 1.338 . . . . 0.0 114.613 168.263 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -62.62 -35.22 78.89 Favored 'General case' 0 N--CA 1.465 0.311 0 O-C-N 120.651 -1.281 . . . . 0.0 110.672 -172.074 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' ALA . . . . . 0.415 ' HB1' HD13 ' A' ' 53' ' ' ILE . . . -72.98 -28.67 62.53 Favored 'General case' 0 N--CA 1.452 -0.334 0 N-CA-C 113.096 0.776 . . . . 0.0 113.096 176.543 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 5.0 tt -61.43 -45.33 94.75 Favored 'General case' 0 CA--C 1.535 0.394 0 N-CA-C 107.308 -1.367 . . . . 0.0 107.308 170.276 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -61.76 -42.24 99.72 Favored Glycine 0 C--N 1.341 0.806 0 N-CA-C 111.302 -0.719 . . . . 0.0 111.302 179.162 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 74.8 mtm -61.94 -41.14 97.62 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 118.094 0.947 . . . . 0.0 111.662 178.244 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.596 HD23 ' CH2' ' A' ' 65' ' ' TRP . 0.1 OUTLIER -72.22 -38.1 69.05 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 119.944 1.247 . . . . 0.0 111.131 -179.297 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 29.4 t-80 -57.21 -46.85 82.53 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 117.855 0.298 . . . . 0.0 110.38 172.587 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -63.85 -45.54 89.06 Favored 'General case' 0 C--N 1.33 -0.239 0 C-N-CA 123.457 0.703 . . . . 0.0 111.604 -177.753 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 24.5 ttmm -54.04 -45.26 71.56 Favored 'General case' 0 N--CA 1.464 0.227 0 C-N-CA 123.764 0.825 . . . . 0.0 109.735 173.287 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 22.2 mt -83.2 -19.89 35.67 Favored 'General case' 0 CA--C 1.514 -0.419 0 N-CA-C 114.887 1.44 . . . . 0.0 114.887 -169.43 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 6.5 t -57.85 -36.12 71.87 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-N 119.826 1.194 . . . . 0.0 110.598 -175.378 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 22.0 p -87.17 -8.33 57.03 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 124.802 1.241 . . . . 0.0 112.341 -179.184 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 32.3 mmmt -85.29 -7.13 59.15 Favored 'General case' 0 C--N 1.345 0.398 0 C-N-CA 124.61 1.164 . . . . 0.0 111.556 174.512 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 72.84 31.93 61.73 Favored Glycine 0 CA--C 1.523 0.567 0 CA-C-O 119.459 -0.634 . . . . 0.0 112.516 171.035 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 17.0 m -74.59 177.45 0.56 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.572 0 CA-C-N 118.386 1.093 . . . . 0.0 109.836 172.758 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -116.66 125.8 52.29 Favored 'General case' 0 CA--C 1.515 -0.388 0 N-CA-C 106.332 -1.729 . . . . 0.0 106.332 170.649 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 68.7 m-85 -91.45 146.03 24.14 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 119.847 1.203 . . . . 0.0 110.198 -177.594 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 33.5 m -133.3 158.43 42.98 Favored 'Isoleucine or valine' 0 C--O 1.235 0.323 0 C-N-CA 125.385 1.474 . . . . 0.0 107.503 169.044 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 85.41 35.19 12.34 Favored Glycine 0 N--CA 1.452 -0.252 0 CA-C-O 118.919 -0.934 . . . . 0.0 114.349 169.729 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 8.2 m-30 -67.86 155.2 39.89 Favored 'General case' 0 CA--C 1.544 0.729 0 CA-C-N 118.815 1.307 . . . . 0.0 109.403 169.611 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 1.6 t90 -136.46 137.96 25.52 Favored Pre-proline 0 CA--C 1.541 0.609 0 CA-C-O 117.305 -1.331 . . . . 0.0 108.342 -171.243 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_exo -70.58 130.92 19.1 Favored 'Trans proline' 0 C--N 1.348 0.501 0 C-N-CA 123.179 2.586 . . . . 0.0 113.037 -170.32 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 40.1 p -70.5 -7.56 44.53 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 113.457 0.91 . . . . 0.0 113.457 172.919 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -59.09 140.1 56.18 Favored 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 124.742 1.217 . . . . 0.0 110.122 -176.204 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 80.55 13.66 81.24 Favored Glycine 0 CA--C 1.534 1.24 0 CA-C-N 115.268 -0.878 . . . . 0.0 113.689 177.105 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 25.4 t80 -136.46 161.28 36.29 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 118.884 1.342 . . . . 0.0 109.617 174.319 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -132.64 136.51 46.54 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 125.251 1.421 . . . . 0.0 107.988 -179.203 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 13.2 p90 -154.06 170.51 20.95 Favored 'General case' 0 C--O 1.235 0.322 0 C-N-CA 125.251 1.42 . . . . 0.0 109.436 -169.319 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 11.6 t -135.77 -34.59 0.82 Allowed 'General case' 0 C--O 1.235 0.323 0 N-CA-C 112.035 0.383 . . . . 0.0 112.035 -176.046 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 58.8 m -74.06 128.83 85.75 Favored Pre-proline 0 CA--C 1.541 0.601 0 N-CA-C 108.912 -0.774 . . . . 0.0 108.912 177.566 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -83.36 -22.62 3.84 Favored 'Trans proline' 0 CA--C 1.538 0.679 0 C-N-CA 122.537 2.158 . . . . 0.0 113.304 -172.518 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 26.2 ttmt -52.88 -42.54 90.5 Favored Pre-proline 0 CA--C 1.541 0.616 0 CA-C-O 117.091 -1.433 . . . . 0.0 114.791 -171.109 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_endo -74.63 -4.5 15.51 Favored 'Trans proline' 0 C--N 1.352 0.717 0 CA-C-N 122.108 1.789 . . . . 0.0 114.11 -178.928 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 20.8 m -131.76 167.89 25.27 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.412 0 CA-C-N 120.96 1.709 . . . . 0.0 111.673 -169.552 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 25.1 pt -127.87 170.05 18.28 Favored 'Isoleucine or valine' 0 C--O 1.234 0.27 0 C-N-CA 126.689 1.996 . . . . 0.0 109.207 175.169 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . 57.91 32.92 22.59 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 125.416 1.486 . . . . 0.0 113.768 167.711 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 27.7 t70 56.21 40.11 30.1 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 126.323 1.849 . . . . 0.0 111.254 -174.931 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 91.31 74.99 1.29 Allowed Glycine 0 C--N 1.338 0.657 0 C-N-CA 124.46 1.029 . . . . 0.0 111.259 177.682 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 74.1 mm-40 -120.66 -49.62 2.23 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 123.179 0.592 . . . . 0.0 110.771 168.251 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -131.0 145.03 51.92 Favored 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 122.997 0.519 . . . . 0.0 110.205 -178.86 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 73.3 m-85 -76.61 17.71 0.38 Allowed 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 125.573 1.549 . . . . 0.0 114.644 174.795 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 4.1 m 47.84 15.26 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.546 0.802 0 C-N-CA 127.915 2.486 . . . . 0.0 114.37 -174.053 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 168.22 174.0 36.66 Favored Glycine 0 CA--C 1.526 0.78 0 N-CA-C 108.792 -1.723 . . . . 0.0 108.792 -169.339 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.477 ' HB2' ' CD1' ' A' ' 160' ' ' TRP . 1.7 tp -71.88 142.13 49.55 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 118.215 1.008 . . . . 0.0 111.92 179.701 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -104.8 130.0 52.99 Favored 'General case' 0 N--CA 1.447 -0.585 0 C-N-CA 127.482 2.313 . . . . 0.0 109.416 178.034 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 87.5 mt -129.62 155.62 45.54 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 125.038 1.335 . . . . 0.0 108.461 173.103 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -128.2 155.0 45.2 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 124.776 1.231 . . . . 0.0 110.302 -179.383 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -132.48 13.12 4.54 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 123.902 0.881 . . . . 0.0 112.705 -176.819 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 97.3 m -135.79 -51.65 0.73 Allowed 'General case' 0 C--N 1.341 0.199 0 O-C-N 121.246 -0.909 . . . . 0.0 112.163 -168.787 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 3.3 p30 -110.67 -31.72 7.12 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 125.429 1.492 . . . . 0.0 111.184 -170.013 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 67.1 mt-30 -133.64 27.07 4.03 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 124.834 1.254 . . . . 0.0 111.046 -172.867 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 41.4 p90 -61.21 -27.14 68.21 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 123.458 0.703 . . . . 0.0 112.187 -176.539 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -64.41 -33.94 77.03 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 122.965 0.506 . . . . 0.0 111.142 176.542 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 97.7 mt -84.83 -14.96 46.37 Favored 'General case' 0 C--O 1.224 -0.287 0 CA-C-O 118.038 -0.982 . . . . 0.0 112.015 -179.291 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 73.3 m -57.28 -28.28 62.87 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 120.42 1.464 . . . . 0.0 111.64 178.5 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -60.35 -45.48 93.33 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 119.51 1.05 . . . . 0.0 111.882 172.387 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 -67.29 -44.23 79.78 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 125.38 1.472 . . . . 0.0 110.244 177.931 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 38.7 mtp180 -62.52 -40.08 95.62 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-O 117.826 -1.083 . . . . 0.0 109.682 179.35 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 48.7 mt -63.18 -55.38 23.68 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.475 0 CA-C-N 119.891 1.223 . . . . 0.0 107.991 172.453 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 70.5 tp60 -50.21 -63.78 1.01 Allowed 'General case' 0 C--O 1.232 0.176 0 C-N-CA 124.808 1.243 . . . . 0.0 111.86 -174.584 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 24.0 m -66.0 -32.99 74.8 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 120.666 -0.414 . . . . 0.0 111.136 -170.365 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 160' ' ' TRP . . . . . 0.477 ' CD1' ' HB2' ' A' ' 142' ' ' LEU . 82.4 t90 -67.09 -46.13 75.16 Favored 'General case' 0 C--O 1.222 -0.39 0 O-C-N 121.999 -0.438 . . . . 0.0 110.889 175.257 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 61.4 m -58.2 -43.9 87.84 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 118.48 0.582 . . . . 0.0 110.157 179.502 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -62.28 -43.91 97.74 Favored 'General case' 0 CA--C 1.528 0.123 0 N-CA-C 109.886 -0.413 . . . . 0.0 109.886 176.842 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 14.9 tt0 -62.58 -50.32 71.76 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-O 117.946 -1.026 . . . . 0.0 110.225 -177.923 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 41.6 pt -65.01 -33.53 64.35 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.485 0 CA-C-N 119.678 1.126 . . . . 0.0 110.224 -176.335 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -70.48 -34.19 72.11 Favored 'General case' 0 C--O 1.223 -0.322 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 -175.998 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -71.33 -45.19 63.58 Favored 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 124.531 1.132 . . . . 0.0 109.982 175.082 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 21.9 tt0 -78.3 -24.57 46.63 Favored 'General case' 0 N--CA 1.441 -0.905 0 C-N-CA 124.22 1.008 . . . . 0.0 110.319 -169.374 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 168' ' ' MET . . . . . . . . . . . . . 19.2 ptp -82.26 -29.72 31.1 Favored 'General case' 0 N--CA 1.461 0.104 0 O-C-N 121.694 -0.629 . . . . 0.0 111.657 171.843 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -79.36 -36.3 39.52 Favored 'General case' 0 N--CA 1.447 -0.613 0 C-N-CA 122.573 0.349 . . . . 0.0 111.001 -178.198 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -68.59 -29.06 67.51 Favored 'General case' 0 CA--C 1.535 0.392 0 O-C-N 122.138 -0.351 . . . . 0.0 110.396 177.356 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 80.9 t60 -64.77 -24.65 67.62 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 123.928 0.891 . . . . 0.0 110.863 174.433 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 2.3 m-85 -83.29 -9.64 58.98 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 124.928 1.291 . . . . 0.0 113.22 174.744 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.205 0 CA-C-N 119.461 1.028 . . . . 0.0 110.265 -178.74 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.498 1.926 0 CA-C-O 118.986 -0.531 . . . . 0.0 110.15 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 5.7 t30 -111.22 147.54 34.77 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-N 119.729 1.149 . . . . 0.0 111.377 -171.5 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 17.5 mtt -112.79 130.12 56.19 Favored 'General case' 0 N--CA 1.462 0.174 0 C-N-CA 124.414 1.086 . . . . 0.0 110.203 -177.467 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -98.94 131.02 10.42 Favored Glycine 0 CA--C 1.522 0.506 0 N-CA-C 107.264 -2.334 . . . . 0.0 107.264 168.54 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -105.74 108.14 19.51 Favored 'General case' 0 N--CA 1.467 0.422 0 N-CA-C 105.058 -2.201 . . . . 0.0 105.058 173.974 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -99.62 145.84 27.12 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 119.401 1.0 . . . . 0.0 112.663 179.335 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.511 ' CE1' HG21 ' A' ' 14' ' ' THR . 79.5 m-85 -145.67 169.61 18.11 Favored 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 126.681 1.992 . . . . 0.0 108.726 -178.401 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -86.8 -168.67 45.11 Favored Glycine 0 CA--C 1.534 1.278 0 N-CA-C 109.867 -1.293 . . . . 0.0 109.867 166.979 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 3.1 p -65.21 -54.33 31.08 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 124.251 1.021 . . . . 0.0 109.46 169.962 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 7.9 m 67.39 146.62 0.04 OUTLIER 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 128.361 2.665 . . . . 0.0 113.415 178.997 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 5.5 m -63.35 122.17 15.55 Favored 'General case' 0 CA--C 1.535 0.397 0 N-CA-C 108.342 -0.985 . . . . 0.0 108.342 -178.488 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 34.8 m 53.0 26.45 4.77 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 124.972 1.309 . . . . 0.0 113.171 -173.66 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . 0.338 43.0 p90 53.51 157.45 0.0 OUTLIER 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 128.923 2.889 . . . . 0.0 115.58 -171.802 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.511 HG21 ' CE1' ' A' ' 7' ' ' TYR . 88.6 m -64.37 151.34 44.26 Favored 'General case' 0 CA--C 1.542 0.66 0 O-C-N 121.317 -0.864 . . . . 0.0 109.511 179.495 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 80.4 mm-40 -65.12 173.4 2.46 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 124.423 1.089 . . . . 0.0 111.252 -176.247 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -65.16 3.56 0.6 Allowed 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 125.629 1.572 . . . . 0.0 113.833 -173.855 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -45.33 -39.09 6.34 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 125.139 1.376 . . . . 0.0 110.236 167.888 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -57.18 -55.18 38.1 Favored 'General case' 0 N--CA 1.465 0.318 0 C-N-CA 123.672 0.789 . . . . 0.0 112.337 179.112 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 70.5 mm-40 -61.08 -45.73 93.54 Favored 'General case' 0 CA--C 1.517 -0.319 0 N-CA-C 108.134 -1.062 . . . . 0.0 108.134 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 30.0 mtpp -66.42 -39.6 89.06 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-O 118.498 -0.763 . . . . 0.0 110.107 -171.971 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 17.6 mt -54.61 -58.65 3.44 Favored 'Isoleucine or valine' 0 C--O 1.233 0.188 0 C-N-CA 124.639 1.175 . . . . 0.0 108.858 176.548 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 18.7 ptt180 -64.91 -39.42 93.49 Favored 'General case' 0 C--O 1.222 -0.372 0 CA-C-O 118.761 -0.637 . . . . 0.0 110.45 -177.272 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -65.53 -39.92 92.32 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.142 0.496 . . . . 0.0 110.018 -172.511 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 70.5 mt -75.5 -53.72 15.43 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.576 0 C-N-CA 125.236 1.415 . . . . 0.0 109.875 -175.419 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 71.8 mt -62.48 -46.89 95.32 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.441 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 -179.232 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 140.77 116.58 1.3 Allowed Glycine 0 CA--C 1.528 0.881 0 C-N-CA 125.842 1.687 . . . . 0.0 109.395 179.26 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -72.78 -8.18 21.97 Favored 'Trans proline' 0 CA--C 1.539 0.743 0 C-N-CA 122.739 2.292 . . . . 0.0 113.337 -170.229 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -79.67 -17.65 53.18 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 118.757 0.708 . . . . 0.0 111.865 178.02 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -125.37 8.08 7.77 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 125.204 1.402 . . . . 0.0 113.343 -174.878 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 61.3 t -124.55 149.22 28.82 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.265 0 N-CA-C 107.925 -1.139 . . . . 0.0 107.925 174.21 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 11.9 m -138.71 136.32 35.68 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 126.034 1.734 . . . . 0.0 107.023 -176.804 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 23.8 mt -90.67 146.59 23.9 Favored 'General case' 0 N--CA 1.466 0.339 0 N-CA-C 107.691 -1.226 . . . . 0.0 107.691 175.553 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 40.5 t-80 -140.34 128.27 22.03 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 107.459 -1.311 . . . . 0.0 107.459 -169.261 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 53.8 t-20 -128.66 111.18 12.91 Favored 'General case' 0 CA--C 1.516 -0.345 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 -169.993 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 88.9 mt -66.86 -10.7 50.97 Favored 'General case' 0 CA--C 1.535 0.381 0 N-CA-C 113.355 0.872 . . . . 0.0 113.355 -174.222 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 40.3 tptt -57.92 -29.13 64.88 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 118.82 0.737 . . . . 0.0 111.234 168.153 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -129.39 -38.01 1.59 Allowed 'General case' 0 N--CA 1.465 0.299 0 C-N-CA 123.84 0.856 . . . . 0.0 112.67 -173.049 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 42.8 m-20 -79.55 130.12 35.1 Favored 'General case' 0 C--O 1.236 0.373 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 179.758 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 14.4 m -73.28 152.7 90.26 Favored Pre-proline 0 CA--C 1.542 0.649 0 C-N-CA 123.22 0.608 . . . . 0.0 109.526 173.368 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -73.04 -24.86 16.81 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.032 1.821 . . . . 0.0 113.992 -169.616 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 1.4 mptm? -63.21 -18.06 63.11 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 119.275 0.943 . . . . 0.0 111.726 178.176 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -63.28 -25.31 68.26 Favored 'General case' 0 N--CA 1.465 0.309 0 C-N-CA 124.847 1.259 . . . . 0.0 110.746 174.341 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 54.2 mtt -61.75 -23.95 66.49 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 119.361 0.982 . . . . 0.0 111.496 177.346 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -64.32 -32.25 73.78 Favored 'General case' 0 CA--C 1.535 0.365 0 O-C-N 121.792 -0.568 . . . . 0.0 110.566 -177.602 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 25.4 mt-30 -67.17 -42.23 84.61 Favored 'General case' 0 CA--C 1.533 0.29 0 N-CA-C 113.594 0.961 . . . . 0.0 113.594 -169.397 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 62.7 m-85 -73.79 144.09 45.73 Favored 'General case' 0 C--O 1.231 0.113 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.637 -165.346 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 41.7 m-20 -77.23 -29.19 54.01 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 122.785 0.434 . . . . 0.0 109.948 -176.433 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 13.5 t -124.57 144.85 33.03 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.34 0 N-CA-C 106.564 -1.643 . . . . 0.0 106.564 168.886 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 25.0 tp -125.2 105.95 9.52 Favored 'General case' 0 N--CA 1.446 -0.669 0 N-CA-C 107.304 -1.369 . . . . 0.0 107.304 175.542 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 51.0 mt -85.83 128.6 39.13 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.687 0 N-CA-C 105.947 -1.872 . . . . 0.0 105.947 174.435 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 1.3 mp -102.55 124.1 47.5 Favored 'General case' 0 CA--C 1.515 -0.375 0 N-CA-C 106.415 -1.698 . . . . 0.0 106.415 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -122.4 120.39 4.3 Favored Glycine 0 N--CA 1.449 -0.449 0 N-CA-C 106.951 -2.46 . . . . 0.0 106.951 177.656 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 5.8 tt -149.64 116.46 3.61 Favored Pre-proline 0 C--N 1.332 -0.185 0 CA-C-N 118.033 0.916 . . . . 0.0 109.483 169.823 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 62.9 Cg_exo -64.96 146.26 87.3 Favored 'Trans proline' 0 N--CA 1.456 -0.687 0 C-N-CA 120.706 0.937 . . . . 0.0 110.394 166.194 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -129.29 134.67 48.05 Favored 'General case' 0 N--CA 1.467 0.394 0 N-CA-C 109.925 -0.398 . . . . 0.0 109.925 168.526 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 22.4 m-90 -141.61 167.17 22.78 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 126.936 2.095 . . . . 0.0 106.115 168.292 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -65.43 -39.66 92.38 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-N 118.074 0.397 . . . . 0.0 110.592 173.844 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 87.9 t80 -73.73 139.48 45.31 Favored 'General case' 0 CA--C 1.532 0.269 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 169.715 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 77.61 -61.27 3.63 Favored Glycine 0 CA--C 1.53 1.012 0 C-N-CA 123.912 0.768 . . . . 0.0 112.197 176.044 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.46 ' HG2' ' H ' ' A' ' 61' ' ' ILE . 13.5 tt0 52.94 -155.98 0.18 Allowed 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 124.504 1.122 . . . . 0.0 109.496 -169.602 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.46 ' H ' ' HG2' ' A' ' 60' ' ' GLU . 48.1 mt -47.21 121.6 0.86 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.512 0 C-N-CA 124.37 1.068 . . . . 0.0 108.605 168.868 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' GLN . . . . . 0.423 ' H ' ' CD ' ' A' ' 62' ' ' GLN . 1.5 pm0 -75.82 154.28 36.29 Favored 'General case' 0 C--O 1.233 0.225 0 C-N-CA 124.711 1.204 . . . . 0.0 109.821 173.662 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -57.11 -41.86 79.76 Favored 'General case' 0 C--O 1.224 -0.289 0 C-N-CA 124.045 0.938 . . . . 0.0 110.952 -171.375 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 27.8 m-20 -69.76 -15.56 63.15 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-N 119.108 0.867 . . . . 0.0 112.395 -173.912 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' TRP . . . . . 0.408 ' CH2' HD23 ' A' ' 104' ' ' LEU . 11.5 t90 -92.11 -46.86 7.56 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 124.52 1.128 . . . . 0.0 108.139 173.313 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -62.66 -35.36 79.41 Favored 'General case' 0 CA--C 1.536 0.428 0 O-C-N 120.789 -1.194 . . . . 0.0 110.585 -178.785 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -61.48 -25.78 67.47 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 124.119 0.968 . . . . 0.0 110.913 -174.926 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 28.1 m -111.21 -14.94 10.39 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.328 0 CA-C-O 117.352 -1.308 . . . . 0.0 112.207 177.502 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 28.3 t90 -51.56 -37.51 49.98 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 120.161 1.346 . . . . 0.0 110.526 177.342 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -63.35 -27.45 69.33 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 125.305 1.442 . . . . 0.0 113.196 176.399 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 30.9 mt-30 -92.4 -20.18 21.31 Favored 'General case' 0 C--O 1.226 -0.163 0 C-N-CA 125.853 1.661 . . . . 0.0 112.567 178.004 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 41.7 mt -63.34 -24.08 67.69 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 118.895 0.77 . . . . 0.0 111.458 -176.108 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -75.8 -27.18 57.87 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 117.903 0.32 . . . . 0.0 111.373 174.541 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -79.32 -17.01 55.42 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 123.951 0.9 . . . . 0.0 112.609 -174.717 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 38.1 mt -62.53 147.9 47.55 Favored 'General case' 0 C--O 1.234 0.275 0 C-N-CA 124.261 1.025 . . . . 0.0 111.43 -170.912 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 24.7 t-20 -83.38 82.58 8.22 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 124.856 1.263 . . . . 0.0 107.933 174.373 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 3.7 pp -140.92 131.6 25.64 Favored 'General case' 0 N--CA 1.453 -0.282 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 170.903 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 25.3 mt-10 -141.1 146.59 37.29 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 127.843 2.457 . . . . 0.0 107.585 168.414 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 69.74 -3.44 9.23 Favored Glycine 0 CA--C 1.534 1.243 0 CA-C-O 118.111 -1.383 . . . . 0.0 116.285 169.658 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.93 161.96 30.07 Favored 'General case' 0 C--N 1.343 0.312 0 CA-C-N 120.282 2.041 . . . . 0.0 109.681 -177.345 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 2.2 mt -85.05 135.41 24.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 N-CA-C 107.329 -1.36 . . . . 0.0 107.329 177.794 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 77.4 t -128.47 138.23 55.19 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 -179.766 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -113.7 156.81 23.1 Favored 'General case' 0 CA--C 1.521 -0.156 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 169.305 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 2.0 mt -138.7 134.73 33.98 Favored 'General case' 0 CA--C 1.515 -0.374 0 N-CA-C 107.002 -1.481 . . . . 0.0 107.002 -178.568 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 12.2 p90 -165.15 171.24 13.99 Favored 'General case' 0 N--CA 1.451 -0.386 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 170.698 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -178.08 176.71 48.16 Favored Glycine 0 N--CA 1.449 -0.439 0 N-CA-C 109.955 -1.258 . . . . 0.0 109.955 167.984 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -107.93 154.87 20.98 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 124.696 1.199 . . . . 0.0 109.905 171.922 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -150.74 -153.61 6.2 Favored Glycine 0 CA--C 1.525 0.679 0 N-CA-C 107.894 -2.083 . . . . 0.0 107.894 169.71 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -145.57 123.68 12.15 Favored 'General case' 0 C--O 1.233 0.202 0 C-N-CA 123.586 0.754 . . . . 0.0 109.499 179.732 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -74.45 -13.3 60.69 Favored 'General case' 0 CA--C 1.543 0.676 0 N-CA-C 113.213 0.82 . . . . 0.0 113.213 179.62 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 72.1 mt -69.29 -19.28 63.9 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 119.543 1.065 . . . . 0.0 110.256 169.812 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -77.32 32.89 1.56 Allowed Glycine 0 CA--C 1.535 1.309 0 C-N-CA 124.699 1.143 . . . . 0.0 110.824 167.569 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 56.0 m-85 56.12 -5.15 0.03 OUTLIER 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 129.051 2.94 . . . . 0.0 115.218 -172.471 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 69.39 9.99 62.2 Favored Glycine 0 CA--C 1.533 1.199 0 O-C-N 121.224 -0.922 . . . . 0.0 110.943 -168.802 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -76.42 -25.43 54.47 Favored 'General case' 0 C--N 1.342 0.25 0 CA-C-N 118.875 1.338 . . . . 0.0 109.999 169.778 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' TRP . . . . . . . . . . . . . 12.7 m0 -112.87 -5.73 13.84 Favored 'General case' 0 C--O 1.234 0.273 0 N-CA-C 113.464 0.913 . . . . 0.0 113.464 -167.75 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 1.6 p90 -82.29 155.15 24.97 Favored 'General case' 0 C--N 1.344 0.33 0 CA-C-N 119.513 1.051 . . . . 0.0 111.804 -174.803 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 71.5 mt 56.17 9.3 0.48 Allowed 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 126.41 1.884 . . . . 0.0 115.49 169.391 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -60.16 -28.7 68.14 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 120.394 1.452 . . . . 0.0 110.967 -175.37 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -71.31 -26.65 62.94 Favored 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 123.968 0.907 . . . . 0.0 112.491 176.82 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 10.1 mp -63.69 -43.47 96.56 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 119.846 1.203 . . . . 0.0 107.854 170.832 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -65.46 -39.83 95.92 Favored Glycine 0 C--N 1.339 0.747 0 N-CA-C 110.801 -0.92 . . . . 0.0 110.801 -174.875 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 70.7 mtm -63.85 -44.74 92.25 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 117.288 0.544 . . . . 0.0 111.762 178.3 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.408 HD23 ' CH2' ' A' ' 65' ' ' TRP . 0.2 OUTLIER -71.04 -39.63 72.19 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 119.635 1.107 . . . . 0.0 109.908 178.865 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 42.9 t-80 -55.13 -51.79 65.32 Favored 'General case' 0 CA--C 1.53 0.206 0 O-C-N 121.64 -0.662 . . . . 0.0 110.516 176.59 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -61.38 -39.7 91.64 Favored 'General case' 0 C--O 1.235 0.311 0 C-N-CA 123.491 0.716 . . . . 0.0 111.864 -176.716 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 24.2 ttmm -56.84 -41.82 78.55 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 123.325 0.65 . . . . 0.0 110.598 173.486 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 38.2 mt -87.21 -16.5 35.12 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-O 117.628 -1.177 . . . . 0.0 114.077 -169.798 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 17.7 m -57.61 -37.83 73.91 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 120.412 1.46 . . . . 0.0 111.247 -179.759 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 21.1 p -82.52 -12.52 57.71 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 124.194 0.998 . . . . 0.0 111.561 -179.409 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 32.0 mmmt -82.27 -6.39 59.2 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 124.517 1.127 . . . . 0.0 110.853 169.582 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 71.44 27.19 71.83 Favored Glycine 0 CA--C 1.527 0.831 0 CA-C-N 119.312 0.96 . . . . 0.0 113.098 168.829 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 7.9 m -74.09 170.29 1.48 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 CA-C-N 118.5 1.15 . . . . 0.0 110.068 178.345 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 54.4 tptt -95.04 135.55 36.45 Favored 'General case' 0 CA--C 1.513 -0.472 0 N-CA-C 105.26 -2.126 . . . . 0.0 105.26 167.785 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 64.7 m-85 -103.14 122.39 44.6 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 108.099 -1.075 . . . . 0.0 108.099 171.815 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 26.2 m -107.84 158.23 7.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 C-N-CA 124.5 1.12 . . . . 0.0 108.685 168.033 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 86.1 24.69 39.91 Favored Glycine 0 CA--C 1.524 0.654 0 CA-C-O 118.076 -1.402 . . . . 0.0 115.13 169.699 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 12.3 m-30 -59.91 156.38 14.58 Favored 'General case' 0 CA--C 1.544 0.721 0 CA-C-N 119.44 1.62 . . . . 0.0 109.298 168.613 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 58.3 t-105 -135.71 143.86 46.52 Favored Pre-proline 0 N--CA 1.472 0.635 0 CA-C-O 118.094 -0.955 . . . . 0.0 111.553 -168.359 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -64.46 129.64 24.44 Favored 'Trans proline' 0 C--N 1.348 0.548 0 C-N-CA 123.344 2.696 . . . . 0.0 112.429 -178.133 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 3.7 p -84.27 -30.86 25.28 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 125.022 1.329 . . . . 0.0 111.062 169.709 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -57.37 126.69 28.42 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 124.369 1.067 . . . . 0.0 110.832 -168.833 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 77.32 -1.51 64.95 Favored Glycine 0 CA--C 1.532 1.132 0 C-N-CA 124.762 1.172 . . . . 0.0 114.288 176.943 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 6.4 t80 -92.46 160.94 14.84 Favored 'General case' 0 C--O 1.236 0.391 0 CA-C-N 119.468 1.634 . . . . 0.0 110.526 178.754 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 18.2 mm-40 -98.7 110.13 22.77 Favored 'General case' 0 C--O 1.233 0.226 0 N-CA-C 108.253 -1.017 . . . . 0.0 108.253 178.395 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 25.6 p90 -160.79 166.54 28.44 Favored 'General case' 0 C--O 1.237 0.395 0 C-N-CA 125.609 1.564 . . . . 0.0 108.981 -179.643 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 12.4 t -156.82 -161.5 1.1 Allowed 'General case' 0 CA--C 1.546 0.822 0 N-CA-C 106.197 -1.779 . . . . 0.0 106.197 166.874 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 75.5 m 61.63 133.02 0.03 OUTLIER Pre-proline 0 CA--C 1.552 1.041 0 C-N-CA 127.638 2.375 . . . . 0.0 113.014 -168.787 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -81.51 -24.78 4.13 Favored 'Trans proline' 0 C--N 1.351 0.68 0 C-N-CA 121.669 1.579 . . . . 0.0 113.906 -169.25 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 23.9 ttmt -58.88 -42.7 95.51 Favored Pre-proline 0 N--CA 1.474 0.762 0 CA-C-N 120.349 1.432 . . . . 0.0 114.305 -169.889 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 80.7 Cg_endo -76.66 -0.53 10.57 Favored 'Trans proline' 0 C--N 1.353 0.812 0 CA-C-N 122.216 1.827 . . . . 0.0 114.079 179.526 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 19.5 m -120.48 149.28 23.3 Favored 'Isoleucine or valine' 0 C--O 1.232 0.171 0 CA-C-N 120.479 1.491 . . . . 0.0 110.217 -178.759 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 133' ' ' ILE . . . . . 0.477 HG23 HG12 ' A' ' 140' ' ' VAL . 3.2 pt -88.08 169.1 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.721 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 169.013 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . 56.0 -154.12 0.33 Allowed 'General case' 0 N--CA 1.441 -0.907 0 CA-C-N 113.603 -1.635 . . . . 0.0 109.175 169.604 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 22.4 t0 -80.67 60.7 4.08 Favored 'General case' 0 C--N 1.325 -0.482 0 C-N-CA 125.022 1.329 . . . . 0.0 109.123 169.94 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 63.54 30.0 76.3 Favored Glycine 0 CA--C 1.529 0.927 0 C-N-CA 124.607 1.099 . . . . 0.0 112.868 177.659 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 56.0 mm-40 -78.33 -29.19 47.49 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 117.706 0.753 . . . . 0.0 111.688 -168.955 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 11.7 tp -158.67 148.96 19.78 Favored 'General case' 0 CA--C 1.53 0.207 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 -174.602 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 72.5 m-85 -77.48 148.53 35.3 Favored 'General case' 0 CA--C 1.522 -0.113 0 CA-C-N 119.146 0.884 . . . . 0.0 108.789 170.088 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 140' ' ' VAL . . . . . 0.477 HG12 HG23 ' A' ' 133' ' ' ILE . 33.8 m -71.43 -0.67 1.82 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.624 0 C-N-CA 123.195 0.598 . . . . 0.0 112.265 175.762 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -176.58 171.9 44.87 Favored Glycine 0 CA--C 1.524 0.633 0 O-C-N 120.745 -1.222 . . . . 0.0 110.346 -172.659 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 1.6 tp -64.67 136.13 56.64 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 118.006 0.903 . . . . 0.0 110.939 179.454 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -101.72 112.81 25.52 Favored 'General case' 0 N--CA 1.447 -0.617 0 C-N-CA 125.841 1.656 . . . . 0.0 108.873 176.266 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 95.7 mt -106.76 158.35 17.04 Favored 'General case' 0 N--CA 1.465 0.295 0 C-N-CA 124.448 1.099 . . . . 0.0 109.317 170.584 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 6.2 t0 -140.99 132.92 27.63 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 104.854 -2.276 . . . . 0.0 104.854 169.186 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -131.64 21.56 4.67 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 123.138 0.575 . . . . 0.0 110.848 177.398 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 17.5 m -98.01 -37.71 9.66 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 124.925 1.29 . . . . 0.0 109.332 170.954 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 41.9 m-80 -116.8 -44.63 2.82 Favored 'General case' 0 CA--C 1.515 -0.372 0 C-N-CA 125.521 1.529 . . . . 0.0 109.635 -169.372 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 24.0 mt-30 -92.03 156.04 17.68 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 124.508 1.123 . . . . 0.0 108.435 177.465 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 91.1 t80 -159.47 -51.35 0.06 Allowed 'General case' 0 N--CA 1.461 0.089 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 172.987 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -61.09 -43.99 98.04 Favored 'General case' 0 C--O 1.234 0.269 0 C-N-CA 123.093 0.557 . . . . 0.0 111.716 -170.78 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . 0.291 0.3 OUTLIER -100.38 0.41 39.87 Favored 'General case' 0 C--N 1.345 0.383 0 N-CA-C 113.97 1.1 . . . . 0.0 113.97 175.929 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 12.5 m -61.5 -31.85 71.85 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-N 120.575 1.534 . . . . 0.0 108.99 169.183 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -59.91 -42.5 94.03 Favored 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 124.235 1.014 . . . . 0.0 111.65 169.673 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -64.41 -47.01 80.79 Favored 'General case' 0 C--N 1.334 -0.102 0 C-N-CA 124.31 1.044 . . . . 0.0 109.848 178.907 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 68.5 mtt180 -57.58 -46.76 83.59 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-O 118.125 -0.94 . . . . 0.0 110.501 177.151 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 47.8 mt -61.03 -51.96 67.14 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.403 0 CA-C-N 119.443 1.02 . . . . 0.0 108.383 177.192 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 71.0 tp60 -52.78 -64.19 0.9 Allowed 'General case' 0 C--O 1.234 0.27 0 C-N-CA 124.633 1.173 . . . . 0.0 111.302 -177.6 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 41.3 m -66.21 -33.26 75.35 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 119.315 -0.374 . . . . 0.0 111.268 -171.459 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 160' ' ' TRP . . . . . . . . . . . . . 60.5 t90 -65.73 -47.87 73.88 Favored 'General case' 0 C--O 1.225 -0.225 0 CA-C-N 118.676 0.671 . . . . 0.0 110.707 174.705 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 64.7 m -61.3 -42.22 98.29 Favored 'General case' 0 N--CA 1.455 -0.204 0 CA-C-N 118.217 0.462 . . . . 0.0 110.299 -178.986 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -61.55 -44.54 96.85 Favored 'General case' 0 N--CA 1.455 -0.203 0 CA-C-N 118.308 0.504 . . . . 0.0 110.076 174.886 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 14.8 tt0 -62.6 -50.81 69.79 Favored 'General case' 0 CA--C 1.512 -0.489 0 CA-C-O 117.699 -1.143 . . . . 0.0 109.803 -176.415 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 44.7 pt -63.98 -34.13 66.58 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.425 0 CA-C-O 117.59 -1.195 . . . . 0.0 109.835 -176.578 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -71.48 -32.36 68.18 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 119.653 1.115 . . . . 0.0 108.955 -174.982 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -70.74 -53.54 15.15 Favored 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 124.347 1.059 . . . . 0.0 109.374 173.737 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 20.1 tt0 -69.02 -31.44 70.24 Favored 'General case' 0 N--CA 1.445 -0.719 0 C-N-CA 125.601 1.561 . . . . 0.0 109.943 -168.619 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 168' ' ' MET . . . . . . . . . . . . . 22.1 ptp -74.11 -34.02 63.78 Favored 'General case' 0 C--O 1.23 0.078 0 O-C-N 122.143 -0.348 . . . . 0.0 111.047 174.658 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -74.86 -37.16 62.28 Favored 'General case' 0 N--CA 1.442 -0.852 0 CA-C-O 119.276 -0.393 . . . . 0.0 111.811 -177.251 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 5.5 mt-10 -62.37 -32.91 73.78 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-O 121.572 0.701 . . . . 0.0 109.682 177.244 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 72.5 t60 -75.01 -34.55 61.93 Favored 'General case' 0 N--CA 1.446 -0.648 0 C-N-CA 124.741 1.216 . . . . 0.0 111.328 -175.774 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 4.7 m-85 -77.9 -27.6 49.61 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 123.507 0.723 . . . . 0.0 112.927 173.63 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.254 1.313 0 C-N-CA 123.461 0.704 . . . . 0.0 110.727 -177.729 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.497 1.898 0 CA-C-O 120.433 0.159 . . . . 0.0 111.286 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 26.1 p-10 -116.39 165.87 12.72 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 125.392 1.477 . . . . 0.0 111.414 -174.425 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 13.9 mtt -130.69 128.44 40.89 Favored 'General case' 0 CA--C 1.522 -0.119 0 C-N-CA 123.27 0.628 . . . . 0.0 110.717 175.367 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -90.12 149.4 20.3 Favored Glycine 0 CA--C 1.525 0.672 0 N-CA-C 106.786 -2.526 . . . . 0.0 106.786 166.56 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 2.4 tt -134.26 100.16 4.61 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 105.364 -2.087 . . . . 0.0 105.364 -178.099 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.557 ' CZ ' HD11 ' A' ' 51' ' ' LEU . 0.5 OUTLIER -106.22 142.84 35.23 Favored 'General case' 0 CA--C 1.519 -0.238 0 CA-C-O 121.63 0.729 . . . . 0.0 112.252 -172.727 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 34.7 p90 -155.63 165.28 37.04 Favored 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 126.697 1.999 . . . . 0.0 106.85 179.425 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -143.25 93.73 0.17 Allowed Glycine 0 CA--C 1.509 -0.306 0 N-CA-C 105.552 -3.019 . . . . 0.0 105.552 177.042 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 6.0 m -140.67 47.52 1.75 Allowed 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 124.78 1.232 . . . . 0.0 107.675 -169.735 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 6.6 m -48.21 130.18 15.81 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 125.975 1.71 . . . . 0.0 111.815 -169.193 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 6.0 m 66.1 -40.92 0.35 Allowed 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 127.834 2.453 . . . . 0.0 114.336 -176.98 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 61.0 m -79.94 -25.76 40.34 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 119.404 1.002 . . . . 0.0 112.84 -174.138 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 7.1 m-85 57.76 -178.69 0.06 Allowed 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 126.533 1.933 . . . . 0.0 111.752 -168.606 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 72.5 p -80.53 -175.7 5.34 Favored 'General case' 0 CA--C 1.548 0.868 0 N-CA-C 106.751 -1.574 . . . . 0.0 106.751 166.908 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 49.0 mm-40 -77.66 55.11 1.29 Allowed 'General case' 0 CA--C 1.543 0.684 0 O-C-N 120.206 -1.559 . . . . 0.0 109.254 169.886 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 52.38 24.19 2.82 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 127.776 2.43 . . . . 0.0 112.56 -171.442 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -65.65 -44.89 84.98 Favored 'General case' 0 C--N 1.34 0.179 0 O-C-N 120.946 -1.096 . . . . 0.0 109.3 -175.205 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -63.77 -45.53 89.32 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 122.195 0.198 . . . . 0.0 110.872 -176.74 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -60.24 -45.38 93.44 Favored 'General case' 0 N--CA 1.465 0.298 0 C-N-CA 123.296 0.638 . . . . 0.0 109.667 176.392 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 30.0 mtpp -70.52 -39.91 73.8 Favored 'General case' 0 C--O 1.222 -0.373 0 CA-C-O 118.441 -0.79 . . . . 0.0 110.144 -173.512 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 43.8 mt -54.88 -54.86 19.47 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.189 0 CA-C-N 119.765 1.166 . . . . 0.0 109.174 176.024 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.83 -33.87 76.56 Favored 'General case' 0 C--O 1.221 -0.399 0 CA-C-N 118.259 0.481 . . . . 0.0 111.316 -174.628 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -63.4 -40.75 98.06 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 122.67 0.388 . . . . 0.0 111.119 175.273 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 55.6 mt -76.72 -55.67 10.25 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.515 0 C-N-CA 124.644 1.178 . . . . 0.0 110.451 -171.698 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 73.4 mt -64.48 -46.3 93.18 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 -179.858 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 143.73 124.01 1.78 Allowed Glycine 0 CA--C 1.527 0.817 0 C-N-CA 124.442 1.02 . . . . 0.0 110.871 174.46 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -73.13 -9.41 23.35 Favored 'Trans proline' 0 CA--C 1.54 0.782 0 C-N-CA 123.101 2.534 . . . . 0.0 113.387 -170.914 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -81.35 -19.09 43.49 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 118.768 0.713 . . . . 0.0 111.416 178.174 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -125.12 -7.2 7.13 Favored 'General case' 0 C--N 1.344 0.335 0 C-N-CA 124.828 1.251 . . . . 0.0 113.724 -174.032 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 40.4 t -115.02 137.27 49.04 Favored 'Isoleucine or valine' 0 C--O 1.233 0.216 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 171.193 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 51.7 m -129.91 132.99 46.57 Favored 'General case' 0 C--O 1.233 0.197 0 C-N-CA 124.807 1.243 . . . . 0.0 108.268 -174.503 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 23.7 mt -75.22 144.22 42.73 Favored 'General case' 0 C--O 1.233 0.194 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 177.073 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' HIS . . . . . 0.417 ' HD1' ' HB2' ' A' ' 6' ' ' PHE . 44.4 t-80 -132.7 66.55 1.56 Allowed 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 125.141 1.376 . . . . 0.0 107.291 -177.679 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 57.0 t-20 -70.43 118.08 12.78 Favored 'General case' 0 C--O 1.233 0.234 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 -179.329 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 48.6 mt -67.74 -18.0 64.74 Favored 'General case' 0 C--O 1.232 0.183 0 N-CA-C 113.16 0.8 . . . . 0.0 113.16 -174.78 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 35.1 tptt -60.14 -23.6 64.03 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 118.698 0.681 . . . . 0.0 111.777 169.445 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -119.46 -39.41 2.89 Favored 'General case' 0 C--O 1.234 0.262 0 N-CA-C 113.279 0.844 . . . . 0.0 113.279 -172.846 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 33.1 m-20 -101.42 139.15 37.48 Favored 'General case' 0 N--CA 1.465 0.302 0 C-N-CA 123.947 0.899 . . . . 0.0 110.531 -177.654 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 11.4 m -75.28 155.82 85.83 Favored Pre-proline 0 CA--C 1.542 0.644 0 C-N-CA 124.124 0.97 . . . . 0.0 110.16 174.779 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -74.71 -25.68 12.26 Favored 'Trans proline' 0 C--N 1.349 0.553 0 C-N-CA 121.909 1.74 . . . . 0.0 113.472 -170.196 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 1.7 mptm? -62.9 -21.08 65.76 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-N 120.329 1.422 . . . . 0.0 112.082 -179.186 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -62.25 -26.53 68.44 Favored 'General case' 0 N--CA 1.465 0.292 0 C-N-CA 125.119 1.368 . . . . 0.0 110.389 174.634 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 68.4 mtt -58.19 -27.66 64.07 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 118.94 0.791 . . . . 0.0 111.43 177.128 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 69.1 mt-10 -63.37 -32.59 74.05 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 118.238 0.472 . . . . 0.0 109.969 -175.814 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 26.2 mt-30 -67.47 -39.78 85.28 Favored 'General case' 0 C--N 1.342 0.278 0 C-N-CA 123.911 0.884 . . . . 0.0 113.191 -172.145 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 71.6 m-85 -72.95 135.16 44.99 Favored 'General case' 0 C--O 1.233 0.219 0 N-CA-C 109.446 -0.575 . . . . 0.0 109.446 -167.904 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -69.7 -44.01 71.27 Favored 'General case' 0 C--O 1.233 0.208 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 -178.843 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 12.3 t -103.52 145.49 12.53 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.396 0 N-CA-C 107.996 -1.113 . . . . 0.0 107.996 169.894 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 34.8 tp -135.41 105.97 6.47 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 175.943 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 32.6 mt -85.11 128.34 39.11 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.826 0 N-CA-C 106.638 -1.616 . . . . 0.0 106.638 177.698 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.557 HD11 ' CZ ' ' A' ' 6' ' ' PHE . 0.8 OUTLIER -94.05 144.32 25.58 Favored 'General case' 0 CA--C 1.516 -0.363 0 C-N-CA 124.787 1.235 . . . . 0.0 109.824 169.588 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -145.34 134.78 5.67 Favored Glycine 0 CA--C 1.52 0.385 0 N-CA-C 109.244 -1.542 . . . . 0.0 109.244 169.234 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 3.5 tt -156.68 139.6 10.81 Favored Pre-proline 0 CA--C 1.542 0.655 0 CA-C-N 118.737 1.268 . . . . 0.0 111.411 172.956 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -78.39 145.14 20.95 Favored 'Trans proline' 0 CA--C 1.538 0.718 0 C-N-CA 122.749 2.3 . . . . 0.0 111.554 167.192 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.429 HG21 ' H ' ' A' ' 99' ' ' ASP . 38.6 m -106.36 147.65 28.99 Favored 'General case' 0 CA--C 1.542 0.665 0 N-CA-C 107.082 -1.451 . . . . 0.0 107.082 167.426 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 20.6 t90 -148.02 145.3 28.44 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 124.327 1.051 . . . . 0.0 109.119 -175.525 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -70.02 -38.21 75.85 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 123.429 0.692 . . . . 0.0 112.361 -176.452 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 69.3 t80 -65.07 -32.95 74.92 Favored 'General case' 0 CA--C 1.537 0.472 0 O-C-N 122.186 -0.321 . . . . 0.0 110.683 -176.712 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 172.8 120.34 0.56 Allowed Glycine 0 CA--C 1.524 0.632 0 N-CA-C 108.269 -1.933 . . . . 0.0 108.269 171.406 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 3.4 pm0 -74.76 158.92 32.68 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 123.331 0.653 . . . . 0.0 110.642 176.361 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . 0.253 49.9 mt 66.74 144.56 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.546 0.804 0 C-N-CA 127.34 2.256 . . . . 0.0 112.415 178.184 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 4.2 mp0 -108.1 153.69 22.78 Favored 'General case' 0 C--N 1.34 0.173 0 C-N-CA 125.569 1.548 . . . . 0.0 107.157 -177.317 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -57.0 -42.47 80.32 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 123.178 0.591 . . . . 0.0 110.951 -173.312 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 23.0 m-20 -66.99 -18.24 65.29 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 122.844 0.458 . . . . 0.0 112.004 -176.409 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' TRP . . . . . 0.788 ' CH2' HD23 ' A' ' 104' ' ' LEU . 13.6 t90 -95.76 -44.79 7.27 Favored 'General case' 0 C--N 1.339 0.14 0 C-N-CA 124.358 1.063 . . . . 0.0 110.263 175.304 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -62.9 -34.75 78.07 Favored 'General case' 0 CA--C 1.538 0.503 0 O-C-N 120.692 -1.255 . . . . 0.0 109.673 -178.864 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -60.16 -25.32 65.43 Favored 'General case' 0 C--O 1.233 0.216 0 C-N-CA 123.839 0.856 . . . . 0.0 111.567 179.29 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 12.2 m -109.85 -16.04 9.25 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.321 0 CA-C-O 117.46 -1.257 . . . . 0.0 112.467 179.446 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 27.9 t90 -53.71 -38.53 64.37 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 120.025 1.284 . . . . 0.0 110.198 176.822 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -66.59 -27.36 67.66 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 125.476 1.51 . . . . 0.0 112.945 175.532 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 68.1 mt-30 -90.73 -23.07 20.8 Favored 'General case' 0 C--O 1.224 -0.289 0 C-N-CA 125.67 1.588 . . . . 0.0 111.978 -176.787 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.608 ' CD1' HD21 ' A' ' 104' ' ' LEU . 50.3 mt -57.74 -32.0 67.02 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 118.537 0.608 . . . . 0.0 110.275 173.398 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -70.4 -26.5 63.72 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 122.694 0.397 . . . . 0.0 111.233 174.548 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -81.31 -34.36 31.97 Favored 'General case' 0 CA--C 1.537 0.475 0 N-CA-C 113.307 0.854 . . . . 0.0 113.307 176.267 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 24.7 mt -59.62 149.56 29.95 Favored 'General case' 0 N--CA 1.464 0.27 0 C-N-CA 124.476 1.11 . . . . 0.0 111.104 -176.117 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 19.9 t-20 -91.15 118.42 30.43 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 169.171 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 70.4 mt -127.98 8.9 6.25 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 123.73 0.812 . . . . 0.0 112.263 -173.113 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 28.9 mt-10 -52.18 129.15 27.04 Favored 'General case' 0 C--O 1.234 0.273 0 C-N-CA 124.3 1.04 . . . . 0.0 112.272 -168.049 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 68.43 0.09 15.3 Favored Glycine 0 CA--C 1.535 1.3 0 C-N-CA 125.436 1.493 . . . . 0.0 115.525 175.828 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.66 151.34 40.81 Favored 'General case' 0 C--N 1.345 0.391 0 CA-C-N 120.555 2.177 . . . . 0.0 109.499 -174.262 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 5.8 mt -80.38 136.47 23.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 N-CA-C 106.65 -1.611 . . . . 0.0 106.65 179.649 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 43.2 t -131.16 134.26 61.52 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 C-N-CA 123.755 0.822 . . . . 0.0 109.809 -179.567 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.415 ' HB1' ' CH2' ' A' ' 160' ' ' TRP . . . -105.34 152.73 22.57 Favored 'General case' 0 N--CA 1.462 0.139 0 N-CA-C 105.865 -1.902 . . . . 0.0 105.865 166.804 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 2.6 mt -134.08 134.4 42.26 Favored 'General case' 0 CA--C 1.512 -0.497 0 N-CA-C 107.096 -1.446 . . . . 0.0 107.096 175.537 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 36.0 p90 -148.86 168.77 22.13 Favored 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 169.628 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -163.41 173.6 39.56 Favored Glycine 0 N--CA 1.446 -0.661 0 N-CA-C 109.91 -1.276 . . . . 0.0 109.91 169.979 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -119.75 153.45 35.65 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 125.012 1.325 . . . . 0.0 108.435 171.035 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -166.06 -155.41 8.76 Favored Glycine 0 CA--C 1.526 0.764 0 N-CA-C 109.595 -1.402 . . . . 0.0 109.595 174.083 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -124.95 146.77 49.22 Favored 'General case' 0 C--O 1.236 0.355 0 C-N-CA 124.733 1.213 . . . . 0.0 109.625 179.973 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' GLN . . . . . 0.529 ' H ' ' ND2' ' A' ' 148' ' ' ASN . 4.8 pt20 -120.55 6.72 10.56 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 124.592 1.157 . . . . 0.0 113.464 171.271 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 21.8 mt -65.88 -40.44 91.59 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 120.1 1.318 . . . . 0.0 109.509 170.078 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -76.01 45.04 1.91 Allowed Glycine 0 CA--C 1.529 0.917 0 C-N-CA 125.233 1.397 . . . . 0.0 111.226 170.533 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 48.6 m-85 57.45 0.57 0.1 Allowed 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 127.675 2.39 . . . . 0.0 114.717 -176.938 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 70.57 27.59 72.31 Favored Glycine 0 CA--C 1.526 0.765 0 O-C-N 121.21 -0.931 . . . . 0.0 110.794 -169.879 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -72.37 -31.14 65.33 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-N 118.507 1.153 . . . . 0.0 108.007 167.316 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' TRP . . . . . . . . . . . . . 14.4 m0 -86.2 -0.68 56.3 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 125.639 1.576 . . . . 0.0 111.979 176.34 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 4.3 t80 -75.31 131.13 40.09 Favored 'General case' 0 C--N 1.341 0.226 0 O-C-N 121.313 -0.867 . . . . 0.0 111.361 -169.139 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 84.3 mt 50.7 23.07 1.25 Allowed 'General case' 0 N--CA 1.47 0.541 0 N-CA-C 116.253 1.945 . . . . 0.0 116.253 166.205 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' ASP . . . . . 0.429 ' H ' HG21 ' A' ' 55' ' ' THR . 13.9 t70 -64.61 -35.03 79.69 Favored 'General case' 0 C--N 1.328 -0.348 0 O-C-N 120.441 -1.412 . . . . 0.0 111.116 -174.305 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -65.9 -31.43 72.36 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 123.845 0.858 . . . . 0.0 111.944 173.458 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 4.2 tt -65.92 -47.93 73.1 Favored 'General case' 0 N--CA 1.468 0.446 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 173.542 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -58.84 -40.53 95.25 Favored Glycine 0 CA--C 1.525 0.713 0 N-CA-C 111.09 -0.804 . . . . 0.0 111.09 178.081 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 3.0 tpp -49.75 -45.44 49.41 Favored 'General case' 0 N--CA 1.464 0.256 0 C-N-CA 124.685 1.194 . . . . 0.0 110.867 172.328 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.788 HD23 ' CH2' ' A' ' 65' ' ' TRP . 0.2 OUTLIER -83.81 -31.26 25.95 Favored 'General case' 0 CA--C 1.52 -0.174 0 O-C-N 122.122 -0.361 . . . . 0.0 111.607 -171.683 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 36.8 t-80 -60.33 -45.26 94.08 Favored 'General case' 0 C--N 1.331 -0.234 0 O-C-N 121.964 -0.46 . . . . 0.0 109.813 169.482 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -63.42 -47.58 81.33 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 123.472 0.709 . . . . 0.0 111.088 179.511 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 2.2 tppm? -54.38 -31.05 53.88 Favored 'General case' 0 N--CA 1.466 0.352 0 C-N-CA 125.342 1.457 . . . . 0.0 111.854 173.863 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 49.2 mt -101.55 -22.32 14.52 Favored 'General case' 0 N--CA 1.465 0.28 0 N-CA-C 114.231 1.197 . . . . 0.0 114.231 -173.668 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 69.0 m -60.42 -34.88 74.59 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 119.897 1.226 . . . . 0.0 111.188 -176.718 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 24.3 p -80.38 -13.13 59.41 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 124.817 1.247 . . . . 0.0 111.833 -179.344 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 31.3 mmmt -88.24 -10.84 48.38 Favored 'General case' 0 C--N 1.342 0.281 0 C-N-CA 125.297 1.439 . . . . 0.0 111.64 179.778 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 75.04 32.92 55.94 Favored Glycine 0 CA--C 1.523 0.572 0 CA-C-O 119.567 -0.574 . . . . 0.0 111.795 173.166 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 9.9 m -72.88 172.42 1.04 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.582 0 CA-C-N 118.26 1.03 . . . . 0.0 109.024 169.721 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -112.25 121.38 44.74 Favored 'General case' 0 CA--C 1.514 -0.422 0 N-CA-C 106.224 -1.769 . . . . 0.0 106.224 176.073 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 63.3 m-85 -88.79 143.99 26.53 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 119.513 1.051 . . . . 0.0 109.756 -176.176 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 30.6 m -129.53 161.17 39.57 Favored 'Isoleucine or valine' 0 C--O 1.234 0.269 0 C-N-CA 124.787 1.235 . . . . 0.0 108.623 170.044 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 95.79 -93.5 1.57 Allowed Glycine 0 N--CA 1.444 -0.79 0 C-N-CA 124.581 1.086 . . . . 0.0 111.122 177.463 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 14.4 m-30 59.25 -178.3 0.08 Allowed 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 124.345 1.058 . . . . 0.0 109.011 -167.275 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -154.93 144.44 15.32 Favored Pre-proline 0 N--CA 1.471 0.6 0 O-C-N 120.192 -1.568 . . . . 0.0 110.604 179.416 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -67.74 123.84 11.21 Favored 'Trans proline' 0 CA--C 1.534 0.515 0 C-N-CA 123.222 2.614 . . . . 0.0 111.705 179.114 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 3.0 p -79.61 -16.57 55.59 Favored 'General case' 0 CA--C 1.538 0.492 0 O-C-N 121.669 -0.644 . . . . 0.0 112.315 174.692 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -59.84 124.05 18.95 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 123.625 0.77 . . . . 0.0 110.476 -169.691 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 73.63 1.59 58.6 Favored Glycine 0 CA--C 1.534 1.242 0 C-N-CA 124.592 1.091 . . . . 0.0 114.083 177.826 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 4.1 t80 -89.39 153.32 20.94 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-N 119.052 1.426 . . . . 0.0 109.956 -179.855 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 18.5 mm-40 -91.92 113.5 25.78 Favored 'General case' 0 C--O 1.233 0.21 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 176.222 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 24.2 p90 -155.81 156.56 34.95 Favored 'General case' 0 C--O 1.237 0.404 0 C-N-CA 125.784 1.633 . . . . 0.0 107.662 172.57 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 5.7 t -148.2 2.32 0.66 Allowed 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 122.663 0.385 . . . . 0.0 111.254 168.521 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 5.0 p -71.75 128.23 89.86 Favored Pre-proline 0 CA--C 1.542 0.662 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 171.673 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -80.16 -28.06 3.3 Favored 'Trans proline' 0 CA--C 1.537 0.654 0 C-N-CA 122.241 1.96 . . . . 0.0 112.286 176.927 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 24.3 ttmt -57.68 -43.03 98.5 Favored Pre-proline 0 CA--C 1.542 0.666 0 CA-C-O 117.603 -1.189 . . . . 0.0 113.538 -173.776 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_endo -83.83 8.22 4.75 Favored 'Trans proline' 0 C--N 1.351 0.681 0 C-N-CA 122.144 1.896 . . . . 0.0 114.436 -179.6 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 29.0 m -126.4 165.31 24.8 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.285 0 CA-C-N 121.156 1.798 . . . . 0.0 111.791 -176.622 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 9.5 pt -132.81 169.2 22.48 Favored 'Isoleucine or valine' 0 C--O 1.234 0.277 0 C-N-CA 127.746 2.419 . . . . 0.0 108.576 179.714 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . 53.87 42.03 31.85 Favored 'General case' 0 C--O 1.227 -0.109 0 C-N-CA 125.296 1.438 . . . . 0.0 112.263 174.109 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 27.7 t70 54.04 42.57 31.57 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 126.479 1.912 . . . . 0.0 111.684 -177.527 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 91.78 16.82 50.66 Favored Glycine 0 CA--C 1.527 0.827 0 CA-C-O 118.721 -1.044 . . . . 0.0 113.642 173.873 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 46.2 mt-30 -89.32 -7.74 54.72 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 119.345 1.573 . . . . 0.0 112.946 179.635 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 7.4 tp -156.23 147.37 22.29 Favored 'General case' 0 C--N 1.344 0.339 0 CA-C-N 119.462 1.028 . . . . 0.0 110.829 169.964 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 67.6 m-85 -81.08 146.7 30.47 Favored 'General case' 0 CA--C 1.52 -0.175 0 N-CA-C 107.817 -1.179 . . . . 0.0 107.817 168.4 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 12.5 m -80.55 9.24 0.82 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 C-N-CA 123.722 0.809 . . . . 0.0 112.386 177.225 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -177.81 170.29 42.56 Favored Glycine 0 CA--C 1.524 0.644 0 N-CA-C 110.271 -1.132 . . . . 0.0 110.271 179.42 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -65.07 137.82 57.93 Favored 'General case' 0 N--CA 1.465 0.305 0 C-N-CA 123.326 0.65 . . . . 0.0 111.295 -176.3 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -93.76 122.84 36.65 Favored 'General case' 0 N--CA 1.444 -0.737 0 C-N-CA 126.229 1.812 . . . . 0.0 109.717 176.447 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 86.5 mt -122.42 161.28 23.8 Favored 'General case' 0 C--N 1.332 -0.177 0 N-CA-C 106.096 -1.816 . . . . 0.0 106.096 168.209 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -138.34 147.38 43.44 Favored 'General case' 0 C--O 1.235 0.314 0 N-CA-C 108.655 -0.869 . . . . 0.0 108.655 178.036 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -125.48 12.88 8.13 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 124.835 1.254 . . . . 0.0 112.94 -174.398 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 16.7 m -135.07 -36.33 0.82 Allowed 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 124.962 1.305 . . . . 0.0 111.929 -178.655 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 148' ' ' ASN . . . . . 0.529 ' ND2' ' H ' ' A' ' 90' ' ' GLN . 5.1 m-80 -93.93 -53.7 3.89 Favored 'General case' 0 CA--C 1.518 -0.264 0 C-N-CA 124.628 1.171 . . . . 0.0 112.234 -166.908 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 3.6 mp0 -134.85 133.04 39.31 Favored 'General case' 0 CA--C 1.523 -0.086 0 N-CA-C 107.72 -1.215 . . . . 0.0 107.72 -179.146 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 91.1 m-85 -113.35 -28.15 7.68 Favored 'General case' 0 N--CA 1.465 0.277 0 C-N-CA 123.68 0.792 . . . . 0.0 111.751 179.29 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -69.79 -43.3 72.41 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 118.272 0.487 . . . . 0.0 111.486 -169.875 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . 0.27 0.4 OUTLIER -84.73 5.36 28.69 Favored 'General case' 0 C--N 1.343 0.324 0 N-CA-C 113.401 0.889 . . . . 0.0 113.401 -177.402 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 48.6 m -59.81 -35.12 74.04 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 120.649 1.568 . . . . 0.0 110.829 174.45 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -60.87 -40.99 95.07 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 118.105 0.412 . . . . 0.0 110.902 174.593 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 -67.43 -50.37 59.65 Favored 'General case' 0 C--O 1.234 0.271 0 C-N-CA 124.614 1.165 . . . . 0.0 110.376 179.662 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 60.4 mtm180 -58.16 -41.46 83.85 Favored 'General case' 0 N--CA 1.463 0.214 0 C-N-CA 123.969 0.908 . . . . 0.0 109.734 -179.042 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 56.2 mt -69.47 -54.18 20.99 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.441 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 176.074 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 70.0 tp60 -52.78 -62.33 1.72 Allowed 'General case' 0 C--O 1.234 0.273 0 C-N-CA 124.546 1.139 . . . . 0.0 111.854 -171.767 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 20.0 m -66.13 -32.28 73.64 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 120.758 -0.377 . . . . 0.0 110.89 -169.493 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 160' ' ' TRP . . . . . 0.415 ' CH2' ' HB1' ' A' ' 83' ' ' ALA . 40.1 t90 -70.75 -43.84 68.0 Favored 'General case' 0 C--O 1.222 -0.386 0 O-C-N 121.99 -0.444 . . . . 0.0 111.267 176.553 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 67.2 m -58.31 -44.65 88.67 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 118.215 0.461 . . . . 0.0 110.173 176.917 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -62.45 -40.93 98.19 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-O 121.009 0.433 . . . . 0.0 110.153 176.752 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 13.6 tt0 -63.03 -52.85 61.23 Favored 'General case' 0 N--CA 1.447 -0.584 0 CA-C-O 118.732 -0.651 . . . . 0.0 110.036 -179.632 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 41.8 pt -63.43 -38.54 82.46 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.345 0 CA-C-O 117.973 -1.013 . . . . 0.0 109.185 -175.37 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -66.67 -32.82 74.38 Favored 'General case' 0 CA--C 1.529 0.152 0 CA-C-N 119.385 0.993 . . . . 0.0 110.414 -178.622 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 31.7 m-80 -68.66 -59.02 3.41 Favored 'General case' 0 CA--C 1.516 -0.352 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 173.303 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 16.2 tt0 -61.04 -37.9 84.22 Favored 'General case' 0 N--CA 1.441 -0.916 0 C-N-CA 125.895 1.678 . . . . 0.0 111.482 -168.904 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 168' ' ' MET . . . . . . . . . . . . . 19.9 ptp -70.06 -30.03 67.19 Favored 'General case' 0 C--N 1.333 -0.131 0 O-C-N 121.442 -0.786 . . . . 0.0 112.23 174.814 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -77.28 -38.52 50.66 Favored 'General case' 0 N--CA 1.446 -0.627 0 C-N-CA 123.126 0.57 . . . . 0.0 112.249 178.658 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -64.91 -32.58 74.35 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-O 121.907 0.86 . . . . 0.0 109.698 -179.276 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 57.4 t60 -62.6 -22.27 66.26 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 124.817 1.247 . . . . 0.0 111.438 178.425 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 24.2 m-85 -107.38 9.57 29.79 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 126.422 1.889 . . . . 0.0 113.871 172.878 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.255 1.356 0 CA-C-N 119.412 1.005 . . . . 0.0 110.05 174.53 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.498 1.932 0 N-CA-C 111.684 0.253 . . . . 0.0 111.684 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 5.8 t30 -113.53 153.08 29.34 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 124.294 1.037 . . . . 0.0 109.297 177.333 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 15.9 mtt -113.7 129.34 56.59 Favored 'General case' 0 N--CA 1.462 0.128 0 C-N-CA 123.802 0.841 . . . . 0.0 110.137 -179.471 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -83.86 150.7 26.78 Favored Glycine 0 CA--C 1.526 0.721 0 N-CA-C 107.43 -2.268 . . . . 0.0 107.43 167.215 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 2.0 tt -138.33 99.15 3.77 Favored 'General case' 0 N--CA 1.467 0.39 0 N-CA-C 105.63 -1.989 . . . . 0.0 105.63 -177.821 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 1.1 p90 -105.18 147.78 27.63 Favored 'General case' 0 CA--C 1.519 -0.229 0 CA-C-N 118.592 0.633 . . . . 0.0 112.028 -171.372 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 43.0 p90 -157.16 171.33 20.62 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 126.077 1.751 . . . . 0.0 107.728 170.483 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -72.92 -88.14 0.17 Allowed Glycine 0 CA--C 1.523 0.593 0 C-N-CA 123.968 0.794 . . . . 0.0 113.232 -168.786 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 3.9 m -105.76 149.67 26.23 Favored 'General case' 0 C--O 1.233 0.214 0 C-N-CA 123.543 0.737 . . . . 0.0 110.453 -169.701 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 1.2 m -58.8 -30.5 67.64 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 124.222 1.009 . . . . 0.0 111.622 176.785 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 3.5 p -75.7 -14.83 60.35 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 125.583 1.553 . . . . 0.0 112.665 -177.028 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 82.1 m -70.63 148.95 47.54 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 119.074 0.852 . . . . 0.0 110.343 -179.117 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 60.9 m-85 -62.83 -18.4 62.78 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 122.716 0.407 . . . . 0.0 112.025 174.859 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -49.99 -27.74 5.89 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 125.876 1.671 . . . . 0.0 112.427 170.007 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 -58.79 -40.05 82.88 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 119.871 1.214 . . . . 0.0 110.649 177.61 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 2.6 mpp? -70.49 -39.87 73.93 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 118.96 0.8 . . . . 0.0 110.284 -178.378 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -59.77 -46.94 87.61 Favored 'General case' 0 C--O 1.224 -0.24 0 N-CA-C 109.076 -0.712 . . . . 0.0 109.076 171.315 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -62.74 -47.7 82.44 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 123.944 0.898 . . . . 0.0 111.381 -174.261 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 31.2 mt-10 -57.98 -44.82 87.35 Favored 'General case' 0 CA--C 1.518 -0.267 0 C-N-CA 123.202 0.601 . . . . 0.0 109.556 175.179 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 49.9 mttm -64.91 -47.54 77.41 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-O 118.796 -0.621 . . . . 0.0 110.484 -177.623 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 83.3 mt -53.12 -55.06 14.08 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.2 0 CA-C-N 118.897 0.771 . . . . 0.0 109.307 -178.812 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.475 ' HG2' HD21 ' A' ' 32' ' ' LEU . 0.0 OUTLIER -66.58 -35.06 79.29 Favored 'General case' 0 CA--C 1.513 -0.461 0 CA-C-O 118.812 -0.613 . . . . 0.0 111.313 -175.434 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -64.46 -39.9 94.69 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.997 0.427 . . . . 0.0 110.563 178.194 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 61.1 mt -78.01 -54.76 11.78 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.786 0 C-N-CA 124.77 1.228 . . . . 0.0 110.236 -171.092 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 71.3 mt -64.16 -46.22 94.17 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.326 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 179.257 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 141.98 124.1 1.93 Allowed Glycine 0 CA--C 1.528 0.898 0 C-N-CA 124.632 1.111 . . . . 0.0 110.969 173.528 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -69.94 -13.61 34.45 Favored 'Trans proline' 0 CA--C 1.539 0.738 0 C-N-CA 122.982 2.455 . . . . 0.0 112.836 -173.288 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -73.48 -21.42 60.43 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 118.509 0.595 . . . . 0.0 111.928 177.701 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -130.53 3.44 4.6 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 124.459 1.104 . . . . 0.0 113.535 -169.692 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 44.9 t -123.74 142.09 41.69 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.241 0 N-CA-C 107.62 -1.252 . . . . 0.0 107.62 171.262 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 30.5 m -129.27 132.48 47.19 Favored 'General case' 0 C--N 1.332 -0.182 0 C-N-CA 124.703 1.201 . . . . 0.0 108.427 -175.771 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.475 HD21 ' HG2' ' A' ' 22' ' ' ARG . 27.7 mt -75.25 135.73 40.97 Favored 'General case' 0 N--CA 1.456 -0.161 0 N-CA-C 107.999 -1.111 . . . . 0.0 107.999 175.432 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 28.5 t-80 -126.19 59.48 1.33 Allowed 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 125.148 1.379 . . . . 0.0 107.416 -176.811 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 33.3 t30 -69.55 113.26 6.67 Favored 'General case' 0 C--O 1.235 0.307 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 -176.296 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 77.6 mt -69.0 -14.89 63.31 Favored 'General case' 0 C--O 1.234 0.289 0 N-CA-C 112.554 0.576 . . . . 0.0 112.554 -171.775 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 1.3 tmtm? -58.81 -20.6 51.66 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 118.843 0.747 . . . . 0.0 111.173 168.82 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -128.03 -41.68 1.6 Allowed 'General case' 0 C--O 1.234 0.255 0 N-CA-C 113.287 0.847 . . . . 0.0 113.287 -175.801 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 30.5 m-20 -91.72 144.17 25.79 Favored 'General case' 0 C--O 1.235 0.301 0 C-N-CA 123.696 0.798 . . . . 0.0 111.07 -174.508 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 14.8 m -79.39 155.47 76.54 Favored Pre-proline 0 CA--C 1.539 0.551 0 C-N-CA 124.563 1.145 . . . . 0.0 110.258 176.361 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -76.93 -26.27 8.12 Favored 'Trans proline' 0 C--N 1.348 0.519 0 C-N-CA 122.232 1.955 . . . . 0.0 113.945 -171.082 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 8.2 mptt -62.64 -21.02 65.38 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 120.236 1.38 . . . . 0.0 111.8 -177.92 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -57.75 -29.74 65.04 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 125.865 1.666 . . . . 0.0 110.5 173.877 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 47.1 mtt -60.22 -26.21 66.23 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 118.763 0.71 . . . . 0.0 111.385 177.84 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 58.6 mt-10 -66.48 -33.51 75.85 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 118.714 0.688 . . . . 0.0 110.471 -176.651 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 24.3 mt-30 -63.77 -45.8 88.15 Favored 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 123.778 0.831 . . . . 0.0 112.868 -169.406 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 45.9 m-85 -76.24 136.02 39.67 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 115.393 -0.821 . . . . 0.0 109.473 -166.82 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -72.48 -30.19 64.31 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 118.865 0.757 . . . . 0.0 110.473 178.374 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 45.0 t -106.16 141.83 20.54 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.368 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 171.517 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 26.6 tp -136.82 118.46 14.95 Favored 'General case' 0 N--CA 1.446 -0.664 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 173.167 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 11.7 mt -93.61 133.48 34.54 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.829 0 N-CA-C 106.37 -1.715 . . . . 0.0 106.37 174.678 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 1.3 mp -111.23 134.07 53.1 Favored 'General case' 0 CA--C 1.518 -0.273 0 N-CA-C 106.703 -1.591 . . . . 0.0 106.703 -177.665 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -130.2 137.43 9.51 Favored Glycine 0 CA--C 1.518 0.257 0 N-CA-C 109.96 -1.256 . . . . 0.0 109.96 173.97 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 2.3 tt -151.57 133.86 8.45 Favored Pre-proline 0 CA--C 1.541 0.604 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 169.491 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_endo -82.38 -21.64 5.23 Favored 'Trans proline' 0 CA--C 1.538 0.703 0 C-N-CA 121.576 1.517 . . . . 0.0 114.521 -170.512 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 58.9 m 61.67 -62.9 0.09 Allowed 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 126.712 2.005 . . . . 0.0 112.261 -168.632 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 2.1 t90 65.72 169.35 0.21 Allowed 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 128.384 2.674 . . . . 0.0 115.335 171.096 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -65.05 109.02 2.0 Favored 'General case' 0 N--CA 1.466 0.342 0 C-N-CA 125.61 1.564 . . . . 0.0 111.409 -171.309 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 29.7 t80 48.8 25.87 1.14 Allowed 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 124.944 1.298 . . . . 0.0 111.563 -169.979 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -85.0 176.38 50.58 Favored Glycine 0 N--CA 1.443 -0.842 0 C-N-CA 124.287 0.946 . . . . 0.0 110.744 -178.623 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -150.17 170.15 19.61 Favored 'General case' 0 C--O 1.238 0.492 0 N-CA-C 106.429 -1.693 . . . . 0.0 106.429 174.976 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 24.8 mt -44.88 128.99 1.63 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.635 0 C-N-CA 124.849 1.26 . . . . 0.0 108.175 167.887 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -93.27 161.61 14.33 Favored 'General case' 0 C--O 1.231 0.122 0 C-N-CA 124.313 1.045 . . . . 0.0 109.929 -178.724 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -54.56 -41.56 69.95 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 124.436 1.094 . . . . 0.0 111.63 -169.285 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 27.5 m-20 -59.71 -27.64 66.64 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-N 118.453 0.57 . . . . 0.0 112.026 -176.785 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' TRP . . . . . 0.464 ' CH2' HD23 ' A' ' 104' ' ' LEU . 4.5 t90 -96.49 -44.86 6.99 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 125.688 1.595 . . . . 0.0 109.479 -178.069 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -63.02 -36.72 84.51 Favored 'General case' 0 CA--C 1.53 0.199 0 O-C-N 121.013 -1.054 . . . . 0.0 110.221 -179.177 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -61.12 -25.57 67.07 Favored 'General case' 0 C--O 1.234 0.268 0 C-N-CA 123.356 0.662 . . . . 0.0 111.015 -177.481 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 23.5 m -106.41 -17.97 7.41 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.539 0 CA-C-O 116.581 -1.676 . . . . 0.0 112.535 176.402 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 18.2 t90 -54.99 -35.65 64.57 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 121.492 1.951 . . . . 0.0 110.995 -179.275 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -63.43 -28.92 70.31 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 125.249 1.42 . . . . 0.0 112.715 174.1 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 62.9 mt-30 -92.57 -25.37 18.37 Favored 'General case' 0 C--O 1.224 -0.287 0 C-N-CA 126.436 1.894 . . . . 0.0 111.31 -179.842 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 37.6 mt -64.16 -26.43 68.52 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 118.727 0.694 . . . . 0.0 110.361 179.927 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -76.59 -25.67 54.21 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 117.794 0.27 . . . . 0.0 110.824 171.463 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -79.55 -33.38 41.93 Favored 'General case' 0 CA--C 1.538 0.494 0 O-C-N 121.257 -0.902 . . . . 0.0 113.049 179.403 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 30.6 mt -56.37 148.67 18.35 Favored 'General case' 0 C--O 1.234 0.265 0 C-N-CA 124.75 1.22 . . . . 0.0 111.02 -177.876 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 20.5 t-20 -86.03 122.88 30.68 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 170.325 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 74.2 mt -130.43 8.78 5.06 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 123.622 0.769 . . . . 0.0 112.222 -173.328 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 29.1 mt-10 -53.52 128.46 29.02 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 124.038 0.935 . . . . 0.0 112.256 -168.418 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 68.13 -0.26 12.42 Favored Glycine 0 CA--C 1.533 1.195 0 C-N-CA 125.443 1.497 . . . . 0.0 115.293 177.92 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.92 149.71 43.17 Favored 'General case' 0 C--N 1.343 0.308 0 CA-C-N 120.388 2.094 . . . . 0.0 109.635 -173.178 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 3.1 mt -80.56 133.33 29.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 N-CA-C 106.596 -1.631 . . . . 0.0 106.596 179.916 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 79.8 t -129.3 140.06 50.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 C-N-CA 124.122 0.969 . . . . 0.0 109.877 -176.93 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -128.42 154.31 46.17 Favored 'General case' 0 CA--C 1.53 0.173 0 C-N-CA 124.809 1.244 . . . . 0.0 108.052 169.795 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 2.4 mt -132.08 131.68 42.62 Favored 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 124.744 1.218 . . . . 0.0 108.334 -171.957 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.41 ' CD2' HD23 ' A' ' 142' ' ' LEU . 45.3 m-85 -130.28 141.93 50.58 Favored 'General case' 0 N--CA 1.451 -0.385 0 N-CA-C 106.643 -1.614 . . . . 0.0 106.643 -177.771 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -157.55 172.27 34.86 Favored Glycine 0 N--CA 1.442 -0.92 0 N-CA-C 108.965 -1.654 . . . . 0.0 108.965 168.502 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -119.94 162.7 18.75 Favored 'General case' 0 C--N 1.324 -0.537 0 C-N-CA 124.527 1.131 . . . . 0.0 109.54 170.149 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -157.98 132.6 3.2 Favored Glycine 0 N--CA 1.443 -0.852 0 N-CA-C 107.362 -2.295 . . . . 0.0 107.362 169.531 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 17.1 t0 -89.95 119.78 30.6 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 108.24 -1.022 . . . . 0.0 108.24 173.333 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 13.3 pt20 -65.5 -22.23 66.71 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 124.2 1.0 . . . . 0.0 112.056 178.372 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 13.9 mt -86.16 -58.9 2.45 Favored 'General case' 0 C--N 1.342 0.259 0 CA-C-N 118.981 0.809 . . . . 0.0 111.287 -174.976 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -67.4 -36.58 89.27 Favored Glycine 0 CA--C 1.525 0.659 0 C-N-CA 124.231 0.919 . . . . 0.0 113.242 -169.153 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 2.7 p90 -136.2 -71.85 0.46 Allowed 'General case' 0 CA--C 1.52 -0.208 0 N-CA-C 108.215 -1.032 . . . . 0.0 108.215 -178.457 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 76.81 -40.1 1.6 Allowed Glycine 0 CA--C 1.529 0.951 0 C-N-CA 124.589 1.09 . . . . 0.0 112.334 172.295 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -59.03 -42.49 90.31 Favored 'General case' 0 CA--C 1.528 0.117 0 CA-C-N 118.557 1.178 . . . . 0.0 109.644 174.955 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' TRP . . . . . . . . . . . . . 2.9 m0 -92.64 26.81 2.53 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 125.392 1.477 . . . . 0.0 111.809 -177.675 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 34.7 t80 -49.26 125.88 11.79 Favored 'General case' 0 N--CA 1.465 0.313 0 N-CA-C 107.942 -1.133 . . . . 0.0 107.942 174.36 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 84.4 mt 55.71 20.77 4.18 Favored 'General case' 0 CA--C 1.537 0.47 0 N-CA-C 113.668 0.988 . . . . 0.0 113.668 173.836 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -56.51 -42.73 78.87 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 120.394 1.452 . . . . 0.0 112.592 -168.468 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -80.95 -14.87 57.57 Favored 'General case' 0 CA--C 1.534 0.329 0 N-CA-C 113.389 0.885 . . . . 0.0 113.389 179.786 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 6.6 tt -60.58 -43.55 97.2 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-N 120.056 1.298 . . . . 0.0 107.911 169.24 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -66.75 -32.7 82.03 Favored Glycine 0 C--N 1.337 0.595 0 N-CA-C 112.031 -0.428 . . . . 0.0 112.031 -175.52 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 77.2 mtm -72.37 -26.9 62.08 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-O 118.363 -0.827 . . . . 0.0 111.796 -175.987 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.464 HD23 ' CH2' ' A' ' 65' ' ' TRP . 0.2 OUTLIER -76.41 -43.17 41.6 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 120.365 1.439 . . . . 0.0 109.372 169.019 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 82.1 t60 -53.34 -47.98 68.9 Favored 'General case' 0 N--CA 1.467 0.393 0 O-C-N 121.758 -0.589 . . . . 0.0 110.974 179.632 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -62.68 -37.24 85.68 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 123.676 0.79 . . . . 0.0 112.682 -177.505 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 25.1 ttmm -58.41 -36.41 73.54 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 123.575 0.75 . . . . 0.0 110.484 172.485 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 24.0 mt -91.95 -20.14 21.69 Favored 'General case' 0 CA--C 1.513 -0.453 0 N-CA-C 115.95 1.833 . . . . 0.0 115.95 -168.158 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 3.2 m -58.28 -32.97 68.92 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 120.665 1.575 . . . . 0.0 111.632 -176.433 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 21.1 p -88.27 -10.66 48.89 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 125.23 1.412 . . . . 0.0 112.409 -179.883 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 32.4 mmmt -82.99 -9.25 59.37 Favored 'General case' 0 C--N 1.347 0.458 0 C-N-CA 124.494 1.117 . . . . 0.0 111.435 175.169 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 73.81 31.93 59.67 Favored Glycine 0 CA--C 1.525 0.663 0 CA-C-O 119.645 -0.531 . . . . 0.0 112.165 172.99 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 5.8 m -73.25 174.44 0.78 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.618 0 CA-C-N 118.219 1.009 . . . . 0.0 109.158 169.748 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -115.63 131.28 56.98 Favored 'General case' 0 CA--C 1.518 -0.265 0 N-CA-C 106.909 -1.515 . . . . 0.0 106.909 172.772 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 80.3 m-85 -96.48 148.29 22.96 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 119.677 1.126 . . . . 0.0 109.384 -179.722 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 31.3 m -126.37 163.91 27.47 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.263 0 C-N-CA 123.847 0.859 . . . . 0.0 109.799 172.006 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 86.91 -91.34 1.73 Allowed Glycine 0 N--CA 1.444 -0.817 0 C-N-CA 124.996 1.284 . . . . 0.0 112.292 172.975 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 16.8 m-30 59.68 170.49 0.08 Allowed 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 126.081 1.752 . . . . 0.0 110.251 -165.599 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -141.09 140.86 21.94 Favored Pre-proline 0 N--CA 1.471 0.58 0 O-C-N 120.442 -1.411 . . . . 0.0 109.479 174.033 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_exo -54.51 129.12 33.16 Favored 'Trans proline' 0 N--CA 1.456 -0.731 0 C-N-CA 122.622 2.215 . . . . 0.0 110.65 169.796 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 20.7 p -70.74 -16.99 62.81 Favored 'General case' 0 N--CA 1.47 0.564 0 N-CA-C 112.465 0.542 . . . . 0.0 112.465 171.681 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -59.55 132.32 53.62 Favored 'General case' 0 C--O 1.237 0.4 0 C-N-CA 123.918 0.887 . . . . 0.0 109.775 -175.344 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 86.79 -9.62 71.01 Favored Glycine 0 CA--C 1.533 1.195 0 CA-C-O 118.509 -1.161 . . . . 0.0 113.963 178.878 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 42.7 m-85 -94.35 156.13 16.65 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-N 119.25 1.525 . . . . 0.0 110.173 171.703 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -123.03 127.27 48.55 Favored 'General case' 0 CA--C 1.531 0.243 0 N-CA-C 106.796 -1.557 . . . . 0.0 106.796 171.664 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 46.5 p90 -164.86 156.64 15.47 Favored 'General case' 0 C--O 1.237 0.446 0 C-N-CA 126.301 1.84 . . . . 0.0 106.263 -170.237 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 25.8 m -126.25 -38.64 2.12 Favored 'General case' 0 N--CA 1.446 -0.667 0 CA-C-N 118.607 0.64 . . . . 0.0 111.596 -171.24 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 41.8 t -59.45 135.54 88.86 Favored Pre-proline 0 CA--C 1.539 0.529 0 CA-C-N 118.145 0.429 . . . . 0.0 110.036 177.354 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_endo -82.38 -13.5 9.83 Favored 'Trans proline' 0 N--CA 1.455 -0.755 0 C-N-CA 122.869 2.379 . . . . 0.0 112.186 172.636 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 54.3 mttt -54.92 -48.1 96.72 Favored Pre-proline 0 CA--C 1.54 0.582 0 CA-C-N 119.888 1.222 . . . . 0.0 112.256 -170.848 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -86.07 11.75 3.23 Favored 'Trans proline' 0 C--N 1.35 0.642 0 C-N-CA 122.001 1.801 . . . . 0.0 113.742 -172.725 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 21.9 m -129.54 161.26 39.4 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.171 0 CA-C-N 120.629 1.559 . . . . 0.0 111.797 -175.155 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 21.5 pt -132.92 173.16 15.26 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.344 0 C-N-CA 127.151 2.18 . . . . 0.0 108.988 -179.788 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . 54.12 43.43 30.7 Favored 'General case' 0 N--CA 1.461 0.112 0 C-N-CA 125.406 1.482 . . . . 0.0 112.07 174.93 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 27.3 t0 54.0 43.44 30.79 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 126.609 1.964 . . . . 0.0 111.603 -176.785 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 87.6 29.5 21.3 Favored Glycine 0 CA--C 1.526 0.77 0 CA-C-O 118.207 -1.329 . . . . 0.0 113.635 171.559 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 47.3 mt-30 -95.54 -23.39 17.1 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 119.141 1.471 . . . . 0.0 113.201 179.201 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -138.79 141.0 38.78 Favored 'General case' 0 CA--C 1.513 -0.477 0 CA-C-N 119.641 1.11 . . . . 0.0 110.56 176.026 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 67.5 m-85 -76.98 138.27 39.52 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 105.106 -2.183 . . . . 0.0 105.106 164.257 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 25.7 m -76.74 4.43 1.17 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.643 0 C-N-CA 123.188 0.595 . . . . 0.0 112.067 -177.945 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -168.5 -174.19 37.01 Favored Glycine 0 CA--C 1.523 0.537 0 C-N-CA 125.742 1.639 . . . . 0.0 109.16 -175.806 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.41 HD23 ' CD2' ' A' ' 85' ' ' TYR . 29.4 tp -75.06 140.95 43.86 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 122.892 0.477 . . . . 0.0 111.722 -171.739 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -89.43 132.71 34.87 Favored 'General case' 0 N--CA 1.447 -0.586 0 C-N-CA 125.876 1.67 . . . . 0.0 109.081 169.2 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 89.9 mt -136.81 141.33 42.89 Favored 'General case' 0 N--CA 1.467 0.425 0 N-CA-C 106.643 -1.614 . . . . 0.0 106.643 172.222 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -104.26 -57.02 2.09 Favored 'General case' 0 C--O 1.233 0.202 0 C-N-CA 123.545 0.738 . . . . 0.0 110.649 -176.835 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 46.69 38.17 5.46 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 125.806 1.643 . . . . 0.0 114.611 174.862 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 53.7 m -136.45 -39.9 0.65 Allowed 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 124.911 1.284 . . . . 0.0 109.81 169.055 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 20.2 m-80 -121.44 -36.93 2.98 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 126.393 1.877 . . . . 0.0 110.912 -166.975 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 34.0 mt-30 -127.56 52.23 1.85 Allowed 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 126.173 1.789 . . . . 0.0 109.786 -168.555 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -56.92 -38.36 72.75 Favored 'General case' 0 N--CA 1.468 0.471 0 O-C-N 121.205 -0.934 . . . . 0.0 111.278 -177.441 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -66.86 -36.61 82.71 Favored 'General case' 0 N--CA 1.466 0.36 0 O-C-N 121.969 -0.457 . . . . 0.0 111.444 -179.44 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -80.92 -23.97 38.55 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-O 118.812 -0.614 . . . . 0.0 110.927 177.619 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 47.9 m -68.77 -42.53 77.33 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 119.008 0.822 . . . . 0.0 109.745 170.974 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -60.12 -44.59 94.78 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 123.431 0.693 . . . . 0.0 110.497 174.154 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 27.3 tt0 -58.46 -46.89 85.68 Favored 'General case' 0 C--O 1.231 0.09 0 C-N-CA 124.171 0.989 . . . . 0.0 110.435 174.367 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.29 -46.24 86.45 Favored 'General case' 0 C--O 1.225 -0.224 0 CA-C-O 117.959 -1.019 . . . . 0.0 109.554 179.023 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 47.6 mt -60.45 -52.44 61.4 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.233 0 CA-C-N 119.687 1.131 . . . . 0.0 108.038 176.928 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 72.7 tp60 -53.29 -65.11 0.62 Allowed 'General case' 0 C--O 1.232 0.155 0 CA-C-N 119.23 0.923 . . . . 0.0 112.073 -177.151 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 19.9 m -68.75 -32.36 72.07 Favored 'General case' 0 C--N 1.325 -0.489 0 C-N-CA 121.4 -0.12 . . . . 0.0 111.309 -168.997 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 160' ' ' TRP . . . . . . . . . . . . . 2.8 t90 -73.13 -41.77 63.6 Favored 'General case' 0 C--O 1.221 -0.423 0 CA-C-O 118.977 -0.535 . . . . 0.0 110.618 177.465 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 23.2 m -55.47 -47.84 75.47 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 118.519 0.599 . . . . 0.0 110.343 173.387 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 162' ' ' GLU . . . . . 0.4 ' HA ' HD23 ' A' ' 165' ' ' LEU . 40.3 mt-10 -60.3 -43.36 96.38 Favored 'General case' 0 C--N 1.332 -0.156 0 N-CA-C 109.681 -0.488 . . . . 0.0 109.681 178.752 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 42.6 tt0 -63.29 -51.71 64.96 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-O 117.904 -1.046 . . . . 0.0 110.383 -178.182 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 39.7 pt -64.15 -33.06 60.01 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.412 0 CA-C-O 118.127 -0.94 . . . . 0.0 109.441 -175.829 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 165' ' ' LEU . . . . . 0.4 HD23 ' HA ' ' A' ' 162' ' ' GLU . 0.3 OUTLIER -72.82 -31.45 64.82 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 119.395 0.998 . . . . 0.0 108.856 -174.375 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -71.53 -52.1 20.04 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 124.692 1.197 . . . . 0.0 109.084 173.277 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -67.7 -35.3 78.56 Favored 'General case' 0 N--CA 1.441 -0.883 0 C-N-CA 125.78 1.632 . . . . 0.0 109.425 -169.485 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 168' ' ' MET . . . . . . . . . . . . . 21.5 ptp -73.03 -29.11 62.76 Favored 'General case' 0 C--N 1.333 -0.128 0 O-C-N 122.28 -0.262 . . . . 0.0 111.583 176.96 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -75.62 -36.56 60.21 Favored 'General case' 0 N--CA 1.444 -0.726 0 CA-C-O 119.16 -0.448 . . . . 0.0 111.779 178.2 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 5.8 mt-10 -64.17 -36.98 85.82 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-O 122.248 1.023 . . . . 0.0 109.275 178.486 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 61.2 t60 -64.33 -25.76 68.18 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 124.966 1.306 . . . . 0.0 110.936 177.391 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -78.87 -44.71 22.27 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 124.363 1.065 . . . . 0.0 111.721 174.767 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.254 1.312 0 C-N-CA 124.907 1.283 . . . . 0.0 109.602 -174.594 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.498 1.964 0 CA-C-O 120.322 0.106 . . . . 0.0 111.197 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 24.8 p-10 -120.61 165.95 14.33 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 125.082 1.353 . . . . 0.0 111.512 -175.333 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 11.9 mtt -130.27 133.91 46.84 Favored 'General case' 0 CA--C 1.52 -0.195 0 C-N-CA 123.361 0.665 . . . . 0.0 110.507 175.625 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -100.48 142.42 15.84 Favored Glycine 0 CA--C 1.523 0.559 0 N-CA-C 106.769 -2.532 . . . . 0.0 106.769 167.538 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 2.2 tt -128.22 101.15 6.12 Favored 'General case' 0 CA--C 1.518 -0.252 0 N-CA-C 105.852 -1.907 . . . . 0.0 105.852 -172.899 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -102.49 144.26 31.16 Favored 'General case' 0 N--CA 1.455 -0.216 0 CA-C-O 121.588 0.709 . . . . 0.0 111.672 -173.809 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 43.7 p90 -160.02 179.7 8.53 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 127.04 2.136 . . . . 0.0 106.489 175.0 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 174.46 74.73 0.05 OUTLIER Glycine 0 N--CA 1.464 0.511 0 N-CA-C 109.388 -1.485 . . . . 0.0 109.388 175.881 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 38.0 m -150.03 132.64 15.81 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 117.717 0.759 . . . . 0.0 109.361 -175.141 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 14.7 m -93.06 -37.07 12.36 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 123.717 0.807 . . . . 0.0 110.757 174.778 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 3.7 m -67.09 124.2 22.4 Favored 'General case' 0 CA--C 1.533 0.292 0 N-CA-C 107.215 -1.402 . . . . 0.0 107.215 174.442 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 58.0 m 47.17 57.18 5.99 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 124.494 1.118 . . . . 0.0 110.05 -170.695 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 19.9 p90 -45.9 128.36 8.91 Favored 'General case' 0 C--N 1.343 0.288 0 C-N-CA 125.132 1.373 . . . . 0.0 113.361 -168.292 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 2.8 m -80.76 -6.53 58.62 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 124.207 1.003 . . . . 0.0 112.21 -169.842 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -55.95 -36.51 67.88 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 124.457 1.103 . . . . 0.0 111.545 -174.631 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 30.0 mmt -67.82 -43.27 79.99 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 118.541 0.61 . . . . 0.0 110.323 -177.842 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -64.1 -45.39 88.85 Favored 'General case' 0 N--CA 1.462 0.168 0 N-CA-C 109.03 -0.729 . . . . 0.0 109.03 176.321 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -64.02 -47.45 80.22 Favored 'General case' 0 N--CA 1.455 -0.19 0 C-N-CA 122.921 0.489 . . . . 0.0 111.54 -175.276 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 10.2 mt-10 -60.95 -42.99 99.33 Favored 'General case' 0 CA--C 1.517 -0.309 0 CA-C-O 118.903 -0.57 . . . . 0.0 109.949 176.678 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 29.3 mtpp -71.14 -40.67 71.22 Favored 'General case' 0 C--O 1.221 -0.435 0 CA-C-O 118.057 -0.973 . . . . 0.0 110.775 -174.132 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 47.6 mt -53.81 -54.27 20.92 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.267 0 CA-C-N 120.014 1.279 . . . . 0.0 108.818 173.07 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 8.5 ttp180 -60.56 -41.07 93.82 Favored 'General case' 0 C--O 1.223 -0.298 0 C-N-CA 123.397 0.679 . . . . 0.0 109.65 -176.703 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -66.74 -41.17 88.25 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 122.945 0.498 . . . . 0.0 111.066 -178.894 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.617 HD13 ' HA ' ' A' ' 158' ' ' GLN . 41.0 mt -68.76 -56.18 13.13 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.57 0 C-N-CA 124.345 1.058 . . . . 0.0 109.691 -175.61 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 79.0 mt -67.89 -44.23 85.4 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.428 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 -175.649 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 138.55 125.39 2.32 Favored Glycine 0 CA--C 1.53 1.022 0 C-N-CA 125.061 1.315 . . . . 0.0 111.493 173.22 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -71.95 -6.21 18.66 Favored 'Trans proline' 0 CA--C 1.537 0.666 0 C-N-CA 123.505 2.803 . . . . 0.0 114.044 -175.674 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -80.15 -18.63 49.23 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 119.232 0.924 . . . . 0.0 111.241 175.953 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -128.66 -10.1 5.03 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 124.532 1.133 . . . . 0.0 113.994 -173.803 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 31.5 t -106.97 150.07 9.84 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.352 0 CA-C-N 119.375 0.989 . . . . 0.0 108.346 170.702 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 2.7 m -137.23 130.97 31.74 Favored 'General case' 0 N--CA 1.456 -0.174 0 N-CA-C 106.599 -1.63 . . . . 0.0 106.599 -172.909 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 21.3 mt -80.46 143.71 33.16 Favored 'General case' 0 CA--C 1.53 0.202 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 176.916 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' HIS . . . . . 0.465 ' HE2' ' HB2' ' A' ' 42' ' ' LEU . 39.0 t-80 -136.77 64.88 1.53 Allowed 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 124.451 1.1 . . . . 0.0 108.195 -174.554 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 64.4 t-20 -72.39 119.12 16.15 Favored 'General case' 0 CA--C 1.53 0.193 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 -178.407 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 81.9 mt -66.06 -18.31 65.26 Favored 'General case' 0 C--O 1.233 0.206 0 C-N-CA 123.782 0.833 . . . . 0.0 112.918 -176.839 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 28.3 tptp -55.35 -27.12 45.19 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-O 118.879 -0.581 . . . . 0.0 111.156 168.654 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -121.47 -41.45 2.49 Favored 'General case' 0 N--CA 1.464 0.271 0 N-CA-C 113.549 0.944 . . . . 0.0 113.549 -173.856 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 29.6 m-20 -96.53 142.29 28.78 Favored 'General case' 0 C--O 1.234 0.276 0 C-N-CA 123.334 0.654 . . . . 0.0 110.702 -176.151 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 14.0 m -75.97 156.27 84.31 Favored Pre-proline 0 CA--C 1.542 0.646 0 C-N-CA 124.181 0.992 . . . . 0.0 109.986 173.632 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo -77.27 -25.1 8.79 Favored 'Trans proline' 0 C--N 1.348 0.533 0 C-N-CA 122.212 1.941 . . . . 0.0 113.312 -169.785 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 23.7 mmmt -69.38 -15.26 63.27 Favored 'General case' 0 N--CA 1.474 0.758 0 O-C-N 120.512 -1.368 . . . . 0.0 111.693 -176.029 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.465 ' HB2' ' HE2' ' A' ' 33' ' ' HIS . 2.1 mm? -62.01 -26.82 68.46 Favored 'General case' 0 N--CA 1.464 0.263 0 C-N-CA 125.555 1.542 . . . . 0.0 110.603 169.426 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 51.3 mtt -58.99 -25.29 63.5 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 119.207 0.912 . . . . 0.0 111.48 177.308 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -64.06 -31.83 73.17 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 118.395 0.543 . . . . 0.0 110.127 -176.535 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 27.3 mt-30 -67.05 -38.79 86.46 Favored 'General case' 0 CA--C 1.534 0.364 0 N-CA-C 113.302 0.852 . . . . 0.0 113.302 -170.873 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 61.0 m-85 -76.08 136.25 39.88 Favored 'General case' 0 CA--C 1.52 -0.202 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 -167.49 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -71.84 -37.75 70.23 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-N 118.281 0.491 . . . . 0.0 110.576 -178.349 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 15.4 t -107.22 144.95 15.26 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.364 0 N-CA-C 107.52 -1.289 . . . . 0.0 107.52 169.003 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 28.8 tp -132.97 120.29 21.22 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 175.098 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 48.3 mt -99.41 129.25 50.19 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.606 0 N-CA-C 106.47 -1.678 . . . . 0.0 106.47 179.774 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -110.13 132.47 54.14 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 125.539 1.536 . . . . 0.0 107.793 -175.342 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -138.44 138.73 9.71 Favored Glycine 0 C--N 1.332 0.346 0 N-CA-C 109.821 -1.312 . . . . 0.0 109.821 178.233 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.427 HD12 ' CD2' ' A' ' 65' ' ' TRP . 3.9 tt -155.75 133.46 6.75 Favored Pre-proline 0 CA--C 1.535 0.37 0 CA-C-N 117.555 0.677 . . . . 0.0 111.164 172.805 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_exo -75.24 127.39 10.48 Favored 'Trans proline' 0 N--CA 1.456 -0.704 0 C-N-CA 122.376 2.051 . . . . 0.0 109.197 164.06 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 20.9 m -97.81 106.96 19.34 Favored 'General case' 0 CA--C 1.535 0.383 0 N-CA-C 104.434 -2.432 . . . . 0.0 104.434 167.084 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 2.6 t90 -91.98 169.36 10.71 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-O 121.021 0.438 . . . . 0.0 111.402 -175.443 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -63.14 -30.2 71.4 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 124.972 1.309 . . . . 0.0 113.062 -172.075 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 84.4 t80 -139.24 155.34 47.85 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 124.788 1.235 . . . . 0.0 109.555 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 74.24 2.65 63.24 Favored Glycine 0 CA--C 1.534 1.273 0 CA-C-O 118.178 -1.346 . . . . 0.0 114.765 170.483 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . 0.273 10.7 pt-20 45.76 -153.87 0.05 OUTLIER 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 126.55 1.94 . . . . 0.0 112.692 -177.928 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 12.8 mt -27.75 129.43 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.543 0.682 0 C-N-CA 128.894 2.878 . . . . 0.0 112.289 170.002 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 21.0 mp0 -72.59 153.99 41.0 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 124.836 1.254 . . . . 0.0 109.828 179.421 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -59.07 -42.84 91.35 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 123.338 0.655 . . . . 0.0 111.593 -170.255 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -60.54 -24.67 65.55 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 123.591 0.757 . . . . 0.0 111.95 -177.639 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' TRP . . . . . 0.433 ' CH2' HD22 ' A' ' 104' ' ' LEU . 1.8 t90 -96.04 -42.63 8.16 Favored 'General case' 0 N--CA 1.447 -0.588 0 C-N-CA 124.695 1.198 . . . . 0.0 109.773 -178.425 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 7.8 tt0 -63.14 -33.86 76.38 Favored 'General case' 0 N--CA 1.446 -0.665 0 O-C-N 120.749 -1.219 . . . . 0.0 109.868 178.708 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -55.82 -24.65 37.47 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 124.333 1.053 . . . . 0.0 111.965 -179.497 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 35.3 m -116.84 -11.42 11.81 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.171 0 CA-C-O 117.596 -1.192 . . . . 0.0 113.179 178.245 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 25.0 t90 -52.87 -38.28 61.41 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 119.959 1.254 . . . . 0.0 110.435 -178.891 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -64.6 -27.11 68.72 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 125.361 1.464 . . . . 0.0 113.303 177.041 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 30.0 mt-30 -92.6 -19.41 21.93 Favored 'General case' 0 C--N 1.342 0.244 0 C-N-CA 125.309 1.443 . . . . 0.0 112.617 178.966 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 60.1 mt -59.55 -25.94 64.96 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 118.633 0.651 . . . . 0.0 111.137 -178.414 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -77.1 -25.15 51.92 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 118.085 0.402 . . . . 0.0 111.626 176.704 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -72.98 -29.98 63.47 Favored 'General case' 0 N--CA 1.467 0.376 0 O-C-N 121.058 -1.026 . . . . 0.0 111.828 178.866 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 76.5 mt -53.62 139.86 30.65 Favored 'General case' 0 C--N 1.341 0.218 0 C-N-CA 125.016 1.326 . . . . 0.0 112.289 -169.008 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 28.8 t-20 -77.2 107.44 9.6 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 169.707 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 65.2 mt -127.6 1.48 6.18 Favored 'General case' 0 N--CA 1.474 0.734 0 N-CA-C 113.912 1.079 . . . . 0.0 113.912 -173.237 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -51.87 129.16 26.04 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-N 119.228 0.922 . . . . 0.0 111.482 -168.442 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 70.63 -2.0 18.69 Favored Glycine 0 CA--C 1.535 1.326 0 C-N-CA 125.935 1.731 . . . . 0.0 115.972 177.523 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.05 151.85 38.67 Favored 'General case' 0 C--N 1.344 0.366 0 CA-C-N 121.002 2.401 . . . . 0.0 110.53 -172.097 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 6.7 mt -81.1 137.49 21.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 N-CA-C 106.676 -1.601 . . . . 0.0 106.676 178.849 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 78.0 t -134.68 136.4 52.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 C-N-CA 123.729 0.812 . . . . 0.0 110.235 -174.365 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -110.82 150.77 28.67 Favored 'General case' 0 N--CA 1.468 0.45 0 N-CA-C 107.878 -1.156 . . . . 0.0 107.878 169.257 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 2.8 mt -130.87 136.54 48.72 Favored 'General case' 0 CA--C 1.51 -0.562 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 174.603 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 43.6 p90 -147.42 166.82 26.06 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 168.669 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -162.46 160.03 32.27 Favored Glycine 0 N--CA 1.447 -0.582 0 N-CA-C 109.811 -1.316 . . . . 0.0 109.811 172.416 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 4.1 tt -112.15 151.6 29.29 Favored 'General case' 0 N--CA 1.448 -0.553 0 C-N-CA 125.457 1.503 . . . . 0.0 108.001 173.934 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -171.75 -155.96 11.52 Favored Glycine 0 CA--C 1.52 0.403 0 N-CA-C 109.89 -1.284 . . . . 0.0 109.89 169.787 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 5.2 t0 -138.54 131.63 29.88 Favored 'General case' 0 C--O 1.234 0.244 0 C-N-CA 124.116 0.966 . . . . 0.0 108.802 172.86 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 3.4 pt20 -81.37 -14.41 57.25 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 124.221 1.009 . . . . 0.0 113.253 179.326 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 98.8 mt -88.76 -46.85 8.65 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 119.439 1.018 . . . . 0.0 112.503 -169.822 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -64.71 -33.22 86.65 Favored Glycine 0 CA--C 1.528 0.905 0 C-N-CA 123.767 0.699 . . . . 0.0 113.557 -169.494 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 5.8 t80 -148.97 -40.85 0.15 Allowed 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 117.785 0.793 . . . . 0.0 110.945 177.083 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 81.57 -39.3 2.51 Favored Glycine 0 C--N 1.336 0.565 0 C-N-CA 124.153 0.882 . . . . 0.0 112.288 173.511 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -64.05 -36.31 83.59 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 118.981 1.39 . . . . 0.0 109.722 174.952 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' TRP . . . . . . . . . . . . . 46.7 m0 -98.17 36.86 1.51 Allowed 'General case' 0 CA--C 1.539 0.528 0 O-C-N 121.358 -0.839 . . . . 0.0 111.352 174.589 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 12.0 t80 -61.27 -53.0 62.4 Favored 'General case' 0 N--CA 1.467 0.381 0 O-C-N 121.461 -0.774 . . . . 0.0 109.479 173.953 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 80.2 mt -141.79 27.84 1.81 Allowed 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 124.236 1.014 . . . . 0.0 110.111 -175.097 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -59.78 -33.77 72.14 Favored 'General case' 0 N--CA 1.467 0.376 0 O-C-N 120.581 -1.325 . . . . 0.0 111.944 -171.415 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' ALA . . . . . 0.421 ' HB1' HD13 ' A' ' 53' ' ' ILE . . . -73.45 -27.92 61.68 Favored 'General case' 0 CA--C 1.535 0.367 0 O-C-N 121.234 -0.916 . . . . 0.0 112.44 177.268 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 4.4 tt -60.67 -47.06 87.93 Favored 'General case' 0 N--CA 1.467 0.419 0 N-CA-C 107.458 -1.312 . . . . 0.0 107.458 169.065 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -62.31 -42.03 99.72 Favored Glycine 0 C--N 1.339 0.715 0 N-CA-C 111.44 -0.664 . . . . 0.0 111.44 -178.925 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 76.3 mtm -63.96 -38.37 90.82 Favored 'General case' 0 CA--C 1.529 0.166 0 CA-C-N 118.182 0.991 . . . . 0.0 111.726 179.564 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.433 HD22 ' CH2' ' A' ' 65' ' ' TRP . 4.2 tp -71.61 -35.45 70.48 Favored 'General case' 0 C--N 1.345 0.373 0 CA-C-N 120.247 1.385 . . . . 0.0 110.341 178.885 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 105' ' ' HIS . . . . . 0.415 ' CG ' HG21 ' A' ' 140' ' ' VAL . 0.2 OUTLIER -54.56 -51.65 64.55 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 118.899 0.772 . . . . 0.0 110.283 169.132 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -64.47 -42.77 95.71 Favored 'General case' 0 C--O 1.233 0.229 0 C-N-CA 122.754 0.422 . . . . 0.0 111.466 -172.289 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 22.5 ttmm -58.43 -39.36 79.6 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 123.897 0.879 . . . . 0.0 110.655 173.225 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 52.0 mt -87.11 -22.23 25.51 Favored 'General case' 0 CA--C 1.517 -0.29 0 N-CA-C 114.152 1.167 . . . . 0.0 114.152 -169.454 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 8.3 t -56.95 -36.24 70.03 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-N 119.393 0.997 . . . . 0.0 110.879 -175.673 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 21.1 p -86.21 -8.1 58.04 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 124.581 1.152 . . . . 0.0 112.2 -178.298 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 32.4 mmmt -83.15 -8.32 59.51 Favored 'General case' 0 C--N 1.346 0.441 0 C-N-CA 124.573 1.149 . . . . 0.0 111.709 175.393 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 74.7 29.11 61.85 Favored Glycine 0 CA--C 1.526 0.777 0 CA-C-N 118.424 0.557 . . . . 0.0 112.462 173.343 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 17.1 m -75.23 176.44 0.64 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 CA-C-N 117.957 0.879 . . . . 0.0 109.989 171.887 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -121.54 125.95 48.01 Favored 'General case' 0 CA--C 1.52 -0.208 0 N-CA-C 106.918 -1.512 . . . . 0.0 106.918 174.442 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 79.5 m-85 -89.5 145.03 25.57 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 119.562 1.074 . . . . 0.0 109.337 -178.649 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 27.3 m -126.68 157.86 37.41 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.212 0 C-N-CA 124.237 1.015 . . . . 0.0 109.084 171.149 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 95.38 -88.4 1.09 Allowed Glycine 0 C--N 1.333 0.364 0 CA-C-O 119.109 -0.829 . . . . 0.0 111.259 173.185 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 22.0 m-30 57.56 -173.49 0.08 Allowed 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 124.104 0.961 . . . . 0.0 110.446 -168.735 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -153.96 146.3 17.33 Favored Pre-proline 0 N--CA 1.473 0.69 0 CA-C-N 120.359 1.436 . . . . 0.0 109.656 178.952 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_endo -67.71 124.42 11.91 Favored 'Trans proline' 0 CA--C 1.535 0.568 0 C-N-CA 122.959 2.439 . . . . 0.0 112.121 178.993 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 2.9 p -77.87 -12.71 60.0 Favored 'General case' 0 CA--C 1.538 0.51 0 O-C-N 121.507 -0.746 . . . . 0.0 112.296 171.958 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -59.84 122.91 15.41 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 123.665 0.786 . . . . 0.0 109.934 -171.403 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 74.64 -0.09 57.28 Favored Glycine 0 CA--C 1.535 1.286 0 CA-C-O 118.563 -1.132 . . . . 0.0 114.066 179.146 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 2.2 t80 -82.87 154.7 24.51 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 119.345 1.572 . . . . 0.0 109.939 177.6 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -106.01 111.08 23.57 Favored 'General case' 0 CA--C 1.532 0.277 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 176.055 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 40.1 p90 -147.68 167.76 23.79 Favored 'General case' 0 C--O 1.236 0.391 0 C-N-CA 126.635 1.974 . . . . 0.0 107.404 178.457 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 14.7 t -143.48 -28.18 0.54 Allowed 'General case' 0 N--CA 1.468 0.433 0 N-CA-C 112.649 0.611 . . . . 0.0 112.649 -177.504 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 3.5 p -77.57 141.34 65.01 Favored Pre-proline 0 CA--C 1.539 0.548 0 CA-C-N 118.741 0.7 . . . . 0.0 109.7 -177.163 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -79.4 -28.01 3.89 Favored 'Trans proline' 0 CA--C 1.537 0.663 0 C-N-CA 122.506 2.138 . . . . 0.0 112.221 178.805 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 7.6 ttmt -61.03 -41.87 83.63 Favored Pre-proline 0 CA--C 1.542 0.647 0 CA-C-O 117.441 -1.266 . . . . 0.0 113.929 -171.784 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_endo -77.41 5.81 4.86 Favored 'Trans proline' 0 C--N 1.352 0.752 0 CA-C-N 122.012 1.754 . . . . 0.0 114.385 179.154 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 26.9 m -132.02 169.58 21.56 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.215 0 CA-C-N 120.411 1.459 . . . . 0.0 110.434 -176.844 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 23.0 pt -138.49 171.97 14.5 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.507 0 C-N-CA 126.768 2.027 . . . . 0.0 108.594 -177.606 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . 54.76 41.27 32.05 Favored 'General case' 0 CA--C 1.528 0.106 0 C-N-CA 125.081 1.352 . . . . 0.0 112.46 174.302 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 27.3 t70 55.7 42.15 29.63 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 126.187 1.795 . . . . 0.0 111.734 -176.121 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 88.19 15.6 60.46 Favored Glycine 0 CA--C 1.528 0.891 0 CA-C-O 118.93 -0.928 . . . . 0.0 113.679 174.446 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 45.4 mt-30 -88.46 -7.59 56.31 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 118.934 1.367 . . . . 0.0 112.524 -179.06 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 8.3 tp -155.44 146.05 22.13 Favored 'General case' 0 C--N 1.344 0.35 0 CA-C-N 119.241 0.928 . . . . 0.0 110.291 172.304 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 58.4 m-85 -76.9 144.1 39.14 Favored 'General case' 0 CA--C 1.514 -0.425 0 N-CA-C 107.472 -1.307 . . . . 0.0 107.472 169.294 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 140' ' ' VAL . . . . . 0.415 HG21 ' CG ' ' A' ' 105' ' ' HIS . 4.4 p -82.23 14.1 0.52 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.573 0 CA-C-O 121.159 0.504 . . . . 0.0 112.13 -179.6 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 178.47 172.42 42.83 Favored Glycine 0 CA--C 1.525 0.685 0 N-CA-C 110.009 -1.237 . . . . 0.0 110.009 176.623 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 1.1 tp -65.79 138.04 57.65 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 117.631 0.715 . . . . 0.0 110.883 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -98.89 114.38 26.96 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 125.941 1.697 . . . . 0.0 110.178 -179.931 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -104.87 144.45 31.76 Favored 'General case' 0 CA--C 1.537 0.457 0 N-CA-C 106.386 -1.709 . . . . 0.0 106.386 166.945 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -144.04 130.56 20.0 Favored 'General case' 0 CA--C 1.531 0.224 0 N-CA-C 107.186 -1.413 . . . . 0.0 107.186 171.2 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 44.7 mm-40 -120.73 21.91 11.33 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 124.254 1.022 . . . . 0.0 111.468 -174.942 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 57.6 m -115.5 -40.44 3.4 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 124.808 1.243 . . . . 0.0 109.555 172.803 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 4.3 m-80 -92.9 -31.84 14.8 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 125.068 1.347 . . . . 0.0 110.223 -171.376 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 68.3 mt-30 -134.01 156.16 48.7 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 126.314 1.846 . . . . 0.0 108.29 -175.023 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 98.4 m-85 -147.28 -48.76 0.18 Allowed 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 124.148 0.979 . . . . 0.0 109.94 -179.421 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -68.5 -43.97 75.7 Favored 'General case' 0 N--CA 1.465 0.32 0 O-C-N 122.162 -0.336 . . . . 0.0 111.818 -171.171 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -90.57 8.83 32.1 Favored 'General case' 0 N--CA 1.465 0.295 0 N-CA-C 113.577 0.955 . . . . 0.0 113.577 -175.338 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 21.9 m -64.12 -33.15 75.11 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 119.56 1.073 . . . . 0.0 110.283 175.375 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -61.23 -40.43 93.98 Favored 'General case' 0 N--CA 1.463 0.179 0 O-C-N 121.917 -0.489 . . . . 0.0 110.884 172.19 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 -65.95 -47.4 74.78 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 124.106 0.962 . . . . 0.0 110.505 179.396 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 75.5 mtt-85 -52.2 -46.01 65.44 Favored 'General case' 0 N--CA 1.463 0.19 0 C-N-CA 124.509 1.124 . . . . 0.0 110.397 176.415 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 30.6 mt -70.37 -53.71 21.7 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 N-CA-C 107.847 -1.168 . . . . 0.0 107.847 179.302 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 158' ' ' GLN . . . . . 0.617 ' HA ' HD13 ' A' ' 24' ' ' ILE . 68.7 tp60 -49.66 -64.77 0.71 Allowed 'General case' 0 C--O 1.233 0.22 0 C-N-CA 125.569 1.548 . . . . 0.0 112.202 -174.132 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 20.1 m -67.8 -31.86 72.02 Favored 'General case' 0 C--N 1.324 -0.512 0 C-N-CA 120.924 -0.31 . . . . 0.0 110.768 -169.075 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 160' ' ' TRP . . . . . . . . . . . . . 36.2 t90 -68.86 -44.2 73.83 Favored 'General case' 0 C--O 1.221 -0.407 0 O-C-N 122.128 -0.357 . . . . 0.0 110.914 176.455 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 87.8 m -60.68 -42.53 97.3 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 122.889 0.476 . . . . 0.0 110.636 177.97 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 162' ' ' GLU . . . . . 0.423 ' HA ' HD23 ' A' ' 165' ' ' LEU . 39.9 mt-10 -63.35 -40.95 98.68 Favored 'General case' 0 CA--C 1.529 0.148 0 CA-C-O 121.481 0.658 . . . . 0.0 110.041 175.153 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 13.7 tt0 -64.67 -49.08 72.35 Favored 'General case' 0 N--CA 1.451 -0.419 0 O-C-N 121.375 -0.828 . . . . 0.0 110.735 -178.798 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 45.7 pt -64.6 -38.88 83.78 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.348 0 CA-C-O 118.089 -0.958 . . . . 0.0 109.62 -176.265 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 165' ' ' LEU . . . . . 0.423 HD23 ' HA ' ' A' ' 162' ' ' GLU . 0.3 OUTLIER -64.93 -32.59 74.39 Favored 'General case' 0 CA--C 1.53 0.176 0 CA-C-N 118.913 0.779 . . . . 0.0 110.229 179.698 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 29.6 m-80 -67.71 -60.69 2.33 Favored 'General case' 0 C--O 1.221 -0.444 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 172.523 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -53.21 -43.93 67.62 Favored 'General case' 0 N--CA 1.441 -0.89 0 C-N-CA 126.965 2.106 . . . . 0.0 111.168 -171.247 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 168' ' ' MET . . . . . . . . . . . . . 19.7 ptp -70.92 -31.68 68.36 Favored 'General case' 0 C--N 1.333 -0.151 0 N-CA-C 112.143 0.423 . . . . 0.0 112.143 179.244 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -75.35 -35.28 61.19 Favored 'General case' 0 N--CA 1.445 -0.723 0 N-CA-C 111.74 0.274 . . . . 0.0 111.74 177.918 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -66.48 -32.99 74.71 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-O 121.579 0.704 . . . . 0.0 109.581 178.634 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 64.9 t60 -67.47 -27.05 66.7 Favored 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 124.868 1.267 . . . . 0.0 111.077 177.851 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 -76.87 -46.43 24.64 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 124.074 0.949 . . . . 0.0 111.55 170.189 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.254 1.309 0 C-N-CA 125.841 1.657 . . . . 0.0 110.571 -169.77 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.498 1.971 0 N-CA-C 111.108 0.04 . . . . 0.0 111.108 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 19.3 p-10 -128.68 163.83 24.25 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 124.843 1.257 . . . . 0.0 111.49 -171.948 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 10.2 mtt -129.15 133.19 47.5 Favored 'General case' 0 CA--C 1.521 -0.153 0 C-N-CA 123.385 0.674 . . . . 0.0 111.418 179.118 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -98.43 147.24 18.48 Favored Glycine 0 CA--C 1.53 1.007 0 N-CA-C 106.395 -2.682 . . . . 0.0 106.395 166.718 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 1.2 tt -133.67 96.7 3.74 Favored 'General case' 0 N--CA 1.465 0.315 0 N-CA-C 105.573 -2.01 . . . . 0.0 105.573 -173.028 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -97.36 146.75 24.87 Favored 'General case' 0 CA--C 1.514 -0.419 0 CA-C-N 118.03 0.377 . . . . 0.0 111.109 -173.635 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 34.2 p90 -158.18 163.53 37.44 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 124.471 1.108 . . . . 0.0 109.518 176.7 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -96.03 -157.34 31.69 Favored Glycine 0 C--N 1.333 0.415 0 C-N-CA 124.17 0.891 . . . . 0.0 111.969 -174.365 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 10.0 m 61.39 167.97 0.1 Allowed 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 126.494 1.917 . . . . 0.0 113.264 -177.073 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 5.8 p -144.06 -49.02 0.28 Allowed 'General case' 0 C--O 1.237 0.396 0 C-N-CA 124.425 1.09 . . . . 0.0 110.51 -179.621 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 8.2 p -69.71 -54.15 15.15 Favored 'General case' 0 CA--C 1.535 0.376 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 171.877 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 83.2 m -82.6 160.08 22.58 Favored 'General case' 0 CA--C 1.536 0.435 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 167.975 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 36.5 p90 -127.5 20.29 6.71 Favored 'General case' 0 CA--C 1.537 0.461 0 N-CA-C 112.945 0.72 . . . . 0.0 112.945 -169.693 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 86.5 m 59.66 28.99 18.53 Favored 'General case' 0 CA--C 1.55 0.976 0 C-N-CA 123.782 0.833 . . . . 0.0 111.906 -178.981 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 58.71 177.47 0.07 Allowed 'General case' 0 CA--C 1.549 0.925 0 C-N-CA 125.501 1.521 . . . . 0.0 111.63 -177.332 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 36.8 mmt -69.43 13.69 0.12 Allowed 'General case' 0 CA--C 1.536 0.429 0 O-C-N 119.845 -1.784 . . . . 0.0 113.434 175.109 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -55.77 -49.25 73.64 Favored 'General case' 0 C--O 1.224 -0.264 0 CA-C-N 120.398 1.454 . . . . 0.0 109.656 173.7 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -61.99 -46.52 88.86 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 118.443 0.565 . . . . 0.0 111.133 -175.49 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -59.54 -48.22 82.5 Favored 'General case' 0 N--CA 1.451 -0.398 0 C-N-CA 124.379 1.072 . . . . 0.0 110.11 176.479 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 28.8 mtpp -68.99 -37.76 78.93 Favored 'General case' 0 C--O 1.224 -0.253 0 CA-C-O 117.992 -1.004 . . . . 0.0 111.033 -175.22 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 63.1 mt -54.21 -57.75 5.28 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.199 0 CA-C-N 119.712 1.142 . . . . 0.0 108.471 175.652 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 15.1 ptt180 -62.84 -39.14 93.46 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-O 118.834 -0.603 . . . . 0.0 110.067 -177.149 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -65.38 -39.18 91.95 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 118.339 0.518 . . . . 0.0 110.358 -173.673 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 62.9 mt -76.62 -52.61 16.82 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.699 0 C-N-CA 124.886 1.274 . . . . 0.0 110.091 -175.855 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 64.1 mt -60.55 -47.54 92.36 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.336 0 C-N-CA 123.025 0.53 . . . . 0.0 109.841 179.283 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 139.61 113.97 1.14 Allowed Glycine 0 CA--C 1.525 0.66 0 C-N-CA 125.656 1.598 . . . . 0.0 109.258 -179.113 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -72.87 -7.93 21.52 Favored 'Trans proline' 0 CA--C 1.537 0.666 0 C-N-CA 122.509 2.139 . . . . 0.0 113.423 -169.599 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -77.39 -20.57 54.5 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 118.934 0.788 . . . . 0.0 111.57 178.726 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -122.37 7.59 9.61 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 124.886 1.275 . . . . 0.0 113.383 -173.49 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 45.4 t -124.28 148.77 28.42 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.231 0 C-N-CA 124.924 1.29 . . . . 0.0 107.713 175.596 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 7.8 m -134.11 133.27 40.89 Favored 'General case' 0 C--N 1.331 -0.211 0 C-N-CA 124.959 1.303 . . . . 0.0 108.045 -175.861 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 21.8 mt -78.62 139.31 38.57 Favored 'General case' 0 C--O 1.232 0.158 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 175.695 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 36.0 t-80 -137.98 54.28 1.8 Allowed 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 124.321 1.049 . . . . 0.0 108.704 -174.409 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 21.3 t-20 -57.0 134.02 55.43 Favored 'General case' 0 CA--C 1.533 0.312 0 O-C-N 120.838 -1.164 . . . . 0.0 108.386 172.695 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 51.6 mt -74.17 -20.98 60.03 Favored 'General case' 0 CA--C 1.531 0.24 0 N-CA-C 114.344 1.238 . . . . 0.0 114.344 -168.872 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 14.9 tmtt? -73.29 -38.46 65.87 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 119.25 0.932 . . . . 0.0 109.014 168.501 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -73.53 -37.69 65.54 Favored 'General case' 0 C--O 1.234 0.258 0 N-CA-C 113.429 0.9 . . . . 0.0 113.429 -173.151 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 3.2 t0 -143.36 153.9 43.19 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 118.762 0.71 . . . . 0.0 112.249 175.405 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 17.2 m -73.68 157.17 87.89 Favored Pre-proline 0 CA--C 1.54 0.596 0 C-N-CA 125.842 1.657 . . . . 0.0 111.759 -169.997 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -72.72 -26.87 15.64 Favored 'Trans proline' 0 C--N 1.349 0.565 0 C-N-CA 122.761 2.307 . . . . 0.0 113.282 -171.211 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 22.4 mmmt -70.78 -13.22 61.97 Favored 'General case' 0 N--CA 1.473 0.696 0 O-C-N 120.252 -1.53 . . . . 0.0 111.842 -175.817 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -60.64 -29.1 69.06 Favored 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 125.526 1.53 . . . . 0.0 110.08 169.409 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 45.7 mtt -56.63 -25.05 52.16 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 118.966 0.803 . . . . 0.0 111.732 178.419 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 93.8 mt-10 -65.3 -31.69 72.96 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 118.432 0.56 . . . . 0.0 110.325 -177.13 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 24.9 mt-30 -67.39 -42.72 82.86 Favored 'General case' 0 N--CA 1.466 0.342 0 N-CA-C 113.259 0.837 . . . . 0.0 113.259 -169.788 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 34.8 m-85 -73.77 140.05 45.63 Favored 'General case' 0 C--O 1.23 0.045 0 C-N-CA 123.53 0.732 . . . . 0.0 109.966 -167.181 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -67.07 -45.22 78.03 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 118.588 0.631 . . . . 0.0 109.801 174.109 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 6.4 t -102.05 142.22 16.85 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.591 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 175.139 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 31.3 tp -129.94 112.77 13.84 Favored 'General case' 0 N--CA 1.442 -0.842 0 N-CA-C 108.439 -0.949 . . . . 0.0 108.439 173.34 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.421 HG23 ' CE1' ' A' ' 85' ' ' TYR . 17.8 mt -88.41 133.57 30.47 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.591 0 N-CA-C 106.334 -1.728 . . . . 0.0 106.334 172.069 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -109.52 140.61 43.08 Favored 'General case' 0 CA--C 1.517 -0.299 0 C-N-CA 125.904 1.681 . . . . 0.0 106.52 179.404 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -141.99 146.89 18.24 Favored Glycine 0 CA--C 1.518 0.249 0 N-CA-C 110.261 -1.136 . . . . 0.0 110.261 175.036 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.519 HD13 ' CB ' ' A' ' 100' ' ' ALA . 16.5 tt -157.97 139.09 9.55 Favored Pre-proline 0 CA--C 1.538 0.506 0 N-CA-C 107.599 -1.259 . . . . 0.0 107.599 177.276 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -77.65 27.44 0.46 Allowed 'Trans proline' 0 CA--C 1.548 1.194 0 C-N-CA 123.163 2.576 . . . . 0.0 112.835 170.187 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.461 HG23 ' H ' ' A' ' 100' ' ' ALA . 82.5 m 57.95 -56.04 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 128.76 2.824 . . . . 0.0 114.092 -167.129 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -154.39 169.95 22.51 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 125.227 1.411 . . . . 0.0 111.045 -173.757 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 21.3 t0 -103.23 51.66 0.79 Allowed 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 124.678 1.191 . . . . 0.0 107.882 167.994 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 92.5 m-85 49.99 44.66 25.58 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 125.889 1.676 . . . . 0.0 112.58 -174.541 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -172.38 -60.2 0.04 OUTLIER Glycine 0 C--N 1.338 0.664 0 N-CA-C 109.684 -1.367 . . . . 0.0 109.684 176.213 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 22.6 tt0 -155.46 174.07 15.77 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 124.989 1.316 . . . . 0.0 107.984 175.83 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 72.0 mt -46.39 136.92 2.26 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.808 0 C-N-CA 126.004 1.722 . . . . 0.0 109.267 169.048 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -77.73 156.82 30.38 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-O 121.583 0.706 . . . . 0.0 111.192 178.979 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -57.99 -42.32 84.89 Favored 'General case' 0 C--O 1.225 -0.236 0 C-N-CA 124.269 1.028 . . . . 0.0 111.722 -169.249 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 45.5 m-20 -61.44 -23.47 65.87 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 119.108 0.867 . . . . 0.0 112.049 -173.861 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' TRP . . . . . 0.475 ' CZ2' HD12 ' A' ' 53' ' ' ILE . 6.9 t90 -96.09 -48.01 5.84 Favored 'General case' 0 CA--C 1.527 0.071 0 C-N-CA 124.496 1.118 . . . . 0.0 109.652 177.374 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 8.2 tt0 -65.33 -36.02 82.77 Favored 'General case' 0 N--CA 1.447 -0.62 0 O-C-N 120.962 -1.086 . . . . 0.0 110.556 -174.182 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -61.49 -25.99 67.61 Favored 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 123.653 0.781 . . . . 0.0 111.055 -174.709 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 28.5 m -108.48 -15.64 9.2 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.289 0 CA-C-O 117.234 -1.365 . . . . 0.0 112.195 177.071 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 34.8 t90 -52.27 -35.09 49.11 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 120.526 1.512 . . . . 0.0 110.861 178.049 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -62.61 -29.42 70.59 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 125.31 1.444 . . . . 0.0 113.163 175.272 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 29.3 mt-30 -92.15 -19.62 22.09 Favored 'General case' 0 C--N 1.341 0.218 0 C-N-CA 125.874 1.67 . . . . 0.0 112.393 177.453 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 53.4 mt -63.05 -20.71 65.59 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-N 118.903 0.774 . . . . 0.0 111.474 -177.607 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -78.93 -23.94 44.34 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 123.055 0.542 . . . . 0.0 111.773 174.602 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -72.21 -29.18 63.72 Favored 'General case' 0 N--CA 1.469 0.514 0 O-C-N 120.918 -1.114 . . . . 0.0 111.706 179.049 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 79.8 mt -53.36 141.15 25.19 Favored 'General case' 0 C--N 1.34 0.194 0 C-N-CA 125.141 1.376 . . . . 0.0 113.106 -168.509 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 3.2 t30 -75.7 102.67 5.48 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 170.025 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 61.3 mt -125.26 -0.14 7.72 Favored 'General case' 0 N--CA 1.475 0.821 0 N-CA-C 114.205 1.187 . . . . 0.0 114.205 -174.025 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 26.9 mt-10 -56.68 129.2 40.09 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-N 119.666 1.121 . . . . 0.0 111.115 -168.613 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 74.18 -2.12 45.69 Favored Glycine 0 CA--C 1.534 1.228 0 C-N-CA 125.493 1.521 . . . . 0.0 114.998 178.525 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.4 151.37 38.16 Favored 'General case' 0 C--N 1.346 0.426 0 CA-C-N 120.617 2.208 . . . . 0.0 110.021 -175.025 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 6.7 mt -80.67 136.29 23.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 N-CA-C 106.661 -1.607 . . . . 0.0 106.661 178.999 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 65.2 t -132.48 140.51 47.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 C-N-CA 124.054 0.942 . . . . 0.0 109.192 -177.376 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -125.28 144.72 50.34 Favored 'General case' 0 N--CA 1.456 -0.162 0 N-CA-C 108.118 -1.068 . . . . 0.0 108.118 170.575 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 4.2 mt -117.83 120.76 38.89 Favored 'General case' 0 CA--C 1.518 -0.26 0 C-N-CA 124.416 1.086 . . . . 0.0 108.612 -175.769 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.488 ' CD2' HD23 ' A' ' 142' ' ' LEU . 22.5 m-85 -113.07 151.98 30.09 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 107.406 -1.331 . . . . 0.0 107.406 169.861 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -155.81 137.5 5.57 Favored Glycine 0 N--CA 1.449 -0.485 0 N-CA-C 107.825 -2.11 . . . . 0.0 107.825 167.619 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 27.1 tp -99.97 146.34 26.82 Favored 'General case' 0 N--CA 1.442 -0.831 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 169.971 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -166.89 -174.72 36.39 Favored Glycine 0 CA--C 1.527 0.798 0 N-CA-C 108.524 -1.83 . . . . 0.0 108.524 175.042 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 2.9 t0 -151.67 127.14 10.03 Favored 'General case' 0 C--O 1.234 0.261 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 176.823 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 16.8 pm0 -72.74 -11.85 60.78 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 125.582 1.553 . . . . 0.0 113.088 -177.999 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 96.5 mt -88.09 -46.1 9.59 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 119.758 1.163 . . . . 0.0 111.29 177.865 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -60.61 -41.45 98.86 Favored Glycine 0 CA--C 1.529 0.947 0 C-N-CA 124.292 0.949 . . . . 0.0 112.26 -172.671 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 23.1 t80 -148.19 -62.95 0.26 Allowed 'General case' 0 N--CA 1.462 0.146 0 N-CA-C 108.871 -0.788 . . . . 0.0 108.871 169.142 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 80.59 -19.99 6.67 Favored Glycine 0 CA--C 1.524 0.606 0 CA-C-O 118.984 -0.898 . . . . 0.0 114.101 168.847 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -64.54 -37.29 87.05 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 119.402 1.601 . . . . 0.0 109.348 174.335 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' TRP . . . . . . . . . . . . . 47.8 m0 -102.85 33.45 3.22 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 126.147 1.779 . . . . 0.0 111.127 177.703 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 27.6 t80 -52.58 129.91 30.52 Favored 'General case' 0 N--CA 1.466 0.369 0 N-CA-C 108.056 -1.09 . . . . 0.0 108.056 174.755 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 90.3 mt 54.35 22.46 3.78 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 123.866 0.866 . . . . 0.0 113.15 173.308 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -61.71 -39.19 90.62 Favored 'General case' 0 N--CA 1.465 0.285 0 O-C-N 120.687 -1.258 . . . . 0.0 111.366 -168.679 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' ALA . . . . . 0.519 ' CB ' HD13 ' A' ' 53' ' ' ILE . . . -79.0 -15.86 57.69 Favored 'General case' 0 N--CA 1.445 -0.698 0 O-C-N 121.093 -1.004 . . . . 0.0 112.885 178.768 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 5.4 tt -63.44 -42.2 98.67 Favored 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 106.568 -1.641 . . . . 0.0 106.568 167.679 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -63.83 -37.58 94.88 Favored Glycine 0 C--N 1.341 0.812 0 N-CA-C 111.34 -0.704 . . . . 0.0 111.34 178.67 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 28.5 mtm -64.53 -45.23 88.08 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 118.397 1.099 . . . . 0.0 111.813 177.873 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.411 HD23 ' CH2' ' A' ' 65' ' ' TRP . 0.2 OUTLIER -66.7 -39.69 88.16 Favored 'General case' 0 C--N 1.344 0.354 0 CA-C-N 120.233 1.379 . . . . 0.0 109.942 177.277 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 85.3 t60 -57.38 -51.34 69.79 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 118.492 0.587 . . . . 0.0 111.053 177.254 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -62.73 -39.26 93.52 Favored 'General case' 0 C--O 1.235 0.3 0 C-N-CA 124.04 0.936 . . . . 0.0 112.067 -176.335 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 25.0 ttmm -56.21 -35.03 66.86 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 123.657 0.783 . . . . 0.0 110.737 172.392 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 21.0 mt -94.34 -20.05 20.1 Favored 'General case' 0 CA--C 1.515 -0.371 0 N-CA-C 115.761 1.763 . . . . 0.0 115.761 -168.92 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 4.0 m -58.24 -33.98 69.95 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-N 120.673 1.579 . . . . 0.0 111.452 -177.843 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 20.0 p -85.79 -10.71 55.05 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 125.4 1.48 . . . . 0.0 112.324 179.871 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 32.6 mmmt -84.69 -6.05 59.34 Favored 'General case' 0 N--CA 1.466 0.342 0 C-N-CA 124.555 1.142 . . . . 0.0 111.334 173.875 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 70.09 33.49 69.65 Favored Glycine 0 CA--C 1.525 0.69 0 CA-C-N 118.438 0.563 . . . . 0.0 112.125 172.001 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 4.9 m -77.48 175.33 0.76 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.599 0 CA-C-N 117.907 0.853 . . . . 0.0 109.635 173.726 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -117.62 116.21 26.63 Favored 'General case' 0 N--CA 1.465 0.317 0 N-CA-C 107.318 -1.364 . . . . 0.0 107.318 175.069 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 71.2 m-85 -83.52 147.25 27.9 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 119.249 0.931 . . . . 0.0 109.185 -179.037 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 35.8 m -125.21 159.17 32.69 Favored 'Isoleucine or valine' 0 C--O 1.234 0.289 0 C-N-CA 123.696 0.798 . . . . 0.0 110.652 172.157 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 93.52 -87.57 1.18 Allowed Glycine 0 N--CA 1.446 -0.65 0 C-N-CA 125.144 1.354 . . . . 0.0 111.956 169.924 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 15.7 m-30 58.53 176.68 0.07 Allowed 'General case' 0 CA--C 1.552 1.04 0 C-N-CA 125.293 1.437 . . . . 0.0 110.87 -168.031 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -148.98 147.15 23.07 Favored Pre-proline 0 N--CA 1.476 0.853 0 O-C-N 120.199 -1.563 . . . . 0.0 110.149 177.8 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo -61.97 127.11 20.41 Favored 'Trans proline' 0 C--N 1.349 0.559 0 C-N-CA 122.831 2.354 . . . . 0.0 110.336 169.387 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 13.7 p -73.08 -13.63 61.24 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 113.32 0.859 . . . . 0.0 113.32 175.618 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -60.07 130.97 49.34 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 123.642 0.777 . . . . 0.0 109.937 -173.99 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 87.59 -6.87 82.74 Favored Glycine 0 CA--C 1.534 1.236 0 C-N-CA 124.798 1.189 . . . . 0.0 114.227 177.357 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 58.3 m-85 -85.96 157.9 20.02 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-N 119.327 1.563 . . . . 0.0 109.783 171.668 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -123.11 118.94 28.84 Favored 'General case' 0 C--O 1.233 0.186 0 N-CA-C 106.51 -1.663 . . . . 0.0 106.51 170.629 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 49.3 p90 -161.27 146.25 13.72 Favored 'General case' 0 C--O 1.237 0.439 0 N-CA-C 106.367 -1.716 . . . . 0.0 106.367 -174.185 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 7.5 m -107.51 -47.85 3.55 Favored 'General case' 0 N--CA 1.447 -0.587 0 N-CA-C 112.318 0.488 . . . . 0.0 112.318 -169.728 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 41.8 m -70.79 142.51 88.35 Favored Pre-proline 0 CA--C 1.542 0.658 0 CA-C-O 119.179 -0.439 . . . . 0.0 110.801 -174.738 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo -82.55 -14.85 8.93 Favored 'Trans proline' 0 CA--C 1.539 0.741 0 C-N-CA 123.108 2.539 . . . . 0.0 113.403 -178.027 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 9.5 ttmm -54.27 -37.41 53.32 Favored Pre-proline 0 CA--C 1.542 0.658 0 N-CA-C 114.68 1.363 . . . . 0.0 114.68 -172.696 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_exo -79.49 -0.34 10.64 Favored 'Trans proline' 0 CA--C 1.538 0.723 0 CA-C-N 122.036 1.763 . . . . 0.0 114.271 -179.109 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 31.4 m -131.51 165.51 31.46 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.427 0 CA-C-N 120.39 1.45 . . . . 0.0 112.647 -168.493 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 10.3 pt -136.5 176.42 8.09 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 C-N-CA 128.723 2.809 . . . . 0.0 108.439 -176.848 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . 56.33 41.87 28.51 Favored 'General case' 0 N--CA 1.465 0.297 0 C-N-CA 125.362 1.465 . . . . 0.0 112.35 174.134 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 27.7 t70 55.2 42.13 30.82 Favored 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 125.938 1.695 . . . . 0.0 111.479 -175.545 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 87.63 16.87 59.39 Favored Glycine 0 CA--C 1.528 0.906 0 CA-C-O 118.715 -1.047 . . . . 0.0 113.974 173.552 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 45.6 mt-30 -91.07 -9.23 46.49 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-N 119.072 1.436 . . . . 0.0 113.168 -178.336 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 4.9 tp -151.66 138.65 19.07 Favored 'General case' 0 C--N 1.342 0.273 0 CA-C-N 119.797 1.18 . . . . 0.0 111.054 -178.646 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 61.9 m-85 -77.82 143.7 37.66 Favored 'General case' 0 CA--C 1.517 -0.314 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 169.931 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 19.4 m -78.31 3.01 1.74 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 C-N-CA 123.587 0.755 . . . . 0.0 112.352 178.306 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -168.91 -172.93 36.2 Favored Glycine 0 C--N 1.335 0.483 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 -178.905 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.488 HD23 ' CD2' ' A' ' 85' ' ' TYR . 46.5 tp -74.65 129.67 38.13 Favored 'General case' 0 N--CA 1.451 -0.384 0 C-N-CA 123.659 0.784 . . . . 0.0 110.505 -179.605 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -81.19 117.36 21.66 Favored 'General case' 0 N--CA 1.443 -0.824 0 N-CA-C 107.322 -1.362 . . . . 0.0 107.322 167.36 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 61.4 mt -108.37 131.87 54.32 Favored 'General case' 0 N--CA 1.462 0.172 0 N-CA-C 107.031 -1.47 . . . . 0.0 107.031 167.827 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -151.89 135.52 16.21 Favored 'General case' 0 C--O 1.236 0.37 0 C-N-CA 128.074 2.549 . . . . 0.0 104.272 177.637 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -134.31 0.44 3.08 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 125.347 1.459 . . . . 0.0 111.338 -179.543 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 36.6 m -89.88 -42.94 10.94 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 124.456 1.102 . . . . 0.0 109.164 -171.523 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 8.1 m-80 -80.95 -34.48 33.18 Favored 'General case' 0 C--N 1.332 -0.176 0 C-N-CA 123.672 0.789 . . . . 0.0 111.29 -168.515 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -143.29 137.09 28.6 Favored 'General case' 0 CA--C 1.533 0.298 0 N-CA-C 105.482 -2.044 . . . . 0.0 105.482 177.677 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 39.8 m-85 -91.37 -19.24 23.12 Favored 'General case' 0 N--CA 1.466 0.325 0 N-CA-C 112.883 0.697 . . . . 0.0 112.883 -169.246 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -90.3 -31.97 16.72 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 123.016 0.527 . . . . 0.0 112.163 -176.69 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 82.5 mt -78.18 -10.48 59.66 Favored 'General case' 0 C--O 1.224 -0.25 0 N-CA-C 113.337 0.865 . . . . 0.0 113.337 -169.147 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 4.9 p -64.12 -47.22 80.85 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 120.331 1.423 . . . . 0.0 110.016 176.116 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -65.17 -38.75 91.51 Favored 'General case' 0 N--CA 1.461 0.11 0 C-N-CA 123.016 0.526 . . . . 0.0 110.641 177.662 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 2.8 tp10 -62.23 -49.06 77.24 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 124.31 1.044 . . . . 0.0 110.78 178.381 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 41.5 mtt180 -56.87 -44.83 82.63 Favored 'General case' 0 C--O 1.226 -0.182 0 C-N-CA 124.617 1.167 . . . . 0.0 109.761 178.536 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 53.8 mt -65.45 -56.0 17.37 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.358 0 N-CA-C 107.91 -1.144 . . . . 0.0 107.91 177.212 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 68.8 tp60 -55.77 -63.65 1.11 Allowed 'General case' 0 C--O 1.232 0.179 0 C-N-CA 124.09 0.956 . . . . 0.0 112.173 -170.503 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 20.2 m -67.35 -32.68 73.79 Favored 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 121.051 -0.259 . . . . 0.0 111.035 -168.695 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 160' ' ' TRP . . . . . . . . . . . . . 3.6 t90 -73.53 -42.37 61.83 Favored 'General case' 0 C--O 1.22 -0.45 0 CA-C-O 119.085 -0.483 . . . . 0.0 110.684 177.962 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 55.2 m -57.12 -45.33 83.55 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 118.525 0.602 . . . . 0.0 110.378 174.398 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -61.21 -42.3 98.36 Favored 'General case' 0 CA--C 1.528 0.111 0 CA-C-O 121.467 0.651 . . . . 0.0 110.191 177.097 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 16.5 tt0 -64.2 -53.44 49.29 Favored 'General case' 0 N--CA 1.448 -0.561 0 O-C-N 121.655 -0.653 . . . . 0.0 110.202 -178.721 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 41.2 pt -62.26 -37.04 77.6 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.331 0 CA-C-O 117.653 -1.165 . . . . 0.0 109.16 -174.814 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -63.47 -37.55 87.75 Favored 'General case' 0 C--O 1.224 -0.268 0 CA-C-N 119.57 1.077 . . . . 0.0 109.708 -179.729 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 34.1 m-80 -67.05 -50.41 61.98 Favored 'General case' 0 N--CA 1.465 0.294 0 N-CA-C 108.887 -0.782 . . . . 0.0 108.887 176.338 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 67.3 tt0 -72.69 -18.03 61.58 Favored 'General case' 0 N--CA 1.437 -1.122 0 C-N-CA 126.167 1.787 . . . . 0.0 112.157 -169.181 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 168' ' ' MET . . . . . . . . . . . . . 19.0 ptp -89.86 -40.05 12.67 Favored 'General case' 0 N--CA 1.456 -0.151 0 C-N-CA 124.115 0.966 . . . . 0.0 111.168 168.813 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -74.35 -24.82 59.23 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 112.647 0.61 . . . . 0.0 112.647 -174.021 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -58.7 -29.69 66.85 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 118.511 0.596 . . . . 0.0 111.626 179.209 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 78.9 m-70 -75.18 -14.13 60.52 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 124.783 1.233 . . . . 0.0 112.401 177.181 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 14.1 m-85 -115.38 -5.43 12.3 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 127.432 2.293 . . . . 0.0 112.173 -174.325 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.255 1.35 0 C-N-CA 124.378 1.071 . . . . 0.0 109.971 175.592 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.406 ' HA ' ' OD2' ' A' ' 47' ' ' ASP . 11.1 tmm? . . . . . 0 N--CA 1.495 1.819 0 N-CA-C 109.832 -0.433 . . . . 0.0 109.832 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 3.0 t30 -142.53 151.41 41.59 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 125.263 1.425 . . . . 0.0 107.911 174.489 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -112.0 128.05 56.06 Favored 'General case' 0 N--CA 1.463 0.221 0 C-N-CA 123.977 0.911 . . . . 0.0 111.573 -177.915 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -87.1 155.49 27.5 Favored Glycine 0 CA--C 1.523 0.584 0 N-CA-C 107.812 -2.115 . . . . 0.0 107.812 167.231 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 3.1 tt -140.39 96.53 3.05 Favored 'General case' 0 N--CA 1.466 0.341 0 N-CA-C 105.397 -2.075 . . . . 0.0 105.397 -177.504 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -98.95 140.51 33.0 Favored 'General case' 0 CA--C 1.516 -0.336 0 CA-C-O 121.225 0.536 . . . . 0.0 111.379 -173.656 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.407 ' CD2' ' HB ' ' A' ' 14' ' ' THR . 43.6 p90 -160.88 -177.56 6.22 Favored 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 125.679 1.592 . . . . 0.0 107.95 177.698 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -175.28 105.55 0.21 Allowed Glycine 0 C--N 1.333 0.376 0 N-CA-C 106.53 -2.628 . . . . 0.0 106.53 179.156 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 65.1 m -79.15 157.63 27.87 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 124.354 1.062 . . . . 0.0 112.249 -169.712 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 74.7 p -120.64 -144.3 0.35 Allowed 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 126.22 1.808 . . . . 0.0 107.353 169.808 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 3.2 p -61.89 -29.31 70.12 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 124.065 0.946 . . . . 0.0 109.377 167.265 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 6.5 t -94.24 128.78 40.9 Favored 'General case' 0 C--N 1.343 0.299 0 N-CA-C 105.13 -2.174 . . . . 0.0 105.13 168.26 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 44.2 p90 -120.15 156.1 31.75 Favored 'General case' 0 N--CA 1.464 0.274 0 N-CA-C 113.811 1.041 . . . . 0.0 113.811 -167.838 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.407 ' HB ' ' CD2' ' A' ' 7' ' ' TYR . 0.3 OUTLIER -116.64 -8.7 11.43 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 124.706 1.203 . . . . 0.0 112.539 -169.875 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -59.97 -38.09 81.52 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 118.983 0.81 . . . . 0.0 111.956 -167.631 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 30.6 mmt -66.97 -42.26 85.46 Favored 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 -177.326 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -65.09 -46.04 82.73 Favored 'General case' 0 C--O 1.226 -0.152 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 177.825 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -63.03 -47.42 83.12 Favored 'General case' 0 C--O 1.233 0.191 0 C-N-CA 122.756 0.422 . . . . 0.0 111.353 -176.047 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 10.4 mt-10 -62.06 -43.04 99.69 Favored 'General case' 0 CA--C 1.516 -0.338 0 CA-C-O 118.912 -0.566 . . . . 0.0 110.275 176.801 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 29.7 mtpp -71.58 -40.39 69.93 Favored 'General case' 0 C--O 1.22 -0.476 0 CA-C-O 117.97 -1.014 . . . . 0.0 110.892 -174.036 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 47.3 mt -52.54 -54.3 16.06 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.255 0 CA-C-N 120.052 1.296 . . . . 0.0 108.524 172.27 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 8.0 ttp180 -61.72 -41.06 97.14 Favored 'General case' 0 C--O 1.223 -0.296 0 C-N-CA 123.209 0.604 . . . . 0.0 109.425 -175.758 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -66.43 -41.61 88.93 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 118.481 0.582 . . . . 0.0 111.421 -179.177 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 49.3 mt -72.58 -53.17 20.01 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.526 0 C-N-CA 124.7 1.2 . . . . 0.0 109.686 -172.171 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 78.0 mt -67.05 -45.3 87.19 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 179.828 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 139.24 125.5 2.28 Favored Glycine 0 CA--C 1.532 1.137 0 C-N-CA 125.165 1.364 . . . . 0.0 112.067 173.737 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 82.2 Cg_endo -73.17 -5.3 16.93 Favored 'Trans proline' 0 CA--C 1.537 0.636 0 C-N-CA 123.664 2.91 . . . . 0.0 113.873 -175.822 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -82.27 -17.41 46.01 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 118.996 0.816 . . . . 0.0 111.072 177.229 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 1.3 pt? -129.94 -13.76 4.05 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 125.114 1.366 . . . . 0.0 113.871 -174.331 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 33.8 t -98.48 153.45 4.08 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.517 0 N-CA-C 107.691 -1.226 . . . . 0.0 107.691 168.56 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 50.5 m -139.65 131.93 28.3 Favored 'General case' 0 C--O 1.234 0.279 0 C-N-CA 126.464 1.905 . . . . 0.0 106.239 -177.117 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 24.3 mt -81.25 142.38 33.21 Favored 'General case' 0 C--O 1.233 0.191 0 N-CA-C 107.839 -1.171 . . . . 0.0 107.839 176.763 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 34.2 t-80 -134.28 57.65 1.8 Allowed 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 124.574 1.15 . . . . 0.0 108.218 -175.157 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 64.3 t-20 -70.43 118.01 12.69 Favored 'General case' 0 C--O 1.235 0.327 0 O-C-N 121.076 -1.015 . . . . 0.0 108.779 -176.673 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 93.9 mt -68.45 -12.94 61.92 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 124.092 0.957 . . . . 0.0 112.505 -174.807 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 65.3 mmtt -53.73 -27.19 26.89 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-O 118.685 -0.674 . . . . 0.0 111.178 167.013 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -132.04 -41.71 1.01 Allowed 'General case' 0 C--O 1.236 0.347 0 N-CA-C 113.437 0.903 . . . . 0.0 113.437 -173.941 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 29.8 m-20 -85.56 141.2 30.03 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-N 118.475 0.58 . . . . 0.0 110.568 -174.324 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 14.8 m -76.32 154.23 84.13 Favored Pre-proline 0 CA--C 1.54 0.59 0 C-N-CA 124.378 1.071 . . . . 0.0 110.342 176.658 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -77.26 -26.84 7.13 Favored 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 122.267 1.978 . . . . 0.0 113.683 -170.085 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.79 -15.38 63.54 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-N 120.657 1.571 . . . . 0.0 112.269 -178.612 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -58.77 -29.23 66.64 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 125.403 1.481 . . . . 0.0 110.363 170.317 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 55.3 mtt -57.43 -27.75 62.68 Favored 'General case' 0 C--N 1.342 0.264 0 C-N-CA 123.589 0.756 . . . . 0.0 111.498 177.339 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 56.7 mt-10 -66.83 -33.09 74.85 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 118.348 0.522 . . . . 0.0 110.537 -176.22 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 16.5 mt-30 -66.9 -43.18 84.09 Favored 'General case' 0 N--CA 1.464 0.232 0 C-N-CA 123.346 0.659 . . . . 0.0 112.336 -170.003 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 22.2 m-85 -70.92 142.11 51.11 Favored 'General case' 0 N--CA 1.454 -0.227 0 CA-C-N 115.387 -0.824 . . . . 0.0 110.528 -166.469 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' ASP . . . . . 0.406 ' OD2' ' HA ' ' A' ' 1' ' ' MET . 24.4 m-20 -74.77 -35.7 62.57 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-O 121.118 0.485 . . . . 0.0 109.726 -178.098 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.525 HG21 ' SD ' ' A' ' 168' ' ' MET . 25.6 t -113.94 147.49 17.44 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.216 0 N-CA-C 107.178 -1.416 . . . . 0.0 107.178 170.003 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 29.8 tp -132.19 109.69 10.12 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 123.778 0.831 . . . . 0.0 108.843 174.889 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 32.0 mt -87.22 133.1 30.93 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.552 0 N-CA-C 107.077 -1.453 . . . . 0.0 107.077 176.583 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 2.4 mp -111.22 127.34 55.57 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 126.141 1.777 . . . . 0.0 106.966 -179.26 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -135.0 136.6 8.65 Favored Glycine 0 C--N 1.335 0.48 0 N-CA-C 109.439 -1.464 . . . . 0.0 109.439 -179.561 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 4.1 tt -150.46 129.31 6.19 Favored Pre-proline 0 CA--C 1.542 0.645 0 CA-C-N 118.772 1.286 . . . . 0.0 110.926 -175.054 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -76.6 -21.63 12.79 Favored 'Trans proline' 0 CA--C 1.542 0.902 0 C-N-CA 122.992 2.461 . . . . 0.0 115.539 170.087 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.533 HG22 ' H ' ' A' ' 56' ' ' TRP . 25.7 m 56.75 -167.47 0.12 Allowed 'General case' 0 CA--C 1.558 1.255 0 CA-C-N 119.592 1.087 . . . . 0.0 109.453 -169.265 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' TRP . . . . . 0.533 ' H ' HG22 ' A' ' 55' ' ' THR . 0.3 OUTLIER -133.74 159.58 40.14 Favored 'General case' 0 CA--C 1.535 0.369 0 O-C-N 120.582 -1.324 . . . . 0.0 108.814 169.914 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -65.7 109.56 2.47 Favored 'General case' 0 C--O 1.236 0.377 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 -179.836 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 85.6 m-85 47.36 37.27 5.77 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 124.001 0.92 . . . . 0.0 111.507 -169.266 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -136.37 149.81 20.25 Favored Glycine 0 C--N 1.337 0.598 0 N-CA-C 110.501 -1.04 . . . . 0.0 110.501 -175.215 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.438 ' HG2' ' H ' ' A' ' 61' ' ' ILE . 14.3 tt0 -77.74 -171.34 2.18 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-O 121.998 0.904 . . . . 0.0 109.738 -177.932 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.438 ' H ' ' HG2' ' A' ' 60' ' ' GLU . 13.1 mt -57.69 141.24 14.94 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.706 0 C-N-CA 126.292 1.837 . . . . 0.0 111.464 -172.622 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' GLN . . . . . 0.555 ' H ' ' CD ' ' A' ' 62' ' ' GLN . 0.3 OUTLIER -56.02 146.89 21.27 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 126.741 2.016 . . . . 0.0 109.715 175.012 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -57.15 -48.23 79.21 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 118.348 0.522 . . . . 0.0 112.172 -169.629 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -69.71 -17.87 63.49 Favored 'General case' 0 N--CA 1.475 0.807 0 CA-C-N 119.019 0.827 . . . . 0.0 112.177 -173.864 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' TRP . . . . . 0.44 ' CH2' HD23 ' A' ' 104' ' ' LEU . 0.2 OUTLIER -93.28 -43.44 8.8 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 124.92 1.288 . . . . 0.0 107.636 -179.822 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -63.46 -35.12 79.39 Favored 'General case' 0 N--CA 1.435 -1.217 0 C-N-CA 126.229 1.812 . . . . 0.0 111.075 177.347 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -55.93 -23.88 34.53 Favored 'General case' 0 CA--C 1.53 0.174 0 C-N-CA 124.582 1.153 . . . . 0.0 112.001 -176.821 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 35.7 m -116.47 -13.49 11.01 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.224 0 CA-C-O 117.913 -1.041 . . . . 0.0 112.709 178.902 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 26.5 t90 -52.55 -38.68 60.31 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 119.824 1.193 . . . . 0.0 111.083 -177.063 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -68.04 -24.02 65.04 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 125.12 1.368 . . . . 0.0 112.967 178.62 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 20.4 mt-30 -91.67 -23.74 19.72 Favored 'General case' 0 C--N 1.34 0.166 0 C-N-CA 125.273 1.429 . . . . 0.0 111.877 -179.347 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 24.7 mt -64.63 -26.13 68.26 Favored 'General case' 0 N--CA 1.468 0.456 0 O-C-N 121.792 -0.567 . . . . 0.0 111.646 -172.227 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -69.27 -22.27 63.83 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-N 118.06 0.391 . . . . 0.0 111.518 176.233 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -77.36 -23.51 50.83 Favored 'General case' 0 CA--C 1.537 0.472 0 O-C-N 120.707 -1.245 . . . . 0.0 112.56 -178.743 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 51.2 mt -65.67 152.07 45.07 Favored 'General case' 0 C--O 1.233 0.226 0 C-N-CA 124.772 1.229 . . . . 0.0 112.056 -170.205 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 3.3 t30 -82.71 100.95 10.55 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 124.682 1.193 . . . . 0.0 108.154 174.127 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 57.2 mt -119.22 0.09 11.12 Favored 'General case' 0 N--CA 1.47 0.548 0 N-CA-C 113.389 0.885 . . . . 0.0 113.389 -174.474 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 25.0 mt-10 -57.41 128.92 39.47 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 119.135 0.88 . . . . 0.0 110.828 -169.705 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 74.25 -3.04 41.71 Favored Glycine 0 CA--C 1.532 1.145 0 CA-C-O 117.749 -1.584 . . . . 0.0 114.824 178.535 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.79 152.86 40.19 Favored 'General case' 0 C--N 1.347 0.49 0 CA-C-N 121.098 2.449 . . . . 0.0 109.503 -179.402 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 2.1 mt -86.18 141.69 14.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 N-CA-C 106.877 -1.527 . . . . 0.0 106.877 179.414 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 61.6 t -135.68 137.58 49.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 C-N-CA 124.279 1.032 . . . . 0.0 109.109 -177.067 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -111.39 152.72 27.02 Favored 'General case' 0 N--CA 1.465 0.291 0 N-CA-C 106.733 -1.58 . . . . 0.0 106.733 168.118 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 1.2 mt -134.19 135.25 42.91 Favored 'General case' 0 CA--C 1.508 -0.637 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 175.366 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 40.9 p90 -147.34 166.14 28.03 Favored 'General case' 0 N--CA 1.447 -0.594 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 169.235 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -160.01 155.01 26.09 Favored Glycine 0 N--CA 1.448 -0.542 0 N-CA-C 109.123 -1.591 . . . . 0.0 109.123 171.946 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 13.0 tp -99.35 146.52 26.19 Favored 'General case' 0 N--CA 1.444 -0.737 0 C-N-CA 125.031 1.332 . . . . 0.0 109.08 177.02 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -152.01 158.11 27.61 Favored Glycine 0 CA--C 1.527 0.786 0 N-CA-C 109.004 -1.638 . . . . 0.0 109.004 169.099 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -94.63 -3.24 49.89 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 124.147 0.979 . . . . 0.0 113.395 -174.084 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 39.4 mt-30 50.95 2.1 0.01 OUTLIER 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 128.637 2.775 . . . . 0.0 116.234 -176.507 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 28.6 mt -111.86 -39.69 4.48 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 125.789 1.636 . . . . 0.0 110.522 -170.851 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -112.48 -41.58 1.03 Allowed Glycine 0 CA--C 1.533 1.168 0 C-N-CA 126.276 1.893 . . . . 0.0 109.21 168.415 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 17.1 m-85 -78.47 61.27 2.82 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 127.047 2.139 . . . . 0.0 107.586 172.062 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -98.99 -67.52 0.88 Allowed Glycine 0 CA--C 1.522 0.475 0 N-CA-C 109.146 -1.582 . . . . 0.0 109.146 179.295 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -73.08 -17.33 61.43 Favored 'General case' 0 CA--C 1.538 0.51 0 O-C-N 122.289 -0.536 . . . . 0.0 110.573 172.346 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' TRP . . . . . . . . . . . . . 4.8 t-105 -118.19 38.25 3.75 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 125.73 1.612 . . . . 0.0 109.883 -178.74 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 11.5 t80 -59.68 -54.89 41.19 Favored 'General case' 0 C--N 1.342 0.261 0 N-CA-C 112.938 0.718 . . . . 0.0 112.938 -172.1 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 96.7 mt -141.84 37.94 1.63 Allowed 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 123.945 0.898 . . . . 0.0 109.964 -169.054 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -52.73 -47.57 67.27 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 123.754 0.821 . . . . 0.0 112.7 -168.783 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -78.94 -19.56 51.44 Favored 'General case' 0 N--CA 1.451 -0.397 0 O-C-N 121.129 -0.982 . . . . 0.0 113.347 -176.323 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 3.8 tt -60.84 -44.79 96.5 Favored 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 107.543 -1.28 . . . . 0.0 107.543 171.383 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -61.24 -43.94 98.74 Favored Glycine 0 C--N 1.341 0.839 0 CA-C-O 119.617 -0.546 . . . . 0.0 111.914 176.398 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 75.1 mtm -63.25 -40.62 97.94 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 118.382 1.091 . . . . 0.0 111.957 -178.863 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.44 HD23 ' CH2' ' A' ' 65' ' ' TRP . 0.1 OUTLIER -69.95 -34.22 73.14 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-N 120.035 1.289 . . . . 0.0 111.241 -179.604 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 56.3 t-80 -58.97 -49.5 77.62 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-N 118.477 0.58 . . . . 0.0 109.533 172.996 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -62.36 -41.66 98.78 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 123.38 0.672 . . . . 0.0 112.295 -177.11 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 24.2 ttmm -55.56 -40.96 72.62 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 123.401 0.681 . . . . 0.0 110.166 173.14 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 28.4 mt -89.82 -20.2 23.75 Favored 'General case' 0 CA--C 1.517 -0.317 0 N-CA-C 115.764 1.765 . . . . 0.0 115.764 -167.653 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 15.9 m -58.28 -36.44 73.3 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 120.732 1.605 . . . . 0.0 111.334 -178.301 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 20.5 p -83.85 -12.88 54.92 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 124.585 1.154 . . . . 0.0 111.903 -179.678 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 32.0 mmmt -83.15 -9.64 59.08 Favored 'General case' 0 C--N 1.343 0.3 0 C-N-CA 124.525 1.13 . . . . 0.0 110.984 170.881 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 72.3 35.91 60.0 Favored Glycine 0 CA--C 1.523 0.561 0 CA-C-N 118.651 0.66 . . . . 0.0 112.469 169.661 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 5.3 m -77.02 170.67 1.46 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.582 0 CA-C-N 117.858 0.829 . . . . 0.0 109.713 172.001 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 53.0 tptt -100.06 130.64 46.23 Favored 'General case' 0 N--CA 1.47 0.564 0 N-CA-C 105.132 -2.173 . . . . 0.0 105.132 167.756 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 73.8 m-85 -94.95 123.01 38.18 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 172.071 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 32.8 m -105.15 154.31 6.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 C-N-CA 124.032 0.933 . . . . 0.0 108.505 167.701 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 105.85 -95.9 1.11 Allowed Glycine 0 N--CA 1.448 -0.56 0 C-N-CA 124.105 0.86 . . . . 0.0 112.011 174.173 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 118' ' ' TYR . . . . . 0.438 ' CD2' ' HA ' ' A' ' 140' ' ' VAL . 75.6 m-85 60.17 -179.61 0.09 Allowed 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 125.182 1.393 . . . . 0.0 109.424 -166.928 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER -153.22 143.55 15.54 Favored Pre-proline 0 N--CA 1.476 0.825 0 O-C-N 120.122 -1.611 . . . . 0.0 111.069 177.17 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -68.9 122.66 9.57 Favored 'Trans proline' 0 CA--C 1.536 0.595 0 C-N-CA 123.505 2.804 . . . . 0.0 111.621 179.238 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 18.1 p -81.85 -14.93 55.61 Favored 'General case' 0 CA--C 1.538 0.492 0 N-CA-C 113.791 1.034 . . . . 0.0 113.791 -179.343 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -47.13 130.37 12.63 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 124.545 1.138 . . . . 0.0 112.414 -168.534 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 82.87 30.2 32.67 Favored Glycine 0 CA--C 1.538 1.52 0 C-N-CA 124.1 0.857 . . . . 0.0 112.802 -174.624 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 50.1 p90 -71.62 158.79 35.57 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-N 118.115 0.958 . . . . 0.0 113.004 -175.893 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -128.3 6.7 5.85 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 125.053 1.341 . . . . 0.0 112.188 171.966 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 3.5 p90 -76.94 175.52 9.46 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 124.721 1.208 . . . . 0.0 110.631 176.607 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 7.4 t -144.34 -38.34 0.3 Allowed 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 124.497 1.119 . . . . 0.0 110.265 174.152 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 13.5 m -59.76 128.04 86.02 Favored Pre-proline 0 CA--C 1.544 0.716 0 C-N-CA 125.071 1.348 . . . . 0.0 110.727 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -84.81 -16.9 5.18 Favored 'Trans proline' 0 CA--C 1.535 0.564 0 C-N-CA 122.448 2.099 . . . . 0.0 114.379 -169.99 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 24.7 ttmt -53.88 -43.96 97.36 Favored Pre-proline 0 N--CA 1.475 0.79 0 N-CA-C 114.734 1.383 . . . . 0.0 114.734 -169.108 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -82.76 3.83 7.54 Favored 'Trans proline' 0 C--N 1.35 0.615 0 CA-C-N 121.836 1.691 . . . . 0.0 114.162 -178.43 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 20.0 m -130.26 165.82 29.46 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.371 0 CA-C-N 120.537 1.517 . . . . 0.0 111.57 -172.252 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 7.4 pt -135.42 171.29 17.68 Favored 'Isoleucine or valine' 0 C--O 1.234 0.279 0 C-N-CA 127.913 2.485 . . . . 0.0 108.969 -177.949 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . 53.88 45.13 28.4 Favored 'General case' 0 N--CA 1.464 0.261 0 C-N-CA 125.488 1.515 . . . . 0.0 112.509 172.553 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 27.0 t0 54.32 43.58 30.28 Favored 'General case' 0 C--N 1.324 -0.521 0 C-N-CA 126.056 1.742 . . . . 0.0 111.624 -176.596 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 87.41 17.4 58.83 Favored Glycine 0 CA--C 1.527 0.825 0 CA-C-O 118.662 -1.077 . . . . 0.0 113.611 173.357 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 60.6 mm-40 -92.09 -8.07 46.82 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 119.399 1.6 . . . . 0.0 113.142 -177.368 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 7.9 tp -152.59 145.03 24.06 Favored 'General case' 0 C--N 1.344 0.33 0 CA-C-N 119.356 0.98 . . . . 0.0 110.761 170.941 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 65.5 m-85 -81.59 144.83 30.97 Favored 'General case' 0 CA--C 1.514 -0.423 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 169.373 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 140' ' ' VAL . . . . . 0.438 ' HA ' ' CD2' ' A' ' 118' ' ' TYR . 13.9 m -76.43 11.07 0.43 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.627 0 N-CA-C 113.128 0.788 . . . . 0.0 113.128 179.512 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 177.39 171.9 41.37 Favored Glycine 0 CA--C 1.525 0.696 0 C-N-CA 124.927 1.251 . . . . 0.0 109.997 -177.617 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 3.2 tp -66.72 133.44 50.19 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 117.962 0.881 . . . . 0.0 110.771 -177.725 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -91.56 117.05 29.37 Favored 'General case' 0 N--CA 1.445 -0.694 0 C-N-CA 125.835 1.654 . . . . 0.0 108.408 173.017 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -99.95 145.33 27.96 Favored 'General case' 0 N--CA 1.463 0.199 0 C-N-CA 124.288 1.035 . . . . 0.0 109.385 172.242 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -140.03 134.01 30.8 Favored 'General case' 0 C--O 1.233 0.187 0 N-CA-C 106.016 -1.846 . . . . 0.0 106.016 168.204 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 25.8 tt0 -141.08 47.34 1.72 Allowed 'General case' 0 CA--C 1.539 0.528 0 N-CA-C 107.607 -1.256 . . . . 0.0 107.607 169.631 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 87.6 m -132.16 -57.59 0.96 Allowed 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 126.329 1.852 . . . . 0.0 108.56 -174.49 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 31.5 m-80 -87.14 -31.01 20.63 Favored 'General case' 0 N--CA 1.453 -0.28 0 C-N-CA 124.559 1.144 . . . . 0.0 108.409 179.057 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 79.6 mt-30 -110.56 162.1 15.05 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 126.761 2.024 . . . . 0.0 108.593 175.284 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 45.7 p90 -151.53 -43.21 0.11 Allowed 'General case' 0 N--CA 1.463 0.224 0 C-N-CA 123.594 0.758 . . . . 0.0 109.574 170.81 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -70.61 -50.19 39.69 Favored 'General case' 0 N--CA 1.465 0.298 0 O-C-N 122.089 -0.382 . . . . 0.0 110.429 -177.849 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -84.68 -0.47 53.62 Favored 'General case' 0 C--O 1.222 -0.39 0 CA-C-O 118.651 -0.69 . . . . 0.0 112.322 179.144 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 21.9 m -60.59 -29.88 69.47 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 120.314 1.415 . . . . 0.0 110.642 170.04 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -64.21 -38.53 91.39 Favored 'General case' 0 N--CA 1.463 0.188 0 C-N-CA 123.208 0.603 . . . . 0.0 111.037 169.998 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -70.23 -40.64 74.36 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 124.599 1.159 . . . . 0.0 111.276 -178.484 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 17.9 mmm-85 -49.39 -43.76 44.56 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 124.23 1.012 . . . . 0.0 109.889 171.253 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 58.0 mt -75.03 -56.74 7.95 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.399 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 -179.716 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 73.1 tp60 -50.68 -62.76 1.4 Allowed 'General case' 0 CA--C 1.521 -0.151 0 C-N-CA 125.709 1.604 . . . . 0.0 112.673 -170.298 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 15.0 m -68.09 -34.16 75.89 Favored 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 121.049 -0.26 . . . . 0.0 110.841 -168.57 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 160' ' ' TRP . . . . . . . . . . . . . 38.0 t90 -67.66 -44.25 78.31 Favored 'General case' 0 C--O 1.222 -0.353 0 O-C-N 122.167 -0.333 . . . . 0.0 110.838 175.128 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 61.2 m -59.74 -43.82 94.07 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 122.834 0.454 . . . . 0.0 110.377 178.965 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -62.03 -41.69 98.37 Favored 'General case' 0 CA--C 1.529 0.141 0 CA-C-N 118.053 0.388 . . . . 0.0 110.173 176.614 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 11.7 tt0 -62.68 -54.13 43.93 Favored 'General case' 0 CA--C 1.514 -0.415 0 CA-C-O 118.15 -0.928 . . . . 0.0 109.929 -179.099 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 40.4 pt -62.78 -33.0 57.71 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.497 0 CA-C-O 118.012 -0.994 . . . . 0.0 109.871 -176.475 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -70.66 -36.58 73.44 Favored 'General case' 0 C--O 1.223 -0.324 0 CA-C-N 119.837 1.198 . . . . 0.0 108.605 -175.572 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -68.73 -45.63 71.02 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 123.386 0.674 . . . . 0.0 109.844 175.096 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 25.1 tt0 -80.79 -13.63 58.79 Favored 'General case' 0 N--CA 1.437 -1.119 0 C-N-CA 124.303 1.041 . . . . 0.0 110.328 -169.382 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 168' ' ' MET . . . . . 0.525 ' SD ' HG21 ' A' ' 48' ' ' VAL . 20.6 ptp -90.7 -41.61 11.19 Favored 'General case' 0 N--CA 1.457 -0.125 0 C-N-CA 122.914 0.486 . . . . 0.0 111.242 168.774 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -70.58 -27.59 64.23 Favored 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 122.652 0.381 . . . . 0.0 111.651 -172.258 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -57.18 -26.78 61.18 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 123.257 0.623 . . . . 0.0 112.4 178.9 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 99.0 m-70 -77.91 -19.84 53.94 Favored 'General case' 0 C--O 1.235 0.291 0 C-N-CA 124.3 1.04 . . . . 0.0 112.64 179.132 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 58.5 m-85 -113.66 -18.82 11.8 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 125.719 1.608 . . . . 0.0 112.656 -173.62 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.254 1.29 0 C-N-CA 124.317 1.047 . . . . 0.0 110.106 175.157 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.498 1.938 0 N-CA-C 111.578 0.214 . . . . 0.0 111.578 . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 6.0 t30 -127.36 151.52 48.67 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 124.624 1.17 . . . . 0.0 108.458 175.414 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 17.3 mtt -110.93 126.37 54.65 Favored 'General case' 0 C--N 1.332 -0.182 0 C-N-CA 123.475 0.71 . . . . 0.0 110.359 -177.385 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -84.22 145.98 22.57 Favored Glycine 0 CA--C 1.522 0.514 0 N-CA-C 107.139 -2.384 . . . . 0.0 107.139 168.023 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 1.2 tt -135.03 93.94 3.08 Favored 'General case' 0 N--CA 1.464 0.273 0 N-CA-C 105.345 -2.094 . . . . 0.0 105.345 -172.927 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.413 ' CE2' ' HG ' ' A' ' 51' ' ' LEU . 0.1 OUTLIER -101.59 143.25 31.8 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-O 121.703 0.763 . . . . 0.0 110.728 -173.322 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 32.3 p90 -158.53 162.39 37.41 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 125.071 1.348 . . . . 0.0 108.078 -178.071 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -97.12 140.35 15.0 Favored Glycine 0 CA--C 1.52 0.398 0 N-CA-C 110.145 -1.182 . . . . 0.0 110.145 176.017 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 46.0 m -144.11 104.83 4.17 Favored 'General case' 0 N--CA 1.446 -0.651 0 C-N-CA 125.207 1.403 . . . . 0.0 107.826 169.288 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 55.8 m -107.39 -122.07 0.24 Allowed 'General case' 0 CA--C 1.541 0.606 0 N-CA-C 106.587 -1.634 . . . . 0.0 106.587 169.946 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 2.8 p -64.89 -45.28 86.6 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 119.453 1.024 . . . . 0.0 109.789 172.911 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 6.3 p -90.24 149.87 22.2 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 124.607 1.163 . . . . 0.0 108.215 168.345 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 23.6 p90 -140.0 150.12 44.06 Favored 'General case' 0 C--O 1.234 0.264 0 C-N-CA 123.357 0.663 . . . . 0.0 112.116 -169.549 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 51.7 m -110.45 6.82 22.43 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 125.26 1.424 . . . . 0.0 111.509 -172.395 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -54.6 -37.19 65.28 Favored 'General case' 0 N--CA 1.465 0.3 0 O-C-N 120.992 -1.068 . . . . 0.0 113.415 -168.674 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 3.2 mpp? -65.54 -37.57 87.12 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 119.592 1.087 . . . . 0.0 111.51 -172.25 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -64.21 -44.3 92.34 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 118.849 0.75 . . . . 0.0 109.079 174.557 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -65.74 -45.66 81.76 Favored 'General case' 0 N--CA 1.455 -0.182 0 C-N-CA 123.732 0.813 . . . . 0.0 111.577 -175.239 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -54.34 -47.69 72.27 Favored 'General case' 0 CA--C 1.517 -0.289 0 C-N-CA 125.262 1.425 . . . . 0.0 109.312 173.647 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 29.8 mtpp -73.51 -38.91 65.18 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-O 118.459 -0.781 . . . . 0.0 110.215 -172.272 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 37.3 mt -53.72 -56.7 7.71 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.288 0 CA-C-N 119.469 1.031 . . . . 0.0 109.024 173.378 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.483 ' HG2' HD21 ' A' ' 32' ' ' LEU . 0.0 OUTLIER -66.33 -35.02 79.3 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 118.49 0.586 . . . . 0.0 111.196 -173.858 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -62.38 -42.7 99.62 Favored 'General case' 0 C--N 1.328 -0.358 0 O-C-N 123.363 0.414 . . . . 0.0 110.892 176.093 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.611 HD13 ' HA ' ' A' ' 158' ' ' GLN . 39.5 mt -72.23 -55.65 12.6 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.52 0 C-N-CA 123.619 0.767 . . . . 0.0 109.971 -174.356 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 73.0 mt -65.8 -45.23 92.17 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.296 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 -175.33 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 141.62 120.69 1.65 Allowed Glycine 0 CA--C 1.53 0.994 0 N-CA-C 110.26 -1.136 . . . . 0.0 110.26 176.335 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -68.64 -10.2 28.37 Favored 'Trans proline' 0 N--CA 1.456 -0.697 0 C-N-CA 123.124 2.55 . . . . 0.0 113.373 -173.985 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 2.4 pm0 -81.56 -18.25 45.56 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-N 119.573 1.079 . . . . 0.0 111.831 179.138 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -126.96 5.74 6.56 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 124.735 1.214 . . . . 0.0 113.679 -173.096 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 38.2 t -126.55 146.2 32.8 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.281 0 N-CA-C 107.842 -1.17 . . . . 0.0 107.842 173.169 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 34.0 m -133.02 131.89 41.22 Favored 'General case' 0 C--N 1.333 -0.129 0 C-N-CA 125.045 1.338 . . . . 0.0 108.635 -175.481 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.483 HD21 ' HG2' ' A' ' 22' ' ' ARG . 22.9 mt -75.53 137.71 41.04 Favored 'General case' 0 C--O 1.231 0.092 0 N-CA-C 108.809 -0.811 . . . . 0.0 108.809 177.393 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 23.2 t-80 -135.45 54.51 1.92 Allowed 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 124.788 1.235 . . . . 0.0 108.477 -177.006 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 38.3 t-20 -53.58 123.52 12.41 Favored 'General case' 0 C--O 1.237 0.41 0 N-CA-C 107.485 -1.302 . . . . 0.0 107.485 170.675 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.405 HD23 ' HA ' ' A' ' 35' ' ' LEU . 31.7 mt -70.46 -19.74 62.93 Favored 'General case' 0 C--O 1.235 0.302 0 N-CA-C 112.824 0.676 . . . . 0.0 112.824 -173.782 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 55.9 tptt -70.63 -19.44 62.82 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-N 118.915 0.78 . . . . 0.0 110.91 169.771 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -103.38 -36.49 8.0 Favored 'General case' 0 C--O 1.233 0.235 0 C-N-CA 123.975 0.91 . . . . 0.0 113.107 -170.732 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 3.3 t0 -139.64 156.24 46.95 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 118.668 0.667 . . . . 0.0 112.539 178.268 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 19.9 m -75.4 157.88 84.17 Favored Pre-proline 0 CA--C 1.541 0.623 0 C-N-CA 125.931 1.692 . . . . 0.0 111.714 -170.58 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 78.1 Cg_endo -74.86 -26.49 11.16 Favored 'Trans proline' 0 C--N 1.349 0.584 0 C-N-CA 122.68 2.254 . . . . 0.0 113.493 -170.297 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 23.0 mmmt -70.79 -12.42 61.54 Favored 'General case' 0 N--CA 1.472 0.65 0 O-C-N 120.685 -1.26 . . . . 0.0 111.531 -176.159 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -60.24 -29.36 68.72 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 125.423 1.489 . . . . 0.0 110.354 168.832 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 48.4 mtt -59.41 -25.37 64.26 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 118.65 0.659 . . . . 0.0 111.436 178.425 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 89.9 mt-10 -65.83 -33.06 74.99 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-O 118.96 -0.543 . . . . 0.0 110.027 -176.84 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 24.9 mt-30 -65.22 -45.51 84.41 Favored 'General case' 0 N--CA 1.465 0.313 0 C-N-CA 123.424 0.69 . . . . 0.0 112.771 -169.959 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 44.5 m-85 -77.73 133.2 38.34 Favored 'General case' 0 CA--C 1.52 -0.204 0 C-N-CA 123.718 0.807 . . . . 0.0 109.205 -167.234 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -75.58 -22.22 57.14 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-N 118.883 0.765 . . . . 0.0 111.833 -177.135 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 53.0 t -113.6 143.33 23.53 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.588 0 N-CA-C 106.633 -1.618 . . . . 0.0 106.633 169.441 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 31.2 tp -133.65 149.03 51.56 Favored 'General case' 0 N--CA 1.444 -0.763 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 172.278 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 28.9 mt -128.71 133.34 66.57 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 N-CA-C 105.38 -2.082 . . . . 0.0 105.38 179.917 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.413 ' HG ' ' CE2' ' A' ' 6' ' ' PHE . 3.1 mp -118.25 128.76 54.99 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 125.701 1.6 . . . . 0.0 107.781 -172.842 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -131.57 134.23 7.58 Favored Glycine 0 C--N 1.332 0.315 0 N-CA-C 110.912 -0.875 . . . . 0.0 110.912 174.69 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 2.9 tt -153.88 137.06 10.16 Favored Pre-proline 0 CA--C 1.542 0.667 0 CA-C-N 118.654 1.227 . . . . 0.0 111.662 170.37 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_exo -72.36 156.87 54.24 Favored 'Trans proline' 0 CA--C 1.536 0.599 0 C-N-CA 123.347 2.698 . . . . 0.0 113.081 167.976 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 3.1 m -132.87 146.71 52.04 Favored 'General case' 0 CA--C 1.538 0.485 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 167.409 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 11.4 m-90 -138.76 169.81 17.12 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 126.013 1.725 . . . . 0.0 108.441 174.319 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -61.88 -31.13 71.39 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 123.383 0.673 . . . . 0.0 112.597 -177.604 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 52.4 p90 -142.44 159.13 42.84 Favored 'General case' 0 C--O 1.239 0.509 0 C-N-CA 124.986 1.314 . . . . 0.0 108.317 172.921 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 66.13 30.29 76.58 Favored Glycine 0 CA--C 1.534 1.241 0 N-CA-C 111.501 -0.639 . . . . 0.0 111.501 -178.953 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 3.9 pm0 -65.54 149.55 49.88 Favored 'General case' 0 C--O 1.239 0.524 0 CA-C-N 117.946 0.873 . . . . 0.0 109.548 170.932 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . 0.256 59.0 mt 60.32 151.4 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.55 0.965 0 C-N-CA 126.208 1.803 . . . . 0.0 111.361 -168.881 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -118.22 156.7 28.32 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 125.265 1.426 . . . . 0.0 107.579 -175.974 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -57.41 -45.01 85.05 Favored 'General case' 0 CA--C 1.529 0.153 0 C-N-CA 123.233 0.613 . . . . 0.0 110.677 -172.053 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -64.42 -19.54 65.58 Favored 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 113.219 0.822 . . . . 0.0 113.219 -177.115 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 13.0 t90 -95.91 -47.2 6.23 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 124.754 1.222 . . . . 0.0 109.485 178.23 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 10.9 tt0 -62.79 -35.26 79.26 Favored 'General case' 0 N--CA 1.446 -0.642 0 O-C-N 120.877 -1.139 . . . . 0.0 109.975 -178.899 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -58.13 -25.76 61.82 Favored 'General case' 0 CA--C 1.529 0.173 0 C-N-CA 124.034 0.933 . . . . 0.0 111.711 -177.262 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 28.6 m -113.29 -13.4 11.4 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.266 0 CA-C-O 117.21 -1.376 . . . . 0.0 112.484 177.675 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 26.0 t90 -52.75 -35.21 55.8 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 120.53 1.514 . . . . 0.0 110.968 -178.908 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -64.3 -27.72 69.23 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 125.567 1.547 . . . . 0.0 113.269 175.944 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 29.3 mt-30 -92.47 -19.61 21.83 Favored 'General case' 0 C--N 1.343 0.288 0 C-N-CA 125.93 1.692 . . . . 0.0 112.524 176.214 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 52.5 mt -63.69 -20.96 66.13 Favored 'General case' 0 CA--C 1.536 0.415 0 O-C-N 121.318 -0.864 . . . . 0.0 111.467 -176.398 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -79.01 -23.34 44.42 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 123.112 0.565 . . . . 0.0 111.503 174.401 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -72.83 -29.82 63.53 Favored 'General case' 0 N--CA 1.469 0.509 0 O-C-N 120.628 -1.295 . . . . 0.0 111.883 178.714 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 80.1 mt -52.85 141.05 22.61 Favored 'General case' 0 C--N 1.34 0.16 0 C-N-CA 125.239 1.415 . . . . 0.0 113.009 -168.484 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 3.7 t30 -75.62 102.48 5.34 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 123.832 0.853 . . . . 0.0 108.729 170.437 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 66.7 mt -125.03 -0.48 7.85 Favored 'General case' 0 N--CA 1.475 0.784 0 N-CA-C 114.058 1.133 . . . . 0.0 114.058 -173.572 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 27.0 mt-10 -57.25 128.78 38.75 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 119.528 1.058 . . . . 0.0 111.144 -169.253 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 73.43 -1.79 41.45 Favored Glycine 0 CA--C 1.534 1.25 0 C-N-CA 125.394 1.474 . . . . 0.0 115.103 178.518 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.68 148.95 40.13 Favored 'General case' 0 C--N 1.344 0.354 0 CA-C-N 120.543 2.171 . . . . 0.0 109.474 -176.362 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 1.8 mt -80.49 136.28 23.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 N-CA-C 106.712 -1.588 . . . . 0.0 106.712 179.246 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 76.2 t -133.0 125.1 51.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 C-N-CA 123.97 0.908 . . . . 0.0 109.805 -175.608 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -98.72 151.73 20.43 Favored 'General case' 0 N--CA 1.463 0.177 0 N-CA-C 107.938 -1.134 . . . . 0.0 107.938 166.674 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 1.2 mt -133.93 138.73 45.69 Favored 'General case' 0 CA--C 1.512 -0.493 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 175.382 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 45.6 p90 -150.48 168.92 22.77 Favored 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 171.223 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -168.12 166.63 39.61 Favored Glycine 0 N--CA 1.444 -0.775 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 173.386 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -111.96 148.46 33.72 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 124.315 1.046 . . . . 0.0 109.037 170.546 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -162.45 -176.44 34.53 Favored Glycine 0 CA--C 1.527 0.814 0 N-CA-C 107.685 -2.166 . . . . 0.0 107.685 174.453 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -146.06 134.25 21.66 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 117.777 0.789 . . . . 0.0 110.223 -179.179 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 15.0 pm0 -78.56 -20.4 50.69 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 126.715 2.006 . . . . 0.0 112.726 -179.799 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 95.3 mt -81.12 -41.48 22.42 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 119.657 1.117 . . . . 0.0 111.826 -175.768 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -58.34 -48.99 80.47 Favored Glycine 0 CA--C 1.528 0.844 0 C-N-CA 123.886 0.755 . . . . 0.0 111.716 -172.873 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 16.9 t80 -156.74 -43.79 0.07 Allowed 'General case' 0 N--CA 1.464 0.27 0 C-N-CA 122.941 0.497 . . . . 0.0 111.012 169.283 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 91.24 -22.98 26.82 Favored Glycine 0 CA--C 1.525 0.701 0 CA-C-O 118.695 -1.058 . . . . 0.0 112.963 171.396 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 81.7 mt-10 -72.62 -15.54 61.73 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 119.677 1.739 . . . . 0.0 112.112 179.53 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' TRP . . . . . . . . . . . . . 38.1 m95 -109.27 22.58 15.65 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 124.422 1.089 . . . . 0.0 111.85 174.354 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 18.0 t80 -54.87 124.42 16.56 Favored 'General case' 0 C--N 1.342 0.27 0 O-C-N 121.066 -1.021 . . . . 0.0 108.903 174.952 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 92.8 mt 53.05 23.54 3.01 Favored 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 124.533 1.133 . . . . 0.0 114.014 169.75 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -62.8 -33.82 76.0 Favored 'General case' 0 C--N 1.332 -0.176 0 O-C-N 120.538 -1.351 . . . . 0.0 110.708 -174.873 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -72.08 -29.97 64.65 Favored 'General case' 0 CA--C 1.533 0.315 0 O-C-N 121.563 -0.711 . . . . 0.0 112.216 176.377 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 4.1 tt -62.04 -46.68 88.11 Favored 'General case' 0 N--CA 1.467 0.395 0 N-CA-C 107.574 -1.269 . . . . 0.0 107.574 170.226 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -63.59 -37.29 94.53 Favored Glycine 0 C--N 1.341 0.84 0 CA-C-O 119.212 -0.771 . . . . 0.0 112.088 178.793 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 65.1 mtm -63.58 -42.9 98.26 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 118.823 1.312 . . . . 0.0 111.69 -179.67 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -70.25 -37.18 74.87 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 120.238 1.381 . . . . 0.0 109.793 176.335 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 59.1 t60 -56.98 -48.6 78.04 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 118.798 0.727 . . . . 0.0 110.892 177.177 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -61.97 -39.27 91.6 Favored 'General case' 0 C--O 1.235 0.315 0 C-N-CA 124.176 0.99 . . . . 0.0 112.041 -178.072 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 24.0 ttmm -58.45 -33.8 70.12 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 123.235 0.614 . . . . 0.0 110.649 172.854 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 19.4 mt -94.63 -21.18 18.97 Favored 'General case' 0 CA--C 1.513 -0.45 0 N-CA-C 116.297 1.962 . . . . 0.0 116.297 -168.956 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 4.3 m -59.01 -33.59 70.9 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 120.951 1.705 . . . . 0.0 111.424 -176.272 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 20.1 p -85.8 -11.97 52.1 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 125.252 1.421 . . . . 0.0 112.152 179.758 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 31.7 mmmt -83.14 -6.32 59.44 Favored 'General case' 0 C--N 1.344 0.352 0 C-N-CA 124.907 1.283 . . . . 0.0 111.386 173.785 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 71.44 32.42 64.9 Favored Glycine 0 C--N 1.337 0.597 0 CA-C-N 118.779 0.718 . . . . 0.0 112.103 170.499 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 4.2 m -75.37 172.3 1.13 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.532 0 CA-C-N 118.027 0.913 . . . . 0.0 109.316 173.563 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -113.15 122.11 46.54 Favored 'General case' 0 N--CA 1.466 0.327 0 N-CA-C 106.579 -1.637 . . . . 0.0 106.579 173.265 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 81.3 m-85 -88.86 145.89 25.29 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 119.422 1.01 . . . . 0.0 109.672 -176.343 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 29.5 m -132.73 160.69 42.44 Favored 'Isoleucine or valine' 0 C--O 1.236 0.355 0 C-N-CA 124.583 1.153 . . . . 0.0 109.153 171.338 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 98.7 -83.29 0.63 Allowed Glycine 0 N--CA 1.448 -0.559 0 C-N-CA 124.906 1.241 . . . . 0.0 111.106 174.196 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 16.7 m-30 55.69 -171.15 0.07 Allowed 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 124.503 1.121 . . . . 0.0 110.179 -169.152 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -154.41 144.05 15.31 Favored Pre-proline 0 N--CA 1.468 0.451 0 O-C-N 120.651 -1.281 . . . . 0.0 108.712 169.902 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -68.5 124.99 12.21 Favored 'Trans proline' 0 CA--C 1.534 0.517 0 C-N-CA 122.34 2.027 . . . . 0.0 111.321 179.612 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 5.9 p -76.78 -25.16 53.07 Favored 'General case' 0 N--CA 1.469 0.48 0 O-C-N 121.794 -0.566 . . . . 0.0 111.804 174.314 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -62.91 127.31 30.64 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 124.056 0.942 . . . . 0.0 109.467 -170.869 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 77.01 1.54 74.0 Favored Glycine 0 CA--C 1.534 1.239 0 CA-C-O 118.76 -1.022 . . . . 0.0 114.072 178.455 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 14.5 t80 -89.46 174.43 7.8 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 119.035 1.417 . . . . 0.0 110.064 173.162 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 48.6 mm-40 -80.86 -99.83 0.03 OUTLIER 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 124.303 1.041 . . . . 0.0 109.697 178.372 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 3.1 p90 46.84 176.51 0.0 OUTLIER 'General case' 0 CA--C 1.548 0.897 0 C-N-CA 129.849 3.26 . . . . 0.0 115.789 -178.027 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 11.3 t -156.97 -31.79 0.08 Allowed 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 123.844 0.858 . . . . 0.0 110.737 168.583 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 11.4 m -54.47 132.45 63.08 Favored Pre-proline 0 CA--C 1.543 0.678 0 C-N-CA 125.234 1.413 . . . . 0.0 112.571 -173.702 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -81.62 -32.08 0.96 Allowed 'Trans proline' 0 CA--C 1.537 0.65 0 C-N-CA 122.773 2.315 . . . . 0.0 113.153 178.875 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 24.2 ttmt -56.6 -40.5 85.4 Favored Pre-proline 0 CA--C 1.542 0.648 0 CA-C-O 117.578 -1.201 . . . . 0.0 113.769 -176.178 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -80.49 5.67 5.94 Favored 'Trans proline' 0 C--N 1.351 0.663 0 C-N-CA 121.944 1.763 . . . . 0.0 114.84 179.002 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 20.3 m -124.77 152.08 30.71 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.379 0 CA-C-N 122.152 2.251 . . . . 0.0 111.486 -178.4 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 133' ' ' ILE . . . . . 0.894 HG23 HG12 ' A' ' 140' ' ' VAL . 15.0 pt -96.53 163.69 2.34 Favored 'Isoleucine or valine' 0 C--O 1.236 0.355 0 C-N-CA 124.765 1.226 . . . . 0.0 109.556 169.246 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . 53.69 43.0 31.7 Favored 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 124.62 1.168 . . . . 0.0 112.19 167.61 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 31.5 t70 63.93 -32.32 0.12 Allowed 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 129.09 2.956 . . . . 0.0 114.616 -171.313 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 177.1 28.51 0.04 OUTLIER Glycine 0 CA--C 1.527 0.809 0 CA-C-O 117.867 -1.518 . . . . 0.0 114.616 177.499 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 74.2 mm-40 -76.2 -41.42 49.56 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 120.351 2.075 . . . . 0.0 111.248 -177.909 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -143.74 153.05 42.03 Favored 'General case' 0 CA--C 1.519 -0.238 0 C-N-CA 123.489 0.716 . . . . 0.0 109.888 176.727 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 74.7 m-85 -72.5 141.35 48.53 Favored 'General case' 0 N--CA 1.447 -0.595 0 N-CA-C 104.994 -2.224 . . . . 0.0 104.994 163.642 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 140' ' ' VAL . . . . . 0.894 HG12 HG23 ' A' ' 133' ' ' ILE . 4.3 m -76.07 4.86 1.01 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.904 0 C-N-CA 122.968 0.507 . . . . 0.0 111.427 -176.608 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -174.06 171.53 44.6 Favored Glycine 0 CA--C 1.528 0.869 0 C-N-CA 125.847 1.689 . . . . 0.0 109.771 -179.139 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -64.2 136.37 57.15 Favored 'General case' 0 N--CA 1.466 0.375 0 C-N-CA 123.642 0.777 . . . . 0.0 111.361 -177.221 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -101.12 113.08 25.78 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 126.161 1.784 . . . . 0.0 109.222 -179.824 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 96.1 mt -108.16 151.64 25.64 Favored 'General case' 0 N--CA 1.464 0.255 0 C-N-CA 124.607 1.163 . . . . 0.0 110.218 175.583 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -154.45 156.35 36.59 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 126.198 1.799 . . . . 0.0 106.87 167.903 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -132.7 -2.1 3.37 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 126.104 1.762 . . . . 0.0 110.637 174.293 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 7.0 m -80.43 -52.12 8.03 Favored 'General case' 0 C--O 1.234 0.274 0 C-N-CA 125.829 1.652 . . . . 0.0 110.187 -171.814 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 6.6 m-80 -80.48 -33.36 36.66 Favored 'General case' 0 C--N 1.331 -0.207 0 C-N-CA 124.549 1.14 . . . . 0.0 110.181 -169.101 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 12.5 pt20 -159.62 152.38 21.57 Favored 'General case' 0 C--O 1.236 0.352 0 C-N-CA 127.073 2.149 . . . . 0.0 106.687 -175.121 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 85.8 t80 -124.26 -27.49 3.8 Favored 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 123.762 0.825 . . . . 0.0 111.594 -176.701 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -68.19 -33.15 73.9 Favored 'General case' 0 N--CA 1.465 0.317 0 O-C-N 121.545 -0.722 . . . . 0.0 111.516 -174.583 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -84.66 -13.52 51.25 Favored 'General case' 0 C--N 1.344 0.334 0 CA-C-O 118.206 -0.902 . . . . 0.0 111.956 -179.943 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 8.1 m -60.57 -34.94 74.91 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 120.824 1.647 . . . . 0.0 110.481 -176.731 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -65.19 -43.73 90.7 Favored 'General case' 0 N--CA 1.463 0.191 0 C-N-CA 123.507 0.723 . . . . 0.0 111.376 173.317 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 19.9 tt0 -64.39 -43.56 94.08 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 124.702 1.201 . . . . 0.0 110.894 -179.094 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 54.0 mtp85 -62.41 -36.83 83.58 Favored 'General case' 0 N--CA 1.462 0.141 0 C-N-CA 124.119 0.967 . . . . 0.0 109.989 -179.858 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 55.7 mt -70.01 -57.38 8.32 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.461 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 172.495 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 158' ' ' GLN . . . . . 0.611 ' HA ' HD13 ' A' ' 24' ' ' ILE . 68.2 tp60 -46.56 -65.77 0.51 Allowed 'General case' 0 C--O 1.235 0.314 0 C-N-CA 126.203 1.801 . . . . 0.0 112.476 -172.974 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 16.9 m -68.23 -29.09 67.84 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 123.091 0.244 . . . . 0.0 111.014 -169.483 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 160' ' ' TRP . . . . . . . . . . . . . 62.2 t90 -72.03 -44.6 63.14 Favored 'General case' 0 CA--C 1.515 -0.391 0 O-C-N 121.808 -0.558 . . . . 0.0 111.156 177.264 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 95.8 m -61.39 -40.52 94.68 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 122.717 0.407 . . . . 0.0 109.951 177.498 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -62.74 -42.58 99.74 Favored 'General case' 0 C--O 1.227 -0.098 0 CA-C-O 121.078 0.466 . . . . 0.0 110.254 174.028 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 12.1 tt0 -62.66 -51.57 66.74 Favored 'General case' 0 N--CA 1.449 -0.513 0 O-C-N 121.614 -0.679 . . . . 0.0 110.154 -178.445 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 45.5 pt -63.04 -38.13 81.22 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.367 0 CA-C-O 117.976 -1.011 . . . . 0.0 109.481 -174.962 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -65.02 -33.59 76.4 Favored 'General case' 0 C--O 1.225 -0.235 0 CA-C-N 119.416 1.007 . . . . 0.0 110.351 179.788 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 35.0 m-80 -69.23 -57.47 5.31 Favored 'General case' 0 C--O 1.223 -0.32 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 174.592 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 13.0 tt0 -63.45 -36.47 83.86 Favored 'General case' 0 N--CA 1.445 -0.68 0 C-N-CA 125.514 1.526 . . . . 0.0 111.131 -169.251 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 168' ' ' MET . . . . . . . . . . . . . 20.0 ptp -70.27 -32.75 70.7 Favored 'General case' 0 C--O 1.226 -0.16 0 O-C-N 121.63 -0.669 . . . . 0.0 111.761 174.08 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -75.28 -34.72 61.35 Favored 'General case' 0 N--CA 1.448 -0.568 0 CA-C-O 119.082 -0.485 . . . . 0.0 112.174 -178.776 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 6.2 mt-10 -63.57 -35.74 81.5 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-O 121.794 0.807 . . . . 0.0 109.317 177.613 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 74.0 t60 -67.15 -22.5 65.77 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 125.127 1.371 . . . . 0.0 111.751 -177.612 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 45.4 m-85 -84.78 -9.9 57.73 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 124.356 1.062 . . . . 0.0 113.441 173.587 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.254 1.311 0 CA-C-N 119.69 1.132 . . . . 0.0 110.122 -178.766 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.498 1.961 0 N-CA-C 111.316 0.117 . . . . 0.0 111.316 . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 9.0 t30 -114.31 152.04 32.02 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 123.736 0.815 . . . . 0.0 110.136 -179.082 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 16.0 mtt -116.21 129.55 56.35 Favored 'General case' 0 N--CA 1.461 0.103 0 C-N-CA 123.948 0.899 . . . . 0.0 110.731 -179.265 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -85.35 154.62 28.85 Favored Glycine 0 CA--C 1.524 0.644 0 N-CA-C 107.484 -2.246 . . . . 0.0 107.484 167.192 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 1.4 tt -142.05 96.51 2.97 Favored 'General case' 0 N--CA 1.466 0.343 0 N-CA-C 106.338 -1.727 . . . . 0.0 106.338 -175.447 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -106.06 144.67 32.44 Favored 'General case' 0 CA--C 1.519 -0.238 0 CA-C-O 121.481 0.658 . . . . 0.0 111.9 -170.761 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 23.6 p90 -162.82 165.69 25.05 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 125.879 1.671 . . . . 0.0 108.015 -177.53 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -159.15 125.86 1.57 Allowed Glycine 0 C--N 1.33 0.232 0 N-CA-C 104.952 -3.259 . . . . 0.0 104.952 169.882 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 8.5 p -148.97 158.36 44.12 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 118.617 1.209 . . . . 0.0 110.412 -168.996 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 13.5 m -58.63 129.32 41.54 Favored 'General case' 0 CA--C 1.534 0.359 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 172.867 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER 53.65 26.81 6.14 Favored 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 124.327 1.051 . . . . 0.0 112.08 -177.492 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 77.3 m 48.78 35.21 6.08 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 125.529 1.531 . . . . 0.0 112.853 -174.296 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 47.9 t80 -60.6 -32.03 71.17 Favored 'General case' 0 CA--C 1.539 0.521 0 O-C-N 121.318 -0.864 . . . . 0.0 112.5 -172.052 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 25.2 m -67.01 -11.38 56.86 Favored 'General case' 0 CA--C 1.54 0.571 0 O-C-N 121.14 -0.975 . . . . 0.0 111.798 178.985 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 5.5 tt0 -62.97 -25.42 68.35 Favored 'General case' 0 CA--C 1.536 0.408 0 O-C-N 120.867 -1.146 . . . . 0.0 111.446 176.665 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 5.2 mpp? -71.56 -40.7 69.79 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 119.7 1.136 . . . . 0.0 110.802 175.203 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -60.9 -45.28 95.22 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 119.259 0.936 . . . . 0.0 108.78 170.547 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -63.45 -47.68 80.87 Favored 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 123.17 0.588 . . . . 0.0 111.907 -174.161 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.1 pp20? -67.38 -35.73 79.91 Favored 'General case' 0 CA--C 1.535 0.383 0 O-C-N 121.596 -0.69 . . . . 0.0 109.274 -179.671 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 29.3 mtpp -67.37 -40.58 85.77 Favored 'General case' 0 C--O 1.225 -0.232 0 O-C-N 121.126 -0.984 . . . . 0.0 110.916 175.968 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 37.8 mt -56.24 -56.18 14.68 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.198 0 CA-C-N 119.995 1.27 . . . . 0.0 109.171 176.196 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.5 -35.89 82.4 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 118.529 0.604 . . . . 0.0 110.946 -175.494 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -63.42 -40.14 96.39 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 117.94 0.336 . . . . 0.0 110.888 177.94 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.4 HD13 ' HA ' ' A' ' 158' ' ' GLN . 67.6 mt -77.14 -53.58 14.49 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 C-N-CA 124.23 1.012 . . . . 0.0 110.353 -174.17 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 70.7 mt -60.3 -49.53 83.85 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.317 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 177.917 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 144.25 119.14 1.31 Allowed Glycine 0 CA--C 1.528 0.887 0 N-CA-C 110.133 -1.187 . . . . 0.0 110.133 179.209 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -68.71 -14.52 39.42 Favored 'Trans proline' 0 CA--C 1.536 0.588 0 C-N-CA 122.955 2.436 . . . . 0.0 113.022 -173.278 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -73.56 -21.54 60.33 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 118.579 0.627 . . . . 0.0 112.051 179.396 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -129.57 8.12 5.36 Favored 'General case' 0 CA--C 1.536 0.405 0 N-CA-C 113.862 1.06 . . . . 0.0 113.862 -169.162 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 33.7 t -128.13 147.09 32.77 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.387 0 C-N-CA 124.449 1.099 . . . . 0.0 108.066 172.308 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 26.9 m -131.53 131.74 43.62 Favored 'General case' 0 C--N 1.332 -0.164 0 C-N-CA 125.643 1.577 . . . . 0.0 108.419 -174.716 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 18.4 mt -75.93 134.01 40.35 Favored 'General case' 0 C--O 1.232 0.154 0 N-CA-C 108.401 -0.963 . . . . 0.0 108.401 175.018 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 25.4 t-80 -130.67 55.75 1.81 Allowed 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 124.806 1.242 . . . . 0.0 108.528 -176.741 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 54.2 t-20 -60.11 125.09 22.33 Favored 'General case' 0 C--O 1.233 0.193 0 N-CA-C 107.974 -1.121 . . . . 0.0 107.974 176.817 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 80.9 mt -69.94 -20.58 63.33 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 118.429 0.559 . . . . 0.0 112.282 -176.93 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 58.2 tptt -63.61 -25.91 68.44 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 118.467 0.576 . . . . 0.0 110.712 168.931 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -106.01 -37.9 6.49 Favored 'General case' 0 C--O 1.235 0.327 0 N-CA-C 113.452 0.908 . . . . 0.0 113.452 -169.426 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 2.6 t0 -134.64 155.82 49.83 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-N 118.834 0.743 . . . . 0.0 112.627 -175.578 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 19.5 m -76.32 156.67 83.49 Favored Pre-proline 0 CA--C 1.539 0.555 0 C-N-CA 125.551 1.54 . . . . 0.0 111.415 -172.097 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -75.59 -26.25 10.19 Favored 'Trans proline' 0 C--N 1.348 0.506 0 C-N-CA 122.603 2.202 . . . . 0.0 113.882 -171.173 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 21.4 mmmt -70.84 -11.75 61.14 Favored 'General case' 0 N--CA 1.474 0.731 0 O-C-N 120.271 -1.518 . . . . 0.0 111.654 -176.232 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -58.02 -30.96 66.53 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 125.879 1.672 . . . . 0.0 110.089 168.329 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 46.1 mtt -57.77 -25.12 60.05 Favored 'General case' 0 N--CA 1.463 0.206 0 C-N-CA 123.341 0.656 . . . . 0.0 111.838 178.616 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 87.1 mt-10 -66.77 -33.92 76.69 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 118.463 0.574 . . . . 0.0 110.02 -177.693 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 13.8 mt-30 -67.49 -45.17 76.64 Favored 'General case' 0 N--CA 1.465 0.307 0 C-N-CA 123.202 0.601 . . . . 0.0 112.412 -169.874 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 26.1 m-85 -72.05 137.55 47.23 Favored 'General case' 0 N--CA 1.456 -0.132 0 CA-C-N 115.317 -0.856 . . . . 0.0 110.042 -166.574 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -74.26 -35.08 63.78 Favored 'General case' 0 N--CA 1.466 0.355 0 O-C-N 121.872 -0.518 . . . . 0.0 110.788 -177.265 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 20.5 t -108.56 145.69 15.21 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.436 0 N-CA-C 106.991 -1.485 . . . . 0.0 106.991 169.386 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 36.4 tp -133.95 112.78 11.53 Favored 'General case' 0 N--CA 1.447 -0.606 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 175.379 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.426 ' HA ' ' HB3' ' A' ' 83' ' ' ALA . 22.8 mt -89.92 134.47 28.89 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.665 0 N-CA-C 107.15 -1.426 . . . . 0.0 107.15 176.248 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 2.7 mp -115.54 130.63 56.94 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 125.613 1.565 . . . . 0.0 107.473 -178.365 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -135.65 136.28 8.38 Favored Glycine 0 C--N 1.333 0.368 0 N-CA-C 109.413 -1.475 . . . . 0.0 109.413 173.986 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 3.1 tt -152.98 137.34 10.71 Favored Pre-proline 0 CA--C 1.536 0.424 0 CA-C-N 118.477 1.138 . . . . 0.0 110.451 171.534 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -82.04 138.62 10.33 Favored 'Trans proline' 0 N--CA 1.453 -0.871 0 C-N-CA 122.476 2.118 . . . . 0.0 109.886 167.561 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 30.2 m -94.63 144.29 25.72 Favored 'General case' 0 CA--C 1.543 0.698 0 N-CA-C 106.084 -1.821 . . . . 0.0 106.084 167.775 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 37.1 m0 -78.62 169.77 17.71 Favored 'General case' 0 CA--C 1.535 0.391 0 O-C-N 121.701 -0.624 . . . . 0.0 110.604 -174.9 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -63.11 -33.17 74.87 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 123.414 0.686 . . . . 0.0 111.196 171.402 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 43.6 t80 -146.12 136.46 23.87 Favored 'General case' 0 C--O 1.235 0.318 0 C-N-CA 125.336 1.454 . . . . 0.0 107.357 173.62 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 71.4 -167.57 51.84 Favored Glycine 0 CA--C 1.535 1.32 0 N-CA-C 110.659 -0.976 . . . . 0.0 110.659 -169.733 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -160.29 161.92 33.45 Favored 'General case' 0 CA--C 1.54 0.562 0 O-C-N 121.822 -0.811 . . . . 0.0 112.234 -179.154 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 55.7 mt 66.17 151.29 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.549 0.91 0 C-N-CA 128.196 2.598 . . . . 0.0 112.821 170.689 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 1.2 pm0 -125.77 156.85 38.8 Favored 'General case' 0 C--O 1.232 0.162 0 C-N-CA 126.172 1.789 . . . . 0.0 108.682 -176.437 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -54.92 -43.26 73.16 Favored 'General case' 0 C--O 1.224 -0.261 0 C-N-CA 124.524 1.13 . . . . 0.0 112.355 -168.746 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -65.23 -20.33 66.38 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-N 119.156 0.889 . . . . 0.0 111.835 -174.082 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' TRP . . . . . 0.407 ' CH2' HD23 ' A' ' 104' ' ' LEU . 12.6 t90 -96.24 -49.04 5.38 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 124.448 1.099 . . . . 0.0 109.75 175.344 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -62.98 -35.28 79.65 Favored 'General case' 0 CA--C 1.536 0.426 0 O-C-N 121.041 -1.037 . . . . 0.0 110.413 -175.434 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -61.89 -27.41 68.78 Favored 'General case' 0 CA--C 1.53 0.179 0 C-N-CA 123.087 0.555 . . . . 0.0 111.059 -174.637 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 30.9 m -107.35 -17.08 8.1 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.372 0 CA-C-O 117.199 -1.382 . . . . 0.0 112.156 177.014 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 35.8 t90 -50.66 -34.75 27.65 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 120.447 1.476 . . . . 0.0 110.931 177.823 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -62.56 -31.14 71.89 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 125.315 1.446 . . . . 0.0 113.319 174.901 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 30.4 mt-30 -88.8 -20.89 24.12 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 126.555 1.942 . . . . 0.0 111.273 178.73 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 50.8 mt -65.25 -20.62 66.51 Favored 'General case' 0 CA--C 1.533 0.301 0 O-C-N 121.41 -0.806 . . . . 0.0 111.672 -173.603 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -79.0 -23.4 44.43 Favored 'General case' 0 CA--C 1.542 0.653 0 CA-C-N 118.399 0.545 . . . . 0.0 111.793 175.25 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -71.99 -30.03 64.84 Favored 'General case' 0 N--CA 1.468 0.47 0 O-C-N 120.723 -1.236 . . . . 0.0 111.958 178.177 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 80.1 mt -52.89 140.92 23.14 Favored 'General case' 0 C--N 1.338 0.102 0 C-N-CA 124.887 1.275 . . . . 0.0 112.994 -168.417 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 29.2 t-20 -76.14 108.95 9.41 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 169.688 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 70.2 mt -131.6 -0.07 3.96 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 114.317 1.228 . . . . 0.0 114.317 -172.348 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 28.8 mt-10 -57.2 129.8 43.38 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 119.68 1.127 . . . . 0.0 111.25 -168.544 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 73.9 -2.0 44.07 Favored Glycine 0 CA--C 1.533 1.204 0 C-N-CA 125.531 1.539 . . . . 0.0 115.023 178.32 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.04 150.3 40.71 Favored 'General case' 0 C--N 1.346 0.414 0 CA-C-N 120.663 2.231 . . . . 0.0 109.683 -176.649 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 4.3 mt -82.25 137.51 20.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 N-CA-C 106.489 -1.671 . . . . 0.0 106.489 179.068 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 67.0 t -130.92 129.49 63.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 C-N-CA 123.629 0.771 . . . . 0.0 109.515 -176.879 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.426 ' HB3' ' HA ' ' A' ' 50' ' ' ILE . . . -100.66 151.59 21.46 Favored 'General case' 0 N--CA 1.463 0.213 0 N-CA-C 107.735 -1.209 . . . . 0.0 107.735 168.715 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 4.5 mt -133.02 134.61 44.65 Favored 'General case' 0 CA--C 1.514 -0.409 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 176.394 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 37.4 p90 -149.91 168.14 24.64 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 107.692 -1.225 . . . . 0.0 107.692 168.655 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -168.19 171.22 42.42 Favored Glycine 0 N--CA 1.446 -0.656 0 N-CA-C 110.449 -1.061 . . . . 0.0 110.449 176.119 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.467 HD13 ' N ' ' A' ' 88' ' ' GLY . 1.9 tm? -126.94 148.34 50.06 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 126.171 1.789 . . . . 0.0 106.781 -175.805 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 88' ' ' GLY . . . . . 0.467 ' N ' HD13 ' A' ' 87' ' ' LEU . . . -166.14 -160.68 13.75 Favored Glycine 0 CA--C 1.521 0.435 0 N-CA-C 109.174 -1.57 . . . . 0.0 109.174 173.25 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 49.5 t0 -140.5 109.98 6.3 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 108.041 -1.096 . . . . 0.0 108.041 169.515 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -68.81 -21.49 64.31 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 123.223 0.609 . . . . 0.0 111.828 -176.948 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 49.1 mt -84.15 -22.96 30.83 Favored 'General case' 0 N--CA 1.466 0.344 0 C-N-CA 124.739 1.216 . . . . 0.0 109.98 174.503 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -66.75 -45.14 86.81 Favored Glycine 0 CA--C 1.529 0.956 0 C-N-CA 124.243 0.925 . . . . 0.0 111.584 -174.902 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 9.4 t80 -146.7 -45.22 0.18 Allowed 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 117.114 0.457 . . . . 0.0 111.825 177.111 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 78.76 -31.58 1.95 Allowed Glycine 0 N--CA 1.47 0.924 0 C-N-CA 124.43 1.014 . . . . 0.0 113.892 172.161 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -72.51 -16.74 61.78 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 124.277 1.031 . . . . 0.0 111.359 171.621 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 96' ' ' TRP . . . . . . . . . . . . . 31.9 m0 -129.57 30.72 4.88 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 125.399 1.48 . . . . 0.0 111.092 179.262 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 15.9 t80 -61.88 134.44 56.69 Favored 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 107.445 -1.317 . . . . 0.0 107.445 173.999 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 97.0 mt 53.4 25.9 4.98 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 124.306 1.042 . . . . 0.0 113.234 172.705 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -65.05 -37.75 88.6 Favored 'General case' 0 N--CA 1.465 0.3 0 O-C-N 120.659 -1.275 . . . . 0.0 110.786 -170.766 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -65.45 -28.79 69.47 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 123.783 0.833 . . . . 0.0 112.304 173.971 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 5.3 tt -64.77 -49.28 71.35 Favored 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 108.039 -1.097 . . . . 0.0 108.039 174.01 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -62.33 -34.08 88.14 Favored Glycine 0 CA--C 1.529 0.948 0 N-CA-C 111.213 -0.755 . . . . 0.0 111.213 179.277 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 7.2 tpp -53.86 -50.97 65.08 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 124.683 1.193 . . . . 0.0 111.566 178.729 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.407 HD23 ' CH2' ' A' ' 65' ' ' TRP . 0.2 OUTLIER -76.52 -36.17 57.89 Favored 'General case' 0 CA--C 1.534 0.355 0 N-CA-C 109.433 -0.581 . . . . 0.0 109.433 -174.966 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 51.0 t-80 -56.99 -44.81 83.11 Favored 'General case' 0 N--CA 1.467 0.381 0 O-C-N 121.463 -0.773 . . . . 0.0 111.296 174.032 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -63.86 -43.68 95.38 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 123.609 0.764 . . . . 0.0 111.384 -178.633 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 25.1 ttmm -56.14 -43.12 77.92 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 123.476 0.71 . . . . 0.0 110.289 173.125 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 21.3 mt -85.75 -19.29 31.01 Favored 'General case' 0 CA--C 1.511 -0.529 0 N-CA-C 115.141 1.534 . . . . 0.0 115.141 -169.755 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 67.8 m -59.97 -29.8 68.67 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 119.659 1.118 . . . . 0.0 111.488 -175.375 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 27.5 p -93.66 -4.23 51.0 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 125.348 1.459 . . . . 0.0 112.316 179.62 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 32.3 mmmt -87.42 -5.94 58.64 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 124.762 1.225 . . . . 0.0 111.685 175.081 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 73.05 30.94 62.4 Favored Glycine 0 CA--C 1.523 0.586 0 CA-C-N 118.368 0.531 . . . . 0.0 112.116 172.712 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 5.3 m -76.15 174.48 0.84 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 CA-C-N 118.211 1.005 . . . . 0.0 109.151 171.752 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -114.29 127.36 55.83 Favored 'General case' 0 CA--C 1.515 -0.372 0 N-CA-C 106.786 -1.561 . . . . 0.0 106.786 170.385 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 66.9 m-85 -92.31 144.69 25.13 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 119.652 1.115 . . . . 0.0 109.865 -178.155 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 35.4 m -131.83 157.34 43.12 Favored 'Isoleucine or valine' 0 C--O 1.234 0.267 0 C-N-CA 125.493 1.517 . . . . 0.0 107.527 169.396 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 86.15 29.61 24.9 Favored Glycine 0 CA--C 1.521 0.41 0 CA-C-O 118.334 -1.259 . . . . 0.0 114.741 169.833 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 11.7 m-30 -62.96 157.91 20.59 Favored 'General case' 0 CA--C 1.541 0.626 0 CA-C-N 119.07 1.435 . . . . 0.0 108.918 168.978 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 36.3 t-105 -135.72 143.55 45.17 Favored Pre-proline 0 N--CA 1.467 0.39 0 CA-C-O 118.008 -0.996 . . . . 0.0 111.95 -168.833 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -59.02 129.05 30.07 Favored 'Trans proline' 0 N--CA 1.458 -0.58 0 C-N-CA 122.986 2.457 . . . . 0.0 111.044 176.124 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 9.0 p -77.74 -20.42 53.48 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 123.297 0.639 . . . . 0.0 111.705 169.884 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -61.53 131.09 48.99 Favored 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 -178.229 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 91.83 -12.45 69.42 Favored Glycine 0 CA--C 1.533 1.195 0 CA-C-O 118.546 -1.141 . . . . 0.0 113.543 -177.586 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 55.9 m-85 -92.02 148.46 22.18 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-N 119.246 1.523 . . . . 0.0 108.596 169.609 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -125.38 104.81 8.66 Favored 'General case' 0 C--N 1.332 -0.163 0 N-CA-C 107.436 -1.32 . . . . 0.0 107.436 175.207 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 21.4 p90 -153.21 172.52 16.84 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 127.674 2.389 . . . . 0.0 106.947 -172.787 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 2.6 t -143.9 6.65 1.39 Allowed 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 112.495 0.554 . . . . 0.0 112.495 176.34 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 1.9 p -65.0 125.24 88.75 Favored Pre-proline 0 CA--C 1.541 0.623 0 O-C-N 121.108 -0.995 . . . . 0.0 109.495 172.778 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -81.84 -26.6 2.95 Favored 'Trans proline' 0 CA--C 1.539 0.746 0 C-N-CA 122.421 2.081 . . . . 0.0 112.305 175.677 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 28.2 ttmt -57.55 -42.46 95.84 Favored Pre-proline 0 CA--C 1.542 0.654 0 CA-C-O 117.531 -1.223 . . . . 0.0 114.073 -173.283 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -82.59 4.9 6.74 Favored 'Trans proline' 0 C--N 1.351 0.674 0 C-N-CA 122.017 1.812 . . . . 0.0 113.882 -179.074 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 16.7 m -128.06 166.09 25.91 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.186 0 CA-C-N 121.033 1.742 . . . . 0.0 112.24 -172.805 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 16.1 pt -131.48 168.57 23.6 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.474 0 C-N-CA 127.674 2.39 . . . . 0.0 108.833 179.023 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . 55.88 39.03 30.67 Favored 'General case' 0 CA--C 1.529 0.163 0 C-N-CA 125.199 1.4 . . . . 0.0 113.328 169.746 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 27.6 t70 59.22 43.29 17.22 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 126.412 1.885 . . . . 0.0 111.715 -177.528 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 89.8 18.86 50.01 Favored Glycine 0 CA--C 1.528 0.905 0 CA-C-N 115.574 -0.739 . . . . 0.0 113.461 171.204 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -85.9 -21.78 27.81 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 125.016 1.326 . . . . 0.0 111.836 -177.662 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 9.8 tp -150.13 144.97 26.04 Favored 'General case' 0 C--N 1.341 0.222 0 CA-C-N 119.322 0.964 . . . . 0.0 110.785 176.948 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 55.8 m-85 -82.33 144.26 30.7 Favored 'General case' 0 CA--C 1.517 -0.293 0 N-CA-C 107.864 -1.162 . . . . 0.0 107.864 169.922 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 17.0 m -76.77 12.03 0.39 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.57 0 C-N-CA 124.43 1.092 . . . . 0.0 112.238 178.827 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -179.64 171.76 43.45 Favored Glycine 0 CA--C 1.526 0.769 0 N-CA-C 109.761 -1.335 . . . . 0.0 109.761 -178.321 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.413 ' HB2' ' CD1' ' A' ' 160' ' ' TRP . 8.0 tp -64.11 134.24 54.51 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 117.617 0.709 . . . . 0.0 110.891 177.579 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -93.49 127.57 39.2 Favored 'General case' 0 N--CA 1.441 -0.9 0 C-N-CA 125.393 1.477 . . . . 0.0 109.627 174.441 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 84.5 mt -120.61 151.5 39.36 Favored 'General case' 0 C--O 1.234 0.239 0 N-CA-C 105.83 -1.915 . . . . 0.0 105.83 167.718 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -137.01 133.57 35.68 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-N 118.445 0.566 . . . . 0.0 110.054 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 30.1 tp10 -80.34 -22.58 41.3 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 125.112 1.365 . . . . 0.0 112.688 -171.96 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 93.3 m -115.38 -41.97 3.21 Favored 'General case' 0 C--O 1.234 0.261 0 C-N-CA 124.561 1.144 . . . . 0.0 110.988 -169.076 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 4.3 m-80 -79.84 -21.9 43.62 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 124.423 1.089 . . . . 0.0 110.953 -170.768 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 64.9 mt-30 -128.8 155.57 44.96 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 125.562 1.545 . . . . 0.0 109.495 -178.198 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 89.9 t80 -147.18 -56.58 0.25 Allowed 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 124.552 1.141 . . . . 0.0 108.167 169.593 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -67.79 -44.97 76.12 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-O 121.386 0.612 . . . . 0.0 110.577 175.194 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 6.4 tp -74.58 -15.98 60.82 Favored 'General case' 0 C--N 1.34 0.194 0 CA-C-O 118.638 -0.696 . . . . 0.0 112.338 -170.813 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 5.2 m -61.09 -38.38 86.08 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 119.015 0.825 . . . . 0.0 110.296 179.798 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -62.17 -45.87 91.48 Favored 'General case' 0 N--CA 1.463 0.178 0 C-N-CA 123.285 0.634 . . . . 0.0 110.415 175.157 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 -63.04 -43.04 99.78 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 123.593 0.757 . . . . 0.0 110.416 179.549 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 2.3 mpt_? -59.14 -45.83 89.92 Favored 'General case' 0 C--N 1.335 -0.05 0 C-N-CA 123.976 0.91 . . . . 0.0 110.368 177.598 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 34.9 mt -64.67 -53.09 46.48 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 176.847 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 158' ' ' GLN . . . . . 0.4 ' HA ' HD13 ' A' ' 24' ' ' ILE . 0.9 OUTLIER -54.28 -66.34 0.41 Allowed 'General case' 0 CA--C 1.518 -0.287 0 C-N-CA 125.437 1.495 . . . . 0.0 112.246 -169.916 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 16.3 m -60.94 -33.7 73.59 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.747 -0.66 . . . . 0.0 111.594 -174.825 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 160' ' ' TRP . . . . . 0.413 ' CD1' ' HB2' ' A' ' 142' ' ' LEU . 67.5 t90 -65.14 -44.99 86.86 Favored 'General case' 0 C--O 1.223 -0.293 0 O-C-N 121.956 -0.465 . . . . 0.0 110.552 173.9 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 65.8 m -60.33 -41.24 93.15 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 118.298 0.499 . . . . 0.0 110.763 179.672 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -62.57 -45.68 91.79 Favored 'General case' 0 C--O 1.228 -0.073 0 CA-C-N 118.818 0.736 . . . . 0.0 110.063 173.201 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 14.4 tt0 -61.53 -48.56 80.49 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-O 117.923 -1.037 . . . . 0.0 110.363 -175.522 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 40.7 pt -65.57 -33.8 66.08 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.422 0 CA-C-O 117.918 -1.039 . . . . 0.0 110.282 -178.299 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -73.05 -31.02 64.14 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 119.58 1.082 . . . . 0.0 108.765 -175.033 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -69.08 -55.87 9.42 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 125.028 1.331 . . . . 0.0 109.194 170.945 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 19.5 tt0 -67.76 -30.68 70.2 Favored 'General case' 0 N--CA 1.442 -0.837 0 C-N-CA 125.546 1.538 . . . . 0.0 110.504 -168.545 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 168' ' ' MET . . . . . . . . . . . . . 20.2 ptp -75.8 -29.13 58.62 Favored 'General case' 0 CA--C 1.523 -0.058 0 O-C-N 122.023 -0.423 . . . . 0.0 111.743 174.708 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -78.3 -33.37 49.41 Favored 'General case' 0 N--CA 1.444 -0.73 0 C-N-CA 123.228 0.611 . . . . 0.0 111.639 179.729 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -57.05 -40.7 77.28 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-O 122.324 1.059 . . . . 0.0 109.149 175.822 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 81.0 t60 -71.1 -16.56 62.58 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 126.155 1.782 . . . . 0.0 111.733 -174.068 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 1.4 m-85 -77.47 -19.38 56.04 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 123.883 0.873 . . . . 0.0 112.163 171.249 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.254 1.323 0 C-N-CA 126.336 1.854 . . . . 0.0 110.974 -177.748 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 34.6 ttp . . . . . 0 N--CA 1.494 1.753 0 N-CA-C 110.368 -0.234 . . . . 0.0 110.368 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 29.1 p-10 -144.51 166.66 24.51 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 126.612 1.965 . . . . 0.0 108.367 177.955 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 1.5 mpt? -129.04 124.4 34.78 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 118.567 0.621 . . . . 0.0 111.1 -179.797 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -90.42 142.1 16.19 Favored Glycine 0 CA--C 1.526 0.724 0 N-CA-C 107.139 -2.384 . . . . 0.0 107.139 167.815 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 1.2 tt -132.2 97.55 4.16 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 119.911 1.855 . . . . 0.0 106.659 -169.866 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -105.03 144.48 31.78 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-O 121.64 0.733 . . . . 0.0 112.138 -170.408 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 35.4 p90 -160.14 176.29 11.95 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 126.698 1.999 . . . . 0.0 107.539 179.512 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -84.75 -141.09 5.18 Favored Glycine 0 CA--C 1.526 0.752 0 C-N-CA 124.241 0.924 . . . . 0.0 112.214 -171.394 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 3.5 m -58.42 148.03 29.41 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 124.926 1.29 . . . . 0.0 111.584 -173.975 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 1.8 m -59.39 -22.9 62.08 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 124.559 1.144 . . . . 0.0 112.751 -179.878 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 4.3 p -71.01 -15.62 62.57 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 125.494 1.518 . . . . 0.0 112.612 177.367 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 63.9 m -68.9 136.32 52.41 Favored 'General case' 0 C--N 1.343 0.299 0 CA-C-N 119.244 0.929 . . . . 0.0 108.855 176.861 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 85.3 m-85 -60.32 -19.85 56.94 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 122.746 0.418 . . . . 0.0 111.573 173.152 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 3.8 m -49.07 -28.31 4.03 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 126.779 2.031 . . . . 0.0 112.669 170.065 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 7.7 tt0 -65.74 -33.69 76.45 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-N 120.435 1.47 . . . . 0.0 110.67 178.678 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 4.8 mpp? -70.17 -39.78 75.09 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 118.931 0.787 . . . . 0.0 110.048 176.464 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -59.33 -42.97 92.68 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 118.809 0.731 . . . . 0.0 109.679 170.984 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -62.74 -48.26 79.99 Favored 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 123.761 0.825 . . . . 0.0 111.379 -175.707 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -67.51 -35.78 79.79 Favored 'General case' 0 CA--C 1.535 0.402 0 O-C-N 121.795 -0.565 . . . . 0.0 110.426 178.96 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 28.9 mtpp -67.39 -37.63 83.42 Favored 'General case' 0 N--CA 1.465 0.293 0 O-C-N 121.272 -0.893 . . . . 0.0 111.182 177.568 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 32.9 mt -56.75 -54.58 27.47 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.25 0 N-CA-C 108.404 -0.961 . . . . 0.0 108.404 175.09 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 22.2 ptt180 -63.31 -37.73 88.42 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 118.904 0.774 . . . . 0.0 110.635 -178.11 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -64.57 -37.78 88.72 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 109.865 -0.42 . . . . 0.0 109.865 -174.736 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.431 HD13 ' HA ' ' A' ' 158' ' ' GLN . 75.6 mt -79.79 -54.47 11.09 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.573 0 C-N-CA 124.805 1.242 . . . . 0.0 110.167 -175.081 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 77.7 mt -62.61 -48.3 88.86 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.292 0 C-N-CA 122.719 0.408 . . . . 0.0 110.172 179.908 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 142.01 119.24 1.48 Allowed Glycine 0 CA--C 1.53 1.026 0 C-N-CA 125.207 1.384 . . . . 0.0 110.449 -179.087 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -76.88 -4.43 14.91 Favored 'Trans proline' 0 CA--C 1.538 0.717 0 C-N-CA 122.829 2.353 . . . . 0.0 113.491 -171.141 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -82.35 -22.68 35.42 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 118.918 0.781 . . . . 0.0 111.157 177.15 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 1.2 pt? -118.51 -21.28 8.06 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 124.847 1.259 . . . . 0.0 113.216 -174.117 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 59.0 t -91.45 147.23 5.41 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.504 0 N-CA-C 107.608 -1.256 . . . . 0.0 107.608 168.714 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 16.5 m -132.13 134.11 45.06 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 125.193 1.397 . . . . 0.0 107.833 178.494 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 18.7 mt -79.43 141.13 37.09 Favored 'General case' 0 N--CA 1.466 0.336 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 175.248 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 21.8 t-80 -135.15 54.09 1.95 Allowed 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 124.761 1.224 . . . . 0.0 108.259 -176.766 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 28.4 t-20 -55.21 124.13 15.96 Favored 'General case' 0 C--O 1.235 0.311 0 N-CA-C 107.348 -1.352 . . . . 0.0 107.348 170.935 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 32.3 mt -72.56 -16.94 61.75 Favored 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 113.105 0.78 . . . . 0.0 113.105 -170.509 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 9.8 tppt? -66.88 -31.06 71.41 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-N 119.354 0.979 . . . . 0.0 109.492 168.078 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -92.48 -36.35 13.12 Favored 'General case' 0 C--O 1.235 0.321 0 N-CA-C 113.525 0.935 . . . . 0.0 113.525 -168.985 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 2.3 t0 -140.47 156.96 46.18 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-N 118.949 0.795 . . . . 0.0 112.477 178.13 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 17.8 m -79.97 160.06 69.58 Favored Pre-proline 0 CA--C 1.541 0.625 0 C-N-CA 126.23 1.812 . . . . 0.0 111.299 -170.249 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -76.0 -24.85 10.92 Favored 'Trans proline' 0 C--N 1.351 0.7 0 C-N-CA 122.41 2.073 . . . . 0.0 113.41 -171.412 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 3.7 mmmm -67.12 -17.74 65.0 Favored 'General case' 0 CA--C 1.542 0.671 0 O-C-N 120.745 -1.222 . . . . 0.0 110.774 -174.968 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -59.49 -31.05 69.0 Favored 'General case' 0 N--CA 1.465 0.317 0 C-N-CA 126.803 2.041 . . . . 0.0 110.548 171.235 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 56.3 mtt -59.24 -24.31 63.07 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 118.83 0.741 . . . . 0.0 111.157 -178.672 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 63.3 mt-10 -64.78 -31.83 73.24 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-N 118.464 0.575 . . . . 0.0 110.385 -178.791 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 24.0 mt-30 -69.93 -39.37 76.16 Favored 'General case' 0 N--CA 1.466 0.354 0 N-CA-C 114.093 1.146 . . . . 0.0 114.093 -169.2 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 53.6 m-85 -72.25 141.58 48.95 Favored 'General case' 0 CA--C 1.528 0.12 0 C-N-CA 123.075 0.55 . . . . 0.0 111.388 -165.928 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 57.6 m-20 -69.68 -30.24 67.86 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 123.651 0.78 . . . . 0.0 110.268 176.564 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 19.0 t -126.15 147.2 30.98 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.467 0 N-CA-C 106.973 -1.491 . . . . 0.0 106.973 172.946 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 22.5 tp -124.87 150.01 46.92 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 169.873 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.44 HG12 ' HB3' ' A' ' 83' ' ' ALA . 43.5 mt -128.9 127.73 66.58 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 N-CA-C 104.596 -2.372 . . . . 0.0 104.596 178.426 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 3.2 mp -107.59 132.88 52.81 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 125.867 1.667 . . . . 0.0 106.791 -178.164 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -139.15 128.7 4.13 Favored Glycine 0 C--N 1.34 0.771 0 N-CA-C 109.182 -1.567 . . . . 0.0 109.182 -177.825 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 3.5 tt -151.77 134.45 8.79 Favored Pre-proline 0 CA--C 1.534 0.363 0 CA-C-N 118.437 1.119 . . . . 0.0 111.685 -179.136 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 75.6 Cg_endo -85.64 135.99 5.2 Favored 'Trans proline' 0 N--CA 1.454 -0.843 0 C-N-CA 121.834 1.69 . . . . 0.0 108.827 168.049 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 23.1 m -102.81 127.24 50.06 Favored 'General case' 0 CA--C 1.536 0.431 0 N-CA-C 106.881 -1.525 . . . . 0.0 106.881 168.962 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 5.2 m-90 -143.72 154.17 43.2 Favored 'General case' 0 C--O 1.232 0.175 0 C-N-CA 125.798 1.639 . . . . 0.0 106.975 172.642 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -63.83 142.32 58.44 Favored 'General case' 0 C--O 1.234 0.277 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 169.419 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 64.7 t80 63.7 -43.3 0.24 Allowed 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 128.289 2.636 . . . . 0.0 114.472 -175.033 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -65.42 -60.1 7.06 Favored Glycine 0 CA--C 1.529 0.927 0 N-CA-C 109.985 -1.246 . . . . 0.0 109.985 178.485 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.472 ' HG2' ' H ' ' A' ' 61' ' ' ILE . 12.0 tt0 49.99 -149.92 0.24 Allowed 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 124.668 1.187 . . . . 0.0 111.029 178.022 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.472 ' H ' ' HG2' ' A' ' 60' ' ' GLU . 73.8 mt -58.59 126.41 16.17 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.717 0 C-N-CA 126.692 1.997 . . . . 0.0 107.644 169.087 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 -76.98 159.77 29.68 Favored 'General case' 0 N--CA 1.465 0.32 0 C-N-CA 123.723 0.809 . . . . 0.0 109.074 178.33 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -55.36 -41.94 73.24 Favored 'General case' 0 C--O 1.225 -0.23 0 C-N-CA 123.645 0.778 . . . . 0.0 110.643 -179.96 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 22.7 m-20 -62.95 -26.25 68.74 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 123.123 0.569 . . . . 0.0 112.013 -177.84 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' TRP . . . . . 0.436 ' CZ3' ' CE3' ' A' ' 69' ' ' TRP . 0.0 OUTLIER -92.53 -46.43 7.63 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 125.462 1.505 . . . . 0.0 107.483 -176.407 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 13.7 tt0 -63.21 -36.65 84.34 Favored 'General case' 0 N--CA 1.445 -0.69 0 O-C-N 120.073 -1.642 . . . . 0.0 110.355 179.396 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -58.53 -26.09 63.15 Favored 'General case' 0 C--O 1.234 0.239 0 C-N-CA 123.844 0.858 . . . . 0.0 111.368 -175.115 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 34.9 m -105.15 -18.01 7.17 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.416 0 CA-C-O 117.221 -1.371 . . . . 0.0 112.51 177.607 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' TRP . . . . . 0.436 ' CE3' ' CZ3' ' A' ' 65' ' ' TRP . 1.8 t-105 -52.32 -35.04 49.77 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 120.464 1.484 . . . . 0.0 111.118 -176.023 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -68.01 -27.12 66.28 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 126.02 1.728 . . . . 0.0 113.357 177.04 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 23.1 mt-30 -92.65 -23.11 19.09 Favored 'General case' 0 C--N 1.341 0.222 0 C-N-CA 126.179 1.792 . . . . 0.0 112.262 178.249 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 71.8 mt -64.66 -26.21 68.29 Favored 'General case' 0 N--CA 1.465 0.285 0 O-C-N 121.514 -0.741 . . . . 0.0 111.861 -174.326 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -76.93 -22.55 53.13 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-N 118.329 0.513 . . . . 0.0 111.465 173.321 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -79.11 -27.88 42.92 Favored 'General case' 0 CA--C 1.534 0.36 0 O-C-N 120.986 -1.071 . . . . 0.0 112.13 179.706 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 39.3 mt -58.25 145.11 38.71 Favored 'General case' 0 C--O 1.234 0.265 0 C-N-CA 124.433 1.093 . . . . 0.0 110.629 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 22.3 t-20 -87.86 112.09 22.11 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 169.839 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 62.0 mt -120.95 6.92 10.35 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 123.558 0.743 . . . . 0.0 111.9 -172.421 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 32.1 mt-10 -51.13 133.24 28.09 Favored 'General case' 0 C--O 1.235 0.319 0 C-N-CA 124.837 1.255 . . . . 0.0 112.551 -168.857 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 71.81 -6.16 10.19 Favored Glycine 0 CA--C 1.531 1.074 0 C-N-CA 125.521 1.534 . . . . 0.0 115.598 173.177 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.34 157.92 33.55 Favored 'General case' 0 C--N 1.346 0.43 0 CA-C-N 120.759 2.28 . . . . 0.0 110.02 -174.476 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 7.3 mt -84.41 139.3 17.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 N-CA-C 106.894 -1.521 . . . . 0.0 106.894 176.576 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 99.2 t -130.97 126.98 60.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 C-N-CA 123.217 0.607 . . . . 0.0 110.864 178.065 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.44 ' HB3' HG12 ' A' ' 50' ' ' ILE . . . -94.02 146.16 24.14 Favored 'General case' 0 C--O 1.233 0.223 0 N-CA-C 106.464 -1.68 . . . . 0.0 106.464 165.751 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 2.0 mt -123.75 139.61 53.81 Favored 'General case' 0 CA--C 1.513 -0.475 0 N-CA-C 106.399 -1.704 . . . . 0.0 106.399 171.93 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 31.7 p90 -152.09 167.35 28.76 Favored 'General case' 0 N--CA 1.445 -0.714 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 167.921 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -164.04 179.06 39.17 Favored Glycine 0 N--CA 1.433 -1.523 0 N-CA-C 109.643 -1.383 . . . . 0.0 109.643 170.511 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 6.1 tt -115.71 143.96 44.63 Favored 'General case' 0 N--CA 1.44 -0.956 0 N-CA-C 107.245 -1.391 . . . . 0.0 107.245 172.971 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -138.45 -174.62 13.51 Favored Glycine 0 CA--C 1.524 0.637 0 N-CA-C 109.167 -1.573 . . . . 0.0 109.167 177.939 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -145.85 136.16 23.92 Favored 'General case' 0 C--O 1.235 0.293 0 C-N-CA 123.843 0.857 . . . . 0.0 109.137 -179.03 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' GLN . . . . . 0.536 ' H ' ' ND2' ' A' ' 148' ' ' ASN . 43.0 mt-30 -101.97 -6.44 23.45 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 124.827 1.251 . . . . 0.0 112.005 177.153 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 49.5 mt -65.65 -41.25 92.8 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 119.817 1.19 . . . . 0.0 108.859 174.664 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -77.55 37.94 1.64 Allowed Glycine 0 CA--C 1.533 1.19 0 C-N-CA 125.706 1.622 . . . . 0.0 111.623 168.467 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 28.2 t80 54.69 6.17 0.11 Allowed 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 128.104 2.562 . . . . 0.0 115.516 -179.863 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 69.61 26.38 74.54 Favored Glycine 0 C--N 1.343 0.96 0 O-C-N 120.332 -1.48 . . . . 0.0 110.833 -172.592 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -75.1 -16.56 60.54 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-N 117.985 0.892 . . . . 0.0 108.871 165.889 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 96' ' ' TRP . . . . . . . . . . . . . 9.3 m0 -112.68 7.08 18.56 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 126.459 1.904 . . . . 0.0 111.278 -179.5 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 3.1 t80 -68.26 115.51 7.8 Favored 'General case' 0 C--N 1.34 0.172 0 CA-C-N 119.769 1.168 . . . . 0.0 110.557 -172.115 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 92.0 mt 54.67 18.97 2.27 Favored 'General case' 0 N--CA 1.47 0.543 0 N-CA-C 114.739 1.385 . . . . 0.0 114.739 168.156 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -60.56 -33.89 73.36 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 120.643 1.565 . . . . 0.0 111.554 -170.163 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -71.77 -29.86 64.94 Favored 'General case' 0 CA--C 1.535 0.397 0 N-CA-C 112.714 0.635 . . . . 0.0 112.714 176.335 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 5.5 tt -59.07 -43.92 91.82 Favored 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 173.194 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -67.07 -32.96 82.01 Favored Glycine 0 C--N 1.338 0.639 0 CA-C-O 119.678 -0.512 . . . . 0.0 112.053 -176.156 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 75.6 mtm -68.4 -41.1 80.97 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 118.108 0.954 . . . . 0.0 110.899 -178.298 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -72.75 -38.04 67.5 Favored 'General case' 0 C--N 1.347 0.497 0 CA-C-N 120.507 1.503 . . . . 0.0 110.693 175.997 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 84.9 t60 -50.61 -49.0 57.74 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 118.37 0.532 . . . . 0.0 110.517 173.589 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -65.4 -41.81 93.27 Favored 'General case' 0 C--O 1.235 0.33 0 C-N-CA 123.522 0.729 . . . . 0.0 112.804 -177.784 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 24.1 ttmm -54.7 -43.46 72.54 Favored 'General case' 0 N--CA 1.465 0.31 0 C-N-CA 123.103 0.561 . . . . 0.0 109.847 171.55 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 7.9 mt -77.91 -25.66 48.57 Favored 'General case' 0 CA--C 1.516 -0.349 0 N-CA-C 115.35 1.611 . . . . 0.0 115.35 -168.247 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 14.1 m -58.73 -33.16 69.91 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-N 120.124 1.329 . . . . 0.0 112.245 -172.658 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 22.8 p -87.23 -9.65 54.55 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 124.413 1.085 . . . . 0.0 111.956 -179.139 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 30.9 mmmt -82.04 -10.01 59.36 Favored 'General case' 0 C--N 1.346 0.416 0 C-N-CA 124.419 1.088 . . . . 0.0 111.383 173.143 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 75.13 32.93 55.51 Favored Glycine 0 CA--C 1.524 0.638 0 CA-C-O 119.665 -0.519 . . . . 0.0 112.615 169.728 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 29.8 m -76.5 179.79 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 CA-C-N 118.208 1.004 . . . . 0.0 110.38 169.602 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -116.6 134.26 55.04 Favored 'General case' 0 CA--C 1.515 -0.369 0 N-CA-C 106.374 -1.713 . . . . 0.0 106.374 169.655 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 59.3 m-85 -95.38 145.01 25.44 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 119.502 1.047 . . . . 0.0 110.17 -179.26 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 35.3 m -132.8 159.61 43.07 Favored 'Isoleucine or valine' 0 C--O 1.233 0.21 0 C-N-CA 125.03 1.332 . . . . 0.0 108.399 171.954 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 82.02 33.44 26.63 Favored Glycine 0 CA--C 1.521 0.456 0 CA-C-O 118.666 -1.074 . . . . 0.0 113.858 170.556 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 8.3 m-30 -62.38 149.93 41.09 Favored 'General case' 0 CA--C 1.544 0.749 0 CA-C-N 119.297 1.549 . . . . 0.0 109.47 169.633 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 119' ' ' TRP . . . . . 0.428 ' HA ' ' HD3' ' A' ' 120' ' ' PRO . 1.5 t90 -134.65 136.37 25.33 Favored Pre-proline 0 CA--C 1.541 0.603 0 CA-C-O 117.273 -1.346 . . . . 0.0 108.592 -170.998 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 120' ' ' PRO . . . . . 0.428 ' HD3' ' HA ' ' A' ' 119' ' ' TRP . 45.2 Cg_exo -66.45 130.26 23.3 Favored 'Trans proline' 0 C--N 1.349 0.574 0 C-N-CA 123.006 2.471 . . . . 0.0 113.366 -172.369 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 33.6 p -68.05 -13.82 62.49 Favored 'General case' 0 CA--C 1.545 0.773 0 N-CA-C 113.235 0.828 . . . . 0.0 113.235 172.875 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -61.13 136.49 58.09 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 124.514 1.126 . . . . 0.0 110.571 -174.329 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 83.65 -8.74 64.38 Favored Glycine 0 CA--C 1.534 1.265 0 C-N-CA 124.99 1.281 . . . . 0.0 114.202 174.282 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 20.7 m-85 -93.33 150.97 20.07 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 118.529 1.164 . . . . 0.0 109.296 172.893 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -116.63 112.45 21.28 Favored 'General case' 0 C--O 1.233 0.221 0 N-CA-C 107.196 -1.409 . . . . 0.0 107.196 175.371 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 36.4 p90 -156.25 171.3 20.44 Favored 'General case' 0 C--O 1.235 0.321 0 C-N-CA 124.745 1.218 . . . . 0.0 109.661 -175.786 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 10.3 t -139.88 -14.37 1.06 Allowed 'General case' 0 CA--C 1.54 0.593 0 CA-C-O 118.695 -0.669 . . . . 0.0 112.515 177.611 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 16.7 m -53.09 119.61 17.26 Favored Pre-proline 0 CA--C 1.546 0.795 0 CA-C-N 119.629 1.104 . . . . 0.0 111.118 176.896 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -90.25 -26.54 0.36 Allowed 'Trans proline' 0 C--N 1.353 0.785 0 C-N-CA 121.929 1.753 . . . . 0.0 113.531 -171.628 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 47.1 mttp -54.74 -45.75 99.55 Favored Pre-proline 0 N--CA 1.473 0.679 0 CA-C-N 119.56 1.073 . . . . 0.0 113.199 -174.887 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -86.58 13.44 2.72 Favored 'Trans proline' 0 N--CA 1.457 -0.659 0 C-N-CA 122.043 1.829 . . . . 0.0 113.057 -171.524 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 15.2 m -127.55 146.23 33.62 Favored 'Isoleucine or valine' 0 C--O 1.232 0.179 0 CA-C-N 121.521 1.964 . . . . 0.0 111.04 -179.297 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 14.5 pt -102.8 169.01 2.01 Favored 'Isoleucine or valine' 0 C--O 1.235 0.313 0 C-N-CA 125.68 1.592 . . . . 0.0 108.96 170.483 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . 56.72 30.96 18.5 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 124.829 1.251 . . . . 0.0 113.514 167.93 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 27.6 t70 55.1 38.98 31.34 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 126.736 2.014 . . . . 0.0 111.292 -176.23 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 98.14 71.74 1.04 Allowed Glycine 0 C--N 1.338 0.693 0 C-N-CA 124.401 1.0 . . . . 0.0 111.29 176.721 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 76.3 mm-40 -120.33 -48.56 2.31 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 123.048 0.539 . . . . 0.0 110.895 167.784 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -131.34 141.98 50.0 Favored 'General case' 0 N--CA 1.467 0.408 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 179.52 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 62.9 m-85 -75.82 18.83 0.23 Allowed 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 125.86 1.664 . . . . 0.0 115.215 177.315 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 4.2 m 49.25 10.8 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.552 1.031 0 C-N-CA 127.576 2.351 . . . . 0.0 114.546 -176.491 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 170.46 175.2 39.05 Favored Glycine 0 CA--C 1.53 1.005 0 C-N-CA 125.941 1.734 . . . . 0.0 108.883 -169.334 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -71.6 141.07 50.0 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 118.439 1.12 . . . . 0.0 111.983 -177.382 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -99.72 129.77 45.87 Favored 'General case' 0 N--CA 1.446 -0.65 0 C-N-CA 126.523 1.929 . . . . 0.0 110.004 174.167 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 86.2 mt -121.71 141.51 51.09 Favored 'General case' 0 N--CA 1.463 0.214 0 N-CA-C 106.554 -1.647 . . . . 0.0 106.554 168.178 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 65.6 t0 -148.12 71.19 1.17 Allowed 'General case' 0 C--O 1.235 0.322 0 CA-C-O 122.705 1.24 . . . . 0.0 109.095 175.202 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -65.52 -26.4 67.88 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-N 114.572 -1.195 . . . . 0.0 110.401 177.532 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 56.4 m -61.01 -44.86 96.8 Favored 'General case' 0 C--O 1.237 0.433 0 O-C-N 121.531 -0.731 . . . . 0.0 110.448 178.782 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 148' ' ' ASN . . . . . 0.536 ' ND2' ' H ' ' A' ' 90' ' ' GLN . 5.7 m-80 -93.77 -37.7 11.65 Favored 'General case' 0 CA--C 1.528 0.134 0 CA-C-O 118.501 -0.761 . . . . 0.0 111.374 -172.784 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 18.7 pt20 -148.77 65.71 1.05 Allowed 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 118.873 0.761 . . . . 0.0 111.545 -172.971 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 31.8 p90 -50.65 -27.97 7.97 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 124.945 1.298 . . . . 0.0 113.414 176.207 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -62.64 -29.69 70.81 Favored 'General case' 0 CA--C 1.535 0.393 0 O-C-N 121.803 -0.56 . . . . 0.0 112.231 -179.46 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -94.76 -10.19 32.33 Favored 'General case' 0 C--N 1.345 0.381 0 CA-C-O 117.791 -1.1 . . . . 0.0 112.714 178.698 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 16.0 m -61.49 -38.2 86.45 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 121.124 1.783 . . . . 0.0 111.404 -172.185 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -62.61 -43.53 98.58 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 118.141 0.428 . . . . 0.0 110.705 176.109 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 12.6 tt0 -67.88 -41.01 83.46 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 124.889 1.276 . . . . 0.0 110.747 -178.497 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.88 -45.11 86.88 Favored 'General case' 0 N--CA 1.463 0.221 0 C-N-CA 124.338 1.055 . . . . 0.0 110.43 173.464 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 43.8 mt -67.03 -55.74 16.54 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.345 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 179.112 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 158' ' ' GLN . . . . . 0.431 ' HA ' HD13 ' A' ' 24' ' ' ILE . 0.4 OUTLIER -50.25 -69.13 0.12 Allowed 'General case' 0 C--O 1.234 0.263 0 C-N-CA 125.888 1.675 . . . . 0.0 112.035 -170.338 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 8.3 m -61.31 -33.42 73.57 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.859 -0.609 . . . . 0.0 111.744 -172.955 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 160' ' ' TRP . . . . . . . . . . . . . 79.6 t90 -66.13 -44.71 83.45 Favored 'General case' 0 CA--C 1.517 -0.326 0 O-C-N 121.833 -0.542 . . . . 0.0 110.988 175.041 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 68.6 m -59.51 -42.15 91.56 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 122.937 0.495 . . . . 0.0 110.501 179.095 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -62.05 -42.45 99.2 Favored 'General case' 0 CA--C 1.523 -0.082 0 CA-C-N 118.57 0.623 . . . . 0.0 110.467 174.869 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 16.4 tt0 -64.58 -51.01 64.95 Favored 'General case' 0 N--CA 1.446 -0.641 0 CA-C-O 118.691 -0.671 . . . . 0.0 110.019 -177.018 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 40.3 pt -63.27 -37.62 79.96 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.442 0 CA-C-O 117.815 -1.088 . . . . 0.0 109.531 -175.465 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -65.87 -32.97 74.79 Favored 'General case' 0 N--CA 1.462 0.165 0 CA-C-N 119.495 1.043 . . . . 0.0 110.329 -178.948 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 35.1 m-80 -69.6 -59.2 3.12 Favored 'General case' 0 C--O 1.223 -0.302 0 N-CA-C 108.099 -1.075 . . . . 0.0 108.099 174.053 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 19.4 tt0 -61.41 -34.31 75.15 Favored 'General case' 0 N--CA 1.443 -0.779 0 C-N-CA 126.412 1.885 . . . . 0.0 111.765 -168.788 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 168' ' ' MET . . . . . . . . . . . . . 22.1 ptp -72.46 -35.09 68.16 Favored 'General case' 0 C--O 1.228 -0.077 0 C-N-CA 123.415 0.686 . . . . 0.0 111.67 173.512 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -74.98 -38.35 61.66 Favored 'General case' 0 N--CA 1.445 -0.724 0 CA-C-O 119.153 -0.451 . . . . 0.0 111.935 -177.026 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -61.69 -31.55 71.7 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 121.446 0.641 . . . . 0.0 109.839 178.611 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 79.3 t60 -74.69 -32.48 62.21 Favored 'General case' 0 N--CA 1.447 -0.604 0 C-N-CA 124.6 1.16 . . . . 0.0 111.727 -174.834 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 12.0 m-85 -83.86 -24.84 30.72 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 123.531 0.732 . . . . 0.0 112.972 172.656 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.254 1.295 0 CA-C-O 118.198 -0.906 . . . . 0.0 110.564 -177.909 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.7 tmm? . . . . . 0 N--CA 1.494 1.755 0 CA-C-O 120.604 0.24 . . . . 0.0 110.603 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 21.9 p-10 -146.6 165.58 29.11 Favored 'General case' 0 N--CA 1.465 0.321 0 C-N-CA 126.334 1.854 . . . . 0.0 109.327 174.567 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 17.5 mtt -127.07 133.87 50.37 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 118.287 0.494 . . . . 0.0 111.144 -179.191 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -104.11 135.82 12.66 Favored Glycine 0 CA--C 1.526 0.722 0 N-CA-C 107.574 -2.21 . . . . 0.0 107.574 168.215 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 4.0 tt -122.93 111.11 16.24 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 105.78 -1.933 . . . . 0.0 105.78 -173.937 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.426 ' CD1' HD11 ' A' ' 35' ' ' LEU . 1.1 p90 -114.64 146.48 40.8 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 118.71 0.686 . . . . 0.0 110.683 -177.711 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 33.0 p90 -159.97 169.99 22.29 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 124.312 1.045 . . . . 0.0 108.44 179.666 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -71.49 126.6 12.98 Favored Glycine 0 CA--C 1.528 0.865 0 N-CA-C 109.28 -1.528 . . . . 0.0 109.28 177.756 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 1.3 m -88.64 4.87 45.55 Favored 'General case' 0 CA--C 1.538 0.486 0 N-CA-C 114.958 1.466 . . . . 0.0 114.958 -166.654 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 9.1 m -79.01 44.22 0.55 Allowed 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 124.702 1.201 . . . . 0.0 113.17 -171.532 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 2.0 m 54.79 35.98 25.38 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 125.538 1.535 . . . . 0.0 111.129 -176.594 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 58.6 m -74.92 158.02 34.04 Favored 'General case' 0 CA--C 1.534 0.337 0 O-C-N 121.53 -0.731 . . . . 0.0 109.189 178.382 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 41.7 t80 -62.95 -18.21 62.9 Favored 'General case' 0 N--CA 1.469 0.514 0 O-C-N 121.761 -0.587 . . . . 0.0 111.838 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -51.29 -24.72 4.82 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 125.217 1.407 . . . . 0.0 112.369 170.789 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -57.6 -39.43 76.82 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 119.943 1.247 . . . . 0.0 110.867 174.602 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 2.5 mpp? -71.33 -42.28 68.78 Favored 'General case' 0 C--N 1.339 0.127 0 CA-C-O 118.95 -0.547 . . . . 0.0 109.587 179.357 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -58.96 -43.84 91.38 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 119.038 0.836 . . . . 0.0 109.935 173.609 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -64.27 -48.74 74.56 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 124.274 1.029 . . . . 0.0 111.18 -176.777 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 6.4 mt-10 -58.96 -43.56 91.33 Favored 'General case' 0 CA--C 1.516 -0.351 0 N-CA-C 109.972 -0.381 . . . . 0.0 109.972 175.641 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 28.9 mtpp -72.13 -41.99 66.55 Favored 'General case' 0 C--O 1.221 -0.402 0 CA-C-O 117.848 -1.072 . . . . 0.0 110.533 -173.334 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 41.2 mt -51.88 -54.93 11.17 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.314 0 CA-C-N 120.301 1.409 . . . . 0.0 108.349 172.544 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 7.9 ttp180 -61.74 -41.7 98.0 Favored 'General case' 0 C--O 1.222 -0.386 0 C-N-CA 123.605 0.762 . . . . 0.0 109.721 -175.193 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -66.56 -42.24 87.37 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 122.878 0.471 . . . . 0.0 111.159 -178.653 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 51.3 mt -71.48 -52.52 25.7 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 C-N-CA 124.749 1.22 . . . . 0.0 109.843 -172.652 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 82.8 mt -67.66 -45.86 83.97 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.433 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 138.75 124.49 2.22 Favored Glycine 0 CA--C 1.53 1.011 0 C-N-CA 125.078 1.323 . . . . 0.0 112.144 174.613 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -71.77 -7.14 20.57 Favored 'Trans proline' 0 CA--C 1.534 0.491 0 C-N-CA 123.57 2.847 . . . . 0.0 113.965 -175.483 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -77.92 -21.15 51.58 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 119.147 0.885 . . . . 0.0 111.148 176.423 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -127.67 -8.34 5.63 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 124.675 1.19 . . . . 0.0 114.011 -172.343 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 25.4 t -106.48 151.54 8.42 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.337 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 169.64 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 2.1 m -140.07 130.1 24.89 Favored 'General case' 0 C--N 1.333 -0.135 0 N-CA-C 106.236 -1.765 . . . . 0.0 106.236 -170.976 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 18.7 mt -89.19 135.64 33.46 Favored 'General case' 0 N--CA 1.464 0.273 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 177.866 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 35.6 m170 -100.57 154.21 18.75 Favored 'General case' 0 N--CA 1.464 0.24 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 169.929 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 11.6 t-20 -132.65 104.11 6.48 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 105.036 -2.209 . . . . 0.0 105.036 172.416 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.426 HD11 ' CD1' ' A' ' 6' ' ' PHE . 69.3 mt -76.59 -6.64 52.85 Favored 'General case' 0 C--O 1.235 0.313 0 N-CA-C 113.028 0.751 . . . . 0.0 113.028 -170.049 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 51.5 tptt -81.75 -14.28 56.68 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 118.803 0.728 . . . . 0.0 109.911 168.974 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -117.76 -41.29 2.93 Favored 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 124.572 1.149 . . . . 0.0 112.97 -173.844 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -106.89 155.76 19.41 Favored 'General case' 0 C--O 1.236 0.386 0 C-N-CA 125.878 1.671 . . . . 0.0 111.588 179.484 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 15.1 m -90.95 147.46 35.91 Favored Pre-proline 0 CA--C 1.539 0.521 0 C-N-CA 124.871 1.268 . . . . 0.0 110.26 -174.209 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -66.62 -20.64 53.13 Favored 'Trans proline' 0 C--N 1.349 0.594 0 C-N-CA 122.218 1.945 . . . . 0.0 113.016 -175.722 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 4.6 mptp? -56.85 -23.32 43.34 Favored 'General case' 0 CA--C 1.538 0.491 0 O-C-N 121.328 -0.857 . . . . 0.0 111.712 174.106 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 5.9 mt -61.87 -32.33 72.68 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 119.477 1.035 . . . . 0.0 111.252 175.682 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 59.8 mtt -60.13 -25.48 65.51 Favored 'General case' 0 N--CA 1.462 0.138 0 C-N-CA 123.774 0.829 . . . . 0.0 111.631 -179.911 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -60.23 -33.83 72.82 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 118.401 0.546 . . . . 0.0 109.95 179.112 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 29.9 mt-30 -72.36 -28.08 62.8 Favored 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 114.121 1.156 . . . . 0.0 114.121 -169.679 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 63.1 m-85 -85.27 138.92 32.01 Favored 'General case' 0 N--CA 1.464 0.258 0 C-N-CA 122.718 0.407 . . . . 0.0 110.222 -167.7 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 26.8 m-20 -67.49 -39.3 85.19 Favored 'General case' 0 N--CA 1.465 0.324 0 N-CA-C 109.838 -0.43 . . . . 0.0 109.838 178.484 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 17.3 t -114.35 143.87 23.13 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.379 0 N-CA-C 107.74 -1.207 . . . . 0.0 107.74 173.302 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 18.3 tp -123.55 143.4 50.22 Favored 'General case' 0 N--CA 1.444 -0.749 0 N-CA-C 107.728 -1.212 . . . . 0.0 107.728 169.339 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 45.9 mt -124.45 126.74 72.37 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 N-CA-C 105.426 -2.065 . . . . 0.0 105.426 179.98 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 3.0 mp -110.02 123.2 49.24 Favored 'General case' 0 CA--C 1.516 -0.33 0 N-CA-C 107.143 -1.429 . . . . 0.0 107.143 -173.012 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -122.74 133.55 9.2 Favored Glycine 0 N--CA 1.459 0.193 0 N-CA-C 109.831 -1.307 . . . . 0.0 109.831 175.627 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 4.3 tt -155.13 125.59 3.39 Favored Pre-proline 0 CA--C 1.538 0.509 0 CA-C-N 118.648 1.224 . . . . 0.0 112.67 169.637 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_exo -63.44 137.93 62.77 Favored 'Trans proline' 0 N--CA 1.452 -0.922 0 C-N-CA 122.378 2.052 . . . . 0.0 111.278 166.02 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 7.7 m -113.22 114.91 27.4 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 106.551 -1.648 . . . . 0.0 106.551 168.65 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 3.2 m0 -167.91 148.95 5.21 Favored 'General case' 0 C--O 1.231 0.092 0 C-N-CA 125.903 1.681 . . . . 0.0 108.609 -174.49 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -61.73 -27.04 68.44 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 122.604 0.362 . . . . 0.0 111.404 169.786 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 9.6 m-85 -70.15 -5.09 24.71 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 125.06 1.344 . . . . 0.0 113.77 -173.631 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -173.94 -34.37 0.04 OUTLIER Glycine 0 CA--C 1.528 0.873 0 CA-C-N 119.186 0.903 . . . . 0.0 113.095 178.01 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 2.8 tp10 51.81 -152.35 0.23 Allowed 'General case' 0 C--O 1.237 0.432 0 C-N-CA 125.035 1.334 . . . . 0.0 110.323 178.996 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 63.9 mt -62.48 101.67 0.21 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.589 0 N-CA-C 105.029 -2.212 . . . . 0.0 105.029 166.486 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' GLN . . . . . 0.448 ' NE2' ' H ' ' A' ' 62' ' ' GLN . 1.7 pm0 -74.57 162.88 28.35 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 124.182 0.993 . . . . 0.0 109.891 175.197 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -48.06 -49.22 32.18 Favored 'General case' 0 C--O 1.226 -0.179 0 C-N-CA 125.45 1.5 . . . . 0.0 112.412 -169.413 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -69.33 -19.52 63.87 Favored 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 112.559 0.577 . . . . 0.0 112.559 -170.378 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 65' ' ' TRP . . . . . 0.806 ' CH2' HD23 ' A' ' 104' ' ' LEU . 3.6 t90 -92.68 -41.46 10.16 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 125.026 1.33 . . . . 0.0 109.022 176.916 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -64.16 -35.52 81.04 Favored 'General case' 0 CA--C 1.537 0.48 0 O-C-N 121.102 -0.999 . . . . 0.0 109.704 177.163 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -62.06 -26.26 68.16 Favored 'General case' 0 C--O 1.233 0.233 0 C-N-CA 124.301 1.04 . . . . 0.0 110.747 -178.956 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.424 HG21 HD13 ' A' ' 35' ' ' LEU . 30.5 m -102.68 -20.38 5.67 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.552 0 CA-C-O 116.438 -1.744 . . . . 0.0 112.373 175.249 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 20.5 t90 -55.18 -36.48 65.93 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 121.508 1.958 . . . . 0.0 110.713 -177.5 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -64.1 -27.77 69.32 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 125.12 1.368 . . . . 0.0 112.939 174.418 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 58.4 mt-30 -97.13 -22.72 16.59 Favored 'General case' 0 C--O 1.224 -0.254 0 C-N-CA 126.802 2.041 . . . . 0.0 112.016 -176.494 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.494 ' CD1' HD21 ' A' ' 104' ' ' LEU . 77.7 mt -62.39 -25.99 68.23 Favored 'General case' 0 N--CA 1.462 0.149 0 O-C-N 121.5 -0.75 . . . . 0.0 110.511 178.0 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -78.33 -29.82 47.86 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 117.845 0.293 . . . . 0.0 110.452 172.279 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -72.41 -32.05 66.03 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 123.84 0.856 . . . . 0.0 112.56 -179.261 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 26.0 mt -53.64 142.84 21.82 Favored 'General case' 0 C--O 1.235 0.322 0 C-N-CA 123.906 0.882 . . . . 0.0 112.537 -169.689 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 26.3 t-20 -81.2 88.0 6.06 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 172.154 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 3.8 pp -144.37 132.71 21.92 Favored 'General case' 0 N--CA 1.454 -0.238 0 N-CA-C 108.579 -0.896 . . . . 0.0 108.579 172.001 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 22.6 mt-10 -140.14 146.52 38.93 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 128.591 2.757 . . . . 0.0 107.19 168.693 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 68.9 -3.57 6.55 Favored Glycine 0 CA--C 1.533 1.202 0 N-CA-C 116.793 1.477 . . . . 0.0 116.793 169.968 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.19 157.86 36.34 Favored 'General case' 0 C--N 1.345 0.389 0 CA-C-N 120.181 1.99 . . . . 0.0 110.021 -174.439 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 4.4 mt -80.42 135.25 25.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 N-CA-C 107.377 -1.342 . . . . 0.0 107.377 178.587 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 67.7 t -132.91 129.73 58.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 C-N-CA 124.604 1.162 . . . . 0.0 109.405 -176.924 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -105.98 153.72 21.61 Favored 'General case' 0 N--CA 1.462 0.136 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 168.549 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 1.4 mt -134.49 137.47 43.93 Favored 'General case' 0 CA--C 1.512 -0.484 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 176.214 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 36.7 p90 -154.98 170.94 20.59 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 170.957 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' GLY . . . . . 0.435 ' HA3' HD11 ' A' ' 101' ' ' LEU . . . 178.25 161.03 25.56 Favored Glycine 0 N--CA 1.445 -0.758 0 C-N-CA 120.701 -0.761 . . . . 0.0 111.919 168.336 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 58.4 tp -90.66 153.68 20.13 Favored 'General case' 0 N--CA 1.442 -0.841 0 C-N-CA 126.426 1.89 . . . . 0.0 110.981 178.995 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -167.12 -162.67 19.38 Favored Glycine 0 CA--C 1.528 0.888 0 N-CA-C 109.049 -1.62 . . . . 0.0 109.049 169.099 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 2.2 t0 -138.88 113.84 9.32 Favored 'General case' 0 CA--C 1.518 -0.28 0 N-CA-C 105.733 -1.951 . . . . 0.0 105.733 168.849 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 1.9 pt20 -66.36 -10.67 45.49 Favored 'General case' 0 CA--C 1.542 0.654 0 N-CA-C 113.207 0.817 . . . . 0.0 113.207 -175.853 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 84.4 mt -85.48 -57.48 3.05 Favored 'General case' 0 C--O 1.232 0.181 0 C-N-CA 124.132 0.973 . . . . 0.0 109.326 -177.707 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -73.09 -37.61 55.69 Favored Glycine 0 CA--C 1.529 0.949 0 C-N-CA 123.654 0.645 . . . . 0.0 111.699 178.314 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -115.85 75.66 0.96 Allowed 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 126.024 1.73 . . . . 0.0 106.466 -179.561 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -90.5 -55.25 1.95 Allowed Glycine 0 CA--C 1.525 0.698 0 N-CA-C 110.574 -1.01 . . . . 0.0 110.574 178.629 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -70.42 -13.07 61.98 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 124.988 1.315 . . . . 0.0 111.247 172.539 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 96' ' ' TRP . . . . . . . . . . . . . 3.6 m-90 -123.63 15.35 9.5 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 124.138 0.975 . . . . 0.0 110.976 -177.45 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 11.7 t80 -57.34 129.02 39.94 Favored 'General case' 0 C--N 1.341 0.198 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 179.1 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 90.6 mt 54.28 19.25 2.14 Favored 'General case' 0 CA--C 1.538 0.511 0 N-CA-C 114.117 1.155 . . . . 0.0 114.117 170.106 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -56.98 -35.17 68.86 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 124.739 1.216 . . . . 0.0 111.581 -175.457 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -72.61 -22.41 60.97 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-O 118.061 -0.971 . . . . 0.0 112.499 178.204 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.435 HD11 ' HA3' ' A' ' 86' ' ' GLY . 9.4 mp -65.76 -41.26 92.3 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-N 120.265 1.393 . . . . 0.0 108.172 169.003 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -65.9 -40.06 95.27 Favored Glycine 0 C--N 1.339 0.729 0 N-CA-C 110.76 -0.936 . . . . 0.0 110.76 -176.123 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 74.7 mtm -62.3 -39.9 94.54 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-O 118.681 -0.676 . . . . 0.0 111.619 178.409 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.806 HD23 ' CH2' ' A' ' 65' ' ' TRP . 0.1 OUTLIER -73.23 -39.1 65.76 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 119.982 1.265 . . . . 0.0 110.34 175.498 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 58.9 t60 -57.95 -51.68 68.63 Favored 'General case' 0 N--CA 1.46 0.06 0 CA-C-N 118.282 0.492 . . . . 0.0 110.189 -179.089 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -61.86 -38.81 89.62 Favored 'General case' 0 C--O 1.234 0.259 0 C-N-CA 123.87 0.868 . . . . 0.0 112.08 -175.783 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 24.4 ttmm -56.8 -39.95 75.06 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 123.542 0.737 . . . . 0.0 110.42 172.599 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 43.6 mt -91.04 -19.83 22.74 Favored 'General case' 0 CA--C 1.52 -0.192 0 N-CA-C 114.32 1.229 . . . . 0.0 114.32 -169.78 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 6.5 m -58.45 -35.86 72.78 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 120.11 1.323 . . . . 0.0 111.179 179.324 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 20.3 p -81.73 -22.81 37.09 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 124.392 1.077 . . . . 0.0 111.418 179.762 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 32.2 mmmt -73.35 -12.21 60.75 Favored 'General case' 0 C--N 1.344 0.354 0 C-N-CA 123.62 0.768 . . . . 0.0 110.824 168.775 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 73.57 34.2 57.28 Favored Glycine 0 C--N 1.336 0.538 0 CA-C-N 118.948 0.794 . . . . 0.0 111.912 169.834 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 9.4 m -73.49 171.53 1.21 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 CA-C-N 118.629 1.215 . . . . 0.0 109.832 174.684 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -108.42 122.4 46.95 Favored 'General case' 0 CA--C 1.515 -0.377 0 N-CA-C 106.389 -1.708 . . . . 0.0 106.389 175.405 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 80.2 m-85 -91.89 144.69 25.22 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 119.072 0.851 . . . . 0.0 109.751 -175.53 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 31.2 m -131.77 160.29 42.5 Favored 'Isoleucine or valine' 0 C--O 1.233 0.234 0 C-N-CA 124.794 1.238 . . . . 0.0 109.188 171.991 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 96.77 -85.08 0.82 Allowed Glycine 0 N--CA 1.446 -0.691 0 C-N-CA 124.379 0.99 . . . . 0.0 110.654 175.904 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 80.7 m-85 54.57 -171.53 0.05 Allowed 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 124.608 1.163 . . . . 0.0 110.446 -169.301 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -156.37 147.26 16.39 Favored Pre-proline 0 N--CA 1.473 0.679 0 O-C-N 120.26 -1.525 . . . . 0.0 110.485 170.06 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -67.82 128.76 18.44 Favored 'Trans proline' 0 CA--C 1.538 0.706 0 C-N-CA 123.091 2.527 . . . . 0.0 112.365 178.36 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 14.4 p -83.53 -17.17 42.74 Favored 'General case' 0 N--CA 1.469 0.494 0 O-C-N 121.631 -0.668 . . . . 0.0 112.379 173.761 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -64.23 126.59 28.26 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 123.239 0.616 . . . . 0.0 109.552 -169.753 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 76.69 -0.93 63.72 Favored Glycine 0 CA--C 1.534 1.256 0 C-N-CA 124.677 1.132 . . . . 0.0 114.12 -179.786 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 1.1 t80 -81.8 158.54 24.07 Favored 'General case' 0 C--O 1.237 0.423 0 CA-C-N 119.185 1.493 . . . . 0.0 109.776 175.271 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -120.5 109.52 15.38 Favored 'General case' 0 CA--C 1.531 0.217 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 179.702 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 21.6 p90 -163.94 173.71 12.32 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 127.571 2.348 . . . . 0.0 106.703 -179.404 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 7.6 t -147.16 -167.9 2.9 Favored 'General case' 0 CA--C 1.542 0.663 0 O-C-N 121.425 -0.797 . . . . 0.0 109.968 168.522 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 49.3 m 60.27 152.16 0.09 OUTLIER Pre-proline 0 CA--C 1.55 0.959 0 C-N-CA 129.022 2.929 . . . . 0.0 113.891 -167.748 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo -86.38 -22.91 1.98 Allowed 'Trans proline' 0 C--N 1.352 0.715 0 C-N-CA 122.164 1.909 . . . . 0.0 114.055 -170.17 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 21.8 ttmt -55.38 -41.21 89.57 Favored Pre-proline 0 N--CA 1.475 0.784 0 CA-C-N 120.684 1.583 . . . . 0.0 114.698 -170.953 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -74.08 -3.36 13.66 Favored 'Trans proline' 0 CA--C 1.538 0.685 0 CA-C-N 122.745 2.016 . . . . 0.0 114.089 -179.018 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 16.8 m -130.04 156.05 41.96 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.21 0 CA-C-N 119.75 1.159 . . . . 0.0 110.841 -170.685 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 133' ' ' ILE . . . . . 0.412 HG23 HG12 ' A' ' 140' ' ' VAL . 2.4 pt -92.79 171.19 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.598 0 C-N-CA 124.151 0.98 . . . . 0.0 109.662 169.433 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . 55.0 -151.95 0.37 Allowed 'General case' 0 N--CA 1.441 -0.876 0 CA-C-N 113.695 -1.593 . . . . 0.0 109.621 168.444 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 24.8 t0 -79.14 51.87 1.23 Allowed 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 124.99 1.316 . . . . 0.0 110.556 170.815 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 68.04 28.63 73.33 Favored Glycine 0 CA--C 1.529 0.944 0 C-N-CA 124.686 1.136 . . . . 0.0 113.167 179.913 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 20.1 mt-30 -81.39 -22.25 38.45 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 118.281 1.041 . . . . 0.0 112.476 -169.902 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 8.8 tp -156.22 143.94 19.45 Favored 'General case' 0 C--N 1.344 0.326 0 CA-C-N 118.21 0.459 . . . . 0.0 111.013 -178.736 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 74.7 m-85 -73.77 140.36 45.84 Favored 'General case' 0 CA--C 1.516 -0.355 0 N-CA-C 107.479 -1.304 . . . . 0.0 107.479 169.601 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 140' ' ' VAL . . . . . 0.412 HG12 HG23 ' A' ' 133' ' ' ILE . 27.6 m -66.13 -3.73 1.94 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.588 0 N-CA-C 113.285 0.846 . . . . 0.0 113.285 -179.083 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -177.33 170.87 43.57 Favored Glycine 0 N--CA 1.447 -0.607 0 C-N-CA 125.046 1.308 . . . . 0.0 110.215 -171.447 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -60.59 127.36 31.32 Favored 'General case' 0 C--O 1.234 0.287 0 C-N-CA 123.351 0.66 . . . . 0.0 110.945 -175.255 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -79.91 118.95 22.13 Favored 'General case' 0 N--CA 1.446 -0.669 0 C-N-CA 124.838 1.255 . . . . 0.0 108.521 169.87 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 13.8 tp -120.86 143.51 48.86 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 108.169 -1.048 . . . . 0.0 108.169 172.811 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -148.73 145.97 27.89 Favored 'General case' 0 C--O 1.237 0.407 0 C-N-CA 124.706 1.202 . . . . 0.0 107.895 -172.276 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -130.47 1.71 4.55 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 124.42 1.088 . . . . 0.0 112.993 -178.16 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 3.7 m -102.48 -43.91 5.51 Favored 'General case' 0 C--O 1.234 0.264 0 C-N-CA 125.269 1.428 . . . . 0.0 108.28 179.179 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 6.5 m-80 -90.03 -30.12 17.95 Favored 'General case' 0 C--N 1.331 -0.202 0 C-N-CA 125.27 1.428 . . . . 0.0 110.027 -173.249 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 76.6 mt-30 -130.21 158.54 39.44 Favored 'General case' 0 CA--C 1.529 0.171 0 C-N-CA 125.941 1.696 . . . . 0.0 108.376 177.763 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 82.7 t80 -148.14 -47.65 0.16 Allowed 'General case' 0 CA--C 1.528 0.126 0 C-N-CA 123.876 0.87 . . . . 0.0 108.767 169.857 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -68.24 -41.18 81.58 Favored 'General case' 0 C--N 1.344 0.352 0 C-N-CA 122.186 0.194 . . . . 0.0 111.025 176.839 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -75.57 -16.85 60.2 Favored 'General case' 0 C--N 1.346 0.452 0 CA-C-O 117.693 -1.146 . . . . 0.0 112.028 177.594 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 7.7 m -62.27 -34.27 76.23 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-N 120.995 1.725 . . . . 0.0 110.012 -173.729 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -63.17 -43.74 97.41 Favored 'General case' 0 N--CA 1.463 0.191 0 C-N-CA 123.576 0.75 . . . . 0.0 111.369 171.307 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 29.0 tt0 -63.92 -41.22 97.71 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 124.546 1.139 . . . . 0.0 110.795 178.814 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 3.5 mmt180 -65.64 -39.48 91.49 Favored 'General case' 0 CA--C 1.527 0.063 0 CA-C-O 118.627 -0.702 . . . . 0.0 109.187 -178.225 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 35.3 mt -66.0 -57.71 9.54 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.426 0 N-CA-C 107.474 -1.306 . . . . 0.0 107.474 173.771 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 68.4 tp60 -47.69 -65.12 0.62 Allowed 'General case' 0 CA--C 1.52 -0.196 0 C-N-CA 125.298 1.439 . . . . 0.0 112.861 -174.619 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 19.9 m -66.31 -31.36 72.11 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 121.26 -0.176 . . . . 0.0 110.855 -169.592 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 160' ' ' TRP . . . . . . . . . . . . . 67.3 t90 -71.28 -45.46 63.07 Favored 'General case' 0 C--O 1.224 -0.26 0 O-C-N 121.93 -0.481 . . . . 0.0 111.035 177.426 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 85.5 m -58.81 -42.13 88.44 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 123.074 0.55 . . . . 0.0 109.855 176.349 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 162' ' ' GLU . . . . . 0.427 ' HA ' HD23 ' A' ' 165' ' ' LEU . 38.0 mt-10 -64.07 -43.45 95.4 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-O 121.28 0.562 . . . . 0.0 110.335 177.325 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 10.8 tt0 -60.07 -51.2 70.65 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 124.006 0.922 . . . . 0.0 110.068 -179.563 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 40.2 pt -62.86 -36.06 73.9 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.394 0 CA-C-O 117.937 -1.03 . . . . 0.0 109.253 -176.603 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 165' ' ' LEU . . . . . 0.427 HD23 ' HA ' ' A' ' 162' ' ' GLU . 0.1 OUTLIER -59.3 -37.93 78.97 Favored 'General case' 0 C--O 1.224 -0.27 0 C-N-CA 124.697 1.199 . . . . 0.0 109.478 177.416 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 33.2 m-80 -75.07 -52.54 10.79 Favored 'General case' 0 CA--C 1.515 -0.372 0 N-CA-C 108.644 -0.873 . . . . 0.0 108.644 -179.531 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 10.6 tt0 -70.43 -28.38 65.0 Favored 'General case' 0 N--CA 1.443 -0.808 0 C-N-CA 124.11 0.964 . . . . 0.0 111.582 -168.798 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 168' ' ' MET . . . . . . . . . . . . . 18.7 ptp -77.64 -31.53 52.77 Favored 'General case' 0 N--CA 1.456 -0.133 0 O-C-N 121.391 -0.818 . . . . 0.0 111.975 172.678 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -78.83 -42.52 27.41 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 122.5 0.32 . . . . 0.0 110.701 -176.31 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -65.43 -28.23 69.09 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 123.542 0.737 . . . . 0.0 110.551 179.298 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 59.2 t60 -64.9 -40.35 94.96 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 124.354 1.061 . . . . 0.0 111.084 174.496 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 12.8 m-85 -80.65 -24.7 38.79 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 123.398 0.679 . . . . 0.0 112.78 177.599 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.242 0 C-N-CA 123.759 0.824 . . . . 0.0 111.087 -177.143 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.497 1.917 0 CA-C-O 119.771 -0.157 . . . . 0.0 111.188 . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 25.2 p-10 -129.8 149.36 51.58 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 124.115 0.966 . . . . 0.0 112.186 -174.445 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 21.9 mtt -105.89 122.38 46.01 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 126.044 1.738 . . . . 0.0 107.213 -176.37 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -86.74 153.88 26.35 Favored Glycine 0 CA--C 1.529 0.942 0 N-CA-C 107.104 -2.398 . . . . 0.0 107.104 166.774 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 2.1 tt -142.6 96.84 3.01 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-N 120.042 1.921 . . . . 0.0 106.832 -173.499 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.696 ' CZ ' HD23 ' A' ' 51' ' ' LEU . 0.5 OUTLIER -101.69 140.52 35.87 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-O 121.033 0.444 . . . . 0.0 111.691 -170.592 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 25.2 p90 -162.93 174.98 11.65 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 126.456 1.903 . . . . 0.0 108.287 -177.143 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -74.48 -165.94 14.37 Favored Glycine 0 CA--C 1.537 1.417 0 C-N-CA 123.364 0.507 . . . . 0.0 112.378 178.169 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 1.6 m -58.11 122.95 14.33 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 124.154 0.982 . . . . 0.0 111.441 -177.472 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 8.2 m -54.87 150.14 10.43 Favored 'General case' 0 C--O 1.236 0.369 0 C-N-CA 124.307 1.043 . . . . 0.0 111.238 176.646 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 4.9 m 67.76 -39.94 0.4 Allowed 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 127.091 2.157 . . . . 0.0 113.164 179.764 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 59.6 m -69.36 -41.46 76.52 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 119.278 0.945 . . . . 0.0 109.995 172.284 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 26.7 m-85 -140.05 162.07 36.1 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 124.815 1.246 . . . . 0.0 109.892 -172.673 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 2.8 m 51.14 44.58 28.63 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 125.187 1.395 . . . . 0.0 111.069 174.928 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -61.53 138.99 58.31 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 122.859 0.464 . . . . 0.0 110.494 -171.794 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' MET . . . . . . . . . . . . 0.261 5.9 ptt? 53.48 -23.32 0.01 OUTLIER 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 130.515 3.526 . . . . 0.0 118.475 -179.847 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -61.64 -45.89 92.13 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 121.252 1.842 . . . . 0.0 110.867 -172.58 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -64.93 -47.1 78.91 Favored 'General case' 0 CA--C 1.527 0.089 0 C-N-CA 122.569 0.348 . . . . 0.0 111.053 -174.932 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -66.58 -35.74 80.95 Favored 'General case' 0 C--O 1.231 0.126 0 CA-C-O 118.602 -0.713 . . . . 0.0 110.735 179.175 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 48.0 mttm -65.61 -49.99 66.7 Favored 'General case' 0 C--O 1.22 -0.486 0 CA-C-O 118.339 -0.838 . . . . 0.0 110.588 175.781 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 40.7 mt -52.46 -52.15 28.2 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.336 0 CA-C-N 119.536 1.062 . . . . 0.0 108.764 178.894 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.61 -39.95 95.38 Favored 'General case' 0 C--O 1.223 -0.323 0 C-N-CA 123.119 0.568 . . . . 0.0 110.267 -177.162 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -67.92 -42.07 81.63 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 118.412 0.551 . . . . 0.0 110.917 -178.735 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 60.6 mt -72.98 -52.77 20.81 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.545 0 C-N-CA 124.911 1.284 . . . . 0.0 109.63 -170.531 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 69.7 mt -66.03 -46.75 87.24 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.375 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 178.443 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 139.37 126.05 2.32 Favored Glycine 0 CA--C 1.531 1.037 0 C-N-CA 124.8 1.191 . . . . 0.0 111.661 174.585 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -72.51 -5.66 17.57 Favored 'Trans proline' 0 CA--C 1.537 0.651 0 C-N-CA 123.593 2.862 . . . . 0.0 114.243 -173.287 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -80.1 -20.52 44.9 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-N 119.329 0.968 . . . . 0.0 111.243 176.794 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -128.02 -1.72 5.85 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 124.793 1.237 . . . . 0.0 113.861 -171.775 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 21.9 t -117.15 147.92 20.22 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.338 0 N-CA-C 107.745 -1.206 . . . . 0.0 107.745 171.748 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 15.5 m -131.66 132.9 44.35 Favored 'General case' 0 N--CA 1.463 0.203 0 N-CA-C 107.688 -1.227 . . . . 0.0 107.688 -177.835 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 17.7 mt -79.01 133.39 36.83 Favored 'General case' 0 C--O 1.233 0.198 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 175.151 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 32.2 t-80 -128.75 58.68 1.57 Allowed 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 124.674 1.19 . . . . 0.0 108.6 -177.551 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 8.0 t-20 -55.5 122.28 10.91 Favored 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 106.413 -1.699 . . . . 0.0 106.413 168.586 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 58.9 mt -66.09 -35.42 80.46 Favored 'General case' 0 C--O 1.236 0.356 0 N-CA-C 112.693 0.627 . . . . 0.0 112.693 -173.306 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 42.3 tttm -64.21 -18.82 64.88 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-O 119.011 -0.519 . . . . 0.0 111.5 172.26 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -97.6 -34.24 11.03 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-N 119.015 0.825 . . . . 0.0 112.574 -177.186 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 4.1 t0 -145.07 145.62 31.52 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 118.763 0.711 . . . . 0.0 112.33 176.636 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 12.4 m -66.72 158.49 79.46 Favored Pre-proline 0 CA--C 1.542 0.655 0 C-N-CA 126.216 1.806 . . . . 0.0 112.261 -169.389 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -73.9 -26.83 12.86 Favored 'Trans proline' 0 C--N 1.35 0.629 0 C-N-CA 122.548 2.165 . . . . 0.0 113.222 -170.993 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 22.9 mmmt -70.66 -11.63 61.06 Favored 'General case' 0 CA--C 1.538 0.497 0 O-C-N 120.456 -1.403 . . . . 0.0 111.676 -176.846 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -61.93 -29.3 70.13 Favored 'General case' 0 N--CA 1.463 0.21 0 C-N-CA 125.683 1.593 . . . . 0.0 110.14 169.142 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 39.7 mtt -55.72 -26.78 46.99 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 123.588 0.755 . . . . 0.0 111.464 178.204 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 94.2 mt-10 -65.49 -31.26 72.23 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 118.191 0.451 . . . . 0.0 110.354 -176.609 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 21.1 mt-30 -69.61 -43.84 71.94 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 123.588 0.755 . . . . 0.0 112.704 -170.103 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 57.3 m-85 -68.33 147.63 51.87 Favored 'General case' 0 C--O 1.231 0.096 0 C-N-CA 123.735 0.814 . . . . 0.0 109.135 -168.47 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -80.59 -37.0 32.02 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 119.105 0.866 . . . . 0.0 108.979 -178.926 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 1.3 m -105.51 151.31 7.7 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.806 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 169.532 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 58.4 tp -140.9 106.6 5.11 Favored 'General case' 0 N--CA 1.448 -0.562 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 174.853 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 22.3 mt -84.4 131.83 33.04 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.744 0 N-CA-C 106.139 -1.8 . . . . 0.0 106.139 176.317 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.696 HD23 ' CZ ' ' A' ' 6' ' ' PHE . 0.5 OUTLIER -106.81 131.85 53.44 Favored 'General case' 0 C--O 1.233 0.217 0 N-CA-C 107.283 -1.377 . . . . 0.0 107.283 169.693 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.579 ' N ' HD22 ' A' ' 51' ' ' LEU . . . -127.3 135.53 8.83 Favored Glycine 0 CA--C 1.521 0.456 0 N-CA-C 109.741 -1.344 . . . . 0.0 109.741 171.301 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 3.8 tt -152.05 134.95 9.06 Favored Pre-proline 0 CA--C 1.535 0.399 0 CA-C-N 118.521 1.161 . . . . 0.0 111.786 173.905 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_endo -75.14 133.59 16.56 Favored 'Trans proline' 0 N--CA 1.456 -0.727 0 C-N-CA 122.176 1.917 . . . . 0.0 109.602 165.044 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.434 HG21 ' H ' ' A' ' 99' ' ' ASP . 91.0 m -100.76 133.29 45.45 Favored 'General case' 0 CA--C 1.534 0.365 0 N-CA-C 106.546 -1.65 . . . . 0.0 106.546 167.976 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 6.1 m-90 -138.91 143.4 38.65 Favored 'General case' 0 C--O 1.236 0.386 0 N-CA-C 105.781 -1.933 . . . . 0.0 105.781 169.628 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -66.76 -45.66 77.84 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 118.938 0.79 . . . . 0.0 110.525 -179.316 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 30.8 p90 -83.92 148.54 26.88 Favored 'General case' 0 CA--C 1.531 0.228 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 168.832 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 78.61 -50.89 3.63 Favored Glycine 0 CA--C 1.533 1.198 0 CA-C-O 118.833 -0.982 . . . . 0.0 112.007 -178.872 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.487 ' HG2' ' H ' ' A' ' 61' ' ' ILE . 13.8 tt0 55.1 -159.38 0.19 Allowed 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 125.175 1.39 . . . . 0.0 110.344 -176.194 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.487 ' H ' ' HG2' ' A' ' 60' ' ' GLU . 23.6 mt -38.05 122.72 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.58 0 C-N-CA 126.33 1.852 . . . . 0.0 109.712 168.451 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 2.2 pm0 -70.11 156.11 39.66 Favored 'General case' 0 C--O 1.232 0.179 0 C-N-CA 123.633 0.773 . . . . 0.0 110.302 176.108 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -54.54 -47.47 73.15 Favored 'General case' 0 N--CA 1.456 -0.167 0 C-N-CA 124.604 1.162 . . . . 0.0 112.457 -168.424 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -67.26 -31.44 71.78 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 119.503 1.047 . . . . 0.0 111.503 -172.225 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' TRP . . . . . 0.546 ' CH2' HD23 ' A' ' 104' ' ' LEU . 5.2 t90 -73.91 -44.54 54.8 Favored 'General case' 0 N--CA 1.455 -0.222 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 178.578 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -61.83 -36.79 82.22 Favored 'General case' 0 CA--C 1.537 0.464 0 O-C-N 121.397 -0.814 . . . . 0.0 109.993 176.241 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -61.91 -25.07 67.35 Favored 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 123.312 0.645 . . . . 0.0 111.117 -174.093 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 25.4 m -108.56 -13.99 10.17 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.271 0 CA-C-O 117.073 -1.441 . . . . 0.0 112.644 175.21 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 18.2 t90 -51.31 -39.46 56.96 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 120.27 1.396 . . . . 0.0 110.075 -178.611 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -66.73 -25.35 66.47 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 125.721 1.608 . . . . 0.0 113.568 177.8 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 25.8 mt-30 -92.06 -19.23 22.56 Favored 'General case' 0 C--N 1.341 0.224 0 C-N-CA 125.688 1.595 . . . . 0.0 112.348 177.007 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 52.6 mt -62.09 -25.78 67.91 Favored 'General case' 0 N--CA 1.466 0.342 0 O-C-N 121.425 -0.797 . . . . 0.0 111.399 -174.937 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -75.92 -21.95 56.55 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-N 118.026 0.376 . . . . 0.0 111.741 176.47 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -73.47 -29.37 62.49 Favored 'General case' 0 N--CA 1.467 0.413 0 O-C-N 120.827 -1.171 . . . . 0.0 111.852 177.173 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 82.9 mt -54.16 138.25 38.66 Favored 'General case' 0 C--N 1.339 0.147 0 C-N-CA 124.926 1.291 . . . . 0.0 112.911 -168.988 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 3.0 t30 -74.97 98.93 3.7 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 123.973 0.909 . . . . 0.0 108.978 170.166 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 56.7 mt -123.07 -0.12 8.99 Favored 'General case' 0 N--CA 1.474 0.769 0 N-CA-C 113.765 1.024 . . . . 0.0 113.765 -176.03 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 25.2 mt-10 -55.2 128.69 35.09 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 119.72 1.146 . . . . 0.0 111.581 -168.974 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 74.88 -1.97 51.94 Favored Glycine 0 CA--C 1.532 1.107 0 C-N-CA 125.487 1.518 . . . . 0.0 114.98 177.095 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.3 155.35 34.32 Favored 'General case' 0 C--N 1.346 0.421 0 CA-C-N 120.172 1.986 . . . . 0.0 109.929 -176.035 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 12.4 mt -78.87 142.52 13.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 N-CA-C 106.615 -1.624 . . . . 0.0 106.615 177.918 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 3.0 t -138.08 139.72 41.74 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 O-C-N 121.42 -0.8 . . . . 0.0 109.251 -179.051 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -117.06 147.71 42.13 Favored 'General case' 0 CA--C 1.511 -0.532 0 N-CA-C 106.43 -1.693 . . . . 0.0 106.43 170.876 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 5.9 mp -127.82 142.08 51.39 Favored 'General case' 0 CA--C 1.509 -0.622 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 170.569 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 35.8 p90 -150.04 166.85 28.47 Favored 'General case' 0 N--CA 1.445 -0.701 0 N-CA-C 107.02 -1.474 . . . . 0.0 107.02 167.644 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -163.07 167.43 37.41 Favored Glycine 0 N--CA 1.444 -0.829 0 N-CA-C 109.915 -1.274 . . . . 0.0 109.915 173.388 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -113.43 142.47 45.86 Favored 'General case' 0 N--CA 1.447 -0.585 0 N-CA-C 106.81 -1.552 . . . . 0.0 106.81 -179.702 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -160.68 -167.75 21.62 Favored Glycine 0 CA--C 1.525 0.676 0 N-CA-C 109.304 -1.519 . . . . 0.0 109.304 175.056 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 4.2 t0 -149.4 122.8 9.05 Favored 'General case' 0 C--O 1.234 0.272 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 171.439 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 16.3 pm0 -75.96 -15.25 60.2 Favored 'General case' 0 N--CA 1.448 -0.556 0 C-N-CA 124.573 1.149 . . . . 0.0 113.337 -178.653 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 94.7 mt -80.11 -49.61 11.49 Favored 'General case' 0 C--O 1.231 0.12 0 CA-C-N 119.232 0.924 . . . . 0.0 109.527 -178.819 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -76.26 -46.43 12.71 Favored Glycine 0 CA--C 1.522 0.502 0 C-N-CA 123.907 0.765 . . . . 0.0 112.077 -179.359 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 18.6 m-85 -98.86 -88.73 0.32 Allowed 'General case' 0 C--N 1.339 0.147 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 -176.448 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 79.14 -43.69 2.52 Favored Glycine 0 CA--C 1.529 0.945 0 C-N-CA 124.097 0.856 . . . . 0.0 112.825 171.897 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -84.27 -14.15 50.59 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 126.095 1.758 . . . . 0.0 111.528 171.086 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 96' ' ' TRP . . . . . . . . . . . . . 2.7 m-90 -128.98 29.01 5.26 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 125.297 1.439 . . . . 0.0 110.416 -178.57 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 18.3 t80 -66.28 132.74 49.07 Favored 'General case' 0 C--N 1.339 0.143 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 -176.056 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 95.5 mt 50.62 28.88 3.73 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 124.841 1.256 . . . . 0.0 113.337 169.456 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 99' ' ' ASP . . . . . 0.434 ' H ' HG21 ' A' ' 55' ' ' THR . 22.5 t70 -57.47 -39.82 77.19 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 124.56 1.144 . . . . 0.0 110.845 -178.165 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -71.46 -32.13 67.95 Favored 'General case' 0 CA--C 1.534 0.331 0 O-C-N 121.666 -0.647 . . . . 0.0 111.9 178.926 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 4.9 tt -62.83 -47.94 81.22 Favored 'General case' 0 N--CA 1.467 0.4 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 171.957 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -63.27 -39.06 97.42 Favored Glycine 0 C--N 1.338 0.66 0 N-CA-C 111.145 -0.782 . . . . 0.0 111.145 -177.314 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 67.7 mtm -64.93 -40.38 94.97 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 118.236 1.018 . . . . 0.0 111.394 176.621 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.546 HD23 ' CH2' ' A' ' 65' ' ' TRP . 0.2 OUTLIER -71.67 -31.54 66.91 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 119.752 1.16 . . . . 0.0 111.244 177.714 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 50.6 t-80 -62.65 -45.81 91.13 Favored 'General case' 0 N--CA 1.462 0.148 0 CA-C-N 118.98 0.809 . . . . 0.0 110.837 171.444 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -63.6 -44.1 95.0 Favored 'General case' 0 C--O 1.234 0.274 0 C-N-CA 122.942 0.497 . . . . 0.0 111.06 -177.09 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 22.3 ttmm -58.0 -48.6 79.53 Favored 'General case' 0 C--O 1.226 -0.177 0 C-N-CA 123.131 0.572 . . . . 0.0 109.962 172.23 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 32.9 mt -74.79 -23.27 58.48 Favored 'General case' 0 N--CA 1.461 0.091 0 CA-C-O 118.622 -0.704 . . . . 0.0 112.547 -170.839 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 70.0 m -61.04 -38.18 85.25 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 119.376 0.989 . . . . 0.0 111.261 -177.506 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 26.1 p -85.1 -6.89 59.29 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 123.551 0.74 . . . . 0.0 111.667 -178.824 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 30.7 mmmt -82.12 -7.63 59.63 Favored 'General case' 0 C--N 1.344 0.36 0 C-N-CA 124.462 1.105 . . . . 0.0 111.806 171.635 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 69.51 34.36 73.55 Favored Glycine 0 CA--C 1.525 0.688 0 CA-C-N 118.764 0.711 . . . . 0.0 111.788 173.92 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 8.0 m -77.94 172.48 1.12 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.469 0 CA-C-N 117.913 0.856 . . . . 0.0 109.383 174.34 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -111.37 116.48 31.03 Favored 'General case' 0 CA--C 1.514 -0.437 0 N-CA-C 105.938 -1.875 . . . . 0.0 105.938 177.484 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 71.4 m-85 -85.56 142.39 29.17 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 118.819 0.736 . . . . 0.0 110.135 -173.881 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 32.6 m -131.9 158.73 43.34 Favored 'Isoleucine or valine' 0 C--O 1.234 0.268 0 C-N-CA 125.612 1.565 . . . . 0.0 107.581 168.921 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 83.93 31.13 27.07 Favored Glycine 0 CA--C 1.521 0.464 0 CA-C-O 118.779 -1.012 . . . . 0.0 114.935 169.73 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 10.6 m-30 -65.78 157.13 31.12 Favored 'General case' 0 CA--C 1.546 0.823 0 CA-C-N 118.941 1.371 . . . . 0.0 109.343 169.042 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 119' ' ' TRP . . . . . 0.4 ' HA ' ' HD3' ' A' ' 120' ' ' PRO . 51.1 t-105 -133.88 147.39 64.01 Favored Pre-proline 0 N--CA 1.476 0.838 0 CA-C-O 118.054 -0.974 . . . . 0.0 112.095 -168.524 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 120' ' ' PRO . . . . . 0.4 ' HD3' ' HA ' ' A' ' 119' ' ' TRP . 50.3 Cg_exo -63.25 129.92 27.05 Favored 'Trans proline' 0 C--N 1.35 0.627 0 C-N-CA 123.077 2.518 . . . . 0.0 113.202 -177.621 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 7.6 p -88.36 -26.63 22.1 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 124.274 1.029 . . . . 0.0 110.764 169.299 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 14.0 mm-40 -65.43 130.52 43.59 Favored 'General case' 0 N--CA 1.451 -0.409 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 -178.954 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 77.67 -5.26 53.24 Favored Glycine 0 CA--C 1.535 1.316 0 CA-C-O 119.029 -0.873 . . . . 0.0 113.436 -176.033 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -87.13 163.34 17.03 Favored 'General case' 0 C--O 1.236 0.342 0 CA-C-N 118.798 1.299 . . . . 0.0 109.096 170.708 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -125.17 124.94 42.86 Favored 'General case' 0 N--CA 1.462 0.135 0 N-CA-C 107.817 -1.179 . . . . 0.0 107.817 175.727 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 22.5 p90 -173.06 170.9 4.3 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 128.091 2.556 . . . . 0.0 106.311 179.706 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 4.8 t -136.44 -10.7 1.9 Allowed 'General case' 0 N--CA 1.472 0.652 0 CA-C-N 118.792 0.724 . . . . 0.0 112.82 168.164 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 14.7 m -59.25 126.66 82.52 Favored Pre-proline 0 CA--C 1.543 0.686 0 C-N-CA 123.796 0.838 . . . . 0.0 111.807 179.227 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_endo -83.57 -22.92 3.57 Favored 'Trans proline' 0 CA--C 1.542 0.905 0 C-N-CA 122.257 1.971 . . . . 0.0 112.999 176.631 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 25.9 ttmt -60.08 -42.07 88.08 Favored Pre-proline 0 CA--C 1.544 0.716 0 O-C-N 120.734 -1.229 . . . . 0.0 113.998 -176.198 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_endo -80.58 5.99 5.74 Favored 'Trans proline' 0 C--N 1.352 0.721 0 C-N-CA 122.046 1.83 . . . . 0.0 114.066 -179.6 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 19.0 m -124.07 147.89 28.4 Favored 'Isoleucine or valine' 0 C--O 1.234 0.273 0 CA-C-N 120.888 1.677 . . . . 0.0 110.982 -177.589 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 133' ' ' ILE . . . . . 0.822 HG23 HG12 ' A' ' 140' ' ' VAL . 2.4 pt -82.69 168.78 1.71 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 N-CA-C 108.056 -1.09 . . . . 0.0 108.056 167.158 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . 55.85 -156.12 0.27 Allowed 'General case' 0 N--CA 1.443 -0.778 0 CA-C-N 114.076 -1.42 . . . . 0.0 110.195 168.587 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 21.8 t0 -80.62 61.11 4.2 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 125.128 1.371 . . . . 0.0 108.92 169.551 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 65.13 28.39 73.49 Favored Glycine 0 CA--C 1.531 1.044 0 C-N-CA 124.302 0.953 . . . . 0.0 113.289 176.768 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 62.5 mm-40 -78.17 -27.49 48.06 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 118.125 0.963 . . . . 0.0 111.886 -169.143 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 12.7 tp -159.17 146.89 17.53 Favored 'General case' 0 C--N 1.341 0.222 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 -177.349 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 63.7 m-85 -75.82 143.09 42.06 Favored 'General case' 0 CA--C 1.517 -0.322 0 N-CA-C 107.821 -1.177 . . . . 0.0 107.821 171.775 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 140' ' ' VAL . . . . . 0.822 HG12 HG23 ' A' ' 133' ' ' ILE . 4.2 m -76.77 10.23 0.5 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.89 0 C-N-CA 123.818 0.847 . . . . 0.0 111.686 -178.43 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 179.25 174.0 44.96 Favored Glycine 0 CA--C 1.529 0.934 0 C-N-CA 125.837 1.684 . . . . 0.0 109.592 -175.478 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 5.0 tp -68.29 134.86 51.02 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-N 118.557 1.179 . . . . 0.0 111.089 178.094 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -96.28 107.64 20.02 Favored 'General case' 0 N--CA 1.442 -0.836 0 C-N-CA 125.367 1.467 . . . . 0.0 108.982 172.557 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 89.6 mt -91.36 151.15 20.97 Favored 'General case' 0 C--O 1.233 0.225 0 N-CA-C 108.096 -1.076 . . . . 0.0 108.096 168.742 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -136.24 155.58 49.9 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 126.537 1.935 . . . . 0.0 107.584 171.799 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 4.9 tp10 -144.0 36.68 1.27 Allowed 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 123.906 0.882 . . . . 0.0 109.773 171.438 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 55.8 m -141.29 -47.87 0.39 Allowed 'General case' 0 C--O 1.236 0.354 0 C-N-CA 124.847 1.259 . . . . 0.0 110.104 -176.612 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 6.1 m-80 -76.14 -35.81 59.06 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 124.5 1.12 . . . . 0.0 108.936 -179.17 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 7.5 mm-40 -121.95 162.59 20.8 Favored 'General case' 0 N--CA 1.452 -0.368 0 C-N-CA 127.103 2.161 . . . . 0.0 109.139 174.594 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 92.8 m-85 -138.57 -36.12 0.58 Allowed 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 124.766 1.226 . . . . 0.0 109.198 167.855 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -71.27 -41.99 69.35 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 123.274 0.63 . . . . 0.0 111.906 177.578 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 87.6 mt -81.83 -6.46 59.1 Favored 'General case' 0 N--CA 1.467 0.424 0 N-CA-C 112.926 0.714 . . . . 0.0 112.926 -170.959 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 12.4 m -62.21 -35.9 80.3 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 119.423 1.011 . . . . 0.0 110.719 -172.492 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -67.51 -39.85 85.14 Favored 'General case' 0 N--CA 1.464 0.258 0 C-N-CA 123.081 0.553 . . . . 0.0 110.853 173.224 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 28.5 tt0 -65.97 -43.33 88.22 Favored 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 124.334 1.054 . . . . 0.0 111.008 -178.326 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.6 -39.93 74.42 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 123.251 0.621 . . . . 0.0 109.475 177.383 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 53.7 mt -70.91 -54.23 18.61 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 N-CA-C 108.277 -1.008 . . . . 0.0 108.277 176.8 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 71.7 tp60 -50.51 -62.32 1.66 Allowed 'General case' 0 N--CA 1.463 0.181 0 C-N-CA 125.183 1.393 . . . . 0.0 111.97 -174.359 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 19.9 m -68.23 -31.98 71.86 Favored 'General case' 0 C--N 1.324 -0.543 0 C-N-CA 121.273 -0.171 . . . . 0.0 110.84 -169.716 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 160' ' ' TRP . . . . . . . . . . . . . 48.7 t90 -66.04 -47.3 74.81 Favored 'General case' 0 C--O 1.223 -0.304 0 O-C-N 122.157 -0.339 . . . . 0.0 110.71 173.388 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 65.5 m -59.93 -43.14 95.13 Favored 'General case' 0 N--CA 1.455 -0.195 0 C-N-CA 122.956 0.503 . . . . 0.0 110.408 -178.554 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -63.16 -40.26 97.03 Favored 'General case' 0 N--CA 1.455 -0.22 0 N-CA-C 110.223 -0.288 . . . . 0.0 110.223 176.995 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 16.6 tt0 -65.85 -51.62 57.29 Favored 'General case' 0 N--CA 1.446 -0.64 0 CA-C-O 118.787 -0.625 . . . . 0.0 110.122 -179.228 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 39.4 pt -63.5 -38.0 81.07 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.377 0 CA-C-O 117.909 -1.043 . . . . 0.0 109.667 -175.212 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -63.74 -36.07 82.66 Favored 'General case' 0 C--O 1.225 -0.225 0 CA-C-N 119.351 0.978 . . . . 0.0 109.833 179.526 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 28.4 m-80 -68.28 -52.59 32.03 Favored 'General case' 0 CA--C 1.515 -0.4 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 175.808 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 15.2 tt0 -70.69 -26.76 63.57 Favored 'General case' 0 N--CA 1.443 -0.786 0 C-N-CA 124.381 1.073 . . . . 0.0 111.504 -168.767 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 168' ' ' MET . . . . . . . . . . . . . 17.1 ptp -79.58 -30.5 41.63 Favored 'General case' 0 C--O 1.227 -0.104 0 O-C-N 120.808 -1.182 . . . . 0.0 112.219 171.699 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -79.75 -40.54 28.55 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 122.923 0.489 . . . . 0.0 111.156 -178.223 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -69.71 -26.15 64.2 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 124.342 1.057 . . . . 0.0 110.532 -178.57 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 52.5 t60 -60.63 -28.18 68.35 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 124.072 0.949 . . . . 0.0 110.97 170.684 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 29.5 m-85 -101.46 10.39 40.47 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 126.064 1.746 . . . . 0.0 113.31 175.125 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.255 1.367 0 CA-C-N 119.475 1.034 . . . . 0.0 109.794 173.595 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 53.6 ttp . . . . . 0 N--CA 1.497 1.905 0 N-CA-C 110.002 -0.37 . . . . 0.0 110.002 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 10.4 t30 -141.44 152.11 43.98 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 124.908 1.283 . . . . 0.0 107.639 174.681 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 11.8 mtt -113.84 121.46 44.08 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 123.246 0.618 . . . . 0.0 111.136 -175.79 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' GLY . . . . . 0.407 ' HA3' ' CD2' ' A' ' 46' ' ' TYR . . . -80.47 155.51 37.8 Favored Glycine 0 CA--C 1.521 0.41 0 N-CA-C 107.606 -2.198 . . . . 0.0 107.606 166.912 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 2.5 tt -141.47 96.01 2.92 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 105.805 -1.924 . . . . 0.0 105.805 -176.517 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -102.71 143.45 32.35 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-O 121.691 0.758 . . . . 0.0 112.142 -170.454 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 30.2 p90 -157.76 160.35 37.76 Favored 'General case' 0 N--CA 1.451 -0.384 0 C-N-CA 126.81 2.044 . . . . 0.0 107.278 177.016 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -101.08 143.28 16.11 Favored Glycine 0 CA--C 1.523 0.58 0 N-CA-C 110.711 -0.956 . . . . 0.0 110.711 -177.99 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 17.5 m 62.73 147.26 0.02 OUTLIER 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 128.084 2.554 . . . . 0.0 115.395 175.965 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 4.8 m -77.85 165.7 23.82 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 114.62 -1.173 . . . . 0.0 109.506 168.987 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 1.3 m 60.32 36.47 20.59 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 124.433 1.093 . . . . 0.0 111.213 171.935 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 76.6 m -124.66 149.03 47.6 Favored 'General case' 0 C--O 1.234 0.243 0 C-N-CA 125.715 1.606 . . . . 0.0 107.048 173.782 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 50.3 t80 -62.43 -21.08 65.14 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 119.064 0.847 . . . . 0.0 112.46 -170.743 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 1.3 m -53.28 -29.44 33.22 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-O 118.182 -0.914 . . . . 0.0 112.045 174.39 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -71.91 -27.88 63.12 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 120.525 1.511 . . . . 0.0 111.519 179.036 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 2.2 mpp? -71.29 -41.94 69.33 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 119.162 0.892 . . . . 0.0 109.163 174.898 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -59.18 -44.15 92.17 Favored 'General case' 0 CA--C 1.531 0.239 0 N-CA-C 109.438 -0.578 . . . . 0.0 109.438 171.758 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -63.87 -46.43 84.95 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 123.728 0.811 . . . . 0.0 111.514 -176.822 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 26.5 mt-10 -58.44 -43.96 88.96 Favored 'General case' 0 CA--C 1.517 -0.303 0 C-N-CA 123.51 0.724 . . . . 0.0 109.843 174.559 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 51.2 mttm -65.1 -47.2 78.05 Favored 'General case' 0 C--O 1.222 -0.359 0 CA-C-O 118.725 -0.655 . . . . 0.0 109.984 -178.613 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 43.0 mt -52.88 -54.81 14.71 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.214 0 CA-C-N 119.024 0.829 . . . . 0.0 109.62 179.807 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.465 ' HG2' HD21 ' A' ' 32' ' ' LEU . 0.0 OUTLIER -66.45 -35.8 81.2 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 118.374 0.533 . . . . 0.0 111.257 -175.372 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -64.35 -40.41 95.8 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.855 0.359 . . . . 0.0 110.592 178.582 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 62.6 mt -78.41 -54.01 12.89 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.548 0 C-N-CA 124.674 1.19 . . . . 0.0 110.038 -170.301 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 69.5 mt -62.71 -47.51 92.54 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 178.552 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 142.33 122.59 1.77 Allowed Glycine 0 CA--C 1.528 0.903 0 C-N-CA 124.646 1.117 . . . . 0.0 110.78 177.133 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -71.87 -11.18 27.32 Favored 'Trans proline' 0 CA--C 1.537 0.666 0 C-N-CA 122.885 2.39 . . . . 0.0 113.248 -170.262 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -79.96 -18.24 50.92 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 118.844 0.747 . . . . 0.0 111.953 -179.753 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -126.89 5.82 6.61 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 125.085 1.354 . . . . 0.0 113.555 -172.618 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 36.8 t -123.91 148.63 27.97 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.518 0 C-N-CA 124.85 1.26 . . . . 0.0 107.872 172.221 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 20.3 m -134.85 131.12 37.03 Favored 'General case' 0 C--N 1.332 -0.186 0 C-N-CA 125.519 1.528 . . . . 0.0 107.851 -175.267 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.465 HD21 ' HG2' ' A' ' 22' ' ' ARG . 20.9 mt -79.72 139.68 37.23 Favored 'General case' 0 C--O 1.232 0.17 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 177.873 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 18.0 t-80 -137.22 54.8 1.84 Allowed 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 124.177 0.991 . . . . 0.0 108.936 -173.419 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 37.8 t-20 -57.27 123.13 14.29 Favored 'General case' 0 N--CA 1.465 0.283 0 N-CA-C 106.367 -1.716 . . . . 0.0 106.367 168.629 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 31.3 mt -70.75 -31.79 68.72 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 118.661 0.664 . . . . 0.0 112.472 -169.072 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 57.7 tptt -58.96 -24.58 62.74 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 124.2 1.0 . . . . 0.0 110.355 169.765 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -95.73 -33.6 12.24 Favored 'General case' 0 C--O 1.236 0.376 0 N-CA-C 113.566 0.95 . . . . 0.0 113.566 -177.049 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 4.4 t0 -147.54 149.8 33.3 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 119.459 1.027 . . . . 0.0 113.18 178.33 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 15.7 m -71.66 158.43 87.86 Favored Pre-proline 0 CA--C 1.541 0.615 0 C-N-CA 126.236 1.814 . . . . 0.0 112.607 -168.92 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -73.53 -25.6 14.92 Favored 'Trans proline' 0 C--N 1.35 0.611 0 C-N-CA 122.467 2.111 . . . . 0.0 113.935 -173.251 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 8.6 mptt -62.4 -20.45 64.47 Favored 'General case' 0 N--CA 1.475 0.786 0 CA-C-N 120.403 1.456 . . . . 0.0 111.912 -179.587 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -58.14 -29.82 65.85 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 125.552 1.541 . . . . 0.0 110.723 173.347 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 50.4 mtt -60.87 -25.93 67.04 Favored 'General case' 0 C--N 1.339 0.151 0 C-N-CA 123.388 0.675 . . . . 0.0 111.428 178.662 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 61.2 mt-10 -64.84 -35.49 81.28 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-N 118.371 0.532 . . . . 0.0 109.717 -178.445 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 13.5 mt-30 -67.78 -46.04 73.1 Favored 'General case' 0 C--N 1.34 0.159 0 C-N-CA 123.65 0.78 . . . . 0.0 111.836 -171.519 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' TYR . . . . . 0.407 ' CD2' ' HA3' ' A' ' 4' ' ' GLY . 17.5 m-85 -69.54 133.55 47.79 Favored 'General case' 0 CA--C 1.521 -0.159 0 CA-C-N 115.424 -0.807 . . . . 0.0 109.235 -167.372 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -75.4 -31.8 60.55 Favored 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 120.361 -0.535 . . . . 0.0 110.86 -176.187 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 20.8 t -109.54 146.08 15.42 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.368 0 N-CA-C 106.717 -1.586 . . . . 0.0 106.717 168.789 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 27.5 tp -133.08 115.77 15.51 Favored 'General case' 0 N--CA 1.445 -0.696 0 N-CA-C 108.439 -0.948 . . . . 0.0 108.439 174.427 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 23.4 mt -94.6 135.88 27.52 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.63 0 N-CA-C 107.045 -1.465 . . . . 0.0 107.045 177.396 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.513 ' CD2' HD12 ' A' ' 104' ' ' LEU . 0.8 OUTLIER -119.45 131.43 55.62 Favored 'General case' 0 CA--C 1.514 -0.418 0 C-N-CA 125.234 1.413 . . . . 0.0 107.324 -174.466 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -132.64 129.77 5.61 Favored Glycine 0 CA--C 1.519 0.295 0 N-CA-C 110.318 -1.113 . . . . 0.0 110.318 175.036 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 5.8 tt -152.25 133.52 8.0 Favored Pre-proline 0 CA--C 1.541 0.616 0 CA-C-N 118.134 0.967 . . . . 0.0 110.18 169.484 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_exo -76.3 150.05 32.28 Favored 'Trans proline' 0 N--CA 1.46 -0.481 0 C-N-CA 122.824 2.349 . . . . 0.0 112.2 167.704 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 6.2 m -122.93 134.13 54.37 Favored 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 107.252 -1.388 . . . . 0.0 107.252 167.489 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 6.4 m-90 -140.88 148.85 41.14 Favored 'General case' 0 C--O 1.232 0.172 0 C-N-CA 124.91 1.284 . . . . 0.0 107.815 173.626 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -68.29 -33.53 74.51 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-N 118.576 0.626 . . . . 0.0 110.836 173.804 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 33.2 p90 -81.12 7.08 11.87 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 124.313 1.045 . . . . 0.0 112.248 175.67 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -139.23 -171.38 12.19 Favored Glycine 0 CA--C 1.527 0.832 0 C-N-CA 124.603 1.097 . . . . 0.0 111.199 -177.585 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -164.86 163.39 21.12 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 126.324 1.85 . . . . 0.0 106.919 178.43 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 17.5 mt -37.25 132.9 0.24 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.781 0 C-N-CA 125.632 1.573 . . . . 0.0 110.669 167.47 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 12.7 mp0 -66.61 146.65 54.26 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 125.578 1.551 . . . . 0.0 108.661 178.544 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -59.11 -42.01 89.53 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 122.906 0.483 . . . . 0.0 110.239 -179.386 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -58.8 -29.55 66.94 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 124.16 0.984 . . . . 0.0 112.043 178.512 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' TRP . . . . . 0.679 ' CH2' HD23 ' A' ' 104' ' ' LEU . 15.9 t90 -87.22 -45.23 10.83 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 124.303 1.041 . . . . 0.0 109.948 179.828 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -61.59 -35.79 78.85 Favored 'General case' 0 CA--C 1.537 0.46 0 O-C-N 120.903 -1.123 . . . . 0.0 109.656 179.851 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -59.6 -25.11 64.35 Favored 'General case' 0 C--O 1.235 0.313 0 C-N-CA 123.951 0.901 . . . . 0.0 111.473 -179.279 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 11.0 m -109.91 -15.65 9.54 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.295 0 CA-C-O 117.478 -1.249 . . . . 0.0 112.732 178.059 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 24.2 t90 -54.76 -38.31 67.05 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-N 120.042 1.292 . . . . 0.0 109.961 178.78 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -65.91 -27.63 68.33 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 125.342 1.457 . . . . 0.0 112.857 175.638 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 69.4 mt-30 -89.19 -25.05 21.99 Favored 'General case' 0 CA--C 1.514 -0.437 0 C-N-CA 125.417 1.487 . . . . 0.0 111.555 -177.154 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.556 ' CD1' HD21 ' A' ' 104' ' ' LEU . 48.2 mt -57.82 -32.02 67.18 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 118.846 0.748 . . . . 0.0 110.255 173.71 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -69.71 -28.03 65.48 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 122.995 0.518 . . . . 0.0 111.457 173.581 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -80.74 -34.62 34.26 Favored 'General case' 0 CA--C 1.538 0.492 0 N-CA-C 113.199 0.814 . . . . 0.0 113.199 176.846 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 21.6 mt -59.76 148.58 33.79 Favored 'General case' 0 N--CA 1.463 0.207 0 C-N-CA 124.44 1.096 . . . . 0.0 111.758 -173.421 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -82.62 114.4 20.98 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 169.667 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 76.8 mt -129.74 1.07 4.9 Favored 'General case' 0 N--CA 1.475 0.815 0 N-CA-C 113.254 0.835 . . . . 0.0 113.254 -172.982 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 32.7 mt-10 -56.8 133.16 54.07 Favored 'General case' 0 C--O 1.235 0.342 0 CA-C-O 122.122 0.963 . . . . 0.0 111.647 -168.644 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 75.07 -3.87 43.05 Favored Glycine 0 CA--C 1.534 1.263 0 C-N-CA 125.483 1.516 . . . . 0.0 114.976 176.499 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.29 149.75 40.54 Favored 'General case' 0 C--N 1.344 0.357 0 CA-C-N 120.574 2.187 . . . . 0.0 110.114 -175.597 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 5.1 mt -80.71 136.69 22.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 N-CA-C 106.344 -1.724 . . . . 0.0 106.344 178.415 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 64.9 t -130.59 128.65 63.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 C-N-CA 123.556 0.742 . . . . 0.0 109.819 -177.2 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -99.57 145.13 27.86 Favored 'General case' 0 CA--C 1.52 -0.184 0 N-CA-C 107.948 -1.13 . . . . 0.0 107.948 168.442 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 10.5 mt -124.79 132.48 53.34 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 107.406 -1.331 . . . . 0.0 107.406 176.44 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 33.7 p90 -148.69 165.06 32.48 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 168.253 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -165.37 172.46 40.94 Favored Glycine 0 N--CA 1.443 -0.85 0 N-CA-C 109.894 -1.283 . . . . 0.0 109.894 172.512 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 6.6 tt -119.45 148.61 43.05 Favored 'General case' 0 N--CA 1.447 -0.608 0 C-N-CA 125.979 1.712 . . . . 0.0 107.694 -179.922 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -165.17 -156.25 9.0 Favored Glycine 0 CA--C 1.524 0.655 0 N-CA-C 111.329 -0.708 . . . . 0.0 111.329 -178.839 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 14.7 t0 -146.68 117.94 7.85 Favored 'General case' 0 C--O 1.234 0.281 0 C-N-CA 124.732 1.213 . . . . 0.0 109.413 -177.186 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 4.2 pt20 -69.51 -15.52 63.26 Favored 'General case' 0 CA--C 1.536 0.407 0 N-CA-C 112.512 0.56 . . . . 0.0 112.512 178.776 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 34.0 mt -73.26 -5.33 38.74 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 119.065 0.848 . . . . 0.0 110.563 170.784 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -79.15 24.34 2.96 Favored Glycine 0 CA--C 1.534 1.236 0 C-N-CA 125.117 1.341 . . . . 0.0 112.586 168.422 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 44.5 m-85 59.27 5.57 0.61 Allowed 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 128.089 2.556 . . . . 0.0 115.568 172.276 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 66.52 18.37 67.73 Favored Glycine 0 CA--C 1.536 1.35 0 CA-C-N 119.08 0.855 . . . . 0.0 111.067 -172.064 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -91.58 -31.21 15.99 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 124.846 1.259 . . . . 0.0 108.722 168.405 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 96' ' ' TRP . . . . . . . . . . . . . 13.3 m0 -119.09 -2.22 10.79 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 124.121 0.968 . . . . 0.0 113.056 -169.01 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 21.3 t80 -71.25 130.67 42.01 Favored 'General case' 0 N--CA 1.458 -0.066 0 O-C-N 121.591 -0.693 . . . . 0.0 109.506 -172.509 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 92.3 mt 51.35 27.08 3.42 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 124.81 1.244 . . . . 0.0 114.23 167.916 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -64.24 -33.4 75.73 Favored 'General case' 0 C--N 1.331 -0.228 0 O-C-N 120.661 -1.274 . . . . 0.0 110.872 -175.329 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -71.18 -29.43 65.17 Favored 'General case' 0 CA--C 1.535 0.394 0 O-C-N 121.731 -0.606 . . . . 0.0 111.911 175.485 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 5.4 tt -62.4 -45.31 93.72 Favored 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 108.026 -1.102 . . . . 0.0 108.026 169.64 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -64.04 -39.93 97.7 Favored Glycine 0 C--N 1.34 0.765 0 N-CA-C 111.149 -0.78 . . . . 0.0 111.149 -178.707 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 71.6 mtm -66.4 -35.42 80.28 Favored 'General case' 0 CA--C 1.529 0.166 0 CA-C-O 118.206 -0.902 . . . . 0.0 111.904 177.468 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.679 HD23 ' CH2' ' A' ' 65' ' ' TRP . 0.2 OUTLIER -72.89 -36.45 67.34 Favored 'General case' 0 C--N 1.342 0.265 0 CA-C-N 120.768 1.622 . . . . 0.0 110.811 176.234 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 1.8 t60 -54.04 -52.86 59.51 Favored 'General case' 0 CA--C 1.531 0.214 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 169.61 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -63.04 -41.62 99.55 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 123.79 0.836 . . . . 0.0 112.321 -175.239 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 1.7 tppm? -54.77 -27.87 44.53 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 125.72 1.608 . . . . 0.0 111.309 171.488 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 40.4 mt -106.94 -17.72 14.11 Favored 'General case' 0 CA--C 1.519 -0.214 0 N-CA-C 115.228 1.566 . . . . 0.0 115.228 -173.408 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -60.24 -37.11 79.36 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 121.008 1.731 . . . . 0.0 110.977 -172.611 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 16.3 p -81.25 -13.6 58.34 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 125.53 1.532 . . . . 0.0 111.833 -179.772 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 31.8 mmmt -84.8 -5.87 59.34 Favored 'General case' 0 C--N 1.344 0.328 0 C-N-CA 124.955 1.302 . . . . 0.0 111.691 178.702 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 72.76 31.33 62.61 Favored Glycine 0 CA--C 1.523 0.549 0 CA-C-N 118.399 0.545 . . . . 0.0 112.401 169.498 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 14.5 m -75.59 176.59 0.64 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.638 0 CA-C-N 118.163 0.981 . . . . 0.0 109.677 171.992 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -118.03 126.54 52.48 Favored 'General case' 0 CA--C 1.518 -0.265 0 N-CA-C 106.628 -1.619 . . . . 0.0 106.628 173.127 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 62.2 m-85 -91.96 143.29 26.63 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 119.847 1.203 . . . . 0.0 109.805 -177.064 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 35.1 m -131.6 160.88 42.05 Favored 'Isoleucine or valine' 0 C--O 1.235 0.335 0 C-N-CA 125.947 1.699 . . . . 0.0 107.334 169.314 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 84.96 28.68 30.72 Favored Glycine 0 CA--C 1.52 0.392 0 CA-C-O 118.509 -1.162 . . . . 0.0 114.133 172.999 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 20.8 m-30 -60.87 157.02 16.02 Favored 'General case' 0 CA--C 1.543 0.675 0 CA-C-N 118.809 1.305 . . . . 0.0 109.475 168.494 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 46.5 t-105 -134.15 142.05 41.72 Favored Pre-proline 0 N--CA 1.467 0.403 0 CA-C-O 118.608 -0.711 . . . . 0.0 109.719 -170.577 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -70.1 132.64 23.2 Favored 'Trans proline' 0 N--CA 1.458 -0.588 0 C-N-CA 122.576 2.184 . . . . 0.0 111.728 -171.197 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 20.8 p -96.52 -4.64 41.05 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 124.519 1.128 . . . . 0.0 113.778 -179.757 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -64.83 129.36 39.45 Favored 'General case' 0 CA--C 1.537 0.452 0 O-C-N 121.119 -0.988 . . . . 0.0 109.456 -169.608 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 84.39 -0.13 89.34 Favored Glycine 0 CA--C 1.534 1.275 0 C-N-CA 124.785 1.184 . . . . 0.0 113.978 -177.367 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 11.0 t80 -91.72 155.09 18.53 Favored 'General case' 0 CA--C 1.542 0.663 0 CA-C-N 118.898 1.349 . . . . 0.0 108.925 174.366 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 76.9 mm-40 -113.38 138.75 49.61 Favored 'General case' 0 N--CA 1.465 0.323 0 C-N-CA 124.621 1.169 . . . . 0.0 109.247 179.777 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 93.3 m-85 -130.88 136.58 48.76 Favored 'General case' 0 CA--C 1.513 -0.467 0 C-N-CA 123.597 0.759 . . . . 0.0 110.172 -168.85 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 6.6 m -126.73 -43.86 1.69 Allowed 'General case' 0 N--CA 1.431 -1.393 0 CA-C-N 115.206 -0.907 . . . . 0.0 109.221 -177.1 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 54.9 m -104.42 128.46 26.94 Favored Pre-proline 0 CA--C 1.544 0.733 0 C-N-CA 124.948 1.299 . . . . 0.0 108.744 168.745 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -89.37 -3.13 5.97 Favored 'Trans proline' 0 CA--C 1.542 0.881 0 C-N-CA 123.251 2.634 . . . . 0.0 114.488 -171.674 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 22.2 ttmt -54.76 -38.34 65.72 Favored Pre-proline 0 CA--C 1.545 0.773 0 CA-C-O 116.938 -1.506 . . . . 0.0 115.016 -175.051 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 66.7 Cg_endo -79.23 2.11 8.6 Favored 'Trans proline' 0 C--N 1.353 0.798 0 CA-C-N 122.807 2.038 . . . . 0.0 114.065 -177.862 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.416 HG12 ' HA ' ' A' ' 139' ' ' PHE . 17.2 m -129.15 169.49 20.35 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 119.767 1.167 . . . . 0.0 110.274 -173.887 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 20.5 pt -122.34 163.92 20.14 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.012 0 C-N-CA 126.493 1.917 . . . . 0.0 108.881 172.778 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . 55.33 -154.09 0.31 Allowed 'General case' 0 N--CA 1.446 -0.649 0 C-N-CA 124.369 1.067 . . . . 0.0 108.391 -178.784 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 24.8 t0 -80.18 52.72 1.61 Allowed 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 125.082 1.353 . . . . 0.0 111.017 -179.154 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 63.82 32.16 83.25 Favored Glycine 0 CA--C 1.529 0.923 0 C-N-CA 124.065 0.84 . . . . 0.0 111.662 -174.518 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 1.3 tt0 -90.24 -24.76 20.87 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 124.711 1.205 . . . . 0.0 111.664 -169.163 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -145.54 146.14 31.3 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 119.2 0.909 . . . . 0.0 110.091 169.656 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 139' ' ' PHE . . . . . 0.416 ' HA ' HG12 ' A' ' 132' ' ' VAL . 49.1 m-85 -74.15 139.38 44.46 Favored 'General case' 0 CA--C 1.508 -0.641 0 N-CA-C 104.393 -2.447 . . . . 0.0 104.393 165.947 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 9.9 p -77.73 6.89 0.86 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.768 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.263 -177.932 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -172.71 175.28 45.79 Favored Glycine 0 CA--C 1.532 1.109 0 C-N-CA 125.349 1.452 . . . . 0.0 110.069 175.951 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 3.9 tp -65.79 144.68 56.71 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 118.285 1.043 . . . . 0.0 111.271 177.687 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -114.97 117.7 31.37 Favored 'General case' 0 N--CA 1.448 -0.565 0 C-N-CA 126.63 1.972 . . . . 0.0 109.826 -179.632 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 79.9 mt -107.94 149.44 28.34 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 124.856 1.263 . . . . 0.0 108.087 170.274 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 17.5 t0 -143.41 108.88 5.07 Favored 'General case' 0 C--O 1.235 0.296 0 C-N-CA 124.127 0.971 . . . . 0.0 109.139 -178.643 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 39.0 mm-40 -88.88 -26.42 21.62 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 123.025 0.53 . . . . 0.0 111.836 -177.85 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 98.1 m -65.9 -36.77 84.32 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 123.323 0.649 . . . . 0.0 110.67 -176.863 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 40.6 m-80 -114.07 -34.21 5.45 Favored 'General case' 0 C--O 1.232 0.163 0 N-CA-C 113.716 1.006 . . . . 0.0 113.716 -166.516 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 17.7 pt20 -151.45 48.02 0.82 Allowed 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 118.835 0.743 . . . . 0.0 111.876 -169.617 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 47.2 p90 -54.75 -29.34 53.59 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 123.821 0.848 . . . . 0.0 112.94 -179.163 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -59.51 -31.37 69.31 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 123.387 0.675 . . . . 0.0 111.633 178.663 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 81.8 mt -82.8 -14.89 53.57 Favored 'General case' 0 CA--C 1.52 -0.2 0 CA-C-O 117.787 -1.101 . . . . 0.0 112.467 179.987 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 70.7 m -60.69 -35.89 77.43 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 120.723 1.601 . . . . 0.0 110.777 -173.448 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -60.02 -42.11 93.64 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 118.966 0.803 . . . . 0.0 111.307 175.22 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 67.8 mm-40 -69.4 -46.05 67.78 Favored 'General case' 0 CA--C 1.515 -0.386 0 C-N-CA 125.763 1.625 . . . . 0.0 109.944 -178.101 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 67.3 mtt180 -61.55 -46.04 91.61 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 118.228 -0.891 . . . . 0.0 109.701 178.673 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 41.7 mt -61.93 -51.01 77.67 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.204 0 N-CA-C 108.285 -1.006 . . . . 0.0 108.285 176.779 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 66.6 tp60 -48.93 -65.57 0.55 Allowed 'General case' 0 C--O 1.236 0.359 0 C-N-CA 124.527 1.131 . . . . 0.0 111.21 179.972 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 29.5 m -70.73 -28.18 64.52 Favored 'General case' 0 C--N 1.321 -0.653 0 C-N-CA 120.625 -0.43 . . . . 0.0 111.477 -169.24 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 160' ' ' TRP . . . . . . . . . . . . . 57.4 t90 -66.76 -45.92 77.01 Favored 'General case' 0 CA--C 1.518 -0.254 0 CA-C-N 118.791 0.723 . . . . 0.0 111.087 171.532 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 60.4 m -60.64 -43.16 97.9 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 118.262 0.483 . . . . 0.0 110.088 -179.068 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -61.46 -41.59 97.47 Favored 'General case' 0 N--CA 1.455 -0.203 0 CA-C-O 120.984 0.421 . . . . 0.0 110.36 175.201 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 16.3 tt0 -64.84 -51.17 63.54 Favored 'General case' 0 N--CA 1.447 -0.601 0 O-C-N 121.691 -0.631 . . . . 0.0 110.129 -178.413 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 43.4 pt -63.88 -37.55 80.04 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.388 0 CA-C-O 118.174 -0.917 . . . . 0.0 109.703 -175.583 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -64.42 -35.2 80.14 Favored 'General case' 0 CA--C 1.529 0.16 0 CA-C-N 119.247 0.93 . . . . 0.0 109.98 179.66 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 34.9 m-80 -68.56 -50.87 48.54 Favored 'General case' 0 N--CA 1.467 0.382 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 174.118 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 21.9 tt0 -71.11 -25.8 62.75 Favored 'General case' 0 N--CA 1.44 -0.957 0 C-N-CA 125.194 1.398 . . . . 0.0 111.946 -168.747 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 168' ' ' MET . . . . . . . . . . . . . 18.9 ptp -82.05 -31.26 30.98 Favored 'General case' 0 C--O 1.231 0.125 0 O-C-N 121.4 -0.813 . . . . 0.0 112.07 171.052 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -77.77 -36.35 50.62 Favored 'General case' 0 N--CA 1.448 -0.557 0 O-C-N 122.108 -0.37 . . . . 0.0 111.037 -178.419 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -69.97 -26.62 64.19 Favored 'General case' 0 CA--C 1.537 0.452 0 O-C-N 121.862 -0.524 . . . . 0.0 110.611 177.209 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 66.4 t60 -66.84 -33.86 76.54 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 123.951 0.9 . . . . 0.0 110.5 172.296 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -71.1 -45.06 64.41 Favored 'General case' 0 C--O 1.237 0.426 0 C-N-CA 123.861 0.864 . . . . 0.0 111.66 171.649 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.286 0 C-N-CA 125.966 1.706 . . . . 0.0 110.398 -170.004 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 45.7 ttp . . . . . 0 N--CA 1.495 1.8 0 N-CA-C 110.239 -0.282 . . . . 0.0 110.239 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 7.4 t30 -120.48 150.02 41.48 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 124.198 0.999 . . . . 0.0 109.249 172.526 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 20.0 mtt -112.31 125.59 54.34 Favored 'General case' 0 CA--C 1.523 -0.069 0 C-N-CA 123.602 0.761 . . . . 0.0 110.774 -176.451 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -85.28 152.88 27.17 Favored Glycine 0 CA--C 1.524 0.597 0 N-CA-C 106.799 -2.521 . . . . 0.0 106.799 166.41 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 2.1 tt -140.19 96.67 3.09 Favored 'General case' 0 CA--C 1.517 -0.32 0 N-CA-C 105.274 -2.121 . . . . 0.0 105.274 -175.545 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -100.12 141.37 33.04 Favored 'General case' 0 CA--C 1.519 -0.237 0 CA-C-O 121.405 0.621 . . . . 0.0 111.834 -173.519 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 29.3 p90 -159.86 175.88 12.56 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 127.464 2.306 . . . . 0.0 106.325 -178.792 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -153.63 157.01 27.14 Favored Glycine 0 CA--C 1.518 0.222 0 N-CA-C 109.847 -1.301 . . . . 0.0 109.847 178.298 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 75.2 m -146.89 139.37 24.89 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 106.838 -1.541 . . . . 0.0 106.838 179.305 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 15.2 m -136.18 -110.47 0.2 Allowed 'General case' 0 CA--C 1.537 0.474 0 N-CA-C 106.478 -1.675 . . . . 0.0 106.478 177.848 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 3.6 p -69.96 -51.72 30.36 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 119.169 0.895 . . . . 0.0 109.169 169.71 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 56.1 m -83.89 149.92 26.05 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 123.963 0.905 . . . . 0.0 108.646 169.771 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -124.81 136.75 54.11 Favored 'General case' 0 C--O 1.233 0.227 0 C-N-CA 123.913 0.885 . . . . 0.0 110.333 -170.486 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 89.5 m -68.36 141.94 55.61 Favored 'General case' 0 CA--C 1.542 0.64 0 N-CA-C 107.004 -1.48 . . . . 0.0 107.004 167.854 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -65.76 164.08 15.36 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 123.595 0.758 . . . . 0.0 109.27 175.657 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 37.9 mmt -69.07 19.75 0.03 OUTLIER 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 124.852 1.261 . . . . 0.0 113.887 -178.825 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -47.7 -40.04 19.09 Favored 'General case' 0 C--O 1.225 -0.234 0 C-N-CA 126.164 1.786 . . . . 0.0 110.582 169.632 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -62.31 -49.33 76.07 Favored 'General case' 0 N--CA 1.461 0.098 0 C-N-CA 123.096 0.559 . . . . 0.0 111.87 -178.315 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 7.1 mt-10 -61.45 -41.07 96.63 Favored 'General case' 0 CA--C 1.518 -0.256 0 O-C-N 121.875 -0.516 . . . . 0.0 110.032 176.086 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 30.2 mtpp -70.31 -43.24 70.75 Favored 'General case' 0 C--O 1.221 -0.4 0 CA-C-O 118.603 -0.713 . . . . 0.0 110.622 -173.991 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 43.4 mt -52.87 -55.41 11.98 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.206 0 CA-C-N 119.492 1.042 . . . . 0.0 108.587 173.53 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 5.0 ttp180 -59.6 -42.1 91.83 Favored 'General case' 0 C--O 1.224 -0.273 0 C-N-CA 123.253 0.621 . . . . 0.0 109.618 -176.256 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -65.13 -40.92 95.13 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 123.21 0.604 . . . . 0.0 111.447 -179.498 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 54.3 mt -74.14 -54.42 14.94 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.537 0 C-N-CA 124.794 1.238 . . . . 0.0 110.139 -172.385 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 73.6 mt -64.3 -46.22 93.83 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 179.03 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 139.16 125.65 2.3 Favored Glycine 0 CA--C 1.533 1.179 0 C-N-CA 125.263 1.411 . . . . 0.0 111.733 172.546 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -70.51 -8.65 24.11 Favored 'Trans proline' 0 CA--C 1.535 0.562 0 C-N-CA 123.499 2.799 . . . . 0.0 113.668 -175.584 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -74.26 -21.92 59.55 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 119.007 0.821 . . . . 0.0 111.624 175.385 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -131.83 2.86 4.07 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 124.514 1.125 . . . . 0.0 113.893 -170.454 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 34.5 t -121.61 149.72 24.79 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.393 0 C-N-CA 124.619 1.168 . . . . 0.0 108.051 171.173 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 31.1 m -137.46 130.44 30.45 Favored 'General case' 0 N--CA 1.456 -0.165 0 C-N-CA 126.043 1.737 . . . . 0.0 106.689 -172.379 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 26.3 mt -79.36 141.22 37.12 Favored 'General case' 0 C--O 1.233 0.19 0 N-CA-C 107.826 -1.176 . . . . 0.0 107.826 176.859 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 34.1 t-80 -132.13 64.9 1.59 Allowed 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 107.393 -1.336 . . . . 0.0 107.393 -177.236 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 65.1 t-20 -73.07 115.11 12.0 Favored 'General case' 0 C--O 1.235 0.29 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 -177.326 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.403 HD13 ' CG2' ' A' ' 68' ' ' VAL . 87.0 mt -67.85 -12.41 60.58 Favored 'General case' 0 CA--C 1.532 0.284 0 N-CA-C 112.959 0.725 . . . . 0.0 112.959 -175.86 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -57.47 -26.14 60.8 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 118.746 0.703 . . . . 0.0 110.66 168.325 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -130.14 -40.43 1.31 Allowed 'General case' 0 N--CA 1.466 0.342 0 N-CA-C 113.558 0.947 . . . . 0.0 113.558 -173.957 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 33.0 m-20 -87.32 141.42 28.65 Favored 'General case' 0 C--O 1.236 0.357 0 C-N-CA 123.33 0.652 . . . . 0.0 110.139 -176.018 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 12.9 m -78.42 156.15 78.64 Favored Pre-proline 0 CA--C 1.542 0.666 0 C-N-CA 124.214 1.006 . . . . 0.0 110.291 177.556 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -77.34 -25.22 8.57 Favored 'Trans proline' 0 C--N 1.35 0.625 0 C-N-CA 122.01 1.807 . . . . 0.0 113.589 -171.232 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 3.7 mptp? -60.94 -22.19 64.17 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-N 119.976 1.262 . . . . 0.0 112.088 -179.874 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -60.49 -28.34 68.27 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 125.945 1.698 . . . . 0.0 110.764 174.773 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 57.1 mtt -58.87 -26.28 64.09 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 118.64 0.654 . . . . 0.0 111.254 178.376 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -65.06 -33.82 76.96 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 118.427 0.558 . . . . 0.0 110.759 -176.461 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 14.4 mt-30 -67.24 -43.61 81.55 Favored 'General case' 0 CA--C 1.531 0.228 0 N-CA-C 113.589 0.959 . . . . 0.0 113.589 -168.907 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 31.1 m-85 -71.17 145.9 49.44 Favored 'General case' 0 CA--C 1.527 0.067 0 CA-C-N 115.488 -0.778 . . . . 0.0 111.634 -165.331 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 41.4 m-20 -75.22 -38.48 60.63 Favored 'General case' 0 N--CA 1.47 0.541 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 -176.833 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.407 HG21 ' SD ' ' A' ' 168' ' ' MET . 17.7 t -112.64 147.41 16.37 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.279 0 N-CA-C 106.828 -1.545 . . . . 0.0 106.828 169.843 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 26.2 tp -129.45 110.22 11.7 Favored 'General case' 0 N--CA 1.447 -0.586 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 172.255 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 23.3 mt -86.67 132.25 32.78 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.583 0 N-CA-C 106.719 -1.586 . . . . 0.0 106.719 174.998 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 2.5 mp -111.93 124.93 53.44 Favored 'General case' 0 CA--C 1.519 -0.238 0 N-CA-C 106.886 -1.524 . . . . 0.0 106.886 -179.081 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -119.96 133.07 9.74 Favored Glycine 0 N--CA 1.451 -0.318 0 N-CA-C 108.994 -1.642 . . . . 0.0 108.994 171.248 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 5.1 tt -152.57 131.42 6.6 Favored Pre-proline 0 CA--C 1.531 0.234 0 CA-C-N 117.765 0.783 . . . . 0.0 109.746 168.766 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_exo -74.74 149.66 38.33 Favored 'Trans proline' 0 N--CA 1.455 -0.762 0 C-N-CA 121.898 1.732 . . . . 0.0 112.87 169.063 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 8.4 m -133.0 101.97 5.44 Favored 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 103.666 -2.716 . . . . 0.0 103.666 165.921 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 13.6 m-90 -78.84 69.35 5.0 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 118.757 0.708 . . . . 0.0 110.889 -170.992 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 12.1 t0 62.08 -85.16 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.268 0 C-N-CA 126.516 1.926 . . . . 0.0 110.146 -170.86 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 31.8 p90 -95.43 -17.02 21.87 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 125.531 1.532 . . . . 0.0 112.092 172.467 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -65.03 151.2 51.59 Favored Glycine 0 CA--C 1.528 0.9 0 C-N-CA 124.183 0.897 . . . . 0.0 111.141 179.61 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 26.5 tt0 -119.58 179.21 4.29 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 124.699 1.2 . . . . 0.0 111.571 -167.333 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 4.8 mt -43.53 138.16 0.82 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.833 0 C-N-CA 128.302 2.641 . . . . 0.0 110.913 175.322 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -89.63 157.88 17.84 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 123.873 0.869 . . . . 0.0 110.356 172.499 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -52.66 -47.64 66.98 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 124.561 1.145 . . . . 0.0 112.994 -168.02 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -67.04 -22.52 65.87 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 119.274 0.943 . . . . 0.0 112.331 -170.883 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' TRP . . . . . 0.78 ' CH2' HD23 ' A' ' 104' ' ' LEU . 2.1 t90 -90.17 -42.12 11.23 Favored 'General case' 0 N--CA 1.456 -0.174 0 C-N-CA 124.468 1.107 . . . . 0.0 109.29 177.147 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 9.3 tt0 -62.55 -35.59 79.93 Favored 'General case' 0 N--CA 1.446 -0.625 0 O-C-N 121.081 -1.012 . . . . 0.0 109.927 178.697 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -58.94 -24.62 62.71 Favored 'General case' 0 C--O 1.234 0.254 0 C-N-CA 124.468 1.107 . . . . 0.0 111.643 -178.279 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.403 ' CG2' HD13 ' A' ' 35' ' ' LEU . 28.3 m -113.54 -13.41 11.39 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.324 0 CA-C-O 117.267 -1.349 . . . . 0.0 112.65 178.305 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 25.6 t90 -52.48 -39.88 61.69 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 120.396 1.453 . . . . 0.0 110.119 177.443 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -64.54 -25.69 68.09 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 125.253 1.421 . . . . 0.0 113.167 176.353 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 60.0 mt-30 -92.44 -17.0 25.16 Favored 'General case' 0 CA--C 1.52 -0.189 0 C-N-CA 125.697 1.599 . . . . 0.0 111.716 -178.971 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.601 HD12 HD21 ' A' ' 104' ' ' LEU . 14.7 mt -69.15 -19.32 64.01 Favored 'General case' 0 CA--C 1.531 0.219 0 O-C-N 121.204 -0.935 . . . . 0.0 111.37 -175.188 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -85.53 -22.21 28.24 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-O 118.994 -0.527 . . . . 0.0 111.192 169.489 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -70.72 -31.05 67.77 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-N 119.438 1.017 . . . . 0.0 111.887 172.05 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 25.5 mt -58.04 144.46 39.76 Favored 'General case' 0 C--O 1.234 0.264 0 C-N-CA 123.752 0.821 . . . . 0.0 112.007 -176.149 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 2.9 t30 -86.75 86.33 7.32 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 125.094 1.358 . . . . 0.0 107.489 173.049 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 3.7 pp -142.09 135.34 29.02 Favored 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 169.707 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -149.52 151.66 34.27 Favored 'General case' 0 N--CA 1.439 -0.992 0 C-N-CA 127.698 2.399 . . . . 0.0 104.835 169.412 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 72.18 -6.54 10.26 Favored Glycine 0 CA--C 1.534 1.26 0 N-CA-C 116.905 1.522 . . . . 0.0 116.905 169.687 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.46 161.51 29.73 Favored 'General case' 0 C--N 1.342 0.282 0 CA-C-N 120.21 2.005 . . . . 0.0 110.047 -175.756 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 3.6 mt -80.26 135.97 24.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 106.923 -1.51 . . . . 0.0 106.923 176.689 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 73.1 t -133.03 132.49 58.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 C-N-CA 123.53 0.732 . . . . 0.0 109.509 -177.12 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -104.01 154.71 19.36 Favored 'General case' 0 CA--C 1.519 -0.25 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 168.674 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 2.0 mt -135.58 138.77 43.31 Favored 'General case' 0 CA--C 1.513 -0.447 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 172.138 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 36.0 p90 -151.89 167.63 27.72 Favored 'General case' 0 N--CA 1.446 -0.647 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 169.617 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -168.49 154.26 23.92 Favored Glycine 0 N--CA 1.448 -0.544 0 N-CA-C 109.414 -1.474 . . . . 0.0 109.414 172.143 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -109.55 158.69 17.75 Favored 'General case' 0 CA--C 1.519 -0.232 0 C-N-CA 123.171 0.588 . . . . 0.0 111.49 169.217 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -161.72 -153.47 7.09 Favored Glycine 0 N--CA 1.448 -0.56 0 N-CA-C 109.938 -1.265 . . . . 0.0 109.938 179.446 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 7.9 t0 -138.74 162.72 34.02 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 106.254 -1.758 . . . . 0.0 106.254 172.729 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 6.3 pt20 -124.25 -6.27 7.71 Favored 'General case' 0 N--CA 1.446 -0.63 0 C-N-CA 125.876 1.671 . . . . 0.0 112.182 178.386 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 90.3 mt -83.22 -5.14 59.02 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 124.534 1.134 . . . . 0.0 112.315 -174.351 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -81.01 -57.55 2.81 Favored Glycine 0 CA--C 1.527 0.829 0 N-CA-C 107.772 -2.131 . . . . 0.0 107.772 168.78 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 27.6 t80 -156.16 -34.48 0.09 Allowed 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 125.043 1.337 . . . . 0.0 111.204 170.609 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 77.41 -34.18 1.56 Allowed Glycine 0 C--N 1.335 0.487 0 C-N-CA 125.474 1.511 . . . . 0.0 114.668 172.554 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 26.6 mt-10 -71.74 -0.48 11.11 Favored 'General case' 0 CA--C 1.543 0.679 0 CA-C-N 119.569 1.684 . . . . 0.0 112.572 -179.305 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 96' ' ' TRP . . . . . . . . . . . . . 8.5 m0 -110.29 -5.72 15.19 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 127.093 2.157 . . . . 0.0 112.463 174.751 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -74.34 166.01 24.21 Favored 'General case' 0 C--N 1.341 0.198 0 CA-C-N 118.992 0.815 . . . . 0.0 112.188 -167.765 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 86.5 mt 56.19 19.32 3.77 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 125.824 1.65 . . . . 0.0 113.805 -177.095 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -58.09 -35.81 71.96 Favored 'General case' 0 C--N 1.33 -0.264 0 O-C-N 120.853 -1.155 . . . . 0.0 111.365 174.301 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -71.99 -30.47 65.28 Favored 'General case' 0 C--N 1.343 0.31 0 O-C-N 121.636 -0.665 . . . . 0.0 112.016 177.775 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 4.8 tt -61.68 -43.14 99.42 Favored 'General case' 0 CA--C 1.539 0.553 0 N-CA-C 107.94 -1.133 . . . . 0.0 107.94 169.243 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -64.06 -39.91 97.65 Favored Glycine 0 CA--C 1.527 0.795 0 CA-C-O 119.383 -0.676 . . . . 0.0 112.823 179.345 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 71.4 mtm -60.36 -38.34 83.54 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 119.163 1.481 . . . . 0.0 112.178 -176.604 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.78 HD23 ' CH2' ' A' ' 65' ' ' TRP . 0.1 OUTLIER -73.43 -34.72 65.59 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 119.221 0.919 . . . . 0.0 110.808 179.652 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 55.8 t-80 -61.29 -43.23 99.23 Favored 'General case' 0 C--O 1.232 0.14 0 O-C-N 121.681 -0.637 . . . . 0.0 110.262 174.758 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -64.54 -43.26 94.55 Favored 'General case' 0 C--O 1.234 0.239 0 C-N-CA 123.033 0.533 . . . . 0.0 111.393 -177.675 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 22.5 ttmm -55.43 -52.63 62.97 Favored 'General case' 0 N--CA 1.463 0.205 0 C-N-CA 123.204 0.602 . . . . 0.0 109.863 170.904 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 35.7 mt -77.62 -20.41 53.94 Favored 'General case' 0 CA--C 1.517 -0.297 0 N-CA-C 114.195 1.183 . . . . 0.0 114.195 -168.188 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 61.2 m -61.22 -33.37 73.39 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 119.353 0.979 . . . . 0.0 110.75 -179.672 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 40.3 p -87.59 -19.04 28.36 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 123.446 0.699 . . . . 0.0 111.16 179.581 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 20.5 mmmt -71.92 -19.87 61.85 Favored 'General case' 0 N--CA 1.468 0.47 0 O-C-N 121.576 -0.703 . . . . 0.0 109.654 167.738 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 76.21 38.02 35.53 Favored Glycine 0 C--N 1.337 0.63 0 C-N-CA 123.846 0.736 . . . . 0.0 111.655 173.811 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 9.6 m -71.57 172.58 0.95 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.581 0 CA-C-N 118.752 1.276 . . . . 0.0 109.755 171.094 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -106.49 125.1 50.58 Favored 'General case' 0 CA--C 1.517 -0.295 0 N-CA-C 106.361 -1.718 . . . . 0.0 106.361 172.348 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 78.1 m-85 -92.91 145.41 24.4 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 119.481 1.037 . . . . 0.0 109.916 -178.015 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 35.5 m -131.74 157.84 43.21 Favored 'Isoleucine or valine' 0 C--O 1.234 0.282 0 C-N-CA 125.187 1.395 . . . . 0.0 107.703 169.569 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 84.02 31.46 25.99 Favored Glycine 0 CA--C 1.524 0.628 0 CA-C-O 118.596 -1.113 . . . . 0.0 114.835 169.837 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 13.6 m-30 -63.59 160.5 16.56 Favored 'General case' 0 CA--C 1.545 0.785 0 CA-C-N 119.257 1.529 . . . . 0.0 109.417 168.784 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 48.2 t-105 -138.84 148.15 57.03 Favored Pre-proline 0 N--CA 1.47 0.561 0 CA-C-O 118.12 -0.943 . . . . 0.0 111.432 -168.236 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -67.52 130.33 22.01 Favored 'Trans proline' 0 CA--C 1.536 0.588 0 C-N-CA 123.345 2.697 . . . . 0.0 112.352 -179.413 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 22.6 p -93.3 6.58 47.6 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 125.679 1.591 . . . . 0.0 112.392 170.988 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -61.68 126.95 29.16 Favored 'General case' 0 CA--C 1.534 0.36 0 O-C-N 121.024 -1.048 . . . . 0.0 109.697 -169.497 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 80.93 5.37 90.16 Favored Glycine 0 CA--C 1.535 1.298 0 C-N-CA 124.723 1.154 . . . . 0.0 113.918 -178.0 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 4.5 t80 -95.36 162.35 13.7 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 119.386 1.593 . . . . 0.0 109.196 175.034 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 74.9 mm-40 -126.75 143.92 51.1 Favored 'General case' 0 N--CA 1.463 0.213 0 C-N-CA 124.467 1.107 . . . . 0.0 108.948 178.91 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 50.4 m-85 -137.93 150.79 47.37 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-O 121.679 0.752 . . . . 0.0 112.337 -175.121 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 8.9 t -132.18 -32.05 1.41 Allowed 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 113.892 -1.504 . . . . 0.0 108.525 168.034 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 56.6 m -83.61 120.45 75.35 Favored Pre-proline 0 CA--C 1.542 0.644 0 N-CA-C 108.08 -1.081 . . . . 0.0 108.08 168.617 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -82.6 -22.73 4.4 Favored 'Trans proline' 0 CA--C 1.538 0.713 0 C-N-CA 122.376 2.051 . . . . 0.0 112.846 -176.292 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 15.2 ttmt -50.24 -41.77 68.36 Favored Pre-proline 0 CA--C 1.543 0.708 0 N-CA-C 115.795 1.776 . . . . 0.0 115.795 -170.712 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_endo -70.66 -11.45 29.68 Favored 'Trans proline' 0 C--N 1.352 0.751 0 CA-C-N 122.345 1.873 . . . . 0.0 114.365 179.651 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 30.9 m -132.51 171.34 18.27 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.428 0 CA-C-N 119.638 1.108 . . . . 0.0 112.874 -167.205 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 14.7 pt -138.56 173.92 11.21 Favored 'Isoleucine or valine' 0 C--O 1.236 0.384 0 C-N-CA 127.985 2.514 . . . . 0.0 108.348 -178.747 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . 55.77 40.0 30.76 Favored 'General case' 0 N--CA 1.463 0.224 0 C-N-CA 125.306 1.442 . . . . 0.0 112.615 174.068 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 27.3 t0 56.0 42.57 28.41 Favored 'General case' 0 C--N 1.324 -0.536 0 C-N-CA 125.998 1.719 . . . . 0.0 111.498 -176.159 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 87.26 21.43 48.99 Favored Glycine 0 CA--C 1.528 0.874 0 CA-C-N 115.211 -0.904 . . . . 0.0 113.541 174.129 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 44.7 mt-30 -97.54 -6.22 34.05 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 118.804 1.302 . . . . 0.0 112.781 -178.844 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 8.1 tp -154.21 147.23 24.56 Favored 'General case' 0 C--N 1.344 0.369 0 CA-C-N 119.618 1.099 . . . . 0.0 110.691 169.579 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 54.7 m-85 -80.76 150.63 29.19 Favored 'General case' 0 CA--C 1.52 -0.18 0 C-N-CA 124.19 0.996 . . . . 0.0 108.695 169.944 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 15.3 m -79.82 11.88 0.54 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.589 0 N-CA-C 112.977 0.732 . . . . 0.0 112.977 173.559 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 178.35 174.87 45.0 Favored Glycine 0 CA--C 1.526 0.755 0 N-CA-C 110.485 -1.046 . . . . 0.0 110.485 -178.44 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 3.5 tp -65.63 133.66 51.62 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 118.471 1.135 . . . . 0.0 110.51 177.758 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -99.62 113.66 26.24 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 125.147 1.379 . . . . 0.0 108.927 173.545 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 69.0 mt -104.45 167.91 9.43 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 125.309 1.444 . . . . 0.0 107.983 169.731 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -137.47 147.28 45.17 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 124.366 1.067 . . . . 0.0 108.243 174.668 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 19.4 tt0 -109.83 -11.11 14.73 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 125.842 1.657 . . . . 0.0 112.04 -172.587 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 76.7 m -124.51 -36.37 2.63 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 125.165 1.386 . . . . 0.0 111.979 -168.125 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 6.1 m-80 -95.46 -34.57 12.03 Favored 'General case' 0 C--N 1.332 -0.188 0 C-N-CA 124.278 1.031 . . . . 0.0 111.598 -168.423 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 68.8 mt-30 -128.26 151.17 49.59 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 125.269 1.428 . . . . 0.0 108.477 179.576 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 92.7 m-85 -137.17 -52.61 0.68 Allowed 'General case' 0 N--CA 1.463 0.192 0 C-N-CA 124.102 0.961 . . . . 0.0 109.044 177.262 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -65.15 -41.81 94.37 Favored 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 122.952 0.501 . . . . 0.0 111.04 179.089 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 67.7 mt -74.78 -22.9 58.5 Favored 'General case' 0 CA--C 1.519 -0.237 0 CA-C-O 118.619 -0.705 . . . . 0.0 111.589 -176.71 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 13.8 m -62.8 -34.11 76.59 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-N 119.487 1.04 . . . . 0.0 109.97 -179.056 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -63.85 -42.46 97.57 Favored 'General case' 0 N--CA 1.465 0.283 0 O-C-N 121.784 -0.572 . . . . 0.0 111.166 173.586 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 -65.4 -42.41 92.63 Favored 'General case' 0 N--CA 1.456 -0.165 0 C-N-CA 124.115 0.966 . . . . 0.0 110.68 177.79 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 73.9 mtt180 -62.46 -46.4 88.69 Favored 'General case' 0 N--CA 1.456 -0.146 0 CA-C-O 118.009 -0.996 . . . . 0.0 109.874 177.401 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 48.7 mt -60.54 -51.2 75.85 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.283 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 177.457 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 72.7 tp60 -53.15 -63.33 1.18 Allowed 'General case' 0 C--O 1.234 0.247 0 C-N-CA 124.3 1.04 . . . . 0.0 111.44 -177.442 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 35.9 m -67.63 -33.06 74.21 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 119.473 -0.298 . . . . 0.0 111.257 -171.092 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 160' ' ' TRP . . . . . . . . . . . . . 49.9 t90 -64.78 -46.96 79.88 Favored 'General case' 0 C--O 1.225 -0.189 0 CA-C-N 118.384 0.538 . . . . 0.0 110.447 173.794 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 55.1 m -60.32 -44.47 95.45 Favored 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 122.843 0.457 . . . . 0.0 110.653 -178.74 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -62.02 -39.17 91.37 Favored 'General case' 0 N--CA 1.456 -0.158 0 CA-C-O 120.946 0.403 . . . . 0.0 110.169 176.838 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 17.3 tt0 -66.89 -52.12 47.23 Favored 'General case' 0 N--CA 1.446 -0.641 0 O-C-N 121.736 -0.602 . . . . 0.0 109.895 -178.779 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 43.4 pt -62.92 -37.49 79.4 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.397 0 CA-C-O 118.072 -0.966 . . . . 0.0 109.36 -175.433 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -64.99 -34.12 77.67 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 119.493 1.042 . . . . 0.0 110.2 -179.672 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 32.9 m-80 -69.48 -52.26 28.23 Favored 'General case' 0 N--CA 1.465 0.277 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 174.419 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 16.1 tt0 -70.73 -26.02 63.2 Favored 'General case' 0 N--CA 1.443 -0.802 0 C-N-CA 124.863 1.265 . . . . 0.0 111.741 -168.647 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 168' ' ' MET . . . . . 0.407 ' SD ' HG21 ' A' ' 48' ' ' VAL . 19.7 ptp -80.64 -32.78 36.1 Favored 'General case' 0 C--N 1.335 -0.03 0 O-C-N 121.117 -0.99 . . . . 0.0 112.051 171.354 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -77.41 -40.08 44.82 Favored 'General case' 0 N--CA 1.447 -0.624 0 O-C-N 122.19 -0.319 . . . . 0.0 110.747 -176.702 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -65.95 -28.46 68.92 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 123.15 0.58 . . . . 0.0 110.719 177.729 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 64.5 t60 -66.51 -38.67 87.72 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 124.105 0.962 . . . . 0.0 111.06 173.727 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 1.9 m-85 -75.2 -29.02 60.21 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 123.551 0.74 . . . . 0.0 112.64 176.105 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.155 0 CA-C-O 118.074 -0.965 . . . . 0.0 111.014 -175.571 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 51.4 ttp . . . . . 0 N--CA 1.498 1.933 0 N-CA-C 110.134 -0.321 . . . . 0.0 110.134 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 9.7 t30 -138.26 152.43 48.55 Favored 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 107.54 -1.281 . . . . 0.0 107.54 170.898 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 20.8 mtt -112.59 123.52 50.48 Favored 'General case' 0 C--N 1.331 -0.221 0 C-N-CA 123.052 0.541 . . . . 0.0 110.835 -176.16 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -83.55 150.55 27.05 Favored Glycine 0 CA--C 1.522 0.474 0 N-CA-C 106.43 -2.668 . . . . 0.0 106.43 166.401 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 2.2 tt -138.43 96.37 3.16 Favored 'General case' 0 CA--C 1.515 -0.388 0 N-CA-C 104.629 -2.36 . . . . 0.0 104.629 -176.877 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -101.0 142.22 32.79 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-O 121.951 0.881 . . . . 0.0 111.312 -171.398 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 45.7 p90 -162.5 -179.22 6.78 Favored 'General case' 0 N--CA 1.446 -0.656 0 C-N-CA 126.319 1.848 . . . . 0.0 106.727 178.937 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -148.11 159.84 28.15 Favored Glycine 0 CA--C 1.52 0.389 0 N-CA-C 107.737 -2.145 . . . . 0.0 107.737 169.955 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 71.0 m -137.42 120.21 16.31 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 107.207 -1.405 . . . . 0.0 107.207 -179.537 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -143.99 -70.99 0.3 Allowed 'General case' 0 CA--C 1.535 0.393 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 -178.531 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 4.5 p -91.01 -71.14 0.65 Allowed 'General case' 0 C--O 1.234 0.28 0 N-CA-C 106.368 -1.716 . . . . 0.0 106.368 173.859 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 96.7 m -79.69 162.48 25.19 Favored 'General case' 0 C--O 1.237 0.402 0 N-CA-C 107.696 -1.224 . . . . 0.0 107.696 165.834 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 33.6 p90 -137.85 151.55 48.18 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 124.442 1.097 . . . . 0.0 109.781 -178.989 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 8.2 m -125.97 -0.11 7.24 Favored 'General case' 0 CA--C 1.541 0.618 0 N-CA-C 113.11 0.781 . . . . 0.0 113.11 -167.751 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -64.09 -30.94 71.98 Favored 'General case' 0 CA--C 1.535 0.365 0 O-C-N 120.525 -1.359 . . . . 0.0 112.951 -167.589 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -63.19 -46.75 85.62 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 119.663 1.119 . . . . 0.0 109.63 -177.356 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -65.59 -43.65 89.03 Favored 'General case' 0 C--O 1.227 -0.109 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 178.574 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -63.1 -47.83 81.15 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 122.315 0.246 . . . . 0.0 111.174 -175.889 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.7 pp20? -70.42 -33.88 71.85 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-O 118.684 -0.674 . . . . 0.0 110.036 -178.647 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 42.5 mmtt -58.88 -51.39 70.25 Favored 'General case' 0 C--O 1.224 -0.269 0 CA-C-N 119.532 1.06 . . . . 0.0 110.74 171.086 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 34.2 mt -54.23 -54.7 19.16 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.271 0 CA-C-N 119.069 0.85 . . . . 0.0 109.619 -176.638 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.404 ' HG2' HD21 ' A' ' 32' ' ' LEU . 0.0 OUTLIER -64.55 -37.13 86.48 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-O 118.704 -0.665 . . . . 0.0 111.024 -177.128 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -64.3 -38.7 91.98 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 118.261 0.482 . . . . 0.0 110.455 179.786 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 68.7 mt -77.41 -54.52 12.58 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.624 0 C-N-CA 124.89 1.276 . . . . 0.0 110.263 -173.777 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 80.7 mt -62.03 -47.51 92.82 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 179.983 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 141.77 121.18 1.69 Allowed Glycine 0 CA--C 1.526 0.773 0 C-N-CA 125.147 1.356 . . . . 0.0 110.199 177.944 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -71.35 -9.63 25.64 Favored 'Trans proline' 0 CA--C 1.538 0.683 0 C-N-CA 123.055 2.504 . . . . 0.0 113.458 -171.476 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -81.46 -16.75 51.01 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 119.025 0.829 . . . . 0.0 111.86 -179.715 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -128.22 5.17 5.8 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 124.87 1.268 . . . . 0.0 113.58 -173.579 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 28.3 t -125.84 147.75 30.55 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.273 0 N-CA-C 107.789 -1.189 . . . . 0.0 107.789 172.972 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 19.8 m -134.77 130.65 36.48 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 125.38 1.472 . . . . 0.0 108.063 -174.139 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.404 HD21 ' HG2' ' A' ' 22' ' ' ARG . 16.7 mt -77.83 135.15 37.9 Favored 'General case' 0 C--O 1.232 0.166 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 175.404 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 38.4 t-80 -126.76 66.11 1.26 Allowed 'General case' 0 CA--C 1.53 0.201 0 N-CA-C 107.289 -1.374 . . . . 0.0 107.289 -175.747 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 65.0 t-20 -74.6 114.26 12.81 Favored 'General case' 0 C--O 1.234 0.274 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 -176.254 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 88.3 mt -66.16 -12.29 54.9 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 124.395 1.078 . . . . 0.0 112.897 -176.44 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 23.0 tptm -58.13 -27.4 63.73 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-N 118.578 0.626 . . . . 0.0 110.571 169.093 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -130.55 -39.59 1.28 Allowed 'General case' 0 N--CA 1.465 0.287 0 N-CA-C 113.486 0.921 . . . . 0.0 113.486 -173.513 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 38.4 m-20 -87.11 138.95 31.06 Favored 'General case' 0 C--O 1.234 0.288 0 C-N-CA 123.568 0.747 . . . . 0.0 110.17 -176.929 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 14.1 m -75.92 154.57 84.93 Favored Pre-proline 0 CA--C 1.541 0.622 0 C-N-CA 124.118 0.967 . . . . 0.0 110.174 177.284 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 66.7 Cg_endo -75.39 -26.12 10.61 Favored 'Trans proline' 0 C--N 1.351 0.705 0 C-N-CA 122.235 1.957 . . . . 0.0 113.908 -170.911 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.79 -16.17 64.08 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-N 120.358 1.436 . . . . 0.0 112.28 -179.057 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -60.08 -27.69 67.2 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 125.144 1.378 . . . . 0.0 110.543 170.82 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 57.1 mtt -58.05 -26.13 62.1 Favored 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 123.376 0.67 . . . . 0.0 111.62 176.832 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 59.6 mt-10 -67.22 -33.71 75.94 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 118.323 0.511 . . . . 0.0 110.391 -175.466 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 19.0 mt-30 -65.23 -43.9 89.95 Favored 'General case' 0 N--CA 1.464 0.257 0 C-N-CA 123.666 0.787 . . . . 0.0 112.396 -169.908 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 18.5 m-85 -72.89 140.05 47.27 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 123.705 0.802 . . . . 0.0 110.176 -166.869 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -74.7 -37.52 62.6 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 118.481 0.582 . . . . 0.0 110.022 -178.297 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 13.5 t -105.34 145.53 13.46 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.328 0 N-CA-C 107.498 -1.297 . . . . 0.0 107.498 170.117 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 32.9 tp -134.19 106.1 6.99 Favored 'General case' 0 N--CA 1.447 -0.611 0 N-CA-C 108.601 -0.889 . . . . 0.0 108.601 175.418 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 24.8 mt -85.76 129.62 37.74 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 N-CA-C 106.638 -1.616 . . . . 0.0 106.638 177.557 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 1.4 mp -104.13 130.79 51.87 Favored 'General case' 0 N--CA 1.467 0.417 0 N-CA-C 105.953 -1.869 . . . . 0.0 105.953 177.207 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -131.17 119.22 2.59 Favored Glycine 0 CA--C 1.505 -0.576 0 N-CA-C 108.635 -1.786 . . . . 0.0 108.635 -176.945 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 1.6 tt -144.07 120.97 6.51 Favored Pre-proline 0 CA--C 1.531 0.238 0 CA-C-N 118.235 1.018 . . . . 0.0 108.706 179.517 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 76.9 Cg_exo -56.58 -40.21 85.99 Favored 'Trans proline' 0 N--CA 1.459 -0.535 0 C-N-CA 122.499 2.133 . . . . 0.0 114.286 -178.502 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 88.9 m 67.21 136.09 0.03 OUTLIER 'General case' 0 CA--C 1.55 0.965 0 C-N-CA 126.495 1.918 . . . . 0.0 110.165 -167.254 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 22.5 t90 -158.01 128.78 6.38 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 124.455 1.102 . . . . 0.0 108.153 -169.651 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -76.41 142.07 41.22 Favored 'General case' 0 C--O 1.236 0.358 0 C-N-CA 123.343 0.657 . . . . 0.0 110.528 177.63 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 30.0 t80 52.6 49.06 21.2 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 125.24 1.416 . . . . 0.0 111.298 178.817 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 178.89 -37.12 0.08 OUTLIER Glycine 0 CA--C 1.532 1.097 0 CA-C-N 115.669 -0.696 . . . . 0.0 111.381 -179.277 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . 0.299 10.7 pt-20 50.53 -156.56 0.11 Allowed 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 126.949 2.099 . . . . 0.0 113.818 169.913 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 20.8 mt -44.05 120.75 0.47 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.654 0 C-N-CA 127.374 2.27 . . . . 0.0 109.768 177.268 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 2.0 pm0 -67.56 151.93 46.5 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 123.585 0.754 . . . . 0.0 110.913 177.197 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -49.2 -51.23 34.2 Favored 'General case' 0 N--CA 1.463 0.205 0 C-N-CA 125.843 1.657 . . . . 0.0 112.669 -168.894 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -68.65 -17.11 64.03 Favored 'General case' 0 N--CA 1.473 0.712 0 CA-C-N 119.019 0.827 . . . . 0.0 112.043 -170.413 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' TRP . . . . . 0.505 ' CZ3' ' CE3' ' A' ' 69' ' ' TRP . 0.0 OUTLIER -88.69 -47.1 8.5 Favored 'General case' 0 CA--C 1.538 0.51 0 N-CA-C 107.449 -1.315 . . . . 0.0 107.449 178.071 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 12.0 tt0 -63.6 -33.46 75.65 Favored 'General case' 0 N--CA 1.449 -0.519 0 O-C-N 120.598 -1.314 . . . . 0.0 110.542 178.804 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -54.75 -25.15 25.91 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 125.085 1.354 . . . . 0.0 112.45 -177.763 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 29.6 m -114.28 -13.85 11.14 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.209 0 CA-C-O 117.204 -1.379 . . . . 0.0 112.918 177.356 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' TRP . . . . . 0.505 ' CE3' ' CZ3' ' A' ' 65' ' ' TRP . 2.6 t-105 -51.13 -39.55 56.51 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 120.136 1.334 . . . . 0.0 111.071 -173.644 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -68.57 -23.65 64.52 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 125.11 1.364 . . . . 0.0 113.2 -179.885 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 18.7 mt-30 -89.51 -23.41 22.06 Favored 'General case' 0 C--N 1.341 0.211 0 C-N-CA 125.311 1.444 . . . . 0.0 112.363 178.613 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 40.3 mt -65.72 -24.61 67.01 Favored 'General case' 0 N--CA 1.469 0.485 0 O-C-N 121.874 -0.516 . . . . 0.0 112.065 -169.968 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -70.06 -21.29 63.18 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 118.087 0.403 . . . . 0.0 111.74 175.78 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -75.1 -23.6 57.97 Favored 'General case' 0 CA--C 1.538 0.505 0 O-C-N 121.139 -0.976 . . . . 0.0 112.635 -178.722 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 53.6 mt -66.16 150.17 49.18 Favored 'General case' 0 C--O 1.231 0.12 0 C-N-CA 124.869 1.268 . . . . 0.0 112.003 -169.594 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 3.7 t30 -82.24 105.79 13.61 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 124.551 1.14 . . . . 0.0 108.204 172.488 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 65.6 mt -124.0 1.29 8.61 Favored 'General case' 0 N--CA 1.472 0.63 0 N-CA-C 113.764 1.024 . . . . 0.0 113.764 -172.491 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 27.2 mt-10 -56.9 130.98 48.21 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-O 121.913 0.863 . . . . 0.0 111.318 -169.747 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 74.04 -2.73 41.46 Favored Glycine 0 CA--C 1.534 1.249 0 C-N-CA 125.401 1.477 . . . . 0.0 114.955 176.951 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.66 148.7 40.4 Favored 'General case' 0 C--N 1.345 0.403 0 CA-C-N 120.346 2.073 . . . . 0.0 109.347 -176.399 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 5.3 mt -81.26 139.79 17.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 N-CA-C 106.711 -1.589 . . . . 0.0 106.711 179.542 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 38.4 t -133.55 139.16 49.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 C-N-CA 124.459 1.103 . . . . 0.0 110.491 -175.897 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -115.37 162.25 17.39 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 123.971 0.908 . . . . 0.0 109.043 169.466 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 6.2 mt -141.61 136.8 31.37 Favored 'General case' 0 N--CA 1.465 0.277 0 N-CA-C 106.867 -1.531 . . . . 0.0 106.867 178.702 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 40.4 p90 -153.64 155.52 36.2 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-N 120.614 1.552 . . . . 0.0 109.116 174.913 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -175.9 -167.33 34.65 Favored Glycine 0 N--CA 1.445 -0.719 0 N-CA-C 108.514 -1.834 . . . . 0.0 108.514 170.656 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -116.09 152.46 33.59 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 122.443 1.116 . . . . 0.0 111.139 176.025 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -131.69 -171.53 12.86 Favored Glycine 0 N--CA 1.445 -0.758 0 N-CA-C 107.589 -2.205 . . . . 0.0 107.589 168.707 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 3.0 t0 -151.19 115.04 4.95 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 105.954 -1.869 . . . . 0.0 105.954 172.405 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -68.25 -7.69 32.73 Favored 'General case' 0 CA--C 1.547 0.853 0 N-CA-C 112.76 0.652 . . . . 0.0 112.76 -175.479 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 66.3 mt -88.82 -65.11 1.05 Allowed 'General case' 0 C--N 1.341 0.201 0 C-N-CA 124.745 1.218 . . . . 0.0 109.461 -179.053 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -94.06 -39.36 4.88 Favored Glycine 0 CA--C 1.527 0.83 0 C-N-CA 124.583 1.087 . . . . 0.0 112.911 -174.235 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 7.6 m-85 -87.28 50.64 2.05 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 118.392 1.096 . . . . 0.0 109.308 -174.773 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -73.12 -41.29 48.0 Favored Glycine 0 CA--C 1.525 0.713 0 O-C-N 120.756 -1.215 . . . . 0.0 110.936 -178.246 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -90.68 -9.28 47.4 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.431 1.093 . . . . 0.0 111.423 174.519 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 96' ' ' TRP . . . . . . . . . . . . . 6.7 m0 -115.49 -5.74 12.25 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 124.199 0.999 . . . . 0.0 112.815 -169.766 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 5.8 t80 -49.11 120.2 3.8 Favored 'General case' 0 C--N 1.343 0.294 0 C-N-CA 124.378 1.071 . . . . 0.0 109.582 -175.7 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 96.6 mt 51.64 23.39 1.92 Allowed 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 114.453 1.279 . . . . 0.0 114.453 170.549 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -57.71 -39.47 77.3 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 119.765 1.166 . . . . 0.0 113.108 -167.601 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -73.35 -19.42 61.01 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-O 118.262 -0.875 . . . . 0.0 112.666 -178.905 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 8.5 mp -65.69 -38.75 90.1 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-N 120.151 1.341 . . . . 0.0 108.45 170.248 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -63.37 -36.89 94.0 Favored Glycine 0 C--N 1.339 0.712 0 N-CA-C 111.218 -0.753 . . . . 0.0 111.218 -179.008 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 77.8 mtm -67.33 -47.82 69.37 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-O 118.077 -0.963 . . . . 0.0 111.006 179.85 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -70.57 -33.4 71.06 Favored 'General case' 0 C--N 1.348 0.535 0 CA-C-N 121.042 1.746 . . . . 0.0 110.995 178.217 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 68.2 t60 -54.51 -51.76 64.11 Favored 'General case' 0 CA--C 1.529 0.14 0 CA-C-N 118.821 0.737 . . . . 0.0 110.164 171.894 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -62.99 -40.02 96.48 Favored 'General case' 0 C--O 1.236 0.379 0 C-N-CA 123.771 0.829 . . . . 0.0 112.094 -176.098 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 24.1 ttmm -54.9 -39.68 69.01 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 123.327 0.651 . . . . 0.0 110.146 171.508 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 35.2 mt -90.96 -19.52 23.17 Favored 'General case' 0 CA--C 1.518 -0.287 0 N-CA-C 115.48 1.659 . . . . 0.0 115.48 -168.566 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 4.5 m -58.81 -36.47 74.54 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 120.86 1.664 . . . . 0.0 111.353 -177.664 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 19.9 p -84.0 -15.45 47.63 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 124.81 1.244 . . . . 0.0 111.66 179.942 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 31.7 mmmt -81.56 -9.97 59.56 Favored 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 124.542 1.137 . . . . 0.0 110.998 172.109 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 73.21 35.42 57.05 Favored Glycine 0 CA--C 1.523 0.569 0 CA-C-O 119.541 -0.589 . . . . 0.0 112.404 169.497 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 5.9 m -74.9 173.9 0.89 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.56 0 CA-C-N 118.122 0.961 . . . . 0.0 109.536 171.252 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -115.23 117.22 29.88 Favored 'General case' 0 CA--C 1.52 -0.211 0 N-CA-C 106.911 -1.515 . . . . 0.0 106.911 175.367 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 87.9 m-85 -85.71 143.15 28.53 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 119.56 1.073 . . . . 0.0 110.022 -175.312 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 32.9 m -133.47 160.7 42.14 Favored 'Isoleucine or valine' 0 C--O 1.235 0.307 0 C-N-CA 125.712 1.605 . . . . 0.0 108.052 169.748 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 86.8 26.95 30.5 Favored Glycine 0 C--N 1.332 0.339 0 CA-C-O 118.327 -1.263 . . . . 0.0 114.097 173.458 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 18.9 m-30 -60.85 159.87 10.5 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-N 119.165 1.482 . . . . 0.0 110.082 169.711 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 1.5 m95 -125.66 143.71 45.88 Favored Pre-proline 0 N--CA 1.469 0.501 0 CA-C-O 118.362 -0.828 . . . . 0.0 109.359 169.722 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -64.05 127.72 20.07 Favored 'Trans proline' 0 N--CA 1.452 -0.954 0 C-N-CA 123.335 2.69 . . . . 0.0 109.845 173.493 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 31.5 p -79.42 -4.05 49.32 Favored 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 113.449 0.907 . . . . 0.0 113.449 175.456 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -60.45 120.07 9.23 Favored 'General case' 0 CA--C 1.535 0.395 0 O-C-N 121.28 -0.888 . . . . 0.0 110.464 -169.124 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 80.89 3.38 90.55 Favored Glycine 0 CA--C 1.535 1.314 0 CA-C-O 118.746 -1.03 . . . . 0.0 114.691 176.734 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 18.5 m-85 -77.02 147.26 36.88 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-N 119.33 1.565 . . . . 0.0 109.695 176.904 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -99.35 106.19 18.25 Favored 'General case' 0 CA--C 1.528 0.127 0 N-CA-C 107.515 -1.291 . . . . 0.0 107.515 171.913 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 20.4 p90 -159.75 167.18 28.88 Favored 'General case' 0 C--O 1.239 0.54 0 C-N-CA 127.254 2.221 . . . . 0.0 106.131 176.001 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 1.9 t -140.04 -14.41 1.04 Allowed 'General case' 0 CA--C 1.537 0.462 0 N-CA-C 112.856 0.688 . . . . 0.0 112.856 179.689 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 2.9 p -72.79 137.52 79.96 Favored Pre-proline 0 CA--C 1.543 0.678 0 O-C-N 121.351 -0.843 . . . . 0.0 110.715 -176.742 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -83.22 -27.8 1.73 Allowed 'Trans proline' 0 CA--C 1.539 0.733 0 C-N-CA 122.406 2.071 . . . . 0.0 112.456 177.377 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 20.5 ttmt -53.92 -44.42 98.17 Favored Pre-proline 0 CA--C 1.544 0.719 0 CA-C-O 117.429 -1.272 . . . . 0.0 114.083 -176.376 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -73.07 -3.66 14.04 Favored 'Trans proline' 0 C--N 1.352 0.719 0 CA-C-N 121.939 1.728 . . . . 0.0 114.447 -178.444 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 19.7 m -129.93 166.84 26.52 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 CA-C-N 119.989 1.268 . . . . 0.0 111.924 -169.588 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 10.3 pt -138.02 174.56 10.56 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.331 0 C-N-CA 127.554 2.342 . . . . 0.0 108.73 -177.088 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . 54.96 43.88 29.17 Favored 'General case' 0 N--CA 1.465 0.284 0 C-N-CA 125.351 1.46 . . . . 0.0 112.051 175.184 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 27.4 t0 54.55 43.18 30.67 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 126.046 1.738 . . . . 0.0 111.46 -175.756 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 89.95 16.06 56.78 Favored Glycine 0 CA--C 1.526 0.723 0 CA-C-O 118.356 -1.247 . . . . 0.0 114.481 171.207 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 47.6 mt-30 -88.08 -16.84 32.47 Favored 'General case' 0 CA--C 1.536 0.404 0 CA-C-N 119.366 1.583 . . . . 0.0 113.691 -175.569 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -143.45 142.86 31.36 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 119.541 1.064 . . . . 0.0 110.661 177.234 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 74.2 m-85 -75.25 141.59 43.47 Favored 'General case' 0 CA--C 1.519 -0.233 0 N-CA-C 105.095 -2.187 . . . . 0.0 105.095 164.642 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 33.5 m -69.98 -0.1 1.38 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.567 0 N-CA-C 113.011 0.745 . . . . 0.0 113.011 -178.099 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -170.13 -170.82 34.96 Favored Glycine 0 N--CA 1.447 -0.618 0 N-CA-C 109.972 -1.251 . . . . 0.0 109.972 -172.607 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.453 ' HG ' ' CG ' ' A' ' 160' ' ' TRP . 1.2 tt -60.05 139.31 57.55 Favored 'General case' 0 N--CA 1.462 0.156 0 C-N-CA 124.424 1.089 . . . . 0.0 110.548 -179.815 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -105.78 96.03 6.21 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 124.553 1.141 . . . . 0.0 108.422 168.794 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 78.2 mt -89.59 147.13 24.1 Favored 'General case' 0 CA--C 1.535 0.397 0 N-CA-C 105.621 -1.992 . . . . 0.0 105.621 168.582 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 29.3 t0 -149.02 102.39 3.25 Favored 'General case' 0 N--CA 1.464 0.266 0 N-CA-C 107.489 -1.301 . . . . 0.0 107.489 176.059 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -82.92 -30.55 28.34 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.536 -178.354 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 86.4 m -61.57 -42.3 98.64 Favored 'General case' 0 C--O 1.235 0.303 0 C-N-CA 123.288 0.635 . . . . 0.0 110.542 -173.909 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 7.2 m-80 -93.66 -27.67 16.42 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-O 119.117 -0.468 . . . . 0.0 112.161 -169.965 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 14.6 pt20 -155.02 57.15 0.66 Allowed 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 123.211 0.604 . . . . 0.0 110.978 -168.628 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 41.9 p90 -53.45 -29.93 38.13 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 124.688 1.195 . . . . 0.0 113.028 -177.108 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -66.9 -24.32 66.09 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 118.597 0.635 . . . . 0.0 112.175 -179.075 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 74.6 mt -92.22 4.59 52.94 Favored 'General case' 0 C--N 1.341 0.217 0 C-N-CA 124.138 0.975 . . . . 0.0 113.143 -172.942 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 31.0 p -59.32 -47.54 85.02 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 120.14 1.336 . . . . 0.0 110.347 -175.122 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -58.22 -40.34 81.4 Favored 'General case' 0 N--CA 1.462 0.173 0 C-N-CA 123.921 0.889 . . . . 0.0 111.064 178.345 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 3.5 tp10 -69.67 -47.36 63.56 Favored 'General case' 0 CA--C 1.529 0.16 0 C-N-CA 124.485 1.114 . . . . 0.0 110.911 -177.485 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 69.9 mtp85 -66.71 -27.39 67.6 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 117.894 -1.051 . . . . 0.0 110.424 179.859 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 25.1 mt -73.14 -53.29 18.84 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.601 0 CA-C-N 119.908 1.231 . . . . 0.0 107.762 168.364 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 70.8 tp60 -50.14 -64.14 0.9 Allowed 'General case' 0 N--CA 1.464 0.259 0 C-N-CA 126.031 1.732 . . . . 0.0 112.14 -175.419 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 25.3 m -66.11 -32.75 74.39 Favored 'General case' 0 C--N 1.327 -0.392 0 O-C-N 123.036 0.21 . . . . 0.0 110.803 -171.01 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 160' ' ' TRP . . . . . 0.453 ' CG ' ' HG ' ' A' ' 142' ' ' LEU . 88.2 t90 -66.41 -46.84 75.22 Favored 'General case' 0 C--O 1.222 -0.349 0 O-C-N 121.958 -0.464 . . . . 0.0 110.836 174.592 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 67.2 m -59.56 -44.42 93.29 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 123.266 0.626 . . . . 0.0 110.501 178.816 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 162' ' ' GLU . . . . . 0.409 ' HA ' HD23 ' A' ' 165' ' ' LEU . 39.7 mt-10 -61.05 -42.95 99.44 Favored 'General case' 0 N--CA 1.457 -0.085 0 CA-C-O 121.021 0.439 . . . . 0.0 110.199 175.723 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 14.4 tt0 -63.71 -52.1 62.07 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-O 117.791 -1.1 . . . . 0.0 109.73 -177.508 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 40.4 pt -63.02 -34.11 64.61 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.519 0 CA-C-N 119.439 1.018 . . . . 0.0 110.077 -176.57 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 165' ' ' LEU . . . . . 0.409 HD23 ' HA ' ' A' ' 162' ' ' GLU . 0.3 OUTLIER -70.16 -34.95 73.66 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 119.382 0.992 . . . . 0.0 108.519 -175.2 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -70.72 -46.27 63.36 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 123.707 0.803 . . . . 0.0 109.993 174.273 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 24.8 tt0 -77.91 -14.09 59.66 Favored 'General case' 0 N--CA 1.437 -1.104 0 C-N-CA 124.9 1.28 . . . . 0.0 110.359 -169.629 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 168' ' ' MET . . . . . . . . . . . . . 18.9 ptp -92.17 -38.9 11.87 Favored 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 122.751 0.42 . . . . 0.0 111.547 169.754 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -75.81 -27.82 58.09 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-O 119.327 -0.368 . . . . 0.0 111.914 -173.447 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -57.02 -27.68 61.83 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 123.655 0.782 . . . . 0.0 112.398 -177.084 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 60.3 m-70 -72.98 -23.64 60.67 Favored 'General case' 0 C--O 1.235 0.339 0 C-N-CA 124.696 1.198 . . . . 0.0 112.036 179.145 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 22.8 m-30 -112.48 -16.33 12.9 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 126.407 1.883 . . . . 0.0 112.402 -172.184 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.285 0 C-N-CA 124.779 1.232 . . . . 0.0 110.123 175.071 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.499 2.015 0 CA-C-O 119.403 -0.332 . . . . 0.0 111.11 . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 11.3 t30 -127.29 151.1 49.18 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-N 119.167 0.894 . . . . 0.0 110.523 -177.815 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 17.5 mtt -117.4 130.41 56.47 Favored 'General case' 0 N--CA 1.461 0.11 0 C-N-CA 124.228 1.011 . . . . 0.0 110.958 -177.873 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' GLY . . . . . 0.409 ' HA3' ' CD2' ' A' ' 46' ' ' TYR . . . -86.88 154.76 27.04 Favored Glycine 0 CA--C 1.522 0.51 0 N-CA-C 107.77 -2.132 . . . . 0.0 107.77 166.541 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 3.0 tt -141.24 99.49 3.59 Favored 'General case' 0 N--CA 1.464 0.244 0 N-CA-C 105.612 -1.995 . . . . 0.0 105.612 -176.456 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.756 ' CZ ' HD23 ' A' ' 51' ' ' LEU . 1.2 p90 -106.18 138.43 42.38 Favored 'General case' 0 CA--C 1.521 -0.162 0 CA-C-N 118.017 0.372 . . . . 0.0 111.707 -169.54 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 19.5 p90 -161.03 160.57 30.73 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 125.693 1.597 . . . . 0.0 108.736 -174.053 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -95.06 163.36 24.31 Favored Glycine 0 CA--C 1.53 1.029 0 N-CA-C 110.029 -1.228 . . . . 0.0 110.029 170.136 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 1.5 m -85.06 -30.84 23.76 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 117.766 0.783 . . . . 0.0 112.778 -169.833 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -88.89 165.03 14.89 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.748 1.219 . . . . 0.0 111.607 -171.87 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 23.2 m 66.98 115.45 0.03 OUTLIER 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 126.988 2.115 . . . . 0.0 112.727 179.426 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 42.6 m 51.46 33.78 10.93 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 125.799 1.639 . . . . 0.0 113.513 172.226 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 78.1 m-85 57.67 -64.25 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 128.216 2.606 . . . . 0.0 115.678 -174.794 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 21.3 m 63.15 -23.27 0.06 Allowed 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 127.019 2.128 . . . . 0.0 113.003 -167.957 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -55.59 -38.71 69.77 Favored 'General case' 0 CA--C 1.534 0.333 0 O-C-N 120.565 -1.335 . . . . 0.0 111.478 174.722 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -63.86 -42.24 97.58 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 118.809 0.731 . . . . 0.0 109.454 179.754 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -63.98 -47.02 81.99 Favored 'General case' 0 N--CA 1.463 0.194 0 N-CA-C 109.238 -0.653 . . . . 0.0 109.238 177.734 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -62.46 -47.71 82.83 Favored 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 123.049 0.539 . . . . 0.0 111.45 -176.481 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 33.8 mt-10 -61.73 -42.38 98.88 Favored 'General case' 0 C--O 1.232 0.178 0 C-N-CA 123.415 0.686 . . . . 0.0 110.14 176.377 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 28.7 mtpp -70.98 -39.63 72.38 Favored 'General case' 0 C--O 1.221 -0.434 0 CA-C-O 118.199 -0.905 . . . . 0.0 110.32 -175.885 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 43.7 mt -53.8 -56.04 10.92 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.285 0 CA-C-N 119.805 1.184 . . . . 0.0 109.266 175.781 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.484 ' HG2' HD21 ' A' ' 32' ' ' LEU . 0.0 OUTLIER -65.71 -35.44 80.74 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 118.406 0.548 . . . . 0.0 111.404 -175.82 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -64.31 -41.06 97.02 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.819 0.342 . . . . 0.0 110.944 177.996 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 56.4 mt -76.13 -54.08 14.24 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.47 0 C-N-CA 124.548 1.139 . . . . 0.0 109.84 -172.557 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 65.2 mt -62.63 -47.56 92.33 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.328 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 179.611 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 142.49 121.47 1.66 Allowed Glycine 0 CA--C 1.528 0.847 0 C-N-CA 124.826 1.203 . . . . 0.0 110.526 177.063 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -70.96 -12.72 31.01 Favored 'Trans proline' 0 CA--C 1.537 0.669 0 C-N-CA 122.784 2.323 . . . . 0.0 113.495 -171.027 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -77.17 -18.52 57.74 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 118.904 0.774 . . . . 0.0 111.729 179.802 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -128.71 9.1 5.88 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 124.604 1.162 . . . . 0.0 113.582 -170.639 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 31.4 t -127.93 148.07 32.55 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 N-CA-C 107.511 -1.292 . . . . 0.0 107.511 173.242 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 25.3 m -132.22 131.06 41.77 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 125.574 1.55 . . . . 0.0 108.164 -175.34 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.484 HD21 ' HG2' ' A' ' 22' ' ' ARG . 26.4 mt -77.73 131.46 37.68 Favored 'General case' 0 CA--C 1.521 -0.168 0 N-CA-C 108.107 -1.072 . . . . 0.0 108.107 176.104 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 22.5 t-80 -129.27 52.82 1.93 Allowed 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 124.748 1.219 . . . . 0.0 108.19 -175.552 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 18.7 t-20 -55.12 128.94 36.14 Favored 'General case' 0 CA--C 1.531 0.241 0 N-CA-C 107.834 -1.173 . . . . 0.0 107.834 171.086 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 39.0 mt -75.44 -16.17 60.36 Favored 'General case' 0 C--O 1.234 0.244 0 N-CA-C 114.021 1.119 . . . . 0.0 114.021 -169.009 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 9.0 tptm -77.47 -26.44 51.39 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 118.951 0.796 . . . . 0.0 110.154 169.614 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -88.13 -35.91 17.17 Favored 'General case' 0 C--O 1.236 0.375 0 C-N-CA 124.155 0.982 . . . . 0.0 112.783 -174.067 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 2.5 t0 -142.76 155.22 44.81 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 118.653 0.661 . . . . 0.0 112.673 178.151 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 19.1 m -75.35 158.34 83.79 Favored Pre-proline 0 CA--C 1.544 0.716 0 C-N-CA 125.998 1.719 . . . . 0.0 111.298 -170.525 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_endo -74.43 -25.75 12.79 Favored 'Trans proline' 0 C--N 1.349 0.594 0 C-N-CA 122.245 1.963 . . . . 0.0 113.231 -170.6 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 22.6 mmmt -71.19 -11.34 60.88 Favored 'General case' 0 CA--C 1.54 0.561 0 O-C-N 120.45 -1.406 . . . . 0.0 111.703 -176.368 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -61.85 -28.68 69.66 Favored 'General case' 0 N--CA 1.465 0.282 0 C-N-CA 125.159 1.384 . . . . 0.0 110.265 169.167 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 45.4 mtt -57.48 -27.3 62.39 Favored 'General case' 0 N--CA 1.464 0.275 0 C-N-CA 123.12 0.568 . . . . 0.0 111.865 177.146 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 84.7 mt-10 -66.17 -32.22 73.52 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 118.118 0.417 . . . . 0.0 110.357 -175.621 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 20.8 mt-30 -66.99 -41.63 86.44 Favored 'General case' 0 N--CA 1.464 0.243 0 C-N-CA 123.804 0.841 . . . . 0.0 112.714 -171.22 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' TYR . . . . . 0.409 ' CD2' ' HA3' ' A' ' 4' ' ' GLY . 15.7 m-85 -72.2 147.05 46.93 Favored 'General case' 0 CA--C 1.522 -0.108 0 C-N-CA 123.5 0.72 . . . . 0.0 110.667 -166.139 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -75.98 -34.47 59.77 Favored 'General case' 0 N--CA 1.467 0.422 0 O-C-N 121.832 -0.542 . . . . 0.0 110.297 176.045 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 6.4 t -113.4 146.76 17.6 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.19 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 172.668 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 48.5 tp -132.24 113.81 13.69 Favored 'General case' 0 N--CA 1.451 -0.424 0 C-N-CA 123.625 0.77 . . . . 0.0 109.06 171.726 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 23.0 mt -89.84 130.33 39.3 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 N-CA-C 106.361 -1.718 . . . . 0.0 106.361 174.982 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.756 HD23 ' CZ ' ' A' ' 6' ' ' PHE . 0.6 OUTLIER -106.01 131.87 52.78 Favored 'General case' 0 C--O 1.232 0.183 0 C-N-CA 125.201 1.4 . . . . 0.0 107.929 172.675 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.587 ' N ' HD22 ' A' ' 51' ' ' LEU . . . -127.46 139.03 10.87 Favored Glycine 0 CA--C 1.524 0.647 0 C-N-CA 124.892 1.234 . . . . 0.0 110.283 169.997 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.611 HD13 ' HB1' ' A' ' 100' ' ' ALA . 6.2 tt -145.47 129.65 8.75 Favored Pre-proline 0 CA--C 1.538 0.511 0 CA-C-N 118.763 1.282 . . . . 0.0 110.584 170.883 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -81.93 84.74 1.82 Allowed 'Trans proline' 0 N--CA 1.456 -0.694 0 C-N-CA 123.099 2.533 . . . . 0.0 110.247 169.748 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 93.1 m -58.33 -39.23 78.9 Favored 'General case' 0 CA--C 1.542 0.665 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 168.198 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 23.4 t90 48.99 -142.59 0.54 Allowed 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 125.75 1.62 . . . . 0.0 109.185 -170.763 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -74.78 -62.58 1.49 Allowed 'General case' 0 C--N 1.332 -0.159 0 C-N-CA 123.725 0.81 . . . . 0.0 109.79 175.68 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 20.3 t80 -140.1 31.84 1.96 Allowed 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 124.106 0.962 . . . . 0.0 109.967 178.771 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -67.7 -40.5 90.12 Favored Glycine 0 CA--C 1.53 1.017 0 N-CA-C 109.036 -1.626 . . . . 0.0 109.036 169.715 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 9.8 tt0 54.73 -144.09 0.7 Allowed 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 124.189 0.996 . . . . 0.0 109.253 -178.357 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.426 ' HA ' HD11 ' A' ' 53' ' ' ILE . 0.9 OUTLIER -83.19 133.98 27.91 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.685 0 C-N-CA 126.663 1.985 . . . . 0.0 108.999 -178.41 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 3.0 mp0 -88.88 156.95 18.61 Favored 'General case' 0 C--O 1.231 0.104 0 C-N-CA 124.622 1.169 . . . . 0.0 108.167 179.446 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -57.41 -40.28 77.94 Favored 'General case' 0 N--CA 1.464 0.249 0 C-N-CA 123.318 0.647 . . . . 0.0 110.45 -179.096 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 80.2 m-20 -58.1 -30.84 66.58 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 124.331 1.053 . . . . 0.0 110.96 -178.439 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' TRP . . . . . 0.67 ' CH2' HD23 ' A' ' 104' ' ' LEU . 1.9 t90 -95.87 -45.29 7.02 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 125.889 1.675 . . . . 0.0 108.297 -170.117 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 24.5 tt0 -63.51 -35.73 81.42 Favored 'General case' 0 N--CA 1.439 -1.011 0 C-N-CA 124.633 1.173 . . . . 0.0 110.347 178.451 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -57.83 -24.16 56.1 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 123.874 0.87 . . . . 0.0 111.759 -178.562 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 34.8 m -116.55 -12.13 11.62 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.345 0 CA-C-O 117.351 -1.309 . . . . 0.0 112.342 177.761 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 26.8 t90 -52.11 -38.71 58.26 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 120.234 1.379 . . . . 0.0 110.568 -176.387 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -65.35 -26.16 67.91 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 125.511 1.524 . . . . 0.0 113.284 177.255 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 25.7 mt-30 -92.58 -19.85 21.51 Favored 'General case' 0 C--N 1.34 0.165 0 C-N-CA 126.086 1.754 . . . . 0.0 112.538 176.836 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 72.6 mt -61.78 -24.14 66.65 Favored 'General case' 0 CA--C 1.532 0.274 0 O-C-N 121.679 -0.638 . . . . 0.0 111.289 -176.31 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -77.31 -27.67 52.99 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 118.074 0.397 . . . . 0.0 111.475 175.738 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -70.29 -33.09 71.14 Favored 'General case' 0 N--CA 1.467 0.379 0 O-C-N 121.424 -0.797 . . . . 0.0 111.381 178.823 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 83.2 mt -50.6 135.61 22.71 Favored 'General case' 0 C--N 1.341 0.2 0 C-N-CA 124.72 1.208 . . . . 0.0 111.935 -170.142 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 4.9 t-20 -74.64 105.39 5.71 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 107.308 -1.368 . . . . 0.0 107.308 168.356 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.448 ' HA ' ' HE2' ' A' ' 80' ' ' LYS . 59.6 mt -123.83 2.13 8.77 Favored 'General case' 0 N--CA 1.467 0.38 0 C-N-CA 124.691 1.196 . . . . 0.0 111.163 -179.622 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 29.6 mp0 -57.24 128.12 35.39 Favored 'General case' 0 N--CA 1.445 -0.681 0 CA-C-O 122.062 0.934 . . . . 0.0 112.287 -166.984 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 70.57 -0.04 28.92 Favored Glycine 0 CA--C 1.537 1.448 0 CA-C-N 113.792 -1.549 . . . . 0.0 115.411 -177.938 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.448 ' HE2' ' HA ' ' A' ' 77' ' ' LEU . 0.0 OUTLIER -77.87 160.01 28.56 Favored 'General case' 0 C--N 1.346 0.426 0 CA-C-N 120.892 2.346 . . . . 0.0 110.277 -175.381 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 1.9 mt -85.91 141.28 14.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 N-CA-C 106.729 -1.582 . . . . 0.0 106.729 178.215 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.409 HG11 HD13 ' A' ' 108' ' ' LEU . 94.2 t -138.42 146.63 26.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 -176.822 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -124.17 145.21 49.45 Favored 'General case' 0 CA--C 1.513 -0.456 0 N-CA-C 104.991 -2.225 . . . . 0.0 104.991 175.444 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 4.9 mp -126.83 141.74 51.74 Favored 'General case' 0 CA--C 1.501 -0.905 0 N-CA-C 107.655 -1.239 . . . . 0.0 107.655 175.007 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 34.4 p90 -153.13 168.71 25.02 Favored 'General case' 0 N--CA 1.441 -0.924 0 N-CA-C 107.236 -1.394 . . . . 0.0 107.236 167.836 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -162.69 171.53 38.53 Favored Glycine 0 N--CA 1.44 -1.042 0 N-CA-C 109.278 -1.529 . . . . 0.0 109.278 169.88 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 6.1 tt -111.08 140.71 45.39 Favored 'General case' 0 N--CA 1.442 -0.845 0 N-CA-C 106.589 -1.634 . . . . 0.0 106.589 173.764 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -136.59 -169.97 11.84 Favored Glycine 0 CA--C 1.526 0.723 0 C-N-CA 125.471 1.51 . . . . 0.0 110.043 -173.98 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 46.0 t0 -148.29 113.61 5.58 Favored 'General case' 0 C--O 1.234 0.252 0 N-CA-C 107.548 -1.278 . . . . 0.0 107.548 169.615 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 5.9 pt20 -82.02 -5.88 58.71 Favored 'General case' 0 CA--C 1.545 0.768 0 N-CA-C 113.726 1.01 . . . . 0.0 113.726 -176.242 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.417 HD23 HG22 ' A' ' 147' ' ' THR . 2.8 tp -114.46 -36.78 4.5 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 126.824 2.05 . . . . 0.0 110.401 -169.699 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -55.85 -40.18 80.05 Favored Glycine 0 CA--C 1.534 1.256 0 C-N-CA 124.027 0.822 . . . . 0.0 112.137 179.43 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 20.6 t80 -155.1 -31.7 0.1 Allowed 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 117.758 0.779 . . . . 0.0 112.001 171.986 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 85.31 -54.26 4.84 Favored Glycine 0 C--N 1.338 0.655 0 C-N-CA 124.124 0.869 . . . . 0.0 110.945 174.183 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 17.5 mt-10 -60.04 -16.88 34.99 Favored 'General case' 0 CA--C 1.542 0.666 0 CA-C-N 118.399 1.1 . . . . 0.0 113.244 -178.578 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 96' ' ' TRP . . . . . . . . . . . . . 33.9 m0 -102.17 9.92 39.78 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 123.97 0.908 . . . . 0.0 112.544 -178.833 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 22.5 t80 -58.56 128.38 36.87 Favored 'General case' 0 C--N 1.343 0.318 0 CA-C-N 119.155 0.888 . . . . 0.0 109.507 -174.514 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 91.1 mt 52.38 25.73 3.67 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 124.201 1.0 . . . . 0.0 113.567 170.129 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -51.31 -48.22 62.38 Favored 'General case' 0 C--O 1.234 0.28 0 C-N-CA 125.284 1.434 . . . . 0.0 110.749 177.796 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 100' ' ' ALA . . . . . 0.611 ' HB1' HD13 ' A' ' 53' ' ' ILE . . . -72.14 -23.97 61.39 Favored 'General case' 0 CA--C 1.539 0.554 0 O-C-N 121.616 -0.678 . . . . 0.0 112.576 -178.543 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 4.8 tt -65.81 -48.06 72.98 Favored 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 171.352 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -61.18 -33.31 83.8 Favored Glycine 0 CA--C 1.527 0.806 0 N-CA-C 111.164 -0.775 . . . . 0.0 111.164 -179.674 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 4.5 tpp -53.76 -52.05 61.44 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 124.647 1.179 . . . . 0.0 111.225 172.885 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.67 HD23 ' CH2' ' A' ' 65' ' ' TRP . 0.2 OUTLIER -72.83 -33.19 66.02 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-O 118.425 -0.798 . . . . 0.0 110.758 -177.894 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 49.0 t60 -58.69 -50.96 71.97 Favored 'General case' 0 C--O 1.226 -0.161 0 CA-C-N 118.718 0.69 . . . . 0.0 110.604 174.696 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -62.13 -41.88 98.7 Favored 'General case' 0 C--O 1.234 0.258 0 C-N-CA 123.354 0.662 . . . . 0.0 111.585 -176.966 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 23.4 ttmm -59.57 -39.4 83.98 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 123.145 0.578 . . . . 0.0 110.098 173.128 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.409 HD13 HG11 ' A' ' 82' ' ' VAL . 16.5 mt -82.53 -25.33 33.49 Favored 'General case' 0 N--CA 1.455 -0.179 0 CA-C-O 117.584 -1.198 . . . . 0.0 113.71 -170.097 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 18.2 m -58.58 -36.73 74.43 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 120.503 1.501 . . . . 0.0 111.722 -175.785 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 21.1 p -82.15 -8.29 59.65 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 124.251 1.021 . . . . 0.0 111.719 -178.416 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 29.6 mmmt -84.03 -3.27 57.91 Favored 'General case' 0 C--N 1.343 0.284 0 C-N-CA 124.985 1.314 . . . . 0.0 111.365 173.786 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 67.53 33.35 81.12 Favored Glycine 0 CA--C 1.527 0.8 0 CA-C-N 118.698 0.681 . . . . 0.0 112.287 170.048 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 15.6 m -83.09 171.65 1.19 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 C-N-CA 123.593 0.757 . . . . 0.0 110.317 179.913 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 15.5 tptm -98.55 129.5 45.1 Favored 'General case' 0 CA--C 1.513 -0.47 0 N-CA-C 104.904 -2.258 . . . . 0.0 104.904 167.588 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 60.3 m-85 -94.84 124.31 38.81 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 171.457 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 35.3 m -107.26 157.77 7.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 C-N-CA 123.566 0.747 . . . . 0.0 109.257 168.531 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 101.12 -97.31 1.65 Allowed Glycine 0 N--CA 1.447 -0.616 0 C-N-CA 124.885 1.231 . . . . 0.0 111.505 174.16 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 11.3 m-30 61.06 172.89 0.1 Allowed 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 125.004 1.321 . . . . 0.0 110.104 -167.255 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 1.2 t90 -155.46 138.83 10.91 Favored Pre-proline 0 N--CA 1.469 0.485 0 CA-C-O 117.386 -1.292 . . . . 0.0 109.297 -177.029 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -71.72 121.67 7.87 Favored 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 123.413 2.742 . . . . 0.0 111.872 -174.49 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 37.5 p -67.35 -18.72 65.26 Favored 'General case' 0 N--CA 1.47 0.545 0 N-CA-C 114.334 1.235 . . . . 0.0 114.334 179.902 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -58.83 127.37 31.88 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 123.417 0.687 . . . . 0.0 110.92 -168.503 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 90.62 -8.22 80.13 Favored Glycine 0 CA--C 1.535 1.338 0 C-N-CA 125.382 1.468 . . . . 0.0 114.264 176.968 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 8.8 m-85 -90.71 167.89 12.17 Favored 'General case' 0 C--O 1.236 0.381 0 CA-C-N 119.194 1.497 . . . . 0.0 110.745 175.948 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -117.25 134.34 54.91 Favored 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 107.316 -1.365 . . . . 0.0 107.316 169.329 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 23.0 p90 -160.02 -31.72 0.06 Allowed 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 124.111 0.964 . . . . 0.0 112.103 -173.108 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 1.9 m 63.81 -61.04 0.17 Allowed 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 128.08 2.552 . . . . 0.0 116.566 168.132 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 70.4 m -69.04 150.85 97.45 Favored Pre-proline 0 CA--C 1.537 0.469 0 C-N-CA 125.574 1.549 . . . . 0.0 110.965 -177.23 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_endo -81.16 -23.7 5.09 Favored 'Trans proline' 0 C--N 1.35 0.641 0 C-N-CA 122.608 2.205 . . . . 0.0 113.061 -177.257 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 33.4 ttmt -50.53 -46.48 85.07 Favored Pre-proline 0 N--CA 1.475 0.791 0 CA-C-N 119.978 1.263 . . . . 0.0 114.142 -175.598 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -73.82 -1.5 10.89 Favored 'Trans proline' 0 C--N 1.35 0.607 0 C-N-CA 121.856 1.704 . . . . 0.0 114.591 -179.527 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 12.3 m -135.91 153.0 31.55 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 CA-C-N 121.563 1.983 . . . . 0.0 112.377 -168.503 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 133' ' ' ILE . . . . . 0.718 HG23 HG12 ' A' ' 140' ' ' VAL . 11.8 pt -90.27 167.73 1.62 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.444 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 167.348 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . 57.9 -156.18 0.32 Allowed 'General case' 0 N--CA 1.447 -0.6 0 C-N-CA 124.934 1.294 . . . . 0.0 109.855 169.523 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 23.1 t0 -76.78 59.0 1.51 Allowed 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 125.065 1.346 . . . . 0.0 109.389 170.08 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 62.9 46.03 94.43 Favored Glycine 0 C--N 1.336 0.583 0 C-N-CA 124.826 1.203 . . . . 0.0 112.147 176.079 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 69.2 mm-40 -93.29 -44.44 8.31 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-N 118.208 1.004 . . . . 0.0 112.571 -169.809 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -134.18 142.83 47.56 Favored 'General case' 0 N--CA 1.47 0.556 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 179.883 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 44.9 m-85 -72.11 15.51 0.16 Allowed 'General case' 0 N--CA 1.479 1.007 0 N-CA-C 116.444 2.016 . . . . 0.0 116.444 179.775 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 140' ' ' VAL . . . . . 0.718 HG12 HG23 ' A' ' 133' ' ' ILE 0.253 1.0 OUTLIER 52.82 8.61 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.549 0.932 0 C-N-CA 127.162 2.185 . . . . 0.0 113.577 -177.245 . . . . . . . . 4 4 . 1 . 019 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 171.69 171.75 37.05 Favored Glycine 0 CA--C 1.528 0.906 0 C-N-CA 126.299 1.904 . . . . 0.0 108.968 -170.433 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -70.03 140.55 52.88 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 118.149 0.975 . . . . 0.0 111.642 -178.254 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -100.36 129.71 46.37 Favored 'General case' 0 N--CA 1.447 -0.587 0 C-N-CA 125.671 1.588 . . . . 0.0 109.995 176.912 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 81.3 mt -124.59 156.45 37.42 Favored 'General case' 0 CA--C 1.533 0.3 0 N-CA-C 106.576 -1.639 . . . . 0.0 106.576 168.406 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -127.29 179.96 5.19 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 124.899 1.279 . . . . 0.0 107.949 173.584 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 3.6 tm-20 -146.29 -49.29 0.21 Allowed 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 124.183 0.993 . . . . 0.0 108.545 176.832 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 147' ' ' THR . . . . . 0.417 HG22 HD23 ' A' ' 91' ' ' LEU . 39.0 m -62.64 -44.9 95.1 Favored 'General case' 0 C--O 1.235 0.341 0 C-N-CA 124.727 1.211 . . . . 0.0 111.383 -176.847 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 8.2 m-80 -81.11 -48.99 11.4 Favored 'General case' 0 C--O 1.232 0.171 0 C-N-CA 123.042 0.537 . . . . 0.0 111.004 -167.445 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 16.7 pt20 -159.7 149.79 18.68 Favored 'General case' 0 C--O 1.233 0.214 0 C-N-CA 124.842 1.257 . . . . 0.0 108.145 -178.004 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 46.6 p90 -126.56 -17.3 5.1 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 123.825 0.85 . . . . 0.0 112.391 179.715 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -70.64 -35.29 72.83 Favored 'General case' 0 N--CA 1.466 0.37 0 O-C-N 121.515 -0.741 . . . . 0.0 111.072 -177.111 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -77.27 -11.16 59.79 Favored 'General case' 0 C--N 1.344 0.36 0 CA-C-O 118.553 -0.737 . . . . 0.0 111.902 -179.801 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 28.9 m -60.7 -34.79 74.89 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-N 119.997 1.272 . . . . 0.0 110.368 179.959 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -59.24 -43.46 92.4 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 118.789 0.722 . . . . 0.0 111.2 175.636 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 -68.94 -47.6 65.3 Favored 'General case' 0 C--O 1.233 0.23 0 C-N-CA 124.934 1.294 . . . . 0.0 110.436 -179.625 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 9.6 mpt_? -54.13 -47.56 71.74 Favored 'General case' 0 N--CA 1.463 0.221 0 C-N-CA 124.355 1.062 . . . . 0.0 109.87 176.348 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 43.2 mt -68.52 -52.82 32.53 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.468 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 -179.41 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 71.4 tp60 -50.89 -63.99 0.95 Allowed 'General case' 0 CA--C 1.516 -0.329 0 C-N-CA 124.922 1.289 . . . . 0.0 111.83 -174.801 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 24.1 m -66.61 -32.62 74.07 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 120.615 -0.434 . . . . 0.0 110.965 -169.742 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 160' ' ' TRP . . . . . . . . . . . . . 36.2 t90 -69.93 -44.65 69.18 Favored 'General case' 0 CA--C 1.517 -0.325 0 O-C-N 121.89 -0.506 . . . . 0.0 111.217 177.536 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 67.1 m -59.77 -42.94 94.39 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 122.779 0.432 . . . . 0.0 110.371 178.046 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -62.06 -42.54 99.3 Favored 'General case' 0 C--O 1.227 -0.083 0 CA-C-O 121.031 0.443 . . . . 0.0 110.08 175.812 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 14.2 tt0 -62.78 -52.15 64.32 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-O 118.824 -0.608 . . . . 0.0 110.187 -178.669 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 43.8 pt -63.0 -38.56 82.35 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.321 0 CA-C-O 117.819 -1.086 . . . . 0.0 109.267 -174.724 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -65.31 -33.88 77.03 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 119.435 1.016 . . . . 0.0 110.405 -179.484 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 34.0 m-80 -69.77 -56.91 5.88 Favored 'General case' 0 CA--C 1.517 -0.305 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 175.379 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 9.9 tt0 -64.72 -37.48 87.73 Favored 'General case' 0 N--CA 1.442 -0.86 0 C-N-CA 124.813 1.245 . . . . 0.0 110.887 -168.68 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 168' ' ' MET . . . . . . . . . . . . . 21.4 ptp -66.98 -32.27 73.39 Favored 'General case' 0 CA--C 1.522 -0.098 0 O-C-N 121.66 -0.65 . . . . 0.0 111.295 174.083 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 169' ' ' ALA . . . . . 0.499 ' HA ' ' CD2' ' A' ' 172' ' ' TYR . . . -76.14 -37.39 58.04 Favored 'General case' 0 N--CA 1.443 -0.793 0 N-CA-C 112.451 0.537 . . . . 0.0 112.451 -178.47 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 -62.38 -35.55 79.53 Favored 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 108.89 -0.782 . . . . 0.0 108.89 174.985 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 63.3 t60 -69.94 -45.31 67.76 Favored 'General case' 0 N--CA 1.446 -0.656 0 C-N-CA 124.592 1.157 . . . . 0.0 111.726 -176.865 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 172' ' ' TYR . . . . . 0.499 ' CD2' ' HA ' ' A' ' 169' ' ' ALA . 0.2 OUTLIER -79.51 -28.97 41.39 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-O 118.935 -0.555 . . . . 0.0 112.21 -174.472 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.286 0 C-N-CA 123.717 0.807 . . . . 0.0 110.794 -179.75 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.498 1.947 0 N-CA-C 111.191 0.071 . . . . 0.0 111.191 . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 19.7 p-10 -102.3 163.33 12.3 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 124.503 1.121 . . . . 0.0 111.467 -175.771 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 16.3 mtt -129.3 127.03 40.31 Favored 'General case' 0 N--CA 1.464 0.237 0 C-N-CA 122.89 0.476 . . . . 0.0 110.712 179.1 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -94.29 121.06 6.57 Favored Glycine 0 C--O 1.225 -0.437 0 N-CA-C 107.573 -2.211 . . . . 0.0 107.573 168.904 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 4.1 tt -104.43 111.54 24.23 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 105.468 -2.049 . . . . 0.0 105.468 179.226 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.423 ' CD1' HD11 ' A' ' 35' ' ' LEU . 0.6 OUTLIER -108.32 143.99 36.45 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-O 121.757 0.789 . . . . 0.0 110.434 175.637 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 20.6 p90 -159.31 178.5 9.89 Favored 'General case' 0 N--CA 1.447 -0.62 0 N-CA-C 106.454 -1.684 . . . . 0.0 106.454 176.963 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -156.56 -138.47 2.54 Favored Glycine 0 CA--C 1.521 0.426 0 N-CA-C 105.697 -2.961 . . . . 0.0 105.697 173.951 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 7.2 m 56.23 61.72 2.62 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-O 122.138 0.971 . . . . 0.0 109.524 178.801 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 38.2 m -50.3 142.86 9.45 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 124.037 0.935 . . . . 0.0 110.955 -178.138 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 1.5 m 69.3 -8.07 0.76 Allowed 'General case' 0 CA--C 1.549 0.939 0 C-N-CA 126.689 1.996 . . . . 0.0 114.306 -178.747 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 64.1 m -74.81 165.75 24.73 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 120.554 1.524 . . . . 0.0 110.27 170.702 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 53.8 m-85 -62.27 -12.88 23.03 Favored 'General case' 0 N--CA 1.469 0.499 0 N-CA-C 113.221 0.823 . . . . 0.0 113.221 179.785 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -51.79 -30.75 24.33 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 124.825 1.25 . . . . 0.0 112.028 171.646 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 91.7 mt-10 -63.63 -44.32 94.23 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-N 119.057 0.844 . . . . 0.0 109.845 178.518 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 32.2 mtm -73.64 -31.7 63.64 Favored 'General case' 0 N--CA 1.462 0.126 0 CA-C-O 118.384 -0.817 . . . . 0.0 110.687 177.701 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -59.28 -48.21 82.46 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 119.618 1.099 . . . . 0.0 110.125 170.575 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -62.99 -46.44 87.69 Favored 'General case' 0 N--CA 1.455 -0.195 0 C-N-CA 123.273 0.629 . . . . 0.0 111.204 -177.11 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 50.3 mm-40 -55.01 -52.41 63.23 Favored 'General case' 0 C--O 1.23 0.043 0 C-N-CA 123.169 0.588 . . . . 0.0 109.706 173.008 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 57.8 mttm -64.21 -42.16 96.73 Favored 'General case' 0 C--O 1.222 -0.344 0 CA-C-O 118.889 -0.577 . . . . 0.0 110.704 -171.433 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 48.3 mt -55.81 -56.61 11.55 Favored 'Isoleucine or valine' 0 C--O 1.233 0.211 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 178.4 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 19.1 ptt180 -63.4 -38.01 89.48 Favored 'General case' 0 C--O 1.221 -0.416 0 CA-C-O 118.884 -0.579 . . . . 0.0 110.251 -177.12 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -66.02 -38.45 88.44 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.208 0.528 . . . . 0.0 109.956 -173.41 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.472 HD13 ' HA ' ' A' ' 158' ' ' GLN . 77.9 mt -80.6 -53.67 12.12 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.516 0 C-N-CA 125.195 1.398 . . . . 0.0 110.165 -173.186 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 76.4 mt -62.67 -47.82 91.11 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 N-CA-C 109.511 -0.551 . . . . 0.0 109.511 178.579 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 140.91 120.45 1.68 Allowed Glycine 0 CA--C 1.529 0.937 0 C-N-CA 125.273 1.416 . . . . 0.0 110.755 177.051 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 82.1 Cg_endo -73.78 -4.09 14.84 Favored 'Trans proline' 0 CA--C 1.541 0.832 0 C-N-CA 123.078 2.519 . . . . 0.0 113.228 -173.12 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -82.36 -21.63 35.85 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 118.841 0.746 . . . . 0.0 111.54 176.593 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -120.97 -12.91 8.68 Favored 'General case' 0 C--N 1.344 0.33 0 C-N-CA 124.927 1.291 . . . . 0.0 113.436 -175.774 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 60.0 t -100.07 145.36 10.92 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 N-CA-C 107.29 -1.374 . . . . 0.0 107.29 169.136 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 6.0 m -134.48 139.29 45.37 Favored 'General case' 0 N--CA 1.463 0.209 0 C-N-CA 125.105 1.362 . . . . 0.0 107.493 -178.2 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 34.7 mt -93.42 145.05 24.77 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 118.888 0.767 . . . . 0.0 110.033 -179.826 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 12.4 m-70 -112.19 130.74 55.81 Favored 'General case' 0 C--O 1.234 0.286 0 N-CA-C 106.454 -1.684 . . . . 0.0 106.454 168.051 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 35.5 t-20 -105.8 100.14 9.71 Favored 'General case' 0 CA--C 1.521 -0.168 0 N-CA-C 106.117 -1.808 . . . . 0.0 106.117 169.014 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.423 HD11 ' CD1' ' A' ' 6' ' ' PHE . 83.5 mt -70.07 -8.8 52.37 Favored 'General case' 0 N--CA 1.466 0.368 0 N-CA-C 113.414 0.894 . . . . 0.0 113.414 -169.935 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 24.5 tptt -62.41 -23.57 66.91 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 118.662 0.664 . . . . 0.0 110.684 168.261 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -129.81 -39.85 1.4 Allowed 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 124.584 1.153 . . . . 0.0 113.171 -173.87 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 41.4 m-20 -75.89 130.94 39.28 Favored 'General case' 0 C--O 1.235 0.302 0 C-N-CA 123.829 0.852 . . . . 0.0 108.727 178.708 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 15.6 m -74.31 149.22 86.69 Favored Pre-proline 0 CA--C 1.54 0.581 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 173.652 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -71.91 -22.12 23.71 Favored 'Trans proline' 0 CA--C 1.532 0.382 0 C-N-CA 121.802 1.668 . . . . 0.0 112.818 -172.961 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 11.9 mptt -56.21 -23.77 37.71 Favored 'General case' 0 N--CA 1.47 0.541 0 O-C-N 120.963 -1.085 . . . . 0.0 112.342 175.074 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -58.45 -34.15 70.53 Favored 'General case' 0 N--CA 1.465 0.314 0 C-N-CA 124.351 1.06 . . . . 0.0 110.69 175.811 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 61.3 mtt -60.02 -26.13 65.84 Favored 'General case' 0 N--CA 1.465 0.297 0 C-N-CA 124.622 1.169 . . . . 0.0 111.967 178.962 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 68.3 mt-10 -61.79 -33.46 74.15 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 118.729 0.695 . . . . 0.0 109.505 -178.466 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 30.8 mt-30 -69.11 -28.33 66.39 Favored 'General case' 0 CA--C 1.536 0.422 0 N-CA-C 113.749 1.018 . . . . 0.0 113.749 -172.189 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 76.5 m-85 -85.08 138.05 32.66 Favored 'General case' 0 N--CA 1.464 0.243 0 C-N-CA 122.991 0.516 . . . . 0.0 110.14 -167.762 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -71.14 -43.13 68.2 Favored 'General case' 0 C--O 1.233 0.237 0 CA-C-N 118.01 0.368 . . . . 0.0 110.45 -178.502 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 11.8 t -105.16 144.95 14.07 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.404 0 N-CA-C 107.101 -1.444 . . . . 0.0 107.101 169.668 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 19.1 tp -122.78 146.34 47.61 Favored 'General case' 0 N--CA 1.447 -0.618 0 N-CA-C 107.398 -1.334 . . . . 0.0 107.398 169.213 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 41.2 mt -128.05 130.0 69.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 N-CA-C 105.5 -2.037 . . . . 0.0 105.5 178.979 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 2.1 mp -114.35 131.06 56.68 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 125.729 1.612 . . . . 0.0 107.839 -172.17 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.438 ' HA3' ' CZ ' ' A' ' 85' ' ' TYR . . . -139.19 134.61 6.82 Favored Glycine 0 C--N 1.332 0.341 0 CA-C-O 118.855 -0.969 . . . . 0.0 111.544 177.902 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.454 HD13 ' HB1' ' A' ' 100' ' ' ALA . 5.5 tt -155.93 137.55 9.67 Favored Pre-proline 0 CA--C 1.533 0.3 0 CA-C-N 118.252 1.026 . . . . 0.0 111.246 177.954 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_endo -84.36 130.34 4.59 Favored 'Trans proline' 0 N--CA 1.453 -0.904 0 C-N-CA 122.383 2.055 . . . . 0.0 107.187 164.881 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 61.6 m -86.51 143.21 27.84 Favored 'General case' 0 CA--C 1.538 0.482 0 N-CA-C 107.843 -1.169 . . . . 0.0 107.843 170.895 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 14.1 t90 -147.81 125.43 11.78 Favored 'General case' 0 C--N 1.334 -0.068 0 N-CA-C 105.375 -2.083 . . . . 0.0 105.375 172.71 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -68.23 -43.9 76.92 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 118.801 0.728 . . . . 0.0 112.141 -170.126 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 79.6 t80 -69.09 -47.67 64.61 Favored 'General case' 0 C--O 1.236 0.352 0 C-N-CA 121.24 -0.184 . . . . 0.0 110.7 -170.866 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -83.99 -21.9 56.32 Favored Glycine 0 CA--C 1.532 1.132 0 CA-C-O 118.752 -1.027 . . . . 0.0 113.046 -178.415 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 57.8 -179.03 0.06 Allowed 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 125.455 1.502 . . . . 0.0 110.408 -167.658 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 11.7 mt -29.46 123.35 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.626 0 C-N-CA 126.668 1.987 . . . . 0.0 110.674 168.855 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 20.9 mp0 -69.64 155.93 39.74 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 124.829 1.252 . . . . 0.0 109.747 -174.455 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -51.3 -46.12 62.41 Favored 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 124.664 1.186 . . . . 0.0 111.155 -173.019 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 -60.19 -27.77 67.41 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 123.624 0.769 . . . . 0.0 110.734 -170.568 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' TRP . . . . . 0.646 ' CH2' HD23 ' A' ' 104' ' ' LEU . 0.1 OUTLIER -96.04 -46.92 6.3 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 126.192 1.797 . . . . 0.0 109.054 -178.579 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 14.6 tt0 -62.81 -34.05 76.48 Favored 'General case' 0 N--CA 1.445 -0.723 0 C-N-CA 125.165 1.386 . . . . 0.0 110.437 -175.187 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -57.37 -23.9 52.0 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 124.606 1.162 . . . . 0.0 111.999 -179.065 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 17.7 m -121.4 -11.12 9.09 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.225 0 C-N-CA 124.882 1.273 . . . . 0.0 112.348 179.879 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 48.5 t90 -55.39 -36.57 66.54 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 124.362 1.065 . . . . 0.0 110.674 -178.437 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -63.52 -27.9 69.58 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 125.403 1.481 . . . . 0.0 112.949 176.183 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 41.9 mt-30 -91.73 -20.97 20.99 Favored 'General case' 0 CA--C 1.519 -0.239 0 C-N-CA 125.186 1.394 . . . . 0.0 112.506 179.998 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 76.1 mt -59.45 -27.47 66.11 Favored 'General case' 0 N--CA 1.467 0.391 0 O-C-N 121.538 -0.726 . . . . 0.0 111.294 178.589 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -76.94 -25.75 53.23 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 122.529 0.331 . . . . 0.0 111.316 173.974 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -77.47 -27.14 51.93 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 124.645 1.178 . . . . 0.0 112.335 -179.467 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 36.3 mt -61.8 147.46 46.34 Favored 'General case' 0 C--N 1.34 0.173 0 C-N-CA 124.296 1.039 . . . . 0.0 111.434 -178.079 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 24.4 t-20 -88.15 122.23 31.48 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 108.111 -1.07 . . . . 0.0 108.111 168.437 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 80.6 mt -130.92 9.33 4.9 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 123.577 0.751 . . . . 0.0 112.518 -170.054 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 26.8 mt-10 -52.42 127.92 23.97 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 124.055 0.942 . . . . 0.0 112.382 -168.064 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 69.35 -0.73 15.8 Favored Glycine 0 CA--C 1.534 1.22 0 C-N-CA 125.473 1.511 . . . . 0.0 115.721 176.659 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.82 149.33 39.68 Favored 'General case' 0 C--N 1.345 0.401 0 CA-C-N 120.551 2.176 . . . . 0.0 109.871 -173.29 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 4.5 mt -80.17 137.14 22.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 N-CA-C 106.923 -1.51 . . . . 0.0 106.923 177.769 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 55.6 t -131.47 124.17 54.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 C-N-CA 124.522 1.129 . . . . 0.0 109.734 -176.882 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -94.34 149.93 20.77 Favored 'General case' 0 CA--C 1.52 -0.186 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 167.147 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 8.4 mt -129.16 129.92 45.72 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 107.521 -1.288 . . . . 0.0 107.521 176.736 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.438 ' CZ ' ' HA3' ' A' ' 52' ' ' GLY . 39.9 p90 -142.94 165.82 26.31 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 107.566 -1.272 . . . . 0.0 107.566 167.712 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -166.68 168.81 40.37 Favored Glycine 0 N--CA 1.442 -0.944 0 N-CA-C 110.147 -1.181 . . . . 0.0 110.147 173.517 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 1.1 mp -115.73 157.17 24.69 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 124.952 1.301 . . . . 0.0 108.925 177.249 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -167.44 -161.26 16.43 Favored Glycine 0 CA--C 1.525 0.7 0 N-CA-C 109.414 -1.475 . . . . 0.0 109.414 174.121 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 89' ' ' ASP . . . . . 0.408 ' CG ' ' H ' ' A' ' 92' ' ' GLY . 60.0 t0 -147.66 114.54 6.11 Favored 'General case' 0 C--O 1.234 0.252 0 N-CA-C 107.121 -1.437 . . . . 0.0 107.121 174.92 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 5.6 pt20 -81.61 -7.89 59.64 Favored 'General case' 0 CA--C 1.541 0.628 0 N-CA-C 112.954 0.724 . . . . 0.0 112.954 -177.603 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 49.1 mt -91.66 -49.86 6.06 Favored 'General case' 0 N--CA 1.465 0.285 0 C-N-CA 124.448 1.099 . . . . 0.0 108.355 171.643 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 92' ' ' GLY . . . . . 0.408 ' H ' ' CG ' ' A' ' 89' ' ' ASP . . . -71.22 -44.93 51.81 Favored Glycine 0 CA--C 1.524 0.601 0 C-N-CA 124.575 1.083 . . . . 0.0 112.119 -174.604 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 5.5 m-85 -105.33 -78.19 0.57 Allowed 'General case' 0 C--N 1.339 0.14 0 N-CA-C 107.665 -1.235 . . . . 0.0 107.665 -178.55 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 78.06 -51.6 3.55 Favored Glycine 0 CA--C 1.526 0.751 0 C-N-CA 125.658 1.599 . . . . 0.0 111.593 173.323 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -67.18 -28.27 67.96 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 123.511 0.724 . . . . 0.0 110.675 173.917 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 96' ' ' TRP . . . . . . . . . . . . . 4.2 m-90 -122.18 27.6 7.91 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 125.16 1.384 . . . . 0.0 111.24 -169.858 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 14.2 t80 -60.36 131.05 49.56 Favored 'General case' 0 N--CA 1.462 0.162 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 -178.801 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 94.6 mt 52.59 24.98 3.37 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 124.253 1.021 . . . . 0.0 113.358 172.206 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -63.9 -34.77 78.71 Favored 'General case' 0 C--N 1.333 -0.134 0 O-C-N 120.746 -1.221 . . . . 0.0 110.741 -170.937 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 100' ' ' ALA . . . . . 0.454 ' HB1' HD13 ' A' ' 53' ' ' ILE . . . -73.89 -26.34 60.49 Favored 'General case' 0 N--CA 1.453 -0.302 0 O-C-N 121.485 -0.76 . . . . 0.0 112.619 176.36 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 5.2 tt -62.22 -44.86 95.61 Favored 'General case' 0 N--CA 1.466 0.36 0 N-CA-C 107.124 -1.435 . . . . 0.0 107.124 169.126 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -64.78 -40.63 97.51 Favored Glycine 0 C--N 1.34 0.803 0 N-CA-C 111.136 -0.786 . . . . 0.0 111.136 -179.02 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 75.0 mtm -62.7 -41.13 98.98 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 118.072 0.936 . . . . 0.0 111.318 177.344 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.646 HD23 ' CH2' ' A' ' 65' ' ' TRP . 0.1 OUTLIER -68.09 -40.21 82.68 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 120.164 1.347 . . . . 0.0 110.485 178.594 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 82.3 t60 -55.98 -51.92 66.01 Favored 'General case' 0 CA--C 1.528 0.112 0 N-CA-C 110.062 -0.348 . . . . 0.0 110.062 175.035 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -64.32 -39.94 94.92 Favored 'General case' 0 C--O 1.235 0.339 0 C-N-CA 123.967 0.907 . . . . 0.0 112.584 -176.102 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 22.3 ttmm -54.85 -39.05 68.22 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 123.794 0.838 . . . . 0.0 109.775 171.567 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 21.8 mt -90.6 -18.78 24.58 Favored 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 114.603 1.334 . . . . 0.0 114.603 -169.379 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 2.5 m -58.86 -33.46 70.49 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 120.561 1.528 . . . . 0.0 111.688 -175.75 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 19.5 p -86.56 -11.94 50.12 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 124.754 1.221 . . . . 0.0 111.999 -179.318 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 32.1 mmmt -82.12 -10.14 59.29 Favored 'General case' 0 C--N 1.344 0.342 0 C-N-CA 124.314 1.046 . . . . 0.0 111.414 176.37 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 73.65 32.99 58.74 Favored Glycine 0 CA--C 1.526 0.723 0 CA-C-O 119.524 -0.598 . . . . 0.0 112.102 173.153 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 17.2 m -75.19 177.54 0.57 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.613 0 CA-C-N 118.193 0.997 . . . . 0.0 109.853 171.224 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -118.91 120.25 36.74 Favored 'General case' 0 CA--C 1.518 -0.274 0 N-CA-C 106.939 -1.504 . . . . 0.0 106.939 174.373 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 76.9 m-85 -87.83 144.67 26.47 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 119.696 1.135 . . . . 0.0 110.231 -175.323 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 35.9 m -134.34 159.68 41.92 Favored 'Isoleucine or valine' 0 C--O 1.234 0.254 0 C-N-CA 125.343 1.457 . . . . 0.0 107.936 169.865 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 85.54 30.62 23.91 Favored Glycine 0 CA--C 1.522 0.513 0 CA-C-O 118.75 -1.028 . . . . 0.0 114.262 170.872 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 13.0 m-30 -62.06 157.01 19.9 Favored 'General case' 0 CA--C 1.545 0.757 0 CA-C-N 119.036 1.418 . . . . 0.0 109.691 169.09 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 119' ' ' TRP . . . . . 0.42 ' HA ' ' HD3' ' A' ' 120' ' ' PRO . 2.5 t90 -135.98 144.26 47.65 Favored Pre-proline 0 N--CA 1.474 0.772 0 CA-C-O 117.712 -1.137 . . . . 0.0 111.849 -168.915 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 120' ' ' PRO . . . . . 0.42 ' HD3' ' HA ' ' A' ' 119' ' ' TRP . 36.2 Cg_exo -66.96 123.0 10.41 Favored 'Trans proline' 0 C--N 1.352 0.761 0 C-N-CA 123.552 2.835 . . . . 0.0 113.144 -176.647 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 3.3 p -77.25 -15.27 59.53 Favored 'General case' 0 N--CA 1.468 0.43 0 N-CA-C 113.847 1.055 . . . . 0.0 113.847 179.341 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -62.33 127.51 31.68 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 118.556 0.616 . . . . 0.0 109.58 -171.475 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 87.01 -7.77 79.13 Favored Glycine 0 CA--C 1.534 1.252 0 C-N-CA 124.888 1.232 . . . . 0.0 114.325 178.448 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 4.9 m-85 -88.76 153.82 20.78 Favored 'General case' 0 C--O 1.237 0.396 0 CA-C-N 119.507 1.654 . . . . 0.0 110.141 172.265 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -105.36 130.94 53.36 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 124.488 1.115 . . . . 0.0 108.181 171.849 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 36.8 p90 -162.84 134.84 5.28 Favored 'General case' 0 CA--C 1.534 0.329 0 N-CA-C 106.135 -1.802 . . . . 0.0 106.135 175.316 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 2.5 m -92.33 -53.45 4.22 Favored 'General case' 0 N--CA 1.45 -0.453 0 O-C-N 121.631 -0.668 . . . . 0.0 111.496 -176.236 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 43.5 m -76.45 149.4 81.41 Favored Pre-proline 0 CA--C 1.543 0.696 0 C-N-CA 123.617 0.767 . . . . 0.0 111.227 -173.698 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 82.1 Cg_endo -84.84 -10.08 8.5 Favored 'Trans proline' 0 CA--C 1.541 0.842 0 C-N-CA 122.905 2.403 . . . . 0.0 113.903 -176.412 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 24.8 ttmt -53.04 -42.27 89.91 Favored Pre-proline 0 N--CA 1.475 0.803 0 N-CA-C 114.845 1.424 . . . . 0.0 114.845 -174.134 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_endo -78.92 -1.04 11.26 Favored 'Trans proline' 0 CA--C 1.539 0.761 0 CA-C-N 122.25 1.839 . . . . 0.0 113.999 179.992 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 18.5 m -127.37 170.58 17.02 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.22 0 CA-C-N 119.875 1.216 . . . . 0.0 110.96 -171.307 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 4.9 pt -128.8 169.29 20.42 Favored 'Isoleucine or valine' 0 C--O 1.241 0.64 0 C-N-CA 127.664 2.386 . . . . 0.0 107.86 175.579 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . 56.41 -156.37 0.28 Allowed 'General case' 0 N--CA 1.446 -0.652 0 C-N-CA 124.622 1.169 . . . . 0.0 108.37 -175.924 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 24.8 t0 -78.51 52.47 1.17 Allowed 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 124.481 1.113 . . . . 0.0 110.833 174.894 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 67.19 26.67 73.4 Favored Glycine 0 CA--C 1.531 1.069 0 C-N-CA 124.657 1.123 . . . . 0.0 112.677 -175.495 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 36.8 mt-30 -88.56 -11.41 45.71 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 118.579 1.19 . . . . 0.0 112.533 -170.128 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 8.5 tp -155.71 143.28 19.54 Favored 'General case' 0 C--N 1.343 0.319 0 CA-C-N 119.255 0.934 . . . . 0.0 110.578 175.671 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 67.9 m-85 -78.4 144.92 35.48 Favored 'General case' 0 CA--C 1.516 -0.365 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 169.771 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 17.0 m -76.56 4.63 1.11 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.732 0 C-N-CA 122.773 0.429 . . . . 0.0 111.959 176.615 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -172.86 172.92 45.38 Favored Glycine 0 CA--C 1.527 0.8 0 O-C-N 120.753 -1.217 . . . . 0.0 110.6 -179.173 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 3.6 tp -62.6 131.78 50.19 Favored 'General case' 0 N--CA 1.464 0.246 0 C-N-CA 124.143 0.977 . . . . 0.0 110.942 179.638 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -91.18 129.08 37.21 Favored 'General case' 0 N--CA 1.444 -0.742 0 C-N-CA 126.288 1.835 . . . . 0.0 109.572 176.811 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 32.4 mt -130.32 144.25 51.26 Favored 'General case' 0 C--O 1.231 0.116 0 N-CA-C 105.926 -1.879 . . . . 0.0 105.926 172.152 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -130.93 130.16 43.11 Favored 'General case' 0 N--CA 1.453 -0.281 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 -179.518 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -90.65 -4.6 56.67 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 124.144 0.977 . . . . 0.0 112.957 -169.871 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 90.0 m -125.37 -44.83 1.84 Allowed 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 124.526 1.13 . . . . 0.0 111.13 -172.743 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 4.9 m-80 -77.88 -29.52 50.31 Favored 'General case' 0 C--N 1.331 -0.197 0 C-N-CA 124.331 1.052 . . . . 0.0 110.871 -172.203 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 76.8 mt-30 -128.42 157.16 41.85 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 125.313 1.445 . . . . 0.0 109.196 -178.329 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 86.8 t80 -152.22 -51.66 0.11 Allowed 'General case' 0 CA--C 1.529 0.164 0 C-N-CA 124.216 1.007 . . . . 0.0 108.752 171.325 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -64.31 -48.8 74.26 Favored 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 122.956 0.503 . . . . 0.0 111.454 -174.823 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . 0.275 0.6 OUTLIER -95.7 6.23 49.44 Favored 'General case' 0 C--N 1.341 0.231 0 N-CA-C 112.971 0.73 . . . . 0.0 112.971 -178.699 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 14.9 m -60.45 -36.02 77.23 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 120.02 1.282 . . . . 0.0 109.299 169.237 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -56.27 -44.22 79.56 Favored 'General case' 0 N--CA 1.464 0.27 0 C-N-CA 124.438 1.095 . . . . 0.0 110.904 169.818 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -65.25 -44.56 87.74 Favored 'General case' 0 C--O 1.234 0.252 0 C-N-CA 124.605 1.162 . . . . 0.0 110.882 -178.718 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 5.9 mmt180 -58.32 -41.36 84.37 Favored 'General case' 0 N--CA 1.462 0.153 0 CA-C-O 118.765 -0.636 . . . . 0.0 109.887 177.944 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 42.0 mt -67.98 -53.97 26.04 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.236 0 N-CA-C 108.228 -1.027 . . . . 0.0 108.228 176.811 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 158' ' ' GLN . . . . . 0.472 ' HA ' HD13 ' A' ' 24' ' ' ILE . 0.8 OUTLIER -49.77 -66.25 0.42 Allowed 'General case' 0 CA--C 1.518 -0.267 0 C-N-CA 125.547 1.539 . . . . 0.0 112.067 -172.178 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 14.6 m -60.95 -34.1 74.22 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 115.554 -0.748 . . . . 0.0 111.713 -174.888 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 160' ' ' TRP . . . . . . . . . . . . . 79.2 t90 -65.55 -43.9 88.48 Favored 'General case' 0 C--O 1.222 -0.373 0 O-C-N 121.775 -0.578 . . . . 0.0 111.005 174.411 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 92.5 m -61.01 -41.36 96.38 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 123.159 0.584 . . . . 0.0 110.652 179.721 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -63.09 -41.1 99.33 Favored 'General case' 0 N--CA 1.462 0.15 0 CA-C-O 121.104 0.478 . . . . 0.0 110.791 173.534 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 16.1 tt0 -65.05 -51.22 62.75 Favored 'General case' 0 N--CA 1.446 -0.654 0 O-C-N 121.566 -0.708 . . . . 0.0 110.122 -177.614 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 41.6 pt -63.38 -36.82 77.65 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.403 0 CA-C-O 117.818 -1.087 . . . . 0.0 109.734 -175.863 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -64.35 -36.25 83.52 Favored 'General case' 0 C--O 1.225 -0.187 0 CA-C-N 119.561 1.073 . . . . 0.0 109.611 -179.704 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 41.3 m-80 -68.59 -51.34 43.63 Favored 'General case' 0 N--CA 1.467 0.387 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 175.422 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 22.8 tt0 -72.85 -16.04 61.6 Favored 'General case' 0 N--CA 1.443 -0.802 0 C-N-CA 125.847 1.659 . . . . 0.0 111.937 -169.448 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 168' ' ' MET . . . . . . . . . . . . . 19.5 ptp -90.94 -38.93 12.55 Favored 'General case' 0 N--CA 1.456 -0.162 0 C-N-CA 123.799 0.84 . . . . 0.0 111.544 168.722 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -75.76 -27.04 57.9 Favored 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 122.703 0.401 . . . . 0.0 112.037 -172.927 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -56.79 -26.58 58.07 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 123.672 0.789 . . . . 0.0 112.252 -179.23 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 80.3 m-70 -78.76 -14.96 58.99 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 124.919 1.288 . . . . 0.0 112.843 178.967 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 50.0 m-85 -127.13 -16.76 4.96 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 125.626 1.571 . . . . 0.0 113.694 -168.694 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.254 1.335 0 C-N-CA 124.442 1.097 . . . . 0.0 110.07 173.694 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.497 1.905 0 N-CA-C 111.146 0.054 . . . . 0.0 111.146 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 22.3 p-10 -130.88 164.17 25.83 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 124.649 1.179 . . . . 0.0 111.487 -173.725 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 16.0 mtt -130.72 124.3 31.21 Favored 'General case' 0 CA--C 1.523 -0.087 0 C-N-CA 123.201 0.6 . . . . 0.0 111.258 179.798 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -87.33 152.18 24.13 Favored Glycine 0 CA--C 1.525 0.682 0 N-CA-C 106.838 -2.505 . . . . 0.0 106.838 166.895 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 2.7 tt -140.11 97.01 3.15 Favored 'General case' 0 N--CA 1.469 0.477 0 N-CA-C 105.783 -1.932 . . . . 0.0 105.783 -172.629 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . 0.694 ' CZ ' HD23 ' A' ' 51' ' ' LEU . 0.7 OUTLIER -105.08 144.0 32.48 Favored 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 123.172 0.589 . . . . 0.0 111.063 -171.664 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 43.1 p90 . . . . . 0 C--O 1.234 0.28 0 C-N-CA 124.16 0.984 . . . . 0.0 109.941 -179.881 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.536 0.408 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -64.0 -48.47 76.26 Favored 'General case' 0 N--CA 1.455 -0.223 0 C-N-CA 123.785 0.834 . . . . 0.0 111.511 -177.909 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -52.76 -47.59 67.37 Favored 'General case' 0 C--O 1.235 0.334 0 C-N-CA 124.146 0.978 . . . . 0.0 109.72 175.492 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 28.7 mtpp -75.82 -42.13 50.65 Favored 'General case' 0 C--O 1.221 -0.428 0 CA-C-O 117.982 -1.008 . . . . 0.0 110.521 -170.446 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 39.0 mt -52.37 -53.34 19.87 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.352 0 CA-C-N 120.258 1.39 . . . . 0.0 108.614 173.494 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.15 -39.23 91.93 Favored 'General case' 0 C--O 1.222 -0.358 0 C-N-CA 123.367 0.667 . . . . 0.0 109.798 -176.821 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -66.46 -42.3 87.77 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 118.599 0.636 . . . . 0.0 110.943 179.678 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 54.7 mt -74.0 -53.78 16.64 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.605 0 C-N-CA 124.995 1.318 . . . . 0.0 109.767 -169.789 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 75.3 mt -65.45 -46.1 90.98 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.446 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 178.76 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 140.21 125.85 2.23 Favored Glycine 0 CA--C 1.533 1.176 0 C-N-CA 124.676 1.132 . . . . 0.0 111.952 172.832 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -71.6 -6.88 20.07 Favored 'Trans proline' 0 CA--C 1.539 0.749 0 C-N-CA 123.701 2.934 . . . . 0.0 113.684 -174.025 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -81.55 -19.24 42.47 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-N 119.123 0.874 . . . . 0.0 111.245 176.812 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -127.25 -5.83 6.01 Favored 'General case' 0 C--N 1.345 0.372 0 C-N-CA 124.653 1.181 . . . . 0.0 113.792 -174.53 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 26.9 t -113.32 147.21 17.07 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.266 0 N-CA-C 108.007 -1.109 . . . . 0.0 108.007 170.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 36.4 m -135.03 132.15 37.93 Favored 'General case' 0 C--O 1.234 0.267 0 C-N-CA 125.896 1.678 . . . . 0.0 106.667 -174.819 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 14.7 mt -76.01 138.09 40.68 Favored 'General case' 0 C--O 1.231 0.101 0 N-CA-C 107.885 -1.154 . . . . 0.0 107.885 174.696 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 35.0 t-80 -126.85 56.48 1.5 Allowed 'General case' 0 CA--C 1.531 0.217 0 N-CA-C 107.422 -1.325 . . . . 0.0 107.422 177.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 48.5 t30 -61.21 128.92 38.75 Favored 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 107.099 -1.445 . . . . 0.0 107.099 176.123 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 40.2 mt -70.33 -29.98 66.82 Favored 'General case' 0 N--CA 1.469 0.496 0 N-CA-C 114.138 1.162 . . . . 0.0 114.138 -167.65 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 21.5 mmmt -62.72 -26.16 68.54 Favored 'General case' 0 N--CA 1.466 0.344 0 O-C-N 121.703 -0.623 . . . . 0.0 111.698 168.369 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -92.62 -34.62 13.93 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-N 118.568 0.622 . . . . 0.0 112.405 -172.566 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 2.2 t0 -146.4 150.73 36.22 Favored 'General case' 0 N--CA 1.466 0.363 0 N-CA-C 113.025 0.75 . . . . 0.0 113.025 177.008 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 15.2 m -72.14 158.11 88.17 Favored Pre-proline 0 CA--C 1.541 0.6 0 C-N-CA 126.083 1.753 . . . . 0.0 111.499 -169.555 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -71.8 -27.5 17.89 Favored 'Trans proline' 0 C--N 1.35 0.628 0 C-N-CA 122.388 2.059 . . . . 0.0 113.385 -170.466 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 14.8 mmmt -68.36 -16.12 63.81 Favored 'General case' 0 N--CA 1.472 0.644 0 O-C-N 120.897 -1.127 . . . . 0.0 111.286 -175.822 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -62.95 -27.97 69.75 Favored 'General case' 0 N--CA 1.465 0.277 0 C-N-CA 125.741 1.616 . . . . 0.0 110.422 171.821 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 47.5 mtt -56.37 -25.39 49.39 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 119.134 0.879 . . . . 0.0 111.422 178.335 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -66.57 -30.21 70.45 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 118.445 0.566 . . . . 0.0 110.895 -176.585 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 23.1 mt-30 -68.88 -41.5 78.23 Favored 'General case' 0 N--CA 1.465 0.277 0 N-CA-C 113.082 0.771 . . . . 0.0 113.082 -170.071 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 43.3 m-85 -72.75 137.47 45.89 Favored 'General case' 0 N--CA 1.461 0.104 0 C-N-CA 123.534 0.734 . . . . 0.0 109.721 -167.197 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -68.27 -36.54 79.56 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 118.539 0.609 . . . . 0.0 110.181 178.908 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 5.9 t -110.39 144.14 19.03 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.295 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 170.948 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 59.4 tp -131.02 108.55 9.87 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 173.484 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 22.8 mt -85.49 131.27 34.7 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 N-CA-C 106.246 -1.761 . . . . 0.0 106.246 175.067 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.694 HD23 ' CZ ' ' A' ' 6' ' ' PHE . 0.8 OUTLIER -107.29 133.36 51.96 Favored 'General case' 0 N--CA 1.456 -0.134 0 C-N-CA 125.574 1.55 . . . . 0.0 107.918 172.058 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.527 ' N ' HD22 ' A' ' 51' ' ' LEU . . . -127.65 126.7 5.59 Favored Glycine 0 C--N 1.331 0.299 0 N-CA-C 109.457 -1.457 . . . . 0.0 109.457 170.47 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 7.0 tt -148.92 123.23 4.77 Favored Pre-proline 0 N--CA 1.471 0.584 0 CA-C-N 119.305 1.552 . . . . 0.0 111.582 170.846 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_exo . . . . . 0 N--CA 1.459 -0.525 0 C-N-CA 122.444 2.096 . . . . 0.0 110.664 166.604 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.425 HD11 ' HE3' ' A' ' 103' ' ' MET . 78.8 mt . . . . . 0 CA--C 1.545 0.77 0 CA-C-O 122.149 0.976 . . . . 0.0 112.772 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.68 163.26 4.46 Favored 'General case' 0 CA--C 1.542 0.655 0 CA-C-O 122.257 1.027 . . . . 0.0 112.376 171.761 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -59.79 -42.27 93.02 Favored 'General case' 0 N--CA 1.455 -0.206 0 C-N-CA 124.377 1.071 . . . . 0.0 112.599 -168.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 55.4 m-20 -66.3 -23.1 66.32 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-N 119.615 1.098 . . . . 0.0 111.723 -169.62 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 12.7 t90 -91.32 -44.83 8.94 Favored 'General case' 0 N--CA 1.456 -0.166 0 C-N-CA 124.379 1.071 . . . . 0.0 110.133 175.419 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -61.7 -35.31 77.66 Favored 'General case' 0 CA--C 1.535 0.396 0 O-C-N 121.266 -0.896 . . . . 0.0 109.945 -178.383 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -58.38 -24.73 60.79 Favored 'General case' 0 C--O 1.233 0.199 0 C-N-CA 124.465 1.106 . . . . 0.0 111.738 -177.725 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 35.7 m -115.13 -13.87 11.07 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.245 0 CA-C-O 117.327 -1.321 . . . . 0.0 112.354 178.0 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 25.1 t90 -52.64 -38.94 61.24 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 120.291 1.405 . . . . 0.0 110.576 -179.02 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -63.17 -26.93 69.03 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 125.098 1.359 . . . . 0.0 113.216 176.543 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 26.0 mt-30 -92.4 -20.09 21.4 Favored 'General case' 0 C--N 1.342 0.243 0 C-N-CA 125.735 1.614 . . . . 0.0 112.31 178.114 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 47.9 mt -64.12 -23.17 67.22 Favored 'General case' 0 N--CA 1.465 0.305 0 O-C-N 121.212 -0.93 . . . . 0.0 111.337 -175.756 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -79.99 -22.25 42.72 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-N 118.372 0.533 . . . . 0.0 111.877 174.684 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -70.72 -27.47 63.99 Favored 'General case' 0 N--CA 1.471 0.618 0 O-C-N 120.979 -1.076 . . . . 0.0 111.521 176.608 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 27.3 mt -62.06 149.67 40.43 Favored 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 124.855 1.262 . . . . 0.0 109.592 -179.636 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 28.1 t-20 -72.0 -59.86 2.53 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-O 122.634 1.206 . . . . 0.0 112.424 -174.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 16.7 mt 58.44 2.25 0.21 Allowed 'General case' 0 C--N 1.32 -0.686 0 C-N-CA 129.5 3.12 . . . . 0.0 116.739 175.679 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 30.9 mt-10 -58.59 130.12 45.33 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 120.188 1.358 . . . . 0.0 111.864 -169.186 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 71.18 0.1 34.35 Favored Glycine 0 CA--C 1.533 1.159 0 CA-C-O 117.964 -1.464 . . . . 0.0 114.908 176.24 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.11 155.29 37.25 Favored 'General case' 0 C--N 1.343 0.323 0 CA-C-N 120.681 2.241 . . . . 0.0 110.225 -174.414 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 1.9 mt -84.71 140.91 15.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 N-CA-C 106.875 -1.528 . . . . 0.0 106.875 178.194 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 54.9 t -135.4 138.98 47.58 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.706 0 C-N-CA 124.012 0.925 . . . . 0.0 109.024 -179.161 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.488 ' HB1' ' CH2' ' A' ' 160' ' ' TRP . . . -111.19 142.68 43.06 Favored 'General case' 0 CA--C 1.517 -0.301 0 N-CA-C 104.365 -2.458 . . . . 0.0 104.365 166.763 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 30.8 mt -122.19 144.88 48.69 Favored 'General case' 0 CA--C 1.51 -0.594 0 CA-C-N 120.262 1.392 . . . . 0.0 107.373 169.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 41.6 p90 -150.4 162.75 39.94 Favored 'General case' 0 N--CA 1.44 -0.934 0 N-CA-C 107.744 -1.206 . . . . 0.0 107.744 168.286 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -157.58 171.58 34.78 Favored Glycine 0 N--CA 1.443 -0.897 0 N-CA-C 109.691 -1.364 . . . . 0.0 109.691 171.459 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 6.8 tt . . . . . 0 N--CA 1.446 -0.632 0 C-N-CA 125.04 1.336 . . . . 0.0 108.334 175.677 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 97.5 mt . . . . . 0 N--CA 1.472 0.663 0 N-CA-C 113.807 1.04 . . . . 0.0 113.807 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -67.28 -32.22 73.06 Favored 'General case' 0 C--N 1.329 -0.302 0 O-C-N 120.539 -1.35 . . . . 0.0 110.577 -171.685 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -70.68 -30.25 66.79 Favored 'General case' 0 CA--C 1.535 0.396 0 O-C-N 121.503 -0.748 . . . . 0.0 111.834 173.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 6.3 tt -61.77 -46.52 89.23 Favored 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 107.845 -1.169 . . . . 0.0 107.845 169.349 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -62.04 -38.07 95.48 Favored Glycine 0 CA--C 1.524 0.603 0 N-CA-C 111.086 -0.806 . . . . 0.0 111.086 -177.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' MET . . . . . 0.425 ' HE3' HD11 ' A' ' 61' ' ' ILE . 74.3 mtm -68.5 -39.26 81.34 Favored 'General case' 0 N--CA 1.454 -0.243 0 CA-C-O 118.246 -0.883 . . . . 0.0 111.489 177.705 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.46 ' HA ' HD22 ' A' ' 104' ' ' LEU . 0.2 OUTLIER -71.98 -32.08 66.88 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-N 120.52 1.509 . . . . 0.0 110.649 177.209 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -56.5 -56.58 19.46 Favored 'General case' 0 N--CA 1.462 0.146 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 167.891 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -63.39 -38.53 91.52 Favored 'General case' 0 C--O 1.235 0.338 0 C-N-CA 123.49 0.716 . . . . 0.0 112.025 -170.852 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 23.5 ttmm -58.34 -44.42 88.72 Favored 'General case' 0 CA--C 1.529 0.161 0 C-N-CA 122.804 0.442 . . . . 0.0 109.834 171.619 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 49.0 mt -83.49 -20.05 34.67 Favored 'General case' 0 CA--C 1.519 -0.238 0 N-CA-C 114.445 1.276 . . . . 0.0 114.445 -169.512 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 1.1 m -59.57 -36.53 76.41 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 120.567 1.53 . . . . 0.0 111.375 -172.544 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 20.0 p -84.33 -15.35 46.86 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 124.922 1.289 . . . . 0.0 111.732 -178.948 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 30.7 mmmt -78.34 -14.1 59.56 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 124.212 1.005 . . . . 0.0 110.844 173.869 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 79.28 33.45 35.61 Favored Glycine 0 CA--C 1.524 0.653 0 CA-C-O 119.333 -0.704 . . . . 0.0 112.335 170.22 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 12.9 m -75.91 170.04 1.58 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.458 0 CA-C-N 118.518 1.159 . . . . 0.0 110.203 173.218 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 16.5 tptm -101.62 129.29 47.71 Favored 'General case' 0 CA--C 1.515 -0.402 0 N-CA-C 105.086 -2.19 . . . . 0.0 105.086 168.219 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 65.9 m-85 -93.78 123.92 37.44 Favored 'General case' 0 C--N 1.33 -0.239 0 N-CA-C 107.654 -1.239 . . . . 0.0 107.654 171.303 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 30.2 m -106.18 160.95 5.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 C-N-CA 123.914 0.886 . . . . 0.0 109.387 168.649 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 99.18 -77.07 0.51 Allowed Glycine 0 N--CA 1.446 -0.67 0 C-N-CA 125.122 1.344 . . . . 0.0 111.839 170.651 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 20.8 m-85 55.39 -170.17 0.07 Allowed 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 124.129 0.972 . . . . 0.0 110.861 -169.639 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -154.57 143.41 14.77 Favored Pre-proline 0 N--CA 1.466 0.332 0 CA-C-O 117.628 -1.177 . . . . 0.0 108.809 168.737 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_exo -61.97 127.72 22.16 Favored 'Trans proline' 0 CA--C 1.533 0.461 0 C-N-CA 122.209 1.94 . . . . 0.0 111.144 178.403 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 10.4 p . . . . . 0 N--CA 1.47 0.527 0 N-CA-C 112.753 0.649 . . . . 0.0 112.753 174.199 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 23.6 ttmt . . . . . 0 CA--C 1.54 0.586 0 CA-C-O 117.457 -1.259 . . . . 0.0 113.844 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -81.99 5.35 6.38 Favored 'Trans proline' 0 C--N 1.352 0.746 0 CA-C-N 122.187 1.817 . . . . 0.0 113.551 -176.588 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 17.1 m -135.5 170.05 19.85 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.249 0 CA-C-N 120.622 1.556 . . . . 0.0 111.36 -169.574 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 14.5 pt -141.1 175.23 6.02 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.657 0 C-N-CA 127.876 2.47 . . . . 0.0 108.254 -179.472 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . 54.8 42.59 31.04 Favored 'General case' 0 N--CA 1.464 0.266 0 C-N-CA 125.27 1.428 . . . . 0.0 112.342 173.849 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 27.1 t0 53.69 41.5 32.06 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 126.184 1.794 . . . . 0.0 111.696 -176.452 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 88.03 14.51 62.49 Favored Glycine 0 CA--C 1.526 0.758 0 CA-C-O 118.496 -1.169 . . . . 0.0 113.771 174.037 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 45.7 mt-30 -84.65 -17.31 39.0 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 119.462 1.631 . . . . 0.0 112.658 -179.892 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -143.91 144.74 31.86 Favored 'General case' 0 C--N 1.342 0.252 0 CA-C-N 119.266 0.939 . . . . 0.0 110.379 174.174 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 68.3 m-85 -73.71 141.43 46.38 Favored 'General case' 0 CA--C 1.512 -0.489 0 N-CA-C 105.08 -2.192 . . . . 0.0 105.08 165.173 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 8.0 p -79.05 14.46 0.35 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.672 0 CA-C-O 121.363 0.601 . . . . 0.0 111.714 -176.412 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -178.82 172.87 45.18 Favored Glycine 0 CA--C 1.525 0.712 0 N-CA-C 109.209 -1.556 . . . . 0.0 109.209 177.262 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -66.21 138.66 57.83 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 117.658 0.729 . . . . 0.0 111.122 -176.214 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -98.5 118.47 35.27 Favored 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 125.716 1.607 . . . . 0.0 109.068 175.883 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 93.5 mt . . . . . 0 C--N 1.33 -0.256 0 C-N-CA 123.776 0.831 . . . . 0.0 109.153 169.651 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 50.7 m . . . . . 0 CA--C 1.536 0.425 0 CA-C-O 119.606 -0.235 . . . . 0.0 110.582 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -60.71 -40.74 93.39 Favored 'General case' 0 N--CA 1.464 0.231 0 C-N-CA 123.35 0.66 . . . . 0.0 111.448 170.398 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -65.02 -45.11 86.88 Favored 'General case' 0 C--O 1.234 0.288 0 C-N-CA 124.869 1.268 . . . . 0.0 110.315 177.042 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 81.8 mtt180 -58.06 -47.58 82.71 Favored 'General case' 0 N--CA 1.462 0.148 0 CA-C-O 118.649 -0.691 . . . . 0.0 110.089 176.314 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 46.4 mt -62.8 -53.23 49.5 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.281 0 N-CA-C 107.904 -1.147 . . . . 0.0 107.904 179.696 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 69.8 tp60 -53.68 -61.15 2.49 Favored 'General case' 0 C--O 1.233 0.22 0 C-N-CA 124.024 0.929 . . . . 0.0 110.867 -175.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 44.3 p -65.02 -36.84 85.66 Favored 'General case' 0 C--N 1.326 -0.418 0 O-C-N 123.062 0.227 . . . . 0.0 110.95 -170.375 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 160' ' ' TRP . . . . . 0.488 ' CH2' ' HB1' ' A' ' 83' ' ' ALA . 36.0 t90 -67.73 -44.17 78.21 Favored 'General case' 0 C--O 1.221 -0.395 0 O-C-N 122.248 -0.283 . . . . 0.0 110.929 177.465 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 58.7 m -59.18 -44.29 92.18 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 123.039 0.536 . . . . 0.0 110.703 178.541 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -62.49 -41.96 99.16 Favored 'General case' 0 N--CA 1.456 -0.13 0 CA-C-O 121.071 0.463 . . . . 0.0 109.888 176.38 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 12.6 tt0 -62.9 -52.92 61.19 Favored 'General case' 0 N--CA 1.448 -0.537 0 O-C-N 121.664 -0.647 . . . . 0.0 110.095 -179.02 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 45.0 pt -62.47 -37.77 79.65 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.399 0 CA-C-O 117.582 -1.199 . . . . 0.0 109.23 -174.401 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -65.53 -33.34 75.69 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 119.552 1.069 . . . . 0.0 110.488 -179.45 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 34.6 m-80 -71.88 -51.68 21.11 Favored 'General case' 0 N--CA 1.465 0.315 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 175.786 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 8.9 tt0 -72.38 -31.92 65.97 Favored 'General case' 0 N--CA 1.441 -0.92 0 C-N-CA 123.79 0.836 . . . . 0.0 110.941 -168.566 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 168' ' ' MET . . . . . . . . . . . . . 21.3 ptp -69.88 -31.8 69.8 Favored 'General case' 0 C--N 1.331 -0.196 0 O-C-N 121.068 -1.02 . . . . 0.0 111.407 171.744 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -78.57 -44.12 24.94 Favored 'General case' 0 N--CA 1.443 -0.796 0 CA-C-O 120.375 0.131 . . . . 0.0 110.983 -175.518 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 . . . . . 0 CA--C 1.54 0.566 0 N-CA-C 110.088 -0.338 . . . . 0.0 110.088 176.893 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.496 1.85 0 N-CA-C 111.252 0.093 . . . . 0.0 111.252 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 3.0 t30 -119.03 151.62 37.9 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 124.223 1.009 . . . . 0.0 109.784 -174.558 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 1.4 mpt? -116.88 125.89 52.18 Favored 'General case' 0 N--CA 1.463 0.22 0 C-N-CA 123.76 0.824 . . . . 0.0 110.706 179.23 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -82.83 153.2 30.92 Favored Glycine 0 CA--C 1.527 0.811 0 N-CA-C 107.51 -2.236 . . . . 0.0 107.51 166.96 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 3.1 tt -140.26 97.11 3.16 Favored 'General case' 0 N--CA 1.465 0.312 0 N-CA-C 104.888 -2.264 . . . . 0.0 104.888 -176.06 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . 0.414 ' CE2' ' HG ' ' A' ' 51' ' ' LEU . 0.3 OUTLIER -103.44 147.02 27.64 Favored 'General case' 0 N--CA 1.455 -0.181 0 CA-C-O 121.577 0.703 . . . . 0.0 111.914 -172.155 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 47.6 p90 . . . . . 0 C--N 1.33 -0.281 0 C-N-CA 126.294 1.838 . . . . 0.0 107.994 176.425 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.223 -0.337 0 CA-C-O 118.523 -0.751 . . . . 0.0 111.054 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -66.11 -43.49 87.05 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 119.94 1.245 . . . . 0.0 111.609 -179.751 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 67.0 mm-40 -62.68 -47.53 83.23 Favored 'General case' 0 N--CA 1.464 0.261 0 N-CA-C 109.16 -0.682 . . . . 0.0 109.16 173.023 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 29.2 mtpp -70.16 -36.85 74.98 Favored 'General case' 0 C--O 1.221 -0.397 0 CA-C-O 118.428 -0.796 . . . . 0.0 110.796 -169.351 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 32.1 mt -53.95 -55.93 11.71 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.223 0 CA-C-N 119.307 0.958 . . . . 0.0 108.687 173.472 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 18.2 ptt180 -65.25 -38.44 90.36 Favored 'General case' 0 C--N 1.344 0.343 0 C-N-CA 120.153 -0.619 . . . . 0.0 110.03 -176.687 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -64.69 -38.63 91.65 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 -174.553 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 64.0 mt -78.27 -56.13 8.3 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.63 0 C-N-CA 125.496 1.518 . . . . 0.0 110.057 -174.435 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 77.0 mt -64.66 -45.88 94.02 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 -177.755 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 141.58 120.35 1.62 Allowed Glycine 0 CA--C 1.53 0.975 0 C-N-CA 125.452 1.501 . . . . 0.0 110.595 176.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -75.53 -4.43 15.26 Favored 'Trans proline' 0 CA--C 1.538 0.705 0 C-N-CA 122.82 2.347 . . . . 0.0 113.183 -171.554 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -82.99 -20.5 35.01 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 118.945 0.793 . . . . 0.0 111.418 176.551 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 1.2 pt? -120.96 -14.19 8.49 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 125.057 1.343 . . . . 0.0 113.589 -175.689 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 62.5 t -97.46 148.02 6.01 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 N-CA-C 107.315 -1.365 . . . . 0.0 107.315 168.622 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 46.6 m -135.3 133.08 38.49 Favored 'General case' 0 C--N 1.332 -0.175 0 C-N-CA 125.659 1.584 . . . . 0.0 108.188 -178.906 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 35.7 mt -82.3 142.57 31.96 Favored 'General case' 0 C--O 1.234 0.263 0 N-CA-C 108.574 -0.898 . . . . 0.0 108.574 177.682 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 28.6 t-80 -139.39 60.65 1.57 Allowed 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 124.481 1.112 . . . . 0.0 108.335 -173.577 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 64.3 t-20 -60.88 126.76 28.57 Favored 'General case' 0 C--O 1.232 0.181 0 N-CA-C 107.128 -1.434 . . . . 0.0 107.128 173.309 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 83.3 mt -66.72 -22.44 66.06 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 123.24 0.616 . . . . 0.0 112.16 -179.64 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 56.7 tttt -66.66 -22.11 66.1 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 118.147 0.43 . . . . 0.0 111.708 169.143 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -107.62 -35.3 6.75 Favored 'General case' 0 C--O 1.234 0.272 0 C-N-CA 124.081 0.953 . . . . 0.0 113.25 -169.661 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 2.9 t0 -139.14 155.53 47.79 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 118.717 0.69 . . . . 0.0 112.151 178.128 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 17.2 m -75.06 157.94 84.81 Favored Pre-proline 0 CA--C 1.54 0.595 0 C-N-CA 125.618 1.567 . . . . 0.0 111.482 -170.68 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -73.89 -26.29 13.44 Favored 'Trans proline' 0 C--N 1.349 0.563 0 C-N-CA 122.778 2.318 . . . . 0.0 113.236 -171.68 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 22.7 mmmt -71.27 -12.08 61.26 Favored 'General case' 0 N--CA 1.471 0.576 0 O-C-N 120.395 -1.441 . . . . 0.0 111.716 -176.44 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -61.21 -28.41 69.13 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 125.451 1.5 . . . . 0.0 110.38 168.923 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 45.5 mtt -58.71 -25.96 63.42 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 118.591 0.632 . . . . 0.0 111.745 177.478 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 88.0 mt-10 -65.93 -32.56 74.14 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-O 119.017 -0.516 . . . . 0.0 110.249 -176.567 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 21.2 mt-30 -65.9 -44.28 85.69 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 123.601 0.76 . . . . 0.0 112.541 -170.362 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 52.5 m-85 -74.78 142.24 44.3 Favored 'General case' 0 N--CA 1.456 -0.153 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.662 -166.724 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -69.21 -42.48 75.68 Favored 'General case' 0 C--O 1.235 0.29 0 N-CA-C 109.894 -0.41 . . . . 0.0 109.894 176.413 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 7.2 t -106.33 143.76 16.7 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.368 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 175.306 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 37.8 tp -131.64 114.36 14.71 Favored 'General case' 0 N--CA 1.444 -0.77 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 174.295 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 31.8 mt -94.44 132.75 37.61 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 N-CA-C 106.781 -1.563 . . . . 0.0 106.781 178.416 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.414 ' HG ' ' CE2' ' A' ' 6' ' ' PHE . 3.1 mp -113.95 130.15 56.54 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 125.641 1.577 . . . . 0.0 107.102 -176.583 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -135.67 126.83 4.06 Favored Glycine 0 C--N 1.335 0.491 0 N-CA-C 109.908 -1.277 . . . . 0.0 109.908 177.607 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 7.4 tt -153.57 127.3 4.36 Favored Pre-proline 0 CA--C 1.538 0.496 0 CA-C-N 117.872 0.836 . . . . 0.0 109.892 172.298 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo . . . . . 0 N--CA 1.459 -0.544 0 C-N-CA 122.268 1.979 . . . . 0.0 112.782 169.496 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 65.9 mt . . . . . 0 N--CA 1.449 -0.492 0 N-CA-C 107.378 -1.342 . . . . 0.0 107.378 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -85.32 164.81 17.76 Favored 'General case' 0 C--O 1.234 0.254 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 173.661 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -55.2 -38.41 68.37 Favored 'General case' 0 C--O 1.222 -0.36 0 C-N-CA 123.811 0.844 . . . . 0.0 110.741 179.793 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -61.2 -24.48 66.36 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-N 118.792 0.724 . . . . 0.0 112.562 -177.074 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' TRP . . . . . 0.415 ' CH2' HD23 ' A' ' 104' ' ' LEU . 12.2 t90 -96.63 -47.57 5.86 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 124.89 1.276 . . . . 0.0 109.348 176.611 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -64.41 -33.71 76.49 Favored 'General case' 0 CA--C 1.539 0.534 0 O-C-N 120.833 -1.167 . . . . 0.0 110.593 -175.282 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -63.46 -26.58 68.79 Favored 'General case' 0 CA--C 1.529 0.135 0 C-N-CA 123.273 0.629 . . . . 0.0 110.872 -173.956 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 29.1 m -108.57 -15.43 9.36 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.314 0 CA-C-O 117.366 -1.302 . . . . 0.0 111.879 177.12 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 29.4 t90 -51.35 -35.5 38.73 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-N 120.189 1.359 . . . . 0.0 110.679 177.108 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -62.86 -29.33 70.67 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 125.441 1.496 . . . . 0.0 113.303 175.367 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 31.0 mt-30 -92.42 -18.3 23.44 Favored 'General case' 0 N--CA 1.463 0.209 0 C-N-CA 126.09 1.756 . . . . 0.0 112.324 177.29 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 56.7 mt -63.48 -21.04 66.09 Favored 'General case' 0 CA--C 1.534 0.338 0 O-C-N 121.304 -0.872 . . . . 0.0 111.496 -178.119 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -80.11 -23.05 41.49 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 123.011 0.525 . . . . 0.0 111.868 173.671 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -71.83 -30.32 65.36 Favored 'General case' 0 N--CA 1.468 0.466 0 O-C-N 120.705 -1.247 . . . . 0.0 111.843 177.529 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 79.5 mt -52.96 140.85 23.68 Favored 'General case' 0 C--N 1.34 0.174 0 C-N-CA 125.012 1.325 . . . . 0.0 112.757 -168.787 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 28.9 t-20 -74.97 106.43 6.47 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 169.312 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 64.7 mt -128.61 0.07 5.52 Favored 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 113.891 1.071 . . . . 0.0 113.891 -174.393 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 27.2 mt-10 -57.79 128.38 36.81 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 119.658 1.117 . . . . 0.0 110.689 -169.031 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 71.65 -0.05 37.45 Favored Glycine 0 CA--C 1.532 1.127 0 C-N-CA 125.397 1.475 . . . . 0.0 115.046 179.445 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.26 151.55 39.87 Favored 'General case' 0 C--N 1.348 0.51 0 CA-C-N 120.798 2.299 . . . . 0.0 109.649 -177.775 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 3.6 mt -80.67 136.9 22.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 N-CA-C 106.765 -1.568 . . . . 0.0 106.765 178.876 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 68.8 t -132.17 131.56 61.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 C-N-CA 123.813 0.845 . . . . 0.0 109.833 -178.555 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -105.39 150.12 25.52 Favored 'General case' 0 N--CA 1.463 0.192 0 N-CA-C 107.417 -1.327 . . . . 0.0 107.417 168.603 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 3.6 mt -132.24 134.19 45.02 Favored 'General case' 0 CA--C 1.51 -0.594 0 N-CA-C 107.265 -1.383 . . . . 0.0 107.265 177.77 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 35.8 p90 -151.03 165.84 32.55 Favored 'General case' 0 N--CA 1.447 -0.595 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 168.764 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -162.62 159.59 31.9 Favored Glycine 0 N--CA 1.444 -0.784 0 N-CA-C 108.556 -1.817 . . . . 0.0 108.556 172.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 7.0 tt . . . . . 0 N--CA 1.445 -0.7 0 N-CA-C 108.493 -0.929 . . . . 0.0 108.493 171.56 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 83.8 mt . . . . . 0 N--CA 1.467 0.379 0 N-CA-C 115.679 1.733 . . . . 0.0 115.679 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -61.84 -36.62 81.72 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-N 121.511 1.959 . . . . 0.0 111.29 -173.37 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -65.83 -27.74 68.47 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 124.328 1.051 . . . . 0.0 112.295 174.52 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 5.3 tt -66.56 -46.69 75.22 Favored 'General case' 0 N--CA 1.467 0.424 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 173.056 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -63.47 -34.6 90.4 Favored Glycine 0 CA--C 1.529 0.944 0 N-CA-C 110.659 -0.976 . . . . 0.0 110.659 -179.732 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 5.2 tpp -50.89 -54.08 27.03 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 124.963 1.305 . . . . 0.0 111.527 175.88 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.415 HD23 ' CH2' ' A' ' 65' ' ' TRP . 0.2 OUTLIER -76.82 -36.61 56.77 Favored 'General case' 0 C--N 1.341 0.238 0 O-C-N 121.891 -0.506 . . . . 0.0 109.782 -175.195 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 43.1 t-80 -55.71 -48.88 74.41 Favored 'General case' 0 N--CA 1.464 0.231 0 O-C-N 121.436 -0.79 . . . . 0.0 110.872 176.261 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -63.44 -38.77 92.42 Favored 'General case' 0 C--O 1.234 0.288 0 C-N-CA 123.288 0.635 . . . . 0.0 112.103 -176.323 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 24.4 ttmm -57.45 -36.09 70.98 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 123.382 0.673 . . . . 0.0 110.727 172.825 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 22.3 mt -91.86 -20.49 21.4 Favored 'General case' 0 CA--C 1.513 -0.45 0 N-CA-C 115.8 1.778 . . . . 0.0 115.8 -168.238 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 6.0 m -58.15 -33.62 69.38 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-N 120.481 1.491 . . . . 0.0 111.627 -178.218 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 20.7 p -87.39 -9.33 55.04 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 124.884 1.274 . . . . 0.0 112.287 -179.807 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 32.5 mmmt -84.53 -4.63 59.06 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 124.461 1.104 . . . . 0.0 111.453 172.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 69.92 31.96 69.89 Favored Glycine 0 CA--C 1.525 0.657 0 CA-C-N 118.605 0.639 . . . . 0.0 112.105 171.827 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 3.5 m -76.33 172.38 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.474 0 CA-C-N 118.104 0.952 . . . . 0.0 109.457 175.237 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -111.9 121.1 44.11 Favored 'General case' 0 CA--C 1.515 -0.386 0 N-CA-C 106.474 -1.676 . . . . 0.0 106.474 173.615 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 64.0 m-85 -88.32 145.35 25.88 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 119.61 1.095 . . . . 0.0 109.378 -178.13 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 27.7 m -129.4 161.08 39.58 Favored 'Isoleucine or valine' 0 C--O 1.233 0.212 0 C-N-CA 124.223 1.009 . . . . 0.0 109.289 171.588 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 93.2 -94.18 1.83 Allowed Glycine 0 N--CA 1.443 -0.877 0 C-N-CA 124.817 1.199 . . . . 0.0 110.804 176.435 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 8.0 m-30 59.57 177.05 0.08 Allowed 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 125.109 1.364 . . . . 0.0 110.188 -167.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -155.27 140.94 12.65 Favored Pre-proline 0 N--CA 1.473 0.7 0 CA-C-O 116.872 -1.537 . . . . 0.0 108.76 -179.468 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -68.13 127.77 16.47 Favored 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 122.698 2.265 . . . . 0.0 112.64 -176.166 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 68.0 p . . . . . 0 N--CA 1.473 0.696 0 N-CA-C 112.393 0.516 . . . . 0.0 112.393 169.619 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 32.5 ttmt . . . . . 0 N--CA 1.471 0.618 0 CA-C-O 117.668 -1.158 . . . . 0.0 113.412 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 62.9 Cg_endo -84.77 13.86 2.64 Favored 'Trans proline' 0 C--N 1.348 0.539 0 C-N-CA 121.844 1.696 . . . . 0.0 113.581 -178.866 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 35.1 m -128.63 154.9 40.11 Favored 'Isoleucine or valine' 0 C--O 1.235 0.3 0 CA-C-N 121.777 2.08 . . . . 0.0 111.109 179.065 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 17.8 pt -114.32 167.94 6.66 Favored 'Isoleucine or valine' 0 C--O 1.235 0.319 0 C-N-CA 126.41 1.884 . . . . 0.0 109.145 174.82 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . 57.73 32.94 22.61 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 124.967 1.307 . . . . 0.0 113.484 167.687 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 27.6 t70 54.99 39.83 31.78 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 126.251 1.82 . . . . 0.0 111.592 -175.164 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 93.63 72.21 1.18 Allowed Glycine 0 CA--C 1.528 0.854 0 C-N-CA 124.487 1.042 . . . . 0.0 111.243 177.013 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 78.8 mm-40 -116.66 -49.57 2.64 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 123.168 0.587 . . . . 0.0 110.354 167.375 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -132.48 146.52 51.99 Favored 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 123.017 0.527 . . . . 0.0 110.969 -179.252 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 58.9 m-85 -77.63 16.79 0.61 Allowed 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 126.189 1.796 . . . . 0.0 115.65 177.879 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 3.7 m 49.64 11.73 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.547 0.831 0 C-N-CA 126.927 2.091 . . . . 0.0 114.469 -176.586 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 170.42 170.06 34.28 Favored Glycine 0 CA--C 1.527 0.805 0 N-CA-C 108.368 -1.893 . . . . 0.0 108.368 -171.562 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -69.24 134.95 49.84 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 117.977 0.888 . . . . 0.0 111.007 -178.347 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -95.87 109.94 22.21 Favored 'General case' 0 N--CA 1.448 -0.571 0 C-N-CA 125.52 1.528 . . . . 0.0 109.056 175.291 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 83.8 mt . . . . . 0 C--N 1.332 -0.179 0 CA-C-N 118.845 0.748 . . . . 0.0 109.561 170.157 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 13.3 m . . . . . 0 CA--C 1.543 0.681 0 N-CA-C 110.156 -0.312 . . . . 0.0 110.156 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -63.96 -39.54 94.36 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 123.972 0.909 . . . . 0.0 111.671 172.645 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 -64.55 -46.98 80.51 Favored 'General case' 0 C--O 1.234 0.263 0 C-N-CA 124.294 1.038 . . . . 0.0 109.858 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 72.1 mtt180 -55.32 -41.1 71.98 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-O 118.795 -0.622 . . . . 0.0 110.627 177.039 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 75.9 mt -68.39 -57.97 7.39 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.299 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 177.316 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 70.8 tp60 -49.64 -63.04 1.23 Allowed 'General case' 0 C--O 1.233 0.193 0 C-N-CA 125.12 1.368 . . . . 0.0 112.106 -173.94 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 20.0 m -66.8 -31.95 72.91 Favored 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 120.826 -0.35 . . . . 0.0 111.245 -170.342 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 160' ' ' TRP . . . . . . . . . . . . . 34.0 t90 -70.87 -44.32 66.61 Favored 'General case' 0 CA--C 1.516 -0.342 0 O-C-N 122.005 -0.434 . . . . 0.0 110.898 176.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 98.4 m -59.46 -42.79 92.81 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 122.846 0.458 . . . . 0.0 110.093 177.454 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -63.44 -41.86 98.66 Favored 'General case' 0 N--CA 1.456 -0.147 0 CA-C-O 121.006 0.431 . . . . 0.0 110.181 175.72 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 14.7 tt0 -62.61 -51.99 65.14 Favored 'General case' 0 N--CA 1.449 -0.495 0 O-C-N 121.692 -0.63 . . . . 0.0 109.934 -178.938 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 42.2 pt -63.27 -37.98 80.9 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.328 0 CA-C-O 117.669 -1.158 . . . . 0.0 109.231 -175.714 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -65.75 -34.91 79.28 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 119.776 1.171 . . . . 0.0 110.486 -179.548 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 31.2 m-80 -68.49 -50.59 51.13 Favored 'General case' 0 CA--C 1.516 -0.34 0 N-CA-C 108.785 -0.821 . . . . 0.0 108.785 175.285 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 15.5 tt0 -71.14 -33.61 70.24 Favored 'General case' 0 N--CA 1.438 -1.062 0 C-N-CA 124.174 0.99 . . . . 0.0 111.131 -168.616 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 168' ' ' MET . . . . . . . . . . . . . 22.9 ptp -72.42 -30.18 64.39 Favored 'General case' 0 C--N 1.332 -0.171 0 O-C-N 121.136 -0.978 . . . . 0.0 111.702 173.738 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -79.48 -41.16 28.08 Favored 'General case' 0 N--CA 1.447 -0.601 0 C-N-CA 122.636 0.375 . . . . 0.0 111.416 -179.765 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 . . . . . 0 CA--C 1.535 0.379 0 C-N-CA 122.964 0.506 . . . . 0.0 110.454 -178.578 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.498 1.931 0 CA-C-O 120.011 -0.042 . . . . 0.0 111.078 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 4.0 t30 -116.66 151.36 36.47 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 124.195 0.998 . . . . 0.0 110.134 -173.483 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 1.2 mpt? -118.75 123.31 44.52 Favored 'General case' 0 C--N 1.334 -0.096 0 C-N-CA 123.747 0.819 . . . . 0.0 111.183 179.47 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -81.85 153.93 33.37 Favored Glycine 0 CA--C 1.524 0.655 0 N-CA-C 107.521 -2.232 . . . . 0.0 107.521 166.655 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 3.3 tt -140.3 96.47 3.05 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 105.422 -2.066 . . . . 0.0 105.422 -176.414 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -102.98 143.83 32.04 Favored 'General case' 0 CA--C 1.517 -0.303 0 CA-C-O 121.769 0.795 . . . . 0.0 112.186 -170.86 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 36.3 p90 . . . . . 0 N--CA 1.451 -0.393 0 C-N-CA 127.676 2.391 . . . . 0.0 106.237 177.141 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.222 -0.373 0 CA-C-O 117.954 -1.022 . . . . 0.0 113.082 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -58.74 -47.09 85.85 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 120.188 1.358 . . . . 0.0 111.077 -179.002 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -64.53 -46.43 82.91 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 123.104 0.562 . . . . 0.0 109.568 177.088 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 58.4 mttm -60.33 -45.58 92.93 Favored 'General case' 0 N--CA 1.466 0.367 0 O-C-N 121.755 -0.59 . . . . 0.0 111.596 -178.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 44.2 mt -53.72 -55.74 12.18 Favored 'Isoleucine or valine' 0 C--O 1.234 0.242 0 C-N-CA 124.465 1.106 . . . . 0.0 108.505 176.215 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 1.3 ttp180 -60.73 -41.29 95.04 Favored 'General case' 0 C--O 1.223 -0.31 0 CA-C-O 118.929 -0.558 . . . . 0.0 109.687 -174.675 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -68.02 -42.66 80.3 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 123.206 0.602 . . . . 0.0 111.173 -177.724 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.413 HD13 ' HA ' ' A' ' 158' ' ' GLN . 61.6 mt -74.12 -53.39 17.48 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.351 0 C-N-CA 124.508 1.123 . . . . 0.0 109.619 -171.251 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 74.5 mt -64.79 -46.0 93.35 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.434 0 N-CA-C 109.195 -0.669 . . . . 0.0 109.195 178.359 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 139.96 126.41 2.3 Favored Glycine 0 CA--C 1.534 1.221 0 C-N-CA 124.868 1.223 . . . . 0.0 112.132 172.562 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -71.23 -7.37 21.2 Favored 'Trans proline' 0 CA--C 1.536 0.585 0 C-N-CA 124.067 3.178 . . . . 0.0 113.613 -176.22 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -83.8 -17.22 41.79 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 119.081 0.855 . . . . 0.0 111.251 177.873 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 1.2 pt? -128.32 -16.14 4.49 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 124.998 1.319 . . . . 0.0 113.625 -175.239 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 41.5 t -97.05 154.79 3.62 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.542 0 N-CA-C 107.292 -1.373 . . . . 0.0 107.292 168.012 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 27.9 m -142.34 130.14 21.65 Favored 'General case' 0 C--O 1.232 0.146 0 N-CA-C 105.934 -1.876 . . . . 0.0 105.934 -176.136 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 17.8 mt -80.57 141.43 35.08 Favored 'General case' 0 C--O 1.232 0.18 0 N-CA-C 107.77 -1.196 . . . . 0.0 107.77 175.952 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 35.0 t-80 -131.9 61.03 1.66 Allowed 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 124.671 1.188 . . . . 0.0 107.847 -174.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 64.6 t-20 -72.09 116.56 12.65 Favored 'General case' 0 C--O 1.234 0.267 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 -178.039 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 99.1 mt -65.54 -13.44 58.94 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 124.345 1.058 . . . . 0.0 112.787 -177.229 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 28.5 tptp -57.06 -25.87 59.42 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 123.243 0.617 . . . . 0.0 110.953 168.631 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -129.46 -40.35 1.43 Allowed 'General case' 0 N--CA 1.464 0.246 0 C-N-CA 123.871 0.868 . . . . 0.0 113.279 -175.002 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 34.0 m-20 -89.59 141.01 28.99 Favored 'General case' 0 C--O 1.234 0.285 0 C-N-CA 123.382 0.673 . . . . 0.0 110.551 -175.676 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 15.2 m -75.88 155.38 84.87 Favored Pre-proline 0 CA--C 1.543 0.677 0 C-N-CA 124.213 1.005 . . . . 0.0 109.992 175.411 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_endo -77.29 -26.27 7.64 Favored 'Trans proline' 0 C--N 1.35 0.615 0 C-N-CA 122.431 2.087 . . . . 0.0 113.588 -169.924 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 22.5 mmmt -71.63 -11.92 61.08 Favored 'General case' 0 N--CA 1.472 0.634 0 O-C-N 120.5 -1.375 . . . . 0.0 111.478 -175.702 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -60.54 -28.66 68.6 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 125.769 1.627 . . . . 0.0 110.145 168.919 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 45.9 mtt -58.08 -26.18 62.23 Favored 'General case' 0 C--N 1.343 0.306 0 C-N-CA 123.198 0.599 . . . . 0.0 111.895 177.353 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 90.8 mt-10 -66.85 -32.7 74.14 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 118.245 0.475 . . . . 0.0 110.307 -176.601 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 18.3 mt-30 -66.17 -44.74 83.17 Favored 'General case' 0 N--CA 1.464 0.267 0 C-N-CA 123.714 0.806 . . . . 0.0 112.022 -171.214 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 20.4 m-85 -70.88 139.74 50.87 Favored 'General case' 0 N--CA 1.456 -0.135 0 CA-C-N 115.403 -0.817 . . . . 0.0 109.758 -166.765 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -72.96 -38.07 66.87 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 118.506 0.594 . . . . 0.0 110.257 -179.023 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 10.5 t -108.57 146.61 14.11 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.304 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 170.715 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 43.1 tp -133.01 106.74 7.83 Favored 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 176.678 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.404 ' HA ' ' HB3' ' A' ' 83' ' ' ALA . 19.8 mt -86.22 135.78 24.32 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 N-CA-C 107.096 -1.446 . . . . 0.0 107.096 176.704 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 1.9 mp -114.0 131.38 56.36 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 126.042 1.737 . . . . 0.0 106.774 -179.013 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -136.69 126.91 3.9 Favored Glycine 0 C--N 1.332 0.343 0 N-CA-C 109.072 -1.611 . . . . 0.0 109.072 177.085 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 4.7 tt -153.74 133.71 7.66 Favored Pre-proline 0 CA--C 1.538 0.511 0 CA-C-N 118.247 1.024 . . . . 0.0 111.055 174.432 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo . . . . . 0 CA--C 1.534 0.501 0 C-N-CA 122.799 2.332 . . . . 0.0 112.78 168.278 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . 0.282 24.7 mt . . . . . 0 CA--C 1.539 0.55 0 CA-C-O 122.985 1.374 . . . . 0.0 112.111 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 3.3 mp0 -117.33 155.81 28.9 Favored 'General case' 0 C--O 1.235 0.331 0 C-N-CA 126.214 1.805 . . . . 0.0 106.568 -173.289 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -57.08 -43.4 82.12 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 122.891 0.476 . . . . 0.0 110.724 -171.458 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 -66.64 -20.9 66.09 Favored 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 112.357 0.503 . . . . 0.0 112.357 -176.023 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 11.3 t90 -91.86 -48.47 6.76 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 124.409 1.084 . . . . 0.0 109.031 177.959 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -64.27 -34.65 78.6 Favored 'General case' 0 CA--C 1.537 0.463 0 O-C-N 121.03 -1.044 . . . . 0.0 109.763 -178.218 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -59.54 -25.62 64.67 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 123.612 0.765 . . . . 0.0 111.815 -177.208 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 28.5 m -111.29 -14.67 10.54 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.315 0 CA-C-O 117.082 -1.437 . . . . 0.0 112.442 177.033 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 30.1 t90 -51.58 -35.13 40.04 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 120.491 1.496 . . . . 0.0 110.97 179.296 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -64.24 -27.9 69.37 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 125.222 1.409 . . . . 0.0 113.524 175.428 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 29.4 mt-30 -92.71 -18.98 22.29 Favored 'General case' 0 N--CA 1.463 0.22 0 C-N-CA 126.11 1.764 . . . . 0.0 112.441 175.786 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 56.3 mt -63.86 -20.57 65.92 Favored 'General case' 0 N--CA 1.465 0.319 0 O-C-N 121.21 -0.931 . . . . 0.0 111.608 -176.081 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -78.52 -22.81 46.79 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 122.985 0.514 . . . . 0.0 111.666 174.37 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -72.8 -29.79 63.55 Favored 'General case' 0 N--CA 1.467 0.411 0 O-C-N 120.729 -1.232 . . . . 0.0 111.942 178.005 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 80.9 mt -52.96 138.53 30.02 Favored 'General case' 0 C--O 1.231 0.101 0 C-N-CA 124.907 1.283 . . . . 0.0 112.896 -168.499 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 3.2 t30 -74.01 98.78 3.14 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 124.02 0.928 . . . . 0.0 108.631 170.515 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.427 HD12 HD22 ' A' ' 108' ' ' LEU . 32.8 mt -118.83 -0.76 11.17 Favored 'General case' 0 N--CA 1.472 0.659 0 N-CA-C 113.858 1.058 . . . . 0.0 113.858 -178.091 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 26.8 mt-10 -54.86 127.55 29.11 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-N 119.831 1.196 . . . . 0.0 111.623 -168.522 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 73.41 -2.24 38.84 Favored Glycine 0 CA--C 1.535 1.298 0 CA-C-O 117.824 -1.542 . . . . 0.0 115.108 179.345 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.4 154.82 36.93 Favored 'General case' 0 C--N 1.344 0.363 0 CA-C-N 120.942 2.371 . . . . 0.0 109.759 -176.678 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 2.3 mt -83.91 138.59 18.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 N-CA-C 106.866 -1.531 . . . . 0.0 106.866 177.508 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 54.3 t -130.71 135.75 59.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 C-N-CA 124.538 1.135 . . . . 0.0 108.498 -179.118 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.404 ' HB3' ' HA ' ' A' ' 50' ' ' ILE . . . -108.33 156.93 18.84 Favored 'General case' 0 CA--C 1.517 -0.299 0 N-CA-C 107.885 -1.154 . . . . 0.0 107.885 168.867 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 5.7 mt -137.76 132.42 32.72 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 107.783 -1.191 . . . . 0.0 107.783 178.714 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 39.2 p90 -149.15 165.68 31.08 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 168.421 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -167.84 157.8 30.29 Favored Glycine 0 N--CA 1.448 -0.517 0 N-CA-C 111.032 -0.827 . . . . 0.0 111.032 175.951 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 58.5 tp . . . . . 0 N--CA 1.445 -0.708 0 C-N-CA 125.691 1.596 . . . . 0.0 109.748 175.057 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 89.7 mt . . . . . 0 N--CA 1.475 0.776 0 N-CA-C 114.257 1.206 . . . . 0.0 114.257 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -62.96 -37.69 88.1 Favored 'General case' 0 C--N 1.328 -0.331 0 O-C-N 120.86 -1.15 . . . . 0.0 111.217 -173.061 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -67.66 -29.31 68.57 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 123.674 0.789 . . . . 0.0 112.416 174.391 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 5.9 tt -63.73 -49.45 73.0 Favored 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 173.375 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -61.29 -36.5 92.54 Favored Glycine 0 CA--C 1.526 0.767 0 N-CA-C 111.623 -0.591 . . . . 0.0 111.623 177.806 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 6.4 tpp -53.99 -48.52 70.31 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 124.756 1.222 . . . . 0.0 111.454 -179.152 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -77.93 -39.69 41.98 Favored 'General case' 0 C--N 1.341 0.238 0 N-CA-C 109.813 -0.439 . . . . 0.0 109.813 -177.898 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 77.9 t60 -54.14 -45.46 71.99 Favored 'General case' 0 CA--C 1.534 0.333 0 O-C-N 121.517 -0.739 . . . . 0.0 111.335 176.638 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -61.53 -41.94 98.08 Favored 'General case' 0 C--O 1.235 0.326 0 C-N-CA 123.801 0.84 . . . . 0.0 111.536 -179.506 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 24.3 ttmm -57.48 -43.39 84.04 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 123.614 0.765 . . . . 0.0 110.278 174.286 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.427 HD22 HD12 ' A' ' 77' ' ' LEU . 27.7 mt -87.25 -14.41 41.07 Favored 'General case' 0 CA--C 1.518 -0.281 0 N-CA-C 113.9 1.074 . . . . 0.0 113.9 -170.552 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 70.9 m -60.13 -32.67 71.23 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 119.835 1.198 . . . . 0.0 111.218 -174.508 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 24.6 p -89.7 -5.17 57.3 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 124.946 1.298 . . . . 0.0 112.085 179.194 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 31.7 mmmt -86.32 -6.29 58.98 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 125.014 1.326 . . . . 0.0 111.6 175.762 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 72.29 34.99 60.53 Favored Glycine 0 CA--C 1.526 0.762 0 CA-C-N 118.622 0.646 . . . . 0.0 112.522 171.483 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 5.6 m -80.97 172.12 1.16 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.51 0 CA-C-N 118.085 0.943 . . . . 0.0 109.815 173.744 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 53.0 tptt -101.85 132.73 47.46 Favored 'General case' 0 N--CA 1.469 0.477 0 N-CA-C 105.378 -2.082 . . . . 0.0 105.378 167.698 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 74.9 m-85 -99.16 123.76 43.69 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 119.161 0.891 . . . . 0.0 108.674 174.107 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 31.6 m -109.9 160.05 9.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 C-N-CA 125.196 1.398 . . . . 0.0 108.459 168.03 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 85.34 27.6 32.7 Favored Glycine 0 CA--C 1.523 0.588 0 CA-C-O 118.526 -1.152 . . . . 0.0 114.928 170.176 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 17.4 m-30 -58.21 158.21 7.37 Favored 'General case' 0 CA--C 1.54 0.596 0 CA-C-N 119.028 1.414 . . . . 0.0 110.463 168.891 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 49.4 t-105 -138.22 147.22 54.96 Favored Pre-proline 0 N--CA 1.468 0.444 0 CA-C-O 118.264 -0.874 . . . . 0.0 111.357 -169.591 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -65.03 130.99 27.27 Favored 'Trans proline' 0 CA--C 1.534 0.516 0 C-N-CA 122.765 2.31 . . . . 0.0 112.441 -179.137 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 11.3 p . . . . . 0 CA--C 1.54 0.564 0 C-N-CA 123.876 0.87 . . . . 0.0 112.002 169.412 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 16.8 ttmt . . . . . 0 CA--C 1.54 0.561 0 CA-C-O 117.355 -1.307 . . . . 0.0 113.801 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -87.5 7.76 4.56 Favored 'Trans proline' 0 C--N 1.35 0.634 0 CA-C-N 121.842 1.693 . . . . 0.0 113.777 -176.702 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 16.4 m -130.21 165.9 29.22 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.278 0 CA-C-N 121.115 1.78 . . . . 0.0 112.481 -171.167 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 12.9 pt -135.09 172.2 16.39 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.531 0 C-N-CA 128.239 2.616 . . . . 0.0 108.263 179.501 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . 53.59 42.2 31.94 Favored 'General case' 0 N--CA 1.464 0.226 0 C-N-CA 125.471 1.509 . . . . 0.0 112.648 173.726 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 27.0 t0 55.0 41.63 31.73 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 126.231 1.812 . . . . 0.0 111.766 -177.509 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 91.31 13.22 58.92 Favored Glycine 0 CA--C 1.527 0.8 0 CA-C-O 118.916 -0.935 . . . . 0.0 113.808 174.442 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 45.2 mt-30 -87.37 -7.65 57.5 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 119.29 1.545 . . . . 0.0 112.862 -177.9 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 7.6 tp -155.58 145.76 21.69 Favored 'General case' 0 C--N 1.344 0.358 0 CA-C-N 119.509 1.05 . . . . 0.0 110.797 172.238 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 61.7 m-85 -82.96 147.16 28.38 Favored 'General case' 0 CA--C 1.518 -0.279 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 169.596 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 16.7 m -77.1 2.62 1.68 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.576 0 C-N-CA 123.881 0.872 . . . . 0.0 112.393 177.234 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -172.28 169.81 42.89 Favored Glycine 0 CA--C 1.526 0.739 0 N-CA-C 110.829 -0.908 . . . . 0.0 110.829 -179.195 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 4.8 tp -63.6 135.01 56.48 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 124.272 1.029 . . . . 0.0 111.19 -179.566 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -92.99 128.04 38.71 Favored 'General case' 0 N--CA 1.446 -0.643 0 C-N-CA 124.981 1.312 . . . . 0.0 109.131 173.254 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 89.8 mt . . . . . 0 N--CA 1.464 0.248 0 C-N-CA 123.708 0.803 . . . . 0.0 109.69 169.886 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 60.9 m . . . . . 0 CA--C 1.537 0.476 0 N-CA-C 110.223 -0.288 . . . . 0.0 110.223 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -56.8 -41.78 78.35 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 123.814 0.846 . . . . 0.0 111.181 169.269 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 28.8 tt0 -70.19 -40.48 74.61 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 124.811 1.244 . . . . 0.0 111.144 -179.636 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 10.9 mmt180 -59.43 -44.22 92.94 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-O 118.296 -0.859 . . . . 0.0 109.271 174.434 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 51.5 mt -60.99 -55.28 25.74 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.242 0 N-CA-C 107.806 -1.183 . . . . 0.0 107.806 175.441 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 158' ' ' GLN . . . . . 0.413 ' HA ' HD13 ' A' ' 24' ' ' ILE . 1.6 tm0? -53.64 -60.74 2.92 Favored 'General case' 0 N--CA 1.454 -0.275 0 CA-C-N 119.141 0.882 . . . . 0.0 112.327 -172.765 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 31.7 m -61.52 -35.92 79.08 Favored 'General case' 0 C--N 1.32 -0.701 0 C-N-CA 122.895 0.478 . . . . 0.0 111.703 -177.022 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 160' ' ' TRP . . . . . . . . . . . . . 57.6 t90 -64.04 -45.47 88.72 Favored 'General case' 0 C--O 1.222 -0.361 0 CA-C-N 118.625 0.648 . . . . 0.0 110.53 173.618 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 99.0 m -61.61 -42.98 99.64 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 123.086 0.554 . . . . 0.0 110.703 -178.551 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -64.91 -35.88 82.58 Favored 'General case' 0 C--N 1.333 -0.123 0 CA-C-N 117.946 0.339 . . . . 0.0 110.857 175.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 17.1 tt0 -68.71 -52.27 32.55 Favored 'General case' 0 N--CA 1.445 -0.689 0 O-C-N 121.485 -0.76 . . . . 0.0 110.029 179.82 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 42.0 pt -62.48 -36.5 75.19 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.445 0 CA-C-O 117.997 -1.001 . . . . 0.0 109.605 -175.704 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -64.57 -36.68 85.02 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 119.466 1.03 . . . . 0.0 109.824 -179.536 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 34.7 m-80 -67.45 -50.55 58.74 Favored 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 174.739 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 25.8 tt0 -73.36 -16.74 61.34 Favored 'General case' 0 N--CA 1.442 -0.858 0 C-N-CA 125.852 1.661 . . . . 0.0 112.034 -169.392 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 168' ' ' MET . . . . . . . . . . . . . 21.2 ptp -90.08 -40.11 12.48 Favored 'General case' 0 N--CA 1.456 -0.168 0 C-N-CA 124.323 1.049 . . . . 0.0 111.448 168.507 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -73.68 -26.37 60.69 Favored 'General case' 0 N--CA 1.454 -0.265 0 CA-C-O 119.147 -0.454 . . . . 0.0 112.152 -173.574 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 . . . . . 0 CA--C 1.541 0.606 0 C-N-CA 123.22 0.608 . . . . 0.0 112.102 -179.427 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.497 1.887 0 N-CA-C 111.261 0.097 . . . . 0.0 111.261 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 26.5 p-10 -126.26 166.22 17.52 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 125.107 1.363 . . . . 0.0 111.385 -173.341 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 11.4 mtt -131.28 123.87 29.27 Favored 'General case' 0 CA--C 1.522 -0.107 0 C-N-CA 123.29 0.636 . . . . 0.0 111.371 178.225 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -86.33 153.27 26.26 Favored Glycine 0 CA--C 1.523 0.594 0 N-CA-C 106.985 -2.446 . . . . 0.0 106.985 167.127 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 1.9 tt -141.73 96.11 2.92 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 119.664 1.732 . . . . 0.0 106.373 -173.265 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -101.68 141.56 34.36 Favored 'General case' 0 CA--C 1.518 -0.267 0 CA-C-O 121.271 0.558 . . . . 0.0 111.938 -170.192 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 43.1 p90 . . . . . 0 CA--C 1.538 0.501 0 C-N-CA 126.749 2.02 . . . . 0.0 107.389 -177.923 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.463 0.223 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -62.84 -48.14 80.33 Favored 'General case' 0 N--CA 1.452 -0.364 0 C-N-CA 122.999 0.52 . . . . 0.0 111.402 -174.832 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -68.42 -37.15 80.03 Favored 'General case' 0 CA--C 1.534 0.327 0 O-C-N 121.743 -0.598 . . . . 0.0 110.485 -179.43 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 28.6 mtpp -66.04 -40.23 90.83 Favored 'General case' 0 C--O 1.224 -0.244 0 CA-C-O 118.564 -0.731 . . . . 0.0 110.629 177.523 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 33.4 mt -55.69 -54.36 26.89 Favored 'Isoleucine or valine' 0 C--O 1.233 0.218 0 CA-C-N 119.642 1.11 . . . . 0.0 109.355 177.023 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 17.5 ptt180 -63.53 -38.6 91.76 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 118.801 0.728 . . . . 0.0 110.113 -177.039 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -64.02 -37.8 88.76 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-O 121.051 0.453 . . . . 0.0 110.151 -175.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 66.7 mt -76.03 -55.11 12.15 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.678 0 C-N-CA 125.136 1.374 . . . . 0.0 110.141 -176.275 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 62.7 mt -61.72 -47.84 91.44 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.403 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 -178.883 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 141.71 114.09 1.04 Allowed Glycine 0 CA--C 1.526 0.773 0 C-N-CA 125.396 1.474 . . . . 0.0 109.465 -175.912 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 70.5 Cg_endo -73.33 -8.4 21.83 Favored 'Trans proline' 0 CA--C 1.538 0.678 0 C-N-CA 122.517 2.145 . . . . 0.0 113.51 -169.729 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -76.63 -21.37 55.59 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 119.116 0.871 . . . . 0.0 111.839 179.107 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -122.74 7.87 9.41 Favored 'General case' 0 C--N 1.342 0.282 0 C-N-CA 124.842 1.257 . . . . 0.0 113.256 -171.542 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 44.0 t -124.89 151.18 30.27 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.369 0 N-CA-C 107.604 -1.258 . . . . 0.0 107.604 175.252 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 24.6 m -136.23 133.9 37.53 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 125.714 1.606 . . . . 0.0 107.927 -176.893 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 17.6 mt -80.52 138.17 36.5 Favored 'General case' 0 N--CA 1.463 0.222 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 176.086 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 24.7 t-80 -131.89 59.9 1.69 Allowed 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 124.588 1.155 . . . . 0.0 108.629 -176.576 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 37.9 t30 -59.7 124.22 19.44 Favored 'General case' 0 CA--C 1.531 0.226 0 N-CA-C 107.935 -1.135 . . . . 0.0 107.935 172.209 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 55.1 mt -71.37 -31.06 66.87 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-N 118.857 0.753 . . . . 0.0 112.73 -169.705 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 22.8 tptm -60.33 -27.46 67.37 Favored 'General case' 0 C--O 1.234 0.264 0 C-N-CA 123.507 0.723 . . . . 0.0 110.379 170.345 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -93.12 -34.64 13.57 Favored 'General case' 0 C--O 1.234 0.282 0 N-CA-C 112.834 0.679 . . . . 0.0 112.834 -174.639 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 3.8 t0 -144.69 148.49 34.28 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 118.869 0.759 . . . . 0.0 113.048 -176.831 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 15.2 m -70.7 157.22 90.67 Favored Pre-proline 0 CA--C 1.543 0.683 0 C-N-CA 125.925 1.69 . . . . 0.0 112.292 -169.342 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -74.64 -26.76 11.37 Favored 'Trans proline' 0 C--N 1.352 0.753 0 C-N-CA 122.662 2.241 . . . . 0.0 113.938 -172.317 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.87 -15.95 63.39 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-N 120.421 1.464 . . . . 0.0 112.187 -179.442 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -57.65 -31.21 66.08 Favored 'General case' 0 N--CA 1.466 0.363 0 C-N-CA 125.811 1.644 . . . . 0.0 110.166 170.777 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 57.2 mtt -56.4 -26.17 52.41 Favored 'General case' 0 N--CA 1.467 0.379 0 C-N-CA 123.699 0.799 . . . . 0.0 111.565 179.133 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 60.1 mt-10 -66.64 -32.93 74.58 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 118.436 0.562 . . . . 0.0 110.553 -177.659 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 19.8 mt-30 -67.65 -43.55 80.0 Favored 'General case' 0 C--O 1.232 0.181 0 N-CA-C 112.872 0.693 . . . . 0.0 112.872 -169.366 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 37.5 m-85 -72.23 135.91 46.21 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.733 -167.103 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -71.19 -38.03 72.11 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-N 118.101 0.41 . . . . 0.0 110.404 -179.468 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 14.8 t -105.31 143.66 16.18 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.56 0 N-CA-C 107.202 -1.407 . . . . 0.0 107.202 168.766 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 33.8 tp -131.6 115.34 15.97 Favored 'General case' 0 N--CA 1.446 -0.657 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 174.078 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 27.9 mt -91.99 131.94 37.72 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.681 0 N-CA-C 106.863 -1.532 . . . . 0.0 106.863 176.802 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 2.4 mp -109.72 127.35 54.54 Favored 'General case' 0 CA--C 1.516 -0.338 0 C-N-CA 125.717 1.607 . . . . 0.0 107.106 -179.832 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -129.18 130.72 6.5 Favored Glycine 0 C--N 1.332 0.329 0 N-CA-C 108.617 -1.793 . . . . 0.0 108.617 176.556 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.417 HD12 ' CD2' ' A' ' 65' ' ' TRP . 4.6 tt -152.26 129.56 5.72 Favored Pre-proline 0 CA--C 1.531 0.226 0 CA-C-N 117.636 0.718 . . . . 0.0 110.914 172.574 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo . . . . . 0 N--CA 1.447 -1.25 0 N-CA-C 107.017 -1.955 . . . . 0.0 107.017 165.548 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 8.4 mt . . . . . 0 CA--C 1.543 0.707 0 N-CA-C 113.039 0.755 . . . . 0.0 113.039 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 3.9 mp0 -74.87 153.8 38.51 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 125.294 1.438 . . . . 0.0 109.5 179.636 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -54.7 -46.17 74.12 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 123.669 0.788 . . . . 0.0 112.207 -169.184 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 23.3 t0 -62.35 -32.71 73.54 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-O 121.57 0.7 . . . . 0.0 112.184 -174.738 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' TRP . . . . . 0.596 ' CH2' HD23 ' A' ' 104' ' ' LEU . 0.9 OUTLIER -82.5 -43.5 17.1 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 123.739 0.816 . . . . 0.0 109.257 -179.587 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 6.1 tt0 -63.05 -35.11 79.15 Favored 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 124.79 1.236 . . . . 0.0 109.805 -179.287 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -58.97 -24.45 62.67 Favored 'General case' 0 C--O 1.233 0.2 0 C-N-CA 124.129 0.971 . . . . 0.0 111.69 -175.825 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 34.6 m -114.7 -14.99 10.5 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.228 0 CA-C-O 117.471 -1.252 . . . . 0.0 112.66 177.206 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 30.6 t90 -52.02 -38.86 58.36 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 119.974 1.261 . . . . 0.0 111.031 -177.032 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -68.36 -23.82 64.73 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 125.039 1.336 . . . . 0.0 113.185 178.218 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 22.7 mt-30 -91.73 -23.94 19.61 Favored 'General case' 0 C--N 1.34 0.167 0 C-N-CA 125.377 1.471 . . . . 0.0 111.973 -179.379 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 19.7 mt -64.26 -25.69 68.17 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 118.167 0.44 . . . . 0.0 111.63 -172.012 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -69.13 -21.77 64.0 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-N 117.966 0.348 . . . . 0.0 111.388 177.284 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -76.39 -24.05 54.08 Favored 'General case' 0 CA--C 1.537 0.462 0 O-C-N 120.971 -1.08 . . . . 0.0 112.68 -178.811 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 49.2 mt -65.63 149.54 49.92 Favored 'General case' 0 C--O 1.233 0.205 0 C-N-CA 124.794 1.238 . . . . 0.0 111.537 -170.296 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 27.8 t-20 -83.77 113.32 20.82 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 171.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 65.2 mt -128.66 1.8 5.5 Favored 'General case' 0 N--CA 1.472 0.659 0 N-CA-C 113.318 0.859 . . . . 0.0 113.318 -172.37 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 30.4 mt-10 -55.55 130.73 44.06 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-O 122.046 0.927 . . . . 0.0 111.347 -168.889 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 73.29 -2.45 36.74 Favored Glycine 0 CA--C 1.533 1.202 0 CA-C-O 117.987 -1.452 . . . . 0.0 115.105 176.791 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.64 149.55 41.93 Favored 'General case' 0 C--N 1.346 0.418 0 CA-C-N 120.749 2.274 . . . . 0.0 109.646 -177.036 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 7.6 mt -80.47 135.56 25.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 N-CA-C 106.269 -1.752 . . . . 0.0 106.269 178.372 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 63.4 t -129.11 128.56 67.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 C-N-CA 123.466 0.706 . . . . 0.0 109.715 -177.769 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -98.3 143.75 28.45 Favored 'General case' 0 CA--C 1.522 -0.114 0 N-CA-C 106.98 -1.489 . . . . 0.0 106.98 167.847 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 9.5 mt -122.11 132.24 54.38 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 107.243 -1.392 . . . . 0.0 107.243 176.241 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 22.9 p90 -150.72 165.05 34.63 Favored 'General case' 0 N--CA 1.444 -0.75 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 168.088 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -163.91 178.2 39.43 Favored Glycine 0 N--CA 1.435 -1.414 0 N-CA-C 109.739 -1.344 . . . . 0.0 109.739 171.314 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 5.8 tt . . . . . 0 N--CA 1.445 -0.706 0 C-N-CA 125.253 1.421 . . . . 0.0 107.448 178.682 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 91.9 mt . . . . . 0 N--CA 1.469 0.521 0 N-CA-C 114.613 1.338 . . . . 0.0 114.613 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -62.62 -35.22 78.89 Favored 'General case' 0 N--CA 1.465 0.311 0 O-C-N 120.651 -1.281 . . . . 0.0 110.672 -172.074 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . 0.415 ' HB1' HD13 ' A' ' 53' ' ' ILE . . . -72.98 -28.67 62.53 Favored 'General case' 0 N--CA 1.452 -0.334 0 N-CA-C 113.096 0.776 . . . . 0.0 113.096 176.543 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 5.0 tt -61.43 -45.33 94.75 Favored 'General case' 0 CA--C 1.535 0.394 0 N-CA-C 107.308 -1.367 . . . . 0.0 107.308 170.276 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -61.76 -42.24 99.72 Favored Glycine 0 C--N 1.341 0.806 0 N-CA-C 111.302 -0.719 . . . . 0.0 111.302 179.162 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 74.8 mtm -61.94 -41.14 97.62 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 118.094 0.947 . . . . 0.0 111.662 178.244 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.596 HD23 ' CH2' ' A' ' 65' ' ' TRP . 0.1 OUTLIER -72.22 -38.1 69.05 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 119.944 1.247 . . . . 0.0 111.131 -179.297 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 29.4 t-80 -57.21 -46.85 82.53 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 117.855 0.298 . . . . 0.0 110.38 172.587 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -63.85 -45.54 89.06 Favored 'General case' 0 C--N 1.33 -0.239 0 C-N-CA 123.457 0.703 . . . . 0.0 111.604 -177.753 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 24.5 ttmm -54.04 -45.26 71.56 Favored 'General case' 0 N--CA 1.464 0.227 0 C-N-CA 123.764 0.825 . . . . 0.0 109.735 173.287 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 22.2 mt -83.2 -19.89 35.67 Favored 'General case' 0 CA--C 1.514 -0.419 0 N-CA-C 114.887 1.44 . . . . 0.0 114.887 -169.43 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 6.5 t -57.85 -36.12 71.87 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-N 119.826 1.194 . . . . 0.0 110.598 -175.378 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 22.0 p -87.17 -8.33 57.03 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 124.802 1.241 . . . . 0.0 112.341 -179.184 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 32.3 mmmt -85.29 -7.13 59.15 Favored 'General case' 0 C--N 1.345 0.398 0 C-N-CA 124.61 1.164 . . . . 0.0 111.556 174.512 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 72.84 31.93 61.73 Favored Glycine 0 CA--C 1.523 0.567 0 CA-C-O 119.459 -0.634 . . . . 0.0 112.516 171.035 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 17.0 m -74.59 177.45 0.56 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.572 0 CA-C-N 118.386 1.093 . . . . 0.0 109.836 172.758 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -116.66 125.8 52.29 Favored 'General case' 0 CA--C 1.515 -0.388 0 N-CA-C 106.332 -1.729 . . . . 0.0 106.332 170.649 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 68.7 m-85 -91.45 146.03 24.14 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 119.847 1.203 . . . . 0.0 110.198 -177.594 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 33.5 m -133.3 158.43 42.98 Favored 'Isoleucine or valine' 0 C--O 1.235 0.323 0 C-N-CA 125.385 1.474 . . . . 0.0 107.503 169.044 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 85.41 35.19 12.34 Favored Glycine 0 N--CA 1.452 -0.252 0 CA-C-O 118.919 -0.934 . . . . 0.0 114.349 169.729 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 8.2 m-30 -67.86 155.2 39.89 Favored 'General case' 0 CA--C 1.544 0.729 0 CA-C-N 118.815 1.307 . . . . 0.0 109.403 169.611 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 1.6 t90 -136.46 137.96 25.52 Favored Pre-proline 0 CA--C 1.541 0.609 0 CA-C-O 117.305 -1.331 . . . . 0.0 108.342 -171.243 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_exo -70.58 130.92 19.1 Favored 'Trans proline' 0 C--N 1.348 0.501 0 C-N-CA 123.179 2.586 . . . . 0.0 113.037 -170.32 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 40.1 p . . . . . 0 N--CA 1.472 0.667 0 N-CA-C 113.457 0.91 . . . . 0.0 113.457 172.919 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 26.2 ttmt . . . . . 0 CA--C 1.541 0.616 0 CA-C-O 117.091 -1.433 . . . . 0.0 114.791 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_endo -74.63 -4.5 15.51 Favored 'Trans proline' 0 C--N 1.352 0.717 0 CA-C-N 122.108 1.789 . . . . 0.0 114.11 -178.928 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 20.8 m -131.76 167.89 25.27 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.412 0 CA-C-N 120.96 1.709 . . . . 0.0 111.673 -169.552 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 25.1 pt -127.87 170.05 18.28 Favored 'Isoleucine or valine' 0 C--O 1.234 0.27 0 C-N-CA 126.689 1.996 . . . . 0.0 109.207 175.169 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . 57.91 32.92 22.59 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 125.416 1.486 . . . . 0.0 113.768 167.711 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 27.7 t70 56.21 40.11 30.1 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 126.323 1.849 . . . . 0.0 111.254 -174.931 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 91.31 74.99 1.29 Allowed Glycine 0 C--N 1.338 0.657 0 C-N-CA 124.46 1.029 . . . . 0.0 111.259 177.682 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 74.1 mm-40 -120.66 -49.62 2.23 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 123.179 0.592 . . . . 0.0 110.771 168.251 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -131.0 145.03 51.92 Favored 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 122.997 0.519 . . . . 0.0 110.205 -178.86 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 73.3 m-85 -76.61 17.71 0.38 Allowed 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 125.573 1.549 . . . . 0.0 114.644 174.795 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 4.1 m 47.84 15.26 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.546 0.802 0 C-N-CA 127.915 2.486 . . . . 0.0 114.37 -174.053 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 168.22 174.0 36.66 Favored Glycine 0 CA--C 1.526 0.78 0 N-CA-C 108.792 -1.723 . . . . 0.0 108.792 -169.339 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 0.477 ' HB2' ' CD1' ' A' ' 160' ' ' TRP . 1.7 tp -71.88 142.13 49.55 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 118.215 1.008 . . . . 0.0 111.92 179.701 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -104.8 130.0 52.99 Favored 'General case' 0 N--CA 1.447 -0.585 0 C-N-CA 127.482 2.313 . . . . 0.0 109.416 178.034 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 87.5 mt . . . . . 0 N--CA 1.471 0.608 0 C-N-CA 125.038 1.335 . . . . 0.0 108.461 173.103 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 73.3 m . . . . . 0 CA--C 1.539 0.535 0 CA-C-O 118.716 -0.659 . . . . 0.0 111.64 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -60.35 -45.48 93.33 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 119.51 1.05 . . . . 0.0 111.882 172.387 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 -67.29 -44.23 79.78 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 125.38 1.472 . . . . 0.0 110.244 177.931 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 38.7 mtp180 -62.52 -40.08 95.62 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-O 117.826 -1.083 . . . . 0.0 109.682 179.35 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 48.7 mt -63.18 -55.38 23.68 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.475 0 CA-C-N 119.891 1.223 . . . . 0.0 107.991 172.453 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 70.5 tp60 -50.21 -63.78 1.01 Allowed 'General case' 0 C--O 1.232 0.176 0 C-N-CA 124.808 1.243 . . . . 0.0 111.86 -174.584 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 24.0 m -66.0 -32.99 74.8 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 120.666 -0.414 . . . . 0.0 111.136 -170.365 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 160' ' ' TRP . . . . . 0.477 ' CD1' ' HB2' ' A' ' 142' ' ' LEU . 82.4 t90 -67.09 -46.13 75.16 Favored 'General case' 0 C--O 1.222 -0.39 0 O-C-N 121.999 -0.438 . . . . 0.0 110.889 175.257 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 61.4 m -58.2 -43.9 87.84 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 118.48 0.582 . . . . 0.0 110.157 179.502 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -62.28 -43.91 97.74 Favored 'General case' 0 CA--C 1.528 0.123 0 N-CA-C 109.886 -0.413 . . . . 0.0 109.886 176.842 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 14.9 tt0 -62.58 -50.32 71.76 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-O 117.946 -1.026 . . . . 0.0 110.225 -177.923 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 41.6 pt -65.01 -33.53 64.35 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.485 0 CA-C-N 119.678 1.126 . . . . 0.0 110.224 -176.335 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -70.48 -34.19 72.11 Favored 'General case' 0 C--O 1.223 -0.322 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 -175.998 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -71.33 -45.19 63.58 Favored 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 124.531 1.132 . . . . 0.0 109.982 175.082 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 21.9 tt0 -78.3 -24.57 46.63 Favored 'General case' 0 N--CA 1.441 -0.905 0 C-N-CA 124.22 1.008 . . . . 0.0 110.319 -169.374 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 168' ' ' MET . . . . . . . . . . . . . 19.2 ptp -82.26 -29.72 31.1 Favored 'General case' 0 N--CA 1.461 0.104 0 O-C-N 121.694 -0.629 . . . . 0.0 111.657 171.843 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -79.36 -36.3 39.52 Favored 'General case' 0 N--CA 1.447 -0.613 0 C-N-CA 122.573 0.349 . . . . 0.0 111.001 -178.198 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 . . . . . 0 CA--C 1.535 0.392 0 O-C-N 122.138 -0.351 . . . . 0.0 110.396 177.356 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.498 1.926 0 CA-C-O 118.986 -0.531 . . . . 0.0 110.15 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 5.7 t30 -111.22 147.54 34.77 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-N 119.729 1.149 . . . . 0.0 111.377 -171.5 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 17.5 mtt -112.79 130.12 56.19 Favored 'General case' 0 N--CA 1.462 0.174 0 C-N-CA 124.414 1.086 . . . . 0.0 110.203 -177.467 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -98.94 131.02 10.42 Favored Glycine 0 CA--C 1.522 0.506 0 N-CA-C 107.264 -2.334 . . . . 0.0 107.264 168.54 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -105.74 108.14 19.51 Favored 'General case' 0 N--CA 1.467 0.422 0 N-CA-C 105.058 -2.201 . . . . 0.0 105.058 173.974 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -99.62 145.84 27.12 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 119.401 1.0 . . . . 0.0 112.663 179.335 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 79.5 m-85 . . . . . 0 N--CA 1.451 -0.416 0 C-N-CA 126.681 1.992 . . . . 0.0 108.726 -178.401 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.536 0.428 0 CA-C-O 119.002 -0.523 . . . . 0.0 110.236 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -57.18 -55.18 38.1 Favored 'General case' 0 N--CA 1.465 0.318 0 C-N-CA 123.672 0.789 . . . . 0.0 112.337 179.112 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 70.5 mm-40 -61.08 -45.73 93.54 Favored 'General case' 0 CA--C 1.517 -0.319 0 N-CA-C 108.134 -1.062 . . . . 0.0 108.134 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 30.0 mtpp -66.42 -39.6 89.06 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-O 118.498 -0.763 . . . . 0.0 110.107 -171.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 17.6 mt -54.61 -58.65 3.44 Favored 'Isoleucine or valine' 0 C--O 1.233 0.188 0 C-N-CA 124.639 1.175 . . . . 0.0 108.858 176.548 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 18.7 ptt180 -64.91 -39.42 93.49 Favored 'General case' 0 C--O 1.222 -0.372 0 CA-C-O 118.761 -0.637 . . . . 0.0 110.45 -177.272 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -65.53 -39.92 92.32 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.142 0.496 . . . . 0.0 110.018 -172.511 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 70.5 mt -75.5 -53.72 15.43 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.576 0 C-N-CA 125.236 1.415 . . . . 0.0 109.875 -175.419 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 71.8 mt -62.48 -46.89 95.32 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.441 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 -179.232 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 140.77 116.58 1.3 Allowed Glycine 0 CA--C 1.528 0.881 0 C-N-CA 125.842 1.687 . . . . 0.0 109.395 179.26 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -72.78 -8.18 21.97 Favored 'Trans proline' 0 CA--C 1.539 0.743 0 C-N-CA 122.739 2.292 . . . . 0.0 113.337 -170.229 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -79.67 -17.65 53.18 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 118.757 0.708 . . . . 0.0 111.865 178.02 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -125.37 8.08 7.77 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 125.204 1.402 . . . . 0.0 113.343 -174.878 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 61.3 t -124.55 149.22 28.82 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.265 0 N-CA-C 107.925 -1.139 . . . . 0.0 107.925 174.21 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 11.9 m -138.71 136.32 35.68 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 126.034 1.734 . . . . 0.0 107.023 -176.804 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 23.8 mt -90.67 146.59 23.9 Favored 'General case' 0 N--CA 1.466 0.339 0 N-CA-C 107.691 -1.226 . . . . 0.0 107.691 175.553 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 40.5 t-80 -140.34 128.27 22.03 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 107.459 -1.311 . . . . 0.0 107.459 -169.261 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 53.8 t-20 -128.66 111.18 12.91 Favored 'General case' 0 CA--C 1.516 -0.345 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 -169.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 88.9 mt -66.86 -10.7 50.97 Favored 'General case' 0 CA--C 1.535 0.381 0 N-CA-C 113.355 0.872 . . . . 0.0 113.355 -174.222 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 40.3 tptt -57.92 -29.13 64.88 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 118.82 0.737 . . . . 0.0 111.234 168.153 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -129.39 -38.01 1.59 Allowed 'General case' 0 N--CA 1.465 0.299 0 C-N-CA 123.84 0.856 . . . . 0.0 112.67 -173.049 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 42.8 m-20 -79.55 130.12 35.1 Favored 'General case' 0 C--O 1.236 0.373 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 179.758 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 14.4 m -73.28 152.7 90.26 Favored Pre-proline 0 CA--C 1.542 0.649 0 C-N-CA 123.22 0.608 . . . . 0.0 109.526 173.368 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -73.04 -24.86 16.81 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.032 1.821 . . . . 0.0 113.992 -169.616 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 1.4 mptm? -63.21 -18.06 63.11 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 119.275 0.943 . . . . 0.0 111.726 178.176 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -63.28 -25.31 68.26 Favored 'General case' 0 N--CA 1.465 0.309 0 C-N-CA 124.847 1.259 . . . . 0.0 110.746 174.341 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 54.2 mtt -61.75 -23.95 66.49 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 119.361 0.982 . . . . 0.0 111.496 177.346 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -64.32 -32.25 73.78 Favored 'General case' 0 CA--C 1.535 0.365 0 O-C-N 121.792 -0.568 . . . . 0.0 110.566 -177.602 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 25.4 mt-30 -67.17 -42.23 84.61 Favored 'General case' 0 CA--C 1.533 0.29 0 N-CA-C 113.594 0.961 . . . . 0.0 113.594 -169.397 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 62.7 m-85 -73.79 144.09 45.73 Favored 'General case' 0 C--O 1.231 0.113 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.637 -165.346 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 41.7 m-20 -77.23 -29.19 54.01 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 122.785 0.434 . . . . 0.0 109.948 -176.433 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 13.5 t -124.57 144.85 33.03 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.34 0 N-CA-C 106.564 -1.643 . . . . 0.0 106.564 168.886 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 25.0 tp -125.2 105.95 9.52 Favored 'General case' 0 N--CA 1.446 -0.669 0 N-CA-C 107.304 -1.369 . . . . 0.0 107.304 175.542 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 51.0 mt -85.83 128.6 39.13 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.687 0 N-CA-C 105.947 -1.872 . . . . 0.0 105.947 174.435 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 1.3 mp -102.55 124.1 47.5 Favored 'General case' 0 CA--C 1.515 -0.375 0 N-CA-C 106.415 -1.698 . . . . 0.0 106.415 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -122.4 120.39 4.3 Favored Glycine 0 N--CA 1.449 -0.449 0 N-CA-C 106.951 -2.46 . . . . 0.0 106.951 177.656 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 5.8 tt -149.64 116.46 3.61 Favored Pre-proline 0 C--N 1.332 -0.185 0 CA-C-N 118.033 0.916 . . . . 0.0 109.483 169.823 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 62.9 Cg_exo . . . . . 0 N--CA 1.456 -0.687 0 C-N-CA 120.706 0.937 . . . . 0.0 110.394 166.194 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 48.1 mt . . . . . 0 CA--C 1.538 0.512 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . 0.423 ' H ' ' CD ' ' A' ' 62' ' ' GLN . 1.5 pm0 -75.82 154.28 36.29 Favored 'General case' 0 C--O 1.233 0.225 0 C-N-CA 124.711 1.204 . . . . 0.0 109.821 173.662 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -57.11 -41.86 79.76 Favored 'General case' 0 C--O 1.224 -0.289 0 C-N-CA 124.045 0.938 . . . . 0.0 110.952 -171.375 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 27.8 m-20 -69.76 -15.56 63.15 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-N 119.108 0.867 . . . . 0.0 112.395 -173.912 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' TRP . . . . . 0.408 ' CH2' HD23 ' A' ' 104' ' ' LEU . 11.5 t90 -92.11 -46.86 7.56 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 124.52 1.128 . . . . 0.0 108.139 173.313 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -62.66 -35.36 79.41 Favored 'General case' 0 CA--C 1.536 0.428 0 O-C-N 120.789 -1.194 . . . . 0.0 110.585 -178.785 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -61.48 -25.78 67.47 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 124.119 0.968 . . . . 0.0 110.913 -174.926 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 28.1 m -111.21 -14.94 10.39 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.328 0 CA-C-O 117.352 -1.308 . . . . 0.0 112.207 177.502 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 28.3 t90 -51.56 -37.51 49.98 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 120.161 1.346 . . . . 0.0 110.526 177.342 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -63.35 -27.45 69.33 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 125.305 1.442 . . . . 0.0 113.196 176.399 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 30.9 mt-30 -92.4 -20.18 21.31 Favored 'General case' 0 C--O 1.226 -0.163 0 C-N-CA 125.853 1.661 . . . . 0.0 112.567 178.004 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 41.7 mt -63.34 -24.08 67.69 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 118.895 0.77 . . . . 0.0 111.458 -176.108 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -75.8 -27.18 57.87 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 117.903 0.32 . . . . 0.0 111.373 174.541 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -79.32 -17.01 55.42 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 123.951 0.9 . . . . 0.0 112.609 -174.717 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 38.1 mt -62.53 147.9 47.55 Favored 'General case' 0 C--O 1.234 0.275 0 C-N-CA 124.261 1.025 . . . . 0.0 111.43 -170.912 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 24.7 t-20 -83.38 82.58 8.22 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 124.856 1.263 . . . . 0.0 107.933 174.373 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 3.7 pp -140.92 131.6 25.64 Favored 'General case' 0 N--CA 1.453 -0.282 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 170.903 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 25.3 mt-10 -141.1 146.59 37.29 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 127.843 2.457 . . . . 0.0 107.585 168.414 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 69.74 -3.44 9.23 Favored Glycine 0 CA--C 1.534 1.243 0 CA-C-O 118.111 -1.383 . . . . 0.0 116.285 169.658 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.93 161.96 30.07 Favored 'General case' 0 C--N 1.343 0.312 0 CA-C-N 120.282 2.041 . . . . 0.0 109.681 -177.345 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 2.2 mt -85.05 135.41 24.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 N-CA-C 107.329 -1.36 . . . . 0.0 107.329 177.794 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 77.4 t -128.47 138.23 55.19 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 -179.766 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -113.7 156.81 23.1 Favored 'General case' 0 CA--C 1.521 -0.156 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 169.305 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 2.0 mt -138.7 134.73 33.98 Favored 'General case' 0 CA--C 1.515 -0.374 0 N-CA-C 107.002 -1.481 . . . . 0.0 107.002 -178.568 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 12.2 p90 -165.15 171.24 13.99 Favored 'General case' 0 N--CA 1.451 -0.386 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 170.698 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -178.08 176.71 48.16 Favored Glycine 0 N--CA 1.449 -0.439 0 N-CA-C 109.955 -1.258 . . . . 0.0 109.955 167.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.329 -0.316 0 C-N-CA 124.696 1.199 . . . . 0.0 109.905 171.922 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 71.5 mt . . . . . 0 CA--C 1.534 0.327 0 N-CA-C 115.49 1.663 . . . . 0.0 115.49 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -60.16 -28.7 68.14 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 120.394 1.452 . . . . 0.0 110.967 -175.37 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -71.31 -26.65 62.94 Favored 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 123.968 0.907 . . . . 0.0 112.491 176.82 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 10.1 mp -63.69 -43.47 96.56 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 119.846 1.203 . . . . 0.0 107.854 170.832 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -65.46 -39.83 95.92 Favored Glycine 0 C--N 1.339 0.747 0 N-CA-C 110.801 -0.92 . . . . 0.0 110.801 -174.875 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 70.7 mtm -63.85 -44.74 92.25 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 117.288 0.544 . . . . 0.0 111.762 178.3 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.408 HD23 ' CH2' ' A' ' 65' ' ' TRP . 0.2 OUTLIER -71.04 -39.63 72.19 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 119.635 1.107 . . . . 0.0 109.908 178.865 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 42.9 t-80 -55.13 -51.79 65.32 Favored 'General case' 0 CA--C 1.53 0.206 0 O-C-N 121.64 -0.662 . . . . 0.0 110.516 176.59 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -61.38 -39.7 91.64 Favored 'General case' 0 C--O 1.235 0.311 0 C-N-CA 123.491 0.716 . . . . 0.0 111.864 -176.716 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 24.2 ttmm -56.84 -41.82 78.55 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 123.325 0.65 . . . . 0.0 110.598 173.486 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 38.2 mt -87.21 -16.5 35.12 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-O 117.628 -1.177 . . . . 0.0 114.077 -169.798 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 17.7 m -57.61 -37.83 73.91 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 120.412 1.46 . . . . 0.0 111.247 -179.759 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 21.1 p -82.52 -12.52 57.71 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 124.194 0.998 . . . . 0.0 111.561 -179.409 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 32.0 mmmt -82.27 -6.39 59.2 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 124.517 1.127 . . . . 0.0 110.853 169.582 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 71.44 27.19 71.83 Favored Glycine 0 CA--C 1.527 0.831 0 CA-C-N 119.312 0.96 . . . . 0.0 113.098 168.829 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 7.9 m -74.09 170.29 1.48 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 CA-C-N 118.5 1.15 . . . . 0.0 110.068 178.345 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 54.4 tptt -95.04 135.55 36.45 Favored 'General case' 0 CA--C 1.513 -0.472 0 N-CA-C 105.26 -2.126 . . . . 0.0 105.26 167.785 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 64.7 m-85 -103.14 122.39 44.6 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 108.099 -1.075 . . . . 0.0 108.099 171.815 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 26.2 m -107.84 158.23 7.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 C-N-CA 124.5 1.12 . . . . 0.0 108.685 168.033 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 86.1 24.69 39.91 Favored Glycine 0 CA--C 1.524 0.654 0 CA-C-O 118.076 -1.402 . . . . 0.0 115.13 169.699 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 12.3 m-30 -59.91 156.38 14.58 Favored 'General case' 0 CA--C 1.544 0.721 0 CA-C-N 119.44 1.62 . . . . 0.0 109.298 168.613 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 58.3 t-105 -135.71 143.86 46.52 Favored Pre-proline 0 N--CA 1.472 0.635 0 CA-C-O 118.094 -0.955 . . . . 0.0 111.553 -168.359 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -64.46 129.64 24.44 Favored 'Trans proline' 0 C--N 1.348 0.548 0 C-N-CA 123.344 2.696 . . . . 0.0 112.429 -178.133 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 3.7 p . . . . . 0 CA--C 1.535 0.384 0 C-N-CA 125.022 1.329 . . . . 0.0 111.062 169.709 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 23.9 ttmt . . . . . 0 N--CA 1.474 0.762 0 CA-C-O 117.453 -1.261 . . . . 0.0 114.305 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 80.7 Cg_endo -76.66 -0.53 10.57 Favored 'Trans proline' 0 C--N 1.353 0.812 0 CA-C-N 122.216 1.827 . . . . 0.0 114.079 179.526 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 19.5 m -120.48 149.28 23.3 Favored 'Isoleucine or valine' 0 C--O 1.232 0.171 0 CA-C-N 120.479 1.491 . . . . 0.0 110.217 -178.759 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . 0.477 HG23 HG12 ' A' ' 140' ' ' VAL . 3.2 pt -88.08 169.1 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.721 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 169.013 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . 56.0 -154.12 0.33 Allowed 'General case' 0 N--CA 1.441 -0.907 0 CA-C-N 113.603 -1.635 . . . . 0.0 109.175 169.604 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 22.4 t0 -80.67 60.7 4.08 Favored 'General case' 0 C--N 1.325 -0.482 0 C-N-CA 125.022 1.329 . . . . 0.0 109.123 169.94 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 63.54 30.0 76.3 Favored Glycine 0 CA--C 1.529 0.927 0 C-N-CA 124.607 1.099 . . . . 0.0 112.868 177.659 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 56.0 mm-40 -78.33 -29.19 47.49 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 117.706 0.753 . . . . 0.0 111.688 -168.955 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 11.7 tp -158.67 148.96 19.78 Favored 'General case' 0 CA--C 1.53 0.207 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 -174.602 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 72.5 m-85 -77.48 148.53 35.3 Favored 'General case' 0 CA--C 1.522 -0.113 0 CA-C-N 119.146 0.884 . . . . 0.0 108.789 170.088 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . 0.477 HG12 HG23 ' A' ' 133' ' ' ILE . 33.8 m -71.43 -0.67 1.82 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.624 0 C-N-CA 123.195 0.598 . . . . 0.0 112.265 175.762 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -176.58 171.9 44.87 Favored Glycine 0 CA--C 1.524 0.633 0 O-C-N 120.745 -1.222 . . . . 0.0 110.346 -172.659 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 1.6 tp -64.67 136.13 56.64 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 118.006 0.903 . . . . 0.0 110.939 179.454 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -101.72 112.81 25.52 Favored 'General case' 0 N--CA 1.447 -0.617 0 C-N-CA 125.841 1.656 . . . . 0.0 108.873 176.266 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 95.7 mt . . . . . 0 N--CA 1.465 0.295 0 C-N-CA 124.448 1.099 . . . . 0.0 109.317 170.584 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 12.5 m . . . . . 0 CA--C 1.54 0.564 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -59.91 -42.5 94.03 Favored 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 124.235 1.014 . . . . 0.0 111.65 169.673 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -64.41 -47.01 80.79 Favored 'General case' 0 C--N 1.334 -0.102 0 C-N-CA 124.31 1.044 . . . . 0.0 109.848 178.907 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 68.5 mtt180 -57.58 -46.76 83.59 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-O 118.125 -0.94 . . . . 0.0 110.501 177.151 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 47.8 mt -61.03 -51.96 67.14 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.403 0 CA-C-N 119.443 1.02 . . . . 0.0 108.383 177.192 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 71.0 tp60 -52.78 -64.19 0.9 Allowed 'General case' 0 C--O 1.234 0.27 0 C-N-CA 124.633 1.173 . . . . 0.0 111.302 -177.6 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 41.3 m -66.21 -33.26 75.35 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 119.315 -0.374 . . . . 0.0 111.268 -171.459 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 160' ' ' TRP . . . . . . . . . . . . . 60.5 t90 -65.73 -47.87 73.88 Favored 'General case' 0 C--O 1.225 -0.225 0 CA-C-N 118.676 0.671 . . . . 0.0 110.707 174.705 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 64.7 m -61.3 -42.22 98.29 Favored 'General case' 0 N--CA 1.455 -0.204 0 CA-C-N 118.217 0.462 . . . . 0.0 110.299 -178.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -61.55 -44.54 96.85 Favored 'General case' 0 N--CA 1.455 -0.203 0 CA-C-N 118.308 0.504 . . . . 0.0 110.076 174.886 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 14.8 tt0 -62.6 -50.81 69.79 Favored 'General case' 0 CA--C 1.512 -0.489 0 CA-C-O 117.699 -1.143 . . . . 0.0 109.803 -176.415 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 44.7 pt -63.98 -34.13 66.58 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.425 0 CA-C-O 117.59 -1.195 . . . . 0.0 109.835 -176.578 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -71.48 -32.36 68.18 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 119.653 1.115 . . . . 0.0 108.955 -174.982 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -70.74 -53.54 15.15 Favored 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 124.347 1.059 . . . . 0.0 109.374 173.737 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 20.1 tt0 -69.02 -31.44 70.24 Favored 'General case' 0 N--CA 1.445 -0.719 0 C-N-CA 125.601 1.561 . . . . 0.0 109.943 -168.619 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 168' ' ' MET . . . . . . . . . . . . . 22.1 ptp -74.11 -34.02 63.78 Favored 'General case' 0 C--O 1.23 0.078 0 O-C-N 122.143 -0.348 . . . . 0.0 111.047 174.658 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -74.86 -37.16 62.28 Favored 'General case' 0 N--CA 1.442 -0.852 0 CA-C-O 119.276 -0.393 . . . . 0.0 111.811 -177.251 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 5.5 mt-10 . . . . . 0 CA--C 1.532 0.283 0 CA-C-O 121.572 0.701 . . . . 0.0 109.682 177.244 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.497 1.898 0 CA-C-O 120.433 0.159 . . . . 0.0 111.286 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 26.1 p-10 -116.39 165.87 12.72 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 125.392 1.477 . . . . 0.0 111.414 -174.425 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 13.9 mtt -130.69 128.44 40.89 Favored 'General case' 0 CA--C 1.522 -0.119 0 C-N-CA 123.27 0.628 . . . . 0.0 110.717 175.367 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -90.12 149.4 20.3 Favored Glycine 0 CA--C 1.525 0.672 0 N-CA-C 106.786 -2.526 . . . . 0.0 106.786 166.56 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 2.4 tt -134.26 100.16 4.61 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 105.364 -2.087 . . . . 0.0 105.364 -178.099 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . 0.557 ' CZ ' HD11 ' A' ' 51' ' ' LEU . 0.5 OUTLIER -106.22 142.84 35.23 Favored 'General case' 0 CA--C 1.519 -0.238 0 CA-C-O 121.63 0.729 . . . . 0.0 112.252 -172.727 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 34.7 p90 . . . . . 0 N--CA 1.45 -0.433 0 C-N-CA 126.697 1.999 . . . . 0.0 106.85 179.425 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.226 -0.136 0 N-CA-C 109.3 -0.629 . . . . 0.0 109.3 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -63.77 -45.53 89.32 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 122.195 0.198 . . . . 0.0 110.872 -176.74 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -60.24 -45.38 93.44 Favored 'General case' 0 N--CA 1.465 0.298 0 C-N-CA 123.296 0.638 . . . . 0.0 109.667 176.392 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 30.0 mtpp -70.52 -39.91 73.8 Favored 'General case' 0 C--O 1.222 -0.373 0 CA-C-O 118.441 -0.79 . . . . 0.0 110.144 -173.512 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 43.8 mt -54.88 -54.86 19.47 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.189 0 CA-C-N 119.765 1.166 . . . . 0.0 109.174 176.024 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.83 -33.87 76.56 Favored 'General case' 0 C--O 1.221 -0.399 0 CA-C-N 118.259 0.481 . . . . 0.0 111.316 -174.628 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -63.4 -40.75 98.06 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 122.67 0.388 . . . . 0.0 111.119 175.273 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 55.6 mt -76.72 -55.67 10.25 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.515 0 C-N-CA 124.644 1.178 . . . . 0.0 110.451 -171.698 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 73.4 mt -64.48 -46.3 93.18 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 -179.858 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 143.73 124.01 1.78 Allowed Glycine 0 CA--C 1.527 0.817 0 C-N-CA 124.442 1.02 . . . . 0.0 110.871 174.46 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -73.13 -9.41 23.35 Favored 'Trans proline' 0 CA--C 1.54 0.782 0 C-N-CA 123.101 2.534 . . . . 0.0 113.387 -170.914 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -81.35 -19.09 43.49 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 118.768 0.713 . . . . 0.0 111.416 178.174 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -125.12 -7.2 7.13 Favored 'General case' 0 C--N 1.344 0.335 0 C-N-CA 124.828 1.251 . . . . 0.0 113.724 -174.032 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 40.4 t -115.02 137.27 49.04 Favored 'Isoleucine or valine' 0 C--O 1.233 0.216 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 171.193 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 51.7 m -129.91 132.99 46.57 Favored 'General case' 0 C--O 1.233 0.197 0 C-N-CA 124.807 1.243 . . . . 0.0 108.268 -174.503 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 23.7 mt -75.22 144.22 42.73 Favored 'General case' 0 C--O 1.233 0.194 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 177.073 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . 0.417 ' HD1' ' HB2' ' A' ' 6' ' ' PHE . 44.4 t-80 -132.7 66.55 1.56 Allowed 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 125.141 1.376 . . . . 0.0 107.291 -177.679 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 57.0 t-20 -70.43 118.08 12.78 Favored 'General case' 0 C--O 1.233 0.234 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 -179.329 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 48.6 mt -67.74 -18.0 64.74 Favored 'General case' 0 C--O 1.232 0.183 0 N-CA-C 113.16 0.8 . . . . 0.0 113.16 -174.78 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 35.1 tptt -60.14 -23.6 64.03 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 118.698 0.681 . . . . 0.0 111.777 169.445 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -119.46 -39.41 2.89 Favored 'General case' 0 C--O 1.234 0.262 0 N-CA-C 113.279 0.844 . . . . 0.0 113.279 -172.846 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 33.1 m-20 -101.42 139.15 37.48 Favored 'General case' 0 N--CA 1.465 0.302 0 C-N-CA 123.947 0.899 . . . . 0.0 110.531 -177.654 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 11.4 m -75.28 155.82 85.83 Favored Pre-proline 0 CA--C 1.542 0.644 0 C-N-CA 124.124 0.97 . . . . 0.0 110.16 174.779 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -74.71 -25.68 12.26 Favored 'Trans proline' 0 C--N 1.349 0.553 0 C-N-CA 121.909 1.74 . . . . 0.0 113.472 -170.196 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 1.7 mptm? -62.9 -21.08 65.76 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-N 120.329 1.422 . . . . 0.0 112.082 -179.186 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -62.25 -26.53 68.44 Favored 'General case' 0 N--CA 1.465 0.292 0 C-N-CA 125.119 1.368 . . . . 0.0 110.389 174.634 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 68.4 mtt -58.19 -27.66 64.07 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 118.94 0.791 . . . . 0.0 111.43 177.128 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 69.1 mt-10 -63.37 -32.59 74.05 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 118.238 0.472 . . . . 0.0 109.969 -175.814 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 26.2 mt-30 -67.47 -39.78 85.28 Favored 'General case' 0 C--N 1.342 0.278 0 C-N-CA 123.911 0.884 . . . . 0.0 113.191 -172.145 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 71.6 m-85 -72.95 135.16 44.99 Favored 'General case' 0 C--O 1.233 0.219 0 N-CA-C 109.446 -0.575 . . . . 0.0 109.446 -167.904 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -69.7 -44.01 71.27 Favored 'General case' 0 C--O 1.233 0.208 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 -178.843 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 12.3 t -103.52 145.49 12.53 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.396 0 N-CA-C 107.996 -1.113 . . . . 0.0 107.996 169.894 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 34.8 tp -135.41 105.97 6.47 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 175.943 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 32.6 mt -85.11 128.34 39.11 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.826 0 N-CA-C 106.638 -1.616 . . . . 0.0 106.638 177.698 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.557 HD11 ' CZ ' ' A' ' 6' ' ' PHE . 0.8 OUTLIER -94.05 144.32 25.58 Favored 'General case' 0 CA--C 1.516 -0.363 0 C-N-CA 124.787 1.235 . . . . 0.0 109.824 169.588 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -145.34 134.78 5.67 Favored Glycine 0 CA--C 1.52 0.385 0 N-CA-C 109.244 -1.542 . . . . 0.0 109.244 169.234 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 3.5 tt -156.68 139.6 10.81 Favored Pre-proline 0 CA--C 1.542 0.655 0 CA-C-N 118.737 1.268 . . . . 0.0 111.411 172.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo . . . . . 0 CA--C 1.538 0.718 0 C-N-CA 122.749 2.3 . . . . 0.0 111.554 167.192 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . 0.253 49.9 mt . . . . . 0 CA--C 1.546 0.804 0 CA-C-O 122.581 1.181 . . . . 0.0 112.415 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 4.2 mp0 -108.1 153.69 22.78 Favored 'General case' 0 C--N 1.34 0.173 0 C-N-CA 125.569 1.548 . . . . 0.0 107.157 -177.317 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -57.0 -42.47 80.32 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 123.178 0.591 . . . . 0.0 110.951 -173.312 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 23.0 m-20 -66.99 -18.24 65.29 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 122.844 0.458 . . . . 0.0 112.004 -176.409 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' TRP . . . . . 0.788 ' CH2' HD23 ' A' ' 104' ' ' LEU . 13.6 t90 -95.76 -44.79 7.27 Favored 'General case' 0 C--N 1.339 0.14 0 C-N-CA 124.358 1.063 . . . . 0.0 110.263 175.304 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -62.9 -34.75 78.07 Favored 'General case' 0 CA--C 1.538 0.503 0 O-C-N 120.692 -1.255 . . . . 0.0 109.673 -178.864 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -60.16 -25.32 65.43 Favored 'General case' 0 C--O 1.233 0.216 0 C-N-CA 123.839 0.856 . . . . 0.0 111.567 179.29 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 12.2 m -109.85 -16.04 9.25 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.321 0 CA-C-O 117.46 -1.257 . . . . 0.0 112.467 179.446 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 27.9 t90 -53.71 -38.53 64.37 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 120.025 1.284 . . . . 0.0 110.198 176.822 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -66.59 -27.36 67.66 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 125.476 1.51 . . . . 0.0 112.945 175.532 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 68.1 mt-30 -90.73 -23.07 20.8 Favored 'General case' 0 C--O 1.224 -0.289 0 C-N-CA 125.67 1.588 . . . . 0.0 111.978 -176.787 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.608 ' CD1' HD21 ' A' ' 104' ' ' LEU . 50.3 mt -57.74 -32.0 67.02 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 118.537 0.608 . . . . 0.0 110.275 173.398 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -70.4 -26.5 63.72 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 122.694 0.397 . . . . 0.0 111.233 174.548 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -81.31 -34.36 31.97 Favored 'General case' 0 CA--C 1.537 0.475 0 N-CA-C 113.307 0.854 . . . . 0.0 113.307 176.267 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 24.7 mt -59.62 149.56 29.95 Favored 'General case' 0 N--CA 1.464 0.27 0 C-N-CA 124.476 1.11 . . . . 0.0 111.104 -176.117 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 19.9 t-20 -91.15 118.42 30.43 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 169.171 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 70.4 mt -127.98 8.9 6.25 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 123.73 0.812 . . . . 0.0 112.263 -173.113 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 28.9 mt-10 -52.18 129.15 27.04 Favored 'General case' 0 C--O 1.234 0.273 0 C-N-CA 124.3 1.04 . . . . 0.0 112.272 -168.049 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 68.43 0.09 15.3 Favored Glycine 0 CA--C 1.535 1.3 0 C-N-CA 125.436 1.493 . . . . 0.0 115.525 175.828 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.66 151.34 40.81 Favored 'General case' 0 C--N 1.345 0.391 0 CA-C-N 120.555 2.177 . . . . 0.0 109.499 -174.262 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 5.8 mt -80.38 136.47 23.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 N-CA-C 106.65 -1.611 . . . . 0.0 106.65 179.649 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 43.2 t -131.16 134.26 61.52 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 C-N-CA 123.755 0.822 . . . . 0.0 109.809 -179.567 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.415 ' HB1' ' CH2' ' A' ' 160' ' ' TRP . . . -105.34 152.73 22.57 Favored 'General case' 0 N--CA 1.462 0.139 0 N-CA-C 105.865 -1.902 . . . . 0.0 105.865 166.804 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 2.6 mt -134.08 134.4 42.26 Favored 'General case' 0 CA--C 1.512 -0.497 0 N-CA-C 107.096 -1.446 . . . . 0.0 107.096 175.537 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 36.0 p90 -148.86 168.77 22.13 Favored 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 169.628 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -163.41 173.6 39.56 Favored Glycine 0 N--CA 1.446 -0.661 0 N-CA-C 109.91 -1.276 . . . . 0.0 109.91 169.979 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.327 -0.375 0 C-N-CA 125.012 1.325 . . . . 0.0 108.435 171.035 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 84.3 mt . . . . . 0 N--CA 1.47 0.541 0 N-CA-C 116.253 1.945 . . . . 0.0 116.253 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -64.61 -35.03 79.69 Favored 'General case' 0 C--N 1.328 -0.348 0 O-C-N 120.441 -1.412 . . . . 0.0 111.116 -174.305 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -65.9 -31.43 72.36 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 123.845 0.858 . . . . 0.0 111.944 173.458 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 4.2 tt -65.92 -47.93 73.1 Favored 'General case' 0 N--CA 1.468 0.446 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 173.542 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -58.84 -40.53 95.25 Favored Glycine 0 CA--C 1.525 0.713 0 N-CA-C 111.09 -0.804 . . . . 0.0 111.09 178.081 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 3.0 tpp -49.75 -45.44 49.41 Favored 'General case' 0 N--CA 1.464 0.256 0 C-N-CA 124.685 1.194 . . . . 0.0 110.867 172.328 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.788 HD23 ' CH2' ' A' ' 65' ' ' TRP . 0.2 OUTLIER -83.81 -31.26 25.95 Favored 'General case' 0 CA--C 1.52 -0.174 0 O-C-N 122.122 -0.361 . . . . 0.0 111.607 -171.683 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 36.8 t-80 -60.33 -45.26 94.08 Favored 'General case' 0 C--N 1.331 -0.234 0 O-C-N 121.964 -0.46 . . . . 0.0 109.813 169.482 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -63.42 -47.58 81.33 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 123.472 0.709 . . . . 0.0 111.088 179.511 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 2.2 tppm? -54.38 -31.05 53.88 Favored 'General case' 0 N--CA 1.466 0.352 0 C-N-CA 125.342 1.457 . . . . 0.0 111.854 173.863 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 49.2 mt -101.55 -22.32 14.52 Favored 'General case' 0 N--CA 1.465 0.28 0 N-CA-C 114.231 1.197 . . . . 0.0 114.231 -173.668 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 69.0 m -60.42 -34.88 74.59 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 119.897 1.226 . . . . 0.0 111.188 -176.718 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 24.3 p -80.38 -13.13 59.41 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 124.817 1.247 . . . . 0.0 111.833 -179.344 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 31.3 mmmt -88.24 -10.84 48.38 Favored 'General case' 0 C--N 1.342 0.281 0 C-N-CA 125.297 1.439 . . . . 0.0 111.64 179.778 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 75.04 32.92 55.94 Favored Glycine 0 CA--C 1.523 0.572 0 CA-C-O 119.567 -0.574 . . . . 0.0 111.795 173.166 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 9.9 m -72.88 172.42 1.04 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.582 0 CA-C-N 118.26 1.03 . . . . 0.0 109.024 169.721 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -112.25 121.38 44.74 Favored 'General case' 0 CA--C 1.514 -0.422 0 N-CA-C 106.224 -1.769 . . . . 0.0 106.224 176.073 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 63.3 m-85 -88.79 143.99 26.53 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 119.513 1.051 . . . . 0.0 109.756 -176.176 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 30.6 m -129.53 161.17 39.57 Favored 'Isoleucine or valine' 0 C--O 1.234 0.269 0 C-N-CA 124.787 1.235 . . . . 0.0 108.623 170.044 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 95.79 -93.5 1.57 Allowed Glycine 0 N--CA 1.444 -0.79 0 C-N-CA 124.581 1.086 . . . . 0.0 111.122 177.463 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 14.4 m-30 59.25 -178.3 0.08 Allowed 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 124.345 1.058 . . . . 0.0 109.011 -167.275 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -154.93 144.44 15.32 Favored Pre-proline 0 N--CA 1.471 0.6 0 O-C-N 120.192 -1.568 . . . . 0.0 110.604 179.416 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -67.74 123.84 11.21 Favored 'Trans proline' 0 CA--C 1.534 0.515 0 C-N-CA 123.222 2.614 . . . . 0.0 111.705 179.114 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 3.0 p . . . . . 0 CA--C 1.538 0.492 0 O-C-N 121.669 -0.644 . . . . 0.0 112.315 174.692 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 24.3 ttmt . . . . . 0 CA--C 1.542 0.666 0 CA-C-O 117.603 -1.189 . . . . 0.0 113.538 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_endo -83.83 8.22 4.75 Favored 'Trans proline' 0 C--N 1.351 0.681 0 C-N-CA 122.144 1.896 . . . . 0.0 114.436 -179.6 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 29.0 m -126.4 165.31 24.8 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.285 0 CA-C-N 121.156 1.798 . . . . 0.0 111.791 -176.622 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 9.5 pt -132.81 169.2 22.48 Favored 'Isoleucine or valine' 0 C--O 1.234 0.277 0 C-N-CA 127.746 2.419 . . . . 0.0 108.576 179.714 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . 53.87 42.03 31.85 Favored 'General case' 0 C--O 1.227 -0.109 0 C-N-CA 125.296 1.438 . . . . 0.0 112.263 174.109 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 27.7 t70 54.04 42.57 31.57 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 126.479 1.912 . . . . 0.0 111.684 -177.527 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 91.78 16.82 50.66 Favored Glycine 0 CA--C 1.527 0.827 0 CA-C-O 118.721 -1.044 . . . . 0.0 113.642 173.873 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 46.2 mt-30 -89.32 -7.74 54.72 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 119.345 1.573 . . . . 0.0 112.946 179.635 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 7.4 tp -156.23 147.37 22.29 Favored 'General case' 0 C--N 1.344 0.339 0 CA-C-N 119.462 1.028 . . . . 0.0 110.829 169.964 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 67.6 m-85 -81.08 146.7 30.47 Favored 'General case' 0 CA--C 1.52 -0.175 0 N-CA-C 107.817 -1.179 . . . . 0.0 107.817 168.4 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 12.5 m -80.55 9.24 0.82 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 C-N-CA 123.722 0.809 . . . . 0.0 112.386 177.225 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -177.81 170.29 42.56 Favored Glycine 0 CA--C 1.524 0.644 0 N-CA-C 110.271 -1.132 . . . . 0.0 110.271 179.42 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -65.07 137.82 57.93 Favored 'General case' 0 N--CA 1.465 0.305 0 C-N-CA 123.326 0.65 . . . . 0.0 111.295 -176.3 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -93.76 122.84 36.65 Favored 'General case' 0 N--CA 1.444 -0.737 0 C-N-CA 126.229 1.812 . . . . 0.0 109.717 176.447 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 86.5 mt . . . . . 0 C--N 1.332 -0.177 0 N-CA-C 106.096 -1.816 . . . . 0.0 106.096 168.209 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 48.6 m . . . . . 0 CA--C 1.53 0.197 0 CA-C-O 119.417 -0.325 . . . . 0.0 110.829 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -60.87 -40.99 95.07 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 118.105 0.412 . . . . 0.0 110.902 174.593 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 -67.43 -50.37 59.65 Favored 'General case' 0 C--O 1.234 0.271 0 C-N-CA 124.614 1.165 . . . . 0.0 110.376 179.662 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 60.4 mtm180 -58.16 -41.46 83.85 Favored 'General case' 0 N--CA 1.463 0.214 0 C-N-CA 123.969 0.908 . . . . 0.0 109.734 -179.042 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 56.2 mt -69.47 -54.18 20.99 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.441 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 176.074 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 70.0 tp60 -52.78 -62.33 1.72 Allowed 'General case' 0 C--O 1.234 0.273 0 C-N-CA 124.546 1.139 . . . . 0.0 111.854 -171.767 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 20.0 m -66.13 -32.28 73.64 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 120.758 -0.377 . . . . 0.0 110.89 -169.493 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 160' ' ' TRP . . . . . 0.415 ' CH2' ' HB1' ' A' ' 83' ' ' ALA . 40.1 t90 -70.75 -43.84 68.0 Favored 'General case' 0 C--O 1.222 -0.386 0 O-C-N 121.99 -0.444 . . . . 0.0 111.267 176.553 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 67.2 m -58.31 -44.65 88.67 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 118.215 0.461 . . . . 0.0 110.173 176.917 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -62.45 -40.93 98.19 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-O 121.009 0.433 . . . . 0.0 110.153 176.752 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 13.6 tt0 -63.03 -52.85 61.23 Favored 'General case' 0 N--CA 1.447 -0.584 0 CA-C-O 118.732 -0.651 . . . . 0.0 110.036 -179.632 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 41.8 pt -63.43 -38.54 82.46 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.345 0 CA-C-O 117.973 -1.013 . . . . 0.0 109.185 -175.37 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -66.67 -32.82 74.38 Favored 'General case' 0 CA--C 1.529 0.152 0 CA-C-N 119.385 0.993 . . . . 0.0 110.414 -178.622 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 31.7 m-80 -68.66 -59.02 3.41 Favored 'General case' 0 CA--C 1.516 -0.352 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 173.303 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 16.2 tt0 -61.04 -37.9 84.22 Favored 'General case' 0 N--CA 1.441 -0.916 0 C-N-CA 125.895 1.678 . . . . 0.0 111.482 -168.904 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 168' ' ' MET . . . . . . . . . . . . . 19.9 ptp -70.06 -30.03 67.19 Favored 'General case' 0 C--N 1.333 -0.131 0 O-C-N 121.442 -0.786 . . . . 0.0 112.23 174.814 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -77.28 -38.52 50.66 Favored 'General case' 0 N--CA 1.446 -0.627 0 C-N-CA 123.126 0.57 . . . . 0.0 112.249 178.658 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 . . . . . 0 N--CA 1.468 0.439 0 CA-C-O 121.907 0.86 . . . . 0.0 109.698 -179.276 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.498 1.932 0 N-CA-C 111.684 0.253 . . . . 0.0 111.684 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 5.8 t30 -113.53 153.08 29.34 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 124.294 1.037 . . . . 0.0 109.297 177.333 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 15.9 mtt -113.7 129.34 56.59 Favored 'General case' 0 N--CA 1.462 0.128 0 C-N-CA 123.802 0.841 . . . . 0.0 110.137 -179.471 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -83.86 150.7 26.78 Favored Glycine 0 CA--C 1.526 0.721 0 N-CA-C 107.43 -2.268 . . . . 0.0 107.43 167.215 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 2.0 tt -138.33 99.15 3.77 Favored 'General case' 0 N--CA 1.467 0.39 0 N-CA-C 105.63 -1.989 . . . . 0.0 105.63 -177.821 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 1.1 p90 -105.18 147.78 27.63 Favored 'General case' 0 CA--C 1.519 -0.229 0 CA-C-N 118.592 0.633 . . . . 0.0 112.028 -171.372 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 43.0 p90 . . . . . 0 CA--C 1.536 0.442 0 C-N-CA 126.077 1.751 . . . . 0.0 107.728 170.483 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.224 -0.24 0 N-CA-C 109.076 -0.712 . . . . 0.0 109.076 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -62.74 -47.7 82.44 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 123.944 0.898 . . . . 0.0 111.381 -174.261 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 31.2 mt-10 -57.98 -44.82 87.35 Favored 'General case' 0 CA--C 1.518 -0.267 0 C-N-CA 123.202 0.601 . . . . 0.0 109.556 175.179 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 49.9 mttm -64.91 -47.54 77.41 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-O 118.796 -0.621 . . . . 0.0 110.484 -177.623 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 83.3 mt -53.12 -55.06 14.08 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.2 0 CA-C-N 118.897 0.771 . . . . 0.0 109.307 -178.812 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.475 ' HG2' HD21 ' A' ' 32' ' ' LEU . 0.0 OUTLIER -66.58 -35.06 79.29 Favored 'General case' 0 CA--C 1.513 -0.461 0 CA-C-O 118.812 -0.613 . . . . 0.0 111.313 -175.434 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -64.46 -39.9 94.69 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.997 0.427 . . . . 0.0 110.563 178.194 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 61.1 mt -78.01 -54.76 11.78 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.786 0 C-N-CA 124.77 1.228 . . . . 0.0 110.236 -171.092 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 71.3 mt -64.16 -46.22 94.17 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.326 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 179.257 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 141.98 124.1 1.93 Allowed Glycine 0 CA--C 1.528 0.898 0 C-N-CA 124.632 1.111 . . . . 0.0 110.969 173.528 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -69.94 -13.61 34.45 Favored 'Trans proline' 0 CA--C 1.539 0.738 0 C-N-CA 122.982 2.455 . . . . 0.0 112.836 -173.288 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -73.48 -21.42 60.43 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 118.509 0.595 . . . . 0.0 111.928 177.701 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -130.53 3.44 4.6 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 124.459 1.104 . . . . 0.0 113.535 -169.692 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 44.9 t -123.74 142.09 41.69 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.241 0 N-CA-C 107.62 -1.252 . . . . 0.0 107.62 171.262 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 30.5 m -129.27 132.48 47.19 Favored 'General case' 0 C--N 1.332 -0.182 0 C-N-CA 124.703 1.201 . . . . 0.0 108.427 -175.771 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.475 HD21 ' HG2' ' A' ' 22' ' ' ARG . 27.7 mt -75.25 135.73 40.97 Favored 'General case' 0 N--CA 1.456 -0.161 0 N-CA-C 107.999 -1.111 . . . . 0.0 107.999 175.432 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 28.5 t-80 -126.19 59.48 1.33 Allowed 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 125.148 1.379 . . . . 0.0 107.416 -176.811 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 33.3 t30 -69.55 113.26 6.67 Favored 'General case' 0 C--O 1.235 0.307 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 -176.296 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 77.6 mt -69.0 -14.89 63.31 Favored 'General case' 0 C--O 1.234 0.289 0 N-CA-C 112.554 0.576 . . . . 0.0 112.554 -171.775 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 1.3 tmtm? -58.81 -20.6 51.66 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 118.843 0.747 . . . . 0.0 111.173 168.82 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -128.03 -41.68 1.6 Allowed 'General case' 0 C--O 1.234 0.255 0 N-CA-C 113.287 0.847 . . . . 0.0 113.287 -175.801 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 30.5 m-20 -91.72 144.17 25.79 Favored 'General case' 0 C--O 1.235 0.301 0 C-N-CA 123.696 0.798 . . . . 0.0 111.07 -174.508 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 14.8 m -79.39 155.47 76.54 Favored Pre-proline 0 CA--C 1.539 0.551 0 C-N-CA 124.563 1.145 . . . . 0.0 110.258 176.361 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -76.93 -26.27 8.12 Favored 'Trans proline' 0 C--N 1.348 0.519 0 C-N-CA 122.232 1.955 . . . . 0.0 113.945 -171.082 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 8.2 mptt -62.64 -21.02 65.38 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 120.236 1.38 . . . . 0.0 111.8 -177.92 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -57.75 -29.74 65.04 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 125.865 1.666 . . . . 0.0 110.5 173.877 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 47.1 mtt -60.22 -26.21 66.23 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 118.763 0.71 . . . . 0.0 111.385 177.84 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 58.6 mt-10 -66.48 -33.51 75.85 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 118.714 0.688 . . . . 0.0 110.471 -176.651 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 24.3 mt-30 -63.77 -45.8 88.15 Favored 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 123.778 0.831 . . . . 0.0 112.868 -169.406 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 45.9 m-85 -76.24 136.02 39.67 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 115.393 -0.821 . . . . 0.0 109.473 -166.82 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -72.48 -30.19 64.31 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 118.865 0.757 . . . . 0.0 110.473 178.374 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 45.0 t -106.16 141.83 20.54 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.368 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 171.517 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 26.6 tp -136.82 118.46 14.95 Favored 'General case' 0 N--CA 1.446 -0.664 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 173.167 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 11.7 mt -93.61 133.48 34.54 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.829 0 N-CA-C 106.37 -1.715 . . . . 0.0 106.37 174.678 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 1.3 mp -111.23 134.07 53.1 Favored 'General case' 0 CA--C 1.518 -0.273 0 N-CA-C 106.703 -1.591 . . . . 0.0 106.703 -177.665 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -130.2 137.43 9.51 Favored Glycine 0 CA--C 1.518 0.257 0 N-CA-C 109.96 -1.256 . . . . 0.0 109.96 173.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 2.3 tt -151.57 133.86 8.45 Favored Pre-proline 0 CA--C 1.541 0.604 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 169.491 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_endo . . . . . 0 CA--C 1.538 0.703 0 C-N-CA 121.576 1.517 . . . . 0.0 114.521 -170.512 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 24.8 mt . . . . . 0 CA--C 1.542 0.635 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -93.27 161.61 14.33 Favored 'General case' 0 C--O 1.231 0.122 0 C-N-CA 124.313 1.045 . . . . 0.0 109.929 -178.724 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -54.56 -41.56 69.95 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 124.436 1.094 . . . . 0.0 111.63 -169.285 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 27.5 m-20 -59.71 -27.64 66.64 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-N 118.453 0.57 . . . . 0.0 112.026 -176.785 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' TRP . . . . . 0.464 ' CH2' HD23 ' A' ' 104' ' ' LEU . 4.5 t90 -96.49 -44.86 6.99 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 125.688 1.595 . . . . 0.0 109.479 -178.069 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -63.02 -36.72 84.51 Favored 'General case' 0 CA--C 1.53 0.199 0 O-C-N 121.013 -1.054 . . . . 0.0 110.221 -179.177 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -61.12 -25.57 67.07 Favored 'General case' 0 C--O 1.234 0.268 0 C-N-CA 123.356 0.662 . . . . 0.0 111.015 -177.481 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 23.5 m -106.41 -17.97 7.41 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.539 0 CA-C-O 116.581 -1.676 . . . . 0.0 112.535 176.402 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 18.2 t90 -54.99 -35.65 64.57 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 121.492 1.951 . . . . 0.0 110.995 -179.275 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -63.43 -28.92 70.31 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 125.249 1.42 . . . . 0.0 112.715 174.1 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 62.9 mt-30 -92.57 -25.37 18.37 Favored 'General case' 0 C--O 1.224 -0.287 0 C-N-CA 126.436 1.894 . . . . 0.0 111.31 -179.842 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 37.6 mt -64.16 -26.43 68.52 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 118.727 0.694 . . . . 0.0 110.361 179.927 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -76.59 -25.67 54.21 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 117.794 0.27 . . . . 0.0 110.824 171.463 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -79.55 -33.38 41.93 Favored 'General case' 0 CA--C 1.538 0.494 0 O-C-N 121.257 -0.902 . . . . 0.0 113.049 179.403 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 30.6 mt -56.37 148.67 18.35 Favored 'General case' 0 C--O 1.234 0.265 0 C-N-CA 124.75 1.22 . . . . 0.0 111.02 -177.876 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 20.5 t-20 -86.03 122.88 30.68 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 170.325 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 74.2 mt -130.43 8.78 5.06 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 123.622 0.769 . . . . 0.0 112.222 -173.328 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 29.1 mt-10 -53.52 128.46 29.02 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 124.038 0.935 . . . . 0.0 112.256 -168.418 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 68.13 -0.26 12.42 Favored Glycine 0 CA--C 1.533 1.195 0 C-N-CA 125.443 1.497 . . . . 0.0 115.293 177.92 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.92 149.71 43.17 Favored 'General case' 0 C--N 1.343 0.308 0 CA-C-N 120.388 2.094 . . . . 0.0 109.635 -173.178 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 3.1 mt -80.56 133.33 29.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 N-CA-C 106.596 -1.631 . . . . 0.0 106.596 179.916 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 79.8 t -129.3 140.06 50.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 C-N-CA 124.122 0.969 . . . . 0.0 109.877 -176.93 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -128.42 154.31 46.17 Favored 'General case' 0 CA--C 1.53 0.173 0 C-N-CA 124.809 1.244 . . . . 0.0 108.052 169.795 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 2.4 mt -132.08 131.68 42.62 Favored 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 124.744 1.218 . . . . 0.0 108.334 -171.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . 0.41 ' CD2' HD23 ' A' ' 142' ' ' LEU . 45.3 m-85 -130.28 141.93 50.58 Favored 'General case' 0 N--CA 1.451 -0.385 0 N-CA-C 106.643 -1.614 . . . . 0.0 106.643 -177.771 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -157.55 172.27 34.86 Favored Glycine 0 N--CA 1.442 -0.92 0 N-CA-C 108.965 -1.654 . . . . 0.0 108.965 168.502 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.324 -0.537 0 C-N-CA 124.527 1.131 . . . . 0.0 109.54 170.149 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 84.4 mt . . . . . 0 CA--C 1.537 0.47 0 N-CA-C 113.668 0.988 . . . . 0.0 113.668 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -56.51 -42.73 78.87 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 120.394 1.452 . . . . 0.0 112.592 -168.468 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -80.95 -14.87 57.57 Favored 'General case' 0 CA--C 1.534 0.329 0 N-CA-C 113.389 0.885 . . . . 0.0 113.389 179.786 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 6.6 tt -60.58 -43.55 97.2 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-N 120.056 1.298 . . . . 0.0 107.911 169.24 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -66.75 -32.7 82.03 Favored Glycine 0 C--N 1.337 0.595 0 N-CA-C 112.031 -0.428 . . . . 0.0 112.031 -175.52 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 77.2 mtm -72.37 -26.9 62.08 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-O 118.363 -0.827 . . . . 0.0 111.796 -175.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.464 HD23 ' CH2' ' A' ' 65' ' ' TRP . 0.2 OUTLIER -76.41 -43.17 41.6 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 120.365 1.439 . . . . 0.0 109.372 169.019 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 82.1 t60 -53.34 -47.98 68.9 Favored 'General case' 0 N--CA 1.467 0.393 0 O-C-N 121.758 -0.589 . . . . 0.0 110.974 179.632 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -62.68 -37.24 85.68 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 123.676 0.79 . . . . 0.0 112.682 -177.505 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 25.1 ttmm -58.41 -36.41 73.54 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 123.575 0.75 . . . . 0.0 110.484 172.485 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 24.0 mt -91.95 -20.14 21.69 Favored 'General case' 0 CA--C 1.513 -0.453 0 N-CA-C 115.95 1.833 . . . . 0.0 115.95 -168.158 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 3.2 m -58.28 -32.97 68.92 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 120.665 1.575 . . . . 0.0 111.632 -176.433 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 21.1 p -88.27 -10.66 48.89 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 125.23 1.412 . . . . 0.0 112.409 -179.883 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 32.4 mmmt -82.99 -9.25 59.37 Favored 'General case' 0 C--N 1.347 0.458 0 C-N-CA 124.494 1.117 . . . . 0.0 111.435 175.169 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 73.81 31.93 59.67 Favored Glycine 0 CA--C 1.525 0.663 0 CA-C-O 119.645 -0.531 . . . . 0.0 112.165 172.99 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 5.8 m -73.25 174.44 0.78 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.618 0 CA-C-N 118.219 1.009 . . . . 0.0 109.158 169.748 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -115.63 131.28 56.98 Favored 'General case' 0 CA--C 1.518 -0.265 0 N-CA-C 106.909 -1.515 . . . . 0.0 106.909 172.772 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 80.3 m-85 -96.48 148.29 22.96 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 119.677 1.126 . . . . 0.0 109.384 -179.722 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 31.3 m -126.37 163.91 27.47 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.263 0 C-N-CA 123.847 0.859 . . . . 0.0 109.799 172.006 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 86.91 -91.34 1.73 Allowed Glycine 0 N--CA 1.444 -0.817 0 C-N-CA 124.996 1.284 . . . . 0.0 112.292 172.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 16.8 m-30 59.68 170.49 0.08 Allowed 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 126.081 1.752 . . . . 0.0 110.251 -165.599 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -141.09 140.86 21.94 Favored Pre-proline 0 N--CA 1.471 0.58 0 O-C-N 120.442 -1.411 . . . . 0.0 109.479 174.033 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_exo -54.51 129.12 33.16 Favored 'Trans proline' 0 N--CA 1.456 -0.731 0 C-N-CA 122.622 2.215 . . . . 0.0 110.65 169.796 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 20.7 p . . . . . 0 N--CA 1.47 0.564 0 N-CA-C 112.465 0.542 . . . . 0.0 112.465 171.681 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 54.3 mttt . . . . . 0 CA--C 1.54 0.582 0 CA-C-O 117.717 -1.135 . . . . 0.0 112.256 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -86.07 11.75 3.23 Favored 'Trans proline' 0 C--N 1.35 0.642 0 C-N-CA 122.001 1.801 . . . . 0.0 113.742 -172.725 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 21.9 m -129.54 161.26 39.4 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.171 0 CA-C-N 120.629 1.559 . . . . 0.0 111.797 -175.155 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 21.5 pt -132.92 173.16 15.26 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.344 0 C-N-CA 127.151 2.18 . . . . 0.0 108.988 -179.788 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . 54.12 43.43 30.7 Favored 'General case' 0 N--CA 1.461 0.112 0 C-N-CA 125.406 1.482 . . . . 0.0 112.07 174.93 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 27.3 t0 54.0 43.44 30.79 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 126.609 1.964 . . . . 0.0 111.603 -176.785 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 87.6 29.5 21.3 Favored Glycine 0 CA--C 1.526 0.77 0 CA-C-O 118.207 -1.329 . . . . 0.0 113.635 171.559 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 47.3 mt-30 -95.54 -23.39 17.1 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 119.141 1.471 . . . . 0.0 113.201 179.201 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -138.79 141.0 38.78 Favored 'General case' 0 CA--C 1.513 -0.477 0 CA-C-N 119.641 1.11 . . . . 0.0 110.56 176.026 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 67.5 m-85 -76.98 138.27 39.52 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 105.106 -2.183 . . . . 0.0 105.106 164.257 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 25.7 m -76.74 4.43 1.17 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.643 0 C-N-CA 123.188 0.595 . . . . 0.0 112.067 -177.945 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -168.5 -174.19 37.01 Favored Glycine 0 CA--C 1.523 0.537 0 C-N-CA 125.742 1.639 . . . . 0.0 109.16 -175.806 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 0.41 HD23 ' CD2' ' A' ' 85' ' ' TYR . 29.4 tp -75.06 140.95 43.86 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 122.892 0.477 . . . . 0.0 111.722 -171.739 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -89.43 132.71 34.87 Favored 'General case' 0 N--CA 1.447 -0.586 0 C-N-CA 125.876 1.67 . . . . 0.0 109.081 169.2 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 89.9 mt . . . . . 0 N--CA 1.467 0.425 0 N-CA-C 106.643 -1.614 . . . . 0.0 106.643 172.222 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 47.9 m . . . . . 0 CA--C 1.538 0.507 0 N-CA-C 109.745 -0.465 . . . . 0.0 109.745 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -60.12 -44.59 94.78 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 123.431 0.693 . . . . 0.0 110.497 174.154 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 27.3 tt0 -58.46 -46.89 85.68 Favored 'General case' 0 C--O 1.231 0.09 0 C-N-CA 124.171 0.989 . . . . 0.0 110.435 174.367 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.29 -46.24 86.45 Favored 'General case' 0 C--O 1.225 -0.224 0 CA-C-O 117.959 -1.019 . . . . 0.0 109.554 179.023 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 47.6 mt -60.45 -52.44 61.4 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.233 0 CA-C-N 119.687 1.131 . . . . 0.0 108.038 176.928 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 72.7 tp60 -53.29 -65.11 0.62 Allowed 'General case' 0 C--O 1.232 0.155 0 CA-C-N 119.23 0.923 . . . . 0.0 112.073 -177.151 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 19.9 m -68.75 -32.36 72.07 Favored 'General case' 0 C--N 1.325 -0.489 0 C-N-CA 121.4 -0.12 . . . . 0.0 111.309 -168.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 160' ' ' TRP . . . . . . . . . . . . . 2.8 t90 -73.13 -41.77 63.6 Favored 'General case' 0 C--O 1.221 -0.423 0 CA-C-O 118.977 -0.535 . . . . 0.0 110.618 177.465 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 23.2 m -55.47 -47.84 75.47 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 118.519 0.599 . . . . 0.0 110.343 173.387 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 162' ' ' GLU . . . . . 0.4 ' HA ' HD23 ' A' ' 165' ' ' LEU . 40.3 mt-10 -60.3 -43.36 96.38 Favored 'General case' 0 C--N 1.332 -0.156 0 N-CA-C 109.681 -0.488 . . . . 0.0 109.681 178.752 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 15.0 tt0 -63.29 -51.71 64.96 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-O 117.904 -1.046 . . . . 0.0 110.383 -178.182 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 39.7 pt -64.15 -33.06 60.01 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.412 0 CA-C-O 118.127 -0.94 . . . . 0.0 109.441 -175.829 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . 0.4 HD23 ' HA ' ' A' ' 162' ' ' GLU . 0.3 OUTLIER -72.82 -31.45 64.82 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 119.395 0.998 . . . . 0.0 108.856 -174.375 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -71.53 -52.1 20.04 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 124.692 1.197 . . . . 0.0 109.084 173.277 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -67.7 -35.3 78.56 Favored 'General case' 0 N--CA 1.441 -0.883 0 C-N-CA 125.78 1.632 . . . . 0.0 109.425 -169.485 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 168' ' ' MET . . . . . . . . . . . . . 21.5 ptp -73.03 -29.11 62.76 Favored 'General case' 0 C--N 1.333 -0.128 0 O-C-N 122.28 -0.262 . . . . 0.0 111.583 176.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -75.62 -36.56 60.21 Favored 'General case' 0 N--CA 1.444 -0.726 0 CA-C-O 119.16 -0.448 . . . . 0.0 111.779 178.2 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 5.8 mt-10 . . . . . 0 N--CA 1.466 0.332 0 CA-C-O 122.248 1.023 . . . . 0.0 109.275 178.486 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.498 1.964 0 CA-C-O 120.322 0.106 . . . . 0.0 111.197 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 24.8 p-10 -120.61 165.95 14.33 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 125.082 1.353 . . . . 0.0 111.512 -175.333 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 11.9 mtt -130.27 133.91 46.84 Favored 'General case' 0 CA--C 1.52 -0.195 0 C-N-CA 123.361 0.665 . . . . 0.0 110.507 175.625 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -100.48 142.42 15.84 Favored Glycine 0 CA--C 1.523 0.559 0 N-CA-C 106.769 -2.532 . . . . 0.0 106.769 167.538 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 2.2 tt -128.22 101.15 6.12 Favored 'General case' 0 CA--C 1.518 -0.252 0 N-CA-C 105.852 -1.907 . . . . 0.0 105.852 -172.899 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -102.49 144.26 31.16 Favored 'General case' 0 N--CA 1.455 -0.216 0 CA-C-O 121.588 0.709 . . . . 0.0 111.672 -173.809 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 43.7 p90 . . . . . 0 CA--C 1.537 0.478 0 C-N-CA 127.04 2.136 . . . . 0.0 106.489 175.0 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.462 0.168 0 N-CA-C 109.03 -0.729 . . . . 0.0 109.03 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -64.02 -47.45 80.22 Favored 'General case' 0 N--CA 1.455 -0.19 0 C-N-CA 122.921 0.489 . . . . 0.0 111.54 -175.276 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 10.2 mt-10 -60.95 -42.99 99.33 Favored 'General case' 0 CA--C 1.517 -0.309 0 CA-C-O 118.903 -0.57 . . . . 0.0 109.949 176.678 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 29.3 mtpp -71.14 -40.67 71.22 Favored 'General case' 0 C--O 1.221 -0.435 0 CA-C-O 118.057 -0.973 . . . . 0.0 110.775 -174.132 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 47.6 mt -53.81 -54.27 20.92 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.267 0 CA-C-N 120.014 1.279 . . . . 0.0 108.818 173.07 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 8.5 ttp180 -60.56 -41.07 93.82 Favored 'General case' 0 C--O 1.223 -0.298 0 C-N-CA 123.397 0.679 . . . . 0.0 109.65 -176.703 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -66.74 -41.17 88.25 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 122.945 0.498 . . . . 0.0 111.066 -178.894 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.617 HD13 ' HA ' ' A' ' 158' ' ' GLN . 41.0 mt -68.76 -56.18 13.13 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.57 0 C-N-CA 124.345 1.058 . . . . 0.0 109.691 -175.61 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 79.0 mt -67.89 -44.23 85.4 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.428 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 -175.649 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 138.55 125.39 2.32 Favored Glycine 0 CA--C 1.53 1.022 0 C-N-CA 125.061 1.315 . . . . 0.0 111.493 173.22 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -71.95 -6.21 18.66 Favored 'Trans proline' 0 CA--C 1.537 0.666 0 C-N-CA 123.505 2.803 . . . . 0.0 114.044 -175.674 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -80.15 -18.63 49.23 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 119.232 0.924 . . . . 0.0 111.241 175.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -128.66 -10.1 5.03 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 124.532 1.133 . . . . 0.0 113.994 -173.803 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 31.5 t -106.97 150.07 9.84 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.352 0 CA-C-N 119.375 0.989 . . . . 0.0 108.346 170.702 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 2.7 m -137.23 130.97 31.74 Favored 'General case' 0 N--CA 1.456 -0.174 0 N-CA-C 106.599 -1.63 . . . . 0.0 106.599 -172.909 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 21.3 mt -80.46 143.71 33.16 Favored 'General case' 0 CA--C 1.53 0.202 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 176.916 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . 0.465 ' HE2' ' HB2' ' A' ' 42' ' ' LEU . 39.0 t-80 -136.77 64.88 1.53 Allowed 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 124.451 1.1 . . . . 0.0 108.195 -174.554 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 64.4 t-20 -72.39 119.12 16.15 Favored 'General case' 0 CA--C 1.53 0.193 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 -178.407 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 81.9 mt -66.06 -18.31 65.26 Favored 'General case' 0 C--O 1.233 0.206 0 C-N-CA 123.782 0.833 . . . . 0.0 112.918 -176.839 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 28.3 tptp -55.35 -27.12 45.19 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-O 118.879 -0.581 . . . . 0.0 111.156 168.654 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -121.47 -41.45 2.49 Favored 'General case' 0 N--CA 1.464 0.271 0 N-CA-C 113.549 0.944 . . . . 0.0 113.549 -173.856 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 29.6 m-20 -96.53 142.29 28.78 Favored 'General case' 0 C--O 1.234 0.276 0 C-N-CA 123.334 0.654 . . . . 0.0 110.702 -176.151 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 14.0 m -75.97 156.27 84.31 Favored Pre-proline 0 CA--C 1.542 0.646 0 C-N-CA 124.181 0.992 . . . . 0.0 109.986 173.632 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo -77.27 -25.1 8.79 Favored 'Trans proline' 0 C--N 1.348 0.533 0 C-N-CA 122.212 1.941 . . . . 0.0 113.312 -169.785 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 23.7 mmmt -69.38 -15.26 63.27 Favored 'General case' 0 N--CA 1.474 0.758 0 O-C-N 120.512 -1.368 . . . . 0.0 111.693 -176.029 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.465 ' HB2' ' HE2' ' A' ' 33' ' ' HIS . 2.1 mm? -62.01 -26.82 68.46 Favored 'General case' 0 N--CA 1.464 0.263 0 C-N-CA 125.555 1.542 . . . . 0.0 110.603 169.426 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 51.3 mtt -58.99 -25.29 63.5 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 119.207 0.912 . . . . 0.0 111.48 177.308 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -64.06 -31.83 73.17 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 118.395 0.543 . . . . 0.0 110.127 -176.535 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 27.3 mt-30 -67.05 -38.79 86.46 Favored 'General case' 0 CA--C 1.534 0.364 0 N-CA-C 113.302 0.852 . . . . 0.0 113.302 -170.873 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 61.0 m-85 -76.08 136.25 39.88 Favored 'General case' 0 CA--C 1.52 -0.202 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 -167.49 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -71.84 -37.75 70.23 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-N 118.281 0.491 . . . . 0.0 110.576 -178.349 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 15.4 t -107.22 144.95 15.26 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.364 0 N-CA-C 107.52 -1.289 . . . . 0.0 107.52 169.003 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 28.8 tp -132.97 120.29 21.22 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 175.098 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 48.3 mt -99.41 129.25 50.19 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.606 0 N-CA-C 106.47 -1.678 . . . . 0.0 106.47 179.774 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -110.13 132.47 54.14 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 125.539 1.536 . . . . 0.0 107.793 -175.342 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -138.44 138.73 9.71 Favored Glycine 0 C--N 1.332 0.346 0 N-CA-C 109.821 -1.312 . . . . 0.0 109.821 178.233 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.427 HD12 ' CD2' ' A' ' 65' ' ' TRP . 3.9 tt -155.75 133.46 6.75 Favored Pre-proline 0 CA--C 1.535 0.37 0 CA-C-N 117.555 0.677 . . . . 0.0 111.164 172.805 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_exo . . . . . 0 N--CA 1.456 -0.704 0 C-N-CA 122.376 2.051 . . . . 0.0 109.197 164.06 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 12.8 mt . . . . . 0 CA--C 1.543 0.682 0 CA-C-O 121.581 0.705 . . . . 0.0 112.289 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 4.1 mp0 -72.59 153.99 41.0 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 124.836 1.254 . . . . 0.0 109.828 179.421 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -59.07 -42.84 91.35 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 123.338 0.655 . . . . 0.0 111.593 -170.255 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -60.54 -24.67 65.55 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 123.591 0.757 . . . . 0.0 111.95 -177.639 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' TRP . . . . . 0.433 ' CH2' HD22 ' A' ' 104' ' ' LEU . 1.8 t90 -96.04 -42.63 8.16 Favored 'General case' 0 N--CA 1.447 -0.588 0 C-N-CA 124.695 1.198 . . . . 0.0 109.773 -178.425 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 7.8 tt0 -63.14 -33.86 76.38 Favored 'General case' 0 N--CA 1.446 -0.665 0 O-C-N 120.749 -1.219 . . . . 0.0 109.868 178.708 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -55.82 -24.65 37.47 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 124.333 1.053 . . . . 0.0 111.965 -179.497 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 35.3 m -116.84 -11.42 11.81 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.171 0 CA-C-O 117.596 -1.192 . . . . 0.0 113.179 178.245 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 25.0 t90 -52.87 -38.28 61.41 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 119.959 1.254 . . . . 0.0 110.435 -178.891 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -64.6 -27.11 68.72 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 125.361 1.464 . . . . 0.0 113.303 177.041 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 30.0 mt-30 -92.6 -19.41 21.93 Favored 'General case' 0 C--N 1.342 0.244 0 C-N-CA 125.309 1.443 . . . . 0.0 112.617 178.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 60.1 mt -59.55 -25.94 64.96 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 118.633 0.651 . . . . 0.0 111.137 -178.414 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -77.1 -25.15 51.92 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 118.085 0.402 . . . . 0.0 111.626 176.704 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -72.98 -29.98 63.47 Favored 'General case' 0 N--CA 1.467 0.376 0 O-C-N 121.058 -1.026 . . . . 0.0 111.828 178.866 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 76.5 mt -53.62 139.86 30.65 Favored 'General case' 0 C--N 1.341 0.218 0 C-N-CA 125.016 1.326 . . . . 0.0 112.289 -169.008 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 28.8 t-20 -77.2 107.44 9.6 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 169.707 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 65.2 mt -127.6 1.48 6.18 Favored 'General case' 0 N--CA 1.474 0.734 0 N-CA-C 113.912 1.079 . . . . 0.0 113.912 -173.237 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -51.87 129.16 26.04 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-N 119.228 0.922 . . . . 0.0 111.482 -168.442 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 70.63 -2.0 18.69 Favored Glycine 0 CA--C 1.535 1.326 0 C-N-CA 125.935 1.731 . . . . 0.0 115.972 177.523 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.05 151.85 38.67 Favored 'General case' 0 C--N 1.344 0.366 0 CA-C-N 121.002 2.401 . . . . 0.0 110.53 -172.097 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 6.7 mt -81.1 137.49 21.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 N-CA-C 106.676 -1.601 . . . . 0.0 106.676 178.849 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 78.0 t -134.68 136.4 52.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 C-N-CA 123.729 0.812 . . . . 0.0 110.235 -174.365 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -110.82 150.77 28.67 Favored 'General case' 0 N--CA 1.468 0.45 0 N-CA-C 107.878 -1.156 . . . . 0.0 107.878 169.257 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 2.8 mt -130.87 136.54 48.72 Favored 'General case' 0 CA--C 1.51 -0.562 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 174.603 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 43.6 p90 -147.42 166.82 26.06 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 168.669 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -162.46 160.03 32.27 Favored Glycine 0 N--CA 1.447 -0.582 0 N-CA-C 109.811 -1.316 . . . . 0.0 109.811 172.416 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 4.1 tt . . . . . 0 N--CA 1.448 -0.553 0 C-N-CA 125.457 1.503 . . . . 0.0 108.001 173.934 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 80.2 mt . . . . . 0 N--CA 1.468 0.433 0 N-CA-C 110.111 -0.329 . . . . 0.0 110.111 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -59.78 -33.77 72.14 Favored 'General case' 0 N--CA 1.467 0.376 0 O-C-N 120.581 -1.325 . . . . 0.0 111.944 -171.415 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . 0.421 ' HB1' HD13 ' A' ' 53' ' ' ILE . . . -73.45 -27.92 61.68 Favored 'General case' 0 CA--C 1.535 0.367 0 O-C-N 121.234 -0.916 . . . . 0.0 112.44 177.268 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 4.4 tt -60.67 -47.06 87.93 Favored 'General case' 0 N--CA 1.467 0.419 0 N-CA-C 107.458 -1.312 . . . . 0.0 107.458 169.065 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -62.31 -42.03 99.72 Favored Glycine 0 C--N 1.339 0.715 0 N-CA-C 111.44 -0.664 . . . . 0.0 111.44 -178.925 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 76.3 mtm -63.96 -38.37 90.82 Favored 'General case' 0 CA--C 1.529 0.166 0 CA-C-N 118.182 0.991 . . . . 0.0 111.726 179.564 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.433 HD22 ' CH2' ' A' ' 65' ' ' TRP . 4.2 tp -71.61 -35.45 70.48 Favored 'General case' 0 C--N 1.345 0.373 0 CA-C-N 120.247 1.385 . . . . 0.0 110.341 178.885 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' HIS . . . . . 0.415 ' CG ' HG21 ' A' ' 140' ' ' VAL . 0.2 OUTLIER -54.56 -51.65 64.55 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 118.899 0.772 . . . . 0.0 110.283 169.132 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -64.47 -42.77 95.71 Favored 'General case' 0 C--O 1.233 0.229 0 C-N-CA 122.754 0.422 . . . . 0.0 111.466 -172.289 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 22.5 ttmm -58.43 -39.36 79.6 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 123.897 0.879 . . . . 0.0 110.655 173.225 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 52.0 mt -87.11 -22.23 25.51 Favored 'General case' 0 CA--C 1.517 -0.29 0 N-CA-C 114.152 1.167 . . . . 0.0 114.152 -169.454 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 8.3 t -56.95 -36.24 70.03 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-N 119.393 0.997 . . . . 0.0 110.879 -175.673 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 21.1 p -86.21 -8.1 58.04 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 124.581 1.152 . . . . 0.0 112.2 -178.298 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 32.4 mmmt -83.15 -8.32 59.51 Favored 'General case' 0 C--N 1.346 0.441 0 C-N-CA 124.573 1.149 . . . . 0.0 111.709 175.393 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 74.7 29.11 61.85 Favored Glycine 0 CA--C 1.526 0.777 0 CA-C-N 118.424 0.557 . . . . 0.0 112.462 173.343 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 17.1 m -75.23 176.44 0.64 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 CA-C-N 117.957 0.879 . . . . 0.0 109.989 171.887 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -121.54 125.95 48.01 Favored 'General case' 0 CA--C 1.52 -0.208 0 N-CA-C 106.918 -1.512 . . . . 0.0 106.918 174.442 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 79.5 m-85 -89.5 145.03 25.57 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 119.562 1.074 . . . . 0.0 109.337 -178.649 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 27.3 m -126.68 157.86 37.41 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.212 0 C-N-CA 124.237 1.015 . . . . 0.0 109.084 171.149 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 95.38 -88.4 1.09 Allowed Glycine 0 C--N 1.333 0.364 0 CA-C-O 119.109 -0.829 . . . . 0.0 111.259 173.185 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 22.0 m-30 57.56 -173.49 0.08 Allowed 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 124.104 0.961 . . . . 0.0 110.446 -168.735 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -153.96 146.3 17.33 Favored Pre-proline 0 N--CA 1.473 0.69 0 CA-C-N 120.359 1.436 . . . . 0.0 109.656 178.952 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_endo -67.71 124.42 11.91 Favored 'Trans proline' 0 CA--C 1.535 0.568 0 C-N-CA 122.959 2.439 . . . . 0.0 112.121 178.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 2.9 p . . . . . 0 CA--C 1.538 0.51 0 O-C-N 121.507 -0.746 . . . . 0.0 112.296 171.958 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 7.6 ttmt . . . . . 0 CA--C 1.542 0.647 0 CA-C-O 117.441 -1.266 . . . . 0.0 113.929 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_endo -77.41 5.81 4.86 Favored 'Trans proline' 0 C--N 1.352 0.752 0 CA-C-N 122.012 1.754 . . . . 0.0 114.385 179.154 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 26.9 m -132.02 169.58 21.56 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.215 0 CA-C-N 120.411 1.459 . . . . 0.0 110.434 -176.844 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 23.0 pt -138.49 171.97 14.5 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.507 0 C-N-CA 126.768 2.027 . . . . 0.0 108.594 -177.606 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . 54.76 41.27 32.05 Favored 'General case' 0 CA--C 1.528 0.106 0 C-N-CA 125.081 1.352 . . . . 0.0 112.46 174.302 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 27.3 t70 55.7 42.15 29.63 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 126.187 1.795 . . . . 0.0 111.734 -176.121 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 88.19 15.6 60.46 Favored Glycine 0 CA--C 1.528 0.891 0 CA-C-O 118.93 -0.928 . . . . 0.0 113.679 174.446 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 45.4 mt-30 -88.46 -7.59 56.31 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 118.934 1.367 . . . . 0.0 112.524 -179.06 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 8.3 tp -155.44 146.05 22.13 Favored 'General case' 0 C--N 1.344 0.35 0 CA-C-N 119.241 0.928 . . . . 0.0 110.291 172.304 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 58.4 m-85 -76.9 144.1 39.14 Favored 'General case' 0 CA--C 1.514 -0.425 0 N-CA-C 107.472 -1.307 . . . . 0.0 107.472 169.294 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . 0.415 HG21 ' CG ' ' A' ' 105' ' ' HIS . 4.4 p -82.23 14.1 0.52 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.573 0 CA-C-O 121.159 0.504 . . . . 0.0 112.13 -179.6 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 178.47 172.42 42.83 Favored Glycine 0 CA--C 1.525 0.685 0 N-CA-C 110.009 -1.237 . . . . 0.0 110.009 176.623 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 1.1 tp -65.79 138.04 57.65 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 117.631 0.715 . . . . 0.0 110.883 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -98.89 114.38 26.96 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 125.941 1.697 . . . . 0.0 110.178 -179.931 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 3.9 mm? . . . . . 0 CA--C 1.537 0.457 0 N-CA-C 106.386 -1.709 . . . . 0.0 106.386 166.945 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 21.9 m . . . . . 0 CA--C 1.534 0.328 0 N-CA-C 110.283 -0.266 . . . . 0.0 110.283 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -61.23 -40.43 93.98 Favored 'General case' 0 N--CA 1.463 0.179 0 O-C-N 121.917 -0.489 . . . . 0.0 110.884 172.19 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 -65.95 -47.4 74.78 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 124.106 0.962 . . . . 0.0 110.505 179.396 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 75.5 mtt-85 -52.2 -46.01 65.44 Favored 'General case' 0 N--CA 1.463 0.19 0 C-N-CA 124.509 1.124 . . . . 0.0 110.397 176.415 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 30.6 mt -70.37 -53.71 21.7 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 N-CA-C 107.847 -1.168 . . . . 0.0 107.847 179.302 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 158' ' ' GLN . . . . . 0.617 ' HA ' HD13 ' A' ' 24' ' ' ILE . 68.7 tp60 -49.66 -64.77 0.71 Allowed 'General case' 0 C--O 1.233 0.22 0 C-N-CA 125.569 1.548 . . . . 0.0 112.202 -174.132 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 20.1 m -67.8 -31.86 72.02 Favored 'General case' 0 C--N 1.324 -0.512 0 C-N-CA 120.924 -0.31 . . . . 0.0 110.768 -169.075 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 160' ' ' TRP . . . . . . . . . . . . . 36.2 t90 -68.86 -44.2 73.83 Favored 'General case' 0 C--O 1.221 -0.407 0 O-C-N 122.128 -0.357 . . . . 0.0 110.914 176.455 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 87.8 m -60.68 -42.53 97.3 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 122.889 0.476 . . . . 0.0 110.636 177.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 162' ' ' GLU . . . . . 0.423 ' HA ' HD23 ' A' ' 165' ' ' LEU . 39.9 mt-10 -63.35 -40.95 98.68 Favored 'General case' 0 CA--C 1.529 0.148 0 CA-C-O 121.481 0.658 . . . . 0.0 110.041 175.153 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 13.7 tt0 -64.67 -49.08 72.35 Favored 'General case' 0 N--CA 1.451 -0.419 0 O-C-N 121.375 -0.828 . . . . 0.0 110.735 -178.798 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 45.7 pt -64.6 -38.88 83.78 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.348 0 CA-C-O 118.089 -0.958 . . . . 0.0 109.62 -176.265 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . 0.423 HD23 ' HA ' ' A' ' 162' ' ' GLU . 0.3 OUTLIER -64.93 -32.59 74.39 Favored 'General case' 0 CA--C 1.53 0.176 0 CA-C-N 118.913 0.779 . . . . 0.0 110.229 179.698 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 29.6 m-80 -67.71 -60.69 2.33 Favored 'General case' 0 C--O 1.221 -0.444 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 172.523 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -53.21 -43.93 67.62 Favored 'General case' 0 N--CA 1.441 -0.89 0 C-N-CA 126.965 2.106 . . . . 0.0 111.168 -171.247 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 168' ' ' MET . . . . . . . . . . . . . 19.7 ptp -70.92 -31.68 68.36 Favored 'General case' 0 C--N 1.333 -0.151 0 N-CA-C 112.143 0.423 . . . . 0.0 112.143 179.244 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -75.35 -35.28 61.19 Favored 'General case' 0 N--CA 1.445 -0.723 0 N-CA-C 111.74 0.274 . . . . 0.0 111.74 177.918 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 . . . . . 0 N--CA 1.467 0.387 0 CA-C-O 121.579 0.704 . . . . 0.0 109.581 178.634 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.498 1.971 0 N-CA-C 111.108 0.04 . . . . 0.0 111.108 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 19.3 p-10 -128.68 163.83 24.25 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 124.843 1.257 . . . . 0.0 111.49 -171.948 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 10.2 mtt -129.15 133.19 47.5 Favored 'General case' 0 CA--C 1.521 -0.153 0 C-N-CA 123.385 0.674 . . . . 0.0 111.418 179.118 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -98.43 147.24 18.48 Favored Glycine 0 CA--C 1.53 1.007 0 N-CA-C 106.395 -2.682 . . . . 0.0 106.395 166.718 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 1.2 tt -133.67 96.7 3.74 Favored 'General case' 0 N--CA 1.465 0.315 0 N-CA-C 105.573 -2.01 . . . . 0.0 105.573 -173.028 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -97.36 146.75 24.87 Favored 'General case' 0 CA--C 1.514 -0.419 0 CA-C-N 118.03 0.377 . . . . 0.0 111.109 -173.635 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 34.2 p90 . . . . . 0 C--N 1.33 -0.268 0 C-N-CA 124.471 1.108 . . . . 0.0 109.518 176.7 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.224 -0.264 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -61.99 -46.52 88.86 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 118.443 0.565 . . . . 0.0 111.133 -175.49 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -59.54 -48.22 82.5 Favored 'General case' 0 N--CA 1.451 -0.398 0 C-N-CA 124.379 1.072 . . . . 0.0 110.11 176.479 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 28.8 mtpp -68.99 -37.76 78.93 Favored 'General case' 0 C--O 1.224 -0.253 0 CA-C-O 117.992 -1.004 . . . . 0.0 111.033 -175.22 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 63.1 mt -54.21 -57.75 5.28 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.199 0 CA-C-N 119.712 1.142 . . . . 0.0 108.471 175.652 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 15.1 ptt180 -62.84 -39.14 93.46 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-O 118.834 -0.603 . . . . 0.0 110.067 -177.149 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -65.38 -39.18 91.95 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 118.339 0.518 . . . . 0.0 110.358 -173.673 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 62.9 mt -76.62 -52.61 16.82 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.699 0 C-N-CA 124.886 1.274 . . . . 0.0 110.091 -175.855 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 64.1 mt -60.55 -47.54 92.36 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.336 0 C-N-CA 123.025 0.53 . . . . 0.0 109.841 179.283 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 139.61 113.97 1.14 Allowed Glycine 0 CA--C 1.525 0.66 0 C-N-CA 125.656 1.598 . . . . 0.0 109.258 -179.113 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -72.87 -7.93 21.52 Favored 'Trans proline' 0 CA--C 1.537 0.666 0 C-N-CA 122.509 2.139 . . . . 0.0 113.423 -169.599 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -77.39 -20.57 54.5 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 118.934 0.788 . . . . 0.0 111.57 178.726 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -122.37 7.59 9.61 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 124.886 1.275 . . . . 0.0 113.383 -173.49 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 45.4 t -124.28 148.77 28.42 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.231 0 C-N-CA 124.924 1.29 . . . . 0.0 107.713 175.596 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 7.8 m -134.11 133.27 40.89 Favored 'General case' 0 C--N 1.331 -0.211 0 C-N-CA 124.959 1.303 . . . . 0.0 108.045 -175.861 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 21.8 mt -78.62 139.31 38.57 Favored 'General case' 0 C--O 1.232 0.158 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 175.695 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 36.0 t-80 -137.98 54.28 1.8 Allowed 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 124.321 1.049 . . . . 0.0 108.704 -174.409 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 21.3 t-20 -57.0 134.02 55.43 Favored 'General case' 0 CA--C 1.533 0.312 0 O-C-N 120.838 -1.164 . . . . 0.0 108.386 172.695 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 51.6 mt -74.17 -20.98 60.03 Favored 'General case' 0 CA--C 1.531 0.24 0 N-CA-C 114.344 1.238 . . . . 0.0 114.344 -168.872 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 14.9 tmtt? -73.29 -38.46 65.87 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 119.25 0.932 . . . . 0.0 109.014 168.501 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -73.53 -37.69 65.54 Favored 'General case' 0 C--O 1.234 0.258 0 N-CA-C 113.429 0.9 . . . . 0.0 113.429 -173.151 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 3.2 t0 -143.36 153.9 43.19 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 118.762 0.71 . . . . 0.0 112.249 175.405 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 17.2 m -73.68 157.17 87.89 Favored Pre-proline 0 CA--C 1.54 0.596 0 C-N-CA 125.842 1.657 . . . . 0.0 111.759 -169.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -72.72 -26.87 15.64 Favored 'Trans proline' 0 C--N 1.349 0.565 0 C-N-CA 122.761 2.307 . . . . 0.0 113.282 -171.211 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 22.4 mmmt -70.78 -13.22 61.97 Favored 'General case' 0 N--CA 1.473 0.696 0 O-C-N 120.252 -1.53 . . . . 0.0 111.842 -175.817 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -60.64 -29.1 69.06 Favored 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 125.526 1.53 . . . . 0.0 110.08 169.409 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 45.7 mtt -56.63 -25.05 52.16 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 118.966 0.803 . . . . 0.0 111.732 178.419 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 93.8 mt-10 -65.3 -31.69 72.96 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 118.432 0.56 . . . . 0.0 110.325 -177.13 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 24.9 mt-30 -67.39 -42.72 82.86 Favored 'General case' 0 N--CA 1.466 0.342 0 N-CA-C 113.259 0.837 . . . . 0.0 113.259 -169.788 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 34.8 m-85 -73.77 140.05 45.63 Favored 'General case' 0 C--O 1.23 0.045 0 C-N-CA 123.53 0.732 . . . . 0.0 109.966 -167.181 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -67.07 -45.22 78.03 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 118.588 0.631 . . . . 0.0 109.801 174.109 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 6.4 t -102.05 142.22 16.85 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.591 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 175.139 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 31.3 tp -129.94 112.77 13.84 Favored 'General case' 0 N--CA 1.442 -0.842 0 N-CA-C 108.439 -0.949 . . . . 0.0 108.439 173.34 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.421 HG23 ' CE1' ' A' ' 85' ' ' TYR . 17.8 mt -88.41 133.57 30.47 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.591 0 N-CA-C 106.334 -1.728 . . . . 0.0 106.334 172.069 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -109.52 140.61 43.08 Favored 'General case' 0 CA--C 1.517 -0.299 0 C-N-CA 125.904 1.681 . . . . 0.0 106.52 179.404 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -141.99 146.89 18.24 Favored Glycine 0 CA--C 1.518 0.249 0 N-CA-C 110.261 -1.136 . . . . 0.0 110.261 175.036 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.519 HD13 ' CB ' ' A' ' 100' ' ' ALA . 16.5 tt -157.97 139.09 9.55 Favored Pre-proline 0 CA--C 1.538 0.506 0 N-CA-C 107.599 -1.259 . . . . 0.0 107.599 177.276 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo . . . . . 0 CA--C 1.548 1.194 0 C-N-CA 123.163 2.576 . . . . 0.0 112.835 170.187 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 72.0 mt . . . . . 0 CA--C 1.546 0.808 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -77.73 156.82 30.38 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-O 121.583 0.706 . . . . 0.0 111.192 178.979 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -57.99 -42.32 84.89 Favored 'General case' 0 C--O 1.225 -0.236 0 C-N-CA 124.269 1.028 . . . . 0.0 111.722 -169.249 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 45.5 m-20 -61.44 -23.47 65.87 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 119.108 0.867 . . . . 0.0 112.049 -173.861 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' TRP . . . . . 0.475 ' CZ2' HD12 ' A' ' 53' ' ' ILE . 6.9 t90 -96.09 -48.01 5.84 Favored 'General case' 0 CA--C 1.527 0.071 0 C-N-CA 124.496 1.118 . . . . 0.0 109.652 177.374 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 8.2 tt0 -65.33 -36.02 82.77 Favored 'General case' 0 N--CA 1.447 -0.62 0 O-C-N 120.962 -1.086 . . . . 0.0 110.556 -174.182 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -61.49 -25.99 67.61 Favored 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 123.653 0.781 . . . . 0.0 111.055 -174.709 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 28.5 m -108.48 -15.64 9.2 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.289 0 CA-C-O 117.234 -1.365 . . . . 0.0 112.195 177.071 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 34.8 t90 -52.27 -35.09 49.11 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 120.526 1.512 . . . . 0.0 110.861 178.049 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -62.61 -29.42 70.59 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 125.31 1.444 . . . . 0.0 113.163 175.272 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 29.3 mt-30 -92.15 -19.62 22.09 Favored 'General case' 0 C--N 1.341 0.218 0 C-N-CA 125.874 1.67 . . . . 0.0 112.393 177.453 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 53.4 mt -63.05 -20.71 65.59 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-N 118.903 0.774 . . . . 0.0 111.474 -177.607 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -78.93 -23.94 44.34 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 123.055 0.542 . . . . 0.0 111.773 174.602 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -72.21 -29.18 63.72 Favored 'General case' 0 N--CA 1.469 0.514 0 O-C-N 120.918 -1.114 . . . . 0.0 111.706 179.049 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 79.8 mt -53.36 141.15 25.19 Favored 'General case' 0 C--N 1.34 0.194 0 C-N-CA 125.141 1.376 . . . . 0.0 113.106 -168.509 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 3.2 t30 -75.7 102.67 5.48 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 170.025 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 61.3 mt -125.26 -0.14 7.72 Favored 'General case' 0 N--CA 1.475 0.821 0 N-CA-C 114.205 1.187 . . . . 0.0 114.205 -174.025 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 26.9 mt-10 -56.68 129.2 40.09 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-N 119.666 1.121 . . . . 0.0 111.115 -168.613 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 74.18 -2.12 45.69 Favored Glycine 0 CA--C 1.534 1.228 0 C-N-CA 125.493 1.521 . . . . 0.0 114.998 178.525 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.4 151.37 38.16 Favored 'General case' 0 C--N 1.346 0.426 0 CA-C-N 120.617 2.208 . . . . 0.0 110.021 -175.025 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 6.7 mt -80.67 136.29 23.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 N-CA-C 106.661 -1.607 . . . . 0.0 106.661 178.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 65.2 t -132.48 140.51 47.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 C-N-CA 124.054 0.942 . . . . 0.0 109.192 -177.376 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -125.28 144.72 50.34 Favored 'General case' 0 N--CA 1.456 -0.162 0 N-CA-C 108.118 -1.068 . . . . 0.0 108.118 170.575 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 4.2 mt -117.83 120.76 38.89 Favored 'General case' 0 CA--C 1.518 -0.26 0 C-N-CA 124.416 1.086 . . . . 0.0 108.612 -175.769 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . 0.488 ' CD2' HD23 ' A' ' 142' ' ' LEU . 22.5 m-85 -113.07 151.98 30.09 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 107.406 -1.331 . . . . 0.0 107.406 169.861 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -155.81 137.5 5.57 Favored Glycine 0 N--CA 1.449 -0.485 0 N-CA-C 107.825 -2.11 . . . . 0.0 107.825 167.619 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 27.1 tp . . . . . 0 N--CA 1.442 -0.831 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 169.971 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 90.3 mt . . . . . 0 N--CA 1.468 0.458 0 N-CA-C 113.15 0.796 . . . . 0.0 113.15 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -61.71 -39.19 90.62 Favored 'General case' 0 N--CA 1.465 0.285 0 O-C-N 120.687 -1.258 . . . . 0.0 111.366 -168.679 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . 0.519 ' CB ' HD13 ' A' ' 53' ' ' ILE . . . -79.0 -15.86 57.69 Favored 'General case' 0 N--CA 1.445 -0.698 0 O-C-N 121.093 -1.004 . . . . 0.0 112.885 178.768 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 5.4 tt -63.44 -42.2 98.67 Favored 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 106.568 -1.641 . . . . 0.0 106.568 167.679 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -63.83 -37.58 94.88 Favored Glycine 0 C--N 1.341 0.812 0 N-CA-C 111.34 -0.704 . . . . 0.0 111.34 178.67 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 28.5 mtm -64.53 -45.23 88.08 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 118.397 1.099 . . . . 0.0 111.813 177.873 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.411 HD23 ' CH2' ' A' ' 65' ' ' TRP . 0.2 OUTLIER -66.7 -39.69 88.16 Favored 'General case' 0 C--N 1.344 0.354 0 CA-C-N 120.233 1.379 . . . . 0.0 109.942 177.277 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 85.3 t60 -57.38 -51.34 69.79 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 118.492 0.587 . . . . 0.0 111.053 177.254 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -62.73 -39.26 93.52 Favored 'General case' 0 C--O 1.235 0.3 0 C-N-CA 124.04 0.936 . . . . 0.0 112.067 -176.335 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 25.0 ttmm -56.21 -35.03 66.86 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 123.657 0.783 . . . . 0.0 110.737 172.392 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 21.0 mt -94.34 -20.05 20.1 Favored 'General case' 0 CA--C 1.515 -0.371 0 N-CA-C 115.761 1.763 . . . . 0.0 115.761 -168.92 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 4.0 m -58.24 -33.98 69.95 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-N 120.673 1.579 . . . . 0.0 111.452 -177.843 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 20.0 p -85.79 -10.71 55.05 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 125.4 1.48 . . . . 0.0 112.324 179.871 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 32.6 mmmt -84.69 -6.05 59.34 Favored 'General case' 0 N--CA 1.466 0.342 0 C-N-CA 124.555 1.142 . . . . 0.0 111.334 173.875 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 70.09 33.49 69.65 Favored Glycine 0 CA--C 1.525 0.69 0 CA-C-N 118.438 0.563 . . . . 0.0 112.125 172.001 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 4.9 m -77.48 175.33 0.76 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.599 0 CA-C-N 117.907 0.853 . . . . 0.0 109.635 173.726 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -117.62 116.21 26.63 Favored 'General case' 0 N--CA 1.465 0.317 0 N-CA-C 107.318 -1.364 . . . . 0.0 107.318 175.069 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 71.2 m-85 -83.52 147.25 27.9 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 119.249 0.931 . . . . 0.0 109.185 -179.037 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 35.8 m -125.21 159.17 32.69 Favored 'Isoleucine or valine' 0 C--O 1.234 0.289 0 C-N-CA 123.696 0.798 . . . . 0.0 110.652 172.157 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 93.52 -87.57 1.18 Allowed Glycine 0 N--CA 1.446 -0.65 0 C-N-CA 125.144 1.354 . . . . 0.0 111.956 169.924 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 15.7 m-30 58.53 176.68 0.07 Allowed 'General case' 0 CA--C 1.552 1.04 0 C-N-CA 125.293 1.437 . . . . 0.0 110.87 -168.031 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -148.98 147.15 23.07 Favored Pre-proline 0 N--CA 1.476 0.853 0 O-C-N 120.199 -1.563 . . . . 0.0 110.149 177.8 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo -61.97 127.11 20.41 Favored 'Trans proline' 0 C--N 1.349 0.559 0 C-N-CA 122.831 2.354 . . . . 0.0 110.336 169.387 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 13.7 p . . . . . 0 N--CA 1.472 0.629 0 N-CA-C 113.32 0.859 . . . . 0.0 113.32 175.618 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 9.5 ttmm . . . . . 0 CA--C 1.542 0.658 0 N-CA-C 114.68 1.363 . . . . 0.0 114.68 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_exo -79.49 -0.34 10.64 Favored 'Trans proline' 0 CA--C 1.538 0.723 0 CA-C-N 122.036 1.763 . . . . 0.0 114.271 -179.109 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 31.4 m -131.51 165.51 31.46 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.427 0 CA-C-N 120.39 1.45 . . . . 0.0 112.647 -168.493 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 10.3 pt -136.5 176.42 8.09 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 C-N-CA 128.723 2.809 . . . . 0.0 108.439 -176.848 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . 56.33 41.87 28.51 Favored 'General case' 0 N--CA 1.465 0.297 0 C-N-CA 125.362 1.465 . . . . 0.0 112.35 174.134 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 27.7 t70 55.2 42.13 30.82 Favored 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 125.938 1.695 . . . . 0.0 111.479 -175.545 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 87.63 16.87 59.39 Favored Glycine 0 CA--C 1.528 0.906 0 CA-C-O 118.715 -1.047 . . . . 0.0 113.974 173.552 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 45.6 mt-30 -91.07 -9.23 46.49 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-N 119.072 1.436 . . . . 0.0 113.168 -178.336 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 4.9 tp -151.66 138.65 19.07 Favored 'General case' 0 C--N 1.342 0.273 0 CA-C-N 119.797 1.18 . . . . 0.0 111.054 -178.646 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 61.9 m-85 -77.82 143.7 37.66 Favored 'General case' 0 CA--C 1.517 -0.314 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 169.931 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 19.4 m -78.31 3.01 1.74 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 C-N-CA 123.587 0.755 . . . . 0.0 112.352 178.306 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -168.91 -172.93 36.2 Favored Glycine 0 C--N 1.335 0.483 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 -178.905 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 0.488 HD23 ' CD2' ' A' ' 85' ' ' TYR . 46.5 tp -74.65 129.67 38.13 Favored 'General case' 0 N--CA 1.451 -0.384 0 C-N-CA 123.659 0.784 . . . . 0.0 110.505 -179.605 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -81.19 117.36 21.66 Favored 'General case' 0 N--CA 1.443 -0.824 0 N-CA-C 107.322 -1.362 . . . . 0.0 107.322 167.36 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 61.4 mt . . . . . 0 N--CA 1.462 0.172 0 N-CA-C 107.031 -1.47 . . . . 0.0 107.031 167.827 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 4.9 p . . . . . 0 CA--C 1.532 0.27 0 N-CA-C 110.016 -0.365 . . . . 0.0 110.016 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -65.17 -38.75 91.51 Favored 'General case' 0 N--CA 1.461 0.11 0 C-N-CA 123.016 0.526 . . . . 0.0 110.641 177.662 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 2.8 tp10 -62.23 -49.06 77.24 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 124.31 1.044 . . . . 0.0 110.78 178.381 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 41.5 mtt180 -56.87 -44.83 82.63 Favored 'General case' 0 C--O 1.226 -0.182 0 C-N-CA 124.617 1.167 . . . . 0.0 109.761 178.536 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 53.8 mt -65.45 -56.0 17.37 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.358 0 N-CA-C 107.91 -1.144 . . . . 0.0 107.91 177.212 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 68.8 tp60 -55.77 -63.65 1.11 Allowed 'General case' 0 C--O 1.232 0.179 0 C-N-CA 124.09 0.956 . . . . 0.0 112.173 -170.503 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 20.2 m -67.35 -32.68 73.79 Favored 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 121.051 -0.259 . . . . 0.0 111.035 -168.695 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 160' ' ' TRP . . . . . . . . . . . . . 3.6 t90 -73.53 -42.37 61.83 Favored 'General case' 0 C--O 1.22 -0.45 0 CA-C-O 119.085 -0.483 . . . . 0.0 110.684 177.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 55.2 m -57.12 -45.33 83.55 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 118.525 0.602 . . . . 0.0 110.378 174.398 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -61.21 -42.3 98.36 Favored 'General case' 0 CA--C 1.528 0.111 0 CA-C-O 121.467 0.651 . . . . 0.0 110.191 177.097 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 16.5 tt0 -64.2 -53.44 49.29 Favored 'General case' 0 N--CA 1.448 -0.561 0 O-C-N 121.655 -0.653 . . . . 0.0 110.202 -178.721 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 41.2 pt -62.26 -37.04 77.6 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.331 0 CA-C-O 117.653 -1.165 . . . . 0.0 109.16 -174.814 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -63.47 -37.55 87.75 Favored 'General case' 0 C--O 1.224 -0.268 0 CA-C-N 119.57 1.077 . . . . 0.0 109.708 -179.729 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 34.1 m-80 -67.05 -50.41 61.98 Favored 'General case' 0 N--CA 1.465 0.294 0 N-CA-C 108.887 -0.782 . . . . 0.0 108.887 176.338 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 67.3 tt0 -72.69 -18.03 61.58 Favored 'General case' 0 N--CA 1.437 -1.122 0 C-N-CA 126.167 1.787 . . . . 0.0 112.157 -169.181 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 168' ' ' MET . . . . . . . . . . . . . 19.0 ptp -89.86 -40.05 12.67 Favored 'General case' 0 N--CA 1.456 -0.151 0 C-N-CA 124.115 0.966 . . . . 0.0 111.168 168.813 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -74.35 -24.82 59.23 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 112.647 0.61 . . . . 0.0 112.647 -174.021 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 . . . . . 0 CA--C 1.539 0.545 0 CA-C-N 118.511 0.596 . . . . 0.0 111.626 179.209 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.406 ' HA ' ' OD2' ' A' ' 47' ' ' ASP . 11.1 tmm? . . . . . 0 N--CA 1.495 1.819 0 N-CA-C 109.832 -0.433 . . . . 0.0 109.832 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 3.0 t30 -142.53 151.41 41.59 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 125.263 1.425 . . . . 0.0 107.911 174.489 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -112.0 128.05 56.06 Favored 'General case' 0 N--CA 1.463 0.221 0 C-N-CA 123.977 0.911 . . . . 0.0 111.573 -177.915 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -87.1 155.49 27.5 Favored Glycine 0 CA--C 1.523 0.584 0 N-CA-C 107.812 -2.115 . . . . 0.0 107.812 167.231 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 3.1 tt -140.39 96.53 3.05 Favored 'General case' 0 N--CA 1.466 0.341 0 N-CA-C 105.397 -2.075 . . . . 0.0 105.397 -177.504 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -98.95 140.51 33.0 Favored 'General case' 0 CA--C 1.516 -0.336 0 CA-C-O 121.225 0.536 . . . . 0.0 111.379 -173.656 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 43.6 p90 . . . . . 0 N--CA 1.454 -0.265 0 C-N-CA 125.679 1.592 . . . . 0.0 107.95 177.698 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.226 -0.152 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -63.03 -47.42 83.12 Favored 'General case' 0 C--O 1.233 0.191 0 C-N-CA 122.756 0.422 . . . . 0.0 111.353 -176.047 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 10.4 mt-10 -62.06 -43.04 99.69 Favored 'General case' 0 CA--C 1.516 -0.338 0 CA-C-O 118.912 -0.566 . . . . 0.0 110.275 176.801 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 29.7 mtpp -71.58 -40.39 69.93 Favored 'General case' 0 C--O 1.22 -0.476 0 CA-C-O 117.97 -1.014 . . . . 0.0 110.892 -174.036 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 47.3 mt -52.54 -54.3 16.06 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.255 0 CA-C-N 120.052 1.296 . . . . 0.0 108.524 172.27 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 8.0 ttp180 -61.72 -41.06 97.14 Favored 'General case' 0 C--O 1.223 -0.296 0 C-N-CA 123.209 0.604 . . . . 0.0 109.425 -175.758 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -66.43 -41.61 88.93 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 118.481 0.582 . . . . 0.0 111.421 -179.177 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 49.3 mt -72.58 -53.17 20.01 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.526 0 C-N-CA 124.7 1.2 . . . . 0.0 109.686 -172.171 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 78.0 mt -67.05 -45.3 87.19 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 179.828 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 139.24 125.5 2.28 Favored Glycine 0 CA--C 1.532 1.137 0 C-N-CA 125.165 1.364 . . . . 0.0 112.067 173.737 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 82.2 Cg_endo -73.17 -5.3 16.93 Favored 'Trans proline' 0 CA--C 1.537 0.636 0 C-N-CA 123.664 2.91 . . . . 0.0 113.873 -175.822 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -82.27 -17.41 46.01 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 118.996 0.816 . . . . 0.0 111.072 177.229 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 1.3 pt? -129.94 -13.76 4.05 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 125.114 1.366 . . . . 0.0 113.871 -174.331 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 33.8 t -98.48 153.45 4.08 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.517 0 N-CA-C 107.691 -1.226 . . . . 0.0 107.691 168.56 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 50.5 m -139.65 131.93 28.3 Favored 'General case' 0 C--O 1.234 0.279 0 C-N-CA 126.464 1.905 . . . . 0.0 106.239 -177.117 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 24.3 mt -81.25 142.38 33.21 Favored 'General case' 0 C--O 1.233 0.191 0 N-CA-C 107.839 -1.171 . . . . 0.0 107.839 176.763 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 34.2 t-80 -134.28 57.65 1.8 Allowed 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 124.574 1.15 . . . . 0.0 108.218 -175.157 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 64.3 t-20 -70.43 118.01 12.69 Favored 'General case' 0 C--O 1.235 0.327 0 O-C-N 121.076 -1.015 . . . . 0.0 108.779 -176.673 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 93.9 mt -68.45 -12.94 61.92 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 124.092 0.957 . . . . 0.0 112.505 -174.807 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 65.3 mmtt -53.73 -27.19 26.89 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-O 118.685 -0.674 . . . . 0.0 111.178 167.013 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -132.04 -41.71 1.01 Allowed 'General case' 0 C--O 1.236 0.347 0 N-CA-C 113.437 0.903 . . . . 0.0 113.437 -173.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 29.8 m-20 -85.56 141.2 30.03 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-N 118.475 0.58 . . . . 0.0 110.568 -174.324 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 14.8 m -76.32 154.23 84.13 Favored Pre-proline 0 CA--C 1.54 0.59 0 C-N-CA 124.378 1.071 . . . . 0.0 110.342 176.658 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -77.26 -26.84 7.13 Favored 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 122.267 1.978 . . . . 0.0 113.683 -170.085 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.79 -15.38 63.54 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-N 120.657 1.571 . . . . 0.0 112.269 -178.612 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -58.77 -29.23 66.64 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 125.403 1.481 . . . . 0.0 110.363 170.317 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 55.3 mtt -57.43 -27.75 62.68 Favored 'General case' 0 C--N 1.342 0.264 0 C-N-CA 123.589 0.756 . . . . 0.0 111.498 177.339 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 56.7 mt-10 -66.83 -33.09 74.85 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 118.348 0.522 . . . . 0.0 110.537 -176.22 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 16.5 mt-30 -66.9 -43.18 84.09 Favored 'General case' 0 N--CA 1.464 0.232 0 C-N-CA 123.346 0.659 . . . . 0.0 112.336 -170.003 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 22.2 m-85 -70.92 142.11 51.11 Favored 'General case' 0 N--CA 1.454 -0.227 0 CA-C-N 115.387 -0.824 . . . . 0.0 110.528 -166.469 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . 0.406 ' OD2' ' HA ' ' A' ' 1' ' ' MET . 24.4 m-20 -74.77 -35.7 62.57 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-O 121.118 0.485 . . . . 0.0 109.726 -178.098 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.525 HG21 ' SD ' ' A' ' 168' ' ' MET . 25.6 t -113.94 147.49 17.44 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.216 0 N-CA-C 107.178 -1.416 . . . . 0.0 107.178 170.003 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 29.8 tp -132.19 109.69 10.12 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 123.778 0.831 . . . . 0.0 108.843 174.889 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 32.0 mt -87.22 133.1 30.93 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.552 0 N-CA-C 107.077 -1.453 . . . . 0.0 107.077 176.583 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 2.4 mp -111.22 127.34 55.57 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 126.141 1.777 . . . . 0.0 106.966 -179.26 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -135.0 136.6 8.65 Favored Glycine 0 C--N 1.335 0.48 0 N-CA-C 109.439 -1.464 . . . . 0.0 109.439 -179.561 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 4.1 tt -150.46 129.31 6.19 Favored Pre-proline 0 CA--C 1.542 0.645 0 CA-C-N 118.772 1.286 . . . . 0.0 110.926 -175.054 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo . . . . . 0 CA--C 1.542 0.902 0 C-N-CA 122.992 2.461 . . . . 0.0 115.539 170.087 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 13.1 mt . . . . . 0 CA--C 1.543 0.706 0 CA-C-O 121.759 0.79 . . . . 0.0 111.464 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . 0.555 ' H ' ' CD ' ' A' ' 62' ' ' GLN . 0.3 OUTLIER -56.02 146.89 21.27 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 126.741 2.016 . . . . 0.0 109.715 175.012 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -57.15 -48.23 79.21 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 118.348 0.522 . . . . 0.0 112.172 -169.629 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -69.71 -17.87 63.49 Favored 'General case' 0 N--CA 1.475 0.807 0 CA-C-N 119.019 0.827 . . . . 0.0 112.177 -173.864 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' TRP . . . . . 0.44 ' CH2' HD23 ' A' ' 104' ' ' LEU . 0.2 OUTLIER -93.28 -43.44 8.8 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 124.92 1.288 . . . . 0.0 107.636 -179.822 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -63.46 -35.12 79.39 Favored 'General case' 0 N--CA 1.435 -1.217 0 C-N-CA 126.229 1.812 . . . . 0.0 111.075 177.347 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -55.93 -23.88 34.53 Favored 'General case' 0 CA--C 1.53 0.174 0 C-N-CA 124.582 1.153 . . . . 0.0 112.001 -176.821 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 35.7 m -116.47 -13.49 11.01 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.224 0 CA-C-O 117.913 -1.041 . . . . 0.0 112.709 178.902 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 26.5 t90 -52.55 -38.68 60.31 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 119.824 1.193 . . . . 0.0 111.083 -177.063 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -68.04 -24.02 65.04 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 125.12 1.368 . . . . 0.0 112.967 178.62 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 20.4 mt-30 -91.67 -23.74 19.72 Favored 'General case' 0 C--N 1.34 0.166 0 C-N-CA 125.273 1.429 . . . . 0.0 111.877 -179.347 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 24.7 mt -64.63 -26.13 68.26 Favored 'General case' 0 N--CA 1.468 0.456 0 O-C-N 121.792 -0.567 . . . . 0.0 111.646 -172.227 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -69.27 -22.27 63.83 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-N 118.06 0.391 . . . . 0.0 111.518 176.233 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -77.36 -23.51 50.83 Favored 'General case' 0 CA--C 1.537 0.472 0 O-C-N 120.707 -1.245 . . . . 0.0 112.56 -178.743 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 51.2 mt -65.67 152.07 45.07 Favored 'General case' 0 C--O 1.233 0.226 0 C-N-CA 124.772 1.229 . . . . 0.0 112.056 -170.205 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 3.3 t30 -82.71 100.95 10.55 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 124.682 1.193 . . . . 0.0 108.154 174.127 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 57.2 mt -119.22 0.09 11.12 Favored 'General case' 0 N--CA 1.47 0.548 0 N-CA-C 113.389 0.885 . . . . 0.0 113.389 -174.474 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 25.0 mt-10 -57.41 128.92 39.47 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 119.135 0.88 . . . . 0.0 110.828 -169.705 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 74.25 -3.04 41.71 Favored Glycine 0 CA--C 1.532 1.145 0 CA-C-O 117.749 -1.584 . . . . 0.0 114.824 178.535 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.79 152.86 40.19 Favored 'General case' 0 C--N 1.347 0.49 0 CA-C-N 121.098 2.449 . . . . 0.0 109.503 -179.402 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 2.1 mt -86.18 141.69 14.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 N-CA-C 106.877 -1.527 . . . . 0.0 106.877 179.414 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 61.6 t -135.68 137.58 49.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 C-N-CA 124.279 1.032 . . . . 0.0 109.109 -177.067 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -111.39 152.72 27.02 Favored 'General case' 0 N--CA 1.465 0.291 0 N-CA-C 106.733 -1.58 . . . . 0.0 106.733 168.118 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 1.2 mt -134.19 135.25 42.91 Favored 'General case' 0 CA--C 1.508 -0.637 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 175.366 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 40.9 p90 -147.34 166.14 28.03 Favored 'General case' 0 N--CA 1.447 -0.594 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 169.235 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -160.01 155.01 26.09 Favored Glycine 0 N--CA 1.448 -0.542 0 N-CA-C 109.123 -1.591 . . . . 0.0 109.123 171.946 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 13.0 tp . . . . . 0 N--CA 1.444 -0.737 0 C-N-CA 125.031 1.332 . . . . 0.0 109.08 177.02 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 96.7 mt . . . . . 0 N--CA 1.471 0.621 0 N-CA-C 109.964 -0.384 . . . . 0.0 109.964 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -52.73 -47.57 67.27 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 123.754 0.821 . . . . 0.0 112.7 -168.783 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -78.94 -19.56 51.44 Favored 'General case' 0 N--CA 1.451 -0.397 0 O-C-N 121.129 -0.982 . . . . 0.0 113.347 -176.323 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 3.8 tt -60.84 -44.79 96.5 Favored 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 107.543 -1.28 . . . . 0.0 107.543 171.383 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -61.24 -43.94 98.74 Favored Glycine 0 C--N 1.341 0.839 0 CA-C-O 119.617 -0.546 . . . . 0.0 111.914 176.398 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 75.1 mtm -63.25 -40.62 97.94 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 118.382 1.091 . . . . 0.0 111.957 -178.863 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.44 HD23 ' CH2' ' A' ' 65' ' ' TRP . 0.1 OUTLIER -69.95 -34.22 73.14 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-N 120.035 1.289 . . . . 0.0 111.241 -179.604 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 56.3 t-80 -58.97 -49.5 77.62 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-N 118.477 0.58 . . . . 0.0 109.533 172.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -62.36 -41.66 98.78 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 123.38 0.672 . . . . 0.0 112.295 -177.11 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 24.2 ttmm -55.56 -40.96 72.62 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 123.401 0.681 . . . . 0.0 110.166 173.14 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 28.4 mt -89.82 -20.2 23.75 Favored 'General case' 0 CA--C 1.517 -0.317 0 N-CA-C 115.764 1.765 . . . . 0.0 115.764 -167.653 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 15.9 m -58.28 -36.44 73.3 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 120.732 1.605 . . . . 0.0 111.334 -178.301 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 20.5 p -83.85 -12.88 54.92 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 124.585 1.154 . . . . 0.0 111.903 -179.678 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 32.0 mmmt -83.15 -9.64 59.08 Favored 'General case' 0 C--N 1.343 0.3 0 C-N-CA 124.525 1.13 . . . . 0.0 110.984 170.881 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 72.3 35.91 60.0 Favored Glycine 0 CA--C 1.523 0.561 0 CA-C-N 118.651 0.66 . . . . 0.0 112.469 169.661 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 5.3 m -77.02 170.67 1.46 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.582 0 CA-C-N 117.858 0.829 . . . . 0.0 109.713 172.001 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 53.0 tptt -100.06 130.64 46.23 Favored 'General case' 0 N--CA 1.47 0.564 0 N-CA-C 105.132 -2.173 . . . . 0.0 105.132 167.756 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 73.8 m-85 -94.95 123.01 38.18 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 172.071 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 32.8 m -105.15 154.31 6.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 C-N-CA 124.032 0.933 . . . . 0.0 108.505 167.701 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 105.85 -95.9 1.11 Allowed Glycine 0 N--CA 1.448 -0.56 0 C-N-CA 124.105 0.86 . . . . 0.0 112.011 174.173 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . 0.438 ' CD2' ' HA ' ' A' ' 140' ' ' VAL . 75.6 m-85 60.17 -179.61 0.09 Allowed 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 125.182 1.393 . . . . 0.0 109.424 -166.928 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER -153.22 143.55 15.54 Favored Pre-proline 0 N--CA 1.476 0.825 0 O-C-N 120.122 -1.611 . . . . 0.0 111.069 177.17 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -68.9 122.66 9.57 Favored 'Trans proline' 0 CA--C 1.536 0.595 0 C-N-CA 123.505 2.804 . . . . 0.0 111.621 179.238 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 18.1 p . . . . . 0 CA--C 1.538 0.492 0 N-CA-C 113.791 1.034 . . . . 0.0 113.791 -179.343 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 24.7 ttmt . . . . . 0 N--CA 1.475 0.79 0 N-CA-C 114.734 1.383 . . . . 0.0 114.734 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -82.76 3.83 7.54 Favored 'Trans proline' 0 C--N 1.35 0.615 0 CA-C-N 121.836 1.691 . . . . 0.0 114.162 -178.43 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 20.0 m -130.26 165.82 29.46 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.371 0 CA-C-N 120.537 1.517 . . . . 0.0 111.57 -172.252 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 7.4 pt -135.42 171.29 17.68 Favored 'Isoleucine or valine' 0 C--O 1.234 0.279 0 C-N-CA 127.913 2.485 . . . . 0.0 108.969 -177.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . 53.88 45.13 28.4 Favored 'General case' 0 N--CA 1.464 0.261 0 C-N-CA 125.488 1.515 . . . . 0.0 112.509 172.553 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 27.0 t0 54.32 43.58 30.28 Favored 'General case' 0 C--N 1.324 -0.521 0 C-N-CA 126.056 1.742 . . . . 0.0 111.624 -176.596 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 87.41 17.4 58.83 Favored Glycine 0 CA--C 1.527 0.825 0 CA-C-O 118.662 -1.077 . . . . 0.0 113.611 173.357 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 60.6 mm-40 -92.09 -8.07 46.82 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 119.399 1.6 . . . . 0.0 113.142 -177.368 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 7.9 tp -152.59 145.03 24.06 Favored 'General case' 0 C--N 1.344 0.33 0 CA-C-N 119.356 0.98 . . . . 0.0 110.761 170.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 65.5 m-85 -81.59 144.83 30.97 Favored 'General case' 0 CA--C 1.514 -0.423 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 169.373 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . 0.438 ' HA ' ' CD2' ' A' ' 118' ' ' TYR . 13.9 m -76.43 11.07 0.43 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.627 0 N-CA-C 113.128 0.788 . . . . 0.0 113.128 179.512 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 177.39 171.9 41.37 Favored Glycine 0 CA--C 1.525 0.696 0 C-N-CA 124.927 1.251 . . . . 0.0 109.997 -177.617 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 3.2 tp -66.72 133.44 50.19 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 117.962 0.881 . . . . 0.0 110.771 -177.725 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -91.56 117.05 29.37 Favored 'General case' 0 N--CA 1.445 -0.694 0 C-N-CA 125.835 1.654 . . . . 0.0 108.408 173.017 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.463 0.199 0 C-N-CA 124.288 1.035 . . . . 0.0 109.385 172.242 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 21.9 m . . . . . 0 CA--C 1.539 0.535 0 N-CA-C 110.642 -0.132 . . . . 0.0 110.642 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -64.21 -38.53 91.39 Favored 'General case' 0 N--CA 1.463 0.188 0 C-N-CA 123.208 0.603 . . . . 0.0 111.037 169.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -70.23 -40.64 74.36 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 124.599 1.159 . . . . 0.0 111.276 -178.484 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 17.9 mmm-85 -49.39 -43.76 44.56 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 124.23 1.012 . . . . 0.0 109.889 171.253 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 58.0 mt -75.03 -56.74 7.95 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.399 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 -179.716 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 73.1 tp60 -50.68 -62.76 1.4 Allowed 'General case' 0 CA--C 1.521 -0.151 0 C-N-CA 125.709 1.604 . . . . 0.0 112.673 -170.298 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 15.0 m -68.09 -34.16 75.89 Favored 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 121.049 -0.26 . . . . 0.0 110.841 -168.57 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 160' ' ' TRP . . . . . . . . . . . . . 38.0 t90 -67.66 -44.25 78.31 Favored 'General case' 0 C--O 1.222 -0.353 0 O-C-N 122.167 -0.333 . . . . 0.0 110.838 175.128 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 61.2 m -59.74 -43.82 94.07 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 122.834 0.454 . . . . 0.0 110.377 178.965 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -62.03 -41.69 98.37 Favored 'General case' 0 CA--C 1.529 0.141 0 CA-C-N 118.053 0.388 . . . . 0.0 110.173 176.614 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 11.7 tt0 -62.68 -54.13 43.93 Favored 'General case' 0 CA--C 1.514 -0.415 0 CA-C-O 118.15 -0.928 . . . . 0.0 109.929 -179.099 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 40.4 pt -62.78 -33.0 57.71 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.497 0 CA-C-O 118.012 -0.994 . . . . 0.0 109.871 -176.475 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -70.66 -36.58 73.44 Favored 'General case' 0 C--O 1.223 -0.324 0 CA-C-N 119.837 1.198 . . . . 0.0 108.605 -175.572 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -68.73 -45.63 71.02 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 123.386 0.674 . . . . 0.0 109.844 175.096 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 25.1 tt0 -80.79 -13.63 58.79 Favored 'General case' 0 N--CA 1.437 -1.119 0 C-N-CA 124.303 1.041 . . . . 0.0 110.328 -169.382 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 168' ' ' MET . . . . . 0.525 ' SD ' HG21 ' A' ' 48' ' ' VAL . 20.6 ptp -90.7 -41.61 11.19 Favored 'General case' 0 N--CA 1.457 -0.125 0 C-N-CA 122.914 0.486 . . . . 0.0 111.242 168.774 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -70.58 -27.59 64.23 Favored 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 122.652 0.381 . . . . 0.0 111.651 -172.258 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 . . . . . 0 CA--C 1.543 0.693 0 C-N-CA 123.257 0.623 . . . . 0.0 112.4 178.9 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.498 1.938 0 N-CA-C 111.578 0.214 . . . . 0.0 111.578 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 6.0 t30 -127.36 151.52 48.67 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 124.624 1.17 . . . . 0.0 108.458 175.414 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 17.3 mtt -110.93 126.37 54.65 Favored 'General case' 0 C--N 1.332 -0.182 0 C-N-CA 123.475 0.71 . . . . 0.0 110.359 -177.385 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -84.22 145.98 22.57 Favored Glycine 0 CA--C 1.522 0.514 0 N-CA-C 107.139 -2.384 . . . . 0.0 107.139 168.023 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 1.2 tt -135.03 93.94 3.08 Favored 'General case' 0 N--CA 1.464 0.273 0 N-CA-C 105.345 -2.094 . . . . 0.0 105.345 -172.927 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . 0.413 ' CE2' ' HG ' ' A' ' 51' ' ' LEU . 0.1 OUTLIER -101.59 143.25 31.8 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-O 121.703 0.763 . . . . 0.0 110.728 -173.322 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 32.3 p90 . . . . . 0 N--CA 1.448 -0.541 0 C-N-CA 125.071 1.348 . . . . 0.0 108.078 -178.071 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.268 0 N-CA-C 109.079 -0.712 . . . . 0.0 109.079 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -65.74 -45.66 81.76 Favored 'General case' 0 N--CA 1.455 -0.182 0 C-N-CA 123.732 0.813 . . . . 0.0 111.577 -175.239 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -54.34 -47.69 72.27 Favored 'General case' 0 CA--C 1.517 -0.289 0 C-N-CA 125.262 1.425 . . . . 0.0 109.312 173.647 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 29.8 mtpp -73.51 -38.91 65.18 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-O 118.459 -0.781 . . . . 0.0 110.215 -172.272 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 37.3 mt -53.72 -56.7 7.71 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.288 0 CA-C-N 119.469 1.031 . . . . 0.0 109.024 173.378 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.483 ' HG2' HD21 ' A' ' 32' ' ' LEU . 0.0 OUTLIER -66.33 -35.02 79.3 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 118.49 0.586 . . . . 0.0 111.196 -173.858 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -62.38 -42.7 99.62 Favored 'General case' 0 C--N 1.328 -0.358 0 O-C-N 123.363 0.414 . . . . 0.0 110.892 176.093 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.611 HD13 ' HA ' ' A' ' 158' ' ' GLN . 39.5 mt -72.23 -55.65 12.6 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.52 0 C-N-CA 123.619 0.767 . . . . 0.0 109.971 -174.356 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 73.0 mt -65.8 -45.23 92.17 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.296 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 -175.33 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 141.62 120.69 1.65 Allowed Glycine 0 CA--C 1.53 0.994 0 N-CA-C 110.26 -1.136 . . . . 0.0 110.26 176.335 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -68.64 -10.2 28.37 Favored 'Trans proline' 0 N--CA 1.456 -0.697 0 C-N-CA 123.124 2.55 . . . . 0.0 113.373 -173.985 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 2.4 pm0 -81.56 -18.25 45.56 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-N 119.573 1.079 . . . . 0.0 111.831 179.138 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -126.96 5.74 6.56 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 124.735 1.214 . . . . 0.0 113.679 -173.096 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 38.2 t -126.55 146.2 32.8 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.281 0 N-CA-C 107.842 -1.17 . . . . 0.0 107.842 173.169 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 34.0 m -133.02 131.89 41.22 Favored 'General case' 0 C--N 1.333 -0.129 0 C-N-CA 125.045 1.338 . . . . 0.0 108.635 -175.481 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.483 HD21 ' HG2' ' A' ' 22' ' ' ARG . 22.9 mt -75.53 137.71 41.04 Favored 'General case' 0 C--O 1.231 0.092 0 N-CA-C 108.809 -0.811 . . . . 0.0 108.809 177.393 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 23.2 t-80 -135.45 54.51 1.92 Allowed 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 124.788 1.235 . . . . 0.0 108.477 -177.006 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 38.3 t-20 -53.58 123.52 12.41 Favored 'General case' 0 C--O 1.237 0.41 0 N-CA-C 107.485 -1.302 . . . . 0.0 107.485 170.675 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.405 HD23 ' HA ' ' A' ' 35' ' ' LEU . 31.7 mt -70.46 -19.74 62.93 Favored 'General case' 0 C--O 1.235 0.302 0 N-CA-C 112.824 0.676 . . . . 0.0 112.824 -173.782 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 55.9 tptt -70.63 -19.44 62.82 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-N 118.915 0.78 . . . . 0.0 110.91 169.771 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -103.38 -36.49 8.0 Favored 'General case' 0 C--O 1.233 0.235 0 C-N-CA 123.975 0.91 . . . . 0.0 113.107 -170.732 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 3.3 t0 -139.64 156.24 46.95 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 118.668 0.667 . . . . 0.0 112.539 178.268 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 19.9 m -75.4 157.88 84.17 Favored Pre-proline 0 CA--C 1.541 0.623 0 C-N-CA 125.931 1.692 . . . . 0.0 111.714 -170.58 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 78.1 Cg_endo -74.86 -26.49 11.16 Favored 'Trans proline' 0 C--N 1.349 0.584 0 C-N-CA 122.68 2.254 . . . . 0.0 113.493 -170.297 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 23.0 mmmt -70.79 -12.42 61.54 Favored 'General case' 0 N--CA 1.472 0.65 0 O-C-N 120.685 -1.26 . . . . 0.0 111.531 -176.159 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -60.24 -29.36 68.72 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 125.423 1.489 . . . . 0.0 110.354 168.832 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 48.4 mtt -59.41 -25.37 64.26 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 118.65 0.659 . . . . 0.0 111.436 178.425 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 89.9 mt-10 -65.83 -33.06 74.99 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-O 118.96 -0.543 . . . . 0.0 110.027 -176.84 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 24.9 mt-30 -65.22 -45.51 84.41 Favored 'General case' 0 N--CA 1.465 0.313 0 C-N-CA 123.424 0.69 . . . . 0.0 112.771 -169.959 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 44.5 m-85 -77.73 133.2 38.34 Favored 'General case' 0 CA--C 1.52 -0.204 0 C-N-CA 123.718 0.807 . . . . 0.0 109.205 -167.234 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -75.58 -22.22 57.14 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-N 118.883 0.765 . . . . 0.0 111.833 -177.135 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 53.0 t -113.6 143.33 23.53 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.588 0 N-CA-C 106.633 -1.618 . . . . 0.0 106.633 169.441 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 31.2 tp -133.65 149.03 51.56 Favored 'General case' 0 N--CA 1.444 -0.763 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 172.278 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 28.9 mt -128.71 133.34 66.57 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 N-CA-C 105.38 -2.082 . . . . 0.0 105.38 179.917 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.413 ' HG ' ' CE2' ' A' ' 6' ' ' PHE . 3.1 mp -118.25 128.76 54.99 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 125.701 1.6 . . . . 0.0 107.781 -172.842 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -131.57 134.23 7.58 Favored Glycine 0 C--N 1.332 0.315 0 N-CA-C 110.912 -0.875 . . . . 0.0 110.912 174.69 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 2.9 tt -153.88 137.06 10.16 Favored Pre-proline 0 CA--C 1.542 0.667 0 CA-C-N 118.654 1.227 . . . . 0.0 111.662 170.37 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_exo . . . . . 0 CA--C 1.536 0.599 0 C-N-CA 123.347 2.698 . . . . 0.0 113.081 167.976 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . 0.256 59.0 mt . . . . . 0 CA--C 1.55 0.965 0 CA-C-O 122.952 1.358 . . . . 0.0 111.361 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -118.22 156.7 28.32 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 125.265 1.426 . . . . 0.0 107.579 -175.974 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -57.41 -45.01 85.05 Favored 'General case' 0 CA--C 1.529 0.153 0 C-N-CA 123.233 0.613 . . . . 0.0 110.677 -172.053 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -64.42 -19.54 65.58 Favored 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 113.219 0.822 . . . . 0.0 113.219 -177.115 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 13.0 t90 -95.91 -47.2 6.23 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 124.754 1.222 . . . . 0.0 109.485 178.23 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 10.9 tt0 -62.79 -35.26 79.26 Favored 'General case' 0 N--CA 1.446 -0.642 0 O-C-N 120.877 -1.139 . . . . 0.0 109.975 -178.899 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -58.13 -25.76 61.82 Favored 'General case' 0 CA--C 1.529 0.173 0 C-N-CA 124.034 0.933 . . . . 0.0 111.711 -177.262 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 28.6 m -113.29 -13.4 11.4 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.266 0 CA-C-O 117.21 -1.376 . . . . 0.0 112.484 177.675 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 26.0 t90 -52.75 -35.21 55.8 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 120.53 1.514 . . . . 0.0 110.968 -178.908 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -64.3 -27.72 69.23 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 125.567 1.547 . . . . 0.0 113.269 175.944 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 29.3 mt-30 -92.47 -19.61 21.83 Favored 'General case' 0 C--N 1.343 0.288 0 C-N-CA 125.93 1.692 . . . . 0.0 112.524 176.214 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 52.5 mt -63.69 -20.96 66.13 Favored 'General case' 0 CA--C 1.536 0.415 0 O-C-N 121.318 -0.864 . . . . 0.0 111.467 -176.398 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -79.01 -23.34 44.42 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 123.112 0.565 . . . . 0.0 111.503 174.401 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -72.83 -29.82 63.53 Favored 'General case' 0 N--CA 1.469 0.509 0 O-C-N 120.628 -1.295 . . . . 0.0 111.883 178.714 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 80.1 mt -52.85 141.05 22.61 Favored 'General case' 0 C--N 1.34 0.16 0 C-N-CA 125.239 1.415 . . . . 0.0 113.009 -168.484 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 3.7 t30 -75.62 102.48 5.34 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 123.832 0.853 . . . . 0.0 108.729 170.437 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 66.7 mt -125.03 -0.48 7.85 Favored 'General case' 0 N--CA 1.475 0.784 0 N-CA-C 114.058 1.133 . . . . 0.0 114.058 -173.572 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 27.0 mt-10 -57.25 128.78 38.75 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 119.528 1.058 . . . . 0.0 111.144 -169.253 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 73.43 -1.79 41.45 Favored Glycine 0 CA--C 1.534 1.25 0 C-N-CA 125.394 1.474 . . . . 0.0 115.103 178.518 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.68 148.95 40.13 Favored 'General case' 0 C--N 1.344 0.354 0 CA-C-N 120.543 2.171 . . . . 0.0 109.474 -176.362 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 1.8 mt -80.49 136.28 23.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 N-CA-C 106.712 -1.588 . . . . 0.0 106.712 179.246 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 76.2 t -133.0 125.1 51.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 C-N-CA 123.97 0.908 . . . . 0.0 109.805 -175.608 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -98.72 151.73 20.43 Favored 'General case' 0 N--CA 1.463 0.177 0 N-CA-C 107.938 -1.134 . . . . 0.0 107.938 166.674 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 1.2 mt -133.93 138.73 45.69 Favored 'General case' 0 CA--C 1.512 -0.493 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 175.382 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 45.6 p90 -150.48 168.92 22.77 Favored 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 171.223 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -168.12 166.63 39.61 Favored Glycine 0 N--CA 1.444 -0.775 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 173.386 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.327 -0.401 0 C-N-CA 124.315 1.046 . . . . 0.0 109.037 170.546 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 92.8 mt . . . . . 0 N--CA 1.467 0.412 0 N-CA-C 114.014 1.116 . . . . 0.0 114.014 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -62.8 -33.82 76.0 Favored 'General case' 0 C--N 1.332 -0.176 0 O-C-N 120.538 -1.351 . . . . 0.0 110.708 -174.873 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -72.08 -29.97 64.65 Favored 'General case' 0 CA--C 1.533 0.315 0 O-C-N 121.563 -0.711 . . . . 0.0 112.216 176.377 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 4.1 tt -62.04 -46.68 88.11 Favored 'General case' 0 N--CA 1.467 0.395 0 N-CA-C 107.574 -1.269 . . . . 0.0 107.574 170.226 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -63.59 -37.29 94.53 Favored Glycine 0 C--N 1.341 0.84 0 CA-C-O 119.212 -0.771 . . . . 0.0 112.088 178.793 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 65.1 mtm -63.58 -42.9 98.26 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 118.823 1.312 . . . . 0.0 111.69 -179.67 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -70.25 -37.18 74.87 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 120.238 1.381 . . . . 0.0 109.793 176.335 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 59.1 t60 -56.98 -48.6 78.04 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 118.798 0.727 . . . . 0.0 110.892 177.177 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -61.97 -39.27 91.6 Favored 'General case' 0 C--O 1.235 0.315 0 C-N-CA 124.176 0.99 . . . . 0.0 112.041 -178.072 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 24.0 ttmm -58.45 -33.8 70.12 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 123.235 0.614 . . . . 0.0 110.649 172.854 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 19.4 mt -94.63 -21.18 18.97 Favored 'General case' 0 CA--C 1.513 -0.45 0 N-CA-C 116.297 1.962 . . . . 0.0 116.297 -168.956 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 4.3 m -59.01 -33.59 70.9 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 120.951 1.705 . . . . 0.0 111.424 -176.272 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 20.1 p -85.8 -11.97 52.1 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 125.252 1.421 . . . . 0.0 112.152 179.758 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 31.7 mmmt -83.14 -6.32 59.44 Favored 'General case' 0 C--N 1.344 0.352 0 C-N-CA 124.907 1.283 . . . . 0.0 111.386 173.785 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 71.44 32.42 64.9 Favored Glycine 0 C--N 1.337 0.597 0 CA-C-N 118.779 0.718 . . . . 0.0 112.103 170.499 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 4.2 m -75.37 172.3 1.13 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.532 0 CA-C-N 118.027 0.913 . . . . 0.0 109.316 173.563 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -113.15 122.11 46.54 Favored 'General case' 0 N--CA 1.466 0.327 0 N-CA-C 106.579 -1.637 . . . . 0.0 106.579 173.265 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 81.3 m-85 -88.86 145.89 25.29 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 119.422 1.01 . . . . 0.0 109.672 -176.343 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 29.5 m -132.73 160.69 42.44 Favored 'Isoleucine or valine' 0 C--O 1.236 0.355 0 C-N-CA 124.583 1.153 . . . . 0.0 109.153 171.338 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 98.7 -83.29 0.63 Allowed Glycine 0 N--CA 1.448 -0.559 0 C-N-CA 124.906 1.241 . . . . 0.0 111.106 174.196 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 16.7 m-30 55.69 -171.15 0.07 Allowed 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 124.503 1.121 . . . . 0.0 110.179 -169.152 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -154.41 144.05 15.31 Favored Pre-proline 0 N--CA 1.468 0.451 0 O-C-N 120.651 -1.281 . . . . 0.0 108.712 169.902 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -68.5 124.99 12.21 Favored 'Trans proline' 0 CA--C 1.534 0.517 0 C-N-CA 122.34 2.027 . . . . 0.0 111.321 179.612 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 5.9 p . . . . . 0 N--CA 1.469 0.48 0 O-C-N 121.794 -0.566 . . . . 0.0 111.804 174.314 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 24.2 ttmt . . . . . 0 CA--C 1.542 0.648 0 CA-C-O 117.578 -1.201 . . . . 0.0 113.769 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -80.49 5.67 5.94 Favored 'Trans proline' 0 C--N 1.351 0.663 0 C-N-CA 121.944 1.763 . . . . 0.0 114.84 179.002 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 20.3 m -124.77 152.08 30.71 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.379 0 CA-C-N 122.152 2.251 . . . . 0.0 111.486 -178.4 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . 0.894 HG23 HG12 ' A' ' 140' ' ' VAL . 15.0 pt -96.53 163.69 2.34 Favored 'Isoleucine or valine' 0 C--O 1.236 0.355 0 C-N-CA 124.765 1.226 . . . . 0.0 109.556 169.246 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . 53.69 43.0 31.7 Favored 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 124.62 1.168 . . . . 0.0 112.19 167.61 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 31.5 t70 63.93 -32.32 0.12 Allowed 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 129.09 2.956 . . . . 0.0 114.616 -171.313 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 177.1 28.51 0.04 OUTLIER Glycine 0 CA--C 1.527 0.809 0 CA-C-O 117.867 -1.518 . . . . 0.0 114.616 177.499 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 74.2 mm-40 -76.2 -41.42 49.56 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 120.351 2.075 . . . . 0.0 111.248 -177.909 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -143.74 153.05 42.03 Favored 'General case' 0 CA--C 1.519 -0.238 0 C-N-CA 123.489 0.716 . . . . 0.0 109.888 176.727 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 74.7 m-85 -72.5 141.35 48.53 Favored 'General case' 0 N--CA 1.447 -0.595 0 N-CA-C 104.994 -2.224 . . . . 0.0 104.994 163.642 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . 0.894 HG12 HG23 ' A' ' 133' ' ' ILE . 4.3 m -76.07 4.86 1.01 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.904 0 C-N-CA 122.968 0.507 . . . . 0.0 111.427 -176.608 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -174.06 171.53 44.6 Favored Glycine 0 CA--C 1.528 0.869 0 C-N-CA 125.847 1.689 . . . . 0.0 109.771 -179.139 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -64.2 136.37 57.15 Favored 'General case' 0 N--CA 1.466 0.375 0 C-N-CA 123.642 0.777 . . . . 0.0 111.361 -177.221 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -101.12 113.08 25.78 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 126.161 1.784 . . . . 0.0 109.222 -179.824 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 96.1 mt . . . . . 0 N--CA 1.464 0.255 0 C-N-CA 124.607 1.163 . . . . 0.0 110.218 175.583 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 8.1 m . . . . . 0 CA--C 1.539 0.521 0 N-CA-C 110.481 -0.192 . . . . 0.0 110.481 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -65.19 -43.73 90.7 Favored 'General case' 0 N--CA 1.463 0.191 0 C-N-CA 123.507 0.723 . . . . 0.0 111.376 173.317 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 19.9 tt0 -64.39 -43.56 94.08 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 124.702 1.201 . . . . 0.0 110.894 -179.094 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 54.0 mtp85 -62.41 -36.83 83.58 Favored 'General case' 0 N--CA 1.462 0.141 0 C-N-CA 124.119 0.967 . . . . 0.0 109.989 -179.858 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 55.7 mt -70.01 -57.38 8.32 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.461 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 172.495 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 158' ' ' GLN . . . . . 0.611 ' HA ' HD13 ' A' ' 24' ' ' ILE . 68.2 tp60 -46.56 -65.77 0.51 Allowed 'General case' 0 C--O 1.235 0.314 0 C-N-CA 126.203 1.801 . . . . 0.0 112.476 -172.974 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 16.9 m -68.23 -29.09 67.84 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 123.091 0.244 . . . . 0.0 111.014 -169.483 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 160' ' ' TRP . . . . . . . . . . . . . 62.2 t90 -72.03 -44.6 63.14 Favored 'General case' 0 CA--C 1.515 -0.391 0 O-C-N 121.808 -0.558 . . . . 0.0 111.156 177.264 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 95.8 m -61.39 -40.52 94.68 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 122.717 0.407 . . . . 0.0 109.951 177.498 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -62.74 -42.58 99.74 Favored 'General case' 0 C--O 1.227 -0.098 0 CA-C-O 121.078 0.466 . . . . 0.0 110.254 174.028 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 12.1 tt0 -62.66 -51.57 66.74 Favored 'General case' 0 N--CA 1.449 -0.513 0 O-C-N 121.614 -0.679 . . . . 0.0 110.154 -178.445 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 45.5 pt -63.04 -38.13 81.22 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.367 0 CA-C-O 117.976 -1.011 . . . . 0.0 109.481 -174.962 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -65.02 -33.59 76.4 Favored 'General case' 0 C--O 1.225 -0.235 0 CA-C-N 119.416 1.007 . . . . 0.0 110.351 179.788 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 35.0 m-80 -69.23 -57.47 5.31 Favored 'General case' 0 C--O 1.223 -0.32 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 174.592 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 13.0 tt0 -63.45 -36.47 83.86 Favored 'General case' 0 N--CA 1.445 -0.68 0 C-N-CA 125.514 1.526 . . . . 0.0 111.131 -169.251 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 168' ' ' MET . . . . . . . . . . . . . 20.0 ptp -70.27 -32.75 70.7 Favored 'General case' 0 C--O 1.226 -0.16 0 O-C-N 121.63 -0.669 . . . . 0.0 111.761 174.08 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -75.28 -34.72 61.35 Favored 'General case' 0 N--CA 1.448 -0.568 0 CA-C-O 119.082 -0.485 . . . . 0.0 112.174 -178.776 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 6.2 mt-10 . . . . . 0 N--CA 1.465 0.306 0 CA-C-O 121.794 0.807 . . . . 0.0 109.317 177.613 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.498 1.961 0 N-CA-C 111.316 0.117 . . . . 0.0 111.316 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 9.0 t30 -114.31 152.04 32.02 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 123.736 0.815 . . . . 0.0 110.136 -179.082 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 16.0 mtt -116.21 129.55 56.35 Favored 'General case' 0 N--CA 1.461 0.103 0 C-N-CA 123.948 0.899 . . . . 0.0 110.731 -179.265 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -85.35 154.62 28.85 Favored Glycine 0 CA--C 1.524 0.644 0 N-CA-C 107.484 -2.246 . . . . 0.0 107.484 167.192 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 1.4 tt -142.05 96.51 2.97 Favored 'General case' 0 N--CA 1.466 0.343 0 N-CA-C 106.338 -1.727 . . . . 0.0 106.338 -175.447 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -106.06 144.67 32.44 Favored 'General case' 0 CA--C 1.519 -0.238 0 CA-C-O 121.481 0.658 . . . . 0.0 111.9 -170.761 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 23.6 p90 . . . . . 0 N--CA 1.453 -0.314 0 C-N-CA 125.879 1.671 . . . . 0.0 108.015 -177.53 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.338 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -63.45 -47.68 80.87 Favored 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 123.17 0.588 . . . . 0.0 111.907 -174.161 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.1 pp20? -67.38 -35.73 79.91 Favored 'General case' 0 CA--C 1.535 0.383 0 O-C-N 121.596 -0.69 . . . . 0.0 109.274 -179.671 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 29.3 mtpp -67.37 -40.58 85.77 Favored 'General case' 0 C--O 1.225 -0.232 0 O-C-N 121.126 -0.984 . . . . 0.0 110.916 175.968 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 37.8 mt -56.24 -56.18 14.68 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.198 0 CA-C-N 119.995 1.27 . . . . 0.0 109.171 176.196 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.5 -35.89 82.4 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 118.529 0.604 . . . . 0.0 110.946 -175.494 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -63.42 -40.14 96.39 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 117.94 0.336 . . . . 0.0 110.888 177.94 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.4 HD13 ' HA ' ' A' ' 158' ' ' GLN . 67.6 mt -77.14 -53.58 14.49 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 C-N-CA 124.23 1.012 . . . . 0.0 110.353 -174.17 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 70.7 mt -60.3 -49.53 83.85 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.317 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 177.917 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 144.25 119.14 1.31 Allowed Glycine 0 CA--C 1.528 0.887 0 N-CA-C 110.133 -1.187 . . . . 0.0 110.133 179.209 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -68.71 -14.52 39.42 Favored 'Trans proline' 0 CA--C 1.536 0.588 0 C-N-CA 122.955 2.436 . . . . 0.0 113.022 -173.278 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -73.56 -21.54 60.33 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 118.579 0.627 . . . . 0.0 112.051 179.396 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -129.57 8.12 5.36 Favored 'General case' 0 CA--C 1.536 0.405 0 N-CA-C 113.862 1.06 . . . . 0.0 113.862 -169.162 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 33.7 t -128.13 147.09 32.77 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.387 0 C-N-CA 124.449 1.099 . . . . 0.0 108.066 172.308 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 26.9 m -131.53 131.74 43.62 Favored 'General case' 0 C--N 1.332 -0.164 0 C-N-CA 125.643 1.577 . . . . 0.0 108.419 -174.716 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 18.4 mt -75.93 134.01 40.35 Favored 'General case' 0 C--O 1.232 0.154 0 N-CA-C 108.401 -0.963 . . . . 0.0 108.401 175.018 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 25.4 t-80 -130.67 55.75 1.81 Allowed 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 124.806 1.242 . . . . 0.0 108.528 -176.741 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 54.2 t-20 -60.11 125.09 22.33 Favored 'General case' 0 C--O 1.233 0.193 0 N-CA-C 107.974 -1.121 . . . . 0.0 107.974 176.817 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 80.9 mt -69.94 -20.58 63.33 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 118.429 0.559 . . . . 0.0 112.282 -176.93 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 58.2 tptt -63.61 -25.91 68.44 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 118.467 0.576 . . . . 0.0 110.712 168.931 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -106.01 -37.9 6.49 Favored 'General case' 0 C--O 1.235 0.327 0 N-CA-C 113.452 0.908 . . . . 0.0 113.452 -169.426 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 2.6 t0 -134.64 155.82 49.83 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-N 118.834 0.743 . . . . 0.0 112.627 -175.578 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 19.5 m -76.32 156.67 83.49 Favored Pre-proline 0 CA--C 1.539 0.555 0 C-N-CA 125.551 1.54 . . . . 0.0 111.415 -172.097 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -75.59 -26.25 10.19 Favored 'Trans proline' 0 C--N 1.348 0.506 0 C-N-CA 122.603 2.202 . . . . 0.0 113.882 -171.173 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 21.4 mmmt -70.84 -11.75 61.14 Favored 'General case' 0 N--CA 1.474 0.731 0 O-C-N 120.271 -1.518 . . . . 0.0 111.654 -176.232 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -58.02 -30.96 66.53 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 125.879 1.672 . . . . 0.0 110.089 168.329 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 46.1 mtt -57.77 -25.12 60.05 Favored 'General case' 0 N--CA 1.463 0.206 0 C-N-CA 123.341 0.656 . . . . 0.0 111.838 178.616 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 87.1 mt-10 -66.77 -33.92 76.69 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 118.463 0.574 . . . . 0.0 110.02 -177.693 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 13.8 mt-30 -67.49 -45.17 76.64 Favored 'General case' 0 N--CA 1.465 0.307 0 C-N-CA 123.202 0.601 . . . . 0.0 112.412 -169.874 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 26.1 m-85 -72.05 137.55 47.23 Favored 'General case' 0 N--CA 1.456 -0.132 0 CA-C-N 115.317 -0.856 . . . . 0.0 110.042 -166.574 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -74.26 -35.08 63.78 Favored 'General case' 0 N--CA 1.466 0.355 0 O-C-N 121.872 -0.518 . . . . 0.0 110.788 -177.265 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 20.5 t -108.56 145.69 15.21 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.436 0 N-CA-C 106.991 -1.485 . . . . 0.0 106.991 169.386 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 36.4 tp -133.95 112.78 11.53 Favored 'General case' 0 N--CA 1.447 -0.606 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 175.379 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.426 ' HA ' ' HB3' ' A' ' 83' ' ' ALA . 22.8 mt -89.92 134.47 28.89 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.665 0 N-CA-C 107.15 -1.426 . . . . 0.0 107.15 176.248 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 2.7 mp -115.54 130.63 56.94 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 125.613 1.565 . . . . 0.0 107.473 -178.365 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -135.65 136.28 8.38 Favored Glycine 0 C--N 1.333 0.368 0 N-CA-C 109.413 -1.475 . . . . 0.0 109.413 173.986 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 3.1 tt -152.98 137.34 10.71 Favored Pre-proline 0 CA--C 1.536 0.424 0 CA-C-N 118.477 1.138 . . . . 0.0 110.451 171.534 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo . . . . . 0 N--CA 1.453 -0.871 0 C-N-CA 122.476 2.118 . . . . 0.0 109.886 167.561 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 55.7 mt . . . . . 0 CA--C 1.549 0.91 0 CA-C-O 122.598 1.19 . . . . 0.0 112.821 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 1.2 pm0 -125.77 156.85 38.8 Favored 'General case' 0 C--O 1.232 0.162 0 C-N-CA 126.172 1.789 . . . . 0.0 108.682 -176.437 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -54.92 -43.26 73.16 Favored 'General case' 0 C--O 1.224 -0.261 0 C-N-CA 124.524 1.13 . . . . 0.0 112.355 -168.746 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -65.23 -20.33 66.38 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-N 119.156 0.889 . . . . 0.0 111.835 -174.082 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' TRP . . . . . 0.407 ' CH2' HD23 ' A' ' 104' ' ' LEU . 12.6 t90 -96.24 -49.04 5.38 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 124.448 1.099 . . . . 0.0 109.75 175.344 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -62.98 -35.28 79.65 Favored 'General case' 0 CA--C 1.536 0.426 0 O-C-N 121.041 -1.037 . . . . 0.0 110.413 -175.434 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -61.89 -27.41 68.78 Favored 'General case' 0 CA--C 1.53 0.179 0 C-N-CA 123.087 0.555 . . . . 0.0 111.059 -174.637 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 30.9 m -107.35 -17.08 8.1 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.372 0 CA-C-O 117.199 -1.382 . . . . 0.0 112.156 177.014 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 35.8 t90 -50.66 -34.75 27.65 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 120.447 1.476 . . . . 0.0 110.931 177.823 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -62.56 -31.14 71.89 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 125.315 1.446 . . . . 0.0 113.319 174.901 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 30.4 mt-30 -88.8 -20.89 24.12 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 126.555 1.942 . . . . 0.0 111.273 178.73 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 50.8 mt -65.25 -20.62 66.51 Favored 'General case' 0 CA--C 1.533 0.301 0 O-C-N 121.41 -0.806 . . . . 0.0 111.672 -173.603 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -79.0 -23.4 44.43 Favored 'General case' 0 CA--C 1.542 0.653 0 CA-C-N 118.399 0.545 . . . . 0.0 111.793 175.25 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -71.99 -30.03 64.84 Favored 'General case' 0 N--CA 1.468 0.47 0 O-C-N 120.723 -1.236 . . . . 0.0 111.958 178.177 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 80.1 mt -52.89 140.92 23.14 Favored 'General case' 0 C--N 1.338 0.102 0 C-N-CA 124.887 1.275 . . . . 0.0 112.994 -168.417 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 29.2 t-20 -76.14 108.95 9.41 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 169.688 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 70.2 mt -131.6 -0.07 3.96 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 114.317 1.228 . . . . 0.0 114.317 -172.348 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 28.8 mt-10 -57.2 129.8 43.38 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 119.68 1.127 . . . . 0.0 111.25 -168.544 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 73.9 -2.0 44.07 Favored Glycine 0 CA--C 1.533 1.204 0 C-N-CA 125.531 1.539 . . . . 0.0 115.023 178.32 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.04 150.3 40.71 Favored 'General case' 0 C--N 1.346 0.414 0 CA-C-N 120.663 2.231 . . . . 0.0 109.683 -176.649 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 4.3 mt -82.25 137.51 20.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 N-CA-C 106.489 -1.671 . . . . 0.0 106.489 179.068 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 67.0 t -130.92 129.49 63.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 C-N-CA 123.629 0.771 . . . . 0.0 109.515 -176.879 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.426 ' HB3' ' HA ' ' A' ' 50' ' ' ILE . . . -100.66 151.59 21.46 Favored 'General case' 0 N--CA 1.463 0.213 0 N-CA-C 107.735 -1.209 . . . . 0.0 107.735 168.715 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 4.5 mt -133.02 134.61 44.65 Favored 'General case' 0 CA--C 1.514 -0.409 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 176.394 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 37.4 p90 -149.91 168.14 24.64 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 107.692 -1.225 . . . . 0.0 107.692 168.655 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -168.19 171.22 42.42 Favored Glycine 0 N--CA 1.446 -0.656 0 N-CA-C 110.449 -1.061 . . . . 0.0 110.449 176.119 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 1.9 tm? . . . . . 0 N--CA 1.449 -0.492 0 C-N-CA 126.171 1.789 . . . . 0.0 106.781 -175.805 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 97.0 mt . . . . . 0 N--CA 1.469 0.524 0 N-CA-C 113.234 0.828 . . . . 0.0 113.234 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -65.05 -37.75 88.6 Favored 'General case' 0 N--CA 1.465 0.3 0 O-C-N 120.659 -1.275 . . . . 0.0 110.786 -170.766 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -65.45 -28.79 69.47 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 123.783 0.833 . . . . 0.0 112.304 173.971 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 5.3 tt -64.77 -49.28 71.35 Favored 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 108.039 -1.097 . . . . 0.0 108.039 174.01 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -62.33 -34.08 88.14 Favored Glycine 0 CA--C 1.529 0.948 0 N-CA-C 111.213 -0.755 . . . . 0.0 111.213 179.277 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 7.2 tpp -53.86 -50.97 65.08 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 124.683 1.193 . . . . 0.0 111.566 178.729 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.407 HD23 ' CH2' ' A' ' 65' ' ' TRP . 0.2 OUTLIER -76.52 -36.17 57.89 Favored 'General case' 0 CA--C 1.534 0.355 0 N-CA-C 109.433 -0.581 . . . . 0.0 109.433 -174.966 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 51.0 t-80 -56.99 -44.81 83.11 Favored 'General case' 0 N--CA 1.467 0.381 0 O-C-N 121.463 -0.773 . . . . 0.0 111.296 174.032 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -63.86 -43.68 95.38 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 123.609 0.764 . . . . 0.0 111.384 -178.633 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 25.1 ttmm -56.14 -43.12 77.92 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 123.476 0.71 . . . . 0.0 110.289 173.125 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 21.3 mt -85.75 -19.29 31.01 Favored 'General case' 0 CA--C 1.511 -0.529 0 N-CA-C 115.141 1.534 . . . . 0.0 115.141 -169.755 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 67.8 m -59.97 -29.8 68.67 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 119.659 1.118 . . . . 0.0 111.488 -175.375 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 27.5 p -93.66 -4.23 51.0 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 125.348 1.459 . . . . 0.0 112.316 179.62 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 32.3 mmmt -87.42 -5.94 58.64 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 124.762 1.225 . . . . 0.0 111.685 175.081 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 73.05 30.94 62.4 Favored Glycine 0 CA--C 1.523 0.586 0 CA-C-N 118.368 0.531 . . . . 0.0 112.116 172.712 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 5.3 m -76.15 174.48 0.84 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 CA-C-N 118.211 1.005 . . . . 0.0 109.151 171.752 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -114.29 127.36 55.83 Favored 'General case' 0 CA--C 1.515 -0.372 0 N-CA-C 106.786 -1.561 . . . . 0.0 106.786 170.385 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 66.9 m-85 -92.31 144.69 25.13 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 119.652 1.115 . . . . 0.0 109.865 -178.155 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 35.4 m -131.83 157.34 43.12 Favored 'Isoleucine or valine' 0 C--O 1.234 0.267 0 C-N-CA 125.493 1.517 . . . . 0.0 107.527 169.396 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 86.15 29.61 24.9 Favored Glycine 0 CA--C 1.521 0.41 0 CA-C-O 118.334 -1.259 . . . . 0.0 114.741 169.833 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 11.7 m-30 -62.96 157.91 20.59 Favored 'General case' 0 CA--C 1.541 0.626 0 CA-C-N 119.07 1.435 . . . . 0.0 108.918 168.978 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 36.3 t-105 -135.72 143.55 45.17 Favored Pre-proline 0 N--CA 1.467 0.39 0 CA-C-O 118.008 -0.996 . . . . 0.0 111.95 -168.833 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -59.02 129.05 30.07 Favored 'Trans proline' 0 N--CA 1.458 -0.58 0 C-N-CA 122.986 2.457 . . . . 0.0 111.044 176.124 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 9.0 p . . . . . 0 CA--C 1.534 0.364 0 C-N-CA 123.297 0.639 . . . . 0.0 111.705 169.884 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 28.2 ttmt . . . . . 0 CA--C 1.542 0.654 0 CA-C-O 117.531 -1.223 . . . . 0.0 114.073 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -82.59 4.9 6.74 Favored 'Trans proline' 0 C--N 1.351 0.674 0 C-N-CA 122.017 1.812 . . . . 0.0 113.882 -179.074 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 16.7 m -128.06 166.09 25.91 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.186 0 CA-C-N 121.033 1.742 . . . . 0.0 112.24 -172.805 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 16.1 pt -131.48 168.57 23.6 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.474 0 C-N-CA 127.674 2.39 . . . . 0.0 108.833 179.023 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . 55.88 39.03 30.67 Favored 'General case' 0 CA--C 1.529 0.163 0 C-N-CA 125.199 1.4 . . . . 0.0 113.328 169.746 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 27.6 t70 59.22 43.29 17.22 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 126.412 1.885 . . . . 0.0 111.715 -177.528 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 89.8 18.86 50.01 Favored Glycine 0 CA--C 1.528 0.905 0 CA-C-N 115.574 -0.739 . . . . 0.0 113.461 171.204 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -85.9 -21.78 27.81 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 125.016 1.326 . . . . 0.0 111.836 -177.662 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 9.8 tp -150.13 144.97 26.04 Favored 'General case' 0 C--N 1.341 0.222 0 CA-C-N 119.322 0.964 . . . . 0.0 110.785 176.948 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 55.8 m-85 -82.33 144.26 30.7 Favored 'General case' 0 CA--C 1.517 -0.293 0 N-CA-C 107.864 -1.162 . . . . 0.0 107.864 169.922 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 17.0 m -76.77 12.03 0.39 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.57 0 C-N-CA 124.43 1.092 . . . . 0.0 112.238 178.827 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -179.64 171.76 43.45 Favored Glycine 0 CA--C 1.526 0.769 0 N-CA-C 109.761 -1.335 . . . . 0.0 109.761 -178.321 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 0.413 ' HB2' ' CD1' ' A' ' 160' ' ' TRP . 8.0 tp -64.11 134.24 54.51 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 117.617 0.709 . . . . 0.0 110.891 177.579 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -93.49 127.57 39.2 Favored 'General case' 0 N--CA 1.441 -0.9 0 C-N-CA 125.393 1.477 . . . . 0.0 109.627 174.441 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 84.5 mt . . . . . 0 C--O 1.234 0.239 0 N-CA-C 105.83 -1.915 . . . . 0.0 105.83 167.718 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 5.2 m . . . . . 0 CA--C 1.535 0.388 0 N-CA-C 110.296 -0.261 . . . . 0.0 110.296 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -62.17 -45.87 91.48 Favored 'General case' 0 N--CA 1.463 0.178 0 C-N-CA 123.285 0.634 . . . . 0.0 110.415 175.157 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 -63.04 -43.04 99.78 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 123.593 0.757 . . . . 0.0 110.416 179.549 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 2.3 mpt_? -59.14 -45.83 89.92 Favored 'General case' 0 C--N 1.335 -0.05 0 C-N-CA 123.976 0.91 . . . . 0.0 110.368 177.598 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 34.9 mt -64.67 -53.09 46.48 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 176.847 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 158' ' ' GLN . . . . . 0.4 ' HA ' HD13 ' A' ' 24' ' ' ILE . 0.9 OUTLIER -54.28 -66.34 0.41 Allowed 'General case' 0 CA--C 1.518 -0.287 0 C-N-CA 125.437 1.495 . . . . 0.0 112.246 -169.916 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 16.3 m -60.94 -33.7 73.59 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.747 -0.66 . . . . 0.0 111.594 -174.825 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 160' ' ' TRP . . . . . 0.413 ' CD1' ' HB2' ' A' ' 142' ' ' LEU . 67.5 t90 -65.14 -44.99 86.86 Favored 'General case' 0 C--O 1.223 -0.293 0 O-C-N 121.956 -0.465 . . . . 0.0 110.552 173.9 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 65.8 m -60.33 -41.24 93.15 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 118.298 0.499 . . . . 0.0 110.763 179.672 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -62.57 -45.68 91.79 Favored 'General case' 0 C--O 1.228 -0.073 0 CA-C-N 118.818 0.736 . . . . 0.0 110.063 173.201 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 14.4 tt0 -61.53 -48.56 80.49 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-O 117.923 -1.037 . . . . 0.0 110.363 -175.522 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 40.7 pt -65.57 -33.8 66.08 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.422 0 CA-C-O 117.918 -1.039 . . . . 0.0 110.282 -178.299 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -73.05 -31.02 64.14 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 119.58 1.082 . . . . 0.0 108.765 -175.033 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -69.08 -55.87 9.42 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 125.028 1.331 . . . . 0.0 109.194 170.945 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 19.5 tt0 -67.76 -30.68 70.2 Favored 'General case' 0 N--CA 1.442 -0.837 0 C-N-CA 125.546 1.538 . . . . 0.0 110.504 -168.545 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 168' ' ' MET . . . . . . . . . . . . . 20.2 ptp -75.8 -29.13 58.62 Favored 'General case' 0 CA--C 1.523 -0.058 0 O-C-N 122.023 -0.423 . . . . 0.0 111.743 174.708 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -78.3 -33.37 49.41 Favored 'General case' 0 N--CA 1.444 -0.73 0 C-N-CA 123.228 0.611 . . . . 0.0 111.639 179.729 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 . . . . . 0 N--CA 1.468 0.447 0 CA-C-O 122.324 1.059 . . . . 0.0 109.149 175.822 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 34.6 ttp . . . . . 0 N--CA 1.494 1.753 0 N-CA-C 110.368 -0.234 . . . . 0.0 110.368 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 29.1 p-10 -144.51 166.66 24.51 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 126.612 1.965 . . . . 0.0 108.367 177.955 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 1.5 mpt? -129.04 124.4 34.78 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 118.567 0.621 . . . . 0.0 111.1 -179.797 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -90.42 142.1 16.19 Favored Glycine 0 CA--C 1.526 0.724 0 N-CA-C 107.139 -2.384 . . . . 0.0 107.139 167.815 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 1.2 tt -132.2 97.55 4.16 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 119.911 1.855 . . . . 0.0 106.659 -169.866 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -105.03 144.48 31.78 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-O 121.64 0.733 . . . . 0.0 112.138 -170.408 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 35.4 p90 . . . . . 0 CA--C 1.533 0.326 0 C-N-CA 126.698 1.999 . . . . 0.0 107.539 179.512 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.338 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -62.74 -48.26 79.99 Favored 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 123.761 0.825 . . . . 0.0 111.379 -175.707 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -67.51 -35.78 79.79 Favored 'General case' 0 CA--C 1.535 0.402 0 O-C-N 121.795 -0.565 . . . . 0.0 110.426 178.96 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 28.9 mtpp -67.39 -37.63 83.42 Favored 'General case' 0 N--CA 1.465 0.293 0 O-C-N 121.272 -0.893 . . . . 0.0 111.182 177.568 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 32.9 mt -56.75 -54.58 27.47 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.25 0 N-CA-C 108.404 -0.961 . . . . 0.0 108.404 175.09 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 22.2 ptt180 -63.31 -37.73 88.42 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 118.904 0.774 . . . . 0.0 110.635 -178.11 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -64.57 -37.78 88.72 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 109.865 -0.42 . . . . 0.0 109.865 -174.736 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.431 HD13 ' HA ' ' A' ' 158' ' ' GLN . 75.6 mt -79.79 -54.47 11.09 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.573 0 C-N-CA 124.805 1.242 . . . . 0.0 110.167 -175.081 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 77.7 mt -62.61 -48.3 88.86 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.292 0 C-N-CA 122.719 0.408 . . . . 0.0 110.172 179.908 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 142.01 119.24 1.48 Allowed Glycine 0 CA--C 1.53 1.026 0 C-N-CA 125.207 1.384 . . . . 0.0 110.449 -179.087 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -76.88 -4.43 14.91 Favored 'Trans proline' 0 CA--C 1.538 0.717 0 C-N-CA 122.829 2.353 . . . . 0.0 113.491 -171.141 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -82.35 -22.68 35.42 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 118.918 0.781 . . . . 0.0 111.157 177.15 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 1.2 pt? -118.51 -21.28 8.06 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 124.847 1.259 . . . . 0.0 113.216 -174.117 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 59.0 t -91.45 147.23 5.41 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.504 0 N-CA-C 107.608 -1.256 . . . . 0.0 107.608 168.714 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 16.5 m -132.13 134.11 45.06 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 125.193 1.397 . . . . 0.0 107.833 178.494 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 18.7 mt -79.43 141.13 37.09 Favored 'General case' 0 N--CA 1.466 0.336 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 175.248 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 21.8 t-80 -135.15 54.09 1.95 Allowed 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 124.761 1.224 . . . . 0.0 108.259 -176.766 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 28.4 t-20 -55.21 124.13 15.96 Favored 'General case' 0 C--O 1.235 0.311 0 N-CA-C 107.348 -1.352 . . . . 0.0 107.348 170.935 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 32.3 mt -72.56 -16.94 61.75 Favored 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 113.105 0.78 . . . . 0.0 113.105 -170.509 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 9.8 tppt? -66.88 -31.06 71.41 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-N 119.354 0.979 . . . . 0.0 109.492 168.078 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -92.48 -36.35 13.12 Favored 'General case' 0 C--O 1.235 0.321 0 N-CA-C 113.525 0.935 . . . . 0.0 113.525 -168.985 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 2.3 t0 -140.47 156.96 46.18 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-N 118.949 0.795 . . . . 0.0 112.477 178.13 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 17.8 m -79.97 160.06 69.58 Favored Pre-proline 0 CA--C 1.541 0.625 0 C-N-CA 126.23 1.812 . . . . 0.0 111.299 -170.249 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -76.0 -24.85 10.92 Favored 'Trans proline' 0 C--N 1.351 0.7 0 C-N-CA 122.41 2.073 . . . . 0.0 113.41 -171.412 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 3.7 mmmm -67.12 -17.74 65.0 Favored 'General case' 0 CA--C 1.542 0.671 0 O-C-N 120.745 -1.222 . . . . 0.0 110.774 -174.968 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -59.49 -31.05 69.0 Favored 'General case' 0 N--CA 1.465 0.317 0 C-N-CA 126.803 2.041 . . . . 0.0 110.548 171.235 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 56.3 mtt -59.24 -24.31 63.07 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 118.83 0.741 . . . . 0.0 111.157 -178.672 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 63.3 mt-10 -64.78 -31.83 73.24 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-N 118.464 0.575 . . . . 0.0 110.385 -178.791 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 24.0 mt-30 -69.93 -39.37 76.16 Favored 'General case' 0 N--CA 1.466 0.354 0 N-CA-C 114.093 1.146 . . . . 0.0 114.093 -169.2 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 53.6 m-85 -72.25 141.58 48.95 Favored 'General case' 0 CA--C 1.528 0.12 0 C-N-CA 123.075 0.55 . . . . 0.0 111.388 -165.928 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 57.6 m-20 -69.68 -30.24 67.86 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 123.651 0.78 . . . . 0.0 110.268 176.564 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 19.0 t -126.15 147.2 30.98 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.467 0 N-CA-C 106.973 -1.491 . . . . 0.0 106.973 172.946 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 22.5 tp -124.87 150.01 46.92 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 169.873 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.44 HG12 ' HB3' ' A' ' 83' ' ' ALA . 43.5 mt -128.9 127.73 66.58 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 N-CA-C 104.596 -2.372 . . . . 0.0 104.596 178.426 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 3.2 mp -107.59 132.88 52.81 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 125.867 1.667 . . . . 0.0 106.791 -178.164 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -139.15 128.7 4.13 Favored Glycine 0 C--N 1.34 0.771 0 N-CA-C 109.182 -1.567 . . . . 0.0 109.182 -177.825 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 3.5 tt -151.77 134.45 8.79 Favored Pre-proline 0 CA--C 1.534 0.363 0 CA-C-N 118.437 1.119 . . . . 0.0 111.685 -179.136 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 75.6 Cg_endo . . . . . 0 N--CA 1.454 -0.843 0 C-N-CA 121.834 1.69 . . . . 0.0 108.827 168.049 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 73.8 mt . . . . . 0 CA--C 1.544 0.717 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 -76.98 159.77 29.68 Favored 'General case' 0 N--CA 1.465 0.32 0 C-N-CA 123.723 0.809 . . . . 0.0 109.074 178.33 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -55.36 -41.94 73.24 Favored 'General case' 0 C--O 1.225 -0.23 0 C-N-CA 123.645 0.778 . . . . 0.0 110.643 -179.96 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 22.7 m-20 -62.95 -26.25 68.74 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 123.123 0.569 . . . . 0.0 112.013 -177.84 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' TRP . . . . . 0.436 ' CZ3' ' CE3' ' A' ' 69' ' ' TRP . 0.0 OUTLIER -92.53 -46.43 7.63 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 125.462 1.505 . . . . 0.0 107.483 -176.407 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 13.7 tt0 -63.21 -36.65 84.34 Favored 'General case' 0 N--CA 1.445 -0.69 0 O-C-N 120.073 -1.642 . . . . 0.0 110.355 179.396 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -58.53 -26.09 63.15 Favored 'General case' 0 C--O 1.234 0.239 0 C-N-CA 123.844 0.858 . . . . 0.0 111.368 -175.115 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 34.9 m -105.15 -18.01 7.17 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.416 0 CA-C-O 117.221 -1.371 . . . . 0.0 112.51 177.607 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' TRP . . . . . 0.436 ' CE3' ' CZ3' ' A' ' 65' ' ' TRP . 1.8 t-105 -52.32 -35.04 49.77 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 120.464 1.484 . . . . 0.0 111.118 -176.023 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -68.01 -27.12 66.28 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 126.02 1.728 . . . . 0.0 113.357 177.04 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 23.1 mt-30 -92.65 -23.11 19.09 Favored 'General case' 0 C--N 1.341 0.222 0 C-N-CA 126.179 1.792 . . . . 0.0 112.262 178.249 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 71.8 mt -64.66 -26.21 68.29 Favored 'General case' 0 N--CA 1.465 0.285 0 O-C-N 121.514 -0.741 . . . . 0.0 111.861 -174.326 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -76.93 -22.55 53.13 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-N 118.329 0.513 . . . . 0.0 111.465 173.321 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -79.11 -27.88 42.92 Favored 'General case' 0 CA--C 1.534 0.36 0 O-C-N 120.986 -1.071 . . . . 0.0 112.13 179.706 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 39.3 mt -58.25 145.11 38.71 Favored 'General case' 0 C--O 1.234 0.265 0 C-N-CA 124.433 1.093 . . . . 0.0 110.629 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 22.3 t-20 -87.86 112.09 22.11 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 169.839 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 62.0 mt -120.95 6.92 10.35 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 123.558 0.743 . . . . 0.0 111.9 -172.421 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 32.1 mt-10 -51.13 133.24 28.09 Favored 'General case' 0 C--O 1.235 0.319 0 C-N-CA 124.837 1.255 . . . . 0.0 112.551 -168.857 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 71.81 -6.16 10.19 Favored Glycine 0 CA--C 1.531 1.074 0 C-N-CA 125.521 1.534 . . . . 0.0 115.598 173.177 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.34 157.92 33.55 Favored 'General case' 0 C--N 1.346 0.43 0 CA-C-N 120.759 2.28 . . . . 0.0 110.02 -174.476 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 7.3 mt -84.41 139.3 17.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 N-CA-C 106.894 -1.521 . . . . 0.0 106.894 176.576 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 99.2 t -130.97 126.98 60.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 C-N-CA 123.217 0.607 . . . . 0.0 110.864 178.065 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.44 ' HB3' HG12 ' A' ' 50' ' ' ILE . . . -94.02 146.16 24.14 Favored 'General case' 0 C--O 1.233 0.223 0 N-CA-C 106.464 -1.68 . . . . 0.0 106.464 165.751 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 2.0 mt -123.75 139.61 53.81 Favored 'General case' 0 CA--C 1.513 -0.475 0 N-CA-C 106.399 -1.704 . . . . 0.0 106.399 171.93 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 31.7 p90 -152.09 167.35 28.76 Favored 'General case' 0 N--CA 1.445 -0.714 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 167.921 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -164.04 179.06 39.17 Favored Glycine 0 N--CA 1.433 -1.523 0 N-CA-C 109.643 -1.383 . . . . 0.0 109.643 170.511 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 6.1 tt . . . . . 0 N--CA 1.44 -0.956 0 N-CA-C 107.245 -1.391 . . . . 0.0 107.245 172.971 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 92.0 mt . . . . . 0 N--CA 1.47 0.543 0 N-CA-C 114.739 1.385 . . . . 0.0 114.739 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -60.56 -33.89 73.36 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 120.643 1.565 . . . . 0.0 111.554 -170.163 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -71.77 -29.86 64.94 Favored 'General case' 0 CA--C 1.535 0.397 0 N-CA-C 112.714 0.635 . . . . 0.0 112.714 176.335 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 5.5 tt -59.07 -43.92 91.82 Favored 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 173.194 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -67.07 -32.96 82.01 Favored Glycine 0 C--N 1.338 0.639 0 CA-C-O 119.678 -0.512 . . . . 0.0 112.053 -176.156 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 75.6 mtm -68.4 -41.1 80.97 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 118.108 0.954 . . . . 0.0 110.899 -178.298 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -72.75 -38.04 67.5 Favored 'General case' 0 C--N 1.347 0.497 0 CA-C-N 120.507 1.503 . . . . 0.0 110.693 175.997 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 84.9 t60 -50.61 -49.0 57.74 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 118.37 0.532 . . . . 0.0 110.517 173.589 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -65.4 -41.81 93.27 Favored 'General case' 0 C--O 1.235 0.33 0 C-N-CA 123.522 0.729 . . . . 0.0 112.804 -177.784 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 24.1 ttmm -54.7 -43.46 72.54 Favored 'General case' 0 N--CA 1.465 0.31 0 C-N-CA 123.103 0.561 . . . . 0.0 109.847 171.55 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 7.9 mt -77.91 -25.66 48.57 Favored 'General case' 0 CA--C 1.516 -0.349 0 N-CA-C 115.35 1.611 . . . . 0.0 115.35 -168.247 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 14.1 m -58.73 -33.16 69.91 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-N 120.124 1.329 . . . . 0.0 112.245 -172.658 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 22.8 p -87.23 -9.65 54.55 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 124.413 1.085 . . . . 0.0 111.956 -179.139 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 30.9 mmmt -82.04 -10.01 59.36 Favored 'General case' 0 C--N 1.346 0.416 0 C-N-CA 124.419 1.088 . . . . 0.0 111.383 173.143 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 75.13 32.93 55.51 Favored Glycine 0 CA--C 1.524 0.638 0 CA-C-O 119.665 -0.519 . . . . 0.0 112.615 169.728 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 29.8 m -76.5 179.79 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 CA-C-N 118.208 1.004 . . . . 0.0 110.38 169.602 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -116.6 134.26 55.04 Favored 'General case' 0 CA--C 1.515 -0.369 0 N-CA-C 106.374 -1.713 . . . . 0.0 106.374 169.655 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 59.3 m-85 -95.38 145.01 25.44 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 119.502 1.047 . . . . 0.0 110.17 -179.26 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 35.3 m -132.8 159.61 43.07 Favored 'Isoleucine or valine' 0 C--O 1.233 0.21 0 C-N-CA 125.03 1.332 . . . . 0.0 108.399 171.954 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 82.02 33.44 26.63 Favored Glycine 0 CA--C 1.521 0.456 0 CA-C-O 118.666 -1.074 . . . . 0.0 113.858 170.556 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 8.3 m-30 -62.38 149.93 41.09 Favored 'General case' 0 CA--C 1.544 0.749 0 CA-C-N 119.297 1.549 . . . . 0.0 109.47 169.633 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' TRP . . . . . 0.428 ' HA ' ' HD3' ' A' ' 120' ' ' PRO . 1.5 t90 -134.65 136.37 25.33 Favored Pre-proline 0 CA--C 1.541 0.603 0 CA-C-O 117.273 -1.346 . . . . 0.0 108.592 -170.998 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' PRO . . . . . 0.428 ' HD3' ' HA ' ' A' ' 119' ' ' TRP . 45.2 Cg_exo -66.45 130.26 23.3 Favored 'Trans proline' 0 C--N 1.349 0.574 0 C-N-CA 123.006 2.471 . . . . 0.0 113.366 -172.369 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 33.6 p . . . . . 0 CA--C 1.545 0.773 0 N-CA-C 113.235 0.828 . . . . 0.0 113.235 172.875 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 47.1 mttp . . . . . 0 N--CA 1.473 0.679 0 CA-C-O 117.848 -1.072 . . . . 0.0 113.199 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -86.58 13.44 2.72 Favored 'Trans proline' 0 N--CA 1.457 -0.659 0 C-N-CA 122.043 1.829 . . . . 0.0 113.057 -171.524 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 15.2 m -127.55 146.23 33.62 Favored 'Isoleucine or valine' 0 C--O 1.232 0.179 0 CA-C-N 121.521 1.964 . . . . 0.0 111.04 -179.297 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 14.5 pt -102.8 169.01 2.01 Favored 'Isoleucine or valine' 0 C--O 1.235 0.313 0 C-N-CA 125.68 1.592 . . . . 0.0 108.96 170.483 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . 56.72 30.96 18.5 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 124.829 1.251 . . . . 0.0 113.514 167.93 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 27.6 t70 55.1 38.98 31.34 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 126.736 2.014 . . . . 0.0 111.292 -176.23 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 98.14 71.74 1.04 Allowed Glycine 0 C--N 1.338 0.693 0 C-N-CA 124.401 1.0 . . . . 0.0 111.29 176.721 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 76.3 mm-40 -120.33 -48.56 2.31 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 123.048 0.539 . . . . 0.0 110.895 167.784 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -131.34 141.98 50.0 Favored 'General case' 0 N--CA 1.467 0.408 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 179.52 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 62.9 m-85 -75.82 18.83 0.23 Allowed 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 125.86 1.664 . . . . 0.0 115.215 177.315 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 4.2 m 49.25 10.8 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.552 1.031 0 C-N-CA 127.576 2.351 . . . . 0.0 114.546 -176.491 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 170.46 175.2 39.05 Favored Glycine 0 CA--C 1.53 1.005 0 C-N-CA 125.941 1.734 . . . . 0.0 108.883 -169.334 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -71.6 141.07 50.0 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 118.439 1.12 . . . . 0.0 111.983 -177.382 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -99.72 129.77 45.87 Favored 'General case' 0 N--CA 1.446 -0.65 0 C-N-CA 126.523 1.929 . . . . 0.0 110.004 174.167 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 86.2 mt . . . . . 0 N--CA 1.463 0.214 0 N-CA-C 106.554 -1.647 . . . . 0.0 106.554 168.178 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 16.0 m . . . . . 0 CA--C 1.534 0.362 0 CA-C-O 119.623 -0.227 . . . . 0.0 111.404 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -62.61 -43.53 98.58 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 118.141 0.428 . . . . 0.0 110.705 176.109 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 12.6 tt0 -67.88 -41.01 83.46 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 124.889 1.276 . . . . 0.0 110.747 -178.497 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.88 -45.11 86.88 Favored 'General case' 0 N--CA 1.463 0.221 0 C-N-CA 124.338 1.055 . . . . 0.0 110.43 173.464 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 43.8 mt -67.03 -55.74 16.54 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.345 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 179.112 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 158' ' ' GLN . . . . . 0.431 ' HA ' HD13 ' A' ' 24' ' ' ILE . 0.4 OUTLIER -50.25 -69.13 0.12 Allowed 'General case' 0 C--O 1.234 0.263 0 C-N-CA 125.888 1.675 . . . . 0.0 112.035 -170.338 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 8.3 m -61.31 -33.42 73.57 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.859 -0.609 . . . . 0.0 111.744 -172.955 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 160' ' ' TRP . . . . . . . . . . . . . 79.6 t90 -66.13 -44.71 83.45 Favored 'General case' 0 CA--C 1.517 -0.326 0 O-C-N 121.833 -0.542 . . . . 0.0 110.988 175.041 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 68.6 m -59.51 -42.15 91.56 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 122.937 0.495 . . . . 0.0 110.501 179.095 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -62.05 -42.45 99.2 Favored 'General case' 0 CA--C 1.523 -0.082 0 CA-C-N 118.57 0.623 . . . . 0.0 110.467 174.869 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 16.4 tt0 -64.58 -51.01 64.95 Favored 'General case' 0 N--CA 1.446 -0.641 0 CA-C-O 118.691 -0.671 . . . . 0.0 110.019 -177.018 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 40.3 pt -63.27 -37.62 79.96 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.442 0 CA-C-O 117.815 -1.088 . . . . 0.0 109.531 -175.465 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -65.87 -32.97 74.79 Favored 'General case' 0 N--CA 1.462 0.165 0 CA-C-N 119.495 1.043 . . . . 0.0 110.329 -178.948 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 35.1 m-80 -69.6 -59.2 3.12 Favored 'General case' 0 C--O 1.223 -0.302 0 N-CA-C 108.099 -1.075 . . . . 0.0 108.099 174.053 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 19.4 tt0 -61.41 -34.31 75.15 Favored 'General case' 0 N--CA 1.443 -0.779 0 C-N-CA 126.412 1.885 . . . . 0.0 111.765 -168.788 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 168' ' ' MET . . . . . . . . . . . . . 22.1 ptp -72.46 -35.09 68.16 Favored 'General case' 0 C--O 1.228 -0.077 0 C-N-CA 123.415 0.686 . . . . 0.0 111.67 173.512 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -74.98 -38.35 61.66 Favored 'General case' 0 N--CA 1.445 -0.724 0 CA-C-O 119.153 -0.451 . . . . 0.0 111.935 -177.026 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 . . . . . 0 N--CA 1.465 0.303 0 CA-C-O 121.446 0.641 . . . . 0.0 109.839 178.611 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.7 tmm? . . . . . 0 N--CA 1.494 1.755 0 CA-C-O 120.604 0.24 . . . . 0.0 110.603 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 21.9 p-10 -146.6 165.58 29.11 Favored 'General case' 0 N--CA 1.465 0.321 0 C-N-CA 126.334 1.854 . . . . 0.0 109.327 174.567 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 17.5 mtt -127.07 133.87 50.37 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 118.287 0.494 . . . . 0.0 111.144 -179.191 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -104.11 135.82 12.66 Favored Glycine 0 CA--C 1.526 0.722 0 N-CA-C 107.574 -2.21 . . . . 0.0 107.574 168.215 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 4.0 tt -122.93 111.11 16.24 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 105.78 -1.933 . . . . 0.0 105.78 -173.937 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . 0.426 ' CD1' HD11 ' A' ' 35' ' ' LEU . 1.1 p90 -114.64 146.48 40.8 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 118.71 0.686 . . . . 0.0 110.683 -177.711 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 33.0 p90 . . . . . 0 CA--C 1.533 0.318 0 C-N-CA 124.312 1.045 . . . . 0.0 108.44 179.666 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.259 0 N-CA-C 109.935 -0.395 . . . . 0.0 109.935 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -64.27 -48.74 74.56 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 124.274 1.029 . . . . 0.0 111.18 -176.777 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 6.4 mt-10 -58.96 -43.56 91.33 Favored 'General case' 0 CA--C 1.516 -0.351 0 N-CA-C 109.972 -0.381 . . . . 0.0 109.972 175.641 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 28.9 mtpp -72.13 -41.99 66.55 Favored 'General case' 0 C--O 1.221 -0.402 0 CA-C-O 117.848 -1.072 . . . . 0.0 110.533 -173.334 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 41.2 mt -51.88 -54.93 11.17 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.314 0 CA-C-N 120.301 1.409 . . . . 0.0 108.349 172.544 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 7.9 ttp180 -61.74 -41.7 98.0 Favored 'General case' 0 C--O 1.222 -0.386 0 C-N-CA 123.605 0.762 . . . . 0.0 109.721 -175.193 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -66.56 -42.24 87.37 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 122.878 0.471 . . . . 0.0 111.159 -178.653 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 51.3 mt -71.48 -52.52 25.7 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 C-N-CA 124.749 1.22 . . . . 0.0 109.843 -172.652 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 82.8 mt -67.66 -45.86 83.97 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.433 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 138.75 124.49 2.22 Favored Glycine 0 CA--C 1.53 1.011 0 C-N-CA 125.078 1.323 . . . . 0.0 112.144 174.613 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -71.77 -7.14 20.57 Favored 'Trans proline' 0 CA--C 1.534 0.491 0 C-N-CA 123.57 2.847 . . . . 0.0 113.965 -175.483 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -77.92 -21.15 51.58 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 119.147 0.885 . . . . 0.0 111.148 176.423 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -127.67 -8.34 5.63 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 124.675 1.19 . . . . 0.0 114.011 -172.343 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 25.4 t -106.48 151.54 8.42 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.337 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 169.64 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 2.1 m -140.07 130.1 24.89 Favored 'General case' 0 C--N 1.333 -0.135 0 N-CA-C 106.236 -1.765 . . . . 0.0 106.236 -170.976 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 18.7 mt -89.19 135.64 33.46 Favored 'General case' 0 N--CA 1.464 0.273 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 177.866 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 35.6 m170 -100.57 154.21 18.75 Favored 'General case' 0 N--CA 1.464 0.24 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 169.929 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 11.6 t-20 -132.65 104.11 6.48 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 105.036 -2.209 . . . . 0.0 105.036 172.416 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.426 HD11 ' CD1' ' A' ' 6' ' ' PHE . 69.3 mt -76.59 -6.64 52.85 Favored 'General case' 0 C--O 1.235 0.313 0 N-CA-C 113.028 0.751 . . . . 0.0 113.028 -170.049 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 51.5 tptt -81.75 -14.28 56.68 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 118.803 0.728 . . . . 0.0 109.911 168.974 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -117.76 -41.29 2.93 Favored 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 124.572 1.149 . . . . 0.0 112.97 -173.844 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -106.89 155.76 19.41 Favored 'General case' 0 C--O 1.236 0.386 0 C-N-CA 125.878 1.671 . . . . 0.0 111.588 179.484 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 15.1 m -90.95 147.46 35.91 Favored Pre-proline 0 CA--C 1.539 0.521 0 C-N-CA 124.871 1.268 . . . . 0.0 110.26 -174.209 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -66.62 -20.64 53.13 Favored 'Trans proline' 0 C--N 1.349 0.594 0 C-N-CA 122.218 1.945 . . . . 0.0 113.016 -175.722 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 4.6 mptp? -56.85 -23.32 43.34 Favored 'General case' 0 CA--C 1.538 0.491 0 O-C-N 121.328 -0.857 . . . . 0.0 111.712 174.106 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 5.9 mt -61.87 -32.33 72.68 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 119.477 1.035 . . . . 0.0 111.252 175.682 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 59.8 mtt -60.13 -25.48 65.51 Favored 'General case' 0 N--CA 1.462 0.138 0 C-N-CA 123.774 0.829 . . . . 0.0 111.631 -179.911 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -60.23 -33.83 72.82 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 118.401 0.546 . . . . 0.0 109.95 179.112 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 29.9 mt-30 -72.36 -28.08 62.8 Favored 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 114.121 1.156 . . . . 0.0 114.121 -169.679 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 63.1 m-85 -85.27 138.92 32.01 Favored 'General case' 0 N--CA 1.464 0.258 0 C-N-CA 122.718 0.407 . . . . 0.0 110.222 -167.7 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 26.8 m-20 -67.49 -39.3 85.19 Favored 'General case' 0 N--CA 1.465 0.324 0 N-CA-C 109.838 -0.43 . . . . 0.0 109.838 178.484 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 17.3 t -114.35 143.87 23.13 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.379 0 N-CA-C 107.74 -1.207 . . . . 0.0 107.74 173.302 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 18.3 tp -123.55 143.4 50.22 Favored 'General case' 0 N--CA 1.444 -0.749 0 N-CA-C 107.728 -1.212 . . . . 0.0 107.728 169.339 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 45.9 mt -124.45 126.74 72.37 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 N-CA-C 105.426 -2.065 . . . . 0.0 105.426 179.98 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 3.0 mp -110.02 123.2 49.24 Favored 'General case' 0 CA--C 1.516 -0.33 0 N-CA-C 107.143 -1.429 . . . . 0.0 107.143 -173.012 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -122.74 133.55 9.2 Favored Glycine 0 N--CA 1.459 0.193 0 N-CA-C 109.831 -1.307 . . . . 0.0 109.831 175.627 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 4.3 tt -155.13 125.59 3.39 Favored Pre-proline 0 CA--C 1.538 0.509 0 CA-C-N 118.648 1.224 . . . . 0.0 112.67 169.637 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_exo . . . . . 0 N--CA 1.452 -0.922 0 C-N-CA 122.378 2.052 . . . . 0.0 111.278 166.02 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 63.9 mt . . . . . 0 CA--C 1.54 0.589 0 N-CA-C 105.029 -2.212 . . . . 0.0 105.029 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . 0.448 ' NE2' ' H ' ' A' ' 62' ' ' GLN . 1.7 pm0 -74.57 162.88 28.35 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 124.182 0.993 . . . . 0.0 109.891 175.197 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -48.06 -49.22 32.18 Favored 'General case' 0 C--O 1.226 -0.179 0 C-N-CA 125.45 1.5 . . . . 0.0 112.412 -169.413 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -69.33 -19.52 63.87 Favored 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 112.559 0.577 . . . . 0.0 112.559 -170.378 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' TRP . . . . . 0.806 ' CH2' HD23 ' A' ' 104' ' ' LEU . 3.6 t90 -92.68 -41.46 10.16 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 125.026 1.33 . . . . 0.0 109.022 176.916 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -64.16 -35.52 81.04 Favored 'General case' 0 CA--C 1.537 0.48 0 O-C-N 121.102 -0.999 . . . . 0.0 109.704 177.163 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -62.06 -26.26 68.16 Favored 'General case' 0 C--O 1.233 0.233 0 C-N-CA 124.301 1.04 . . . . 0.0 110.747 -178.956 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.424 HG21 HD13 ' A' ' 35' ' ' LEU . 30.5 m -102.68 -20.38 5.67 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.552 0 CA-C-O 116.438 -1.744 . . . . 0.0 112.373 175.249 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 20.5 t90 -55.18 -36.48 65.93 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 121.508 1.958 . . . . 0.0 110.713 -177.5 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -64.1 -27.77 69.32 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 125.12 1.368 . . . . 0.0 112.939 174.418 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 58.4 mt-30 -97.13 -22.72 16.59 Favored 'General case' 0 C--O 1.224 -0.254 0 C-N-CA 126.802 2.041 . . . . 0.0 112.016 -176.494 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.494 ' CD1' HD21 ' A' ' 104' ' ' LEU . 77.7 mt -62.39 -25.99 68.23 Favored 'General case' 0 N--CA 1.462 0.149 0 O-C-N 121.5 -0.75 . . . . 0.0 110.511 178.0 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -78.33 -29.82 47.86 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 117.845 0.293 . . . . 0.0 110.452 172.279 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -72.41 -32.05 66.03 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 123.84 0.856 . . . . 0.0 112.56 -179.261 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 26.0 mt -53.64 142.84 21.82 Favored 'General case' 0 C--O 1.235 0.322 0 C-N-CA 123.906 0.882 . . . . 0.0 112.537 -169.689 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 26.3 t-20 -81.2 88.0 6.06 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 172.154 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 3.8 pp -144.37 132.71 21.92 Favored 'General case' 0 N--CA 1.454 -0.238 0 N-CA-C 108.579 -0.896 . . . . 0.0 108.579 172.001 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 22.6 mt-10 -140.14 146.52 38.93 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 128.591 2.757 . . . . 0.0 107.19 168.693 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 68.9 -3.57 6.55 Favored Glycine 0 CA--C 1.533 1.202 0 N-CA-C 116.793 1.477 . . . . 0.0 116.793 169.968 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.19 157.86 36.34 Favored 'General case' 0 C--N 1.345 0.389 0 CA-C-N 120.181 1.99 . . . . 0.0 110.021 -174.439 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 4.4 mt -80.42 135.25 25.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 N-CA-C 107.377 -1.342 . . . . 0.0 107.377 178.587 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 67.7 t -132.91 129.73 58.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 C-N-CA 124.604 1.162 . . . . 0.0 109.405 -176.924 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -105.98 153.72 21.61 Favored 'General case' 0 N--CA 1.462 0.136 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 168.549 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 1.4 mt -134.49 137.47 43.93 Favored 'General case' 0 CA--C 1.512 -0.484 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 176.214 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 36.7 p90 -154.98 170.94 20.59 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 170.957 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . 0.435 ' HA3' HD11 ' A' ' 101' ' ' LEU . . . 178.25 161.03 25.56 Favored Glycine 0 N--CA 1.445 -0.758 0 C-N-CA 120.701 -0.761 . . . . 0.0 111.919 168.336 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 58.4 tp . . . . . 0 N--CA 1.442 -0.841 0 C-N-CA 126.426 1.89 . . . . 0.0 110.981 178.995 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 90.6 mt . . . . . 0 CA--C 1.538 0.511 0 N-CA-C 114.117 1.155 . . . . 0.0 114.117 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -56.98 -35.17 68.86 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 124.739 1.216 . . . . 0.0 111.581 -175.457 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -72.61 -22.41 60.97 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-O 118.061 -0.971 . . . . 0.0 112.499 178.204 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.435 HD11 ' HA3' ' A' ' 86' ' ' GLY . 9.4 mp -65.76 -41.26 92.3 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-N 120.265 1.393 . . . . 0.0 108.172 169.003 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -65.9 -40.06 95.27 Favored Glycine 0 C--N 1.339 0.729 0 N-CA-C 110.76 -0.936 . . . . 0.0 110.76 -176.123 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 74.7 mtm -62.3 -39.9 94.54 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-O 118.681 -0.676 . . . . 0.0 111.619 178.409 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.806 HD23 ' CH2' ' A' ' 65' ' ' TRP . 0.1 OUTLIER -73.23 -39.1 65.76 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 119.982 1.265 . . . . 0.0 110.34 175.498 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 58.9 t60 -57.95 -51.68 68.63 Favored 'General case' 0 N--CA 1.46 0.06 0 CA-C-N 118.282 0.492 . . . . 0.0 110.189 -179.089 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -61.86 -38.81 89.62 Favored 'General case' 0 C--O 1.234 0.259 0 C-N-CA 123.87 0.868 . . . . 0.0 112.08 -175.783 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 24.4 ttmm -56.8 -39.95 75.06 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 123.542 0.737 . . . . 0.0 110.42 172.599 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 43.6 mt -91.04 -19.83 22.74 Favored 'General case' 0 CA--C 1.52 -0.192 0 N-CA-C 114.32 1.229 . . . . 0.0 114.32 -169.78 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 6.5 m -58.45 -35.86 72.78 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 120.11 1.323 . . . . 0.0 111.179 179.324 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 20.3 p -81.73 -22.81 37.09 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 124.392 1.077 . . . . 0.0 111.418 179.762 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 32.2 mmmt -73.35 -12.21 60.75 Favored 'General case' 0 C--N 1.344 0.354 0 C-N-CA 123.62 0.768 . . . . 0.0 110.824 168.775 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 73.57 34.2 57.28 Favored Glycine 0 C--N 1.336 0.538 0 CA-C-N 118.948 0.794 . . . . 0.0 111.912 169.834 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 9.4 m -73.49 171.53 1.21 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 CA-C-N 118.629 1.215 . . . . 0.0 109.832 174.684 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -108.42 122.4 46.95 Favored 'General case' 0 CA--C 1.515 -0.377 0 N-CA-C 106.389 -1.708 . . . . 0.0 106.389 175.405 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 80.2 m-85 -91.89 144.69 25.22 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 119.072 0.851 . . . . 0.0 109.751 -175.53 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 31.2 m -131.77 160.29 42.5 Favored 'Isoleucine or valine' 0 C--O 1.233 0.234 0 C-N-CA 124.794 1.238 . . . . 0.0 109.188 171.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 96.77 -85.08 0.82 Allowed Glycine 0 N--CA 1.446 -0.691 0 C-N-CA 124.379 0.99 . . . . 0.0 110.654 175.904 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 80.7 m-85 54.57 -171.53 0.05 Allowed 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 124.608 1.163 . . . . 0.0 110.446 -169.301 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -156.37 147.26 16.39 Favored Pre-proline 0 N--CA 1.473 0.679 0 O-C-N 120.26 -1.525 . . . . 0.0 110.485 170.06 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -67.82 128.76 18.44 Favored 'Trans proline' 0 CA--C 1.538 0.706 0 C-N-CA 123.091 2.527 . . . . 0.0 112.365 178.36 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 14.4 p . . . . . 0 N--CA 1.469 0.494 0 O-C-N 121.631 -0.668 . . . . 0.0 112.379 173.761 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 21.8 ttmt . . . . . 0 N--CA 1.475 0.784 0 CA-C-O 117.046 -1.454 . . . . 0.0 114.698 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -74.08 -3.36 13.66 Favored 'Trans proline' 0 CA--C 1.538 0.685 0 CA-C-N 122.745 2.016 . . . . 0.0 114.089 -179.018 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 16.8 m -130.04 156.05 41.96 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.21 0 CA-C-N 119.75 1.159 . . . . 0.0 110.841 -170.685 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . 0.412 HG23 HG12 ' A' ' 140' ' ' VAL . 2.4 pt -92.79 171.19 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.598 0 C-N-CA 124.151 0.98 . . . . 0.0 109.662 169.433 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . 55.0 -151.95 0.37 Allowed 'General case' 0 N--CA 1.441 -0.876 0 CA-C-N 113.695 -1.593 . . . . 0.0 109.621 168.444 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 24.8 t0 -79.14 51.87 1.23 Allowed 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 124.99 1.316 . . . . 0.0 110.556 170.815 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 68.04 28.63 73.33 Favored Glycine 0 CA--C 1.529 0.944 0 C-N-CA 124.686 1.136 . . . . 0.0 113.167 179.913 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 20.1 mt-30 -81.39 -22.25 38.45 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 118.281 1.041 . . . . 0.0 112.476 -169.902 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 8.8 tp -156.22 143.94 19.45 Favored 'General case' 0 C--N 1.344 0.326 0 CA-C-N 118.21 0.459 . . . . 0.0 111.013 -178.736 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 74.7 m-85 -73.77 140.36 45.84 Favored 'General case' 0 CA--C 1.516 -0.355 0 N-CA-C 107.479 -1.304 . . . . 0.0 107.479 169.601 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . 0.412 HG12 HG23 ' A' ' 133' ' ' ILE . 27.6 m -66.13 -3.73 1.94 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.588 0 N-CA-C 113.285 0.846 . . . . 0.0 113.285 -179.083 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -177.33 170.87 43.57 Favored Glycine 0 N--CA 1.447 -0.607 0 C-N-CA 125.046 1.308 . . . . 0.0 110.215 -171.447 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -60.59 127.36 31.32 Favored 'General case' 0 C--O 1.234 0.287 0 C-N-CA 123.351 0.66 . . . . 0.0 110.945 -175.255 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -79.91 118.95 22.13 Favored 'General case' 0 N--CA 1.446 -0.669 0 C-N-CA 124.838 1.255 . . . . 0.0 108.521 169.87 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 13.8 tp . . . . . 0 N--CA 1.449 -0.499 0 N-CA-C 108.169 -1.048 . . . . 0.0 108.169 172.811 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 7.7 m . . . . . 0 CA--C 1.536 0.425 0 N-CA-C 110.012 -0.366 . . . . 0.0 110.012 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -63.17 -43.74 97.41 Favored 'General case' 0 N--CA 1.463 0.191 0 C-N-CA 123.576 0.75 . . . . 0.0 111.369 171.307 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 29.0 tt0 -63.92 -41.22 97.71 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 124.546 1.139 . . . . 0.0 110.795 178.814 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 3.5 mmt180 -65.64 -39.48 91.49 Favored 'General case' 0 CA--C 1.527 0.063 0 CA-C-O 118.627 -0.702 . . . . 0.0 109.187 -178.225 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 35.3 mt -66.0 -57.71 9.54 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.426 0 N-CA-C 107.474 -1.306 . . . . 0.0 107.474 173.771 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 68.4 tp60 -47.69 -65.12 0.62 Allowed 'General case' 0 CA--C 1.52 -0.196 0 C-N-CA 125.298 1.439 . . . . 0.0 112.861 -174.619 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 19.9 m -66.31 -31.36 72.11 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 121.26 -0.176 . . . . 0.0 110.855 -169.592 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 160' ' ' TRP . . . . . . . . . . . . . 67.3 t90 -71.28 -45.46 63.07 Favored 'General case' 0 C--O 1.224 -0.26 0 O-C-N 121.93 -0.481 . . . . 0.0 111.035 177.426 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 85.5 m -58.81 -42.13 88.44 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 123.074 0.55 . . . . 0.0 109.855 176.349 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 162' ' ' GLU . . . . . 0.427 ' HA ' HD23 ' A' ' 165' ' ' LEU . 38.0 mt-10 -64.07 -43.45 95.4 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-O 121.28 0.562 . . . . 0.0 110.335 177.325 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 10.8 tt0 -60.07 -51.2 70.65 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 124.006 0.922 . . . . 0.0 110.068 -179.563 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 40.2 pt -62.86 -36.06 73.9 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.394 0 CA-C-O 117.937 -1.03 . . . . 0.0 109.253 -176.603 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . 0.427 HD23 ' HA ' ' A' ' 162' ' ' GLU . 0.1 OUTLIER -59.3 -37.93 78.97 Favored 'General case' 0 C--O 1.224 -0.27 0 C-N-CA 124.697 1.199 . . . . 0.0 109.478 177.416 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 33.2 m-80 -75.07 -52.54 10.79 Favored 'General case' 0 CA--C 1.515 -0.372 0 N-CA-C 108.644 -0.873 . . . . 0.0 108.644 -179.531 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 10.6 tt0 -70.43 -28.38 65.0 Favored 'General case' 0 N--CA 1.443 -0.808 0 C-N-CA 124.11 0.964 . . . . 0.0 111.582 -168.798 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 168' ' ' MET . . . . . . . . . . . . . 18.7 ptp -77.64 -31.53 52.77 Favored 'General case' 0 N--CA 1.456 -0.133 0 O-C-N 121.391 -0.818 . . . . 0.0 111.975 172.678 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -78.83 -42.52 27.41 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 122.5 0.32 . . . . 0.0 110.701 -176.31 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 . . . . . 0 CA--C 1.538 0.489 0 C-N-CA 123.542 0.737 . . . . 0.0 110.551 179.298 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.497 1.917 0 CA-C-O 119.771 -0.157 . . . . 0.0 111.188 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 25.2 p-10 -129.8 149.36 51.58 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 124.115 0.966 . . . . 0.0 112.186 -174.445 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 21.9 mtt -105.89 122.38 46.01 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 126.044 1.738 . . . . 0.0 107.213 -176.37 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -86.74 153.88 26.35 Favored Glycine 0 CA--C 1.529 0.942 0 N-CA-C 107.104 -2.398 . . . . 0.0 107.104 166.774 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 2.1 tt -142.6 96.84 3.01 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-N 120.042 1.921 . . . . 0.0 106.832 -173.499 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . 0.696 ' CZ ' HD23 ' A' ' 51' ' ' LEU . 0.5 OUTLIER -101.69 140.52 35.87 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-O 121.033 0.444 . . . . 0.0 111.691 -170.592 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 25.2 p90 . . . . . 0 CA--C 1.538 0.513 0 C-N-CA 126.456 1.903 . . . . 0.0 108.287 -177.143 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.314 0 CA-C-O 119.738 -0.173 . . . . 0.0 110.867 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -64.93 -47.1 78.91 Favored 'General case' 0 CA--C 1.527 0.089 0 C-N-CA 122.569 0.348 . . . . 0.0 111.053 -174.932 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -66.58 -35.74 80.95 Favored 'General case' 0 C--O 1.231 0.126 0 CA-C-O 118.602 -0.713 . . . . 0.0 110.735 179.175 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 48.0 mttm -65.61 -49.99 66.7 Favored 'General case' 0 C--O 1.22 -0.486 0 CA-C-O 118.339 -0.838 . . . . 0.0 110.588 175.781 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 40.7 mt -52.46 -52.15 28.2 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.336 0 CA-C-N 119.536 1.062 . . . . 0.0 108.764 178.894 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.61 -39.95 95.38 Favored 'General case' 0 C--O 1.223 -0.323 0 C-N-CA 123.119 0.568 . . . . 0.0 110.267 -177.162 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -67.92 -42.07 81.63 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 118.412 0.551 . . . . 0.0 110.917 -178.735 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 60.6 mt -72.98 -52.77 20.81 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.545 0 C-N-CA 124.911 1.284 . . . . 0.0 109.63 -170.531 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 69.7 mt -66.03 -46.75 87.24 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.375 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 178.443 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 139.37 126.05 2.32 Favored Glycine 0 CA--C 1.531 1.037 0 C-N-CA 124.8 1.191 . . . . 0.0 111.661 174.585 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -72.51 -5.66 17.57 Favored 'Trans proline' 0 CA--C 1.537 0.651 0 C-N-CA 123.593 2.862 . . . . 0.0 114.243 -173.287 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -80.1 -20.52 44.9 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-N 119.329 0.968 . . . . 0.0 111.243 176.794 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -128.02 -1.72 5.85 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 124.793 1.237 . . . . 0.0 113.861 -171.775 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 21.9 t -117.15 147.92 20.22 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.338 0 N-CA-C 107.745 -1.206 . . . . 0.0 107.745 171.748 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 15.5 m -131.66 132.9 44.35 Favored 'General case' 0 N--CA 1.463 0.203 0 N-CA-C 107.688 -1.227 . . . . 0.0 107.688 -177.835 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 17.7 mt -79.01 133.39 36.83 Favored 'General case' 0 C--O 1.233 0.198 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 175.151 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 32.2 t-80 -128.75 58.68 1.57 Allowed 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 124.674 1.19 . . . . 0.0 108.6 -177.551 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 8.0 t-20 -55.5 122.28 10.91 Favored 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 106.413 -1.699 . . . . 0.0 106.413 168.586 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 58.9 mt -66.09 -35.42 80.46 Favored 'General case' 0 C--O 1.236 0.356 0 N-CA-C 112.693 0.627 . . . . 0.0 112.693 -173.306 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 42.3 tttm -64.21 -18.82 64.88 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-O 119.011 -0.519 . . . . 0.0 111.5 172.26 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -97.6 -34.24 11.03 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-N 119.015 0.825 . . . . 0.0 112.574 -177.186 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 4.1 t0 -145.07 145.62 31.52 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 118.763 0.711 . . . . 0.0 112.33 176.636 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 12.4 m -66.72 158.49 79.46 Favored Pre-proline 0 CA--C 1.542 0.655 0 C-N-CA 126.216 1.806 . . . . 0.0 112.261 -169.389 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -73.9 -26.83 12.86 Favored 'Trans proline' 0 C--N 1.35 0.629 0 C-N-CA 122.548 2.165 . . . . 0.0 113.222 -170.993 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 22.9 mmmt -70.66 -11.63 61.06 Favored 'General case' 0 CA--C 1.538 0.497 0 O-C-N 120.456 -1.403 . . . . 0.0 111.676 -176.846 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -61.93 -29.3 70.13 Favored 'General case' 0 N--CA 1.463 0.21 0 C-N-CA 125.683 1.593 . . . . 0.0 110.14 169.142 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 39.7 mtt -55.72 -26.78 46.99 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 123.588 0.755 . . . . 0.0 111.464 178.204 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 94.2 mt-10 -65.49 -31.26 72.23 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 118.191 0.451 . . . . 0.0 110.354 -176.609 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 21.1 mt-30 -69.61 -43.84 71.94 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 123.588 0.755 . . . . 0.0 112.704 -170.103 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 57.3 m-85 -68.33 147.63 51.87 Favored 'General case' 0 C--O 1.231 0.096 0 C-N-CA 123.735 0.814 . . . . 0.0 109.135 -168.47 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -80.59 -37.0 32.02 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 119.105 0.866 . . . . 0.0 108.979 -178.926 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 1.3 m -105.51 151.31 7.7 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.806 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 169.532 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 58.4 tp -140.9 106.6 5.11 Favored 'General case' 0 N--CA 1.448 -0.562 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 174.853 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 22.3 mt -84.4 131.83 33.04 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.744 0 N-CA-C 106.139 -1.8 . . . . 0.0 106.139 176.317 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.696 HD23 ' CZ ' ' A' ' 6' ' ' PHE . 0.5 OUTLIER -106.81 131.85 53.44 Favored 'General case' 0 C--O 1.233 0.217 0 N-CA-C 107.283 -1.377 . . . . 0.0 107.283 169.693 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.579 ' N ' HD22 ' A' ' 51' ' ' LEU . . . -127.3 135.53 8.83 Favored Glycine 0 CA--C 1.521 0.456 0 N-CA-C 109.741 -1.344 . . . . 0.0 109.741 171.301 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 3.8 tt -152.05 134.95 9.06 Favored Pre-proline 0 CA--C 1.535 0.399 0 CA-C-N 118.521 1.161 . . . . 0.0 111.786 173.905 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_endo . . . . . 0 N--CA 1.456 -0.727 0 C-N-CA 122.176 1.917 . . . . 0.0 109.602 165.044 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 23.6 mt . . . . . 0 CA--C 1.54 0.58 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 2.2 pm0 -70.11 156.11 39.66 Favored 'General case' 0 C--O 1.232 0.179 0 C-N-CA 123.633 0.773 . . . . 0.0 110.302 176.108 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -54.54 -47.47 73.15 Favored 'General case' 0 N--CA 1.456 -0.167 0 C-N-CA 124.604 1.162 . . . . 0.0 112.457 -168.424 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -67.26 -31.44 71.78 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 119.503 1.047 . . . . 0.0 111.503 -172.225 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' TRP . . . . . 0.546 ' CH2' HD23 ' A' ' 104' ' ' LEU . 5.2 t90 -73.91 -44.54 54.8 Favored 'General case' 0 N--CA 1.455 -0.222 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 178.578 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -61.83 -36.79 82.22 Favored 'General case' 0 CA--C 1.537 0.464 0 O-C-N 121.397 -0.814 . . . . 0.0 109.993 176.241 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -61.91 -25.07 67.35 Favored 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 123.312 0.645 . . . . 0.0 111.117 -174.093 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 25.4 m -108.56 -13.99 10.17 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.271 0 CA-C-O 117.073 -1.441 . . . . 0.0 112.644 175.21 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 18.2 t90 -51.31 -39.46 56.96 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 120.27 1.396 . . . . 0.0 110.075 -178.611 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -66.73 -25.35 66.47 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 125.721 1.608 . . . . 0.0 113.568 177.8 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 25.8 mt-30 -92.06 -19.23 22.56 Favored 'General case' 0 C--N 1.341 0.224 0 C-N-CA 125.688 1.595 . . . . 0.0 112.348 177.007 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 52.6 mt -62.09 -25.78 67.91 Favored 'General case' 0 N--CA 1.466 0.342 0 O-C-N 121.425 -0.797 . . . . 0.0 111.399 -174.937 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -75.92 -21.95 56.55 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-N 118.026 0.376 . . . . 0.0 111.741 176.47 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -73.47 -29.37 62.49 Favored 'General case' 0 N--CA 1.467 0.413 0 O-C-N 120.827 -1.171 . . . . 0.0 111.852 177.173 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 82.9 mt -54.16 138.25 38.66 Favored 'General case' 0 C--N 1.339 0.147 0 C-N-CA 124.926 1.291 . . . . 0.0 112.911 -168.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 3.0 t30 -74.97 98.93 3.7 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 123.973 0.909 . . . . 0.0 108.978 170.166 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 56.7 mt -123.07 -0.12 8.99 Favored 'General case' 0 N--CA 1.474 0.769 0 N-CA-C 113.765 1.024 . . . . 0.0 113.765 -176.03 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 25.2 mt-10 -55.2 128.69 35.09 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 119.72 1.146 . . . . 0.0 111.581 -168.974 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 74.88 -1.97 51.94 Favored Glycine 0 CA--C 1.532 1.107 0 C-N-CA 125.487 1.518 . . . . 0.0 114.98 177.095 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.3 155.35 34.32 Favored 'General case' 0 C--N 1.346 0.421 0 CA-C-N 120.172 1.986 . . . . 0.0 109.929 -176.035 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 12.4 mt -78.87 142.52 13.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 N-CA-C 106.615 -1.624 . . . . 0.0 106.615 177.918 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 3.0 t -138.08 139.72 41.74 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 O-C-N 121.42 -0.8 . . . . 0.0 109.251 -179.051 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -117.06 147.71 42.13 Favored 'General case' 0 CA--C 1.511 -0.532 0 N-CA-C 106.43 -1.693 . . . . 0.0 106.43 170.876 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 5.9 mp -127.82 142.08 51.39 Favored 'General case' 0 CA--C 1.509 -0.622 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 170.569 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 35.8 p90 -150.04 166.85 28.47 Favored 'General case' 0 N--CA 1.445 -0.701 0 N-CA-C 107.02 -1.474 . . . . 0.0 107.02 167.644 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -163.07 167.43 37.41 Favored Glycine 0 N--CA 1.444 -0.829 0 N-CA-C 109.915 -1.274 . . . . 0.0 109.915 173.388 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 1.7 tm? . . . . . 0 N--CA 1.447 -0.585 0 N-CA-C 106.81 -1.552 . . . . 0.0 106.81 -179.702 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 95.5 mt . . . . . 0 N--CA 1.472 0.659 0 N-CA-C 113.337 0.866 . . . . 0.0 113.337 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -57.47 -39.82 77.19 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 124.56 1.144 . . . . 0.0 110.845 -178.165 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -71.46 -32.13 67.95 Favored 'General case' 0 CA--C 1.534 0.331 0 O-C-N 121.666 -0.647 . . . . 0.0 111.9 178.926 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 4.9 tt -62.83 -47.94 81.22 Favored 'General case' 0 N--CA 1.467 0.4 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 171.957 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -63.27 -39.06 97.42 Favored Glycine 0 C--N 1.338 0.66 0 N-CA-C 111.145 -0.782 . . . . 0.0 111.145 -177.314 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 67.7 mtm -64.93 -40.38 94.97 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 118.236 1.018 . . . . 0.0 111.394 176.621 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.546 HD23 ' CH2' ' A' ' 65' ' ' TRP . 0.2 OUTLIER -71.67 -31.54 66.91 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 119.752 1.16 . . . . 0.0 111.244 177.714 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 50.6 t-80 -62.65 -45.81 91.13 Favored 'General case' 0 N--CA 1.462 0.148 0 CA-C-N 118.98 0.809 . . . . 0.0 110.837 171.444 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -63.6 -44.1 95.0 Favored 'General case' 0 C--O 1.234 0.274 0 C-N-CA 122.942 0.497 . . . . 0.0 111.06 -177.09 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 22.3 ttmm -58.0 -48.6 79.53 Favored 'General case' 0 C--O 1.226 -0.177 0 C-N-CA 123.131 0.572 . . . . 0.0 109.962 172.23 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 32.9 mt -74.79 -23.27 58.48 Favored 'General case' 0 N--CA 1.461 0.091 0 CA-C-O 118.622 -0.704 . . . . 0.0 112.547 -170.839 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 70.0 m -61.04 -38.18 85.25 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 119.376 0.989 . . . . 0.0 111.261 -177.506 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 26.1 p -85.1 -6.89 59.29 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 123.551 0.74 . . . . 0.0 111.667 -178.824 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 30.7 mmmt -82.12 -7.63 59.63 Favored 'General case' 0 C--N 1.344 0.36 0 C-N-CA 124.462 1.105 . . . . 0.0 111.806 171.635 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 69.51 34.36 73.55 Favored Glycine 0 CA--C 1.525 0.688 0 CA-C-N 118.764 0.711 . . . . 0.0 111.788 173.92 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 8.0 m -77.94 172.48 1.12 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.469 0 CA-C-N 117.913 0.856 . . . . 0.0 109.383 174.34 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -111.37 116.48 31.03 Favored 'General case' 0 CA--C 1.514 -0.437 0 N-CA-C 105.938 -1.875 . . . . 0.0 105.938 177.484 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 71.4 m-85 -85.56 142.39 29.17 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 118.819 0.736 . . . . 0.0 110.135 -173.881 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 32.6 m -131.9 158.73 43.34 Favored 'Isoleucine or valine' 0 C--O 1.234 0.268 0 C-N-CA 125.612 1.565 . . . . 0.0 107.581 168.921 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 83.93 31.13 27.07 Favored Glycine 0 CA--C 1.521 0.464 0 CA-C-O 118.779 -1.012 . . . . 0.0 114.935 169.73 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 10.6 m-30 -65.78 157.13 31.12 Favored 'General case' 0 CA--C 1.546 0.823 0 CA-C-N 118.941 1.371 . . . . 0.0 109.343 169.042 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' TRP . . . . . 0.4 ' HA ' ' HD3' ' A' ' 120' ' ' PRO . 51.1 t-105 -133.88 147.39 64.01 Favored Pre-proline 0 N--CA 1.476 0.838 0 CA-C-O 118.054 -0.974 . . . . 0.0 112.095 -168.524 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' PRO . . . . . 0.4 ' HD3' ' HA ' ' A' ' 119' ' ' TRP . 50.3 Cg_exo -63.25 129.92 27.05 Favored 'Trans proline' 0 C--N 1.35 0.627 0 C-N-CA 123.077 2.518 . . . . 0.0 113.202 -177.621 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 7.6 p . . . . . 0 CA--C 1.534 0.348 0 C-N-CA 124.274 1.029 . . . . 0.0 110.764 169.299 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 25.9 ttmt . . . . . 0 CA--C 1.544 0.716 0 CA-C-O 117.64 -1.171 . . . . 0.0 113.998 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_endo -80.58 5.99 5.74 Favored 'Trans proline' 0 C--N 1.352 0.721 0 C-N-CA 122.046 1.83 . . . . 0.0 114.066 -179.6 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 19.0 m -124.07 147.89 28.4 Favored 'Isoleucine or valine' 0 C--O 1.234 0.273 0 CA-C-N 120.888 1.677 . . . . 0.0 110.982 -177.589 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . 0.822 HG23 HG12 ' A' ' 140' ' ' VAL . 2.4 pt -82.69 168.78 1.71 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 N-CA-C 108.056 -1.09 . . . . 0.0 108.056 167.158 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . 55.85 -156.12 0.27 Allowed 'General case' 0 N--CA 1.443 -0.778 0 CA-C-N 114.076 -1.42 . . . . 0.0 110.195 168.587 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 21.8 t0 -80.62 61.11 4.2 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 125.128 1.371 . . . . 0.0 108.92 169.551 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 65.13 28.39 73.49 Favored Glycine 0 CA--C 1.531 1.044 0 C-N-CA 124.302 0.953 . . . . 0.0 113.289 176.768 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 62.5 mm-40 -78.17 -27.49 48.06 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 118.125 0.963 . . . . 0.0 111.886 -169.143 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 12.7 tp -159.17 146.89 17.53 Favored 'General case' 0 C--N 1.341 0.222 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 -177.349 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 63.7 m-85 -75.82 143.09 42.06 Favored 'General case' 0 CA--C 1.517 -0.322 0 N-CA-C 107.821 -1.177 . . . . 0.0 107.821 171.775 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . 0.822 HG12 HG23 ' A' ' 133' ' ' ILE . 4.2 m -76.77 10.23 0.5 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.89 0 C-N-CA 123.818 0.847 . . . . 0.0 111.686 -178.43 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 179.25 174.0 44.96 Favored Glycine 0 CA--C 1.529 0.934 0 C-N-CA 125.837 1.684 . . . . 0.0 109.592 -175.478 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 5.0 tp -68.29 134.86 51.02 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-N 118.557 1.179 . . . . 0.0 111.089 178.094 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -96.28 107.64 20.02 Favored 'General case' 0 N--CA 1.442 -0.836 0 C-N-CA 125.367 1.467 . . . . 0.0 108.982 172.557 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 89.6 mt . . . . . 0 C--O 1.233 0.225 0 N-CA-C 108.096 -1.076 . . . . 0.0 108.096 168.742 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 12.4 m . . . . . 0 CA--C 1.536 0.438 0 N-CA-C 110.719 -0.104 . . . . 0.0 110.719 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -67.51 -39.85 85.14 Favored 'General case' 0 N--CA 1.464 0.258 0 C-N-CA 123.081 0.553 . . . . 0.0 110.853 173.224 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 28.5 tt0 -65.97 -43.33 88.22 Favored 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 124.334 1.054 . . . . 0.0 111.008 -178.326 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.6 -39.93 74.42 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 123.251 0.621 . . . . 0.0 109.475 177.383 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 53.7 mt -70.91 -54.23 18.61 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 N-CA-C 108.277 -1.008 . . . . 0.0 108.277 176.8 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 71.7 tp60 -50.51 -62.32 1.66 Allowed 'General case' 0 N--CA 1.463 0.181 0 C-N-CA 125.183 1.393 . . . . 0.0 111.97 -174.359 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 19.9 m -68.23 -31.98 71.86 Favored 'General case' 0 C--N 1.324 -0.543 0 C-N-CA 121.273 -0.171 . . . . 0.0 110.84 -169.716 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 160' ' ' TRP . . . . . . . . . . . . . 48.7 t90 -66.04 -47.3 74.81 Favored 'General case' 0 C--O 1.223 -0.304 0 O-C-N 122.157 -0.339 . . . . 0.0 110.71 173.388 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 65.5 m -59.93 -43.14 95.13 Favored 'General case' 0 N--CA 1.455 -0.195 0 C-N-CA 122.956 0.503 . . . . 0.0 110.408 -178.554 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -63.16 -40.26 97.03 Favored 'General case' 0 N--CA 1.455 -0.22 0 N-CA-C 110.223 -0.288 . . . . 0.0 110.223 176.995 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 16.6 tt0 -65.85 -51.62 57.29 Favored 'General case' 0 N--CA 1.446 -0.64 0 CA-C-O 118.787 -0.625 . . . . 0.0 110.122 -179.228 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 39.4 pt -63.5 -38.0 81.07 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.377 0 CA-C-O 117.909 -1.043 . . . . 0.0 109.667 -175.212 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -63.74 -36.07 82.66 Favored 'General case' 0 C--O 1.225 -0.225 0 CA-C-N 119.351 0.978 . . . . 0.0 109.833 179.526 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 28.4 m-80 -68.28 -52.59 32.03 Favored 'General case' 0 CA--C 1.515 -0.4 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 175.808 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 15.2 tt0 -70.69 -26.76 63.57 Favored 'General case' 0 N--CA 1.443 -0.786 0 C-N-CA 124.381 1.073 . . . . 0.0 111.504 -168.767 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 168' ' ' MET . . . . . . . . . . . . . 17.1 ptp -79.58 -30.5 41.63 Favored 'General case' 0 C--O 1.227 -0.104 0 O-C-N 120.808 -1.182 . . . . 0.0 112.219 171.699 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -79.75 -40.54 28.55 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 122.923 0.489 . . . . 0.0 111.156 -178.223 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.534 0.361 0 C-N-CA 124.342 1.057 . . . . 0.0 110.532 -178.57 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 53.6 ttp . . . . . 0 N--CA 1.497 1.905 0 N-CA-C 110.002 -0.37 . . . . 0.0 110.002 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 10.4 t30 -141.44 152.11 43.98 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 124.908 1.283 . . . . 0.0 107.639 174.681 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 11.8 mtt -113.84 121.46 44.08 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 123.246 0.618 . . . . 0.0 111.136 -175.79 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . 0.407 ' HA3' ' CD2' ' A' ' 46' ' ' TYR . . . -80.47 155.51 37.8 Favored Glycine 0 CA--C 1.521 0.41 0 N-CA-C 107.606 -2.198 . . . . 0.0 107.606 166.912 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 2.5 tt -141.47 96.01 2.92 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 105.805 -1.924 . . . . 0.0 105.805 -176.517 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -102.71 143.45 32.35 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-O 121.691 0.758 . . . . 0.0 112.142 -170.454 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 30.2 p90 . . . . . 0 N--CA 1.451 -0.384 0 C-N-CA 126.81 2.044 . . . . 0.0 107.278 177.016 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 0.239 0 N-CA-C 109.438 -0.578 . . . . 0.0 109.438 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -63.87 -46.43 84.95 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 123.728 0.811 . . . . 0.0 111.514 -176.822 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 26.5 mt-10 -58.44 -43.96 88.96 Favored 'General case' 0 CA--C 1.517 -0.303 0 C-N-CA 123.51 0.724 . . . . 0.0 109.843 174.559 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 51.2 mttm -65.1 -47.2 78.05 Favored 'General case' 0 C--O 1.222 -0.359 0 CA-C-O 118.725 -0.655 . . . . 0.0 109.984 -178.613 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 43.0 mt -52.88 -54.81 14.71 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.214 0 CA-C-N 119.024 0.829 . . . . 0.0 109.62 179.807 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.465 ' HG2' HD21 ' A' ' 32' ' ' LEU . 0.0 OUTLIER -66.45 -35.8 81.2 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 118.374 0.533 . . . . 0.0 111.257 -175.372 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -64.35 -40.41 95.8 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.855 0.359 . . . . 0.0 110.592 178.582 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 62.6 mt -78.41 -54.01 12.89 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.548 0 C-N-CA 124.674 1.19 . . . . 0.0 110.038 -170.301 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 69.5 mt -62.71 -47.51 92.54 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 178.552 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 142.33 122.59 1.77 Allowed Glycine 0 CA--C 1.528 0.903 0 C-N-CA 124.646 1.117 . . . . 0.0 110.78 177.133 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -71.87 -11.18 27.32 Favored 'Trans proline' 0 CA--C 1.537 0.666 0 C-N-CA 122.885 2.39 . . . . 0.0 113.248 -170.262 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -79.96 -18.24 50.92 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 118.844 0.747 . . . . 0.0 111.953 -179.753 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -126.89 5.82 6.61 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 125.085 1.354 . . . . 0.0 113.555 -172.618 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 36.8 t -123.91 148.63 27.97 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.518 0 C-N-CA 124.85 1.26 . . . . 0.0 107.872 172.221 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 20.3 m -134.85 131.12 37.03 Favored 'General case' 0 C--N 1.332 -0.186 0 C-N-CA 125.519 1.528 . . . . 0.0 107.851 -175.267 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.465 HD21 ' HG2' ' A' ' 22' ' ' ARG . 20.9 mt -79.72 139.68 37.23 Favored 'General case' 0 C--O 1.232 0.17 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 177.873 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 18.0 t-80 -137.22 54.8 1.84 Allowed 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 124.177 0.991 . . . . 0.0 108.936 -173.419 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 37.8 t-20 -57.27 123.13 14.29 Favored 'General case' 0 N--CA 1.465 0.283 0 N-CA-C 106.367 -1.716 . . . . 0.0 106.367 168.629 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 31.3 mt -70.75 -31.79 68.72 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 118.661 0.664 . . . . 0.0 112.472 -169.072 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 57.7 tptt -58.96 -24.58 62.74 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 124.2 1.0 . . . . 0.0 110.355 169.765 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -95.73 -33.6 12.24 Favored 'General case' 0 C--O 1.236 0.376 0 N-CA-C 113.566 0.95 . . . . 0.0 113.566 -177.049 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 4.4 t0 -147.54 149.8 33.3 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 119.459 1.027 . . . . 0.0 113.18 178.33 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 15.7 m -71.66 158.43 87.86 Favored Pre-proline 0 CA--C 1.541 0.615 0 C-N-CA 126.236 1.814 . . . . 0.0 112.607 -168.92 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -73.53 -25.6 14.92 Favored 'Trans proline' 0 C--N 1.35 0.611 0 C-N-CA 122.467 2.111 . . . . 0.0 113.935 -173.251 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 8.6 mptt -62.4 -20.45 64.47 Favored 'General case' 0 N--CA 1.475 0.786 0 CA-C-N 120.403 1.456 . . . . 0.0 111.912 -179.587 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -58.14 -29.82 65.85 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 125.552 1.541 . . . . 0.0 110.723 173.347 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 50.4 mtt -60.87 -25.93 67.04 Favored 'General case' 0 C--N 1.339 0.151 0 C-N-CA 123.388 0.675 . . . . 0.0 111.428 178.662 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 61.2 mt-10 -64.84 -35.49 81.28 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-N 118.371 0.532 . . . . 0.0 109.717 -178.445 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 13.5 mt-30 -67.78 -46.04 73.1 Favored 'General case' 0 C--N 1.34 0.159 0 C-N-CA 123.65 0.78 . . . . 0.0 111.836 -171.519 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . 0.407 ' CD2' ' HA3' ' A' ' 4' ' ' GLY . 17.5 m-85 -69.54 133.55 47.79 Favored 'General case' 0 CA--C 1.521 -0.159 0 CA-C-N 115.424 -0.807 . . . . 0.0 109.235 -167.372 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -75.4 -31.8 60.55 Favored 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 120.361 -0.535 . . . . 0.0 110.86 -176.187 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 20.8 t -109.54 146.08 15.42 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.368 0 N-CA-C 106.717 -1.586 . . . . 0.0 106.717 168.789 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 27.5 tp -133.08 115.77 15.51 Favored 'General case' 0 N--CA 1.445 -0.696 0 N-CA-C 108.439 -0.948 . . . . 0.0 108.439 174.427 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 23.4 mt -94.6 135.88 27.52 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.63 0 N-CA-C 107.045 -1.465 . . . . 0.0 107.045 177.396 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.513 ' CD2' HD12 ' A' ' 104' ' ' LEU . 0.8 OUTLIER -119.45 131.43 55.62 Favored 'General case' 0 CA--C 1.514 -0.418 0 C-N-CA 125.234 1.413 . . . . 0.0 107.324 -174.466 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -132.64 129.77 5.61 Favored Glycine 0 CA--C 1.519 0.295 0 N-CA-C 110.318 -1.113 . . . . 0.0 110.318 175.036 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 5.8 tt -152.25 133.52 8.0 Favored Pre-proline 0 CA--C 1.541 0.616 0 CA-C-N 118.134 0.967 . . . . 0.0 110.18 169.484 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_exo . . . . . 0 N--CA 1.46 -0.481 0 C-N-CA 122.824 2.349 . . . . 0.0 112.2 167.704 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 17.5 mt . . . . . 0 CA--C 1.545 0.781 0 CA-C-O 121.469 0.652 . . . . 0.0 110.669 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 3.9 mp0 -66.61 146.65 54.26 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 125.578 1.551 . . . . 0.0 108.661 178.544 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -59.11 -42.01 89.53 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 122.906 0.483 . . . . 0.0 110.239 -179.386 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -58.8 -29.55 66.94 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 124.16 0.984 . . . . 0.0 112.043 178.512 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' TRP . . . . . 0.679 ' CH2' HD23 ' A' ' 104' ' ' LEU . 15.9 t90 -87.22 -45.23 10.83 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 124.303 1.041 . . . . 0.0 109.948 179.828 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -61.59 -35.79 78.85 Favored 'General case' 0 CA--C 1.537 0.46 0 O-C-N 120.903 -1.123 . . . . 0.0 109.656 179.851 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -59.6 -25.11 64.35 Favored 'General case' 0 C--O 1.235 0.313 0 C-N-CA 123.951 0.901 . . . . 0.0 111.473 -179.279 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 11.0 m -109.91 -15.65 9.54 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.295 0 CA-C-O 117.478 -1.249 . . . . 0.0 112.732 178.059 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 24.2 t90 -54.76 -38.31 67.05 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-N 120.042 1.292 . . . . 0.0 109.961 178.78 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -65.91 -27.63 68.33 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 125.342 1.457 . . . . 0.0 112.857 175.638 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 69.4 mt-30 -89.19 -25.05 21.99 Favored 'General case' 0 CA--C 1.514 -0.437 0 C-N-CA 125.417 1.487 . . . . 0.0 111.555 -177.154 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.556 ' CD1' HD21 ' A' ' 104' ' ' LEU . 48.2 mt -57.82 -32.02 67.18 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 118.846 0.748 . . . . 0.0 110.255 173.71 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -69.71 -28.03 65.48 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 122.995 0.518 . . . . 0.0 111.457 173.581 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -80.74 -34.62 34.26 Favored 'General case' 0 CA--C 1.538 0.492 0 N-CA-C 113.199 0.814 . . . . 0.0 113.199 176.846 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 21.6 mt -59.76 148.58 33.79 Favored 'General case' 0 N--CA 1.463 0.207 0 C-N-CA 124.44 1.096 . . . . 0.0 111.758 -173.421 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -82.62 114.4 20.98 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 169.667 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 76.8 mt -129.74 1.07 4.9 Favored 'General case' 0 N--CA 1.475 0.815 0 N-CA-C 113.254 0.835 . . . . 0.0 113.254 -172.982 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 32.7 mt-10 -56.8 133.16 54.07 Favored 'General case' 0 C--O 1.235 0.342 0 CA-C-O 122.122 0.963 . . . . 0.0 111.647 -168.644 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 75.07 -3.87 43.05 Favored Glycine 0 CA--C 1.534 1.263 0 C-N-CA 125.483 1.516 . . . . 0.0 114.976 176.499 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.29 149.75 40.54 Favored 'General case' 0 C--N 1.344 0.357 0 CA-C-N 120.574 2.187 . . . . 0.0 110.114 -175.597 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 5.1 mt -80.71 136.69 22.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 N-CA-C 106.344 -1.724 . . . . 0.0 106.344 178.415 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 64.9 t -130.59 128.65 63.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 C-N-CA 123.556 0.742 . . . . 0.0 109.819 -177.2 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -99.57 145.13 27.86 Favored 'General case' 0 CA--C 1.52 -0.184 0 N-CA-C 107.948 -1.13 . . . . 0.0 107.948 168.442 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 10.5 mt -124.79 132.48 53.34 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 107.406 -1.331 . . . . 0.0 107.406 176.44 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 33.7 p90 -148.69 165.06 32.48 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 168.253 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -165.37 172.46 40.94 Favored Glycine 0 N--CA 1.443 -0.85 0 N-CA-C 109.894 -1.283 . . . . 0.0 109.894 172.512 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 6.6 tt . . . . . 0 N--CA 1.447 -0.608 0 C-N-CA 125.979 1.712 . . . . 0.0 107.694 -179.922 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 92.3 mt . . . . . 0 N--CA 1.468 0.453 0 N-CA-C 114.23 1.196 . . . . 0.0 114.23 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -64.24 -33.4 75.73 Favored 'General case' 0 C--N 1.331 -0.228 0 O-C-N 120.661 -1.274 . . . . 0.0 110.872 -175.329 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -71.18 -29.43 65.17 Favored 'General case' 0 CA--C 1.535 0.394 0 O-C-N 121.731 -0.606 . . . . 0.0 111.911 175.485 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 5.4 tt -62.4 -45.31 93.72 Favored 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 108.026 -1.102 . . . . 0.0 108.026 169.64 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -64.04 -39.93 97.7 Favored Glycine 0 C--N 1.34 0.765 0 N-CA-C 111.149 -0.78 . . . . 0.0 111.149 -178.707 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 71.6 mtm -66.4 -35.42 80.28 Favored 'General case' 0 CA--C 1.529 0.166 0 CA-C-O 118.206 -0.902 . . . . 0.0 111.904 177.468 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.679 HD23 ' CH2' ' A' ' 65' ' ' TRP . 0.2 OUTLIER -72.89 -36.45 67.34 Favored 'General case' 0 C--N 1.342 0.265 0 CA-C-N 120.768 1.622 . . . . 0.0 110.811 176.234 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 1.8 t60 -54.04 -52.86 59.51 Favored 'General case' 0 CA--C 1.531 0.214 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 169.61 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -63.04 -41.62 99.55 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 123.79 0.836 . . . . 0.0 112.321 -175.239 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 1.7 tppm? -54.77 -27.87 44.53 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 125.72 1.608 . . . . 0.0 111.309 171.488 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 40.4 mt -106.94 -17.72 14.11 Favored 'General case' 0 CA--C 1.519 -0.214 0 N-CA-C 115.228 1.566 . . . . 0.0 115.228 -173.408 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -60.24 -37.11 79.36 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 121.008 1.731 . . . . 0.0 110.977 -172.611 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 16.3 p -81.25 -13.6 58.34 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 125.53 1.532 . . . . 0.0 111.833 -179.772 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 31.8 mmmt -84.8 -5.87 59.34 Favored 'General case' 0 C--N 1.344 0.328 0 C-N-CA 124.955 1.302 . . . . 0.0 111.691 178.702 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 72.76 31.33 62.61 Favored Glycine 0 CA--C 1.523 0.549 0 CA-C-N 118.399 0.545 . . . . 0.0 112.401 169.498 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 14.5 m -75.59 176.59 0.64 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.638 0 CA-C-N 118.163 0.981 . . . . 0.0 109.677 171.992 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -118.03 126.54 52.48 Favored 'General case' 0 CA--C 1.518 -0.265 0 N-CA-C 106.628 -1.619 . . . . 0.0 106.628 173.127 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 62.2 m-85 -91.96 143.29 26.63 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 119.847 1.203 . . . . 0.0 109.805 -177.064 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 35.1 m -131.6 160.88 42.05 Favored 'Isoleucine or valine' 0 C--O 1.235 0.335 0 C-N-CA 125.947 1.699 . . . . 0.0 107.334 169.314 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 84.96 28.68 30.72 Favored Glycine 0 CA--C 1.52 0.392 0 CA-C-O 118.509 -1.162 . . . . 0.0 114.133 172.999 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 20.8 m-30 -60.87 157.02 16.02 Favored 'General case' 0 CA--C 1.543 0.675 0 CA-C-N 118.809 1.305 . . . . 0.0 109.475 168.494 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 46.5 t-105 -134.15 142.05 41.72 Favored Pre-proline 0 N--CA 1.467 0.403 0 CA-C-O 118.608 -0.711 . . . . 0.0 109.719 -170.577 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -70.1 132.64 23.2 Favored 'Trans proline' 0 N--CA 1.458 -0.588 0 C-N-CA 122.576 2.184 . . . . 0.0 111.728 -171.197 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 20.8 p . . . . . 0 N--CA 1.473 0.677 0 C-N-CA 124.519 1.128 . . . . 0.0 113.778 -179.757 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 22.2 ttmt . . . . . 0 CA--C 1.545 0.773 0 CA-C-O 116.938 -1.506 . . . . 0.0 115.016 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 66.7 Cg_endo -79.23 2.11 8.6 Favored 'Trans proline' 0 C--N 1.353 0.798 0 CA-C-N 122.807 2.038 . . . . 0.0 114.065 -177.862 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.416 HG12 ' HA ' ' A' ' 139' ' ' PHE . 17.2 m -129.15 169.49 20.35 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 119.767 1.167 . . . . 0.0 110.274 -173.887 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 20.5 pt -122.34 163.92 20.14 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.012 0 C-N-CA 126.493 1.917 . . . . 0.0 108.881 172.778 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . 55.33 -154.09 0.31 Allowed 'General case' 0 N--CA 1.446 -0.649 0 C-N-CA 124.369 1.067 . . . . 0.0 108.391 -178.784 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 24.8 t0 -80.18 52.72 1.61 Allowed 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 125.082 1.353 . . . . 0.0 111.017 -179.154 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 63.82 32.16 83.25 Favored Glycine 0 CA--C 1.529 0.923 0 C-N-CA 124.065 0.84 . . . . 0.0 111.662 -174.518 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 1.3 tt0 -90.24 -24.76 20.87 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 124.711 1.205 . . . . 0.0 111.664 -169.163 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -145.54 146.14 31.3 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 119.2 0.909 . . . . 0.0 110.091 169.656 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . 0.416 ' HA ' HG12 ' A' ' 132' ' ' VAL . 49.1 m-85 -74.15 139.38 44.46 Favored 'General case' 0 CA--C 1.508 -0.641 0 N-CA-C 104.393 -2.447 . . . . 0.0 104.393 165.947 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 9.9 p -77.73 6.89 0.86 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.768 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.263 -177.932 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -172.71 175.28 45.79 Favored Glycine 0 CA--C 1.532 1.109 0 C-N-CA 125.349 1.452 . . . . 0.0 110.069 175.951 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 3.9 tp -65.79 144.68 56.71 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 118.285 1.043 . . . . 0.0 111.271 177.687 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -114.97 117.7 31.37 Favored 'General case' 0 N--CA 1.448 -0.565 0 C-N-CA 126.63 1.972 . . . . 0.0 109.826 -179.632 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 79.9 mt . . . . . 0 N--CA 1.468 0.46 0 C-N-CA 124.856 1.263 . . . . 0.0 108.087 170.274 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 70.7 m . . . . . 0 CA--C 1.533 0.307 0 CA-C-O 118.962 -0.542 . . . . 0.0 110.777 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -60.02 -42.11 93.64 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 118.966 0.803 . . . . 0.0 111.307 175.22 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 67.8 mm-40 -69.4 -46.05 67.78 Favored 'General case' 0 CA--C 1.515 -0.386 0 C-N-CA 125.763 1.625 . . . . 0.0 109.944 -178.101 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 67.3 mtt180 -61.55 -46.04 91.61 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 118.228 -0.891 . . . . 0.0 109.701 178.673 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 41.7 mt -61.93 -51.01 77.67 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.204 0 N-CA-C 108.285 -1.006 . . . . 0.0 108.285 176.779 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 66.6 tp60 -48.93 -65.57 0.55 Allowed 'General case' 0 C--O 1.236 0.359 0 C-N-CA 124.527 1.131 . . . . 0.0 111.21 179.972 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 29.5 m -70.73 -28.18 64.52 Favored 'General case' 0 C--N 1.321 -0.653 0 C-N-CA 120.625 -0.43 . . . . 0.0 111.477 -169.24 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 160' ' ' TRP . . . . . . . . . . . . . 57.4 t90 -66.76 -45.92 77.01 Favored 'General case' 0 CA--C 1.518 -0.254 0 CA-C-N 118.791 0.723 . . . . 0.0 111.087 171.532 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 60.4 m -60.64 -43.16 97.9 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 118.262 0.483 . . . . 0.0 110.088 -179.068 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -61.46 -41.59 97.47 Favored 'General case' 0 N--CA 1.455 -0.203 0 CA-C-O 120.984 0.421 . . . . 0.0 110.36 175.201 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 16.3 tt0 -64.84 -51.17 63.54 Favored 'General case' 0 N--CA 1.447 -0.601 0 O-C-N 121.691 -0.631 . . . . 0.0 110.129 -178.413 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 43.4 pt -63.88 -37.55 80.04 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.388 0 CA-C-O 118.174 -0.917 . . . . 0.0 109.703 -175.583 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -64.42 -35.2 80.14 Favored 'General case' 0 CA--C 1.529 0.16 0 CA-C-N 119.247 0.93 . . . . 0.0 109.98 179.66 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 34.9 m-80 -68.56 -50.87 48.54 Favored 'General case' 0 N--CA 1.467 0.382 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 174.118 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 21.9 tt0 -71.11 -25.8 62.75 Favored 'General case' 0 N--CA 1.44 -0.957 0 C-N-CA 125.194 1.398 . . . . 0.0 111.946 -168.747 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 168' ' ' MET . . . . . . . . . . . . . 18.9 ptp -82.05 -31.26 30.98 Favored 'General case' 0 C--O 1.231 0.125 0 O-C-N 121.4 -0.813 . . . . 0.0 112.07 171.052 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -77.77 -36.35 50.62 Favored 'General case' 0 N--CA 1.448 -0.557 0 O-C-N 122.108 -0.37 . . . . 0.0 111.037 -178.419 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 . . . . . 0 CA--C 1.537 0.452 0 O-C-N 121.862 -0.524 . . . . 0.0 110.611 177.209 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 45.7 ttp . . . . . 0 N--CA 1.495 1.8 0 N-CA-C 110.239 -0.282 . . . . 0.0 110.239 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 7.4 t30 -120.48 150.02 41.48 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 124.198 0.999 . . . . 0.0 109.249 172.526 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 20.0 mtt -112.31 125.59 54.34 Favored 'General case' 0 CA--C 1.523 -0.069 0 C-N-CA 123.602 0.761 . . . . 0.0 110.774 -176.451 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -85.28 152.88 27.17 Favored Glycine 0 CA--C 1.524 0.597 0 N-CA-C 106.799 -2.521 . . . . 0.0 106.799 166.41 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 2.1 tt -140.19 96.67 3.09 Favored 'General case' 0 CA--C 1.517 -0.32 0 N-CA-C 105.274 -2.121 . . . . 0.0 105.274 -175.545 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -100.12 141.37 33.04 Favored 'General case' 0 CA--C 1.519 -0.237 0 CA-C-O 121.405 0.621 . . . . 0.0 111.834 -173.519 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 29.3 p90 . . . . . 0 C--N 1.327 -0.376 0 C-N-CA 127.464 2.306 . . . . 0.0 106.325 -178.792 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.225 -0.234 0 CA-C-O 119.331 -0.366 . . . . 0.0 110.582 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -62.31 -49.33 76.07 Favored 'General case' 0 N--CA 1.461 0.098 0 C-N-CA 123.096 0.559 . . . . 0.0 111.87 -178.315 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 7.1 mt-10 -61.45 -41.07 96.63 Favored 'General case' 0 CA--C 1.518 -0.256 0 O-C-N 121.875 -0.516 . . . . 0.0 110.032 176.086 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 30.2 mtpp -70.31 -43.24 70.75 Favored 'General case' 0 C--O 1.221 -0.4 0 CA-C-O 118.603 -0.713 . . . . 0.0 110.622 -173.991 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 43.4 mt -52.87 -55.41 11.98 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.206 0 CA-C-N 119.492 1.042 . . . . 0.0 108.587 173.53 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 5.0 ttp180 -59.6 -42.1 91.83 Favored 'General case' 0 C--O 1.224 -0.273 0 C-N-CA 123.253 0.621 . . . . 0.0 109.618 -176.256 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -65.13 -40.92 95.13 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 123.21 0.604 . . . . 0.0 111.447 -179.498 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 54.3 mt -74.14 -54.42 14.94 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.537 0 C-N-CA 124.794 1.238 . . . . 0.0 110.139 -172.385 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 73.6 mt -64.3 -46.22 93.83 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 179.03 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 139.16 125.65 2.3 Favored Glycine 0 CA--C 1.533 1.179 0 C-N-CA 125.263 1.411 . . . . 0.0 111.733 172.546 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -70.51 -8.65 24.11 Favored 'Trans proline' 0 CA--C 1.535 0.562 0 C-N-CA 123.499 2.799 . . . . 0.0 113.668 -175.584 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -74.26 -21.92 59.55 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 119.007 0.821 . . . . 0.0 111.624 175.385 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -131.83 2.86 4.07 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 124.514 1.125 . . . . 0.0 113.893 -170.454 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 34.5 t -121.61 149.72 24.79 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.393 0 C-N-CA 124.619 1.168 . . . . 0.0 108.051 171.173 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 31.1 m -137.46 130.44 30.45 Favored 'General case' 0 N--CA 1.456 -0.165 0 C-N-CA 126.043 1.737 . . . . 0.0 106.689 -172.379 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 26.3 mt -79.36 141.22 37.12 Favored 'General case' 0 C--O 1.233 0.19 0 N-CA-C 107.826 -1.176 . . . . 0.0 107.826 176.859 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 34.1 t-80 -132.13 64.9 1.59 Allowed 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 107.393 -1.336 . . . . 0.0 107.393 -177.236 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 65.1 t-20 -73.07 115.11 12.0 Favored 'General case' 0 C--O 1.235 0.29 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 -177.326 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.403 HD13 ' CG2' ' A' ' 68' ' ' VAL . 87.0 mt -67.85 -12.41 60.58 Favored 'General case' 0 CA--C 1.532 0.284 0 N-CA-C 112.959 0.725 . . . . 0.0 112.959 -175.86 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -57.47 -26.14 60.8 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 118.746 0.703 . . . . 0.0 110.66 168.325 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -130.14 -40.43 1.31 Allowed 'General case' 0 N--CA 1.466 0.342 0 N-CA-C 113.558 0.947 . . . . 0.0 113.558 -173.957 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 33.0 m-20 -87.32 141.42 28.65 Favored 'General case' 0 C--O 1.236 0.357 0 C-N-CA 123.33 0.652 . . . . 0.0 110.139 -176.018 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 12.9 m -78.42 156.15 78.64 Favored Pre-proline 0 CA--C 1.542 0.666 0 C-N-CA 124.214 1.006 . . . . 0.0 110.291 177.556 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -77.34 -25.22 8.57 Favored 'Trans proline' 0 C--N 1.35 0.625 0 C-N-CA 122.01 1.807 . . . . 0.0 113.589 -171.232 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 3.7 mptp? -60.94 -22.19 64.17 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-N 119.976 1.262 . . . . 0.0 112.088 -179.874 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -60.49 -28.34 68.27 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 125.945 1.698 . . . . 0.0 110.764 174.773 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 57.1 mtt -58.87 -26.28 64.09 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 118.64 0.654 . . . . 0.0 111.254 178.376 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -65.06 -33.82 76.96 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 118.427 0.558 . . . . 0.0 110.759 -176.461 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 14.4 mt-30 -67.24 -43.61 81.55 Favored 'General case' 0 CA--C 1.531 0.228 0 N-CA-C 113.589 0.959 . . . . 0.0 113.589 -168.907 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 31.1 m-85 -71.17 145.9 49.44 Favored 'General case' 0 CA--C 1.527 0.067 0 CA-C-N 115.488 -0.778 . . . . 0.0 111.634 -165.331 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 41.4 m-20 -75.22 -38.48 60.63 Favored 'General case' 0 N--CA 1.47 0.541 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 -176.833 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.407 HG21 ' SD ' ' A' ' 168' ' ' MET . 17.7 t -112.64 147.41 16.37 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.279 0 N-CA-C 106.828 -1.545 . . . . 0.0 106.828 169.843 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 26.2 tp -129.45 110.22 11.7 Favored 'General case' 0 N--CA 1.447 -0.586 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 172.255 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 23.3 mt -86.67 132.25 32.78 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.583 0 N-CA-C 106.719 -1.586 . . . . 0.0 106.719 174.998 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 2.5 mp -111.93 124.93 53.44 Favored 'General case' 0 CA--C 1.519 -0.238 0 N-CA-C 106.886 -1.524 . . . . 0.0 106.886 -179.081 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -119.96 133.07 9.74 Favored Glycine 0 N--CA 1.451 -0.318 0 N-CA-C 108.994 -1.642 . . . . 0.0 108.994 171.248 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 5.1 tt -152.57 131.42 6.6 Favored Pre-proline 0 CA--C 1.531 0.234 0 CA-C-N 117.765 0.783 . . . . 0.0 109.746 168.766 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_exo . . . . . 0 N--CA 1.455 -0.762 0 C-N-CA 121.898 1.732 . . . . 0.0 112.87 169.063 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 4.8 mt . . . . . 0 CA--C 1.547 0.833 0 CA-C-O 120.18 0.038 . . . . 0.0 110.913 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -89.63 157.88 17.84 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 123.873 0.869 . . . . 0.0 110.356 172.499 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -52.66 -47.64 66.98 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 124.561 1.145 . . . . 0.0 112.994 -168.02 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -67.04 -22.52 65.87 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 119.274 0.943 . . . . 0.0 112.331 -170.883 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' TRP . . . . . 0.78 ' CH2' HD23 ' A' ' 104' ' ' LEU . 2.1 t90 -90.17 -42.12 11.23 Favored 'General case' 0 N--CA 1.456 -0.174 0 C-N-CA 124.468 1.107 . . . . 0.0 109.29 177.147 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 9.3 tt0 -62.55 -35.59 79.93 Favored 'General case' 0 N--CA 1.446 -0.625 0 O-C-N 121.081 -1.012 . . . . 0.0 109.927 178.697 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -58.94 -24.62 62.71 Favored 'General case' 0 C--O 1.234 0.254 0 C-N-CA 124.468 1.107 . . . . 0.0 111.643 -178.279 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.403 ' CG2' HD13 ' A' ' 35' ' ' LEU . 28.3 m -113.54 -13.41 11.39 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.324 0 CA-C-O 117.267 -1.349 . . . . 0.0 112.65 178.305 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 25.6 t90 -52.48 -39.88 61.69 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 120.396 1.453 . . . . 0.0 110.119 177.443 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -64.54 -25.69 68.09 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 125.253 1.421 . . . . 0.0 113.167 176.353 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 60.0 mt-30 -92.44 -17.0 25.16 Favored 'General case' 0 CA--C 1.52 -0.189 0 C-N-CA 125.697 1.599 . . . . 0.0 111.716 -178.971 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.601 HD12 HD21 ' A' ' 104' ' ' LEU . 14.7 mt -69.15 -19.32 64.01 Favored 'General case' 0 CA--C 1.531 0.219 0 O-C-N 121.204 -0.935 . . . . 0.0 111.37 -175.188 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -85.53 -22.21 28.24 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-O 118.994 -0.527 . . . . 0.0 111.192 169.489 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -70.72 -31.05 67.77 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-N 119.438 1.017 . . . . 0.0 111.887 172.05 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 25.5 mt -58.04 144.46 39.76 Favored 'General case' 0 C--O 1.234 0.264 0 C-N-CA 123.752 0.821 . . . . 0.0 112.007 -176.149 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 2.9 t30 -86.75 86.33 7.32 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 125.094 1.358 . . . . 0.0 107.489 173.049 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 3.7 pp -142.09 135.34 29.02 Favored 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 169.707 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -149.52 151.66 34.27 Favored 'General case' 0 N--CA 1.439 -0.992 0 C-N-CA 127.698 2.399 . . . . 0.0 104.835 169.412 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 72.18 -6.54 10.26 Favored Glycine 0 CA--C 1.534 1.26 0 N-CA-C 116.905 1.522 . . . . 0.0 116.905 169.687 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.46 161.51 29.73 Favored 'General case' 0 C--N 1.342 0.282 0 CA-C-N 120.21 2.005 . . . . 0.0 110.047 -175.756 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 3.6 mt -80.26 135.97 24.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 106.923 -1.51 . . . . 0.0 106.923 176.689 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 73.1 t -133.03 132.49 58.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 C-N-CA 123.53 0.732 . . . . 0.0 109.509 -177.12 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -104.01 154.71 19.36 Favored 'General case' 0 CA--C 1.519 -0.25 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 168.674 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 2.0 mt -135.58 138.77 43.31 Favored 'General case' 0 CA--C 1.513 -0.447 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 172.138 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 36.0 p90 -151.89 167.63 27.72 Favored 'General case' 0 N--CA 1.446 -0.647 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 169.617 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -168.49 154.26 23.92 Favored Glycine 0 N--CA 1.448 -0.544 0 N-CA-C 109.414 -1.474 . . . . 0.0 109.414 172.143 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 CA--C 1.519 -0.232 0 C-N-CA 123.171 0.588 . . . . 0.0 111.49 169.217 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 86.5 mt . . . . . 0 N--CA 1.469 0.495 0 N-CA-C 113.805 1.039 . . . . 0.0 113.805 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -58.09 -35.81 71.96 Favored 'General case' 0 C--N 1.33 -0.264 0 O-C-N 120.853 -1.155 . . . . 0.0 111.365 174.301 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -71.99 -30.47 65.28 Favored 'General case' 0 C--N 1.343 0.31 0 O-C-N 121.636 -0.665 . . . . 0.0 112.016 177.775 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 4.8 tt -61.68 -43.14 99.42 Favored 'General case' 0 CA--C 1.539 0.553 0 N-CA-C 107.94 -1.133 . . . . 0.0 107.94 169.243 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -64.06 -39.91 97.65 Favored Glycine 0 CA--C 1.527 0.795 0 CA-C-O 119.383 -0.676 . . . . 0.0 112.823 179.345 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 71.4 mtm -60.36 -38.34 83.54 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 119.163 1.481 . . . . 0.0 112.178 -176.604 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.78 HD23 ' CH2' ' A' ' 65' ' ' TRP . 0.1 OUTLIER -73.43 -34.72 65.59 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 119.221 0.919 . . . . 0.0 110.808 179.652 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 55.8 t-80 -61.29 -43.23 99.23 Favored 'General case' 0 C--O 1.232 0.14 0 O-C-N 121.681 -0.637 . . . . 0.0 110.262 174.758 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -64.54 -43.26 94.55 Favored 'General case' 0 C--O 1.234 0.239 0 C-N-CA 123.033 0.533 . . . . 0.0 111.393 -177.675 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 22.5 ttmm -55.43 -52.63 62.97 Favored 'General case' 0 N--CA 1.463 0.205 0 C-N-CA 123.204 0.602 . . . . 0.0 109.863 170.904 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 35.7 mt -77.62 -20.41 53.94 Favored 'General case' 0 CA--C 1.517 -0.297 0 N-CA-C 114.195 1.183 . . . . 0.0 114.195 -168.188 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 61.2 m -61.22 -33.37 73.39 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 119.353 0.979 . . . . 0.0 110.75 -179.672 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 40.3 p -87.59 -19.04 28.36 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 123.446 0.699 . . . . 0.0 111.16 179.581 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 20.5 mmmt -71.92 -19.87 61.85 Favored 'General case' 0 N--CA 1.468 0.47 0 O-C-N 121.576 -0.703 . . . . 0.0 109.654 167.738 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 76.21 38.02 35.53 Favored Glycine 0 C--N 1.337 0.63 0 C-N-CA 123.846 0.736 . . . . 0.0 111.655 173.811 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 9.6 m -71.57 172.58 0.95 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.581 0 CA-C-N 118.752 1.276 . . . . 0.0 109.755 171.094 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -106.49 125.1 50.58 Favored 'General case' 0 CA--C 1.517 -0.295 0 N-CA-C 106.361 -1.718 . . . . 0.0 106.361 172.348 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 78.1 m-85 -92.91 145.41 24.4 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 119.481 1.037 . . . . 0.0 109.916 -178.015 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 35.5 m -131.74 157.84 43.21 Favored 'Isoleucine or valine' 0 C--O 1.234 0.282 0 C-N-CA 125.187 1.395 . . . . 0.0 107.703 169.569 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 84.02 31.46 25.99 Favored Glycine 0 CA--C 1.524 0.628 0 CA-C-O 118.596 -1.113 . . . . 0.0 114.835 169.837 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 13.6 m-30 -63.59 160.5 16.56 Favored 'General case' 0 CA--C 1.545 0.785 0 CA-C-N 119.257 1.529 . . . . 0.0 109.417 168.784 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 48.2 t-105 -138.84 148.15 57.03 Favored Pre-proline 0 N--CA 1.47 0.561 0 CA-C-O 118.12 -0.943 . . . . 0.0 111.432 -168.236 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -67.52 130.33 22.01 Favored 'Trans proline' 0 CA--C 1.536 0.588 0 C-N-CA 123.345 2.697 . . . . 0.0 112.352 -179.413 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 22.6 p . . . . . 0 N--CA 1.474 0.771 0 C-N-CA 125.679 1.591 . . . . 0.0 112.392 170.988 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 15.2 ttmt . . . . . 0 CA--C 1.543 0.708 0 N-CA-C 115.795 1.776 . . . . 0.0 115.795 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_endo -70.66 -11.45 29.68 Favored 'Trans proline' 0 C--N 1.352 0.751 0 CA-C-N 122.345 1.873 . . . . 0.0 114.365 179.651 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 30.9 m -132.51 171.34 18.27 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.428 0 CA-C-N 119.638 1.108 . . . . 0.0 112.874 -167.205 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 14.7 pt -138.56 173.92 11.21 Favored 'Isoleucine or valine' 0 C--O 1.236 0.384 0 C-N-CA 127.985 2.514 . . . . 0.0 108.348 -178.747 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . 55.77 40.0 30.76 Favored 'General case' 0 N--CA 1.463 0.224 0 C-N-CA 125.306 1.442 . . . . 0.0 112.615 174.068 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 27.3 t0 56.0 42.57 28.41 Favored 'General case' 0 C--N 1.324 -0.536 0 C-N-CA 125.998 1.719 . . . . 0.0 111.498 -176.159 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 87.26 21.43 48.99 Favored Glycine 0 CA--C 1.528 0.874 0 CA-C-N 115.211 -0.904 . . . . 0.0 113.541 174.129 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 44.7 mt-30 -97.54 -6.22 34.05 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 118.804 1.302 . . . . 0.0 112.781 -178.844 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 8.1 tp -154.21 147.23 24.56 Favored 'General case' 0 C--N 1.344 0.369 0 CA-C-N 119.618 1.099 . . . . 0.0 110.691 169.579 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 54.7 m-85 -80.76 150.63 29.19 Favored 'General case' 0 CA--C 1.52 -0.18 0 C-N-CA 124.19 0.996 . . . . 0.0 108.695 169.944 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 15.3 m -79.82 11.88 0.54 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.589 0 N-CA-C 112.977 0.732 . . . . 0.0 112.977 173.559 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 178.35 174.87 45.0 Favored Glycine 0 CA--C 1.526 0.755 0 N-CA-C 110.485 -1.046 . . . . 0.0 110.485 -178.44 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 3.5 tp -65.63 133.66 51.62 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 118.471 1.135 . . . . 0.0 110.51 177.758 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -99.62 113.66 26.24 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 125.147 1.379 . . . . 0.0 108.927 173.545 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 69.0 mt . . . . . 0 CA--C 1.534 0.347 0 C-N-CA 125.309 1.444 . . . . 0.0 107.983 169.731 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 13.8 m . . . . . 0 CA--C 1.534 0.343 0 N-CA-C 109.97 -0.381 . . . . 0.0 109.97 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -63.85 -42.46 97.57 Favored 'General case' 0 N--CA 1.465 0.283 0 O-C-N 121.784 -0.572 . . . . 0.0 111.166 173.586 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 -65.4 -42.41 92.63 Favored 'General case' 0 N--CA 1.456 -0.165 0 C-N-CA 124.115 0.966 . . . . 0.0 110.68 177.79 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 73.9 mtt180 -62.46 -46.4 88.69 Favored 'General case' 0 N--CA 1.456 -0.146 0 CA-C-O 118.009 -0.996 . . . . 0.0 109.874 177.401 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 48.7 mt -60.54 -51.2 75.85 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.283 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 177.457 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 72.7 tp60 -53.15 -63.33 1.18 Allowed 'General case' 0 C--O 1.234 0.247 0 C-N-CA 124.3 1.04 . . . . 0.0 111.44 -177.442 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 35.9 m -67.63 -33.06 74.21 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 119.473 -0.298 . . . . 0.0 111.257 -171.092 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 160' ' ' TRP . . . . . . . . . . . . . 49.9 t90 -64.78 -46.96 79.88 Favored 'General case' 0 C--O 1.225 -0.189 0 CA-C-N 118.384 0.538 . . . . 0.0 110.447 173.794 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 55.1 m -60.32 -44.47 95.45 Favored 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 122.843 0.457 . . . . 0.0 110.653 -178.74 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -62.02 -39.17 91.37 Favored 'General case' 0 N--CA 1.456 -0.158 0 CA-C-O 120.946 0.403 . . . . 0.0 110.169 176.838 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 17.3 tt0 -66.89 -52.12 47.23 Favored 'General case' 0 N--CA 1.446 -0.641 0 O-C-N 121.736 -0.602 . . . . 0.0 109.895 -178.779 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 43.4 pt -62.92 -37.49 79.4 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.397 0 CA-C-O 118.072 -0.966 . . . . 0.0 109.36 -175.433 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -64.99 -34.12 77.67 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 119.493 1.042 . . . . 0.0 110.2 -179.672 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 32.9 m-80 -69.48 -52.26 28.23 Favored 'General case' 0 N--CA 1.465 0.277 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 174.419 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 16.1 tt0 -70.73 -26.02 63.2 Favored 'General case' 0 N--CA 1.443 -0.802 0 C-N-CA 124.863 1.265 . . . . 0.0 111.741 -168.647 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 168' ' ' MET . . . . . 0.407 ' SD ' HG21 ' A' ' 48' ' ' VAL . 19.7 ptp -80.64 -32.78 36.1 Favored 'General case' 0 C--N 1.335 -0.03 0 O-C-N 121.117 -0.99 . . . . 0.0 112.051 171.354 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -77.41 -40.08 44.82 Favored 'General case' 0 N--CA 1.447 -0.624 0 O-C-N 122.19 -0.319 . . . . 0.0 110.747 -176.702 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 . . . . . 0 CA--C 1.539 0.533 0 C-N-CA 123.15 0.58 . . . . 0.0 110.719 177.729 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 51.4 ttp . . . . . 0 N--CA 1.498 1.933 0 N-CA-C 110.134 -0.321 . . . . 0.0 110.134 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 9.7 t30 -138.26 152.43 48.55 Favored 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 107.54 -1.281 . . . . 0.0 107.54 170.898 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 20.8 mtt -112.59 123.52 50.48 Favored 'General case' 0 C--N 1.331 -0.221 0 C-N-CA 123.052 0.541 . . . . 0.0 110.835 -176.16 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -83.55 150.55 27.05 Favored Glycine 0 CA--C 1.522 0.474 0 N-CA-C 106.43 -2.668 . . . . 0.0 106.43 166.401 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 2.2 tt -138.43 96.37 3.16 Favored 'General case' 0 CA--C 1.515 -0.388 0 N-CA-C 104.629 -2.36 . . . . 0.0 104.629 -176.877 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -101.0 142.22 32.79 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-O 121.951 0.881 . . . . 0.0 111.312 -171.398 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 45.7 p90 . . . . . 0 N--CA 1.446 -0.656 0 C-N-CA 126.319 1.848 . . . . 0.0 106.727 178.937 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.227 -0.109 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -63.1 -47.83 81.15 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 122.315 0.246 . . . . 0.0 111.174 -175.889 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.7 pp20? -70.42 -33.88 71.85 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-O 118.684 -0.674 . . . . 0.0 110.036 -178.647 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 42.5 mmtt -58.88 -51.39 70.25 Favored 'General case' 0 C--O 1.224 -0.269 0 CA-C-N 119.532 1.06 . . . . 0.0 110.74 171.086 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 34.2 mt -54.23 -54.7 19.16 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.271 0 CA-C-N 119.069 0.85 . . . . 0.0 109.619 -176.638 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.404 ' HG2' HD21 ' A' ' 32' ' ' LEU . 0.0 OUTLIER -64.55 -37.13 86.48 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-O 118.704 -0.665 . . . . 0.0 111.024 -177.128 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -64.3 -38.7 91.98 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 118.261 0.482 . . . . 0.0 110.455 179.786 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 68.7 mt -77.41 -54.52 12.58 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.624 0 C-N-CA 124.89 1.276 . . . . 0.0 110.263 -173.777 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 80.7 mt -62.03 -47.51 92.82 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 179.983 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 141.77 121.18 1.69 Allowed Glycine 0 CA--C 1.526 0.773 0 C-N-CA 125.147 1.356 . . . . 0.0 110.199 177.944 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -71.35 -9.63 25.64 Favored 'Trans proline' 0 CA--C 1.538 0.683 0 C-N-CA 123.055 2.504 . . . . 0.0 113.458 -171.476 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -81.46 -16.75 51.01 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 119.025 0.829 . . . . 0.0 111.86 -179.715 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -128.22 5.17 5.8 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 124.87 1.268 . . . . 0.0 113.58 -173.579 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 28.3 t -125.84 147.75 30.55 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.273 0 N-CA-C 107.789 -1.189 . . . . 0.0 107.789 172.972 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 19.8 m -134.77 130.65 36.48 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 125.38 1.472 . . . . 0.0 108.063 -174.139 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.404 HD21 ' HG2' ' A' ' 22' ' ' ARG . 16.7 mt -77.83 135.15 37.9 Favored 'General case' 0 C--O 1.232 0.166 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 175.404 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 38.4 t-80 -126.76 66.11 1.26 Allowed 'General case' 0 CA--C 1.53 0.201 0 N-CA-C 107.289 -1.374 . . . . 0.0 107.289 -175.747 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 65.0 t-20 -74.6 114.26 12.81 Favored 'General case' 0 C--O 1.234 0.274 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 -176.254 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 88.3 mt -66.16 -12.29 54.9 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 124.395 1.078 . . . . 0.0 112.897 -176.44 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 23.0 tptm -58.13 -27.4 63.73 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-N 118.578 0.626 . . . . 0.0 110.571 169.093 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -130.55 -39.59 1.28 Allowed 'General case' 0 N--CA 1.465 0.287 0 N-CA-C 113.486 0.921 . . . . 0.0 113.486 -173.513 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 38.4 m-20 -87.11 138.95 31.06 Favored 'General case' 0 C--O 1.234 0.288 0 C-N-CA 123.568 0.747 . . . . 0.0 110.17 -176.929 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 14.1 m -75.92 154.57 84.93 Favored Pre-proline 0 CA--C 1.541 0.622 0 C-N-CA 124.118 0.967 . . . . 0.0 110.174 177.284 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 66.7 Cg_endo -75.39 -26.12 10.61 Favored 'Trans proline' 0 C--N 1.351 0.705 0 C-N-CA 122.235 1.957 . . . . 0.0 113.908 -170.911 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.79 -16.17 64.08 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-N 120.358 1.436 . . . . 0.0 112.28 -179.057 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -60.08 -27.69 67.2 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 125.144 1.378 . . . . 0.0 110.543 170.82 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 57.1 mtt -58.05 -26.13 62.1 Favored 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 123.376 0.67 . . . . 0.0 111.62 176.832 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 59.6 mt-10 -67.22 -33.71 75.94 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 118.323 0.511 . . . . 0.0 110.391 -175.466 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 19.0 mt-30 -65.23 -43.9 89.95 Favored 'General case' 0 N--CA 1.464 0.257 0 C-N-CA 123.666 0.787 . . . . 0.0 112.396 -169.908 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 18.5 m-85 -72.89 140.05 47.27 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 123.705 0.802 . . . . 0.0 110.176 -166.869 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -74.7 -37.52 62.6 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 118.481 0.582 . . . . 0.0 110.022 -178.297 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 13.5 t -105.34 145.53 13.46 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.328 0 N-CA-C 107.498 -1.297 . . . . 0.0 107.498 170.117 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 32.9 tp -134.19 106.1 6.99 Favored 'General case' 0 N--CA 1.447 -0.611 0 N-CA-C 108.601 -0.889 . . . . 0.0 108.601 175.418 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 24.8 mt -85.76 129.62 37.74 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 N-CA-C 106.638 -1.616 . . . . 0.0 106.638 177.557 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 1.4 mp -104.13 130.79 51.87 Favored 'General case' 0 N--CA 1.467 0.417 0 N-CA-C 105.953 -1.869 . . . . 0.0 105.953 177.207 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -131.17 119.22 2.59 Favored Glycine 0 CA--C 1.505 -0.576 0 N-CA-C 108.635 -1.786 . . . . 0.0 108.635 -176.945 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 1.6 tt -144.07 120.97 6.51 Favored Pre-proline 0 CA--C 1.531 0.238 0 CA-C-N 118.235 1.018 . . . . 0.0 108.706 179.517 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 76.9 Cg_exo . . . . . 0 N--CA 1.459 -0.535 0 C-N-CA 122.499 2.133 . . . . 0.0 114.286 -178.502 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 20.8 mt . . . . . 0 CA--C 1.542 0.654 0 N-CA-C 109.768 -0.456 . . . . 0.0 109.768 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 2.0 pm0 -67.56 151.93 46.5 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 123.585 0.754 . . . . 0.0 110.913 177.197 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -49.2 -51.23 34.2 Favored 'General case' 0 N--CA 1.463 0.205 0 C-N-CA 125.843 1.657 . . . . 0.0 112.669 -168.894 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -68.65 -17.11 64.03 Favored 'General case' 0 N--CA 1.473 0.712 0 CA-C-N 119.019 0.827 . . . . 0.0 112.043 -170.413 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' TRP . . . . . 0.505 ' CZ3' ' CE3' ' A' ' 69' ' ' TRP . 0.0 OUTLIER -88.69 -47.1 8.5 Favored 'General case' 0 CA--C 1.538 0.51 0 N-CA-C 107.449 -1.315 . . . . 0.0 107.449 178.071 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 12.0 tt0 -63.6 -33.46 75.65 Favored 'General case' 0 N--CA 1.449 -0.519 0 O-C-N 120.598 -1.314 . . . . 0.0 110.542 178.804 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -54.75 -25.15 25.91 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 125.085 1.354 . . . . 0.0 112.45 -177.763 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 29.6 m -114.28 -13.85 11.14 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.209 0 CA-C-O 117.204 -1.379 . . . . 0.0 112.918 177.356 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' TRP . . . . . 0.505 ' CE3' ' CZ3' ' A' ' 65' ' ' TRP . 2.6 t-105 -51.13 -39.55 56.51 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 120.136 1.334 . . . . 0.0 111.071 -173.644 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -68.57 -23.65 64.52 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 125.11 1.364 . . . . 0.0 113.2 -179.885 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 18.7 mt-30 -89.51 -23.41 22.06 Favored 'General case' 0 C--N 1.341 0.211 0 C-N-CA 125.311 1.444 . . . . 0.0 112.363 178.613 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 40.3 mt -65.72 -24.61 67.01 Favored 'General case' 0 N--CA 1.469 0.485 0 O-C-N 121.874 -0.516 . . . . 0.0 112.065 -169.968 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -70.06 -21.29 63.18 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 118.087 0.403 . . . . 0.0 111.74 175.78 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -75.1 -23.6 57.97 Favored 'General case' 0 CA--C 1.538 0.505 0 O-C-N 121.139 -0.976 . . . . 0.0 112.635 -178.722 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 53.6 mt -66.16 150.17 49.18 Favored 'General case' 0 C--O 1.231 0.12 0 C-N-CA 124.869 1.268 . . . . 0.0 112.003 -169.594 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 3.7 t30 -82.24 105.79 13.61 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 124.551 1.14 . . . . 0.0 108.204 172.488 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 65.6 mt -124.0 1.29 8.61 Favored 'General case' 0 N--CA 1.472 0.63 0 N-CA-C 113.764 1.024 . . . . 0.0 113.764 -172.491 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 27.2 mt-10 -56.9 130.98 48.21 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-O 121.913 0.863 . . . . 0.0 111.318 -169.747 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 74.04 -2.73 41.46 Favored Glycine 0 CA--C 1.534 1.249 0 C-N-CA 125.401 1.477 . . . . 0.0 114.955 176.951 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.66 148.7 40.4 Favored 'General case' 0 C--N 1.345 0.403 0 CA-C-N 120.346 2.073 . . . . 0.0 109.347 -176.399 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 5.3 mt -81.26 139.79 17.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 N-CA-C 106.711 -1.589 . . . . 0.0 106.711 179.542 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 38.4 t -133.55 139.16 49.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 C-N-CA 124.459 1.103 . . . . 0.0 110.491 -175.897 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -115.37 162.25 17.39 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 123.971 0.908 . . . . 0.0 109.043 169.466 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 6.2 mt -141.61 136.8 31.37 Favored 'General case' 0 N--CA 1.465 0.277 0 N-CA-C 106.867 -1.531 . . . . 0.0 106.867 178.702 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 40.4 p90 -153.64 155.52 36.2 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-N 120.614 1.552 . . . . 0.0 109.116 174.913 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -175.9 -167.33 34.65 Favored Glycine 0 N--CA 1.445 -0.719 0 N-CA-C 108.514 -1.834 . . . . 0.0 108.514 170.656 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.327 -0.373 0 CA-C-O 122.443 1.116 . . . . 0.0 111.139 176.025 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 96.6 mt . . . . . 0 CA--C 1.541 0.625 0 N-CA-C 114.453 1.279 . . . . 0.0 114.453 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -57.71 -39.47 77.3 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 119.765 1.166 . . . . 0.0 113.108 -167.601 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -73.35 -19.42 61.01 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-O 118.262 -0.875 . . . . 0.0 112.666 -178.905 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 8.5 mp -65.69 -38.75 90.1 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-N 120.151 1.341 . . . . 0.0 108.45 170.248 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -63.37 -36.89 94.0 Favored Glycine 0 C--N 1.339 0.712 0 N-CA-C 111.218 -0.753 . . . . 0.0 111.218 -179.008 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 77.8 mtm -67.33 -47.82 69.37 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-O 118.077 -0.963 . . . . 0.0 111.006 179.85 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -70.57 -33.4 71.06 Favored 'General case' 0 C--N 1.348 0.535 0 CA-C-N 121.042 1.746 . . . . 0.0 110.995 178.217 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 68.2 t60 -54.51 -51.76 64.11 Favored 'General case' 0 CA--C 1.529 0.14 0 CA-C-N 118.821 0.737 . . . . 0.0 110.164 171.894 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -62.99 -40.02 96.48 Favored 'General case' 0 C--O 1.236 0.379 0 C-N-CA 123.771 0.829 . . . . 0.0 112.094 -176.098 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 24.1 ttmm -54.9 -39.68 69.01 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 123.327 0.651 . . . . 0.0 110.146 171.508 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 35.2 mt -90.96 -19.52 23.17 Favored 'General case' 0 CA--C 1.518 -0.287 0 N-CA-C 115.48 1.659 . . . . 0.0 115.48 -168.566 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 4.5 m -58.81 -36.47 74.54 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 120.86 1.664 . . . . 0.0 111.353 -177.664 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 19.9 p -84.0 -15.45 47.63 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 124.81 1.244 . . . . 0.0 111.66 179.942 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 31.7 mmmt -81.56 -9.97 59.56 Favored 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 124.542 1.137 . . . . 0.0 110.998 172.109 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 73.21 35.42 57.05 Favored Glycine 0 CA--C 1.523 0.569 0 CA-C-O 119.541 -0.589 . . . . 0.0 112.404 169.497 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 5.9 m -74.9 173.9 0.89 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.56 0 CA-C-N 118.122 0.961 . . . . 0.0 109.536 171.252 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -115.23 117.22 29.88 Favored 'General case' 0 CA--C 1.52 -0.211 0 N-CA-C 106.911 -1.515 . . . . 0.0 106.911 175.367 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 87.9 m-85 -85.71 143.15 28.53 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 119.56 1.073 . . . . 0.0 110.022 -175.312 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 32.9 m -133.47 160.7 42.14 Favored 'Isoleucine or valine' 0 C--O 1.235 0.307 0 C-N-CA 125.712 1.605 . . . . 0.0 108.052 169.748 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 86.8 26.95 30.5 Favored Glycine 0 C--N 1.332 0.339 0 CA-C-O 118.327 -1.263 . . . . 0.0 114.097 173.458 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 18.9 m-30 -60.85 159.87 10.5 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-N 119.165 1.482 . . . . 0.0 110.082 169.711 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 1.5 m95 -125.66 143.71 45.88 Favored Pre-proline 0 N--CA 1.469 0.501 0 CA-C-O 118.362 -0.828 . . . . 0.0 109.359 169.722 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -64.05 127.72 20.07 Favored 'Trans proline' 0 N--CA 1.452 -0.954 0 C-N-CA 123.335 2.69 . . . . 0.0 109.845 173.493 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 31.5 p . . . . . 0 N--CA 1.471 0.621 0 N-CA-C 113.449 0.907 . . . . 0.0 113.449 175.456 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 20.5 ttmt . . . . . 0 CA--C 1.544 0.719 0 CA-C-O 117.429 -1.272 . . . . 0.0 114.083 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -73.07 -3.66 14.04 Favored 'Trans proline' 0 C--N 1.352 0.719 0 CA-C-N 121.939 1.728 . . . . 0.0 114.447 -178.444 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 19.7 m -129.93 166.84 26.52 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 CA-C-N 119.989 1.268 . . . . 0.0 111.924 -169.588 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 10.3 pt -138.02 174.56 10.56 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.331 0 C-N-CA 127.554 2.342 . . . . 0.0 108.73 -177.088 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . 54.96 43.88 29.17 Favored 'General case' 0 N--CA 1.465 0.284 0 C-N-CA 125.351 1.46 . . . . 0.0 112.051 175.184 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 27.4 t0 54.55 43.18 30.67 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 126.046 1.738 . . . . 0.0 111.46 -175.756 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 89.95 16.06 56.78 Favored Glycine 0 CA--C 1.526 0.723 0 CA-C-O 118.356 -1.247 . . . . 0.0 114.481 171.207 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 47.6 mt-30 -88.08 -16.84 32.47 Favored 'General case' 0 CA--C 1.536 0.404 0 CA-C-N 119.366 1.583 . . . . 0.0 113.691 -175.569 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -143.45 142.86 31.36 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 119.541 1.064 . . . . 0.0 110.661 177.234 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 74.2 m-85 -75.25 141.59 43.47 Favored 'General case' 0 CA--C 1.519 -0.233 0 N-CA-C 105.095 -2.187 . . . . 0.0 105.095 164.642 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 33.5 m -69.98 -0.1 1.38 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.567 0 N-CA-C 113.011 0.745 . . . . 0.0 113.011 -178.099 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -170.13 -170.82 34.96 Favored Glycine 0 N--CA 1.447 -0.618 0 N-CA-C 109.972 -1.251 . . . . 0.0 109.972 -172.607 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 0.453 ' HG ' ' CG ' ' A' ' 160' ' ' TRP . 1.2 tt -60.05 139.31 57.55 Favored 'General case' 0 N--CA 1.462 0.156 0 C-N-CA 124.424 1.089 . . . . 0.0 110.548 -179.815 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -105.78 96.03 6.21 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 124.553 1.141 . . . . 0.0 108.422 168.794 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 78.2 mt . . . . . 0 CA--C 1.535 0.397 0 N-CA-C 105.621 -1.992 . . . . 0.0 105.621 168.582 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 31.0 p . . . . . 0 CA--C 1.531 0.216 0 N-CA-C 110.347 -0.242 . . . . 0.0 110.347 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -58.22 -40.34 81.4 Favored 'General case' 0 N--CA 1.462 0.173 0 C-N-CA 123.921 0.889 . . . . 0.0 111.064 178.345 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 3.5 tp10 -69.67 -47.36 63.56 Favored 'General case' 0 CA--C 1.529 0.16 0 C-N-CA 124.485 1.114 . . . . 0.0 110.911 -177.485 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 69.9 mtp85 -66.71 -27.39 67.6 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 117.894 -1.051 . . . . 0.0 110.424 179.859 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 25.1 mt -73.14 -53.29 18.84 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.601 0 CA-C-N 119.908 1.231 . . . . 0.0 107.762 168.364 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 70.8 tp60 -50.14 -64.14 0.9 Allowed 'General case' 0 N--CA 1.464 0.259 0 C-N-CA 126.031 1.732 . . . . 0.0 112.14 -175.419 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 25.3 m -66.11 -32.75 74.39 Favored 'General case' 0 C--N 1.327 -0.392 0 O-C-N 123.036 0.21 . . . . 0.0 110.803 -171.01 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 160' ' ' TRP . . . . . 0.453 ' CG ' ' HG ' ' A' ' 142' ' ' LEU . 88.2 t90 -66.41 -46.84 75.22 Favored 'General case' 0 C--O 1.222 -0.349 0 O-C-N 121.958 -0.464 . . . . 0.0 110.836 174.592 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 67.2 m -59.56 -44.42 93.29 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 123.266 0.626 . . . . 0.0 110.501 178.816 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 162' ' ' GLU . . . . . 0.409 ' HA ' HD23 ' A' ' 165' ' ' LEU . 39.7 mt-10 -61.05 -42.95 99.44 Favored 'General case' 0 N--CA 1.457 -0.085 0 CA-C-O 121.021 0.439 . . . . 0.0 110.199 175.723 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 14.4 tt0 -63.71 -52.1 62.07 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-O 117.791 -1.1 . . . . 0.0 109.73 -177.508 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 40.4 pt -63.02 -34.11 64.61 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.519 0 CA-C-N 119.439 1.018 . . . . 0.0 110.077 -176.57 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . 0.409 HD23 ' HA ' ' A' ' 162' ' ' GLU . 0.3 OUTLIER -70.16 -34.95 73.66 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 119.382 0.992 . . . . 0.0 108.519 -175.2 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -70.72 -46.27 63.36 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 123.707 0.803 . . . . 0.0 109.993 174.273 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 24.8 tt0 -77.91 -14.09 59.66 Favored 'General case' 0 N--CA 1.437 -1.104 0 C-N-CA 124.9 1.28 . . . . 0.0 110.359 -169.629 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 168' ' ' MET . . . . . . . . . . . . . 18.9 ptp -92.17 -38.9 11.87 Favored 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 122.751 0.42 . . . . 0.0 111.547 169.754 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -75.81 -27.82 58.09 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-O 119.327 -0.368 . . . . 0.0 111.914 -173.447 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 . . . . . 0 CA--C 1.541 0.617 0 C-N-CA 123.655 0.782 . . . . 0.0 112.398 -177.084 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.499 2.015 0 CA-C-O 119.403 -0.332 . . . . 0.0 111.11 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 11.3 t30 -127.29 151.1 49.18 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-N 119.167 0.894 . . . . 0.0 110.523 -177.815 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 17.5 mtt -117.4 130.41 56.47 Favored 'General case' 0 N--CA 1.461 0.11 0 C-N-CA 124.228 1.011 . . . . 0.0 110.958 -177.873 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . 0.409 ' HA3' ' CD2' ' A' ' 46' ' ' TYR . . . -86.88 154.76 27.04 Favored Glycine 0 CA--C 1.522 0.51 0 N-CA-C 107.77 -2.132 . . . . 0.0 107.77 166.541 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 3.0 tt -141.24 99.49 3.59 Favored 'General case' 0 N--CA 1.464 0.244 0 N-CA-C 105.612 -1.995 . . . . 0.0 105.612 -176.456 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . 0.756 ' CZ ' HD23 ' A' ' 51' ' ' LEU . 1.2 p90 -106.18 138.43 42.38 Favored 'General case' 0 CA--C 1.521 -0.162 0 CA-C-N 118.017 0.372 . . . . 0.0 111.707 -169.54 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 19.5 p90 . . . . . 0 CA--C 1.536 0.43 0 C-N-CA 125.693 1.597 . . . . 0.0 108.736 -174.053 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.463 0.194 0 N-CA-C 109.238 -0.653 . . . . 0.0 109.238 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -62.46 -47.71 82.83 Favored 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 123.049 0.539 . . . . 0.0 111.45 -176.481 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 33.8 mt-10 -61.73 -42.38 98.88 Favored 'General case' 0 C--O 1.232 0.178 0 C-N-CA 123.415 0.686 . . . . 0.0 110.14 176.377 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 28.7 mtpp -70.98 -39.63 72.38 Favored 'General case' 0 C--O 1.221 -0.434 0 CA-C-O 118.199 -0.905 . . . . 0.0 110.32 -175.885 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 43.7 mt -53.8 -56.04 10.92 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.285 0 CA-C-N 119.805 1.184 . . . . 0.0 109.266 175.781 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.484 ' HG2' HD21 ' A' ' 32' ' ' LEU . 0.0 OUTLIER -65.71 -35.44 80.74 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 118.406 0.548 . . . . 0.0 111.404 -175.82 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -64.31 -41.06 97.02 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.819 0.342 . . . . 0.0 110.944 177.996 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 56.4 mt -76.13 -54.08 14.24 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.47 0 C-N-CA 124.548 1.139 . . . . 0.0 109.84 -172.557 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 65.2 mt -62.63 -47.56 92.33 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.328 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 179.611 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 142.49 121.47 1.66 Allowed Glycine 0 CA--C 1.528 0.847 0 C-N-CA 124.826 1.203 . . . . 0.0 110.526 177.063 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -70.96 -12.72 31.01 Favored 'Trans proline' 0 CA--C 1.537 0.669 0 C-N-CA 122.784 2.323 . . . . 0.0 113.495 -171.027 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -77.17 -18.52 57.74 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 118.904 0.774 . . . . 0.0 111.729 179.802 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -128.71 9.1 5.88 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 124.604 1.162 . . . . 0.0 113.582 -170.639 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 31.4 t -127.93 148.07 32.55 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 N-CA-C 107.511 -1.292 . . . . 0.0 107.511 173.242 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 25.3 m -132.22 131.06 41.77 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 125.574 1.55 . . . . 0.0 108.164 -175.34 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.484 HD21 ' HG2' ' A' ' 22' ' ' ARG . 26.4 mt -77.73 131.46 37.68 Favored 'General case' 0 CA--C 1.521 -0.168 0 N-CA-C 108.107 -1.072 . . . . 0.0 108.107 176.104 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 22.5 t-80 -129.27 52.82 1.93 Allowed 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 124.748 1.219 . . . . 0.0 108.19 -175.552 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 18.7 t-20 -55.12 128.94 36.14 Favored 'General case' 0 CA--C 1.531 0.241 0 N-CA-C 107.834 -1.173 . . . . 0.0 107.834 171.086 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 39.0 mt -75.44 -16.17 60.36 Favored 'General case' 0 C--O 1.234 0.244 0 N-CA-C 114.021 1.119 . . . . 0.0 114.021 -169.009 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 9.0 tptm -77.47 -26.44 51.39 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 118.951 0.796 . . . . 0.0 110.154 169.614 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -88.13 -35.91 17.17 Favored 'General case' 0 C--O 1.236 0.375 0 C-N-CA 124.155 0.982 . . . . 0.0 112.783 -174.067 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 2.5 t0 -142.76 155.22 44.81 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 118.653 0.661 . . . . 0.0 112.673 178.151 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 19.1 m -75.35 158.34 83.79 Favored Pre-proline 0 CA--C 1.544 0.716 0 C-N-CA 125.998 1.719 . . . . 0.0 111.298 -170.525 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_endo -74.43 -25.75 12.79 Favored 'Trans proline' 0 C--N 1.349 0.594 0 C-N-CA 122.245 1.963 . . . . 0.0 113.231 -170.6 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 22.6 mmmt -71.19 -11.34 60.88 Favored 'General case' 0 CA--C 1.54 0.561 0 O-C-N 120.45 -1.406 . . . . 0.0 111.703 -176.368 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -61.85 -28.68 69.66 Favored 'General case' 0 N--CA 1.465 0.282 0 C-N-CA 125.159 1.384 . . . . 0.0 110.265 169.167 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 45.4 mtt -57.48 -27.3 62.39 Favored 'General case' 0 N--CA 1.464 0.275 0 C-N-CA 123.12 0.568 . . . . 0.0 111.865 177.146 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 84.7 mt-10 -66.17 -32.22 73.52 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 118.118 0.417 . . . . 0.0 110.357 -175.621 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 20.8 mt-30 -66.99 -41.63 86.44 Favored 'General case' 0 N--CA 1.464 0.243 0 C-N-CA 123.804 0.841 . . . . 0.0 112.714 -171.22 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . 0.409 ' CD2' ' HA3' ' A' ' 4' ' ' GLY . 15.7 m-85 -72.2 147.05 46.93 Favored 'General case' 0 CA--C 1.522 -0.108 0 C-N-CA 123.5 0.72 . . . . 0.0 110.667 -166.139 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -75.98 -34.47 59.77 Favored 'General case' 0 N--CA 1.467 0.422 0 O-C-N 121.832 -0.542 . . . . 0.0 110.297 176.045 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 6.4 t -113.4 146.76 17.6 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.19 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 172.668 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 48.5 tp -132.24 113.81 13.69 Favored 'General case' 0 N--CA 1.451 -0.424 0 C-N-CA 123.625 0.77 . . . . 0.0 109.06 171.726 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 23.0 mt -89.84 130.33 39.3 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 N-CA-C 106.361 -1.718 . . . . 0.0 106.361 174.982 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.756 HD23 ' CZ ' ' A' ' 6' ' ' PHE . 0.6 OUTLIER -106.01 131.87 52.78 Favored 'General case' 0 C--O 1.232 0.183 0 C-N-CA 125.201 1.4 . . . . 0.0 107.929 172.675 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.587 ' N ' HD22 ' A' ' 51' ' ' LEU . . . -127.46 139.03 10.87 Favored Glycine 0 CA--C 1.524 0.647 0 C-N-CA 124.892 1.234 . . . . 0.0 110.283 169.997 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.611 HD13 ' HB1' ' A' ' 100' ' ' ALA . 6.2 tt -145.47 129.65 8.75 Favored Pre-proline 0 CA--C 1.538 0.511 0 CA-C-N 118.763 1.282 . . . . 0.0 110.584 170.883 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo . . . . . 0 N--CA 1.456 -0.694 0 C-N-CA 123.099 2.533 . . . . 0.0 110.247 169.748 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.426 ' HA ' HD11 ' A' ' 53' ' ' ILE . 0.9 OUTLIER . . . . . 0 N--CA 1.445 -0.685 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 . . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 3.0 mp0 -88.88 156.95 18.61 Favored 'General case' 0 C--O 1.231 0.104 0 C-N-CA 124.622 1.169 . . . . 0.0 108.167 179.446 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -57.41 -40.28 77.94 Favored 'General case' 0 N--CA 1.464 0.249 0 C-N-CA 123.318 0.647 . . . . 0.0 110.45 -179.096 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 80.2 m-20 -58.1 -30.84 66.58 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 124.331 1.053 . . . . 0.0 110.96 -178.439 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' TRP . . . . . 0.67 ' CH2' HD23 ' A' ' 104' ' ' LEU . 1.9 t90 -95.87 -45.29 7.02 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 125.889 1.675 . . . . 0.0 108.297 -170.117 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 24.5 tt0 -63.51 -35.73 81.42 Favored 'General case' 0 N--CA 1.439 -1.011 0 C-N-CA 124.633 1.173 . . . . 0.0 110.347 178.451 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -57.83 -24.16 56.1 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 123.874 0.87 . . . . 0.0 111.759 -178.562 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 34.8 m -116.55 -12.13 11.62 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.345 0 CA-C-O 117.351 -1.309 . . . . 0.0 112.342 177.761 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 26.8 t90 -52.11 -38.71 58.26 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 120.234 1.379 . . . . 0.0 110.568 -176.387 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -65.35 -26.16 67.91 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 125.511 1.524 . . . . 0.0 113.284 177.255 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 25.7 mt-30 -92.58 -19.85 21.51 Favored 'General case' 0 C--N 1.34 0.165 0 C-N-CA 126.086 1.754 . . . . 0.0 112.538 176.836 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 72.6 mt -61.78 -24.14 66.65 Favored 'General case' 0 CA--C 1.532 0.274 0 O-C-N 121.679 -0.638 . . . . 0.0 111.289 -176.31 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -77.31 -27.67 52.99 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 118.074 0.397 . . . . 0.0 111.475 175.738 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -70.29 -33.09 71.14 Favored 'General case' 0 N--CA 1.467 0.379 0 O-C-N 121.424 -0.797 . . . . 0.0 111.381 178.823 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 83.2 mt -50.6 135.61 22.71 Favored 'General case' 0 C--N 1.341 0.2 0 C-N-CA 124.72 1.208 . . . . 0.0 111.935 -170.142 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 4.9 t-20 -74.64 105.39 5.71 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 107.308 -1.368 . . . . 0.0 107.308 168.356 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.448 ' HA ' ' HE2' ' A' ' 80' ' ' LYS . 59.6 mt -123.83 2.13 8.77 Favored 'General case' 0 N--CA 1.467 0.38 0 C-N-CA 124.691 1.196 . . . . 0.0 111.163 -179.622 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 29.6 mp0 -57.24 128.12 35.39 Favored 'General case' 0 N--CA 1.445 -0.681 0 CA-C-O 122.062 0.934 . . . . 0.0 112.287 -166.984 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 70.57 -0.04 28.92 Favored Glycine 0 CA--C 1.537 1.448 0 CA-C-N 113.792 -1.549 . . . . 0.0 115.411 -177.938 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.448 ' HE2' ' HA ' ' A' ' 77' ' ' LEU . 0.0 OUTLIER -77.87 160.01 28.56 Favored 'General case' 0 C--N 1.346 0.426 0 CA-C-N 120.892 2.346 . . . . 0.0 110.277 -175.381 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 1.9 mt -85.91 141.28 14.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 N-CA-C 106.729 -1.582 . . . . 0.0 106.729 178.215 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.409 HG11 HD13 ' A' ' 108' ' ' LEU . 94.2 t -138.42 146.63 26.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 -176.822 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -124.17 145.21 49.45 Favored 'General case' 0 CA--C 1.513 -0.456 0 N-CA-C 104.991 -2.225 . . . . 0.0 104.991 175.444 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 4.9 mp -126.83 141.74 51.74 Favored 'General case' 0 CA--C 1.501 -0.905 0 N-CA-C 107.655 -1.239 . . . . 0.0 107.655 175.007 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 34.4 p90 -153.13 168.71 25.02 Favored 'General case' 0 N--CA 1.441 -0.924 0 N-CA-C 107.236 -1.394 . . . . 0.0 107.236 167.836 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -162.69 171.53 38.53 Favored Glycine 0 N--CA 1.44 -1.042 0 N-CA-C 109.278 -1.529 . . . . 0.0 109.278 169.88 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 6.1 tt . . . . . 0 N--CA 1.442 -0.845 0 N-CA-C 106.589 -1.634 . . . . 0.0 106.589 173.764 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 91.1 mt . . . . . 0 N--CA 1.472 0.648 0 N-CA-C 113.567 0.951 . . . . 0.0 113.567 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -51.31 -48.22 62.38 Favored 'General case' 0 C--O 1.234 0.28 0 C-N-CA 125.284 1.434 . . . . 0.0 110.749 177.796 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . 0.611 ' HB1' HD13 ' A' ' 53' ' ' ILE . . . -72.14 -23.97 61.39 Favored 'General case' 0 CA--C 1.539 0.554 0 O-C-N 121.616 -0.678 . . . . 0.0 112.576 -178.543 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 4.8 tt -65.81 -48.06 72.98 Favored 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 171.352 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -61.18 -33.31 83.8 Favored Glycine 0 CA--C 1.527 0.806 0 N-CA-C 111.164 -0.775 . . . . 0.0 111.164 -179.674 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 4.5 tpp -53.76 -52.05 61.44 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 124.647 1.179 . . . . 0.0 111.225 172.885 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.67 HD23 ' CH2' ' A' ' 65' ' ' TRP . 0.2 OUTLIER -72.83 -33.19 66.02 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-O 118.425 -0.798 . . . . 0.0 110.758 -177.894 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 49.0 t60 -58.69 -50.96 71.97 Favored 'General case' 0 C--O 1.226 -0.161 0 CA-C-N 118.718 0.69 . . . . 0.0 110.604 174.696 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -62.13 -41.88 98.7 Favored 'General case' 0 C--O 1.234 0.258 0 C-N-CA 123.354 0.662 . . . . 0.0 111.585 -176.966 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 23.4 ttmm -59.57 -39.4 83.98 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 123.145 0.578 . . . . 0.0 110.098 173.128 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.409 HD13 HG11 ' A' ' 82' ' ' VAL . 16.5 mt -82.53 -25.33 33.49 Favored 'General case' 0 N--CA 1.455 -0.179 0 CA-C-O 117.584 -1.198 . . . . 0.0 113.71 -170.097 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 18.2 m -58.58 -36.73 74.43 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 120.503 1.501 . . . . 0.0 111.722 -175.785 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 21.1 p -82.15 -8.29 59.65 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 124.251 1.021 . . . . 0.0 111.719 -178.416 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 29.6 mmmt -84.03 -3.27 57.91 Favored 'General case' 0 C--N 1.343 0.284 0 C-N-CA 124.985 1.314 . . . . 0.0 111.365 173.786 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 67.53 33.35 81.12 Favored Glycine 0 CA--C 1.527 0.8 0 CA-C-N 118.698 0.681 . . . . 0.0 112.287 170.048 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 15.6 m -83.09 171.65 1.19 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 C-N-CA 123.593 0.757 . . . . 0.0 110.317 179.913 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 15.5 tptm -98.55 129.5 45.1 Favored 'General case' 0 CA--C 1.513 -0.47 0 N-CA-C 104.904 -2.258 . . . . 0.0 104.904 167.588 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 60.3 m-85 -94.84 124.31 38.81 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 171.457 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 35.3 m -107.26 157.77 7.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 C-N-CA 123.566 0.747 . . . . 0.0 109.257 168.531 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 101.12 -97.31 1.65 Allowed Glycine 0 N--CA 1.447 -0.616 0 C-N-CA 124.885 1.231 . . . . 0.0 111.505 174.16 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 11.3 m-30 61.06 172.89 0.1 Allowed 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 125.004 1.321 . . . . 0.0 110.104 -167.255 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 1.2 t90 -155.46 138.83 10.91 Favored Pre-proline 0 N--CA 1.469 0.485 0 CA-C-O 117.386 -1.292 . . . . 0.0 109.297 -177.029 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -71.72 121.67 7.87 Favored 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 123.413 2.742 . . . . 0.0 111.872 -174.49 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 37.5 p . . . . . 0 N--CA 1.47 0.545 0 N-CA-C 114.334 1.235 . . . . 0.0 114.334 179.902 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 33.4 ttmt . . . . . 0 N--CA 1.475 0.791 0 CA-C-O 117.529 -1.224 . . . . 0.0 114.142 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -73.82 -1.5 10.89 Favored 'Trans proline' 0 C--N 1.35 0.607 0 C-N-CA 121.856 1.704 . . . . 0.0 114.591 -179.527 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 12.3 m -135.91 153.0 31.55 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 CA-C-N 121.563 1.983 . . . . 0.0 112.377 -168.503 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . 0.718 HG23 HG12 ' A' ' 140' ' ' VAL . 11.8 pt -90.27 167.73 1.62 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.444 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 167.348 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . 57.9 -156.18 0.32 Allowed 'General case' 0 N--CA 1.447 -0.6 0 C-N-CA 124.934 1.294 . . . . 0.0 109.855 169.523 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 23.1 t0 -76.78 59.0 1.51 Allowed 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 125.065 1.346 . . . . 0.0 109.389 170.08 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 62.9 46.03 94.43 Favored Glycine 0 C--N 1.336 0.583 0 C-N-CA 124.826 1.203 . . . . 0.0 112.147 176.079 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 69.2 mm-40 -93.29 -44.44 8.31 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-N 118.208 1.004 . . . . 0.0 112.571 -169.809 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -134.18 142.83 47.56 Favored 'General case' 0 N--CA 1.47 0.556 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 179.883 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 44.9 m-85 -72.11 15.51 0.16 Allowed 'General case' 0 N--CA 1.479 1.007 0 N-CA-C 116.444 2.016 . . . . 0.0 116.444 179.775 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . 0.718 HG12 HG23 ' A' ' 133' ' ' ILE 0.253 1.0 OUTLIER 52.82 8.61 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.549 0.932 0 C-N-CA 127.162 2.185 . . . . 0.0 113.577 -177.245 . . . . . . . . 4 4 . 1 . 019 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 171.69 171.75 37.05 Favored Glycine 0 CA--C 1.528 0.906 0 C-N-CA 126.299 1.904 . . . . 0.0 108.968 -170.433 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -70.03 140.55 52.88 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 118.149 0.975 . . . . 0.0 111.642 -178.254 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -100.36 129.71 46.37 Favored 'General case' 0 N--CA 1.447 -0.587 0 C-N-CA 125.671 1.588 . . . . 0.0 109.995 176.912 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 81.3 mt . . . . . 0 CA--C 1.533 0.3 0 N-CA-C 106.576 -1.639 . . . . 0.0 106.576 168.406 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 28.9 m . . . . . 0 CA--C 1.53 0.189 0 CA-C-O 119.232 -0.413 . . . . 0.0 110.368 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -59.24 -43.46 92.4 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 118.789 0.722 . . . . 0.0 111.2 175.636 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 -68.94 -47.6 65.3 Favored 'General case' 0 C--O 1.233 0.23 0 C-N-CA 124.934 1.294 . . . . 0.0 110.436 -179.625 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 9.6 mpt_? -54.13 -47.56 71.74 Favored 'General case' 0 N--CA 1.463 0.221 0 C-N-CA 124.355 1.062 . . . . 0.0 109.87 176.348 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 43.2 mt -68.52 -52.82 32.53 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.468 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 -179.41 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 71.4 tp60 -50.89 -63.99 0.95 Allowed 'General case' 0 CA--C 1.516 -0.329 0 C-N-CA 124.922 1.289 . . . . 0.0 111.83 -174.801 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 24.1 m -66.61 -32.62 74.07 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 120.615 -0.434 . . . . 0.0 110.965 -169.742 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 160' ' ' TRP . . . . . . . . . . . . . 36.2 t90 -69.93 -44.65 69.18 Favored 'General case' 0 CA--C 1.517 -0.325 0 O-C-N 121.89 -0.506 . . . . 0.0 111.217 177.536 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 67.1 m -59.77 -42.94 94.39 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 122.779 0.432 . . . . 0.0 110.371 178.046 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -62.06 -42.54 99.3 Favored 'General case' 0 C--O 1.227 -0.083 0 CA-C-O 121.031 0.443 . . . . 0.0 110.08 175.812 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 14.2 tt0 -62.78 -52.15 64.32 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-O 118.824 -0.608 . . . . 0.0 110.187 -178.669 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 43.8 pt -63.0 -38.56 82.35 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.321 0 CA-C-O 117.819 -1.086 . . . . 0.0 109.267 -174.724 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -65.31 -33.88 77.03 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 119.435 1.016 . . . . 0.0 110.405 -179.484 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 34.0 m-80 -69.77 -56.91 5.88 Favored 'General case' 0 CA--C 1.517 -0.305 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 175.379 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 9.9 tt0 -64.72 -37.48 87.73 Favored 'General case' 0 N--CA 1.442 -0.86 0 C-N-CA 124.813 1.245 . . . . 0.0 110.887 -168.68 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 168' ' ' MET . . . . . . . . . . . . . 21.4 ptp -66.98 -32.27 73.39 Favored 'General case' 0 CA--C 1.522 -0.098 0 O-C-N 121.66 -0.65 . . . . 0.0 111.295 174.083 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -76.14 -37.39 58.04 Favored 'General case' 0 N--CA 1.443 -0.793 0 N-CA-C 112.451 0.537 . . . . 0.0 112.451 -178.47 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 . . . . . 0 CA--C 1.533 0.326 0 N-CA-C 108.89 -0.782 . . . . 0.0 108.89 174.985 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.498 1.947 0 N-CA-C 111.191 0.071 . . . . 0.0 111.191 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 19.7 p-10 -102.3 163.33 12.3 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 124.503 1.121 . . . . 0.0 111.467 -175.771 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 16.3 mtt -129.3 127.03 40.31 Favored 'General case' 0 N--CA 1.464 0.237 0 C-N-CA 122.89 0.476 . . . . 0.0 110.712 179.1 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -94.29 121.06 6.57 Favored Glycine 0 C--O 1.225 -0.437 0 N-CA-C 107.573 -2.211 . . . . 0.0 107.573 168.904 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 4.1 tt -104.43 111.54 24.23 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 105.468 -2.049 . . . . 0.0 105.468 179.226 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . 0.423 ' CD1' HD11 ' A' ' 35' ' ' LEU . 0.6 OUTLIER -108.32 143.99 36.45 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-O 121.757 0.789 . . . . 0.0 110.434 175.637 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 20.6 p90 . . . . . 0 N--CA 1.447 -0.62 0 N-CA-C 106.454 -1.684 . . . . 0.0 106.454 176.963 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.274 0 N-CA-C 110.125 -0.324 . . . . 0.0 110.125 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -62.99 -46.44 87.69 Favored 'General case' 0 N--CA 1.455 -0.195 0 C-N-CA 123.273 0.629 . . . . 0.0 111.204 -177.11 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 50.3 mm-40 -55.01 -52.41 63.23 Favored 'General case' 0 C--O 1.23 0.043 0 C-N-CA 123.169 0.588 . . . . 0.0 109.706 173.008 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 57.8 mttm -64.21 -42.16 96.73 Favored 'General case' 0 C--O 1.222 -0.344 0 CA-C-O 118.889 -0.577 . . . . 0.0 110.704 -171.433 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 48.3 mt -55.81 -56.61 11.55 Favored 'Isoleucine or valine' 0 C--O 1.233 0.211 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 178.4 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 19.1 ptt180 -63.4 -38.01 89.48 Favored 'General case' 0 C--O 1.221 -0.416 0 CA-C-O 118.884 -0.579 . . . . 0.0 110.251 -177.12 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -66.02 -38.45 88.44 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.208 0.528 . . . . 0.0 109.956 -173.41 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.472 HD13 ' HA ' ' A' ' 158' ' ' GLN . 77.9 mt -80.6 -53.67 12.12 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.516 0 C-N-CA 125.195 1.398 . . . . 0.0 110.165 -173.186 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 76.4 mt -62.67 -47.82 91.11 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 N-CA-C 109.511 -0.551 . . . . 0.0 109.511 178.579 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 140.91 120.45 1.68 Allowed Glycine 0 CA--C 1.529 0.937 0 C-N-CA 125.273 1.416 . . . . 0.0 110.755 177.051 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 82.1 Cg_endo -73.78 -4.09 14.84 Favored 'Trans proline' 0 CA--C 1.541 0.832 0 C-N-CA 123.078 2.519 . . . . 0.0 113.228 -173.12 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -82.36 -21.63 35.85 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 118.841 0.746 . . . . 0.0 111.54 176.593 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -120.97 -12.91 8.68 Favored 'General case' 0 C--N 1.344 0.33 0 C-N-CA 124.927 1.291 . . . . 0.0 113.436 -175.774 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 60.0 t -100.07 145.36 10.92 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 N-CA-C 107.29 -1.374 . . . . 0.0 107.29 169.136 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 6.0 m -134.48 139.29 45.37 Favored 'General case' 0 N--CA 1.463 0.209 0 C-N-CA 125.105 1.362 . . . . 0.0 107.493 -178.2 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 34.7 mt -93.42 145.05 24.77 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 118.888 0.767 . . . . 0.0 110.033 -179.826 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 12.4 m-70 -112.19 130.74 55.81 Favored 'General case' 0 C--O 1.234 0.286 0 N-CA-C 106.454 -1.684 . . . . 0.0 106.454 168.051 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 35.5 t-20 -105.8 100.14 9.71 Favored 'General case' 0 CA--C 1.521 -0.168 0 N-CA-C 106.117 -1.808 . . . . 0.0 106.117 169.014 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.423 HD11 ' CD1' ' A' ' 6' ' ' PHE . 83.5 mt -70.07 -8.8 52.37 Favored 'General case' 0 N--CA 1.466 0.368 0 N-CA-C 113.414 0.894 . . . . 0.0 113.414 -169.935 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 24.5 tptt -62.41 -23.57 66.91 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 118.662 0.664 . . . . 0.0 110.684 168.261 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -129.81 -39.85 1.4 Allowed 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 124.584 1.153 . . . . 0.0 113.171 -173.87 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 41.4 m-20 -75.89 130.94 39.28 Favored 'General case' 0 C--O 1.235 0.302 0 C-N-CA 123.829 0.852 . . . . 0.0 108.727 178.708 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 15.6 m -74.31 149.22 86.69 Favored Pre-proline 0 CA--C 1.54 0.581 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 173.652 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -71.91 -22.12 23.71 Favored 'Trans proline' 0 CA--C 1.532 0.382 0 C-N-CA 121.802 1.668 . . . . 0.0 112.818 -172.961 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 11.9 mptt -56.21 -23.77 37.71 Favored 'General case' 0 N--CA 1.47 0.541 0 O-C-N 120.963 -1.085 . . . . 0.0 112.342 175.074 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -58.45 -34.15 70.53 Favored 'General case' 0 N--CA 1.465 0.314 0 C-N-CA 124.351 1.06 . . . . 0.0 110.69 175.811 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 61.3 mtt -60.02 -26.13 65.84 Favored 'General case' 0 N--CA 1.465 0.297 0 C-N-CA 124.622 1.169 . . . . 0.0 111.967 178.962 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 68.3 mt-10 -61.79 -33.46 74.15 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 118.729 0.695 . . . . 0.0 109.505 -178.466 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 30.8 mt-30 -69.11 -28.33 66.39 Favored 'General case' 0 CA--C 1.536 0.422 0 N-CA-C 113.749 1.018 . . . . 0.0 113.749 -172.189 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 76.5 m-85 -85.08 138.05 32.66 Favored 'General case' 0 N--CA 1.464 0.243 0 C-N-CA 122.991 0.516 . . . . 0.0 110.14 -167.762 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -71.14 -43.13 68.2 Favored 'General case' 0 C--O 1.233 0.237 0 CA-C-N 118.01 0.368 . . . . 0.0 110.45 -178.502 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 11.8 t -105.16 144.95 14.07 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.404 0 N-CA-C 107.101 -1.444 . . . . 0.0 107.101 169.668 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 19.1 tp -122.78 146.34 47.61 Favored 'General case' 0 N--CA 1.447 -0.618 0 N-CA-C 107.398 -1.334 . . . . 0.0 107.398 169.213 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 41.2 mt -128.05 130.0 69.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 N-CA-C 105.5 -2.037 . . . . 0.0 105.5 178.979 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 2.1 mp -114.35 131.06 56.68 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 125.729 1.612 . . . . 0.0 107.839 -172.17 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.438 ' HA3' ' CZ ' ' A' ' 85' ' ' TYR . . . -139.19 134.61 6.82 Favored Glycine 0 C--N 1.332 0.341 0 CA-C-O 118.855 -0.969 . . . . 0.0 111.544 177.902 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.454 HD13 ' HB1' ' A' ' 100' ' ' ALA . 5.5 tt -155.93 137.55 9.67 Favored Pre-proline 0 CA--C 1.533 0.3 0 CA-C-N 118.252 1.026 . . . . 0.0 111.246 177.954 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_endo . . . . . 0 N--CA 1.453 -0.904 0 C-N-CA 122.383 2.055 . . . . 0.0 107.187 164.881 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 11.7 mt . . . . . 0 CA--C 1.541 0.626 0 CA-C-O 121.611 0.719 . . . . 0.0 110.674 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 3.8 mp0 -69.64 155.93 39.74 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 124.829 1.252 . . . . 0.0 109.747 -174.455 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -51.3 -46.12 62.41 Favored 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 124.664 1.186 . . . . 0.0 111.155 -173.019 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 -60.19 -27.77 67.41 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 123.624 0.769 . . . . 0.0 110.734 -170.568 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' TRP . . . . . 0.646 ' CH2' HD23 ' A' ' 104' ' ' LEU . 0.1 OUTLIER -96.04 -46.92 6.3 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 126.192 1.797 . . . . 0.0 109.054 -178.579 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 14.6 tt0 -62.81 -34.05 76.48 Favored 'General case' 0 N--CA 1.445 -0.723 0 C-N-CA 125.165 1.386 . . . . 0.0 110.437 -175.187 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -57.37 -23.9 52.0 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 124.606 1.162 . . . . 0.0 111.999 -179.065 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 17.7 m -121.4 -11.12 9.09 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.225 0 C-N-CA 124.882 1.273 . . . . 0.0 112.348 179.879 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 48.5 t90 -55.39 -36.57 66.54 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 124.362 1.065 . . . . 0.0 110.674 -178.437 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -63.52 -27.9 69.58 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 125.403 1.481 . . . . 0.0 112.949 176.183 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 41.9 mt-30 -91.73 -20.97 20.99 Favored 'General case' 0 CA--C 1.519 -0.239 0 C-N-CA 125.186 1.394 . . . . 0.0 112.506 179.998 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 76.1 mt -59.45 -27.47 66.11 Favored 'General case' 0 N--CA 1.467 0.391 0 O-C-N 121.538 -0.726 . . . . 0.0 111.294 178.589 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -76.94 -25.75 53.23 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 122.529 0.331 . . . . 0.0 111.316 173.974 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -77.47 -27.14 51.93 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 124.645 1.178 . . . . 0.0 112.335 -179.467 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 36.3 mt -61.8 147.46 46.34 Favored 'General case' 0 C--N 1.34 0.173 0 C-N-CA 124.296 1.039 . . . . 0.0 111.434 -178.079 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 24.4 t-20 -88.15 122.23 31.48 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 108.111 -1.07 . . . . 0.0 108.111 168.437 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 80.6 mt -130.92 9.33 4.9 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 123.577 0.751 . . . . 0.0 112.518 -170.054 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 26.8 mt-10 -52.42 127.92 23.97 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 124.055 0.942 . . . . 0.0 112.382 -168.064 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 69.35 -0.73 15.8 Favored Glycine 0 CA--C 1.534 1.22 0 C-N-CA 125.473 1.511 . . . . 0.0 115.721 176.659 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.82 149.33 39.68 Favored 'General case' 0 C--N 1.345 0.401 0 CA-C-N 120.551 2.176 . . . . 0.0 109.871 -173.29 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 4.5 mt -80.17 137.14 22.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 N-CA-C 106.923 -1.51 . . . . 0.0 106.923 177.769 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 55.6 t -131.47 124.17 54.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 C-N-CA 124.522 1.129 . . . . 0.0 109.734 -176.882 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -94.34 149.93 20.77 Favored 'General case' 0 CA--C 1.52 -0.186 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 167.147 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 8.4 mt -129.16 129.92 45.72 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 107.521 -1.288 . . . . 0.0 107.521 176.736 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . 0.438 ' CZ ' ' HA3' ' A' ' 52' ' ' GLY . 39.9 p90 -142.94 165.82 26.31 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 107.566 -1.272 . . . . 0.0 107.566 167.712 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -166.68 168.81 40.37 Favored Glycine 0 N--CA 1.442 -0.944 0 N-CA-C 110.147 -1.181 . . . . 0.0 110.147 173.517 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 1.1 mp . . . . . 0 N--CA 1.45 -0.467 0 C-N-CA 124.952 1.301 . . . . 0.0 108.925 177.249 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 94.6 mt . . . . . 0 N--CA 1.469 0.486 0 N-CA-C 113.358 0.874 . . . . 0.0 113.358 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -63.9 -34.77 78.71 Favored 'General case' 0 C--N 1.333 -0.134 0 O-C-N 120.746 -1.221 . . . . 0.0 110.741 -170.937 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . 0.454 ' HB1' HD13 ' A' ' 53' ' ' ILE . . . -73.89 -26.34 60.49 Favored 'General case' 0 N--CA 1.453 -0.302 0 O-C-N 121.485 -0.76 . . . . 0.0 112.619 176.36 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 5.2 tt -62.22 -44.86 95.61 Favored 'General case' 0 N--CA 1.466 0.36 0 N-CA-C 107.124 -1.435 . . . . 0.0 107.124 169.126 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -64.78 -40.63 97.51 Favored Glycine 0 C--N 1.34 0.803 0 N-CA-C 111.136 -0.786 . . . . 0.0 111.136 -179.02 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 75.0 mtm -62.7 -41.13 98.98 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 118.072 0.936 . . . . 0.0 111.318 177.344 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.646 HD23 ' CH2' ' A' ' 65' ' ' TRP . 0.1 OUTLIER -68.09 -40.21 82.68 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 120.164 1.347 . . . . 0.0 110.485 178.594 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 82.3 t60 -55.98 -51.92 66.01 Favored 'General case' 0 CA--C 1.528 0.112 0 N-CA-C 110.062 -0.348 . . . . 0.0 110.062 175.035 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -64.32 -39.94 94.92 Favored 'General case' 0 C--O 1.235 0.339 0 C-N-CA 123.967 0.907 . . . . 0.0 112.584 -176.102 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 22.3 ttmm -54.85 -39.05 68.22 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 123.794 0.838 . . . . 0.0 109.775 171.567 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 21.8 mt -90.6 -18.78 24.58 Favored 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 114.603 1.334 . . . . 0.0 114.603 -169.379 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 2.5 m -58.86 -33.46 70.49 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 120.561 1.528 . . . . 0.0 111.688 -175.75 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 19.5 p -86.56 -11.94 50.12 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 124.754 1.221 . . . . 0.0 111.999 -179.318 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 32.1 mmmt -82.12 -10.14 59.29 Favored 'General case' 0 C--N 1.344 0.342 0 C-N-CA 124.314 1.046 . . . . 0.0 111.414 176.37 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 73.65 32.99 58.74 Favored Glycine 0 CA--C 1.526 0.723 0 CA-C-O 119.524 -0.598 . . . . 0.0 112.102 173.153 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 17.2 m -75.19 177.54 0.57 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.613 0 CA-C-N 118.193 0.997 . . . . 0.0 109.853 171.224 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -118.91 120.25 36.74 Favored 'General case' 0 CA--C 1.518 -0.274 0 N-CA-C 106.939 -1.504 . . . . 0.0 106.939 174.373 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 76.9 m-85 -87.83 144.67 26.47 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 119.696 1.135 . . . . 0.0 110.231 -175.323 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 35.9 m -134.34 159.68 41.92 Favored 'Isoleucine or valine' 0 C--O 1.234 0.254 0 C-N-CA 125.343 1.457 . . . . 0.0 107.936 169.865 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 85.54 30.62 23.91 Favored Glycine 0 CA--C 1.522 0.513 0 CA-C-O 118.75 -1.028 . . . . 0.0 114.262 170.872 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 13.0 m-30 -62.06 157.01 19.9 Favored 'General case' 0 CA--C 1.545 0.757 0 CA-C-N 119.036 1.418 . . . . 0.0 109.691 169.09 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 119' ' ' TRP . . . . . 0.42 ' HA ' ' HD3' ' A' ' 120' ' ' PRO . 2.5 t90 -135.98 144.26 47.65 Favored Pre-proline 0 N--CA 1.474 0.772 0 CA-C-O 117.712 -1.137 . . . . 0.0 111.849 -168.915 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 120' ' ' PRO . . . . . 0.42 ' HD3' ' HA ' ' A' ' 119' ' ' TRP . 36.2 Cg_exo -66.96 123.0 10.41 Favored 'Trans proline' 0 C--N 1.352 0.761 0 C-N-CA 123.552 2.835 . . . . 0.0 113.144 -176.647 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 3.3 p . . . . . 0 N--CA 1.468 0.43 0 N-CA-C 113.847 1.055 . . . . 0.0 113.847 179.341 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 24.8 ttmt . . . . . 0 N--CA 1.475 0.803 0 N-CA-C 114.845 1.424 . . . . 0.0 114.845 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_endo -78.92 -1.04 11.26 Favored 'Trans proline' 0 CA--C 1.539 0.761 0 CA-C-N 122.25 1.839 . . . . 0.0 113.999 179.992 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 18.5 m -127.37 170.58 17.02 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.22 0 CA-C-N 119.875 1.216 . . . . 0.0 110.96 -171.307 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 4.9 pt -128.8 169.29 20.42 Favored 'Isoleucine or valine' 0 C--O 1.241 0.64 0 C-N-CA 127.664 2.386 . . . . 0.0 107.86 175.579 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . 56.41 -156.37 0.28 Allowed 'General case' 0 N--CA 1.446 -0.652 0 C-N-CA 124.622 1.169 . . . . 0.0 108.37 -175.924 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 24.8 t0 -78.51 52.47 1.17 Allowed 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 124.481 1.113 . . . . 0.0 110.833 174.894 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 67.19 26.67 73.4 Favored Glycine 0 CA--C 1.531 1.069 0 C-N-CA 124.657 1.123 . . . . 0.0 112.677 -175.495 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 36.8 mt-30 -88.56 -11.41 45.71 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 118.579 1.19 . . . . 0.0 112.533 -170.128 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 8.5 tp -155.71 143.28 19.54 Favored 'General case' 0 C--N 1.343 0.319 0 CA-C-N 119.255 0.934 . . . . 0.0 110.578 175.671 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 67.9 m-85 -78.4 144.92 35.48 Favored 'General case' 0 CA--C 1.516 -0.365 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 169.771 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 17.0 m -76.56 4.63 1.11 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.732 0 C-N-CA 122.773 0.429 . . . . 0.0 111.959 176.615 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -172.86 172.92 45.38 Favored Glycine 0 CA--C 1.527 0.8 0 O-C-N 120.753 -1.217 . . . . 0.0 110.6 -179.173 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 3.6 tp -62.6 131.78 50.19 Favored 'General case' 0 N--CA 1.464 0.246 0 C-N-CA 124.143 0.977 . . . . 0.0 110.942 179.638 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -91.18 129.08 37.21 Favored 'General case' 0 N--CA 1.444 -0.742 0 C-N-CA 126.288 1.835 . . . . 0.0 109.572 176.811 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 32.4 mt . . . . . 0 C--O 1.231 0.116 0 N-CA-C 105.926 -1.879 . . . . 0.0 105.926 172.152 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 14.9 m . . . . . 0 CA--C 1.537 0.477 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -56.27 -44.22 79.56 Favored 'General case' 0 N--CA 1.464 0.27 0 C-N-CA 124.438 1.095 . . . . 0.0 110.904 169.818 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -65.25 -44.56 87.74 Favored 'General case' 0 C--O 1.234 0.252 0 C-N-CA 124.605 1.162 . . . . 0.0 110.882 -178.718 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 5.9 mmt180 -58.32 -41.36 84.37 Favored 'General case' 0 N--CA 1.462 0.153 0 CA-C-O 118.765 -0.636 . . . . 0.0 109.887 177.944 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 42.0 mt -67.98 -53.97 26.04 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.236 0 N-CA-C 108.228 -1.027 . . . . 0.0 108.228 176.811 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 158' ' ' GLN . . . . . 0.472 ' HA ' HD13 ' A' ' 24' ' ' ILE . 0.8 OUTLIER -49.77 -66.25 0.42 Allowed 'General case' 0 CA--C 1.518 -0.267 0 C-N-CA 125.547 1.539 . . . . 0.0 112.067 -172.178 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 14.6 m -60.95 -34.1 74.22 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 115.554 -0.748 . . . . 0.0 111.713 -174.888 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 160' ' ' TRP . . . . . . . . . . . . . 79.2 t90 -65.55 -43.9 88.48 Favored 'General case' 0 C--O 1.222 -0.373 0 O-C-N 121.775 -0.578 . . . . 0.0 111.005 174.411 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 92.5 m -61.01 -41.36 96.38 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 123.159 0.584 . . . . 0.0 110.652 179.721 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -63.09 -41.1 99.33 Favored 'General case' 0 N--CA 1.462 0.15 0 CA-C-O 121.104 0.478 . . . . 0.0 110.791 173.534 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 16.1 tt0 -65.05 -51.22 62.75 Favored 'General case' 0 N--CA 1.446 -0.654 0 O-C-N 121.566 -0.708 . . . . 0.0 110.122 -177.614 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 41.6 pt -63.38 -36.82 77.65 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.403 0 CA-C-O 117.818 -1.087 . . . . 0.0 109.734 -175.863 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -64.35 -36.25 83.52 Favored 'General case' 0 C--O 1.225 -0.187 0 CA-C-N 119.561 1.073 . . . . 0.0 109.611 -179.704 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 41.3 m-80 -68.59 -51.34 43.63 Favored 'General case' 0 N--CA 1.467 0.387 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 175.422 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 22.8 tt0 -72.85 -16.04 61.6 Favored 'General case' 0 N--CA 1.443 -0.802 0 C-N-CA 125.847 1.659 . . . . 0.0 111.937 -169.448 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 168' ' ' MET . . . . . . . . . . . . . 19.5 ptp -90.94 -38.93 12.55 Favored 'General case' 0 N--CA 1.456 -0.162 0 C-N-CA 123.799 0.84 . . . . 0.0 111.544 168.722 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -75.76 -27.04 57.9 Favored 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 122.703 0.401 . . . . 0.0 112.037 -172.927 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 . . . . . 0 CA--C 1.543 0.677 0 C-N-CA 123.672 0.789 . . . . 0.0 112.252 -179.23 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.497 1.905 0 N-CA-C 111.146 0.054 . . . . 0.0 111.146 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 22.3 p-10 -130.88 164.17 25.83 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 124.649 1.179 . . . . 0.0 111.487 -173.725 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 16.0 mtt -130.72 124.3 31.21 Favored 'General case' 0 CA--C 1.523 -0.087 0 C-N-CA 123.201 0.6 . . . . 0.0 111.258 179.798 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -87.33 152.18 24.13 Favored Glycine 0 CA--C 1.525 0.682 0 N-CA-C 106.838 -2.505 . . . . 0.0 106.838 166.895 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 2.7 tt -140.11 97.01 3.15 Favored 'General case' 0 N--CA 1.469 0.477 0 N-CA-C 105.783 -1.932 . . . . 0.0 105.783 -172.629 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.694 ' CZ ' HD23 ' A' ' 51' ' ' LEU . 0.7 OUTLIER -105.08 144.0 32.48 Favored 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 123.172 0.589 . . . . 0.0 111.063 -171.664 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 43.1 p90 -156.89 163.41 39.2 Favored 'General case' 0 C--O 1.234 0.28 0 C-N-CA 124.16 0.984 . . . . 0.0 109.941 -179.881 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -80.47 123.95 6.27 Favored Glycine 0 C--N 1.336 0.567 0 N-CA-C 109.204 -1.558 . . . . 0.0 109.204 179.633 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 5.0 m -67.21 -29.13 68.7 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 123.832 0.853 . . . . 0.0 113.023 -169.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -79.04 -18.85 52.78 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 123.314 0.645 . . . . 0.0 111.947 -174.795 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -79.94 142.24 35.28 Favored 'General case' 0 C--O 1.236 0.362 0 C-N-CA 123.353 0.661 . . . . 0.0 110.829 -172.803 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 28.1 m -71.36 161.85 30.39 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 123.767 0.827 . . . . 0.0 110.264 174.929 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 10.3 t80 65.0 -33.96 0.16 Allowed 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 127.99 2.516 . . . . 0.0 116.124 175.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -61.05 -27.43 68.33 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 120.434 1.47 . . . . 0.0 111.799 -174.551 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -61.89 -47.28 85.67 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 118.794 0.724 . . . . 0.0 110.103 176.052 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 17.8 ptp -75.66 -32.55 60.21 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 119.269 0.94 . . . . 0.0 111.069 -178.369 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -56.23 -47.49 78.37 Favored 'General case' 0 CA--C 1.536 0.408 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 169.644 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -64.0 -48.47 76.26 Favored 'General case' 0 N--CA 1.455 -0.223 0 C-N-CA 123.785 0.834 . . . . 0.0 111.511 -177.909 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -52.76 -47.59 67.37 Favored 'General case' 0 C--O 1.235 0.334 0 C-N-CA 124.146 0.978 . . . . 0.0 109.72 175.492 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 28.7 mtpp -75.82 -42.13 50.65 Favored 'General case' 0 C--O 1.221 -0.428 0 CA-C-O 117.982 -1.008 . . . . 0.0 110.521 -170.446 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 39.0 mt -52.37 -53.34 19.87 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.352 0 CA-C-N 120.258 1.39 . . . . 0.0 108.614 173.494 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.15 -39.23 91.93 Favored 'General case' 0 C--O 1.222 -0.358 0 C-N-CA 123.367 0.667 . . . . 0.0 109.798 -176.821 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -66.46 -42.3 87.77 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 118.599 0.636 . . . . 0.0 110.943 179.678 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 54.7 mt -74.0 -53.78 16.64 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.605 0 C-N-CA 124.995 1.318 . . . . 0.0 109.767 -169.789 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 75.3 mt -65.45 -46.1 90.98 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.446 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 178.76 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 140.21 125.85 2.23 Favored Glycine 0 CA--C 1.533 1.176 0 C-N-CA 124.676 1.132 . . . . 0.0 111.952 172.832 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -71.6 -6.88 20.07 Favored 'Trans proline' 0 CA--C 1.539 0.749 0 C-N-CA 123.701 2.934 . . . . 0.0 113.684 -174.025 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -81.55 -19.24 42.47 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-N 119.123 0.874 . . . . 0.0 111.245 176.812 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -127.25 -5.83 6.01 Favored 'General case' 0 C--N 1.345 0.372 0 C-N-CA 124.653 1.181 . . . . 0.0 113.792 -174.53 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 26.9 t -113.32 147.21 17.07 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.266 0 N-CA-C 108.007 -1.109 . . . . 0.0 108.007 170.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 36.4 m -135.03 132.15 37.93 Favored 'General case' 0 C--O 1.234 0.267 0 C-N-CA 125.896 1.678 . . . . 0.0 106.667 -174.819 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 14.7 mt -76.01 138.09 40.68 Favored 'General case' 0 C--O 1.231 0.101 0 N-CA-C 107.885 -1.154 . . . . 0.0 107.885 174.696 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 35.0 t-80 -126.85 56.48 1.5 Allowed 'General case' 0 CA--C 1.531 0.217 0 N-CA-C 107.422 -1.325 . . . . 0.0 107.422 177.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 48.5 t30 -61.21 128.92 38.75 Favored 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 107.099 -1.445 . . . . 0.0 107.099 176.123 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 40.2 mt -70.33 -29.98 66.82 Favored 'General case' 0 N--CA 1.469 0.496 0 N-CA-C 114.138 1.162 . . . . 0.0 114.138 -167.65 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 21.5 mmmt -62.72 -26.16 68.54 Favored 'General case' 0 N--CA 1.466 0.344 0 O-C-N 121.703 -0.623 . . . . 0.0 111.698 168.369 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -92.62 -34.62 13.93 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-N 118.568 0.622 . . . . 0.0 112.405 -172.566 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 2.2 t0 -146.4 150.73 36.22 Favored 'General case' 0 N--CA 1.466 0.363 0 N-CA-C 113.025 0.75 . . . . 0.0 113.025 177.008 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 15.2 m -72.14 158.11 88.17 Favored Pre-proline 0 CA--C 1.541 0.6 0 C-N-CA 126.083 1.753 . . . . 0.0 111.499 -169.555 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -71.8 -27.5 17.89 Favored 'Trans proline' 0 C--N 1.35 0.628 0 C-N-CA 122.388 2.059 . . . . 0.0 113.385 -170.466 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 14.8 mmmt -68.36 -16.12 63.81 Favored 'General case' 0 N--CA 1.472 0.644 0 O-C-N 120.897 -1.127 . . . . 0.0 111.286 -175.822 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -62.95 -27.97 69.75 Favored 'General case' 0 N--CA 1.465 0.277 0 C-N-CA 125.741 1.616 . . . . 0.0 110.422 171.821 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 47.5 mtt -56.37 -25.39 49.39 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 119.134 0.879 . . . . 0.0 111.422 178.335 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -66.57 -30.21 70.45 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 118.445 0.566 . . . . 0.0 110.895 -176.585 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 23.1 mt-30 -68.88 -41.5 78.23 Favored 'General case' 0 N--CA 1.465 0.277 0 N-CA-C 113.082 0.771 . . . . 0.0 113.082 -170.071 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 43.3 m-85 -72.75 137.47 45.89 Favored 'General case' 0 N--CA 1.461 0.104 0 C-N-CA 123.534 0.734 . . . . 0.0 109.721 -167.197 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -68.27 -36.54 79.56 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 118.539 0.609 . . . . 0.0 110.181 178.908 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 5.9 t -110.39 144.14 19.03 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.295 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 170.948 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 59.4 tp -131.02 108.55 9.87 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 173.484 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 22.8 mt -85.49 131.27 34.7 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 N-CA-C 106.246 -1.761 . . . . 0.0 106.246 175.067 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.694 HD23 ' CZ ' ' A' ' 6' ' ' PHE . 0.8 OUTLIER -107.29 133.36 51.96 Favored 'General case' 0 N--CA 1.456 -0.134 0 C-N-CA 125.574 1.55 . . . . 0.0 107.918 172.058 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.527 ' N ' HD22 ' A' ' 51' ' ' LEU . . . -127.65 126.7 5.59 Favored Glycine 0 C--N 1.331 0.299 0 N-CA-C 109.457 -1.457 . . . . 0.0 109.457 170.47 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 7.0 tt -148.92 123.23 4.77 Favored Pre-proline 0 N--CA 1.471 0.584 0 CA-C-N 119.305 1.552 . . . . 0.0 111.582 170.846 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_exo -65.79 142.54 70.16 Favored 'Trans proline' 0 N--CA 1.459 -0.525 0 C-N-CA 122.444 2.096 . . . . 0.0 110.664 166.604 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.415 HG21 ' H ' ' A' ' 99' ' ' ASP . 85.3 m -98.8 131.01 45.25 Favored 'General case' 0 CA--C 1.54 0.562 0 N-CA-C 107.389 -1.337 . . . . 0.0 107.389 169.268 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' TRP . . . . . . . . . . . . 0.281 1.3 t-105 51.26 53.49 12.82 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 125.715 1.606 . . . . 0.0 113.306 177.314 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -80.33 -75.04 0.28 Allowed 'General case' 0 CA--C 1.533 0.298 0 N-CA-C 107.403 -1.332 . . . . 0.0 107.403 168.27 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 88.9 t80 -81.0 -37.68 28.78 Favored 'General case' 0 CA--C 1.539 0.552 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 168.25 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 179.7 -174.13 45.79 Favored Glycine 0 CA--C 1.526 0.74 0 C-N-CA 127.186 2.327 . . . . 0.0 107.489 178.366 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -62.93 132.5 52.3 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 118.867 1.333 . . . . 0.0 108.324 169.795 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.425 HD11 ' HE3' ' A' ' 103' ' ' MET . 78.8 mt 34.05 95.66 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.545 0.77 0 C-N-CA 128.769 2.828 . . . . 0.0 112.772 174.015 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.68 163.26 4.46 Favored 'General case' 0 CA--C 1.542 0.655 0 CA-C-O 122.257 1.027 . . . . 0.0 112.376 171.761 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -59.79 -42.27 93.02 Favored 'General case' 0 N--CA 1.455 -0.206 0 C-N-CA 124.377 1.071 . . . . 0.0 112.599 -168.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 55.4 m-20 -66.3 -23.1 66.32 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-N 119.615 1.098 . . . . 0.0 111.723 -169.62 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 12.7 t90 -91.32 -44.83 8.94 Favored 'General case' 0 N--CA 1.456 -0.166 0 C-N-CA 124.379 1.071 . . . . 0.0 110.133 175.419 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -61.7 -35.31 77.66 Favored 'General case' 0 CA--C 1.535 0.396 0 O-C-N 121.266 -0.896 . . . . 0.0 109.945 -178.383 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -58.38 -24.73 60.79 Favored 'General case' 0 C--O 1.233 0.199 0 C-N-CA 124.465 1.106 . . . . 0.0 111.738 -177.725 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 35.7 m -115.13 -13.87 11.07 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.245 0 CA-C-O 117.327 -1.321 . . . . 0.0 112.354 178.0 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 25.1 t90 -52.64 -38.94 61.24 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 120.291 1.405 . . . . 0.0 110.576 -179.02 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -63.17 -26.93 69.03 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 125.098 1.359 . . . . 0.0 113.216 176.543 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 26.0 mt-30 -92.4 -20.09 21.4 Favored 'General case' 0 C--N 1.342 0.243 0 C-N-CA 125.735 1.614 . . . . 0.0 112.31 178.114 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 47.9 mt -64.12 -23.17 67.22 Favored 'General case' 0 N--CA 1.465 0.305 0 O-C-N 121.212 -0.93 . . . . 0.0 111.337 -175.756 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -79.99 -22.25 42.72 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-N 118.372 0.533 . . . . 0.0 111.877 174.684 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -70.72 -27.47 63.99 Favored 'General case' 0 N--CA 1.471 0.618 0 O-C-N 120.979 -1.076 . . . . 0.0 111.521 176.608 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 27.3 mt -62.06 149.67 40.43 Favored 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 124.855 1.262 . . . . 0.0 109.592 -179.636 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 28.1 t-20 -72.0 -59.86 2.53 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-O 122.634 1.206 . . . . 0.0 112.424 -174.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 16.7 mt 58.44 2.25 0.21 Allowed 'General case' 0 C--N 1.32 -0.686 0 C-N-CA 129.5 3.12 . . . . 0.0 116.739 175.679 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 30.9 mt-10 -58.59 130.12 45.33 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 120.188 1.358 . . . . 0.0 111.864 -169.186 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 71.18 0.1 34.35 Favored Glycine 0 CA--C 1.533 1.159 0 CA-C-O 117.964 -1.464 . . . . 0.0 114.908 176.24 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.11 155.29 37.25 Favored 'General case' 0 C--N 1.343 0.323 0 CA-C-N 120.681 2.241 . . . . 0.0 110.225 -174.414 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 1.9 mt -84.71 140.91 15.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 N-CA-C 106.875 -1.528 . . . . 0.0 106.875 178.194 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 54.9 t -135.4 138.98 47.58 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.706 0 C-N-CA 124.012 0.925 . . . . 0.0 109.024 -179.161 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.488 ' HB1' ' CH2' ' A' ' 160' ' ' TRP . . . -111.19 142.68 43.06 Favored 'General case' 0 CA--C 1.517 -0.301 0 N-CA-C 104.365 -2.458 . . . . 0.0 104.365 166.763 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 30.8 mt -122.19 144.88 48.69 Favored 'General case' 0 CA--C 1.51 -0.594 0 CA-C-N 120.262 1.392 . . . . 0.0 107.373 169.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 41.6 p90 -150.4 162.75 39.94 Favored 'General case' 0 N--CA 1.44 -0.934 0 N-CA-C 107.744 -1.206 . . . . 0.0 107.744 168.286 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -157.58 171.58 34.78 Favored Glycine 0 N--CA 1.443 -0.897 0 N-CA-C 109.691 -1.364 . . . . 0.0 109.691 171.459 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 6.8 tt -117.08 150.31 38.87 Favored 'General case' 0 N--CA 1.446 -0.632 0 C-N-CA 125.04 1.336 . . . . 0.0 108.334 175.677 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -160.23 -158.51 9.27 Favored Glycine 0 CA--C 1.528 0.866 0 N-CA-C 107.799 -2.12 . . . . 0.0 107.799 169.636 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -152.11 120.57 6.41 Favored 'General case' 0 N--CA 1.465 0.289 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 168.713 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 14.7 pm0 -78.55 -10.75 59.84 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 123.945 0.898 . . . . 0.0 112.81 -176.011 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 26.5 mt -76.98 -56.73 4.33 Favored 'General case' 0 C--N 1.343 0.289 0 CA-C-N 119.139 0.881 . . . . 0.0 109.748 176.164 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -88.01 -32.58 12.29 Favored Glycine 0 CA--C 1.523 0.554 0 CA-C-O 118.606 -1.108 . . . . 0.0 113.603 -170.023 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -90.35 -97.48 0.11 Allowed 'General case' 0 C--O 1.236 0.367 0 N-CA-C 106.935 -1.505 . . . . 0.0 106.935 172.268 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 84.39 133.42 2.57 Favored Glycine 0 CA--C 1.527 0.808 0 N-CA-C 107.652 -2.179 . . . . 0.0 107.652 -173.502 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 69.36 -45.37 0.56 Allowed 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 128.075 2.55 . . . . 0.0 112.251 -175.23 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' TRP . . . . . . . . . . . . . 3.4 m-90 -77.2 23.44 0.19 Allowed 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 124.545 1.138 . . . . 0.0 112.258 175.38 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 21.6 t80 -76.77 135.64 38.98 Favored 'General case' 0 N--CA 1.457 -0.105 0 O-C-N 121.297 -0.877 . . . . 0.0 108.886 -175.105 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 97.5 mt 52.27 26.69 4.17 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 124.527 1.131 . . . . 0.0 113.807 169.475 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . 0.415 ' H ' HG21 ' A' ' 55' ' ' THR . 11.2 t70 -67.28 -32.22 73.06 Favored 'General case' 0 C--N 1.329 -0.302 0 O-C-N 120.539 -1.35 . . . . 0.0 110.577 -171.685 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -70.68 -30.25 66.79 Favored 'General case' 0 CA--C 1.535 0.396 0 O-C-N 121.503 -0.748 . . . . 0.0 111.834 173.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 6.3 tt -61.77 -46.52 89.23 Favored 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 107.845 -1.169 . . . . 0.0 107.845 169.349 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -62.04 -38.07 95.48 Favored Glycine 0 CA--C 1.524 0.603 0 N-CA-C 111.086 -0.806 . . . . 0.0 111.086 -177.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' MET . . . . . 0.425 ' HE3' HD11 ' A' ' 61' ' ' ILE . 74.3 mtm -68.5 -39.26 81.34 Favored 'General case' 0 N--CA 1.454 -0.243 0 CA-C-O 118.246 -0.883 . . . . 0.0 111.489 177.705 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.46 ' HA ' HD22 ' A' ' 104' ' ' LEU . 0.2 OUTLIER -71.98 -32.08 66.88 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-N 120.52 1.509 . . . . 0.0 110.649 177.209 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -56.5 -56.58 19.46 Favored 'General case' 0 N--CA 1.462 0.146 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 167.891 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -63.39 -38.53 91.52 Favored 'General case' 0 C--O 1.235 0.338 0 C-N-CA 123.49 0.716 . . . . 0.0 112.025 -170.852 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 23.5 ttmm -58.34 -44.42 88.72 Favored 'General case' 0 CA--C 1.529 0.161 0 C-N-CA 122.804 0.442 . . . . 0.0 109.834 171.619 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 49.0 mt -83.49 -20.05 34.67 Favored 'General case' 0 CA--C 1.519 -0.238 0 N-CA-C 114.445 1.276 . . . . 0.0 114.445 -169.512 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 1.1 m -59.57 -36.53 76.41 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 120.567 1.53 . . . . 0.0 111.375 -172.544 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 20.0 p -84.33 -15.35 46.86 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 124.922 1.289 . . . . 0.0 111.732 -178.948 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 30.7 mmmt -78.34 -14.1 59.56 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 124.212 1.005 . . . . 0.0 110.844 173.869 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 79.28 33.45 35.61 Favored Glycine 0 CA--C 1.524 0.653 0 CA-C-O 119.333 -0.704 . . . . 0.0 112.335 170.22 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 12.9 m -75.91 170.04 1.58 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.458 0 CA-C-N 118.518 1.159 . . . . 0.0 110.203 173.218 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 16.5 tptm -101.62 129.29 47.71 Favored 'General case' 0 CA--C 1.515 -0.402 0 N-CA-C 105.086 -2.19 . . . . 0.0 105.086 168.219 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 65.9 m-85 -93.78 123.92 37.44 Favored 'General case' 0 C--N 1.33 -0.239 0 N-CA-C 107.654 -1.239 . . . . 0.0 107.654 171.303 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 30.2 m -106.18 160.95 5.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 C-N-CA 123.914 0.886 . . . . 0.0 109.387 168.649 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 99.18 -77.07 0.51 Allowed Glycine 0 N--CA 1.446 -0.67 0 C-N-CA 125.122 1.344 . . . . 0.0 111.839 170.651 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 20.8 m-85 55.39 -170.17 0.07 Allowed 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 124.129 0.972 . . . . 0.0 110.861 -169.639 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -154.57 143.41 14.77 Favored Pre-proline 0 N--CA 1.466 0.332 0 CA-C-O 117.628 -1.177 . . . . 0.0 108.809 168.737 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_exo -61.97 127.72 22.16 Favored 'Trans proline' 0 CA--C 1.533 0.461 0 C-N-CA 122.209 1.94 . . . . 0.0 111.144 178.403 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 10.4 p -79.1 -14.1 59.34 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 112.753 0.649 . . . . 0.0 112.753 174.199 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -63.12 129.14 39.05 Favored 'General case' 0 CA--C 1.536 0.415 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 -178.462 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 93.56 -11.52 71.21 Favored Glycine 0 CA--C 1.534 1.271 0 C-N-CA 124.848 1.213 . . . . 0.0 113.729 -176.39 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 11.6 m-85 -96.45 158.84 15.25 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 119.013 1.407 . . . . 0.0 109.508 169.171 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -132.11 129.75 40.29 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 124.601 1.161 . . . . 0.0 108.05 175.691 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 41.0 p90 -165.2 170.51 14.78 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 126.829 2.052 . . . . 0.0 107.345 -176.384 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 3.0 t -133.4 -3.38 3.03 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 123.489 0.716 . . . . 0.0 111.238 169.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 2.1 p -77.66 131.46 70.92 Favored Pre-proline 0 CA--C 1.543 0.675 0 C-N-CA 125.244 1.417 . . . . 0.0 109.699 -175.25 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -84.39 -24.85 2.31 Favored 'Trans proline' 0 CA--C 1.537 0.663 0 C-N-CA 122.355 2.037 . . . . 0.0 112.928 -177.733 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 23.6 ttmt -58.81 -43.66 98.02 Favored Pre-proline 0 CA--C 1.54 0.586 0 CA-C-O 117.457 -1.259 . . . . 0.0 113.844 -169.624 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -81.99 5.35 6.38 Favored 'Trans proline' 0 C--N 1.352 0.746 0 CA-C-N 122.187 1.817 . . . . 0.0 113.551 -176.588 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 17.1 m -135.5 170.05 19.85 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.249 0 CA-C-N 120.622 1.556 . . . . 0.0 111.36 -169.574 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 14.5 pt -141.1 175.23 6.02 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.657 0 C-N-CA 127.876 2.47 . . . . 0.0 108.254 -179.472 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . 54.8 42.59 31.04 Favored 'General case' 0 N--CA 1.464 0.266 0 C-N-CA 125.27 1.428 . . . . 0.0 112.342 173.849 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 27.1 t0 53.69 41.5 32.06 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 126.184 1.794 . . . . 0.0 111.696 -176.452 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 88.03 14.51 62.49 Favored Glycine 0 CA--C 1.526 0.758 0 CA-C-O 118.496 -1.169 . . . . 0.0 113.771 174.037 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 45.7 mt-30 -84.65 -17.31 39.0 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 119.462 1.631 . . . . 0.0 112.658 -179.892 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -143.91 144.74 31.86 Favored 'General case' 0 C--N 1.342 0.252 0 CA-C-N 119.266 0.939 . . . . 0.0 110.379 174.174 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 68.3 m-85 -73.71 141.43 46.38 Favored 'General case' 0 CA--C 1.512 -0.489 0 N-CA-C 105.08 -2.192 . . . . 0.0 105.08 165.173 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 8.0 p -79.05 14.46 0.35 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.672 0 CA-C-O 121.363 0.601 . . . . 0.0 111.714 -176.412 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -178.82 172.87 45.18 Favored Glycine 0 CA--C 1.525 0.712 0 N-CA-C 109.209 -1.556 . . . . 0.0 109.209 177.262 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -66.21 138.66 57.83 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 117.658 0.729 . . . . 0.0 111.122 -176.214 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -98.5 118.47 35.27 Favored 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 125.716 1.607 . . . . 0.0 109.068 175.883 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 93.5 mt -107.61 156.79 18.65 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 123.776 0.831 . . . . 0.0 109.153 169.651 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -135.54 159.76 40.61 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 125.907 1.683 . . . . 0.0 108.625 174.584 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -135.29 6.8 3.33 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 124.704 1.201 . . . . 0.0 113.105 169.558 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 80.9 m -112.78 -44.0 3.37 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 124.548 1.139 . . . . 0.0 112.062 -171.823 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 6.9 p30 -105.62 -33.81 7.95 Favored 'General case' 0 C--O 1.232 0.175 0 C-N-CA 124.235 1.014 . . . . 0.0 113.244 -169.895 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 35.5 mt-30 -141.15 33.74 1.72 Allowed 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 125.101 1.36 . . . . 0.0 110.87 -170.699 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 28.0 p90 -55.56 -29.08 58.35 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 124.27 1.028 . . . . 0.0 112.364 -178.217 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -59.58 -37.68 79.16 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 123.607 0.763 . . . . 0.0 112.005 177.89 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 3.6 pp -105.52 5.35 31.37 Favored 'General case' 0 C--N 1.34 0.17 0 C-N-CA 125.084 1.354 . . . . 0.0 112.773 -176.505 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 50.7 m -60.33 -28.88 68.49 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-N 120.593 1.542 . . . . 0.0 110.582 169.503 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -60.71 -40.74 93.39 Favored 'General case' 0 N--CA 1.464 0.231 0 C-N-CA 123.35 0.66 . . . . 0.0 111.448 170.398 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -65.02 -45.11 86.88 Favored 'General case' 0 C--O 1.234 0.288 0 C-N-CA 124.869 1.268 . . . . 0.0 110.315 177.042 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 81.8 mtt180 -58.06 -47.58 82.71 Favored 'General case' 0 N--CA 1.462 0.148 0 CA-C-O 118.649 -0.691 . . . . 0.0 110.089 176.314 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 46.4 mt -62.8 -53.23 49.5 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.281 0 N-CA-C 107.904 -1.147 . . . . 0.0 107.904 179.696 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 69.8 tp60 -53.68 -61.15 2.49 Favored 'General case' 0 C--O 1.233 0.22 0 C-N-CA 124.024 0.929 . . . . 0.0 110.867 -175.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 44.3 p -65.02 -36.84 85.66 Favored 'General case' 0 C--N 1.326 -0.418 0 O-C-N 123.062 0.227 . . . . 0.0 110.95 -170.375 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 160' ' ' TRP . . . . . 0.488 ' CH2' ' HB1' ' A' ' 83' ' ' ALA . 36.0 t90 -67.73 -44.17 78.21 Favored 'General case' 0 C--O 1.221 -0.395 0 O-C-N 122.248 -0.283 . . . . 0.0 110.929 177.465 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 58.7 m -59.18 -44.29 92.18 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 123.039 0.536 . . . . 0.0 110.703 178.541 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -62.49 -41.96 99.16 Favored 'General case' 0 N--CA 1.456 -0.13 0 CA-C-O 121.071 0.463 . . . . 0.0 109.888 176.38 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 12.6 tt0 -62.9 -52.92 61.19 Favored 'General case' 0 N--CA 1.448 -0.537 0 O-C-N 121.664 -0.647 . . . . 0.0 110.095 -179.02 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 45.0 pt -62.47 -37.77 79.65 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.399 0 CA-C-O 117.582 -1.199 . . . . 0.0 109.23 -174.401 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -65.53 -33.34 75.69 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 119.552 1.069 . . . . 0.0 110.488 -179.45 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 34.6 m-80 -71.88 -51.68 21.11 Favored 'General case' 0 N--CA 1.465 0.315 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 175.786 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 8.9 tt0 -72.38 -31.92 65.97 Favored 'General case' 0 N--CA 1.441 -0.92 0 C-N-CA 123.79 0.836 . . . . 0.0 110.941 -168.566 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 168' ' ' MET . . . . . . . . . . . . . 21.3 ptp -69.88 -31.8 69.8 Favored 'General case' 0 C--N 1.331 -0.196 0 O-C-N 121.068 -1.02 . . . . 0.0 111.407 171.744 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . 0.504 ' HA ' ' CD2' ' A' ' 172' ' ' TYR . . . -78.57 -44.12 24.94 Favored 'General case' 0 N--CA 1.443 -0.796 0 CA-C-O 120.375 0.131 . . . . 0.0 110.983 -175.518 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -65.06 -29.23 70.1 Favored 'General case' 0 CA--C 1.54 0.566 0 N-CA-C 110.088 -0.338 . . . . 0.0 110.088 176.893 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 65.8 t60 -65.35 -48.69 72.11 Favored 'General case' 0 C--O 1.235 0.294 0 C-N-CA 123.601 0.76 . . . . 0.0 111.04 174.129 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 172' ' ' TYR . . . . . 0.504 ' CD2' ' HA ' ' A' ' 169' ' ' ALA . 0.2 OUTLIER -77.14 -30.14 54.98 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-O 119.046 -0.502 . . . . 0.0 112.031 -172.928 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.268 0 C-N-CA 124.148 0.979 . . . . 0.0 110.73 -179.177 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.496 1.85 0 N-CA-C 111.252 0.093 . . . . 0.0 111.252 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 3.0 t30 -119.03 151.62 37.9 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 124.223 1.009 . . . . 0.0 109.784 -174.558 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 1.4 mpt? -116.88 125.89 52.18 Favored 'General case' 0 N--CA 1.463 0.22 0 C-N-CA 123.76 0.824 . . . . 0.0 110.706 179.23 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -82.83 153.2 30.92 Favored Glycine 0 CA--C 1.527 0.811 0 N-CA-C 107.51 -2.236 . . . . 0.0 107.51 166.96 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 3.1 tt -140.26 97.11 3.16 Favored 'General case' 0 N--CA 1.465 0.312 0 N-CA-C 104.888 -2.264 . . . . 0.0 104.888 -176.06 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.414 ' CE2' ' HG ' ' A' ' 51' ' ' LEU . 0.3 OUTLIER -103.44 147.02 27.64 Favored 'General case' 0 N--CA 1.455 -0.181 0 CA-C-O 121.577 0.703 . . . . 0.0 111.914 -172.155 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 47.6 p90 -159.97 173.68 15.52 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 126.294 1.838 . . . . 0.0 107.994 176.425 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -123.53 153.72 17.27 Favored Glycine 0 CA--C 1.526 0.746 0 N-CA-C 108.009 -2.036 . . . . 0.0 108.009 168.683 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 29.9 p -157.38 159.81 37.79 Favored 'General case' 0 C--O 1.238 0.451 0 C-N-CA 123.903 0.881 . . . . 0.0 109.289 178.036 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 11.7 m -69.47 -44.26 71.54 Favored 'General case' 0 CA--C 1.534 0.352 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 169.77 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 1.1 p -152.59 156.46 39.34 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 126.803 2.041 . . . . 0.0 107.974 177.729 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 35.2 m 55.28 -157.26 0.23 Allowed 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 125.213 1.405 . . . . 0.0 111.983 175.031 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 1.3 p90 -66.54 153.09 43.89 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.011 0.924 . . . . 0.0 110.479 174.725 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 3.6 t -63.86 -40.07 95.68 Favored 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 171.301 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -158.87 153.85 25.07 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 105.054 -2.202 . . . . 0.0 105.054 177.524 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 9.2 mtm -62.13 -9.35 7.32 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-N 119.321 0.964 . . . . 0.0 112.239 178.132 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -50.47 -37.07 36.57 Favored 'General case' 0 C--O 1.223 -0.337 0 CA-C-N 118.972 0.806 . . . . 0.0 111.054 167.612 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -66.11 -43.49 87.05 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 119.94 1.245 . . . . 0.0 111.609 -179.751 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 67.0 mm-40 -62.68 -47.53 83.23 Favored 'General case' 0 N--CA 1.464 0.261 0 N-CA-C 109.16 -0.682 . . . . 0.0 109.16 173.023 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 29.2 mtpp -70.16 -36.85 74.98 Favored 'General case' 0 C--O 1.221 -0.397 0 CA-C-O 118.428 -0.796 . . . . 0.0 110.796 -169.351 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 32.1 mt -53.95 -55.93 11.71 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.223 0 CA-C-N 119.307 0.958 . . . . 0.0 108.687 173.472 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 18.2 ptt180 -65.25 -38.44 90.36 Favored 'General case' 0 C--N 1.344 0.343 0 C-N-CA 120.153 -0.619 . . . . 0.0 110.03 -176.687 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -64.69 -38.63 91.65 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 -174.553 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 64.0 mt -78.27 -56.13 8.3 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.63 0 C-N-CA 125.496 1.518 . . . . 0.0 110.057 -174.435 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 77.0 mt -64.66 -45.88 94.02 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 -177.755 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 141.58 120.35 1.62 Allowed Glycine 0 CA--C 1.53 0.975 0 C-N-CA 125.452 1.501 . . . . 0.0 110.595 176.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -75.53 -4.43 15.26 Favored 'Trans proline' 0 CA--C 1.538 0.705 0 C-N-CA 122.82 2.347 . . . . 0.0 113.183 -171.554 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -82.99 -20.5 35.01 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 118.945 0.793 . . . . 0.0 111.418 176.551 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 1.2 pt? -120.96 -14.19 8.49 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 125.057 1.343 . . . . 0.0 113.589 -175.689 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 62.5 t -97.46 148.02 6.01 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 N-CA-C 107.315 -1.365 . . . . 0.0 107.315 168.622 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 46.6 m -135.3 133.08 38.49 Favored 'General case' 0 C--N 1.332 -0.175 0 C-N-CA 125.659 1.584 . . . . 0.0 108.188 -178.906 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 35.7 mt -82.3 142.57 31.96 Favored 'General case' 0 C--O 1.234 0.263 0 N-CA-C 108.574 -0.898 . . . . 0.0 108.574 177.682 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 28.6 t-80 -139.39 60.65 1.57 Allowed 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 124.481 1.112 . . . . 0.0 108.335 -173.577 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 64.3 t-20 -60.88 126.76 28.57 Favored 'General case' 0 C--O 1.232 0.181 0 N-CA-C 107.128 -1.434 . . . . 0.0 107.128 173.309 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 83.3 mt -66.72 -22.44 66.06 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 123.24 0.616 . . . . 0.0 112.16 -179.64 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 56.7 tttt -66.66 -22.11 66.1 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 118.147 0.43 . . . . 0.0 111.708 169.143 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -107.62 -35.3 6.75 Favored 'General case' 0 C--O 1.234 0.272 0 C-N-CA 124.081 0.953 . . . . 0.0 113.25 -169.661 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 2.9 t0 -139.14 155.53 47.79 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 118.717 0.69 . . . . 0.0 112.151 178.128 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 17.2 m -75.06 157.94 84.81 Favored Pre-proline 0 CA--C 1.54 0.595 0 C-N-CA 125.618 1.567 . . . . 0.0 111.482 -170.68 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -73.89 -26.29 13.44 Favored 'Trans proline' 0 C--N 1.349 0.563 0 C-N-CA 122.778 2.318 . . . . 0.0 113.236 -171.68 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 22.7 mmmt -71.27 -12.08 61.26 Favored 'General case' 0 N--CA 1.471 0.576 0 O-C-N 120.395 -1.441 . . . . 0.0 111.716 -176.44 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -61.21 -28.41 69.13 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 125.451 1.5 . . . . 0.0 110.38 168.923 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 45.5 mtt -58.71 -25.96 63.42 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 118.591 0.632 . . . . 0.0 111.745 177.478 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 88.0 mt-10 -65.93 -32.56 74.14 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-O 119.017 -0.516 . . . . 0.0 110.249 -176.567 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 21.2 mt-30 -65.9 -44.28 85.69 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 123.601 0.76 . . . . 0.0 112.541 -170.362 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 52.5 m-85 -74.78 142.24 44.3 Favored 'General case' 0 N--CA 1.456 -0.153 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.662 -166.724 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -69.21 -42.48 75.68 Favored 'General case' 0 C--O 1.235 0.29 0 N-CA-C 109.894 -0.41 . . . . 0.0 109.894 176.413 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 7.2 t -106.33 143.76 16.7 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.368 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 175.306 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 37.8 tp -131.64 114.36 14.71 Favored 'General case' 0 N--CA 1.444 -0.77 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 174.295 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 31.8 mt -94.44 132.75 37.61 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 N-CA-C 106.781 -1.563 . . . . 0.0 106.781 178.416 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.414 ' HG ' ' CE2' ' A' ' 6' ' ' PHE . 3.1 mp -113.95 130.15 56.54 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 125.641 1.577 . . . . 0.0 107.102 -176.583 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -135.67 126.83 4.06 Favored Glycine 0 C--N 1.335 0.491 0 N-CA-C 109.908 -1.277 . . . . 0.0 109.908 177.607 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 7.4 tt -153.57 127.3 4.36 Favored Pre-proline 0 CA--C 1.538 0.496 0 CA-C-N 117.872 0.836 . . . . 0.0 109.892 172.298 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -73.67 156.33 49.09 Favored 'Trans proline' 0 N--CA 1.459 -0.544 0 C-N-CA 122.268 1.979 . . . . 0.0 112.782 169.496 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 1.9 m -132.34 135.53 46.23 Favored 'General case' 0 CA--C 1.535 0.372 0 N-CA-C 108.547 -0.909 . . . . 0.0 108.547 168.14 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 5.9 m-90 -144.19 178.85 7.6 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 125.46 1.504 . . . . 0.0 107.404 169.283 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -59.93 -29.23 68.25 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 123.512 0.725 . . . . 0.0 112.299 171.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 70.5 t80 -115.64 164.34 14.48 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 125.206 1.403 . . . . 0.0 109.856 177.349 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 79.77 -75.92 2.08 Favored Glycine 0 CA--C 1.528 0.857 0 N-CA-C 110.492 -1.043 . . . . 0.0 110.492 176.899 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.505 ' HG2' ' H ' ' A' ' 61' ' ' ILE . 5.3 tt0 53.18 -155.21 0.21 Allowed 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 124.864 1.266 . . . . 0.0 110.324 -175.126 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.505 ' H ' ' HG2' ' A' ' 60' ' ' GLU . 65.9 mt -55.18 119.38 1.82 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.492 0 C-N-CA 125.211 1.404 . . . . 0.0 107.378 169.981 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -85.32 164.81 17.76 Favored 'General case' 0 C--O 1.234 0.254 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 173.661 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -55.2 -38.41 68.37 Favored 'General case' 0 C--O 1.222 -0.36 0 C-N-CA 123.811 0.844 . . . . 0.0 110.741 179.793 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -61.2 -24.48 66.36 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-N 118.792 0.724 . . . . 0.0 112.562 -177.074 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' TRP . . . . . 0.415 ' CH2' HD23 ' A' ' 104' ' ' LEU . 12.2 t90 -96.63 -47.57 5.86 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 124.89 1.276 . . . . 0.0 109.348 176.611 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -64.41 -33.71 76.49 Favored 'General case' 0 CA--C 1.539 0.534 0 O-C-N 120.833 -1.167 . . . . 0.0 110.593 -175.282 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -63.46 -26.58 68.79 Favored 'General case' 0 CA--C 1.529 0.135 0 C-N-CA 123.273 0.629 . . . . 0.0 110.872 -173.956 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 29.1 m -108.57 -15.43 9.36 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.314 0 CA-C-O 117.366 -1.302 . . . . 0.0 111.879 177.12 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 29.4 t90 -51.35 -35.5 38.73 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-N 120.189 1.359 . . . . 0.0 110.679 177.108 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -62.86 -29.33 70.67 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 125.441 1.496 . . . . 0.0 113.303 175.367 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 31.0 mt-30 -92.42 -18.3 23.44 Favored 'General case' 0 N--CA 1.463 0.209 0 C-N-CA 126.09 1.756 . . . . 0.0 112.324 177.29 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 56.7 mt -63.48 -21.04 66.09 Favored 'General case' 0 CA--C 1.534 0.338 0 O-C-N 121.304 -0.872 . . . . 0.0 111.496 -178.119 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -80.11 -23.05 41.49 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 123.011 0.525 . . . . 0.0 111.868 173.671 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -71.83 -30.32 65.36 Favored 'General case' 0 N--CA 1.468 0.466 0 O-C-N 120.705 -1.247 . . . . 0.0 111.843 177.529 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 79.5 mt -52.96 140.85 23.68 Favored 'General case' 0 C--N 1.34 0.174 0 C-N-CA 125.012 1.325 . . . . 0.0 112.757 -168.787 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 28.9 t-20 -74.97 106.43 6.47 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 169.312 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 64.7 mt -128.61 0.07 5.52 Favored 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 113.891 1.071 . . . . 0.0 113.891 -174.393 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 27.2 mt-10 -57.79 128.38 36.81 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 119.658 1.117 . . . . 0.0 110.689 -169.031 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 71.65 -0.05 37.45 Favored Glycine 0 CA--C 1.532 1.127 0 C-N-CA 125.397 1.475 . . . . 0.0 115.046 179.445 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.26 151.55 39.87 Favored 'General case' 0 C--N 1.348 0.51 0 CA-C-N 120.798 2.299 . . . . 0.0 109.649 -177.775 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 3.6 mt -80.67 136.9 22.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 N-CA-C 106.765 -1.568 . . . . 0.0 106.765 178.876 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 68.8 t -132.17 131.56 61.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 C-N-CA 123.813 0.845 . . . . 0.0 109.833 -178.555 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -105.39 150.12 25.52 Favored 'General case' 0 N--CA 1.463 0.192 0 N-CA-C 107.417 -1.327 . . . . 0.0 107.417 168.603 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 3.6 mt -132.24 134.19 45.02 Favored 'General case' 0 CA--C 1.51 -0.594 0 N-CA-C 107.265 -1.383 . . . . 0.0 107.265 177.77 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 35.8 p90 -151.03 165.84 32.55 Favored 'General case' 0 N--CA 1.447 -0.595 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 168.764 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -162.62 159.59 31.9 Favored Glycine 0 N--CA 1.444 -0.784 0 N-CA-C 108.556 -1.817 . . . . 0.0 108.556 172.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 7.0 tt -103.55 147.47 27.14 Favored 'General case' 0 N--CA 1.445 -0.7 0 N-CA-C 108.493 -0.929 . . . . 0.0 108.493 171.56 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -150.53 -169.39 16.45 Favored Glycine 0 CA--C 1.522 0.514 0 N-CA-C 109.904 -1.278 . . . . 0.0 109.904 174.96 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -148.04 139.22 23.41 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 124.823 1.249 . . . . 0.0 107.935 178.541 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 16.6 pm0 -108.81 1.05 20.69 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 124.009 0.924 . . . . 0.0 113.176 177.392 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 28.3 mt -67.06 -38.73 86.33 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 119.696 1.135 . . . . 0.0 108.701 168.361 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -74.44 43.57 1.33 Allowed Glycine 0 CA--C 1.533 1.212 0 C-N-CA 126.04 1.781 . . . . 0.0 111.82 169.237 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 49.4 m-85 62.84 -19.7 0.05 OUTLIER 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 129.267 3.027 . . . . 0.0 116.565 177.228 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 77.35 15.6 81.31 Favored Glycine 0 CA--C 1.529 0.932 0 CA-C-N 120.148 1.34 . . . . 0.0 112.132 -179.774 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -77.14 -16.89 58.98 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 118.796 1.298 . . . . 0.0 110.965 169.72 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' TRP . . . . . . . . . . . . . 53.7 m95 -109.18 6.67 24.96 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 125.074 1.35 . . . . 0.0 111.62 177.37 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 8.6 t80 -61.74 126.34 27.0 Favored 'General case' 0 C--N 1.343 0.297 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 -175.852 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 83.8 mt 51.73 19.31 0.89 Allowed 'General case' 0 N--CA 1.467 0.379 0 N-CA-C 115.679 1.733 . . . . 0.0 115.679 167.668 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -61.84 -36.62 81.72 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-N 121.511 1.959 . . . . 0.0 111.29 -173.37 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -65.83 -27.74 68.47 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 124.328 1.051 . . . . 0.0 112.295 174.52 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 5.3 tt -66.56 -46.69 75.22 Favored 'General case' 0 N--CA 1.467 0.424 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 173.056 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -63.47 -34.6 90.4 Favored Glycine 0 CA--C 1.529 0.944 0 N-CA-C 110.659 -0.976 . . . . 0.0 110.659 -179.732 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 5.2 tpp -50.89 -54.08 27.03 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 124.963 1.305 . . . . 0.0 111.527 175.88 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.415 HD23 ' CH2' ' A' ' 65' ' ' TRP . 0.2 OUTLIER -76.82 -36.61 56.77 Favored 'General case' 0 C--N 1.341 0.238 0 O-C-N 121.891 -0.506 . . . . 0.0 109.782 -175.195 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 43.1 t-80 -55.71 -48.88 74.41 Favored 'General case' 0 N--CA 1.464 0.231 0 O-C-N 121.436 -0.79 . . . . 0.0 110.872 176.261 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -63.44 -38.77 92.42 Favored 'General case' 0 C--O 1.234 0.288 0 C-N-CA 123.288 0.635 . . . . 0.0 112.103 -176.323 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 24.4 ttmm -57.45 -36.09 70.98 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 123.382 0.673 . . . . 0.0 110.727 172.825 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 22.3 mt -91.86 -20.49 21.4 Favored 'General case' 0 CA--C 1.513 -0.45 0 N-CA-C 115.8 1.778 . . . . 0.0 115.8 -168.238 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 6.0 m -58.15 -33.62 69.38 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-N 120.481 1.491 . . . . 0.0 111.627 -178.218 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 20.7 p -87.39 -9.33 55.04 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 124.884 1.274 . . . . 0.0 112.287 -179.807 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 32.5 mmmt -84.53 -4.63 59.06 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 124.461 1.104 . . . . 0.0 111.453 172.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 69.92 31.96 69.89 Favored Glycine 0 CA--C 1.525 0.657 0 CA-C-N 118.605 0.639 . . . . 0.0 112.105 171.827 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 3.5 m -76.33 172.38 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.474 0 CA-C-N 118.104 0.952 . . . . 0.0 109.457 175.237 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -111.9 121.1 44.11 Favored 'General case' 0 CA--C 1.515 -0.386 0 N-CA-C 106.474 -1.676 . . . . 0.0 106.474 173.615 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 64.0 m-85 -88.32 145.35 25.88 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 119.61 1.095 . . . . 0.0 109.378 -178.13 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 27.7 m -129.4 161.08 39.58 Favored 'Isoleucine or valine' 0 C--O 1.233 0.212 0 C-N-CA 124.223 1.009 . . . . 0.0 109.289 171.588 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 93.2 -94.18 1.83 Allowed Glycine 0 N--CA 1.443 -0.877 0 C-N-CA 124.817 1.199 . . . . 0.0 110.804 176.435 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 8.0 m-30 59.57 177.05 0.08 Allowed 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 125.109 1.364 . . . . 0.0 110.188 -167.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -155.27 140.94 12.65 Favored Pre-proline 0 N--CA 1.473 0.7 0 CA-C-O 116.872 -1.537 . . . . 0.0 108.76 -179.468 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -68.13 127.77 16.47 Favored 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 122.698 2.265 . . . . 0.0 112.64 -176.166 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 68.0 p -80.88 -7.65 59.53 Favored 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 112.393 0.516 . . . . 0.0 112.393 169.619 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -59.75 122.62 14.62 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 124.031 0.933 . . . . 0.0 110.314 -169.878 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 71.48 5.01 59.02 Favored Glycine 0 CA--C 1.536 1.382 0 C-N-CA 124.495 1.045 . . . . 0.0 114.293 178.352 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 2.9 t80 -80.29 151.26 29.63 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 118.853 1.326 . . . . 0.0 110.213 -177.538 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -103.02 108.18 19.26 Favored 'General case' 0 N--CA 1.463 0.206 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 174.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 18.9 p90 -164.33 166.06 21.14 Favored 'General case' 0 C--O 1.241 0.641 0 C-N-CA 127.298 2.239 . . . . 0.0 105.583 179.538 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 86.0 m -131.81 -31.56 1.52 Allowed 'General case' 0 N--CA 1.44 -0.961 0 C-N-CA 122.683 0.393 . . . . 0.0 111.62 -173.623 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 1.4 m -53.96 127.3 53.46 Favored Pre-proline 0 CA--C 1.547 0.842 0 C-N-CA 124.325 1.05 . . . . 0.0 112.269 -176.501 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_endo -84.84 -30.01 0.62 Allowed 'Trans proline' 0 CA--C 1.541 0.829 0 C-N-CA 122.408 2.072 . . . . 0.0 112.732 177.451 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 32.5 ttmt -57.14 -42.86 98.36 Favored Pre-proline 0 N--CA 1.471 0.618 0 CA-C-O 117.668 -1.158 . . . . 0.0 113.412 -173.447 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 62.9 Cg_endo -84.77 13.86 2.64 Favored 'Trans proline' 0 C--N 1.348 0.539 0 C-N-CA 121.844 1.696 . . . . 0.0 113.581 -178.866 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 35.1 m -128.63 154.9 40.11 Favored 'Isoleucine or valine' 0 C--O 1.235 0.3 0 CA-C-N 121.777 2.08 . . . . 0.0 111.109 179.065 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 17.8 pt -114.32 167.94 6.66 Favored 'Isoleucine or valine' 0 C--O 1.235 0.319 0 C-N-CA 126.41 1.884 . . . . 0.0 109.145 174.82 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . 57.73 32.94 22.61 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 124.967 1.307 . . . . 0.0 113.484 167.687 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 27.6 t70 54.99 39.83 31.78 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 126.251 1.82 . . . . 0.0 111.592 -175.164 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 93.63 72.21 1.18 Allowed Glycine 0 CA--C 1.528 0.854 0 C-N-CA 124.487 1.042 . . . . 0.0 111.243 177.013 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 78.8 mm-40 -116.66 -49.57 2.64 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 123.168 0.587 . . . . 0.0 110.354 167.375 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -132.48 146.52 51.99 Favored 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 123.017 0.527 . . . . 0.0 110.969 -179.252 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 58.9 m-85 -77.63 16.79 0.61 Allowed 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 126.189 1.796 . . . . 0.0 115.65 177.879 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 3.7 m 49.64 11.73 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.547 0.831 0 C-N-CA 126.927 2.091 . . . . 0.0 114.469 -176.586 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 170.42 170.06 34.28 Favored Glycine 0 CA--C 1.527 0.805 0 N-CA-C 108.368 -1.893 . . . . 0.0 108.368 -171.562 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -69.24 134.95 49.84 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 117.977 0.888 . . . . 0.0 111.007 -178.347 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -95.87 109.94 22.21 Favored 'General case' 0 N--CA 1.448 -0.571 0 C-N-CA 125.52 1.528 . . . . 0.0 109.056 175.291 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 83.8 mt -101.63 154.73 18.61 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 118.845 0.748 . . . . 0.0 109.561 170.157 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -151.54 145.67 25.32 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 106.231 -1.766 . . . . 0.0 106.231 169.321 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 16.2 tt0 -140.95 26.6 2.04 Favored 'General case' 0 CA--C 1.543 0.704 0 CA-C-O 121.45 0.643 . . . . 0.0 110.013 169.82 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 56.5 m -109.9 -42.26 4.28 Favored 'General case' 0 C--O 1.235 0.324 0 C-N-CA 125.311 1.444 . . . . 0.0 109.351 175.36 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 4.5 m-80 -86.83 -34.24 19.57 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 124.069 0.948 . . . . 0.0 109.025 -176.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 3.5 mt-30 -122.03 173.76 7.34 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 127.321 2.248 . . . . 0.0 108.632 177.489 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 81.6 t80 -146.1 -47.84 0.21 Allowed 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 123.5 0.72 . . . . 0.0 110.146 170.026 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -68.26 -48.52 64.84 Favored 'General case' 0 N--CA 1.466 0.331 0 O-C-N 122.182 -0.324 . . . . 0.0 111.868 -172.741 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -85.73 -1.54 57.3 Favored 'General case' 0 N--CA 1.466 0.361 0 N-CA-C 113.13 0.789 . . . . 0.0 113.13 -173.305 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 13.3 m -59.52 -31.57 69.51 Favored 'General case' 0 CA--C 1.543 0.681 0 O-C-N 121.017 -1.052 . . . . 0.0 110.156 171.871 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -63.96 -39.54 94.36 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 123.972 0.909 . . . . 0.0 111.671 172.645 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 -64.55 -46.98 80.51 Favored 'General case' 0 C--O 1.234 0.263 0 C-N-CA 124.294 1.038 . . . . 0.0 109.858 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 72.1 mtt180 -55.32 -41.1 71.98 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-O 118.795 -0.622 . . . . 0.0 110.627 177.039 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 75.9 mt -68.39 -57.97 7.39 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.299 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 177.316 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 70.8 tp60 -49.64 -63.04 1.23 Allowed 'General case' 0 C--O 1.233 0.193 0 C-N-CA 125.12 1.368 . . . . 0.0 112.106 -173.94 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 20.0 m -66.8 -31.95 72.91 Favored 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 120.826 -0.35 . . . . 0.0 111.245 -170.342 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 160' ' ' TRP . . . . . . . . . . . . . 34.0 t90 -70.87 -44.32 66.61 Favored 'General case' 0 CA--C 1.516 -0.342 0 O-C-N 122.005 -0.434 . . . . 0.0 110.898 176.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 98.4 m -59.46 -42.79 92.81 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 122.846 0.458 . . . . 0.0 110.093 177.454 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -63.44 -41.86 98.66 Favored 'General case' 0 N--CA 1.456 -0.147 0 CA-C-O 121.006 0.431 . . . . 0.0 110.181 175.72 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 14.7 tt0 -62.61 -51.99 65.14 Favored 'General case' 0 N--CA 1.449 -0.495 0 O-C-N 121.692 -0.63 . . . . 0.0 109.934 -178.938 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 42.2 pt -63.27 -37.98 80.9 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.328 0 CA-C-O 117.669 -1.158 . . . . 0.0 109.231 -175.714 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -65.75 -34.91 79.28 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 119.776 1.171 . . . . 0.0 110.486 -179.548 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 31.2 m-80 -68.49 -50.59 51.13 Favored 'General case' 0 CA--C 1.516 -0.34 0 N-CA-C 108.785 -0.821 . . . . 0.0 108.785 175.285 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 15.5 tt0 -71.14 -33.61 70.24 Favored 'General case' 0 N--CA 1.438 -1.062 0 C-N-CA 124.174 0.99 . . . . 0.0 111.131 -168.616 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 168' ' ' MET . . . . . . . . . . . . . 22.9 ptp -72.42 -30.18 64.39 Favored 'General case' 0 C--N 1.332 -0.171 0 O-C-N 121.136 -0.978 . . . . 0.0 111.702 173.738 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -79.48 -41.16 28.08 Favored 'General case' 0 N--CA 1.447 -0.601 0 C-N-CA 122.636 0.375 . . . . 0.0 111.416 -179.765 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -71.59 -26.16 62.48 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 122.964 0.506 . . . . 0.0 110.454 -178.578 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 77.6 t60 -58.09 -27.28 63.53 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 123.65 0.78 . . . . 0.0 110.995 169.794 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 6.7 m-85 -94.17 -2.75 52.11 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 125.633 1.573 . . . . 0.0 113.731 176.015 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.254 1.339 0 CA-C-N 119.611 1.096 . . . . 0.0 109.971 177.893 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.498 1.931 0 CA-C-O 120.011 -0.042 . . . . 0.0 111.078 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 4.0 t30 -116.66 151.36 36.47 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 124.195 0.998 . . . . 0.0 110.134 -173.483 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 1.2 mpt? -118.75 123.31 44.52 Favored 'General case' 0 C--N 1.334 -0.096 0 C-N-CA 123.747 0.819 . . . . 0.0 111.183 179.47 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -81.85 153.93 33.37 Favored Glycine 0 CA--C 1.524 0.655 0 N-CA-C 107.521 -2.232 . . . . 0.0 107.521 166.655 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 3.3 tt -140.3 96.47 3.05 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 105.422 -2.066 . . . . 0.0 105.422 -176.414 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -102.98 143.83 32.04 Favored 'General case' 0 CA--C 1.517 -0.303 0 CA-C-O 121.769 0.795 . . . . 0.0 112.186 -170.86 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 36.3 p90 -161.03 173.4 15.27 Favored 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 127.676 2.391 . . . . 0.0 106.237 177.141 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -156.12 106.6 0.3 Allowed Glycine 0 CA--C 1.51 -0.259 0 N-CA-C 106.286 -2.726 . . . . 0.0 106.286 175.308 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 14.5 m -144.58 160.43 41.16 Favored 'General case' 0 C--O 1.235 0.335 0 C-N-CA 124.085 0.954 . . . . 0.0 109.745 -169.2 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 7.4 m -70.88 -31.4 68.05 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 122.842 0.457 . . . . 0.0 110.441 172.418 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 9.5 p -72.71 158.4 35.67 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 124.864 1.265 . . . . 0.0 109.914 172.446 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 62.7 m -66.35 -25.16 66.68 Favored 'General case' 0 CA--C 1.535 0.399 0 O-C-N 122.054 -0.404 . . . . 0.0 111.961 179.174 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 31.4 m-85 -138.95 173.74 11.25 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 126.362 1.865 . . . . 0.0 108.442 -176.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 22.7 p -74.46 82.43 1.96 Allowed 'General case' 0 CA--C 1.536 0.433 0 N-CA-C 106.429 -1.693 . . . . 0.0 106.429 168.821 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 59.91 -86.8 0.02 OUTLIER 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 125.387 1.475 . . . . 0.0 109.006 -167.446 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -135.87 -2.36 2.37 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 125.165 1.386 . . . . 0.0 113.008 171.259 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -68.98 -39.28 79.48 Favored 'General case' 0 C--O 1.222 -0.373 0 O-C-N 120.917 -1.114 . . . . 0.0 113.082 -167.724 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -58.74 -47.09 85.85 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 120.188 1.358 . . . . 0.0 111.077 -179.002 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -64.53 -46.43 82.91 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 123.104 0.562 . . . . 0.0 109.568 177.088 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 58.4 mttm -60.33 -45.58 92.93 Favored 'General case' 0 N--CA 1.466 0.367 0 O-C-N 121.755 -0.59 . . . . 0.0 111.596 -178.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 44.2 mt -53.72 -55.74 12.18 Favored 'Isoleucine or valine' 0 C--O 1.234 0.242 0 C-N-CA 124.465 1.106 . . . . 0.0 108.505 176.215 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 1.3 ttp180 -60.73 -41.29 95.04 Favored 'General case' 0 C--O 1.223 -0.31 0 CA-C-O 118.929 -0.558 . . . . 0.0 109.687 -174.675 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -68.02 -42.66 80.3 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 123.206 0.602 . . . . 0.0 111.173 -177.724 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.413 HD13 ' HA ' ' A' ' 158' ' ' GLN . 61.6 mt -74.12 -53.39 17.48 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.351 0 C-N-CA 124.508 1.123 . . . . 0.0 109.619 -171.251 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 74.5 mt -64.79 -46.0 93.35 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.434 0 N-CA-C 109.195 -0.669 . . . . 0.0 109.195 178.359 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 139.96 126.41 2.3 Favored Glycine 0 CA--C 1.534 1.221 0 C-N-CA 124.868 1.223 . . . . 0.0 112.132 172.562 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -71.23 -7.37 21.2 Favored 'Trans proline' 0 CA--C 1.536 0.585 0 C-N-CA 124.067 3.178 . . . . 0.0 113.613 -176.22 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -83.8 -17.22 41.79 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 119.081 0.855 . . . . 0.0 111.251 177.873 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 1.2 pt? -128.32 -16.14 4.49 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 124.998 1.319 . . . . 0.0 113.625 -175.239 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 41.5 t -97.05 154.79 3.62 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.542 0 N-CA-C 107.292 -1.373 . . . . 0.0 107.292 168.012 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 27.9 m -142.34 130.14 21.65 Favored 'General case' 0 C--O 1.232 0.146 0 N-CA-C 105.934 -1.876 . . . . 0.0 105.934 -176.136 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 17.8 mt -80.57 141.43 35.08 Favored 'General case' 0 C--O 1.232 0.18 0 N-CA-C 107.77 -1.196 . . . . 0.0 107.77 175.952 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 35.0 t-80 -131.9 61.03 1.66 Allowed 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 124.671 1.188 . . . . 0.0 107.847 -174.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 64.6 t-20 -72.09 116.56 12.65 Favored 'General case' 0 C--O 1.234 0.267 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 -178.039 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 99.1 mt -65.54 -13.44 58.94 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 124.345 1.058 . . . . 0.0 112.787 -177.229 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 28.5 tptp -57.06 -25.87 59.42 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 123.243 0.617 . . . . 0.0 110.953 168.631 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -129.46 -40.35 1.43 Allowed 'General case' 0 N--CA 1.464 0.246 0 C-N-CA 123.871 0.868 . . . . 0.0 113.279 -175.002 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 34.0 m-20 -89.59 141.01 28.99 Favored 'General case' 0 C--O 1.234 0.285 0 C-N-CA 123.382 0.673 . . . . 0.0 110.551 -175.676 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 15.2 m -75.88 155.38 84.87 Favored Pre-proline 0 CA--C 1.543 0.677 0 C-N-CA 124.213 1.005 . . . . 0.0 109.992 175.411 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_endo -77.29 -26.27 7.64 Favored 'Trans proline' 0 C--N 1.35 0.615 0 C-N-CA 122.431 2.087 . . . . 0.0 113.588 -169.924 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 22.5 mmmt -71.63 -11.92 61.08 Favored 'General case' 0 N--CA 1.472 0.634 0 O-C-N 120.5 -1.375 . . . . 0.0 111.478 -175.702 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -60.54 -28.66 68.6 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 125.769 1.627 . . . . 0.0 110.145 168.919 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 45.9 mtt -58.08 -26.18 62.23 Favored 'General case' 0 C--N 1.343 0.306 0 C-N-CA 123.198 0.599 . . . . 0.0 111.895 177.353 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 90.8 mt-10 -66.85 -32.7 74.14 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 118.245 0.475 . . . . 0.0 110.307 -176.601 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 18.3 mt-30 -66.17 -44.74 83.17 Favored 'General case' 0 N--CA 1.464 0.267 0 C-N-CA 123.714 0.806 . . . . 0.0 112.022 -171.214 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 20.4 m-85 -70.88 139.74 50.87 Favored 'General case' 0 N--CA 1.456 -0.135 0 CA-C-N 115.403 -0.817 . . . . 0.0 109.758 -166.765 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -72.96 -38.07 66.87 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 118.506 0.594 . . . . 0.0 110.257 -179.023 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 10.5 t -108.57 146.61 14.11 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.304 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 170.715 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 43.1 tp -133.01 106.74 7.83 Favored 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 176.678 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.404 ' HA ' ' HB3' ' A' ' 83' ' ' ALA . 19.8 mt -86.22 135.78 24.32 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 N-CA-C 107.096 -1.446 . . . . 0.0 107.096 176.704 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 1.9 mp -114.0 131.38 56.36 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 126.042 1.737 . . . . 0.0 106.774 -179.013 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -136.69 126.91 3.9 Favored Glycine 0 C--N 1.332 0.343 0 N-CA-C 109.072 -1.611 . . . . 0.0 109.072 177.085 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 4.7 tt -153.74 133.71 7.66 Favored Pre-proline 0 CA--C 1.538 0.511 0 CA-C-N 118.247 1.024 . . . . 0.0 111.055 174.432 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -73.33 153.51 50.69 Favored 'Trans proline' 0 CA--C 1.534 0.501 0 C-N-CA 122.799 2.332 . . . . 0.0 112.78 168.278 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.446 HG21 ' H ' ' A' ' 99' ' ' ASP . 22.8 m -117.18 140.54 49.4 Favored 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 105.462 -2.051 . . . . 0.0 105.462 166.912 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 5.1 m-90 -142.06 147.72 37.27 Favored 'General case' 0 C--O 1.231 0.123 0 C-N-CA 123.933 0.893 . . . . 0.0 110.487 -174.809 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -61.48 -27.21 68.42 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 123.682 0.793 . . . . 0.0 111.304 169.492 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 14.6 m-85 -65.2 -6.16 8.7 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 124.882 1.273 . . . . 0.0 112.988 175.243 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 106.07 122.17 4.94 Favored Glycine 0 CA--C 1.525 0.691 0 N-CA-C 108.087 -2.005 . . . . 0.0 108.087 -173.322 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 2.8 pm0 -79.99 162.84 24.67 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 124.488 1.115 . . . . 0.0 111.807 179.122 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . 0.282 24.7 mt 65.09 145.48 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.55 0 C-N-CA 127.645 2.378 . . . . 0.0 112.111 -176.428 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 3.3 mp0 -117.33 155.81 28.9 Favored 'General case' 0 C--O 1.235 0.331 0 C-N-CA 126.214 1.805 . . . . 0.0 106.568 -173.289 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -57.08 -43.4 82.12 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 122.891 0.476 . . . . 0.0 110.724 -171.458 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 -66.64 -20.9 66.09 Favored 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 112.357 0.503 . . . . 0.0 112.357 -176.023 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 11.3 t90 -91.86 -48.47 6.76 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 124.409 1.084 . . . . 0.0 109.031 177.959 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -64.27 -34.65 78.6 Favored 'General case' 0 CA--C 1.537 0.463 0 O-C-N 121.03 -1.044 . . . . 0.0 109.763 -178.218 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -59.54 -25.62 64.67 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 123.612 0.765 . . . . 0.0 111.815 -177.208 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 28.5 m -111.29 -14.67 10.54 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.315 0 CA-C-O 117.082 -1.437 . . . . 0.0 112.442 177.033 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 30.1 t90 -51.58 -35.13 40.04 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 120.491 1.496 . . . . 0.0 110.97 179.296 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -64.24 -27.9 69.37 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 125.222 1.409 . . . . 0.0 113.524 175.428 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 29.4 mt-30 -92.71 -18.98 22.29 Favored 'General case' 0 N--CA 1.463 0.22 0 C-N-CA 126.11 1.764 . . . . 0.0 112.441 175.786 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 56.3 mt -63.86 -20.57 65.92 Favored 'General case' 0 N--CA 1.465 0.319 0 O-C-N 121.21 -0.931 . . . . 0.0 111.608 -176.081 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -78.52 -22.81 46.79 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 122.985 0.514 . . . . 0.0 111.666 174.37 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -72.8 -29.79 63.55 Favored 'General case' 0 N--CA 1.467 0.411 0 O-C-N 120.729 -1.232 . . . . 0.0 111.942 178.005 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 80.9 mt -52.96 138.53 30.02 Favored 'General case' 0 C--O 1.231 0.101 0 C-N-CA 124.907 1.283 . . . . 0.0 112.896 -168.499 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 3.2 t30 -74.01 98.78 3.14 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 124.02 0.928 . . . . 0.0 108.631 170.515 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.427 HD12 HD22 ' A' ' 108' ' ' LEU . 32.8 mt -118.83 -0.76 11.17 Favored 'General case' 0 N--CA 1.472 0.659 0 N-CA-C 113.858 1.058 . . . . 0.0 113.858 -178.091 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 26.8 mt-10 -54.86 127.55 29.11 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-N 119.831 1.196 . . . . 0.0 111.623 -168.522 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 73.41 -2.24 38.84 Favored Glycine 0 CA--C 1.535 1.298 0 CA-C-O 117.824 -1.542 . . . . 0.0 115.108 179.345 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.4 154.82 36.93 Favored 'General case' 0 C--N 1.344 0.363 0 CA-C-N 120.942 2.371 . . . . 0.0 109.759 -176.678 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 2.3 mt -83.91 138.59 18.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 N-CA-C 106.866 -1.531 . . . . 0.0 106.866 177.508 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 54.3 t -130.71 135.75 59.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 C-N-CA 124.538 1.135 . . . . 0.0 108.498 -179.118 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.404 ' HB3' ' HA ' ' A' ' 50' ' ' ILE . . . -108.33 156.93 18.84 Favored 'General case' 0 CA--C 1.517 -0.299 0 N-CA-C 107.885 -1.154 . . . . 0.0 107.885 168.867 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 5.7 mt -137.76 132.42 32.72 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 107.783 -1.191 . . . . 0.0 107.783 178.714 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 39.2 p90 -149.15 165.68 31.08 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 168.421 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -167.84 157.8 30.29 Favored Glycine 0 N--CA 1.448 -0.517 0 N-CA-C 111.032 -0.827 . . . . 0.0 111.032 175.951 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 58.5 tp -97.87 146.4 25.48 Favored 'General case' 0 N--CA 1.445 -0.708 0 C-N-CA 125.691 1.596 . . . . 0.0 109.748 175.057 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -155.83 -168.75 19.26 Favored Glycine 0 CA--C 1.529 0.944 0 N-CA-C 108.754 -1.738 . . . . 0.0 108.754 172.777 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 54.9 t0 -146.71 118.28 7.99 Favored 'General case' 0 C--O 1.234 0.276 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 172.046 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 26.1 mp0 -63.68 -31.59 72.81 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 124.69 1.196 . . . . 0.0 112.016 -179.006 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 43.9 mt -88.13 -36.06 17.09 Favored 'General case' 0 N--CA 1.463 0.221 0 C-N-CA 125.44 1.496 . . . . 0.0 109.492 -178.693 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -65.22 -48.35 70.84 Favored Glycine 0 CA--C 1.528 0.894 0 N-CA-C 111.356 -0.698 . . . . 0.0 111.356 -177.268 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -139.98 -72.74 0.37 Allowed 'General case' 0 N--CA 1.463 0.196 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 -174.995 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 77.88 -39.58 1.8 Allowed Glycine 0 CA--C 1.531 1.062 0 C-N-CA 124.16 0.886 . . . . 0.0 114.458 169.055 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -60.58 -37.54 81.69 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 118.805 1.303 . . . . 0.0 109.849 170.875 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' TRP . . . . . . . . . . . . . 4.0 m-90 -109.08 32.76 4.69 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 125.856 1.662 . . . . 0.0 110.606 -178.799 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 14.1 t80 -57.76 135.46 56.79 Favored 'General case' 0 CA--C 1.531 0.222 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 177.35 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 89.7 mt 53.82 24.65 4.59 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 124.846 1.258 . . . . 0.0 114.257 169.416 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . 0.446 ' H ' HG21 ' A' ' 55' ' ' THR . 8.2 t70 -62.96 -37.69 88.1 Favored 'General case' 0 C--N 1.328 -0.331 0 O-C-N 120.86 -1.15 . . . . 0.0 111.217 -173.061 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -67.66 -29.31 68.57 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 123.674 0.789 . . . . 0.0 112.416 174.391 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 5.9 tt -63.73 -49.45 73.0 Favored 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 173.375 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -61.29 -36.5 92.54 Favored Glycine 0 CA--C 1.526 0.767 0 N-CA-C 111.623 -0.591 . . . . 0.0 111.623 177.806 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 6.4 tpp -53.99 -48.52 70.31 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 124.756 1.222 . . . . 0.0 111.454 -179.152 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -77.93 -39.69 41.98 Favored 'General case' 0 C--N 1.341 0.238 0 N-CA-C 109.813 -0.439 . . . . 0.0 109.813 -177.898 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 77.9 t60 -54.14 -45.46 71.99 Favored 'General case' 0 CA--C 1.534 0.333 0 O-C-N 121.517 -0.739 . . . . 0.0 111.335 176.638 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -61.53 -41.94 98.08 Favored 'General case' 0 C--O 1.235 0.326 0 C-N-CA 123.801 0.84 . . . . 0.0 111.536 -179.506 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 24.3 ttmm -57.48 -43.39 84.04 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 123.614 0.765 . . . . 0.0 110.278 174.286 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.427 HD22 HD12 ' A' ' 77' ' ' LEU . 27.7 mt -87.25 -14.41 41.07 Favored 'General case' 0 CA--C 1.518 -0.281 0 N-CA-C 113.9 1.074 . . . . 0.0 113.9 -170.552 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 70.9 m -60.13 -32.67 71.23 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 119.835 1.198 . . . . 0.0 111.218 -174.508 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 24.6 p -89.7 -5.17 57.3 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 124.946 1.298 . . . . 0.0 112.085 179.194 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 31.7 mmmt -86.32 -6.29 58.98 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 125.014 1.326 . . . . 0.0 111.6 175.762 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 72.29 34.99 60.53 Favored Glycine 0 CA--C 1.526 0.762 0 CA-C-N 118.622 0.646 . . . . 0.0 112.522 171.483 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 5.6 m -80.97 172.12 1.16 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.51 0 CA-C-N 118.085 0.943 . . . . 0.0 109.815 173.744 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 53.0 tptt -101.85 132.73 47.46 Favored 'General case' 0 N--CA 1.469 0.477 0 N-CA-C 105.378 -2.082 . . . . 0.0 105.378 167.698 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 74.9 m-85 -99.16 123.76 43.69 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 119.161 0.891 . . . . 0.0 108.674 174.107 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 31.6 m -109.9 160.05 9.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 C-N-CA 125.196 1.398 . . . . 0.0 108.459 168.03 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 85.34 27.6 32.7 Favored Glycine 0 CA--C 1.523 0.588 0 CA-C-O 118.526 -1.152 . . . . 0.0 114.928 170.176 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 17.4 m-30 -58.21 158.21 7.37 Favored 'General case' 0 CA--C 1.54 0.596 0 CA-C-N 119.028 1.414 . . . . 0.0 110.463 168.891 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 49.4 t-105 -138.22 147.22 54.96 Favored Pre-proline 0 N--CA 1.468 0.444 0 CA-C-O 118.264 -0.874 . . . . 0.0 111.357 -169.591 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -65.03 130.99 27.27 Favored 'Trans proline' 0 CA--C 1.534 0.516 0 C-N-CA 122.765 2.31 . . . . 0.0 112.441 -179.137 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 11.3 p -87.21 -11.12 50.76 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 123.876 0.87 . . . . 0.0 112.002 169.412 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -59.96 141.6 55.29 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 124.415 1.086 . . . . 0.0 111.208 -169.51 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 78.26 11.43 85.34 Favored Glycine 0 CA--C 1.532 1.148 0 CA-C-N 114.769 -1.105 . . . . 0.0 113.715 178.693 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 24.7 t80 -141.52 162.09 36.32 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 119.007 1.403 . . . . 0.0 110.196 176.865 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -140.47 144.81 36.25 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 125.62 1.568 . . . . 0.0 108.985 -176.642 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 3.8 p90 -154.37 172.41 17.74 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 127.804 2.441 . . . . 0.0 106.447 -170.256 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 6.2 t -127.65 -27.72 2.82 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-O 118.338 -0.839 . . . . 0.0 112.628 -178.932 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 47.9 t -65.14 129.75 94.57 Favored Pre-proline 0 CA--C 1.542 0.643 0 CA-C-N 120.026 1.284 . . . . 0.0 108.541 169.599 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -83.39 -11.37 9.55 Favored 'Trans proline' 0 CA--C 1.537 0.669 0 C-N-CA 123.071 2.514 . . . . 0.0 112.053 173.468 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 16.8 ttmt -55.12 -44.3 99.54 Favored Pre-proline 0 CA--C 1.54 0.561 0 CA-C-O 117.355 -1.307 . . . . 0.0 113.801 -168.486 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -87.5 7.76 4.56 Favored 'Trans proline' 0 C--N 1.35 0.634 0 CA-C-N 121.842 1.693 . . . . 0.0 113.777 -176.702 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 16.4 m -130.21 165.9 29.22 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.278 0 CA-C-N 121.115 1.78 . . . . 0.0 112.481 -171.167 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 12.9 pt -135.09 172.2 16.39 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.531 0 C-N-CA 128.239 2.616 . . . . 0.0 108.263 179.501 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . 53.59 42.2 31.94 Favored 'General case' 0 N--CA 1.464 0.226 0 C-N-CA 125.471 1.509 . . . . 0.0 112.648 173.726 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 27.0 t0 55.0 41.63 31.73 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 126.231 1.812 . . . . 0.0 111.766 -177.509 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 91.31 13.22 58.92 Favored Glycine 0 CA--C 1.527 0.8 0 CA-C-O 118.916 -0.935 . . . . 0.0 113.808 174.442 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 45.2 mt-30 -87.37 -7.65 57.5 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 119.29 1.545 . . . . 0.0 112.862 -177.9 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 7.6 tp -155.58 145.76 21.69 Favored 'General case' 0 C--N 1.344 0.358 0 CA-C-N 119.509 1.05 . . . . 0.0 110.797 172.238 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 61.7 m-85 -82.96 147.16 28.38 Favored 'General case' 0 CA--C 1.518 -0.279 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 169.596 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 16.7 m -77.1 2.62 1.68 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.576 0 C-N-CA 123.881 0.872 . . . . 0.0 112.393 177.234 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -172.28 169.81 42.89 Favored Glycine 0 CA--C 1.526 0.739 0 N-CA-C 110.829 -0.908 . . . . 0.0 110.829 -179.195 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 4.8 tp -63.6 135.01 56.48 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 124.272 1.029 . . . . 0.0 111.19 -179.566 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -92.99 128.04 38.71 Favored 'General case' 0 N--CA 1.446 -0.643 0 C-N-CA 124.981 1.312 . . . . 0.0 109.131 173.254 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 89.8 mt -116.47 157.92 24.4 Favored 'General case' 0 N--CA 1.464 0.248 0 C-N-CA 123.708 0.803 . . . . 0.0 109.69 169.886 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -151.79 154.45 36.27 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 126.784 2.034 . . . . 0.0 107.858 -179.606 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 74.0 mm-40 -131.56 21.84 4.7 Favored 'General case' 0 CA--C 1.546 0.827 0 C-N-CA 124.191 0.996 . . . . 0.0 111.239 176.39 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 27.5 m -131.92 -48.91 0.95 Allowed 'General case' 0 C--O 1.234 0.246 0 C-N-CA 124.703 1.201 . . . . 0.0 110.638 -173.739 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 4.6 m-80 -82.19 -42.51 18.91 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 125.896 1.678 . . . . 0.0 111.248 -170.275 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 18.5 pt20 -143.62 29.09 1.41 Allowed 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 124.453 1.101 . . . . 0.0 112.376 -168.703 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 44.1 p90 -52.32 -29.15 22.17 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 124.55 1.14 . . . . 0.0 113.685 -170.226 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -57.95 -33.59 69.0 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 124.381 1.073 . . . . 0.0 112.552 178.958 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . 0.282 0.2 OUTLIER -118.88 11.11 12.49 Favored 'General case' 0 C--O 1.221 -0.415 0 C-N-CA 124.583 1.153 . . . . 0.0 112.147 -179.216 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 60.9 m -60.11 -33.69 72.48 Favored 'General case' 0 CA--C 1.537 0.476 0 O-C-N 120.036 -1.665 . . . . 0.0 110.223 168.886 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -56.8 -41.78 78.35 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 123.814 0.846 . . . . 0.0 111.181 169.269 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 28.8 tt0 -70.19 -40.48 74.61 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 124.811 1.244 . . . . 0.0 111.144 -179.636 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 10.9 mmt180 -59.43 -44.22 92.94 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-O 118.296 -0.859 . . . . 0.0 109.271 174.434 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 51.5 mt -60.99 -55.28 25.74 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.242 0 N-CA-C 107.806 -1.183 . . . . 0.0 107.806 175.441 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 158' ' ' GLN . . . . . 0.413 ' HA ' HD13 ' A' ' 24' ' ' ILE . 1.6 tm0? -53.64 -60.74 2.92 Favored 'General case' 0 N--CA 1.454 -0.275 0 CA-C-N 119.141 0.882 . . . . 0.0 112.327 -172.765 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 31.7 m -61.52 -35.92 79.08 Favored 'General case' 0 C--N 1.32 -0.701 0 C-N-CA 122.895 0.478 . . . . 0.0 111.703 -177.022 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 160' ' ' TRP . . . . . . . . . . . . . 57.6 t90 -64.04 -45.47 88.72 Favored 'General case' 0 C--O 1.222 -0.361 0 CA-C-N 118.625 0.648 . . . . 0.0 110.53 173.618 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 99.0 m -61.61 -42.98 99.64 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 123.086 0.554 . . . . 0.0 110.703 -178.551 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -64.91 -35.88 82.58 Favored 'General case' 0 C--N 1.333 -0.123 0 CA-C-N 117.946 0.339 . . . . 0.0 110.857 175.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 17.1 tt0 -68.71 -52.27 32.55 Favored 'General case' 0 N--CA 1.445 -0.689 0 O-C-N 121.485 -0.76 . . . . 0.0 110.029 179.82 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 42.0 pt -62.48 -36.5 75.19 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.445 0 CA-C-O 117.997 -1.001 . . . . 0.0 109.605 -175.704 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -64.57 -36.68 85.02 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 119.466 1.03 . . . . 0.0 109.824 -179.536 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 34.7 m-80 -67.45 -50.55 58.74 Favored 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 174.739 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 25.8 tt0 -73.36 -16.74 61.34 Favored 'General case' 0 N--CA 1.442 -0.858 0 C-N-CA 125.852 1.661 . . . . 0.0 112.034 -169.392 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 168' ' ' MET . . . . . . . . . . . . . 21.2 ptp -90.08 -40.11 12.48 Favored 'General case' 0 N--CA 1.456 -0.168 0 C-N-CA 124.323 1.049 . . . . 0.0 111.448 168.507 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -73.68 -26.37 60.69 Favored 'General case' 0 N--CA 1.454 -0.265 0 CA-C-O 119.147 -0.454 . . . . 0.0 112.152 -173.574 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -58.23 -29.82 66.03 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 123.22 0.608 . . . . 0.0 112.102 -179.427 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 98.6 m-70 -72.84 -14.0 61.41 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 124.562 1.145 . . . . 0.0 112.486 177.84 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 67.1 m-85 -132.18 17.06 4.55 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 126.866 2.067 . . . . 0.0 111.601 -169.78 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.255 1.357 0 C-N-CA 124.247 1.019 . . . . 0.0 109.893 175.537 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.497 1.887 0 N-CA-C 111.261 0.097 . . . . 0.0 111.261 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 26.5 p-10 -126.26 166.22 17.52 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 125.107 1.363 . . . . 0.0 111.385 -173.341 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 11.4 mtt -131.28 123.87 29.27 Favored 'General case' 0 CA--C 1.522 -0.107 0 C-N-CA 123.29 0.636 . . . . 0.0 111.371 178.225 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -86.33 153.27 26.26 Favored Glycine 0 CA--C 1.523 0.594 0 N-CA-C 106.985 -2.446 . . . . 0.0 106.985 167.127 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 1.9 tt -141.73 96.11 2.92 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 119.664 1.732 . . . . 0.0 106.373 -173.265 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -101.68 141.56 34.36 Favored 'General case' 0 CA--C 1.518 -0.267 0 CA-C-O 121.271 0.558 . . . . 0.0 111.938 -170.192 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 43.1 p90 -163.58 176.87 9.26 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 126.749 2.02 . . . . 0.0 107.389 -177.923 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 168.82 88.97 0.07 OUTLIER Glycine 0 C--N 1.337 0.587 0 N-CA-C 109.164 -1.575 . . . . 0.0 109.164 178.774 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 3.8 m -140.4 130.67 25.1 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 117.198 0.499 . . . . 0.0 110.81 -168.721 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 2.8 p -80.5 -60.27 2.38 Favored 'General case' 0 C--O 1.236 0.343 0 C-N-CA 125.026 1.33 . . . . 0.0 109.173 173.606 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 3.0 p -70.6 143.81 51.39 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 124.285 1.034 . . . . 0.0 108.746 170.421 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 71.2 m 45.59 55.64 6.52 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 125.349 1.46 . . . . 0.0 111.238 -178.337 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 43.7 p90 -51.17 122.05 7.09 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-O 122.141 0.972 . . . . 0.0 110.657 -169.212 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 4.3 m -79.0 -5.59 54.27 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 124.731 1.212 . . . . 0.0 113.598 -166.728 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -52.89 -40.91 63.88 Favored 'General case' 0 N--CA 1.466 0.363 0 C-N-CA 123.722 0.809 . . . . 0.0 111.205 -175.614 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 21.4 ptp -65.38 -43.01 92.06 Favored 'General case' 0 C--N 1.342 0.276 0 CA-C-N 118.383 0.538 . . . . 0.0 112.014 -176.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -63.12 -44.78 94.68 Favored 'General case' 0 C--N 1.342 0.264 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 175.097 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -62.84 -48.14 80.33 Favored 'General case' 0 N--CA 1.452 -0.364 0 C-N-CA 122.999 0.52 . . . . 0.0 111.402 -174.832 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -68.42 -37.15 80.03 Favored 'General case' 0 CA--C 1.534 0.327 0 O-C-N 121.743 -0.598 . . . . 0.0 110.485 -179.43 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 28.6 mtpp -66.04 -40.23 90.83 Favored 'General case' 0 C--O 1.224 -0.244 0 CA-C-O 118.564 -0.731 . . . . 0.0 110.629 177.523 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 33.4 mt -55.69 -54.36 26.89 Favored 'Isoleucine or valine' 0 C--O 1.233 0.218 0 CA-C-N 119.642 1.11 . . . . 0.0 109.355 177.023 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 17.5 ptt180 -63.53 -38.6 91.76 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 118.801 0.728 . . . . 0.0 110.113 -177.039 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -64.02 -37.8 88.76 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-O 121.051 0.453 . . . . 0.0 110.151 -175.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 66.7 mt -76.03 -55.11 12.15 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.678 0 C-N-CA 125.136 1.374 . . . . 0.0 110.141 -176.275 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 62.7 mt -61.72 -47.84 91.44 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.403 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 -178.883 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 141.71 114.09 1.04 Allowed Glycine 0 CA--C 1.526 0.773 0 C-N-CA 125.396 1.474 . . . . 0.0 109.465 -175.912 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 70.5 Cg_endo -73.33 -8.4 21.83 Favored 'Trans proline' 0 CA--C 1.538 0.678 0 C-N-CA 122.517 2.145 . . . . 0.0 113.51 -169.729 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -76.63 -21.37 55.59 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 119.116 0.871 . . . . 0.0 111.839 179.107 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -122.74 7.87 9.41 Favored 'General case' 0 C--N 1.342 0.282 0 C-N-CA 124.842 1.257 . . . . 0.0 113.256 -171.542 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 44.0 t -124.89 151.18 30.27 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.369 0 N-CA-C 107.604 -1.258 . . . . 0.0 107.604 175.252 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 24.6 m -136.23 133.9 37.53 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 125.714 1.606 . . . . 0.0 107.927 -176.893 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 17.6 mt -80.52 138.17 36.5 Favored 'General case' 0 N--CA 1.463 0.222 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 176.086 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 24.7 t-80 -131.89 59.9 1.69 Allowed 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 124.588 1.155 . . . . 0.0 108.629 -176.576 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 37.9 t30 -59.7 124.22 19.44 Favored 'General case' 0 CA--C 1.531 0.226 0 N-CA-C 107.935 -1.135 . . . . 0.0 107.935 172.209 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 55.1 mt -71.37 -31.06 66.87 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-N 118.857 0.753 . . . . 0.0 112.73 -169.705 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 22.8 tptm -60.33 -27.46 67.37 Favored 'General case' 0 C--O 1.234 0.264 0 C-N-CA 123.507 0.723 . . . . 0.0 110.379 170.345 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -93.12 -34.64 13.57 Favored 'General case' 0 C--O 1.234 0.282 0 N-CA-C 112.834 0.679 . . . . 0.0 112.834 -174.639 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 3.8 t0 -144.69 148.49 34.28 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 118.869 0.759 . . . . 0.0 113.048 -176.831 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 15.2 m -70.7 157.22 90.67 Favored Pre-proline 0 CA--C 1.543 0.683 0 C-N-CA 125.925 1.69 . . . . 0.0 112.292 -169.342 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -74.64 -26.76 11.37 Favored 'Trans proline' 0 C--N 1.352 0.753 0 C-N-CA 122.662 2.241 . . . . 0.0 113.938 -172.317 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.87 -15.95 63.39 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-N 120.421 1.464 . . . . 0.0 112.187 -179.442 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -57.65 -31.21 66.08 Favored 'General case' 0 N--CA 1.466 0.363 0 C-N-CA 125.811 1.644 . . . . 0.0 110.166 170.777 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 57.2 mtt -56.4 -26.17 52.41 Favored 'General case' 0 N--CA 1.467 0.379 0 C-N-CA 123.699 0.799 . . . . 0.0 111.565 179.133 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 60.1 mt-10 -66.64 -32.93 74.58 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 118.436 0.562 . . . . 0.0 110.553 -177.659 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 19.8 mt-30 -67.65 -43.55 80.0 Favored 'General case' 0 C--O 1.232 0.181 0 N-CA-C 112.872 0.693 . . . . 0.0 112.872 -169.366 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 37.5 m-85 -72.23 135.91 46.21 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.733 -167.103 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -71.19 -38.03 72.11 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-N 118.101 0.41 . . . . 0.0 110.404 -179.468 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 14.8 t -105.31 143.66 16.18 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.56 0 N-CA-C 107.202 -1.407 . . . . 0.0 107.202 168.766 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 33.8 tp -131.6 115.34 15.97 Favored 'General case' 0 N--CA 1.446 -0.657 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 174.078 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 27.9 mt -91.99 131.94 37.72 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.681 0 N-CA-C 106.863 -1.532 . . . . 0.0 106.863 176.802 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 2.4 mp -109.72 127.35 54.54 Favored 'General case' 0 CA--C 1.516 -0.338 0 C-N-CA 125.717 1.607 . . . . 0.0 107.106 -179.832 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -129.18 130.72 6.5 Favored Glycine 0 C--N 1.332 0.329 0 N-CA-C 108.617 -1.793 . . . . 0.0 108.617 176.556 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.417 HD12 ' CD2' ' A' ' 65' ' ' TRP . 4.6 tt -152.26 129.56 5.72 Favored Pre-proline 0 CA--C 1.531 0.226 0 CA-C-N 117.636 0.718 . . . . 0.0 110.914 172.574 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -80.0 132.81 9.7 Favored 'Trans proline' 0 N--CA 1.447 -1.25 0 N-CA-C 107.017 -1.955 . . . . 0.0 107.017 165.548 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 41.7 m -94.38 111.38 23.12 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 103.122 -2.918 . . . . 0.0 103.122 167.137 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 9.7 t90 -67.29 151.3 47.73 Favored 'General case' 0 CA--C 1.535 0.389 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 -176.033 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -64.72 125.07 23.6 Favored 'General case' 0 C--O 1.236 0.386 0 N-CA-C 109.889 -0.412 . . . . 0.0 109.889 -175.732 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 1.8 t80 48.01 40.47 13.29 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 124.748 1.219 . . . . 0.0 111.404 -171.298 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -140.7 -166.78 10.82 Favored Glycine 0 CA--C 1.529 0.961 0 C-N-CA 125.603 1.573 . . . . 0.0 111.261 -177.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 30.6 tt0 -147.39 169.44 19.47 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 125.087 1.355 . . . . 0.0 108.836 -173.021 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 8.4 mt -28.66 131.0 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.543 0.707 0 C-N-CA 128.688 2.795 . . . . 0.0 113.039 173.788 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 3.9 mp0 -74.87 153.8 38.51 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 125.294 1.438 . . . . 0.0 109.5 179.636 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -54.7 -46.17 74.12 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 123.669 0.788 . . . . 0.0 112.207 -169.184 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 23.3 t0 -62.35 -32.71 73.54 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-O 121.57 0.7 . . . . 0.0 112.184 -174.738 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' TRP . . . . . 0.596 ' CH2' HD23 ' A' ' 104' ' ' LEU . 0.9 OUTLIER -82.5 -43.5 17.1 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 123.739 0.816 . . . . 0.0 109.257 -179.587 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 6.1 tt0 -63.05 -35.11 79.15 Favored 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 124.79 1.236 . . . . 0.0 109.805 -179.287 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -58.97 -24.45 62.67 Favored 'General case' 0 C--O 1.233 0.2 0 C-N-CA 124.129 0.971 . . . . 0.0 111.69 -175.825 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 34.6 m -114.7 -14.99 10.5 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.228 0 CA-C-O 117.471 -1.252 . . . . 0.0 112.66 177.206 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 30.6 t90 -52.02 -38.86 58.36 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 119.974 1.261 . . . . 0.0 111.031 -177.032 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -68.36 -23.82 64.73 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 125.039 1.336 . . . . 0.0 113.185 178.218 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 22.7 mt-30 -91.73 -23.94 19.61 Favored 'General case' 0 C--N 1.34 0.167 0 C-N-CA 125.377 1.471 . . . . 0.0 111.973 -179.379 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 19.7 mt -64.26 -25.69 68.17 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 118.167 0.44 . . . . 0.0 111.63 -172.012 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -69.13 -21.77 64.0 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-N 117.966 0.348 . . . . 0.0 111.388 177.284 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -76.39 -24.05 54.08 Favored 'General case' 0 CA--C 1.537 0.462 0 O-C-N 120.971 -1.08 . . . . 0.0 112.68 -178.811 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 49.2 mt -65.63 149.54 49.92 Favored 'General case' 0 C--O 1.233 0.205 0 C-N-CA 124.794 1.238 . . . . 0.0 111.537 -170.296 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 27.8 t-20 -83.77 113.32 20.82 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 171.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 65.2 mt -128.66 1.8 5.5 Favored 'General case' 0 N--CA 1.472 0.659 0 N-CA-C 113.318 0.859 . . . . 0.0 113.318 -172.37 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 30.4 mt-10 -55.55 130.73 44.06 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-O 122.046 0.927 . . . . 0.0 111.347 -168.889 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 73.29 -2.45 36.74 Favored Glycine 0 CA--C 1.533 1.202 0 CA-C-O 117.987 -1.452 . . . . 0.0 115.105 176.791 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.64 149.55 41.93 Favored 'General case' 0 C--N 1.346 0.418 0 CA-C-N 120.749 2.274 . . . . 0.0 109.646 -177.036 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 7.6 mt -80.47 135.56 25.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 N-CA-C 106.269 -1.752 . . . . 0.0 106.269 178.372 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 63.4 t -129.11 128.56 67.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 C-N-CA 123.466 0.706 . . . . 0.0 109.715 -177.769 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -98.3 143.75 28.45 Favored 'General case' 0 CA--C 1.522 -0.114 0 N-CA-C 106.98 -1.489 . . . . 0.0 106.98 167.847 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 9.5 mt -122.11 132.24 54.38 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 107.243 -1.392 . . . . 0.0 107.243 176.241 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 22.9 p90 -150.72 165.05 34.63 Favored 'General case' 0 N--CA 1.444 -0.75 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 168.088 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -163.91 178.2 39.43 Favored Glycine 0 N--CA 1.435 -1.414 0 N-CA-C 109.739 -1.344 . . . . 0.0 109.739 171.314 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 5.8 tt -127.18 155.22 43.74 Favored 'General case' 0 N--CA 1.445 -0.706 0 C-N-CA 125.253 1.421 . . . . 0.0 107.448 178.682 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -158.95 -159.83 9.94 Favored Glycine 0 CA--C 1.523 0.535 0 N-CA-C 109.068 -1.613 . . . . 0.0 109.068 169.805 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 20.2 t0 -119.56 118.2 30.39 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 107.409 -1.33 . . . . 0.0 107.409 169.88 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 23.1 mt-30 -70.61 -21.39 62.66 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 123.559 0.744 . . . . 0.0 110.853 179.478 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 80.1 mt -75.58 -0.66 21.22 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-N 119.415 1.007 . . . . 0.0 111.109 168.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -77.06 19.67 3.4 Favored Glycine 0 CA--C 1.535 1.33 0 C-N-CA 125.237 1.399 . . . . 0.0 112.129 167.83 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 35.3 m-85 61.96 3.05 0.86 Allowed 'General case' 0 N--CA 1.465 0.289 0 C-N-CA 127.593 2.357 . . . . 0.0 115.231 171.473 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 71.19 21.13 78.45 Favored Glycine 0 CA--C 1.53 1.015 0 N-CA-C 110.8 -0.92 . . . . 0.0 110.8 -174.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -85.86 -28.63 24.29 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 124.424 1.089 . . . . 0.0 108.55 167.176 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' TRP . . . . . . . . . . . . . 7.7 m0 -126.45 1.63 6.95 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 124.838 1.255 . . . . 0.0 113.552 -168.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 14.7 t80 -73.58 131.39 41.66 Favored 'General case' 0 N--CA 1.46 0.061 0 O-C-N 121.279 -0.888 . . . . 0.0 109.022 -171.536 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 91.9 mt 52.53 23.47 2.59 Favored 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 114.613 1.338 . . . . 0.0 114.613 168.263 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -62.62 -35.22 78.89 Favored 'General case' 0 N--CA 1.465 0.311 0 O-C-N 120.651 -1.281 . . . . 0.0 110.672 -172.074 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . 0.415 ' HB1' HD13 ' A' ' 53' ' ' ILE . . . -72.98 -28.67 62.53 Favored 'General case' 0 N--CA 1.452 -0.334 0 N-CA-C 113.096 0.776 . . . . 0.0 113.096 176.543 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 5.0 tt -61.43 -45.33 94.75 Favored 'General case' 0 CA--C 1.535 0.394 0 N-CA-C 107.308 -1.367 . . . . 0.0 107.308 170.276 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -61.76 -42.24 99.72 Favored Glycine 0 C--N 1.341 0.806 0 N-CA-C 111.302 -0.719 . . . . 0.0 111.302 179.162 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 74.8 mtm -61.94 -41.14 97.62 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 118.094 0.947 . . . . 0.0 111.662 178.244 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.596 HD23 ' CH2' ' A' ' 65' ' ' TRP . 0.1 OUTLIER -72.22 -38.1 69.05 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 119.944 1.247 . . . . 0.0 111.131 -179.297 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 29.4 t-80 -57.21 -46.85 82.53 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 117.855 0.298 . . . . 0.0 110.38 172.587 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -63.85 -45.54 89.06 Favored 'General case' 0 C--N 1.33 -0.239 0 C-N-CA 123.457 0.703 . . . . 0.0 111.604 -177.753 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 24.5 ttmm -54.04 -45.26 71.56 Favored 'General case' 0 N--CA 1.464 0.227 0 C-N-CA 123.764 0.825 . . . . 0.0 109.735 173.287 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 22.2 mt -83.2 -19.89 35.67 Favored 'General case' 0 CA--C 1.514 -0.419 0 N-CA-C 114.887 1.44 . . . . 0.0 114.887 -169.43 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 6.5 t -57.85 -36.12 71.87 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-N 119.826 1.194 . . . . 0.0 110.598 -175.378 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 22.0 p -87.17 -8.33 57.03 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 124.802 1.241 . . . . 0.0 112.341 -179.184 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 32.3 mmmt -85.29 -7.13 59.15 Favored 'General case' 0 C--N 1.345 0.398 0 C-N-CA 124.61 1.164 . . . . 0.0 111.556 174.512 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 72.84 31.93 61.73 Favored Glycine 0 CA--C 1.523 0.567 0 CA-C-O 119.459 -0.634 . . . . 0.0 112.516 171.035 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 17.0 m -74.59 177.45 0.56 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.572 0 CA-C-N 118.386 1.093 . . . . 0.0 109.836 172.758 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -116.66 125.8 52.29 Favored 'General case' 0 CA--C 1.515 -0.388 0 N-CA-C 106.332 -1.729 . . . . 0.0 106.332 170.649 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 68.7 m-85 -91.45 146.03 24.14 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 119.847 1.203 . . . . 0.0 110.198 -177.594 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 33.5 m -133.3 158.43 42.98 Favored 'Isoleucine or valine' 0 C--O 1.235 0.323 0 C-N-CA 125.385 1.474 . . . . 0.0 107.503 169.044 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 85.41 35.19 12.34 Favored Glycine 0 N--CA 1.452 -0.252 0 CA-C-O 118.919 -0.934 . . . . 0.0 114.349 169.729 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 8.2 m-30 -67.86 155.2 39.89 Favored 'General case' 0 CA--C 1.544 0.729 0 CA-C-N 118.815 1.307 . . . . 0.0 109.403 169.611 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 1.6 t90 -136.46 137.96 25.52 Favored Pre-proline 0 CA--C 1.541 0.609 0 CA-C-O 117.305 -1.331 . . . . 0.0 108.342 -171.243 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_exo -70.58 130.92 19.1 Favored 'Trans proline' 0 C--N 1.348 0.501 0 C-N-CA 123.179 2.586 . . . . 0.0 113.037 -170.32 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 40.1 p -70.5 -7.56 44.53 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 113.457 0.91 . . . . 0.0 113.457 172.919 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -59.09 140.1 56.18 Favored 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 124.742 1.217 . . . . 0.0 110.122 -176.204 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 80.55 13.66 81.24 Favored Glycine 0 CA--C 1.534 1.24 0 CA-C-N 115.268 -0.878 . . . . 0.0 113.689 177.105 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 25.4 t80 -136.46 161.28 36.29 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 118.884 1.342 . . . . 0.0 109.617 174.319 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -132.64 136.51 46.54 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 125.251 1.421 . . . . 0.0 107.988 -179.203 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 13.2 p90 -154.06 170.51 20.95 Favored 'General case' 0 C--O 1.235 0.322 0 C-N-CA 125.251 1.42 . . . . 0.0 109.436 -169.319 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 11.6 t -135.77 -34.59 0.82 Allowed 'General case' 0 C--O 1.235 0.323 0 N-CA-C 112.035 0.383 . . . . 0.0 112.035 -176.046 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 58.8 m -74.06 128.83 85.75 Favored Pre-proline 0 CA--C 1.541 0.601 0 N-CA-C 108.912 -0.774 . . . . 0.0 108.912 177.566 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -83.36 -22.62 3.84 Favored 'Trans proline' 0 CA--C 1.538 0.679 0 C-N-CA 122.537 2.158 . . . . 0.0 113.304 -172.518 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 26.2 ttmt -52.88 -42.54 90.5 Favored Pre-proline 0 CA--C 1.541 0.616 0 CA-C-O 117.091 -1.433 . . . . 0.0 114.791 -171.109 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_endo -74.63 -4.5 15.51 Favored 'Trans proline' 0 C--N 1.352 0.717 0 CA-C-N 122.108 1.789 . . . . 0.0 114.11 -178.928 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 20.8 m -131.76 167.89 25.27 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.412 0 CA-C-N 120.96 1.709 . . . . 0.0 111.673 -169.552 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 25.1 pt -127.87 170.05 18.28 Favored 'Isoleucine or valine' 0 C--O 1.234 0.27 0 C-N-CA 126.689 1.996 . . . . 0.0 109.207 175.169 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . 57.91 32.92 22.59 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 125.416 1.486 . . . . 0.0 113.768 167.711 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 27.7 t70 56.21 40.11 30.1 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 126.323 1.849 . . . . 0.0 111.254 -174.931 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 91.31 74.99 1.29 Allowed Glycine 0 C--N 1.338 0.657 0 C-N-CA 124.46 1.029 . . . . 0.0 111.259 177.682 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 74.1 mm-40 -120.66 -49.62 2.23 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 123.179 0.592 . . . . 0.0 110.771 168.251 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -131.0 145.03 51.92 Favored 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 122.997 0.519 . . . . 0.0 110.205 -178.86 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 73.3 m-85 -76.61 17.71 0.38 Allowed 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 125.573 1.549 . . . . 0.0 114.644 174.795 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 4.1 m 47.84 15.26 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.546 0.802 0 C-N-CA 127.915 2.486 . . . . 0.0 114.37 -174.053 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 168.22 174.0 36.66 Favored Glycine 0 CA--C 1.526 0.78 0 N-CA-C 108.792 -1.723 . . . . 0.0 108.792 -169.339 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.477 ' HB2' ' CD1' ' A' ' 160' ' ' TRP . 1.7 tp -71.88 142.13 49.55 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 118.215 1.008 . . . . 0.0 111.92 179.701 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -104.8 130.0 52.99 Favored 'General case' 0 N--CA 1.447 -0.585 0 C-N-CA 127.482 2.313 . . . . 0.0 109.416 178.034 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 87.5 mt -129.62 155.62 45.54 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 125.038 1.335 . . . . 0.0 108.461 173.103 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -128.2 155.0 45.2 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 124.776 1.231 . . . . 0.0 110.302 -179.383 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -132.48 13.12 4.54 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 123.902 0.881 . . . . 0.0 112.705 -176.819 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 97.3 m -135.79 -51.65 0.73 Allowed 'General case' 0 C--N 1.341 0.199 0 O-C-N 121.246 -0.909 . . . . 0.0 112.163 -168.787 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 3.3 p30 -110.67 -31.72 7.12 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 125.429 1.492 . . . . 0.0 111.184 -170.013 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 29.6 mt-30 -133.64 27.07 4.03 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 124.834 1.254 . . . . 0.0 111.046 -172.867 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 41.4 p90 -61.21 -27.14 68.21 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 123.458 0.703 . . . . 0.0 112.187 -176.539 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -64.41 -33.94 77.03 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 122.965 0.506 . . . . 0.0 111.142 176.542 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 97.7 mt -84.83 -14.96 46.37 Favored 'General case' 0 C--O 1.224 -0.287 0 CA-C-O 118.038 -0.982 . . . . 0.0 112.015 -179.291 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 73.3 m -57.28 -28.28 62.87 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 120.42 1.464 . . . . 0.0 111.64 178.5 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -60.35 -45.48 93.33 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 119.51 1.05 . . . . 0.0 111.882 172.387 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 -67.29 -44.23 79.78 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 125.38 1.472 . . . . 0.0 110.244 177.931 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 38.7 mtp180 -62.52 -40.08 95.62 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-O 117.826 -1.083 . . . . 0.0 109.682 179.35 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 48.7 mt -63.18 -55.38 23.68 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.475 0 CA-C-N 119.891 1.223 . . . . 0.0 107.991 172.453 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 70.5 tp60 -50.21 -63.78 1.01 Allowed 'General case' 0 C--O 1.232 0.176 0 C-N-CA 124.808 1.243 . . . . 0.0 111.86 -174.584 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 24.0 m -66.0 -32.99 74.8 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 120.666 -0.414 . . . . 0.0 111.136 -170.365 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 160' ' ' TRP . . . . . 0.477 ' CD1' ' HB2' ' A' ' 142' ' ' LEU . 82.4 t90 -67.09 -46.13 75.16 Favored 'General case' 0 C--O 1.222 -0.39 0 O-C-N 121.999 -0.438 . . . . 0.0 110.889 175.257 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 61.4 m -58.2 -43.9 87.84 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 118.48 0.582 . . . . 0.0 110.157 179.502 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -62.28 -43.91 97.74 Favored 'General case' 0 CA--C 1.528 0.123 0 N-CA-C 109.886 -0.413 . . . . 0.0 109.886 176.842 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 14.9 tt0 -62.58 -50.32 71.76 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-O 117.946 -1.026 . . . . 0.0 110.225 -177.923 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 41.6 pt -65.01 -33.53 64.35 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.485 0 CA-C-N 119.678 1.126 . . . . 0.0 110.224 -176.335 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -70.48 -34.19 72.11 Favored 'General case' 0 C--O 1.223 -0.322 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 -175.998 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -71.33 -45.19 63.58 Favored 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 124.531 1.132 . . . . 0.0 109.982 175.082 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 21.9 tt0 -78.3 -24.57 46.63 Favored 'General case' 0 N--CA 1.441 -0.905 0 C-N-CA 124.22 1.008 . . . . 0.0 110.319 -169.374 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 168' ' ' MET . . . . . . . . . . . . . 19.2 ptp -82.26 -29.72 31.1 Favored 'General case' 0 N--CA 1.461 0.104 0 O-C-N 121.694 -0.629 . . . . 0.0 111.657 171.843 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -79.36 -36.3 39.52 Favored 'General case' 0 N--CA 1.447 -0.613 0 C-N-CA 122.573 0.349 . . . . 0.0 111.001 -178.198 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -68.59 -29.06 67.51 Favored 'General case' 0 CA--C 1.535 0.392 0 O-C-N 122.138 -0.351 . . . . 0.0 110.396 177.356 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 80.9 t60 -64.77 -24.65 67.62 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 123.928 0.891 . . . . 0.0 110.863 174.433 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 2.3 m-85 -83.29 -9.64 58.98 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 124.928 1.291 . . . . 0.0 113.22 174.744 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.205 0 CA-C-N 119.461 1.028 . . . . 0.0 110.265 -178.74 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.498 1.926 0 CA-C-O 118.986 -0.531 . . . . 0.0 110.15 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 5.7 t30 -111.22 147.54 34.77 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-N 119.729 1.149 . . . . 0.0 111.377 -171.5 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 17.5 mtt -112.79 130.12 56.19 Favored 'General case' 0 N--CA 1.462 0.174 0 C-N-CA 124.414 1.086 . . . . 0.0 110.203 -177.467 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -98.94 131.02 10.42 Favored Glycine 0 CA--C 1.522 0.506 0 N-CA-C 107.264 -2.334 . . . . 0.0 107.264 168.54 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -105.74 108.14 19.51 Favored 'General case' 0 N--CA 1.467 0.422 0 N-CA-C 105.058 -2.201 . . . . 0.0 105.058 173.974 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -99.62 145.84 27.12 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 119.401 1.0 . . . . 0.0 112.663 179.335 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.511 ' CE1' HG21 ' A' ' 14' ' ' THR . 79.5 m-85 -145.67 169.61 18.11 Favored 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 126.681 1.992 . . . . 0.0 108.726 -178.401 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -86.8 -168.67 45.11 Favored Glycine 0 CA--C 1.534 1.278 0 N-CA-C 109.867 -1.293 . . . . 0.0 109.867 166.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 3.1 p -65.21 -54.33 31.08 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 124.251 1.021 . . . . 0.0 109.46 169.962 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 7.9 m 67.39 146.62 0.04 OUTLIER 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 128.361 2.665 . . . . 0.0 113.415 178.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 5.5 m -63.35 122.17 15.55 Favored 'General case' 0 CA--C 1.535 0.397 0 N-CA-C 108.342 -0.985 . . . . 0.0 108.342 -178.488 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 34.8 m 53.0 26.45 4.77 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 124.972 1.309 . . . . 0.0 113.171 -173.66 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . 0.338 43.0 p90 53.51 157.45 0.0 OUTLIER 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 128.923 2.889 . . . . 0.0 115.58 -171.802 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.511 HG21 ' CE1' ' A' ' 7' ' ' TYR . 88.6 m -64.37 151.34 44.26 Favored 'General case' 0 CA--C 1.542 0.66 0 O-C-N 121.317 -0.864 . . . . 0.0 109.511 179.495 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 80.4 mm-40 -65.12 173.4 2.46 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 124.423 1.089 . . . . 0.0 111.252 -176.247 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -65.16 3.56 0.6 Allowed 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 125.629 1.572 . . . . 0.0 113.833 -173.855 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -45.33 -39.09 6.34 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 125.139 1.376 . . . . 0.0 110.236 167.888 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -57.18 -55.18 38.1 Favored 'General case' 0 N--CA 1.465 0.318 0 C-N-CA 123.672 0.789 . . . . 0.0 112.337 179.112 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 70.5 mm-40 -61.08 -45.73 93.54 Favored 'General case' 0 CA--C 1.517 -0.319 0 N-CA-C 108.134 -1.062 . . . . 0.0 108.134 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 30.0 mtpp -66.42 -39.6 89.06 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-O 118.498 -0.763 . . . . 0.0 110.107 -171.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 17.6 mt -54.61 -58.65 3.44 Favored 'Isoleucine or valine' 0 C--O 1.233 0.188 0 C-N-CA 124.639 1.175 . . . . 0.0 108.858 176.548 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 18.7 ptt180 -64.91 -39.42 93.49 Favored 'General case' 0 C--O 1.222 -0.372 0 CA-C-O 118.761 -0.637 . . . . 0.0 110.45 -177.272 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -65.53 -39.92 92.32 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.142 0.496 . . . . 0.0 110.018 -172.511 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 70.5 mt -75.5 -53.72 15.43 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.576 0 C-N-CA 125.236 1.415 . . . . 0.0 109.875 -175.419 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 71.8 mt -62.48 -46.89 95.32 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.441 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 -179.232 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 140.77 116.58 1.3 Allowed Glycine 0 CA--C 1.528 0.881 0 C-N-CA 125.842 1.687 . . . . 0.0 109.395 179.26 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -72.78 -8.18 21.97 Favored 'Trans proline' 0 CA--C 1.539 0.743 0 C-N-CA 122.739 2.292 . . . . 0.0 113.337 -170.229 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -79.67 -17.65 53.18 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 118.757 0.708 . . . . 0.0 111.865 178.02 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -125.37 8.08 7.77 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 125.204 1.402 . . . . 0.0 113.343 -174.878 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 61.3 t -124.55 149.22 28.82 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.265 0 N-CA-C 107.925 -1.139 . . . . 0.0 107.925 174.21 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 11.9 m -138.71 136.32 35.68 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 126.034 1.734 . . . . 0.0 107.023 -176.804 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 23.8 mt -90.67 146.59 23.9 Favored 'General case' 0 N--CA 1.466 0.339 0 N-CA-C 107.691 -1.226 . . . . 0.0 107.691 175.553 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 40.5 t-80 -140.34 128.27 22.03 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 107.459 -1.311 . . . . 0.0 107.459 -169.261 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 53.8 t-20 -128.66 111.18 12.91 Favored 'General case' 0 CA--C 1.516 -0.345 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 -169.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 88.9 mt -66.86 -10.7 50.97 Favored 'General case' 0 CA--C 1.535 0.381 0 N-CA-C 113.355 0.872 . . . . 0.0 113.355 -174.222 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 40.3 tptt -57.92 -29.13 64.88 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 118.82 0.737 . . . . 0.0 111.234 168.153 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -129.39 -38.01 1.59 Allowed 'General case' 0 N--CA 1.465 0.299 0 C-N-CA 123.84 0.856 . . . . 0.0 112.67 -173.049 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 42.8 m-20 -79.55 130.12 35.1 Favored 'General case' 0 C--O 1.236 0.373 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 179.758 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 14.4 m -73.28 152.7 90.26 Favored Pre-proline 0 CA--C 1.542 0.649 0 C-N-CA 123.22 0.608 . . . . 0.0 109.526 173.368 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -73.04 -24.86 16.81 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.032 1.821 . . . . 0.0 113.992 -169.616 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 1.4 mptm? -63.21 -18.06 63.11 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 119.275 0.943 . . . . 0.0 111.726 178.176 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -63.28 -25.31 68.26 Favored 'General case' 0 N--CA 1.465 0.309 0 C-N-CA 124.847 1.259 . . . . 0.0 110.746 174.341 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 54.2 mtt -61.75 -23.95 66.49 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 119.361 0.982 . . . . 0.0 111.496 177.346 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -64.32 -32.25 73.78 Favored 'General case' 0 CA--C 1.535 0.365 0 O-C-N 121.792 -0.568 . . . . 0.0 110.566 -177.602 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 25.4 mt-30 -67.17 -42.23 84.61 Favored 'General case' 0 CA--C 1.533 0.29 0 N-CA-C 113.594 0.961 . . . . 0.0 113.594 -169.397 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 62.7 m-85 -73.79 144.09 45.73 Favored 'General case' 0 C--O 1.231 0.113 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.637 -165.346 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 41.7 m-20 -77.23 -29.19 54.01 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 122.785 0.434 . . . . 0.0 109.948 -176.433 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 13.5 t -124.57 144.85 33.03 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.34 0 N-CA-C 106.564 -1.643 . . . . 0.0 106.564 168.886 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 25.0 tp -125.2 105.95 9.52 Favored 'General case' 0 N--CA 1.446 -0.669 0 N-CA-C 107.304 -1.369 . . . . 0.0 107.304 175.542 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 51.0 mt -85.83 128.6 39.13 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.687 0 N-CA-C 105.947 -1.872 . . . . 0.0 105.947 174.435 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 1.3 mp -102.55 124.1 47.5 Favored 'General case' 0 CA--C 1.515 -0.375 0 N-CA-C 106.415 -1.698 . . . . 0.0 106.415 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -122.4 120.39 4.3 Favored Glycine 0 N--CA 1.449 -0.449 0 N-CA-C 106.951 -2.46 . . . . 0.0 106.951 177.656 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 5.8 tt -149.64 116.46 3.61 Favored Pre-proline 0 C--N 1.332 -0.185 0 CA-C-N 118.033 0.916 . . . . 0.0 109.483 169.823 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 62.9 Cg_exo -64.96 146.26 87.3 Favored 'Trans proline' 0 N--CA 1.456 -0.687 0 C-N-CA 120.706 0.937 . . . . 0.0 110.394 166.194 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -129.29 134.67 48.05 Favored 'General case' 0 N--CA 1.467 0.394 0 N-CA-C 109.925 -0.398 . . . . 0.0 109.925 168.526 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 22.4 m-90 -141.61 167.17 22.78 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 126.936 2.095 . . . . 0.0 106.115 168.292 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -65.43 -39.66 92.38 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-N 118.074 0.397 . . . . 0.0 110.592 173.844 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 87.9 t80 -73.73 139.48 45.31 Favored 'General case' 0 CA--C 1.532 0.269 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 169.715 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 77.61 -61.27 3.63 Favored Glycine 0 CA--C 1.53 1.012 0 C-N-CA 123.912 0.768 . . . . 0.0 112.197 176.044 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.46 ' HG2' ' H ' ' A' ' 61' ' ' ILE . 13.5 tt0 52.94 -155.98 0.18 Allowed 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 124.504 1.122 . . . . 0.0 109.496 -169.602 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.46 ' H ' ' HG2' ' A' ' 60' ' ' GLU . 48.1 mt -47.21 121.6 0.86 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.512 0 C-N-CA 124.37 1.068 . . . . 0.0 108.605 168.868 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . 0.423 ' H ' ' CD ' ' A' ' 62' ' ' GLN . 1.5 pm0 -75.82 154.28 36.29 Favored 'General case' 0 C--O 1.233 0.225 0 C-N-CA 124.711 1.204 . . . . 0.0 109.821 173.662 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -57.11 -41.86 79.76 Favored 'General case' 0 C--O 1.224 -0.289 0 C-N-CA 124.045 0.938 . . . . 0.0 110.952 -171.375 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 27.8 m-20 -69.76 -15.56 63.15 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-N 119.108 0.867 . . . . 0.0 112.395 -173.912 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' TRP . . . . . 0.408 ' CH2' HD23 ' A' ' 104' ' ' LEU . 11.5 t90 -92.11 -46.86 7.56 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 124.52 1.128 . . . . 0.0 108.139 173.313 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -62.66 -35.36 79.41 Favored 'General case' 0 CA--C 1.536 0.428 0 O-C-N 120.789 -1.194 . . . . 0.0 110.585 -178.785 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -61.48 -25.78 67.47 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 124.119 0.968 . . . . 0.0 110.913 -174.926 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 28.1 m -111.21 -14.94 10.39 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.328 0 CA-C-O 117.352 -1.308 . . . . 0.0 112.207 177.502 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 28.3 t90 -51.56 -37.51 49.98 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 120.161 1.346 . . . . 0.0 110.526 177.342 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -63.35 -27.45 69.33 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 125.305 1.442 . . . . 0.0 113.196 176.399 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 30.9 mt-30 -92.4 -20.18 21.31 Favored 'General case' 0 C--O 1.226 -0.163 0 C-N-CA 125.853 1.661 . . . . 0.0 112.567 178.004 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 41.7 mt -63.34 -24.08 67.69 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 118.895 0.77 . . . . 0.0 111.458 -176.108 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -75.8 -27.18 57.87 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 117.903 0.32 . . . . 0.0 111.373 174.541 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -79.32 -17.01 55.42 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 123.951 0.9 . . . . 0.0 112.609 -174.717 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 38.1 mt -62.53 147.9 47.55 Favored 'General case' 0 C--O 1.234 0.275 0 C-N-CA 124.261 1.025 . . . . 0.0 111.43 -170.912 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 24.7 t-20 -83.38 82.58 8.22 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 124.856 1.263 . . . . 0.0 107.933 174.373 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 3.7 pp -140.92 131.6 25.64 Favored 'General case' 0 N--CA 1.453 -0.282 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 170.903 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 25.3 mt-10 -141.1 146.59 37.29 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 127.843 2.457 . . . . 0.0 107.585 168.414 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 69.74 -3.44 9.23 Favored Glycine 0 CA--C 1.534 1.243 0 CA-C-O 118.111 -1.383 . . . . 0.0 116.285 169.658 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.93 161.96 30.07 Favored 'General case' 0 C--N 1.343 0.312 0 CA-C-N 120.282 2.041 . . . . 0.0 109.681 -177.345 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 2.2 mt -85.05 135.41 24.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 N-CA-C 107.329 -1.36 . . . . 0.0 107.329 177.794 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 77.4 t -128.47 138.23 55.19 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 -179.766 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -113.7 156.81 23.1 Favored 'General case' 0 CA--C 1.521 -0.156 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 169.305 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 2.0 mt -138.7 134.73 33.98 Favored 'General case' 0 CA--C 1.515 -0.374 0 N-CA-C 107.002 -1.481 . . . . 0.0 107.002 -178.568 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 12.2 p90 -165.15 171.24 13.99 Favored 'General case' 0 N--CA 1.451 -0.386 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 170.698 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -178.08 176.71 48.16 Favored Glycine 0 N--CA 1.449 -0.439 0 N-CA-C 109.955 -1.258 . . . . 0.0 109.955 167.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -107.93 154.87 20.98 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 124.696 1.199 . . . . 0.0 109.905 171.922 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -150.74 -153.61 6.2 Favored Glycine 0 CA--C 1.525 0.679 0 N-CA-C 107.894 -2.083 . . . . 0.0 107.894 169.71 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -145.57 123.68 12.15 Favored 'General case' 0 C--O 1.233 0.202 0 C-N-CA 123.586 0.754 . . . . 0.0 109.499 179.732 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -74.45 -13.3 60.69 Favored 'General case' 0 CA--C 1.543 0.676 0 N-CA-C 113.213 0.82 . . . . 0.0 113.213 179.62 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 72.1 mt -69.29 -19.28 63.9 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 119.543 1.065 . . . . 0.0 110.256 169.812 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -77.32 32.89 1.56 Allowed Glycine 0 CA--C 1.535 1.309 0 C-N-CA 124.699 1.143 . . . . 0.0 110.824 167.569 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 56.0 m-85 56.12 -5.15 0.03 OUTLIER 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 129.051 2.94 . . . . 0.0 115.218 -172.471 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 69.39 9.99 62.2 Favored Glycine 0 CA--C 1.533 1.199 0 O-C-N 121.224 -0.922 . . . . 0.0 110.943 -168.802 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -76.42 -25.43 54.47 Favored 'General case' 0 C--N 1.342 0.25 0 CA-C-N 118.875 1.338 . . . . 0.0 109.999 169.778 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' TRP . . . . . . . . . . . . . 12.7 m0 -112.87 -5.73 13.84 Favored 'General case' 0 C--O 1.234 0.273 0 N-CA-C 113.464 0.913 . . . . 0.0 113.464 -167.75 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 1.6 p90 -82.29 155.15 24.97 Favored 'General case' 0 C--N 1.344 0.33 0 CA-C-N 119.513 1.051 . . . . 0.0 111.804 -174.803 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 71.5 mt 56.17 9.3 0.48 Allowed 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 126.41 1.884 . . . . 0.0 115.49 169.391 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -60.16 -28.7 68.14 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 120.394 1.452 . . . . 0.0 110.967 -175.37 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -71.31 -26.65 62.94 Favored 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 123.968 0.907 . . . . 0.0 112.491 176.82 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 10.1 mp -63.69 -43.47 96.56 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 119.846 1.203 . . . . 0.0 107.854 170.832 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -65.46 -39.83 95.92 Favored Glycine 0 C--N 1.339 0.747 0 N-CA-C 110.801 -0.92 . . . . 0.0 110.801 -174.875 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 70.7 mtm -63.85 -44.74 92.25 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 117.288 0.544 . . . . 0.0 111.762 178.3 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.408 HD23 ' CH2' ' A' ' 65' ' ' TRP . 0.2 OUTLIER -71.04 -39.63 72.19 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 119.635 1.107 . . . . 0.0 109.908 178.865 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 42.9 t-80 -55.13 -51.79 65.32 Favored 'General case' 0 CA--C 1.53 0.206 0 O-C-N 121.64 -0.662 . . . . 0.0 110.516 176.59 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -61.38 -39.7 91.64 Favored 'General case' 0 C--O 1.235 0.311 0 C-N-CA 123.491 0.716 . . . . 0.0 111.864 -176.716 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 24.2 ttmm -56.84 -41.82 78.55 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 123.325 0.65 . . . . 0.0 110.598 173.486 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 38.2 mt -87.21 -16.5 35.12 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-O 117.628 -1.177 . . . . 0.0 114.077 -169.798 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 17.7 m -57.61 -37.83 73.91 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 120.412 1.46 . . . . 0.0 111.247 -179.759 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 21.1 p -82.52 -12.52 57.71 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 124.194 0.998 . . . . 0.0 111.561 -179.409 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 32.0 mmmt -82.27 -6.39 59.2 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 124.517 1.127 . . . . 0.0 110.853 169.582 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 71.44 27.19 71.83 Favored Glycine 0 CA--C 1.527 0.831 0 CA-C-N 119.312 0.96 . . . . 0.0 113.098 168.829 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 7.9 m -74.09 170.29 1.48 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 CA-C-N 118.5 1.15 . . . . 0.0 110.068 178.345 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 54.4 tptt -95.04 135.55 36.45 Favored 'General case' 0 CA--C 1.513 -0.472 0 N-CA-C 105.26 -2.126 . . . . 0.0 105.26 167.785 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 64.7 m-85 -103.14 122.39 44.6 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 108.099 -1.075 . . . . 0.0 108.099 171.815 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 26.2 m -107.84 158.23 7.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 C-N-CA 124.5 1.12 . . . . 0.0 108.685 168.033 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 86.1 24.69 39.91 Favored Glycine 0 CA--C 1.524 0.654 0 CA-C-O 118.076 -1.402 . . . . 0.0 115.13 169.699 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 12.3 m-30 -59.91 156.38 14.58 Favored 'General case' 0 CA--C 1.544 0.721 0 CA-C-N 119.44 1.62 . . . . 0.0 109.298 168.613 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 58.3 t-105 -135.71 143.86 46.52 Favored Pre-proline 0 N--CA 1.472 0.635 0 CA-C-O 118.094 -0.955 . . . . 0.0 111.553 -168.359 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -64.46 129.64 24.44 Favored 'Trans proline' 0 C--N 1.348 0.548 0 C-N-CA 123.344 2.696 . . . . 0.0 112.429 -178.133 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 3.7 p -84.27 -30.86 25.28 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 125.022 1.329 . . . . 0.0 111.062 169.709 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -57.37 126.69 28.42 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 124.369 1.067 . . . . 0.0 110.832 -168.833 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 77.32 -1.51 64.95 Favored Glycine 0 CA--C 1.532 1.132 0 C-N-CA 124.762 1.172 . . . . 0.0 114.288 176.943 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 6.4 t80 -92.46 160.94 14.84 Favored 'General case' 0 C--O 1.236 0.391 0 CA-C-N 119.468 1.634 . . . . 0.0 110.526 178.754 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 18.2 mm-40 -98.7 110.13 22.77 Favored 'General case' 0 C--O 1.233 0.226 0 N-CA-C 108.253 -1.017 . . . . 0.0 108.253 178.395 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 25.6 p90 -160.79 166.54 28.44 Favored 'General case' 0 C--O 1.237 0.395 0 C-N-CA 125.609 1.564 . . . . 0.0 108.981 -179.643 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 12.4 t -156.82 -161.5 1.1 Allowed 'General case' 0 CA--C 1.546 0.822 0 N-CA-C 106.197 -1.779 . . . . 0.0 106.197 166.874 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 75.5 m 61.63 133.02 0.03 OUTLIER Pre-proline 0 CA--C 1.552 1.041 0 C-N-CA 127.638 2.375 . . . . 0.0 113.014 -168.787 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -81.51 -24.78 4.13 Favored 'Trans proline' 0 C--N 1.351 0.68 0 C-N-CA 121.669 1.579 . . . . 0.0 113.906 -169.25 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 23.9 ttmt -58.88 -42.7 95.51 Favored Pre-proline 0 N--CA 1.474 0.762 0 CA-C-N 120.349 1.432 . . . . 0.0 114.305 -169.889 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 80.7 Cg_endo -76.66 -0.53 10.57 Favored 'Trans proline' 0 C--N 1.353 0.812 0 CA-C-N 122.216 1.827 . . . . 0.0 114.079 179.526 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 19.5 m -120.48 149.28 23.3 Favored 'Isoleucine or valine' 0 C--O 1.232 0.171 0 CA-C-N 120.479 1.491 . . . . 0.0 110.217 -178.759 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . 0.477 HG23 HG12 ' A' ' 140' ' ' VAL . 3.2 pt -88.08 169.1 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.721 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 169.013 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . 56.0 -154.12 0.33 Allowed 'General case' 0 N--CA 1.441 -0.907 0 CA-C-N 113.603 -1.635 . . . . 0.0 109.175 169.604 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 22.4 t0 -80.67 60.7 4.08 Favored 'General case' 0 C--N 1.325 -0.482 0 C-N-CA 125.022 1.329 . . . . 0.0 109.123 169.94 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 63.54 30.0 76.3 Favored Glycine 0 CA--C 1.529 0.927 0 C-N-CA 124.607 1.099 . . . . 0.0 112.868 177.659 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 56.0 mm-40 -78.33 -29.19 47.49 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 117.706 0.753 . . . . 0.0 111.688 -168.955 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 11.7 tp -158.67 148.96 19.78 Favored 'General case' 0 CA--C 1.53 0.207 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 -174.602 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 72.5 m-85 -77.48 148.53 35.3 Favored 'General case' 0 CA--C 1.522 -0.113 0 CA-C-N 119.146 0.884 . . . . 0.0 108.789 170.088 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . 0.477 HG12 HG23 ' A' ' 133' ' ' ILE . 33.8 m -71.43 -0.67 1.82 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.624 0 C-N-CA 123.195 0.598 . . . . 0.0 112.265 175.762 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -176.58 171.9 44.87 Favored Glycine 0 CA--C 1.524 0.633 0 O-C-N 120.745 -1.222 . . . . 0.0 110.346 -172.659 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 1.6 tp -64.67 136.13 56.64 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 118.006 0.903 . . . . 0.0 110.939 179.454 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -101.72 112.81 25.52 Favored 'General case' 0 N--CA 1.447 -0.617 0 C-N-CA 125.841 1.656 . . . . 0.0 108.873 176.266 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 95.7 mt -106.76 158.35 17.04 Favored 'General case' 0 N--CA 1.465 0.295 0 C-N-CA 124.448 1.099 . . . . 0.0 109.317 170.584 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 6.2 t0 -140.99 132.92 27.63 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 104.854 -2.276 . . . . 0.0 104.854 169.186 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -131.64 21.56 4.67 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 123.138 0.575 . . . . 0.0 110.848 177.398 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 17.5 m -98.01 -37.71 9.66 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 124.925 1.29 . . . . 0.0 109.332 170.954 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 41.9 m-80 -116.8 -44.63 2.82 Favored 'General case' 0 CA--C 1.515 -0.372 0 C-N-CA 125.521 1.529 . . . . 0.0 109.635 -169.372 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 24.0 mt-30 -92.03 156.04 17.68 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 124.508 1.123 . . . . 0.0 108.435 177.465 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 91.1 t80 -159.47 -51.35 0.06 Allowed 'General case' 0 N--CA 1.461 0.089 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 172.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -61.09 -43.99 98.04 Favored 'General case' 0 C--O 1.234 0.269 0 C-N-CA 123.093 0.557 . . . . 0.0 111.716 -170.78 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . 0.291 0.3 OUTLIER -100.38 0.41 39.87 Favored 'General case' 0 C--N 1.345 0.383 0 N-CA-C 113.97 1.1 . . . . 0.0 113.97 175.929 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 12.5 m -61.5 -31.85 71.85 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-N 120.575 1.534 . . . . 0.0 108.99 169.183 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -59.91 -42.5 94.03 Favored 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 124.235 1.014 . . . . 0.0 111.65 169.673 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -64.41 -47.01 80.79 Favored 'General case' 0 C--N 1.334 -0.102 0 C-N-CA 124.31 1.044 . . . . 0.0 109.848 178.907 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 68.5 mtt180 -57.58 -46.76 83.59 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-O 118.125 -0.94 . . . . 0.0 110.501 177.151 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 47.8 mt -61.03 -51.96 67.14 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.403 0 CA-C-N 119.443 1.02 . . . . 0.0 108.383 177.192 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 71.0 tp60 -52.78 -64.19 0.9 Allowed 'General case' 0 C--O 1.234 0.27 0 C-N-CA 124.633 1.173 . . . . 0.0 111.302 -177.6 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 41.3 m -66.21 -33.26 75.35 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 119.315 -0.374 . . . . 0.0 111.268 -171.459 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 160' ' ' TRP . . . . . . . . . . . . . 60.5 t90 -65.73 -47.87 73.88 Favored 'General case' 0 C--O 1.225 -0.225 0 CA-C-N 118.676 0.671 . . . . 0.0 110.707 174.705 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 64.7 m -61.3 -42.22 98.29 Favored 'General case' 0 N--CA 1.455 -0.204 0 CA-C-N 118.217 0.462 . . . . 0.0 110.299 -178.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -61.55 -44.54 96.85 Favored 'General case' 0 N--CA 1.455 -0.203 0 CA-C-N 118.308 0.504 . . . . 0.0 110.076 174.886 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 14.8 tt0 -62.6 -50.81 69.79 Favored 'General case' 0 CA--C 1.512 -0.489 0 CA-C-O 117.699 -1.143 . . . . 0.0 109.803 -176.415 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 44.7 pt -63.98 -34.13 66.58 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.425 0 CA-C-O 117.59 -1.195 . . . . 0.0 109.835 -176.578 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -71.48 -32.36 68.18 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 119.653 1.115 . . . . 0.0 108.955 -174.982 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -70.74 -53.54 15.15 Favored 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 124.347 1.059 . . . . 0.0 109.374 173.737 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 20.1 tt0 -69.02 -31.44 70.24 Favored 'General case' 0 N--CA 1.445 -0.719 0 C-N-CA 125.601 1.561 . . . . 0.0 109.943 -168.619 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 168' ' ' MET . . . . . . . . . . . . . 22.1 ptp -74.11 -34.02 63.78 Favored 'General case' 0 C--O 1.23 0.078 0 O-C-N 122.143 -0.348 . . . . 0.0 111.047 174.658 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -74.86 -37.16 62.28 Favored 'General case' 0 N--CA 1.442 -0.852 0 CA-C-O 119.276 -0.393 . . . . 0.0 111.811 -177.251 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 5.5 mt-10 -62.37 -32.91 73.78 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-O 121.572 0.701 . . . . 0.0 109.682 177.244 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 72.5 t60 -75.01 -34.55 61.93 Favored 'General case' 0 N--CA 1.446 -0.648 0 C-N-CA 124.741 1.216 . . . . 0.0 111.328 -175.774 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 4.7 m-85 -77.9 -27.6 49.61 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 123.507 0.723 . . . . 0.0 112.927 173.63 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.254 1.313 0 C-N-CA 123.461 0.704 . . . . 0.0 110.727 -177.729 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.497 1.898 0 CA-C-O 120.433 0.159 . . . . 0.0 111.286 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 26.1 p-10 -116.39 165.87 12.72 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 125.392 1.477 . . . . 0.0 111.414 -174.425 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 13.9 mtt -130.69 128.44 40.89 Favored 'General case' 0 CA--C 1.522 -0.119 0 C-N-CA 123.27 0.628 . . . . 0.0 110.717 175.367 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -90.12 149.4 20.3 Favored Glycine 0 CA--C 1.525 0.672 0 N-CA-C 106.786 -2.526 . . . . 0.0 106.786 166.56 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 2.4 tt -134.26 100.16 4.61 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 105.364 -2.087 . . . . 0.0 105.364 -178.099 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.557 ' CZ ' HD11 ' A' ' 51' ' ' LEU . 0.5 OUTLIER -106.22 142.84 35.23 Favored 'General case' 0 CA--C 1.519 -0.238 0 CA-C-O 121.63 0.729 . . . . 0.0 112.252 -172.727 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 34.7 p90 -155.63 165.28 37.04 Favored 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 126.697 1.999 . . . . 0.0 106.85 179.425 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -143.25 93.73 0.17 Allowed Glycine 0 CA--C 1.509 -0.306 0 N-CA-C 105.552 -3.019 . . . . 0.0 105.552 177.042 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 6.0 m -140.67 47.52 1.75 Allowed 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 124.78 1.232 . . . . 0.0 107.675 -169.735 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 6.6 m -48.21 130.18 15.81 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 125.975 1.71 . . . . 0.0 111.815 -169.193 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 6.0 m 66.1 -40.92 0.35 Allowed 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 127.834 2.453 . . . . 0.0 114.336 -176.98 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 61.0 m -79.94 -25.76 40.34 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 119.404 1.002 . . . . 0.0 112.84 -174.138 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 7.1 m-85 57.76 -178.69 0.06 Allowed 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 126.533 1.933 . . . . 0.0 111.752 -168.606 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 72.5 p -80.53 -175.7 5.34 Favored 'General case' 0 CA--C 1.548 0.868 0 N-CA-C 106.751 -1.574 . . . . 0.0 106.751 166.908 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 49.0 mm-40 -77.66 55.11 1.29 Allowed 'General case' 0 CA--C 1.543 0.684 0 O-C-N 120.206 -1.559 . . . . 0.0 109.254 169.886 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 52.38 24.19 2.82 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 127.776 2.43 . . . . 0.0 112.56 -171.442 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -65.65 -44.89 84.98 Favored 'General case' 0 C--N 1.34 0.179 0 O-C-N 120.946 -1.096 . . . . 0.0 109.3 -175.205 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -63.77 -45.53 89.32 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 122.195 0.198 . . . . 0.0 110.872 -176.74 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -60.24 -45.38 93.44 Favored 'General case' 0 N--CA 1.465 0.298 0 C-N-CA 123.296 0.638 . . . . 0.0 109.667 176.392 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 30.0 mtpp -70.52 -39.91 73.8 Favored 'General case' 0 C--O 1.222 -0.373 0 CA-C-O 118.441 -0.79 . . . . 0.0 110.144 -173.512 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 43.8 mt -54.88 -54.86 19.47 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.189 0 CA-C-N 119.765 1.166 . . . . 0.0 109.174 176.024 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.83 -33.87 76.56 Favored 'General case' 0 C--O 1.221 -0.399 0 CA-C-N 118.259 0.481 . . . . 0.0 111.316 -174.628 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -63.4 -40.75 98.06 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 122.67 0.388 . . . . 0.0 111.119 175.273 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 55.6 mt -76.72 -55.67 10.25 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.515 0 C-N-CA 124.644 1.178 . . . . 0.0 110.451 -171.698 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 73.4 mt -64.48 -46.3 93.18 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 -179.858 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 143.73 124.01 1.78 Allowed Glycine 0 CA--C 1.527 0.817 0 C-N-CA 124.442 1.02 . . . . 0.0 110.871 174.46 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -73.13 -9.41 23.35 Favored 'Trans proline' 0 CA--C 1.54 0.782 0 C-N-CA 123.101 2.534 . . . . 0.0 113.387 -170.914 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -81.35 -19.09 43.49 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 118.768 0.713 . . . . 0.0 111.416 178.174 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -125.12 -7.2 7.13 Favored 'General case' 0 C--N 1.344 0.335 0 C-N-CA 124.828 1.251 . . . . 0.0 113.724 -174.032 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 40.4 t -115.02 137.27 49.04 Favored 'Isoleucine or valine' 0 C--O 1.233 0.216 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 171.193 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 51.7 m -129.91 132.99 46.57 Favored 'General case' 0 C--O 1.233 0.197 0 C-N-CA 124.807 1.243 . . . . 0.0 108.268 -174.503 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 23.7 mt -75.22 144.22 42.73 Favored 'General case' 0 C--O 1.233 0.194 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 177.073 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . 0.417 ' HD1' ' HB2' ' A' ' 6' ' ' PHE . 44.4 t-80 -132.7 66.55 1.56 Allowed 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 125.141 1.376 . . . . 0.0 107.291 -177.679 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 57.0 t-20 -70.43 118.08 12.78 Favored 'General case' 0 C--O 1.233 0.234 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 -179.329 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 48.6 mt -67.74 -18.0 64.74 Favored 'General case' 0 C--O 1.232 0.183 0 N-CA-C 113.16 0.8 . . . . 0.0 113.16 -174.78 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 35.1 tptt -60.14 -23.6 64.03 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 118.698 0.681 . . . . 0.0 111.777 169.445 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -119.46 -39.41 2.89 Favored 'General case' 0 C--O 1.234 0.262 0 N-CA-C 113.279 0.844 . . . . 0.0 113.279 -172.846 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 33.1 m-20 -101.42 139.15 37.48 Favored 'General case' 0 N--CA 1.465 0.302 0 C-N-CA 123.947 0.899 . . . . 0.0 110.531 -177.654 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 11.4 m -75.28 155.82 85.83 Favored Pre-proline 0 CA--C 1.542 0.644 0 C-N-CA 124.124 0.97 . . . . 0.0 110.16 174.779 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -74.71 -25.68 12.26 Favored 'Trans proline' 0 C--N 1.349 0.553 0 C-N-CA 121.909 1.74 . . . . 0.0 113.472 -170.196 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 1.7 mptm? -62.9 -21.08 65.76 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-N 120.329 1.422 . . . . 0.0 112.082 -179.186 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -62.25 -26.53 68.44 Favored 'General case' 0 N--CA 1.465 0.292 0 C-N-CA 125.119 1.368 . . . . 0.0 110.389 174.634 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 68.4 mtt -58.19 -27.66 64.07 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 118.94 0.791 . . . . 0.0 111.43 177.128 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 69.1 mt-10 -63.37 -32.59 74.05 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 118.238 0.472 . . . . 0.0 109.969 -175.814 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 26.2 mt-30 -67.47 -39.78 85.28 Favored 'General case' 0 C--N 1.342 0.278 0 C-N-CA 123.911 0.884 . . . . 0.0 113.191 -172.145 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 71.6 m-85 -72.95 135.16 44.99 Favored 'General case' 0 C--O 1.233 0.219 0 N-CA-C 109.446 -0.575 . . . . 0.0 109.446 -167.904 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -69.7 -44.01 71.27 Favored 'General case' 0 C--O 1.233 0.208 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 -178.843 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 12.3 t -103.52 145.49 12.53 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.396 0 N-CA-C 107.996 -1.113 . . . . 0.0 107.996 169.894 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 34.8 tp -135.41 105.97 6.47 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 175.943 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 32.6 mt -85.11 128.34 39.11 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.826 0 N-CA-C 106.638 -1.616 . . . . 0.0 106.638 177.698 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.557 HD11 ' CZ ' ' A' ' 6' ' ' PHE . 0.8 OUTLIER -94.05 144.32 25.58 Favored 'General case' 0 CA--C 1.516 -0.363 0 C-N-CA 124.787 1.235 . . . . 0.0 109.824 169.588 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -145.34 134.78 5.67 Favored Glycine 0 CA--C 1.52 0.385 0 N-CA-C 109.244 -1.542 . . . . 0.0 109.244 169.234 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 3.5 tt -156.68 139.6 10.81 Favored Pre-proline 0 CA--C 1.542 0.655 0 CA-C-N 118.737 1.268 . . . . 0.0 111.411 172.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -78.39 145.14 20.95 Favored 'Trans proline' 0 CA--C 1.538 0.718 0 C-N-CA 122.749 2.3 . . . . 0.0 111.554 167.192 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.429 HG21 ' H ' ' A' ' 99' ' ' ASP . 38.6 m -106.36 147.65 28.99 Favored 'General case' 0 CA--C 1.542 0.665 0 N-CA-C 107.082 -1.451 . . . . 0.0 107.082 167.426 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 20.6 t90 -148.02 145.3 28.44 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 124.327 1.051 . . . . 0.0 109.119 -175.525 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -70.02 -38.21 75.85 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 123.429 0.692 . . . . 0.0 112.361 -176.452 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 69.3 t80 -65.07 -32.95 74.92 Favored 'General case' 0 CA--C 1.537 0.472 0 O-C-N 122.186 -0.321 . . . . 0.0 110.683 -176.712 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 172.8 120.34 0.56 Allowed Glycine 0 CA--C 1.524 0.632 0 N-CA-C 108.269 -1.933 . . . . 0.0 108.269 171.406 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 3.4 pm0 -74.76 158.92 32.68 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 123.331 0.653 . . . . 0.0 110.642 176.361 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . 0.253 49.9 mt 66.74 144.56 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.546 0.804 0 C-N-CA 127.34 2.256 . . . . 0.0 112.415 178.184 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 4.2 mp0 -108.1 153.69 22.78 Favored 'General case' 0 C--N 1.34 0.173 0 C-N-CA 125.569 1.548 . . . . 0.0 107.157 -177.317 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -57.0 -42.47 80.32 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 123.178 0.591 . . . . 0.0 110.951 -173.312 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 23.0 m-20 -66.99 -18.24 65.29 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 122.844 0.458 . . . . 0.0 112.004 -176.409 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' TRP . . . . . 0.788 ' CH2' HD23 ' A' ' 104' ' ' LEU . 13.6 t90 -95.76 -44.79 7.27 Favored 'General case' 0 C--N 1.339 0.14 0 C-N-CA 124.358 1.063 . . . . 0.0 110.263 175.304 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -62.9 -34.75 78.07 Favored 'General case' 0 CA--C 1.538 0.503 0 O-C-N 120.692 -1.255 . . . . 0.0 109.673 -178.864 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -60.16 -25.32 65.43 Favored 'General case' 0 C--O 1.233 0.216 0 C-N-CA 123.839 0.856 . . . . 0.0 111.567 179.29 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 12.2 m -109.85 -16.04 9.25 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.321 0 CA-C-O 117.46 -1.257 . . . . 0.0 112.467 179.446 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 27.9 t90 -53.71 -38.53 64.37 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 120.025 1.284 . . . . 0.0 110.198 176.822 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -66.59 -27.36 67.66 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 125.476 1.51 . . . . 0.0 112.945 175.532 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 68.1 mt-30 -90.73 -23.07 20.8 Favored 'General case' 0 C--O 1.224 -0.289 0 C-N-CA 125.67 1.588 . . . . 0.0 111.978 -176.787 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.608 ' CD1' HD21 ' A' ' 104' ' ' LEU . 50.3 mt -57.74 -32.0 67.02 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 118.537 0.608 . . . . 0.0 110.275 173.398 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -70.4 -26.5 63.72 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 122.694 0.397 . . . . 0.0 111.233 174.548 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -81.31 -34.36 31.97 Favored 'General case' 0 CA--C 1.537 0.475 0 N-CA-C 113.307 0.854 . . . . 0.0 113.307 176.267 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 24.7 mt -59.62 149.56 29.95 Favored 'General case' 0 N--CA 1.464 0.27 0 C-N-CA 124.476 1.11 . . . . 0.0 111.104 -176.117 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 19.9 t-20 -91.15 118.42 30.43 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 169.171 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 70.4 mt -127.98 8.9 6.25 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 123.73 0.812 . . . . 0.0 112.263 -173.113 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 28.9 mt-10 -52.18 129.15 27.04 Favored 'General case' 0 C--O 1.234 0.273 0 C-N-CA 124.3 1.04 . . . . 0.0 112.272 -168.049 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 68.43 0.09 15.3 Favored Glycine 0 CA--C 1.535 1.3 0 C-N-CA 125.436 1.493 . . . . 0.0 115.525 175.828 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.66 151.34 40.81 Favored 'General case' 0 C--N 1.345 0.391 0 CA-C-N 120.555 2.177 . . . . 0.0 109.499 -174.262 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 5.8 mt -80.38 136.47 23.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 N-CA-C 106.65 -1.611 . . . . 0.0 106.65 179.649 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 43.2 t -131.16 134.26 61.52 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 C-N-CA 123.755 0.822 . . . . 0.0 109.809 -179.567 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.415 ' HB1' ' CH2' ' A' ' 160' ' ' TRP . . . -105.34 152.73 22.57 Favored 'General case' 0 N--CA 1.462 0.139 0 N-CA-C 105.865 -1.902 . . . . 0.0 105.865 166.804 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 2.6 mt -134.08 134.4 42.26 Favored 'General case' 0 CA--C 1.512 -0.497 0 N-CA-C 107.096 -1.446 . . . . 0.0 107.096 175.537 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 36.0 p90 -148.86 168.77 22.13 Favored 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 169.628 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -163.41 173.6 39.56 Favored Glycine 0 N--CA 1.446 -0.661 0 N-CA-C 109.91 -1.276 . . . . 0.0 109.91 169.979 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -119.75 153.45 35.65 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 125.012 1.325 . . . . 0.0 108.435 171.035 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -166.06 -155.41 8.76 Favored Glycine 0 CA--C 1.526 0.764 0 N-CA-C 109.595 -1.402 . . . . 0.0 109.595 174.083 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -124.95 146.77 49.22 Favored 'General case' 0 C--O 1.236 0.355 0 C-N-CA 124.733 1.213 . . . . 0.0 109.625 179.973 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . 0.529 ' H ' ' ND2' ' A' ' 148' ' ' ASN . 4.8 pt20 -120.55 6.72 10.56 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 124.592 1.157 . . . . 0.0 113.464 171.271 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 21.8 mt -65.88 -40.44 91.59 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 120.1 1.318 . . . . 0.0 109.509 170.078 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -76.01 45.04 1.91 Allowed Glycine 0 CA--C 1.529 0.917 0 C-N-CA 125.233 1.397 . . . . 0.0 111.226 170.533 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 48.6 m-85 57.45 0.57 0.1 Allowed 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 127.675 2.39 . . . . 0.0 114.717 -176.938 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 70.57 27.59 72.31 Favored Glycine 0 CA--C 1.526 0.765 0 O-C-N 121.21 -0.931 . . . . 0.0 110.794 -169.879 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -72.37 -31.14 65.33 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-N 118.507 1.153 . . . . 0.0 108.007 167.316 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' TRP . . . . . . . . . . . . . 14.4 m0 -86.2 -0.68 56.3 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 125.639 1.576 . . . . 0.0 111.979 176.34 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 4.3 t80 -75.31 131.13 40.09 Favored 'General case' 0 C--N 1.341 0.226 0 O-C-N 121.313 -0.867 . . . . 0.0 111.361 -169.139 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 84.3 mt 50.7 23.07 1.25 Allowed 'General case' 0 N--CA 1.47 0.541 0 N-CA-C 116.253 1.945 . . . . 0.0 116.253 166.205 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . 0.429 ' H ' HG21 ' A' ' 55' ' ' THR . 13.9 t70 -64.61 -35.03 79.69 Favored 'General case' 0 C--N 1.328 -0.348 0 O-C-N 120.441 -1.412 . . . . 0.0 111.116 -174.305 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -65.9 -31.43 72.36 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 123.845 0.858 . . . . 0.0 111.944 173.458 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 4.2 tt -65.92 -47.93 73.1 Favored 'General case' 0 N--CA 1.468 0.446 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 173.542 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -58.84 -40.53 95.25 Favored Glycine 0 CA--C 1.525 0.713 0 N-CA-C 111.09 -0.804 . . . . 0.0 111.09 178.081 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 3.0 tpp -49.75 -45.44 49.41 Favored 'General case' 0 N--CA 1.464 0.256 0 C-N-CA 124.685 1.194 . . . . 0.0 110.867 172.328 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.788 HD23 ' CH2' ' A' ' 65' ' ' TRP . 0.2 OUTLIER -83.81 -31.26 25.95 Favored 'General case' 0 CA--C 1.52 -0.174 0 O-C-N 122.122 -0.361 . . . . 0.0 111.607 -171.683 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 36.8 t-80 -60.33 -45.26 94.08 Favored 'General case' 0 C--N 1.331 -0.234 0 O-C-N 121.964 -0.46 . . . . 0.0 109.813 169.482 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -63.42 -47.58 81.33 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 123.472 0.709 . . . . 0.0 111.088 179.511 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 2.2 tppm? -54.38 -31.05 53.88 Favored 'General case' 0 N--CA 1.466 0.352 0 C-N-CA 125.342 1.457 . . . . 0.0 111.854 173.863 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 49.2 mt -101.55 -22.32 14.52 Favored 'General case' 0 N--CA 1.465 0.28 0 N-CA-C 114.231 1.197 . . . . 0.0 114.231 -173.668 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 69.0 m -60.42 -34.88 74.59 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 119.897 1.226 . . . . 0.0 111.188 -176.718 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 24.3 p -80.38 -13.13 59.41 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 124.817 1.247 . . . . 0.0 111.833 -179.344 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 31.3 mmmt -88.24 -10.84 48.38 Favored 'General case' 0 C--N 1.342 0.281 0 C-N-CA 125.297 1.439 . . . . 0.0 111.64 179.778 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 75.04 32.92 55.94 Favored Glycine 0 CA--C 1.523 0.572 0 CA-C-O 119.567 -0.574 . . . . 0.0 111.795 173.166 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 9.9 m -72.88 172.42 1.04 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.582 0 CA-C-N 118.26 1.03 . . . . 0.0 109.024 169.721 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -112.25 121.38 44.74 Favored 'General case' 0 CA--C 1.514 -0.422 0 N-CA-C 106.224 -1.769 . . . . 0.0 106.224 176.073 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 63.3 m-85 -88.79 143.99 26.53 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 119.513 1.051 . . . . 0.0 109.756 -176.176 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 30.6 m -129.53 161.17 39.57 Favored 'Isoleucine or valine' 0 C--O 1.234 0.269 0 C-N-CA 124.787 1.235 . . . . 0.0 108.623 170.044 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 95.79 -93.5 1.57 Allowed Glycine 0 N--CA 1.444 -0.79 0 C-N-CA 124.581 1.086 . . . . 0.0 111.122 177.463 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 14.4 m-30 59.25 -178.3 0.08 Allowed 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 124.345 1.058 . . . . 0.0 109.011 -167.275 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -154.93 144.44 15.32 Favored Pre-proline 0 N--CA 1.471 0.6 0 O-C-N 120.192 -1.568 . . . . 0.0 110.604 179.416 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -67.74 123.84 11.21 Favored 'Trans proline' 0 CA--C 1.534 0.515 0 C-N-CA 123.222 2.614 . . . . 0.0 111.705 179.114 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 3.0 p -79.61 -16.57 55.59 Favored 'General case' 0 CA--C 1.538 0.492 0 O-C-N 121.669 -0.644 . . . . 0.0 112.315 174.692 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -59.84 124.05 18.95 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 123.625 0.77 . . . . 0.0 110.476 -169.691 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 73.63 1.59 58.6 Favored Glycine 0 CA--C 1.534 1.242 0 C-N-CA 124.592 1.091 . . . . 0.0 114.083 177.826 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 4.1 t80 -89.39 153.32 20.94 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-N 119.052 1.426 . . . . 0.0 109.956 -179.855 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 18.5 mm-40 -91.92 113.5 25.78 Favored 'General case' 0 C--O 1.233 0.21 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 176.222 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 24.2 p90 -155.81 156.56 34.95 Favored 'General case' 0 C--O 1.237 0.404 0 C-N-CA 125.784 1.633 . . . . 0.0 107.662 172.57 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 5.7 t -148.2 2.32 0.66 Allowed 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 122.663 0.385 . . . . 0.0 111.254 168.521 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 5.0 p -71.75 128.23 89.86 Favored Pre-proline 0 CA--C 1.542 0.662 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 171.673 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -80.16 -28.06 3.3 Favored 'Trans proline' 0 CA--C 1.537 0.654 0 C-N-CA 122.241 1.96 . . . . 0.0 112.286 176.927 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 24.3 ttmt -57.68 -43.03 98.5 Favored Pre-proline 0 CA--C 1.542 0.666 0 CA-C-O 117.603 -1.189 . . . . 0.0 113.538 -173.776 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_endo -83.83 8.22 4.75 Favored 'Trans proline' 0 C--N 1.351 0.681 0 C-N-CA 122.144 1.896 . . . . 0.0 114.436 -179.6 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 29.0 m -126.4 165.31 24.8 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.285 0 CA-C-N 121.156 1.798 . . . . 0.0 111.791 -176.622 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 9.5 pt -132.81 169.2 22.48 Favored 'Isoleucine or valine' 0 C--O 1.234 0.277 0 C-N-CA 127.746 2.419 . . . . 0.0 108.576 179.714 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . 53.87 42.03 31.85 Favored 'General case' 0 C--O 1.227 -0.109 0 C-N-CA 125.296 1.438 . . . . 0.0 112.263 174.109 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 27.7 t70 54.04 42.57 31.57 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 126.479 1.912 . . . . 0.0 111.684 -177.527 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 91.78 16.82 50.66 Favored Glycine 0 CA--C 1.527 0.827 0 CA-C-O 118.721 -1.044 . . . . 0.0 113.642 173.873 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 46.2 mt-30 -89.32 -7.74 54.72 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 119.345 1.573 . . . . 0.0 112.946 179.635 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 7.4 tp -156.23 147.37 22.29 Favored 'General case' 0 C--N 1.344 0.339 0 CA-C-N 119.462 1.028 . . . . 0.0 110.829 169.964 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 67.6 m-85 -81.08 146.7 30.47 Favored 'General case' 0 CA--C 1.52 -0.175 0 N-CA-C 107.817 -1.179 . . . . 0.0 107.817 168.4 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 12.5 m -80.55 9.24 0.82 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 C-N-CA 123.722 0.809 . . . . 0.0 112.386 177.225 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -177.81 170.29 42.56 Favored Glycine 0 CA--C 1.524 0.644 0 N-CA-C 110.271 -1.132 . . . . 0.0 110.271 179.42 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -65.07 137.82 57.93 Favored 'General case' 0 N--CA 1.465 0.305 0 C-N-CA 123.326 0.65 . . . . 0.0 111.295 -176.3 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -93.76 122.84 36.65 Favored 'General case' 0 N--CA 1.444 -0.737 0 C-N-CA 126.229 1.812 . . . . 0.0 109.717 176.447 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 86.5 mt -122.42 161.28 23.8 Favored 'General case' 0 C--N 1.332 -0.177 0 N-CA-C 106.096 -1.816 . . . . 0.0 106.096 168.209 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -138.34 147.38 43.44 Favored 'General case' 0 C--O 1.235 0.314 0 N-CA-C 108.655 -0.869 . . . . 0.0 108.655 178.036 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -125.48 12.88 8.13 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 124.835 1.254 . . . . 0.0 112.94 -174.398 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 16.7 m -135.07 -36.33 0.82 Allowed 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 124.962 1.305 . . . . 0.0 111.929 -178.655 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . 0.529 ' ND2' ' H ' ' A' ' 90' ' ' GLN . 5.1 m-80 -93.93 -53.7 3.89 Favored 'General case' 0 CA--C 1.518 -0.264 0 C-N-CA 124.628 1.171 . . . . 0.0 112.234 -166.908 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 3.6 mp0 -134.85 133.04 39.31 Favored 'General case' 0 CA--C 1.523 -0.086 0 N-CA-C 107.72 -1.215 . . . . 0.0 107.72 -179.146 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 91.1 m-85 -113.35 -28.15 7.68 Favored 'General case' 0 N--CA 1.465 0.277 0 C-N-CA 123.68 0.792 . . . . 0.0 111.751 179.29 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -69.79 -43.3 72.41 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 118.272 0.487 . . . . 0.0 111.486 -169.875 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . 0.27 0.4 OUTLIER -84.73 5.36 28.69 Favored 'General case' 0 C--N 1.343 0.324 0 N-CA-C 113.401 0.889 . . . . 0.0 113.401 -177.402 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 48.6 m -59.81 -35.12 74.04 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 120.649 1.568 . . . . 0.0 110.829 174.45 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -60.87 -40.99 95.07 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 118.105 0.412 . . . . 0.0 110.902 174.593 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 -67.43 -50.37 59.65 Favored 'General case' 0 C--O 1.234 0.271 0 C-N-CA 124.614 1.165 . . . . 0.0 110.376 179.662 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 60.4 mtm180 -58.16 -41.46 83.85 Favored 'General case' 0 N--CA 1.463 0.214 0 C-N-CA 123.969 0.908 . . . . 0.0 109.734 -179.042 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 56.2 mt -69.47 -54.18 20.99 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.441 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 176.074 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 70.0 tp60 -52.78 -62.33 1.72 Allowed 'General case' 0 C--O 1.234 0.273 0 C-N-CA 124.546 1.139 . . . . 0.0 111.854 -171.767 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 20.0 m -66.13 -32.28 73.64 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 120.758 -0.377 . . . . 0.0 110.89 -169.493 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 160' ' ' TRP . . . . . 0.415 ' CH2' ' HB1' ' A' ' 83' ' ' ALA . 40.1 t90 -70.75 -43.84 68.0 Favored 'General case' 0 C--O 1.222 -0.386 0 O-C-N 121.99 -0.444 . . . . 0.0 111.267 176.553 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 67.2 m -58.31 -44.65 88.67 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 118.215 0.461 . . . . 0.0 110.173 176.917 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -62.45 -40.93 98.19 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-O 121.009 0.433 . . . . 0.0 110.153 176.752 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 13.6 tt0 -63.03 -52.85 61.23 Favored 'General case' 0 N--CA 1.447 -0.584 0 CA-C-O 118.732 -0.651 . . . . 0.0 110.036 -179.632 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 41.8 pt -63.43 -38.54 82.46 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.345 0 CA-C-O 117.973 -1.013 . . . . 0.0 109.185 -175.37 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -66.67 -32.82 74.38 Favored 'General case' 0 CA--C 1.529 0.152 0 CA-C-N 119.385 0.993 . . . . 0.0 110.414 -178.622 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 31.7 m-80 -68.66 -59.02 3.41 Favored 'General case' 0 CA--C 1.516 -0.352 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 173.303 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 16.2 tt0 -61.04 -37.9 84.22 Favored 'General case' 0 N--CA 1.441 -0.916 0 C-N-CA 125.895 1.678 . . . . 0.0 111.482 -168.904 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 168' ' ' MET . . . . . . . . . . . . . 19.9 ptp -70.06 -30.03 67.19 Favored 'General case' 0 C--N 1.333 -0.131 0 O-C-N 121.442 -0.786 . . . . 0.0 112.23 174.814 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -77.28 -38.52 50.66 Favored 'General case' 0 N--CA 1.446 -0.627 0 C-N-CA 123.126 0.57 . . . . 0.0 112.249 178.658 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -64.91 -32.58 74.35 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-O 121.907 0.86 . . . . 0.0 109.698 -179.276 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 57.4 t60 -62.6 -22.27 66.26 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 124.817 1.247 . . . . 0.0 111.438 178.425 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 24.2 m-85 -107.38 9.57 29.79 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 126.422 1.889 . . . . 0.0 113.871 172.878 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.255 1.356 0 CA-C-N 119.412 1.005 . . . . 0.0 110.05 174.53 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.498 1.932 0 N-CA-C 111.684 0.253 . . . . 0.0 111.684 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 5.8 t30 -113.53 153.08 29.34 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 124.294 1.037 . . . . 0.0 109.297 177.333 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 15.9 mtt -113.7 129.34 56.59 Favored 'General case' 0 N--CA 1.462 0.128 0 C-N-CA 123.802 0.841 . . . . 0.0 110.137 -179.471 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -83.86 150.7 26.78 Favored Glycine 0 CA--C 1.526 0.721 0 N-CA-C 107.43 -2.268 . . . . 0.0 107.43 167.215 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 2.0 tt -138.33 99.15 3.77 Favored 'General case' 0 N--CA 1.467 0.39 0 N-CA-C 105.63 -1.989 . . . . 0.0 105.63 -177.821 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 1.1 p90 -105.18 147.78 27.63 Favored 'General case' 0 CA--C 1.519 -0.229 0 CA-C-N 118.592 0.633 . . . . 0.0 112.028 -171.372 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 43.0 p90 -157.16 171.33 20.62 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 126.077 1.751 . . . . 0.0 107.728 170.483 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -72.92 -88.14 0.17 Allowed Glycine 0 CA--C 1.523 0.593 0 C-N-CA 123.968 0.794 . . . . 0.0 113.232 -168.786 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 3.9 m -105.76 149.67 26.23 Favored 'General case' 0 C--O 1.233 0.214 0 C-N-CA 123.543 0.737 . . . . 0.0 110.453 -169.701 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 1.2 m -58.8 -30.5 67.64 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 124.222 1.009 . . . . 0.0 111.622 176.785 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 3.5 p -75.7 -14.83 60.35 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 125.583 1.553 . . . . 0.0 112.665 -177.028 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 82.1 m -70.63 148.95 47.54 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 119.074 0.852 . . . . 0.0 110.343 -179.117 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 60.9 m-85 -62.83 -18.4 62.78 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 122.716 0.407 . . . . 0.0 112.025 174.859 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -49.99 -27.74 5.89 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 125.876 1.671 . . . . 0.0 112.427 170.007 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 -58.79 -40.05 82.88 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 119.871 1.214 . . . . 0.0 110.649 177.61 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 2.6 mpp? -70.49 -39.87 73.93 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 118.96 0.8 . . . . 0.0 110.284 -178.378 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -59.77 -46.94 87.61 Favored 'General case' 0 C--O 1.224 -0.24 0 N-CA-C 109.076 -0.712 . . . . 0.0 109.076 171.315 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -62.74 -47.7 82.44 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 123.944 0.898 . . . . 0.0 111.381 -174.261 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 31.2 mt-10 -57.98 -44.82 87.35 Favored 'General case' 0 CA--C 1.518 -0.267 0 C-N-CA 123.202 0.601 . . . . 0.0 109.556 175.179 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 49.9 mttm -64.91 -47.54 77.41 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-O 118.796 -0.621 . . . . 0.0 110.484 -177.623 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 83.3 mt -53.12 -55.06 14.08 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.2 0 CA-C-N 118.897 0.771 . . . . 0.0 109.307 -178.812 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.475 ' HG2' HD21 ' A' ' 32' ' ' LEU . 0.0 OUTLIER -66.58 -35.06 79.29 Favored 'General case' 0 CA--C 1.513 -0.461 0 CA-C-O 118.812 -0.613 . . . . 0.0 111.313 -175.434 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -64.46 -39.9 94.69 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.997 0.427 . . . . 0.0 110.563 178.194 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 61.1 mt -78.01 -54.76 11.78 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.786 0 C-N-CA 124.77 1.228 . . . . 0.0 110.236 -171.092 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 71.3 mt -64.16 -46.22 94.17 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.326 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 179.257 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 141.98 124.1 1.93 Allowed Glycine 0 CA--C 1.528 0.898 0 C-N-CA 124.632 1.111 . . . . 0.0 110.969 173.528 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -69.94 -13.61 34.45 Favored 'Trans proline' 0 CA--C 1.539 0.738 0 C-N-CA 122.982 2.455 . . . . 0.0 112.836 -173.288 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -73.48 -21.42 60.43 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 118.509 0.595 . . . . 0.0 111.928 177.701 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -130.53 3.44 4.6 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 124.459 1.104 . . . . 0.0 113.535 -169.692 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 44.9 t -123.74 142.09 41.69 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.241 0 N-CA-C 107.62 -1.252 . . . . 0.0 107.62 171.262 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 30.5 m -129.27 132.48 47.19 Favored 'General case' 0 C--N 1.332 -0.182 0 C-N-CA 124.703 1.201 . . . . 0.0 108.427 -175.771 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.475 HD21 ' HG2' ' A' ' 22' ' ' ARG . 27.7 mt -75.25 135.73 40.97 Favored 'General case' 0 N--CA 1.456 -0.161 0 N-CA-C 107.999 -1.111 . . . . 0.0 107.999 175.432 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 28.5 t-80 -126.19 59.48 1.33 Allowed 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 125.148 1.379 . . . . 0.0 107.416 -176.811 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 33.3 t30 -69.55 113.26 6.67 Favored 'General case' 0 C--O 1.235 0.307 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 -176.296 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 77.6 mt -69.0 -14.89 63.31 Favored 'General case' 0 C--O 1.234 0.289 0 N-CA-C 112.554 0.576 . . . . 0.0 112.554 -171.775 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 1.3 tmtm? -58.81 -20.6 51.66 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 118.843 0.747 . . . . 0.0 111.173 168.82 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -128.03 -41.68 1.6 Allowed 'General case' 0 C--O 1.234 0.255 0 N-CA-C 113.287 0.847 . . . . 0.0 113.287 -175.801 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 30.5 m-20 -91.72 144.17 25.79 Favored 'General case' 0 C--O 1.235 0.301 0 C-N-CA 123.696 0.798 . . . . 0.0 111.07 -174.508 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 14.8 m -79.39 155.47 76.54 Favored Pre-proline 0 CA--C 1.539 0.551 0 C-N-CA 124.563 1.145 . . . . 0.0 110.258 176.361 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -76.93 -26.27 8.12 Favored 'Trans proline' 0 C--N 1.348 0.519 0 C-N-CA 122.232 1.955 . . . . 0.0 113.945 -171.082 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 8.2 mptt -62.64 -21.02 65.38 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 120.236 1.38 . . . . 0.0 111.8 -177.92 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -57.75 -29.74 65.04 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 125.865 1.666 . . . . 0.0 110.5 173.877 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 47.1 mtt -60.22 -26.21 66.23 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 118.763 0.71 . . . . 0.0 111.385 177.84 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 58.6 mt-10 -66.48 -33.51 75.85 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 118.714 0.688 . . . . 0.0 110.471 -176.651 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 24.3 mt-30 -63.77 -45.8 88.15 Favored 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 123.778 0.831 . . . . 0.0 112.868 -169.406 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 45.9 m-85 -76.24 136.02 39.67 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 115.393 -0.821 . . . . 0.0 109.473 -166.82 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -72.48 -30.19 64.31 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 118.865 0.757 . . . . 0.0 110.473 178.374 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 45.0 t -106.16 141.83 20.54 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.368 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 171.517 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 26.6 tp -136.82 118.46 14.95 Favored 'General case' 0 N--CA 1.446 -0.664 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 173.167 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 11.7 mt -93.61 133.48 34.54 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.829 0 N-CA-C 106.37 -1.715 . . . . 0.0 106.37 174.678 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 1.3 mp -111.23 134.07 53.1 Favored 'General case' 0 CA--C 1.518 -0.273 0 N-CA-C 106.703 -1.591 . . . . 0.0 106.703 -177.665 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -130.2 137.43 9.51 Favored Glycine 0 CA--C 1.518 0.257 0 N-CA-C 109.96 -1.256 . . . . 0.0 109.96 173.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 2.3 tt -151.57 133.86 8.45 Favored Pre-proline 0 CA--C 1.541 0.604 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 169.491 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_endo -82.38 -21.64 5.23 Favored 'Trans proline' 0 CA--C 1.538 0.703 0 C-N-CA 121.576 1.517 . . . . 0.0 114.521 -170.512 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 58.9 m 61.67 -62.9 0.09 Allowed 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 126.712 2.005 . . . . 0.0 112.261 -168.632 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 2.1 t90 65.72 169.35 0.21 Allowed 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 128.384 2.674 . . . . 0.0 115.335 171.096 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -65.05 109.02 2.0 Favored 'General case' 0 N--CA 1.466 0.342 0 C-N-CA 125.61 1.564 . . . . 0.0 111.409 -171.309 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 29.7 t80 48.8 25.87 1.14 Allowed 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 124.944 1.298 . . . . 0.0 111.563 -169.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -85.0 176.38 50.58 Favored Glycine 0 N--CA 1.443 -0.842 0 C-N-CA 124.287 0.946 . . . . 0.0 110.744 -178.623 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -150.17 170.15 19.61 Favored 'General case' 0 C--O 1.238 0.492 0 N-CA-C 106.429 -1.693 . . . . 0.0 106.429 174.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 24.8 mt -44.88 128.99 1.63 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.635 0 C-N-CA 124.849 1.26 . . . . 0.0 108.175 167.887 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -93.27 161.61 14.33 Favored 'General case' 0 C--O 1.231 0.122 0 C-N-CA 124.313 1.045 . . . . 0.0 109.929 -178.724 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -54.56 -41.56 69.95 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 124.436 1.094 . . . . 0.0 111.63 -169.285 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 27.5 m-20 -59.71 -27.64 66.64 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-N 118.453 0.57 . . . . 0.0 112.026 -176.785 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' TRP . . . . . 0.464 ' CH2' HD23 ' A' ' 104' ' ' LEU . 4.5 t90 -96.49 -44.86 6.99 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 125.688 1.595 . . . . 0.0 109.479 -178.069 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -63.02 -36.72 84.51 Favored 'General case' 0 CA--C 1.53 0.199 0 O-C-N 121.013 -1.054 . . . . 0.0 110.221 -179.177 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -61.12 -25.57 67.07 Favored 'General case' 0 C--O 1.234 0.268 0 C-N-CA 123.356 0.662 . . . . 0.0 111.015 -177.481 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 23.5 m -106.41 -17.97 7.41 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.539 0 CA-C-O 116.581 -1.676 . . . . 0.0 112.535 176.402 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 18.2 t90 -54.99 -35.65 64.57 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 121.492 1.951 . . . . 0.0 110.995 -179.275 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -63.43 -28.92 70.31 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 125.249 1.42 . . . . 0.0 112.715 174.1 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 62.9 mt-30 -92.57 -25.37 18.37 Favored 'General case' 0 C--O 1.224 -0.287 0 C-N-CA 126.436 1.894 . . . . 0.0 111.31 -179.842 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 37.6 mt -64.16 -26.43 68.52 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 118.727 0.694 . . . . 0.0 110.361 179.927 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -76.59 -25.67 54.21 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 117.794 0.27 . . . . 0.0 110.824 171.463 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -79.55 -33.38 41.93 Favored 'General case' 0 CA--C 1.538 0.494 0 O-C-N 121.257 -0.902 . . . . 0.0 113.049 179.403 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 30.6 mt -56.37 148.67 18.35 Favored 'General case' 0 C--O 1.234 0.265 0 C-N-CA 124.75 1.22 . . . . 0.0 111.02 -177.876 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 20.5 t-20 -86.03 122.88 30.68 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 170.325 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 74.2 mt -130.43 8.78 5.06 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 123.622 0.769 . . . . 0.0 112.222 -173.328 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 29.1 mt-10 -53.52 128.46 29.02 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 124.038 0.935 . . . . 0.0 112.256 -168.418 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 68.13 -0.26 12.42 Favored Glycine 0 CA--C 1.533 1.195 0 C-N-CA 125.443 1.497 . . . . 0.0 115.293 177.92 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.92 149.71 43.17 Favored 'General case' 0 C--N 1.343 0.308 0 CA-C-N 120.388 2.094 . . . . 0.0 109.635 -173.178 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 3.1 mt -80.56 133.33 29.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 N-CA-C 106.596 -1.631 . . . . 0.0 106.596 179.916 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 79.8 t -129.3 140.06 50.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 C-N-CA 124.122 0.969 . . . . 0.0 109.877 -176.93 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -128.42 154.31 46.17 Favored 'General case' 0 CA--C 1.53 0.173 0 C-N-CA 124.809 1.244 . . . . 0.0 108.052 169.795 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 2.4 mt -132.08 131.68 42.62 Favored 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 124.744 1.218 . . . . 0.0 108.334 -171.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.41 ' CD2' HD23 ' A' ' 142' ' ' LEU . 45.3 m-85 -130.28 141.93 50.58 Favored 'General case' 0 N--CA 1.451 -0.385 0 N-CA-C 106.643 -1.614 . . . . 0.0 106.643 -177.771 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -157.55 172.27 34.86 Favored Glycine 0 N--CA 1.442 -0.92 0 N-CA-C 108.965 -1.654 . . . . 0.0 108.965 168.502 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -119.94 162.7 18.75 Favored 'General case' 0 C--N 1.324 -0.537 0 C-N-CA 124.527 1.131 . . . . 0.0 109.54 170.149 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -157.98 132.6 3.2 Favored Glycine 0 N--CA 1.443 -0.852 0 N-CA-C 107.362 -2.295 . . . . 0.0 107.362 169.531 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 17.1 t0 -89.95 119.78 30.6 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 108.24 -1.022 . . . . 0.0 108.24 173.333 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 13.3 pt20 -65.5 -22.23 66.71 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 124.2 1.0 . . . . 0.0 112.056 178.372 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 13.9 mt -86.16 -58.9 2.45 Favored 'General case' 0 C--N 1.342 0.259 0 CA-C-N 118.981 0.809 . . . . 0.0 111.287 -174.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -67.4 -36.58 89.27 Favored Glycine 0 CA--C 1.525 0.659 0 C-N-CA 124.231 0.919 . . . . 0.0 113.242 -169.153 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 2.7 p90 -136.2 -71.85 0.46 Allowed 'General case' 0 CA--C 1.52 -0.208 0 N-CA-C 108.215 -1.032 . . . . 0.0 108.215 -178.457 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 76.81 -40.1 1.6 Allowed Glycine 0 CA--C 1.529 0.951 0 C-N-CA 124.589 1.09 . . . . 0.0 112.334 172.295 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -59.03 -42.49 90.31 Favored 'General case' 0 CA--C 1.528 0.117 0 CA-C-N 118.557 1.178 . . . . 0.0 109.644 174.955 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' TRP . . . . . . . . . . . . . 2.9 m0 -92.64 26.81 2.53 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 125.392 1.477 . . . . 0.0 111.809 -177.675 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 34.7 t80 -49.26 125.88 11.79 Favored 'General case' 0 N--CA 1.465 0.313 0 N-CA-C 107.942 -1.133 . . . . 0.0 107.942 174.36 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 84.4 mt 55.71 20.77 4.18 Favored 'General case' 0 CA--C 1.537 0.47 0 N-CA-C 113.668 0.988 . . . . 0.0 113.668 173.836 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -56.51 -42.73 78.87 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 120.394 1.452 . . . . 0.0 112.592 -168.468 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -80.95 -14.87 57.57 Favored 'General case' 0 CA--C 1.534 0.329 0 N-CA-C 113.389 0.885 . . . . 0.0 113.389 179.786 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 6.6 tt -60.58 -43.55 97.2 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-N 120.056 1.298 . . . . 0.0 107.911 169.24 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -66.75 -32.7 82.03 Favored Glycine 0 C--N 1.337 0.595 0 N-CA-C 112.031 -0.428 . . . . 0.0 112.031 -175.52 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 77.2 mtm -72.37 -26.9 62.08 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-O 118.363 -0.827 . . . . 0.0 111.796 -175.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.464 HD23 ' CH2' ' A' ' 65' ' ' TRP . 0.2 OUTLIER -76.41 -43.17 41.6 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 120.365 1.439 . . . . 0.0 109.372 169.019 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 82.1 t60 -53.34 -47.98 68.9 Favored 'General case' 0 N--CA 1.467 0.393 0 O-C-N 121.758 -0.589 . . . . 0.0 110.974 179.632 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -62.68 -37.24 85.68 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 123.676 0.79 . . . . 0.0 112.682 -177.505 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 25.1 ttmm -58.41 -36.41 73.54 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 123.575 0.75 . . . . 0.0 110.484 172.485 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 24.0 mt -91.95 -20.14 21.69 Favored 'General case' 0 CA--C 1.513 -0.453 0 N-CA-C 115.95 1.833 . . . . 0.0 115.95 -168.158 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 3.2 m -58.28 -32.97 68.92 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 120.665 1.575 . . . . 0.0 111.632 -176.433 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 21.1 p -88.27 -10.66 48.89 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 125.23 1.412 . . . . 0.0 112.409 -179.883 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 32.4 mmmt -82.99 -9.25 59.37 Favored 'General case' 0 C--N 1.347 0.458 0 C-N-CA 124.494 1.117 . . . . 0.0 111.435 175.169 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 73.81 31.93 59.67 Favored Glycine 0 CA--C 1.525 0.663 0 CA-C-O 119.645 -0.531 . . . . 0.0 112.165 172.99 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 5.8 m -73.25 174.44 0.78 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.618 0 CA-C-N 118.219 1.009 . . . . 0.0 109.158 169.748 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -115.63 131.28 56.98 Favored 'General case' 0 CA--C 1.518 -0.265 0 N-CA-C 106.909 -1.515 . . . . 0.0 106.909 172.772 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 80.3 m-85 -96.48 148.29 22.96 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 119.677 1.126 . . . . 0.0 109.384 -179.722 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 31.3 m -126.37 163.91 27.47 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.263 0 C-N-CA 123.847 0.859 . . . . 0.0 109.799 172.006 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 86.91 -91.34 1.73 Allowed Glycine 0 N--CA 1.444 -0.817 0 C-N-CA 124.996 1.284 . . . . 0.0 112.292 172.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 16.8 m-30 59.68 170.49 0.08 Allowed 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 126.081 1.752 . . . . 0.0 110.251 -165.599 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -141.09 140.86 21.94 Favored Pre-proline 0 N--CA 1.471 0.58 0 O-C-N 120.442 -1.411 . . . . 0.0 109.479 174.033 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_exo -54.51 129.12 33.16 Favored 'Trans proline' 0 N--CA 1.456 -0.731 0 C-N-CA 122.622 2.215 . . . . 0.0 110.65 169.796 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 20.7 p -70.74 -16.99 62.81 Favored 'General case' 0 N--CA 1.47 0.564 0 N-CA-C 112.465 0.542 . . . . 0.0 112.465 171.681 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -59.55 132.32 53.62 Favored 'General case' 0 C--O 1.237 0.4 0 C-N-CA 123.918 0.887 . . . . 0.0 109.775 -175.344 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 86.79 -9.62 71.01 Favored Glycine 0 CA--C 1.533 1.195 0 CA-C-O 118.509 -1.161 . . . . 0.0 113.963 178.878 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 42.7 m-85 -94.35 156.13 16.65 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-N 119.25 1.525 . . . . 0.0 110.173 171.703 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -123.03 127.27 48.55 Favored 'General case' 0 CA--C 1.531 0.243 0 N-CA-C 106.796 -1.557 . . . . 0.0 106.796 171.664 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 46.5 p90 -164.86 156.64 15.47 Favored 'General case' 0 C--O 1.237 0.446 0 C-N-CA 126.301 1.84 . . . . 0.0 106.263 -170.237 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 25.8 m -126.25 -38.64 2.12 Favored 'General case' 0 N--CA 1.446 -0.667 0 CA-C-N 118.607 0.64 . . . . 0.0 111.596 -171.24 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 41.8 t -59.45 135.54 88.86 Favored Pre-proline 0 CA--C 1.539 0.529 0 CA-C-N 118.145 0.429 . . . . 0.0 110.036 177.354 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_endo -82.38 -13.5 9.83 Favored 'Trans proline' 0 N--CA 1.455 -0.755 0 C-N-CA 122.869 2.379 . . . . 0.0 112.186 172.636 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 54.3 mttt -54.92 -48.1 96.72 Favored Pre-proline 0 CA--C 1.54 0.582 0 CA-C-N 119.888 1.222 . . . . 0.0 112.256 -170.848 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -86.07 11.75 3.23 Favored 'Trans proline' 0 C--N 1.35 0.642 0 C-N-CA 122.001 1.801 . . . . 0.0 113.742 -172.725 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 21.9 m -129.54 161.26 39.4 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.171 0 CA-C-N 120.629 1.559 . . . . 0.0 111.797 -175.155 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 21.5 pt -132.92 173.16 15.26 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.344 0 C-N-CA 127.151 2.18 . . . . 0.0 108.988 -179.788 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . 54.12 43.43 30.7 Favored 'General case' 0 N--CA 1.461 0.112 0 C-N-CA 125.406 1.482 . . . . 0.0 112.07 174.93 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 27.3 t0 54.0 43.44 30.79 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 126.609 1.964 . . . . 0.0 111.603 -176.785 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 87.6 29.5 21.3 Favored Glycine 0 CA--C 1.526 0.77 0 CA-C-O 118.207 -1.329 . . . . 0.0 113.635 171.559 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 47.3 mt-30 -95.54 -23.39 17.1 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 119.141 1.471 . . . . 0.0 113.201 179.201 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -138.79 141.0 38.78 Favored 'General case' 0 CA--C 1.513 -0.477 0 CA-C-N 119.641 1.11 . . . . 0.0 110.56 176.026 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 67.5 m-85 -76.98 138.27 39.52 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 105.106 -2.183 . . . . 0.0 105.106 164.257 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 25.7 m -76.74 4.43 1.17 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.643 0 C-N-CA 123.188 0.595 . . . . 0.0 112.067 -177.945 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -168.5 -174.19 37.01 Favored Glycine 0 CA--C 1.523 0.537 0 C-N-CA 125.742 1.639 . . . . 0.0 109.16 -175.806 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.41 HD23 ' CD2' ' A' ' 85' ' ' TYR . 29.4 tp -75.06 140.95 43.86 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 122.892 0.477 . . . . 0.0 111.722 -171.739 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -89.43 132.71 34.87 Favored 'General case' 0 N--CA 1.447 -0.586 0 C-N-CA 125.876 1.67 . . . . 0.0 109.081 169.2 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 89.9 mt -136.81 141.33 42.89 Favored 'General case' 0 N--CA 1.467 0.425 0 N-CA-C 106.643 -1.614 . . . . 0.0 106.643 172.222 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -104.26 -57.02 2.09 Favored 'General case' 0 C--O 1.233 0.202 0 C-N-CA 123.545 0.738 . . . . 0.0 110.649 -176.835 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 46.69 38.17 5.46 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 125.806 1.643 . . . . 0.0 114.611 174.862 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 53.7 m -136.45 -39.9 0.65 Allowed 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 124.911 1.284 . . . . 0.0 109.81 169.055 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 20.2 m-80 -121.44 -36.93 2.98 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 126.393 1.877 . . . . 0.0 110.912 -166.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 34.0 mt-30 -127.56 52.23 1.85 Allowed 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 126.173 1.789 . . . . 0.0 109.786 -168.555 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -56.92 -38.36 72.75 Favored 'General case' 0 N--CA 1.468 0.471 0 O-C-N 121.205 -0.934 . . . . 0.0 111.278 -177.441 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -66.86 -36.61 82.71 Favored 'General case' 0 N--CA 1.466 0.36 0 O-C-N 121.969 -0.457 . . . . 0.0 111.444 -179.44 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -80.92 -23.97 38.55 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-O 118.812 -0.614 . . . . 0.0 110.927 177.619 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 47.9 m -68.77 -42.53 77.33 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 119.008 0.822 . . . . 0.0 109.745 170.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -60.12 -44.59 94.78 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 123.431 0.693 . . . . 0.0 110.497 174.154 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 27.3 tt0 -58.46 -46.89 85.68 Favored 'General case' 0 C--O 1.231 0.09 0 C-N-CA 124.171 0.989 . . . . 0.0 110.435 174.367 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.29 -46.24 86.45 Favored 'General case' 0 C--O 1.225 -0.224 0 CA-C-O 117.959 -1.019 . . . . 0.0 109.554 179.023 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 47.6 mt -60.45 -52.44 61.4 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.233 0 CA-C-N 119.687 1.131 . . . . 0.0 108.038 176.928 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 72.7 tp60 -53.29 -65.11 0.62 Allowed 'General case' 0 C--O 1.232 0.155 0 CA-C-N 119.23 0.923 . . . . 0.0 112.073 -177.151 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 19.9 m -68.75 -32.36 72.07 Favored 'General case' 0 C--N 1.325 -0.489 0 C-N-CA 121.4 -0.12 . . . . 0.0 111.309 -168.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 160' ' ' TRP . . . . . . . . . . . . . 2.8 t90 -73.13 -41.77 63.6 Favored 'General case' 0 C--O 1.221 -0.423 0 CA-C-O 118.977 -0.535 . . . . 0.0 110.618 177.465 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 23.2 m -55.47 -47.84 75.47 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 118.519 0.599 . . . . 0.0 110.343 173.387 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 162' ' ' GLU . . . . . 0.4 ' HA ' HD23 ' A' ' 165' ' ' LEU . 40.3 mt-10 -60.3 -43.36 96.38 Favored 'General case' 0 C--N 1.332 -0.156 0 N-CA-C 109.681 -0.488 . . . . 0.0 109.681 178.752 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 15.0 tt0 -63.29 -51.71 64.96 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-O 117.904 -1.046 . . . . 0.0 110.383 -178.182 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 39.7 pt -64.15 -33.06 60.01 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.412 0 CA-C-O 118.127 -0.94 . . . . 0.0 109.441 -175.829 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . 0.4 HD23 ' HA ' ' A' ' 162' ' ' GLU . 0.3 OUTLIER -72.82 -31.45 64.82 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 119.395 0.998 . . . . 0.0 108.856 -174.375 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -71.53 -52.1 20.04 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 124.692 1.197 . . . . 0.0 109.084 173.277 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -67.7 -35.3 78.56 Favored 'General case' 0 N--CA 1.441 -0.883 0 C-N-CA 125.78 1.632 . . . . 0.0 109.425 -169.485 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 168' ' ' MET . . . . . . . . . . . . . 21.5 ptp -73.03 -29.11 62.76 Favored 'General case' 0 C--N 1.333 -0.128 0 O-C-N 122.28 -0.262 . . . . 0.0 111.583 176.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -75.62 -36.56 60.21 Favored 'General case' 0 N--CA 1.444 -0.726 0 CA-C-O 119.16 -0.448 . . . . 0.0 111.779 178.2 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 5.8 mt-10 -64.17 -36.98 85.82 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-O 122.248 1.023 . . . . 0.0 109.275 178.486 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 61.2 t60 -64.33 -25.76 68.18 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 124.966 1.306 . . . . 0.0 110.936 177.391 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -78.87 -44.71 22.27 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 124.363 1.065 . . . . 0.0 111.721 174.767 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.254 1.312 0 C-N-CA 124.907 1.283 . . . . 0.0 109.602 -174.594 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.498 1.964 0 CA-C-O 120.322 0.106 . . . . 0.0 111.197 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 24.8 p-10 -120.61 165.95 14.33 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 125.082 1.353 . . . . 0.0 111.512 -175.333 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 11.9 mtt -130.27 133.91 46.84 Favored 'General case' 0 CA--C 1.52 -0.195 0 C-N-CA 123.361 0.665 . . . . 0.0 110.507 175.625 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -100.48 142.42 15.84 Favored Glycine 0 CA--C 1.523 0.559 0 N-CA-C 106.769 -2.532 . . . . 0.0 106.769 167.538 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 2.2 tt -128.22 101.15 6.12 Favored 'General case' 0 CA--C 1.518 -0.252 0 N-CA-C 105.852 -1.907 . . . . 0.0 105.852 -172.899 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -102.49 144.26 31.16 Favored 'General case' 0 N--CA 1.455 -0.216 0 CA-C-O 121.588 0.709 . . . . 0.0 111.672 -173.809 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 43.7 p90 -160.02 179.7 8.53 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 127.04 2.136 . . . . 0.0 106.489 175.0 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 174.46 74.73 0.05 OUTLIER Glycine 0 N--CA 1.464 0.511 0 N-CA-C 109.388 -1.485 . . . . 0.0 109.388 175.881 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 38.0 m -150.03 132.64 15.81 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 117.717 0.759 . . . . 0.0 109.361 -175.141 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 14.7 m -93.06 -37.07 12.36 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 123.717 0.807 . . . . 0.0 110.757 174.778 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 3.7 m -67.09 124.2 22.4 Favored 'General case' 0 CA--C 1.533 0.292 0 N-CA-C 107.215 -1.402 . . . . 0.0 107.215 174.442 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 58.0 m 47.17 57.18 5.99 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 124.494 1.118 . . . . 0.0 110.05 -170.695 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 19.9 p90 -45.9 128.36 8.91 Favored 'General case' 0 C--N 1.343 0.288 0 C-N-CA 125.132 1.373 . . . . 0.0 113.361 -168.292 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 2.8 m -80.76 -6.53 58.62 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 124.207 1.003 . . . . 0.0 112.21 -169.842 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -55.95 -36.51 67.88 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 124.457 1.103 . . . . 0.0 111.545 -174.631 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 30.0 mmt -67.82 -43.27 79.99 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 118.541 0.61 . . . . 0.0 110.323 -177.842 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -64.1 -45.39 88.85 Favored 'General case' 0 N--CA 1.462 0.168 0 N-CA-C 109.03 -0.729 . . . . 0.0 109.03 176.321 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -64.02 -47.45 80.22 Favored 'General case' 0 N--CA 1.455 -0.19 0 C-N-CA 122.921 0.489 . . . . 0.0 111.54 -175.276 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 10.2 mt-10 -60.95 -42.99 99.33 Favored 'General case' 0 CA--C 1.517 -0.309 0 CA-C-O 118.903 -0.57 . . . . 0.0 109.949 176.678 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 29.3 mtpp -71.14 -40.67 71.22 Favored 'General case' 0 C--O 1.221 -0.435 0 CA-C-O 118.057 -0.973 . . . . 0.0 110.775 -174.132 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 47.6 mt -53.81 -54.27 20.92 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.267 0 CA-C-N 120.014 1.279 . . . . 0.0 108.818 173.07 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 8.5 ttp180 -60.56 -41.07 93.82 Favored 'General case' 0 C--O 1.223 -0.298 0 C-N-CA 123.397 0.679 . . . . 0.0 109.65 -176.703 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -66.74 -41.17 88.25 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 122.945 0.498 . . . . 0.0 111.066 -178.894 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.617 HD13 ' HA ' ' A' ' 158' ' ' GLN . 41.0 mt -68.76 -56.18 13.13 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.57 0 C-N-CA 124.345 1.058 . . . . 0.0 109.691 -175.61 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 79.0 mt -67.89 -44.23 85.4 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.428 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 -175.649 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 138.55 125.39 2.32 Favored Glycine 0 CA--C 1.53 1.022 0 C-N-CA 125.061 1.315 . . . . 0.0 111.493 173.22 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -71.95 -6.21 18.66 Favored 'Trans proline' 0 CA--C 1.537 0.666 0 C-N-CA 123.505 2.803 . . . . 0.0 114.044 -175.674 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -80.15 -18.63 49.23 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 119.232 0.924 . . . . 0.0 111.241 175.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -128.66 -10.1 5.03 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 124.532 1.133 . . . . 0.0 113.994 -173.803 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 31.5 t -106.97 150.07 9.84 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.352 0 CA-C-N 119.375 0.989 . . . . 0.0 108.346 170.702 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 2.7 m -137.23 130.97 31.74 Favored 'General case' 0 N--CA 1.456 -0.174 0 N-CA-C 106.599 -1.63 . . . . 0.0 106.599 -172.909 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 21.3 mt -80.46 143.71 33.16 Favored 'General case' 0 CA--C 1.53 0.202 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 176.916 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . 0.465 ' HE2' ' HB2' ' A' ' 42' ' ' LEU . 39.0 t-80 -136.77 64.88 1.53 Allowed 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 124.451 1.1 . . . . 0.0 108.195 -174.554 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 64.4 t-20 -72.39 119.12 16.15 Favored 'General case' 0 CA--C 1.53 0.193 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 -178.407 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 81.9 mt -66.06 -18.31 65.26 Favored 'General case' 0 C--O 1.233 0.206 0 C-N-CA 123.782 0.833 . . . . 0.0 112.918 -176.839 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 28.3 tptp -55.35 -27.12 45.19 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-O 118.879 -0.581 . . . . 0.0 111.156 168.654 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -121.47 -41.45 2.49 Favored 'General case' 0 N--CA 1.464 0.271 0 N-CA-C 113.549 0.944 . . . . 0.0 113.549 -173.856 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 29.6 m-20 -96.53 142.29 28.78 Favored 'General case' 0 C--O 1.234 0.276 0 C-N-CA 123.334 0.654 . . . . 0.0 110.702 -176.151 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 14.0 m -75.97 156.27 84.31 Favored Pre-proline 0 CA--C 1.542 0.646 0 C-N-CA 124.181 0.992 . . . . 0.0 109.986 173.632 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo -77.27 -25.1 8.79 Favored 'Trans proline' 0 C--N 1.348 0.533 0 C-N-CA 122.212 1.941 . . . . 0.0 113.312 -169.785 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 23.7 mmmt -69.38 -15.26 63.27 Favored 'General case' 0 N--CA 1.474 0.758 0 O-C-N 120.512 -1.368 . . . . 0.0 111.693 -176.029 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.465 ' HB2' ' HE2' ' A' ' 33' ' ' HIS . 2.1 mm? -62.01 -26.82 68.46 Favored 'General case' 0 N--CA 1.464 0.263 0 C-N-CA 125.555 1.542 . . . . 0.0 110.603 169.426 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 51.3 mtt -58.99 -25.29 63.5 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 119.207 0.912 . . . . 0.0 111.48 177.308 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -64.06 -31.83 73.17 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 118.395 0.543 . . . . 0.0 110.127 -176.535 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 27.3 mt-30 -67.05 -38.79 86.46 Favored 'General case' 0 CA--C 1.534 0.364 0 N-CA-C 113.302 0.852 . . . . 0.0 113.302 -170.873 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 61.0 m-85 -76.08 136.25 39.88 Favored 'General case' 0 CA--C 1.52 -0.202 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 -167.49 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -71.84 -37.75 70.23 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-N 118.281 0.491 . . . . 0.0 110.576 -178.349 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 15.4 t -107.22 144.95 15.26 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.364 0 N-CA-C 107.52 -1.289 . . . . 0.0 107.52 169.003 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 28.8 tp -132.97 120.29 21.22 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 175.098 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 48.3 mt -99.41 129.25 50.19 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.606 0 N-CA-C 106.47 -1.678 . . . . 0.0 106.47 179.774 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -110.13 132.47 54.14 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 125.539 1.536 . . . . 0.0 107.793 -175.342 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -138.44 138.73 9.71 Favored Glycine 0 C--N 1.332 0.346 0 N-CA-C 109.821 -1.312 . . . . 0.0 109.821 178.233 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.427 HD12 ' CD2' ' A' ' 65' ' ' TRP . 3.9 tt -155.75 133.46 6.75 Favored Pre-proline 0 CA--C 1.535 0.37 0 CA-C-N 117.555 0.677 . . . . 0.0 111.164 172.805 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_exo -75.24 127.39 10.48 Favored 'Trans proline' 0 N--CA 1.456 -0.704 0 C-N-CA 122.376 2.051 . . . . 0.0 109.197 164.06 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 20.9 m -97.81 106.96 19.34 Favored 'General case' 0 CA--C 1.535 0.383 0 N-CA-C 104.434 -2.432 . . . . 0.0 104.434 167.084 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 2.6 t90 -91.98 169.36 10.71 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-O 121.021 0.438 . . . . 0.0 111.402 -175.443 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -63.14 -30.2 71.4 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 124.972 1.309 . . . . 0.0 113.062 -172.075 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 84.4 t80 -139.24 155.34 47.85 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 124.788 1.235 . . . . 0.0 109.555 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 74.24 2.65 63.24 Favored Glycine 0 CA--C 1.534 1.273 0 CA-C-O 118.178 -1.346 . . . . 0.0 114.765 170.483 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . 0.273 10.7 pt-20 45.76 -153.87 0.05 OUTLIER 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 126.55 1.94 . . . . 0.0 112.692 -177.928 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 12.8 mt -27.75 129.43 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.543 0.682 0 C-N-CA 128.894 2.878 . . . . 0.0 112.289 170.002 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 4.1 mp0 -72.59 153.99 41.0 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 124.836 1.254 . . . . 0.0 109.828 179.421 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -59.07 -42.84 91.35 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 123.338 0.655 . . . . 0.0 111.593 -170.255 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -60.54 -24.67 65.55 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 123.591 0.757 . . . . 0.0 111.95 -177.639 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' TRP . . . . . 0.433 ' CH2' HD22 ' A' ' 104' ' ' LEU . 1.8 t90 -96.04 -42.63 8.16 Favored 'General case' 0 N--CA 1.447 -0.588 0 C-N-CA 124.695 1.198 . . . . 0.0 109.773 -178.425 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 7.8 tt0 -63.14 -33.86 76.38 Favored 'General case' 0 N--CA 1.446 -0.665 0 O-C-N 120.749 -1.219 . . . . 0.0 109.868 178.708 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -55.82 -24.65 37.47 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 124.333 1.053 . . . . 0.0 111.965 -179.497 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 35.3 m -116.84 -11.42 11.81 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.171 0 CA-C-O 117.596 -1.192 . . . . 0.0 113.179 178.245 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 25.0 t90 -52.87 -38.28 61.41 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 119.959 1.254 . . . . 0.0 110.435 -178.891 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -64.6 -27.11 68.72 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 125.361 1.464 . . . . 0.0 113.303 177.041 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 30.0 mt-30 -92.6 -19.41 21.93 Favored 'General case' 0 C--N 1.342 0.244 0 C-N-CA 125.309 1.443 . . . . 0.0 112.617 178.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 60.1 mt -59.55 -25.94 64.96 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 118.633 0.651 . . . . 0.0 111.137 -178.414 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -77.1 -25.15 51.92 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 118.085 0.402 . . . . 0.0 111.626 176.704 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -72.98 -29.98 63.47 Favored 'General case' 0 N--CA 1.467 0.376 0 O-C-N 121.058 -1.026 . . . . 0.0 111.828 178.866 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 76.5 mt -53.62 139.86 30.65 Favored 'General case' 0 C--N 1.341 0.218 0 C-N-CA 125.016 1.326 . . . . 0.0 112.289 -169.008 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 28.8 t-20 -77.2 107.44 9.6 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 169.707 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 65.2 mt -127.6 1.48 6.18 Favored 'General case' 0 N--CA 1.474 0.734 0 N-CA-C 113.912 1.079 . . . . 0.0 113.912 -173.237 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -51.87 129.16 26.04 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-N 119.228 0.922 . . . . 0.0 111.482 -168.442 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 70.63 -2.0 18.69 Favored Glycine 0 CA--C 1.535 1.326 0 C-N-CA 125.935 1.731 . . . . 0.0 115.972 177.523 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.05 151.85 38.67 Favored 'General case' 0 C--N 1.344 0.366 0 CA-C-N 121.002 2.401 . . . . 0.0 110.53 -172.097 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 6.7 mt -81.1 137.49 21.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 N-CA-C 106.676 -1.601 . . . . 0.0 106.676 178.849 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 78.0 t -134.68 136.4 52.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 C-N-CA 123.729 0.812 . . . . 0.0 110.235 -174.365 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -110.82 150.77 28.67 Favored 'General case' 0 N--CA 1.468 0.45 0 N-CA-C 107.878 -1.156 . . . . 0.0 107.878 169.257 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 2.8 mt -130.87 136.54 48.72 Favored 'General case' 0 CA--C 1.51 -0.562 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 174.603 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 43.6 p90 -147.42 166.82 26.06 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 168.669 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -162.46 160.03 32.27 Favored Glycine 0 N--CA 1.447 -0.582 0 N-CA-C 109.811 -1.316 . . . . 0.0 109.811 172.416 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 4.1 tt -112.15 151.6 29.29 Favored 'General case' 0 N--CA 1.448 -0.553 0 C-N-CA 125.457 1.503 . . . . 0.0 108.001 173.934 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -171.75 -155.96 11.52 Favored Glycine 0 CA--C 1.52 0.403 0 N-CA-C 109.89 -1.284 . . . . 0.0 109.89 169.787 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 5.2 t0 -138.54 131.63 29.88 Favored 'General case' 0 C--O 1.234 0.244 0 C-N-CA 124.116 0.966 . . . . 0.0 108.802 172.86 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 3.4 pt20 -81.37 -14.41 57.25 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 124.221 1.009 . . . . 0.0 113.253 179.326 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 98.8 mt -88.76 -46.85 8.65 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 119.439 1.018 . . . . 0.0 112.503 -169.822 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -64.71 -33.22 86.65 Favored Glycine 0 CA--C 1.528 0.905 0 C-N-CA 123.767 0.699 . . . . 0.0 113.557 -169.494 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 5.8 t80 -148.97 -40.85 0.15 Allowed 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 117.785 0.793 . . . . 0.0 110.945 177.083 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 81.57 -39.3 2.51 Favored Glycine 0 C--N 1.336 0.565 0 C-N-CA 124.153 0.882 . . . . 0.0 112.288 173.511 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -64.05 -36.31 83.59 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 118.981 1.39 . . . . 0.0 109.722 174.952 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' TRP . . . . . . . . . . . . . 46.7 m0 -98.17 36.86 1.51 Allowed 'General case' 0 CA--C 1.539 0.528 0 O-C-N 121.358 -0.839 . . . . 0.0 111.352 174.589 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 12.0 t80 -61.27 -53.0 62.4 Favored 'General case' 0 N--CA 1.467 0.381 0 O-C-N 121.461 -0.774 . . . . 0.0 109.479 173.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 80.2 mt -141.79 27.84 1.81 Allowed 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 124.236 1.014 . . . . 0.0 110.111 -175.097 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -59.78 -33.77 72.14 Favored 'General case' 0 N--CA 1.467 0.376 0 O-C-N 120.581 -1.325 . . . . 0.0 111.944 -171.415 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . 0.421 ' HB1' HD13 ' A' ' 53' ' ' ILE . . . -73.45 -27.92 61.68 Favored 'General case' 0 CA--C 1.535 0.367 0 O-C-N 121.234 -0.916 . . . . 0.0 112.44 177.268 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 4.4 tt -60.67 -47.06 87.93 Favored 'General case' 0 N--CA 1.467 0.419 0 N-CA-C 107.458 -1.312 . . . . 0.0 107.458 169.065 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -62.31 -42.03 99.72 Favored Glycine 0 C--N 1.339 0.715 0 N-CA-C 111.44 -0.664 . . . . 0.0 111.44 -178.925 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 76.3 mtm -63.96 -38.37 90.82 Favored 'General case' 0 CA--C 1.529 0.166 0 CA-C-N 118.182 0.991 . . . . 0.0 111.726 179.564 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.433 HD22 ' CH2' ' A' ' 65' ' ' TRP . 4.2 tp -71.61 -35.45 70.48 Favored 'General case' 0 C--N 1.345 0.373 0 CA-C-N 120.247 1.385 . . . . 0.0 110.341 178.885 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' HIS . . . . . 0.415 ' CG ' HG21 ' A' ' 140' ' ' VAL . 0.2 OUTLIER -54.56 -51.65 64.55 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 118.899 0.772 . . . . 0.0 110.283 169.132 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -64.47 -42.77 95.71 Favored 'General case' 0 C--O 1.233 0.229 0 C-N-CA 122.754 0.422 . . . . 0.0 111.466 -172.289 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 22.5 ttmm -58.43 -39.36 79.6 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 123.897 0.879 . . . . 0.0 110.655 173.225 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 52.0 mt -87.11 -22.23 25.51 Favored 'General case' 0 CA--C 1.517 -0.29 0 N-CA-C 114.152 1.167 . . . . 0.0 114.152 -169.454 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 8.3 t -56.95 -36.24 70.03 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-N 119.393 0.997 . . . . 0.0 110.879 -175.673 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 21.1 p -86.21 -8.1 58.04 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 124.581 1.152 . . . . 0.0 112.2 -178.298 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 32.4 mmmt -83.15 -8.32 59.51 Favored 'General case' 0 C--N 1.346 0.441 0 C-N-CA 124.573 1.149 . . . . 0.0 111.709 175.393 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 74.7 29.11 61.85 Favored Glycine 0 CA--C 1.526 0.777 0 CA-C-N 118.424 0.557 . . . . 0.0 112.462 173.343 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 17.1 m -75.23 176.44 0.64 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 CA-C-N 117.957 0.879 . . . . 0.0 109.989 171.887 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -121.54 125.95 48.01 Favored 'General case' 0 CA--C 1.52 -0.208 0 N-CA-C 106.918 -1.512 . . . . 0.0 106.918 174.442 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 79.5 m-85 -89.5 145.03 25.57 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 119.562 1.074 . . . . 0.0 109.337 -178.649 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 27.3 m -126.68 157.86 37.41 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.212 0 C-N-CA 124.237 1.015 . . . . 0.0 109.084 171.149 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 95.38 -88.4 1.09 Allowed Glycine 0 C--N 1.333 0.364 0 CA-C-O 119.109 -0.829 . . . . 0.0 111.259 173.185 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 22.0 m-30 57.56 -173.49 0.08 Allowed 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 124.104 0.961 . . . . 0.0 110.446 -168.735 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -153.96 146.3 17.33 Favored Pre-proline 0 N--CA 1.473 0.69 0 CA-C-N 120.359 1.436 . . . . 0.0 109.656 178.952 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_endo -67.71 124.42 11.91 Favored 'Trans proline' 0 CA--C 1.535 0.568 0 C-N-CA 122.959 2.439 . . . . 0.0 112.121 178.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 2.9 p -77.87 -12.71 60.0 Favored 'General case' 0 CA--C 1.538 0.51 0 O-C-N 121.507 -0.746 . . . . 0.0 112.296 171.958 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -59.84 122.91 15.41 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 123.665 0.786 . . . . 0.0 109.934 -171.403 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 74.64 -0.09 57.28 Favored Glycine 0 CA--C 1.535 1.286 0 CA-C-O 118.563 -1.132 . . . . 0.0 114.066 179.146 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 2.2 t80 -82.87 154.7 24.51 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 119.345 1.572 . . . . 0.0 109.939 177.6 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -106.01 111.08 23.57 Favored 'General case' 0 CA--C 1.532 0.277 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 176.055 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 40.1 p90 -147.68 167.76 23.79 Favored 'General case' 0 C--O 1.236 0.391 0 C-N-CA 126.635 1.974 . . . . 0.0 107.404 178.457 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 14.7 t -143.48 -28.18 0.54 Allowed 'General case' 0 N--CA 1.468 0.433 0 N-CA-C 112.649 0.611 . . . . 0.0 112.649 -177.504 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 3.5 p -77.57 141.34 65.01 Favored Pre-proline 0 CA--C 1.539 0.548 0 CA-C-N 118.741 0.7 . . . . 0.0 109.7 -177.163 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -79.4 -28.01 3.89 Favored 'Trans proline' 0 CA--C 1.537 0.663 0 C-N-CA 122.506 2.138 . . . . 0.0 112.221 178.805 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 7.6 ttmt -61.03 -41.87 83.63 Favored Pre-proline 0 CA--C 1.542 0.647 0 CA-C-O 117.441 -1.266 . . . . 0.0 113.929 -171.784 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_endo -77.41 5.81 4.86 Favored 'Trans proline' 0 C--N 1.352 0.752 0 CA-C-N 122.012 1.754 . . . . 0.0 114.385 179.154 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 26.9 m -132.02 169.58 21.56 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.215 0 CA-C-N 120.411 1.459 . . . . 0.0 110.434 -176.844 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 23.0 pt -138.49 171.97 14.5 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.507 0 C-N-CA 126.768 2.027 . . . . 0.0 108.594 -177.606 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . 54.76 41.27 32.05 Favored 'General case' 0 CA--C 1.528 0.106 0 C-N-CA 125.081 1.352 . . . . 0.0 112.46 174.302 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 27.3 t70 55.7 42.15 29.63 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 126.187 1.795 . . . . 0.0 111.734 -176.121 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 88.19 15.6 60.46 Favored Glycine 0 CA--C 1.528 0.891 0 CA-C-O 118.93 -0.928 . . . . 0.0 113.679 174.446 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 45.4 mt-30 -88.46 -7.59 56.31 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 118.934 1.367 . . . . 0.0 112.524 -179.06 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 8.3 tp -155.44 146.05 22.13 Favored 'General case' 0 C--N 1.344 0.35 0 CA-C-N 119.241 0.928 . . . . 0.0 110.291 172.304 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 58.4 m-85 -76.9 144.1 39.14 Favored 'General case' 0 CA--C 1.514 -0.425 0 N-CA-C 107.472 -1.307 . . . . 0.0 107.472 169.294 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . 0.415 HG21 ' CG ' ' A' ' 105' ' ' HIS . 4.4 p -82.23 14.1 0.52 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.573 0 CA-C-O 121.159 0.504 . . . . 0.0 112.13 -179.6 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 178.47 172.42 42.83 Favored Glycine 0 CA--C 1.525 0.685 0 N-CA-C 110.009 -1.237 . . . . 0.0 110.009 176.623 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 1.1 tp -65.79 138.04 57.65 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 117.631 0.715 . . . . 0.0 110.883 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -98.89 114.38 26.96 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 125.941 1.697 . . . . 0.0 110.178 -179.931 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -104.87 144.45 31.76 Favored 'General case' 0 CA--C 1.537 0.457 0 N-CA-C 106.386 -1.709 . . . . 0.0 106.386 166.945 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -144.04 130.56 20.0 Favored 'General case' 0 CA--C 1.531 0.224 0 N-CA-C 107.186 -1.413 . . . . 0.0 107.186 171.2 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 44.7 mm-40 -120.73 21.91 11.33 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 124.254 1.022 . . . . 0.0 111.468 -174.942 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 57.6 m -115.5 -40.44 3.4 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 124.808 1.243 . . . . 0.0 109.555 172.803 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 4.3 m-80 -92.9 -31.84 14.8 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 125.068 1.347 . . . . 0.0 110.223 -171.376 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 68.3 mt-30 -134.01 156.16 48.7 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 126.314 1.846 . . . . 0.0 108.29 -175.023 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 98.4 m-85 -147.28 -48.76 0.18 Allowed 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 124.148 0.979 . . . . 0.0 109.94 -179.421 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -68.5 -43.97 75.7 Favored 'General case' 0 N--CA 1.465 0.32 0 O-C-N 122.162 -0.336 . . . . 0.0 111.818 -171.171 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -90.57 8.83 32.1 Favored 'General case' 0 N--CA 1.465 0.295 0 N-CA-C 113.577 0.955 . . . . 0.0 113.577 -175.338 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 21.9 m -64.12 -33.15 75.11 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 119.56 1.073 . . . . 0.0 110.283 175.375 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -61.23 -40.43 93.98 Favored 'General case' 0 N--CA 1.463 0.179 0 O-C-N 121.917 -0.489 . . . . 0.0 110.884 172.19 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 -65.95 -47.4 74.78 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 124.106 0.962 . . . . 0.0 110.505 179.396 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 75.5 mtt-85 -52.2 -46.01 65.44 Favored 'General case' 0 N--CA 1.463 0.19 0 C-N-CA 124.509 1.124 . . . . 0.0 110.397 176.415 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 30.6 mt -70.37 -53.71 21.7 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 N-CA-C 107.847 -1.168 . . . . 0.0 107.847 179.302 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 158' ' ' GLN . . . . . 0.617 ' HA ' HD13 ' A' ' 24' ' ' ILE . 68.7 tp60 -49.66 -64.77 0.71 Allowed 'General case' 0 C--O 1.233 0.22 0 C-N-CA 125.569 1.548 . . . . 0.0 112.202 -174.132 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 20.1 m -67.8 -31.86 72.02 Favored 'General case' 0 C--N 1.324 -0.512 0 C-N-CA 120.924 -0.31 . . . . 0.0 110.768 -169.075 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 160' ' ' TRP . . . . . . . . . . . . . 36.2 t90 -68.86 -44.2 73.83 Favored 'General case' 0 C--O 1.221 -0.407 0 O-C-N 122.128 -0.357 . . . . 0.0 110.914 176.455 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 87.8 m -60.68 -42.53 97.3 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 122.889 0.476 . . . . 0.0 110.636 177.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 162' ' ' GLU . . . . . 0.423 ' HA ' HD23 ' A' ' 165' ' ' LEU . 39.9 mt-10 -63.35 -40.95 98.68 Favored 'General case' 0 CA--C 1.529 0.148 0 CA-C-O 121.481 0.658 . . . . 0.0 110.041 175.153 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 13.7 tt0 -64.67 -49.08 72.35 Favored 'General case' 0 N--CA 1.451 -0.419 0 O-C-N 121.375 -0.828 . . . . 0.0 110.735 -178.798 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 45.7 pt -64.6 -38.88 83.78 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.348 0 CA-C-O 118.089 -0.958 . . . . 0.0 109.62 -176.265 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . 0.423 HD23 ' HA ' ' A' ' 162' ' ' GLU . 0.3 OUTLIER -64.93 -32.59 74.39 Favored 'General case' 0 CA--C 1.53 0.176 0 CA-C-N 118.913 0.779 . . . . 0.0 110.229 179.698 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 29.6 m-80 -67.71 -60.69 2.33 Favored 'General case' 0 C--O 1.221 -0.444 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 172.523 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -53.21 -43.93 67.62 Favored 'General case' 0 N--CA 1.441 -0.89 0 C-N-CA 126.965 2.106 . . . . 0.0 111.168 -171.247 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 168' ' ' MET . . . . . . . . . . . . . 19.7 ptp -70.92 -31.68 68.36 Favored 'General case' 0 C--N 1.333 -0.151 0 N-CA-C 112.143 0.423 . . . . 0.0 112.143 179.244 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -75.35 -35.28 61.19 Favored 'General case' 0 N--CA 1.445 -0.723 0 N-CA-C 111.74 0.274 . . . . 0.0 111.74 177.918 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -66.48 -32.99 74.71 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-O 121.579 0.704 . . . . 0.0 109.581 178.634 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 64.9 t60 -67.47 -27.05 66.7 Favored 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 124.868 1.267 . . . . 0.0 111.077 177.851 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 -76.87 -46.43 24.64 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 124.074 0.949 . . . . 0.0 111.55 170.189 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.254 1.309 0 C-N-CA 125.841 1.657 . . . . 0.0 110.571 -169.77 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.498 1.971 0 N-CA-C 111.108 0.04 . . . . 0.0 111.108 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 19.3 p-10 -128.68 163.83 24.25 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 124.843 1.257 . . . . 0.0 111.49 -171.948 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 10.2 mtt -129.15 133.19 47.5 Favored 'General case' 0 CA--C 1.521 -0.153 0 C-N-CA 123.385 0.674 . . . . 0.0 111.418 179.118 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -98.43 147.24 18.48 Favored Glycine 0 CA--C 1.53 1.007 0 N-CA-C 106.395 -2.682 . . . . 0.0 106.395 166.718 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 1.2 tt -133.67 96.7 3.74 Favored 'General case' 0 N--CA 1.465 0.315 0 N-CA-C 105.573 -2.01 . . . . 0.0 105.573 -173.028 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -97.36 146.75 24.87 Favored 'General case' 0 CA--C 1.514 -0.419 0 CA-C-N 118.03 0.377 . . . . 0.0 111.109 -173.635 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 34.2 p90 -158.18 163.53 37.44 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 124.471 1.108 . . . . 0.0 109.518 176.7 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -96.03 -157.34 31.69 Favored Glycine 0 C--N 1.333 0.415 0 C-N-CA 124.17 0.891 . . . . 0.0 111.969 -174.365 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 10.0 m 61.39 167.97 0.1 Allowed 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 126.494 1.917 . . . . 0.0 113.264 -177.073 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 5.8 p -144.06 -49.02 0.28 Allowed 'General case' 0 C--O 1.237 0.396 0 C-N-CA 124.425 1.09 . . . . 0.0 110.51 -179.621 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 8.2 p -69.71 -54.15 15.15 Favored 'General case' 0 CA--C 1.535 0.376 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 171.877 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 83.2 m -82.6 160.08 22.58 Favored 'General case' 0 CA--C 1.536 0.435 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 167.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 36.5 p90 -127.5 20.29 6.71 Favored 'General case' 0 CA--C 1.537 0.461 0 N-CA-C 112.945 0.72 . . . . 0.0 112.945 -169.693 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 86.5 m 59.66 28.99 18.53 Favored 'General case' 0 CA--C 1.55 0.976 0 C-N-CA 123.782 0.833 . . . . 0.0 111.906 -178.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 58.71 177.47 0.07 Allowed 'General case' 0 CA--C 1.549 0.925 0 C-N-CA 125.501 1.521 . . . . 0.0 111.63 -177.332 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 36.8 mmt -69.43 13.69 0.12 Allowed 'General case' 0 CA--C 1.536 0.429 0 O-C-N 119.845 -1.784 . . . . 0.0 113.434 175.109 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -55.77 -49.25 73.64 Favored 'General case' 0 C--O 1.224 -0.264 0 CA-C-N 120.398 1.454 . . . . 0.0 109.656 173.7 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -61.99 -46.52 88.86 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 118.443 0.565 . . . . 0.0 111.133 -175.49 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -59.54 -48.22 82.5 Favored 'General case' 0 N--CA 1.451 -0.398 0 C-N-CA 124.379 1.072 . . . . 0.0 110.11 176.479 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 28.8 mtpp -68.99 -37.76 78.93 Favored 'General case' 0 C--O 1.224 -0.253 0 CA-C-O 117.992 -1.004 . . . . 0.0 111.033 -175.22 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 63.1 mt -54.21 -57.75 5.28 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.199 0 CA-C-N 119.712 1.142 . . . . 0.0 108.471 175.652 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 15.1 ptt180 -62.84 -39.14 93.46 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-O 118.834 -0.603 . . . . 0.0 110.067 -177.149 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -65.38 -39.18 91.95 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 118.339 0.518 . . . . 0.0 110.358 -173.673 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 62.9 mt -76.62 -52.61 16.82 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.699 0 C-N-CA 124.886 1.274 . . . . 0.0 110.091 -175.855 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 64.1 mt -60.55 -47.54 92.36 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.336 0 C-N-CA 123.025 0.53 . . . . 0.0 109.841 179.283 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 139.61 113.97 1.14 Allowed Glycine 0 CA--C 1.525 0.66 0 C-N-CA 125.656 1.598 . . . . 0.0 109.258 -179.113 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -72.87 -7.93 21.52 Favored 'Trans proline' 0 CA--C 1.537 0.666 0 C-N-CA 122.509 2.139 . . . . 0.0 113.423 -169.599 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -77.39 -20.57 54.5 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 118.934 0.788 . . . . 0.0 111.57 178.726 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -122.37 7.59 9.61 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 124.886 1.275 . . . . 0.0 113.383 -173.49 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 45.4 t -124.28 148.77 28.42 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.231 0 C-N-CA 124.924 1.29 . . . . 0.0 107.713 175.596 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 7.8 m -134.11 133.27 40.89 Favored 'General case' 0 C--N 1.331 -0.211 0 C-N-CA 124.959 1.303 . . . . 0.0 108.045 -175.861 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 21.8 mt -78.62 139.31 38.57 Favored 'General case' 0 C--O 1.232 0.158 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 175.695 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 36.0 t-80 -137.98 54.28 1.8 Allowed 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 124.321 1.049 . . . . 0.0 108.704 -174.409 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 21.3 t-20 -57.0 134.02 55.43 Favored 'General case' 0 CA--C 1.533 0.312 0 O-C-N 120.838 -1.164 . . . . 0.0 108.386 172.695 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 51.6 mt -74.17 -20.98 60.03 Favored 'General case' 0 CA--C 1.531 0.24 0 N-CA-C 114.344 1.238 . . . . 0.0 114.344 -168.872 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 14.9 tmtt? -73.29 -38.46 65.87 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 119.25 0.932 . . . . 0.0 109.014 168.501 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -73.53 -37.69 65.54 Favored 'General case' 0 C--O 1.234 0.258 0 N-CA-C 113.429 0.9 . . . . 0.0 113.429 -173.151 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 3.2 t0 -143.36 153.9 43.19 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 118.762 0.71 . . . . 0.0 112.249 175.405 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 17.2 m -73.68 157.17 87.89 Favored Pre-proline 0 CA--C 1.54 0.596 0 C-N-CA 125.842 1.657 . . . . 0.0 111.759 -169.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -72.72 -26.87 15.64 Favored 'Trans proline' 0 C--N 1.349 0.565 0 C-N-CA 122.761 2.307 . . . . 0.0 113.282 -171.211 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 22.4 mmmt -70.78 -13.22 61.97 Favored 'General case' 0 N--CA 1.473 0.696 0 O-C-N 120.252 -1.53 . . . . 0.0 111.842 -175.817 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -60.64 -29.1 69.06 Favored 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 125.526 1.53 . . . . 0.0 110.08 169.409 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 45.7 mtt -56.63 -25.05 52.16 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 118.966 0.803 . . . . 0.0 111.732 178.419 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 93.8 mt-10 -65.3 -31.69 72.96 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 118.432 0.56 . . . . 0.0 110.325 -177.13 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 24.9 mt-30 -67.39 -42.72 82.86 Favored 'General case' 0 N--CA 1.466 0.342 0 N-CA-C 113.259 0.837 . . . . 0.0 113.259 -169.788 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 34.8 m-85 -73.77 140.05 45.63 Favored 'General case' 0 C--O 1.23 0.045 0 C-N-CA 123.53 0.732 . . . . 0.0 109.966 -167.181 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -67.07 -45.22 78.03 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 118.588 0.631 . . . . 0.0 109.801 174.109 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 6.4 t -102.05 142.22 16.85 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.591 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 175.139 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 31.3 tp -129.94 112.77 13.84 Favored 'General case' 0 N--CA 1.442 -0.842 0 N-CA-C 108.439 -0.949 . . . . 0.0 108.439 173.34 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.421 HG23 ' CE1' ' A' ' 85' ' ' TYR . 17.8 mt -88.41 133.57 30.47 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.591 0 N-CA-C 106.334 -1.728 . . . . 0.0 106.334 172.069 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -109.52 140.61 43.08 Favored 'General case' 0 CA--C 1.517 -0.299 0 C-N-CA 125.904 1.681 . . . . 0.0 106.52 179.404 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -141.99 146.89 18.24 Favored Glycine 0 CA--C 1.518 0.249 0 N-CA-C 110.261 -1.136 . . . . 0.0 110.261 175.036 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.519 HD13 ' CB ' ' A' ' 100' ' ' ALA . 16.5 tt -157.97 139.09 9.55 Favored Pre-proline 0 CA--C 1.538 0.506 0 N-CA-C 107.599 -1.259 . . . . 0.0 107.599 177.276 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -77.65 27.44 0.46 Allowed 'Trans proline' 0 CA--C 1.548 1.194 0 C-N-CA 123.163 2.576 . . . . 0.0 112.835 170.187 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.461 HG23 ' H ' ' A' ' 100' ' ' ALA . 82.5 m 57.95 -56.04 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 128.76 2.824 . . . . 0.0 114.092 -167.129 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -154.39 169.95 22.51 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 125.227 1.411 . . . . 0.0 111.045 -173.757 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 21.3 t0 -103.23 51.66 0.79 Allowed 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 124.678 1.191 . . . . 0.0 107.882 167.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 92.5 m-85 49.99 44.66 25.58 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 125.889 1.676 . . . . 0.0 112.58 -174.541 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -172.38 -60.2 0.04 OUTLIER Glycine 0 C--N 1.338 0.664 0 N-CA-C 109.684 -1.367 . . . . 0.0 109.684 176.213 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 22.6 tt0 -155.46 174.07 15.77 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 124.989 1.316 . . . . 0.0 107.984 175.83 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 72.0 mt -46.39 136.92 2.26 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.808 0 C-N-CA 126.004 1.722 . . . . 0.0 109.267 169.048 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -77.73 156.82 30.38 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-O 121.583 0.706 . . . . 0.0 111.192 178.979 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -57.99 -42.32 84.89 Favored 'General case' 0 C--O 1.225 -0.236 0 C-N-CA 124.269 1.028 . . . . 0.0 111.722 -169.249 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 45.5 m-20 -61.44 -23.47 65.87 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 119.108 0.867 . . . . 0.0 112.049 -173.861 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' TRP . . . . . 0.475 ' CZ2' HD12 ' A' ' 53' ' ' ILE . 6.9 t90 -96.09 -48.01 5.84 Favored 'General case' 0 CA--C 1.527 0.071 0 C-N-CA 124.496 1.118 . . . . 0.0 109.652 177.374 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 8.2 tt0 -65.33 -36.02 82.77 Favored 'General case' 0 N--CA 1.447 -0.62 0 O-C-N 120.962 -1.086 . . . . 0.0 110.556 -174.182 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -61.49 -25.99 67.61 Favored 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 123.653 0.781 . . . . 0.0 111.055 -174.709 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 28.5 m -108.48 -15.64 9.2 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.289 0 CA-C-O 117.234 -1.365 . . . . 0.0 112.195 177.071 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 34.8 t90 -52.27 -35.09 49.11 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 120.526 1.512 . . . . 0.0 110.861 178.049 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -62.61 -29.42 70.59 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 125.31 1.444 . . . . 0.0 113.163 175.272 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 29.3 mt-30 -92.15 -19.62 22.09 Favored 'General case' 0 C--N 1.341 0.218 0 C-N-CA 125.874 1.67 . . . . 0.0 112.393 177.453 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 53.4 mt -63.05 -20.71 65.59 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-N 118.903 0.774 . . . . 0.0 111.474 -177.607 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -78.93 -23.94 44.34 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 123.055 0.542 . . . . 0.0 111.773 174.602 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -72.21 -29.18 63.72 Favored 'General case' 0 N--CA 1.469 0.514 0 O-C-N 120.918 -1.114 . . . . 0.0 111.706 179.049 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 79.8 mt -53.36 141.15 25.19 Favored 'General case' 0 C--N 1.34 0.194 0 C-N-CA 125.141 1.376 . . . . 0.0 113.106 -168.509 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 3.2 t30 -75.7 102.67 5.48 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 170.025 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 61.3 mt -125.26 -0.14 7.72 Favored 'General case' 0 N--CA 1.475 0.821 0 N-CA-C 114.205 1.187 . . . . 0.0 114.205 -174.025 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 26.9 mt-10 -56.68 129.2 40.09 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-N 119.666 1.121 . . . . 0.0 111.115 -168.613 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 74.18 -2.12 45.69 Favored Glycine 0 CA--C 1.534 1.228 0 C-N-CA 125.493 1.521 . . . . 0.0 114.998 178.525 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.4 151.37 38.16 Favored 'General case' 0 C--N 1.346 0.426 0 CA-C-N 120.617 2.208 . . . . 0.0 110.021 -175.025 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 6.7 mt -80.67 136.29 23.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 N-CA-C 106.661 -1.607 . . . . 0.0 106.661 178.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 65.2 t -132.48 140.51 47.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 C-N-CA 124.054 0.942 . . . . 0.0 109.192 -177.376 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -125.28 144.72 50.34 Favored 'General case' 0 N--CA 1.456 -0.162 0 N-CA-C 108.118 -1.068 . . . . 0.0 108.118 170.575 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 4.2 mt -117.83 120.76 38.89 Favored 'General case' 0 CA--C 1.518 -0.26 0 C-N-CA 124.416 1.086 . . . . 0.0 108.612 -175.769 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.488 ' CD2' HD23 ' A' ' 142' ' ' LEU . 22.5 m-85 -113.07 151.98 30.09 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 107.406 -1.331 . . . . 0.0 107.406 169.861 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -155.81 137.5 5.57 Favored Glycine 0 N--CA 1.449 -0.485 0 N-CA-C 107.825 -2.11 . . . . 0.0 107.825 167.619 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 27.1 tp -99.97 146.34 26.82 Favored 'General case' 0 N--CA 1.442 -0.831 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 169.971 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -166.89 -174.72 36.39 Favored Glycine 0 CA--C 1.527 0.798 0 N-CA-C 108.524 -1.83 . . . . 0.0 108.524 175.042 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 2.9 t0 -151.67 127.14 10.03 Favored 'General case' 0 C--O 1.234 0.261 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 176.823 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 16.8 pm0 -72.74 -11.85 60.78 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 125.582 1.553 . . . . 0.0 113.088 -177.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 96.5 mt -88.09 -46.1 9.59 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 119.758 1.163 . . . . 0.0 111.29 177.865 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -60.61 -41.45 98.86 Favored Glycine 0 CA--C 1.529 0.947 0 C-N-CA 124.292 0.949 . . . . 0.0 112.26 -172.671 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 23.1 t80 -148.19 -62.95 0.26 Allowed 'General case' 0 N--CA 1.462 0.146 0 N-CA-C 108.871 -0.788 . . . . 0.0 108.871 169.142 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 80.59 -19.99 6.67 Favored Glycine 0 CA--C 1.524 0.606 0 CA-C-O 118.984 -0.898 . . . . 0.0 114.101 168.847 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -64.54 -37.29 87.05 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 119.402 1.601 . . . . 0.0 109.348 174.335 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' TRP . . . . . . . . . . . . . 47.8 m0 -102.85 33.45 3.22 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 126.147 1.779 . . . . 0.0 111.127 177.703 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 27.6 t80 -52.58 129.91 30.52 Favored 'General case' 0 N--CA 1.466 0.369 0 N-CA-C 108.056 -1.09 . . . . 0.0 108.056 174.755 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 90.3 mt 54.35 22.46 3.78 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 123.866 0.866 . . . . 0.0 113.15 173.308 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -61.71 -39.19 90.62 Favored 'General case' 0 N--CA 1.465 0.285 0 O-C-N 120.687 -1.258 . . . . 0.0 111.366 -168.679 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . 0.519 ' CB ' HD13 ' A' ' 53' ' ' ILE . . . -79.0 -15.86 57.69 Favored 'General case' 0 N--CA 1.445 -0.698 0 O-C-N 121.093 -1.004 . . . . 0.0 112.885 178.768 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 5.4 tt -63.44 -42.2 98.67 Favored 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 106.568 -1.641 . . . . 0.0 106.568 167.679 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -63.83 -37.58 94.88 Favored Glycine 0 C--N 1.341 0.812 0 N-CA-C 111.34 -0.704 . . . . 0.0 111.34 178.67 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 28.5 mtm -64.53 -45.23 88.08 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 118.397 1.099 . . . . 0.0 111.813 177.873 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.411 HD23 ' CH2' ' A' ' 65' ' ' TRP . 0.2 OUTLIER -66.7 -39.69 88.16 Favored 'General case' 0 C--N 1.344 0.354 0 CA-C-N 120.233 1.379 . . . . 0.0 109.942 177.277 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 85.3 t60 -57.38 -51.34 69.79 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 118.492 0.587 . . . . 0.0 111.053 177.254 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -62.73 -39.26 93.52 Favored 'General case' 0 C--O 1.235 0.3 0 C-N-CA 124.04 0.936 . . . . 0.0 112.067 -176.335 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 25.0 ttmm -56.21 -35.03 66.86 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 123.657 0.783 . . . . 0.0 110.737 172.392 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 21.0 mt -94.34 -20.05 20.1 Favored 'General case' 0 CA--C 1.515 -0.371 0 N-CA-C 115.761 1.763 . . . . 0.0 115.761 -168.92 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 4.0 m -58.24 -33.98 69.95 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-N 120.673 1.579 . . . . 0.0 111.452 -177.843 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 20.0 p -85.79 -10.71 55.05 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 125.4 1.48 . . . . 0.0 112.324 179.871 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 32.6 mmmt -84.69 -6.05 59.34 Favored 'General case' 0 N--CA 1.466 0.342 0 C-N-CA 124.555 1.142 . . . . 0.0 111.334 173.875 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 70.09 33.49 69.65 Favored Glycine 0 CA--C 1.525 0.69 0 CA-C-N 118.438 0.563 . . . . 0.0 112.125 172.001 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 4.9 m -77.48 175.33 0.76 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.599 0 CA-C-N 117.907 0.853 . . . . 0.0 109.635 173.726 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -117.62 116.21 26.63 Favored 'General case' 0 N--CA 1.465 0.317 0 N-CA-C 107.318 -1.364 . . . . 0.0 107.318 175.069 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 71.2 m-85 -83.52 147.25 27.9 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 119.249 0.931 . . . . 0.0 109.185 -179.037 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 35.8 m -125.21 159.17 32.69 Favored 'Isoleucine or valine' 0 C--O 1.234 0.289 0 C-N-CA 123.696 0.798 . . . . 0.0 110.652 172.157 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 93.52 -87.57 1.18 Allowed Glycine 0 N--CA 1.446 -0.65 0 C-N-CA 125.144 1.354 . . . . 0.0 111.956 169.924 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 15.7 m-30 58.53 176.68 0.07 Allowed 'General case' 0 CA--C 1.552 1.04 0 C-N-CA 125.293 1.437 . . . . 0.0 110.87 -168.031 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -148.98 147.15 23.07 Favored Pre-proline 0 N--CA 1.476 0.853 0 O-C-N 120.199 -1.563 . . . . 0.0 110.149 177.8 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo -61.97 127.11 20.41 Favored 'Trans proline' 0 C--N 1.349 0.559 0 C-N-CA 122.831 2.354 . . . . 0.0 110.336 169.387 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 13.7 p -73.08 -13.63 61.24 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 113.32 0.859 . . . . 0.0 113.32 175.618 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -60.07 130.97 49.34 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 123.642 0.777 . . . . 0.0 109.937 -173.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 87.59 -6.87 82.74 Favored Glycine 0 CA--C 1.534 1.236 0 C-N-CA 124.798 1.189 . . . . 0.0 114.227 177.357 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 58.3 m-85 -85.96 157.9 20.02 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-N 119.327 1.563 . . . . 0.0 109.783 171.668 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -123.11 118.94 28.84 Favored 'General case' 0 C--O 1.233 0.186 0 N-CA-C 106.51 -1.663 . . . . 0.0 106.51 170.629 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 49.3 p90 -161.27 146.25 13.72 Favored 'General case' 0 C--O 1.237 0.439 0 N-CA-C 106.367 -1.716 . . . . 0.0 106.367 -174.185 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 7.5 m -107.51 -47.85 3.55 Favored 'General case' 0 N--CA 1.447 -0.587 0 N-CA-C 112.318 0.488 . . . . 0.0 112.318 -169.728 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 41.8 m -70.79 142.51 88.35 Favored Pre-proline 0 CA--C 1.542 0.658 0 CA-C-O 119.179 -0.439 . . . . 0.0 110.801 -174.738 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo -82.55 -14.85 8.93 Favored 'Trans proline' 0 CA--C 1.539 0.741 0 C-N-CA 123.108 2.539 . . . . 0.0 113.403 -178.027 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 9.5 ttmm -54.27 -37.41 53.32 Favored Pre-proline 0 CA--C 1.542 0.658 0 N-CA-C 114.68 1.363 . . . . 0.0 114.68 -172.696 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_exo -79.49 -0.34 10.64 Favored 'Trans proline' 0 CA--C 1.538 0.723 0 CA-C-N 122.036 1.763 . . . . 0.0 114.271 -179.109 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 31.4 m -131.51 165.51 31.46 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.427 0 CA-C-N 120.39 1.45 . . . . 0.0 112.647 -168.493 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 10.3 pt -136.5 176.42 8.09 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 C-N-CA 128.723 2.809 . . . . 0.0 108.439 -176.848 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . 56.33 41.87 28.51 Favored 'General case' 0 N--CA 1.465 0.297 0 C-N-CA 125.362 1.465 . . . . 0.0 112.35 174.134 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 27.7 t70 55.2 42.13 30.82 Favored 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 125.938 1.695 . . . . 0.0 111.479 -175.545 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 87.63 16.87 59.39 Favored Glycine 0 CA--C 1.528 0.906 0 CA-C-O 118.715 -1.047 . . . . 0.0 113.974 173.552 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 45.6 mt-30 -91.07 -9.23 46.49 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-N 119.072 1.436 . . . . 0.0 113.168 -178.336 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 4.9 tp -151.66 138.65 19.07 Favored 'General case' 0 C--N 1.342 0.273 0 CA-C-N 119.797 1.18 . . . . 0.0 111.054 -178.646 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 61.9 m-85 -77.82 143.7 37.66 Favored 'General case' 0 CA--C 1.517 -0.314 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 169.931 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 19.4 m -78.31 3.01 1.74 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 C-N-CA 123.587 0.755 . . . . 0.0 112.352 178.306 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -168.91 -172.93 36.2 Favored Glycine 0 C--N 1.335 0.483 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 -178.905 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.488 HD23 ' CD2' ' A' ' 85' ' ' TYR . 46.5 tp -74.65 129.67 38.13 Favored 'General case' 0 N--CA 1.451 -0.384 0 C-N-CA 123.659 0.784 . . . . 0.0 110.505 -179.605 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -81.19 117.36 21.66 Favored 'General case' 0 N--CA 1.443 -0.824 0 N-CA-C 107.322 -1.362 . . . . 0.0 107.322 167.36 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 61.4 mt -108.37 131.87 54.32 Favored 'General case' 0 N--CA 1.462 0.172 0 N-CA-C 107.031 -1.47 . . . . 0.0 107.031 167.827 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -151.89 135.52 16.21 Favored 'General case' 0 C--O 1.236 0.37 0 C-N-CA 128.074 2.549 . . . . 0.0 104.272 177.637 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -134.31 0.44 3.08 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 125.347 1.459 . . . . 0.0 111.338 -179.543 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 36.6 m -89.88 -42.94 10.94 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 124.456 1.102 . . . . 0.0 109.164 -171.523 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 8.1 m-80 -80.95 -34.48 33.18 Favored 'General case' 0 C--N 1.332 -0.176 0 C-N-CA 123.672 0.789 . . . . 0.0 111.29 -168.515 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -143.29 137.09 28.6 Favored 'General case' 0 CA--C 1.533 0.298 0 N-CA-C 105.482 -2.044 . . . . 0.0 105.482 177.677 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 39.8 m-85 -91.37 -19.24 23.12 Favored 'General case' 0 N--CA 1.466 0.325 0 N-CA-C 112.883 0.697 . . . . 0.0 112.883 -169.246 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -90.3 -31.97 16.72 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 123.016 0.527 . . . . 0.0 112.163 -176.69 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 82.5 mt -78.18 -10.48 59.66 Favored 'General case' 0 C--O 1.224 -0.25 0 N-CA-C 113.337 0.865 . . . . 0.0 113.337 -169.147 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 4.9 p -64.12 -47.22 80.85 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 120.331 1.423 . . . . 0.0 110.016 176.116 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -65.17 -38.75 91.51 Favored 'General case' 0 N--CA 1.461 0.11 0 C-N-CA 123.016 0.526 . . . . 0.0 110.641 177.662 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 2.8 tp10 -62.23 -49.06 77.24 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 124.31 1.044 . . . . 0.0 110.78 178.381 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 41.5 mtt180 -56.87 -44.83 82.63 Favored 'General case' 0 C--O 1.226 -0.182 0 C-N-CA 124.617 1.167 . . . . 0.0 109.761 178.536 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 53.8 mt -65.45 -56.0 17.37 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.358 0 N-CA-C 107.91 -1.144 . . . . 0.0 107.91 177.212 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 68.8 tp60 -55.77 -63.65 1.11 Allowed 'General case' 0 C--O 1.232 0.179 0 C-N-CA 124.09 0.956 . . . . 0.0 112.173 -170.503 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 20.2 m -67.35 -32.68 73.79 Favored 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 121.051 -0.259 . . . . 0.0 111.035 -168.695 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 160' ' ' TRP . . . . . . . . . . . . . 3.6 t90 -73.53 -42.37 61.83 Favored 'General case' 0 C--O 1.22 -0.45 0 CA-C-O 119.085 -0.483 . . . . 0.0 110.684 177.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 55.2 m -57.12 -45.33 83.55 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 118.525 0.602 . . . . 0.0 110.378 174.398 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -61.21 -42.3 98.36 Favored 'General case' 0 CA--C 1.528 0.111 0 CA-C-O 121.467 0.651 . . . . 0.0 110.191 177.097 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 16.5 tt0 -64.2 -53.44 49.29 Favored 'General case' 0 N--CA 1.448 -0.561 0 O-C-N 121.655 -0.653 . . . . 0.0 110.202 -178.721 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 41.2 pt -62.26 -37.04 77.6 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.331 0 CA-C-O 117.653 -1.165 . . . . 0.0 109.16 -174.814 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -63.47 -37.55 87.75 Favored 'General case' 0 C--O 1.224 -0.268 0 CA-C-N 119.57 1.077 . . . . 0.0 109.708 -179.729 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 34.1 m-80 -67.05 -50.41 61.98 Favored 'General case' 0 N--CA 1.465 0.294 0 N-CA-C 108.887 -0.782 . . . . 0.0 108.887 176.338 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 67.3 tt0 -72.69 -18.03 61.58 Favored 'General case' 0 N--CA 1.437 -1.122 0 C-N-CA 126.167 1.787 . . . . 0.0 112.157 -169.181 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 168' ' ' MET . . . . . . . . . . . . . 19.0 ptp -89.86 -40.05 12.67 Favored 'General case' 0 N--CA 1.456 -0.151 0 C-N-CA 124.115 0.966 . . . . 0.0 111.168 168.813 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -74.35 -24.82 59.23 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 112.647 0.61 . . . . 0.0 112.647 -174.021 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -58.7 -29.69 66.85 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 118.511 0.596 . . . . 0.0 111.626 179.209 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 78.9 m-70 -75.18 -14.13 60.52 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 124.783 1.233 . . . . 0.0 112.401 177.181 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 14.1 m-85 -115.38 -5.43 12.3 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 127.432 2.293 . . . . 0.0 112.173 -174.325 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.255 1.35 0 C-N-CA 124.378 1.071 . . . . 0.0 109.971 175.592 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.406 ' HA ' ' OD2' ' A' ' 47' ' ' ASP . 11.1 tmm? . . . . . 0 N--CA 1.495 1.819 0 N-CA-C 109.832 -0.433 . . . . 0.0 109.832 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 3.0 t30 -142.53 151.41 41.59 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 125.263 1.425 . . . . 0.0 107.911 174.489 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -112.0 128.05 56.06 Favored 'General case' 0 N--CA 1.463 0.221 0 C-N-CA 123.977 0.911 . . . . 0.0 111.573 -177.915 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -87.1 155.49 27.5 Favored Glycine 0 CA--C 1.523 0.584 0 N-CA-C 107.812 -2.115 . . . . 0.0 107.812 167.231 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 3.1 tt -140.39 96.53 3.05 Favored 'General case' 0 N--CA 1.466 0.341 0 N-CA-C 105.397 -2.075 . . . . 0.0 105.397 -177.504 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -98.95 140.51 33.0 Favored 'General case' 0 CA--C 1.516 -0.336 0 CA-C-O 121.225 0.536 . . . . 0.0 111.379 -173.656 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.407 ' CD2' ' HB ' ' A' ' 14' ' ' THR . 43.6 p90 -160.88 -177.56 6.22 Favored 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 125.679 1.592 . . . . 0.0 107.95 177.698 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -175.28 105.55 0.21 Allowed Glycine 0 C--N 1.333 0.376 0 N-CA-C 106.53 -2.628 . . . . 0.0 106.53 179.156 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 65.1 m -79.15 157.63 27.87 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 124.354 1.062 . . . . 0.0 112.249 -169.712 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 74.7 p -120.64 -144.3 0.35 Allowed 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 126.22 1.808 . . . . 0.0 107.353 169.808 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 3.2 p -61.89 -29.31 70.12 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 124.065 0.946 . . . . 0.0 109.377 167.265 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 6.5 t -94.24 128.78 40.9 Favored 'General case' 0 C--N 1.343 0.299 0 N-CA-C 105.13 -2.174 . . . . 0.0 105.13 168.26 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 44.2 p90 -120.15 156.1 31.75 Favored 'General case' 0 N--CA 1.464 0.274 0 N-CA-C 113.811 1.041 . . . . 0.0 113.811 -167.838 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.407 ' HB ' ' CD2' ' A' ' 7' ' ' TYR . 0.3 OUTLIER -116.64 -8.7 11.43 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 124.706 1.203 . . . . 0.0 112.539 -169.875 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -59.97 -38.09 81.52 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 118.983 0.81 . . . . 0.0 111.956 -167.631 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 30.6 mmt -66.97 -42.26 85.46 Favored 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 -177.326 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -65.09 -46.04 82.73 Favored 'General case' 0 C--O 1.226 -0.152 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 177.825 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -63.03 -47.42 83.12 Favored 'General case' 0 C--O 1.233 0.191 0 C-N-CA 122.756 0.422 . . . . 0.0 111.353 -176.047 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 10.4 mt-10 -62.06 -43.04 99.69 Favored 'General case' 0 CA--C 1.516 -0.338 0 CA-C-O 118.912 -0.566 . . . . 0.0 110.275 176.801 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 29.7 mtpp -71.58 -40.39 69.93 Favored 'General case' 0 C--O 1.22 -0.476 0 CA-C-O 117.97 -1.014 . . . . 0.0 110.892 -174.036 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 47.3 mt -52.54 -54.3 16.06 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.255 0 CA-C-N 120.052 1.296 . . . . 0.0 108.524 172.27 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 8.0 ttp180 -61.72 -41.06 97.14 Favored 'General case' 0 C--O 1.223 -0.296 0 C-N-CA 123.209 0.604 . . . . 0.0 109.425 -175.758 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -66.43 -41.61 88.93 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 118.481 0.582 . . . . 0.0 111.421 -179.177 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 49.3 mt -72.58 -53.17 20.01 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.526 0 C-N-CA 124.7 1.2 . . . . 0.0 109.686 -172.171 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 78.0 mt -67.05 -45.3 87.19 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 179.828 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 139.24 125.5 2.28 Favored Glycine 0 CA--C 1.532 1.137 0 C-N-CA 125.165 1.364 . . . . 0.0 112.067 173.737 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 82.2 Cg_endo -73.17 -5.3 16.93 Favored 'Trans proline' 0 CA--C 1.537 0.636 0 C-N-CA 123.664 2.91 . . . . 0.0 113.873 -175.822 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -82.27 -17.41 46.01 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 118.996 0.816 . . . . 0.0 111.072 177.229 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 1.3 pt? -129.94 -13.76 4.05 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 125.114 1.366 . . . . 0.0 113.871 -174.331 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 33.8 t -98.48 153.45 4.08 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.517 0 N-CA-C 107.691 -1.226 . . . . 0.0 107.691 168.56 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 50.5 m -139.65 131.93 28.3 Favored 'General case' 0 C--O 1.234 0.279 0 C-N-CA 126.464 1.905 . . . . 0.0 106.239 -177.117 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 24.3 mt -81.25 142.38 33.21 Favored 'General case' 0 C--O 1.233 0.191 0 N-CA-C 107.839 -1.171 . . . . 0.0 107.839 176.763 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 34.2 t-80 -134.28 57.65 1.8 Allowed 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 124.574 1.15 . . . . 0.0 108.218 -175.157 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 64.3 t-20 -70.43 118.01 12.69 Favored 'General case' 0 C--O 1.235 0.327 0 O-C-N 121.076 -1.015 . . . . 0.0 108.779 -176.673 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 93.9 mt -68.45 -12.94 61.92 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 124.092 0.957 . . . . 0.0 112.505 -174.807 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 65.3 mmtt -53.73 -27.19 26.89 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-O 118.685 -0.674 . . . . 0.0 111.178 167.013 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -132.04 -41.71 1.01 Allowed 'General case' 0 C--O 1.236 0.347 0 N-CA-C 113.437 0.903 . . . . 0.0 113.437 -173.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 29.8 m-20 -85.56 141.2 30.03 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-N 118.475 0.58 . . . . 0.0 110.568 -174.324 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 14.8 m -76.32 154.23 84.13 Favored Pre-proline 0 CA--C 1.54 0.59 0 C-N-CA 124.378 1.071 . . . . 0.0 110.342 176.658 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -77.26 -26.84 7.13 Favored 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 122.267 1.978 . . . . 0.0 113.683 -170.085 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.79 -15.38 63.54 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-N 120.657 1.571 . . . . 0.0 112.269 -178.612 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -58.77 -29.23 66.64 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 125.403 1.481 . . . . 0.0 110.363 170.317 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 55.3 mtt -57.43 -27.75 62.68 Favored 'General case' 0 C--N 1.342 0.264 0 C-N-CA 123.589 0.756 . . . . 0.0 111.498 177.339 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 56.7 mt-10 -66.83 -33.09 74.85 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 118.348 0.522 . . . . 0.0 110.537 -176.22 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 16.5 mt-30 -66.9 -43.18 84.09 Favored 'General case' 0 N--CA 1.464 0.232 0 C-N-CA 123.346 0.659 . . . . 0.0 112.336 -170.003 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 22.2 m-85 -70.92 142.11 51.11 Favored 'General case' 0 N--CA 1.454 -0.227 0 CA-C-N 115.387 -0.824 . . . . 0.0 110.528 -166.469 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . 0.406 ' OD2' ' HA ' ' A' ' 1' ' ' MET . 24.4 m-20 -74.77 -35.7 62.57 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-O 121.118 0.485 . . . . 0.0 109.726 -178.098 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.525 HG21 ' SD ' ' A' ' 168' ' ' MET . 25.6 t -113.94 147.49 17.44 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.216 0 N-CA-C 107.178 -1.416 . . . . 0.0 107.178 170.003 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 29.8 tp -132.19 109.69 10.12 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 123.778 0.831 . . . . 0.0 108.843 174.889 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 32.0 mt -87.22 133.1 30.93 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.552 0 N-CA-C 107.077 -1.453 . . . . 0.0 107.077 176.583 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 2.4 mp -111.22 127.34 55.57 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 126.141 1.777 . . . . 0.0 106.966 -179.26 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -135.0 136.6 8.65 Favored Glycine 0 C--N 1.335 0.48 0 N-CA-C 109.439 -1.464 . . . . 0.0 109.439 -179.561 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 4.1 tt -150.46 129.31 6.19 Favored Pre-proline 0 CA--C 1.542 0.645 0 CA-C-N 118.772 1.286 . . . . 0.0 110.926 -175.054 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -76.6 -21.63 12.79 Favored 'Trans proline' 0 CA--C 1.542 0.902 0 C-N-CA 122.992 2.461 . . . . 0.0 115.539 170.087 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.533 HG22 ' H ' ' A' ' 56' ' ' TRP . 25.7 m 56.75 -167.47 0.12 Allowed 'General case' 0 CA--C 1.558 1.255 0 CA-C-N 119.592 1.087 . . . . 0.0 109.453 -169.265 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' TRP . . . . . 0.533 ' H ' HG22 ' A' ' 55' ' ' THR . 0.3 OUTLIER -133.74 159.58 40.14 Favored 'General case' 0 CA--C 1.535 0.369 0 O-C-N 120.582 -1.324 . . . . 0.0 108.814 169.914 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -65.7 109.56 2.47 Favored 'General case' 0 C--O 1.236 0.377 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 -179.836 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 85.6 m-85 47.36 37.27 5.77 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 124.001 0.92 . . . . 0.0 111.507 -169.266 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -136.37 149.81 20.25 Favored Glycine 0 C--N 1.337 0.598 0 N-CA-C 110.501 -1.04 . . . . 0.0 110.501 -175.215 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.438 ' HG2' ' H ' ' A' ' 61' ' ' ILE . 14.3 tt0 -77.74 -171.34 2.18 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-O 121.998 0.904 . . . . 0.0 109.738 -177.932 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.438 ' H ' ' HG2' ' A' ' 60' ' ' GLU . 13.1 mt -57.69 141.24 14.94 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.706 0 C-N-CA 126.292 1.837 . . . . 0.0 111.464 -172.622 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . 0.555 ' H ' ' CD ' ' A' ' 62' ' ' GLN . 0.3 OUTLIER -56.02 146.89 21.27 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 126.741 2.016 . . . . 0.0 109.715 175.012 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -57.15 -48.23 79.21 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 118.348 0.522 . . . . 0.0 112.172 -169.629 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -69.71 -17.87 63.49 Favored 'General case' 0 N--CA 1.475 0.807 0 CA-C-N 119.019 0.827 . . . . 0.0 112.177 -173.864 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' TRP . . . . . 0.44 ' CH2' HD23 ' A' ' 104' ' ' LEU . 0.2 OUTLIER -93.28 -43.44 8.8 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 124.92 1.288 . . . . 0.0 107.636 -179.822 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -63.46 -35.12 79.39 Favored 'General case' 0 N--CA 1.435 -1.217 0 C-N-CA 126.229 1.812 . . . . 0.0 111.075 177.347 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -55.93 -23.88 34.53 Favored 'General case' 0 CA--C 1.53 0.174 0 C-N-CA 124.582 1.153 . . . . 0.0 112.001 -176.821 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 35.7 m -116.47 -13.49 11.01 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.224 0 CA-C-O 117.913 -1.041 . . . . 0.0 112.709 178.902 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 26.5 t90 -52.55 -38.68 60.31 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 119.824 1.193 . . . . 0.0 111.083 -177.063 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -68.04 -24.02 65.04 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 125.12 1.368 . . . . 0.0 112.967 178.62 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 20.4 mt-30 -91.67 -23.74 19.72 Favored 'General case' 0 C--N 1.34 0.166 0 C-N-CA 125.273 1.429 . . . . 0.0 111.877 -179.347 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 24.7 mt -64.63 -26.13 68.26 Favored 'General case' 0 N--CA 1.468 0.456 0 O-C-N 121.792 -0.567 . . . . 0.0 111.646 -172.227 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -69.27 -22.27 63.83 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-N 118.06 0.391 . . . . 0.0 111.518 176.233 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -77.36 -23.51 50.83 Favored 'General case' 0 CA--C 1.537 0.472 0 O-C-N 120.707 -1.245 . . . . 0.0 112.56 -178.743 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 51.2 mt -65.67 152.07 45.07 Favored 'General case' 0 C--O 1.233 0.226 0 C-N-CA 124.772 1.229 . . . . 0.0 112.056 -170.205 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 3.3 t30 -82.71 100.95 10.55 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 124.682 1.193 . . . . 0.0 108.154 174.127 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 57.2 mt -119.22 0.09 11.12 Favored 'General case' 0 N--CA 1.47 0.548 0 N-CA-C 113.389 0.885 . . . . 0.0 113.389 -174.474 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 25.0 mt-10 -57.41 128.92 39.47 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 119.135 0.88 . . . . 0.0 110.828 -169.705 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 74.25 -3.04 41.71 Favored Glycine 0 CA--C 1.532 1.145 0 CA-C-O 117.749 -1.584 . . . . 0.0 114.824 178.535 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.79 152.86 40.19 Favored 'General case' 0 C--N 1.347 0.49 0 CA-C-N 121.098 2.449 . . . . 0.0 109.503 -179.402 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 2.1 mt -86.18 141.69 14.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 N-CA-C 106.877 -1.527 . . . . 0.0 106.877 179.414 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 61.6 t -135.68 137.58 49.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 C-N-CA 124.279 1.032 . . . . 0.0 109.109 -177.067 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -111.39 152.72 27.02 Favored 'General case' 0 N--CA 1.465 0.291 0 N-CA-C 106.733 -1.58 . . . . 0.0 106.733 168.118 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 1.2 mt -134.19 135.25 42.91 Favored 'General case' 0 CA--C 1.508 -0.637 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 175.366 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 40.9 p90 -147.34 166.14 28.03 Favored 'General case' 0 N--CA 1.447 -0.594 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 169.235 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -160.01 155.01 26.09 Favored Glycine 0 N--CA 1.448 -0.542 0 N-CA-C 109.123 -1.591 . . . . 0.0 109.123 171.946 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 13.0 tp -99.35 146.52 26.19 Favored 'General case' 0 N--CA 1.444 -0.737 0 C-N-CA 125.031 1.332 . . . . 0.0 109.08 177.02 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -152.01 158.11 27.61 Favored Glycine 0 CA--C 1.527 0.786 0 N-CA-C 109.004 -1.638 . . . . 0.0 109.004 169.099 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -94.63 -3.24 49.89 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 124.147 0.979 . . . . 0.0 113.395 -174.084 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 39.4 mt-30 50.95 2.1 0.01 OUTLIER 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 128.637 2.775 . . . . 0.0 116.234 -176.507 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 28.6 mt -111.86 -39.69 4.48 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 125.789 1.636 . . . . 0.0 110.522 -170.851 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -112.48 -41.58 1.03 Allowed Glycine 0 CA--C 1.533 1.168 0 C-N-CA 126.276 1.893 . . . . 0.0 109.21 168.415 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 17.1 m-85 -78.47 61.27 2.82 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 127.047 2.139 . . . . 0.0 107.586 172.062 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -98.99 -67.52 0.88 Allowed Glycine 0 CA--C 1.522 0.475 0 N-CA-C 109.146 -1.582 . . . . 0.0 109.146 179.295 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -73.08 -17.33 61.43 Favored 'General case' 0 CA--C 1.538 0.51 0 O-C-N 122.289 -0.536 . . . . 0.0 110.573 172.346 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' TRP . . . . . . . . . . . . . 4.8 t-105 -118.19 38.25 3.75 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 125.73 1.612 . . . . 0.0 109.883 -178.74 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 11.5 t80 -59.68 -54.89 41.19 Favored 'General case' 0 C--N 1.342 0.261 0 N-CA-C 112.938 0.718 . . . . 0.0 112.938 -172.1 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 96.7 mt -141.84 37.94 1.63 Allowed 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 123.945 0.898 . . . . 0.0 109.964 -169.054 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -52.73 -47.57 67.27 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 123.754 0.821 . . . . 0.0 112.7 -168.783 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -78.94 -19.56 51.44 Favored 'General case' 0 N--CA 1.451 -0.397 0 O-C-N 121.129 -0.982 . . . . 0.0 113.347 -176.323 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 3.8 tt -60.84 -44.79 96.5 Favored 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 107.543 -1.28 . . . . 0.0 107.543 171.383 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -61.24 -43.94 98.74 Favored Glycine 0 C--N 1.341 0.839 0 CA-C-O 119.617 -0.546 . . . . 0.0 111.914 176.398 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 75.1 mtm -63.25 -40.62 97.94 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 118.382 1.091 . . . . 0.0 111.957 -178.863 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.44 HD23 ' CH2' ' A' ' 65' ' ' TRP . 0.1 OUTLIER -69.95 -34.22 73.14 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-N 120.035 1.289 . . . . 0.0 111.241 -179.604 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 56.3 t-80 -58.97 -49.5 77.62 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-N 118.477 0.58 . . . . 0.0 109.533 172.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -62.36 -41.66 98.78 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 123.38 0.672 . . . . 0.0 112.295 -177.11 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 24.2 ttmm -55.56 -40.96 72.62 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 123.401 0.681 . . . . 0.0 110.166 173.14 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 28.4 mt -89.82 -20.2 23.75 Favored 'General case' 0 CA--C 1.517 -0.317 0 N-CA-C 115.764 1.765 . . . . 0.0 115.764 -167.653 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 15.9 m -58.28 -36.44 73.3 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 120.732 1.605 . . . . 0.0 111.334 -178.301 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 20.5 p -83.85 -12.88 54.92 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 124.585 1.154 . . . . 0.0 111.903 -179.678 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 32.0 mmmt -83.15 -9.64 59.08 Favored 'General case' 0 C--N 1.343 0.3 0 C-N-CA 124.525 1.13 . . . . 0.0 110.984 170.881 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 72.3 35.91 60.0 Favored Glycine 0 CA--C 1.523 0.561 0 CA-C-N 118.651 0.66 . . . . 0.0 112.469 169.661 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 5.3 m -77.02 170.67 1.46 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.582 0 CA-C-N 117.858 0.829 . . . . 0.0 109.713 172.001 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 53.0 tptt -100.06 130.64 46.23 Favored 'General case' 0 N--CA 1.47 0.564 0 N-CA-C 105.132 -2.173 . . . . 0.0 105.132 167.756 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 73.8 m-85 -94.95 123.01 38.18 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 172.071 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 32.8 m -105.15 154.31 6.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 C-N-CA 124.032 0.933 . . . . 0.0 108.505 167.701 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 105.85 -95.9 1.11 Allowed Glycine 0 N--CA 1.448 -0.56 0 C-N-CA 124.105 0.86 . . . . 0.0 112.011 174.173 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . 0.438 ' CD2' ' HA ' ' A' ' 140' ' ' VAL . 75.6 m-85 60.17 -179.61 0.09 Allowed 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 125.182 1.393 . . . . 0.0 109.424 -166.928 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER -153.22 143.55 15.54 Favored Pre-proline 0 N--CA 1.476 0.825 0 O-C-N 120.122 -1.611 . . . . 0.0 111.069 177.17 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -68.9 122.66 9.57 Favored 'Trans proline' 0 CA--C 1.536 0.595 0 C-N-CA 123.505 2.804 . . . . 0.0 111.621 179.238 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 18.1 p -81.85 -14.93 55.61 Favored 'General case' 0 CA--C 1.538 0.492 0 N-CA-C 113.791 1.034 . . . . 0.0 113.791 -179.343 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -47.13 130.37 12.63 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 124.545 1.138 . . . . 0.0 112.414 -168.534 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 82.87 30.2 32.67 Favored Glycine 0 CA--C 1.538 1.52 0 C-N-CA 124.1 0.857 . . . . 0.0 112.802 -174.624 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 50.1 p90 -71.62 158.79 35.57 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-N 118.115 0.958 . . . . 0.0 113.004 -175.893 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -128.3 6.7 5.85 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 125.053 1.341 . . . . 0.0 112.188 171.966 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 3.5 p90 -76.94 175.52 9.46 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 124.721 1.208 . . . . 0.0 110.631 176.607 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 7.4 t -144.34 -38.34 0.3 Allowed 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 124.497 1.119 . . . . 0.0 110.265 174.152 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 13.5 m -59.76 128.04 86.02 Favored Pre-proline 0 CA--C 1.544 0.716 0 C-N-CA 125.071 1.348 . . . . 0.0 110.727 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -84.81 -16.9 5.18 Favored 'Trans proline' 0 CA--C 1.535 0.564 0 C-N-CA 122.448 2.099 . . . . 0.0 114.379 -169.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 24.7 ttmt -53.88 -43.96 97.36 Favored Pre-proline 0 N--CA 1.475 0.79 0 N-CA-C 114.734 1.383 . . . . 0.0 114.734 -169.108 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -82.76 3.83 7.54 Favored 'Trans proline' 0 C--N 1.35 0.615 0 CA-C-N 121.836 1.691 . . . . 0.0 114.162 -178.43 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 20.0 m -130.26 165.82 29.46 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.371 0 CA-C-N 120.537 1.517 . . . . 0.0 111.57 -172.252 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 7.4 pt -135.42 171.29 17.68 Favored 'Isoleucine or valine' 0 C--O 1.234 0.279 0 C-N-CA 127.913 2.485 . . . . 0.0 108.969 -177.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . 53.88 45.13 28.4 Favored 'General case' 0 N--CA 1.464 0.261 0 C-N-CA 125.488 1.515 . . . . 0.0 112.509 172.553 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 27.0 t0 54.32 43.58 30.28 Favored 'General case' 0 C--N 1.324 -0.521 0 C-N-CA 126.056 1.742 . . . . 0.0 111.624 -176.596 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 87.41 17.4 58.83 Favored Glycine 0 CA--C 1.527 0.825 0 CA-C-O 118.662 -1.077 . . . . 0.0 113.611 173.357 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 60.6 mm-40 -92.09 -8.07 46.82 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 119.399 1.6 . . . . 0.0 113.142 -177.368 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 7.9 tp -152.59 145.03 24.06 Favored 'General case' 0 C--N 1.344 0.33 0 CA-C-N 119.356 0.98 . . . . 0.0 110.761 170.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 65.5 m-85 -81.59 144.83 30.97 Favored 'General case' 0 CA--C 1.514 -0.423 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 169.373 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . 0.438 ' HA ' ' CD2' ' A' ' 118' ' ' TYR . 13.9 m -76.43 11.07 0.43 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.627 0 N-CA-C 113.128 0.788 . . . . 0.0 113.128 179.512 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 177.39 171.9 41.37 Favored Glycine 0 CA--C 1.525 0.696 0 C-N-CA 124.927 1.251 . . . . 0.0 109.997 -177.617 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 3.2 tp -66.72 133.44 50.19 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 117.962 0.881 . . . . 0.0 110.771 -177.725 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -91.56 117.05 29.37 Favored 'General case' 0 N--CA 1.445 -0.694 0 C-N-CA 125.835 1.654 . . . . 0.0 108.408 173.017 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -99.95 145.33 27.96 Favored 'General case' 0 N--CA 1.463 0.199 0 C-N-CA 124.288 1.035 . . . . 0.0 109.385 172.242 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -140.03 134.01 30.8 Favored 'General case' 0 C--O 1.233 0.187 0 N-CA-C 106.016 -1.846 . . . . 0.0 106.016 168.204 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 25.8 tt0 -141.08 47.34 1.72 Allowed 'General case' 0 CA--C 1.539 0.528 0 N-CA-C 107.607 -1.256 . . . . 0.0 107.607 169.631 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 87.6 m -132.16 -57.59 0.96 Allowed 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 126.329 1.852 . . . . 0.0 108.56 -174.49 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 31.5 m-80 -87.14 -31.01 20.63 Favored 'General case' 0 N--CA 1.453 -0.28 0 C-N-CA 124.559 1.144 . . . . 0.0 108.409 179.057 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 79.6 mt-30 -110.56 162.1 15.05 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 126.761 2.024 . . . . 0.0 108.593 175.284 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 45.7 p90 -151.53 -43.21 0.11 Allowed 'General case' 0 N--CA 1.463 0.224 0 C-N-CA 123.594 0.758 . . . . 0.0 109.574 170.81 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -70.61 -50.19 39.69 Favored 'General case' 0 N--CA 1.465 0.298 0 O-C-N 122.089 -0.382 . . . . 0.0 110.429 -177.849 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -84.68 -0.47 53.62 Favored 'General case' 0 C--O 1.222 -0.39 0 CA-C-O 118.651 -0.69 . . . . 0.0 112.322 179.144 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 21.9 m -60.59 -29.88 69.47 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 120.314 1.415 . . . . 0.0 110.642 170.04 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -64.21 -38.53 91.39 Favored 'General case' 0 N--CA 1.463 0.188 0 C-N-CA 123.208 0.603 . . . . 0.0 111.037 169.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -70.23 -40.64 74.36 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 124.599 1.159 . . . . 0.0 111.276 -178.484 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 17.9 mmm-85 -49.39 -43.76 44.56 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 124.23 1.012 . . . . 0.0 109.889 171.253 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 58.0 mt -75.03 -56.74 7.95 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.399 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 -179.716 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 73.1 tp60 -50.68 -62.76 1.4 Allowed 'General case' 0 CA--C 1.521 -0.151 0 C-N-CA 125.709 1.604 . . . . 0.0 112.673 -170.298 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 15.0 m -68.09 -34.16 75.89 Favored 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 121.049 -0.26 . . . . 0.0 110.841 -168.57 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 160' ' ' TRP . . . . . . . . . . . . . 38.0 t90 -67.66 -44.25 78.31 Favored 'General case' 0 C--O 1.222 -0.353 0 O-C-N 122.167 -0.333 . . . . 0.0 110.838 175.128 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 61.2 m -59.74 -43.82 94.07 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 122.834 0.454 . . . . 0.0 110.377 178.965 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -62.03 -41.69 98.37 Favored 'General case' 0 CA--C 1.529 0.141 0 CA-C-N 118.053 0.388 . . . . 0.0 110.173 176.614 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 11.7 tt0 -62.68 -54.13 43.93 Favored 'General case' 0 CA--C 1.514 -0.415 0 CA-C-O 118.15 -0.928 . . . . 0.0 109.929 -179.099 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 40.4 pt -62.78 -33.0 57.71 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.497 0 CA-C-O 118.012 -0.994 . . . . 0.0 109.871 -176.475 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -70.66 -36.58 73.44 Favored 'General case' 0 C--O 1.223 -0.324 0 CA-C-N 119.837 1.198 . . . . 0.0 108.605 -175.572 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -68.73 -45.63 71.02 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 123.386 0.674 . . . . 0.0 109.844 175.096 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 25.1 tt0 -80.79 -13.63 58.79 Favored 'General case' 0 N--CA 1.437 -1.119 0 C-N-CA 124.303 1.041 . . . . 0.0 110.328 -169.382 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 168' ' ' MET . . . . . 0.525 ' SD ' HG21 ' A' ' 48' ' ' VAL . 20.6 ptp -90.7 -41.61 11.19 Favored 'General case' 0 N--CA 1.457 -0.125 0 C-N-CA 122.914 0.486 . . . . 0.0 111.242 168.774 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -70.58 -27.59 64.23 Favored 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 122.652 0.381 . . . . 0.0 111.651 -172.258 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -57.18 -26.78 61.18 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 123.257 0.623 . . . . 0.0 112.4 178.9 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 99.0 m-70 -77.91 -19.84 53.94 Favored 'General case' 0 C--O 1.235 0.291 0 C-N-CA 124.3 1.04 . . . . 0.0 112.64 179.132 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 58.5 m-85 -113.66 -18.82 11.8 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 125.719 1.608 . . . . 0.0 112.656 -173.62 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.254 1.29 0 C-N-CA 124.317 1.047 . . . . 0.0 110.106 175.157 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.498 1.938 0 N-CA-C 111.578 0.214 . . . . 0.0 111.578 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 6.0 t30 -127.36 151.52 48.67 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 124.624 1.17 . . . . 0.0 108.458 175.414 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 17.3 mtt -110.93 126.37 54.65 Favored 'General case' 0 C--N 1.332 -0.182 0 C-N-CA 123.475 0.71 . . . . 0.0 110.359 -177.385 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -84.22 145.98 22.57 Favored Glycine 0 CA--C 1.522 0.514 0 N-CA-C 107.139 -2.384 . . . . 0.0 107.139 168.023 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 1.2 tt -135.03 93.94 3.08 Favored 'General case' 0 N--CA 1.464 0.273 0 N-CA-C 105.345 -2.094 . . . . 0.0 105.345 -172.927 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.413 ' CE2' ' HG ' ' A' ' 51' ' ' LEU . 0.1 OUTLIER -101.59 143.25 31.8 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-O 121.703 0.763 . . . . 0.0 110.728 -173.322 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 32.3 p90 -158.53 162.39 37.41 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 125.071 1.348 . . . . 0.0 108.078 -178.071 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -97.12 140.35 15.0 Favored Glycine 0 CA--C 1.52 0.398 0 N-CA-C 110.145 -1.182 . . . . 0.0 110.145 176.017 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 46.0 m -144.11 104.83 4.17 Favored 'General case' 0 N--CA 1.446 -0.651 0 C-N-CA 125.207 1.403 . . . . 0.0 107.826 169.288 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 55.8 m -107.39 -122.07 0.24 Allowed 'General case' 0 CA--C 1.541 0.606 0 N-CA-C 106.587 -1.634 . . . . 0.0 106.587 169.946 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 2.8 p -64.89 -45.28 86.6 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 119.453 1.024 . . . . 0.0 109.789 172.911 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 6.3 p -90.24 149.87 22.2 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 124.607 1.163 . . . . 0.0 108.215 168.345 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 23.6 p90 -140.0 150.12 44.06 Favored 'General case' 0 C--O 1.234 0.264 0 C-N-CA 123.357 0.663 . . . . 0.0 112.116 -169.549 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 51.7 m -110.45 6.82 22.43 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 125.26 1.424 . . . . 0.0 111.509 -172.395 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -54.6 -37.19 65.28 Favored 'General case' 0 N--CA 1.465 0.3 0 O-C-N 120.992 -1.068 . . . . 0.0 113.415 -168.674 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 3.2 mpp? -65.54 -37.57 87.12 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 119.592 1.087 . . . . 0.0 111.51 -172.25 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -64.21 -44.3 92.34 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 118.849 0.75 . . . . 0.0 109.079 174.557 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -65.74 -45.66 81.76 Favored 'General case' 0 N--CA 1.455 -0.182 0 C-N-CA 123.732 0.813 . . . . 0.0 111.577 -175.239 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -54.34 -47.69 72.27 Favored 'General case' 0 CA--C 1.517 -0.289 0 C-N-CA 125.262 1.425 . . . . 0.0 109.312 173.647 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 29.8 mtpp -73.51 -38.91 65.18 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-O 118.459 -0.781 . . . . 0.0 110.215 -172.272 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 37.3 mt -53.72 -56.7 7.71 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.288 0 CA-C-N 119.469 1.031 . . . . 0.0 109.024 173.378 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.483 ' HG2' HD21 ' A' ' 32' ' ' LEU . 0.0 OUTLIER -66.33 -35.02 79.3 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 118.49 0.586 . . . . 0.0 111.196 -173.858 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -62.38 -42.7 99.62 Favored 'General case' 0 C--N 1.328 -0.358 0 O-C-N 123.363 0.414 . . . . 0.0 110.892 176.093 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.611 HD13 ' HA ' ' A' ' 158' ' ' GLN . 39.5 mt -72.23 -55.65 12.6 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.52 0 C-N-CA 123.619 0.767 . . . . 0.0 109.971 -174.356 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 73.0 mt -65.8 -45.23 92.17 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.296 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 -175.33 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 141.62 120.69 1.65 Allowed Glycine 0 CA--C 1.53 0.994 0 N-CA-C 110.26 -1.136 . . . . 0.0 110.26 176.335 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -68.64 -10.2 28.37 Favored 'Trans proline' 0 N--CA 1.456 -0.697 0 C-N-CA 123.124 2.55 . . . . 0.0 113.373 -173.985 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 2.4 pm0 -81.56 -18.25 45.56 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-N 119.573 1.079 . . . . 0.0 111.831 179.138 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -126.96 5.74 6.56 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 124.735 1.214 . . . . 0.0 113.679 -173.096 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 38.2 t -126.55 146.2 32.8 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.281 0 N-CA-C 107.842 -1.17 . . . . 0.0 107.842 173.169 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 34.0 m -133.02 131.89 41.22 Favored 'General case' 0 C--N 1.333 -0.129 0 C-N-CA 125.045 1.338 . . . . 0.0 108.635 -175.481 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.483 HD21 ' HG2' ' A' ' 22' ' ' ARG . 22.9 mt -75.53 137.71 41.04 Favored 'General case' 0 C--O 1.231 0.092 0 N-CA-C 108.809 -0.811 . . . . 0.0 108.809 177.393 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 23.2 t-80 -135.45 54.51 1.92 Allowed 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 124.788 1.235 . . . . 0.0 108.477 -177.006 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 38.3 t-20 -53.58 123.52 12.41 Favored 'General case' 0 C--O 1.237 0.41 0 N-CA-C 107.485 -1.302 . . . . 0.0 107.485 170.675 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.405 HD23 ' HA ' ' A' ' 35' ' ' LEU . 31.7 mt -70.46 -19.74 62.93 Favored 'General case' 0 C--O 1.235 0.302 0 N-CA-C 112.824 0.676 . . . . 0.0 112.824 -173.782 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 55.9 tptt -70.63 -19.44 62.82 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-N 118.915 0.78 . . . . 0.0 110.91 169.771 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -103.38 -36.49 8.0 Favored 'General case' 0 C--O 1.233 0.235 0 C-N-CA 123.975 0.91 . . . . 0.0 113.107 -170.732 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 3.3 t0 -139.64 156.24 46.95 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 118.668 0.667 . . . . 0.0 112.539 178.268 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 19.9 m -75.4 157.88 84.17 Favored Pre-proline 0 CA--C 1.541 0.623 0 C-N-CA 125.931 1.692 . . . . 0.0 111.714 -170.58 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 78.1 Cg_endo -74.86 -26.49 11.16 Favored 'Trans proline' 0 C--N 1.349 0.584 0 C-N-CA 122.68 2.254 . . . . 0.0 113.493 -170.297 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 23.0 mmmt -70.79 -12.42 61.54 Favored 'General case' 0 N--CA 1.472 0.65 0 O-C-N 120.685 -1.26 . . . . 0.0 111.531 -176.159 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -60.24 -29.36 68.72 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 125.423 1.489 . . . . 0.0 110.354 168.832 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 48.4 mtt -59.41 -25.37 64.26 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 118.65 0.659 . . . . 0.0 111.436 178.425 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 89.9 mt-10 -65.83 -33.06 74.99 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-O 118.96 -0.543 . . . . 0.0 110.027 -176.84 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 24.9 mt-30 -65.22 -45.51 84.41 Favored 'General case' 0 N--CA 1.465 0.313 0 C-N-CA 123.424 0.69 . . . . 0.0 112.771 -169.959 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 44.5 m-85 -77.73 133.2 38.34 Favored 'General case' 0 CA--C 1.52 -0.204 0 C-N-CA 123.718 0.807 . . . . 0.0 109.205 -167.234 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -75.58 -22.22 57.14 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-N 118.883 0.765 . . . . 0.0 111.833 -177.135 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 53.0 t -113.6 143.33 23.53 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.588 0 N-CA-C 106.633 -1.618 . . . . 0.0 106.633 169.441 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 31.2 tp -133.65 149.03 51.56 Favored 'General case' 0 N--CA 1.444 -0.763 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 172.278 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 28.9 mt -128.71 133.34 66.57 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 N-CA-C 105.38 -2.082 . . . . 0.0 105.38 179.917 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.413 ' HG ' ' CE2' ' A' ' 6' ' ' PHE . 3.1 mp -118.25 128.76 54.99 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 125.701 1.6 . . . . 0.0 107.781 -172.842 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -131.57 134.23 7.58 Favored Glycine 0 C--N 1.332 0.315 0 N-CA-C 110.912 -0.875 . . . . 0.0 110.912 174.69 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 2.9 tt -153.88 137.06 10.16 Favored Pre-proline 0 CA--C 1.542 0.667 0 CA-C-N 118.654 1.227 . . . . 0.0 111.662 170.37 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_exo -72.36 156.87 54.24 Favored 'Trans proline' 0 CA--C 1.536 0.599 0 C-N-CA 123.347 2.698 . . . . 0.0 113.081 167.976 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 3.1 m -132.87 146.71 52.04 Favored 'General case' 0 CA--C 1.538 0.485 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 167.409 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 11.4 m-90 -138.76 169.81 17.12 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 126.013 1.725 . . . . 0.0 108.441 174.319 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -61.88 -31.13 71.39 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 123.383 0.673 . . . . 0.0 112.597 -177.604 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 52.4 p90 -142.44 159.13 42.84 Favored 'General case' 0 C--O 1.239 0.509 0 C-N-CA 124.986 1.314 . . . . 0.0 108.317 172.921 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 66.13 30.29 76.58 Favored Glycine 0 CA--C 1.534 1.241 0 N-CA-C 111.501 -0.639 . . . . 0.0 111.501 -178.953 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 3.9 pm0 -65.54 149.55 49.88 Favored 'General case' 0 C--O 1.239 0.524 0 CA-C-N 117.946 0.873 . . . . 0.0 109.548 170.932 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . 0.256 59.0 mt 60.32 151.4 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.55 0.965 0 C-N-CA 126.208 1.803 . . . . 0.0 111.361 -168.881 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -118.22 156.7 28.32 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 125.265 1.426 . . . . 0.0 107.579 -175.974 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -57.41 -45.01 85.05 Favored 'General case' 0 CA--C 1.529 0.153 0 C-N-CA 123.233 0.613 . . . . 0.0 110.677 -172.053 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -64.42 -19.54 65.58 Favored 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 113.219 0.822 . . . . 0.0 113.219 -177.115 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 13.0 t90 -95.91 -47.2 6.23 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 124.754 1.222 . . . . 0.0 109.485 178.23 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 10.9 tt0 -62.79 -35.26 79.26 Favored 'General case' 0 N--CA 1.446 -0.642 0 O-C-N 120.877 -1.139 . . . . 0.0 109.975 -178.899 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -58.13 -25.76 61.82 Favored 'General case' 0 CA--C 1.529 0.173 0 C-N-CA 124.034 0.933 . . . . 0.0 111.711 -177.262 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 28.6 m -113.29 -13.4 11.4 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.266 0 CA-C-O 117.21 -1.376 . . . . 0.0 112.484 177.675 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 26.0 t90 -52.75 -35.21 55.8 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 120.53 1.514 . . . . 0.0 110.968 -178.908 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -64.3 -27.72 69.23 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 125.567 1.547 . . . . 0.0 113.269 175.944 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 29.3 mt-30 -92.47 -19.61 21.83 Favored 'General case' 0 C--N 1.343 0.288 0 C-N-CA 125.93 1.692 . . . . 0.0 112.524 176.214 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 52.5 mt -63.69 -20.96 66.13 Favored 'General case' 0 CA--C 1.536 0.415 0 O-C-N 121.318 -0.864 . . . . 0.0 111.467 -176.398 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -79.01 -23.34 44.42 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 123.112 0.565 . . . . 0.0 111.503 174.401 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -72.83 -29.82 63.53 Favored 'General case' 0 N--CA 1.469 0.509 0 O-C-N 120.628 -1.295 . . . . 0.0 111.883 178.714 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 80.1 mt -52.85 141.05 22.61 Favored 'General case' 0 C--N 1.34 0.16 0 C-N-CA 125.239 1.415 . . . . 0.0 113.009 -168.484 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 3.7 t30 -75.62 102.48 5.34 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 123.832 0.853 . . . . 0.0 108.729 170.437 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 66.7 mt -125.03 -0.48 7.85 Favored 'General case' 0 N--CA 1.475 0.784 0 N-CA-C 114.058 1.133 . . . . 0.0 114.058 -173.572 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 27.0 mt-10 -57.25 128.78 38.75 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 119.528 1.058 . . . . 0.0 111.144 -169.253 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 73.43 -1.79 41.45 Favored Glycine 0 CA--C 1.534 1.25 0 C-N-CA 125.394 1.474 . . . . 0.0 115.103 178.518 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.68 148.95 40.13 Favored 'General case' 0 C--N 1.344 0.354 0 CA-C-N 120.543 2.171 . . . . 0.0 109.474 -176.362 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 1.8 mt -80.49 136.28 23.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 N-CA-C 106.712 -1.588 . . . . 0.0 106.712 179.246 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 76.2 t -133.0 125.1 51.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 C-N-CA 123.97 0.908 . . . . 0.0 109.805 -175.608 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -98.72 151.73 20.43 Favored 'General case' 0 N--CA 1.463 0.177 0 N-CA-C 107.938 -1.134 . . . . 0.0 107.938 166.674 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 1.2 mt -133.93 138.73 45.69 Favored 'General case' 0 CA--C 1.512 -0.493 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 175.382 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 45.6 p90 -150.48 168.92 22.77 Favored 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 171.223 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -168.12 166.63 39.61 Favored Glycine 0 N--CA 1.444 -0.775 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 173.386 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -111.96 148.46 33.72 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 124.315 1.046 . . . . 0.0 109.037 170.546 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -162.45 -176.44 34.53 Favored Glycine 0 CA--C 1.527 0.814 0 N-CA-C 107.685 -2.166 . . . . 0.0 107.685 174.453 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -146.06 134.25 21.66 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 117.777 0.789 . . . . 0.0 110.223 -179.179 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 15.0 pm0 -78.56 -20.4 50.69 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 126.715 2.006 . . . . 0.0 112.726 -179.799 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 95.3 mt -81.12 -41.48 22.42 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 119.657 1.117 . . . . 0.0 111.826 -175.768 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -58.34 -48.99 80.47 Favored Glycine 0 CA--C 1.528 0.844 0 C-N-CA 123.886 0.755 . . . . 0.0 111.716 -172.873 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 16.9 t80 -156.74 -43.79 0.07 Allowed 'General case' 0 N--CA 1.464 0.27 0 C-N-CA 122.941 0.497 . . . . 0.0 111.012 169.283 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 91.24 -22.98 26.82 Favored Glycine 0 CA--C 1.525 0.701 0 CA-C-O 118.695 -1.058 . . . . 0.0 112.963 171.396 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 81.7 mt-10 -72.62 -15.54 61.73 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 119.677 1.739 . . . . 0.0 112.112 179.53 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' TRP . . . . . . . . . . . . . 38.1 m95 -109.27 22.58 15.65 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 124.422 1.089 . . . . 0.0 111.85 174.354 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 18.0 t80 -54.87 124.42 16.56 Favored 'General case' 0 C--N 1.342 0.27 0 O-C-N 121.066 -1.021 . . . . 0.0 108.903 174.952 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 92.8 mt 53.05 23.54 3.01 Favored 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 124.533 1.133 . . . . 0.0 114.014 169.75 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -62.8 -33.82 76.0 Favored 'General case' 0 C--N 1.332 -0.176 0 O-C-N 120.538 -1.351 . . . . 0.0 110.708 -174.873 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -72.08 -29.97 64.65 Favored 'General case' 0 CA--C 1.533 0.315 0 O-C-N 121.563 -0.711 . . . . 0.0 112.216 176.377 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 4.1 tt -62.04 -46.68 88.11 Favored 'General case' 0 N--CA 1.467 0.395 0 N-CA-C 107.574 -1.269 . . . . 0.0 107.574 170.226 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -63.59 -37.29 94.53 Favored Glycine 0 C--N 1.341 0.84 0 CA-C-O 119.212 -0.771 . . . . 0.0 112.088 178.793 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 65.1 mtm -63.58 -42.9 98.26 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 118.823 1.312 . . . . 0.0 111.69 -179.67 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -70.25 -37.18 74.87 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 120.238 1.381 . . . . 0.0 109.793 176.335 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 59.1 t60 -56.98 -48.6 78.04 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 118.798 0.727 . . . . 0.0 110.892 177.177 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -61.97 -39.27 91.6 Favored 'General case' 0 C--O 1.235 0.315 0 C-N-CA 124.176 0.99 . . . . 0.0 112.041 -178.072 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 24.0 ttmm -58.45 -33.8 70.12 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 123.235 0.614 . . . . 0.0 110.649 172.854 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 19.4 mt -94.63 -21.18 18.97 Favored 'General case' 0 CA--C 1.513 -0.45 0 N-CA-C 116.297 1.962 . . . . 0.0 116.297 -168.956 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 4.3 m -59.01 -33.59 70.9 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 120.951 1.705 . . . . 0.0 111.424 -176.272 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 20.1 p -85.8 -11.97 52.1 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 125.252 1.421 . . . . 0.0 112.152 179.758 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 31.7 mmmt -83.14 -6.32 59.44 Favored 'General case' 0 C--N 1.344 0.352 0 C-N-CA 124.907 1.283 . . . . 0.0 111.386 173.785 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 71.44 32.42 64.9 Favored Glycine 0 C--N 1.337 0.597 0 CA-C-N 118.779 0.718 . . . . 0.0 112.103 170.499 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 4.2 m -75.37 172.3 1.13 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.532 0 CA-C-N 118.027 0.913 . . . . 0.0 109.316 173.563 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -113.15 122.11 46.54 Favored 'General case' 0 N--CA 1.466 0.327 0 N-CA-C 106.579 -1.637 . . . . 0.0 106.579 173.265 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 81.3 m-85 -88.86 145.89 25.29 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 119.422 1.01 . . . . 0.0 109.672 -176.343 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 29.5 m -132.73 160.69 42.44 Favored 'Isoleucine or valine' 0 C--O 1.236 0.355 0 C-N-CA 124.583 1.153 . . . . 0.0 109.153 171.338 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 98.7 -83.29 0.63 Allowed Glycine 0 N--CA 1.448 -0.559 0 C-N-CA 124.906 1.241 . . . . 0.0 111.106 174.196 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 16.7 m-30 55.69 -171.15 0.07 Allowed 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 124.503 1.121 . . . . 0.0 110.179 -169.152 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -154.41 144.05 15.31 Favored Pre-proline 0 N--CA 1.468 0.451 0 O-C-N 120.651 -1.281 . . . . 0.0 108.712 169.902 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -68.5 124.99 12.21 Favored 'Trans proline' 0 CA--C 1.534 0.517 0 C-N-CA 122.34 2.027 . . . . 0.0 111.321 179.612 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 5.9 p -76.78 -25.16 53.07 Favored 'General case' 0 N--CA 1.469 0.48 0 O-C-N 121.794 -0.566 . . . . 0.0 111.804 174.314 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -62.91 127.31 30.64 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 124.056 0.942 . . . . 0.0 109.467 -170.869 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 77.01 1.54 74.0 Favored Glycine 0 CA--C 1.534 1.239 0 CA-C-O 118.76 -1.022 . . . . 0.0 114.072 178.455 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 14.5 t80 -89.46 174.43 7.8 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 119.035 1.417 . . . . 0.0 110.064 173.162 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 48.6 mm-40 -80.86 -99.83 0.03 OUTLIER 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 124.303 1.041 . . . . 0.0 109.697 178.372 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 3.1 p90 46.84 176.51 0.0 OUTLIER 'General case' 0 CA--C 1.548 0.897 0 C-N-CA 129.849 3.26 . . . . 0.0 115.789 -178.027 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 11.3 t -156.97 -31.79 0.08 Allowed 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 123.844 0.858 . . . . 0.0 110.737 168.583 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 11.4 m -54.47 132.45 63.08 Favored Pre-proline 0 CA--C 1.543 0.678 0 C-N-CA 125.234 1.413 . . . . 0.0 112.571 -173.702 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -81.62 -32.08 0.96 Allowed 'Trans proline' 0 CA--C 1.537 0.65 0 C-N-CA 122.773 2.315 . . . . 0.0 113.153 178.875 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 24.2 ttmt -56.6 -40.5 85.4 Favored Pre-proline 0 CA--C 1.542 0.648 0 CA-C-O 117.578 -1.201 . . . . 0.0 113.769 -176.178 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -80.49 5.67 5.94 Favored 'Trans proline' 0 C--N 1.351 0.663 0 C-N-CA 121.944 1.763 . . . . 0.0 114.84 179.002 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 20.3 m -124.77 152.08 30.71 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.379 0 CA-C-N 122.152 2.251 . . . . 0.0 111.486 -178.4 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . 0.894 HG23 HG12 ' A' ' 140' ' ' VAL . 15.0 pt -96.53 163.69 2.34 Favored 'Isoleucine or valine' 0 C--O 1.236 0.355 0 C-N-CA 124.765 1.226 . . . . 0.0 109.556 169.246 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . 53.69 43.0 31.7 Favored 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 124.62 1.168 . . . . 0.0 112.19 167.61 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 31.5 t70 63.93 -32.32 0.12 Allowed 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 129.09 2.956 . . . . 0.0 114.616 -171.313 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 177.1 28.51 0.04 OUTLIER Glycine 0 CA--C 1.527 0.809 0 CA-C-O 117.867 -1.518 . . . . 0.0 114.616 177.499 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 74.2 mm-40 -76.2 -41.42 49.56 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 120.351 2.075 . . . . 0.0 111.248 -177.909 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -143.74 153.05 42.03 Favored 'General case' 0 CA--C 1.519 -0.238 0 C-N-CA 123.489 0.716 . . . . 0.0 109.888 176.727 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 74.7 m-85 -72.5 141.35 48.53 Favored 'General case' 0 N--CA 1.447 -0.595 0 N-CA-C 104.994 -2.224 . . . . 0.0 104.994 163.642 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . 0.894 HG12 HG23 ' A' ' 133' ' ' ILE . 4.3 m -76.07 4.86 1.01 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.904 0 C-N-CA 122.968 0.507 . . . . 0.0 111.427 -176.608 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -174.06 171.53 44.6 Favored Glycine 0 CA--C 1.528 0.869 0 C-N-CA 125.847 1.689 . . . . 0.0 109.771 -179.139 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -64.2 136.37 57.15 Favored 'General case' 0 N--CA 1.466 0.375 0 C-N-CA 123.642 0.777 . . . . 0.0 111.361 -177.221 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -101.12 113.08 25.78 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 126.161 1.784 . . . . 0.0 109.222 -179.824 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 96.1 mt -108.16 151.64 25.64 Favored 'General case' 0 N--CA 1.464 0.255 0 C-N-CA 124.607 1.163 . . . . 0.0 110.218 175.583 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -154.45 156.35 36.59 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 126.198 1.799 . . . . 0.0 106.87 167.903 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -132.7 -2.1 3.37 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 126.104 1.762 . . . . 0.0 110.637 174.293 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 7.0 m -80.43 -52.12 8.03 Favored 'General case' 0 C--O 1.234 0.274 0 C-N-CA 125.829 1.652 . . . . 0.0 110.187 -171.814 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 6.6 m-80 -80.48 -33.36 36.66 Favored 'General case' 0 C--N 1.331 -0.207 0 C-N-CA 124.549 1.14 . . . . 0.0 110.181 -169.101 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 12.5 pt20 -159.62 152.38 21.57 Favored 'General case' 0 C--O 1.236 0.352 0 C-N-CA 127.073 2.149 . . . . 0.0 106.687 -175.121 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 85.8 t80 -124.26 -27.49 3.8 Favored 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 123.762 0.825 . . . . 0.0 111.594 -176.701 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -68.19 -33.15 73.9 Favored 'General case' 0 N--CA 1.465 0.317 0 O-C-N 121.545 -0.722 . . . . 0.0 111.516 -174.583 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -84.66 -13.52 51.25 Favored 'General case' 0 C--N 1.344 0.334 0 CA-C-O 118.206 -0.902 . . . . 0.0 111.956 -179.943 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 8.1 m -60.57 -34.94 74.91 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 120.824 1.647 . . . . 0.0 110.481 -176.731 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -65.19 -43.73 90.7 Favored 'General case' 0 N--CA 1.463 0.191 0 C-N-CA 123.507 0.723 . . . . 0.0 111.376 173.317 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 19.9 tt0 -64.39 -43.56 94.08 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 124.702 1.201 . . . . 0.0 110.894 -179.094 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 54.0 mtp85 -62.41 -36.83 83.58 Favored 'General case' 0 N--CA 1.462 0.141 0 C-N-CA 124.119 0.967 . . . . 0.0 109.989 -179.858 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 55.7 mt -70.01 -57.38 8.32 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.461 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 172.495 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 158' ' ' GLN . . . . . 0.611 ' HA ' HD13 ' A' ' 24' ' ' ILE . 68.2 tp60 -46.56 -65.77 0.51 Allowed 'General case' 0 C--O 1.235 0.314 0 C-N-CA 126.203 1.801 . . . . 0.0 112.476 -172.974 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 16.9 m -68.23 -29.09 67.84 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 123.091 0.244 . . . . 0.0 111.014 -169.483 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 160' ' ' TRP . . . . . . . . . . . . . 62.2 t90 -72.03 -44.6 63.14 Favored 'General case' 0 CA--C 1.515 -0.391 0 O-C-N 121.808 -0.558 . . . . 0.0 111.156 177.264 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 95.8 m -61.39 -40.52 94.68 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 122.717 0.407 . . . . 0.0 109.951 177.498 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -62.74 -42.58 99.74 Favored 'General case' 0 C--O 1.227 -0.098 0 CA-C-O 121.078 0.466 . . . . 0.0 110.254 174.028 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 12.1 tt0 -62.66 -51.57 66.74 Favored 'General case' 0 N--CA 1.449 -0.513 0 O-C-N 121.614 -0.679 . . . . 0.0 110.154 -178.445 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 45.5 pt -63.04 -38.13 81.22 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.367 0 CA-C-O 117.976 -1.011 . . . . 0.0 109.481 -174.962 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -65.02 -33.59 76.4 Favored 'General case' 0 C--O 1.225 -0.235 0 CA-C-N 119.416 1.007 . . . . 0.0 110.351 179.788 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 35.0 m-80 -69.23 -57.47 5.31 Favored 'General case' 0 C--O 1.223 -0.32 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 174.592 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 13.0 tt0 -63.45 -36.47 83.86 Favored 'General case' 0 N--CA 1.445 -0.68 0 C-N-CA 125.514 1.526 . . . . 0.0 111.131 -169.251 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 168' ' ' MET . . . . . . . . . . . . . 20.0 ptp -70.27 -32.75 70.7 Favored 'General case' 0 C--O 1.226 -0.16 0 O-C-N 121.63 -0.669 . . . . 0.0 111.761 174.08 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -75.28 -34.72 61.35 Favored 'General case' 0 N--CA 1.448 -0.568 0 CA-C-O 119.082 -0.485 . . . . 0.0 112.174 -178.776 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 6.2 mt-10 -63.57 -35.74 81.5 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-O 121.794 0.807 . . . . 0.0 109.317 177.613 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 74.0 t60 -67.15 -22.5 65.77 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 125.127 1.371 . . . . 0.0 111.751 -177.612 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 45.4 m-85 -84.78 -9.9 57.73 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 124.356 1.062 . . . . 0.0 113.441 173.587 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.254 1.311 0 CA-C-N 119.69 1.132 . . . . 0.0 110.122 -178.766 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.498 1.961 0 N-CA-C 111.316 0.117 . . . . 0.0 111.316 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 9.0 t30 -114.31 152.04 32.02 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 123.736 0.815 . . . . 0.0 110.136 -179.082 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 16.0 mtt -116.21 129.55 56.35 Favored 'General case' 0 N--CA 1.461 0.103 0 C-N-CA 123.948 0.899 . . . . 0.0 110.731 -179.265 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -85.35 154.62 28.85 Favored Glycine 0 CA--C 1.524 0.644 0 N-CA-C 107.484 -2.246 . . . . 0.0 107.484 167.192 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 1.4 tt -142.05 96.51 2.97 Favored 'General case' 0 N--CA 1.466 0.343 0 N-CA-C 106.338 -1.727 . . . . 0.0 106.338 -175.447 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -106.06 144.67 32.44 Favored 'General case' 0 CA--C 1.519 -0.238 0 CA-C-O 121.481 0.658 . . . . 0.0 111.9 -170.761 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 23.6 p90 -162.82 165.69 25.05 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 125.879 1.671 . . . . 0.0 108.015 -177.53 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -159.15 125.86 1.57 Allowed Glycine 0 C--N 1.33 0.232 0 N-CA-C 104.952 -3.259 . . . . 0.0 104.952 169.882 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 8.5 p -148.97 158.36 44.12 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 118.617 1.209 . . . . 0.0 110.412 -168.996 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 13.5 m -58.63 129.32 41.54 Favored 'General case' 0 CA--C 1.534 0.359 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 172.867 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER 53.65 26.81 6.14 Favored 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 124.327 1.051 . . . . 0.0 112.08 -177.492 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 77.3 m 48.78 35.21 6.08 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 125.529 1.531 . . . . 0.0 112.853 -174.296 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 47.9 t80 -60.6 -32.03 71.17 Favored 'General case' 0 CA--C 1.539 0.521 0 O-C-N 121.318 -0.864 . . . . 0.0 112.5 -172.052 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 25.2 m -67.01 -11.38 56.86 Favored 'General case' 0 CA--C 1.54 0.571 0 O-C-N 121.14 -0.975 . . . . 0.0 111.798 178.985 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 5.5 tt0 -62.97 -25.42 68.35 Favored 'General case' 0 CA--C 1.536 0.408 0 O-C-N 120.867 -1.146 . . . . 0.0 111.446 176.665 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 5.2 mpp? -71.56 -40.7 69.79 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 119.7 1.136 . . . . 0.0 110.802 175.203 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -60.9 -45.28 95.22 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 119.259 0.936 . . . . 0.0 108.78 170.547 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -63.45 -47.68 80.87 Favored 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 123.17 0.588 . . . . 0.0 111.907 -174.161 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.1 pp20? -67.38 -35.73 79.91 Favored 'General case' 0 CA--C 1.535 0.383 0 O-C-N 121.596 -0.69 . . . . 0.0 109.274 -179.671 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 29.3 mtpp -67.37 -40.58 85.77 Favored 'General case' 0 C--O 1.225 -0.232 0 O-C-N 121.126 -0.984 . . . . 0.0 110.916 175.968 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 37.8 mt -56.24 -56.18 14.68 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.198 0 CA-C-N 119.995 1.27 . . . . 0.0 109.171 176.196 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.5 -35.89 82.4 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 118.529 0.604 . . . . 0.0 110.946 -175.494 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -63.42 -40.14 96.39 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 117.94 0.336 . . . . 0.0 110.888 177.94 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.4 HD13 ' HA ' ' A' ' 158' ' ' GLN . 67.6 mt -77.14 -53.58 14.49 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 C-N-CA 124.23 1.012 . . . . 0.0 110.353 -174.17 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 70.7 mt -60.3 -49.53 83.85 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.317 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 177.917 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 144.25 119.14 1.31 Allowed Glycine 0 CA--C 1.528 0.887 0 N-CA-C 110.133 -1.187 . . . . 0.0 110.133 179.209 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -68.71 -14.52 39.42 Favored 'Trans proline' 0 CA--C 1.536 0.588 0 C-N-CA 122.955 2.436 . . . . 0.0 113.022 -173.278 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -73.56 -21.54 60.33 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 118.579 0.627 . . . . 0.0 112.051 179.396 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -129.57 8.12 5.36 Favored 'General case' 0 CA--C 1.536 0.405 0 N-CA-C 113.862 1.06 . . . . 0.0 113.862 -169.162 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 33.7 t -128.13 147.09 32.77 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.387 0 C-N-CA 124.449 1.099 . . . . 0.0 108.066 172.308 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 26.9 m -131.53 131.74 43.62 Favored 'General case' 0 C--N 1.332 -0.164 0 C-N-CA 125.643 1.577 . . . . 0.0 108.419 -174.716 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 18.4 mt -75.93 134.01 40.35 Favored 'General case' 0 C--O 1.232 0.154 0 N-CA-C 108.401 -0.963 . . . . 0.0 108.401 175.018 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 25.4 t-80 -130.67 55.75 1.81 Allowed 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 124.806 1.242 . . . . 0.0 108.528 -176.741 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 54.2 t-20 -60.11 125.09 22.33 Favored 'General case' 0 C--O 1.233 0.193 0 N-CA-C 107.974 -1.121 . . . . 0.0 107.974 176.817 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 80.9 mt -69.94 -20.58 63.33 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 118.429 0.559 . . . . 0.0 112.282 -176.93 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 58.2 tptt -63.61 -25.91 68.44 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 118.467 0.576 . . . . 0.0 110.712 168.931 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -106.01 -37.9 6.49 Favored 'General case' 0 C--O 1.235 0.327 0 N-CA-C 113.452 0.908 . . . . 0.0 113.452 -169.426 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 2.6 t0 -134.64 155.82 49.83 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-N 118.834 0.743 . . . . 0.0 112.627 -175.578 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 19.5 m -76.32 156.67 83.49 Favored Pre-proline 0 CA--C 1.539 0.555 0 C-N-CA 125.551 1.54 . . . . 0.0 111.415 -172.097 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -75.59 -26.25 10.19 Favored 'Trans proline' 0 C--N 1.348 0.506 0 C-N-CA 122.603 2.202 . . . . 0.0 113.882 -171.173 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 21.4 mmmt -70.84 -11.75 61.14 Favored 'General case' 0 N--CA 1.474 0.731 0 O-C-N 120.271 -1.518 . . . . 0.0 111.654 -176.232 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -58.02 -30.96 66.53 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 125.879 1.672 . . . . 0.0 110.089 168.329 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 46.1 mtt -57.77 -25.12 60.05 Favored 'General case' 0 N--CA 1.463 0.206 0 C-N-CA 123.341 0.656 . . . . 0.0 111.838 178.616 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 87.1 mt-10 -66.77 -33.92 76.69 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 118.463 0.574 . . . . 0.0 110.02 -177.693 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 13.8 mt-30 -67.49 -45.17 76.64 Favored 'General case' 0 N--CA 1.465 0.307 0 C-N-CA 123.202 0.601 . . . . 0.0 112.412 -169.874 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 26.1 m-85 -72.05 137.55 47.23 Favored 'General case' 0 N--CA 1.456 -0.132 0 CA-C-N 115.317 -0.856 . . . . 0.0 110.042 -166.574 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -74.26 -35.08 63.78 Favored 'General case' 0 N--CA 1.466 0.355 0 O-C-N 121.872 -0.518 . . . . 0.0 110.788 -177.265 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 20.5 t -108.56 145.69 15.21 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.436 0 N-CA-C 106.991 -1.485 . . . . 0.0 106.991 169.386 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 36.4 tp -133.95 112.78 11.53 Favored 'General case' 0 N--CA 1.447 -0.606 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 175.379 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.426 ' HA ' ' HB3' ' A' ' 83' ' ' ALA . 22.8 mt -89.92 134.47 28.89 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.665 0 N-CA-C 107.15 -1.426 . . . . 0.0 107.15 176.248 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 2.7 mp -115.54 130.63 56.94 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 125.613 1.565 . . . . 0.0 107.473 -178.365 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -135.65 136.28 8.38 Favored Glycine 0 C--N 1.333 0.368 0 N-CA-C 109.413 -1.475 . . . . 0.0 109.413 173.986 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 3.1 tt -152.98 137.34 10.71 Favored Pre-proline 0 CA--C 1.536 0.424 0 CA-C-N 118.477 1.138 . . . . 0.0 110.451 171.534 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -82.04 138.62 10.33 Favored 'Trans proline' 0 N--CA 1.453 -0.871 0 C-N-CA 122.476 2.118 . . . . 0.0 109.886 167.561 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 30.2 m -94.63 144.29 25.72 Favored 'General case' 0 CA--C 1.543 0.698 0 N-CA-C 106.084 -1.821 . . . . 0.0 106.084 167.775 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 37.1 m0 -78.62 169.77 17.71 Favored 'General case' 0 CA--C 1.535 0.391 0 O-C-N 121.701 -0.624 . . . . 0.0 110.604 -174.9 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -63.11 -33.17 74.87 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 123.414 0.686 . . . . 0.0 111.196 171.402 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 43.6 t80 -146.12 136.46 23.87 Favored 'General case' 0 C--O 1.235 0.318 0 C-N-CA 125.336 1.454 . . . . 0.0 107.357 173.62 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 71.4 -167.57 51.84 Favored Glycine 0 CA--C 1.535 1.32 0 N-CA-C 110.659 -0.976 . . . . 0.0 110.659 -169.733 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -160.29 161.92 33.45 Favored 'General case' 0 CA--C 1.54 0.562 0 O-C-N 121.822 -0.811 . . . . 0.0 112.234 -179.154 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 55.7 mt 66.17 151.29 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.549 0.91 0 C-N-CA 128.196 2.598 . . . . 0.0 112.821 170.689 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 1.2 pm0 -125.77 156.85 38.8 Favored 'General case' 0 C--O 1.232 0.162 0 C-N-CA 126.172 1.789 . . . . 0.0 108.682 -176.437 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -54.92 -43.26 73.16 Favored 'General case' 0 C--O 1.224 -0.261 0 C-N-CA 124.524 1.13 . . . . 0.0 112.355 -168.746 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -65.23 -20.33 66.38 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-N 119.156 0.889 . . . . 0.0 111.835 -174.082 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' TRP . . . . . 0.407 ' CH2' HD23 ' A' ' 104' ' ' LEU . 12.6 t90 -96.24 -49.04 5.38 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 124.448 1.099 . . . . 0.0 109.75 175.344 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -62.98 -35.28 79.65 Favored 'General case' 0 CA--C 1.536 0.426 0 O-C-N 121.041 -1.037 . . . . 0.0 110.413 -175.434 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -61.89 -27.41 68.78 Favored 'General case' 0 CA--C 1.53 0.179 0 C-N-CA 123.087 0.555 . . . . 0.0 111.059 -174.637 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 30.9 m -107.35 -17.08 8.1 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.372 0 CA-C-O 117.199 -1.382 . . . . 0.0 112.156 177.014 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 35.8 t90 -50.66 -34.75 27.65 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 120.447 1.476 . . . . 0.0 110.931 177.823 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -62.56 -31.14 71.89 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 125.315 1.446 . . . . 0.0 113.319 174.901 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 30.4 mt-30 -88.8 -20.89 24.12 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 126.555 1.942 . . . . 0.0 111.273 178.73 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 50.8 mt -65.25 -20.62 66.51 Favored 'General case' 0 CA--C 1.533 0.301 0 O-C-N 121.41 -0.806 . . . . 0.0 111.672 -173.603 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -79.0 -23.4 44.43 Favored 'General case' 0 CA--C 1.542 0.653 0 CA-C-N 118.399 0.545 . . . . 0.0 111.793 175.25 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -71.99 -30.03 64.84 Favored 'General case' 0 N--CA 1.468 0.47 0 O-C-N 120.723 -1.236 . . . . 0.0 111.958 178.177 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 80.1 mt -52.89 140.92 23.14 Favored 'General case' 0 C--N 1.338 0.102 0 C-N-CA 124.887 1.275 . . . . 0.0 112.994 -168.417 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 29.2 t-20 -76.14 108.95 9.41 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 169.688 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 70.2 mt -131.6 -0.07 3.96 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 114.317 1.228 . . . . 0.0 114.317 -172.348 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 28.8 mt-10 -57.2 129.8 43.38 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 119.68 1.127 . . . . 0.0 111.25 -168.544 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 73.9 -2.0 44.07 Favored Glycine 0 CA--C 1.533 1.204 0 C-N-CA 125.531 1.539 . . . . 0.0 115.023 178.32 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.04 150.3 40.71 Favored 'General case' 0 C--N 1.346 0.414 0 CA-C-N 120.663 2.231 . . . . 0.0 109.683 -176.649 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 4.3 mt -82.25 137.51 20.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 N-CA-C 106.489 -1.671 . . . . 0.0 106.489 179.068 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 67.0 t -130.92 129.49 63.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 C-N-CA 123.629 0.771 . . . . 0.0 109.515 -176.879 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.426 ' HB3' ' HA ' ' A' ' 50' ' ' ILE . . . -100.66 151.59 21.46 Favored 'General case' 0 N--CA 1.463 0.213 0 N-CA-C 107.735 -1.209 . . . . 0.0 107.735 168.715 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 4.5 mt -133.02 134.61 44.65 Favored 'General case' 0 CA--C 1.514 -0.409 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 176.394 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 37.4 p90 -149.91 168.14 24.64 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 107.692 -1.225 . . . . 0.0 107.692 168.655 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -168.19 171.22 42.42 Favored Glycine 0 N--CA 1.446 -0.656 0 N-CA-C 110.449 -1.061 . . . . 0.0 110.449 176.119 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.467 HD13 ' N ' ' A' ' 88' ' ' GLY . 1.9 tm? -126.94 148.34 50.06 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 126.171 1.789 . . . . 0.0 106.781 -175.805 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . 0.467 ' N ' HD13 ' A' ' 87' ' ' LEU . . . -166.14 -160.68 13.75 Favored Glycine 0 CA--C 1.521 0.435 0 N-CA-C 109.174 -1.57 . . . . 0.0 109.174 173.25 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 49.5 t0 -140.5 109.98 6.3 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 108.041 -1.096 . . . . 0.0 108.041 169.515 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -68.81 -21.49 64.31 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 123.223 0.609 . . . . 0.0 111.828 -176.948 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 49.1 mt -84.15 -22.96 30.83 Favored 'General case' 0 N--CA 1.466 0.344 0 C-N-CA 124.739 1.216 . . . . 0.0 109.98 174.503 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -66.75 -45.14 86.81 Favored Glycine 0 CA--C 1.529 0.956 0 C-N-CA 124.243 0.925 . . . . 0.0 111.584 -174.902 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 9.4 t80 -146.7 -45.22 0.18 Allowed 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 117.114 0.457 . . . . 0.0 111.825 177.111 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 78.76 -31.58 1.95 Allowed Glycine 0 N--CA 1.47 0.924 0 C-N-CA 124.43 1.014 . . . . 0.0 113.892 172.161 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -72.51 -16.74 61.78 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 124.277 1.031 . . . . 0.0 111.359 171.621 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' TRP . . . . . . . . . . . . . 31.9 m0 -129.57 30.72 4.88 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 125.399 1.48 . . . . 0.0 111.092 179.262 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 15.9 t80 -61.88 134.44 56.69 Favored 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 107.445 -1.317 . . . . 0.0 107.445 173.999 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 97.0 mt 53.4 25.9 4.98 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 124.306 1.042 . . . . 0.0 113.234 172.705 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -65.05 -37.75 88.6 Favored 'General case' 0 N--CA 1.465 0.3 0 O-C-N 120.659 -1.275 . . . . 0.0 110.786 -170.766 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -65.45 -28.79 69.47 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 123.783 0.833 . . . . 0.0 112.304 173.971 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 5.3 tt -64.77 -49.28 71.35 Favored 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 108.039 -1.097 . . . . 0.0 108.039 174.01 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -62.33 -34.08 88.14 Favored Glycine 0 CA--C 1.529 0.948 0 N-CA-C 111.213 -0.755 . . . . 0.0 111.213 179.277 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 7.2 tpp -53.86 -50.97 65.08 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 124.683 1.193 . . . . 0.0 111.566 178.729 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.407 HD23 ' CH2' ' A' ' 65' ' ' TRP . 0.2 OUTLIER -76.52 -36.17 57.89 Favored 'General case' 0 CA--C 1.534 0.355 0 N-CA-C 109.433 -0.581 . . . . 0.0 109.433 -174.966 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 51.0 t-80 -56.99 -44.81 83.11 Favored 'General case' 0 N--CA 1.467 0.381 0 O-C-N 121.463 -0.773 . . . . 0.0 111.296 174.032 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -63.86 -43.68 95.38 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 123.609 0.764 . . . . 0.0 111.384 -178.633 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 25.1 ttmm -56.14 -43.12 77.92 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 123.476 0.71 . . . . 0.0 110.289 173.125 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 21.3 mt -85.75 -19.29 31.01 Favored 'General case' 0 CA--C 1.511 -0.529 0 N-CA-C 115.141 1.534 . . . . 0.0 115.141 -169.755 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 67.8 m -59.97 -29.8 68.67 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 119.659 1.118 . . . . 0.0 111.488 -175.375 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 27.5 p -93.66 -4.23 51.0 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 125.348 1.459 . . . . 0.0 112.316 179.62 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 32.3 mmmt -87.42 -5.94 58.64 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 124.762 1.225 . . . . 0.0 111.685 175.081 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 73.05 30.94 62.4 Favored Glycine 0 CA--C 1.523 0.586 0 CA-C-N 118.368 0.531 . . . . 0.0 112.116 172.712 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 5.3 m -76.15 174.48 0.84 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 CA-C-N 118.211 1.005 . . . . 0.0 109.151 171.752 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -114.29 127.36 55.83 Favored 'General case' 0 CA--C 1.515 -0.372 0 N-CA-C 106.786 -1.561 . . . . 0.0 106.786 170.385 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 66.9 m-85 -92.31 144.69 25.13 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 119.652 1.115 . . . . 0.0 109.865 -178.155 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 35.4 m -131.83 157.34 43.12 Favored 'Isoleucine or valine' 0 C--O 1.234 0.267 0 C-N-CA 125.493 1.517 . . . . 0.0 107.527 169.396 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 86.15 29.61 24.9 Favored Glycine 0 CA--C 1.521 0.41 0 CA-C-O 118.334 -1.259 . . . . 0.0 114.741 169.833 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 11.7 m-30 -62.96 157.91 20.59 Favored 'General case' 0 CA--C 1.541 0.626 0 CA-C-N 119.07 1.435 . . . . 0.0 108.918 168.978 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 36.3 t-105 -135.72 143.55 45.17 Favored Pre-proline 0 N--CA 1.467 0.39 0 CA-C-O 118.008 -0.996 . . . . 0.0 111.95 -168.833 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -59.02 129.05 30.07 Favored 'Trans proline' 0 N--CA 1.458 -0.58 0 C-N-CA 122.986 2.457 . . . . 0.0 111.044 176.124 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 9.0 p -77.74 -20.42 53.48 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 123.297 0.639 . . . . 0.0 111.705 169.884 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -61.53 131.09 48.99 Favored 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 -178.229 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 91.83 -12.45 69.42 Favored Glycine 0 CA--C 1.533 1.195 0 CA-C-O 118.546 -1.141 . . . . 0.0 113.543 -177.586 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 55.9 m-85 -92.02 148.46 22.18 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-N 119.246 1.523 . . . . 0.0 108.596 169.609 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -125.38 104.81 8.66 Favored 'General case' 0 C--N 1.332 -0.163 0 N-CA-C 107.436 -1.32 . . . . 0.0 107.436 175.207 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 21.4 p90 -153.21 172.52 16.84 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 127.674 2.389 . . . . 0.0 106.947 -172.787 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 2.6 t -143.9 6.65 1.39 Allowed 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 112.495 0.554 . . . . 0.0 112.495 176.34 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 1.9 p -65.0 125.24 88.75 Favored Pre-proline 0 CA--C 1.541 0.623 0 O-C-N 121.108 -0.995 . . . . 0.0 109.495 172.778 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -81.84 -26.6 2.95 Favored 'Trans proline' 0 CA--C 1.539 0.746 0 C-N-CA 122.421 2.081 . . . . 0.0 112.305 175.677 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 28.2 ttmt -57.55 -42.46 95.84 Favored Pre-proline 0 CA--C 1.542 0.654 0 CA-C-O 117.531 -1.223 . . . . 0.0 114.073 -173.283 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -82.59 4.9 6.74 Favored 'Trans proline' 0 C--N 1.351 0.674 0 C-N-CA 122.017 1.812 . . . . 0.0 113.882 -179.074 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 16.7 m -128.06 166.09 25.91 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.186 0 CA-C-N 121.033 1.742 . . . . 0.0 112.24 -172.805 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 16.1 pt -131.48 168.57 23.6 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.474 0 C-N-CA 127.674 2.39 . . . . 0.0 108.833 179.023 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . 55.88 39.03 30.67 Favored 'General case' 0 CA--C 1.529 0.163 0 C-N-CA 125.199 1.4 . . . . 0.0 113.328 169.746 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 27.6 t70 59.22 43.29 17.22 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 126.412 1.885 . . . . 0.0 111.715 -177.528 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 89.8 18.86 50.01 Favored Glycine 0 CA--C 1.528 0.905 0 CA-C-N 115.574 -0.739 . . . . 0.0 113.461 171.204 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -85.9 -21.78 27.81 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 125.016 1.326 . . . . 0.0 111.836 -177.662 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 9.8 tp -150.13 144.97 26.04 Favored 'General case' 0 C--N 1.341 0.222 0 CA-C-N 119.322 0.964 . . . . 0.0 110.785 176.948 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 55.8 m-85 -82.33 144.26 30.7 Favored 'General case' 0 CA--C 1.517 -0.293 0 N-CA-C 107.864 -1.162 . . . . 0.0 107.864 169.922 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 17.0 m -76.77 12.03 0.39 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.57 0 C-N-CA 124.43 1.092 . . . . 0.0 112.238 178.827 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -179.64 171.76 43.45 Favored Glycine 0 CA--C 1.526 0.769 0 N-CA-C 109.761 -1.335 . . . . 0.0 109.761 -178.321 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.413 ' HB2' ' CD1' ' A' ' 160' ' ' TRP . 8.0 tp -64.11 134.24 54.51 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 117.617 0.709 . . . . 0.0 110.891 177.579 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -93.49 127.57 39.2 Favored 'General case' 0 N--CA 1.441 -0.9 0 C-N-CA 125.393 1.477 . . . . 0.0 109.627 174.441 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 84.5 mt -120.61 151.5 39.36 Favored 'General case' 0 C--O 1.234 0.239 0 N-CA-C 105.83 -1.915 . . . . 0.0 105.83 167.718 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -137.01 133.57 35.68 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-N 118.445 0.566 . . . . 0.0 110.054 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 30.1 tp10 -80.34 -22.58 41.3 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 125.112 1.365 . . . . 0.0 112.688 -171.96 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 93.3 m -115.38 -41.97 3.21 Favored 'General case' 0 C--O 1.234 0.261 0 C-N-CA 124.561 1.144 . . . . 0.0 110.988 -169.076 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 4.3 m-80 -79.84 -21.9 43.62 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 124.423 1.089 . . . . 0.0 110.953 -170.768 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 64.9 mt-30 -128.8 155.57 44.96 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 125.562 1.545 . . . . 0.0 109.495 -178.198 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 89.9 t80 -147.18 -56.58 0.25 Allowed 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 124.552 1.141 . . . . 0.0 108.167 169.593 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -67.79 -44.97 76.12 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-O 121.386 0.612 . . . . 0.0 110.577 175.194 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 6.4 tp -74.58 -15.98 60.82 Favored 'General case' 0 C--N 1.34 0.194 0 CA-C-O 118.638 -0.696 . . . . 0.0 112.338 -170.813 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 5.2 m -61.09 -38.38 86.08 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 119.015 0.825 . . . . 0.0 110.296 179.798 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -62.17 -45.87 91.48 Favored 'General case' 0 N--CA 1.463 0.178 0 C-N-CA 123.285 0.634 . . . . 0.0 110.415 175.157 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 -63.04 -43.04 99.78 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 123.593 0.757 . . . . 0.0 110.416 179.549 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 2.3 mpt_? -59.14 -45.83 89.92 Favored 'General case' 0 C--N 1.335 -0.05 0 C-N-CA 123.976 0.91 . . . . 0.0 110.368 177.598 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 34.9 mt -64.67 -53.09 46.48 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 176.847 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 158' ' ' GLN . . . . . 0.4 ' HA ' HD13 ' A' ' 24' ' ' ILE . 0.9 OUTLIER -54.28 -66.34 0.41 Allowed 'General case' 0 CA--C 1.518 -0.287 0 C-N-CA 125.437 1.495 . . . . 0.0 112.246 -169.916 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 16.3 m -60.94 -33.7 73.59 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.747 -0.66 . . . . 0.0 111.594 -174.825 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 160' ' ' TRP . . . . . 0.413 ' CD1' ' HB2' ' A' ' 142' ' ' LEU . 67.5 t90 -65.14 -44.99 86.86 Favored 'General case' 0 C--O 1.223 -0.293 0 O-C-N 121.956 -0.465 . . . . 0.0 110.552 173.9 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 65.8 m -60.33 -41.24 93.15 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 118.298 0.499 . . . . 0.0 110.763 179.672 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -62.57 -45.68 91.79 Favored 'General case' 0 C--O 1.228 -0.073 0 CA-C-N 118.818 0.736 . . . . 0.0 110.063 173.201 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 14.4 tt0 -61.53 -48.56 80.49 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-O 117.923 -1.037 . . . . 0.0 110.363 -175.522 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 40.7 pt -65.57 -33.8 66.08 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.422 0 CA-C-O 117.918 -1.039 . . . . 0.0 110.282 -178.299 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -73.05 -31.02 64.14 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 119.58 1.082 . . . . 0.0 108.765 -175.033 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -69.08 -55.87 9.42 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 125.028 1.331 . . . . 0.0 109.194 170.945 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 19.5 tt0 -67.76 -30.68 70.2 Favored 'General case' 0 N--CA 1.442 -0.837 0 C-N-CA 125.546 1.538 . . . . 0.0 110.504 -168.545 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 168' ' ' MET . . . . . . . . . . . . . 20.2 ptp -75.8 -29.13 58.62 Favored 'General case' 0 CA--C 1.523 -0.058 0 O-C-N 122.023 -0.423 . . . . 0.0 111.743 174.708 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -78.3 -33.37 49.41 Favored 'General case' 0 N--CA 1.444 -0.73 0 C-N-CA 123.228 0.611 . . . . 0.0 111.639 179.729 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -57.05 -40.7 77.28 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-O 122.324 1.059 . . . . 0.0 109.149 175.822 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 81.0 t60 -71.1 -16.56 62.58 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 126.155 1.782 . . . . 0.0 111.733 -174.068 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 1.4 m-85 -77.47 -19.38 56.04 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 123.883 0.873 . . . . 0.0 112.163 171.249 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.254 1.323 0 C-N-CA 126.336 1.854 . . . . 0.0 110.974 -177.748 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 34.6 ttp . . . . . 0 N--CA 1.494 1.753 0 N-CA-C 110.368 -0.234 . . . . 0.0 110.368 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 29.1 p-10 -144.51 166.66 24.51 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 126.612 1.965 . . . . 0.0 108.367 177.955 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 1.5 mpt? -129.04 124.4 34.78 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 118.567 0.621 . . . . 0.0 111.1 -179.797 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -90.42 142.1 16.19 Favored Glycine 0 CA--C 1.526 0.724 0 N-CA-C 107.139 -2.384 . . . . 0.0 107.139 167.815 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 1.2 tt -132.2 97.55 4.16 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 119.911 1.855 . . . . 0.0 106.659 -169.866 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -105.03 144.48 31.78 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-O 121.64 0.733 . . . . 0.0 112.138 -170.408 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 35.4 p90 -160.14 176.29 11.95 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 126.698 1.999 . . . . 0.0 107.539 179.512 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -84.75 -141.09 5.18 Favored Glycine 0 CA--C 1.526 0.752 0 C-N-CA 124.241 0.924 . . . . 0.0 112.214 -171.394 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 3.5 m -58.42 148.03 29.41 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 124.926 1.29 . . . . 0.0 111.584 -173.975 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 1.8 m -59.39 -22.9 62.08 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 124.559 1.144 . . . . 0.0 112.751 -179.878 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 4.3 p -71.01 -15.62 62.57 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 125.494 1.518 . . . . 0.0 112.612 177.367 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 63.9 m -68.9 136.32 52.41 Favored 'General case' 0 C--N 1.343 0.299 0 CA-C-N 119.244 0.929 . . . . 0.0 108.855 176.861 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 85.3 m-85 -60.32 -19.85 56.94 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 122.746 0.418 . . . . 0.0 111.573 173.152 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 3.8 m -49.07 -28.31 4.03 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 126.779 2.031 . . . . 0.0 112.669 170.065 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 7.7 tt0 -65.74 -33.69 76.45 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-N 120.435 1.47 . . . . 0.0 110.67 178.678 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 4.8 mpp? -70.17 -39.78 75.09 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 118.931 0.787 . . . . 0.0 110.048 176.464 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -59.33 -42.97 92.68 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 118.809 0.731 . . . . 0.0 109.679 170.984 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -62.74 -48.26 79.99 Favored 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 123.761 0.825 . . . . 0.0 111.379 -175.707 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -67.51 -35.78 79.79 Favored 'General case' 0 CA--C 1.535 0.402 0 O-C-N 121.795 -0.565 . . . . 0.0 110.426 178.96 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 28.9 mtpp -67.39 -37.63 83.42 Favored 'General case' 0 N--CA 1.465 0.293 0 O-C-N 121.272 -0.893 . . . . 0.0 111.182 177.568 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 32.9 mt -56.75 -54.58 27.47 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.25 0 N-CA-C 108.404 -0.961 . . . . 0.0 108.404 175.09 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 22.2 ptt180 -63.31 -37.73 88.42 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 118.904 0.774 . . . . 0.0 110.635 -178.11 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -64.57 -37.78 88.72 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 109.865 -0.42 . . . . 0.0 109.865 -174.736 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.431 HD13 ' HA ' ' A' ' 158' ' ' GLN . 75.6 mt -79.79 -54.47 11.09 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.573 0 C-N-CA 124.805 1.242 . . . . 0.0 110.167 -175.081 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 77.7 mt -62.61 -48.3 88.86 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.292 0 C-N-CA 122.719 0.408 . . . . 0.0 110.172 179.908 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 142.01 119.24 1.48 Allowed Glycine 0 CA--C 1.53 1.026 0 C-N-CA 125.207 1.384 . . . . 0.0 110.449 -179.087 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -76.88 -4.43 14.91 Favored 'Trans proline' 0 CA--C 1.538 0.717 0 C-N-CA 122.829 2.353 . . . . 0.0 113.491 -171.141 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -82.35 -22.68 35.42 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 118.918 0.781 . . . . 0.0 111.157 177.15 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 1.2 pt? -118.51 -21.28 8.06 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 124.847 1.259 . . . . 0.0 113.216 -174.117 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 59.0 t -91.45 147.23 5.41 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.504 0 N-CA-C 107.608 -1.256 . . . . 0.0 107.608 168.714 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 16.5 m -132.13 134.11 45.06 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 125.193 1.397 . . . . 0.0 107.833 178.494 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 18.7 mt -79.43 141.13 37.09 Favored 'General case' 0 N--CA 1.466 0.336 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 175.248 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 21.8 t-80 -135.15 54.09 1.95 Allowed 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 124.761 1.224 . . . . 0.0 108.259 -176.766 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 28.4 t-20 -55.21 124.13 15.96 Favored 'General case' 0 C--O 1.235 0.311 0 N-CA-C 107.348 -1.352 . . . . 0.0 107.348 170.935 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 32.3 mt -72.56 -16.94 61.75 Favored 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 113.105 0.78 . . . . 0.0 113.105 -170.509 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 9.8 tppt? -66.88 -31.06 71.41 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-N 119.354 0.979 . . . . 0.0 109.492 168.078 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -92.48 -36.35 13.12 Favored 'General case' 0 C--O 1.235 0.321 0 N-CA-C 113.525 0.935 . . . . 0.0 113.525 -168.985 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 2.3 t0 -140.47 156.96 46.18 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-N 118.949 0.795 . . . . 0.0 112.477 178.13 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 17.8 m -79.97 160.06 69.58 Favored Pre-proline 0 CA--C 1.541 0.625 0 C-N-CA 126.23 1.812 . . . . 0.0 111.299 -170.249 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -76.0 -24.85 10.92 Favored 'Trans proline' 0 C--N 1.351 0.7 0 C-N-CA 122.41 2.073 . . . . 0.0 113.41 -171.412 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 3.7 mmmm -67.12 -17.74 65.0 Favored 'General case' 0 CA--C 1.542 0.671 0 O-C-N 120.745 -1.222 . . . . 0.0 110.774 -174.968 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -59.49 -31.05 69.0 Favored 'General case' 0 N--CA 1.465 0.317 0 C-N-CA 126.803 2.041 . . . . 0.0 110.548 171.235 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 56.3 mtt -59.24 -24.31 63.07 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 118.83 0.741 . . . . 0.0 111.157 -178.672 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 63.3 mt-10 -64.78 -31.83 73.24 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-N 118.464 0.575 . . . . 0.0 110.385 -178.791 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 24.0 mt-30 -69.93 -39.37 76.16 Favored 'General case' 0 N--CA 1.466 0.354 0 N-CA-C 114.093 1.146 . . . . 0.0 114.093 -169.2 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 53.6 m-85 -72.25 141.58 48.95 Favored 'General case' 0 CA--C 1.528 0.12 0 C-N-CA 123.075 0.55 . . . . 0.0 111.388 -165.928 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 57.6 m-20 -69.68 -30.24 67.86 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 123.651 0.78 . . . . 0.0 110.268 176.564 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 19.0 t -126.15 147.2 30.98 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.467 0 N-CA-C 106.973 -1.491 . . . . 0.0 106.973 172.946 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 22.5 tp -124.87 150.01 46.92 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 169.873 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.44 HG12 ' HB3' ' A' ' 83' ' ' ALA . 43.5 mt -128.9 127.73 66.58 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 N-CA-C 104.596 -2.372 . . . . 0.0 104.596 178.426 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 3.2 mp -107.59 132.88 52.81 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 125.867 1.667 . . . . 0.0 106.791 -178.164 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -139.15 128.7 4.13 Favored Glycine 0 C--N 1.34 0.771 0 N-CA-C 109.182 -1.567 . . . . 0.0 109.182 -177.825 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 3.5 tt -151.77 134.45 8.79 Favored Pre-proline 0 CA--C 1.534 0.363 0 CA-C-N 118.437 1.119 . . . . 0.0 111.685 -179.136 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 75.6 Cg_endo -85.64 135.99 5.2 Favored 'Trans proline' 0 N--CA 1.454 -0.843 0 C-N-CA 121.834 1.69 . . . . 0.0 108.827 168.049 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 23.1 m -102.81 127.24 50.06 Favored 'General case' 0 CA--C 1.536 0.431 0 N-CA-C 106.881 -1.525 . . . . 0.0 106.881 168.962 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 5.2 m-90 -143.72 154.17 43.2 Favored 'General case' 0 C--O 1.232 0.175 0 C-N-CA 125.798 1.639 . . . . 0.0 106.975 172.642 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -63.83 142.32 58.44 Favored 'General case' 0 C--O 1.234 0.277 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 169.419 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 64.7 t80 63.7 -43.3 0.24 Allowed 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 128.289 2.636 . . . . 0.0 114.472 -175.033 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -65.42 -60.1 7.06 Favored Glycine 0 CA--C 1.529 0.927 0 N-CA-C 109.985 -1.246 . . . . 0.0 109.985 178.485 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.472 ' HG2' ' H ' ' A' ' 61' ' ' ILE . 12.0 tt0 49.99 -149.92 0.24 Allowed 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 124.668 1.187 . . . . 0.0 111.029 178.022 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.472 ' H ' ' HG2' ' A' ' 60' ' ' GLU . 73.8 mt -58.59 126.41 16.17 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.717 0 C-N-CA 126.692 1.997 . . . . 0.0 107.644 169.087 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 -76.98 159.77 29.68 Favored 'General case' 0 N--CA 1.465 0.32 0 C-N-CA 123.723 0.809 . . . . 0.0 109.074 178.33 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -55.36 -41.94 73.24 Favored 'General case' 0 C--O 1.225 -0.23 0 C-N-CA 123.645 0.778 . . . . 0.0 110.643 -179.96 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 22.7 m-20 -62.95 -26.25 68.74 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 123.123 0.569 . . . . 0.0 112.013 -177.84 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' TRP . . . . . 0.436 ' CZ3' ' CE3' ' A' ' 69' ' ' TRP . 0.0 OUTLIER -92.53 -46.43 7.63 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 125.462 1.505 . . . . 0.0 107.483 -176.407 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 13.7 tt0 -63.21 -36.65 84.34 Favored 'General case' 0 N--CA 1.445 -0.69 0 O-C-N 120.073 -1.642 . . . . 0.0 110.355 179.396 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -58.53 -26.09 63.15 Favored 'General case' 0 C--O 1.234 0.239 0 C-N-CA 123.844 0.858 . . . . 0.0 111.368 -175.115 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 34.9 m -105.15 -18.01 7.17 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.416 0 CA-C-O 117.221 -1.371 . . . . 0.0 112.51 177.607 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' TRP . . . . . 0.436 ' CE3' ' CZ3' ' A' ' 65' ' ' TRP . 1.8 t-105 -52.32 -35.04 49.77 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 120.464 1.484 . . . . 0.0 111.118 -176.023 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -68.01 -27.12 66.28 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 126.02 1.728 . . . . 0.0 113.357 177.04 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 23.1 mt-30 -92.65 -23.11 19.09 Favored 'General case' 0 C--N 1.341 0.222 0 C-N-CA 126.179 1.792 . . . . 0.0 112.262 178.249 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 71.8 mt -64.66 -26.21 68.29 Favored 'General case' 0 N--CA 1.465 0.285 0 O-C-N 121.514 -0.741 . . . . 0.0 111.861 -174.326 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -76.93 -22.55 53.13 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-N 118.329 0.513 . . . . 0.0 111.465 173.321 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -79.11 -27.88 42.92 Favored 'General case' 0 CA--C 1.534 0.36 0 O-C-N 120.986 -1.071 . . . . 0.0 112.13 179.706 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 39.3 mt -58.25 145.11 38.71 Favored 'General case' 0 C--O 1.234 0.265 0 C-N-CA 124.433 1.093 . . . . 0.0 110.629 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 22.3 t-20 -87.86 112.09 22.11 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 169.839 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 62.0 mt -120.95 6.92 10.35 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 123.558 0.743 . . . . 0.0 111.9 -172.421 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 32.1 mt-10 -51.13 133.24 28.09 Favored 'General case' 0 C--O 1.235 0.319 0 C-N-CA 124.837 1.255 . . . . 0.0 112.551 -168.857 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 71.81 -6.16 10.19 Favored Glycine 0 CA--C 1.531 1.074 0 C-N-CA 125.521 1.534 . . . . 0.0 115.598 173.177 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.34 157.92 33.55 Favored 'General case' 0 C--N 1.346 0.43 0 CA-C-N 120.759 2.28 . . . . 0.0 110.02 -174.476 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 7.3 mt -84.41 139.3 17.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 N-CA-C 106.894 -1.521 . . . . 0.0 106.894 176.576 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 99.2 t -130.97 126.98 60.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 C-N-CA 123.217 0.607 . . . . 0.0 110.864 178.065 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.44 ' HB3' HG12 ' A' ' 50' ' ' ILE . . . -94.02 146.16 24.14 Favored 'General case' 0 C--O 1.233 0.223 0 N-CA-C 106.464 -1.68 . . . . 0.0 106.464 165.751 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 2.0 mt -123.75 139.61 53.81 Favored 'General case' 0 CA--C 1.513 -0.475 0 N-CA-C 106.399 -1.704 . . . . 0.0 106.399 171.93 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 31.7 p90 -152.09 167.35 28.76 Favored 'General case' 0 N--CA 1.445 -0.714 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 167.921 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -164.04 179.06 39.17 Favored Glycine 0 N--CA 1.433 -1.523 0 N-CA-C 109.643 -1.383 . . . . 0.0 109.643 170.511 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 6.1 tt -115.71 143.96 44.63 Favored 'General case' 0 N--CA 1.44 -0.956 0 N-CA-C 107.245 -1.391 . . . . 0.0 107.245 172.971 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -138.45 -174.62 13.51 Favored Glycine 0 CA--C 1.524 0.637 0 N-CA-C 109.167 -1.573 . . . . 0.0 109.167 177.939 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -145.85 136.16 23.92 Favored 'General case' 0 C--O 1.235 0.293 0 C-N-CA 123.843 0.857 . . . . 0.0 109.137 -179.03 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . 0.536 ' H ' ' ND2' ' A' ' 148' ' ' ASN . 43.0 mt-30 -101.97 -6.44 23.45 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 124.827 1.251 . . . . 0.0 112.005 177.153 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 49.5 mt -65.65 -41.25 92.8 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 119.817 1.19 . . . . 0.0 108.859 174.664 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -77.55 37.94 1.64 Allowed Glycine 0 CA--C 1.533 1.19 0 C-N-CA 125.706 1.622 . . . . 0.0 111.623 168.467 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 28.2 t80 54.69 6.17 0.11 Allowed 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 128.104 2.562 . . . . 0.0 115.516 -179.863 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 69.61 26.38 74.54 Favored Glycine 0 C--N 1.343 0.96 0 O-C-N 120.332 -1.48 . . . . 0.0 110.833 -172.592 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -75.1 -16.56 60.54 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-N 117.985 0.892 . . . . 0.0 108.871 165.889 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' TRP . . . . . . . . . . . . . 9.3 m0 -112.68 7.08 18.56 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 126.459 1.904 . . . . 0.0 111.278 -179.5 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 3.1 t80 -68.26 115.51 7.8 Favored 'General case' 0 C--N 1.34 0.172 0 CA-C-N 119.769 1.168 . . . . 0.0 110.557 -172.115 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 92.0 mt 54.67 18.97 2.27 Favored 'General case' 0 N--CA 1.47 0.543 0 N-CA-C 114.739 1.385 . . . . 0.0 114.739 168.156 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -60.56 -33.89 73.36 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 120.643 1.565 . . . . 0.0 111.554 -170.163 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -71.77 -29.86 64.94 Favored 'General case' 0 CA--C 1.535 0.397 0 N-CA-C 112.714 0.635 . . . . 0.0 112.714 176.335 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 5.5 tt -59.07 -43.92 91.82 Favored 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 173.194 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -67.07 -32.96 82.01 Favored Glycine 0 C--N 1.338 0.639 0 CA-C-O 119.678 -0.512 . . . . 0.0 112.053 -176.156 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 75.6 mtm -68.4 -41.1 80.97 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 118.108 0.954 . . . . 0.0 110.899 -178.298 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -72.75 -38.04 67.5 Favored 'General case' 0 C--N 1.347 0.497 0 CA-C-N 120.507 1.503 . . . . 0.0 110.693 175.997 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 84.9 t60 -50.61 -49.0 57.74 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 118.37 0.532 . . . . 0.0 110.517 173.589 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -65.4 -41.81 93.27 Favored 'General case' 0 C--O 1.235 0.33 0 C-N-CA 123.522 0.729 . . . . 0.0 112.804 -177.784 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 24.1 ttmm -54.7 -43.46 72.54 Favored 'General case' 0 N--CA 1.465 0.31 0 C-N-CA 123.103 0.561 . . . . 0.0 109.847 171.55 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 7.9 mt -77.91 -25.66 48.57 Favored 'General case' 0 CA--C 1.516 -0.349 0 N-CA-C 115.35 1.611 . . . . 0.0 115.35 -168.247 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 14.1 m -58.73 -33.16 69.91 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-N 120.124 1.329 . . . . 0.0 112.245 -172.658 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 22.8 p -87.23 -9.65 54.55 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 124.413 1.085 . . . . 0.0 111.956 -179.139 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 30.9 mmmt -82.04 -10.01 59.36 Favored 'General case' 0 C--N 1.346 0.416 0 C-N-CA 124.419 1.088 . . . . 0.0 111.383 173.143 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 75.13 32.93 55.51 Favored Glycine 0 CA--C 1.524 0.638 0 CA-C-O 119.665 -0.519 . . . . 0.0 112.615 169.728 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 29.8 m -76.5 179.79 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 CA-C-N 118.208 1.004 . . . . 0.0 110.38 169.602 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -116.6 134.26 55.04 Favored 'General case' 0 CA--C 1.515 -0.369 0 N-CA-C 106.374 -1.713 . . . . 0.0 106.374 169.655 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 59.3 m-85 -95.38 145.01 25.44 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 119.502 1.047 . . . . 0.0 110.17 -179.26 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 35.3 m -132.8 159.61 43.07 Favored 'Isoleucine or valine' 0 C--O 1.233 0.21 0 C-N-CA 125.03 1.332 . . . . 0.0 108.399 171.954 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 82.02 33.44 26.63 Favored Glycine 0 CA--C 1.521 0.456 0 CA-C-O 118.666 -1.074 . . . . 0.0 113.858 170.556 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 8.3 m-30 -62.38 149.93 41.09 Favored 'General case' 0 CA--C 1.544 0.749 0 CA-C-N 119.297 1.549 . . . . 0.0 109.47 169.633 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' TRP . . . . . 0.428 ' HA ' ' HD3' ' A' ' 120' ' ' PRO . 1.5 t90 -134.65 136.37 25.33 Favored Pre-proline 0 CA--C 1.541 0.603 0 CA-C-O 117.273 -1.346 . . . . 0.0 108.592 -170.998 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . 0.428 ' HD3' ' HA ' ' A' ' 119' ' ' TRP . 45.2 Cg_exo -66.45 130.26 23.3 Favored 'Trans proline' 0 C--N 1.349 0.574 0 C-N-CA 123.006 2.471 . . . . 0.0 113.366 -172.369 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 33.6 p -68.05 -13.82 62.49 Favored 'General case' 0 CA--C 1.545 0.773 0 N-CA-C 113.235 0.828 . . . . 0.0 113.235 172.875 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -61.13 136.49 58.09 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 124.514 1.126 . . . . 0.0 110.571 -174.329 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 83.65 -8.74 64.38 Favored Glycine 0 CA--C 1.534 1.265 0 C-N-CA 124.99 1.281 . . . . 0.0 114.202 174.282 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 20.7 m-85 -93.33 150.97 20.07 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 118.529 1.164 . . . . 0.0 109.296 172.893 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -116.63 112.45 21.28 Favored 'General case' 0 C--O 1.233 0.221 0 N-CA-C 107.196 -1.409 . . . . 0.0 107.196 175.371 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 36.4 p90 -156.25 171.3 20.44 Favored 'General case' 0 C--O 1.235 0.321 0 C-N-CA 124.745 1.218 . . . . 0.0 109.661 -175.786 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 10.3 t -139.88 -14.37 1.06 Allowed 'General case' 0 CA--C 1.54 0.593 0 CA-C-O 118.695 -0.669 . . . . 0.0 112.515 177.611 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 16.7 m -53.09 119.61 17.26 Favored Pre-proline 0 CA--C 1.546 0.795 0 CA-C-N 119.629 1.104 . . . . 0.0 111.118 176.896 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -90.25 -26.54 0.36 Allowed 'Trans proline' 0 C--N 1.353 0.785 0 C-N-CA 121.929 1.753 . . . . 0.0 113.531 -171.628 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 47.1 mttp -54.74 -45.75 99.55 Favored Pre-proline 0 N--CA 1.473 0.679 0 CA-C-N 119.56 1.073 . . . . 0.0 113.199 -174.887 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -86.58 13.44 2.72 Favored 'Trans proline' 0 N--CA 1.457 -0.659 0 C-N-CA 122.043 1.829 . . . . 0.0 113.057 -171.524 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 15.2 m -127.55 146.23 33.62 Favored 'Isoleucine or valine' 0 C--O 1.232 0.179 0 CA-C-N 121.521 1.964 . . . . 0.0 111.04 -179.297 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 14.5 pt -102.8 169.01 2.01 Favored 'Isoleucine or valine' 0 C--O 1.235 0.313 0 C-N-CA 125.68 1.592 . . . . 0.0 108.96 170.483 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . 56.72 30.96 18.5 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 124.829 1.251 . . . . 0.0 113.514 167.93 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 27.6 t70 55.1 38.98 31.34 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 126.736 2.014 . . . . 0.0 111.292 -176.23 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 98.14 71.74 1.04 Allowed Glycine 0 C--N 1.338 0.693 0 C-N-CA 124.401 1.0 . . . . 0.0 111.29 176.721 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 76.3 mm-40 -120.33 -48.56 2.31 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 123.048 0.539 . . . . 0.0 110.895 167.784 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -131.34 141.98 50.0 Favored 'General case' 0 N--CA 1.467 0.408 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 179.52 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 62.9 m-85 -75.82 18.83 0.23 Allowed 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 125.86 1.664 . . . . 0.0 115.215 177.315 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 4.2 m 49.25 10.8 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.552 1.031 0 C-N-CA 127.576 2.351 . . . . 0.0 114.546 -176.491 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 170.46 175.2 39.05 Favored Glycine 0 CA--C 1.53 1.005 0 C-N-CA 125.941 1.734 . . . . 0.0 108.883 -169.334 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -71.6 141.07 50.0 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 118.439 1.12 . . . . 0.0 111.983 -177.382 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -99.72 129.77 45.87 Favored 'General case' 0 N--CA 1.446 -0.65 0 C-N-CA 126.523 1.929 . . . . 0.0 110.004 174.167 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 86.2 mt -121.71 141.51 51.09 Favored 'General case' 0 N--CA 1.463 0.214 0 N-CA-C 106.554 -1.647 . . . . 0.0 106.554 168.178 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 65.6 t0 -148.12 71.19 1.17 Allowed 'General case' 0 C--O 1.235 0.322 0 CA-C-O 122.705 1.24 . . . . 0.0 109.095 175.202 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -65.52 -26.4 67.88 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-N 114.572 -1.195 . . . . 0.0 110.401 177.532 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 56.4 m -61.01 -44.86 96.8 Favored 'General case' 0 C--O 1.237 0.433 0 O-C-N 121.531 -0.731 . . . . 0.0 110.448 178.782 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . 0.536 ' ND2' ' H ' ' A' ' 90' ' ' GLN . 5.7 m-80 -93.77 -37.7 11.65 Favored 'General case' 0 CA--C 1.528 0.134 0 CA-C-O 118.501 -0.761 . . . . 0.0 111.374 -172.784 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 18.7 pt20 -148.77 65.71 1.05 Allowed 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 118.873 0.761 . . . . 0.0 111.545 -172.971 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 31.8 p90 -50.65 -27.97 7.97 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 124.945 1.298 . . . . 0.0 113.414 176.207 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -62.64 -29.69 70.81 Favored 'General case' 0 CA--C 1.535 0.393 0 O-C-N 121.803 -0.56 . . . . 0.0 112.231 -179.46 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -94.76 -10.19 32.33 Favored 'General case' 0 C--N 1.345 0.381 0 CA-C-O 117.791 -1.1 . . . . 0.0 112.714 178.698 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 16.0 m -61.49 -38.2 86.45 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 121.124 1.783 . . . . 0.0 111.404 -172.185 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -62.61 -43.53 98.58 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 118.141 0.428 . . . . 0.0 110.705 176.109 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 12.6 tt0 -67.88 -41.01 83.46 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 124.889 1.276 . . . . 0.0 110.747 -178.497 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.88 -45.11 86.88 Favored 'General case' 0 N--CA 1.463 0.221 0 C-N-CA 124.338 1.055 . . . . 0.0 110.43 173.464 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 43.8 mt -67.03 -55.74 16.54 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.345 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 179.112 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 158' ' ' GLN . . . . . 0.431 ' HA ' HD13 ' A' ' 24' ' ' ILE . 0.4 OUTLIER -50.25 -69.13 0.12 Allowed 'General case' 0 C--O 1.234 0.263 0 C-N-CA 125.888 1.675 . . . . 0.0 112.035 -170.338 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 8.3 m -61.31 -33.42 73.57 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.859 -0.609 . . . . 0.0 111.744 -172.955 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 160' ' ' TRP . . . . . . . . . . . . . 79.6 t90 -66.13 -44.71 83.45 Favored 'General case' 0 CA--C 1.517 -0.326 0 O-C-N 121.833 -0.542 . . . . 0.0 110.988 175.041 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 68.6 m -59.51 -42.15 91.56 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 122.937 0.495 . . . . 0.0 110.501 179.095 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -62.05 -42.45 99.2 Favored 'General case' 0 CA--C 1.523 -0.082 0 CA-C-N 118.57 0.623 . . . . 0.0 110.467 174.869 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 16.4 tt0 -64.58 -51.01 64.95 Favored 'General case' 0 N--CA 1.446 -0.641 0 CA-C-O 118.691 -0.671 . . . . 0.0 110.019 -177.018 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 40.3 pt -63.27 -37.62 79.96 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.442 0 CA-C-O 117.815 -1.088 . . . . 0.0 109.531 -175.465 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -65.87 -32.97 74.79 Favored 'General case' 0 N--CA 1.462 0.165 0 CA-C-N 119.495 1.043 . . . . 0.0 110.329 -178.948 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 35.1 m-80 -69.6 -59.2 3.12 Favored 'General case' 0 C--O 1.223 -0.302 0 N-CA-C 108.099 -1.075 . . . . 0.0 108.099 174.053 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 19.4 tt0 -61.41 -34.31 75.15 Favored 'General case' 0 N--CA 1.443 -0.779 0 C-N-CA 126.412 1.885 . . . . 0.0 111.765 -168.788 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 168' ' ' MET . . . . . . . . . . . . . 22.1 ptp -72.46 -35.09 68.16 Favored 'General case' 0 C--O 1.228 -0.077 0 C-N-CA 123.415 0.686 . . . . 0.0 111.67 173.512 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -74.98 -38.35 61.66 Favored 'General case' 0 N--CA 1.445 -0.724 0 CA-C-O 119.153 -0.451 . . . . 0.0 111.935 -177.026 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -61.69 -31.55 71.7 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 121.446 0.641 . . . . 0.0 109.839 178.611 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 79.3 t60 -74.69 -32.48 62.21 Favored 'General case' 0 N--CA 1.447 -0.604 0 C-N-CA 124.6 1.16 . . . . 0.0 111.727 -174.834 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 12.0 m-85 -83.86 -24.84 30.72 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 123.531 0.732 . . . . 0.0 112.972 172.656 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.254 1.295 0 CA-C-O 118.198 -0.906 . . . . 0.0 110.564 -177.909 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.7 tmm? . . . . . 0 N--CA 1.494 1.755 0 CA-C-O 120.604 0.24 . . . . 0.0 110.603 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 21.9 p-10 -146.6 165.58 29.11 Favored 'General case' 0 N--CA 1.465 0.321 0 C-N-CA 126.334 1.854 . . . . 0.0 109.327 174.567 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 17.5 mtt -127.07 133.87 50.37 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 118.287 0.494 . . . . 0.0 111.144 -179.191 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -104.11 135.82 12.66 Favored Glycine 0 CA--C 1.526 0.722 0 N-CA-C 107.574 -2.21 . . . . 0.0 107.574 168.215 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 4.0 tt -122.93 111.11 16.24 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 105.78 -1.933 . . . . 0.0 105.78 -173.937 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.426 ' CD1' HD11 ' A' ' 35' ' ' LEU . 1.1 p90 -114.64 146.48 40.8 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 118.71 0.686 . . . . 0.0 110.683 -177.711 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 33.0 p90 -159.97 169.99 22.29 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 124.312 1.045 . . . . 0.0 108.44 179.666 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -71.49 126.6 12.98 Favored Glycine 0 CA--C 1.528 0.865 0 N-CA-C 109.28 -1.528 . . . . 0.0 109.28 177.756 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 1.3 m -88.64 4.87 45.55 Favored 'General case' 0 CA--C 1.538 0.486 0 N-CA-C 114.958 1.466 . . . . 0.0 114.958 -166.654 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 9.1 m -79.01 44.22 0.55 Allowed 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 124.702 1.201 . . . . 0.0 113.17 -171.532 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 2.0 m 54.79 35.98 25.38 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 125.538 1.535 . . . . 0.0 111.129 -176.594 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 58.6 m -74.92 158.02 34.04 Favored 'General case' 0 CA--C 1.534 0.337 0 O-C-N 121.53 -0.731 . . . . 0.0 109.189 178.382 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 41.7 t80 -62.95 -18.21 62.9 Favored 'General case' 0 N--CA 1.469 0.514 0 O-C-N 121.761 -0.587 . . . . 0.0 111.838 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -51.29 -24.72 4.82 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 125.217 1.407 . . . . 0.0 112.369 170.789 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -57.6 -39.43 76.82 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 119.943 1.247 . . . . 0.0 110.867 174.602 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 2.5 mpp? -71.33 -42.28 68.78 Favored 'General case' 0 C--N 1.339 0.127 0 CA-C-O 118.95 -0.547 . . . . 0.0 109.587 179.357 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -58.96 -43.84 91.38 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 119.038 0.836 . . . . 0.0 109.935 173.609 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -64.27 -48.74 74.56 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 124.274 1.029 . . . . 0.0 111.18 -176.777 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 6.4 mt-10 -58.96 -43.56 91.33 Favored 'General case' 0 CA--C 1.516 -0.351 0 N-CA-C 109.972 -0.381 . . . . 0.0 109.972 175.641 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 28.9 mtpp -72.13 -41.99 66.55 Favored 'General case' 0 C--O 1.221 -0.402 0 CA-C-O 117.848 -1.072 . . . . 0.0 110.533 -173.334 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 41.2 mt -51.88 -54.93 11.17 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.314 0 CA-C-N 120.301 1.409 . . . . 0.0 108.349 172.544 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 7.9 ttp180 -61.74 -41.7 98.0 Favored 'General case' 0 C--O 1.222 -0.386 0 C-N-CA 123.605 0.762 . . . . 0.0 109.721 -175.193 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -66.56 -42.24 87.37 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 122.878 0.471 . . . . 0.0 111.159 -178.653 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 51.3 mt -71.48 -52.52 25.7 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 C-N-CA 124.749 1.22 . . . . 0.0 109.843 -172.652 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 82.8 mt -67.66 -45.86 83.97 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.433 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 138.75 124.49 2.22 Favored Glycine 0 CA--C 1.53 1.011 0 C-N-CA 125.078 1.323 . . . . 0.0 112.144 174.613 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -71.77 -7.14 20.57 Favored 'Trans proline' 0 CA--C 1.534 0.491 0 C-N-CA 123.57 2.847 . . . . 0.0 113.965 -175.483 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -77.92 -21.15 51.58 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 119.147 0.885 . . . . 0.0 111.148 176.423 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -127.67 -8.34 5.63 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 124.675 1.19 . . . . 0.0 114.011 -172.343 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 25.4 t -106.48 151.54 8.42 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.337 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 169.64 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 2.1 m -140.07 130.1 24.89 Favored 'General case' 0 C--N 1.333 -0.135 0 N-CA-C 106.236 -1.765 . . . . 0.0 106.236 -170.976 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 18.7 mt -89.19 135.64 33.46 Favored 'General case' 0 N--CA 1.464 0.273 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 177.866 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 35.6 m170 -100.57 154.21 18.75 Favored 'General case' 0 N--CA 1.464 0.24 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 169.929 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 11.6 t-20 -132.65 104.11 6.48 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 105.036 -2.209 . . . . 0.0 105.036 172.416 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.426 HD11 ' CD1' ' A' ' 6' ' ' PHE . 69.3 mt -76.59 -6.64 52.85 Favored 'General case' 0 C--O 1.235 0.313 0 N-CA-C 113.028 0.751 . . . . 0.0 113.028 -170.049 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 51.5 tptt -81.75 -14.28 56.68 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 118.803 0.728 . . . . 0.0 109.911 168.974 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -117.76 -41.29 2.93 Favored 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 124.572 1.149 . . . . 0.0 112.97 -173.844 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -106.89 155.76 19.41 Favored 'General case' 0 C--O 1.236 0.386 0 C-N-CA 125.878 1.671 . . . . 0.0 111.588 179.484 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 15.1 m -90.95 147.46 35.91 Favored Pre-proline 0 CA--C 1.539 0.521 0 C-N-CA 124.871 1.268 . . . . 0.0 110.26 -174.209 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -66.62 -20.64 53.13 Favored 'Trans proline' 0 C--N 1.349 0.594 0 C-N-CA 122.218 1.945 . . . . 0.0 113.016 -175.722 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 4.6 mptp? -56.85 -23.32 43.34 Favored 'General case' 0 CA--C 1.538 0.491 0 O-C-N 121.328 -0.857 . . . . 0.0 111.712 174.106 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 5.9 mt -61.87 -32.33 72.68 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 119.477 1.035 . . . . 0.0 111.252 175.682 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 59.8 mtt -60.13 -25.48 65.51 Favored 'General case' 0 N--CA 1.462 0.138 0 C-N-CA 123.774 0.829 . . . . 0.0 111.631 -179.911 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -60.23 -33.83 72.82 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 118.401 0.546 . . . . 0.0 109.95 179.112 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 29.9 mt-30 -72.36 -28.08 62.8 Favored 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 114.121 1.156 . . . . 0.0 114.121 -169.679 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 63.1 m-85 -85.27 138.92 32.01 Favored 'General case' 0 N--CA 1.464 0.258 0 C-N-CA 122.718 0.407 . . . . 0.0 110.222 -167.7 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 26.8 m-20 -67.49 -39.3 85.19 Favored 'General case' 0 N--CA 1.465 0.324 0 N-CA-C 109.838 -0.43 . . . . 0.0 109.838 178.484 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 17.3 t -114.35 143.87 23.13 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.379 0 N-CA-C 107.74 -1.207 . . . . 0.0 107.74 173.302 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 18.3 tp -123.55 143.4 50.22 Favored 'General case' 0 N--CA 1.444 -0.749 0 N-CA-C 107.728 -1.212 . . . . 0.0 107.728 169.339 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 45.9 mt -124.45 126.74 72.37 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 N-CA-C 105.426 -2.065 . . . . 0.0 105.426 179.98 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 3.0 mp -110.02 123.2 49.24 Favored 'General case' 0 CA--C 1.516 -0.33 0 N-CA-C 107.143 -1.429 . . . . 0.0 107.143 -173.012 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -122.74 133.55 9.2 Favored Glycine 0 N--CA 1.459 0.193 0 N-CA-C 109.831 -1.307 . . . . 0.0 109.831 175.627 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 4.3 tt -155.13 125.59 3.39 Favored Pre-proline 0 CA--C 1.538 0.509 0 CA-C-N 118.648 1.224 . . . . 0.0 112.67 169.637 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_exo -63.44 137.93 62.77 Favored 'Trans proline' 0 N--CA 1.452 -0.922 0 C-N-CA 122.378 2.052 . . . . 0.0 111.278 166.02 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 7.7 m -113.22 114.91 27.4 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 106.551 -1.648 . . . . 0.0 106.551 168.65 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 3.2 m0 -167.91 148.95 5.21 Favored 'General case' 0 C--O 1.231 0.092 0 C-N-CA 125.903 1.681 . . . . 0.0 108.609 -174.49 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -61.73 -27.04 68.44 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 122.604 0.362 . . . . 0.0 111.404 169.786 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 9.6 m-85 -70.15 -5.09 24.71 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 125.06 1.344 . . . . 0.0 113.77 -173.631 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -173.94 -34.37 0.04 OUTLIER Glycine 0 CA--C 1.528 0.873 0 CA-C-N 119.186 0.903 . . . . 0.0 113.095 178.01 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 2.8 tp10 51.81 -152.35 0.23 Allowed 'General case' 0 C--O 1.237 0.432 0 C-N-CA 125.035 1.334 . . . . 0.0 110.323 178.996 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 63.9 mt -62.48 101.67 0.21 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.589 0 N-CA-C 105.029 -2.212 . . . . 0.0 105.029 166.486 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . 0.448 ' NE2' ' H ' ' A' ' 62' ' ' GLN . 1.7 pm0 -74.57 162.88 28.35 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 124.182 0.993 . . . . 0.0 109.891 175.197 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -48.06 -49.22 32.18 Favored 'General case' 0 C--O 1.226 -0.179 0 C-N-CA 125.45 1.5 . . . . 0.0 112.412 -169.413 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -69.33 -19.52 63.87 Favored 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 112.559 0.577 . . . . 0.0 112.559 -170.378 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' TRP . . . . . 0.806 ' CH2' HD23 ' A' ' 104' ' ' LEU . 3.6 t90 -92.68 -41.46 10.16 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 125.026 1.33 . . . . 0.0 109.022 176.916 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -64.16 -35.52 81.04 Favored 'General case' 0 CA--C 1.537 0.48 0 O-C-N 121.102 -0.999 . . . . 0.0 109.704 177.163 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -62.06 -26.26 68.16 Favored 'General case' 0 C--O 1.233 0.233 0 C-N-CA 124.301 1.04 . . . . 0.0 110.747 -178.956 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.424 HG21 HD13 ' A' ' 35' ' ' LEU . 30.5 m -102.68 -20.38 5.67 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.552 0 CA-C-O 116.438 -1.744 . . . . 0.0 112.373 175.249 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 20.5 t90 -55.18 -36.48 65.93 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 121.508 1.958 . . . . 0.0 110.713 -177.5 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -64.1 -27.77 69.32 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 125.12 1.368 . . . . 0.0 112.939 174.418 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 58.4 mt-30 -97.13 -22.72 16.59 Favored 'General case' 0 C--O 1.224 -0.254 0 C-N-CA 126.802 2.041 . . . . 0.0 112.016 -176.494 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.494 ' CD1' HD21 ' A' ' 104' ' ' LEU . 77.7 mt -62.39 -25.99 68.23 Favored 'General case' 0 N--CA 1.462 0.149 0 O-C-N 121.5 -0.75 . . . . 0.0 110.511 178.0 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -78.33 -29.82 47.86 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 117.845 0.293 . . . . 0.0 110.452 172.279 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -72.41 -32.05 66.03 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 123.84 0.856 . . . . 0.0 112.56 -179.261 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 26.0 mt -53.64 142.84 21.82 Favored 'General case' 0 C--O 1.235 0.322 0 C-N-CA 123.906 0.882 . . . . 0.0 112.537 -169.689 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 26.3 t-20 -81.2 88.0 6.06 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 172.154 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 3.8 pp -144.37 132.71 21.92 Favored 'General case' 0 N--CA 1.454 -0.238 0 N-CA-C 108.579 -0.896 . . . . 0.0 108.579 172.001 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 22.6 mt-10 -140.14 146.52 38.93 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 128.591 2.757 . . . . 0.0 107.19 168.693 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 68.9 -3.57 6.55 Favored Glycine 0 CA--C 1.533 1.202 0 N-CA-C 116.793 1.477 . . . . 0.0 116.793 169.968 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.19 157.86 36.34 Favored 'General case' 0 C--N 1.345 0.389 0 CA-C-N 120.181 1.99 . . . . 0.0 110.021 -174.439 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 4.4 mt -80.42 135.25 25.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 N-CA-C 107.377 -1.342 . . . . 0.0 107.377 178.587 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 67.7 t -132.91 129.73 58.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 C-N-CA 124.604 1.162 . . . . 0.0 109.405 -176.924 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -105.98 153.72 21.61 Favored 'General case' 0 N--CA 1.462 0.136 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 168.549 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 1.4 mt -134.49 137.47 43.93 Favored 'General case' 0 CA--C 1.512 -0.484 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 176.214 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 36.7 p90 -154.98 170.94 20.59 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 170.957 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . 0.435 ' HA3' HD11 ' A' ' 101' ' ' LEU . . . 178.25 161.03 25.56 Favored Glycine 0 N--CA 1.445 -0.758 0 C-N-CA 120.701 -0.761 . . . . 0.0 111.919 168.336 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 58.4 tp -90.66 153.68 20.13 Favored 'General case' 0 N--CA 1.442 -0.841 0 C-N-CA 126.426 1.89 . . . . 0.0 110.981 178.995 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -167.12 -162.67 19.38 Favored Glycine 0 CA--C 1.528 0.888 0 N-CA-C 109.049 -1.62 . . . . 0.0 109.049 169.099 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 2.2 t0 -138.88 113.84 9.32 Favored 'General case' 0 CA--C 1.518 -0.28 0 N-CA-C 105.733 -1.951 . . . . 0.0 105.733 168.849 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 1.9 pt20 -66.36 -10.67 45.49 Favored 'General case' 0 CA--C 1.542 0.654 0 N-CA-C 113.207 0.817 . . . . 0.0 113.207 -175.853 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 84.4 mt -85.48 -57.48 3.05 Favored 'General case' 0 C--O 1.232 0.181 0 C-N-CA 124.132 0.973 . . . . 0.0 109.326 -177.707 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -73.09 -37.61 55.69 Favored Glycine 0 CA--C 1.529 0.949 0 C-N-CA 123.654 0.645 . . . . 0.0 111.699 178.314 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -115.85 75.66 0.96 Allowed 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 126.024 1.73 . . . . 0.0 106.466 -179.561 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -90.5 -55.25 1.95 Allowed Glycine 0 CA--C 1.525 0.698 0 N-CA-C 110.574 -1.01 . . . . 0.0 110.574 178.629 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -70.42 -13.07 61.98 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 124.988 1.315 . . . . 0.0 111.247 172.539 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' TRP . . . . . . . . . . . . . 3.6 m-90 -123.63 15.35 9.5 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 124.138 0.975 . . . . 0.0 110.976 -177.45 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 11.7 t80 -57.34 129.02 39.94 Favored 'General case' 0 C--N 1.341 0.198 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 179.1 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 90.6 mt 54.28 19.25 2.14 Favored 'General case' 0 CA--C 1.538 0.511 0 N-CA-C 114.117 1.155 . . . . 0.0 114.117 170.106 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -56.98 -35.17 68.86 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 124.739 1.216 . . . . 0.0 111.581 -175.457 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -72.61 -22.41 60.97 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-O 118.061 -0.971 . . . . 0.0 112.499 178.204 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.435 HD11 ' HA3' ' A' ' 86' ' ' GLY . 9.4 mp -65.76 -41.26 92.3 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-N 120.265 1.393 . . . . 0.0 108.172 169.003 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -65.9 -40.06 95.27 Favored Glycine 0 C--N 1.339 0.729 0 N-CA-C 110.76 -0.936 . . . . 0.0 110.76 -176.123 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 74.7 mtm -62.3 -39.9 94.54 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-O 118.681 -0.676 . . . . 0.0 111.619 178.409 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.806 HD23 ' CH2' ' A' ' 65' ' ' TRP . 0.1 OUTLIER -73.23 -39.1 65.76 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 119.982 1.265 . . . . 0.0 110.34 175.498 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 58.9 t60 -57.95 -51.68 68.63 Favored 'General case' 0 N--CA 1.46 0.06 0 CA-C-N 118.282 0.492 . . . . 0.0 110.189 -179.089 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -61.86 -38.81 89.62 Favored 'General case' 0 C--O 1.234 0.259 0 C-N-CA 123.87 0.868 . . . . 0.0 112.08 -175.783 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 24.4 ttmm -56.8 -39.95 75.06 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 123.542 0.737 . . . . 0.0 110.42 172.599 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 43.6 mt -91.04 -19.83 22.74 Favored 'General case' 0 CA--C 1.52 -0.192 0 N-CA-C 114.32 1.229 . . . . 0.0 114.32 -169.78 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 6.5 m -58.45 -35.86 72.78 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 120.11 1.323 . . . . 0.0 111.179 179.324 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 20.3 p -81.73 -22.81 37.09 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 124.392 1.077 . . . . 0.0 111.418 179.762 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 32.2 mmmt -73.35 -12.21 60.75 Favored 'General case' 0 C--N 1.344 0.354 0 C-N-CA 123.62 0.768 . . . . 0.0 110.824 168.775 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 73.57 34.2 57.28 Favored Glycine 0 C--N 1.336 0.538 0 CA-C-N 118.948 0.794 . . . . 0.0 111.912 169.834 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 9.4 m -73.49 171.53 1.21 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 CA-C-N 118.629 1.215 . . . . 0.0 109.832 174.684 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -108.42 122.4 46.95 Favored 'General case' 0 CA--C 1.515 -0.377 0 N-CA-C 106.389 -1.708 . . . . 0.0 106.389 175.405 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 80.2 m-85 -91.89 144.69 25.22 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 119.072 0.851 . . . . 0.0 109.751 -175.53 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 31.2 m -131.77 160.29 42.5 Favored 'Isoleucine or valine' 0 C--O 1.233 0.234 0 C-N-CA 124.794 1.238 . . . . 0.0 109.188 171.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 96.77 -85.08 0.82 Allowed Glycine 0 N--CA 1.446 -0.691 0 C-N-CA 124.379 0.99 . . . . 0.0 110.654 175.904 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 80.7 m-85 54.57 -171.53 0.05 Allowed 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 124.608 1.163 . . . . 0.0 110.446 -169.301 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -156.37 147.26 16.39 Favored Pre-proline 0 N--CA 1.473 0.679 0 O-C-N 120.26 -1.525 . . . . 0.0 110.485 170.06 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -67.82 128.76 18.44 Favored 'Trans proline' 0 CA--C 1.538 0.706 0 C-N-CA 123.091 2.527 . . . . 0.0 112.365 178.36 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 14.4 p -83.53 -17.17 42.74 Favored 'General case' 0 N--CA 1.469 0.494 0 O-C-N 121.631 -0.668 . . . . 0.0 112.379 173.761 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -64.23 126.59 28.26 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 123.239 0.616 . . . . 0.0 109.552 -169.753 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 76.69 -0.93 63.72 Favored Glycine 0 CA--C 1.534 1.256 0 C-N-CA 124.677 1.132 . . . . 0.0 114.12 -179.786 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 1.1 t80 -81.8 158.54 24.07 Favored 'General case' 0 C--O 1.237 0.423 0 CA-C-N 119.185 1.493 . . . . 0.0 109.776 175.271 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -120.5 109.52 15.38 Favored 'General case' 0 CA--C 1.531 0.217 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 179.702 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 21.6 p90 -163.94 173.71 12.32 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 127.571 2.348 . . . . 0.0 106.703 -179.404 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 7.6 t -147.16 -167.9 2.9 Favored 'General case' 0 CA--C 1.542 0.663 0 O-C-N 121.425 -0.797 . . . . 0.0 109.968 168.522 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 49.3 m 60.27 152.16 0.09 OUTLIER Pre-proline 0 CA--C 1.55 0.959 0 C-N-CA 129.022 2.929 . . . . 0.0 113.891 -167.748 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo -86.38 -22.91 1.98 Allowed 'Trans proline' 0 C--N 1.352 0.715 0 C-N-CA 122.164 1.909 . . . . 0.0 114.055 -170.17 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 21.8 ttmt -55.38 -41.21 89.57 Favored Pre-proline 0 N--CA 1.475 0.784 0 CA-C-N 120.684 1.583 . . . . 0.0 114.698 -170.953 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -74.08 -3.36 13.66 Favored 'Trans proline' 0 CA--C 1.538 0.685 0 CA-C-N 122.745 2.016 . . . . 0.0 114.089 -179.018 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 16.8 m -130.04 156.05 41.96 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.21 0 CA-C-N 119.75 1.159 . . . . 0.0 110.841 -170.685 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . 0.412 HG23 HG12 ' A' ' 140' ' ' VAL . 2.4 pt -92.79 171.19 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.598 0 C-N-CA 124.151 0.98 . . . . 0.0 109.662 169.433 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . 55.0 -151.95 0.37 Allowed 'General case' 0 N--CA 1.441 -0.876 0 CA-C-N 113.695 -1.593 . . . . 0.0 109.621 168.444 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 24.8 t0 -79.14 51.87 1.23 Allowed 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 124.99 1.316 . . . . 0.0 110.556 170.815 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 68.04 28.63 73.33 Favored Glycine 0 CA--C 1.529 0.944 0 C-N-CA 124.686 1.136 . . . . 0.0 113.167 179.913 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 20.1 mt-30 -81.39 -22.25 38.45 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 118.281 1.041 . . . . 0.0 112.476 -169.902 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 8.8 tp -156.22 143.94 19.45 Favored 'General case' 0 C--N 1.344 0.326 0 CA-C-N 118.21 0.459 . . . . 0.0 111.013 -178.736 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 74.7 m-85 -73.77 140.36 45.84 Favored 'General case' 0 CA--C 1.516 -0.355 0 N-CA-C 107.479 -1.304 . . . . 0.0 107.479 169.601 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . 0.412 HG12 HG23 ' A' ' 133' ' ' ILE . 27.6 m -66.13 -3.73 1.94 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.588 0 N-CA-C 113.285 0.846 . . . . 0.0 113.285 -179.083 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -177.33 170.87 43.57 Favored Glycine 0 N--CA 1.447 -0.607 0 C-N-CA 125.046 1.308 . . . . 0.0 110.215 -171.447 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -60.59 127.36 31.32 Favored 'General case' 0 C--O 1.234 0.287 0 C-N-CA 123.351 0.66 . . . . 0.0 110.945 -175.255 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -79.91 118.95 22.13 Favored 'General case' 0 N--CA 1.446 -0.669 0 C-N-CA 124.838 1.255 . . . . 0.0 108.521 169.87 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 13.8 tp -120.86 143.51 48.86 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 108.169 -1.048 . . . . 0.0 108.169 172.811 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -148.73 145.97 27.89 Favored 'General case' 0 C--O 1.237 0.407 0 C-N-CA 124.706 1.202 . . . . 0.0 107.895 -172.276 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -130.47 1.71 4.55 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 124.42 1.088 . . . . 0.0 112.993 -178.16 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 3.7 m -102.48 -43.91 5.51 Favored 'General case' 0 C--O 1.234 0.264 0 C-N-CA 125.269 1.428 . . . . 0.0 108.28 179.179 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 6.5 m-80 -90.03 -30.12 17.95 Favored 'General case' 0 C--N 1.331 -0.202 0 C-N-CA 125.27 1.428 . . . . 0.0 110.027 -173.249 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 76.6 mt-30 -130.21 158.54 39.44 Favored 'General case' 0 CA--C 1.529 0.171 0 C-N-CA 125.941 1.696 . . . . 0.0 108.376 177.763 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 82.7 t80 -148.14 -47.65 0.16 Allowed 'General case' 0 CA--C 1.528 0.126 0 C-N-CA 123.876 0.87 . . . . 0.0 108.767 169.857 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -68.24 -41.18 81.58 Favored 'General case' 0 C--N 1.344 0.352 0 C-N-CA 122.186 0.194 . . . . 0.0 111.025 176.839 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -75.57 -16.85 60.2 Favored 'General case' 0 C--N 1.346 0.452 0 CA-C-O 117.693 -1.146 . . . . 0.0 112.028 177.594 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 7.7 m -62.27 -34.27 76.23 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-N 120.995 1.725 . . . . 0.0 110.012 -173.729 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -63.17 -43.74 97.41 Favored 'General case' 0 N--CA 1.463 0.191 0 C-N-CA 123.576 0.75 . . . . 0.0 111.369 171.307 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 29.0 tt0 -63.92 -41.22 97.71 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 124.546 1.139 . . . . 0.0 110.795 178.814 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 3.5 mmt180 -65.64 -39.48 91.49 Favored 'General case' 0 CA--C 1.527 0.063 0 CA-C-O 118.627 -0.702 . . . . 0.0 109.187 -178.225 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 35.3 mt -66.0 -57.71 9.54 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.426 0 N-CA-C 107.474 -1.306 . . . . 0.0 107.474 173.771 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 68.4 tp60 -47.69 -65.12 0.62 Allowed 'General case' 0 CA--C 1.52 -0.196 0 C-N-CA 125.298 1.439 . . . . 0.0 112.861 -174.619 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 19.9 m -66.31 -31.36 72.11 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 121.26 -0.176 . . . . 0.0 110.855 -169.592 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 160' ' ' TRP . . . . . . . . . . . . . 67.3 t90 -71.28 -45.46 63.07 Favored 'General case' 0 C--O 1.224 -0.26 0 O-C-N 121.93 -0.481 . . . . 0.0 111.035 177.426 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 85.5 m -58.81 -42.13 88.44 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 123.074 0.55 . . . . 0.0 109.855 176.349 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 162' ' ' GLU . . . . . 0.427 ' HA ' HD23 ' A' ' 165' ' ' LEU . 38.0 mt-10 -64.07 -43.45 95.4 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-O 121.28 0.562 . . . . 0.0 110.335 177.325 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 10.8 tt0 -60.07 -51.2 70.65 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 124.006 0.922 . . . . 0.0 110.068 -179.563 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 40.2 pt -62.86 -36.06 73.9 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.394 0 CA-C-O 117.937 -1.03 . . . . 0.0 109.253 -176.603 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . 0.427 HD23 ' HA ' ' A' ' 162' ' ' GLU . 0.1 OUTLIER -59.3 -37.93 78.97 Favored 'General case' 0 C--O 1.224 -0.27 0 C-N-CA 124.697 1.199 . . . . 0.0 109.478 177.416 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 33.2 m-80 -75.07 -52.54 10.79 Favored 'General case' 0 CA--C 1.515 -0.372 0 N-CA-C 108.644 -0.873 . . . . 0.0 108.644 -179.531 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 10.6 tt0 -70.43 -28.38 65.0 Favored 'General case' 0 N--CA 1.443 -0.808 0 C-N-CA 124.11 0.964 . . . . 0.0 111.582 -168.798 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 168' ' ' MET . . . . . . . . . . . . . 18.7 ptp -77.64 -31.53 52.77 Favored 'General case' 0 N--CA 1.456 -0.133 0 O-C-N 121.391 -0.818 . . . . 0.0 111.975 172.678 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -78.83 -42.52 27.41 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 122.5 0.32 . . . . 0.0 110.701 -176.31 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -65.43 -28.23 69.09 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 123.542 0.737 . . . . 0.0 110.551 179.298 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 59.2 t60 -64.9 -40.35 94.96 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 124.354 1.061 . . . . 0.0 111.084 174.496 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 12.8 m-85 -80.65 -24.7 38.79 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 123.398 0.679 . . . . 0.0 112.78 177.599 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.242 0 C-N-CA 123.759 0.824 . . . . 0.0 111.087 -177.143 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.497 1.917 0 CA-C-O 119.771 -0.157 . . . . 0.0 111.188 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 25.2 p-10 -129.8 149.36 51.58 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 124.115 0.966 . . . . 0.0 112.186 -174.445 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 21.9 mtt -105.89 122.38 46.01 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 126.044 1.738 . . . . 0.0 107.213 -176.37 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -86.74 153.88 26.35 Favored Glycine 0 CA--C 1.529 0.942 0 N-CA-C 107.104 -2.398 . . . . 0.0 107.104 166.774 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 2.1 tt -142.6 96.84 3.01 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-N 120.042 1.921 . . . . 0.0 106.832 -173.499 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.696 ' CZ ' HD23 ' A' ' 51' ' ' LEU . 0.5 OUTLIER -101.69 140.52 35.87 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-O 121.033 0.444 . . . . 0.0 111.691 -170.592 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 25.2 p90 -162.93 174.98 11.65 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 126.456 1.903 . . . . 0.0 108.287 -177.143 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -74.48 -165.94 14.37 Favored Glycine 0 CA--C 1.537 1.417 0 C-N-CA 123.364 0.507 . . . . 0.0 112.378 178.169 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 1.6 m -58.11 122.95 14.33 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 124.154 0.982 . . . . 0.0 111.441 -177.472 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 8.2 m -54.87 150.14 10.43 Favored 'General case' 0 C--O 1.236 0.369 0 C-N-CA 124.307 1.043 . . . . 0.0 111.238 176.646 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 4.9 m 67.76 -39.94 0.4 Allowed 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 127.091 2.157 . . . . 0.0 113.164 179.764 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 59.6 m -69.36 -41.46 76.52 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 119.278 0.945 . . . . 0.0 109.995 172.284 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 26.7 m-85 -140.05 162.07 36.1 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 124.815 1.246 . . . . 0.0 109.892 -172.673 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 2.8 m 51.14 44.58 28.63 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 125.187 1.395 . . . . 0.0 111.069 174.928 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -61.53 138.99 58.31 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 122.859 0.464 . . . . 0.0 110.494 -171.794 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' MET . . . . . . . . . . . . 0.261 5.9 ptt? 53.48 -23.32 0.01 OUTLIER 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 130.515 3.526 . . . . 0.0 118.475 -179.847 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -61.64 -45.89 92.13 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 121.252 1.842 . . . . 0.0 110.867 -172.58 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -64.93 -47.1 78.91 Favored 'General case' 0 CA--C 1.527 0.089 0 C-N-CA 122.569 0.348 . . . . 0.0 111.053 -174.932 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -66.58 -35.74 80.95 Favored 'General case' 0 C--O 1.231 0.126 0 CA-C-O 118.602 -0.713 . . . . 0.0 110.735 179.175 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 48.0 mttm -65.61 -49.99 66.7 Favored 'General case' 0 C--O 1.22 -0.486 0 CA-C-O 118.339 -0.838 . . . . 0.0 110.588 175.781 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 40.7 mt -52.46 -52.15 28.2 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.336 0 CA-C-N 119.536 1.062 . . . . 0.0 108.764 178.894 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.61 -39.95 95.38 Favored 'General case' 0 C--O 1.223 -0.323 0 C-N-CA 123.119 0.568 . . . . 0.0 110.267 -177.162 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -67.92 -42.07 81.63 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 118.412 0.551 . . . . 0.0 110.917 -178.735 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 60.6 mt -72.98 -52.77 20.81 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.545 0 C-N-CA 124.911 1.284 . . . . 0.0 109.63 -170.531 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 69.7 mt -66.03 -46.75 87.24 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.375 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 178.443 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 139.37 126.05 2.32 Favored Glycine 0 CA--C 1.531 1.037 0 C-N-CA 124.8 1.191 . . . . 0.0 111.661 174.585 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -72.51 -5.66 17.57 Favored 'Trans proline' 0 CA--C 1.537 0.651 0 C-N-CA 123.593 2.862 . . . . 0.0 114.243 -173.287 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -80.1 -20.52 44.9 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-N 119.329 0.968 . . . . 0.0 111.243 176.794 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -128.02 -1.72 5.85 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 124.793 1.237 . . . . 0.0 113.861 -171.775 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 21.9 t -117.15 147.92 20.22 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.338 0 N-CA-C 107.745 -1.206 . . . . 0.0 107.745 171.748 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 15.5 m -131.66 132.9 44.35 Favored 'General case' 0 N--CA 1.463 0.203 0 N-CA-C 107.688 -1.227 . . . . 0.0 107.688 -177.835 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 17.7 mt -79.01 133.39 36.83 Favored 'General case' 0 C--O 1.233 0.198 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 175.151 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 32.2 t-80 -128.75 58.68 1.57 Allowed 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 124.674 1.19 . . . . 0.0 108.6 -177.551 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 8.0 t-20 -55.5 122.28 10.91 Favored 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 106.413 -1.699 . . . . 0.0 106.413 168.586 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 58.9 mt -66.09 -35.42 80.46 Favored 'General case' 0 C--O 1.236 0.356 0 N-CA-C 112.693 0.627 . . . . 0.0 112.693 -173.306 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 42.3 tttm -64.21 -18.82 64.88 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-O 119.011 -0.519 . . . . 0.0 111.5 172.26 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -97.6 -34.24 11.03 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-N 119.015 0.825 . . . . 0.0 112.574 -177.186 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 4.1 t0 -145.07 145.62 31.52 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 118.763 0.711 . . . . 0.0 112.33 176.636 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 12.4 m -66.72 158.49 79.46 Favored Pre-proline 0 CA--C 1.542 0.655 0 C-N-CA 126.216 1.806 . . . . 0.0 112.261 -169.389 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -73.9 -26.83 12.86 Favored 'Trans proline' 0 C--N 1.35 0.629 0 C-N-CA 122.548 2.165 . . . . 0.0 113.222 -170.993 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 22.9 mmmt -70.66 -11.63 61.06 Favored 'General case' 0 CA--C 1.538 0.497 0 O-C-N 120.456 -1.403 . . . . 0.0 111.676 -176.846 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -61.93 -29.3 70.13 Favored 'General case' 0 N--CA 1.463 0.21 0 C-N-CA 125.683 1.593 . . . . 0.0 110.14 169.142 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 39.7 mtt -55.72 -26.78 46.99 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 123.588 0.755 . . . . 0.0 111.464 178.204 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 94.2 mt-10 -65.49 -31.26 72.23 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 118.191 0.451 . . . . 0.0 110.354 -176.609 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 21.1 mt-30 -69.61 -43.84 71.94 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 123.588 0.755 . . . . 0.0 112.704 -170.103 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 57.3 m-85 -68.33 147.63 51.87 Favored 'General case' 0 C--O 1.231 0.096 0 C-N-CA 123.735 0.814 . . . . 0.0 109.135 -168.47 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -80.59 -37.0 32.02 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 119.105 0.866 . . . . 0.0 108.979 -178.926 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 1.3 m -105.51 151.31 7.7 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.806 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 169.532 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 58.4 tp -140.9 106.6 5.11 Favored 'General case' 0 N--CA 1.448 -0.562 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 174.853 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 22.3 mt -84.4 131.83 33.04 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.744 0 N-CA-C 106.139 -1.8 . . . . 0.0 106.139 176.317 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.696 HD23 ' CZ ' ' A' ' 6' ' ' PHE . 0.5 OUTLIER -106.81 131.85 53.44 Favored 'General case' 0 C--O 1.233 0.217 0 N-CA-C 107.283 -1.377 . . . . 0.0 107.283 169.693 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.579 ' N ' HD22 ' A' ' 51' ' ' LEU . . . -127.3 135.53 8.83 Favored Glycine 0 CA--C 1.521 0.456 0 N-CA-C 109.741 -1.344 . . . . 0.0 109.741 171.301 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 3.8 tt -152.05 134.95 9.06 Favored Pre-proline 0 CA--C 1.535 0.399 0 CA-C-N 118.521 1.161 . . . . 0.0 111.786 173.905 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_endo -75.14 133.59 16.56 Favored 'Trans proline' 0 N--CA 1.456 -0.727 0 C-N-CA 122.176 1.917 . . . . 0.0 109.602 165.044 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.434 HG21 ' H ' ' A' ' 99' ' ' ASP . 91.0 m -100.76 133.29 45.45 Favored 'General case' 0 CA--C 1.534 0.365 0 N-CA-C 106.546 -1.65 . . . . 0.0 106.546 167.976 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 6.1 m-90 -138.91 143.4 38.65 Favored 'General case' 0 C--O 1.236 0.386 0 N-CA-C 105.781 -1.933 . . . . 0.0 105.781 169.628 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -66.76 -45.66 77.84 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 118.938 0.79 . . . . 0.0 110.525 -179.316 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 30.8 p90 -83.92 148.54 26.88 Favored 'General case' 0 CA--C 1.531 0.228 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 168.832 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 78.61 -50.89 3.63 Favored Glycine 0 CA--C 1.533 1.198 0 CA-C-O 118.833 -0.982 . . . . 0.0 112.007 -178.872 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.487 ' HG2' ' H ' ' A' ' 61' ' ' ILE . 13.8 tt0 55.1 -159.38 0.19 Allowed 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 125.175 1.39 . . . . 0.0 110.344 -176.194 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.487 ' H ' ' HG2' ' A' ' 60' ' ' GLU . 23.6 mt -38.05 122.72 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.58 0 C-N-CA 126.33 1.852 . . . . 0.0 109.712 168.451 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 2.2 pm0 -70.11 156.11 39.66 Favored 'General case' 0 C--O 1.232 0.179 0 C-N-CA 123.633 0.773 . . . . 0.0 110.302 176.108 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -54.54 -47.47 73.15 Favored 'General case' 0 N--CA 1.456 -0.167 0 C-N-CA 124.604 1.162 . . . . 0.0 112.457 -168.424 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -67.26 -31.44 71.78 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 119.503 1.047 . . . . 0.0 111.503 -172.225 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' TRP . . . . . 0.546 ' CH2' HD23 ' A' ' 104' ' ' LEU . 5.2 t90 -73.91 -44.54 54.8 Favored 'General case' 0 N--CA 1.455 -0.222 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 178.578 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -61.83 -36.79 82.22 Favored 'General case' 0 CA--C 1.537 0.464 0 O-C-N 121.397 -0.814 . . . . 0.0 109.993 176.241 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -61.91 -25.07 67.35 Favored 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 123.312 0.645 . . . . 0.0 111.117 -174.093 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 25.4 m -108.56 -13.99 10.17 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.271 0 CA-C-O 117.073 -1.441 . . . . 0.0 112.644 175.21 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 18.2 t90 -51.31 -39.46 56.96 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 120.27 1.396 . . . . 0.0 110.075 -178.611 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -66.73 -25.35 66.47 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 125.721 1.608 . . . . 0.0 113.568 177.8 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 25.8 mt-30 -92.06 -19.23 22.56 Favored 'General case' 0 C--N 1.341 0.224 0 C-N-CA 125.688 1.595 . . . . 0.0 112.348 177.007 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 52.6 mt -62.09 -25.78 67.91 Favored 'General case' 0 N--CA 1.466 0.342 0 O-C-N 121.425 -0.797 . . . . 0.0 111.399 -174.937 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -75.92 -21.95 56.55 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-N 118.026 0.376 . . . . 0.0 111.741 176.47 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -73.47 -29.37 62.49 Favored 'General case' 0 N--CA 1.467 0.413 0 O-C-N 120.827 -1.171 . . . . 0.0 111.852 177.173 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 82.9 mt -54.16 138.25 38.66 Favored 'General case' 0 C--N 1.339 0.147 0 C-N-CA 124.926 1.291 . . . . 0.0 112.911 -168.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 3.0 t30 -74.97 98.93 3.7 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 123.973 0.909 . . . . 0.0 108.978 170.166 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 56.7 mt -123.07 -0.12 8.99 Favored 'General case' 0 N--CA 1.474 0.769 0 N-CA-C 113.765 1.024 . . . . 0.0 113.765 -176.03 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 25.2 mt-10 -55.2 128.69 35.09 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 119.72 1.146 . . . . 0.0 111.581 -168.974 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 74.88 -1.97 51.94 Favored Glycine 0 CA--C 1.532 1.107 0 C-N-CA 125.487 1.518 . . . . 0.0 114.98 177.095 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.3 155.35 34.32 Favored 'General case' 0 C--N 1.346 0.421 0 CA-C-N 120.172 1.986 . . . . 0.0 109.929 -176.035 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 12.4 mt -78.87 142.52 13.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 N-CA-C 106.615 -1.624 . . . . 0.0 106.615 177.918 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 3.0 t -138.08 139.72 41.74 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 O-C-N 121.42 -0.8 . . . . 0.0 109.251 -179.051 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -117.06 147.71 42.13 Favored 'General case' 0 CA--C 1.511 -0.532 0 N-CA-C 106.43 -1.693 . . . . 0.0 106.43 170.876 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 5.9 mp -127.82 142.08 51.39 Favored 'General case' 0 CA--C 1.509 -0.622 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 170.569 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 35.8 p90 -150.04 166.85 28.47 Favored 'General case' 0 N--CA 1.445 -0.701 0 N-CA-C 107.02 -1.474 . . . . 0.0 107.02 167.644 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -163.07 167.43 37.41 Favored Glycine 0 N--CA 1.444 -0.829 0 N-CA-C 109.915 -1.274 . . . . 0.0 109.915 173.388 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -113.43 142.47 45.86 Favored 'General case' 0 N--CA 1.447 -0.585 0 N-CA-C 106.81 -1.552 . . . . 0.0 106.81 -179.702 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -160.68 -167.75 21.62 Favored Glycine 0 CA--C 1.525 0.676 0 N-CA-C 109.304 -1.519 . . . . 0.0 109.304 175.056 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 4.2 t0 -149.4 122.8 9.05 Favored 'General case' 0 C--O 1.234 0.272 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 171.439 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 16.3 pm0 -75.96 -15.25 60.2 Favored 'General case' 0 N--CA 1.448 -0.556 0 C-N-CA 124.573 1.149 . . . . 0.0 113.337 -178.653 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 94.7 mt -80.11 -49.61 11.49 Favored 'General case' 0 C--O 1.231 0.12 0 CA-C-N 119.232 0.924 . . . . 0.0 109.527 -178.819 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -76.26 -46.43 12.71 Favored Glycine 0 CA--C 1.522 0.502 0 C-N-CA 123.907 0.765 . . . . 0.0 112.077 -179.359 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 18.6 m-85 -98.86 -88.73 0.32 Allowed 'General case' 0 C--N 1.339 0.147 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 -176.448 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 79.14 -43.69 2.52 Favored Glycine 0 CA--C 1.529 0.945 0 C-N-CA 124.097 0.856 . . . . 0.0 112.825 171.897 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -84.27 -14.15 50.59 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 126.095 1.758 . . . . 0.0 111.528 171.086 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' TRP . . . . . . . . . . . . . 2.7 m-90 -128.98 29.01 5.26 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 125.297 1.439 . . . . 0.0 110.416 -178.57 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 18.3 t80 -66.28 132.74 49.07 Favored 'General case' 0 C--N 1.339 0.143 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 -176.056 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 95.5 mt 50.62 28.88 3.73 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 124.841 1.256 . . . . 0.0 113.337 169.456 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . 0.434 ' H ' HG21 ' A' ' 55' ' ' THR . 22.5 t70 -57.47 -39.82 77.19 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 124.56 1.144 . . . . 0.0 110.845 -178.165 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -71.46 -32.13 67.95 Favored 'General case' 0 CA--C 1.534 0.331 0 O-C-N 121.666 -0.647 . . . . 0.0 111.9 178.926 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 4.9 tt -62.83 -47.94 81.22 Favored 'General case' 0 N--CA 1.467 0.4 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 171.957 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -63.27 -39.06 97.42 Favored Glycine 0 C--N 1.338 0.66 0 N-CA-C 111.145 -0.782 . . . . 0.0 111.145 -177.314 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 67.7 mtm -64.93 -40.38 94.97 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 118.236 1.018 . . . . 0.0 111.394 176.621 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.546 HD23 ' CH2' ' A' ' 65' ' ' TRP . 0.2 OUTLIER -71.67 -31.54 66.91 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 119.752 1.16 . . . . 0.0 111.244 177.714 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 50.6 t-80 -62.65 -45.81 91.13 Favored 'General case' 0 N--CA 1.462 0.148 0 CA-C-N 118.98 0.809 . . . . 0.0 110.837 171.444 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -63.6 -44.1 95.0 Favored 'General case' 0 C--O 1.234 0.274 0 C-N-CA 122.942 0.497 . . . . 0.0 111.06 -177.09 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 22.3 ttmm -58.0 -48.6 79.53 Favored 'General case' 0 C--O 1.226 -0.177 0 C-N-CA 123.131 0.572 . . . . 0.0 109.962 172.23 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 32.9 mt -74.79 -23.27 58.48 Favored 'General case' 0 N--CA 1.461 0.091 0 CA-C-O 118.622 -0.704 . . . . 0.0 112.547 -170.839 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 70.0 m -61.04 -38.18 85.25 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 119.376 0.989 . . . . 0.0 111.261 -177.506 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 26.1 p -85.1 -6.89 59.29 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 123.551 0.74 . . . . 0.0 111.667 -178.824 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 30.7 mmmt -82.12 -7.63 59.63 Favored 'General case' 0 C--N 1.344 0.36 0 C-N-CA 124.462 1.105 . . . . 0.0 111.806 171.635 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 69.51 34.36 73.55 Favored Glycine 0 CA--C 1.525 0.688 0 CA-C-N 118.764 0.711 . . . . 0.0 111.788 173.92 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 8.0 m -77.94 172.48 1.12 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.469 0 CA-C-N 117.913 0.856 . . . . 0.0 109.383 174.34 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -111.37 116.48 31.03 Favored 'General case' 0 CA--C 1.514 -0.437 0 N-CA-C 105.938 -1.875 . . . . 0.0 105.938 177.484 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 71.4 m-85 -85.56 142.39 29.17 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 118.819 0.736 . . . . 0.0 110.135 -173.881 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 32.6 m -131.9 158.73 43.34 Favored 'Isoleucine or valine' 0 C--O 1.234 0.268 0 C-N-CA 125.612 1.565 . . . . 0.0 107.581 168.921 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 83.93 31.13 27.07 Favored Glycine 0 CA--C 1.521 0.464 0 CA-C-O 118.779 -1.012 . . . . 0.0 114.935 169.73 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 10.6 m-30 -65.78 157.13 31.12 Favored 'General case' 0 CA--C 1.546 0.823 0 CA-C-N 118.941 1.371 . . . . 0.0 109.343 169.042 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' TRP . . . . . 0.4 ' HA ' ' HD3' ' A' ' 120' ' ' PRO . 51.1 t-105 -133.88 147.39 64.01 Favored Pre-proline 0 N--CA 1.476 0.838 0 CA-C-O 118.054 -0.974 . . . . 0.0 112.095 -168.524 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . 0.4 ' HD3' ' HA ' ' A' ' 119' ' ' TRP . 50.3 Cg_exo -63.25 129.92 27.05 Favored 'Trans proline' 0 C--N 1.35 0.627 0 C-N-CA 123.077 2.518 . . . . 0.0 113.202 -177.621 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 7.6 p -88.36 -26.63 22.1 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 124.274 1.029 . . . . 0.0 110.764 169.299 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 14.0 mm-40 -65.43 130.52 43.59 Favored 'General case' 0 N--CA 1.451 -0.409 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 -178.954 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 77.67 -5.26 53.24 Favored Glycine 0 CA--C 1.535 1.316 0 CA-C-O 119.029 -0.873 . . . . 0.0 113.436 -176.033 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -87.13 163.34 17.03 Favored 'General case' 0 C--O 1.236 0.342 0 CA-C-N 118.798 1.299 . . . . 0.0 109.096 170.708 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -125.17 124.94 42.86 Favored 'General case' 0 N--CA 1.462 0.135 0 N-CA-C 107.817 -1.179 . . . . 0.0 107.817 175.727 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 22.5 p90 -173.06 170.9 4.3 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 128.091 2.556 . . . . 0.0 106.311 179.706 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 4.8 t -136.44 -10.7 1.9 Allowed 'General case' 0 N--CA 1.472 0.652 0 CA-C-N 118.792 0.724 . . . . 0.0 112.82 168.164 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 14.7 m -59.25 126.66 82.52 Favored Pre-proline 0 CA--C 1.543 0.686 0 C-N-CA 123.796 0.838 . . . . 0.0 111.807 179.227 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_endo -83.57 -22.92 3.57 Favored 'Trans proline' 0 CA--C 1.542 0.905 0 C-N-CA 122.257 1.971 . . . . 0.0 112.999 176.631 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 25.9 ttmt -60.08 -42.07 88.08 Favored Pre-proline 0 CA--C 1.544 0.716 0 O-C-N 120.734 -1.229 . . . . 0.0 113.998 -176.198 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_endo -80.58 5.99 5.74 Favored 'Trans proline' 0 C--N 1.352 0.721 0 C-N-CA 122.046 1.83 . . . . 0.0 114.066 -179.6 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 19.0 m -124.07 147.89 28.4 Favored 'Isoleucine or valine' 0 C--O 1.234 0.273 0 CA-C-N 120.888 1.677 . . . . 0.0 110.982 -177.589 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . 0.822 HG23 HG12 ' A' ' 140' ' ' VAL . 2.4 pt -82.69 168.78 1.71 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 N-CA-C 108.056 -1.09 . . . . 0.0 108.056 167.158 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . 55.85 -156.12 0.27 Allowed 'General case' 0 N--CA 1.443 -0.778 0 CA-C-N 114.076 -1.42 . . . . 0.0 110.195 168.587 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 21.8 t0 -80.62 61.11 4.2 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 125.128 1.371 . . . . 0.0 108.92 169.551 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 65.13 28.39 73.49 Favored Glycine 0 CA--C 1.531 1.044 0 C-N-CA 124.302 0.953 . . . . 0.0 113.289 176.768 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 62.5 mm-40 -78.17 -27.49 48.06 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 118.125 0.963 . . . . 0.0 111.886 -169.143 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 12.7 tp -159.17 146.89 17.53 Favored 'General case' 0 C--N 1.341 0.222 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 -177.349 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 63.7 m-85 -75.82 143.09 42.06 Favored 'General case' 0 CA--C 1.517 -0.322 0 N-CA-C 107.821 -1.177 . . . . 0.0 107.821 171.775 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . 0.822 HG12 HG23 ' A' ' 133' ' ' ILE . 4.2 m -76.77 10.23 0.5 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.89 0 C-N-CA 123.818 0.847 . . . . 0.0 111.686 -178.43 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 179.25 174.0 44.96 Favored Glycine 0 CA--C 1.529 0.934 0 C-N-CA 125.837 1.684 . . . . 0.0 109.592 -175.478 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 5.0 tp -68.29 134.86 51.02 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-N 118.557 1.179 . . . . 0.0 111.089 178.094 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -96.28 107.64 20.02 Favored 'General case' 0 N--CA 1.442 -0.836 0 C-N-CA 125.367 1.467 . . . . 0.0 108.982 172.557 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 89.6 mt -91.36 151.15 20.97 Favored 'General case' 0 C--O 1.233 0.225 0 N-CA-C 108.096 -1.076 . . . . 0.0 108.096 168.742 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -136.24 155.58 49.9 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 126.537 1.935 . . . . 0.0 107.584 171.799 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 4.9 tp10 -144.0 36.68 1.27 Allowed 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 123.906 0.882 . . . . 0.0 109.773 171.438 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 55.8 m -141.29 -47.87 0.39 Allowed 'General case' 0 C--O 1.236 0.354 0 C-N-CA 124.847 1.259 . . . . 0.0 110.104 -176.612 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 6.1 m-80 -76.14 -35.81 59.06 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 124.5 1.12 . . . . 0.0 108.936 -179.17 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 7.5 mm-40 -121.95 162.59 20.8 Favored 'General case' 0 N--CA 1.452 -0.368 0 C-N-CA 127.103 2.161 . . . . 0.0 109.139 174.594 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 92.8 m-85 -138.57 -36.12 0.58 Allowed 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 124.766 1.226 . . . . 0.0 109.198 167.855 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -71.27 -41.99 69.35 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 123.274 0.63 . . . . 0.0 111.906 177.578 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 87.6 mt -81.83 -6.46 59.1 Favored 'General case' 0 N--CA 1.467 0.424 0 N-CA-C 112.926 0.714 . . . . 0.0 112.926 -170.959 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 12.4 m -62.21 -35.9 80.3 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 119.423 1.011 . . . . 0.0 110.719 -172.492 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -67.51 -39.85 85.14 Favored 'General case' 0 N--CA 1.464 0.258 0 C-N-CA 123.081 0.553 . . . . 0.0 110.853 173.224 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 28.5 tt0 -65.97 -43.33 88.22 Favored 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 124.334 1.054 . . . . 0.0 111.008 -178.326 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.6 -39.93 74.42 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 123.251 0.621 . . . . 0.0 109.475 177.383 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 53.7 mt -70.91 -54.23 18.61 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 N-CA-C 108.277 -1.008 . . . . 0.0 108.277 176.8 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 71.7 tp60 -50.51 -62.32 1.66 Allowed 'General case' 0 N--CA 1.463 0.181 0 C-N-CA 125.183 1.393 . . . . 0.0 111.97 -174.359 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 19.9 m -68.23 -31.98 71.86 Favored 'General case' 0 C--N 1.324 -0.543 0 C-N-CA 121.273 -0.171 . . . . 0.0 110.84 -169.716 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 160' ' ' TRP . . . . . . . . . . . . . 48.7 t90 -66.04 -47.3 74.81 Favored 'General case' 0 C--O 1.223 -0.304 0 O-C-N 122.157 -0.339 . . . . 0.0 110.71 173.388 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 65.5 m -59.93 -43.14 95.13 Favored 'General case' 0 N--CA 1.455 -0.195 0 C-N-CA 122.956 0.503 . . . . 0.0 110.408 -178.554 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -63.16 -40.26 97.03 Favored 'General case' 0 N--CA 1.455 -0.22 0 N-CA-C 110.223 -0.288 . . . . 0.0 110.223 176.995 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 16.6 tt0 -65.85 -51.62 57.29 Favored 'General case' 0 N--CA 1.446 -0.64 0 CA-C-O 118.787 -0.625 . . . . 0.0 110.122 -179.228 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 39.4 pt -63.5 -38.0 81.07 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.377 0 CA-C-O 117.909 -1.043 . . . . 0.0 109.667 -175.212 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -63.74 -36.07 82.66 Favored 'General case' 0 C--O 1.225 -0.225 0 CA-C-N 119.351 0.978 . . . . 0.0 109.833 179.526 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 28.4 m-80 -68.28 -52.59 32.03 Favored 'General case' 0 CA--C 1.515 -0.4 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 175.808 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 15.2 tt0 -70.69 -26.76 63.57 Favored 'General case' 0 N--CA 1.443 -0.786 0 C-N-CA 124.381 1.073 . . . . 0.0 111.504 -168.767 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 168' ' ' MET . . . . . . . . . . . . . 17.1 ptp -79.58 -30.5 41.63 Favored 'General case' 0 C--O 1.227 -0.104 0 O-C-N 120.808 -1.182 . . . . 0.0 112.219 171.699 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -79.75 -40.54 28.55 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 122.923 0.489 . . . . 0.0 111.156 -178.223 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -69.71 -26.15 64.2 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 124.342 1.057 . . . . 0.0 110.532 -178.57 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 52.5 t60 -60.63 -28.18 68.35 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 124.072 0.949 . . . . 0.0 110.97 170.684 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 29.5 m-85 -101.46 10.39 40.47 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 126.064 1.746 . . . . 0.0 113.31 175.125 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.255 1.367 0 CA-C-N 119.475 1.034 . . . . 0.0 109.794 173.595 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 53.6 ttp . . . . . 0 N--CA 1.497 1.905 0 N-CA-C 110.002 -0.37 . . . . 0.0 110.002 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 10.4 t30 -141.44 152.11 43.98 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 124.908 1.283 . . . . 0.0 107.639 174.681 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 11.8 mtt -113.84 121.46 44.08 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 123.246 0.618 . . . . 0.0 111.136 -175.79 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . 0.407 ' HA3' ' CD2' ' A' ' 46' ' ' TYR . . . -80.47 155.51 37.8 Favored Glycine 0 CA--C 1.521 0.41 0 N-CA-C 107.606 -2.198 . . . . 0.0 107.606 166.912 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 2.5 tt -141.47 96.01 2.92 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 105.805 -1.924 . . . . 0.0 105.805 -176.517 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -102.71 143.45 32.35 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-O 121.691 0.758 . . . . 0.0 112.142 -170.454 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 30.2 p90 -157.76 160.35 37.76 Favored 'General case' 0 N--CA 1.451 -0.384 0 C-N-CA 126.81 2.044 . . . . 0.0 107.278 177.016 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -101.08 143.28 16.11 Favored Glycine 0 CA--C 1.523 0.58 0 N-CA-C 110.711 -0.956 . . . . 0.0 110.711 -177.99 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 17.5 m 62.73 147.26 0.02 OUTLIER 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 128.084 2.554 . . . . 0.0 115.395 175.965 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 4.8 m -77.85 165.7 23.82 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 114.62 -1.173 . . . . 0.0 109.506 168.987 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 1.3 m 60.32 36.47 20.59 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 124.433 1.093 . . . . 0.0 111.213 171.935 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 76.6 m -124.66 149.03 47.6 Favored 'General case' 0 C--O 1.234 0.243 0 C-N-CA 125.715 1.606 . . . . 0.0 107.048 173.782 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 50.3 t80 -62.43 -21.08 65.14 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 119.064 0.847 . . . . 0.0 112.46 -170.743 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 1.3 m -53.28 -29.44 33.22 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-O 118.182 -0.914 . . . . 0.0 112.045 174.39 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -71.91 -27.88 63.12 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 120.525 1.511 . . . . 0.0 111.519 179.036 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 2.2 mpp? -71.29 -41.94 69.33 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 119.162 0.892 . . . . 0.0 109.163 174.898 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -59.18 -44.15 92.17 Favored 'General case' 0 CA--C 1.531 0.239 0 N-CA-C 109.438 -0.578 . . . . 0.0 109.438 171.758 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -63.87 -46.43 84.95 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 123.728 0.811 . . . . 0.0 111.514 -176.822 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 26.5 mt-10 -58.44 -43.96 88.96 Favored 'General case' 0 CA--C 1.517 -0.303 0 C-N-CA 123.51 0.724 . . . . 0.0 109.843 174.559 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 51.2 mttm -65.1 -47.2 78.05 Favored 'General case' 0 C--O 1.222 -0.359 0 CA-C-O 118.725 -0.655 . . . . 0.0 109.984 -178.613 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 43.0 mt -52.88 -54.81 14.71 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.214 0 CA-C-N 119.024 0.829 . . . . 0.0 109.62 179.807 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.465 ' HG2' HD21 ' A' ' 32' ' ' LEU . 0.0 OUTLIER -66.45 -35.8 81.2 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 118.374 0.533 . . . . 0.0 111.257 -175.372 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -64.35 -40.41 95.8 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.855 0.359 . . . . 0.0 110.592 178.582 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 62.6 mt -78.41 -54.01 12.89 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.548 0 C-N-CA 124.674 1.19 . . . . 0.0 110.038 -170.301 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 69.5 mt -62.71 -47.51 92.54 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 178.552 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 142.33 122.59 1.77 Allowed Glycine 0 CA--C 1.528 0.903 0 C-N-CA 124.646 1.117 . . . . 0.0 110.78 177.133 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -71.87 -11.18 27.32 Favored 'Trans proline' 0 CA--C 1.537 0.666 0 C-N-CA 122.885 2.39 . . . . 0.0 113.248 -170.262 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -79.96 -18.24 50.92 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 118.844 0.747 . . . . 0.0 111.953 -179.753 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -126.89 5.82 6.61 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 125.085 1.354 . . . . 0.0 113.555 -172.618 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 36.8 t -123.91 148.63 27.97 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.518 0 C-N-CA 124.85 1.26 . . . . 0.0 107.872 172.221 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 20.3 m -134.85 131.12 37.03 Favored 'General case' 0 C--N 1.332 -0.186 0 C-N-CA 125.519 1.528 . . . . 0.0 107.851 -175.267 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.465 HD21 ' HG2' ' A' ' 22' ' ' ARG . 20.9 mt -79.72 139.68 37.23 Favored 'General case' 0 C--O 1.232 0.17 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 177.873 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 18.0 t-80 -137.22 54.8 1.84 Allowed 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 124.177 0.991 . . . . 0.0 108.936 -173.419 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 37.8 t-20 -57.27 123.13 14.29 Favored 'General case' 0 N--CA 1.465 0.283 0 N-CA-C 106.367 -1.716 . . . . 0.0 106.367 168.629 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 31.3 mt -70.75 -31.79 68.72 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 118.661 0.664 . . . . 0.0 112.472 -169.072 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 57.7 tptt -58.96 -24.58 62.74 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 124.2 1.0 . . . . 0.0 110.355 169.765 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -95.73 -33.6 12.24 Favored 'General case' 0 C--O 1.236 0.376 0 N-CA-C 113.566 0.95 . . . . 0.0 113.566 -177.049 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 4.4 t0 -147.54 149.8 33.3 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 119.459 1.027 . . . . 0.0 113.18 178.33 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 15.7 m -71.66 158.43 87.86 Favored Pre-proline 0 CA--C 1.541 0.615 0 C-N-CA 126.236 1.814 . . . . 0.0 112.607 -168.92 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -73.53 -25.6 14.92 Favored 'Trans proline' 0 C--N 1.35 0.611 0 C-N-CA 122.467 2.111 . . . . 0.0 113.935 -173.251 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 8.6 mptt -62.4 -20.45 64.47 Favored 'General case' 0 N--CA 1.475 0.786 0 CA-C-N 120.403 1.456 . . . . 0.0 111.912 -179.587 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -58.14 -29.82 65.85 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 125.552 1.541 . . . . 0.0 110.723 173.347 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 50.4 mtt -60.87 -25.93 67.04 Favored 'General case' 0 C--N 1.339 0.151 0 C-N-CA 123.388 0.675 . . . . 0.0 111.428 178.662 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 61.2 mt-10 -64.84 -35.49 81.28 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-N 118.371 0.532 . . . . 0.0 109.717 -178.445 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 13.5 mt-30 -67.78 -46.04 73.1 Favored 'General case' 0 C--N 1.34 0.159 0 C-N-CA 123.65 0.78 . . . . 0.0 111.836 -171.519 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . 0.407 ' CD2' ' HA3' ' A' ' 4' ' ' GLY . 17.5 m-85 -69.54 133.55 47.79 Favored 'General case' 0 CA--C 1.521 -0.159 0 CA-C-N 115.424 -0.807 . . . . 0.0 109.235 -167.372 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -75.4 -31.8 60.55 Favored 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 120.361 -0.535 . . . . 0.0 110.86 -176.187 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 20.8 t -109.54 146.08 15.42 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.368 0 N-CA-C 106.717 -1.586 . . . . 0.0 106.717 168.789 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 27.5 tp -133.08 115.77 15.51 Favored 'General case' 0 N--CA 1.445 -0.696 0 N-CA-C 108.439 -0.948 . . . . 0.0 108.439 174.427 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 23.4 mt -94.6 135.88 27.52 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.63 0 N-CA-C 107.045 -1.465 . . . . 0.0 107.045 177.396 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.513 ' CD2' HD12 ' A' ' 104' ' ' LEU . 0.8 OUTLIER -119.45 131.43 55.62 Favored 'General case' 0 CA--C 1.514 -0.418 0 C-N-CA 125.234 1.413 . . . . 0.0 107.324 -174.466 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -132.64 129.77 5.61 Favored Glycine 0 CA--C 1.519 0.295 0 N-CA-C 110.318 -1.113 . . . . 0.0 110.318 175.036 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 5.8 tt -152.25 133.52 8.0 Favored Pre-proline 0 CA--C 1.541 0.616 0 CA-C-N 118.134 0.967 . . . . 0.0 110.18 169.484 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_exo -76.3 150.05 32.28 Favored 'Trans proline' 0 N--CA 1.46 -0.481 0 C-N-CA 122.824 2.349 . . . . 0.0 112.2 167.704 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 6.2 m -122.93 134.13 54.37 Favored 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 107.252 -1.388 . . . . 0.0 107.252 167.489 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 6.4 m-90 -140.88 148.85 41.14 Favored 'General case' 0 C--O 1.232 0.172 0 C-N-CA 124.91 1.284 . . . . 0.0 107.815 173.626 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -68.29 -33.53 74.51 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-N 118.576 0.626 . . . . 0.0 110.836 173.804 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 33.2 p90 -81.12 7.08 11.87 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 124.313 1.045 . . . . 0.0 112.248 175.67 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -139.23 -171.38 12.19 Favored Glycine 0 CA--C 1.527 0.832 0 C-N-CA 124.603 1.097 . . . . 0.0 111.199 -177.585 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -164.86 163.39 21.12 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 126.324 1.85 . . . . 0.0 106.919 178.43 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 17.5 mt -37.25 132.9 0.24 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.781 0 C-N-CA 125.632 1.573 . . . . 0.0 110.669 167.47 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 3.9 mp0 -66.61 146.65 54.26 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 125.578 1.551 . . . . 0.0 108.661 178.544 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -59.11 -42.01 89.53 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 122.906 0.483 . . . . 0.0 110.239 -179.386 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -58.8 -29.55 66.94 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 124.16 0.984 . . . . 0.0 112.043 178.512 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' TRP . . . . . 0.679 ' CH2' HD23 ' A' ' 104' ' ' LEU . 15.9 t90 -87.22 -45.23 10.83 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 124.303 1.041 . . . . 0.0 109.948 179.828 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -61.59 -35.79 78.85 Favored 'General case' 0 CA--C 1.537 0.46 0 O-C-N 120.903 -1.123 . . . . 0.0 109.656 179.851 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -59.6 -25.11 64.35 Favored 'General case' 0 C--O 1.235 0.313 0 C-N-CA 123.951 0.901 . . . . 0.0 111.473 -179.279 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 11.0 m -109.91 -15.65 9.54 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.295 0 CA-C-O 117.478 -1.249 . . . . 0.0 112.732 178.059 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 24.2 t90 -54.76 -38.31 67.05 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-N 120.042 1.292 . . . . 0.0 109.961 178.78 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -65.91 -27.63 68.33 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 125.342 1.457 . . . . 0.0 112.857 175.638 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 69.4 mt-30 -89.19 -25.05 21.99 Favored 'General case' 0 CA--C 1.514 -0.437 0 C-N-CA 125.417 1.487 . . . . 0.0 111.555 -177.154 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.556 ' CD1' HD21 ' A' ' 104' ' ' LEU . 48.2 mt -57.82 -32.02 67.18 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 118.846 0.748 . . . . 0.0 110.255 173.71 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -69.71 -28.03 65.48 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 122.995 0.518 . . . . 0.0 111.457 173.581 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -80.74 -34.62 34.26 Favored 'General case' 0 CA--C 1.538 0.492 0 N-CA-C 113.199 0.814 . . . . 0.0 113.199 176.846 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 21.6 mt -59.76 148.58 33.79 Favored 'General case' 0 N--CA 1.463 0.207 0 C-N-CA 124.44 1.096 . . . . 0.0 111.758 -173.421 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -82.62 114.4 20.98 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 169.667 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 76.8 mt -129.74 1.07 4.9 Favored 'General case' 0 N--CA 1.475 0.815 0 N-CA-C 113.254 0.835 . . . . 0.0 113.254 -172.982 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 32.7 mt-10 -56.8 133.16 54.07 Favored 'General case' 0 C--O 1.235 0.342 0 CA-C-O 122.122 0.963 . . . . 0.0 111.647 -168.644 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 75.07 -3.87 43.05 Favored Glycine 0 CA--C 1.534 1.263 0 C-N-CA 125.483 1.516 . . . . 0.0 114.976 176.499 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.29 149.75 40.54 Favored 'General case' 0 C--N 1.344 0.357 0 CA-C-N 120.574 2.187 . . . . 0.0 110.114 -175.597 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 5.1 mt -80.71 136.69 22.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 N-CA-C 106.344 -1.724 . . . . 0.0 106.344 178.415 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 64.9 t -130.59 128.65 63.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 C-N-CA 123.556 0.742 . . . . 0.0 109.819 -177.2 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -99.57 145.13 27.86 Favored 'General case' 0 CA--C 1.52 -0.184 0 N-CA-C 107.948 -1.13 . . . . 0.0 107.948 168.442 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 10.5 mt -124.79 132.48 53.34 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 107.406 -1.331 . . . . 0.0 107.406 176.44 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 33.7 p90 -148.69 165.06 32.48 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 168.253 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -165.37 172.46 40.94 Favored Glycine 0 N--CA 1.443 -0.85 0 N-CA-C 109.894 -1.283 . . . . 0.0 109.894 172.512 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 6.6 tt -119.45 148.61 43.05 Favored 'General case' 0 N--CA 1.447 -0.608 0 C-N-CA 125.979 1.712 . . . . 0.0 107.694 -179.922 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -165.17 -156.25 9.0 Favored Glycine 0 CA--C 1.524 0.655 0 N-CA-C 111.329 -0.708 . . . . 0.0 111.329 -178.839 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 14.7 t0 -146.68 117.94 7.85 Favored 'General case' 0 C--O 1.234 0.281 0 C-N-CA 124.732 1.213 . . . . 0.0 109.413 -177.186 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 4.2 pt20 -69.51 -15.52 63.26 Favored 'General case' 0 CA--C 1.536 0.407 0 N-CA-C 112.512 0.56 . . . . 0.0 112.512 178.776 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 34.0 mt -73.26 -5.33 38.74 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 119.065 0.848 . . . . 0.0 110.563 170.784 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -79.15 24.34 2.96 Favored Glycine 0 CA--C 1.534 1.236 0 C-N-CA 125.117 1.341 . . . . 0.0 112.586 168.422 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 44.5 m-85 59.27 5.57 0.61 Allowed 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 128.089 2.556 . . . . 0.0 115.568 172.276 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 66.52 18.37 67.73 Favored Glycine 0 CA--C 1.536 1.35 0 CA-C-N 119.08 0.855 . . . . 0.0 111.067 -172.064 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -91.58 -31.21 15.99 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 124.846 1.259 . . . . 0.0 108.722 168.405 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' TRP . . . . . . . . . . . . . 13.3 m0 -119.09 -2.22 10.79 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 124.121 0.968 . . . . 0.0 113.056 -169.01 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 21.3 t80 -71.25 130.67 42.01 Favored 'General case' 0 N--CA 1.458 -0.066 0 O-C-N 121.591 -0.693 . . . . 0.0 109.506 -172.509 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 92.3 mt 51.35 27.08 3.42 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 124.81 1.244 . . . . 0.0 114.23 167.916 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -64.24 -33.4 75.73 Favored 'General case' 0 C--N 1.331 -0.228 0 O-C-N 120.661 -1.274 . . . . 0.0 110.872 -175.329 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -71.18 -29.43 65.17 Favored 'General case' 0 CA--C 1.535 0.394 0 O-C-N 121.731 -0.606 . . . . 0.0 111.911 175.485 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 5.4 tt -62.4 -45.31 93.72 Favored 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 108.026 -1.102 . . . . 0.0 108.026 169.64 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -64.04 -39.93 97.7 Favored Glycine 0 C--N 1.34 0.765 0 N-CA-C 111.149 -0.78 . . . . 0.0 111.149 -178.707 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 71.6 mtm -66.4 -35.42 80.28 Favored 'General case' 0 CA--C 1.529 0.166 0 CA-C-O 118.206 -0.902 . . . . 0.0 111.904 177.468 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.679 HD23 ' CH2' ' A' ' 65' ' ' TRP . 0.2 OUTLIER -72.89 -36.45 67.34 Favored 'General case' 0 C--N 1.342 0.265 0 CA-C-N 120.768 1.622 . . . . 0.0 110.811 176.234 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 1.8 t60 -54.04 -52.86 59.51 Favored 'General case' 0 CA--C 1.531 0.214 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 169.61 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -63.04 -41.62 99.55 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 123.79 0.836 . . . . 0.0 112.321 -175.239 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 1.7 tppm? -54.77 -27.87 44.53 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 125.72 1.608 . . . . 0.0 111.309 171.488 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 40.4 mt -106.94 -17.72 14.11 Favored 'General case' 0 CA--C 1.519 -0.214 0 N-CA-C 115.228 1.566 . . . . 0.0 115.228 -173.408 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -60.24 -37.11 79.36 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 121.008 1.731 . . . . 0.0 110.977 -172.611 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 16.3 p -81.25 -13.6 58.34 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 125.53 1.532 . . . . 0.0 111.833 -179.772 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 31.8 mmmt -84.8 -5.87 59.34 Favored 'General case' 0 C--N 1.344 0.328 0 C-N-CA 124.955 1.302 . . . . 0.0 111.691 178.702 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 72.76 31.33 62.61 Favored Glycine 0 CA--C 1.523 0.549 0 CA-C-N 118.399 0.545 . . . . 0.0 112.401 169.498 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 14.5 m -75.59 176.59 0.64 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.638 0 CA-C-N 118.163 0.981 . . . . 0.0 109.677 171.992 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -118.03 126.54 52.48 Favored 'General case' 0 CA--C 1.518 -0.265 0 N-CA-C 106.628 -1.619 . . . . 0.0 106.628 173.127 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 62.2 m-85 -91.96 143.29 26.63 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 119.847 1.203 . . . . 0.0 109.805 -177.064 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 35.1 m -131.6 160.88 42.05 Favored 'Isoleucine or valine' 0 C--O 1.235 0.335 0 C-N-CA 125.947 1.699 . . . . 0.0 107.334 169.314 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 84.96 28.68 30.72 Favored Glycine 0 CA--C 1.52 0.392 0 CA-C-O 118.509 -1.162 . . . . 0.0 114.133 172.999 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 20.8 m-30 -60.87 157.02 16.02 Favored 'General case' 0 CA--C 1.543 0.675 0 CA-C-N 118.809 1.305 . . . . 0.0 109.475 168.494 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 46.5 t-105 -134.15 142.05 41.72 Favored Pre-proline 0 N--CA 1.467 0.403 0 CA-C-O 118.608 -0.711 . . . . 0.0 109.719 -170.577 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -70.1 132.64 23.2 Favored 'Trans proline' 0 N--CA 1.458 -0.588 0 C-N-CA 122.576 2.184 . . . . 0.0 111.728 -171.197 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 20.8 p -96.52 -4.64 41.05 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 124.519 1.128 . . . . 0.0 113.778 -179.757 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -64.83 129.36 39.45 Favored 'General case' 0 CA--C 1.537 0.452 0 O-C-N 121.119 -0.988 . . . . 0.0 109.456 -169.608 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 84.39 -0.13 89.34 Favored Glycine 0 CA--C 1.534 1.275 0 C-N-CA 124.785 1.184 . . . . 0.0 113.978 -177.367 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 11.0 t80 -91.72 155.09 18.53 Favored 'General case' 0 CA--C 1.542 0.663 0 CA-C-N 118.898 1.349 . . . . 0.0 108.925 174.366 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 76.9 mm-40 -113.38 138.75 49.61 Favored 'General case' 0 N--CA 1.465 0.323 0 C-N-CA 124.621 1.169 . . . . 0.0 109.247 179.777 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 93.3 m-85 -130.88 136.58 48.76 Favored 'General case' 0 CA--C 1.513 -0.467 0 C-N-CA 123.597 0.759 . . . . 0.0 110.172 -168.85 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 6.6 m -126.73 -43.86 1.69 Allowed 'General case' 0 N--CA 1.431 -1.393 0 CA-C-N 115.206 -0.907 . . . . 0.0 109.221 -177.1 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 54.9 m -104.42 128.46 26.94 Favored Pre-proline 0 CA--C 1.544 0.733 0 C-N-CA 124.948 1.299 . . . . 0.0 108.744 168.745 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -89.37 -3.13 5.97 Favored 'Trans proline' 0 CA--C 1.542 0.881 0 C-N-CA 123.251 2.634 . . . . 0.0 114.488 -171.674 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 22.2 ttmt -54.76 -38.34 65.72 Favored Pre-proline 0 CA--C 1.545 0.773 0 CA-C-O 116.938 -1.506 . . . . 0.0 115.016 -175.051 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 66.7 Cg_endo -79.23 2.11 8.6 Favored 'Trans proline' 0 C--N 1.353 0.798 0 CA-C-N 122.807 2.038 . . . . 0.0 114.065 -177.862 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.416 HG12 ' HA ' ' A' ' 139' ' ' PHE . 17.2 m -129.15 169.49 20.35 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 119.767 1.167 . . . . 0.0 110.274 -173.887 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 20.5 pt -122.34 163.92 20.14 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.012 0 C-N-CA 126.493 1.917 . . . . 0.0 108.881 172.778 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . 55.33 -154.09 0.31 Allowed 'General case' 0 N--CA 1.446 -0.649 0 C-N-CA 124.369 1.067 . . . . 0.0 108.391 -178.784 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 24.8 t0 -80.18 52.72 1.61 Allowed 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 125.082 1.353 . . . . 0.0 111.017 -179.154 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 63.82 32.16 83.25 Favored Glycine 0 CA--C 1.529 0.923 0 C-N-CA 124.065 0.84 . . . . 0.0 111.662 -174.518 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 1.3 tt0 -90.24 -24.76 20.87 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 124.711 1.205 . . . . 0.0 111.664 -169.163 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -145.54 146.14 31.3 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 119.2 0.909 . . . . 0.0 110.091 169.656 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . 0.416 ' HA ' HG12 ' A' ' 132' ' ' VAL . 49.1 m-85 -74.15 139.38 44.46 Favored 'General case' 0 CA--C 1.508 -0.641 0 N-CA-C 104.393 -2.447 . . . . 0.0 104.393 165.947 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 9.9 p -77.73 6.89 0.86 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.768 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.263 -177.932 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -172.71 175.28 45.79 Favored Glycine 0 CA--C 1.532 1.109 0 C-N-CA 125.349 1.452 . . . . 0.0 110.069 175.951 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 3.9 tp -65.79 144.68 56.71 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 118.285 1.043 . . . . 0.0 111.271 177.687 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -114.97 117.7 31.37 Favored 'General case' 0 N--CA 1.448 -0.565 0 C-N-CA 126.63 1.972 . . . . 0.0 109.826 -179.632 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 79.9 mt -107.94 149.44 28.34 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 124.856 1.263 . . . . 0.0 108.087 170.274 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 17.5 t0 -143.41 108.88 5.07 Favored 'General case' 0 C--O 1.235 0.296 0 C-N-CA 124.127 0.971 . . . . 0.0 109.139 -178.643 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 39.0 mm-40 -88.88 -26.42 21.62 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 123.025 0.53 . . . . 0.0 111.836 -177.85 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 98.1 m -65.9 -36.77 84.32 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 123.323 0.649 . . . . 0.0 110.67 -176.863 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 40.6 m-80 -114.07 -34.21 5.45 Favored 'General case' 0 C--O 1.232 0.163 0 N-CA-C 113.716 1.006 . . . . 0.0 113.716 -166.516 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 17.7 pt20 -151.45 48.02 0.82 Allowed 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 118.835 0.743 . . . . 0.0 111.876 -169.617 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 47.2 p90 -54.75 -29.34 53.59 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 123.821 0.848 . . . . 0.0 112.94 -179.163 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -59.51 -31.37 69.31 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 123.387 0.675 . . . . 0.0 111.633 178.663 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 81.8 mt -82.8 -14.89 53.57 Favored 'General case' 0 CA--C 1.52 -0.2 0 CA-C-O 117.787 -1.101 . . . . 0.0 112.467 179.987 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 70.7 m -60.69 -35.89 77.43 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 120.723 1.601 . . . . 0.0 110.777 -173.448 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -60.02 -42.11 93.64 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 118.966 0.803 . . . . 0.0 111.307 175.22 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 67.8 mm-40 -69.4 -46.05 67.78 Favored 'General case' 0 CA--C 1.515 -0.386 0 C-N-CA 125.763 1.625 . . . . 0.0 109.944 -178.101 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 67.3 mtt180 -61.55 -46.04 91.61 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 118.228 -0.891 . . . . 0.0 109.701 178.673 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 41.7 mt -61.93 -51.01 77.67 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.204 0 N-CA-C 108.285 -1.006 . . . . 0.0 108.285 176.779 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 66.6 tp60 -48.93 -65.57 0.55 Allowed 'General case' 0 C--O 1.236 0.359 0 C-N-CA 124.527 1.131 . . . . 0.0 111.21 179.972 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 29.5 m -70.73 -28.18 64.52 Favored 'General case' 0 C--N 1.321 -0.653 0 C-N-CA 120.625 -0.43 . . . . 0.0 111.477 -169.24 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 160' ' ' TRP . . . . . . . . . . . . . 57.4 t90 -66.76 -45.92 77.01 Favored 'General case' 0 CA--C 1.518 -0.254 0 CA-C-N 118.791 0.723 . . . . 0.0 111.087 171.532 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 60.4 m -60.64 -43.16 97.9 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 118.262 0.483 . . . . 0.0 110.088 -179.068 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -61.46 -41.59 97.47 Favored 'General case' 0 N--CA 1.455 -0.203 0 CA-C-O 120.984 0.421 . . . . 0.0 110.36 175.201 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 16.3 tt0 -64.84 -51.17 63.54 Favored 'General case' 0 N--CA 1.447 -0.601 0 O-C-N 121.691 -0.631 . . . . 0.0 110.129 -178.413 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 43.4 pt -63.88 -37.55 80.04 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.388 0 CA-C-O 118.174 -0.917 . . . . 0.0 109.703 -175.583 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -64.42 -35.2 80.14 Favored 'General case' 0 CA--C 1.529 0.16 0 CA-C-N 119.247 0.93 . . . . 0.0 109.98 179.66 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 34.9 m-80 -68.56 -50.87 48.54 Favored 'General case' 0 N--CA 1.467 0.382 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 174.118 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 21.9 tt0 -71.11 -25.8 62.75 Favored 'General case' 0 N--CA 1.44 -0.957 0 C-N-CA 125.194 1.398 . . . . 0.0 111.946 -168.747 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 168' ' ' MET . . . . . . . . . . . . . 18.9 ptp -82.05 -31.26 30.98 Favored 'General case' 0 C--O 1.231 0.125 0 O-C-N 121.4 -0.813 . . . . 0.0 112.07 171.052 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -77.77 -36.35 50.62 Favored 'General case' 0 N--CA 1.448 -0.557 0 O-C-N 122.108 -0.37 . . . . 0.0 111.037 -178.419 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -69.97 -26.62 64.19 Favored 'General case' 0 CA--C 1.537 0.452 0 O-C-N 121.862 -0.524 . . . . 0.0 110.611 177.209 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 66.4 t60 -66.84 -33.86 76.54 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 123.951 0.9 . . . . 0.0 110.5 172.296 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -71.1 -45.06 64.41 Favored 'General case' 0 C--O 1.237 0.426 0 C-N-CA 123.861 0.864 . . . . 0.0 111.66 171.649 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.286 0 C-N-CA 125.966 1.706 . . . . 0.0 110.398 -170.004 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 45.7 ttp . . . . . 0 N--CA 1.495 1.8 0 N-CA-C 110.239 -0.282 . . . . 0.0 110.239 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 7.4 t30 -120.48 150.02 41.48 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 124.198 0.999 . . . . 0.0 109.249 172.526 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 20.0 mtt -112.31 125.59 54.34 Favored 'General case' 0 CA--C 1.523 -0.069 0 C-N-CA 123.602 0.761 . . . . 0.0 110.774 -176.451 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -85.28 152.88 27.17 Favored Glycine 0 CA--C 1.524 0.597 0 N-CA-C 106.799 -2.521 . . . . 0.0 106.799 166.41 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 2.1 tt -140.19 96.67 3.09 Favored 'General case' 0 CA--C 1.517 -0.32 0 N-CA-C 105.274 -2.121 . . . . 0.0 105.274 -175.545 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -100.12 141.37 33.04 Favored 'General case' 0 CA--C 1.519 -0.237 0 CA-C-O 121.405 0.621 . . . . 0.0 111.834 -173.519 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 29.3 p90 -159.86 175.88 12.56 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 127.464 2.306 . . . . 0.0 106.325 -178.792 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -153.63 157.01 27.14 Favored Glycine 0 CA--C 1.518 0.222 0 N-CA-C 109.847 -1.301 . . . . 0.0 109.847 178.298 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 75.2 m -146.89 139.37 24.89 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 106.838 -1.541 . . . . 0.0 106.838 179.305 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 15.2 m -136.18 -110.47 0.2 Allowed 'General case' 0 CA--C 1.537 0.474 0 N-CA-C 106.478 -1.675 . . . . 0.0 106.478 177.848 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 3.6 p -69.96 -51.72 30.36 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 119.169 0.895 . . . . 0.0 109.169 169.71 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 56.1 m -83.89 149.92 26.05 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 123.963 0.905 . . . . 0.0 108.646 169.771 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -124.81 136.75 54.11 Favored 'General case' 0 C--O 1.233 0.227 0 C-N-CA 123.913 0.885 . . . . 0.0 110.333 -170.486 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 89.5 m -68.36 141.94 55.61 Favored 'General case' 0 CA--C 1.542 0.64 0 N-CA-C 107.004 -1.48 . . . . 0.0 107.004 167.854 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -65.76 164.08 15.36 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 123.595 0.758 . . . . 0.0 109.27 175.657 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 37.9 mmt -69.07 19.75 0.03 OUTLIER 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 124.852 1.261 . . . . 0.0 113.887 -178.825 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -47.7 -40.04 19.09 Favored 'General case' 0 C--O 1.225 -0.234 0 C-N-CA 126.164 1.786 . . . . 0.0 110.582 169.632 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -62.31 -49.33 76.07 Favored 'General case' 0 N--CA 1.461 0.098 0 C-N-CA 123.096 0.559 . . . . 0.0 111.87 -178.315 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 7.1 mt-10 -61.45 -41.07 96.63 Favored 'General case' 0 CA--C 1.518 -0.256 0 O-C-N 121.875 -0.516 . . . . 0.0 110.032 176.086 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 30.2 mtpp -70.31 -43.24 70.75 Favored 'General case' 0 C--O 1.221 -0.4 0 CA-C-O 118.603 -0.713 . . . . 0.0 110.622 -173.991 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 43.4 mt -52.87 -55.41 11.98 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.206 0 CA-C-N 119.492 1.042 . . . . 0.0 108.587 173.53 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 5.0 ttp180 -59.6 -42.1 91.83 Favored 'General case' 0 C--O 1.224 -0.273 0 C-N-CA 123.253 0.621 . . . . 0.0 109.618 -176.256 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -65.13 -40.92 95.13 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 123.21 0.604 . . . . 0.0 111.447 -179.498 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 54.3 mt -74.14 -54.42 14.94 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.537 0 C-N-CA 124.794 1.238 . . . . 0.0 110.139 -172.385 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 73.6 mt -64.3 -46.22 93.83 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 179.03 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 139.16 125.65 2.3 Favored Glycine 0 CA--C 1.533 1.179 0 C-N-CA 125.263 1.411 . . . . 0.0 111.733 172.546 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -70.51 -8.65 24.11 Favored 'Trans proline' 0 CA--C 1.535 0.562 0 C-N-CA 123.499 2.799 . . . . 0.0 113.668 -175.584 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -74.26 -21.92 59.55 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 119.007 0.821 . . . . 0.0 111.624 175.385 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -131.83 2.86 4.07 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 124.514 1.125 . . . . 0.0 113.893 -170.454 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 34.5 t -121.61 149.72 24.79 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.393 0 C-N-CA 124.619 1.168 . . . . 0.0 108.051 171.173 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 31.1 m -137.46 130.44 30.45 Favored 'General case' 0 N--CA 1.456 -0.165 0 C-N-CA 126.043 1.737 . . . . 0.0 106.689 -172.379 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 26.3 mt -79.36 141.22 37.12 Favored 'General case' 0 C--O 1.233 0.19 0 N-CA-C 107.826 -1.176 . . . . 0.0 107.826 176.859 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 34.1 t-80 -132.13 64.9 1.59 Allowed 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 107.393 -1.336 . . . . 0.0 107.393 -177.236 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 65.1 t-20 -73.07 115.11 12.0 Favored 'General case' 0 C--O 1.235 0.29 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 -177.326 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.403 HD13 ' CG2' ' A' ' 68' ' ' VAL . 87.0 mt -67.85 -12.41 60.58 Favored 'General case' 0 CA--C 1.532 0.284 0 N-CA-C 112.959 0.725 . . . . 0.0 112.959 -175.86 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -57.47 -26.14 60.8 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 118.746 0.703 . . . . 0.0 110.66 168.325 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -130.14 -40.43 1.31 Allowed 'General case' 0 N--CA 1.466 0.342 0 N-CA-C 113.558 0.947 . . . . 0.0 113.558 -173.957 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 33.0 m-20 -87.32 141.42 28.65 Favored 'General case' 0 C--O 1.236 0.357 0 C-N-CA 123.33 0.652 . . . . 0.0 110.139 -176.018 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 12.9 m -78.42 156.15 78.64 Favored Pre-proline 0 CA--C 1.542 0.666 0 C-N-CA 124.214 1.006 . . . . 0.0 110.291 177.556 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -77.34 -25.22 8.57 Favored 'Trans proline' 0 C--N 1.35 0.625 0 C-N-CA 122.01 1.807 . . . . 0.0 113.589 -171.232 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 3.7 mptp? -60.94 -22.19 64.17 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-N 119.976 1.262 . . . . 0.0 112.088 -179.874 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -60.49 -28.34 68.27 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 125.945 1.698 . . . . 0.0 110.764 174.773 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 57.1 mtt -58.87 -26.28 64.09 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 118.64 0.654 . . . . 0.0 111.254 178.376 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -65.06 -33.82 76.96 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 118.427 0.558 . . . . 0.0 110.759 -176.461 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 14.4 mt-30 -67.24 -43.61 81.55 Favored 'General case' 0 CA--C 1.531 0.228 0 N-CA-C 113.589 0.959 . . . . 0.0 113.589 -168.907 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 31.1 m-85 -71.17 145.9 49.44 Favored 'General case' 0 CA--C 1.527 0.067 0 CA-C-N 115.488 -0.778 . . . . 0.0 111.634 -165.331 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 41.4 m-20 -75.22 -38.48 60.63 Favored 'General case' 0 N--CA 1.47 0.541 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 -176.833 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.407 HG21 ' SD ' ' A' ' 168' ' ' MET . 17.7 t -112.64 147.41 16.37 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.279 0 N-CA-C 106.828 -1.545 . . . . 0.0 106.828 169.843 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 26.2 tp -129.45 110.22 11.7 Favored 'General case' 0 N--CA 1.447 -0.586 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 172.255 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 23.3 mt -86.67 132.25 32.78 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.583 0 N-CA-C 106.719 -1.586 . . . . 0.0 106.719 174.998 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 2.5 mp -111.93 124.93 53.44 Favored 'General case' 0 CA--C 1.519 -0.238 0 N-CA-C 106.886 -1.524 . . . . 0.0 106.886 -179.081 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -119.96 133.07 9.74 Favored Glycine 0 N--CA 1.451 -0.318 0 N-CA-C 108.994 -1.642 . . . . 0.0 108.994 171.248 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 5.1 tt -152.57 131.42 6.6 Favored Pre-proline 0 CA--C 1.531 0.234 0 CA-C-N 117.765 0.783 . . . . 0.0 109.746 168.766 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_exo -74.74 149.66 38.33 Favored 'Trans proline' 0 N--CA 1.455 -0.762 0 C-N-CA 121.898 1.732 . . . . 0.0 112.87 169.063 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 8.4 m -133.0 101.97 5.44 Favored 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 103.666 -2.716 . . . . 0.0 103.666 165.921 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 13.6 m-90 -78.84 69.35 5.0 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 118.757 0.708 . . . . 0.0 110.889 -170.992 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 12.1 t0 62.08 -85.16 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.268 0 C-N-CA 126.516 1.926 . . . . 0.0 110.146 -170.86 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 31.8 p90 -95.43 -17.02 21.87 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 125.531 1.532 . . . . 0.0 112.092 172.467 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -65.03 151.2 51.59 Favored Glycine 0 CA--C 1.528 0.9 0 C-N-CA 124.183 0.897 . . . . 0.0 111.141 179.61 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 26.5 tt0 -119.58 179.21 4.29 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 124.699 1.2 . . . . 0.0 111.571 -167.333 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 4.8 mt -43.53 138.16 0.82 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.833 0 C-N-CA 128.302 2.641 . . . . 0.0 110.913 175.322 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -89.63 157.88 17.84 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 123.873 0.869 . . . . 0.0 110.356 172.499 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -52.66 -47.64 66.98 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 124.561 1.145 . . . . 0.0 112.994 -168.02 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -67.04 -22.52 65.87 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 119.274 0.943 . . . . 0.0 112.331 -170.883 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' TRP . . . . . 0.78 ' CH2' HD23 ' A' ' 104' ' ' LEU . 2.1 t90 -90.17 -42.12 11.23 Favored 'General case' 0 N--CA 1.456 -0.174 0 C-N-CA 124.468 1.107 . . . . 0.0 109.29 177.147 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 9.3 tt0 -62.55 -35.59 79.93 Favored 'General case' 0 N--CA 1.446 -0.625 0 O-C-N 121.081 -1.012 . . . . 0.0 109.927 178.697 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -58.94 -24.62 62.71 Favored 'General case' 0 C--O 1.234 0.254 0 C-N-CA 124.468 1.107 . . . . 0.0 111.643 -178.279 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.403 ' CG2' HD13 ' A' ' 35' ' ' LEU . 28.3 m -113.54 -13.41 11.39 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.324 0 CA-C-O 117.267 -1.349 . . . . 0.0 112.65 178.305 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 25.6 t90 -52.48 -39.88 61.69 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 120.396 1.453 . . . . 0.0 110.119 177.443 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -64.54 -25.69 68.09 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 125.253 1.421 . . . . 0.0 113.167 176.353 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 60.0 mt-30 -92.44 -17.0 25.16 Favored 'General case' 0 CA--C 1.52 -0.189 0 C-N-CA 125.697 1.599 . . . . 0.0 111.716 -178.971 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.601 HD12 HD21 ' A' ' 104' ' ' LEU . 14.7 mt -69.15 -19.32 64.01 Favored 'General case' 0 CA--C 1.531 0.219 0 O-C-N 121.204 -0.935 . . . . 0.0 111.37 -175.188 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -85.53 -22.21 28.24 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-O 118.994 -0.527 . . . . 0.0 111.192 169.489 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -70.72 -31.05 67.77 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-N 119.438 1.017 . . . . 0.0 111.887 172.05 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 25.5 mt -58.04 144.46 39.76 Favored 'General case' 0 C--O 1.234 0.264 0 C-N-CA 123.752 0.821 . . . . 0.0 112.007 -176.149 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 2.9 t30 -86.75 86.33 7.32 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 125.094 1.358 . . . . 0.0 107.489 173.049 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 3.7 pp -142.09 135.34 29.02 Favored 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 169.707 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -149.52 151.66 34.27 Favored 'General case' 0 N--CA 1.439 -0.992 0 C-N-CA 127.698 2.399 . . . . 0.0 104.835 169.412 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 72.18 -6.54 10.26 Favored Glycine 0 CA--C 1.534 1.26 0 N-CA-C 116.905 1.522 . . . . 0.0 116.905 169.687 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.46 161.51 29.73 Favored 'General case' 0 C--N 1.342 0.282 0 CA-C-N 120.21 2.005 . . . . 0.0 110.047 -175.756 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 3.6 mt -80.26 135.97 24.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 106.923 -1.51 . . . . 0.0 106.923 176.689 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 73.1 t -133.03 132.49 58.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 C-N-CA 123.53 0.732 . . . . 0.0 109.509 -177.12 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -104.01 154.71 19.36 Favored 'General case' 0 CA--C 1.519 -0.25 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 168.674 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 2.0 mt -135.58 138.77 43.31 Favored 'General case' 0 CA--C 1.513 -0.447 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 172.138 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 36.0 p90 -151.89 167.63 27.72 Favored 'General case' 0 N--CA 1.446 -0.647 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 169.617 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -168.49 154.26 23.92 Favored Glycine 0 N--CA 1.448 -0.544 0 N-CA-C 109.414 -1.474 . . . . 0.0 109.414 172.143 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -109.55 158.69 17.75 Favored 'General case' 0 CA--C 1.519 -0.232 0 C-N-CA 123.171 0.588 . . . . 0.0 111.49 169.217 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -161.72 -153.47 7.09 Favored Glycine 0 N--CA 1.448 -0.56 0 N-CA-C 109.938 -1.265 . . . . 0.0 109.938 179.446 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 7.9 t0 -138.74 162.72 34.02 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 106.254 -1.758 . . . . 0.0 106.254 172.729 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 6.3 pt20 -124.25 -6.27 7.71 Favored 'General case' 0 N--CA 1.446 -0.63 0 C-N-CA 125.876 1.671 . . . . 0.0 112.182 178.386 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 90.3 mt -83.22 -5.14 59.02 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 124.534 1.134 . . . . 0.0 112.315 -174.351 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -81.01 -57.55 2.81 Favored Glycine 0 CA--C 1.527 0.829 0 N-CA-C 107.772 -2.131 . . . . 0.0 107.772 168.78 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 27.6 t80 -156.16 -34.48 0.09 Allowed 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 125.043 1.337 . . . . 0.0 111.204 170.609 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 77.41 -34.18 1.56 Allowed Glycine 0 C--N 1.335 0.487 0 C-N-CA 125.474 1.511 . . . . 0.0 114.668 172.554 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 26.6 mt-10 -71.74 -0.48 11.11 Favored 'General case' 0 CA--C 1.543 0.679 0 CA-C-N 119.569 1.684 . . . . 0.0 112.572 -179.305 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' TRP . . . . . . . . . . . . . 8.5 m0 -110.29 -5.72 15.19 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 127.093 2.157 . . . . 0.0 112.463 174.751 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -74.34 166.01 24.21 Favored 'General case' 0 C--N 1.341 0.198 0 CA-C-N 118.992 0.815 . . . . 0.0 112.188 -167.765 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 86.5 mt 56.19 19.32 3.77 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 125.824 1.65 . . . . 0.0 113.805 -177.095 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -58.09 -35.81 71.96 Favored 'General case' 0 C--N 1.33 -0.264 0 O-C-N 120.853 -1.155 . . . . 0.0 111.365 174.301 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -71.99 -30.47 65.28 Favored 'General case' 0 C--N 1.343 0.31 0 O-C-N 121.636 -0.665 . . . . 0.0 112.016 177.775 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 4.8 tt -61.68 -43.14 99.42 Favored 'General case' 0 CA--C 1.539 0.553 0 N-CA-C 107.94 -1.133 . . . . 0.0 107.94 169.243 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -64.06 -39.91 97.65 Favored Glycine 0 CA--C 1.527 0.795 0 CA-C-O 119.383 -0.676 . . . . 0.0 112.823 179.345 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 71.4 mtm -60.36 -38.34 83.54 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 119.163 1.481 . . . . 0.0 112.178 -176.604 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.78 HD23 ' CH2' ' A' ' 65' ' ' TRP . 0.1 OUTLIER -73.43 -34.72 65.59 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 119.221 0.919 . . . . 0.0 110.808 179.652 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 55.8 t-80 -61.29 -43.23 99.23 Favored 'General case' 0 C--O 1.232 0.14 0 O-C-N 121.681 -0.637 . . . . 0.0 110.262 174.758 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -64.54 -43.26 94.55 Favored 'General case' 0 C--O 1.234 0.239 0 C-N-CA 123.033 0.533 . . . . 0.0 111.393 -177.675 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 22.5 ttmm -55.43 -52.63 62.97 Favored 'General case' 0 N--CA 1.463 0.205 0 C-N-CA 123.204 0.602 . . . . 0.0 109.863 170.904 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 35.7 mt -77.62 -20.41 53.94 Favored 'General case' 0 CA--C 1.517 -0.297 0 N-CA-C 114.195 1.183 . . . . 0.0 114.195 -168.188 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 61.2 m -61.22 -33.37 73.39 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 119.353 0.979 . . . . 0.0 110.75 -179.672 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 40.3 p -87.59 -19.04 28.36 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 123.446 0.699 . . . . 0.0 111.16 179.581 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 20.5 mmmt -71.92 -19.87 61.85 Favored 'General case' 0 N--CA 1.468 0.47 0 O-C-N 121.576 -0.703 . . . . 0.0 109.654 167.738 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 76.21 38.02 35.53 Favored Glycine 0 C--N 1.337 0.63 0 C-N-CA 123.846 0.736 . . . . 0.0 111.655 173.811 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 9.6 m -71.57 172.58 0.95 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.581 0 CA-C-N 118.752 1.276 . . . . 0.0 109.755 171.094 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -106.49 125.1 50.58 Favored 'General case' 0 CA--C 1.517 -0.295 0 N-CA-C 106.361 -1.718 . . . . 0.0 106.361 172.348 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 78.1 m-85 -92.91 145.41 24.4 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 119.481 1.037 . . . . 0.0 109.916 -178.015 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 35.5 m -131.74 157.84 43.21 Favored 'Isoleucine or valine' 0 C--O 1.234 0.282 0 C-N-CA 125.187 1.395 . . . . 0.0 107.703 169.569 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 84.02 31.46 25.99 Favored Glycine 0 CA--C 1.524 0.628 0 CA-C-O 118.596 -1.113 . . . . 0.0 114.835 169.837 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 13.6 m-30 -63.59 160.5 16.56 Favored 'General case' 0 CA--C 1.545 0.785 0 CA-C-N 119.257 1.529 . . . . 0.0 109.417 168.784 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 48.2 t-105 -138.84 148.15 57.03 Favored Pre-proline 0 N--CA 1.47 0.561 0 CA-C-O 118.12 -0.943 . . . . 0.0 111.432 -168.236 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -67.52 130.33 22.01 Favored 'Trans proline' 0 CA--C 1.536 0.588 0 C-N-CA 123.345 2.697 . . . . 0.0 112.352 -179.413 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 22.6 p -93.3 6.58 47.6 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 125.679 1.591 . . . . 0.0 112.392 170.988 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -61.68 126.95 29.16 Favored 'General case' 0 CA--C 1.534 0.36 0 O-C-N 121.024 -1.048 . . . . 0.0 109.697 -169.497 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 80.93 5.37 90.16 Favored Glycine 0 CA--C 1.535 1.298 0 C-N-CA 124.723 1.154 . . . . 0.0 113.918 -178.0 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 4.5 t80 -95.36 162.35 13.7 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 119.386 1.593 . . . . 0.0 109.196 175.034 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 74.9 mm-40 -126.75 143.92 51.1 Favored 'General case' 0 N--CA 1.463 0.213 0 C-N-CA 124.467 1.107 . . . . 0.0 108.948 178.91 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 50.4 m-85 -137.93 150.79 47.37 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-O 121.679 0.752 . . . . 0.0 112.337 -175.121 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 8.9 t -132.18 -32.05 1.41 Allowed 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 113.892 -1.504 . . . . 0.0 108.525 168.034 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 56.6 m -83.61 120.45 75.35 Favored Pre-proline 0 CA--C 1.542 0.644 0 N-CA-C 108.08 -1.081 . . . . 0.0 108.08 168.617 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -82.6 -22.73 4.4 Favored 'Trans proline' 0 CA--C 1.538 0.713 0 C-N-CA 122.376 2.051 . . . . 0.0 112.846 -176.292 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 15.2 ttmt -50.24 -41.77 68.36 Favored Pre-proline 0 CA--C 1.543 0.708 0 N-CA-C 115.795 1.776 . . . . 0.0 115.795 -170.712 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_endo -70.66 -11.45 29.68 Favored 'Trans proline' 0 C--N 1.352 0.751 0 CA-C-N 122.345 1.873 . . . . 0.0 114.365 179.651 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 30.9 m -132.51 171.34 18.27 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.428 0 CA-C-N 119.638 1.108 . . . . 0.0 112.874 -167.205 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 14.7 pt -138.56 173.92 11.21 Favored 'Isoleucine or valine' 0 C--O 1.236 0.384 0 C-N-CA 127.985 2.514 . . . . 0.0 108.348 -178.747 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . 55.77 40.0 30.76 Favored 'General case' 0 N--CA 1.463 0.224 0 C-N-CA 125.306 1.442 . . . . 0.0 112.615 174.068 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 27.3 t0 56.0 42.57 28.41 Favored 'General case' 0 C--N 1.324 -0.536 0 C-N-CA 125.998 1.719 . . . . 0.0 111.498 -176.159 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 87.26 21.43 48.99 Favored Glycine 0 CA--C 1.528 0.874 0 CA-C-N 115.211 -0.904 . . . . 0.0 113.541 174.129 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 44.7 mt-30 -97.54 -6.22 34.05 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 118.804 1.302 . . . . 0.0 112.781 -178.844 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 8.1 tp -154.21 147.23 24.56 Favored 'General case' 0 C--N 1.344 0.369 0 CA-C-N 119.618 1.099 . . . . 0.0 110.691 169.579 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 54.7 m-85 -80.76 150.63 29.19 Favored 'General case' 0 CA--C 1.52 -0.18 0 C-N-CA 124.19 0.996 . . . . 0.0 108.695 169.944 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 15.3 m -79.82 11.88 0.54 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.589 0 N-CA-C 112.977 0.732 . . . . 0.0 112.977 173.559 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 178.35 174.87 45.0 Favored Glycine 0 CA--C 1.526 0.755 0 N-CA-C 110.485 -1.046 . . . . 0.0 110.485 -178.44 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 3.5 tp -65.63 133.66 51.62 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 118.471 1.135 . . . . 0.0 110.51 177.758 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -99.62 113.66 26.24 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 125.147 1.379 . . . . 0.0 108.927 173.545 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 69.0 mt -104.45 167.91 9.43 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 125.309 1.444 . . . . 0.0 107.983 169.731 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -137.47 147.28 45.17 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 124.366 1.067 . . . . 0.0 108.243 174.668 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 19.4 tt0 -109.83 -11.11 14.73 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 125.842 1.657 . . . . 0.0 112.04 -172.587 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 76.7 m -124.51 -36.37 2.63 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 125.165 1.386 . . . . 0.0 111.979 -168.125 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 6.1 m-80 -95.46 -34.57 12.03 Favored 'General case' 0 C--N 1.332 -0.188 0 C-N-CA 124.278 1.031 . . . . 0.0 111.598 -168.423 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 68.8 mt-30 -128.26 151.17 49.59 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 125.269 1.428 . . . . 0.0 108.477 179.576 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 92.7 m-85 -137.17 -52.61 0.68 Allowed 'General case' 0 N--CA 1.463 0.192 0 C-N-CA 124.102 0.961 . . . . 0.0 109.044 177.262 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -65.15 -41.81 94.37 Favored 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 122.952 0.501 . . . . 0.0 111.04 179.089 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 67.7 mt -74.78 -22.9 58.5 Favored 'General case' 0 CA--C 1.519 -0.237 0 CA-C-O 118.619 -0.705 . . . . 0.0 111.589 -176.71 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 13.8 m -62.8 -34.11 76.59 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-N 119.487 1.04 . . . . 0.0 109.97 -179.056 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -63.85 -42.46 97.57 Favored 'General case' 0 N--CA 1.465 0.283 0 O-C-N 121.784 -0.572 . . . . 0.0 111.166 173.586 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 -65.4 -42.41 92.63 Favored 'General case' 0 N--CA 1.456 -0.165 0 C-N-CA 124.115 0.966 . . . . 0.0 110.68 177.79 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 73.9 mtt180 -62.46 -46.4 88.69 Favored 'General case' 0 N--CA 1.456 -0.146 0 CA-C-O 118.009 -0.996 . . . . 0.0 109.874 177.401 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 48.7 mt -60.54 -51.2 75.85 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.283 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 177.457 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 72.7 tp60 -53.15 -63.33 1.18 Allowed 'General case' 0 C--O 1.234 0.247 0 C-N-CA 124.3 1.04 . . . . 0.0 111.44 -177.442 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 35.9 m -67.63 -33.06 74.21 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 119.473 -0.298 . . . . 0.0 111.257 -171.092 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 160' ' ' TRP . . . . . . . . . . . . . 49.9 t90 -64.78 -46.96 79.88 Favored 'General case' 0 C--O 1.225 -0.189 0 CA-C-N 118.384 0.538 . . . . 0.0 110.447 173.794 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 55.1 m -60.32 -44.47 95.45 Favored 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 122.843 0.457 . . . . 0.0 110.653 -178.74 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -62.02 -39.17 91.37 Favored 'General case' 0 N--CA 1.456 -0.158 0 CA-C-O 120.946 0.403 . . . . 0.0 110.169 176.838 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 17.3 tt0 -66.89 -52.12 47.23 Favored 'General case' 0 N--CA 1.446 -0.641 0 O-C-N 121.736 -0.602 . . . . 0.0 109.895 -178.779 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 43.4 pt -62.92 -37.49 79.4 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.397 0 CA-C-O 118.072 -0.966 . . . . 0.0 109.36 -175.433 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -64.99 -34.12 77.67 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 119.493 1.042 . . . . 0.0 110.2 -179.672 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 32.9 m-80 -69.48 -52.26 28.23 Favored 'General case' 0 N--CA 1.465 0.277 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 174.419 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 16.1 tt0 -70.73 -26.02 63.2 Favored 'General case' 0 N--CA 1.443 -0.802 0 C-N-CA 124.863 1.265 . . . . 0.0 111.741 -168.647 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 168' ' ' MET . . . . . 0.407 ' SD ' HG21 ' A' ' 48' ' ' VAL . 19.7 ptp -80.64 -32.78 36.1 Favored 'General case' 0 C--N 1.335 -0.03 0 O-C-N 121.117 -0.99 . . . . 0.0 112.051 171.354 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -77.41 -40.08 44.82 Favored 'General case' 0 N--CA 1.447 -0.624 0 O-C-N 122.19 -0.319 . . . . 0.0 110.747 -176.702 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -65.95 -28.46 68.92 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 123.15 0.58 . . . . 0.0 110.719 177.729 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 64.5 t60 -66.51 -38.67 87.72 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 124.105 0.962 . . . . 0.0 111.06 173.727 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 1.9 m-85 -75.2 -29.02 60.21 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 123.551 0.74 . . . . 0.0 112.64 176.105 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.155 0 CA-C-O 118.074 -0.965 . . . . 0.0 111.014 -175.571 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 51.4 ttp . . . . . 0 N--CA 1.498 1.933 0 N-CA-C 110.134 -0.321 . . . . 0.0 110.134 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 9.7 t30 -138.26 152.43 48.55 Favored 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 107.54 -1.281 . . . . 0.0 107.54 170.898 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 20.8 mtt -112.59 123.52 50.48 Favored 'General case' 0 C--N 1.331 -0.221 0 C-N-CA 123.052 0.541 . . . . 0.0 110.835 -176.16 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -83.55 150.55 27.05 Favored Glycine 0 CA--C 1.522 0.474 0 N-CA-C 106.43 -2.668 . . . . 0.0 106.43 166.401 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 2.2 tt -138.43 96.37 3.16 Favored 'General case' 0 CA--C 1.515 -0.388 0 N-CA-C 104.629 -2.36 . . . . 0.0 104.629 -176.877 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -101.0 142.22 32.79 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-O 121.951 0.881 . . . . 0.0 111.312 -171.398 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 45.7 p90 -162.5 -179.22 6.78 Favored 'General case' 0 N--CA 1.446 -0.656 0 C-N-CA 126.319 1.848 . . . . 0.0 106.727 178.937 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -148.11 159.84 28.15 Favored Glycine 0 CA--C 1.52 0.389 0 N-CA-C 107.737 -2.145 . . . . 0.0 107.737 169.955 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 71.0 m -137.42 120.21 16.31 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 107.207 -1.405 . . . . 0.0 107.207 -179.537 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -143.99 -70.99 0.3 Allowed 'General case' 0 CA--C 1.535 0.393 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 -178.531 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 4.5 p -91.01 -71.14 0.65 Allowed 'General case' 0 C--O 1.234 0.28 0 N-CA-C 106.368 -1.716 . . . . 0.0 106.368 173.859 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 96.7 m -79.69 162.48 25.19 Favored 'General case' 0 C--O 1.237 0.402 0 N-CA-C 107.696 -1.224 . . . . 0.0 107.696 165.834 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 33.6 p90 -137.85 151.55 48.18 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 124.442 1.097 . . . . 0.0 109.781 -178.989 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 8.2 m -125.97 -0.11 7.24 Favored 'General case' 0 CA--C 1.541 0.618 0 N-CA-C 113.11 0.781 . . . . 0.0 113.11 -167.751 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -64.09 -30.94 71.98 Favored 'General case' 0 CA--C 1.535 0.365 0 O-C-N 120.525 -1.359 . . . . 0.0 112.951 -167.589 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -63.19 -46.75 85.62 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 119.663 1.119 . . . . 0.0 109.63 -177.356 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -65.59 -43.65 89.03 Favored 'General case' 0 C--O 1.227 -0.109 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 178.574 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -63.1 -47.83 81.15 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 122.315 0.246 . . . . 0.0 111.174 -175.889 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.7 pp20? -70.42 -33.88 71.85 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-O 118.684 -0.674 . . . . 0.0 110.036 -178.647 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 42.5 mmtt -58.88 -51.39 70.25 Favored 'General case' 0 C--O 1.224 -0.269 0 CA-C-N 119.532 1.06 . . . . 0.0 110.74 171.086 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 34.2 mt -54.23 -54.7 19.16 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.271 0 CA-C-N 119.069 0.85 . . . . 0.0 109.619 -176.638 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.404 ' HG2' HD21 ' A' ' 32' ' ' LEU . 0.0 OUTLIER -64.55 -37.13 86.48 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-O 118.704 -0.665 . . . . 0.0 111.024 -177.128 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -64.3 -38.7 91.98 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 118.261 0.482 . . . . 0.0 110.455 179.786 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 68.7 mt -77.41 -54.52 12.58 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.624 0 C-N-CA 124.89 1.276 . . . . 0.0 110.263 -173.777 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 80.7 mt -62.03 -47.51 92.82 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 179.983 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 141.77 121.18 1.69 Allowed Glycine 0 CA--C 1.526 0.773 0 C-N-CA 125.147 1.356 . . . . 0.0 110.199 177.944 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -71.35 -9.63 25.64 Favored 'Trans proline' 0 CA--C 1.538 0.683 0 C-N-CA 123.055 2.504 . . . . 0.0 113.458 -171.476 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -81.46 -16.75 51.01 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 119.025 0.829 . . . . 0.0 111.86 -179.715 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -128.22 5.17 5.8 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 124.87 1.268 . . . . 0.0 113.58 -173.579 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 28.3 t -125.84 147.75 30.55 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.273 0 N-CA-C 107.789 -1.189 . . . . 0.0 107.789 172.972 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 19.8 m -134.77 130.65 36.48 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 125.38 1.472 . . . . 0.0 108.063 -174.139 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.404 HD21 ' HG2' ' A' ' 22' ' ' ARG . 16.7 mt -77.83 135.15 37.9 Favored 'General case' 0 C--O 1.232 0.166 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 175.404 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 38.4 t-80 -126.76 66.11 1.26 Allowed 'General case' 0 CA--C 1.53 0.201 0 N-CA-C 107.289 -1.374 . . . . 0.0 107.289 -175.747 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 65.0 t-20 -74.6 114.26 12.81 Favored 'General case' 0 C--O 1.234 0.274 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 -176.254 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 88.3 mt -66.16 -12.29 54.9 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 124.395 1.078 . . . . 0.0 112.897 -176.44 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 23.0 tptm -58.13 -27.4 63.73 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-N 118.578 0.626 . . . . 0.0 110.571 169.093 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -130.55 -39.59 1.28 Allowed 'General case' 0 N--CA 1.465 0.287 0 N-CA-C 113.486 0.921 . . . . 0.0 113.486 -173.513 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 38.4 m-20 -87.11 138.95 31.06 Favored 'General case' 0 C--O 1.234 0.288 0 C-N-CA 123.568 0.747 . . . . 0.0 110.17 -176.929 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 14.1 m -75.92 154.57 84.93 Favored Pre-proline 0 CA--C 1.541 0.622 0 C-N-CA 124.118 0.967 . . . . 0.0 110.174 177.284 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 66.7 Cg_endo -75.39 -26.12 10.61 Favored 'Trans proline' 0 C--N 1.351 0.705 0 C-N-CA 122.235 1.957 . . . . 0.0 113.908 -170.911 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.79 -16.17 64.08 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-N 120.358 1.436 . . . . 0.0 112.28 -179.057 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -60.08 -27.69 67.2 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 125.144 1.378 . . . . 0.0 110.543 170.82 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 57.1 mtt -58.05 -26.13 62.1 Favored 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 123.376 0.67 . . . . 0.0 111.62 176.832 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 59.6 mt-10 -67.22 -33.71 75.94 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 118.323 0.511 . . . . 0.0 110.391 -175.466 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 19.0 mt-30 -65.23 -43.9 89.95 Favored 'General case' 0 N--CA 1.464 0.257 0 C-N-CA 123.666 0.787 . . . . 0.0 112.396 -169.908 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 18.5 m-85 -72.89 140.05 47.27 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 123.705 0.802 . . . . 0.0 110.176 -166.869 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -74.7 -37.52 62.6 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 118.481 0.582 . . . . 0.0 110.022 -178.297 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 13.5 t -105.34 145.53 13.46 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.328 0 N-CA-C 107.498 -1.297 . . . . 0.0 107.498 170.117 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 32.9 tp -134.19 106.1 6.99 Favored 'General case' 0 N--CA 1.447 -0.611 0 N-CA-C 108.601 -0.889 . . . . 0.0 108.601 175.418 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 24.8 mt -85.76 129.62 37.74 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 N-CA-C 106.638 -1.616 . . . . 0.0 106.638 177.557 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 1.4 mp -104.13 130.79 51.87 Favored 'General case' 0 N--CA 1.467 0.417 0 N-CA-C 105.953 -1.869 . . . . 0.0 105.953 177.207 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -131.17 119.22 2.59 Favored Glycine 0 CA--C 1.505 -0.576 0 N-CA-C 108.635 -1.786 . . . . 0.0 108.635 -176.945 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 1.6 tt -144.07 120.97 6.51 Favored Pre-proline 0 CA--C 1.531 0.238 0 CA-C-N 118.235 1.018 . . . . 0.0 108.706 179.517 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 76.9 Cg_exo -56.58 -40.21 85.99 Favored 'Trans proline' 0 N--CA 1.459 -0.535 0 C-N-CA 122.499 2.133 . . . . 0.0 114.286 -178.502 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 88.9 m 67.21 136.09 0.03 OUTLIER 'General case' 0 CA--C 1.55 0.965 0 C-N-CA 126.495 1.918 . . . . 0.0 110.165 -167.254 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 22.5 t90 -158.01 128.78 6.38 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 124.455 1.102 . . . . 0.0 108.153 -169.651 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -76.41 142.07 41.22 Favored 'General case' 0 C--O 1.236 0.358 0 C-N-CA 123.343 0.657 . . . . 0.0 110.528 177.63 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 30.0 t80 52.6 49.06 21.2 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 125.24 1.416 . . . . 0.0 111.298 178.817 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 178.89 -37.12 0.08 OUTLIER Glycine 0 CA--C 1.532 1.097 0 CA-C-N 115.669 -0.696 . . . . 0.0 111.381 -179.277 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . 0.299 10.7 pt-20 50.53 -156.56 0.11 Allowed 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 126.949 2.099 . . . . 0.0 113.818 169.913 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 20.8 mt -44.05 120.75 0.47 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.654 0 C-N-CA 127.374 2.27 . . . . 0.0 109.768 177.268 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 2.0 pm0 -67.56 151.93 46.5 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 123.585 0.754 . . . . 0.0 110.913 177.197 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -49.2 -51.23 34.2 Favored 'General case' 0 N--CA 1.463 0.205 0 C-N-CA 125.843 1.657 . . . . 0.0 112.669 -168.894 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -68.65 -17.11 64.03 Favored 'General case' 0 N--CA 1.473 0.712 0 CA-C-N 119.019 0.827 . . . . 0.0 112.043 -170.413 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' TRP . . . . . 0.505 ' CZ3' ' CE3' ' A' ' 69' ' ' TRP . 0.0 OUTLIER -88.69 -47.1 8.5 Favored 'General case' 0 CA--C 1.538 0.51 0 N-CA-C 107.449 -1.315 . . . . 0.0 107.449 178.071 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 12.0 tt0 -63.6 -33.46 75.65 Favored 'General case' 0 N--CA 1.449 -0.519 0 O-C-N 120.598 -1.314 . . . . 0.0 110.542 178.804 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -54.75 -25.15 25.91 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 125.085 1.354 . . . . 0.0 112.45 -177.763 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 29.6 m -114.28 -13.85 11.14 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.209 0 CA-C-O 117.204 -1.379 . . . . 0.0 112.918 177.356 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' TRP . . . . . 0.505 ' CE3' ' CZ3' ' A' ' 65' ' ' TRP . 2.6 t-105 -51.13 -39.55 56.51 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 120.136 1.334 . . . . 0.0 111.071 -173.644 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -68.57 -23.65 64.52 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 125.11 1.364 . . . . 0.0 113.2 -179.885 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 18.7 mt-30 -89.51 -23.41 22.06 Favored 'General case' 0 C--N 1.341 0.211 0 C-N-CA 125.311 1.444 . . . . 0.0 112.363 178.613 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 40.3 mt -65.72 -24.61 67.01 Favored 'General case' 0 N--CA 1.469 0.485 0 O-C-N 121.874 -0.516 . . . . 0.0 112.065 -169.968 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -70.06 -21.29 63.18 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 118.087 0.403 . . . . 0.0 111.74 175.78 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -75.1 -23.6 57.97 Favored 'General case' 0 CA--C 1.538 0.505 0 O-C-N 121.139 -0.976 . . . . 0.0 112.635 -178.722 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 53.6 mt -66.16 150.17 49.18 Favored 'General case' 0 C--O 1.231 0.12 0 C-N-CA 124.869 1.268 . . . . 0.0 112.003 -169.594 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 3.7 t30 -82.24 105.79 13.61 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 124.551 1.14 . . . . 0.0 108.204 172.488 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 65.6 mt -124.0 1.29 8.61 Favored 'General case' 0 N--CA 1.472 0.63 0 N-CA-C 113.764 1.024 . . . . 0.0 113.764 -172.491 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 27.2 mt-10 -56.9 130.98 48.21 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-O 121.913 0.863 . . . . 0.0 111.318 -169.747 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 74.04 -2.73 41.46 Favored Glycine 0 CA--C 1.534 1.249 0 C-N-CA 125.401 1.477 . . . . 0.0 114.955 176.951 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.66 148.7 40.4 Favored 'General case' 0 C--N 1.345 0.403 0 CA-C-N 120.346 2.073 . . . . 0.0 109.347 -176.399 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 5.3 mt -81.26 139.79 17.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 N-CA-C 106.711 -1.589 . . . . 0.0 106.711 179.542 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 38.4 t -133.55 139.16 49.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 C-N-CA 124.459 1.103 . . . . 0.0 110.491 -175.897 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -115.37 162.25 17.39 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 123.971 0.908 . . . . 0.0 109.043 169.466 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 6.2 mt -141.61 136.8 31.37 Favored 'General case' 0 N--CA 1.465 0.277 0 N-CA-C 106.867 -1.531 . . . . 0.0 106.867 178.702 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 40.4 p90 -153.64 155.52 36.2 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-N 120.614 1.552 . . . . 0.0 109.116 174.913 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -175.9 -167.33 34.65 Favored Glycine 0 N--CA 1.445 -0.719 0 N-CA-C 108.514 -1.834 . . . . 0.0 108.514 170.656 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -116.09 152.46 33.59 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 122.443 1.116 . . . . 0.0 111.139 176.025 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -131.69 -171.53 12.86 Favored Glycine 0 N--CA 1.445 -0.758 0 N-CA-C 107.589 -2.205 . . . . 0.0 107.589 168.707 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 3.0 t0 -151.19 115.04 4.95 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 105.954 -1.869 . . . . 0.0 105.954 172.405 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -68.25 -7.69 32.73 Favored 'General case' 0 CA--C 1.547 0.853 0 N-CA-C 112.76 0.652 . . . . 0.0 112.76 -175.479 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 66.3 mt -88.82 -65.11 1.05 Allowed 'General case' 0 C--N 1.341 0.201 0 C-N-CA 124.745 1.218 . . . . 0.0 109.461 -179.053 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -94.06 -39.36 4.88 Favored Glycine 0 CA--C 1.527 0.83 0 C-N-CA 124.583 1.087 . . . . 0.0 112.911 -174.235 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 7.6 m-85 -87.28 50.64 2.05 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 118.392 1.096 . . . . 0.0 109.308 -174.773 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -73.12 -41.29 48.0 Favored Glycine 0 CA--C 1.525 0.713 0 O-C-N 120.756 -1.215 . . . . 0.0 110.936 -178.246 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -90.68 -9.28 47.4 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.431 1.093 . . . . 0.0 111.423 174.519 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' TRP . . . . . . . . . . . . . 6.7 m0 -115.49 -5.74 12.25 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 124.199 0.999 . . . . 0.0 112.815 -169.766 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 5.8 t80 -49.11 120.2 3.8 Favored 'General case' 0 C--N 1.343 0.294 0 C-N-CA 124.378 1.071 . . . . 0.0 109.582 -175.7 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 96.6 mt 51.64 23.39 1.92 Allowed 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 114.453 1.279 . . . . 0.0 114.453 170.549 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -57.71 -39.47 77.3 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 119.765 1.166 . . . . 0.0 113.108 -167.601 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -73.35 -19.42 61.01 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-O 118.262 -0.875 . . . . 0.0 112.666 -178.905 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 8.5 mp -65.69 -38.75 90.1 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-N 120.151 1.341 . . . . 0.0 108.45 170.248 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -63.37 -36.89 94.0 Favored Glycine 0 C--N 1.339 0.712 0 N-CA-C 111.218 -0.753 . . . . 0.0 111.218 -179.008 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 77.8 mtm -67.33 -47.82 69.37 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-O 118.077 -0.963 . . . . 0.0 111.006 179.85 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -70.57 -33.4 71.06 Favored 'General case' 0 C--N 1.348 0.535 0 CA-C-N 121.042 1.746 . . . . 0.0 110.995 178.217 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 68.2 t60 -54.51 -51.76 64.11 Favored 'General case' 0 CA--C 1.529 0.14 0 CA-C-N 118.821 0.737 . . . . 0.0 110.164 171.894 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -62.99 -40.02 96.48 Favored 'General case' 0 C--O 1.236 0.379 0 C-N-CA 123.771 0.829 . . . . 0.0 112.094 -176.098 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 24.1 ttmm -54.9 -39.68 69.01 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 123.327 0.651 . . . . 0.0 110.146 171.508 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 35.2 mt -90.96 -19.52 23.17 Favored 'General case' 0 CA--C 1.518 -0.287 0 N-CA-C 115.48 1.659 . . . . 0.0 115.48 -168.566 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 4.5 m -58.81 -36.47 74.54 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 120.86 1.664 . . . . 0.0 111.353 -177.664 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 19.9 p -84.0 -15.45 47.63 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 124.81 1.244 . . . . 0.0 111.66 179.942 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 31.7 mmmt -81.56 -9.97 59.56 Favored 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 124.542 1.137 . . . . 0.0 110.998 172.109 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 73.21 35.42 57.05 Favored Glycine 0 CA--C 1.523 0.569 0 CA-C-O 119.541 -0.589 . . . . 0.0 112.404 169.497 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 5.9 m -74.9 173.9 0.89 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.56 0 CA-C-N 118.122 0.961 . . . . 0.0 109.536 171.252 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -115.23 117.22 29.88 Favored 'General case' 0 CA--C 1.52 -0.211 0 N-CA-C 106.911 -1.515 . . . . 0.0 106.911 175.367 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 87.9 m-85 -85.71 143.15 28.53 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 119.56 1.073 . . . . 0.0 110.022 -175.312 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 32.9 m -133.47 160.7 42.14 Favored 'Isoleucine or valine' 0 C--O 1.235 0.307 0 C-N-CA 125.712 1.605 . . . . 0.0 108.052 169.748 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 86.8 26.95 30.5 Favored Glycine 0 C--N 1.332 0.339 0 CA-C-O 118.327 -1.263 . . . . 0.0 114.097 173.458 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 18.9 m-30 -60.85 159.87 10.5 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-N 119.165 1.482 . . . . 0.0 110.082 169.711 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 1.5 m95 -125.66 143.71 45.88 Favored Pre-proline 0 N--CA 1.469 0.501 0 CA-C-O 118.362 -0.828 . . . . 0.0 109.359 169.722 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -64.05 127.72 20.07 Favored 'Trans proline' 0 N--CA 1.452 -0.954 0 C-N-CA 123.335 2.69 . . . . 0.0 109.845 173.493 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 31.5 p -79.42 -4.05 49.32 Favored 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 113.449 0.907 . . . . 0.0 113.449 175.456 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -60.45 120.07 9.23 Favored 'General case' 0 CA--C 1.535 0.395 0 O-C-N 121.28 -0.888 . . . . 0.0 110.464 -169.124 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 80.89 3.38 90.55 Favored Glycine 0 CA--C 1.535 1.314 0 CA-C-O 118.746 -1.03 . . . . 0.0 114.691 176.734 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 18.5 m-85 -77.02 147.26 36.88 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-N 119.33 1.565 . . . . 0.0 109.695 176.904 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -99.35 106.19 18.25 Favored 'General case' 0 CA--C 1.528 0.127 0 N-CA-C 107.515 -1.291 . . . . 0.0 107.515 171.913 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 20.4 p90 -159.75 167.18 28.88 Favored 'General case' 0 C--O 1.239 0.54 0 C-N-CA 127.254 2.221 . . . . 0.0 106.131 176.001 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 1.9 t -140.04 -14.41 1.04 Allowed 'General case' 0 CA--C 1.537 0.462 0 N-CA-C 112.856 0.688 . . . . 0.0 112.856 179.689 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 2.9 p -72.79 137.52 79.96 Favored Pre-proline 0 CA--C 1.543 0.678 0 O-C-N 121.351 -0.843 . . . . 0.0 110.715 -176.742 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -83.22 -27.8 1.73 Allowed 'Trans proline' 0 CA--C 1.539 0.733 0 C-N-CA 122.406 2.071 . . . . 0.0 112.456 177.377 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 20.5 ttmt -53.92 -44.42 98.17 Favored Pre-proline 0 CA--C 1.544 0.719 0 CA-C-O 117.429 -1.272 . . . . 0.0 114.083 -176.376 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -73.07 -3.66 14.04 Favored 'Trans proline' 0 C--N 1.352 0.719 0 CA-C-N 121.939 1.728 . . . . 0.0 114.447 -178.444 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 19.7 m -129.93 166.84 26.52 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 CA-C-N 119.989 1.268 . . . . 0.0 111.924 -169.588 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 10.3 pt -138.02 174.56 10.56 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.331 0 C-N-CA 127.554 2.342 . . . . 0.0 108.73 -177.088 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . 54.96 43.88 29.17 Favored 'General case' 0 N--CA 1.465 0.284 0 C-N-CA 125.351 1.46 . . . . 0.0 112.051 175.184 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 27.4 t0 54.55 43.18 30.67 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 126.046 1.738 . . . . 0.0 111.46 -175.756 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 89.95 16.06 56.78 Favored Glycine 0 CA--C 1.526 0.723 0 CA-C-O 118.356 -1.247 . . . . 0.0 114.481 171.207 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 47.6 mt-30 -88.08 -16.84 32.47 Favored 'General case' 0 CA--C 1.536 0.404 0 CA-C-N 119.366 1.583 . . . . 0.0 113.691 -175.569 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -143.45 142.86 31.36 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 119.541 1.064 . . . . 0.0 110.661 177.234 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 74.2 m-85 -75.25 141.59 43.47 Favored 'General case' 0 CA--C 1.519 -0.233 0 N-CA-C 105.095 -2.187 . . . . 0.0 105.095 164.642 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 33.5 m -69.98 -0.1 1.38 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.567 0 N-CA-C 113.011 0.745 . . . . 0.0 113.011 -178.099 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -170.13 -170.82 34.96 Favored Glycine 0 N--CA 1.447 -0.618 0 N-CA-C 109.972 -1.251 . . . . 0.0 109.972 -172.607 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.453 ' HG ' ' CG ' ' A' ' 160' ' ' TRP . 1.2 tt -60.05 139.31 57.55 Favored 'General case' 0 N--CA 1.462 0.156 0 C-N-CA 124.424 1.089 . . . . 0.0 110.548 -179.815 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -105.78 96.03 6.21 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 124.553 1.141 . . . . 0.0 108.422 168.794 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 78.2 mt -89.59 147.13 24.1 Favored 'General case' 0 CA--C 1.535 0.397 0 N-CA-C 105.621 -1.992 . . . . 0.0 105.621 168.582 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 29.3 t0 -149.02 102.39 3.25 Favored 'General case' 0 N--CA 1.464 0.266 0 N-CA-C 107.489 -1.301 . . . . 0.0 107.489 176.059 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -82.92 -30.55 28.34 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.536 -178.354 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 86.4 m -61.57 -42.3 98.64 Favored 'General case' 0 C--O 1.235 0.303 0 C-N-CA 123.288 0.635 . . . . 0.0 110.542 -173.909 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 7.2 m-80 -93.66 -27.67 16.42 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-O 119.117 -0.468 . . . . 0.0 112.161 -169.965 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 14.6 pt20 -155.02 57.15 0.66 Allowed 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 123.211 0.604 . . . . 0.0 110.978 -168.628 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 41.9 p90 -53.45 -29.93 38.13 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 124.688 1.195 . . . . 0.0 113.028 -177.108 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -66.9 -24.32 66.09 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 118.597 0.635 . . . . 0.0 112.175 -179.075 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 74.6 mt -92.22 4.59 52.94 Favored 'General case' 0 C--N 1.341 0.217 0 C-N-CA 124.138 0.975 . . . . 0.0 113.143 -172.942 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 31.0 p -59.32 -47.54 85.02 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 120.14 1.336 . . . . 0.0 110.347 -175.122 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -58.22 -40.34 81.4 Favored 'General case' 0 N--CA 1.462 0.173 0 C-N-CA 123.921 0.889 . . . . 0.0 111.064 178.345 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 3.5 tp10 -69.67 -47.36 63.56 Favored 'General case' 0 CA--C 1.529 0.16 0 C-N-CA 124.485 1.114 . . . . 0.0 110.911 -177.485 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 69.9 mtp85 -66.71 -27.39 67.6 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 117.894 -1.051 . . . . 0.0 110.424 179.859 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 25.1 mt -73.14 -53.29 18.84 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.601 0 CA-C-N 119.908 1.231 . . . . 0.0 107.762 168.364 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 70.8 tp60 -50.14 -64.14 0.9 Allowed 'General case' 0 N--CA 1.464 0.259 0 C-N-CA 126.031 1.732 . . . . 0.0 112.14 -175.419 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 25.3 m -66.11 -32.75 74.39 Favored 'General case' 0 C--N 1.327 -0.392 0 O-C-N 123.036 0.21 . . . . 0.0 110.803 -171.01 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 160' ' ' TRP . . . . . 0.453 ' CG ' ' HG ' ' A' ' 142' ' ' LEU . 88.2 t90 -66.41 -46.84 75.22 Favored 'General case' 0 C--O 1.222 -0.349 0 O-C-N 121.958 -0.464 . . . . 0.0 110.836 174.592 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 67.2 m -59.56 -44.42 93.29 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 123.266 0.626 . . . . 0.0 110.501 178.816 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 162' ' ' GLU . . . . . 0.409 ' HA ' HD23 ' A' ' 165' ' ' LEU . 39.7 mt-10 -61.05 -42.95 99.44 Favored 'General case' 0 N--CA 1.457 -0.085 0 CA-C-O 121.021 0.439 . . . . 0.0 110.199 175.723 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 14.4 tt0 -63.71 -52.1 62.07 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-O 117.791 -1.1 . . . . 0.0 109.73 -177.508 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 40.4 pt -63.02 -34.11 64.61 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.519 0 CA-C-N 119.439 1.018 . . . . 0.0 110.077 -176.57 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . 0.409 HD23 ' HA ' ' A' ' 162' ' ' GLU . 0.3 OUTLIER -70.16 -34.95 73.66 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 119.382 0.992 . . . . 0.0 108.519 -175.2 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -70.72 -46.27 63.36 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 123.707 0.803 . . . . 0.0 109.993 174.273 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 24.8 tt0 -77.91 -14.09 59.66 Favored 'General case' 0 N--CA 1.437 -1.104 0 C-N-CA 124.9 1.28 . . . . 0.0 110.359 -169.629 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 168' ' ' MET . . . . . . . . . . . . . 18.9 ptp -92.17 -38.9 11.87 Favored 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 122.751 0.42 . . . . 0.0 111.547 169.754 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -75.81 -27.82 58.09 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-O 119.327 -0.368 . . . . 0.0 111.914 -173.447 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -57.02 -27.68 61.83 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 123.655 0.782 . . . . 0.0 112.398 -177.084 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 60.3 m-70 -72.98 -23.64 60.67 Favored 'General case' 0 C--O 1.235 0.339 0 C-N-CA 124.696 1.198 . . . . 0.0 112.036 179.145 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 22.8 m-30 -112.48 -16.33 12.9 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 126.407 1.883 . . . . 0.0 112.402 -172.184 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.285 0 C-N-CA 124.779 1.232 . . . . 0.0 110.123 175.071 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.499 2.015 0 CA-C-O 119.403 -0.332 . . . . 0.0 111.11 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 11.3 t30 -127.29 151.1 49.18 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-N 119.167 0.894 . . . . 0.0 110.523 -177.815 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 17.5 mtt -117.4 130.41 56.47 Favored 'General case' 0 N--CA 1.461 0.11 0 C-N-CA 124.228 1.011 . . . . 0.0 110.958 -177.873 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . 0.409 ' HA3' ' CD2' ' A' ' 46' ' ' TYR . . . -86.88 154.76 27.04 Favored Glycine 0 CA--C 1.522 0.51 0 N-CA-C 107.77 -2.132 . . . . 0.0 107.77 166.541 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 3.0 tt -141.24 99.49 3.59 Favored 'General case' 0 N--CA 1.464 0.244 0 N-CA-C 105.612 -1.995 . . . . 0.0 105.612 -176.456 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.756 ' CZ ' HD23 ' A' ' 51' ' ' LEU . 1.2 p90 -106.18 138.43 42.38 Favored 'General case' 0 CA--C 1.521 -0.162 0 CA-C-N 118.017 0.372 . . . . 0.0 111.707 -169.54 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 19.5 p90 -161.03 160.57 30.73 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 125.693 1.597 . . . . 0.0 108.736 -174.053 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -95.06 163.36 24.31 Favored Glycine 0 CA--C 1.53 1.029 0 N-CA-C 110.029 -1.228 . . . . 0.0 110.029 170.136 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 1.5 m -85.06 -30.84 23.76 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 117.766 0.783 . . . . 0.0 112.778 -169.833 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -88.89 165.03 14.89 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.748 1.219 . . . . 0.0 111.607 -171.87 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 23.2 m 66.98 115.45 0.03 OUTLIER 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 126.988 2.115 . . . . 0.0 112.727 179.426 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 42.6 m 51.46 33.78 10.93 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 125.799 1.639 . . . . 0.0 113.513 172.226 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 78.1 m-85 57.67 -64.25 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 128.216 2.606 . . . . 0.0 115.678 -174.794 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 21.3 m 63.15 -23.27 0.06 Allowed 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 127.019 2.128 . . . . 0.0 113.003 -167.957 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -55.59 -38.71 69.77 Favored 'General case' 0 CA--C 1.534 0.333 0 O-C-N 120.565 -1.335 . . . . 0.0 111.478 174.722 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -63.86 -42.24 97.58 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 118.809 0.731 . . . . 0.0 109.454 179.754 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -63.98 -47.02 81.99 Favored 'General case' 0 N--CA 1.463 0.194 0 N-CA-C 109.238 -0.653 . . . . 0.0 109.238 177.734 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -62.46 -47.71 82.83 Favored 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 123.049 0.539 . . . . 0.0 111.45 -176.481 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 33.8 mt-10 -61.73 -42.38 98.88 Favored 'General case' 0 C--O 1.232 0.178 0 C-N-CA 123.415 0.686 . . . . 0.0 110.14 176.377 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 28.7 mtpp -70.98 -39.63 72.38 Favored 'General case' 0 C--O 1.221 -0.434 0 CA-C-O 118.199 -0.905 . . . . 0.0 110.32 -175.885 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 43.7 mt -53.8 -56.04 10.92 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.285 0 CA-C-N 119.805 1.184 . . . . 0.0 109.266 175.781 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.484 ' HG2' HD21 ' A' ' 32' ' ' LEU . 0.0 OUTLIER -65.71 -35.44 80.74 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 118.406 0.548 . . . . 0.0 111.404 -175.82 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -64.31 -41.06 97.02 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.819 0.342 . . . . 0.0 110.944 177.996 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 56.4 mt -76.13 -54.08 14.24 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.47 0 C-N-CA 124.548 1.139 . . . . 0.0 109.84 -172.557 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 65.2 mt -62.63 -47.56 92.33 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.328 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 179.611 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 142.49 121.47 1.66 Allowed Glycine 0 CA--C 1.528 0.847 0 C-N-CA 124.826 1.203 . . . . 0.0 110.526 177.063 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -70.96 -12.72 31.01 Favored 'Trans proline' 0 CA--C 1.537 0.669 0 C-N-CA 122.784 2.323 . . . . 0.0 113.495 -171.027 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -77.17 -18.52 57.74 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 118.904 0.774 . . . . 0.0 111.729 179.802 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -128.71 9.1 5.88 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 124.604 1.162 . . . . 0.0 113.582 -170.639 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 31.4 t -127.93 148.07 32.55 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 N-CA-C 107.511 -1.292 . . . . 0.0 107.511 173.242 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 25.3 m -132.22 131.06 41.77 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 125.574 1.55 . . . . 0.0 108.164 -175.34 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.484 HD21 ' HG2' ' A' ' 22' ' ' ARG . 26.4 mt -77.73 131.46 37.68 Favored 'General case' 0 CA--C 1.521 -0.168 0 N-CA-C 108.107 -1.072 . . . . 0.0 108.107 176.104 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 22.5 t-80 -129.27 52.82 1.93 Allowed 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 124.748 1.219 . . . . 0.0 108.19 -175.552 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 18.7 t-20 -55.12 128.94 36.14 Favored 'General case' 0 CA--C 1.531 0.241 0 N-CA-C 107.834 -1.173 . . . . 0.0 107.834 171.086 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 39.0 mt -75.44 -16.17 60.36 Favored 'General case' 0 C--O 1.234 0.244 0 N-CA-C 114.021 1.119 . . . . 0.0 114.021 -169.009 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 9.0 tptm -77.47 -26.44 51.39 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 118.951 0.796 . . . . 0.0 110.154 169.614 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -88.13 -35.91 17.17 Favored 'General case' 0 C--O 1.236 0.375 0 C-N-CA 124.155 0.982 . . . . 0.0 112.783 -174.067 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 2.5 t0 -142.76 155.22 44.81 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 118.653 0.661 . . . . 0.0 112.673 178.151 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 19.1 m -75.35 158.34 83.79 Favored Pre-proline 0 CA--C 1.544 0.716 0 C-N-CA 125.998 1.719 . . . . 0.0 111.298 -170.525 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_endo -74.43 -25.75 12.79 Favored 'Trans proline' 0 C--N 1.349 0.594 0 C-N-CA 122.245 1.963 . . . . 0.0 113.231 -170.6 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 22.6 mmmt -71.19 -11.34 60.88 Favored 'General case' 0 CA--C 1.54 0.561 0 O-C-N 120.45 -1.406 . . . . 0.0 111.703 -176.368 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -61.85 -28.68 69.66 Favored 'General case' 0 N--CA 1.465 0.282 0 C-N-CA 125.159 1.384 . . . . 0.0 110.265 169.167 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 45.4 mtt -57.48 -27.3 62.39 Favored 'General case' 0 N--CA 1.464 0.275 0 C-N-CA 123.12 0.568 . . . . 0.0 111.865 177.146 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 84.7 mt-10 -66.17 -32.22 73.52 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 118.118 0.417 . . . . 0.0 110.357 -175.621 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 20.8 mt-30 -66.99 -41.63 86.44 Favored 'General case' 0 N--CA 1.464 0.243 0 C-N-CA 123.804 0.841 . . . . 0.0 112.714 -171.22 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . 0.409 ' CD2' ' HA3' ' A' ' 4' ' ' GLY . 15.7 m-85 -72.2 147.05 46.93 Favored 'General case' 0 CA--C 1.522 -0.108 0 C-N-CA 123.5 0.72 . . . . 0.0 110.667 -166.139 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -75.98 -34.47 59.77 Favored 'General case' 0 N--CA 1.467 0.422 0 O-C-N 121.832 -0.542 . . . . 0.0 110.297 176.045 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 6.4 t -113.4 146.76 17.6 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.19 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 172.668 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 48.5 tp -132.24 113.81 13.69 Favored 'General case' 0 N--CA 1.451 -0.424 0 C-N-CA 123.625 0.77 . . . . 0.0 109.06 171.726 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 23.0 mt -89.84 130.33 39.3 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 N-CA-C 106.361 -1.718 . . . . 0.0 106.361 174.982 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.756 HD23 ' CZ ' ' A' ' 6' ' ' PHE . 0.6 OUTLIER -106.01 131.87 52.78 Favored 'General case' 0 C--O 1.232 0.183 0 C-N-CA 125.201 1.4 . . . . 0.0 107.929 172.675 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.587 ' N ' HD22 ' A' ' 51' ' ' LEU . . . -127.46 139.03 10.87 Favored Glycine 0 CA--C 1.524 0.647 0 C-N-CA 124.892 1.234 . . . . 0.0 110.283 169.997 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.611 HD13 ' HB1' ' A' ' 100' ' ' ALA . 6.2 tt -145.47 129.65 8.75 Favored Pre-proline 0 CA--C 1.538 0.511 0 CA-C-N 118.763 1.282 . . . . 0.0 110.584 170.883 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -81.93 84.74 1.82 Allowed 'Trans proline' 0 N--CA 1.456 -0.694 0 C-N-CA 123.099 2.533 . . . . 0.0 110.247 169.748 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 93.1 m -58.33 -39.23 78.9 Favored 'General case' 0 CA--C 1.542 0.665 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 168.198 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 23.4 t90 48.99 -142.59 0.54 Allowed 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 125.75 1.62 . . . . 0.0 109.185 -170.763 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -74.78 -62.58 1.49 Allowed 'General case' 0 C--N 1.332 -0.159 0 C-N-CA 123.725 0.81 . . . . 0.0 109.79 175.68 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 20.3 t80 -140.1 31.84 1.96 Allowed 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 124.106 0.962 . . . . 0.0 109.967 178.771 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -67.7 -40.5 90.12 Favored Glycine 0 CA--C 1.53 1.017 0 N-CA-C 109.036 -1.626 . . . . 0.0 109.036 169.715 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 9.8 tt0 54.73 -144.09 0.7 Allowed 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 124.189 0.996 . . . . 0.0 109.253 -178.357 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.426 ' HA ' HD11 ' A' ' 53' ' ' ILE . 0.9 OUTLIER -83.19 133.98 27.91 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.685 0 C-N-CA 126.663 1.985 . . . . 0.0 108.999 -178.41 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 3.0 mp0 -88.88 156.95 18.61 Favored 'General case' 0 C--O 1.231 0.104 0 C-N-CA 124.622 1.169 . . . . 0.0 108.167 179.446 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -57.41 -40.28 77.94 Favored 'General case' 0 N--CA 1.464 0.249 0 C-N-CA 123.318 0.647 . . . . 0.0 110.45 -179.096 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 80.2 m-20 -58.1 -30.84 66.58 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 124.331 1.053 . . . . 0.0 110.96 -178.439 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' TRP . . . . . 0.67 ' CH2' HD23 ' A' ' 104' ' ' LEU . 1.9 t90 -95.87 -45.29 7.02 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 125.889 1.675 . . . . 0.0 108.297 -170.117 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 24.5 tt0 -63.51 -35.73 81.42 Favored 'General case' 0 N--CA 1.439 -1.011 0 C-N-CA 124.633 1.173 . . . . 0.0 110.347 178.451 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -57.83 -24.16 56.1 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 123.874 0.87 . . . . 0.0 111.759 -178.562 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 34.8 m -116.55 -12.13 11.62 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.345 0 CA-C-O 117.351 -1.309 . . . . 0.0 112.342 177.761 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 26.8 t90 -52.11 -38.71 58.26 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 120.234 1.379 . . . . 0.0 110.568 -176.387 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -65.35 -26.16 67.91 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 125.511 1.524 . . . . 0.0 113.284 177.255 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 25.7 mt-30 -92.58 -19.85 21.51 Favored 'General case' 0 C--N 1.34 0.165 0 C-N-CA 126.086 1.754 . . . . 0.0 112.538 176.836 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 72.6 mt -61.78 -24.14 66.65 Favored 'General case' 0 CA--C 1.532 0.274 0 O-C-N 121.679 -0.638 . . . . 0.0 111.289 -176.31 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -77.31 -27.67 52.99 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 118.074 0.397 . . . . 0.0 111.475 175.738 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -70.29 -33.09 71.14 Favored 'General case' 0 N--CA 1.467 0.379 0 O-C-N 121.424 -0.797 . . . . 0.0 111.381 178.823 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 83.2 mt -50.6 135.61 22.71 Favored 'General case' 0 C--N 1.341 0.2 0 C-N-CA 124.72 1.208 . . . . 0.0 111.935 -170.142 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 4.9 t-20 -74.64 105.39 5.71 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 107.308 -1.368 . . . . 0.0 107.308 168.356 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.448 ' HA ' ' HE2' ' A' ' 80' ' ' LYS . 59.6 mt -123.83 2.13 8.77 Favored 'General case' 0 N--CA 1.467 0.38 0 C-N-CA 124.691 1.196 . . . . 0.0 111.163 -179.622 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 29.6 mp0 -57.24 128.12 35.39 Favored 'General case' 0 N--CA 1.445 -0.681 0 CA-C-O 122.062 0.934 . . . . 0.0 112.287 -166.984 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 70.57 -0.04 28.92 Favored Glycine 0 CA--C 1.537 1.448 0 CA-C-N 113.792 -1.549 . . . . 0.0 115.411 -177.938 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.448 ' HE2' ' HA ' ' A' ' 77' ' ' LEU . 0.0 OUTLIER -77.87 160.01 28.56 Favored 'General case' 0 C--N 1.346 0.426 0 CA-C-N 120.892 2.346 . . . . 0.0 110.277 -175.381 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 1.9 mt -85.91 141.28 14.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 N-CA-C 106.729 -1.582 . . . . 0.0 106.729 178.215 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.409 HG11 HD13 ' A' ' 108' ' ' LEU . 94.2 t -138.42 146.63 26.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 -176.822 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -124.17 145.21 49.45 Favored 'General case' 0 CA--C 1.513 -0.456 0 N-CA-C 104.991 -2.225 . . . . 0.0 104.991 175.444 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 4.9 mp -126.83 141.74 51.74 Favored 'General case' 0 CA--C 1.501 -0.905 0 N-CA-C 107.655 -1.239 . . . . 0.0 107.655 175.007 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 34.4 p90 -153.13 168.71 25.02 Favored 'General case' 0 N--CA 1.441 -0.924 0 N-CA-C 107.236 -1.394 . . . . 0.0 107.236 167.836 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -162.69 171.53 38.53 Favored Glycine 0 N--CA 1.44 -1.042 0 N-CA-C 109.278 -1.529 . . . . 0.0 109.278 169.88 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 6.1 tt -111.08 140.71 45.39 Favored 'General case' 0 N--CA 1.442 -0.845 0 N-CA-C 106.589 -1.634 . . . . 0.0 106.589 173.764 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -136.59 -169.97 11.84 Favored Glycine 0 CA--C 1.526 0.723 0 C-N-CA 125.471 1.51 . . . . 0.0 110.043 -173.98 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 46.0 t0 -148.29 113.61 5.58 Favored 'General case' 0 C--O 1.234 0.252 0 N-CA-C 107.548 -1.278 . . . . 0.0 107.548 169.615 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 5.9 pt20 -82.02 -5.88 58.71 Favored 'General case' 0 CA--C 1.545 0.768 0 N-CA-C 113.726 1.01 . . . . 0.0 113.726 -176.242 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.417 HD23 HG22 ' A' ' 147' ' ' THR . 2.8 tp -114.46 -36.78 4.5 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 126.824 2.05 . . . . 0.0 110.401 -169.699 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -55.85 -40.18 80.05 Favored Glycine 0 CA--C 1.534 1.256 0 C-N-CA 124.027 0.822 . . . . 0.0 112.137 179.43 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 20.6 t80 -155.1 -31.7 0.1 Allowed 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 117.758 0.779 . . . . 0.0 112.001 171.986 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 85.31 -54.26 4.84 Favored Glycine 0 C--N 1.338 0.655 0 C-N-CA 124.124 0.869 . . . . 0.0 110.945 174.183 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 17.5 mt-10 -60.04 -16.88 34.99 Favored 'General case' 0 CA--C 1.542 0.666 0 CA-C-N 118.399 1.1 . . . . 0.0 113.244 -178.578 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' TRP . . . . . . . . . . . . . 33.9 m0 -102.17 9.92 39.78 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 123.97 0.908 . . . . 0.0 112.544 -178.833 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 22.5 t80 -58.56 128.38 36.87 Favored 'General case' 0 C--N 1.343 0.318 0 CA-C-N 119.155 0.888 . . . . 0.0 109.507 -174.514 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 91.1 mt 52.38 25.73 3.67 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 124.201 1.0 . . . . 0.0 113.567 170.129 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -51.31 -48.22 62.38 Favored 'General case' 0 C--O 1.234 0.28 0 C-N-CA 125.284 1.434 . . . . 0.0 110.749 177.796 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . 0.611 ' HB1' HD13 ' A' ' 53' ' ' ILE . . . -72.14 -23.97 61.39 Favored 'General case' 0 CA--C 1.539 0.554 0 O-C-N 121.616 -0.678 . . . . 0.0 112.576 -178.543 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 4.8 tt -65.81 -48.06 72.98 Favored 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 171.352 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -61.18 -33.31 83.8 Favored Glycine 0 CA--C 1.527 0.806 0 N-CA-C 111.164 -0.775 . . . . 0.0 111.164 -179.674 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 4.5 tpp -53.76 -52.05 61.44 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 124.647 1.179 . . . . 0.0 111.225 172.885 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.67 HD23 ' CH2' ' A' ' 65' ' ' TRP . 0.2 OUTLIER -72.83 -33.19 66.02 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-O 118.425 -0.798 . . . . 0.0 110.758 -177.894 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 49.0 t60 -58.69 -50.96 71.97 Favored 'General case' 0 C--O 1.226 -0.161 0 CA-C-N 118.718 0.69 . . . . 0.0 110.604 174.696 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -62.13 -41.88 98.7 Favored 'General case' 0 C--O 1.234 0.258 0 C-N-CA 123.354 0.662 . . . . 0.0 111.585 -176.966 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 23.4 ttmm -59.57 -39.4 83.98 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 123.145 0.578 . . . . 0.0 110.098 173.128 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.409 HD13 HG11 ' A' ' 82' ' ' VAL . 16.5 mt -82.53 -25.33 33.49 Favored 'General case' 0 N--CA 1.455 -0.179 0 CA-C-O 117.584 -1.198 . . . . 0.0 113.71 -170.097 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 18.2 m -58.58 -36.73 74.43 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 120.503 1.501 . . . . 0.0 111.722 -175.785 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 21.1 p -82.15 -8.29 59.65 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 124.251 1.021 . . . . 0.0 111.719 -178.416 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 29.6 mmmt -84.03 -3.27 57.91 Favored 'General case' 0 C--N 1.343 0.284 0 C-N-CA 124.985 1.314 . . . . 0.0 111.365 173.786 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 67.53 33.35 81.12 Favored Glycine 0 CA--C 1.527 0.8 0 CA-C-N 118.698 0.681 . . . . 0.0 112.287 170.048 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 15.6 m -83.09 171.65 1.19 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 C-N-CA 123.593 0.757 . . . . 0.0 110.317 179.913 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 15.5 tptm -98.55 129.5 45.1 Favored 'General case' 0 CA--C 1.513 -0.47 0 N-CA-C 104.904 -2.258 . . . . 0.0 104.904 167.588 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 60.3 m-85 -94.84 124.31 38.81 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 171.457 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 35.3 m -107.26 157.77 7.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 C-N-CA 123.566 0.747 . . . . 0.0 109.257 168.531 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 101.12 -97.31 1.65 Allowed Glycine 0 N--CA 1.447 -0.616 0 C-N-CA 124.885 1.231 . . . . 0.0 111.505 174.16 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 11.3 m-30 61.06 172.89 0.1 Allowed 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 125.004 1.321 . . . . 0.0 110.104 -167.255 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 1.2 t90 -155.46 138.83 10.91 Favored Pre-proline 0 N--CA 1.469 0.485 0 CA-C-O 117.386 -1.292 . . . . 0.0 109.297 -177.029 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -71.72 121.67 7.87 Favored 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 123.413 2.742 . . . . 0.0 111.872 -174.49 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 37.5 p -67.35 -18.72 65.26 Favored 'General case' 0 N--CA 1.47 0.545 0 N-CA-C 114.334 1.235 . . . . 0.0 114.334 179.902 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -58.83 127.37 31.88 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 123.417 0.687 . . . . 0.0 110.92 -168.503 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 90.62 -8.22 80.13 Favored Glycine 0 CA--C 1.535 1.338 0 C-N-CA 125.382 1.468 . . . . 0.0 114.264 176.968 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 8.8 m-85 -90.71 167.89 12.17 Favored 'General case' 0 C--O 1.236 0.381 0 CA-C-N 119.194 1.497 . . . . 0.0 110.745 175.948 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -117.25 134.34 54.91 Favored 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 107.316 -1.365 . . . . 0.0 107.316 169.329 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 23.0 p90 -160.02 -31.72 0.06 Allowed 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 124.111 0.964 . . . . 0.0 112.103 -173.108 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 1.9 m 63.81 -61.04 0.17 Allowed 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 128.08 2.552 . . . . 0.0 116.566 168.132 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 70.4 m -69.04 150.85 97.45 Favored Pre-proline 0 CA--C 1.537 0.469 0 C-N-CA 125.574 1.549 . . . . 0.0 110.965 -177.23 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_endo -81.16 -23.7 5.09 Favored 'Trans proline' 0 C--N 1.35 0.641 0 C-N-CA 122.608 2.205 . . . . 0.0 113.061 -177.257 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 33.4 ttmt -50.53 -46.48 85.07 Favored Pre-proline 0 N--CA 1.475 0.791 0 CA-C-N 119.978 1.263 . . . . 0.0 114.142 -175.598 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -73.82 -1.5 10.89 Favored 'Trans proline' 0 C--N 1.35 0.607 0 C-N-CA 121.856 1.704 . . . . 0.0 114.591 -179.527 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 12.3 m -135.91 153.0 31.55 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 CA-C-N 121.563 1.983 . . . . 0.0 112.377 -168.503 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . 0.718 HG23 HG12 ' A' ' 140' ' ' VAL . 11.8 pt -90.27 167.73 1.62 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.444 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 167.348 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . 57.9 -156.18 0.32 Allowed 'General case' 0 N--CA 1.447 -0.6 0 C-N-CA 124.934 1.294 . . . . 0.0 109.855 169.523 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 23.1 t0 -76.78 59.0 1.51 Allowed 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 125.065 1.346 . . . . 0.0 109.389 170.08 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 62.9 46.03 94.43 Favored Glycine 0 C--N 1.336 0.583 0 C-N-CA 124.826 1.203 . . . . 0.0 112.147 176.079 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 69.2 mm-40 -93.29 -44.44 8.31 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-N 118.208 1.004 . . . . 0.0 112.571 -169.809 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -134.18 142.83 47.56 Favored 'General case' 0 N--CA 1.47 0.556 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 179.883 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 44.9 m-85 -72.11 15.51 0.16 Allowed 'General case' 0 N--CA 1.479 1.007 0 N-CA-C 116.444 2.016 . . . . 0.0 116.444 179.775 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . 0.718 HG12 HG23 ' A' ' 133' ' ' ILE 0.253 1.0 OUTLIER 52.82 8.61 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.549 0.932 0 C-N-CA 127.162 2.185 . . . . 0.0 113.577 -177.245 . . . . . . . . 4 4 . 1 . 019 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 171.69 171.75 37.05 Favored Glycine 0 CA--C 1.528 0.906 0 C-N-CA 126.299 1.904 . . . . 0.0 108.968 -170.433 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -70.03 140.55 52.88 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 118.149 0.975 . . . . 0.0 111.642 -178.254 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -100.36 129.71 46.37 Favored 'General case' 0 N--CA 1.447 -0.587 0 C-N-CA 125.671 1.588 . . . . 0.0 109.995 176.912 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 81.3 mt -124.59 156.45 37.42 Favored 'General case' 0 CA--C 1.533 0.3 0 N-CA-C 106.576 -1.639 . . . . 0.0 106.576 168.406 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -127.29 179.96 5.19 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 124.899 1.279 . . . . 0.0 107.949 173.584 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 3.6 tm-20 -146.29 -49.29 0.21 Allowed 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 124.183 0.993 . . . . 0.0 108.545 176.832 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . 0.417 HG22 HD23 ' A' ' 91' ' ' LEU . 39.0 m -62.64 -44.9 95.1 Favored 'General case' 0 C--O 1.235 0.341 0 C-N-CA 124.727 1.211 . . . . 0.0 111.383 -176.847 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 8.2 m-80 -81.11 -48.99 11.4 Favored 'General case' 0 C--O 1.232 0.171 0 C-N-CA 123.042 0.537 . . . . 0.0 111.004 -167.445 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 16.7 pt20 -159.7 149.79 18.68 Favored 'General case' 0 C--O 1.233 0.214 0 C-N-CA 124.842 1.257 . . . . 0.0 108.145 -178.004 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 46.6 p90 -126.56 -17.3 5.1 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 123.825 0.85 . . . . 0.0 112.391 179.715 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -70.64 -35.29 72.83 Favored 'General case' 0 N--CA 1.466 0.37 0 O-C-N 121.515 -0.741 . . . . 0.0 111.072 -177.111 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -77.27 -11.16 59.79 Favored 'General case' 0 C--N 1.344 0.36 0 CA-C-O 118.553 -0.737 . . . . 0.0 111.902 -179.801 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 28.9 m -60.7 -34.79 74.89 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-N 119.997 1.272 . . . . 0.0 110.368 179.959 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -59.24 -43.46 92.4 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 118.789 0.722 . . . . 0.0 111.2 175.636 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 -68.94 -47.6 65.3 Favored 'General case' 0 C--O 1.233 0.23 0 C-N-CA 124.934 1.294 . . . . 0.0 110.436 -179.625 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 9.6 mpt_? -54.13 -47.56 71.74 Favored 'General case' 0 N--CA 1.463 0.221 0 C-N-CA 124.355 1.062 . . . . 0.0 109.87 176.348 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 43.2 mt -68.52 -52.82 32.53 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.468 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 -179.41 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 71.4 tp60 -50.89 -63.99 0.95 Allowed 'General case' 0 CA--C 1.516 -0.329 0 C-N-CA 124.922 1.289 . . . . 0.0 111.83 -174.801 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 24.1 m -66.61 -32.62 74.07 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 120.615 -0.434 . . . . 0.0 110.965 -169.742 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 160' ' ' TRP . . . . . . . . . . . . . 36.2 t90 -69.93 -44.65 69.18 Favored 'General case' 0 CA--C 1.517 -0.325 0 O-C-N 121.89 -0.506 . . . . 0.0 111.217 177.536 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 67.1 m -59.77 -42.94 94.39 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 122.779 0.432 . . . . 0.0 110.371 178.046 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -62.06 -42.54 99.3 Favored 'General case' 0 C--O 1.227 -0.083 0 CA-C-O 121.031 0.443 . . . . 0.0 110.08 175.812 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 14.2 tt0 -62.78 -52.15 64.32 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-O 118.824 -0.608 . . . . 0.0 110.187 -178.669 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 43.8 pt -63.0 -38.56 82.35 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.321 0 CA-C-O 117.819 -1.086 . . . . 0.0 109.267 -174.724 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -65.31 -33.88 77.03 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 119.435 1.016 . . . . 0.0 110.405 -179.484 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 34.0 m-80 -69.77 -56.91 5.88 Favored 'General case' 0 CA--C 1.517 -0.305 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 175.379 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 9.9 tt0 -64.72 -37.48 87.73 Favored 'General case' 0 N--CA 1.442 -0.86 0 C-N-CA 124.813 1.245 . . . . 0.0 110.887 -168.68 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 168' ' ' MET . . . . . . . . . . . . . 21.4 ptp -66.98 -32.27 73.39 Favored 'General case' 0 CA--C 1.522 -0.098 0 O-C-N 121.66 -0.65 . . . . 0.0 111.295 174.083 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . 0.499 ' HA ' ' CD2' ' A' ' 172' ' ' TYR . . . -76.14 -37.39 58.04 Favored 'General case' 0 N--CA 1.443 -0.793 0 N-CA-C 112.451 0.537 . . . . 0.0 112.451 -178.47 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 -62.38 -35.55 79.53 Favored 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 108.89 -0.782 . . . . 0.0 108.89 174.985 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 63.3 t60 -69.94 -45.31 67.76 Favored 'General case' 0 N--CA 1.446 -0.656 0 C-N-CA 124.592 1.157 . . . . 0.0 111.726 -176.865 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 172' ' ' TYR . . . . . 0.499 ' CD2' ' HA ' ' A' ' 169' ' ' ALA . 0.2 OUTLIER -79.51 -28.97 41.39 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-O 118.935 -0.555 . . . . 0.0 112.21 -174.472 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.286 0 C-N-CA 123.717 0.807 . . . . 0.0 110.794 -179.75 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.498 1.947 0 N-CA-C 111.191 0.071 . . . . 0.0 111.191 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 19.7 p-10 -102.3 163.33 12.3 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 124.503 1.121 . . . . 0.0 111.467 -175.771 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 16.3 mtt -129.3 127.03 40.31 Favored 'General case' 0 N--CA 1.464 0.237 0 C-N-CA 122.89 0.476 . . . . 0.0 110.712 179.1 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -94.29 121.06 6.57 Favored Glycine 0 C--O 1.225 -0.437 0 N-CA-C 107.573 -2.211 . . . . 0.0 107.573 168.904 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 4.1 tt -104.43 111.54 24.23 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 105.468 -2.049 . . . . 0.0 105.468 179.226 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.423 ' CD1' HD11 ' A' ' 35' ' ' LEU . 0.6 OUTLIER -108.32 143.99 36.45 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-O 121.757 0.789 . . . . 0.0 110.434 175.637 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 20.6 p90 -159.31 178.5 9.89 Favored 'General case' 0 N--CA 1.447 -0.62 0 N-CA-C 106.454 -1.684 . . . . 0.0 106.454 176.963 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -156.56 -138.47 2.54 Favored Glycine 0 CA--C 1.521 0.426 0 N-CA-C 105.697 -2.961 . . . . 0.0 105.697 173.951 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 7.2 m 56.23 61.72 2.62 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-O 122.138 0.971 . . . . 0.0 109.524 178.801 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 38.2 m -50.3 142.86 9.45 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 124.037 0.935 . . . . 0.0 110.955 -178.138 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 1.5 m 69.3 -8.07 0.76 Allowed 'General case' 0 CA--C 1.549 0.939 0 C-N-CA 126.689 1.996 . . . . 0.0 114.306 -178.747 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 64.1 m -74.81 165.75 24.73 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 120.554 1.524 . . . . 0.0 110.27 170.702 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 53.8 m-85 -62.27 -12.88 23.03 Favored 'General case' 0 N--CA 1.469 0.499 0 N-CA-C 113.221 0.823 . . . . 0.0 113.221 179.785 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -51.79 -30.75 24.33 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 124.825 1.25 . . . . 0.0 112.028 171.646 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 91.7 mt-10 -63.63 -44.32 94.23 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-N 119.057 0.844 . . . . 0.0 109.845 178.518 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 32.2 mtm -73.64 -31.7 63.64 Favored 'General case' 0 N--CA 1.462 0.126 0 CA-C-O 118.384 -0.817 . . . . 0.0 110.687 177.701 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -59.28 -48.21 82.46 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 119.618 1.099 . . . . 0.0 110.125 170.575 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -62.99 -46.44 87.69 Favored 'General case' 0 N--CA 1.455 -0.195 0 C-N-CA 123.273 0.629 . . . . 0.0 111.204 -177.11 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 50.3 mm-40 -55.01 -52.41 63.23 Favored 'General case' 0 C--O 1.23 0.043 0 C-N-CA 123.169 0.588 . . . . 0.0 109.706 173.008 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 57.8 mttm -64.21 -42.16 96.73 Favored 'General case' 0 C--O 1.222 -0.344 0 CA-C-O 118.889 -0.577 . . . . 0.0 110.704 -171.433 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 48.3 mt -55.81 -56.61 11.55 Favored 'Isoleucine or valine' 0 C--O 1.233 0.211 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 178.4 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 19.1 ptt180 -63.4 -38.01 89.48 Favored 'General case' 0 C--O 1.221 -0.416 0 CA-C-O 118.884 -0.579 . . . . 0.0 110.251 -177.12 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -66.02 -38.45 88.44 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.208 0.528 . . . . 0.0 109.956 -173.41 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.472 HD13 ' HA ' ' A' ' 158' ' ' GLN . 77.9 mt -80.6 -53.67 12.12 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.516 0 C-N-CA 125.195 1.398 . . . . 0.0 110.165 -173.186 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 76.4 mt -62.67 -47.82 91.11 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 N-CA-C 109.511 -0.551 . . . . 0.0 109.511 178.579 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 140.91 120.45 1.68 Allowed Glycine 0 CA--C 1.529 0.937 0 C-N-CA 125.273 1.416 . . . . 0.0 110.755 177.051 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 82.1 Cg_endo -73.78 -4.09 14.84 Favored 'Trans proline' 0 CA--C 1.541 0.832 0 C-N-CA 123.078 2.519 . . . . 0.0 113.228 -173.12 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -82.36 -21.63 35.85 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 118.841 0.746 . . . . 0.0 111.54 176.593 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -120.97 -12.91 8.68 Favored 'General case' 0 C--N 1.344 0.33 0 C-N-CA 124.927 1.291 . . . . 0.0 113.436 -175.774 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 60.0 t -100.07 145.36 10.92 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 N-CA-C 107.29 -1.374 . . . . 0.0 107.29 169.136 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 6.0 m -134.48 139.29 45.37 Favored 'General case' 0 N--CA 1.463 0.209 0 C-N-CA 125.105 1.362 . . . . 0.0 107.493 -178.2 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 34.7 mt -93.42 145.05 24.77 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 118.888 0.767 . . . . 0.0 110.033 -179.826 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 12.4 m-70 -112.19 130.74 55.81 Favored 'General case' 0 C--O 1.234 0.286 0 N-CA-C 106.454 -1.684 . . . . 0.0 106.454 168.051 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 35.5 t-20 -105.8 100.14 9.71 Favored 'General case' 0 CA--C 1.521 -0.168 0 N-CA-C 106.117 -1.808 . . . . 0.0 106.117 169.014 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.423 HD11 ' CD1' ' A' ' 6' ' ' PHE . 83.5 mt -70.07 -8.8 52.37 Favored 'General case' 0 N--CA 1.466 0.368 0 N-CA-C 113.414 0.894 . . . . 0.0 113.414 -169.935 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 24.5 tptt -62.41 -23.57 66.91 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 118.662 0.664 . . . . 0.0 110.684 168.261 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -129.81 -39.85 1.4 Allowed 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 124.584 1.153 . . . . 0.0 113.171 -173.87 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 41.4 m-20 -75.89 130.94 39.28 Favored 'General case' 0 C--O 1.235 0.302 0 C-N-CA 123.829 0.852 . . . . 0.0 108.727 178.708 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 15.6 m -74.31 149.22 86.69 Favored Pre-proline 0 CA--C 1.54 0.581 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 173.652 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -71.91 -22.12 23.71 Favored 'Trans proline' 0 CA--C 1.532 0.382 0 C-N-CA 121.802 1.668 . . . . 0.0 112.818 -172.961 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 11.9 mptt -56.21 -23.77 37.71 Favored 'General case' 0 N--CA 1.47 0.541 0 O-C-N 120.963 -1.085 . . . . 0.0 112.342 175.074 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -58.45 -34.15 70.53 Favored 'General case' 0 N--CA 1.465 0.314 0 C-N-CA 124.351 1.06 . . . . 0.0 110.69 175.811 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 61.3 mtt -60.02 -26.13 65.84 Favored 'General case' 0 N--CA 1.465 0.297 0 C-N-CA 124.622 1.169 . . . . 0.0 111.967 178.962 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 68.3 mt-10 -61.79 -33.46 74.15 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 118.729 0.695 . . . . 0.0 109.505 -178.466 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 30.8 mt-30 -69.11 -28.33 66.39 Favored 'General case' 0 CA--C 1.536 0.422 0 N-CA-C 113.749 1.018 . . . . 0.0 113.749 -172.189 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 76.5 m-85 -85.08 138.05 32.66 Favored 'General case' 0 N--CA 1.464 0.243 0 C-N-CA 122.991 0.516 . . . . 0.0 110.14 -167.762 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -71.14 -43.13 68.2 Favored 'General case' 0 C--O 1.233 0.237 0 CA-C-N 118.01 0.368 . . . . 0.0 110.45 -178.502 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 11.8 t -105.16 144.95 14.07 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.404 0 N-CA-C 107.101 -1.444 . . . . 0.0 107.101 169.668 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 19.1 tp -122.78 146.34 47.61 Favored 'General case' 0 N--CA 1.447 -0.618 0 N-CA-C 107.398 -1.334 . . . . 0.0 107.398 169.213 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 41.2 mt -128.05 130.0 69.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 N-CA-C 105.5 -2.037 . . . . 0.0 105.5 178.979 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 2.1 mp -114.35 131.06 56.68 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 125.729 1.612 . . . . 0.0 107.839 -172.17 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.438 ' HA3' ' CZ ' ' A' ' 85' ' ' TYR . . . -139.19 134.61 6.82 Favored Glycine 0 C--N 1.332 0.341 0 CA-C-O 118.855 -0.969 . . . . 0.0 111.544 177.902 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.454 HD13 ' HB1' ' A' ' 100' ' ' ALA . 5.5 tt -155.93 137.55 9.67 Favored Pre-proline 0 CA--C 1.533 0.3 0 CA-C-N 118.252 1.026 . . . . 0.0 111.246 177.954 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_endo -84.36 130.34 4.59 Favored 'Trans proline' 0 N--CA 1.453 -0.904 0 C-N-CA 122.383 2.055 . . . . 0.0 107.187 164.881 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 61.6 m -86.51 143.21 27.84 Favored 'General case' 0 CA--C 1.538 0.482 0 N-CA-C 107.843 -1.169 . . . . 0.0 107.843 170.895 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 14.1 t90 -147.81 125.43 11.78 Favored 'General case' 0 C--N 1.334 -0.068 0 N-CA-C 105.375 -2.083 . . . . 0.0 105.375 172.71 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -68.23 -43.9 76.92 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 118.801 0.728 . . . . 0.0 112.141 -170.126 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 79.6 t80 -69.09 -47.67 64.61 Favored 'General case' 0 C--O 1.236 0.352 0 C-N-CA 121.24 -0.184 . . . . 0.0 110.7 -170.866 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -83.99 -21.9 56.32 Favored Glycine 0 CA--C 1.532 1.132 0 CA-C-O 118.752 -1.027 . . . . 0.0 113.046 -178.415 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 57.8 -179.03 0.06 Allowed 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 125.455 1.502 . . . . 0.0 110.408 -167.658 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 11.7 mt -29.46 123.35 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.626 0 C-N-CA 126.668 1.987 . . . . 0.0 110.674 168.855 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 3.8 mp0 -69.64 155.93 39.74 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 124.829 1.252 . . . . 0.0 109.747 -174.455 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -51.3 -46.12 62.41 Favored 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 124.664 1.186 . . . . 0.0 111.155 -173.019 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 -60.19 -27.77 67.41 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 123.624 0.769 . . . . 0.0 110.734 -170.568 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' TRP . . . . . 0.646 ' CH2' HD23 ' A' ' 104' ' ' LEU . 0.1 OUTLIER -96.04 -46.92 6.3 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 126.192 1.797 . . . . 0.0 109.054 -178.579 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 14.6 tt0 -62.81 -34.05 76.48 Favored 'General case' 0 N--CA 1.445 -0.723 0 C-N-CA 125.165 1.386 . . . . 0.0 110.437 -175.187 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -57.37 -23.9 52.0 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 124.606 1.162 . . . . 0.0 111.999 -179.065 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 17.7 m -121.4 -11.12 9.09 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.225 0 C-N-CA 124.882 1.273 . . . . 0.0 112.348 179.879 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 48.5 t90 -55.39 -36.57 66.54 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 124.362 1.065 . . . . 0.0 110.674 -178.437 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -63.52 -27.9 69.58 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 125.403 1.481 . . . . 0.0 112.949 176.183 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 41.9 mt-30 -91.73 -20.97 20.99 Favored 'General case' 0 CA--C 1.519 -0.239 0 C-N-CA 125.186 1.394 . . . . 0.0 112.506 179.998 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 76.1 mt -59.45 -27.47 66.11 Favored 'General case' 0 N--CA 1.467 0.391 0 O-C-N 121.538 -0.726 . . . . 0.0 111.294 178.589 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -76.94 -25.75 53.23 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 122.529 0.331 . . . . 0.0 111.316 173.974 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -77.47 -27.14 51.93 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 124.645 1.178 . . . . 0.0 112.335 -179.467 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 36.3 mt -61.8 147.46 46.34 Favored 'General case' 0 C--N 1.34 0.173 0 C-N-CA 124.296 1.039 . . . . 0.0 111.434 -178.079 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 24.4 t-20 -88.15 122.23 31.48 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 108.111 -1.07 . . . . 0.0 108.111 168.437 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 80.6 mt -130.92 9.33 4.9 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 123.577 0.751 . . . . 0.0 112.518 -170.054 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 26.8 mt-10 -52.42 127.92 23.97 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 124.055 0.942 . . . . 0.0 112.382 -168.064 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 69.35 -0.73 15.8 Favored Glycine 0 CA--C 1.534 1.22 0 C-N-CA 125.473 1.511 . . . . 0.0 115.721 176.659 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.82 149.33 39.68 Favored 'General case' 0 C--N 1.345 0.401 0 CA-C-N 120.551 2.176 . . . . 0.0 109.871 -173.29 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 4.5 mt -80.17 137.14 22.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 N-CA-C 106.923 -1.51 . . . . 0.0 106.923 177.769 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 55.6 t -131.47 124.17 54.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 C-N-CA 124.522 1.129 . . . . 0.0 109.734 -176.882 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -94.34 149.93 20.77 Favored 'General case' 0 CA--C 1.52 -0.186 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 167.147 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 8.4 mt -129.16 129.92 45.72 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 107.521 -1.288 . . . . 0.0 107.521 176.736 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.438 ' CZ ' ' HA3' ' A' ' 52' ' ' GLY . 39.9 p90 -142.94 165.82 26.31 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 107.566 -1.272 . . . . 0.0 107.566 167.712 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -166.68 168.81 40.37 Favored Glycine 0 N--CA 1.442 -0.944 0 N-CA-C 110.147 -1.181 . . . . 0.0 110.147 173.517 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 1.1 mp -115.73 157.17 24.69 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 124.952 1.301 . . . . 0.0 108.925 177.249 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -167.44 -161.26 16.43 Favored Glycine 0 CA--C 1.525 0.7 0 N-CA-C 109.414 -1.475 . . . . 0.0 109.414 174.121 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . 0.408 ' CG ' ' H ' ' A' ' 92' ' ' GLY . 60.0 t0 -147.66 114.54 6.11 Favored 'General case' 0 C--O 1.234 0.252 0 N-CA-C 107.121 -1.437 . . . . 0.0 107.121 174.92 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 5.6 pt20 -81.61 -7.89 59.64 Favored 'General case' 0 CA--C 1.541 0.628 0 N-CA-C 112.954 0.724 . . . . 0.0 112.954 -177.603 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 49.1 mt -91.66 -49.86 6.06 Favored 'General case' 0 N--CA 1.465 0.285 0 C-N-CA 124.448 1.099 . . . . 0.0 108.355 171.643 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . 0.408 ' H ' ' CG ' ' A' ' 89' ' ' ASP . . . -71.22 -44.93 51.81 Favored Glycine 0 CA--C 1.524 0.601 0 C-N-CA 124.575 1.083 . . . . 0.0 112.119 -174.604 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 5.5 m-85 -105.33 -78.19 0.57 Allowed 'General case' 0 C--N 1.339 0.14 0 N-CA-C 107.665 -1.235 . . . . 0.0 107.665 -178.55 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 78.06 -51.6 3.55 Favored Glycine 0 CA--C 1.526 0.751 0 C-N-CA 125.658 1.599 . . . . 0.0 111.593 173.323 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -67.18 -28.27 67.96 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 123.511 0.724 . . . . 0.0 110.675 173.917 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' TRP . . . . . . . . . . . . . 4.2 m-90 -122.18 27.6 7.91 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 125.16 1.384 . . . . 0.0 111.24 -169.858 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 14.2 t80 -60.36 131.05 49.56 Favored 'General case' 0 N--CA 1.462 0.162 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 -178.801 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 94.6 mt 52.59 24.98 3.37 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 124.253 1.021 . . . . 0.0 113.358 172.206 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -63.9 -34.77 78.71 Favored 'General case' 0 C--N 1.333 -0.134 0 O-C-N 120.746 -1.221 . . . . 0.0 110.741 -170.937 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . 0.454 ' HB1' HD13 ' A' ' 53' ' ' ILE . . . -73.89 -26.34 60.49 Favored 'General case' 0 N--CA 1.453 -0.302 0 O-C-N 121.485 -0.76 . . . . 0.0 112.619 176.36 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 5.2 tt -62.22 -44.86 95.61 Favored 'General case' 0 N--CA 1.466 0.36 0 N-CA-C 107.124 -1.435 . . . . 0.0 107.124 169.126 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -64.78 -40.63 97.51 Favored Glycine 0 C--N 1.34 0.803 0 N-CA-C 111.136 -0.786 . . . . 0.0 111.136 -179.02 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 75.0 mtm -62.7 -41.13 98.98 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 118.072 0.936 . . . . 0.0 111.318 177.344 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.646 HD23 ' CH2' ' A' ' 65' ' ' TRP . 0.1 OUTLIER -68.09 -40.21 82.68 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 120.164 1.347 . . . . 0.0 110.485 178.594 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 82.3 t60 -55.98 -51.92 66.01 Favored 'General case' 0 CA--C 1.528 0.112 0 N-CA-C 110.062 -0.348 . . . . 0.0 110.062 175.035 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -64.32 -39.94 94.92 Favored 'General case' 0 C--O 1.235 0.339 0 C-N-CA 123.967 0.907 . . . . 0.0 112.584 -176.102 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 22.3 ttmm -54.85 -39.05 68.22 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 123.794 0.838 . . . . 0.0 109.775 171.567 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 21.8 mt -90.6 -18.78 24.58 Favored 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 114.603 1.334 . . . . 0.0 114.603 -169.379 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 2.5 m -58.86 -33.46 70.49 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 120.561 1.528 . . . . 0.0 111.688 -175.75 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 19.5 p -86.56 -11.94 50.12 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 124.754 1.221 . . . . 0.0 111.999 -179.318 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 32.1 mmmt -82.12 -10.14 59.29 Favored 'General case' 0 C--N 1.344 0.342 0 C-N-CA 124.314 1.046 . . . . 0.0 111.414 176.37 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 73.65 32.99 58.74 Favored Glycine 0 CA--C 1.526 0.723 0 CA-C-O 119.524 -0.598 . . . . 0.0 112.102 173.153 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 17.2 m -75.19 177.54 0.57 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.613 0 CA-C-N 118.193 0.997 . . . . 0.0 109.853 171.224 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -118.91 120.25 36.74 Favored 'General case' 0 CA--C 1.518 -0.274 0 N-CA-C 106.939 -1.504 . . . . 0.0 106.939 174.373 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 76.9 m-85 -87.83 144.67 26.47 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 119.696 1.135 . . . . 0.0 110.231 -175.323 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 35.9 m -134.34 159.68 41.92 Favored 'Isoleucine or valine' 0 C--O 1.234 0.254 0 C-N-CA 125.343 1.457 . . . . 0.0 107.936 169.865 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 85.54 30.62 23.91 Favored Glycine 0 CA--C 1.522 0.513 0 CA-C-O 118.75 -1.028 . . . . 0.0 114.262 170.872 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 13.0 m-30 -62.06 157.01 19.9 Favored 'General case' 0 CA--C 1.545 0.757 0 CA-C-N 119.036 1.418 . . . . 0.0 109.691 169.09 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' TRP . . . . . 0.42 ' HA ' ' HD3' ' A' ' 120' ' ' PRO . 2.5 t90 -135.98 144.26 47.65 Favored Pre-proline 0 N--CA 1.474 0.772 0 CA-C-O 117.712 -1.137 . . . . 0.0 111.849 -168.915 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . 0.42 ' HD3' ' HA ' ' A' ' 119' ' ' TRP . 36.2 Cg_exo -66.96 123.0 10.41 Favored 'Trans proline' 0 C--N 1.352 0.761 0 C-N-CA 123.552 2.835 . . . . 0.0 113.144 -176.647 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 3.3 p -77.25 -15.27 59.53 Favored 'General case' 0 N--CA 1.468 0.43 0 N-CA-C 113.847 1.055 . . . . 0.0 113.847 179.341 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -62.33 127.51 31.68 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 118.556 0.616 . . . . 0.0 109.58 -171.475 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 87.01 -7.77 79.13 Favored Glycine 0 CA--C 1.534 1.252 0 C-N-CA 124.888 1.232 . . . . 0.0 114.325 178.448 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 4.9 m-85 -88.76 153.82 20.78 Favored 'General case' 0 C--O 1.237 0.396 0 CA-C-N 119.507 1.654 . . . . 0.0 110.141 172.265 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -105.36 130.94 53.36 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 124.488 1.115 . . . . 0.0 108.181 171.849 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 36.8 p90 -162.84 134.84 5.28 Favored 'General case' 0 CA--C 1.534 0.329 0 N-CA-C 106.135 -1.802 . . . . 0.0 106.135 175.316 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 2.5 m -92.33 -53.45 4.22 Favored 'General case' 0 N--CA 1.45 -0.453 0 O-C-N 121.631 -0.668 . . . . 0.0 111.496 -176.236 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 43.5 m -76.45 149.4 81.41 Favored Pre-proline 0 CA--C 1.543 0.696 0 C-N-CA 123.617 0.767 . . . . 0.0 111.227 -173.698 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 82.1 Cg_endo -84.84 -10.08 8.5 Favored 'Trans proline' 0 CA--C 1.541 0.842 0 C-N-CA 122.905 2.403 . . . . 0.0 113.903 -176.412 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 24.8 ttmt -53.04 -42.27 89.91 Favored Pre-proline 0 N--CA 1.475 0.803 0 N-CA-C 114.845 1.424 . . . . 0.0 114.845 -174.134 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_endo -78.92 -1.04 11.26 Favored 'Trans proline' 0 CA--C 1.539 0.761 0 CA-C-N 122.25 1.839 . . . . 0.0 113.999 179.992 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 18.5 m -127.37 170.58 17.02 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.22 0 CA-C-N 119.875 1.216 . . . . 0.0 110.96 -171.307 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 4.9 pt -128.8 169.29 20.42 Favored 'Isoleucine or valine' 0 C--O 1.241 0.64 0 C-N-CA 127.664 2.386 . . . . 0.0 107.86 175.579 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . 56.41 -156.37 0.28 Allowed 'General case' 0 N--CA 1.446 -0.652 0 C-N-CA 124.622 1.169 . . . . 0.0 108.37 -175.924 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 24.8 t0 -78.51 52.47 1.17 Allowed 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 124.481 1.113 . . . . 0.0 110.833 174.894 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 67.19 26.67 73.4 Favored Glycine 0 CA--C 1.531 1.069 0 C-N-CA 124.657 1.123 . . . . 0.0 112.677 -175.495 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 36.8 mt-30 -88.56 -11.41 45.71 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 118.579 1.19 . . . . 0.0 112.533 -170.128 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 8.5 tp -155.71 143.28 19.54 Favored 'General case' 0 C--N 1.343 0.319 0 CA-C-N 119.255 0.934 . . . . 0.0 110.578 175.671 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 67.9 m-85 -78.4 144.92 35.48 Favored 'General case' 0 CA--C 1.516 -0.365 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 169.771 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 17.0 m -76.56 4.63 1.11 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.732 0 C-N-CA 122.773 0.429 . . . . 0.0 111.959 176.615 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -172.86 172.92 45.38 Favored Glycine 0 CA--C 1.527 0.8 0 O-C-N 120.753 -1.217 . . . . 0.0 110.6 -179.173 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 3.6 tp -62.6 131.78 50.19 Favored 'General case' 0 N--CA 1.464 0.246 0 C-N-CA 124.143 0.977 . . . . 0.0 110.942 179.638 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -91.18 129.08 37.21 Favored 'General case' 0 N--CA 1.444 -0.742 0 C-N-CA 126.288 1.835 . . . . 0.0 109.572 176.811 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 32.4 mt -130.32 144.25 51.26 Favored 'General case' 0 C--O 1.231 0.116 0 N-CA-C 105.926 -1.879 . . . . 0.0 105.926 172.152 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -130.93 130.16 43.11 Favored 'General case' 0 N--CA 1.453 -0.281 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 -179.518 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -90.65 -4.6 56.67 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 124.144 0.977 . . . . 0.0 112.957 -169.871 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 90.0 m -125.37 -44.83 1.84 Allowed 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 124.526 1.13 . . . . 0.0 111.13 -172.743 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 4.9 m-80 -77.88 -29.52 50.31 Favored 'General case' 0 C--N 1.331 -0.197 0 C-N-CA 124.331 1.052 . . . . 0.0 110.871 -172.203 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 76.8 mt-30 -128.42 157.16 41.85 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 125.313 1.445 . . . . 0.0 109.196 -178.329 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 86.8 t80 -152.22 -51.66 0.11 Allowed 'General case' 0 CA--C 1.529 0.164 0 C-N-CA 124.216 1.007 . . . . 0.0 108.752 171.325 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -64.31 -48.8 74.26 Favored 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 122.956 0.503 . . . . 0.0 111.454 -174.823 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . 0.275 0.6 OUTLIER -95.7 6.23 49.44 Favored 'General case' 0 C--N 1.341 0.231 0 N-CA-C 112.971 0.73 . . . . 0.0 112.971 -178.699 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 14.9 m -60.45 -36.02 77.23 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 120.02 1.282 . . . . 0.0 109.299 169.237 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -56.27 -44.22 79.56 Favored 'General case' 0 N--CA 1.464 0.27 0 C-N-CA 124.438 1.095 . . . . 0.0 110.904 169.818 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -65.25 -44.56 87.74 Favored 'General case' 0 C--O 1.234 0.252 0 C-N-CA 124.605 1.162 . . . . 0.0 110.882 -178.718 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 5.9 mmt180 -58.32 -41.36 84.37 Favored 'General case' 0 N--CA 1.462 0.153 0 CA-C-O 118.765 -0.636 . . . . 0.0 109.887 177.944 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 42.0 mt -67.98 -53.97 26.04 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.236 0 N-CA-C 108.228 -1.027 . . . . 0.0 108.228 176.811 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 158' ' ' GLN . . . . . 0.472 ' HA ' HD13 ' A' ' 24' ' ' ILE . 0.8 OUTLIER -49.77 -66.25 0.42 Allowed 'General case' 0 CA--C 1.518 -0.267 0 C-N-CA 125.547 1.539 . . . . 0.0 112.067 -172.178 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 14.6 m -60.95 -34.1 74.22 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 115.554 -0.748 . . . . 0.0 111.713 -174.888 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 160' ' ' TRP . . . . . . . . . . . . . 79.2 t90 -65.55 -43.9 88.48 Favored 'General case' 0 C--O 1.222 -0.373 0 O-C-N 121.775 -0.578 . . . . 0.0 111.005 174.411 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 92.5 m -61.01 -41.36 96.38 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 123.159 0.584 . . . . 0.0 110.652 179.721 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -63.09 -41.1 99.33 Favored 'General case' 0 N--CA 1.462 0.15 0 CA-C-O 121.104 0.478 . . . . 0.0 110.791 173.534 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 16.1 tt0 -65.05 -51.22 62.75 Favored 'General case' 0 N--CA 1.446 -0.654 0 O-C-N 121.566 -0.708 . . . . 0.0 110.122 -177.614 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 41.6 pt -63.38 -36.82 77.65 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.403 0 CA-C-O 117.818 -1.087 . . . . 0.0 109.734 -175.863 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -64.35 -36.25 83.52 Favored 'General case' 0 C--O 1.225 -0.187 0 CA-C-N 119.561 1.073 . . . . 0.0 109.611 -179.704 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 41.3 m-80 -68.59 -51.34 43.63 Favored 'General case' 0 N--CA 1.467 0.387 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 175.422 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 22.8 tt0 -72.85 -16.04 61.6 Favored 'General case' 0 N--CA 1.443 -0.802 0 C-N-CA 125.847 1.659 . . . . 0.0 111.937 -169.448 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 168' ' ' MET . . . . . . . . . . . . . 19.5 ptp -90.94 -38.93 12.55 Favored 'General case' 0 N--CA 1.456 -0.162 0 C-N-CA 123.799 0.84 . . . . 0.0 111.544 168.722 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -75.76 -27.04 57.9 Favored 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 122.703 0.401 . . . . 0.0 112.037 -172.927 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -56.79 -26.58 58.07 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 123.672 0.789 . . . . 0.0 112.252 -179.23 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 80.3 m-70 -78.76 -14.96 58.99 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 124.919 1.288 . . . . 0.0 112.843 178.967 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 50.0 m-85 -127.13 -16.76 4.96 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 125.626 1.571 . . . . 0.0 113.694 -168.694 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.254 1.335 0 C-N-CA 124.442 1.097 . . . . 0.0 110.07 173.694 . . . . . . . . 0 0 . 1 stop_ save_